Citrus Sinensis ID: 012170

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430-------440-------450-------460-------47
Protein Sequence
MRKKRKGSETDATEDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF
Secondary Structure (PSIPRED)
cccccccccccccccccccccccccccccccccccccHHHHHccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccEEEccEEcccccEEEEEEEEcccccEEEEEEccccHHHHHHHHHHHHHccccccEEEEEEEEEEcccEEEEEEcccccHHHHHHHHcccccHHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEEccccEEEcccccccccccccccccccccccccccccHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHccccccccccHHHHHcccccccccccccccHHHHHHHHHHHHccccHHHHHHHHHHHHHHcccccccccccccccccccccccHHHHcHHHHHHHHHHHHcccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccccccccccccccccccccccccEccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHcEHHEEcccccccEEEEEEEccccccccHHHHHHHHHHHHHHHHHHHHHcccccEccEEEEEEcccEEEEEEEcccccEHHHHHHHHccccHHHHHHHHHHHHHHHHHHHHccEEcccccHHHEEEcccccEEEccccccEEccccccEccccccHHHccHHHHHHccccHHHHHHHHHHHHHHHccccccccccHHHHHHHHHcccccccccccccccHHHHHHHHHHHcccHHHcccHHHHHcccHHcccccHHHHHccccccccccEEcccccHHHHcHcccccccccccccccccHHHHcccccccccccccccccccccHEEccccccccccccccccccccccEEccccHcHcHHHccc
Coil and Loop (DISEMBL)
mrkkrkgsetdateDELKQGHDSRTSIIRSHYSLEDYSRLKKRCkedagtqpigsfksrlagiatappcgassslvpagrglkrkigcidvhtqmgrknkieddhtkvevighgkfgSVWLCrskasgaeFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHdmgvvhrdikpenillttsgkikladfglamrisngqtlsglagspayvapevlsgnysekvDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARitadevlrhpwilfyTERTLRTLTIKSklknqvgashhhpailsgvesdenkidrgsrndeshalssseslnsesevqdegGFVDALAVAISnvrisepkrsrlcgpsgpieqqcssnlTANALCRAF
Flexible Loop (DISEMBL)
mrkkrkgsetdatedelkqghdsrtsiirshysledysRLKKRCKEdagtqpigsfksRLAGIATAppcgassslvpagrglKRKIGCIDvhtqmgrknkieddhTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSaritadevlrhpwiLFYTERTLRTLTIKSKLknqvgashhhpailsgvesdenKIDRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISnvrisepkrsrlcgpsgpieqqcssnltANALCRAF
Low Complexity Region (SEG)
MRKKRKGSETDATEDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSagvllhallvaalPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDeshalssseslnseseVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF
Disordered region (IsUnstruct)
************************************************************AGIA**********LVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLK****************************************************FVDALAVAISNVR*********************************
Disordered Region (DISOPRED)
**********************************************************************************************MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER*L********L*NQVGASHHHP*I********************************************************PKRSRLCGPS*************NALCRAF
Disordered Region (DISEMBL)
*********************DSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESD*******************************GGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF
Disordered Region (DISPRO)
**************************************************************************************************NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLT*NALCR*F
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
SSSSSSSSSSSSSSSSSSSSSSSSSSSSSSSiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiHHHHHHHHHHHHHHHHoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (Phobius)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MRKKRKGSETDATEDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	469	2.2.26 [Sep-21-2011]
Q8W490	470	Serine/threonine-protein	yes	no	0.991	0.989	0.706	0.0
Q8RWL2	534	Calcium-dependent protein	no	no	0.518	0.455	0.474	6e-67
Q9SJ61	520	Calcium-dependent protein	no	no	0.554	0.5	0.414	3e-64
Q38871	556	Calcium-dependent protein	no	no	0.594	0.501	0.406	7e-64
A5A7I7	557	Calcium-dependent protein	N/A	no	0.601	0.506	0.412	1e-63
P53683	533	Calcium-dependent protein	no	no	0.518	0.455	0.446	2e-63
Q9C6P3	521	Calcium-dependent protein	no	no	0.530	0.477	0.436	5e-63
Q9ZV15	583	Calcium-dependent protein	no	no	0.562	0.452	0.418	7e-63
P28583	508	Calcium-dependent protein	no	no	0.520	0.480	0.456	2e-62
Q38872	544	Calcium-dependent protein	no	no	0.594	0.512	0.4	3e-62

>sp|Q8W490|PEPK2_ARATH Serine/threonine-protein kinase PEPKR2 OS=Arabidopsis thaliana GN=PEPKR2 PE=2 SV=1

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/474 (70%), Positives = 395/474 (83%), Gaps = 9/474 (1%)

Query: 1   MRKKRKGSETDATE---DELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
           MRKKRKGSET+  E   D+L     SR+S  RSH+SLE Y+RLKKRCKE    + +GSFK
Sbjct: 1   MRKKRKGSETEGWENLPDDLSCSTASRSSNFRSHFSLEGYARLKKRCKETEAVESVGSFK 60

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
            R+AG+ATAPPCGASS LV +GRGLKRKIGCIDV TQ GRKNKI+DD+     IG GKFG
Sbjct: 61  RRIAGVATAPPCGASS-LVSSGRGLKRKIGCIDVSTQTGRKNKIDDDYVFGRNIGKGKFG 119

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
           SV +C+S+ +G EFACKTL+KGEETVHREVEIMQHLSGH  VVTLH+VYEE+DCFHLVME
Sbjct: 120 SVRICKSRKNGTEFACKTLKKGEETVHREVEIMQHLSGHPRVVTLHAVYEESDCFHLVME 179

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
           LCSGGRLIDQMV+VG+YSEQRAANIFKD+M VI YCH+MGVVHRDIKPENILLT +GKI+
Sbjct: 180 LCSGGRLIDQMVKVGRYSEQRAANIFKDLMLVINYCHEMGVVHRDIKPENILLTAAGKIQ 239

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
           LADFGLAMRI+ GQTLSGLAGSPAYVAPEVLS NYSEKVD+WSAGVLL+ALL   LPFKG
Sbjct: 240 LADFGLAMRIAKGQTLSGLAGSPAYVAPEVLSENYSEKVDVWSAGVLLYALLSGVLPFKG 299

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           DSL+A+F+AIKNVKLDF++GVWE+VSKPARDL+ARMLTR+ SARITADEVLRHPWILFYT
Sbjct: 300 DSLDAIFEAIKNVKLDFNTGVWESVSKPARDLLARMLTREESARITADEVLRHPWILFYT 359

Query: 358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
           +RTL+T+ IKSK K+Q G+S     + +   +++  ++R  R  +  + S ++S ++  E
Sbjct: 360 DRTLKTMCIKSKHKSQAGSS---TCLQNRSPTEKTDLNRADREKKIPSDSPTDSFSNTEE 416

Query: 418 VQDEGGFVDALAVAISNVRISEPKRSRLCGPS-GPIEQQCSSNLTANA-LCRAF 469
            +DE G VD L VAI+NVRISEPKRSR+C P+  PIEQQ SSNLT+ + LCRAF
Sbjct: 417 EEDESGVVDVLVVAIANVRISEPKRSRVCSPTNNPIEQQHSSNLTSTSTLCRAF 470

Arabidopsis thaliana (taxid: 3702)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: -

>sp|Q8RWL2|CDPKT_ARATH Calcium-dependent protein kinase 29 OS=Arabidopsis thaliana GN=CPK29 PE=2 SV=2

 Score =  255 bits (651), Expect = 6e-67,   Method: Compositional matrix adjust.
 Identities = 120/253 (47%), Positives = 166/253 (65%), Gaps = 10/253 (3%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTLH 163
           +G G+FG  + C  K++G E+ACK++       RK  E V REV I+QHL+G   +V   
Sbjct: 91  LGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRREVMILQHLTGQPNIVEFR 150

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             YE+ D  HLVMELCSGG L D++++ G YSE+ AANIF+ ++ V+  CH MGVVHRD+
Sbjct: 151 GAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQIVNVVHVCHFMGVVHRDL 210

Query: 224 KPENILLTTS---GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPEN LL ++     IK  DFGL++ I  G+    + GS  YVAPEVL  NY +++D+WS
Sbjct: 211 KPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLHRNYGKEIDVWS 270

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
           AGV+L+ LL    PF G++ + +F+AI   KLD  +  W T+S+ A+DL+ +ML RD   
Sbjct: 271 AGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTISESAKDLIRKMLIRDPKK 330

Query: 341 RITADEVLRHPWI 353
           RITA E L HPW+
Sbjct: 331 RITAAEALEHPWM 343

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9SJ61|CDPKP_ARATH Calcium-dependent protein kinase 25 OS=Arabidopsis thaliana GN=CPK25 PE=2 SV=1

 Score =  246 bits (627), Expect = 3e-64,   Method: Compositional matrix adjust.
 Identities = 117/282 (41%), Positives = 178/282 (63%), Gaps = 22/282 (7%)

Query: 82  LKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE- 140
           LK K G +  +  +G K            +GHG+FG+ ++C  K +G E+ACK++ K + 
Sbjct: 121 LKTKTGHLKEYYNLGSK------------LGHGQFGTTFVCVEKGTGEEYACKSIPKRKL 168

Query: 141 ------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY 194
                 E V RE+EIM+HL G   V+++   YE++   H+VMELC GG L D++VE G Y
Sbjct: 169 ENEEDVEDVRREIEIMKHLLGQPNVISIKGAYEDSVAVHMVMELCRGGELFDRIVERGHY 228

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQ 251
           SE++AA++ K ++ V++ CH +GV+HRD+KPEN L     +   +K  DFGL+M +  G+
Sbjct: 229 SERKAAHLAKVILGVVQTCHSLGVMHRDLKPENFLFVNDDEDSPLKAIDFGLSMFLKPGE 288

Query: 252 TLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK 311
             + + GSP Y+APEVL+ NY  + DIWSAGV+++ LL  + PF G++ E +F+ +   +
Sbjct: 289 NFTDVVGSPYYIAPEVLNKNYGPEADIWSAGVMIYVLLSGSAPFWGETEEEIFNEVLEGE 348

Query: 312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           LD  S  W  VS+ A+DL+ +ML R+   R+TA +VL HPWI
Sbjct: 349 LDLTSDPWPQVSESAKDLIRKMLERNPIQRLTAQQVLCHPWI 390

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38871|CDPK5_ARATH Calcium-dependent protein kinase 5 OS=Arabidopsis thaliana GN=CPK5 PE=1 SV=1

 Score =  245 bits (625), Expect = 7e-64,   Method: Compositional matrix adjust.
 Identities = 118/290 (40%), Positives = 179/290 (61%), Gaps = 11/290 (3%)

Query: 75  LVPAGRGLKRKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFAC 133
           ++P    + R+      +  +G K   I D +T    +G G+FG+ +LC   ASG ++AC
Sbjct: 66  VIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLCTEIASGVDYAC 125

Query: 134 KTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID 186
           K++ K +       E V RE++IM HL+GH  +VT+   YE++   H+VMELC+GG L D
Sbjct: 126 KSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIVMELCAGGELFD 185

Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGL 243
           ++++ G YSE++AA + K ++ V++ CH +GV+HRD+KPEN LL        +K  DFGL
Sbjct: 186 RIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 245

Query: 244 AMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAV 303
           ++    GQ  + + GSP YVAPEVL   Y  + D+W+AGV+L+ LL    PF  ++ + +
Sbjct: 246 SVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGVPPFWAETQQGI 305

Query: 304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           FDA+    +DF S  W  +S  A+DL+ RML+   + R+TA EVLRHPWI
Sbjct: 306 FDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVLRHPWI 355

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|A5A7I7|CDPK4_SOLTU Calcium-dependent protein kinase 4 OS=Solanum tuberosum GN=CPK4 PE=2 SV=1

 Score =  244 bits (622), Expect = 1e-63,   Method: Compositional matrix adjust.
 Identities = 121/293 (41%), Positives = 179/293 (61%), Gaps = 11/293 (3%)

Query: 72  SSSLVPAGRGLKRKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAE 130
           S SLV   +    + G    +  MG     I D +T    +G G+FG+ +LC   ++GAE
Sbjct: 60  SLSLVSPRKASMNRSGSNQAYYVMGHMTPNIRDLYTLGRKLGQGQFGTTYLCTENSTGAE 119

Query: 131 FACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR 183
           +ACK++ K +       E V RE++IM HLSGH  +VT+   YE+    H+VME+CSGG 
Sbjct: 120 YACKSISKRKLISKEDVEDVRREIQIMHHLSGHRNIVTIKGAYEDPLYVHIVMEICSGGE 179

Query: 184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLAD 240
           L D++++ G YSE++AA + K ++ V++ CH +GV+HRD+KPEN LL        +K  D
Sbjct: 180 LFDRIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDNDFSLKAID 239

Query: 241 FGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSL 300
           FGL++    GQ  + + GSP YVAPEVL  +Y  + D+W+AGV+L+ LL    PF  ++ 
Sbjct: 240 FGLSVFFKPGQIFTDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQ 299

Query: 301 EAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + +FDA+    +DF S  W  +S+ A+DL+ +ML    S R+TA EVL HPWI
Sbjct: 300 QGIFDAVLKGHIDFDSDPWPLISESAKDLIRKMLCMQPSERLTAHEVLCHPWI 352

Regulates the production of reactive oxygen species (ROS) by NADPH oxidase.

Solanum tuberosum (taxid: 4113)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P53683|CDPK2_ORYSJ Calcium-dependent protein kinase isoform 2 OS=Oryza sativa subsp. japonica GN=CPK2 PE=2 SV=2

 Score =  243 bits (620), Expect = 2e-63,   Method: Compositional matrix adjust.
 Identities = 113/253 (44%), Positives = 166/253 (65%), Gaps = 10/253 (3%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLH 163
           +G G+FG  +LC   ASG ++ACK++ K        +E + RE++IMQHLSG   +V   
Sbjct: 91  LGRGQFGVTYLCTEIASGKQYACKSISKRKLVSKADKEDIRREIQIMQHLSGQQNIVEFR 150

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             YE+    H+VMELC+GG L D+++  G YSE+ AA I + V+ V+  CH MGV+HRD+
Sbjct: 151 GAYEDKSNVHVVMELCAGGELFDRIIAKGHYSERAAATICRAVVNVVNICHFMGVMHRDL 210

Query: 224 KPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPEN LL T   +  +K  DFGL++ I  G+    + GS  YVAPEVL  NY +++D+WS
Sbjct: 211 KPENFLLATKEENAMLKATDFGLSVFIEEGKMYRDIVGSAYYVAPEVLRRNYGKEIDVWS 270

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
           AGV+L+ LL    PF  ++ + +FDAI   ++DF S  W ++S+ A+DL+ +MLT+D   
Sbjct: 271 AGVILYILLSGVPPFWAETEKGIFDAILQGEIDFESQPWPSISESAKDLVRKMLTQDPKK 330

Query: 341 RITADEVLRHPWI 353
           RIT+ +VL+HPW+
Sbjct: 331 RITSAQVLQHPWL 343

May play a role in signal transduction pathways that involve calcium as a second messenger.

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9C6P3|CDPKX_ARATH Calcium-dependent protein kinase 33 OS=Arabidopsis thaliana GN=CPK33 PE=2 SV=1

 Score =  242 bits (617), Expect = 5e-63,   Method: Compositional matrix adjust.
 Identities = 113/259 (43%), Positives = 169/259 (65%), Gaps = 10/259 (3%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHT 157
           +T  + +G G+FG  +LC  K++G  FACK++ K        +E + RE++IMQHLSG  
Sbjct: 73  YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V     YE+    +LVMELC+GG L D+++  G YSE+ AA++ + ++ V+  CH MG
Sbjct: 133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMG 192

Query: 218 VVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE 274
           V+HRD+KPEN LL++  +   IK  DFGL++ I  G+    + GS  YVAPEVL   Y +
Sbjct: 193 VMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGK 252

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           ++DIWSAG++L+ LL    PF  ++ + +FDAI   ++DF S  W ++S  A+DL+ RML
Sbjct: 253 EIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRML 312

Query: 335 TRDVSARITADEVLRHPWI 353
           T+D   RI+A EVL+HPW+
Sbjct: 313 TQDPKRRISAAEVLKHPWL 331

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q9ZV15|CDPKK_ARATH Calcium-dependent protein kinase 20 OS=Arabidopsis thaliana GN=CPK20 PE=2 SV=1

 Score =  241 bits (616), Expect = 7e-63,   Method: Compositional matrix adjust.
 Identities = 115/275 (41%), Positives = 179/275 (65%), Gaps = 11/275 (4%)

Query: 89  IDVHTQMGRKNK-IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------- 140
           + + + +GRK + ++D ++    +G G+FG+ +LC  K +G EFACKT+ K +       
Sbjct: 117 LQIDSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKRKLTTPEDV 176

Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA 200
           E V RE++IM HLSGH  V+ +   YE+A   H+VME+C+GG L D++++ G Y+E++AA
Sbjct: 177 EDVRREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRGHYTEKKAA 236

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLA 257
            + + ++ VI+ CH +GV+HRD+KPEN L  +  +   +K  DFGL++    G+T + + 
Sbjct: 237 ELARIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKPGETFTDVV 296

Query: 258 GSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG 317
           GSP YVAPEVL  +YS + D+WSAGV+++ LL    PF  ++ + +F+ +    LDF S 
Sbjct: 297 GSPYYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLKGDLDFISE 356

Query: 318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
            W +VS+ A+DL+ RML RD   R+T  EVL HPW
Sbjct: 357 PWPSVSESAKDLVRRMLIRDPKKRMTTHEVLCHPW 391

May play a role in signal transduction pathways that involve calcium as a second messenger.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|P28583|CDPK_SOYBN Calcium-dependent protein kinase SK5 OS=Glycine max PE=1 SV=1

 Score =  240 bits (612), Expect = 2e-62,   Method: Compositional matrix adjust.
 Identities = 116/254 (45%), Positives = 164/254 (64%), Gaps = 10/254 (3%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLH 163
           +G G+FG+ + C  +ASG +FACK++ K +       E V RE++IM HLS H  VV + 
Sbjct: 40  LGQGQFGTTFECTRRASGGKFACKSIPKRKLLCKEDYEDVWREIQIMHHLSEHANVVRIE 99

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             YE++   HLVMELC GG L D++V+ G YSE++AA + K ++ V++ CH +GV+HRD+
Sbjct: 100 GTYEDSTAVHLVMELCEGGELFDRIVQKGHYSERQAARLIKTIVEVVEACHSLGVMHRDL 159

Query: 224 KPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPEN L  T     K+K  DFGL++    G++   + GSP YVAPEVL   Y  + D+WS
Sbjct: 160 KPENFLFDTIDEDAKLKATDFGLSVFYKPGESFCDVVGSPYYVAPEVLRKLYGPESDVWS 219

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
           AGV+L+ LL    PF  +S   +F  I   KLDFHS  W ++S  A+DL+ +ML ++   
Sbjct: 220 AGVILYILLSGVPPFWAESEPGIFRQILLGKLDFHSEPWPSISDSAKDLIRKMLDQNPKT 279

Query: 341 RITADEVLRHPWIL 354
           R+TA EVLRHPWI+
Sbjct: 280 RLTAHEVLRHPWIV 293

May play a role in signal transduction pathways that involve calcium as a second messenger.

Glycine max (taxid: 3847)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

>sp|Q38872|CDPK6_ARATH Calcium-dependent protein kinase 6 OS=Arabidopsis thaliana GN=CPK6 PE=1 SV=1

 Score =  239 bits (611), Expect = 3e-62,   Method: Compositional matrix adjust.
 Identities = 116/290 (40%), Positives = 176/290 (60%), Gaps = 11/290 (3%)

Query: 75  LVPAGRGLKRKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFAC 133
           ++P    + R+      +  +G K   I D +T    +G G+FG+ +LC   A+G ++AC
Sbjct: 54  VIPVKEPIMRRNVDNQSYYVLGHKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYAC 113

Query: 134 KTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID 186
           K++ K +       E V RE++IM HL+GH  +VT+   YE+    H+VMELC+GG L D
Sbjct: 114 KSISKRKLISKEDVEDVRREIQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFD 173

Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGL 243
           +++  G YSE++AA + K ++ V++ CH +GV+HRD+KPEN LL        +K  DFGL
Sbjct: 174 RIIHRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 233

Query: 244 AMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAV 303
           ++    GQ    + GSP YVAPEVL  +Y  + D+W+AGV+L+ LL    PF  ++ + +
Sbjct: 234 SVFFKPGQIFKDVVGSPYYVAPEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGI 293

Query: 304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           FDA+    +DF +  W  +S  A+DL+ +ML    S R+TA EVLRHPWI
Sbjct: 294 FDAVLKGYIDFDTDPWPVISDSAKDLIRKMLCSSPSERLTAHEVLRHPWI 343

May play a role in signal transduction pathways that involve calcium as a second messenger. Functions in abscisic acid (ABA) regulation of guard cell S-type anion-and Ca(2+)-permeable channels and stomatal closure.

Arabidopsis thaliana (taxid: 3702)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 1

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	469
224086044	469	predicted protein [Populus trichocarpa]	0.993	0.993	0.777	0.0
449436972	472	PREDICTED: serine/threonine-protein kina	0.993	0.987	0.713	0.0
255545880	490	calcium-dependent protein kinase, putati	0.933	0.893	0.774	0.0
356510139	495	PREDICTED: serine/threonine-protein kina	0.985	0.933	0.729	0.0
359492476	468	PREDICTED: serine/threonine-protein kina	0.978	0.980	0.705	0.0
9502386	1245	T12C24.22 [Arabidopsis thaliana]	0.991	0.373	0.706	0.0
15222045	470	serine/threonine-protein kinase PEPKR2 [	0.991	0.989	0.706	0.0
297849640	470	hypothetical protein ARALYDRAFT_471419 [	0.991	0.989	0.708	0.0
356515756	467	PREDICTED: serine/threonine-protein kina	0.985	0.989	0.710	0.0
302142023	366	unnamed protein product [Vitis vinifera]	0.780	1.0	0.736	1e-160

>gi|224086044|ref|XP_002307792.1| predicted protein [Populus trichocarpa] gi|222857241|gb|EEE94788.1| predicted protein [Populus trichocarpa]

 Score =  749 bits (1935), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 367/472 (77%), Positives = 412/472 (87%), Gaps = 6/472 (1%)

Query: 1   MRKKRKGSETDATED---ELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
           MRKKRKGSE D  E+   E+    D ++S +RSHYSLEDY+RLKKRCKED G +P+ SFK
Sbjct: 1   MRKKRKGSEADTGENAQEEVIPTCDLKSSNVRSHYSLEDYNRLKKRCKEDLGREPVTSFK 60

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
           SRLAGIATAPPCGASSSLV  GRGLKRKIGCIDV TQ GRKNK EDD+   + IG GKFG
Sbjct: 61  SRLAGIATAPPCGASSSLVLPGRGLKRKIGCIDVSTQTGRKNKFEDDYILGDAIGRGKFG 120

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
           SVWLCRSK +G EFACKTL+KGEETVHREVEIMQHLSGH GVVTLH+VYEE++CF LVME
Sbjct: 121 SVWLCRSKVTGVEFACKTLQKGEETVHREVEIMQHLSGHPGVVTLHAVYEESECFQLVME 180

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
           LCSGGRLIDQMV+ G+YSEQRAANIFKDVM VIKYCHDMGVVHRDIKPENILL + GK+K
Sbjct: 181 LCSGGRLIDQMVDEGRYSEQRAANIFKDVMLVIKYCHDMGVVHRDIKPENILLVSLGKMK 240

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
           LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLV  LPF+G
Sbjct: 241 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVGGLPFQG 300

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           DSLEAVF+AIKNVKLDFH+G+W+++SKPARDL+ARMLTRDVSARITADEVLRHPWILFYT
Sbjct: 301 DSLEAVFEAIKNVKLDFHTGIWDSISKPARDLVARMLTRDVSARITADEVLRHPWILFYT 360

Query: 358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
           ERTL+TL+I+SK KNQ  A+   PA  + + S  N++  GS ++E  +   S+SL+ +SE
Sbjct: 361 ERTLKTLSIRSKTKNQGAATSCQPA--NALVSPGNQVGAGS-SEEDLSQHPSDSLSCKSE 417

Query: 418 VQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF 469
            QDE G VDALAVAIS+V+ISEPKRSRLCGP+GPIEQQCSSN+TAN LCRAF
Sbjct: 418 EQDECGLVDALAVAISHVKISEPKRSRLCGPTGPIEQQCSSNITANNLCRAF 469

Source: Populus trichocarpa

Species: Populus trichocarpa

Genus: Populus

Family: Salicaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|449436972|ref|XP_004136266.1| PREDICTED: serine/threonine-protein kinase PEPKR2-like [Cucumis sativus] gi|449497006|ref|XP_004160287.1| PREDICTED: serine/threonine-protein kinase PEPKR2-like [Cucumis sativus]

 Score =  695 bits (1793), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 339/475 (71%), Positives = 396/475 (83%), Gaps = 9/475 (1%)

Query: 1   MRKKRKGSETDAT---EDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
           MRKKRKGSETD     +D + + H+SR+S +++HYSLEDY+RL KRCKED G +P+ S K
Sbjct: 1   MRKKRKGSETDGPLNLQDNVTESHESRSSKLKAHYSLEDYTRLNKRCKEDVGIEPVLSCK 60

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
           SR AGIATAPP G+SS ++P GRGLKRKIGCIDV TQ+GRK+ IE+D+   + IGHGKFG
Sbjct: 61  SRFAGIATAPPSGSSSLILP-GRGLKRKIGCIDVATQIGRKHNIENDYVSGKTIGHGKFG 119

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
           SVWLC+ K SGAE+ACKTL+KGEETVHREVEIMQHLSG+ GVVTL +VYE+++CFHLVME
Sbjct: 120 SVWLCKCKVSGAEYACKTLKKGEETVHREVEIMQHLSGYPGVVTLLAVYEDSECFHLVME 179

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
           LC GGRL++QM   GQYSE RAANI K+VM VIKYCHDMGVVHRDIKPENILLTTSGKIK
Sbjct: 180 LCGGGRLVEQMGSEGQYSEHRAANILKEVMLVIKYCHDMGVVHRDIKPENILLTTSGKIK 239

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
           LADFGLA RIS GQ+L+GLAGSPAYVAPEVL+G YSEKVDIWSAGVLLHALLV  LPF+G
Sbjct: 240 LADFGLATRISYGQSLTGLAGSPAYVAPEVLTGKYSEKVDIWSAGVLLHALLVGTLPFQG 299

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           DSLE+VF+AIKN KLDFHSG+WE++SKPARDL+ RMLTRD+SARITA+EVLRHPWILFYT
Sbjct: 300 DSLESVFEAIKNSKLDFHSGMWESISKPARDLIGRMLTRDISARITAEEVLRHPWILFYT 359

Query: 358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRN---DESHALSSSESLNS 414
           ERTL+ L IK KLKNQ   S     I + ++SD N+ID  +     +E   LSSSES N+
Sbjct: 360 ERTLKALPIKLKLKNQ--ESSQQSPIAAKIKSDRNRIDSAANMTSLNEVSNLSSSESCNA 417

Query: 415 ESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF 469
           + +  D+   VDALA AIS+VRISEPKRSRLC P+GPIEQ  SSN+ AN LC+AF
Sbjct: 418 DGDDVDDCFLVDALATAISHVRISEPKRSRLCVPTGPIEQHSSSNMKANNLCKAF 472

Source: Cucumis sativus

Species: Cucumis sativus

Genus: Cucumis

Family: Cucurbitaceae

Order: Cucurbitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|255545880|ref|XP_002514000.1| calcium-dependent protein kinase, putative [Ricinus communis] gi|223547086|gb|EEF48583.1| calcium-dependent protein kinase, putative [Ricinus communis]

 Score =  692 bits (1785), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 344/444 (77%), Positives = 388/444 (87%), Gaps = 6/444 (1%)

Query: 1   MRKKRKGSETDATED----ELKQGHDSRTSIIRSHYSLEDYSRLKKRCKE--DAGTQPIG 54
           MRKKRKGSET+A +D    E+   HD ++S +RSHYSLEDY+R+KKRCKE  DA  +P+ 
Sbjct: 25  MRKKRKGSETEACQDVLQNEITPRHDVKSSNLRSHYSLEDYNRIKKRCKEEEDACNEPVS 84

Query: 55  SFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHG 114
           SFKSRLAG+ATAPPCGASSSL+  GRGLKRKIGCID  TQ GRKNKIEDD+     IG G
Sbjct: 85  SFKSRLAGVATAPPCGASSSLLLPGRGLKRKIGCIDAATQTGRKNKIEDDYISGATIGRG 144

Query: 115 KFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL 174
           KFGSVWLCRSK++G EFACKTLRKGEETVHREVEIMQHLSGH GVVTLHSVYEE++CFHL
Sbjct: 145 KFGSVWLCRSKSTGVEFACKTLRKGEETVHREVEIMQHLSGHPGVVTLHSVYEESECFHL 204

Query: 175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG 234
           VMELCS GRLIDQMVE GQYSEQRAANIFKDVM VIKYCHDMGVVHRD+KPEN+LL +SG
Sbjct: 205 VMELCSEGRLIDQMVEEGQYSEQRAANIFKDVMSVIKYCHDMGVVHRDVKPENLLLMSSG 264

Query: 235 KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALP 294
           KIKLADFGLAMRISNGQTLSG+AGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLV  LP
Sbjct: 265 KIKLADFGLAMRISNGQTLSGVAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVGVLP 324

Query: 295 FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           F+GDSLEAVF+AIKNVKLDFH+G+WE +SKPARDL++RMLTRDVSARITADEVLRHPWIL
Sbjct: 325 FQGDSLEAVFEAIKNVKLDFHTGIWEGISKPARDLVSRMLTRDVSARITADEVLRHPWIL 384

Query: 355 FYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNS 414
           FYTERTL+TL+IK+KLKNQVG      A    +E + NK + G   ++S+ L+SS+SL+S
Sbjct: 385 FYTERTLKTLSIKTKLKNQVGQVSCQTANAPLLEINGNKSESGPVIEDSNHLASSDSLSS 444

Query: 415 ESEVQDEGGFVDALAVAISNVRIS 438
           +SE QDE GFVDALAVAISN+ ++
Sbjct: 445 KSEEQDECGFVDALAVAISNMYMT 468

Source: Ricinus communis

Species: Ricinus communis

Genus: Ricinus

Family: Euphorbiaceae

Order: Malpighiales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356510139|ref|XP_003523797.1| PREDICTED: serine/threonine-protein kinase PEPKR2-like [Glycine max]

 Score =  690 bits (1781), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 346/474 (72%), Positives = 386/474 (81%), Gaps = 12/474 (2%)

Query: 1   MRKKRKGSETDATEDE---LKQGHDSRTSIIRSHYSLEDYSRLKKRC--KEDAGTQPIGS 55
           MRKKRKGSETD + D    L   H S +S ++SHYSLED  RLKKRC  +ED  T+P  S
Sbjct: 29  MRKKRKGSETDGSADLAVILAPNHGSASSNLKSHYSLEDCCRLKKRCCKEEDVDTEPATS 88

Query: 56  FKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGK 115
           FK RLAGIATAPPCG SS + P GRGLKRKIGCIDV TQMGRK KIEDD+   E IG GK
Sbjct: 89  FKRRLAGIATAPPCGTSSLITP-GRGLKRKIGCIDVATQMGRKKKIEDDYVSGETIGQGK 147

Query: 116 FGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV 175
           FGSVWLCRSK SGAE+ACKTL+KGEETVHREVEIMQHLSGH+GVVTL +VYEEA+CFHLV
Sbjct: 148 FGSVWLCRSKVSGAEYACKTLKKGEETVHREVEIMQHLSGHSGVVTLQAVYEEAECFHLV 207

Query: 176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK 235
           MELCSGGRLID+MVE G YSEQRAAN+ K+VM VIKYCHDMGVVHRDIKPENILLT SGK
Sbjct: 208 MELCSGGRLIDRMVEDGPYSEQRAANVLKEVMLVIKYCHDMGVVHRDIKPENILLTASGK 267

Query: 236 IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPF 295
           IKLADFGLAMRIS GQ L+GLAGSPAYVAPEVL G YSEKVDIWSAGVLLHALLV +LPF
Sbjct: 268 IKLADFGLAMRISEGQNLTGLAGSPAYVAPEVLLGRYSEKVDIWSAGVLLHALLVGSLPF 327

Query: 296 KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF 355
           +GDSLEAVF+AIK VKLDF +G+WE++SKPARDL+ RMLTRD+SARI+ADEVLRHPWILF
Sbjct: 328 QGDSLEAVFEAIKTVKLDFQNGMWESISKPARDLIGRMLTRDISARISADEVLRHPWILF 387

Query: 356 YTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSE 415
           YT  TL+ L IK+K KNQ+GAS      +       N+ID  S  +     SSSES NS+
Sbjct: 388 YTANTLKMLPIKTKFKNQIGASCQQLVAVPEPRLGGNRIDTYSLREG----SSSESCNSD 443

Query: 416 SEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF 469
              QDE   +D LA AIS+VRISEPKRSR+CGP+GPI QQ SSN+  N LC+AF
Sbjct: 444 D--QDECVLIDVLASAISHVRISEPKRSRVCGPTGPIVQQGSSNMKPNNLCKAF 495

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|359492476|ref|XP_002285713.2| PREDICTED: serine/threonine-protein kinase PEPKR2 [Vitis vinifera]

 Score =  684 bits (1764), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/476 (70%), Positives = 393/476 (82%), Gaps = 17/476 (3%)

Query: 1   MRKKRKGSETDATEDE------LKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAG-TQPI 53
           + +KRKGSETD   ++        +   S  S++RSH+SLEDY+RL+K+CKED G  +P+
Sbjct: 3   LMRKRKGSETDTCLNQSGVLSSYPRNSGSDLSVVRSHFSLEDYARLRKKCKEDVGKVEPV 62

Query: 54  GSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGH 113
           GS KSRL G AT PPCG SS LVP+GRGLKRKIGCIDV TQMGRKNKIE+D+   E IG 
Sbjct: 63  GSCKSRLTGAATVPPCGISS-LVPSGRGLKRKIGCIDVATQMGRKNKIENDYALGETIGQ 121

Query: 114 GKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH 173
           GKFGSVWLCRS+ SG EFACKTL+KGEETVHREVEIMQHLSGH G+VTL +VYE+ +CFH
Sbjct: 122 GKFGSVWLCRSRISGVEFACKTLKKGEETVHREVEIMQHLSGHAGIVTLRAVYEDPECFH 181

Query: 174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS 233
           LVMELCSGGRL+DQMVE GQYSE RAANI ++++ VIKYCHDMGVVHRDIKPENILLT +
Sbjct: 182 LVMELCSGGRLVDQMVEEGQYSEHRAANILRELILVIKYCHDMGVVHRDIKPENILLTAA 241

Query: 234 GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAAL 293
           GK+KLADFGLAMR++ GQ+LSGLAGSPAYVAPEVL GNYSEKVDIWSAGVLLHALLV  L
Sbjct: 242 GKLKLADFGLAMRVAKGQSLSGLAGSPAYVAPEVLLGNYSEKVDIWSAGVLLHALLVGML 301

Query: 294 PFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           PF+GDSL+AVF+AIKNVKLDFH+G+WE++SKPARDL+ RMLTRDVSARITA+EVLRHPWI
Sbjct: 302 PFRGDSLQAVFEAIKNVKLDFHTGIWESISKPARDLIERMLTRDVSARITAEEVLRHPWI 361

Query: 354 LFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLN 413
           LF+TERTL TL+IKSK+K+Q  AS           SD  +I  G   D    +S S S +
Sbjct: 362 LFFTERTLNTLSIKSKVKSQQVASEL---------SDRRRIRGGPLGDALGPVSFSGSSS 412

Query: 414 SESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF 469
            +SE QD+ G VDALAVAIS+VRIS+PKRSRLC P+ P++QQCSSN+ AN LC+AF
Sbjct: 413 CKSEDQDDAGLVDALAVAISHVRISKPKRSRLCEPACPVQQQCSSNMKANNLCKAF 468

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|9502386|gb|AAF88093.1|AC025417_21 T12C24.22 [Arabidopsis thaliana]

 Score =  681 bits (1756), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/474 (70%), Positives = 395/474 (83%), Gaps = 9/474 (1%)

Query: 1    MRKKRKGSETDATE---DELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
            MRKKRKGSET+  E   D+L     SR+S  RSH+SLE Y+RLKKRCKE    + +GSFK
Sbjct: 776  MRKKRKGSETEGWENLPDDLSCSTASRSSNFRSHFSLEGYARLKKRCKETEAVESVGSFK 835

Query: 58   SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
             R+AG+ATAPPCGASS LV +GRGLKRKIGCIDV TQ GRKNKI+DD+     IG GKFG
Sbjct: 836  RRIAGVATAPPCGASS-LVSSGRGLKRKIGCIDVSTQTGRKNKIDDDYVFGRNIGKGKFG 894

Query: 118  SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
            SV +C+S+ +G EFACKTL+KGEETVHREVEIMQHLSGH  VVTLH+VYEE+DCFHLVME
Sbjct: 895  SVRICKSRKNGTEFACKTLKKGEETVHREVEIMQHLSGHPRVVTLHAVYEESDCFHLVME 954

Query: 178  LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
            LCSGGRLIDQMV+VG+YSEQRAANIFKD+M VI YCH+MGVVHRDIKPENILLT +GKI+
Sbjct: 955  LCSGGRLIDQMVKVGRYSEQRAANIFKDLMLVINYCHEMGVVHRDIKPENILLTAAGKIQ 1014

Query: 238  LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
            LADFGLAMRI+ GQTLSGLAGSPAYVAPEVLS NYSEKVD+WSAGVLL+ALL   LPFKG
Sbjct: 1015 LADFGLAMRIAKGQTLSGLAGSPAYVAPEVLSENYSEKVDVWSAGVLLYALLSGVLPFKG 1074

Query: 298  DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
            DSL+A+F+AIKNVKLDF++GVWE+VSKPARDL+ARMLTR+ SARITADEVLRHPWILFYT
Sbjct: 1075 DSLDAIFEAIKNVKLDFNTGVWESVSKPARDLLARMLTREESARITADEVLRHPWILFYT 1134

Query: 358  ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
            +RTL+T+ IKSK K+Q G+S     + +   +++  ++R  R  +  + S ++S ++  E
Sbjct: 1135 DRTLKTMCIKSKHKSQAGSS---TCLQNRSPTEKTDLNRADREKKIPSDSPTDSFSNTEE 1191

Query: 418  VQDEGGFVDALAVAISNVRISEPKRSRLCGPS-GPIEQQCSSNLTANA-LCRAF 469
             +DE G VD L VAI+NVRISEPKRSR+C P+  PIEQQ SSNLT+ + LCRAF
Sbjct: 1192 EEDESGVVDVLVVAIANVRISEPKRSRVCSPTNNPIEQQHSSNLTSTSTLCRAF 1245

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|15222045|ref|NP_172728.1| serine/threonine-protein kinase PEPKR2 [Arabidopsis thaliana] gi|75331381|sp|Q8W490.1|PEPK2_ARATH RecName: Full=Serine/threonine-protein kinase PEPKR2; AltName: Full=Protein PHOSPHOENOLPYRUVATE CARBOXYLASE-RELATED KINASE 2 gi|17065356|gb|AAL32832.1| Unknown protein [Arabidopsis thaliana] gi|30387573|gb|AAP31952.1| At1g12680 [Arabidopsis thaliana] gi|332190793|gb|AEE28914.1| serine/threonine-protein kinase PEPKR2 [Arabidopsis thaliana]

 Score =  678 bits (1749), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 335/474 (70%), Positives = 395/474 (83%), Gaps = 9/474 (1%)

Query: 1   MRKKRKGSETDATE---DELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
           MRKKRKGSET+  E   D+L     SR+S  RSH+SLE Y+RLKKRCKE    + +GSFK
Sbjct: 1   MRKKRKGSETEGWENLPDDLSCSTASRSSNFRSHFSLEGYARLKKRCKETEAVESVGSFK 60

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
            R+AG+ATAPPCGASS LV +GRGLKRKIGCIDV TQ GRKNKI+DD+     IG GKFG
Sbjct: 61  RRIAGVATAPPCGASS-LVSSGRGLKRKIGCIDVSTQTGRKNKIDDDYVFGRNIGKGKFG 119

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
           SV +C+S+ +G EFACKTL+KGEETVHREVEIMQHLSGH  VVTLH+VYEE+DCFHLVME
Sbjct: 120 SVRICKSRKNGTEFACKTLKKGEETVHREVEIMQHLSGHPRVVTLHAVYEESDCFHLVME 179

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
           LCSGGRLIDQMV+VG+YSEQRAANIFKD+M VI YCH+MGVVHRDIKPENILLT +GKI+
Sbjct: 180 LCSGGRLIDQMVKVGRYSEQRAANIFKDLMLVINYCHEMGVVHRDIKPENILLTAAGKIQ 239

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
           LADFGLAMRI+ GQTLSGLAGSPAYVAPEVLS NYSEKVD+WSAGVLL+ALL   LPFKG
Sbjct: 240 LADFGLAMRIAKGQTLSGLAGSPAYVAPEVLSENYSEKVDVWSAGVLLYALLSGVLPFKG 299

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           DSL+A+F+AIKNVKLDF++GVWE+VSKPARDL+ARMLTR+ SARITADEVLRHPWILFYT
Sbjct: 300 DSLDAIFEAIKNVKLDFNTGVWESVSKPARDLLARMLTREESARITADEVLRHPWILFYT 359

Query: 358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
           +RTL+T+ IKSK K+Q G+S     + +   +++  ++R  R  +  + S ++S ++  E
Sbjct: 360 DRTLKTMCIKSKHKSQAGSS---TCLQNRSPTEKTDLNRADREKKIPSDSPTDSFSNTEE 416

Query: 418 VQDEGGFVDALAVAISNVRISEPKRSRLCGPS-GPIEQQCSSNLTANA-LCRAF 469
            +DE G VD L VAI+NVRISEPKRSR+C P+  PIEQQ SSNLT+ + LCRAF
Sbjct: 417 EEDESGVVDVLVVAIANVRISEPKRSRVCSPTNNPIEQQHSSNLTSTSTLCRAF 470

Source: Arabidopsis thaliana

Species: Arabidopsis thaliana

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|297849640|ref|XP_002892701.1| hypothetical protein ARALYDRAFT_471419 [Arabidopsis lyrata subsp. lyrata] gi|297338543|gb|EFH68960.1| hypothetical protein ARALYDRAFT_471419 [Arabidopsis lyrata subsp. lyrata]

 Score =  675 bits (1741), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 336/474 (70%), Positives = 393/474 (82%), Gaps = 9/474 (1%)

Query: 1   MRKKRKGSETDATED---ELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
           MRKKRKGSET+  E+   +L     SR+S  RSH+SLE Y+RLKKRCKE    + +GSFK
Sbjct: 1   MRKKRKGSETEGWENLPEDLLCSTASRSSNFRSHFSLEGYARLKKRCKETEAVESVGSFK 60

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
            R+AG+ATAPPCGASS LV +GRGLKRKIGCIDV TQ GRKNKI DD+     IG GKFG
Sbjct: 61  RRIAGVATAPPCGASS-LVSSGRGLKRKIGCIDVSTQTGRKNKIGDDYVFGRNIGKGKFG 119

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
           SV +C+S+ +G EFACKTL+KGEETVHREVEIMQHLSGH  VVTLH+VYEE+D FHLVME
Sbjct: 120 SVRICKSRKNGTEFACKTLKKGEETVHREVEIMQHLSGHPRVVTLHAVYEESDSFHLVME 179

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
           LCSGGRLIDQMV+VG+YSEQRAANIFKD+M VI YCH+MGVVHRDIKPENILLT +GKI+
Sbjct: 180 LCSGGRLIDQMVKVGRYSEQRAANIFKDLMLVINYCHEMGVVHRDIKPENILLTAAGKIQ 239

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKG 297
           LADFGLAMRI+ GQTLSGLAGSPAYVAPEVLS NYSEKVDIWSAGVLL+ALL   LPFKG
Sbjct: 240 LADFGLAMRIAKGQTLSGLAGSPAYVAPEVLSENYSEKVDIWSAGVLLYALLSGVLPFKG 299

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           DSL+A+F+AIKNVKLDF+SGVWE+VSKPARDL+ARMLTR+ SARITADEVLRHPWILFYT
Sbjct: 300 DSLDAIFEAIKNVKLDFNSGVWESVSKPARDLLARMLTREESARITADEVLRHPWILFYT 359

Query: 358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
           +RTL+T+ IKSK K+Q  +    P + +   +++  ++R +R  +  + S ++S ++  E
Sbjct: 360 DRTLKTMCIKSKHKSQAAS---LPCLQNRSPTEKTDLNRANREKKIPSDSPTDSFSNTEE 416

Query: 418 VQDEGGFVDALAVAISNVRISEPKRSRLCGPS-GPIEQQCSSNLTA-NALCRAF 469
            +DE G VD L VAISNVRISEPKRSR+C P+  PIEQQ SSNLT+ N LCRAF
Sbjct: 417 EEDESGVVDVLVVAISNVRISEPKRSRVCSPTNNPIEQQHSSNLTSTNTLCRAF 470

Source: Arabidopsis lyrata subsp. lyrata

Species: Arabidopsis lyrata

Genus: Arabidopsis

Family: Brassicaceae

Order: Brassicales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|356515756|ref|XP_003526564.1| PREDICTED: serine/threonine-protein kinase PEPKR2-like [Glycine max]

 Score =  669 bits (1726), Expect = 0.0,   Method: Compositional matrix adjust.
 Identities = 337/474 (71%), Positives = 383/474 (80%), Gaps = 12/474 (2%)

Query: 1   MRKKRKGSETDATEDE---LKQGHDSRTSIIRSHYSLEDYSRLKKRC--KEDAGTQPIGS 55
           MRKKRKGS+TD + D    L   H S +S ++SHYSLED  RLKKRC  +EDA T+P  S
Sbjct: 1   MRKKRKGSKTDGSADLAVILAPNHGSASSNLKSHYSLEDCCRLKKRCCKEEDADTEPATS 60

Query: 56  FKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGK 115
           F  RLAGIATAPPCG SS + P GRGLKRKIGCIDV TQMGRK KIEDD+   E IG GK
Sbjct: 61  FTRRLAGIATAPPCGTSSLITP-GRGLKRKIGCIDVATQMGRKKKIEDDYVSGETIGQGK 119

Query: 116 FGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV 175
           FGSVWLCRSK SGAE+ACKTL+KGEETVHREVEIMQHLSGH+GVVTL +VYEEA+CFHLV
Sbjct: 120 FGSVWLCRSKVSGAEYACKTLKKGEETVHREVEIMQHLSGHSGVVTLQAVYEEAECFHLV 179

Query: 176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK 235
           MELCSGGRLID MV+ G YSEQR AN+ K+VM VIKYCHDMGVVHRDIKPENILLT SGK
Sbjct: 180 MELCSGGRLIDGMVKDGLYSEQRVANVLKEVMLVIKYCHDMGVVHRDIKPENILLTASGK 239

Query: 236 IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPF 295
           IKLADFGLAMRIS GQ L+GLAGSPAYVAPEVL G YSEKVDIWSAGVLLHALLV +LPF
Sbjct: 240 IKLADFGLAMRISEGQNLTGLAGSPAYVAPEVLLGRYSEKVDIWSAGVLLHALLVGSLPF 299

Query: 296 KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF 355
           +GDSLEAVF+AIK VKLDF +G+W+++SKPA+DL+ RMLTRD+SARI+A+EVLRHPWILF
Sbjct: 300 QGDSLEAVFEAIKTVKLDFQNGMWKSISKPAQDLIGRMLTRDISARISAEEVLRHPWILF 359

Query: 356 YTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSE 415
           YT  TL+ L IK+KLKNQ+GA+         V   E ++  G+R D       S S +  
Sbjct: 360 YTANTLKMLPIKTKLKNQIGATCQQL-----VAVREPRLG-GNRIDNYSLSEGSSSESCY 413

Query: 416 SEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF 469
           S+ QDE   +D LA AIS+VRISEPKRSR+CGP+GPI QQ SSN+  N LC+AF
Sbjct: 414 SDDQDECVLIDVLASAISHVRISEPKRSRVCGPTGPIVQQGSSNMKPNNLCKAF 467

Source: Glycine max

Species: Glycine max

Genus: Glycine

Family: Fabaceae

Order: Fabales

Phylum: Streptophyta

Superkingdom: Eukaryota

>gi|302142023|emb|CBI19226.3| unnamed protein product [Vitis vinifera]

 Score =  569 bits (1467), Expect = e-160,   Method: Compositional matrix adjust.
 Identities = 276/375 (73%), Positives = 319/375 (85%), Gaps = 9/375 (2%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS 154
           MGRKNKIE+D+   E IG GKFGSVWLCRS+ SG EFACKTL+KGEETVHREVEIMQHLS
Sbjct: 1   MGRKNKIENDYALGETIGQGKFGSVWLCRSRISGVEFACKTLKKGEETVHREVEIMQHLS 60

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           GH G+VTL +VYE+ +CFHLVMELCSGGRL+DQMVE GQYSE RAANI ++++ VIKYCH
Sbjct: 61  GHAGIVTLRAVYEDPECFHLVMELCSGGRLVDQMVEEGQYSEHRAANILRELILVIKYCH 120

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE 274
           DMGVVHRDIKPENILLT +GK+KLADFGLAMR++ GQ+LSGLAGSPAYVAPEVL GNYSE
Sbjct: 121 DMGVVHRDIKPENILLTAAGKLKLADFGLAMRVAKGQSLSGLAGSPAYVAPEVLLGNYSE 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           KVDIWSAGVLLHALLV  LPF+GDSL+AVF+AIKNVKLDFH+G+WE++SKPARDL+ RML
Sbjct: 181 KVDIWSAGVLLHALLVGMLPFRGDSLQAVFEAIKNVKLDFHTGIWESISKPARDLIERML 240

Query: 335 TRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKI 394
           TRDVSARITA+EVLRHPWILF+TERTL TL+IKSK+K+Q  AS           SD  +I
Sbjct: 241 TRDVSARITAEEVLRHPWILFFTERTLNTLSIKSKVKSQQVASEL---------SDRRRI 291

Query: 395 DRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQ 454
             G   D    +S S S + +SE QD+ G VDALAVAIS+VRIS+PKRSRLC P+ P++Q
Sbjct: 292 RGGPLGDALGPVSFSGSSSCKSEDQDDAGLVDALAVAISHVRISKPKRSRLCEPACPVQQ 351

Query: 455 QCSSNLTANALCRAF 469
           QCSSN+ AN LC+AF
Sbjct: 352 QCSSNMKANNLCKAF 366

Source: Vitis vinifera

Species: Vitis vinifera

Genus: Vitis

Family: Vitaceae

Order: Vitales

Phylum: Streptophyta

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	469
TAIR|locus:2195037	470	PEPKR2 "phosphoenolpyruvate ca	0.991	0.989	0.681	3.7e-167
TAIR|locus:2034720	522	PEPKR1 "phosphoenolpyruvate ca	0.543	0.488	0.437	4.6e-57
TAIR|locus:2204340	561	CPK29 "calcium-dependent prote	0.518	0.433	0.450	4.6e-57
TAIR|locus:2122063	556	CPK5 "calmodulin-domain protei	0.594	0.501	0.386	1.8e-55
TAIR|locus:2065021	583	CPK20 "calcium-dependent prote	0.577	0.464	0.395	2.9e-55
TAIR|locus:2092399	541	CPK9 "calmodulin-domain protei	0.545	0.473	0.401	1.1e-54
TAIR|locus:2039215	520	CPK25 "calcium-dependent prote	0.518	0.467	0.426	1.3e-54
TAIR|locus:2015846	521	CPK33 "calcium-dependent prote	0.530	0.477	0.420	2.6e-54
TAIR|locus:2827528	544	CPK6 "calcium dependent protei	0.552	0.476	0.4	4.3e-54
TAIR|locus:2150225	523	CPK34 "AT5G19360" [Arabidopsis	0.618	0.554	0.386	4.9e-53

TAIR|locus:2195037 PEPKR2 "phosphoenolpyruvate carboxylase-related kinase 2" [Arabidopsis thaliana (taxid:3702)]

 Score = 1626 (577.4 bits), Expect = 3.7e-167, P = 3.7e-167
 Identities = 323/474 (68%), Positives = 376/474 (79%)

Query:     1 MRKKRKGSETDATE---DELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFK 57
             MRKKRKGSET+  E   D+L     SR+S  RSH+SLE Y+RLKKRCKE    + +GSFK
Sbjct:     1 MRKKRKGSETEGWENLPDDLSCSTASRSSNFRSHFSLEGYARLKKRCKETEAVESVGSFK 60

Query:    58 SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
              R+AG+ATAPPCGASS LV +GRGLKRKIGCIDV TQ GRKNKI+DD+     IG GKFG
Sbjct:    61 RRIAGVATAPPCGASS-LVSSGRGLKRKIGCIDVSTQTGRKNKIDDDYVFGRNIGKGKFG 119

Query:   118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME 177
             SV +C+S+ +G EFACKTL+KGEETVHREVEIMQHLSGH  VVTLH+VYEE+DCFHLVME
Sbjct:   120 SVRICKSRKNGTEFACKTLKKGEETVHREVEIMQHLSGHPRVVTLHAVYEESDCFHLVME 179

Query:   178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK 237
             LCSGGRLIDQMV+VG+YSEQRAANIFKD+M VI YCH+MGVVHRDIKPENILLT +GKI+
Sbjct:   180 LCSGGRLIDQMVKVGRYSEQRAANIFKDLMLVINYCHEMGVVHRDIKPENILLTAAGKIQ 239

Query:   238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKG 297
             LADFGLAMRI+ GQTLSGLAGSPAYVAPEVLS NYSEKVD+WS             PFKG
Sbjct:   240 LADFGLAMRIAKGQTLSGLAGSPAYVAPEVLSENYSEKVDVWSAGVLLYALLSGVLPFKG 299

Query:   298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
             DSL+A+F+AIKNVKLDF++GVWE+VSKPARDL+ARMLTR+ SARITADEVLRHPWILFYT
Sbjct:   300 DSLDAIFEAIKNVKLDFNTGVWESVSKPARDLLARMLTREESARITADEVLRHPWILFYT 359

Query:   358 ERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDXXXXXXXXXXXXXXXX 417
             +RTL+T+ IKSK K+Q G+S     + +   +++  ++R  R                  
Sbjct:   360 DRTLKTMCIKSKHKSQAGSS---TCLQNRSPTEKTDLNRADREKKIPSDSPTDSFSNTEE 416

Query:   418 VQDEGGFVDALAVAISNVRISEPKRSRLCGPSG-PIEQQCSSNLTANA-LCRAF 469
              +DE G VD L VAI+NVRISEPKRSR+C P+  PIEQQ SSNLT+ + LCRAF
Sbjct:   417 EEDESGVVDVLVVAIANVRISEPKRSRVCSPTNNPIEQQHSSNLTSTSTLCRAF 470

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2034720 PEPKR1 "phosphoenolpyruvate carboxylase-related kinase 1" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 4.6e-57, P = 4.6e-57
 Identities = 116/265 (43%), Positives = 164/265 (61%)

Query:    99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQ 151
             + ++D +   E +G G+FG + +C  K +G   ACK++ K         +++  E+ IM 
Sbjct:    38 SNLKDRYVLGEQLGWGQFGVIRVCSDKLTGERLACKSISKDRLVTQDDMKSIKLEIAIMA 97

Query:   152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
              L+GH  VV L +VYEE D  HLVMELC+GG L  ++ + G+YSE RA  +FK +M V+K
Sbjct:    98 KLAGHPNVVNLKAVYEEKDSVHLVMELCAGGELFHKLEKYGRYSEVRARVLFKHLMQVVK 157

Query:   212 YCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
             +CHD G+VHRD+KPENIL+ T   S  IKLADFGLA  I  G+ LSG  GSP Y+APEVL
Sbjct:   158 FCHDSGIVHRDLKPENILMATMSSSSPIKLADFGLATYIKPGEKLSGTVGSPFYIAPEVL 217

Query:   269 SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
             +G Y++  D+WS             PF G +   +FDA++   L F +  W+ ++  A+D
Sbjct:   218 AGGYNQAADVWSAGVILYILLSGAPPFWGKTKSKIFDAVRAADLRFSAEPWDNITSYAKD 277

Query:   329 LMARMLTRDVSARITADEVLRHPWI 353
             L+  ML  D S R++ADEVL H W+
Sbjct:   278 LIRGMLCVDPSQRLSADEVLAHSWM 302

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0046777 "protein autophosphorylation" evidence=IDA

TAIR|locus:2204340 CPK29 "calcium-dependent protein kinase 29" [Arabidopsis thaliana (taxid:3702)]

 Score = 587 (211.7 bits), Expect = 4.6e-57, P = 4.6e-57
 Identities = 114/253 (45%), Positives = 159/253 (62%)

Query:   111 IGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTLH 163
             +G G+FG  + C  K++G E+ACK++       RK  E V REV I+QHL+G   +V   
Sbjct:   118 LGRGQFGITYKCTDKSNGREYACKSISKRKLIRRKDIEDVRREVMILQHLTGQPNIVEFR 177

Query:   164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
               YE+ D  HLVMELCSGG L D++++ G YSE+ AANIF+ ++ V+  CH MGVVHRD+
Sbjct:   178 GAYEDKDNLHLVMELCSGGELFDRIIKKGSYSEKEAANIFRQIVNVVHVCHFMGVVHRDL 237

Query:   224 KPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
             KPEN LL ++ +   IK  DFGL++ I  G+    + GS  YVAPEVL  NY +++D+WS
Sbjct:   238 KPENFLLVSNEEDSPIKATDFGLSVFIEEGKVYRDIVGSAYYVAPEVLHRNYGKEIDVWS 297

Query:   281 XXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                          PF G++ + +F+AI   KLD  +  W T+S+ A+DL+ +ML RD   
Sbjct:   298 AGVMLYILLSGVPPFWGETEKTIFEAILEGKLDLETSPWPTISESAKDLIRKMLIRDPKK 357

Query:   341 RITADEVLRHPWI 353
             RITA E L HPW+
Sbjct:   358 RITAAEALEHPWM 370

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IDA

GO:0009627 "systemic acquired resistance" evidence=RCA

GO:0009697 "salicylic acid biosynthetic process" evidence=RCA

TAIR|locus:2122063 CPK5 "calmodulin-domain protein kinase 5" [Arabidopsis thaliana (taxid:3702)]

 Score = 572 (206.4 bits), Expect = 1.8e-55, P = 1.8e-55
 Identities = 112/290 (38%), Positives = 171/290 (58%)

Query:    75 LVPAGRGLKRKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFAC 133
             ++P    + R+      +  +G K   I D +T    +G G+FG+ +LC   ASG ++AC
Sbjct:    66 VIPLREPIMRRNPDNQAYYVLGHKTPNIRDIYTLSRKLGQGQFGTTYLCTEIASGVDYAC 125

Query:   134 KTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID 186
             K++ K +       E V RE++IM HL+GH  +VT+   YE++   H+VMELC+GG L D
Sbjct:   126 KSISKRKLISKEDVEDVRREIQIMHHLAGHGSIVTIKGAYEDSLYVHIVMELCAGGELFD 185

Query:   187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGL 243
             ++++ G YSE++AA + K ++ V++ CH +GV+HRD+KPEN LL        +K  DFGL
Sbjct:   186 RIIQRGHYSERKAAELTKIIVGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGL 245

Query:   244 AMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAV 303
             ++    GQ  + + GSP YVAPEVL   Y  + D+W+             PF  ++ + +
Sbjct:   246 SVFFKPGQIFTDVVGSPYYVAPEVLLKRYGPEADVWTAGVILYILLSGVPPFWAETQQGI 305

Query:   304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             FDA+    +DF S  W  +S  A+DL+ RML+   + R+TA EVLRHPWI
Sbjct:   306 FDAVLKGYIDFESDPWPVISDSAKDLIRRMLSSKPAERLTAHEVLRHPWI 355

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=IDA

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0048767 "root hair elongation" evidence=RCA

TAIR|locus:2065021 CPK20 "calcium-dependent protein kinase 20" [Arabidopsis thaliana (taxid:3702)]

 Score = 570 (205.7 bits), Expect = 2.9e-55, P = 2.9e-55
 Identities = 112/283 (39%), Positives = 174/283 (61%)

Query:    82 LKRKIGC-IDVHTQMGRKNK-IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG 139
             +KR     + + + +GRK + ++D ++    +G G+FG+ +LC  K +G EFACKT+ K 
Sbjct:   109 MKRMASAGLQIDSVLGRKTENLKDIYSVGRKLGQGQFGTTFLCVDKKTGKEFACKTIAKR 168

Query:   140 E-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG 192
             +       E V RE++IM HLSGH  V+ +   YE+A   H+VME+C+GG L D++++ G
Sbjct:   169 KLTTPEDVEDVRREIQIMHHLSGHPNVIQIVGAYEDAVAVHVVMEICAGGELFDRIIQRG 228

Query:   193 QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISN 249
              Y+E++AA + + ++ VI+ CH +GV+HRD+KPEN L  +  +   +K  DFGL++    
Sbjct:   229 HYTEKKAAELARIIVGVIEACHSLGVMHRDLKPENFLFVSGDEEAALKTIDFGLSVFFKP 288

Query:   250 GQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKN 309
             G+T + + GSP YVAPEVL  +YS + D+WS             PF  ++ + +F+ +  
Sbjct:   289 GETFTDVVGSPYYVAPEVLRKHYSHECDVWSAGVIIYILLSGVPPFWDETEQGIFEQVLK 348

Query:   310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
               LDF S  W +VS+ A+DL+ RML RD   R+T  EVL HPW
Sbjct:   349 GDLDFISEPWPSVSESAKDLVRRMLIRDPKKRMTTHEVLCHPW 391

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0009827 "plant-type cell wall modification" evidence=RCA

GO:0009860 "pollen tube growth" evidence=RCA

TAIR|locus:2092399 CPK9 "calmodulin-domain protein kinase 9" [Arabidopsis thaliana (taxid:3702)]

 Score = 545 (196.9 bits), Expect = 1.1e-54, Sum P(2) = 1.1e-54
 Identities = 108/269 (40%), Positives = 164/269 (60%)

Query:    98 KNKIEDD---HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREV 147
             +N  ED    +T  + +G G+FG  +LC   ++G ++ACK++ K        ++ + RE+
Sbjct:    81 ENAFEDVKLFYTLGKELGRGQFGVTYLCTENSTGKKYACKSISKKKLVTKADKDDMRREI 140

Query:   148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             +IMQHLSG   +V     YE+    +LVMELC+GG L D+++  G Y+E+ AA++ + ++
Sbjct:   141 QIMQHLSGQPNIVEFKGAYEDEKAVNLVMELCAGGELFDRIIAKGHYTERAAASVCRQIV 200

Query:   208 WVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVA 264
              V+K CH MGV+HRD+KPEN LL++  +   IK  DFGL++ I  G+    + GS  YVA
Sbjct:   201 NVVKICHFMGVLHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGKVYRDIVGSAYYVA 260

Query:   265 PEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
             PEVL   Y ++VDIWS             PF  ++ + +FDAI    +DF S  W ++S 
Sbjct:   261 PEVLRRRYGKEVDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGHIDFESQPWPSISS 320

Query:   325 PARDLMARMLTRDVSARITADEVLRHPWI 353
              A+DL+ RMLT D   RI+A +VL+HPW+
Sbjct:   321 SAKDLVRRMLTADPKRRISAADVLQHPWL 349

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0007165 "signal transduction" evidence=TAS

GO:0005886 "plasma membrane" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2039215 CPK25 "calcium-dependent protein kinase 25" [Arabidopsis thaliana (taxid:3702)]

 Score = 564 (203.6 bits), Expect = 1.3e-54, P = 1.3e-54
 Identities = 108/253 (42%), Positives = 161/253 (63%)

Query:   111 IGHGKFGSVWLCRSKASGAEFACKTL--RKGE-----ETVHREVEIMQHLSGHTGVVTLH 163
             +GHG+FG+ ++C  K +G E+ACK++  RK E     E V RE+EIM+HL G   V+++ 
Sbjct:   138 LGHGQFGTTFVCVEKGTGEEYACKSIPKRKLENEEDVEDVRREIEIMKHLLGQPNVISIK 197

Query:   164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
               YE++   H+VMELC GG L D++VE G YSE++AA++ K ++ V++ CH +GV+HRD+
Sbjct:   198 GAYEDSVAVHMVMELCRGGELFDRIVERGHYSERKAAHLAKVILGVVQTCHSLGVMHRDL 257

Query:   224 KPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
             KPEN L     +   +K  DFGL+M +  G+  + + GSP Y+APEVL+ NY  + DIWS
Sbjct:   258 KPENFLFVNDDEDSPLKAIDFGLSMFLKPGENFTDVVGSPYYIAPEVLNKNYGPEADIWS 317

Query:   281 XXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                          PF G++ E +F+ +   +LD  S  W  VS+ A+DL+ +ML R+   
Sbjct:   318 AGVMIYVLLSGSAPFWGETEEEIFNEVLEGELDLTSDPWPQVSESAKDLIRKMLERNPIQ 377

Query:   341 RITADEVLRHPWI 353
             R+TA +VL HPWI
Sbjct:   378 RLTAQQVLCHPWI 390

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2015846 CPK33 "calcium-dependent protein kinase 33" [Arabidopsis thaliana (taxid:3702)]

 Score = 561 (202.5 bits), Expect = 2.6e-54, P = 2.6e-54
 Identities = 109/259 (42%), Positives = 162/259 (62%)

Query:   105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE-ETVHREVEIMQHLSGHT 157
             +T  + +G G+FG  +LC  K++G  FACK++ K      G+ E + RE++IMQHLSG  
Sbjct:    73 YTLSKELGRGQFGVTYLCTEKSTGKRFACKSISKKKLVTKGDKEDMRREIQIMQHLSGQP 132

Query:   158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
              +V     YE+    +LVMELC+GG L D+++  G YSE+ AA++ + ++ V+  CH MG
Sbjct:   133 NIVEFKGAYEDEKAVNLVMELCAGGELFDRILAKGHYSERAAASVCRQIVNVVNICHFMG 192

Query:   218 VVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE 274
             V+HRD+KPEN LL++  +   IK  DFGL++ I  G+    + GS  YVAPEVL   Y +
Sbjct:   193 VMHRDLKPENFLLSSKDEKALIKATDFGLSVFIEEGRVYKDIVGSAYYVAPEVLKRRYGK 252

Query:   275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
             ++DIWS             PF  ++ + +FDAI   ++DF S  W ++S  A+DL+ RML
Sbjct:   253 EIDIWSAGIILYILLSGVPPFWAETEKGIFDAILEGEIDFESQPWPSISNSAKDLVRRML 312

Query:   335 TRDVSARITADEVLRHPWI 353
             T+D   RI+A EVL+HPW+
Sbjct:   313 TQDPKRRISAAEVLKHPWL 331

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

TAIR|locus:2827528 CPK6 "calcium dependent protein kinase 6" [Arabidopsis thaliana (taxid:3702)]

 Score = 559 (201.8 bits), Expect = 4.3e-54, P = 4.3e-54
 Identities = 108/270 (40%), Positives = 161/270 (59%)

Query:    95 MGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHRE 146
             +G K   I D +T    +G G+FG+ +LC   A+G ++ACK++ K +       E V RE
Sbjct:    74 LGHKTPNIRDLYTLSRKLGQGQFGTTYLCTDIATGVDYACKSISKRKLISKEDVEDVRRE 133

Query:   147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
             ++IM HL+GH  +VT+   YE+    H+VMELC+GG L D+++  G YSE++AA + K +
Sbjct:   134 IQIMHHLAGHKNIVTIKGAYEDPLYVHIVMELCAGGELFDRIIHRGHYSERKAAELTKII 193

Query:   207 MWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
             + V++ CH +GV+HRD+KPEN LL        +K  DFGL++    GQ    + GSP YV
Sbjct:   194 VGVVEACHSLGVMHRDLKPENFLLVNKDDDFSLKAIDFGLSVFFKPGQIFKDVVGSPYYV 253

Query:   264 APEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
             APEVL  +Y  + D+W+             PF  ++ + +FDA+    +DF +  W  +S
Sbjct:   254 APEVLLKHYGPEADVWTAGVILYILLSGVPPFWAETQQGIFDAVLKGYIDFDTDPWPVIS 313

Query:   324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
               A+DL+ +ML    S R+TA EVLRHPWI
Sbjct:   314 DSAKDLIRKMLCSSPSERLTAHEVLRHPWI 343

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA;IDA

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005509 "calcium ion binding" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISM

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0016020 "membrane" evidence=TAS

GO:0009738 "abscisic acid mediated signaling pathway" evidence=RCA;IMP

GO:0010119 "regulation of stomatal movement" evidence=IMP

GO:0010359 "regulation of anion channel activity" evidence=RCA;IMP

GO:0005886 "plasma membrane" evidence=IDA

GO:0005829 "cytosol" evidence=RCA;IDA

GO:0005515 "protein binding" evidence=IPI

GO:0009737 "response to abscisic acid stimulus" evidence=IDA

GO:0046777 "protein autophosphorylation" evidence=IDA

GO:0000165 "MAPK cascade" evidence=RCA

GO:0006612 "protein targeting to membrane" evidence=RCA

GO:0006820 "anion transport" evidence=RCA

GO:0006862 "nucleotide transport" evidence=RCA

GO:0006888 "ER to Golgi vesicle-mediated transport" evidence=RCA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0007154 "cell communication" evidence=RCA

GO:0007165 "signal transduction" evidence=RCA

GO:0009409 "response to cold" evidence=RCA

GO:0009414 "response to water deprivation" evidence=RCA

GO:0009611 "response to wounding" evidence=RCA

GO:0009723 "response to ethylene stimulus" evidence=RCA

GO:0009733 "response to auxin stimulus" evidence=RCA

GO:0009753 "response to jasmonic acid stimulus" evidence=RCA

GO:0009862 "systemic acquired resistance, salicylic acid mediated signaling pathway" evidence=RCA

GO:0009867 "jasmonic acid mediated signaling pathway" evidence=RCA

GO:0010363 "regulation of plant-type hypersensitive response" evidence=RCA

GO:0015696 "ammonium transport" evidence=RCA

GO:0015802 "basic amino acid transport" evidence=RCA

GO:0030968 "endoplasmic reticulum unfolded protein response" evidence=RCA

GO:0031348 "negative regulation of defense response" evidence=RCA

GO:0035556 "intracellular signal transduction" evidence=RCA

GO:0042538 "hyperosmotic salinity response" evidence=RCA

GO:0043069 "negative regulation of programmed cell death" evidence=RCA

GO:0043090 "amino acid import" evidence=RCA

GO:0043269 "regulation of ion transport" evidence=RCA

GO:0050832 "defense response to fungus" evidence=RCA

TAIR|locus:2150225 CPK34 "AT5G19360" [Arabidopsis thaliana (taxid:3702)]

 Score = 549 (198.3 bits), Expect = 4.9e-53, P = 4.9e-53
 Identities = 117/303 (38%), Positives = 169/303 (55%)

Query:    62 GIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNK-IEDDHTKVEVIGHGKFGSVW 120
             G+  A     +S   PA      K G I     +GR  + ++  +T  + +G G+FG   
Sbjct:    26 GVGAAEASVRASKHPPASPPPATKQGPIG--PVLGRPMEDVKSSYTLGKELGRGQFGVTH 83

Query:   121 LCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH 173
             LC  KA+G +FACKT+ K +       E V REV+IM HL+G   +V L   YE+    H
Sbjct:    84 LCTQKATGLQFACKTIAKRKLVNKEDIEDVRREVQIMHHLTGQPNIVELKGAYEDKHSVH 143

Query:   174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS 233
             LVMELC+GG L D+++  G YSE+ AA++ + ++ +I  CH MGV+HRD+KPEN LL + 
Sbjct:   144 LVMELCAGGELFDRIIAKGHYSERAAASLLRTIVQIIHTCHSMGVIHRDLKPENFLLLSK 203

Query:   234 GK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXX 290
              +   +K  DFGL++    G+    + GS  Y+APEVL   Y  + DIWS          
Sbjct:   204 DENSPLKATDFGLSVFYKPGEVFKDIVGSAYYIAPEVLRRKYGPEADIWSIGVMLYILLC 263

Query:   291 XXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                PF  +S   +F+AI + ++DF S  W  +S  A+DL+ +ML  D   R+TA +VL H
Sbjct:   264 GVPPFWAESENGIFNAILSGQVDFSSDPWPVISPQAKDLVRKMLNSDPKQRLTAAQVLNH 323

Query:   351 PWI 353
             PWI
Sbjct:   324 PWI 326

GO:0004683 "calmodulin-dependent protein kinase activity" evidence=ISS

GO:0005886 "plasma membrane" evidence=ISM;IDA

GO:0006468 "protein phosphorylation" evidence=IEA;ISS

GO:0016301 "kinase activity" evidence=ISS

GO:0080092 "regulation of pollen tube growth" evidence=IMP

GO:0005737 "cytoplasm" evidence=IDA

GO:0006944 "cellular membrane fusion" evidence=RCA

GO:0004672 "protein kinase activity" evidence=IDA

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q8W490	PEPK2_ARATH	2, ., 7, ., 1, 1, ., -	0.7067	0.9914	0.9893	yes	no

EC Number Prediction by Ezypred Server

Original result from Ezypred Server

Fail to connect to Ezypred Server

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.1	0.737
3rd Layer	2.7.11	0.691

---

Prediction of Functionally Associated Proteins

Functionally Associated Proteins Detected by STRING

Original result from the STRING server

Your Input: GSVIVG00015148001 SubName- Full=Chromosome chr18 scaffold_1, whole genome shotgun sequence; (468 aa) (Vitis vinifera)

Predicted Functional Partners:

Sorry, there are no predicted associations at the current settings.

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database part I

ID	Length	Definition	E-value
Query	469
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	7e-96
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	6e-81
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	1e-61
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-60
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-56
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	3e-56
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	1e-55
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-53
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	3e-51
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	1e-50
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	1e-49
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	1e-46
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	3e-46
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	5e-46
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-45
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	3e-45
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	5e-45
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-44
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	1e-43
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	2e-42
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	3e-42
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	9e-42
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-41
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	1e-40
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	3e-40
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	5e-40
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	9e-40
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	9e-39
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	3e-38
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	4e-38
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	5e-38
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	6e-38
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	6e-38
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	1e-37
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	1e-37
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	4e-37
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	5e-37
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	6e-37
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	8e-37
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	2e-36
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	4e-36
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	6e-36
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	6e-36
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	7e-36
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	8e-36
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	2e-35
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	3e-35
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	3e-35
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	5e-35
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	7e-35
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	1e-34
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	2e-34
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	2e-34
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	2e-34
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	4e-34
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	6e-34
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	1e-33
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	1e-33
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	1e-33
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	1e-33
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	2e-33
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	2e-33
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	3e-33
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	4e-33
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	4e-33
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	6e-33
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	7e-33
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	9e-33
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	1e-32
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-32
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-32
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	2e-32
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-32
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	2e-32
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	2e-32
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	2e-32
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	4e-32
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	6e-32
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	8e-32
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	2e-31
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	2e-31
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	2e-31
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-31
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-31
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	5e-31
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	1e-30
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	2e-30
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	2e-30
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	3e-30
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	3e-30
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	3e-30
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	5e-30
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	7e-30
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	7e-30
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	8e-30
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	1e-29
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	1e-29
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	1e-29
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	2e-29
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	2e-29
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	2e-29
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	3e-29
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	4e-29
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	4e-29
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-29
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	4e-29
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-29
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	5e-29
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	6e-29
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	9e-29
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	1e-28
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-28
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	3e-28
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	4e-28
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	6e-28
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	6e-28
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	8e-28
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	9e-28
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	9e-28
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	1e-27
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-27
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	3e-27
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	3e-27
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	3e-27
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	4e-27
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	6e-27
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-27
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	1e-26
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	2e-26
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	2e-26
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	3e-26
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	3e-26
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	3e-26
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	3e-26
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	4e-26
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	5e-26
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-26
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	1e-25
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-25
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	2e-25
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	2e-25
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-25
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	4e-25
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	6e-25
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	7e-25
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	8e-25
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-25
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	1e-24
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	2e-24
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	2e-24
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	2e-24
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-24
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	3e-24
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	3e-24
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	4e-24
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	5e-24
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	7e-24
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	8e-24
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	1e-23
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	1e-23
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-23
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	3e-23
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	4e-23
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	5e-23
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	5e-23
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	5e-23
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	7e-23
cd06622	286	cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of	8e-23
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	2e-22
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	2e-22
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	4e-22
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	4e-22
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	5e-22
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	5e-22
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	7e-22
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-21
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	1e-21
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	1e-21
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-21
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-21
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-21
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	3e-21
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	5e-21
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	5e-21
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-21
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	1e-20
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	3e-20
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	3e-20
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	3e-20
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-20
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	4e-20
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-19
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-19
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	4e-19
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	6e-19
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	6e-19
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	8e-18
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	1e-17
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	1e-17
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	1e-17
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	2e-17
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	2e-17
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	3e-17
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	4e-17
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	9e-17
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	9e-17
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	2e-16
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	2e-16
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	3e-16
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	5e-16
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	7e-16
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	1e-15
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	1e-15
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	1e-15
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	1e-15
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-15
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	2e-15
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	6e-15
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	6e-15
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	9e-15
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	1e-14
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	1e-14
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	1e-14
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	3e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	3e-14
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	1e-13
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-13
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	3e-13
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	3e-13
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-13
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	5e-13
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	8e-13
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	1e-12
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	1e-12
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	1e-12
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	2e-12
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	2e-12
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-12
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	3e-12
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	4e-12
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	4e-12
cd05576	237	cd05576, STKc_RPK118_like, Catalytic domain of the	5e-12
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	8e-12
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	1e-11
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-11
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	2e-11
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	3e-11
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	4e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	4e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	7e-11
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-10
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-10
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	1e-10
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	1e-10
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	2e-10
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	5e-10
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	2e-09
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	2e-09
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	3e-09
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	4e-09
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	4e-09
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	6e-09
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	8e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	8e-09
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-08
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-08
cd05064	266	cd05064, PTKc_EphR_A10, Catalytic domain of the Pr	2e-08
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	2e-08
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-08
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	5e-08
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	8e-08
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-07
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	7e-07
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	9e-07
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	2e-06
PHA02882	294	PHA02882, PHA02882, putative serine/threonine kina	2e-06
cd05120	155	cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot	2e-06
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	2e-06
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	2e-06
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	4e-06
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	4e-06
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	6e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	8e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	8e-06
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	9e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	1e-05
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	1e-05
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	1e-05
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	2e-05
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	2e-05
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	5e-05
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-05
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	9e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	1e-04
COG0478	304	COG0478, COG0478, RIO-like serine/threonine protei	1e-04
PRK14879	211	PRK14879, PRK14879, serine/threonine protein kinas	2e-04
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	2e-04
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	4e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	0.001
smart00750	176	smart00750, KIND, kinase non-catalytic C-lobe doma	0.001
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	0.001
cd05043	280	cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece	0.002

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  289 bits (741), Expect = 7e-96
 Identities = 105/255 (41%), Positives = 154/255 (60%), Gaps = 9/255 (3%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVV 160
             +E +G G FG V+L R K +G   A K ++K +     E + RE++I++ L  H  +V
Sbjct: 2   EILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKL-KHPNIV 60

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            L+ V+E+ D  +LVME C GG L D + + G+ SE  A    + ++  ++Y H  G+VH
Sbjct: 61  RLYDVFEDEDKLYLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLHSKGIVH 120

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           RD+KPENILL   G +KLADFGLA ++  G+ L+   G+P Y+APEVL G  Y + VDIW
Sbjct: 121 RDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIW 180

Query: 280 SAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           S GV+L+ LL    PF GD  L  +F  I   K  F    W+ +S  A+DL+ ++L +D 
Sbjct: 181 SLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWD-ISPEAKDLIRKLLVKDP 239

Query: 339 SARITADEVLRHPWI 353
             R+TA+E L+HP+ 
Sbjct: 240 EKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  251 bits (642), Expect = 6e-81
 Identities = 100/260 (38%), Positives = 150/260 (57%), Gaps = 13/260 (5%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGV 159
             +  +G G FG+V+  + K +G   A K L+K       ++T  RE+ I++ LS H  +
Sbjct: 2   ELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARREIRILRRLS-HPNI 60

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           V L   +E+ D  +LVME C GG L D +   G  SE  A  I   ++  ++Y H  G++
Sbjct: 61  VRLIDAFEDKDHLYLVMEYCEGGDLFDYLSRGGPLSEDEAKKIALQILRGLEYLHSNGII 120

Query: 220 HRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKV 276
           HRD+KPENILL  +G +K+ADFGLA   + +  +L+   G+P Y+APEVL G   Y  KV
Sbjct: 121 HRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKV 180

Query: 277 DIWSAGVLLHALLVAALPFKGDSLE---AVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           D+WS GV+L+ LL    PF G+++     +   I    L+F    W + S+ A+DL+ + 
Sbjct: 181 DVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGPPLEFDEPKWSSGSEEAKDLIKKC 240

Query: 334 LTRDVSARITADEVLRHPWI 353
           L +D S R TA+E+L+HPW 
Sbjct: 241 LNKDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  201 bits (513), Expect = 1e-61
 Identities = 92/254 (36%), Positives = 143/254 (56%), Gaps = 17/254 (6%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTLH 163
           +G G FG V L R K +G  +A K L+K +    +EVE       I+  ++ H  +V LH
Sbjct: 1   LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLH 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             ++  +  +LV+E   GG L   + + G++SE+RA     +++  ++Y H +G+++RD+
Sbjct: 60  YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDL 119

Query: 224 KPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSA 281
           KPENILL   G IKL DFGLA    S G   +   G+P Y+APEVL G  Y + VD WS 
Sbjct: 120 KPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSL 179

Query: 282 GVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
           GVLL+ +L    PF  +  + +++ I    L F     E +S  ARDL++ +L +D + R
Sbjct: 180 GVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPTKR 235

Query: 342 IT---ADEVLRHPW 352
           +    A+E+  HP+
Sbjct: 236 LGSGGAEEIKAHPF 249

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  196 bits (501), Expect = 2e-60
 Identities = 93/251 (37%), Positives = 137/251 (54%), Gaps = 46/251 (18%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSV 165
           +G G FG+V+L R K +G + A K ++K +     E + RE+EI++ L+ H  +V L+ V
Sbjct: 1   LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGV 59

Query: 166 YEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           +E+ +  +LVME C GG L D + E  G+ SE     I   ++  ++Y H  G++HRD+K
Sbjct: 60  FEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLK 119

Query: 225 PENILLT-TSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWS 280
           PENILL   +GK+KLADFGL+  + S+   L  + G+PAY+APEVL G   YSEK DIWS
Sbjct: 120 PENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWS 179

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GV+L+ L                                      +DL+ +ML +D   
Sbjct: 180 LGVILYEL-----------------------------------PELKDLIRKMLQKDPEK 204

Query: 341 RITADEVLRHP 351
           R +A E+L H 
Sbjct: 205 RPSAKEILEHL 215

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  188 bits (480), Expect = 1e-56
 Identities = 83/264 (31%), Positives = 137/264 (51%), Gaps = 18/264 (6%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           + T+ E++G G FGSV+L   K +G   A K++          E + RE+ I+  L  H 
Sbjct: 1   EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HP 59

Query: 158 GVVTL--HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V        EE +  ++ +E  SGG L   + + G+  E       + ++  + Y H 
Sbjct: 60  NIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHS 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG---LAGSPAYVAPEVLSGN- 271
            G+VHRDIK  NIL+ + G +KLADFG A R+ + +T  G   + G+P ++APEV+ G  
Sbjct: 120 NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEE 179

Query: 272 YSEKVDIWSAGVLLHALLVAALPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           Y    DIWS G  +  +     P+   G+ + A++    + +      + E +S+ A+D 
Sbjct: 180 YGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSGE---PPEIPEHLSEEAKDF 236

Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + + L RD   R TADE+L+HP++
Sbjct: 237 LRKCLRRDPKKRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  187 bits (478), Expect = 3e-56
 Identities = 73/277 (26%), Positives = 129/277 (46%), Gaps = 37/277 (13%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVT 161
           ++IG G F +V L + K +  E+A K L K         + V  E E++  L+GH G++ 
Sbjct: 7   KIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIK 66

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+  +++ +  + V+E    G L+  + + G   E+       +++  ++Y H  G++HR
Sbjct: 67  LYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHR 126

Query: 222 DIKPENILLTTSGKIKLADFGLAM---------------------RISNGQTLSGLAGSP 260
           D+KPENILL     IK+ DFG A                         N +  +   G+ 
Sbjct: 127 DLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTA 186

Query: 261 AYVAPEVLSGNYSEK-VDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW 319
            YV+PE+L+   + K  D+W+ G +++ +L    PF+G +    F  I  ++  F     
Sbjct: 187 EYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSFPPN-- 244

Query: 320 ETVSKPARDLMARMLTRDVSARITA----DEVLRHPW 352
                 A+DL+ ++L  D   R+      DE+  HP+
Sbjct: 245 --FPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  185 bits (472), Expect = 1e-55
 Identities = 78/260 (30%), Positives = 135/260 (51%), Gaps = 16/260 (6%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLSGHTGV 159
             ++ IG G FG V+L R K+ G  +  K +       K  E    EV+I++ L+ H  +
Sbjct: 3   EIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNI 61

Query: 160 VTLHSVYEEADCFHLVMELCSGGRL---IDQMVEVGQY-SEQRAANIFKDVMWVIKYCHD 215
           +  +  +EE     +VME   GG L   I +  + G+   E++  + F  +   +KY H 
Sbjct: 62  IKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHS 121

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             ++HRDIKP+NI LT++G +KL DFG++ +  S       + G+P Y++PE+     Y+
Sbjct: 122 RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYN 181

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
            K DIWS G +L+ L     PF+G++L  +   I   +   +  +    S   R+L++ +
Sbjct: 182 YKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQ---YPPIPSQYSSELRNLVSSL 238

Query: 334 LTRDVSARITADEVLRHPWI 353
           L +D   R +  ++L+ P+I
Sbjct: 239 LQKDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  179 bits (457), Expect = 2e-53
 Identities = 82/254 (32%), Positives = 141/254 (55%), Gaps = 10/254 (3%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR----KGEETVHREVEIMQHLSGHTGVVT 161
             +E IG G FG V+  R K +G E A K ++    + +E +  E++I++    H  +V 
Sbjct: 3   EILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVK 61

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVH 220
            +  Y + D   +VME CSGG L D +    Q  +E + A + K+++  ++Y H  G++H
Sbjct: 62  YYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIH 121

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIW 279
           RDIK  NILLT+ G++KL DFGL+ ++S+ +  + + G+P ++APEV++G  Y  K DIW
Sbjct: 122 RDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIW 181

Query: 280 SAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           S G+    L     P+ +   ++A+F    N      +      S   +D + + L ++ 
Sbjct: 182 SLGITAIELAEGKPPYSELPPMKALFKIATNGPPGLRNPEK--WSDEFKDFLKKCLQKNP 239

Query: 339 SARITADEVLRHPW 352
             R TA+++L+HP+
Sbjct: 240 EKRPTAEQLLKHPF 253

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score =  175 bits (445), Expect = 3e-51
 Identities = 88/268 (32%), Positives = 138/268 (51%), Gaps = 30/268 (11%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSG 155
           DD   ++ +G G FG V L R K SG  +A K L K         E V  E  I+Q +  
Sbjct: 1   DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR- 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR----AANIFKDVMWVIK 211
           H  +V L+  +++    +LVME   GG L   + + G++ E      AA +       ++
Sbjct: 60  HPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVV----LALE 115

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEV-LS 269
           Y H + +V+RD+KPEN+LL + G IK+ DFG A R+     TL    G+P Y+APE+ LS
Sbjct: 116 YLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGRTYTLC---GTPEYLAPEIILS 172

Query: 270 GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
             Y + VD W+ G+L++ +L    PF  D+   +++ I   K+ F S      S  A+DL
Sbjct: 173 KGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF----FSPDAKDL 228

Query: 330 MARMLTRDVSARI-----TADEVLRHPW 352
           +  +L  D++ R+       +++  HPW
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score =  175 bits (446), Expect = 1e-50
 Identities = 90/289 (31%), Positives = 137/289 (47%), Gaps = 41/289 (14%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEET-VHREVEIMQHLSG 155
           DD   ++VIG G FG VWL R K +G  +A K LRK       +   V  E +I+   + 
Sbjct: 1   DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILAD-AD 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L+  +++ +  +LVME   GG L++ ++    + E+ A     +++  +   H 
Sbjct: 60  SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHK 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGL------------------ 256
           +G +HRDIKP+NIL+   G IKLADFGL  ++         L                  
Sbjct: 120 LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRD 179

Query: 257 -----------AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF 304
                       G+P Y+APEVL G  Y  + D WS GV+L+ +L    PF  D+L+  +
Sbjct: 180 HKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY 239

Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT-ADEVLRHPW 352
           + I N K          VS  A DL+ R+L  D   R+   +E+  HP+
Sbjct: 240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPF 287

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  170 bits (432), Expect = 1e-49
 Identities = 83/263 (31%), Positives = 138/263 (52%), Gaps = 23/263 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHR---EVEIMQHLSGHTGVVTLH 163
           I  G +G V+L + K++G  +A K ++K     +  V +   E +I+        VV L+
Sbjct: 1   ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLY 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             ++     +LVME   GG L   +  VG   E  A     +++  ++Y H  G++HRD+
Sbjct: 60  YSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDL 119

Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTL---------SGLAGSPAYVAPEVLSGN-YS 273
           KP+NIL+ ++G +KL DFGL+      + +           + G+P Y+APEV+ G  +S
Sbjct: 120 KPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHS 179

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           + VD WS G +L+  LV   PF G++ E +F  I N K+++   V   VS  A DL++++
Sbjct: 180 KTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPEDV--EVSDEAIDLISKL 237

Query: 334 LTRDVSARITA---DEVLRHPWI 353
           L  D   R+ A   +E+  HP+ 
Sbjct: 238 LVPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score =  163 bits (415), Expect = 1e-46
 Identities = 93/294 (31%), Positives = 139/294 (47%), Gaps = 47/294 (15%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET----VHR---EVEIMQHLSG 155
               K++++G G  G V+L R K +G  FA K L K E      V R   E EI+  L  
Sbjct: 1   KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD- 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYC 213
           H  + TL++ ++      LVM+ C GG L    Q       SE+ A     +V+  ++Y 
Sbjct: 60  HPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYL 119

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPA--------- 261
           H +G+V+RD+KPENILL  SG I L+DF L+ +          +   GS           
Sbjct: 120 HLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSE 179

Query: 262 ------------------YVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEA 302
                             Y+APEV+SG+ +   VD W+ G+LL+ +L    PFKG + + 
Sbjct: 180 TFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE 239

Query: 303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI----TADEVLRHPW 352
            F  I   ++ F       VS  ARDL+ ++L +D S R+     A E+ +HP+
Sbjct: 240 TFSNILKKEVTFPGSP--PVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPF 291

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score =  162 bits (413), Expect = 3e-46
 Identities = 79/256 (30%), Positives = 131/256 (51%), Gaps = 18/256 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V L   K +   +A K L+K         E    E  ++     H  +  L
Sbjct: 2   VLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQL 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           HS ++  D    VME  +GG L+  +   G++ E RA     +++  +++ H+ G+++RD
Sbjct: 62  HSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRD 121

Query: 223 IKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +K +N+LL + G IK+ADFG+    I  G T S   G+P Y+APE+LS   Y   VD W+
Sbjct: 122 LKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWA 181

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+ +L    PF+GD  + +F +I   ++ +       +SK A+ ++   LT++   
Sbjct: 182 LGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW----LSKEAKSILKSFLTKNPEK 237

Query: 341 RITA-----DEVLRHP 351
           R+        ++  HP
Sbjct: 238 RLGCLPTGEQDIKGHP 253

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  164 bits (414), Expect = 5e-46
 Identities = 92/340 (27%), Positives = 144/340 (42%), Gaps = 34/340 (10%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTG 158
             +  +G G FG V+L R +      A K L K         E   RE++I+  L+    
Sbjct: 3   RILRKLGEGSFGEVYLARDRK---LVALKVLAKKLESKSKEVERFLREIQILASLNHPPN 59

Query: 159 VVTLHSVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           +V L+  +++    +LVME   GG    L+ ++   G  SE  A  I   ++  ++Y H 
Sbjct: 60  IVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119

Query: 216 MGVVHRDIKPENILLTTSG-KIKLADFGLA-------MRISNGQTLSGLAGSPAYVAPEV 267
            G++HRDIKPENILL   G  +KL DFGLA          S     S   G+P Y+APEV
Sbjct: 120 KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEV 179

Query: 268 LSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI---------KNVKLDF 314
           L G      S   DIWS G+ L+ LL    PF+G+   +               ++    
Sbjct: 180 LLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPL 239

Query: 315 HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQV 374
                E +SK A DL+ ++L +D   R+++   L H  +     +      +     +  
Sbjct: 240 SPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299

Query: 375 GASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNS 414
                 P++ + + S  +    GS      +  S E   +
Sbjct: 300 LRLSLPPSLEALISSLNSLAISGSDLKLDDSNFSKELAPN 339

Length = 384

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score =  159 bits (403), Expect = 1e-45
 Identities = 78/257 (30%), Positives = 129/257 (50%), Gaps = 18/257 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTL 162
           VIG G FG V + + + +   FA K + K +         V  E  I+Q L+ H  +V L
Sbjct: 7   VIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNL 65

Query: 163 HSVYEEADCFHLVMELCSGGRL---IDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
              +++ +  +LV++L  GG L   + Q V   ++SE++      +++  ++Y H  G++
Sbjct: 66  WYSFQDEENMYLVVDLLLGGDLRYHLSQKV---KFSEEQVKFWICEIVLALEYLHSKGII 122

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDI 278
           HRDIKP+NILL   G + + DF +A +++     +  +G+P Y+APEVL    YS  VD 
Sbjct: 123 HRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDW 182

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           WS GV  +  L    P++G S     D I+  +         T S  A D + ++L RD 
Sbjct: 183 WSLGVTAYECLRGKRPYRGHSRTIR-DQIRAKQETADVLYPATWSTEAIDAINKLLERDP 241

Query: 339 SARI--TADEVLRHPWI 353
             R+     ++  HP+ 
Sbjct: 242 QKRLGDNLKDLKNHPYF 258

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score =  158 bits (401), Expect = 3e-45
 Identities = 82/259 (31%), Positives = 138/259 (53%), Gaps = 22/259 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G FG V L + K+    FA K ++K        +E +  E EI++  + H  +V L+
Sbjct: 1   LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLY 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +++    +++ME C GG L   + + G + E  A      V+   +Y H+ G+++RD+
Sbjct: 60  RTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDL 119

Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAG 282
           KPEN+LL ++G +KL DFG A ++ +GQ      G+P YVAPE++    Y   VD WS G
Sbjct: 120 KPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLG 179

Query: 283 VLLHALLVAALPFKGDSLE--AVFDAI--KNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           +LL+ LL    PF  D  +   +++ I   N KL+F +     + K A+DL+ ++L R+ 
Sbjct: 180 ILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN----YIDKAAKDLIKQLLRRNP 235

Query: 339 SARI-----TADEVLRHPW 352
             R+        ++ +H W
Sbjct: 236 EERLGNLKGGIKDIKKHKW 254

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score =  157 bits (399), Expect = 5e-45
 Identities = 83/253 (32%), Positives = 129/253 (50%), Gaps = 14/253 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLH 163
           I  G FGSV+L + +++G  FA K L+K +         V  E  IM        V  L+
Sbjct: 4   ISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLY 63

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             ++  D  +LVME  +GG     +  +G   E  A     +V+  ++  H  G++HRDI
Sbjct: 64  YSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDI 123

Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAG 282
           KPEN+L+  +G +KL DFGL+    NG       G+P Y+APE + G    +  D WS G
Sbjct: 124 KPENLLIDQTGHLKLTDFGLS---RNGLENKKFVGTPDYLAPETILGVGDDKMSDWWSLG 180

Query: 283 VLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
            ++   L    PF  ++ +AVFD I + ++++   V E  S  A DL+ R+L  D + R+
Sbjct: 181 CVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAKRL 240

Query: 343 TAD---EVLRHPW 352
            A+   E+  HP+
Sbjct: 241 GANGYQEIKSHPF 253

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  155 bits (393), Expect = 3e-44
 Identities = 75/254 (29%), Positives = 132/254 (51%), Gaps = 14/254 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTL 162
           ++IG G FG V+   +  +G   A K +   +      +++ +E++++++L  H  +V  
Sbjct: 6   DLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKY 64

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
               E +D  ++++E    G L   + + G + E   A     V+  + Y H+ GV+HRD
Sbjct: 65  IGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRD 124

Query: 223 IKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
           IK  NIL T  G +KLADFG+A +++   +  + + G+P ++APEV+     S   DIWS
Sbjct: 125 IKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWS 184

Query: 281 AGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
            G  +  LL    P +  + + A+F  I     D H  + E +S   +D + +   +D +
Sbjct: 185 LGCTVIELLTGNPPYYDLNPMAALF-RIVQ---DDHPPLPEGISPELKDFLMQCFQKDPN 240

Query: 340 ARITADEVLRHPWI 353
            R TA ++L+HPWI
Sbjct: 241 LRPTAKQLLKHPWI 254

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  155 bits (393), Expect = 1e-43
 Identities = 82/262 (31%), Positives = 135/262 (51%), Gaps = 30/262 (11%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR---KGEETVHREVEIMQHLSGHTGVVTLHSV 165
           E IG G  G V+    +A+G E A K +R   + +E +  E+ IM+    H  +V  +  
Sbjct: 25  EKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDS 83

Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQY----SEQRAANIFKDVMWVIKYCHDMGVVHR 221
           Y   D   +VME   GG L D ++   Q     +E + A + ++V+  ++Y H   V+HR
Sbjct: 84  YLVGDELWVVMEYMDGGSLTD-IIT--QNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHR 140

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           DIK +NILL+  G +KLADFG A +++  +   + + G+P ++APEV+    Y  KVDIW
Sbjct: 141 DIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIW 200

Query: 280 SAGVLLHALLVAALPFKGDS-LEAVF-------DAIKNVKLDFHSGVWETVSKPARDLMA 331
           S G++   +     P+  +  L A+F         +KN          E  S   +D + 
Sbjct: 201 SLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPPLKNP---------EKWSPEFKDFLN 251

Query: 332 RMLTRDVSARITADEVLRHPWI 353
           + L +D   R +A+E+L+HP++
Sbjct: 252 KCLVKDPEKRPSAEELLQHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score =  152 bits (386), Expect = 2e-42
 Identities = 89/261 (34%), Positives = 137/261 (52%), Gaps = 25/261 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLS--GHTGVV 160
           V+G G FG V L   K +G  +A K L+KG+     EVE       I +  +   H  +V
Sbjct: 6   VLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLV 65

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            L + ++  D    VME  +GG L+   +    +SE RA      V+  ++Y H+  +V+
Sbjct: 66  NLFACFQTEDHVCFVMEYAAGGDLMMH-IHTDVFSEPRAVFYAACVVLGLQYLHENKIVY 124

Query: 221 RDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDI 278
           RD+K +N+LL T G +K+ADFGL    +  G   S   G+P ++APEVL+  +Y+  VD 
Sbjct: 125 RDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDW 184

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKN--VKLDFHSGVWETVSKPARDLMARMLTR 336
           W  GVL++ +LV   PF GD  E VFD+I N  V+          +S+ A  +M R+L R
Sbjct: 185 WGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRF------LSREAISIMRRLLRR 238

Query: 337 DVSARI-----TADEVLRHPW 352
           +   R+      A++V + P+
Sbjct: 239 NPERRLGSGEKDAEDVKKQPF 259

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score =  153 bits (388), Expect = 3e-42
 Identities = 99/271 (36%), Positives = 142/271 (52%), Gaps = 28/271 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR--------EVEIMQHLS 154
           +D   ++VIG G FG V L R K+S   +A K L K  E + R        E +IM H +
Sbjct: 43  EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSK-FEMIKRSDSAFFWEERDIMAH-A 100

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY--SEQRAANIFKDVMWVIKY 212
               +V LH  +++    ++VME   GG L++ M     Y   E+ A     +V+  +  
Sbjct: 101 NSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLM---SNYDIPEKWARFYTAEVVLALDA 157

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA-GSPAYVAPEVL-- 268
            H MG +HRD+KP+N+LL  SG +KLADFG  M++ +NG      A G+P Y++PEVL  
Sbjct: 158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKS 217

Query: 269 ---SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVS 323
               G Y  + D WS GV L+ +LV   PF  DSL   +  I + K  L F   +   +S
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDI--EIS 275

Query: 324 KPARDLMARMLT-RDVS-ARITADEVLRHPW 352
           K A+DL+   LT R+V   R   DE+  HP+
Sbjct: 276 KQAKDLICAFLTDREVRLGRNGVDEIKSHPF 306

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  149 bits (379), Expect = 9e-42
 Identities = 85/298 (28%), Positives = 127/298 (42%), Gaps = 64/298 (21%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+  IG G +G V+  R K +G   A K ++   E      T  RE+++++ L+ H  
Sbjct: 1   YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPN 59

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI----KYCH 214
           ++ L  V+      +LV E        D    +         ++ K  ++ +     +CH
Sbjct: 60  IIKLLDVFRHKGDLYLVFEFM----DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCH 115

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-----------YV 263
             G++HRD+KPEN+L+ T G +KLADFGLA             GSP            Y 
Sbjct: 116 SHGILHRDLKPENLLINTEGVLKLADFGLAR----------SFGSPVRPYTHYVVTRWYR 165

Query: 264 APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI---------- 307
           APE+L     YS  VDIWS G +   LL     F G S    L  +F  +          
Sbjct: 166 APELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPK 225

Query: 308 -----KNVKLDFHSGV---WETV----SKPARDLMARMLTRDVSARITADEVLRHPWI 353
                +N K  F          +    S  A DL+++ML  D   RITA++ L HP+ 
Sbjct: 226 FTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  148 bits (377), Expect = 2e-41
 Identities = 86/291 (29%), Positives = 129/291 (44%), Gaps = 53/291 (18%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGV 159
            K+E +G G +G V+  R K +G   A K +R   E      T  RE+ +++ L  H  +
Sbjct: 2   EKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNI 60

Query: 160 VTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           V L  V       +LV E C     + +D+    G  S     +I   ++  + YCH   
Sbjct: 61  VKLLDVIHTERKLYLVFEYCDMDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR 118

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA------MR--ISNGQTLSGLAGSPAYVAPEVLS 269
           ++HRD+KP+NIL+   G +KLADFGLA      +R       TL        Y APE+L 
Sbjct: 119 ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHEVVTL-------WYRAPEILL 171

Query: 270 G--NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVF--------------DAIKN 309
           G  +YS  VDIWS G +   ++     F GDS    L  +F                + +
Sbjct: 172 GSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPD 231

Query: 310 VKLDFH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            K  F          V   +     DL+++ML  + + RI+A E L+HP+ 
Sbjct: 232 YKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score =  146 bits (371), Expect = 1e-40
 Identities = 82/263 (31%), Positives = 140/263 (53%), Gaps = 20/263 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-------KGEETVHREVEIMQHLSG 155
           DD  +++ +G G FG V L R + S   +A K +        K E+ VH E  +++ +S 
Sbjct: 1   DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS- 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ L     +    +++ME   GG L   +   G++S         +++  ++Y H 
Sbjct: 60  HPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHS 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSE 274
             +V+RD+KPENILL   G IKL DFG A ++ + +T + L G+P Y+APEV+ S  +++
Sbjct: 120 KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRD-RTWT-LCGTPEYLAPEVIQSKGHNK 177

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+ G+L++ +LV   PF  D+   +++ I   KL+F       +   A+DL+ ++L
Sbjct: 178 AVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKKLL 233

Query: 335 TRDVSARI-----TADEVLRHPW 352
             D + R+      AD+V  H W
Sbjct: 234 VVDRTRRLGNMKNGADDVKNHRW 256

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score =  145 bits (367), Expect = 3e-40
 Identities = 73/257 (28%), Positives = 127/257 (49%), Gaps = 12/257 (4%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHTGVVT 161
           +V+V+G G  G V+  R K +G  +A K +    +   R     E++ +        VV 
Sbjct: 5   RVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTL-RSCESPYVVK 63

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVVH 220
            +  + +     +V+E   GG L D + +VG+  E   A I + ++  + Y H    ++H
Sbjct: 64  CYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIH 123

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSG-NYSEKVDI 278
           RDIKP N+L+ + G++K+ADFG++  + N     +   G+  Y++PE + G +YS   DI
Sbjct: 124 RDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADI 183

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW--ETVSKPARDLMARMLTR 336
           WS G+ L    +   PF      + F+ ++ +  D        E  S   RD ++  L +
Sbjct: 184 WSLGLTLLECALGKFPFLPPGQPSFFELMQAI-CDGPPPSLPAEEFSPEFRDFISACLQK 242

Query: 337 DVSARITADEVLRHPWI 353
           D   R +A E+L+HP+I
Sbjct: 243 DPKKRPSAAELLQHPFI 259

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  144 bits (365), Expect = 5e-40
 Identities = 83/274 (30%), Positives = 126/274 (45%), Gaps = 48/274 (17%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLSGHTGVVTLHS 164
           IG G FG V+   +  +G   A K +R      K  + +  E+++++ L  H  +V  + 
Sbjct: 8   IGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYG 66

Query: 165 VYEEADCFHLVMELCSGGRL--------IDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
           V    +  ++ ME CSGG L        I     +  Y+ Q    + + +     Y H  
Sbjct: 67  VEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQ----LLEGLA----YLHSH 118

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-----LSGLAGSPAYVAPEVLSGN 271
           G+VHRDIKP NI L  +G IKL DFG A+++ N  T     +  LAG+PAY+APEV++G 
Sbjct: 119 GIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGG 178

Query: 272 ----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
               +    DIWS G ++  +     P+    L+  F  I      FH G       P  
Sbjct: 179 KGKGHGRAADIWSLGCVVLEMATGKRPWSE--LDNEF-QIM-----FHVGAGHKPPIPDS 230

Query: 328 DLMA--------RMLTRDVSARITADEVLRHPWI 353
             ++        R L  D   R TA E+L+HP++
Sbjct: 231 LQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score =  145 bits (367), Expect = 9e-40
 Identities = 85/258 (32%), Positives = 133/258 (51%), Gaps = 19/258 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHR--EVEIMQHLSGHTGVVT 161
           +++G G FG V L R KA+G  +A K L+K      +E  H   E  ++Q+ + H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQN-TRHPFLTA 59

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H   VV+R
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYR 119

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+K EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y   VD W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             GV+++ ++   LPF     E +F+ I   ++ F      T+S  A+ L+A +L +D  
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPK 235

Query: 340 ARI-----TADEVLRHPW 352
            R+      A E++ H +
Sbjct: 236 QRLGGGPEDAKEIMEHRF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score =  140 bits (356), Expect = 9e-39
 Identities = 75/267 (28%), Positives = 129/267 (48%), Gaps = 27/267 (10%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET--VHREVEIMQHLSGHTGV 159
           E+    +E +G G +GSV+    K +G   A K +   E+   + +E+ I++       +
Sbjct: 2   EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQ-CDSPYI 60

Query: 160 VTLH-SVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMG 217
           V  + S ++  D + +VME C  G + D M       +E+  A I    +  ++Y H   
Sbjct: 61  VKYYGSYFKNTDLW-IVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNK 119

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLSG-NYSEK 275
            +HRDIK  NILL   G+ KLADFG++ ++++       + G+P ++APEV+    Y+ K
Sbjct: 120 KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNK 179

Query: 276 VDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVW--ETVSKPAR----- 327
            DIWS G+    +     P+     + A+F  I N             T+S P +     
Sbjct: 180 ADIWSLGITAIEMAEGKPPYSDIHPMRAIF-MIPN---------KPPPTLSDPEKWSPEF 229

Query: 328 -DLMARMLTRDVSARITADEVLRHPWI 353
            D + + L +D   R +A ++L+HP+I
Sbjct: 230 NDFVKKCLVKDPEERPSAIQLLQHPFI 256

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  140 bits (355), Expect = 3e-38
 Identities = 86/293 (29%), Positives = 126/293 (43%), Gaps = 62/293 (21%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSGHTGVVTL 162
           ++ +G G FGSV+L R+K +G   A K ++K   +       REV+ ++ L+ H  +V L
Sbjct: 4   IKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKL 63

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
             V+ E D  + V E   G  L   M   +   +SE    +I   ++  + + H  G  H
Sbjct: 64  KEVFRENDELYFVFEYMEGN-LYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFH 122

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYV------APEVL--S 269
           RD+KPEN+L++    +K+ADFGLA  I +          P    YV      APE+L  S
Sbjct: 123 RDLKPENLLVSGPEVVKIADFGLAREIRS---------RPPYTDYVSTRWYRAPEILLRS 173

Query: 270 GNYSEKVDIWSAGVLLHALLVAALP-FKGDS----------------------------- 299
            +YS  VDIW+ G ++ A L    P F G S                             
Sbjct: 174 TSYSSPVDIWALGCIM-AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASK 232

Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
           L   F       L     +    S  A DL+  ML  D   R TA + L+HP+
Sbjct: 233 LGFRFPQFAPTSLHQ---LIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPY 282

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  139 bits (354), Expect = 4e-38
 Identities = 82/300 (27%), Positives = 130/300 (43%), Gaps = 68/300 (22%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           K+  IG G +G V+  R+K +G   A K +R   E      T  RE++++Q L  H  +V
Sbjct: 3   KIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIV 61

Query: 161 TLHSVYEEADC--FHLVMELC----SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            L  +         ++V E      +G  L+D      +++E +     K ++  ++Y H
Sbjct: 62  RLKEIVTSKGKGSIYMVFEYMDHDLTG--LLDS--PEVKFTESQIKCYMKQLLEGLQYLH 117

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---------TLSGLAGSPAYVAP 265
             G++HRDIK  NIL+   G +KLADFGLA   +            TL        Y  P
Sbjct: 118 SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVITL-------WYRPP 170

Query: 266 EVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI------------ 307
           E+L G   Y  +VD+WS G +L  L +    F+G +    LE +F+              
Sbjct: 171 ELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVS 230

Query: 308 --------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                         K    +F   +   +   A DL+ ++LT D   RI+AD+ L+H + 
Sbjct: 231 KLPWFENLKPKKPYKRRLREFFKHL---IDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  139 bits (351), Expect = 5e-38
 Identities = 82/258 (31%), Positives = 127/258 (49%), Gaps = 14/258 (5%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETV---HREVEIMQHLSGHT 157
           K E++G G FGSV+   +   G  FA K +      + G+E V    +E+ ++  L  H 
Sbjct: 4   KGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HP 62

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V       E D  ++ +EL  GG L   + + G + E       + ++  ++Y HD  
Sbjct: 63  NIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL--SGNYSEK 275
            VHRDIK  NIL+ T+G +KLADFG+A ++          GSP ++APEV+   G Y   
Sbjct: 123 TVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLA 182

Query: 276 VDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
            DIWS G  +  +     P+    LE V    K  +      + + +S  A+D + + L 
Sbjct: 183 ADIWSLGCTVLEMATGKPPWS--QLEGVAAVFKIGRSKELPPIPDHLSDEAKDFILKCLQ 240

Query: 336 RDVSARITADEVLRHPWI 353
           RD S R TA E+L HP++
Sbjct: 241 RDPSLRPTAAELLEHPFV 258

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  138 bits (351), Expect = 6e-38
 Identities = 80/274 (29%), Positives = 122/274 (44%), Gaps = 33/274 (12%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR------EVEIMQHLSGHT 157
           D+  +E IG G FG+V   R K+ G     K +  G  T         EV I++ L  H 
Sbjct: 1   DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HP 59

Query: 158 GVVTL--HSVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAA-NIFKDVMWVIK 211
            +V      +       ++VME C GG   +LI +  +  +Y E+     I   ++  + 
Sbjct: 60  NIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALY 119

Query: 212 YCH-----DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAP 265
            CH        V+HRD+KP NI L  +  +KL DFGLA  + +  +      G+P Y++P
Sbjct: 120 ECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSP 179

Query: 266 EVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----FHSGVW 319
           E L+   Y EK DIWS G L++ L   + PF   +   +   IK  K       + S + 
Sbjct: 180 EQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIPYRYSSELN 239

Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           E +          ML  D   R + +E+L+ P I
Sbjct: 240 EVIKS--------MLNVDPDKRPSTEELLQLPLI 265

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score =  140 bits (355), Expect = 6e-38
 Identities = 78/258 (30%), Positives = 135/258 (52%), Gaps = 22/258 (8%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
           E +G G FG V + + K +G  +A K L+K E       + V +E  I+  LS H  +V 
Sbjct: 24  ETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVN 82

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           +   +++ +  + ++E   GG L   + + G++    A     +++   +Y H   +++R
Sbjct: 83  MMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYR 142

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
           D+KPEN+LL   G +K+ DFG A ++ + +T + L G+P Y+APEV+ S  + + VD W+
Sbjct: 143 DLKPENLLLDNKGHVKVTDFGFAKKVPD-RTFT-LCGTPEYLAPEVIQSKGHGKAVDWWT 200

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+  +    PF  D+   +++ I   +L F +  W      ARDL+  +L  D + 
Sbjct: 201 MGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFPN--W--FDGRARDLVKGLLQTDHTK 256

Query: 341 RI------TADEVLRHPW 352
           R+       AD V  HP+
Sbjct: 257 RLGTLKGGVAD-VKNHPY 273

Length = 329

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score =  138 bits (350), Expect = 1e-37
 Identities = 85/256 (33%), Positives = 136/256 (53%), Gaps = 16/256 (6%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTLH 163
           +G G FG V  C+ KA+G  +ACK L       RKGE+    E +I++ +S    +V+L 
Sbjct: 1   LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRF-IVSLA 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHR 221
             +E  D   LVM L +GG L   +  VG+  + E RA      ++  +++ H   +V+R
Sbjct: 60  YAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYR 119

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           D+KPEN+LL   G ++++D GLA+ +  G+ + G AG+P Y+APEVL G  Y   VD ++
Sbjct: 120 DLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFA 179

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            G  L+ ++    PF+    +   + +K   L+      +  S  A+DL   +L +D   
Sbjct: 180 LGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK 239

Query: 341 RI-----TADEVLRHP 351
           R+     +ADEV  HP
Sbjct: 240 RLGCRGGSADEVREHP 255

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  139 bits (352), Expect = 1e-37
 Identities = 84/299 (28%), Positives = 130/299 (43%), Gaps = 69/299 (23%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---------TVHREVEIMQHLSGH 156
            K + +G G +  V+  R K +G   A K ++ GE          T  RE++++Q L  H
Sbjct: 3   EKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-H 61

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWV----I 210
             ++ L  V+      +LV E       ++I     V   +    A+I K  M +    +
Sbjct: 62  PNIIGLLDVFGHKSNINLVFEFMETDLEKVIKDKSIV--LT---PADI-KSYMLMTLRGL 115

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--------- 261
           +Y H   ++HRD+KP N+L+ + G +KLADFGLA             GSP          
Sbjct: 116 EYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSF----------GSPNRKMTHQVVT 165

Query: 262 --YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKN---- 309
             Y APE+L G  +Y   VD+WS G +   LL+      GDS    L  +F+A+      
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225

Query: 310 -----------VKLDFHSG-----VWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                      V+           ++   S  A DL+ R+LT + + RITA + L HP+
Sbjct: 226 NWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score =  137 bits (347), Expect = 4e-37
 Identities = 89/254 (35%), Positives = 138/254 (54%), Gaps = 17/254 (6%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V + R K SG + A K   LRK +  E +  EV IM+    H  VV ++  Y
Sbjct: 29  IGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSY 87

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              +   ++ME   GG L D + +  + +E++ A + + V+  + Y H  GV+HRDIK +
Sbjct: 88  LVGEELWVLMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSD 146

Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVL 284
           +ILLT  G++KL+DFG   +IS        L G+P ++APEV+S   Y  +VDIWS G++
Sbjct: 147 SILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIM 206

Query: 285 LHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
           +  ++    P+  DS    ++ + D+      + H      +S   RD + RMLTR+   
Sbjct: 207 VIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK-----ISPVLRDFLERMLTREPQE 261

Query: 341 RITADEVLRHPWIL 354
           R TA E+L HP++L
Sbjct: 262 RATAQELLDHPFLL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score =  136 bits (345), Expect = 5e-37
 Identities = 85/283 (30%), Positives = 139/283 (49%), Gaps = 33/283 (11%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE---ETVHREVEIMQHLSGHT 157
           +  T +E IG G FG V+    K +    A K   L + E   E + +E++    LS   
Sbjct: 1   ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQF---LS--- 54

Query: 158 GVVTLHSVY--EEADCF------HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
                 S Y  +    F       ++ME C GG  +D +++ G+  E   A I ++V+  
Sbjct: 55  ---QCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLD-LLKPGKLDETYIAFILREVLLG 110

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVL 268
           ++Y H+ G +HRDIK  NILL+  G +KLADFG++ ++++  +  +   G+P ++APEV+
Sbjct: 111 LEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVI 170

Query: 269 S-GNYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNV--KLDFHSGVWETVSK 324
               Y EK DIWS G+    L     P      +  +F   KN    L+ +       SK
Sbjct: 171 KQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNK-----FSK 225

Query: 325 PARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIK 367
           P +D ++  L +D   R +A E+L+H +I    + +  TL I+
Sbjct: 226 PFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKTSYLTLLIE 268

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score =  137 bits (347), Expect = 6e-37
 Identities = 87/256 (33%), Positives = 134/256 (52%), Gaps = 19/256 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSGHTGVVT 161
           +++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + H  +  
Sbjct: 1   KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TRHPFLTA 59

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H   VV+R
Sbjct: 60  LKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYR 119

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           DIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y   VD W
Sbjct: 120 DIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             GV+++ ++   LPF     E +F+ I   ++ F      T+S  A+ L+A +L +D  
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPK 235

Query: 340 ARI-----TADEVLRH 350
            R+      A EV+ H
Sbjct: 236 QRLGGGPSDAKEVMEH 251

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score =  137 bits (346), Expect = 8e-37
 Identities = 85/265 (32%), Positives = 140/265 (52%), Gaps = 22/265 (8%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
            V+G G FG V L R K SG  +A K L+K         E    E  I+     H  +  
Sbjct: 1   RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+  ++  D    VME  +GG L+  + +  ++ E RA     ++   + + HD G+++R
Sbjct: 61  LYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+K +N+LL   G  KLADFG+    I NG+T S   G+P Y+APE+L    Y   VD W
Sbjct: 121 DLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           + GVLL+ +L    PF+ ++ + +F+AI N ++ + +  W  +S+ A D++   +T++ +
Sbjct: 181 AMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPT--W--LSQDAVDILKAFMTKNPT 236

Query: 340 ARITA------DEVLRHPWILFYTE 358
            R+ +      + +LRHP   F+ E
Sbjct: 237 MRLGSLTLGGEEAILRHP---FFKE 258

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score =  134 bits (340), Expect = 2e-36
 Identities = 82/268 (30%), Positives = 126/268 (47%), Gaps = 18/268 (6%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGHT 157
           DD+  +EVIG G    V+      +  + A K +     +   + + +EV+ M     H 
Sbjct: 1   DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMS-QCNHP 59

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQM---VEVGQYSEQRAANIFKDVMWVIKYCH 214
            VV  ++ +   D   LVM   SGG L+D M      G   E   A + K+V+  ++Y H
Sbjct: 60  NVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLH 119

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGL-AMRISNGQTLSG----LAGSPAYVAPEVLS 269
             G +HRDIK  NILL   G +K+ADFG+ A     G           G+P ++APEV+ 
Sbjct: 120 SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVME 179

Query: 270 --GNYSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDFHSGVWETV-SKP 325
               Y  K DIWS G+    L   A P+ K   ++ +   ++N      +G      SK 
Sbjct: 180 QVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS 239

Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
            R +++  L +D S R TA+E+L+H + 
Sbjct: 240 FRKMISLCLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score =  134 bits (339), Expect = 4e-36
 Identities = 85/252 (33%), Positives = 135/252 (53%), Gaps = 13/252 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   K++G + A K   LRK +  E +  EV IM+    H  +V ++S Y
Sbjct: 27  IGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSY 85

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  + + H  GV+HRDIK +
Sbjct: 86  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSD 144

Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVL 284
           +ILLT+ G++KL+DFG   ++S        L G+P ++APEV+S   Y  +VDIWS G++
Sbjct: 145 SILLTSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 204

Query: 285 LHALLVAALPFKGDSLEAVFDAIKNVKLDF--HSGVWETVSKPARDLMARMLTRDVSARI 342
           +  ++    P+  +       A+K ++ +          VS   R  + RML RD + R 
Sbjct: 205 VIEMVDGEPPYFNEP---PLQAMKRIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA 261

Query: 343 TADEVLRHPWIL 354
           TA E+L HP++ 
Sbjct: 262 TAAELLNHPFLA 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score =  134 bits (340), Expect = 6e-36
 Identities = 86/255 (33%), Positives = 136/255 (53%), Gaps = 18/255 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG--------EET-VHREVEIMQHLSGHTGVV 160
           V+G G FG V L   K +   FA K L+K         E T V R V  +     H  + 
Sbjct: 2   VLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALA--WEHPFLT 59

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            L   ++  +    VME  +GG L+  +   G++ E RA     +++  +++ H  G+++
Sbjct: 60  HLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIY 119

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RD+K +N+LL   G IK+ADFG+     NG+   S   G+P Y+APE+L G  Y+E VD 
Sbjct: 120 RDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDW 179

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           WS GVLL+ +L+   PF G+  + +FD+I N +  F       +SK A+D ++++  RD 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDP 235

Query: 339 SARITADEVLR-HPW 352
           + R+  D  +R HP+
Sbjct: 236 TKRLGVDGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score =  136 bits (343), Expect = 6e-36
 Identities = 97/277 (35%), Positives = 139/277 (50%), Gaps = 26/277 (9%)

Query: 99  NKIED------DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR------- 145
           NKI D      D+  V+VIG G FG V L R K++   +A K L K E  + R       
Sbjct: 33  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFE-MIKRSDSAFFW 91

Query: 146 -EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK 204
            E +IM   +    VV L   +++    ++VME   GG L++ M       E+ A     
Sbjct: 92  EERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTA 149

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLA-GSPAY 262
           +V+  +   H MG +HRD+KP+N+LL  SG +KLADFG  M+++  G      A G+P Y
Sbjct: 150 EVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDY 209

Query: 263 VAPEVLS-----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG 317
           ++PEVL      G Y  + D WS GV L+ +LV   PF  DSL   +  I N K      
Sbjct: 210 ISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFP 269

Query: 318 VWETVSKPARDLMARMLT-RDVS-ARITADEVLRHPW 352
               +SK A++L+   LT R+V   R   +E+ RH +
Sbjct: 270 DDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score =  133 bits (337), Expect = 7e-36
 Identities = 85/261 (32%), Positives = 135/261 (51%), Gaps = 24/261 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V  C+ +A+G  +ACK L       RKGE     E +I++ ++    VV+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRF-VVSL 65

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVH 220
              YE  D   LV+ L +GG L   +  +G   + E+RA     ++   ++  H   +V+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVY 125

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           RD+KPENILL   G I+++D GLA+ I  G+T+ G  G+  Y+APEV+    Y+   D W
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWW 185

Query: 280 SAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
             G L++ ++    PF+        E V   +K  + ++     E  S+ AR +  ++LT
Sbjct: 186 GLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYS----EKFSEAARSICRQLLT 241

Query: 336 RDVSARI-----TADEVLRHP 351
           +D   R+      A+EV  HP
Sbjct: 242 KDPGFRLGCRGEGAEEVKAHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score =  134 bits (340), Expect = 8e-36
 Identities = 77/264 (29%), Positives = 127/264 (48%), Gaps = 21/264 (7%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS--------G 155
           D   +  +G G +G V+L + K +G   A K ++K    + +  E+   L+         
Sbjct: 2   DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKK--SLLFKLNEVRHVLTERDILTTTK 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++ +  +L ME   GG     +  +G  SE  A     ++   +   H+
Sbjct: 60  SEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHE 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSG-NYS 273
           +G +HRD+KPEN L+  SG IKL DFGL+       T +  + GSP Y+APEVL G  Y 
Sbjct: 120 LGYIHRDLKPENFLIDASGHIKLTDFGLS---KGIVTYANSVVGSPDYMAPEVLRGKGYD 176

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET----VSKPARDL 329
             VD WS G +L+  L    PF G +    ++ +K  K      V++     +S  A DL
Sbjct: 177 FTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDL 236

Query: 330 MARMLTRDVSARITA-DEVLRHPW 352
           + +++  D S R  + +++  HP+
Sbjct: 237 ITKLIN-DPSRRFGSLEDIKNHPF 259

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score =  134 bits (338), Expect = 2e-35
 Identities = 87/269 (32%), Positives = 132/269 (49%), Gaps = 23/269 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETV---HREVEIMQHLSG 155
            D     ++G G FG V + R KA+G  +A K ++K     +ETV     E +I+  +S 
Sbjct: 1   KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISN 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCH 214
              +  L   +++ D  +LVME   GG L+  +     Q+ E  A     +++  I   H
Sbjct: 60  SPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVH 119

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGL-AGSPAYVAPEVLS--- 269
            MG VHRDIKPEN+L+  +G IKLADFG A R++ N    S L  G+P Y+APEVL+   
Sbjct: 120 QMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMN 179

Query: 270 ----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVS 323
               G Y  + D WS GV+ + ++    PF   +    ++ I N +  L F       VS
Sbjct: 180 GDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDP--KVS 237

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPW 352
               DL+  +L      R+  + +  HP+
Sbjct: 238 SDFLDLIQSLLC-GQKERLGYEGLCCHPF 265

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  132 bits (334), Expect = 3e-35
 Identities = 91/296 (30%), Positives = 136/296 (45%), Gaps = 51/296 (17%)

Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQH 152
           NK E     + V+G G +G V  CR+KA+G   A K  ++ E+         REV++++ 
Sbjct: 1   NKYE----VLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQ 56

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW---- 208
           L  H  +V L   +      +LV E     R + +++E         A   +  +W    
Sbjct: 57  LR-HENIVNLKEAFRRKGRLYLVFEYV--ERTLLELLEASPGGLPPDA--VRSYIWQLLQ 111

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPAYVAPE 266
            I YCH   ++HRDIKPENIL++ SG +KL DFG A  +R      L+    +  Y APE
Sbjct: 112 AIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPE 171

Query: 267 VLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS--------LEAVFDAIKNVKLDFHS 316
           +L G  NY + VD+W+ G ++  LL     F GDS         + +     + +  F S
Sbjct: 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSS 231

Query: 317 -----GVW-------ET--------VSKPARDLMARMLTRDVSARITADEVLRHPW 352
                GV        E+        VS PA D +   L  D   R+T DE+L+HP+
Sbjct: 232 NPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPY 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score =  133 bits (336), Expect = 3e-35
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 20/260 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
           +V+G G FG V L   K +   +A K L+K         +    E  I+   + H  +  
Sbjct: 1   KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           LH  ++  D    VME  +GG L+ Q+    ++ E R+     +V   + + H  GV++R
Sbjct: 61  LHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIW 279
           D+K +NILL   G  KLADFG+    I NG T +   G+P Y+APE+L    Y   VD W
Sbjct: 121 DLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           + GVL++ ++    PF+ D+ + +F++I +   D    VW  +SK A  ++   +T++ +
Sbjct: 181 ALGVLMYEMMAGQPPFEADNEDDLFESILHD--DVLYPVW--LSKEAVSILKAFMTKNPN 236

Query: 340 ARI-------TADEVLRHPW 352
            R+         D + +HP+
Sbjct: 237 KRLGCVASQGGEDAIKQHPF 256

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score =  132 bits (333), Expect = 5e-35
 Identities = 79/255 (30%), Positives = 136/255 (53%), Gaps = 16/255 (6%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ------HLSGHTGVVT- 161
           +V+G G FG V L   K  G  FA K L+K    +  +VE          L+     +T 
Sbjct: 1   KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+  ++  +    VME  +GG L+  + + G++   RA     +++  +++ H  G+++R
Sbjct: 61  LYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIW 279
           D+K +N++L   G IK+ADFG+      G    S   G+P Y+APE+L G  Y+  VD W
Sbjct: 121 DLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-HSGVWETVSKPARDLMARMLTRDV 338
           S GVLL+ +L+   PF GD  + +F++I   ++D  H   W  ++K ++D++ ++  RD 
Sbjct: 181 SFGVLLYEMLIGQSPFHGDDEDELFESI---RVDTPHYPRW--ITKESKDILEKLFERDP 235

Query: 339 SARITADEVLR-HPW 352
           + R+     +R HP+
Sbjct: 236 TRRLGVVGNIRGHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  131 bits (331), Expect = 7e-35
 Identities = 80/280 (28%), Positives = 126/280 (45%), Gaps = 41/280 (14%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACK--TLRKGEE----TVHREVEIMQHLSGHTGVVTLHS 164
           IG G  G V+  + + +G   A K   LR+ E        RE++ +Q    H  VV L  
Sbjct: 8   IGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLD 66

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
           V+     F LVME      L + + +  +   E +  +  + ++  + Y H  G++HRD+
Sbjct: 67  VFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDL 125

Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG--NYSEKVDI 278
           KP N+L++  G +K+ADFGLA R+ + +     S    +  Y APE+L G   Y   VD+
Sbjct: 126 KPANLLISADGVLKIADFGLA-RLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDL 184

Query: 279 WSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGV---------------- 318
           W+ G +   LL  +  F G++    L  VF  +     +   G+                
Sbjct: 185 WAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKP 244

Query: 319 --WET----VSKPARDLMARMLTRDVSARITADEVLRHPW 352
              E      S  A DL+  +L  D S R++A E LRHP+
Sbjct: 245 IPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPY 284

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score =  130 bits (328), Expect = 1e-34
 Identities = 82/259 (31%), Positives = 134/259 (51%), Gaps = 16/259 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V  C+ +A+G  +ACK L       RKGE     E +I++ ++    VV L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQF-VVNL 65

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVH 220
              YE  D   LV+ + +GG L   +  +G   + E+RA     +++  ++  H    V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVY 125

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           RD+KPENILL   G I+++D GLA++I  G+++ G  G+  Y+APEVL+   Y+   D W
Sbjct: 126 RDLKPENILLDDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYW 185

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             G L++ ++    PF+G   +   + +    L+         S+ A+ +   +LT+D  
Sbjct: 186 GLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLLTKDPK 245

Query: 340 ARI-----TADEVLRHPWI 353
            R+      A EV RHP+ 
Sbjct: 246 QRLGCQEEGAGEVKRHPFF 264

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score =  130 bits (327), Expect = 2e-34
 Identities = 83/257 (32%), Positives = 131/257 (50%), Gaps = 16/257 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V  C+ +A+G  +ACK L       RKGE     E +I++ ++    VV+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRF-VVSL 65

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVH 220
              YE  D   LV+ L +GG L   +  +G+  + E RA     ++   ++  H   +V+
Sbjct: 66  AYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVY 125

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           RD+KPENILL   G I+++D GLA+ +  GQT+ G  G+  Y+APEV+    Y+   D W
Sbjct: 126 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 185

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           + G LL+ ++    PF+    +   + ++ +  +      E  S  AR L   +L +D  
Sbjct: 186 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSEKFSPDARSLCKMLLCKDPK 245

Query: 340 ARI-----TADEVLRHP 351
            R+      A EV  HP
Sbjct: 246 ERLGCQGGGAREVKEHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score =  129 bits (325), Expect = 2e-34
 Identities = 78/266 (29%), Positives = 133/266 (50%), Gaps = 28/266 (10%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFA------CKTLRKGEETVHREVEIMQHLSGHTG 158
           + KV+ IG G FG   L +SK  G ++        K   K  E   +EV ++ ++  H  
Sbjct: 2   YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPN 60

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL---IDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           +V     +EE    ++VM+ C GG L   I+    V  + E +  + F  +   +K+ HD
Sbjct: 61  IVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGV-LFPEDQILDWFVQICLALKHVHD 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-GSPAYVAPEVLSGN-YS 273
             ++HRDIK +NI LT  G IKL DFG+A  +++   L+    G+P Y++PE+     Y+
Sbjct: 120 RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYN 179

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDA--IKNVKLDFHSGVWETV----SKPAR 327
            K DIW+ G +L+ +          +L+  F+A  +KN+ L    G +  V    S   R
Sbjct: 180 NKSDIWALGCVLYEMC---------TLKHAFEAGNMKNLVLKIIRGSYPPVSSHYSYDLR 230

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           +L++++  R+   R + + +L   +I
Sbjct: 231 NLVSQLFKRNPRDRPSVNSILEKNFI 256

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score =  130 bits (329), Expect = 2e-34
 Identities = 82/270 (30%), Positives = 138/270 (51%), Gaps = 22/270 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT--------GVVTL 162
           IG G FG V   R + +   +A KT+RK    V R  E+   L+  T         +V L
Sbjct: 1   IGKGSFGKVMQVRKRDTQRIYALKTIRKAH-IVSRS-EVTHTLAERTVLAQVNCPFIVPL 58

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
              ++  +  +LV+   +GG L   +   G++   RA     +++  ++  H   V++RD
Sbjct: 59  KFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRD 118

Query: 223 IKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +KPENILL   G I L DFGL  + + +    +   G+P Y+APE+L G+ Y++ VD W+
Sbjct: 119 LKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWT 178

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+ +L    PF  +++  ++  I    L F  G      + A+DL+  +L+RD + 
Sbjct: 179 LGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDG----FDRDAKDLLIGLLSRDPTR 234

Query: 341 RI---TADEVLRHPWILFYTERTLRTLTIK 367
           R+    A E+  HP   F+++ + + L +K
Sbjct: 235 RLGYNGAQEIKNHP---FFSQLSWKKLLMK 261

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score =  131 bits (330), Expect = 4e-34
 Identities = 95/269 (35%), Positives = 139/269 (51%), Gaps = 24/269 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR--------EVEIMQHLS 154
           +D+  V+VIG G FG V L R K+S   +A K L K E  + R        E +IM   +
Sbjct: 43  EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFE-MIKRSDSAFFWEERDIMA-FA 100

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
               VV L   +++    ++VME   GG L++ M       E+ A     +V+  +   H
Sbjct: 101 NSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIH 159

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA-GSPAYVAPEVLS--- 269
            MG++HRD+KP+N+LL   G +KLADFG  M++   G      A G+P Y++PEVL    
Sbjct: 160 SMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQG 219

Query: 270 --GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVSKP 325
             G Y  + D WS GV L  +LV   PF  DSL   +  I + K  L+F   V   +SK 
Sbjct: 220 GDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDV--EISKH 277

Query: 326 ARDLMARMLT-RDVS-ARITADEVLRHPW 352
           A++L+   LT R+V   R   +E+ +HP+
Sbjct: 278 AKNLICAFLTDREVRLGRNGVEEIKQHPF 306

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score =  129 bits (325), Expect = 6e-34
 Identities = 83/279 (29%), Positives = 144/279 (51%), Gaps = 29/279 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACK-------TLRKGEETVHREVEIMQHLSG 155
           +D   +++I +G +G+V+L R K +   FA K        LR   + V  E +I+   + 
Sbjct: 1   EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAE 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           +  VV++   +E      +VME   GG     +  +G      A   F + +  ++Y H+
Sbjct: 60  NPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHN 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTL---------------SGLAGS 259
            G+VHRD+KP+N+L+T+ G IKL DFGL+ + + +  T                  + G+
Sbjct: 120 YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGT 179

Query: 260 PAYVAPEV-LSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV 318
           P Y+APEV L   Y + VD W+ G++L+  LV  +PF GD+ E +F  + +  +++  G 
Sbjct: 180 PEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD 239

Query: 319 WETVSKPARDLMARMLTRDVSARI---TADEVLRHPWIL 354
            E +   A+DL++R+L ++   R+    A EV +H + L
Sbjct: 240 -EALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score =  128 bits (322), Expect = 1e-33
 Identities = 81/256 (31%), Positives = 135/256 (52%), Gaps = 11/256 (4%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A K +    +  +E +  E+ +M+    H  +V
Sbjct: 21  YTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIV 79

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E     E + A + ++ +  +++ H   V+H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQVIH 138

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLS-GNYSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 279 WSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMD 256

Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+HP++
Sbjct: 257 VEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  129 bits (326), Expect = 1e-33
 Identities = 78/300 (26%), Positives = 123/300 (41%), Gaps = 68/300 (22%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGHTGVVT 161
           ++ IG G +G V     K +G + A K +    + +       RE+++++HL  H  ++ 
Sbjct: 5   LKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHL-RHENIIG 63

Query: 162 LHSVY--EEADCFH---LVMELC---------SGGRLIDQMVEVGQYSEQRAANIFKDVM 207
           L  +      + F+   +V EL          S   L D  ++   Y   R         
Sbjct: 64  LLDILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTDDHIQYFLYQILRG-------- 115

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV---- 263
             +KY H   V+HRD+KP NIL+ ++  +K+ DFGLA R  +         +  YV    
Sbjct: 116 --LKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLA-RGVDPDEDEKGFLTE-YVVTRW 171

Query: 264 --APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKLDFH 315
             APE+L  S  Y++ +DIWS G +   LL     F G    D L  + + +     +  
Sbjct: 172 YRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDL 231

Query: 316 SGV-------------------WETV----SKPARDLMARMLTRDVSARITADEVLRHPW 352
             +                      +    S  A DL+ +ML  D   RITADE L HP+
Sbjct: 232 KFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPY 291

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score =  127 bits (321), Expect = 1e-33
 Identities = 75/260 (28%), Positives = 131/260 (50%), Gaps = 15/260 (5%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-----VHREVEIMQHL--SGHT 157
           + ++E+IG G +G+V+  +   +G   A K +           + REV ++  L  S   
Sbjct: 3   YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPP 62

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +   +  Y +     ++ME   GG +   M + G  +E+  + I ++V+  +KY H +G
Sbjct: 63  NITKYYGSYLKGPRLWIIMEYAEGGSVRTLM-KAGPIAEKYISVIIREVLVALKYIHKVG 121

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN--YSE 274
           V+HRDIK  NIL+T +G +KL DFG+A  +  N    S   G+P ++APEV++    Y  
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDT 181

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS G+ ++ +     P+   D+  A+    K+         +   SK  R+ +A  
Sbjct: 182 KADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLEDNGY---SKLLREFVAAC 238

Query: 334 LTRDVSARITADEVLRHPWI 353
           L  +   R++A+E+L+  WI
Sbjct: 239 LDEEPKERLSAEELLKSKWI 258

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (320), Expect = 1e-33
 Identities = 86/267 (32%), Positives = 134/267 (50%), Gaps = 24/267 (8%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK--TLRKGE--ETVHREVEIMQHLSGHT 157
           ++D+  ++ IG G +G V+  R  A+G   A K   L  G+  E + +E+ +++    H 
Sbjct: 2   QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HP 60

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            +V     Y   D   +VME C GG L D   V  G  SE + A + ++ +  + Y H+ 
Sbjct: 61  NIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHET 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEVLS---- 269
           G +HRDIK  NILLT  G +KLADFG++ +++   T++      G+P ++APEV +    
Sbjct: 121 GKIHRDIKGANILLTEDGDVKLADFGVSAQLTA--TIAKRKSFIGTPYWMAPEVAAVERK 178

Query: 270 GNYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNV----KLDFHSGVWETVSK 324
           G Y  K DIW+ G+    L     P F    + A+F   K+     KL      W   S 
Sbjct: 179 GGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLK-DKEKW---SP 234

Query: 325 PARDLMARMLTRDVSARITADEVLRHP 351
              D + + LT+D   R TA ++L+HP
Sbjct: 235 VFHDFIKKCLTKDPKKRPTATKLLQHP 261

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score =  128 bits (322), Expect = 2e-33
 Identities = 81/258 (31%), Positives = 133/258 (51%), Gaps = 19/258 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSGHTGVVT 161
           +++G G FG V L R KASG  +A K L+K      +E  H   E  ++++ + H  + +
Sbjct: 1   KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKN-TRHPFLTS 59

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L   ++  D    VME  +GG L   +     +SE R      +++  + Y H   +V+R
Sbjct: 60  LKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYR 119

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+K EN++L   G IK+ DFGL    I++  T+    G+P Y+APEVL  N Y   VD W
Sbjct: 120 DLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 179

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             GV+++ ++   LPF     E +F+ I    + F      T+S  A+ L++ +L +D +
Sbjct: 180 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKDPN 235

Query: 340 ARI-----TADEVLRHPW 352
            R+      A E++RH +
Sbjct: 236 KRLGGGPDDAKEIMRHSF 253

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score =  127 bits (320), Expect = 2e-33
 Identities = 87/251 (34%), Positives = 138/251 (54%), Gaps = 13/251 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   K +G + A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 30  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSY 88

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  + Y H+ GV+HRDIK +
Sbjct: 89  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 147

Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVL 284
           +ILLT+ G+IKL+DFG   ++S        L G+P ++APEV+S   Y  +VDIWS G++
Sbjct: 148 SILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 207

Query: 285 LHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET--VSKPARDLMARMLTRDVSARI 342
           +  ++    P+     E    A++ ++ +    V ++  VS   R  +  ML R+ S R 
Sbjct: 208 VIEMIDGEPPYFN---EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLMLVREPSQRA 264

Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 265 TAQELLQHPFL 275

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score =  127 bits (322), Expect = 3e-33
 Identities = 84/269 (31%), Positives = 133/269 (49%), Gaps = 20/269 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGH 156
           DD   ++VIG G FG V + + K +G  +A K L K       E    RE   +      
Sbjct: 1   DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHD 215
             +  LH  +++ +  +LVM+   GG L+  + +   +  E  A     +++  I   H 
Sbjct: 61  RWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQ 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA-GSPAYVAPEVL----- 268
           +G VHRDIKP+N+LL  +G I+LADFG  +R+ ++G   S +A G+P Y++PE+L     
Sbjct: 121 LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMED 180

Query: 269 -SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVSKP 325
             G Y  + D WS GV ++ +L    PF  +SL   +  I N K    F   V   VS+ 
Sbjct: 181 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPPDV-TDVSEE 239

Query: 326 ARDLMARMLTRDVS--ARITADEVLRHPW 352
           A+DL+ R++    +   R    +   HP+
Sbjct: 240 AKDLIRRLICSPETRLGRNGLQDFKDHPF 268

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score =  125 bits (317), Expect = 4e-33
 Identities = 80/271 (29%), Positives = 128/271 (47%), Gaps = 25/271 (9%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSGHT 157
           DD   +  +G G  G V     + +G   A KT+R            RE++I+       
Sbjct: 1   DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHK-CNSP 59

Query: 158 GVVTLH-SVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCH- 214
            +V  + + Y   D   + ME   GG L   + EV G+  E+    I   V+  + Y H 
Sbjct: 60  YIVGFYGAFYNNGDIS-ICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHE 118

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
              ++HRD+KP NIL+ + G+IKL DFG++ ++ N    +   G+ +Y+APE + GN YS
Sbjct: 119 KHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-FVGTSSYMAPERIQGNDYS 177

Query: 274 EKVDIWSAGVLLHALLVAALPFK--GDSLEAVFDAIKNV------KLDFHSGVWETVSKP 325
            K DIWS G+ L  L     P+    D  + +F+ ++ +      +L   SG +   S  
Sbjct: 178 VKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP--SGKF---SPD 232

Query: 326 ARDLMARMLTRDVSARITADEVLRHPWILFY 356
            +D +   L +D   R +  E+L HP+I  Y
Sbjct: 233 FQDFVNLCLIKDPRERPSYKELLEHPFIKKY 263

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score =  128 bits (323), Expect = 4e-33
 Identities = 87/302 (28%), Positives = 130/302 (43%), Gaps = 57/302 (18%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTG 158
            K++ IG G FG V L R   + A +A KTLRK +         V  E +I+   + +  
Sbjct: 4   VKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAE-ADNEW 62

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           VV L+  +++ D  + VM+   GG ++  ++ +G + E  A     ++   I+  H MG 
Sbjct: 63  VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122

Query: 219 VHRDIKPENILLTTSGKIKLADFGL----------------------------------- 243
           +HRDIKP+NIL+   G IKL DFGL                                   
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDR 182

Query: 244 ---------AMRISNGQTLSGLAGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLVAAL 293
                      R         L G+P Y+APEVL    Y++  D WS GV+L+ +LV   
Sbjct: 183 CRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQP 242

Query: 294 PFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI---TADEVLRH 350
           PF  D+       + N +   H      +S+ A DL+ R L      R+    ADE+  H
Sbjct: 243 PFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILR-LCCGAEDRLGKNGADEIKAH 301

Query: 351 PW 352
           P+
Sbjct: 302 PF 303

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  125 bits (315), Expect = 6e-33
 Identities = 73/259 (28%), Positives = 129/259 (49%), Gaps = 21/259 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---------REVEIMQHLSGHTGVVT 161
           +G G FG V+LC    +G E A K +    ++            E++++++L  H  +V 
Sbjct: 10  LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQ 68

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
            +    + +   + ME   GG + DQ+   G  +E       + ++  ++Y H   +VHR
Sbjct: 69  YYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHR 128

Query: 222 DIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPAYVAPEVLSGN-YSEKV 276
           DIK  NIL  ++G +KL DFG + R+    S+G  +  + G+P +++PEV+SG  Y  K 
Sbjct: 129 DIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKA 188

Query: 277 DIWSAGVLLHALLVAALPFKG-DSLEAVFD-AIKNVKLDFHSGVWETVSKPARDLMARML 334
           D+WS G  +  +L    P+   +++ A+F  A +       S     VS  AR+ + R  
Sbjct: 189 DVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPQLPSH----VSPDARNFLRRTF 244

Query: 335 TRDVSARITADEVLRHPWI 353
             +   R +A+E+LRH ++
Sbjct: 245 VENAKKRPSAEELLRHFFV 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score =  126 bits (319), Expect = 7e-33
 Identities = 81/263 (30%), Positives = 133/263 (50%), Gaps = 23/263 (8%)

Query: 108 VEVIGHGKFGSVWLCR---SKASGAEFACKTLRKG------EETVHREVE--IMQHLSGH 156
           ++V+G G +G V+  R      +G  FA K L+K       ++T H + E  I++ +  H
Sbjct: 1   LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-H 59

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V L   ++     +L++E  SGG L   +   G + E  A     ++   +++ H  
Sbjct: 60  PFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQ 119

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLS-GNYSE 274
           G+++RD+KPENILL   G +KL DFGL    I  G       G+  Y+APE+L    + +
Sbjct: 120 GIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGK 179

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD WS G L++ +L  A PF  ++ +   D I   KL+        ++  ARDL+ ++L
Sbjct: 180 AVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLPP----YLTPEARDLLKKLL 235

Query: 335 TRDVSARI-----TADEVLRHPW 352
            R+ S+R+      A EV  HP+
Sbjct: 236 KRNPSSRLGAGPGDAAEVQSHPF 258

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score =  126 bits (318), Expect = 9e-33
 Identities = 74/253 (29%), Positives = 120/253 (47%), Gaps = 9/253 (3%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVT 161
           +VIG G FG V L + K  G  +A K L       RK ++ +  E  ++     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           LH  ++  +  + V++  +GG L   +     + E RA     ++   + Y H + +V+R
Sbjct: 61  LHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+KPENILL + G + L DFGL    I+   T +   G+P Y+APEV+    Y   VD W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             G +L+ +L    PF    +  ++D I +  L    G   T      +L+ +   R + 
Sbjct: 181 CLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGASLTAWSILEELLEKDRQRRLG 240

Query: 340 ARITADEVLRHPW 352
           A+    E+  HP+
Sbjct: 241 AKEDFLEIQEHPF 253

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  125 bits (316), Expect = 1e-32
 Identities = 92/308 (29%), Positives = 128/308 (41%), Gaps = 69/308 (22%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           D    +  IG G +G V+  R K +G   A K +R   E      T  RE++I++ L+ H
Sbjct: 7   DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-H 65

Query: 157 TGVVTLHSVY----------EEADCFHLVMELCSG---GRLIDQMVEVGQYSEQRAANIF 203
             +V L  +           ++   F+LV E       G L   +V    +SE    +  
Sbjct: 66  RNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVH---FSEDHIKSFM 122

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----------TL 253
           K ++  + YCH    +HRDIK  NILL   G+IKLADFGLA R+ N +          TL
Sbjct: 123 KQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLA-RLYNSEESRPYTNKVITL 181

Query: 254 SGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK 311
                   Y  PE+L G   Y   +D+WS G +L  L      F+ +   A  + I  + 
Sbjct: 182 -------WYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLC 234

Query: 312 LDFHSGVWETVSK--------------------------PARDLMARMLTRDVSARITAD 345
                 VW  V K                          PA DL+  MLT D S R TA+
Sbjct: 235 GSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAE 294

Query: 346 EVLRHPWI 353
           E L  PW+
Sbjct: 295 EALNSPWL 302

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score =  125 bits (316), Expect = 2e-32
 Identities = 75/248 (30%), Positives = 132/248 (53%), Gaps = 13/248 (5%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ------HLSGHT 157
           D   + V+G G FG V L   K +   +A K L+K       +VE          LSG  
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60

Query: 158 GVVT-LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +T LHS ++  D  + VME  +GG L+ Q+ +VG++ E  A     ++   + + H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           G+++RD+K +N++L + G IK+ADFG+    + +G T     G+P Y+APE+++   Y +
Sbjct: 121 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGK 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+ GVLL+ +L    PF+G+  + +F +I    ++ +    +++SK A  +   ++
Sbjct: 181 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPKSMSKEAVAICKGLM 236

Query: 335 TRDVSARI 342
           T+    R+
Sbjct: 237 TKHPGKRL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score =  124 bits (314), Expect = 2e-32
 Identities = 80/283 (28%), Positives = 132/283 (46%), Gaps = 19/283 (6%)

Query: 108 VEVIGHGKFGSVWLCRS---KASGAEFACKTLRKG--------EETVHREVEIMQHLSGH 156
           + V+G G +G V+L R      +G  +A K L+K          E    E ++++ +   
Sbjct: 5   LRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRC 64

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +VTLH  ++     HL+++  +GG L   + +   ++E        +++  + + H +
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPAYVAPEVL---SGN 271
           G+++RDIK ENILL + G + L DFGL+        +      G+  Y+APEV+   SG 
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGG 184

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + + VD WS GVL   LL  A PF  D  +     I    L       +T+S  ARD + 
Sbjct: 185 HDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPFPKTMSAEARDFIQ 244

Query: 332 RMLTRDVSARI---TADEVLRHPWILFYTERTLRTLTIKSKLK 371
           ++L +D   R+    ADE+  HP+        L    I +  K
Sbjct: 245 KLLEKDPKKRLGANGADEIKNHPFFQGIDWDDLAAKRIPAPFK 287

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score =  125 bits (316), Expect = 2e-32
 Identities = 72/248 (29%), Positives = 126/248 (50%), Gaps = 13/248 (5%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH 156
           D   + V+G G FG V L   K +   +A K L+K         E    E  ++      
Sbjct: 1   DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +  LHS ++  D  + VME  +GG L+  + +VG++ E  A     ++   + + H  
Sbjct: 61  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           G+++RD+K +N++L   G IK+ADFG+    I  G+T     G+P Y+APE+++   Y +
Sbjct: 121 GIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGK 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+ GVLL+ +L    PF G+  + +F +I    + +     +++SK A  +   +L
Sbjct: 181 SVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLL 236

Query: 335 TRDVSARI 342
           T+  + R+
Sbjct: 237 TKHPAKRL 244

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score =  125 bits (315), Expect = 2e-32
 Identities = 80/247 (32%), Positives = 121/247 (48%), Gaps = 13/247 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVT 161
           +VIG G FG V L R KA    +A K L       +K E+ +  E  ++     H  +V 
Sbjct: 1   KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           LH  ++ AD  + V++  +GG L   +     + E RA     ++   + Y H + +V+R
Sbjct: 61  LHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+KPENILL + G I L DFGL    I +  T S   G+P Y+APEVL    Y   VD W
Sbjct: 121 DLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             G +L+ +L    PF   +   ++D I N  L         ++  AR L+  +L +D +
Sbjct: 181 CLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP----NITNSARHLLEGLLQKDRT 236

Query: 340 ARITADE 346
            R+ A +
Sbjct: 237 KRLGAKD 243

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score =  125 bits (315), Expect = 2e-32
 Identities = 83/257 (32%), Positives = 133/257 (51%), Gaps = 20/257 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVVT 161
           +++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  +  
Sbjct: 1   KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTA 59

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVVH 220
           L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV+
Sbjct: 60  LKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVY 119

Query: 221 RDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD 
Sbjct: 120 RDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDW 179

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           W  GV+++ ++   LPF     E +F+ I   ++ F      T+S  A+ L++ +L +D 
Sbjct: 180 WGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKKDP 235

Query: 339 SARI-----TADEVLRH 350
             R+      A E+++H
Sbjct: 236 KQRLGGGPDDAKEIMQH 252

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score =  124 bits (313), Expect = 2e-32
 Identities = 76/266 (28%), Positives = 136/266 (51%), Gaps = 21/266 (7%)

Query: 108 VEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKGE--------ETVHREVEIMQHLSGH 156
           ++V+G G +G V+L R  +   SG  +A K L+K          E    E ++++H+   
Sbjct: 5   LKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 64

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +VTLH  ++     HL+++  +GG L   + +  ++ EQ       +++  +++ H +
Sbjct: 65  PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG--LAGSPAYVAPEVLSG---N 271
           G+++RDIK ENILL ++G + L DFGL+      +        G+  Y+AP+++ G    
Sbjct: 125 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGG 184

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + + VD WS GVL++ LL  A PF  D  +     I    L       + +S  A+D++ 
Sbjct: 185 HDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDIIQ 244

Query: 332 RMLTRDVSARI-----TADEVLRHPW 352
           R+L +D   R+      ADE+ +HP+
Sbjct: 245 RLLMKDPKKRLGCGPSDADEIKKHPF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score =  125 bits (315), Expect = 2e-32
 Identities = 82/258 (31%), Positives = 124/258 (48%), Gaps = 17/258 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-IMQHLS------GHTGVVTL 162
           VIG G FG V L + KA G  +A K L+K      +E + IM   +       H  +V L
Sbjct: 2   VIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGL 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           H  ++ AD  + V++  +GG L   +     + E RA     ++   + Y H + +++RD
Sbjct: 62  HYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRD 121

Query: 223 IKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +KPENILL + G + L DFGL    I + +T S   G+P Y+APEVL    Y   VD W 
Sbjct: 122 LKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWC 181

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            G +L+ +L    PF       ++D I N  L         +S  AR L+  +L +D + 
Sbjct: 182 LGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPN----ISVSARHLLEGLLQKDRTK 237

Query: 341 RITAD----EVLRHPWIL 354
           R+ A     E+  H +  
Sbjct: 238 RLGAKDDFLEIKNHVFFS 255

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score =  123 bits (310), Expect = 4e-32
 Identities = 81/258 (31%), Positives = 132/258 (51%), Gaps = 18/258 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V  C+ +A+G  +ACK L       RKGE     E  I++ ++    VV+L
Sbjct: 7   VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRF-VVSL 65

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVH 220
              YE  D   LV+ + +GG L   +  +G   + EQRA     ++   ++      +V+
Sbjct: 66  AYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVY 125

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIW 279
           RD+KPENILL   G I+++D GLA++I  G+T+ G  G+  Y+APEV++   Y+   D W
Sbjct: 126 RDLKPENILLDDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWW 185

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
             G L++ ++    PF+        + + + VK D      E  S+ A+ +   +LT++ 
Sbjct: 186 GLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKED-QEEYSEKFSEDAKSICRMLLTKNP 244

Query: 339 SARI-----TADEVLRHP 351
             R+      A  V +HP
Sbjct: 245 KERLGCRGNGAAGVKQHP 262

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score =  122 bits (308), Expect = 6e-32
 Identities = 78/269 (28%), Positives = 129/269 (47%), Gaps = 27/269 (10%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTL-------------RKGEETVHREVEIMQHL 153
           K  +IG G FGSV+L  + +SG   A K +             R   + + RE+ +++ L
Sbjct: 4   KGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKEL 63

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
             H  +V       +AD  ++ +E   GG +   +   G + E    N  + ++  + Y 
Sbjct: 64  Q-HENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYL 122

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-------SNGQTLSGLAGSPAYVAPE 266
           H+ G++HRDIK  NIL+   G IK++DFG++ ++               L GS  ++APE
Sbjct: 123 HNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPE 182

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           V+    Y+ K DIWS G L+  +L    PF     L+A+F   +N   +  S     +S 
Sbjct: 183 VVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENASPEIPS----NISS 238

Query: 325 PARDLMARMLTRDVSARITADEVLRHPWI 353
            A D + +    D + R TA E+L+HP++
Sbjct: 239 EAIDFLEKTFEIDHNKRPTAAELLKHPFL 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  124 bits (314), Expect = 8e-32
 Identities = 86/302 (28%), Positives = 139/302 (46%), Gaps = 56/302 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           DD   ++VIG G FG V L + K +G  +A K LRK E         V  E +I+   + 
Sbjct: 1   DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAE-AD 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           +  VV L+  +++ +  +L+ME   GG ++  +++   ++E+       + +  I   H 
Sbjct: 60  NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHK 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAM-----------RISNGQTLSGLA------- 257
           +G +HRDIKP+N+LL   G IKL+DFGL             RI +    S          
Sbjct: 120 LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPM 179

Query: 258 ---------------------GSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPF 295
                                G+P Y+APEV     Y+++ D WS GV+++ +LV   PF
Sbjct: 180 SSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF 239

Query: 296 KGDSLEAVFDAIKNVK--LDFHSGVWETVSKPARDLMARMLTRDVSARI---TADEVLRH 350
             D+ +  +  I N K  L F   V   +S  A+DL+ R+   +   R+     +E+  H
Sbjct: 240 CSDNPQETYRKIINWKETLQFPDEV--PLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSH 296

Query: 351 PW 352
           P+
Sbjct: 297 PF 298

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score =  122 bits (308), Expect = 2e-31
 Identities = 74/255 (29%), Positives = 134/255 (52%), Gaps = 16/255 (6%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVT 161
           +++G G FG V+L   K +   FA K L+K    +  +VE       ++     H  +  
Sbjct: 1   KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+  ++  +    VME  +GG L+  +    ++   RA     +++  +++ H  G+V+R
Sbjct: 61  LYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR--ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           D+K +NILL T G IK+ADFG+     + + +T     G+P Y+APE+L G  Y+  VD 
Sbjct: 121 DLKLDNILLDTDGHIKIADFGMCKENMLGDAKT-CTFCGTPDYIAPEILLGQKYNTSVDW 179

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           WS GVLL+ +L+   PF G   E +F +I+     +    W  +++ A+D++ ++  R+ 
Sbjct: 180 WSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPR--W--LTREAKDILVKLFVREP 235

Query: 339 SARI-TADEVLRHPW 352
             R+    ++ +HP+
Sbjct: 236 ERRLGVKGDIRQHPF 250

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score =  123 bits (309), Expect = 2e-31
 Identities = 91/332 (27%), Positives = 147/332 (44%), Gaps = 31/332 (9%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVH----REVEIMQHLSGHTGVVT 161
           IG G FG V+  R K +   +A K L K E     E  H    R + +   L     +V 
Sbjct: 1   IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L   ++     +LV +  SGG L   + + G++SE RA     +++  +++ H   +V+R
Sbjct: 61  LKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAM-RISNGQTLSGLAGSPAYVAPEVL--SGNYSEKVDI 278
           D+KPENILL  +G I L DFGL+   +++ +T +   G+  Y+APEVL     Y++ VD 
Sbjct: 121 DLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDF 180

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           WS GVL+  +     PF  +  + ++  I   K+ F   V   +S   R  +  +L R+ 
Sbjct: 181 WSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKNV---LSDEGRQFVKGLLNRNP 237

Query: 339 SARI----TADEVLRHP------WILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVE 388
             R+     A E+  HP      W L    +   T   K  + +    S+  P   +   
Sbjct: 238 QHRLGAHRDAVELKEHPFFADIDWDLLS--KKQITPPFKPIVDSDEDVSNFDPEFTNSSL 295

Query: 389 SDENKIDRGSRNDESHALSSSESLNSESEVQD 420
            +   +          A S+  S    S VQ+
Sbjct: 296 LNAGIVPWEDVPGLPGANSTPLS----SSVQE 323

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score =  122 bits (306), Expect = 2e-31
 Identities = 84/251 (33%), Positives = 134/251 (53%), Gaps = 13/251 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   K+SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 28  IGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 86

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 87  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSD 145

Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVL 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS G++
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205

Query: 285 LHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
           +  ++    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 206 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPKLKNLHKVSPSLKGFLDRLLVRDPAQRA 262

Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 263 TAAELLKHPFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score =  121 bits (305), Expect = 3e-31
 Identities = 79/270 (29%), Positives = 125/270 (46%), Gaps = 21/270 (7%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEET----VHREVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  + K +G   A K ++   E        E++I+     H  +V L+  Y
Sbjct: 13  LGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAY 71

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
              +   +++E C GG L   M+E+ +  +E +   + + ++  + + H   V+HRD+K 
Sbjct: 72  FYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKA 131

Query: 226 ENILLTTSGKIKLADFGL-AMRISNGQTLSGLAGSPAYVAPEVL------SGNYSEKVDI 278
            NILLT  G +KLADFG+ A   S  Q      G+P ++APEV+         Y  K DI
Sbjct: 132 GNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADI 191

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNV---KLDFHSGVWETVSKPARDLMARMLT 335
           WS G+ L  L     P    +   V   I       LD  S  W   S    D +   L 
Sbjct: 192 WSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTLDQPSK-W---SSSFNDFLKSCLV 247

Query: 336 RDVSARITADEVLRHPWILFYTER-TLRTL 364
           +D   R TA E+L+HP++   ++   ++ L
Sbjct: 248 KDPDDRPTAAELLKHPFVSDQSDNKAIKDL 277

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  120 bits (303), Expect = 5e-31
 Identities = 76/277 (27%), Positives = 123/277 (44%), Gaps = 37/277 (13%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVH-REVEIMQHLSGHTGVVTLHSV 165
           IG G F  V   +S+ +G  +A K ++K     E+  + RE++ ++ LS H  ++ L  V
Sbjct: 7   IGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEV 66

Query: 166 Y--EEADCFHLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVMWVIKYCHDMGVVHRD 222
               +     LV EL     L + +    +   E+R  +    ++  + + H  G+ HRD
Sbjct: 67  LFDRKTGRLALVFELMDMN-LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRD 125

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL--SGNYSEKVDIWS 280
           IKPENIL+     +KLADFG    I +    +    +  Y APE L   G Y  K+DIW+
Sbjct: 126 IKPENILI-KDDILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWA 184

Query: 281 AGVLLHALLVAALPFKG----DSLEAVFDAI------------KNVKLDFHS----GVWE 320
            G +   +L     F G    D +  + D +            K+  ++++     G   
Sbjct: 185 VGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGL 244

Query: 321 T-----VSKPARDLMARMLTRDVSARITADEVLRHPW 352
                  S    DL+ ++L  D   RITA + LRHP+
Sbjct: 245 RKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPY 281

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score =  120 bits (303), Expect = 5e-31
 Identities = 80/256 (31%), Positives = 136/256 (53%), Gaps = 11/256 (4%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A K +    +  +E +  E+ +M+ L  +  +V
Sbjct: 21  YTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIV 79

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                +   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 80  NFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAA-VCRECLQALEFLHANQVIH 138

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +N+LL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 279 WSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSPIFRDFLNRCLEMD 256

Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+HP++
Sbjct: 257 VEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score =  119 bits (300), Expect = 1e-30
 Identities = 69/255 (27%), Positives = 121/255 (47%), Gaps = 25/255 (9%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFAC------------KTLRKGEETVHR---EVEIMQHL 153
           E +G G FG V+  R K +G                 K  R+ ++++     EV I++  
Sbjct: 6   EHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQ 65

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSG---GRLIDQMVEVGQ-YSEQRAANIFKDVMWV 209
             H  +V  +  + E D  ++VM+L  G   G   + + E  Q ++E+R  NIF  ++  
Sbjct: 66  LRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLA 125

Query: 210 IKYCH-DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           ++Y H +  +VHRD+ P NI+L    K+ + DFGLA +      L+ + G+  Y  PE++
Sbjct: 126 LRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIV 185

Query: 269 SGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-FHSGVWETVSKPA 326
               Y EK D+W+ G +L+ +     PF   ++ ++   I     +    G++   S+  
Sbjct: 186 KNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLPEGMY---SEDV 242

Query: 327 RDLMARMLTRDVSAR 341
            D++   LT D  AR
Sbjct: 243 TDVITSCLTPDAEAR 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score =  119 bits (300), Expect = 2e-30
 Identities = 70/242 (28%), Positives = 126/242 (52%), Gaps = 13/242 (5%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V L   K +   +A K L+K         E    E  ++        +  L
Sbjct: 7   VLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQL 66

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           HS ++  D  + VME  +GG L+  + +VG++ E +A     ++   + + H  G+++RD
Sbjct: 67  HSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRD 126

Query: 223 IKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +K +N++L + G IK+ADFG+    + +G T     G+P Y+APE+++   Y + VD W+
Sbjct: 127 LKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWA 186

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+ +L    PF G+  + +F +I    + +     +++SK A  +   ++T+  S 
Sbjct: 187 YGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLMTKHPSK 242

Query: 341 RI 342
           R+
Sbjct: 243 RL 244

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score =  119 bits (298), Expect = 2e-30
 Identities = 80/256 (31%), Positives = 135/256 (52%), Gaps = 11/256 (4%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A K +    +  +E +  E+ +M+  + +  +V
Sbjct: 21  YTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRE-NKNPNIV 79

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E     E + A + ++ +  + + H   V+H
Sbjct: 80  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALDFLHSNQVIH 138

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 198

Query: 279 WSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 199 WSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP--ERLSAVFRDFLNRCLEMD 256

Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+HP++
Sbjct: 257 VDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score =  118 bits (298), Expect = 3e-30
 Identities = 81/268 (30%), Positives = 125/268 (46%), Gaps = 30/268 (11%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT-LRKGEETVH----REVEIMQHLSGHTGVVTLH-S 164
           +G G  GSV  CR K +G  FA KT        +     RE+EI +       +V  + +
Sbjct: 9   LGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGA 67

Query: 165 VYEEADC-FHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
             +E+     + ME C GG L     +V    G+  E+    I + V+  + Y H   ++
Sbjct: 68  FLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKII 127

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----GSPAYVAPEVLSG-NYSE 274
           HRDIKP NILLT  G++KL DFG++     G+ ++ LA    G+  Y+APE + G  YS 
Sbjct: 128 HRDIKPSNILLTRKGQVKLCDFGVS-----GELVNSLAGTFTGTSFYMAPERIQGKPYSI 182

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAV--------FDAIKNVKLDFHSGVWETVSKPA 326
             D+WS G+ L  +     PF  +    +           + N +L    G     S+  
Sbjct: 183 TSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEF 242

Query: 327 RDLMARMLTRDVSARITADEVLRHPWIL 354
           +D + + L +D + R T  ++L HPWI 
Sbjct: 243 KDFIKQCLEKDPTRRPTPWDMLEHPWIK 270

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  118 bits (298), Expect = 3e-30
 Identities = 89/292 (30%), Positives = 136/292 (46%), Gaps = 51/292 (17%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEE-----TVHREVEIMQHLSGHT 157
           D+TK+E IG G +G V+  R+K +G   A K +R + EE     T  RE+ +++ L  H 
Sbjct: 1   DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HP 59

Query: 158 GVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V L  V  +    +L+ E  S    + +D + +      +   +    ++  I +CH 
Sbjct: 60  NIVCLQDVLMQESRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHS 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLA------MRISNGQ--TLSGLAGSPAYVAPEV 267
             V+HRD+KP+N+L+   G IKLADFGLA      +R+   +  TL        Y APEV
Sbjct: 120 RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTL-------WYRAPEV 172

Query: 268 LSGN--YSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGV--- 318
           L G+  YS  VDIWS G +   +      F GDS    L  +F  +     D   GV   
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSL 232

Query: 319 ---------WET---------VSKPARDLMARMLTRDVSARITADEVLRHPW 352
                    W+          + +   DL+ +ML  D + RI+A + L HP+
Sbjct: 233 PDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPY 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score =  118 bits (297), Expect = 3e-30
 Identities = 81/271 (29%), Positives = 132/271 (48%), Gaps = 31/271 (11%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL---RKGEETVHREVEIMQHLSGHTGVVTLHS 164
           VEVIG G +G V+  R K +G   A K +      EE +  E  I++  S H  + T + 
Sbjct: 11  VEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYG 70

Query: 165 VY------EEADCFHLVMELCSGGRLIDQMVEV-----GQYSEQRAANIFKDVMWVIKYC 213
            +         D   LVMELC GG + D +V+       +  E+  A I ++ +  + Y 
Sbjct: 71  AFIKKNPPGNDDQLWLVMELCGGGSVTD-LVKGLRKKGKRLKEEWIAYILRETLRGLAYL 129

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPAYVAPEVLSGN 271
           H+  V+HRDIK +NILLT + ++KL DFG++  +  + G+  + + G+P ++APEV++ +
Sbjct: 130 HENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFI-GTPYWMAPEVIACD 188

Query: 272 ------YSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNV--KLDFHSGVWETV 322
                 Y  + D+WS G+    L     P      + A+F   +N    L      W   
Sbjct: 189 EQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLK-SPENW--- 244

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           SK   D ++  L ++   R   +E+L HP+I
Sbjct: 245 SKKFNDFISECLIKNYEQRPFMEELLEHPFI 275

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score =  117 bits (294), Expect = 5e-30
 Identities = 72/262 (27%), Positives = 117/262 (44%), Gaps = 24/262 (9%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHTG 158
           +  + V+G G FG   L R     +    K +       K       E+ I+  L  H  
Sbjct: 2   YIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPN 60

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDM 216
           ++  ++ + + +   + ME  +GG L D++V      + E+        ++  + Y H  
Sbjct: 61  IIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKA 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG--LAGSPAYVAPEVLSG-NYS 273
           G++HRDIK  NI LT +G IKL DFG++ +I   +      + G+P Y++PE+  G  Y+
Sbjct: 121 GILHRDIKTLNIFLTKAGLIKLGDFGIS-KILGSEYSMAETVVGTPYYMSPELCQGVKYN 179

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV----SKPARDL 329
            K DIW+ G +L+ LL     F   +   +   I         G +  V    S     L
Sbjct: 180 FKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIV-------QGNYTPVVSVYSSELISL 232

Query: 330 MARMLTRDVSARITADEVLRHP 351
           +  +L +D   R TADEVL  P
Sbjct: 233 VHSLLQQDPEKRPTADEVLDQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score =  116 bits (293), Expect = 7e-30
 Identities = 71/257 (27%), Positives = 132/257 (51%), Gaps = 15/257 (5%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLSGHTGVVT 161
           ++ IG G FG ++L ++K+       K +       K +E   +EV ++  +  H  +VT
Sbjct: 5   IKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVT 63

Query: 162 LHSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
             + ++E     +VME C GG L+          +SE +  + F  +   +K+ HD  ++
Sbjct: 64  FFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKIL 123

Query: 220 HRDIKPENILLTTSGKI-KLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSGN-YSEKV 276
           HRDIK +NI L+ +G + KL DFG+A ++++   L+    G+P Y++PE+     Y+ K 
Sbjct: 124 HRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKT 183

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           DIWS G +L+ L     PF+G++L  +   +K  +  F   +    S+  R L++++   
Sbjct: 184 DIWSLGCVLYELCTLKHPFEGNNLHQL--VLKICQGYFAP-ISPNFSRDLRSLISQLFKV 240

Query: 337 DVSARITADEVLRHPWI 353
               R +   +L+ P++
Sbjct: 241 SPRDRPSITSILKRPFL 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score =  116 bits (293), Expect = 7e-30
 Identities = 83/258 (32%), Positives = 133/258 (51%), Gaps = 20/258 (7%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK---GE----ETVHREVEIMQHLS--GHTGVVT 161
           +G G FG+V+L + K + AE   K L++   GE    ETV    E  Q LS   H  +V 
Sbjct: 8   LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQE-AQLLSKLDHPAIVK 66

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVIKYCHDMG 217
            H+ + E D F ++ E C G  L  ++ E+       SE +    F  ++  + Y H   
Sbjct: 67  FHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR 126

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSGN-YSEK 275
           ++HRD+K +NI L  +  +K+ DFG++  +     L +   G+P Y++PE L    Y  K
Sbjct: 127 ILHRDLKAKNIFLKNN-LLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSK 185

Query: 276 VDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
            DIWS G +L+ +   A  F+G +  +V   ++ V+    S + ET S+    +M  ML 
Sbjct: 186 SDIWSLGCILYEMCCLAHAFEGQNFLSV--VLRIVEGPTPS-LPETYSRQLNSIMQSMLN 242

Query: 336 RDVSARITADEVLRHPWI 353
           +D S R +A E+LR+P+I
Sbjct: 243 KDPSLRPSAAEILRNPFI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score =  116 bits (293), Expect = 8e-30
 Identities = 63/218 (28%), Positives = 100/218 (45%), Gaps = 15/218 (6%)

Query: 106 TKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGH 156
           T  + +G G FG V+  +          E A KTL++       E   RE  IM+ L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLD-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVMWVIKYCHD 215
             VV L  V  E +  ++VME   GG L+  + +     S     +    +   ++Y   
Sbjct: 61  PNVVKLLGVCTEEEPLYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFALQIARGMEYLES 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG-SP-AYVAPEVL-SGNY 272
              +HRD+   N L+  +  +K++DFGL+  + +        G  P  ++APE L  G +
Sbjct: 121 KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYRKRGGKLPIRWMAPESLKEGKF 180

Query: 273 SEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           + K D+WS GVLL  +  +   P+ G S E V + +KN
Sbjct: 181 TSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKN 218

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score =  116 bits (291), Expect = 1e-29
 Identities = 67/257 (26%), Positives = 120/257 (46%), Gaps = 14/257 (5%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHTG 158
           + K+ V+G G FG V LCR KA       K +      +        E ++++ LS H  
Sbjct: 2   YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPN 60

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDM 216
           ++  +  + E     +VME   GG L + + +       E    + F  ++  + + H  
Sbjct: 61  IIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTK 120

Query: 217 GVVHRDIKPENILLTTSGKI-KLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
            ++HRD+K +NILL     + K+ DFG++  +S+      + G+P Y++PE+  G  Y++
Sbjct: 121 LILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQ 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           K DIW+ G +L+ L      F+  +L A+   I +      + + +  S   R L+  ML
Sbjct: 181 KSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTF---APISDRYSPDLRQLILSML 237

Query: 335 TRDVSARITADEVLRHP 351
             D S R    +++  P
Sbjct: 238 NLDPSKRPQLSQIMAQP 254

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score =  118 bits (298), Expect = 1e-29
 Identities = 90/311 (28%), Positives = 139/311 (44%), Gaps = 64/311 (20%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLS 154
           ED HT V+VIG G FG V L + K +G  +A KTL K E         V  E +++   S
Sbjct: 1   EDFHT-VKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAE-S 58

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
               VV+L+  +++A   +L+ME   GG L+  +++   +SE        + +  I+  H
Sbjct: 59  DSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVH 118

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAM----------------------RISNGQ- 251
            +G +HRDIKP+NIL+   G IKL+DFGL+                       RI N   
Sbjct: 119 KLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNS 178

Query: 252 --------TLSGLA-----------------GSPAYVAPEVLSGN-YSEKVDIWSAGVLL 285
                   T+S                    G+P Y+APE+     Y ++ D WS G ++
Sbjct: 179 VAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIM 238

Query: 286 HALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVSKPARDLMARMLTRDVS--AR 341
              L+   PF  ++    +  I N +  L F   +   +S  A DL+ R++T   +   R
Sbjct: 239 FECLIGWPPFCSENSHETYRKIINWRETLYFPDDI--HLSVEAEDLIRRLITNAENRLGR 296

Query: 342 ITADEVLRHPW 352
             A E+  HP+
Sbjct: 297 GGAHEIKSHPF 307

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score =  117 bits (295), Expect = 1e-29
 Identities = 76/261 (29%), Positives = 135/261 (51%), Gaps = 21/261 (8%)

Query: 108 VEVIGHGKFGSVWLCRS---KASGAEFACKTLRKGEETVHREV------EIMQHLSGHTG 158
           ++V+G G FG V+L R      +G  +A K L+K    V   V      +I+  +  H  
Sbjct: 1   LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEV-NHPF 59

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V LH  ++     +L+++   GG L  ++ +   ++E+       ++   + + H +G+
Sbjct: 60  IVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLS-GNYSEKV 276
           ++RD+KPENILL   G IKL DFGL+   I + +      G+  Y+APEV++   +++  
Sbjct: 120 IYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSA 179

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D WS GVL+  +L  +LPF+G   +     I   KL    G+ + +S  A+ L+  +  R
Sbjct: 180 DWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKL----GMPQFLSPEAQSLLRALFKR 235

Query: 337 DVSARITA-----DEVLRHPW 352
           + + R+ A     +E+ RHP+
Sbjct: 236 NPANRLGAGPDGVEEIKRHPF 256

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  117 bits (294), Expect = 2e-29
 Identities = 78/289 (26%), Positives = 118/289 (40%), Gaps = 50/289 (17%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           K+  IG G +G V+  R   SG   A K +R   E      +  RE+ ++ +L  H  +V
Sbjct: 11  KLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIV 69

Query: 161 TLHSVY--EEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            L  V   +  D   LVME C      L+D M     +SE +   +   ++  ++Y H+ 
Sbjct: 70  ELKEVVVGKHLDSIFLVMEYCEQDLASLLDNMPT--PFSESQVKCLMLQLLRGLQYLHEN 127

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-----YVAPEVLSG- 270
            ++HRD+K  N+LLT  G +K+ADFGLA              +P      Y APE+L G 
Sbjct: 128 FIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAK----PMTPKVVTLWYRAPELLLGC 183

Query: 271 -NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK-PA-- 326
             Y+  +D+W+ G +L  LL       G S     D I  +    +  +W   S  P   
Sbjct: 184 TTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVG 243

Query: 327 -----------------------RDLMARMLTRDVSARITADEVLRHPW 352
                                    L+  +L  D   R TA+E L   +
Sbjct: 244 KFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSY 292

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  116 bits (292), Expect = 2e-29
 Identities = 82/288 (28%), Positives = 130/288 (45%), Gaps = 50/288 (17%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEE----TVHREVEIMQHLSGHTGVVT 161
           ++E +G G + +V+  R++ +G   A K +    EE    T  RE+ +M+ L  H  +V 
Sbjct: 4   QLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVR 62

Query: 162 LHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRA--ANIFKDVMWV----IKYC 213
           LH V    +   LV E       + +D       +  + A   N  K   +     I +C
Sbjct: 63  LHDVIHTENKLMLVFEYMDKDLKKYMDT------HGVRGALDPNTVKSFTYQLLKGIAFC 116

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN- 271
           H+  V+HRD+KP+N+L+   G++KLADFGLA        T S    +  Y AP+VL G+ 
Sbjct: 117 HENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSR 176

Query: 272 -YSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSK----- 324
            YS  +DIWS G ++ A ++   P F G + E     I  +        W  +S+     
Sbjct: 177 TYSTSIDIWSVGCIM-AEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK 235

Query: 325 ------PAR--------------DLMARMLTRDVSARITADEVLRHPW 352
                 P +              DL+ R+L  +   RI+A + L+HPW
Sbjct: 236 PTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPW 283

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  116 bits (291), Expect = 2e-29
 Identities = 87/287 (30%), Positives = 134/287 (46%), Gaps = 48/287 (16%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           KVE IG G +G V+  R+K +G   A K +R   E      T  RE+ +++ L+ H  +V
Sbjct: 4   KVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIV 62

Query: 161 TLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V    +  +LV E       + +D     G       + +F+ ++  + +CH   V
Sbjct: 63  KLLDVIHTENKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCHSHRV 121

Query: 219 VHRDIKPENILLTTSGKIKLADFGLA------MRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           +HRD+KP+N+L+ T G IKLADFGLA      +R    + ++       Y APE+L G  
Sbjct: 122 LHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLW-----YRAPEILLGCK 176

Query: 272 -YSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVF--------------DAIKNVKL 312
            YS  VDIWS G +   ++     F GDS    L  +F               ++ + K 
Sbjct: 177 YYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP 236

Query: 313 DF-------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
            F        S V   + +  RDL+++ML  D + RI+A   L HP+
Sbjct: 237 SFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPF 283

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score =  116 bits (292), Expect = 3e-29
 Identities = 78/245 (31%), Positives = 123/245 (50%), Gaps = 13/245 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVT 161
           +VIG G FG V L + K+ G+ +A K L       +K +  +  E  ++     H  +V 
Sbjct: 1   KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           LH  ++ A+  + V++  +GG L   +     + E RA     +V   I Y H + +++R
Sbjct: 61  LHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYR 120

Query: 222 DIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+KPENILL + G + L DFGL    +   +T S   G+P Y+APEVL    Y   VD W
Sbjct: 121 DLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWW 180

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             G +L+ +L    PF    +  ++D I +  L    G  +TV+  A DL+  +L +D  
Sbjct: 181 CLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGG--KTVA--ACDLLVGLLHKDQR 236

Query: 340 ARITA 344
            R+ A
Sbjct: 237 RRLGA 241

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score =  115 bits (290), Expect = 4e-29
 Identities = 78/256 (30%), Positives = 135/256 (52%), Gaps = 11/256 (4%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E     E + A + ++ +  +++ H   V+H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM-DEGQIAAVCRECLQALEFLHSNQVIH 139

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199

Query: 279 WSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLDMD 257

Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score =  115 bits (289), Expect = 4e-29
 Identities = 75/261 (28%), Positives = 131/261 (50%), Gaps = 23/261 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGHTGVVTLH 163
           +G G FG V  C+ +A+G  +ACK L       RKG E    E  I+  +     +V+L 
Sbjct: 1   LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRF-IVSLA 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVIKYCHDMGVV 219
             ++      LVM + +GG L   +  V +    + E RA      ++  +++ H   ++
Sbjct: 60  YAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRII 119

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSG-NYSEKVD 277
           +RD+KPEN+LL   G ++++D GLA+ + +GQ+ + G AG+P ++APE+L G  Y   VD
Sbjct: 120 YRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVD 179

Query: 278 IWSAGVLLHALLVAALPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
            ++ GV L+ ++ A  PF  +G+ +E     +K   L+      +  S  ++     +L 
Sbjct: 180 YFALGVTLYEMIAARGPFRARGEKVEN--KELKQRILNDSVTYPDKFSPASKSFCEALLA 237

Query: 336 RDVSARI-----TADEVLRHP 351
           +D   R+       D +  HP
Sbjct: 238 KDPEKRLGFRDGNCDGLRTHP 258

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score =  114 bits (287), Expect = 4e-29
 Identities = 75/258 (29%), Positives = 126/258 (48%), Gaps = 21/258 (8%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
            +  + V+G G FG   L +   S  ++A K +R        E   +E  ++  +  H  
Sbjct: 1   QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPN 59

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQ-YSEQRAANIFKDVMWVIKYCHDM 216
           +V     +E     ++VME C GG L+ ++ ++ G+ + E      F  +   +++ H+ 
Sbjct: 60  IVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEK 119

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSPAYVAPEVLSG-NYSE 274
            V+HRDIK +NI LT +GK+KL DFG A  +++ G       G+P YV PE+     Y+ 
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNN 179

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV----SKPARDLM 330
           K DIWS G +L+ L     PF+ +S        KN+ L    G ++ +    S   R L+
Sbjct: 180 KSDIWSLGCILYELCTLKHPFQANSW-------KNLILKVCQGSYKPLPSHYSYELRSLI 232

Query: 331 ARMLTRDVSARITADEVL 348
            +M  R+  +R +A  +L
Sbjct: 233 KQMFKRNPRSRPSATTIL 250

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score =  116 bits (291), Expect = 4e-29
 Identities = 78/248 (31%), Positives = 127/248 (51%), Gaps = 16/248 (6%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACK------TLRKGEETVHREVEIMQHLSGH 156
           +D   ++VIG G FG V + + K +   FA K       L++ E    RE   +     +
Sbjct: 1   EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDN 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD 215
             + TLH  +++ +  +LVM+   GG L+  + +   +  E  A     +++  I   H 
Sbjct: 61  QWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQ 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA-GSPAYVAPEVLS---- 269
           +  VHRDIKP+NIL+  +G I+LADFG  +++  +G   S +A G+P Y++PE+L     
Sbjct: 121 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 270 --GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET-VSKPA 326
             G Y  + D WS GV ++ +L    PF  +SL   +  I N K  F      T VS+ A
Sbjct: 181 GKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSEDA 240

Query: 327 RDLMARML 334
           +DL+ R++
Sbjct: 241 KDLIRRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score =  117 bits (294), Expect = 5e-29
 Identities = 98/357 (27%), Positives = 157/357 (43%), Gaps = 66/357 (18%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREV-------EIMQHLSGHTGV 159
           K++ +G G FG V L R   + A +A KTLRK +  +  +V       +I+   + +  V
Sbjct: 5   KIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAE-ADNEWV 63

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           V L+  +++ D  + VM+   GG ++  ++ +G + E  A     ++   ++  H MG +
Sbjct: 64  VRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFI 123

Query: 220 HRDIKPENILLTTSGKIKLADFGL----------------------AMRISN-------- 249
           HRDIKP+NIL+   G IKL DFGL                      +M  SN        
Sbjct: 124 HRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANC 183

Query: 250 --GQTLS----------------GLAGSPAYVAPEV-LSGNYSEKVDIWSAGVLLHALLV 290
             G  L                  L G+P Y+APEV L   Y++  D WS GV+L+ +LV
Sbjct: 184 RCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV 243

Query: 291 AALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML--TRDVSARITADEV 347
              PF   + LE     I N +   H      +S  A DL+ ++     D   +  ADE+
Sbjct: 244 GQPPFLAQTPLETQMKVI-NWQTSLHIPPQAKLSPEASDLIIKLCRGPEDRLGKNGADEI 302

Query: 348 LRHPW---ILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRND 401
             HP+   I F ++   ++     K+ +    S+  P     + SD++    G+ ND
Sbjct: 303 KAHPFFKTIDFSSDLRQQSAPYIPKITHPTDTSNFDPVDPDKLWSDDD--KEGNVND 357

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score =  115 bits (288), Expect = 5e-29
 Identities = 79/266 (29%), Positives = 131/266 (49%), Gaps = 22/266 (8%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL---RKGEETVHREVEIMQHLSGHTGVVTLHS 164
           +E IG G +G V+   +K +G++ A K L      +E +  E  I++ LS H  VV  + 
Sbjct: 23  IETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYG 82

Query: 165 VY-----EEADCFHLVMELCSGGRLID---QMVEVGQ-YSEQRAANIFKDVMWVIKYCHD 215
           +Y     +  D   LV+ELC+GG + D     ++ G+   E   A I  + +  +++ H 
Sbjct: 83  MYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHV 142

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-GSPAYVAPEV------L 268
              +HRD+K  NILLTT G +KL DFG++ ++++ +     + G+P ++APEV      L
Sbjct: 143 NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQL 202

Query: 269 SGNYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
              Y  + D+WS G+    L     P      + A+F   +N     H    E  S    
Sbjct: 203 DSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPPTLHQP--ELWSNEFN 260

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           D + + LT+D   R T  ++L+H +I
Sbjct: 261 DFIRKCLTKDYEKRPTVSDLLQHVFI 286

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score =  116 bits (291), Expect = 6e-29
 Identities = 78/249 (31%), Positives = 130/249 (52%), Gaps = 18/249 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQH-----LSGHT 157
           DD   ++VIG G FG V + + K +   +A K L K E     E    +      ++G  
Sbjct: 1   DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60

Query: 158 G-VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD 215
             + TLH  +++ +  +LVM+   GG L+  + +   +  E  A     +++  I   H 
Sbjct: 61  QWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQ 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLA-GSPAYVAPEVLS---- 269
           +  VHRDIKP+N+LL  +G I+LADFG  ++++ +G   S +A G+P Y++PE+L     
Sbjct: 121 LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMED 180

Query: 270 --GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN--VKLDFHSGVWETVSKP 325
             G Y  + D WS GV ++ +L    PF  +SL   +  I N   +  F S + + VS+ 
Sbjct: 181 GMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITD-VSEE 239

Query: 326 ARDLMARML 334
           A+DL+ R++
Sbjct: 240 AKDLIQRLI 248

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score =  115 bits (289), Expect = 9e-29
 Identities = 75/267 (28%), Positives = 130/267 (48%), Gaps = 24/267 (8%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG--------EETVHREVEIMQHLSG 155
           ++V+G G +G V+L R K +G +    +A K L+K          E    E  +++H+  
Sbjct: 5   LKVLGTGAYGKVFLVR-KVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQ 63

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +VTLH  ++     HL+++  SGG +   + +   +SE        +++  +++ H 
Sbjct: 64  SPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHK 123

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGN- 271
           +G+V+RDIK ENILL + G + L DFGL+         +T S   G+  Y+APE++ G  
Sbjct: 124 LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKERTYS-FCGTIEYMAPEIIRGKG 182

Query: 272 -YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
            + + VD WS G+L+  LL  A PF  +        +    L         +   A+DL+
Sbjct: 183 GHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFPSFIGPEAQDLL 242

Query: 331 ARMLTRDVSARI-----TADEVLRHPW 352
            ++L +D   R+      A E+  HP+
Sbjct: 243 HKLLRKDPKKRLGAGPQGASEIKEHPF 269

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score =  113 bits (285), Expect = 1e-28
 Identities = 60/226 (26%), Positives = 93/226 (41%), Gaps = 30/226 (13%)

Query: 106 TKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGH 156
           T  + +G G FG V+             E A KTL++       E   RE  IM+ L  H
Sbjct: 2   TLGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLD-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---------DVM 207
             +V L  V  E +   +VME   GG L         Y  +                 + 
Sbjct: 61  PNIVKLLGVCTEEEPLMIVMEYMPGGDL-------LDYLRKNRPKELSLSDLLSFALQIA 113

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG-SP-AYVAP 265
             ++Y      +HRD+   N L+  +  +K++DFGL+  + +        G  P  ++AP
Sbjct: 114 RGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKVKGGKLPIRWMAP 173

Query: 266 EVL-SGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           E L  G ++ K D+WS GVLL  +  +   P+ G S   V + +K 
Sbjct: 174 ESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKK 219

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  113 bits (284), Expect = 2e-28
 Identities = 81/293 (27%), Positives = 129/293 (44%), Gaps = 51/293 (17%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGH 156
           + + K+  IG G +G V+ CR++ +G   A K   + E+         RE+ +++ L  H
Sbjct: 1   EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-H 59

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV--EVGQY----SEQRAANIFKDVMWVI 210
             +V L  V+      HLV E C      D  V  E+ +      E     I    +  +
Sbjct: 60  PNLVNLIEVFRRKRKLHLVFEYC------DHTVLNELEKNPRGVPEHLIKKIIWQTLQAV 113

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVL 268
            +CH    +HRD+KPENIL+T  G+IKL DFG A RI  G     +    +  Y APE+L
Sbjct: 114 NFCHKHNCIHRDVKPENILITKQGQIKLCDFGFA-RILTGPGDDYTDYVATRWYRAPELL 172

Query: 269 SGN--YSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNV-KL-----------D 313
            G+  Y   VD+W+ G +   LL     + G S ++ ++   K +  L            
Sbjct: 173 VGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232

Query: 314 FHSGV--------------WETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
           F  G+              +  +S PA   +   L  D + R++ +E+L HP+
Sbjct: 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPY 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  112 bits (283), Expect = 3e-28
 Identities = 88/293 (30%), Positives = 127/293 (43%), Gaps = 60/293 (20%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           KVE IG G +G V+  R K +G   A K +R   E      T  RE+ +++ L+ H  +V
Sbjct: 3   KVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIV 61

Query: 161 TLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWV----IKYCH 214
            L  V    +  +LV E       + +D     G         + K  ++     I YCH
Sbjct: 62  RLLDVVHSENKLYLVFEFLDLDLKKYMDSSPLTG-----LDPPLIKSYLYQLLQGIAYCH 116

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLA------MRISNGQ--TLSGLAGSPAYVAPE 266
              V+HRD+KP+N+L+   G +KLADFGLA      +R    +  TL        Y APE
Sbjct: 117 SHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTL-------WYRAPE 169

Query: 267 VLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGV-- 318
           +L G+  YS  VDIWS G +   ++     F GDS    L  +F  +     D   GV  
Sbjct: 170 ILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTS 229

Query: 319 ----------WETVSKP---------ARDLMARMLTRDVSARITADEVLRHPW 352
                     W                 DL+++ML  D + RI+A   L+HP+
Sbjct: 230 LPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPY 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score =  112 bits (280), Expect = 4e-28
 Identities = 84/273 (30%), Positives = 137/273 (50%), Gaps = 22/273 (8%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGEE--TVHREVEIM 150
           + R+N  ++D   ++ IG G +G V+  R+  +G   A K   L  GE+   V +E+ IM
Sbjct: 2   LSRRNP-QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEI-IM 59

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
                H+ +V     Y   D   + ME C GG L D     G  SE + A + ++ +  +
Sbjct: 60  MKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGL 119

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEV 267
            Y H  G +HRDIK  NILLT +G +KLADFG++ +I+   T++      G+P ++APEV
Sbjct: 120 YYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQIT--ATIAKRKSFIGTPYWMAPEV 177

Query: 268 LS----GNYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETV 322
            +    G Y++  DIW+ G+    L     P F    + A+F   K+   +F     +  
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKS---NFQPPKLKDK 234

Query: 323 SKPARD---LMARMLTRDVSARITADEVLRHPW 352
            K +      +   LT++   R TA+++L+HP+
Sbjct: 235 MKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score =  111 bits (279), Expect = 6e-28
 Identities = 76/265 (28%), Positives = 130/265 (49%), Gaps = 28/265 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET---------VHREVEIMQHLSGHTGV 159
           +++G G FG V+LC    +G E A K ++   E+         +  E++++++L  H  +
Sbjct: 8   KLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERI 66

Query: 160 VTLHSVYEEA--DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           V  +    +       + ME   GG + DQ+   G  +E       + ++  + Y H   
Sbjct: 67  VQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNM 126

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRIS----NGQTLSGLAGSPAYVAPEVLSGN-Y 272
           +VHRDIK  NIL  + G +KL DFG + R+     +G  +  + G+P +++PEV+SG  Y
Sbjct: 127 IVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGY 186

Query: 273 SEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAI---KNVKLDFHSGVWETVSKPARD 328
             K DIWS G  +  +L    P+ + +++ A+F       N  L  H      VS   RD
Sbjct: 187 GRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNPVLPPH------VSDHCRD 240

Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
            + R+   +   R +ADE+LRH ++
Sbjct: 241 FLKRIFV-EAKLRPSADELLRHTFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score =  113 bits (285), Expect = 6e-28
 Identities = 84/299 (28%), Positives = 135/299 (45%), Gaps = 53/299 (17%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVH--REVEIMQHLSG 155
           DD   ++VIG G FG V L + K +G  +A K LRK      E+  H   E +I+    G
Sbjct: 1   DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADG 60

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              VV +   +++    +L+ME   GG ++  +++    SE+       + +  I   H 
Sbjct: 61  -AWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQ 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG------------------------- 250
           +G +HRDIKP+N+LL   G +KL+DFGL   +                            
Sbjct: 120 LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSK 179

Query: 251 -----------QTLSGLAGSPAYVAPEV-LSGNYSEKVDIWSAGVLLHALLVAALPFKGD 298
                      Q      G+P Y+APEV +   Y++  D WS GV+++ +L+   PF  +
Sbjct: 180 RKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239

Query: 299 SLEAVFDAIKNVK--LDFHSGVWETVSKPARDLMARMLTRDVSARI---TADEVLRHPW 352
           + +  +  + N K  L F   V   +S+ A+DL+ R  T D   RI     +E+  HP+
Sbjct: 240 TPQETYRKVMNWKETLVFPPEV--PISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPF 295

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score =  111 bits (278), Expect = 8e-28
 Identities = 80/271 (29%), Positives = 123/271 (45%), Gaps = 31/271 (11%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACK----------TLRKGEETVHREVEIMQHLSG 155
           TK EV+G G +G+V+ C     G   A K             K  E +  EV++++ L  
Sbjct: 3   TKGEVLGKGAYGTVY-CGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK- 60

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V       + +   + ME   GG +   +   G   E       K ++  + Y H+
Sbjct: 61  HVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-------SNGQTLSGLAGSPAYVAPEVL 268
             VVHRDIK  N++L  +G IKL DFG A R+       ++   L  + G+P ++APEV+
Sbjct: 121 NCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVI 180

Query: 269 S-GNYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVW----ETV 322
           +   Y  K DIWS G  +  +     P    D L A+F  I       H G+     ++ 
Sbjct: 181 NESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMF-YIGA-----HRGLMPRLPDSF 234

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S  A D +   LTRD   R +A ++LRH ++
Sbjct: 235 SAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score =  111 bits (279), Expect = 9e-28
 Identities = 67/261 (25%), Positives = 115/261 (44%), Gaps = 21/261 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKG-----EETVHREVEIMQHLSGH 156
              + +G G FG V+    K  G       A KTL++G      E    E  IM+ LS H
Sbjct: 2   ELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLS-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHD 215
             +V L  V  + +  ++V E   GG L+D + + G+  + +    +   +   ++Y   
Sbjct: 61  PNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQIAKGMEYLES 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLA---MRISNGQTLSGLAGSPAYVAPEVLSGN- 271
              VHRD+   N L+T +  +K++DFGL+         +   G      ++APE L    
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRDIYEDDYYRKRGGGKLPIKWMAPESLKDGK 180

Query: 272 YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN-VKLDFHSGVWETVSKPARDL 329
           ++ K D+WS GVLL  +  +   P+ G S E V + +++  +L       + +     +L
Sbjct: 181 FTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLPRPENCPDEL----YEL 236

Query: 330 MARMLTRDVSARITADEVLRH 350
           M +    D   R T  E++  
Sbjct: 237 MLQCWAYDPEDRPTFSELVED 257

Length = 258

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score =  111 bits (279), Expect = 9e-28
 Identities = 76/267 (28%), Positives = 132/267 (49%), Gaps = 24/267 (8%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL---RKGEETVHREVEIMQHLSGHTGVVTLHS 164
           +E IG G +G V+   +K  G+  A K L      +E +  E  I+Q L  H  VV  + 
Sbjct: 27  IETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYG 86

Query: 165 VYEEADCFH-----LVMELCSGG---RLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHD 215
           ++ +AD        LV+ELC+GG    L+  ++  GQ   E   + I    +  +++ H+
Sbjct: 87  MFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHN 146

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-GSPAYVAPEVLS----- 269
             ++HRD+K  NILLTT G +KL DFG++ ++++ +     + G+P ++APEV++     
Sbjct: 147 NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQY 206

Query: 270 -GNYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDF-HSGVWETVSKPA 326
             +Y  + D+WS G+    L     P F    ++ +F   +N      H   W    +  
Sbjct: 207 DYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLLHPEKW---CRSF 263

Query: 327 RDLMARMLTRDVSARITADEVLRHPWI 353
              +++ L +D  AR +   +L HP+I
Sbjct: 264 NHFISQCLIKDFEARPSVTHLLEHPFI 290

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  112 bits (282), Expect = 1e-27
 Identities = 78/292 (26%), Positives = 136/292 (46%), Gaps = 48/292 (16%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGH 156
           D +  +  +G G +G V       +G + A K L +  ++        RE+ +++H+  H
Sbjct: 15  DRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-H 73

Query: 157 TGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             V+ L  V+      E+    +LV  L   G  ++ +V+  + S+     +   ++  +
Sbjct: 74  ENVIGLLDVFTPASSLEDFQDVYLVTHLM--GADLNNIVKCQKLSDDHIQFLVYQILRGL 131

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-- 268
           KY H  G++HRD+KP NI +    ++K+ DFGLA R ++ + ++G   +  Y APE++  
Sbjct: 132 KYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA-RHTDDE-MTGYVATRWYRAPEIMLN 189

Query: 269 SGNYSEKVDIWSAGVLLHALLVAALPFKGD------------------------SLEAVF 304
             +Y++ VDIWS G ++  LL     F G                         S E+  
Sbjct: 190 WMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESAR 249

Query: 305 DAIKNV----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
           + I+++    K DF   V+   +  A DL+ +ML  D   RITA E L HP+
Sbjct: 250 NYIQSLPQMPKKDFKE-VFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  110 bits (278), Expect = 2e-27
 Identities = 86/289 (29%), Positives = 132/289 (45%), Gaps = 50/289 (17%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEE----TVHREVEIMQHL--SGHTGV 159
           +  IG G +G+V+  R   +G   A K +R    EE    +  RE+ +++ L    H  +
Sbjct: 4   LAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNI 63

Query: 160 VTLHSV-----YEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVI-- 210
           V L  V      +      LV E         + +  + G   E       KD+M  +  
Sbjct: 64  VRLLDVCHGPRTDRELKLTLVFEHVDQDLATYLSKCPKPGLPPET-----IKDLMRQLLR 118

Query: 211 --KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
              + H   +VHRD+KP+NIL+T+ G++K+ADFGLA   S    L+ +  +  Y APEVL
Sbjct: 119 GVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVL 178

Query: 269 SGN-YSEKVDIWSAGVLLHAL-LVAALPFKGDS----LEAVFDAI---------KNVKL- 312
             + Y+  VD+WS G +   L     L F+G S    L+ +FD I         +NV L 
Sbjct: 179 LQSSYATPVDMWSVGCIFAELFRRRPL-FRGTSEADQLDKIFDVIGLPSEEEWPRNVSLP 237

Query: 313 --DFHSG-------VWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
              F S            + +   DL+ +MLT +   RI+A E L+HP+
Sbjct: 238 RSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPY 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  111 bits (279), Expect = 3e-27
 Identities = 84/302 (27%), Positives = 137/302 (45%), Gaps = 41/302 (13%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVE 148
            G   +I + +  ++ +G G FG V   R + +G   A K + K   T       +RE++
Sbjct: 2   FGTVFEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELK 61

Query: 149 IMQHLSGHTGVVTLHSVY-EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
           +++HL  H  +++L  ++    +  + V EL   G  + +++      +Q        ++
Sbjct: 62  LLKHLR-HENIISLSDIFISPLEDIYFVTELL--GTDLHRLLTSRPLEKQFIQYFLYQIL 118

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H  GVVHRD+KP NIL+  +  +K+ DFGLA RI + Q ++G   +  Y APE+
Sbjct: 119 RGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLA-RIQDPQ-MTGYVSTRYYRAPEI 176

Query: 268 LSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF------------DAIKNV--- 310
           +     Y  +VDIWSAG +   +L     F G      F            D I  +   
Sbjct: 177 MLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSE 236

Query: 311 -KLDF-----------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             L F            S  ++     A DL+ +ML  D   RI+A E L HP++  Y +
Sbjct: 237 NTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYHD 296

Query: 359 RT 360
            T
Sbjct: 297 PT 298

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score =  111 bits (278), Expect = 3e-27
 Identities = 62/195 (31%), Positives = 100/195 (51%), Gaps = 9/195 (4%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           VIG G +  V L R K +   +A K ++K         + V  E  + +  S H  +V L
Sbjct: 2   VIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGL 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           HS ++       V+E  +GG L+  M    +  E+ A     ++   + Y H+ G+++RD
Sbjct: 62  HSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRD 121

Query: 223 IKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
           +K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE+L G +Y   VD W+
Sbjct: 122 LKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 281 AGVLLHALLVAALPF 295
            GVL+  ++    PF
Sbjct: 182 LGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score =  109 bits (274), Expect = 3e-27
 Identities = 74/255 (29%), Positives = 122/255 (47%), Gaps = 28/255 (10%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLH 163
           +G G FG V   + K +G  +ACK L K       GE+    E EI++ ++    +V L 
Sbjct: 1   LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNS-PFIVNLA 59

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ----------YSEQRAANIFKDVMWVIKYC 213
             +E      LVM L +GG L   +  VG+          YS Q    I         + 
Sbjct: 60  YAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL--------HL 111

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-Y 272
           H M +V+RD+KPEN+LL   G  +L+D GLA+ + +G+T++  AG+  Y+APE+L    Y
Sbjct: 112 HSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPY 171

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-DFHSGVWETVSKPARDLMA 331
           S  VD ++ G  ++ ++    PFK    +   + +K   L D      +  ++ ++D+  
Sbjct: 172 SYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFEHQNFTEESKDICR 231

Query: 332 RMLTRDVSARITADE 346
             L +    R+ + E
Sbjct: 232 LFLAKKPEDRLGSRE 246

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score =  109 bits (274), Expect = 4e-27
 Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 23/223 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           + +G G FG V+  + K    +    A KTL++      R     E  +M+ L GH  VV
Sbjct: 1   KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKL-GHPNVV 59

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY---------SEQRAANIFKDVMWVIK 211
            L  V  E +  +LV+E   GG L+D + +             S +   +    +   ++
Sbjct: 60  RLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGME 119

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPA-YVAPEVL 268
           Y      VHRD+   N L+     +K++DFGL+  + +            P  ++APE L
Sbjct: 120 YLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESL 179

Query: 269 -SGNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKN 309
             G ++ K D+WS GVLL  +    A P+ G S E V + ++ 
Sbjct: 180 KDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score =  109 bits (273), Expect = 6e-27
 Identities = 75/256 (29%), Positives = 127/256 (49%), Gaps = 24/256 (9%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-------KGEETVHREVEIMQHLSGHTGVVTLH 163
           IG G+F  V+       G   A K ++       K  +   +E+++++ L  H  V+   
Sbjct: 10  IGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYL 68

Query: 164 SVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAA-NIFKDVMWVIKYCHDMGVV 219
           + + E +  ++V+EL   G   R+I    +  +   +R     F  +   +++ H   ++
Sbjct: 69  ASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIM 128

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG--LAGSPAYVAPEVLSGN-YSEKV 276
           HRDIKP N+ +T +G +KL D GL  R  + +T +   L G+P Y++PE +  N Y+ K 
Sbjct: 129 HRDIKPANVFITATGVVKLGDLGLG-RFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKS 187

Query: 277 DIWSAGVLLHALLVAAL--PFKGD--SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
           DIWS G LL+ +  AAL  PF GD  +L ++   I+  K D+     +  S+  RDL++R
Sbjct: 188 DIWSLGCLLYEM--AALQSPFYGDKMNLYSLCKKIE--KCDYPPLPADHYSEELRDLVSR 243

Query: 333 MLTRDVSARITADEVL 348
            +  D   R     VL
Sbjct: 244 CINPDPEKRPDISYVL 259

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score =  110 bits (276), Expect = 7e-27
 Identities = 71/278 (25%), Positives = 134/278 (48%), Gaps = 22/278 (7%)

Query: 90  DVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASG------AEF-ACKTLRKGE- 140
           D   +  RKNK++ +D   +  +G G FG V L   K           F   K +++ + 
Sbjct: 16  DSTKEPKRKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQV 75

Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA 200
           + V  E +I+ +++ H   V L+  +++    +LV+E   GG     +    ++      
Sbjct: 76  DHVFSERKILNYIN-HPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGC 134

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
                ++ + +Y   + +V+RD+KPEN+LL   G IK+ DFG A ++ + +T + L G+P
Sbjct: 135 FYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFA-KVVDTRTYT-LCGTP 192

Query: 261 AYVAPEV-LSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW 319
            Y+APE+ L+  + +  D W+ G+ ++ +LV   PF  +    ++  I    + F     
Sbjct: 193 EYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP---- 248

Query: 320 ETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
           + +    + LM ++L+ D++ R       A  V  HPW
Sbjct: 249 KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPW 286

Length = 340

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  108 bits (272), Expect = 1e-26
 Identities = 85/296 (28%), Positives = 132/296 (44%), Gaps = 52/296 (17%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           D++ K+  I  G +G V+  R K +G   A K L+  +E      T  RE+ I+  L  H
Sbjct: 5   DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-H 63

Query: 157 TGVVTLHSVY--EEADCFHLVME-----LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
             +VT+  V      D  ++VME     L S   L++ M +    SE +   +   ++  
Sbjct: 64  PNIVTVKEVVVGSNLDKIYMVMEYVEHDLKS---LMETMKQPFLQSEVK--CLMLQLLSG 118

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVL 268
           + + HD  ++HRD+K  N+LL   G +K+ DFGLA    S  +  + L  +  Y APE+L
Sbjct: 119 VAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELL 178

Query: 269 SG--NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFD----------------- 305
            G   YS  +D+WS G +   LL     F G    D L  +F                  
Sbjct: 179 LGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELP 238

Query: 306 AIKNVKLDFHSGVWETVSK-PAR-------DLMARMLTRDVSARITADEVLRHPWI 353
             K      +    +   K PA        DL+ R+LT D + RI+A++ L+HP+ 
Sbjct: 239 GAKKKTFTKYPY-NQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score =  107 bits (269), Expect = 2e-26
 Identities = 77/267 (28%), Positives = 128/267 (47%), Gaps = 14/267 (5%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +   E     E + +E+ ++      
Sbjct: 3   EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +   +  Y +     ++ME   GG  +D +++ G   E   A I ++++  + Y H  
Sbjct: 63  Y-ITRYYGSYLKGTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSE 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G +KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 121 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDF 180

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS G+    L     P      +  +F   KN             SKP ++ +   
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----QYSKPFKEFVEAC 236

Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L +D   R TA E+L+H +I  YT++T
Sbjct: 237 LNKDPRFRPTAKELLKHKFITRYTKKT 263

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score =  108 bits (272), Expect = 2e-26
 Identities = 62/195 (31%), Positives = 97/195 (49%), Gaps = 9/195 (4%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHREVEIMQHLSGHTGVVTL 162
           VIG G +  V L   K +   +A K ++K           V  E  + +  S H  +V L
Sbjct: 2   VIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGL 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           HS ++       V+E  SGG L+  M    +  E+ A     ++   + + H+ G+++RD
Sbjct: 62  HSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRD 121

Query: 223 IKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
           +K +N+LL   G IKL D+G+    I  G T S   G+P Y+APE+L G +Y   VD W+
Sbjct: 122 LKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWA 181

Query: 281 AGVLLHALLVAALPF 295
            GVL+  ++    PF
Sbjct: 182 LGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  107 bits (269), Expect = 3e-26
 Identities = 64/201 (31%), Positives = 98/201 (48%), Gaps = 10/201 (4%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGHTGVVT 161
           + ++G G +G V  C+ K +G   A K   + E+         RE+ +++ L  H  +V 
Sbjct: 6   LGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVN 64

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L  V+      +LV E      L D         E R       ++  I++CH   ++HR
Sbjct: 65  LIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHR 124

Query: 222 DIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDI 278
           DIKPENIL++ SG +KL DFG A  + + G+  +    +  Y APE+L G+  Y   VDI
Sbjct: 125 DIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDI 184

Query: 279 WSAGVLLHALLVAALPFKGDS 299
           W+ G L+  +L     F GDS
Sbjct: 185 WAVGCLVTEMLTGEPLFPGDS 205

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score =  108 bits (271), Expect = 3e-26
 Identities = 63/197 (31%), Positives = 100/197 (50%), Gaps = 13/197 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---------REVEIMQHLSGHTGVV 160
           VIG G +  V L R K +   +A K ++K  E VH          E  + +  S +  +V
Sbjct: 2   VIGRGSYAKVLLVRLKKNDQIYAMKVVKK--ELVHDDEDIDWVQTEKHVFEQASSNPFLV 59

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            LHS ++      LV+E  +GG L+  M    +  E+ A     ++   + + H+ G+++
Sbjct: 60  GLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIY 119

Query: 221 RDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDI 278
           RD+K +N+LL   G IKL D+G+    +  G T S   G+P Y+APE+L G  Y   VD 
Sbjct: 120 RDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDW 179

Query: 279 WSAGVLLHALLVAALPF 295
           W+ GVL+  ++    PF
Sbjct: 180 WALGVLMFEMMAGRSPF 196

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score =  106 bits (267), Expect = 3e-26
 Identities = 70/264 (26%), Positives = 124/264 (46%), Gaps = 19/264 (7%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGE-----ETVHREVEIMQHLSG 155
            K + +G G F S +  R   +G   A K +        E     E + +E+ +M  L+ 
Sbjct: 3   LKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN- 61

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ +     E   F+L +E  +GG +   + + G + E    N  + ++  + Y H+
Sbjct: 62  HPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHE 121

Query: 216 MGVVHRDIKPENILLTTSGK-IKLADFGLAMRISNGQTLSG-----LAGSPAYVAPEVLS 269
             ++HRD+K  N+L+ ++G+ +++ADFG A R++   T +G     L G+ A++APEVL 
Sbjct: 122 NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLR 181

Query: 270 G-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           G  Y    D+WS G ++  +  A  P+  +        I K         + E +S   R
Sbjct: 182 GEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLR 241

Query: 328 DLMARMLTRDVSARITADEVLRHP 351
           D+  R L      R  + E+L+HP
Sbjct: 242 DVTLRCLELQPEDRPPSRELLKHP 265

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score =  106 bits (267), Expect = 3e-26
 Identities = 64/253 (25%), Positives = 120/253 (47%), Gaps = 18/253 (7%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G +GSV+  +  +    +A K +  G       E+ V+ E+ I+  ++ H  +++  
Sbjct: 8   LGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVN-EIRILASVN-HPNIISYK 65

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVIKYCHDMGVV 219
             + + +   +VME    G L   + +  +      EQ    IF  ++  ++  H+  ++
Sbjct: 66  EAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKIL 125

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           HRD+K  NILL  +  +K+ D G++  +      + + G+P Y+APEV  G  YS K DI
Sbjct: 126 HRDLKSANILLVANDLVKIGDLGISKVLKKNMAKTQI-GTPHYMAPEVWKGRPYSYKSDI 184

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           WS G LL+ +   A PF+  S++ +   ++  K      +    S+  ++ +  ML    
Sbjct: 185 WSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYP---PIPPIYSQDLQNFIRSMLQVKP 241

Query: 339 SARITADEVLRHP 351
             R   D++L  P
Sbjct: 242 KLRPNCDKILASP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score =  106 bits (266), Expect = 4e-26
 Identities = 77/267 (28%), Positives = 132/267 (49%), Gaps = 14/267 (5%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +   E     E + +E+ ++      
Sbjct: 3   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 62

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 63  Y-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 121 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 180

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS G+    L     P      ++ +F   KN             SKP ++ +   
Sbjct: 181 KADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPTLEG----NYSKPLKEFVEAC 236

Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L ++ S R TA E+L+H +I+ + ++T
Sbjct: 237 LNKEPSFRPTAKELLKHKFIVRFAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score =  106 bits (265), Expect = 5e-26
 Identities = 70/257 (27%), Positives = 125/257 (48%), Gaps = 15/257 (5%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHTGVVT 161
           V V+G G +G V L R +  G ++  K L      R+  +   +E +++  L  H  +V 
Sbjct: 5   VRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVA 63

Query: 162 LHSVYEEADC-FHLVMELCSGGRLIDQMVEV-GQY-SEQRAANIFKDVMWVIKYCHDMGV 218
               +E  D   ++VM  C GG L  ++ E  G+   E +    F  +   ++Y H+  +
Sbjct: 64  YRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHI 123

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSGN-YSEKV 276
           +HRD+K +N+ LT +  IK+ D G+A  + N   + S L G+P Y++PE+ S   Y+ K 
Sbjct: 124 LHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKS 183

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D+W+ G  ++ +      F    + ++   I   KL     + +  S    +L+A ML++
Sbjct: 184 DVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL---PPMPKDYSPELGELIATMLSK 240

Query: 337 DVSARITADEVLRHPWI 353
               R +   +LR P+I
Sbjct: 241 RPEKRPSVKSILRQPYI 257

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score =  106 bits (265), Expect = 6e-26
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 28/264 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR---------KGEETVHREVEIMQHLSGHTGV 159
           +++G G FG V+LC    +G E A K ++         K    +  E++++++L  H  +
Sbjct: 8   KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERI 66

Query: 160 VTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           V  +    +       + ME   GG + DQ+   G  +E       + ++  + Y H   
Sbjct: 67  VQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNM 126

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRIS----NGQTLSGLAGSPAYVAPEVLSGN-Y 272
           +VHRDIK  NIL  ++G +KL DFG + R+     +G  +  + G+P +++PEV+SG  Y
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGY 186

Query: 273 SEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAI---KNVKLDFHSGVWETVSKPARD 328
             K D+WS G  +  +L    P+ + +++ A+F       N +L  H      +S+ ARD
Sbjct: 187 GRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTNPQLPSH------ISEHARD 240

Query: 329 LMARMLTRDVSARITADEVLRHPW 352
            +  +   +   R +A+E+LRHP+
Sbjct: 241 FLGCIFV-EARHRPSAEELLRHPF 263

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score =  105 bits (264), Expect = 1e-25
 Identities = 72/270 (26%), Positives = 125/270 (46%), Gaps = 25/270 (9%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACK-------------TLRKGE-ETVHREVEIMQH 152
           K E+IG G +G V+L  +  +G   A K             + +K   + +  E+E ++ 
Sbjct: 5   KGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKD 64

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  +V         +   + +E   GG +   +   G++ EQ      + V+  + Y
Sbjct: 65  LD-HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAY 123

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR----ISNGQTLSGLAGSPAYVAPEVL 268
            H  G++HRD+K +N+L+   G  K++DFG++ +      N Q +S + GS  ++APEV+
Sbjct: 124 LHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMS-MQGSVFWMAPEVI 182

Query: 269 SGN---YSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKL-DFHSGVWETVS 323
                 YS KVDIWS G ++  +     P+  + ++ A+F              V   +S
Sbjct: 183 HSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLS 242

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
             A D +    T +   R TA E+L+HP+I
Sbjct: 243 PVALDFLNACFTINPDNRPTARELLQHPFI 272

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  105 bits (264), Expect = 1e-25
 Identities = 89/302 (29%), Positives = 129/302 (42%), Gaps = 61/302 (20%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEE-----TVHREVEIMQHLSGH 156
           D + K+E IG G +G V+  R K +G   A K T  + +E     T  RE+ ++Q LS  
Sbjct: 1   DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSES 60

Query: 157 TGVVTLHSV--YEEAD---CFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWV 209
             +V L  V   EE +     +LV E       + +D             A   K  M+ 
Sbjct: 61  IYIVRLLDVEHVEEKNGKPSLYLVFEYLDSDLKKFMDS--NGRGPGRPLPAKTIKSFMYQ 118

Query: 210 ----IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPA--- 261
               + +CH  GV+HRD+KP+N+L+    G +K+AD GL      G+  S    S     
Sbjct: 119 LLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGL------GRAFSIPVKSYTHEI 172

Query: 262 ----YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS---------------L 300
               Y APEVL G  +YS  VDIWS G +   +      F GDS                
Sbjct: 173 VTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPT 232

Query: 301 EAVFDAIKNVKLDFH----------SGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
           E V+  +  ++ D+H          S     +S    DL+ +ML  D + RI+A   L H
Sbjct: 233 EQVWPGVSKLR-DWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTH 291

Query: 351 PW 352
           P+
Sbjct: 292 PY 293

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score =  105 bits (264), Expect = 2e-25
 Identities = 78/258 (30%), Positives = 119/258 (46%), Gaps = 23/258 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHR------EVEIMQHLSGHTGVVTLH 163
           IGHG FG+V+  R   +    A K +   G+++  +      EV  +Q L  H   +   
Sbjct: 23  IGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYK 81

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHR 221
             Y       LVME C G      ++EV +    E   A I    +  + Y H    +HR
Sbjct: 82  GCYLREHTAWLVMEYCLGS--ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHR 139

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL----SGNYSEKVD 277
           DIK  NILLT  G +KLADFG A  +S   +     G+P ++APEV+     G Y  KVD
Sbjct: 140 DIKAGNILLTEPGTVKLADFGSASLVSPANS---FVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 278 IWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           +WS G+    L     P F  +++ A++   +N      S  W   S   R+ +   L +
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLSSNDW---SDYFRNFVDSCLQK 253

Query: 337 DVSARITADEVLRHPWIL 354
               R +++E+L+H ++L
Sbjct: 254 IPQDRPSSEELLKHRFVL 271

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score =  105 bits (262), Expect = 2e-25
 Identities = 77/279 (27%), Positives = 142/279 (50%), Gaps = 30/279 (10%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +G   A K +  K EE +     E++I+     H  +V L   +
Sbjct: 13  LGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAF 71

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
              +   +++E C+GG +   M+E+ +  +E +   + K  +  + Y H+  ++HRD+K 
Sbjct: 72  YYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKA 131

Query: 226 ENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEVLSGN------YSEKV 276
            NIL T  G IKLADFG++ +  N +T+       G+P ++APEV+         Y  K 
Sbjct: 132 GNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 189

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR------DLM 330
           D+WS G+ L  + +A +      L  +   +K  K +       T+++P+R      D +
Sbjct: 190 DVWSLGITL--IEMAQIEPPHHELNPMRVLLKIAKSEP-----PTLAQPSRWSSEFKDFL 242

Query: 331 ARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSK 369
            + L ++V AR T  ++L+HP++   + + +R L  ++K
Sbjct: 243 KKCLEKNVDARWTTTQLLQHPFVTVNSNKPIRELIAEAK 281

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score =  106 bits (266), Expect = 2e-25
 Identities = 83/304 (27%), Positives = 129/304 (42%), Gaps = 59/304 (19%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGV 159
           K++ +G G FG V L     + A +A KTLRK +         V  E +I+   + +  V
Sbjct: 5   KIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAE-ADNEWV 63

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           V L+  +++ D  + VM+   GG ++  ++ +  + E  A     ++   I+  H MG +
Sbjct: 64  VKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFI 123

Query: 220 HRDIKPENILLTTSGKIKLADFGLAM-----------------------------RISN- 249
           HRDIKP+NIL+   G IKL DFGL                                +SN 
Sbjct: 124 HRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNC 183

Query: 250 --GQTLS----------------GLAGSPAYVAPEV-LSGNYSEKVDIWSAGVLLHALLV 290
             G  L                  L G+P Y+APEV L   Y++  D WS GV+L  +LV
Sbjct: 184 RCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLV 243

Query: 291 AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML--TRDVSARITADEVL 348
              PF   +       + N +   H      +S  A DL+ ++     +   R  AD++ 
Sbjct: 244 GQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIK 303

Query: 349 RHPW 352
            HP+
Sbjct: 304 AHPF 307

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  104 bits (261), Expect = 4e-25
 Identities = 87/290 (30%), Positives = 128/290 (44%), Gaps = 45/290 (15%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           D + KVE IG G +G V+  R + +    A K +R  +E      T  RE+ +++ +  H
Sbjct: 2   DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV----IKY 212
             +V L  V       +LV E      L   M     ++  +   + K  ++     I Y
Sbjct: 61  GNIVRLQDVVHSEKRLYLVFEYLDLD-LKKHMDSSPDFA--KNPRLIKTYLYQILRGIAY 117

Query: 213 CHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG 270
           CH   V+HRD+KP+N+L+      +KLADFGLA       +T +    +  Y APE+L G
Sbjct: 118 CHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLG 177

Query: 271 --NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAIKNVKLDFHSGV----- 318
             +YS  VDIWS G +  A +V   P F GDS    L  +F  +     +   GV     
Sbjct: 178 SRHYSTPVDIWSVGCIF-AEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPD 236

Query: 319 -------WE---------TVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                  W          T+     DL+++ML  D S RITA   L H +
Sbjct: 237 YKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEY 286

Length = 294

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score =  105 bits (263), Expect = 6e-25
 Identities = 81/269 (30%), Positives = 137/269 (50%), Gaps = 35/269 (13%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH----REVEIMQHLSGHTGVVT 161
           +V  IG G  G+V+    + +G  +A K +    E+TV     RE+EI++ ++ H  VV 
Sbjct: 78  RVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVK 136

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
            H +++      +++E   GG L    +      EQ  A++ + ++  I Y H   +VHR
Sbjct: 137 CHDMFDHNGEIQVLLEFMDGGSLEGTHI----ADEQFLADVARQILSGIAYLHRRHIVHR 192

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPAYVAPEVLS-----GNYS 273
           DIKP N+L+ ++  +K+ADFG++ RI   QT+   +   G+ AY++PE ++     G Y 
Sbjct: 193 DIKPSNLLINSAKNVKIADFGVS-RILA-QTMDPCNSSVGTIAYMSPERINTDLNHGAYD 250

Query: 274 EKV-DIWSAGVLLHALLVAALPF----KGDSLEAVFDAIKNVKLDFHSGVWE---TVSKP 325
               DIWS GV +    +   PF    +GD   ++  AI        S   E   T S+ 
Sbjct: 251 GYAGDIWSLGVSILEFYLGRFPFGVGRQGD-WASLMCAI------CMSQPPEAPATASRE 303

Query: 326 ARDLMARMLTRDVSARITADEVLRHPWIL 354
            R  ++  L R+ + R +A ++L+HP+IL
Sbjct: 304 FRHFISCCLQREPAKRWSAMQLLQHPFIL 332

Length = 353

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score =  103 bits (257), Expect = 7e-25
 Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 24/263 (9%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFA---------CKTLRKGEETVHREVEIMQHLSGHTGV 159
           +++G G FG V+LC    +G E A          +   K    +  E++++++L  H  +
Sbjct: 8   KLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRI 66

Query: 160 VTLHSVYE--EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           V  +      E     + +E   GG + DQ+   G  +E       + ++  + Y H   
Sbjct: 67  VQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNM 126

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRIS----NGQTLSGLAGSPAYVAPEVLSGN-Y 272
           +VHRDIK  NIL  ++G +KL DFG + RI     +G  +  + G+P +++PEV+SG  Y
Sbjct: 127 IVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGY 186

Query: 273 SEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFD-AIKNVKLDFHSGVWETVSKPARDLM 330
             K D+WS    +  +L    P+ + +++ A+F  A +  K     G    VS   RD +
Sbjct: 187 GRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPTKPMLPDG----VSDACRDFL 242

Query: 331 ARMLTRDVSARITADEVLRHPWI 353
            ++   +   R TA+ +LRHP++
Sbjct: 243 KQIFVEE-KRRPTAEFLLRHPFV 264

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score =  103 bits (257), Expect = 8e-25
 Identities = 79/264 (29%), Positives = 124/264 (46%), Gaps = 28/264 (10%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHTG----V 159
           +IG G FG V+ CR   +G  +A K L       K  ET+     IM  L   TG    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFI 59

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           V +   +   D    +++L +GG L   + + G +SE        +++  +++ H+  VV
Sbjct: 60  VCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVV 119

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVD 277
           +RD+KP NILL   G ++++D GLA   S  +  + + G+  Y+APEVL     Y    D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGVAYDSSAD 178

Query: 278 IWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
            +S G +L  LL    PF+     D  E     I  + L     + ++ S   R L+  +
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHE-----IDRMTLTMAVELPDSFSPELRSLLEGL 233

Query: 334 LTRDVSARI-----TADEVLRHPW 352
           L RDV+ R+      A EV  HP+
Sbjct: 234 LQRDVNRRLGCLGRGAQEVKEHPF 257

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  103 bits (258), Expect = 8e-25
 Identities = 82/291 (28%), Positives = 134/291 (46%), Gaps = 56/291 (19%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           K+E IG G +G+V+  +++ +    A K +R  ++      +  RE+ +++ L  H  +V
Sbjct: 4   KLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIV 62

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE----QRAANIFKDVMWV----IKY 212
            L+ V        LV E C      DQ  ++ +Y +         I K  M+     + +
Sbjct: 63  RLYDVLHSDKKLTLVFEYC------DQ--DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAF 114

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---QTLSGLAGSPAYVAPEVLS 269
           CH   V+HRD+KP+N+L+  +G++KLADFGLA   + G   +  S    +  Y  P+VL 
Sbjct: 115 CHSHNVLHRDLKPQNLLINKNGELKLADFGLAR--AFGIPVRCYSAEVVTLWYRPPDVLF 172

Query: 270 GN--YSEKVDIWSAGVLLHALLVAALP-FKG----DSLEAVFDAIKNVKLDFHSGV---- 318
           G   YS  +D+WSAG +   L  A  P F G    D L+ +F  +     +   GV    
Sbjct: 173 GAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232

Query: 319 -------------WETV----SKPARDLMARMLTRDVSARITADEVLRHPW 352
                           V    +   RDL+  +L  +   RI+A+E L+HP+
Sbjct: 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPY 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  104 bits (260), Expect = 1e-24
 Identities = 81/300 (27%), Positives = 139/300 (46%), Gaps = 55/300 (18%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVH-----REVEIMQHLSGHTG 158
           + +++ IG G  G V        G   A K L R  +   H     RE+ +++ ++ H  
Sbjct: 23  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKN 81

Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++ + +   +R + +   ++  IK+
Sbjct: 82  IISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIHM-ELDHERMSYLLYQMLCGIKH 138

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 198

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS G ++  L+  ++ F+G    D    V + +     +F + +  TV     
Sbjct: 199 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE 258

Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D   RI+ DE LRHP+I
Sbjct: 259 NRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 318

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score =  102 bits (255), Expect = 2e-24
 Identities = 78/271 (28%), Positives = 132/271 (48%), Gaps = 22/271 (8%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +   E     E + +E+ ++      
Sbjct: 3   EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 61

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++  G + E + A + K+++  + Y H  
Sbjct: 62  PYVTKYYGSYLKGTKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEILKGLDYLHSE 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G +KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 121 KKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDS 180

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKN----VKLDFHSGVWETVSKPARDL 329
           K DIWS G+    L     P      +  +F   KN    +  +F        SKP ++ 
Sbjct: 181 KADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLTGEF--------SKPFKEF 232

Query: 330 MARMLTRDVSARITADEVLRHPWILFYTERT 360
           +   L +D S R TA E+L+H +I+   ++T
Sbjct: 233 IDACLNKDPSFRPTAKELLKHKFIVKNAKKT 263

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score =  103 bits (257), Expect = 2e-24
 Identities = 80/268 (29%), Positives = 124/268 (46%), Gaps = 25/268 (9%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEET------VHREVEIMQHLSGHTGVVTLH 163
           IGHG FG+V+   +  +    A K +   G++T      + +EV+ +Q L  H   +   
Sbjct: 29  IGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYK 87

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHR 221
             Y +     LVME C G      ++EV +    E   A I    +  + Y H   ++HR
Sbjct: 88  GCYLKEHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHR 145

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL----SGNYSEKVD 277
           DIK  NILLT  G++KLADFG A + S   +     G+P ++APEV+     G Y  KVD
Sbjct: 146 DIKAGNILLTEPGQVKLADFGSASKSSPANS---FVGTPYWMAPEVILAMDEGQYDGKVD 202

Query: 278 IWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           +WS G+    L     P F  +++ A++   +N      S  W   +   R  +   L +
Sbjct: 203 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLQSNEW---TDSFRGFVDYCLQK 259

Query: 337 DVSARITADEVLRHPWILFYTERTLRTL 364
               R  + E+LRH ++    +R  R L
Sbjct: 260 IPQERPASAELLRHDFV--RRDRPARVL 285

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score =  102 bits (256), Expect = 2e-24
 Identities = 79/263 (30%), Positives = 124/263 (47%), Gaps = 23/263 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEET------VHREVEIMQHLSGHTG 158
           T +  IGHG FG+V+  R   +    A K +   G+++      + +EV+ +Q +  H  
Sbjct: 28  TDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPN 86

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDM 216
            +     Y       LVME C G      ++EV +    E   A I    +  + Y H  
Sbjct: 87  SIEYKGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSH 144

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL----SGNY 272
            ++HRDIK  NILLT  G++KLADFG A   S   +     G+P ++APEV+     G Y
Sbjct: 145 NMIHRDIKAGNILLTEPGQVKLADFGSASIASPANS---FVGTPYWMAPEVILAMDEGQY 201

Query: 273 SEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
             KVD+WS G+    L     P F  +++ A++   +N      S  W   S   R+ + 
Sbjct: 202 DGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SDYFRNFVD 258

Query: 332 RMLTRDVSARITADEVLRHPWIL 354
             L +    R T++E+L+H ++L
Sbjct: 259 SCLQKIPQDRPTSEELLKHMFVL 281

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score =  102 bits (254), Expect = 2e-24
 Identities = 82/278 (29%), Positives = 139/278 (50%), Gaps = 27/278 (9%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +GA  A K +  K EE +     E+EI+   +    V  L + Y
Sbjct: 20  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFY 79

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
            +   + +++E C GG +   M+E+ +  +E +   I + ++  ++Y H M ++HRD+K 
Sbjct: 80  WDGKLW-IMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKA 138

Query: 226 ENILLTTSGKIKLADFGL-AMRISNGQTLSGLAGSPAYVAPEVL------SGNYSEKVDI 278
            N+LLT  G IKLADFG+ A  +   Q      G+P ++APEV+         Y  K DI
Sbjct: 139 GNVLLTLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 198

Query: 279 WSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA------RDLMAR 332
           WS G+ L  + +A +      L  +   +K  K +       T+S+P+      RD +  
Sbjct: 199 WSLGITL--IEMAQIEPPHHELNPMRVLLKIAKSEP-----PTLSQPSKWSMEFRDFLKT 251

Query: 333 MLTRDVSARITADEVLRHPWI-LFYTERTLRTLTIKSK 369
            L +    R +A ++L HP++    + R LR L  ++K
Sbjct: 252 ALDKHPETRPSAAQLLEHPFVSSVTSNRPLRELVAEAK 289

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score =  101 bits (253), Expect = 3e-24
 Identities = 72/266 (27%), Positives = 132/266 (49%), Gaps = 24/266 (9%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR---KGEETVHREVEIMQHLSGHTGVVTLHS 164
           VE++G+G +G V+  R   +G   A K +      EE + +E+ +++  S H  + T + 
Sbjct: 11  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 70

Query: 165 VYEEA------DCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            + +       D   LVME C  G + D  +  +     E+  A I ++++  + + H  
Sbjct: 71  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 130

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSPAYVAPEVLS----- 269
            V+HRDIK +N+LLT + ++KL DFG++ ++    G+  +   G+P ++APEV++     
Sbjct: 131 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDENP 189

Query: 270 -GNYSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
              Y  K D+WS G+    +   A P      + A+F   +N      S  W   SK  +
Sbjct: 190 DATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQ 246

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
             +   L ++ S R T +++++HP+I
Sbjct: 247 SFIESCLVKNHSQRPTTEQLMKHPFI 272

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  102 bits (257), Expect = 3e-24
 Identities = 79/308 (25%), Positives = 129/308 (41%), Gaps = 64/308 (20%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSG 155
           +   +  +  IG G +G V     K +G + A K +   E         RE++I++    
Sbjct: 3   VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK- 61

Query: 156 HTGVVTLHSV-----YEEADCFHLV---ME-----LCSGGRLIDQMVEVGQYSEQRAANI 202
           H  ++ +  +     +E  +  ++V   ME     L     L +  ++   Y   R    
Sbjct: 62  HENIIGILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLSNDHIQYFLYQILRG--- 118

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-----NGQTLSGLA 257
                  +KY H   V+HRD+KP N+LL T+  +K+ DFGLA RI+     +   L+   
Sbjct: 119 -------LKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLA-RIADPEHDHTGFLTEYV 170

Query: 258 GSPAYVAPEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFD------ 305
            +  Y APE++  S  Y++ +DIWS G +L  +L     F G      L  +        
Sbjct: 171 ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPS 230

Query: 306 -----AIKNVK-------LDFHSGV-WET----VSKPARDLMARMLTRDVSARITADEVL 348
                 I +++       L F   V W          A DL+ +MLT +   RIT +E L
Sbjct: 231 QEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEAL 290

Query: 349 RHPWILFY 356
            HP++  Y
Sbjct: 291 AHPYLEQY 298

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score =  101 bits (254), Expect = 4e-24
 Identities = 80/290 (27%), Positives = 134/290 (46%), Gaps = 40/290 (13%)

Query: 93  TQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EET--VHRE 146
           T  G+K   + +D   +  IG G  G V+  R K +G   A K +R+    EE   +  +
Sbjct: 4   TIDGQKYPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMD 63

Query: 147 VEIMQ--HLSGHTGVVTLHSVY-EEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAAN 201
           ++++   H   +  +V  +  +  ++D F + MEL S    +L+ ++   G   E     
Sbjct: 64  LDVVLKSHDCPY--IVKCYGYFITDSDVF-ICMELMSTCLDKLLKRIQ--GPIPEDILGK 118

Query: 202 IFKDVMWVIKYCHDM----GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           +    + ++K  H +    GV+HRD+KP NILL  SG +KL DFG++ R+ + +  +  A
Sbjct: 119 M---TVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRSA 175

Query: 258 GSPAYVAPEVLS-----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV-- 310
           G  AY+APE +        Y  + D+WS G+ L  L     P+K    E  F+ +  +  
Sbjct: 176 GCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTE--FEVLTKILQ 233

Query: 311 ----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                L  + G     S      +   LT+D   R    E+L+HP+I  Y
Sbjct: 234 EEPPSLPPNEG----FSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRY 279

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score =  102 bits (256), Expect = 5e-24
 Identities = 73/278 (26%), Positives = 123/278 (44%), Gaps = 53/278 (19%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG---- 158
           +D   ++VIG G FG V L + K +G  +A K LRK +     E E + H+         
Sbjct: 1   EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADML---EKEQVGHIRAERDILVE 57

Query: 159 -----VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
                VV +   +++    +L+ME   GG ++  +++    +E+       + +  I   
Sbjct: 58  ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSI 117

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----------------------- 250
           H +G +HRDIKP+N+LL + G +KL+DFGL   +                          
Sbjct: 118 HQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMN 177

Query: 251 -------------QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFK 296
                        Q      G+P Y+APEV     Y++  D WS GV+++ +L+   PF 
Sbjct: 178 SKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFC 237

Query: 297 GDSLEAVFDAIKNVK--LDFHSGVWETVSKPARDLMAR 332
            ++ +  +  + N K  L F   V   +S+ A+DL+ R
Sbjct: 238 SETPQETYKKVMNWKETLIFPPEV--PISEKAKDLILR 273

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  101 bits (253), Expect = 7e-24
 Identities = 82/316 (25%), Positives = 129/316 (40%), Gaps = 82/316 (25%)

Query: 111 IGHGKFGSVWLCRSKAS--GAEFACKTLRKGEETVH--------REVEIMQHLSGHTGVV 160
           IG G +G V+  + K    G E+A K   KG++  +        RE+ +++ L  H  VV
Sbjct: 8   IGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELK-HENVV 65

Query: 161 TLHSVY-EEAD-CFHLVMELCSGGRLIDQMVEVGQYSEQRAA-----NIFKDVMWVI--- 210
           +L  V+ E AD   +L+ +          + ++ ++  Q        ++ K ++W I   
Sbjct: 66  SLVEVFLEHADKSVYLLFDYAE-----HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNG 120

Query: 211 -KYCHDMGVVHRDIKPENILLT----TSGKIKLADFGLAMRISNGQTLSGLAGSPA---- 261
             Y H   V+HRD+KP NIL+       G +K+ D GLA R+ N          P     
Sbjct: 121 VHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA-RLFNAPLKPLADLDPVVVTI 179

Query: 262 -YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKG-------------DSLEAVF- 304
            Y APE+L G  +Y++ +DIW+ G +   LL     FKG             D LE +F 
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239

Query: 305 -----------------------DAIKNVKLDFHS-----GVWETVSKPARDLMARMLTR 336
                                     K      +S        +       DL+ ++L  
Sbjct: 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEY 299

Query: 337 DVSARITADEVLRHPW 352
           D + RITA+E L HP+
Sbjct: 300 DPTKRITAEEALEHPY 315

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  101 bits (254), Expect = 8e-24
 Identities = 88/302 (29%), Positives = 133/302 (44%), Gaps = 77/302 (25%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK-----GEET----VHREVEIMQHLSGHTGVVT 161
           +G G +G VW    + +    A   L+K        T      RE+  +Q L  H  +V 
Sbjct: 15  LGKGAYGIVWKAIDRRTKEVVA---LKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVK 71

Query: 162 LHSVYEEADC---FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV-----MW----V 209
           L +V + A+     +LV E           +E   ++  RA NI +DV     M+     
Sbjct: 72  LLNVIK-AENDKDIYLVFEY----------METDLHAVIRA-NILEDVHKRYIMYQLLKA 119

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YVA-- 264
           +KY H   V+HRD+KP NILL +  ++KLADFGLA  +S    L     +P    YVA  
Sbjct: 120 LKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLS---ELEENPENPVLTDYVATR 176

Query: 265 ----PEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLD- 313
               PE+L  S  Y++ VD+WS G +L  +L+    F G S    LE + + I     + 
Sbjct: 177 WYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAED 236

Query: 314 ---FHSGVWETV-------------------SKPARDLMARMLTRDVSARITADEVLRHP 351
                S    T+                   S  A DL+ ++L  + + R+TA+E L HP
Sbjct: 237 IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHP 296

Query: 352 WI 353
           ++
Sbjct: 297 YV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  101 bits (253), Expect = 1e-23
 Identities = 82/290 (28%), Positives = 136/290 (46%), Gaps = 49/290 (16%)

Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHL----- 153
           +T ++ +G G +GSV     K +G + A K L +  ++       +RE+ +++H+     
Sbjct: 17  YTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENV 76

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLID-QMVEVGQYSEQRAANIFKDVMWVIKY 212
            G   V T     +E   F+LVM         D Q +     SE +   +   ++  +KY
Sbjct: 77  IGLLDVFTSAVSGDEFQDFYLVMPYMQ----TDLQKIMGHPLSEDKVQYLVYQMLCGLKY 132

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-- 270
            H  G++HRD+KP N+ +    ++K+ DFGLA R ++ + ++G   +  Y APEV+    
Sbjct: 133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLA-RHADAE-MTGYVVTRWYRAPEVILNWM 190

Query: 271 NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFD----------------AIKNV 310
           +Y++ VDIWS G ++  +L     FKG    D L  +                  A K+ 
Sbjct: 191 HYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSY 250

Query: 311 --------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                   + DF S ++   S  A DL+ +ML  DV  R+TA E L HP+
Sbjct: 251 IKSLPKYPRKDF-STLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPY 299

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  100 bits (250), Expect = 1e-23
 Identities = 81/298 (27%), Positives = 126/298 (42%), Gaps = 56/298 (18%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVV 160
           K+  IG G FG V+  R K +    A K +    E      T  RE++I+Q L  H  VV
Sbjct: 16  KLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVV 74

Query: 161 TLHSV-YEEAD-------CFHLVMELCS---GGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
            L  +   +A         F+LV E C     G L ++ V   +++      + K ++  
Sbjct: 75  NLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNV---KFTLSEIKKVMKMLLNG 131

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQT--LSGLAGSPAYVA 264
           + Y H   ++HRD+K  NIL+T  G +KLADFGLA   S   N +    +    +  Y  
Sbjct: 132 LYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRP 191

Query: 265 PEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           PE+L G  +Y   +D+W AG ++  +   +   +G++ +     I  +       VW  V
Sbjct: 192 PELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGV 251

Query: 323 SK---------P-------------------ARDLMARMLTRDVSARITADEVLRHPW 352
            K         P                   A DL+ ++L  D + RI AD  L H +
Sbjct: 252 DKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDF 309

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 99.4 bits (247), Expect = 3e-23
 Identities = 73/257 (28%), Positives = 119/257 (46%), Gaps = 23/257 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEET------VHREVEIMQHLSGHTGVVTLH 163
           IGHG FG+V+  R   +    A K +   G+++      + +EV  +Q L  H   +   
Sbjct: 23  IGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYR 81

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHR 221
             Y       LVME C G      ++EV +    E   A +    +  + Y H   ++HR
Sbjct: 82  GCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHR 139

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL----SGNYSEKVD 277
           D+K  NILL+  G +KL DFG A  ++         G+P ++APEV+     G Y  KVD
Sbjct: 140 DVKAGNILLSEPGLVKLGDFGSASIMAPANX---FVGTPYWMAPEVILAMDEGQYDGKVD 196

Query: 278 IWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           +WS G+    L     P F  +++ A++   +N      SG W   S+  R+ +   L +
Sbjct: 197 VWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNFVDSCLQK 253

Query: 337 DVSARITADEVLRHPWI 353
               R T++ +L+H ++
Sbjct: 254 IPQDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 98.0 bits (244), Expect = 3e-23
 Identities = 65/263 (24%), Positives = 120/263 (45%), Gaps = 24/263 (9%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHT 157
           D   +  IG G FG V+    KA    +A K +      R+  E    E  ++  L   +
Sbjct: 1   DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SS 59

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQ-YSEQRAANIFKDVMWVIKYCHD 215
            ++  +  + +    ++VME    G L   + ++ G+   E +    F  ++  + + H 
Sbjct: 60  YIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHS 119

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYVAPEVLSGN-Y 272
             ++HRDIK  N+ L     +K+ D G+A ++ +  T   + + G+P Y++PE+     Y
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVA-KLLSDNTNFANTIVGTPYYLSPELCEDKPY 178

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR----D 328
           +EK D+W+ GV+L+       PF  ++  A+   I         GV+  VS+        
Sbjct: 179 NEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIR-------GVFPPVSQMYSQQLAQ 231

Query: 329 LMARMLTRDVSARITADEVLRHP 351
           L+ + LT+D   R    ++LR+P
Sbjct: 232 LIDQCLTKDYRQRPDTFQLLRNP 254

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 98.5 bits (245), Expect = 4e-23
 Identities = 73/266 (27%), Positives = 130/266 (48%), Gaps = 24/266 (9%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL---RKGEETVHREVEIMQHLSGHTGVVTLHS 164
           VEV+G+G +G V+  R   +G   A K +      EE +  E+ +++  S H  + T + 
Sbjct: 21  VEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYG 80

Query: 165 VYEEA------DCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            + +       D   LVME C  G + D  +  +     E   A I ++++  + + H  
Sbjct: 81  AFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAH 140

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSPAYVAPEVLS----- 269
            V+HRDIK +N+LLT + ++KL DFG++ ++    G+  +   G+P ++APEV++     
Sbjct: 141 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRR-NTFIGTPYWMAPEVIACDENP 199

Query: 270 -GNYSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
              Y  + DIWS G+    +   A P      + A+F   +N      S  W   SK   
Sbjct: 200 DATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPPKLKSKKW---SKKFI 256

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           D +   L ++  +R + +++L+HP+I
Sbjct: 257 DFIEGCLVKNYLSRPSTEQLLKHPFI 282

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score = 98.6 bits (245), Expect = 5e-23
 Identities = 77/285 (27%), Positives = 129/285 (45%), Gaps = 37/285 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K++ +G G + +V+  RSK +    A K +R   E     T  REV ++++L  H 
Sbjct: 5   ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HA 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK-DVMWVIKYCHDM 216
            +VTLH +     C  LV E      L   +   G         IF   ++  + YCH  
Sbjct: 64  NIVTLHDIIHTERCLTLVFEYLDSD-LKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKR 122

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YS 273
            ++HRD+KP+N+L+   G++KLADFGLA   S   +T S    +  Y  P+VL G+  YS
Sbjct: 123 KILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYS 182

Query: 274 EKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKLDFHSGV-----WETVSK 324
             +D+W  G +L+ +      F G    + L  +F  +     +   G+     + +   
Sbjct: 183 TPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF 242

Query: 325 PAR-----------------DLMARMLTRDVSARITADEVLRHPW 352
           P                   DL++ +L  +  +RI+A+  LRH +
Sbjct: 243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSY 287

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 97.8 bits (243), Expect = 5e-23
 Identities = 63/198 (31%), Positives = 106/198 (53%), Gaps = 15/198 (7%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK--TLRKGEE--TVHREVEIMQH 152
           R+N  + D+  ++ +G G +G V+  R+  +G   A K   L  G++   + +E+ +++ 
Sbjct: 4   RRNP-QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKE 62

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
              H  +V     Y   +   + ME C GG L D     G  SE + A + ++ +  + Y
Sbjct: 63  CK-HCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAY 121

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEVLS 269
            H  G +HRDIK  NILLT +G +KLADFG+A +I+   T++      G+P ++APEV +
Sbjct: 122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT--ATIAKRKSFIGTPYWMAPEVAA 179

Query: 270 ----GNYSEKVDIWSAGV 283
               G Y++  DIW+ G+
Sbjct: 180 VEKNGGYNQLCDIWAVGI 197

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score = 99.0 bits (247), Expect = 5e-23
 Identities = 73/303 (24%), Positives = 129/303 (42%), Gaps = 75/303 (24%)

Query: 111 IGHGKFGSVWLCRSKASGAE-------------FACKTLRKGEETVHREVEIMQHLSGHT 157
           +G G +G V  C ++ +                F+ K L K      RE+++++H  GH 
Sbjct: 8   LGQGAYGIV--CSARNAETSEEETVAIKKITNVFSKKILAK---RALRELKLLRHFRGHK 62

Query: 158 GVVTLH-------SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI-FKDVMWV 209
            +  L+         + E   +  +ME     ++I         S Q   +  F+  ++ 
Sbjct: 63  NITCLYDMDIVFPGNFNELYLYEELME-ADLHQII--------RSGQPLTDAHFQSFIYQ 113

Query: 210 I----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-----NGQTLSGLAGSP 260
           I    KY H   V+HRD+KP N+L+    ++K+ DFGLA   S     N   ++    + 
Sbjct: 114 ILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173

Query: 261 AYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVF------------- 304
            Y APE++     Y++ +D+WS G +L  LL     FKG D ++ +              
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEET 233

Query: 305 ----------DAIKN----VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                     + I++     K  F S ++   +  A DL+ ++L  D + RI+ +E L H
Sbjct: 234 LSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRISVEEALEH 292

Query: 351 PWI 353
           P++
Sbjct: 293 PYL 295

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score = 97.7 bits (243), Expect = 7e-23
 Identities = 88/299 (29%), Positives = 131/299 (43%), Gaps = 68/299 (22%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEE-----TVHREVEIMQHLSG--HTG 158
           V  IG G +G+V+  R   SG   A K++R    E+     TV REV +++ L    H  
Sbjct: 5   VAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTV-REVALLKRLEAFDHPN 63

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ-----RA-----------ANI 202
           +V L             M++C+  R  D+  +V    E      R            A  
Sbjct: 64  IVRL-------------MDVCATSR-TDRETKVTLVFEHVDQDLRTYLDKVPPPGLPAET 109

Query: 203 FKDVMWV----IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
            KD+M      + + H   +VHRD+KPENIL+T+ G++KLADFGLA   S    L+ +  
Sbjct: 110 IKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVV 169

Query: 259 SPAYVAPEV-LSGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI------ 307
           +  Y APEV L   Y+  VD+WS G +   +      F G+S    L  +FD I      
Sbjct: 170 TLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPED 229

Query: 308 ---KNVKLDFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              ++V L   +           V   + +    L+  MLT +   RI+A   L+HP+ 
Sbjct: 230 DWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

 Score = 97.6 bits (243), Expect = 8e-23
 Identities = 63/274 (22%), Positives = 126/274 (45%), Gaps = 26/274 (9%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           D+   ++ +G G +GSV+    + +G   A K +R   +      +  E++I+ H +   
Sbjct: 1   DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDIL-HKAVSP 59

Query: 158 GVVTLHSVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAANIFKDVMWVIKYC- 213
            +V  +  +      ++ ME    G   +L    V      E     I   V+  +K+  
Sbjct: 60  YIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLK 119

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----GSPAYVAPEVLS 269
            +  ++HRD+KP N+L+  +G++KL DFG++     G  ++ LA    G  +Y+APE + 
Sbjct: 120 EEHNIIHRDVKPTNVLVNGNGQVKLCDFGVS-----GNLVASLAKTNIGCQSYMAPERIK 174

Query: 270 G-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
                    Y+ + D+WS G+ +  + +   P+  ++   +F  +  +       +    
Sbjct: 175 SGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGY 234

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
           S  A+D +A+ L +  + R T  ++L HPW++ Y
Sbjct: 235 SDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKY 268

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 99.3 bits (247), Expect = 2e-22
 Identities = 65/202 (32%), Positives = 101/202 (50%), Gaps = 13/202 (6%)

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQ----MVEVGQYSEQRAANIFKDVMWVIK 211
           H G+V     ++  D   L+ME  SGG L  Q    + E   + E     +F  ++  + 
Sbjct: 124 HFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALD 183

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPAYVAPEVL 268
             H   ++HRD+K  NI L  +G IKL DFG + + S+  +L   S   G+P Y+APE+ 
Sbjct: 184 EVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELW 243

Query: 269 S-GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-FHSGVWETVSKPA 326
               YS+K D+WS GV+L+ LL    PFKG S   +   +   K D F       VS   
Sbjct: 244 ERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPFPCP----VSSGM 299

Query: 327 RDLMARMLTRDVSARITADEVL 348
           + L+  +L+++ + R T  ++L
Sbjct: 300 KALLDPLLSKNPALRPTTQQLL 321

Length = 478

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 97.4 bits (243), Expect = 2e-22
 Identities = 70/303 (23%), Positives = 128/303 (42%), Gaps = 50/303 (16%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
            +   +  +E IG G +G V       SG + A K +    +         RE++I++H 
Sbjct: 2   DVGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHF 61

Query: 154 SGHTGVVTLHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMW 208
             H  ++ +  +      +    ++VM+L      +  ++   Q  +E+        ++ 
Sbjct: 62  K-HDNIIAIRDILRPPGADFKDVYVVMDLMESD--LHHIIHSDQPLTEEHIRYFLYQLLR 118

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG------LAGSPAY 262
            +KY H   V+HRD+KP N+L+    ++++ DFG+A  +S+  T         +A    Y
Sbjct: 119 GLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRW-Y 177

Query: 263 VAPEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDSL---------------EAVFD 305
            APE+L     Y+  +D+WS G +   +L     F G +                E V +
Sbjct: 178 RAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLN 237

Query: 306 AI-----KNVKLDF--HSGV-WETV----SKPARDLMARMLTRDVSARITADEVLRHPWI 353
            I     +    +      V W  +    S  A DL+++ML  D   RIT ++ L+HP++
Sbjct: 238 RIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFL 297

Query: 354 LFY 356
             Y
Sbjct: 298 AQY 300

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score = 96.9 bits (241), Expect = 4e-22
 Identities = 79/295 (26%), Positives = 143/295 (48%), Gaps = 48/295 (16%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHL 153
           ++ D +  ++ +G G +G+V     + +GA+ A K L +  ++       +RE+ +++H+
Sbjct: 12  EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 71

Query: 154 SGHTGVVTLHSVY---EEADCFH---LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      D FH   LVM     G  + ++++  + SE R   +   ++
Sbjct: 72  K-HENVIGLLDVFTPDLSLDRFHDFYLVMPFM--GTDLGKLMKHEKLSEDRIQFLVYQML 128

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H  G++HRD+KP N+ +    ++K+ DFGLA +  +   ++G   +  Y APEV
Sbjct: 129 KGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDS--EMTGYVVTRWYRAPEV 186

Query: 268 LSG--NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNV-------------- 310
           +    +Y++ VDIWS G ++  +L     FKG D L+ + + +K                
Sbjct: 187 ILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE 246

Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                        K DF S +    +  A +++ +ML  D  +RITA E L HP+
Sbjct: 247 DAKNYVKKLPRFRKKDFRS-LLPNANPLAVNVLEKMLVLDAESRITAAEALAHPY 300

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score = 95.8 bits (238), Expect = 4e-22
 Identities = 75/295 (25%), Positives = 136/295 (46%), Gaps = 37/295 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K++ +G G + +V+  RSK +    A K +R   E     T  REV +++ L  H 
Sbjct: 6   ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HA 64

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK-DVMWVIKYCHDM 216
            +VTLH +        LV E      L   + + G         +F   ++  + YCH  
Sbjct: 65  NIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRR 123

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG--NYS 273
            V+HRD+KP+N+L+   G++KLADFGLA   S   +T S    +  Y  P++L G  +YS
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYS 183

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEA----VFDAIKNVKLDFHSGV-----WETVSK 324
            ++D+W  G + + +      F G ++E     +F  +     +   G+     +++ + 
Sbjct: 184 TQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNY 243

Query: 325 P-----------------ARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           P                   +L++++L  +   RI+A+E ++HP+     ER  +
Sbjct: 244 PKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGERIHK 298

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 95.1 bits (236), Expect = 5e-22
 Identities = 61/207 (29%), Positives = 106/207 (51%), Gaps = 22/207 (10%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-------KGEETVHREVEIMQHLSGHTGVVTLH 163
           IG G+F  V+       G   A K ++       K      +E+++++ L+ H  V+  +
Sbjct: 10  IGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYY 68

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW--------VIKYCHD 215
           + + E +  ++V+EL   G L  +M++   + +Q+   I +  +W         +++ H 
Sbjct: 69  ASFIEDNELNIVLELADAGDL-SRMIK--HFKKQKRL-IPEKTVWKYFVQLCSALEHMHS 124

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSGN-YS 273
             V+HRDIKP N+ +T +G +KL D GL    S+  T +  L G+P Y++PE +  N Y+
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSL 300
            K DIWS G LL+ +     PF GD +
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKM 211

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 75/295 (25%), Positives = 124/295 (42%), Gaps = 54/295 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K++ +G G + +V+  RSK +G   A K +R   E     T  RE  +++ L  H 
Sbjct: 5   ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HA 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ-------RAANIFK-DVMWV 209
            +VTLH +        LV E            ++ QY +            +F   ++  
Sbjct: 64  NIVTLHDIIHTKKTLTLVFEYLD--------TDLKQYMDDCGGGLSMHNVRLFLFQLLRG 115

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL 268
           + YCH   V+HRD+KP+N+L++  G++KLADFGLA   S   +T S    +  Y  P+VL
Sbjct: 116 LAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVL 175

Query: 269 SG--NYSEKVDIWSAGVLLHALLVAALPFKG-----DSLEAVF----------------- 304
            G   YS  +D+W  G + + +      F G     D L  +F                 
Sbjct: 176 LGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235

Query: 305 DAIKNVKLDFHSG-----VWETVSKP--ARDLMARMLTRDVSARITADEVLRHPW 352
              K     F+           + +     +L  + L  +   RI+A E ++HP+
Sbjct: 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPY 290

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score = 96.3 bits (239), Expect = 7e-22
 Identities = 72/299 (24%), Positives = 137/299 (45%), Gaps = 48/299 (16%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 14  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 73

Query: 154 SGHTGVVTLHSVYEEADCF------HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+  A         +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 74  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 130

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   ++G   +  Y APE+
Sbjct: 131 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMTGYVATRWYRAPEI 188

Query: 268 LSG--NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVF----------------D 305
           +    +Y++ VDIWS G ++  LL     F G    D L+ +                 +
Sbjct: 189 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 248

Query: 306 AIKNV--------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
           + +N         K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 249 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 306

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score = 94.6 bits (235), Expect = 1e-21
 Identities = 82/290 (28%), Positives = 127/290 (43%), Gaps = 54/290 (18%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEE----TVHREVEIMQHLSGHTGVVTL 162
           +E +G G + +V+   S+ +G   A K +  K EE    T  RE  +++ L  H  +V L
Sbjct: 10  LEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLL 68

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK-DVMWV-------IKYCH 214
           H +    +    V E            ++ QY  Q    +   +V          + Y H
Sbjct: 69  HDIIHTKETLTFVFEYMH--------TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIH 120

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG--N 271
              ++HRD+KP+N+L++  G++KLADFGLA   S   QT S    +  Y  P+VL G  +
Sbjct: 121 GQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATD 180

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKGDS-----LEAVFDAIKNVKLDFHSG--------- 317
           YS  +DIW AG +   +L     F G S     LE ++  +     D   G         
Sbjct: 181 YSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKP 240

Query: 318 -------------VWETVSKP--ARDLMARMLTRDVSARITADEVLRHPW 352
                        VW+ +S+P  A DL ++ML      RI+A + L HP+
Sbjct: 241 EWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPY 290

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 93.6 bits (232), Expect = 1e-21
 Identities = 69/248 (27%), Positives = 119/248 (47%), Gaps = 22/248 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-------KGEETVHREVEIMQHLSGHTGVVTLH 163
           IG G+F  V+           A K ++       K  +   +E+++++ L+ H  V+   
Sbjct: 10  IGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYL 68

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW--------VIKYCHD 215
             + E +  ++V+EL   G L  QM+   +Y +++   I +  +W         +++ H 
Sbjct: 69  DSFIEDNELNIVLELADAGDL-SQMI---KYFKKQKRLIPERTVWKYFVQLCSAVEHMHS 124

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSGN-YS 273
             V+HRDIKP N+ +T +G +KL D GL    S+  T +  L G+P Y++PE +  N Y+
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYN 184

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
            K DIWS G LL+ +     PF GD +       K  + D+     E  S+  R+L++  
Sbjct: 185 FKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPLPTEHYSEKLRELVSMC 244

Query: 334 LTRDVSAR 341
           +  D   R
Sbjct: 245 IYPDPDQR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score = 94.4 bits (234), Expect = 1e-21
 Identities = 77/295 (26%), Positives = 128/295 (43%), Gaps = 54/295 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           D + K+E +G G + +V+  +SK +G   A K +R  EE     T  RE  +++ L  H 
Sbjct: 5   DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HA 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD--------VMWV 209
            +V LH +    +   LV E            ++ QY ++    +  +        ++  
Sbjct: 64  NIVLLHDIIHTKETLTLVFEYVH--------TDLCQYMDKHPGGLHPENVKLFLFQLLRG 115

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL 268
           + Y H   ++HRD+KP+N+L++ +G++KLADFGLA   S    T S    +  Y  P+VL
Sbjct: 116 LSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVL 175

Query: 269 SGN--YSEKVDIWSAGVLLHALLVAALPFKG-----DSLEAVFDAIKNVKLDFHSGV--- 318
            G+  YS  +D+W  G +   ++     F G     D LE +F  +     D   GV   
Sbjct: 176 LGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSL 235

Query: 319 -------------------WETVS--KPARDLMARMLTRDVSARITADEVLRHPW 352
                              W  +S    A DL +++L      R++A   L H +
Sbjct: 236 PHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEY 290

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 72/245 (29%), Positives = 120/245 (48%), Gaps = 15/245 (6%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTG----V 159
           +IG G FG V+ CR   +G  +A K L K        ET+     IM  L   TG    +
Sbjct: 1   IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS-TGDCPFI 59

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           V +   +   D    +++L +GG L   + + G +SE+       +++  +++ H+  VV
Sbjct: 60  VCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVV 119

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVD 277
           +RD+KP NILL   G ++++D GLA   S  +  + + G+  Y+APEVL     Y    D
Sbjct: 120 YRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-GTHGYMAPEVLQKGTAYDSSAD 178

Query: 278 IWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            +S G +L  LL    PF+    +   + I  + L  +  + ++ S   + L+  +L RD
Sbjct: 179 WFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTVNVELPDSFSPELKSLLEGLLQRD 237

Query: 338 VSARI 342
           VS R+
Sbjct: 238 VSKRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 93.4 bits (232), Expect = 2e-21
 Identities = 75/262 (28%), Positives = 123/262 (46%), Gaps = 26/262 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL--RKGEET--VHREVEIMQHLSGHTGVVTLHSV 165
           V+G G +G V+  R  ++    A K +  R       +H E+ +  +L  H  +V     
Sbjct: 15  VLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGS 73

Query: 166 YEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIF--KDVMWVIKYCHDMGVVHRD 222
             E   F + ME   GG L   +  + G   +     IF  K ++  +KY HD  +VHRD
Sbjct: 74  DSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133

Query: 223 IKPENILLTT-SGKIKLADFGLAMRIS--NGQTLSGLAGSPAYVAPEVLSG---NYSEKV 276
           IK +N+L+ T SG +K++DFG + R++  N  T     G+  Y+APEV+      Y    
Sbjct: 134 IKGDNVLVNTYSGVVKISDFGTSKRLAGINPCT-ETFTGTLQYMAPEVIDKGPRGYGAPA 192

Query: 277 DIWSAGVLLHALLVAALPFK--GDSLEAVFDAIKNVKLDF---HSGVWETVSKPARDLMA 331
           DIWS G  +  +     PF   G+   A+F      K+     H  + E++S  A++ + 
Sbjct: 193 DIWSLGCTIVEMATGKPPFIELGEPQAAMF------KVGMFKIHPEIPESLSAEAKNFIL 246

Query: 332 RMLTRDVSARITADEVLRHPWI 353
           R    D   R +A ++L+ P++
Sbjct: 247 RCFEPDPDKRASAHDLLQDPFL 268

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score = 93.9 bits (233), Expect = 2e-21
 Identities = 78/285 (27%), Positives = 125/285 (43%), Gaps = 37/285 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K+E +G G + +V+  RSK +    A K +R   E     T  REV +++ L  H 
Sbjct: 6   ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HA 64

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMWVIKYCHDM 216
            +VTLH +        LV E      L   M + G         IF   ++  + YCH  
Sbjct: 65  NIVTLHDIVHTDKSLTLVFEYLDKD-LKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRR 123

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YS 273
            V+HRD+KP+N+L+   G++KLADFGLA   S   +T S    +  Y  P+VL G+  YS
Sbjct: 124 KVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYS 183

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS---------- 323
            ++D+W  G +   +      F G ++E     I  +        W  +S          
Sbjct: 184 TQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF 243

Query: 324 ---KP-------------ARDLMARMLTRDVSARITADEVLRHPW 352
              KP               +L+ + L  +   RI+A+E ++H +
Sbjct: 244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAY 288

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score = 94.7 bits (235), Expect = 3e-21
 Identities = 69/255 (27%), Positives = 122/255 (47%), Gaps = 49/255 (19%)

Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126

Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186

Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS G ++  ++   + F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246

Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306

Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score = 92.8 bits (230), Expect = 5e-21
 Identities = 79/281 (28%), Positives = 127/281 (45%), Gaps = 42/281 (14%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLH 163
           V+G G +G V  CR K +    A K  +  E      ET  RE+++++ L     +V L 
Sbjct: 8   VVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELK 66

Query: 164 SVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
             +      +LV E        L+++M   G   E+  + I++ ++  I +CH   +VHR
Sbjct: 67  EAFRRRGKLYLVFEYVEKNMLELLEEM-PNGVPPEKVRSYIYQ-LIKAIHWCHKNDIVHR 124

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           DIKPEN+L++ +  +KL DFG A  +S G     +    +  Y +PE+L G  Y + VD+
Sbjct: 125 DIKPENLLISHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDM 184

Query: 279 WSAGVLLHALLVAALPFKGDS-LEAVFDAIK--------NVKL-----DFHSGVWETVSK 324
           WS G +L  L      F G+S ++ +F   K         +KL      FH   +  V+ 
Sbjct: 185 WSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNH 244

Query: 325 PAR--------------DLMARMLTRDVSARITADEVLRHP 351
           P                DLM  +L  + + R   ++ L HP
Sbjct: 245 PQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHP 285

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score = 94.0 bits (233), Expect = 5e-21
 Identities = 69/255 (27%), Positives = 123/255 (48%), Gaps = 49/255 (19%)

Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  +++L +V+      EE    +LVMEL      + Q++++ +   +
Sbjct: 64  YRELVLMKCVN-HKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN--LCQVIQM-ELDHE 119

Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 120 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 179

Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS G ++  ++   + F G    D    V + +     
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 239

Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 240 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 299

Query: 339 SARITADEVLRHPWI 353
           + RI+ DE L+HP+I
Sbjct: 300 AKRISVDEALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 91.5 bits (228), Expect = 9e-21
 Identities = 71/252 (28%), Positives = 114/252 (45%), Gaps = 21/252 (8%)

Query: 114 GKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQH--LSGHTGVVTLHSVYEEADC 171
           GKFG V + + K +   F  K +   +      +E M H  +  +   + L+        
Sbjct: 27  GKFGKVSVLKHKPTQKLFVQKII---KAKNFNAIEPMVHQLMKDNPNFIKLYYSVTTLKG 83

Query: 172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT 231
             L+M+    G L D + + G+ SE     I + ++  +   H   ++H DIK EN+L  
Sbjct: 84  HVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD 143

Query: 232 TS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALL 289
            +  +I L D+GL   I    T S   G+  Y +PE + G NY    D W+ GVL + LL
Sbjct: 144 RAKDRIYLCDYGLCKIIG---TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELL 200

Query: 290 VAALPFKGD-----SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR-IT 343
               PFK D      LE++    +  KL F       VSK A D +  ML  +++ R   
Sbjct: 201 TGKHPFKEDEDEELDLESLLKRQQK-KLPFIKN----VSKNANDFVQSMLKYNINYRLTN 255

Query: 344 ADEVLRHPWILF 355
            +E+++HP++  
Sbjct: 256 YNEIIKHPFLKI 267

Length = 267

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score = 92.4 bits (229), Expect = 1e-20
 Identities = 73/287 (25%), Positives = 129/287 (44%), Gaps = 46/287 (16%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVH-----REVEIMQHLSGHTGVVTLHS 164
           +G G +GSV          + A K L R  +  +H     RE+ +++H+  H  V+ L  
Sbjct: 23  VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLD 81

Query: 165 VY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V+      E  +  +LV  L   G  ++ +V+  + S++    +   ++  +KY H  G+
Sbjct: 82  VFTPATSIENFNEVYLVTNLM--GADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGI 139

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKV 276
           +HRD+KP N+ +    ++++ DFGLA +  +  T  G   +  Y APE++    +Y++ V
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLARQADDEMT--GYVATRWYRAPEIMLNWMHYNQTV 197

Query: 277 DIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVKLDF-------H---------- 315
           DIWS G ++  LL     F G    D L+ + + +     +        H          
Sbjct: 198 DIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPH 257

Query: 316 ------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                   ++   +  A DL+ +ML  D   RI+A E L HP+   Y
Sbjct: 258 MPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY 304

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score = 91.7 bits (228), Expect = 3e-20
 Identities = 70/258 (27%), Positives = 118/258 (45%), Gaps = 54/258 (20%)

Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQ--YS 195
           +RE+ +M+ L  H  ++ L +V+      EE    +LVMEL         + +V Q    
Sbjct: 63  YRELVLMK-LVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMDA-----NLCQVIQMDLD 116

Query: 196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG 255
            +R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++ 
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTP 176

Query: 256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNV 310
              +  Y APEV+ G  Y E VDIWS G ++  ++   + F G    D    + + +   
Sbjct: 177 YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTP 236

Query: 311 KLDFHSGVWETV-----SKP------------------------------ARDLMARMLT 335
             +F S +  TV     ++P                              ARDL+++ML 
Sbjct: 237 SDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLV 296

Query: 336 RDVSARITADEVLRHPWI 353
            D   RI+ D+ L+HP+I
Sbjct: 297 IDPEKRISVDDALQHPYI 314

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 90.5 bits (225), Expect = 3e-20
 Identities = 73/285 (25%), Positives = 129/285 (45%), Gaps = 40/285 (14%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
           +D   +  IG G FG+V     K SG   A K +R     K ++ +  +++++   S   
Sbjct: 4   EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCP 63

Query: 158 GVVTLH-SVYEEADCFHLVMELCS--------------GGRLIDQMVEVGQYSEQRAANI 202
            +V  + +++ E DC+ + MEL                   + ++++     +  +A N 
Sbjct: 64  YIVKFYGALFREGDCW-ICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
            K+         ++ ++HRD+KP NILL  +G IKL DFG++ ++ +    +  AG   Y
Sbjct: 123 LKE---------ELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGCRPY 173

Query: 263 VAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN-VKLD---F 314
           +APE +  +    Y  + D+WS G+ L+ +     P+      +VFD +   VK D    
Sbjct: 174 MAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPY--PKWNSVFDQLTQVVKGDPPIL 231

Query: 315 HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER 359
            +      S    + +   L +D S R    E+L HP+I  Y ER
Sbjct: 232 SNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYEER 276

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 90.8 bits (226), Expect = 3e-20
 Identities = 75/310 (24%), Positives = 122/310 (39%), Gaps = 67/310 (21%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
            D+  +  +G G FG V+  R   +G   A K +    E      T  RE++I++ L  H
Sbjct: 8   RDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-H 66

Query: 157 TGVVTL-HSVYEEAD-------CFHLVM-----ELCSGGRLIDQMVEVGQYSEQRAANIF 203
             VV L     E  D         ++V      +L   G L +  V   + +E +     
Sbjct: 67  PNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLS--GLLENPSV---KLTESQIKCYM 121

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-- 261
             ++  I Y H+  ++HRDIK  NIL+   G +K+ADFGLA R  +G   +   G     
Sbjct: 122 LQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLA-RPYDGPPPNPKGGGGGGT 180

Query: 262 -----------YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVF 304
                      Y  PE+L G   Y+  VDIW  G +   +       +G    D L  +F
Sbjct: 181 RKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240

Query: 305 DAI-------------------KNVKLDFHSGV---WETVSKPARDLMARMLTRDVSARI 342
                                  +   ++   +   +  +     DL++++L+ D   R+
Sbjct: 241 KLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL 300

Query: 343 TADEVLRHPW 352
           TA + L HP+
Sbjct: 301 TASDALEHPY 310

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score = 90.5 bits (224), Expect = 3e-20
 Identities = 75/225 (33%), Positives = 107/225 (47%), Gaps = 30/225 (13%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-ACKTLRKGEE------TVHREVEIMQHLSG--HTG 158
           V  IG G +G V+  R   +G  F A K +R          +  REV +++HL    H  
Sbjct: 6   VAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPN 65

Query: 159 VVTLHSV-----YEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVI- 210
           VV L  V      +      LV E         +D++ E G  +E       KD+M+ + 
Sbjct: 66  VVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTET-----IKDMMFQLL 120

Query: 211 ---KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
               + H   VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y APEV
Sbjct: 121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEV 180

Query: 268 -LSGNYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAI 307
            L  +Y+  VD+WS G +   +      F+G    D L  + D I
Sbjct: 181 LLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVI 225

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 89.2 bits (221), Expect = 4e-20
 Identities = 63/190 (33%), Positives = 95/190 (50%), Gaps = 9/190 (4%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV 159
            + T V+ IG G+FG VWL        + A KT+R+G   EE    E ++M  LS H  +
Sbjct: 4   SELTLVQEIGSGQFGLVWL-GYWLEKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKL 61

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V L+ V  E     LV E    G L D +  + G++S++    +  DV   + Y     V
Sbjct: 62  VQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNV 121

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEK 275
           +HRD+   N L+  +  +K++DFG+   + + Q  S  G      + +PEV S   YS K
Sbjct: 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181

Query: 276 VDIWSAGVLL 285
            D+WS GVL+
Sbjct: 182 SDVWSFGVLM 191

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 90.7 bits (225), Expect = 2e-19
 Identities = 52/164 (31%), Positives = 88/164 (53%), Gaps = 11/164 (6%)

Query: 194 YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL 253
           + E  A  +F  V+  + + H   ++HRDIK  NILL ++G +KL DFG +   +   T+
Sbjct: 140 FREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAA--TV 197

Query: 254 SG-----LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI 307
           S        G+P YVAPE+     YS+K D++S GVLL+ LL    PF G+++E V    
Sbjct: 198 SDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKT 257

Query: 308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
              + D    +  ++S   ++++  +L+ D   R ++ ++L  P
Sbjct: 258 LAGRYD---PLPPSISPEMQEIVTALLSSDPKRRPSSSKLLNMP 298

Length = 496

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 88.7 bits (220), Expect = 2e-19
 Identities = 73/304 (24%), Positives = 119/304 (39%), Gaps = 67/304 (22%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEE------------------TVHREVEIMQH 152
           +G G +G V       +G   A K ++  E                   T  RE++IM  
Sbjct: 17  LGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNE 76

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           +  H  ++ L  VY E D  +LVM++ +    +++D+ +   + +E +   I   ++  +
Sbjct: 77  IK-HENIMGLVDVYVEGDFINLVMDIMASDLKKVVDRKI---RLTESQVKCILLQILNGL 132

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--------- 261
              H    +HRD+ P NI + + G  K+ADFGLA R         L+             
Sbjct: 133 NVLHKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTS 192

Query: 262 ------YVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAI-- 307
                 Y APE+L G   Y   VD+WS G +   LL     F G    D L  +F+ +  
Sbjct: 193 KVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGT 252

Query: 308 -------------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVL 348
                                   D  + ++   S  A DL+  +L  +   RI+A E L
Sbjct: 253 PNEDNWPQAKKLPLYTEFTPRKPKDLKT-IFPNASDDAIDLLQSLLKLNPLERISAKEAL 311

Query: 349 RHPW 352
           +H +
Sbjct: 312 KHEY 315

Length = 335

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 87.1 bits (216), Expect = 4e-19
 Identities = 62/214 (28%), Positives = 92/214 (42%), Gaps = 35/214 (16%)

Query: 102 EDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRK-GEETV----HREVEIMQ 151
           E  H K ++ +G G FG V LCR       +G + A K+L   GEE       RE+EI++
Sbjct: 2   EKRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILR 61

Query: 152 HLSGHTGVVTLHSVYEEADC--FHLVMELCSGGRLIDQMVEVG---------QYSEQRAA 200
            L  H  +V    V E+       L+ME    G L D +              +S Q   
Sbjct: 62  TLD-HENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICK 120

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLA 257
            +         Y      +HRD+   NIL+ +   +K++DFGLA  +   +    +    
Sbjct: 121 GM--------DYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172

Query: 258 GSPA-YVAPEVLSGN-YSEKVDIWSAGVLLHALL 289
            SP  + APE L  + +S   D+WS GV L+ L 
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 89.8 bits (223), Expect = 6e-19
 Identities = 63/227 (27%), Positives = 104/227 (45%), Gaps = 39/227 (17%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVH----REVEIMQHLSGHTGVV 160
           + +IG G  G V+L          A K +R+       +     RE +I   L  H G+V
Sbjct: 7   IRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIV 65

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ-------YSEQRAA----NIFKDVMWV 209
            ++S+  + D  +  M    G  L   +  V Q        +E+ +     +IF  +   
Sbjct: 66  PVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICAT 125

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ------------------ 251
           I+Y H  GV+HRD+KP+NILL   G++ + D+G A+     +                  
Sbjct: 126 IEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSM 185

Query: 252 TLSG-LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFK 296
           T+ G + G+P Y+APE L G   SE  DI++ GV+L+ +L  + P++
Sbjct: 186 TIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYR 232

Length = 932

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 85.9 bits (213), Expect = 6e-19
 Identities = 60/201 (29%), Positives = 90/201 (44%), Gaps = 16/201 (7%)

Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTL 162
           +GHG FGSV             E A KTL++     G++   RE  +M  L  H  +V L
Sbjct: 3   LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRL 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
             V +  +   LVMEL   G L+  + +  +        +   V   + Y      VHRD
Sbjct: 62  IGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRD 120

Query: 223 IKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-P-AYVAPEVLS-GNYSEKVD 277
           +   N+LL    + K++DFG+  A+   +    +  AG  P  + APE ++ G +S K D
Sbjct: 121 LAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSD 180

Query: 278 IWSAGVLL-HALLVAALPFKG 297
           +WS GV L  A    A P+  
Sbjct: 181 VWSYGVTLWEAFSYGAKPYGE 201

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 86.1 bits (213), Expect = 8e-18
 Identities = 47/148 (31%), Positives = 76/148 (51%), Gaps = 6/148 (4%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ------HLSGH 156
           ++   V+ I  G FG V+L R K +   +A K ++K +      V  +Q       LS  
Sbjct: 4   EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKS 63

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V L+   + A+  +LVME   GG +   +   G + E+ A     +V   + Y H  
Sbjct: 64  PFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRH 123

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLA 244
           G++HRD+KP+N+L++  G IKL DFGL+
Sbjct: 124 GIIHRDLKPDNMLISNEGHIKLTDFGLS 151

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 82.4 bits (204), Expect = 1e-17
 Identities = 62/191 (32%), Positives = 95/191 (49%), Gaps = 20/191 (10%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW+     +  + A KTL+ G    E   +E +IM+ L  H  +V L++V  
Sbjct: 14  LGAGQFGEVWMGTWNGT-TKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCS 71

Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQR-------AANIFKDVMWVIKYCHDMGVVH 220
           E +  ++V E  S G L+D +   G+  + R       AA I  + M    Y      +H
Sbjct: 72  EEEPIYIVTEYMSKGSLLDFLKS-GEGKKLRLPQLVDMAAQI-AEGMA---YLESRNYIH 126

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSP-AYVAPE-VLSGNYSEKVD 277
           RD+   NIL+  +   K+ADFGLA  I + + T    A  P  + APE    G ++ K D
Sbjct: 127 RDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSD 186

Query: 278 IWSAGVLLHAL 288
           +WS G+LL  +
Sbjct: 187 VWSFGILLTEI 197

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 74/286 (25%), Positives = 125/286 (43%), Gaps = 47/286 (16%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGHTGVVTLHS 164
           IG G +G V   ++  +  + A K +    +         RE+++++HL  H  V+ +  
Sbjct: 13  IGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKD 71

Query: 165 VYE--EADCF---HLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGV 218
           +      + F   ++V EL      + Q++   Q  S+         ++  +KY H   V
Sbjct: 72  IMPPPHREAFNDVYIVYELMDTD--LHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANV 129

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSPAYVAPEVL--SGNYSE 274
           +HRD+KP N+LL  +  +K+ DFGLA R ++  G  ++    +  Y APE+L     Y+ 
Sbjct: 130 LHRDLKPSNLLLNANCDLKICDFGLA-RTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTT 188

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSL--------------EAVFDAIKNVK-------L 312
            +D+WS G +   LL     F G D +              E     I+N K       L
Sbjct: 189 AIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSL 248

Query: 313 DFHSGV-----WETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            +         +   +  A DL+ +ML  D S RIT +E L HP++
Sbjct: 249 PYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 82.5 bits (204), Expect = 1e-17
 Identities = 55/203 (27%), Positives = 96/203 (47%), Gaps = 15/203 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHL-SGH 156
           +D   +  +G G  GSV   +   +G   A K +         + + RE++IM    S +
Sbjct: 5   EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPY 64

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V+ +  +   +   + ME    G L     + G    +    I   V+  + Y +++
Sbjct: 65  --IVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNV 122

Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSPAYVAPE-VLSGNY 272
             ++HRDIKP NIL+ + G+IKL DFG++  + N    T     G+  Y++PE +  G Y
Sbjct: 123 HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADT---FVGTSTYMSPERIQGGKY 179

Query: 273 SEKVDIWSAGVLLHALLVAALPF 295
           + K D+WS G+ +  L +   PF
Sbjct: 180 TVKSDVWSLGISIIELALGKFPF 202

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 81.7 bits (202), Expect = 2e-17
 Identities = 58/194 (29%), Positives = 85/194 (43%), Gaps = 23/194 (11%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVV 160
           +      IG G+FG V L   +  G + A K L+           E  +M  L  H  +V
Sbjct: 7   ELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLV 63

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK-------DVMWVIKYC 213
            L  V  + +  ++V E  + G L+D +      S  RA            DV   ++Y 
Sbjct: 64  QLLGVVLQGNPLYIVTEYMAKGSLVDYL-----RSRGRAVITLAQQLGFALDVCEGMEYL 118

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-YVAPEVLS-GN 271
            +   VHRD+   N+L++     K++DFGLA   S GQ    L   P  + APE L    
Sbjct: 119 EEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL---PVKWTAPEALREKK 175

Query: 272 YSEKVDIWSAGVLL 285
           +S K D+WS G+LL
Sbjct: 176 FSTKSDVWSFGILL 189

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 82.1 bits (203), Expect = 2e-17
 Identities = 69/290 (23%), Positives = 130/290 (44%), Gaps = 32/290 (11%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ-HLSGHTG--V 159
           DD   +E +G G +G V   R   +G   A K +R    +  ++  +M   +S  +    
Sbjct: 1   DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCP 60

Query: 160 VTLH---SVYEEADCFHLVMEL--CSGGRLIDQMVEVGQYSEQRA-ANIFKDVMWVIKYC 213
            T+    +++ E D + + ME+   S  +   ++ + G    +     I   ++  ++Y 
Sbjct: 61  YTVTFYGALFREGDVW-ICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYL 119

Query: 214 HD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           H  + V+HRD+KP N+L+  +G++KL DFG++  + +    +  AG   Y+APE ++   
Sbjct: 120 HSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 179

Query: 272 ----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV------KLDFHSGVWET 321
               Y  K D+WS G+ +  L     P+  DS +  F  +K V      +L       E 
Sbjct: 180 NQKGYDVKSDVWSLGITMIELATGRFPY--DSWKTPFQQLKQVVEEPSPQLPA-----EK 232

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLK 371
            S   +D + + L ++   R    E+L+HP   F+     +   + S + 
Sbjct: 233 FSPEFQDFVNKCLKKNYKERPNYPELLQHP---FFELHLSKNTDVASFVS 279

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 81.7 bits (202), Expect = 3e-17
 Identities = 63/222 (28%), Positives = 104/222 (46%), Gaps = 30/222 (13%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR---KGE--ETVHREVEIMQ-----H 152
           DD  K+  +G G  G V     + SG   A K +    K      + RE++++      +
Sbjct: 1   DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPY 60

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           + G  G     + Y + +   + ME   GG L   + + G+  E     I   V+  + Y
Sbjct: 61  IVGFYG-----AFYSDGE-ISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTY 114

Query: 213 CHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----GSPAYVAPEV 267
             +   ++HRD+KP NIL+ + G+IKL DFG++     GQ +  +A    G+ +Y++PE 
Sbjct: 115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPER 169

Query: 268 LSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFD 305
           L G  Y+ + DIWS G+ L  + +   P        LEA+F 
Sbjct: 170 LQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFG 211

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 80.8 bits (199), Expect = 4e-17
 Identities = 59/210 (28%), Positives = 109/210 (51%), Gaps = 11/210 (5%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHS 164
           V+ +G G+FG VW+     S  + A KTL+ G  +V     E  +M+ L  H  +V L++
Sbjct: 11  VKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYA 68

Query: 165 VYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E  + G L+D  +  E G+    +  +    +   + Y      +HRD
Sbjct: 69  VVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 128

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  N+L++ S   K+ADFGLA  I + +  +  G      + APE ++ G+++ K D+W
Sbjct: 129 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVW 188

Query: 280 SAGVLLHALLV-AALPFKGDSLEAVFDAIK 308
           S G+LL+ ++    +P+ G S   V  A++
Sbjct: 189 SFGILLYEIVTYGKIPYPGMSNSDVMSALQ 218

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score = 81.0 bits (200), Expect = 9e-17
 Identities = 66/263 (25%), Positives = 116/263 (44%), Gaps = 56/263 (21%)

Query: 145 REVEIMQHLSGHTGVVTLHSVY--------------EEADCFHLVMELCSG--GRLIDQM 188
           RE++I++ L  H  +V ++ V                E +  ++V E        +++Q 
Sbjct: 51  REIKIIRRLD-HDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ- 108

Query: 189 VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI-KLADFGLAMRI 247
              G  SE+ A      ++  +KY H   V+HRD+KP N+ + T   + K+ DFGLA RI
Sbjct: 109 ---GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLA-RI 164

Query: 248 -----SNGQTLSGLAGSPAYVAPEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKG--- 297
                S+   LS    +  Y +P +L    NY++ +D+W+AG +   +L     F G   
Sbjct: 165 VDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHE 224

Query: 298 --------DSLEAVFDAIKN-------VKLDFHSG--------VWETVSKPARDLMARML 334
                   +S+  V +  +N         +    G        +   V+  A D + ++L
Sbjct: 225 LEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQIL 284

Query: 335 TRDVSARITADEVLRHPWILFYT 357
           T +   R+TA+E L HP++  Y+
Sbjct: 285 TFNPMDRLTAEEALMHPYMSCYS 307

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 79.4 bits (196), Expect = 9e-17
 Identities = 59/210 (28%), Positives = 104/210 (49%), Gaps = 10/210 (4%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTL 162
           T ++ +G G+FG V L + +    + A K +R+G   E+    E ++M  LS H  +V L
Sbjct: 7   TFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQL 64

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           + V  +     +V E  + G L++ + E  G+   +   ++  DV   ++Y    G +HR
Sbjct: 65  YGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHR 124

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPA-YVAPEVLS-GNYSEKVDI 278
           D+   N L+     +K++DFGLA  + + Q T S     P  +  PEV     +S K D+
Sbjct: 125 DLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDV 184

Query: 279 WSAGVLLHALLV-AALPFKGDSLEAVFDAI 307
           WS GVL+  +     +P++  S   V +++
Sbjct: 185 WSFGVLMWEVFSEGKMPYERFSNSEVVESV 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 78.9 bits (194), Expect = 2e-16
 Identities = 65/221 (29%), Positives = 109/221 (49%), Gaps = 17/221 (7%)

Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 2   EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ----RAANIFKDVMWVIK 211
           H  +V L++V  E +  ++V E  S G L+D +   G+  +     +  ++   +   + 
Sbjct: 60  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLK--GEMGKYLRLPQLVDMAAQIASGMA 116

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VL 268
           Y   M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L
Sbjct: 117 YVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAAL 176

Query: 269 SGNYSEKVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIK 308
            G ++ K D+WS G+LL  L     +P+ G     V D ++
Sbjct: 177 YGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 217

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score = 80.6 bits (199), Expect = 2e-16
 Identities = 82/296 (27%), Positives = 124/296 (41%), Gaps = 65/296 (21%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHS 164
           IG+G FG VW       G   A K +          + V RE++++     H  V++   
Sbjct: 8   IGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALD 66

Query: 165 VYEEA--DCFH---LVMEL---------CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + +    D F    +V EL          S   L    V+V  Y   R           +
Sbjct: 67  ILQPPHIDPFEEIYVVTELMQSDLHKIIVSPQPLSSDHVKVFLYQILRG----------L 116

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN---GQTLSGLAGSPAYVAPEV 267
           KY H  G++HRDIKP N+L+ ++  +K+ DFGLA R+      + ++    +  Y APE+
Sbjct: 117 KYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLA-RVEEPDESKHMTQEVVTQYYRAPEI 175

Query: 268 LSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS----------------LEAVFDAIKN 309
           L G  +Y+  VDIWS G +   LL   + F+  S                LEA+  A + 
Sbjct: 176 LMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEG 235

Query: 310 VKLDFHSG--------VWETVSKP----ARDLMARMLTRDVSARITADEVLRHPWI 353
            +     G        V  T+S      A  L+ RML  D   RI+A + L HP++
Sbjct: 236 ARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYL 291

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 77.9 bits (192), Expect = 3e-16
 Identities = 59/208 (28%), Positives = 94/208 (45%), Gaps = 15/208 (7%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG VW    K      A K L+  +    +    EV+ ++ L  H  +++L +V 
Sbjct: 14  LGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVC 71

Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI----KYCHDMGVVHRD 222
              +  +++ EL   G L+  +          A+ I  D+   +     Y  +   +HRD
Sbjct: 72  SVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLI--DMACQVAEGMAYLEEQNSIHRD 129

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP-AYVAPEVLS-GNYSEKVDIWS 280
           +   NIL+      K+ADFGLA  I     LS     P  + APE  S G +S K D+WS
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWS 189

Query: 281 AGVLLHALLV-AALPFKGDSLEAVFDAI 307
            G+LL+ +     +P+ G +   V+D I
Sbjct: 190 FGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 77.4 bits (190), Expect = 5e-16
 Identities = 63/208 (30%), Positives = 108/208 (51%), Gaps = 13/208 (6%)

Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSG 155
           +I  +  +++V +G G FG VW+     +  + A KTL+ G    E   +E +IM+ L  
Sbjct: 2   EIPRESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR- 59

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E    G L+D + E  G+Y +  +  ++   +   + Y 
Sbjct: 60  HDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYI 118

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  +HRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 119 ERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 178

Query: 271 NYSEKVDIWSAGVLLHALLVAA-LPFKG 297
            ++ K D+WS G+LL  L+    +P+ G
Sbjct: 179 RFTIKSDVWSFGILLTELVTKGRVPYPG 206

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 77.0 bits (189), Expect = 7e-16
 Identities = 63/211 (29%), Positives = 108/211 (51%), Gaps = 14/211 (6%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           ++ +G+G+FG VW+     +  + A KTL+ G    E+   E +IM+ L  H  +V L++
Sbjct: 11  IKKLGNGQFGEVWMGTWNGN-TKVAVKTLKPGTMSPESFLEEAQIMKKLR-HDKLVQLYA 68

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---IKYCHDMGVVHR 221
           V  E +  ++V E  S G L+D  ++ G+    +  N+      V   + Y   M  +HR
Sbjct: 69  VVSE-EPIYIVTEYMSKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 126

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSGNYSEKVDI 278
           D++  NIL+      K+ADFGLA  I + +  +  G      + APE  L G ++ K D+
Sbjct: 127 DLRSANILVGDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDV 186

Query: 279 WSAGVLLHALLVAA-LPFKGDSLEAVFDAIK 308
           WS G+LL  L+    +P+ G +   V + ++
Sbjct: 187 WSFGILLTELVTKGRVPYPGMNNREVLEQVE 217

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 77.8 bits (191), Expect = 1e-15
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 20/217 (9%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 4   DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-HECNS 62

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 122

Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----GSPAYVAPEVLSG- 270
             ++HRD+KP NIL+ + G+IKL DFG++     GQ +  +A    G+ +Y++PE L G 
Sbjct: 123 HKIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 177

Query: 271 NYSEKVDIWSAGVLLHALLVAALPF---KGDSLEAVF 304
           +YS + DIWS G+ L  + +   P        LE +F
Sbjct: 178 HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMF 214

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 58/205 (28%), Positives = 105/205 (51%), Gaps = 10/205 (4%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG V L + +A   + A K + +G   EE    E ++M  LS H  +V L+ V  
Sbjct: 12  LGSGQFGVVHLGKWRAQ-IKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCT 69

Query: 168 EADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
           +    ++V E    G L++ + +  G+ S+    ++ +DV   ++Y      +HRD+   
Sbjct: 70  QQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAAR 129

Query: 227 NILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLSGN-YSEKVDIWSAGV 283
           N L++++G +K++DFG+   + + +  S  G      +  PEV + + YS K D+WS GV
Sbjct: 130 NCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGV 189

Query: 284 LLHALLV-AALPFKGDSLEAVFDAI 307
           L+  +     +PF+  S   V + I
Sbjct: 190 LMWEVFTEGKMPFEKKSNYEVVEMI 214

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 76.4 bits (188), Expect = 1e-15
 Identities = 56/209 (26%), Positives = 101/209 (48%), Gaps = 12/209 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHSVYE 167
           +G G++G V+    K      A KTL++    V    +E  +M+ +  H  +V L  V  
Sbjct: 14  LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCT 72

Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGVVHRDIKP 225
               F+++ E  + G L+D + E  +        ++    +   ++Y      +HRD+  
Sbjct: 73  REPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAA 132

Query: 226 ENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSEKVDIWSA 281
            N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S K D+W+ 
Sbjct: 133 RNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAF 191

Query: 282 GVLLHALLVAAL-PFKGDSLEAVFDAIKN 309
           GVLL  +    + P+ G  L  V++ ++ 
Sbjct: 192 GVLLWEIATYGMSPYPGIDLSQVYELLEK 220

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 76.2 bits (187), Expect = 1e-15
 Identities = 65/224 (29%), Positives = 106/224 (47%), Gaps = 29/224 (12%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLH 163
           E IG G FG V+  R +A     A K+ R+      +    +E  I++  S H  +V L 
Sbjct: 1   ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLI 59

Query: 164 SVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            V  +    ++VMEL  GG  +          ++ E+ Q  E  AA +        +Y  
Sbjct: 60  GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGM--------EYLE 111

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG--QTLSGLAGSPA-YVAPEVLS-G 270
               +HRD+   N L+T    +K++DFG++    +G   +  G+   P  + APE L+ G
Sbjct: 112 SKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYG 171

Query: 271 NYSEKVDIWSAGVLL-HALLVAALPFKGDSLEAVFDAI-KNVKL 312
            YS + D+WS G+LL  A  + A+P+   S +   +AI + V+L
Sbjct: 172 RYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL 215

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 77.0 bits (189), Expect = 2e-15
 Identities = 62/217 (28%), Positives = 103/217 (47%), Gaps = 20/217 (9%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  ++  +G G  G V   + K SG   A K +           + RE++++ H    
Sbjct: 4   DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVL-HECNS 62

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + E  +  E+    +   V+  + Y  + 
Sbjct: 63  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 122

Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----GSPAYVAPEVLSG- 270
             ++HRD+KP NIL+ + G+IKL DFG++     GQ +  +A    G+ +Y++PE L G 
Sbjct: 123 HQIMHRDVKPSNILVNSRGEIKLCDFGVS-----GQLIDSMANSFVGTRSYMSPERLQGT 177

Query: 271 NYSEKVDIWSAGVLLHALLVAALPF---KGDSLEAVF 304
           +YS + DIWS G+ L  L +   P        LEA+F
Sbjct: 178 HYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIF 214

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 78.6 bits (193), Expect = 2e-15
 Identities = 63/232 (27%), Positives = 114/232 (49%), Gaps = 40/232 (17%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFAC------KTLRKGEET-VHREVEIMQHLSG 155
           +++  ++ IG+G+FG V+L + K +  EF C      + L++ E++ +  EV +M+ L  
Sbjct: 13  NEYEVIKKIGNGRFGEVFLVKHKRT-QEFFCWKAISYRGLKEREKSQLVIEVNVMRELKH 71

Query: 156 HTGVVTLHSVYEEADC-FHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVI 210
              V  +     +A+   +++ME C  G L   + +     G+  E    +I + ++  +
Sbjct: 72  KNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131

Query: 211 KYCHDMG-------VVHRDIKPENILLTTS----GKI-------------KLADFGLAMR 246
            YCH++        V+HRD+KP+NI L+T     GKI             K+ DFGL+  
Sbjct: 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKN 191

Query: 247 ISNGQTLSGLAGSPAYVAPEVL---SGNYSEKVDIWSAGVLLHALLVAALPF 295
           I          G+P Y +PE+L   + +Y +K D+W+ G +++ L     PF
Sbjct: 192 IGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPF 243

Length = 1021

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 74.9 bits (184), Expect = 6e-15
 Identities = 60/262 (22%), Positives = 113/262 (43%), Gaps = 19/262 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS-----GHTGVVTLH 163
           E++GHG  G+V+      +    A K +   + TV  + +IM  L          ++  +
Sbjct: 7   EILGHGNGGTVYKAYHLLTRRILAVKVIPL-DITVELQKQIMSELEILYKCDSPYIIGFY 65

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
             +   +   +  E   GG L     +V  +  E     I   V+  + Y   + ++HRD
Sbjct: 66  GAFFVENRISICTEFMDGGSL-----DVYRKIPEHVLGRIAVAVVKGLTYLWSLKILHRD 120

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSA 281
           +KP N+L+ T G++KL DFG++ ++ N        G+ AY+APE +SG  Y    D+WS 
Sbjct: 121 VKPSNMLVNTRGQVKLCDFGVSTQLVN-SIAKTYVGTNAYMAPERISGEQYGIHSDVWSL 179

Query: 282 GVLLHALLVAALP---FKGDSLEAVFDAIKNVKLDFHSGVWET--VSKPARDLMARMLTR 336
           G+    L +   P    + +    +   +    +D    V      S+     + + + +
Sbjct: 180 GISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVLPVGQFSEKFVHFITQCMRK 239

Query: 337 DVSARITADEVLRHPWILFYTE 358
               R   + ++ HP+I+ Y +
Sbjct: 240 QPKERPAPENLMDHPFIVQYND 261

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 76.7 bits (188), Expect = 6e-15
 Identities = 71/217 (32%), Positives = 97/217 (44%), Gaps = 45/217 (20%)

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGS 259
           I K ++  ++Y HD  ++HRDIK ENI L   GKI L DFG AM     +     G  G+
Sbjct: 272 IMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGT 331

Query: 260 PAYVAPEVLSGN-YSEKVDIWSAG-VLLHALLVAALPFKG-------------DSLEA-- 302
            A  +PE+L+G+ Y E  DIWS G +LL  L     P                DSL    
Sbjct: 332 VATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD 391

Query: 303 ---------VFDAIKNVKLDFHSGVWETVSKPARDL---------MARMLTRDVSARITA 344
                    +FD I + ++D H+G   +V    R+L         + +MLT D   R  A
Sbjct: 392 EEFPDPPCKLFDYIDSAEID-HAGH--SVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGA 448

Query: 345 DEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP 381
            E+L  P  LF  E     +     LK+  GA+H  P
Sbjct: 449 AELLALP--LFSAEEE-EEILFIHGLKS--GAAHFKP 480

Length = 501

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score = 75.8 bits (186), Expect = 9e-15
 Identities = 60/212 (28%), Positives = 102/212 (48%), Gaps = 31/212 (14%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY--- 166
           +IG+G FG V+      +  + A K + +  +  +RE+ IM++L+ H  ++ L   Y   
Sbjct: 73  IIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN-HINIIFLKDYYYTE 131

Query: 167 ----EEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---------- 211
                E + F ++VME       I Q V   +Y +  A N     ++++K          
Sbjct: 132 CFKKNEKNIFLNVVMEF------IPQTVH--KYMKHYARNNHALPLFLVKLYSYQLCRAL 183

Query: 212 -YCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
            Y H   + HRD+KP+N+L+   +  +KL DFG A  +  GQ       S  Y APE++ 
Sbjct: 184 AYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELML 243

Query: 270 G--NYSEKVDIWSAGVLLHALLVAALPFKGDS 299
           G  NY+  +D+WS G ++  +++    F G S
Sbjct: 244 GATNYTTHIDLWSLGCIIAEMILGYPIFSGQS 275

Length = 440

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 73.7 bits (181), Expect = 1e-14
 Identities = 54/203 (26%), Positives = 99/203 (48%), Gaps = 20/203 (9%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           V+ +G G+FG VW+        + A K+L++G    E    E  +M+ L  H  +V L++
Sbjct: 11  VKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYA 68

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK------DVMWVIKYCHDMGV 218
           V  + +  +++ E    G L+D +    +  E     I K       +   + +      
Sbjct: 69  VVTQ-EPIYIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEK 275
           +HRD++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K
Sbjct: 124 IHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIK 183

Query: 276 VDIWSAGVLLHALLV-AALPFKG 297
            D+WS G+LL  ++    +P+ G
Sbjct: 184 SDVWSFGILLTEIVTYGRIPYPG 206

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 74.9 bits (184), Expect = 1e-14
 Identities = 69/294 (23%), Positives = 118/294 (40%), Gaps = 46/294 (15%)

Query: 114 GKFGSVWLC--RSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADC 171
           G  G V++C         +   K +  G+ T  RE++I++ +S H  ++ L   Y     
Sbjct: 103 GSEGEVFVCTKHGDEQRKKVIVKAVTGGK-TPGREIDILKTIS-HRAIINLIHAYRWKST 160

Query: 172 FHLVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL 229
             +VM    C     +D+    G    ++A  I + ++  + Y H  G++HRD+K ENI 
Sbjct: 161 VCMVMPKYKCDLFTYVDRS---GPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIF 217

Query: 230 LTTSGKIKLADFGLAMRIS---NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLL 285
           L       L DFG A ++    +     G +G+    +PE+L+ + Y  K DIWSAG++L
Sbjct: 218 LDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVL 277

Query: 286 HALLVAALPF-------KGDSLEAVFDAIKNVKLDF----------HSGVWETVSKP--- 325
             + V  +             L ++   ++   L+F          H   +  V +P   
Sbjct: 278 FEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYT 337

Query: 326 -------------ARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTI 366
                           L+A+MLT D   R +A ++L  P         L     
Sbjct: 338 IPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPINLLNITPS 391

Length = 392

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 73.1 bits (180), Expect = 1e-14
 Identities = 53/194 (27%), Positives = 93/194 (47%), Gaps = 16/194 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           T  +VIG G+FG V   R K  G +    A KTL+ G     R     E  IM     H 
Sbjct: 7   TIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HP 65

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHD 215
            ++ L  V  ++    ++ E    G L D+ +    G+++  +   + + +   +KY  +
Sbjct: 66  NIIRLEGVVTKSRPVMIITEYMENGSL-DKFLRENDGKFTVGQLVGMLRGIASGMKYLSE 124

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG--SPA-YVAPEVLS-GN 271
           M  VHRD+   NIL+ ++   K++DFGL+ R+ + +      G   P  + APE ++   
Sbjct: 125 MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRK 184

Query: 272 YSEKVDIWSAGVLL 285
           ++   D+WS G+++
Sbjct: 185 FTSASDVWSFGIVM 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 72.1 bits (177), Expect = 3e-14
 Identities = 54/197 (27%), Positives = 90/197 (45%), Gaps = 13/197 (6%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW      +    A KTL+ G    +    E +IM+ L  H  ++ L++V  
Sbjct: 14  LGAGQFGEVWEGLWNNT-TPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCT 71

Query: 168 EADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
             +  ++V EL   G L++  Q          +  ++   V   + Y      +HRD+  
Sbjct: 72  LEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAA 131

Query: 226 ENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPE-VLSGNYSEKVDIWSA 281
            N+L+  +   K+ADFGLA R+          G+     + APE  L   +S K D+WS 
Sbjct: 132 RNVLVGENNICKVADFGLA-RVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSF 190

Query: 282 GVLLHALLV-AALPFKG 297
           G+LL  ++    +P+ G
Sbjct: 191 GILLTEIVTYGRMPYPG 207

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.4 bits (180), Expect = 3e-14
 Identities = 34/92 (36%), Positives = 51/92 (55%), Gaps = 1/92 (1%)

Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
           A  I K ++  ++Y H   ++HRD+K ENI +    ++ + D G A          GLAG
Sbjct: 159 ALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218

Query: 259 SPAYVAPEVLS-GNYSEKVDIWSAGVLLHALL 289
           +    APEVL+   Y+ K DIWSAG++L  +L
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML 250

Length = 357

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 58/216 (26%), Positives = 106/216 (49%), Gaps = 28/216 (12%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW+  +     + A KT++ G  +V     E  +M+ L  H  +V LH+V  
Sbjct: 14  LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT 71

Query: 168 EADCFHLVMELCSGGRLID----------QMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           + +  +++ E  + G L+D           + ++  +S Q A  +         +     
Sbjct: 72  K-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM--------AFIEQRN 122

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
            +HRD++  NIL++ S   K+ADFGLA  I + +  +  G      + APE ++ G+++ 
Sbjct: 123 YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTI 182

Query: 275 KVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKN 309
           K D+WS G+LL  ++    +P+ G S   V  A++ 
Sbjct: 183 KSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 218

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 70.2 bits (172), Expect = 1e-13
 Identities = 54/187 (28%), Positives = 88/187 (47%), Gaps = 12/187 (6%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLH 163
           E IG G FG V+    K    E A KT R       +    +E EI++    H  +V L 
Sbjct: 1   EKIGKGNFGDVYKGVLK-GNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLI 58

Query: 164 SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
            V  +    ++VMEL  GG L+  +  +  + + ++   +  D    ++Y      +HRD
Sbjct: 59  GVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRD 118

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNG--QTLSGLAGSP-AYVAPEVLS-GNYSEKVDI 278
           +   N L+  +  +K++DFG++     G      GL   P  + APE L+ G Y+ + D+
Sbjct: 119 LAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDV 178

Query: 279 WSAGVLL 285
           WS G+LL
Sbjct: 179 WSYGILL 185

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.3 bits (170), Expect = 2e-13
 Identities = 52/200 (26%), Positives = 81/200 (40%), Gaps = 33/200 (16%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGE-----ETVHREVEIMQHLSGHTGVV 160
           + +G G FG V       SG +    A K L+  +     +   +E  IM  L  H  ++
Sbjct: 1   KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLI 59

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVG----------QYSEQRAANIFKDVMWVI 210
            L+ V        +V EL   G L+D++ +             Y+ Q A  +        
Sbjct: 60  RLYGVVL-THPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGM-------- 110

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSP-AYVAPE 266
           +Y      +HRD+   NILL +  K+K+ DFGL   +   +    +      P A+ APE
Sbjct: 111 RYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPE 170

Query: 267 VLS-GNYSEKVDIWSAGVLL 285
            L    +S   D+W  GV L
Sbjct: 171 SLRTRTFSHASDVWMFGVTL 190

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 69.8 bits (171), Expect = 2e-13
 Identities = 63/221 (28%), Positives = 94/221 (42%), Gaps = 38/221 (17%)

Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWL-----CRSKASGAEFACKTL-----RKGEET 142
            ++ R +      T +  +GHG FG V+          A   + A KTL      + E  
Sbjct: 1   PEVPRDSI-----TLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESD 55

Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
              E  IM   + H  +V L  V  E     +++EL +GG L   + E     E+ ++  
Sbjct: 56  FLMEALIMSKFN-HQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLT 114

Query: 203 FKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRI----- 247
            KD+++         KY  +   +HRDI   N LLT  G     K+ADFG+A  I     
Sbjct: 115 MKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY 174

Query: 248 --SNGQTLSGLAGSPAYVAPEV-LSGNYSEKVDIWSAGVLL 285
               G+ +  +   P    PE  L G ++ K D+WS GVLL
Sbjct: 175 YRKGGRAMLPIKWMP----PEAFLDGIFTSKTDVWSFGVLL 211

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 69.2 bits (169), Expect = 3e-13
 Identities = 62/243 (25%), Positives = 99/243 (40%), Gaps = 11/243 (4%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLH 163
           +   ++ IG G+FG V L   + +     C       +    E  +M  L     V  L 
Sbjct: 7   ELKLLQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLG 66

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHR 221
            + EE    ++V E  + G L+D +   G+             DV   ++Y      VHR
Sbjct: 67  VIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHR 126

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
           D+   N+L++     K++DFGL    S+ Q    L     + APE L    +S K D+WS
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWS 184

Query: 281 AGVLLHALL-VAALPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
            G+LL  +     +P+    L+ V   + K  K+D   G    V     D+M +    D 
Sbjct: 185 FGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMDAPDGCPPVVY----DVMKQCWHLDA 240

Query: 339 SAR 341
           + R
Sbjct: 241 ATR 243

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 69.1 bits (169), Expect = 3e-13
 Identities = 54/189 (28%), Positives = 96/189 (50%), Gaps = 9/189 (4%)

Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M  LS H  +V
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLV 62

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE-QRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +    ++V E  S G L++ + E G+  +  +   + KDV   + Y      +
Sbjct: 63  QLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 123 HRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKS 182

Query: 277 DIWSAGVLL 285
           D+W+ GVL+
Sbjct: 183 DVWAFGVLM 191

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 69.2 bits (169), Expect = 4e-13
 Identities = 55/205 (26%), Positives = 93/205 (45%), Gaps = 28/205 (13%)

Query: 107 KVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEETVH-----REVEIMQHLSGHT 157
           ++  +G G FG V LCR       +G + A K+L+      H     +E+EI+++L  H 
Sbjct: 8   RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HE 66

Query: 158 GVVTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V    +  E   +   L+ME    G L + +        +   N+ + + + ++ C  
Sbjct: 67  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPR-----NKNKINLKQQLKYAVQICKG 121

Query: 216 MGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAY-VAP 265
           M        VHRD+   N+L+ +  ++K+ DFGL   I   +   T+     SP +  AP
Sbjct: 122 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAP 181

Query: 266 EVL-SGNYSEKVDIWSAGVLLHALL 289
           E L    +    D+WS GV L+ LL
Sbjct: 182 ECLIQSKFYIASDVWSFGVTLYELL 206

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score = 69.4 bits (170), Expect = 5e-13
 Identities = 78/302 (25%), Positives = 124/302 (41%), Gaps = 73/302 (24%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLSGHTGVVT- 161
           EVIG G +G V       +G + A K +    E V       RE+++++ L  H  +V  
Sbjct: 6   EVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEI 64

Query: 162 --------------LHSVYE--EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
                         ++ V+E  E+D  H V++  +   L  +  +   Y   RA      
Sbjct: 65  KHIMLPPSRREFKDIYVVFELMESD-LHQVIK--ANDDLTPEHHQFFLYQLLRA------ 115

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL-----AGSP 260
               +KY H   V HRD+KP+NIL     K+K+ DFGLA R++   T + +       + 
Sbjct: 116 ----LKYIHTANVFHRDLKPKNILANADCKLKICDFGLA-RVAFNDTPTAIFWTDYVATR 170

Query: 261 AYVAPEVLS---GNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFD-------- 305
            Y APE+       Y+  +DIWS G +   +L     F G +    L+ + D        
Sbjct: 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPE 230

Query: 306 ---AIKNVKL-DFHSGVWETVSKP-----------ARDLMARMLTRDVSARITADEVLRH 350
               ++N K   + S + +    P           A  L+ R+L  D   R TA+E L  
Sbjct: 231 TISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290

Query: 351 PW 352
           P+
Sbjct: 291 PY 292

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 69.5 bits (170), Expect = 8e-13
 Identities = 35/80 (43%), Positives = 48/80 (60%), Gaps = 4/80 (5%)

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPE 266
           I Y H  G++HRDIK EN+L+     I L DFG A       +     G+AG+    APE
Sbjct: 273 IDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPE 332

Query: 267 VLSGN-YSEKVDIWSAGVLL 285
           VL+G+ Y+  VDIWSAG+++
Sbjct: 333 VLAGDPYTPSVDIWSAGLVI 352

Length = 461

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 68.1 bits (166), Expect = 1e-12
 Identities = 56/195 (28%), Positives = 93/195 (47%), Gaps = 17/195 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           TK +VIG G+FG V+    K  G      A KTL+ G     R     E  IM   S H 
Sbjct: 8   TKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HH 66

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHD 215
            ++ L  V  +     ++ E    G L D+ +    G++S  +   + + +   +KY  D
Sbjct: 67  NIIRLEGVVTKFKPAMIITEYMENGAL-DKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD 125

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----TLSGLAGSPAYVAPEVLS-G 270
           M  VHRD+   NIL+ ++ + K++DFGL+  + +      T SG      + APE ++  
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYR 185

Query: 271 NYSEKVDIWSAGVLL 285
            ++   D+WS G+++
Sbjct: 186 KFTSASDVWSFGIVM 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 68.9 bits (168), Expect = 1e-12
 Identities = 44/116 (37%), Positives = 65/116 (56%), Gaps = 6/116 (5%)

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA---MRISNGQTLSGLAG 258
           I + V+  I+Y H+  ++HRDIK ENI +   G + L DFG A   + I N     G AG
Sbjct: 187 IERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDI-NANKYYGWAG 245

Query: 259 SPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKL 312
           + A  APE+L+ + Y   VDIWSAG++L  +       F+ D L+   D+ + +KL
Sbjct: 246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKL 301

Length = 391

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 67.3 bits (164), Expect = 1e-12
 Identities = 54/187 (28%), Positives = 89/187 (47%), Gaps = 13/187 (6%)

Query: 109 EVIGHGKFGSVW--LCRSKASGAEFACKTLRKGEETVH--REVEIMQHLSGHTGVVTLHS 164
           E++G G FG V+    + K   A   CK     E  +    E  I++    H  +V L  
Sbjct: 1   ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIG 59

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---DVMWVIKYCHDMGVVHR 221
           V  +    ++VMEL  GG  +  + +  +  E +   + K   D    + Y      +HR
Sbjct: 60  VCTQRQPIYIVMELVPGGDFLSFLRK--KKDELKTKQLVKFALDAAAGMAYLESKNCIHR 117

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSP-AYVAPEVLS-GNYSEKVDI 278
           D+   N L+  +  +K++DFG++ +  +G  + SGL   P  + APE L+ G YS + D+
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDV 177

Query: 279 WSAGVLL 285
           WS G+LL
Sbjct: 178 WSYGILL 184

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 67.8 bits (166), Expect = 2e-12
 Identities = 41/155 (26%), Positives = 71/155 (45%), Gaps = 16/155 (10%)

Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR---LIDQMVEVGQYSEQRA 199
           + +E+   + L  H  ++   + +      ++V  L + G    L+      G   E   
Sbjct: 46  LQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEG-LPELAI 103

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAG 258
           A I KDV+  + Y H  G +HR +K  +ILL+  GK+ L+    ++  I +G+    +  
Sbjct: 104 AFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHD 163

Query: 259 SPAY-------VAPEVLSGN---YSEKVDIWSAGV 283
            P         ++PEVL  N   Y+EK DI+S G+
Sbjct: 164 FPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGI 198

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score = 67.8 bits (165), Expect = 2e-12
 Identities = 74/314 (23%), Positives = 127/314 (40%), Gaps = 78/314 (24%)

Query: 111 IGHGKFGSVWLCRSK--ASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSV- 165
           +G G +G V+  + K      E+A K +       +  RE+ +++ L  H  V+ L  V 
Sbjct: 9   VGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK-HPNVIALQKVF 67

Query: 166 -------------YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
                        Y E D +H++       R      +  Q       ++   ++  I Y
Sbjct: 68  LSHSDRKVWLLFDYAEHDLWHII----KFHRASKANKKPMQLPRSMVKSLLYQILDGIHY 123

Query: 213 CHDMGVVHRDIKPENILLT----TSGKIKLADFGLAMRISNG-----QTLSGLAGSPAYV 263
            H   V+HRD+KP NIL+       G++K+AD G A R+ N        L  +  +  Y 
Sbjct: 124 LHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVVTFWYR 182

Query: 264 APEVLSG--NYSEKVDIWSAGVLLHALLVA-------------ALPFKGDSLEAVFDAI- 307
           APE+L G  +Y++ +DIW+ G +   LL +             + PF  D L+ +F  + 
Sbjct: 183 APELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMG 242

Query: 308 ----------------KNVKLDFHSGVWETVS----------KPARD---LMARMLTRDV 338
                             ++ DF    +   S          KP      L+ ++LT D 
Sbjct: 243 FPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDP 302

Query: 339 SARITADEVLRHPW 352
           + RIT+++ L+ P+
Sbjct: 303 TKRITSEQALQDPY 316

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 67.2 bits (164), Expect = 2e-12
 Identities = 58/203 (28%), Positives = 94/203 (46%), Gaps = 25/203 (12%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQ 151
           KIE      EVIG G+FG V   R K  G      A KTL+ G     R     E  IM 
Sbjct: 7   KIE------EVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMG 60

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWV 209
               H  ++ L  V  ++    ++ E    G L D  +    GQ++  +   + + +   
Sbjct: 61  QFD-HPNIIHLEGVVTKSRPVMIITEFMENGAL-DSFLRQNDGQFTVIQLVGMLRGIAAG 118

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGLAGS-PA-YV 263
           +KY  +M  VHRD+   NIL+ ++   K++DFGL+  + +  +     S L G  P  + 
Sbjct: 119 MKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWT 178

Query: 264 APEVLS-GNYSEKVDIWSAGVLL 285
           APE ++   ++   D+WS G+++
Sbjct: 179 APEAIAYRKFTSASDVWSYGIVM 201

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 66.7 bits (163), Expect = 3e-12
 Identities = 62/216 (28%), Positives = 96/216 (44%), Gaps = 42/216 (19%)

Query: 102 EDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIMQH 152
           E+ H K ++ +G G FGSV LCR       +G   A K L+           RE+EI++ 
Sbjct: 2   EERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKS 61

Query: 153 LSGHTGVVTLHSVYEEADCF-------HLVMELCSGGRLIDQMVEVGQYSEQRAANIF-- 203
           L  H  +V    V     C+        LVME    G L D       Y ++    +   
Sbjct: 62  LQ-HDNIVKYKGV-----CYSAGRRNLRLVMEYLPYGSLRD-------YLQKHRERLDHR 108

Query: 204 KDVMWVIKYCHDMG------VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLS 254
           K +++  + C  M        VHRD+   NIL+ +  ++K+ DFGL   +   +    + 
Sbjct: 109 KLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVR 168

Query: 255 GLAGSPAY-VAPEVLSGN-YSEKVDIWSAGVLLHAL 288
               SP +  APE L+ + +S   D+WS GV+L+ L
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 58/201 (28%), Positives = 93/201 (46%), Gaps = 18/201 (8%)

Query: 101 IEDDHTKVE-VIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQ 151
           I+    K+E VIG G+FG V   R K  G      A KTL+ G     R     E  IM 
Sbjct: 1   IDASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMG 60

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWV 209
               H  ++ L  V  ++    +V E    G L D  +    GQ++  +   + + +   
Sbjct: 61  QFD-HPNIIHLEGVVTKSKPVMIVTEYMENGSL-DAFLRKHDGQFTVIQLVGMLRGIASG 118

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAP 265
           +KY  DMG VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + AP
Sbjct: 119 MKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAP 178

Query: 266 EVLS-GNYSEKVDIWSAGVLL 285
           E ++   ++   D+WS G+++
Sbjct: 179 EAIAYRKFTSASDVWSYGIVM 199

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 65.9 bits (161), Expect = 4e-12
 Identities = 57/227 (25%), Positives = 96/227 (42%), Gaps = 35/227 (15%)

Query: 107 KVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTL 162
           K++V+G G FG+V    W+   +      A K LR+       + EI+        V   
Sbjct: 11  KIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANK-EILDEAYVMASV--- 66

Query: 163 HSVYEEADCFHLV--MELCSGGR--LIDQMVEVG---QYSEQRAANIFKDVM--WVI--- 210
                  D  H+V  + +C   +  LI Q++ +G    Y      NI    +  W +   
Sbjct: 67  -------DHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIA 119

Query: 211 ---KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YVA 264
               Y  +  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++A
Sbjct: 120 KGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMA 179

Query: 265 PE-VLSGNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKN 309
            E +L   Y+ K D+WS GV +  L+   A P++G     + D ++ 
Sbjct: 180 LESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEK 226

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 65/242 (26%), Positives = 102/242 (42%), Gaps = 22/242 (9%)

Query: 119 VWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL 178
           V L     +   F  K LRK  E     + I+ H   +  +V LH      D   LV++ 
Sbjct: 9   VLLVMDTRTQQTFILKGLRKSSEYSRERLTIIPHCVPN--MVCLHKYIVSEDSVFLVLQH 66

Query: 179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL 238
             GG+L   + +     E+       +++  +   H  G+V RD+ P NILL   G I+L
Sbjct: 67  AEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQL 126

Query: 239 ADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKV---DIWSAGVLLHALLVAALPF 295
             F     +    +  G A    Y APEV  G  SE+    D WS G +L  LL      
Sbjct: 127 TYFSRWSEVE--DSCDGEAVENMYCAPEV--GGISEETEACDWWSLGAILFELLT----- 177

Query: 296 KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITA-----DEVLRH 350
            G +L     +  N     +  + E VS+ AR L+ ++L  + + R+ A     +++  H
Sbjct: 178 -GKTLVECHPSGINTHTTLN--IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSH 234

Query: 351 PW 352
           P+
Sbjct: 235 PF 236

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 65.2 bits (159), Expect = 8e-12
 Identities = 63/253 (24%), Positives = 110/253 (43%), Gaps = 40/253 (15%)

Query: 110 VIGHGKFGSVWLCRSKASGAE-----FACKTLRKGEET-----VHREVEIMQHLSGHTGV 159
            +G G+FG V+L ++K    E        K L+K ++        RE+++ + LS H  V
Sbjct: 12  TLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNV 70

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG-- 217
           V L  +  EA+  ++++E    G L  Q +   +  +++           +  C  +   
Sbjct: 71  VRLLGLCREAEPHYMILEYTDLGDL-KQFLRATKSKDEKLKPPPLSTKQKVALCTQIALG 129

Query: 218 --------VVHRDIKPENILLTTSGKIKLADFGLAMRISNG------QTLSGLAGSPAYV 263
                    VHRD+   N L+++  ++K++   L+  + N         L  L     ++
Sbjct: 130 MDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLR----WL 185

Query: 264 APE-VLSGNYSEKVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDF--HSGVW 319
           APE V   ++S K D+WS GVL+  +     LPF G S E V + ++  KL+     G  
Sbjct: 186 APEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPVPEGCP 245

Query: 320 ETVSKPARDLMAR 332
             + K    LM R
Sbjct: 246 SRLYK----LMTR 254

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 62/183 (33%), Positives = 92/183 (50%), Gaps = 13/183 (7%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHSV 165
           E+IG G+FG+V   + + +G + A K + K + T      E  +M  L  H  +V L  V
Sbjct: 12  EIIGEGEFGAVL--QGEYTGQKVAVKNI-KCDVTAQAFLEETAVMTKLH-HKNLVRLLGV 67

Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQY--SEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
               +  ++VMEL S G L++ +   G+   S  +      DV   ++Y     +VHRD+
Sbjct: 68  ILH-NGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDL 126

Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS-GNYSEKVDIWSAG 282
              NIL++  G  K++DFGLA   S G   S L     + APE L    +S K D+WS G
Sbjct: 127 AARNILVSEDGVAKVSDFGLARVGSMGVDNSKL--PVKWTAPEALKHKKFSSKSDVWSYG 184

Query: 283 VLL 285
           VLL
Sbjct: 185 VLL 187

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 64.4 bits (157), Expect = 1e-11
 Identities = 70/275 (25%), Positives = 107/275 (38%), Gaps = 52/275 (18%)

Query: 103 DDHTKVEVIGHGKFGSVW------LCRSKASGAEFACKTLRKGE--ETVHREVEIMQHLS 154
           +D T    IG G+FG V+          K + A   CK        E   +E  IM+   
Sbjct: 6   EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD 65

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC- 213
            H  +V L  V  E +   +VMEL   G       E+  Y +    ++  D+  +I Y  
Sbjct: 66  -HPHIVKLIGVITE-NPVWIVMELAPLG-------ELRSYLQVNKYSL--DLASLILYSY 114

Query: 214 ---------HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-P-AY 262
                         VHRDI   N+L+++   +KL DFGL+  + +        G  P  +
Sbjct: 115 QLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKW 174

Query: 263 VAPEVLSGNY---SEKVDIWSAGVLLHALLVAAL-PFKGDSLEAVFDAIKNVKLDFHSGV 318
           +APE  S N+   +   D+W  GV +  +L+  + PF+G     V   I+N         
Sbjct: 175 MAPE--SINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIEN--------- 223

Query: 319 WETVSKPAR------DLMARMLTRDVSARITADEV 347
            E +  P         LM +    D S R    E+
Sbjct: 224 GERLPMPPNCPPTLYSLMTKCWAYDPSKRPRFTEL 258

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 63.8 bits (155), Expect = 2e-11
 Identities = 58/202 (28%), Positives = 89/202 (44%), Gaps = 20/202 (9%)

Query: 111 IGHGKFGSV--WLCRSKASGAEFACKTLRKGEET-----VHREVEIMQHLSGHTGVVTLH 163
           +G G FG V   + + +    + A K L+   E      + RE EIM  L  +  +V + 
Sbjct: 3   LGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMI 61

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI---FKDVMWVIKYCHDMGVVH 220
            V E A+   LVME+ SGG L       G+  E   +N+      V   +KY      VH
Sbjct: 62  GVCE-AEALMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVH 118

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPAYVAPE-VLSGNYSEK 275
           RD+   N+LL      K++DFGL+  +    S  +  S       + APE +    +S +
Sbjct: 119 RDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSR 178

Query: 276 VDIWSAGVLL-HALLVAALPFK 296
            D+WS G+ +  A      P+K
Sbjct: 179 SDVWSYGITMWEAFSYGQKPYK 200

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 64.7 bits (157), Expect = 3e-11
 Identities = 35/97 (36%), Positives = 55/97 (56%), Gaps = 11/97 (11%)

Query: 178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI----KYCHDMGVVHRDIKPENILLTTS 233
           + +G ++ D M +     ++R  N+ K VM  +    +  H +G+VHRDIKPEN+L+T  
Sbjct: 291 MMAGKKIPDNMPQ-----DKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVD 345

Query: 234 GKIKLADFGLAMRISNGQTLSGLAG--SPAYVAPEVL 268
           G++K+ DFG A+ +  G   + L G   P Y  PE L
Sbjct: 346 GQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEEL 382

Length = 507

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score = 63.5 bits (154), Expect = 4e-11
 Identities = 74/315 (23%), Positives = 131/315 (41%), Gaps = 80/315 (25%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEET-----VHREVEIMQHLSGHTGVVTLHSV 165
           +G G +G V+  + K  G +     L++ E T       RE+ +++ L  H  V++L  V
Sbjct: 9   VGRGTYGHVYKAKRK-DGKDDRDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKV 66

Query: 166 --------------YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
                         Y E D +H++ +     +   + V   Q       ++   ++  I 
Sbjct: 67  FLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPV---QLPRGMVKSLLYQILDGIH 122

Query: 212 YCHDMGVVHRDIKPENILLT----TSGKIKLADFGLAMRISNG-----QTLSGLAGSPAY 262
           Y H   V+HRD+KP NIL+       G++K+AD G A R+ N        L  +  +  Y
Sbjct: 123 YLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLADLDPVVVTFWY 181

Query: 263 VAPEVLSG--NYSEKVDIWSAGVLLHALLVA-------------ALPFKGDSLEAVFDAI 307
            APE+L G  +Y++ +DIW+ G +   LL +             + P+  D L+ +F+ +
Sbjct: 182 RAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVM 241

Query: 308 -----------------KNVKLDFHSGVWETVS----------KP---ARDLMARMLTRD 337
                              +  DF    +   S          KP   A  L+ ++LT D
Sbjct: 242 GFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMD 301

Query: 338 VSARITADEVLRHPW 352
              RIT+++ ++ P+
Sbjct: 302 PIKRITSEQAMQDPY 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.7 bits (152), Expect = 4e-11
 Identities = 57/201 (28%), Positives = 93/201 (46%), Gaps = 16/201 (7%)

Query: 111 IGHGKFGSV--WLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTL 162
           +G G FG+V   + + K S    A K L+        ++ + RE  +MQ L  +  +V +
Sbjct: 3   LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRM 61

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
             + E A+ + LVMEL   G L   + +    +E+    +   V   +KY  +   VHRD
Sbjct: 62  IGICE-AESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRD 120

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP----AYVAPEVLS-GNYSEKVD 277
           +   N+LL T    K++DFGL+  +   +              + APE ++   +S K D
Sbjct: 121 LAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSD 180

Query: 278 IWSAGVLL-HALLVAALPFKG 297
           +WS GVL+  A      P+KG
Sbjct: 181 VWSFGVLMWEAFSYGQKPYKG 201

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 62.6 bits (152), Expect = 7e-11
 Identities = 57/205 (27%), Positives = 87/205 (42%), Gaps = 30/205 (14%)

Query: 107 KVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           K+ V+G G FG V L      +  +G   A KTL++     +      E+ I++ L  H 
Sbjct: 8   KIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HE 66

Query: 158 GVVTLHSVYEEA--DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV------ 209
            +V       E       L+ME    G L D       Y  +   N+ + +++       
Sbjct: 67  NIVKYKGCCSEQGGKGLQLIMEYVPLGSLRD-------YLPKHKLNLAQLLLFAQQICEG 119

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAY-VAP 265
           + Y H    +HRD+   N+LL     +K+ DFGLA  +  G     +     SP +  A 
Sbjct: 120 MAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAV 179

Query: 266 EVLSGN-YSEKVDIWSAGVLLHALL 289
           E L  N +S   D+WS GV L+ LL
Sbjct: 180 ECLKENKFSYASDVWSFGVTLYELL 204

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 61.8 bits (150), Expect = 1e-10
 Identities = 60/206 (29%), Positives = 93/206 (45%), Gaps = 28/206 (13%)

Query: 111 IGHGKFGSVWLCRSK---ASGAE---FACKTLRKGEETVHREVEIMQ--HLSG---HTGV 159
           +G G FG V+   +      G+     A KTLRKG  T   + E ++  HL     H  +
Sbjct: 3   LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA-TDQEKKEFLKEAHLMSNFNHPNI 61

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW----VIKYCH- 214
           V L  V    +  +++MEL  GG L+  + +             K+++     V K C  
Sbjct: 62  VKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVY 121

Query: 215 --DMGVVHRDIKPENILLTTSGK-----IKLADFGLAMRI--SNGQTLSGLAGSPA-YVA 264
              M  +HRD+   N L++  G      +K+ DFGLA  I  S+     G    P  ++A
Sbjct: 122 LEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181

Query: 265 PEVL-SGNYSEKVDIWSAGVLLHALL 289
           PE L  G ++ + D+WS GVL+  +L
Sbjct: 182 PESLLDGKFTTQSDVWSFGVLMWEIL 207

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 62.1 bits (151), Expect = 1e-10
 Identities = 54/201 (26%), Positives = 88/201 (43%), Gaps = 34/201 (16%)

Query: 110 VIGHGKFGSV------WLCRSKASGAEFACKTLRKGEETVHR--------EVEIMQHLSG 155
            +G G FG V       L +S A   + A K L+    T H         E++IM HL  
Sbjct: 42  TLGAGAFGKVVEATAYGLSKSDAV-MKVAVKMLK---PTAHSSEREALMSELKIMSHLGN 97

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV------ 209
           H  +V L           ++ E C  G L++ +       ++ +    +D++        
Sbjct: 98  HENIVNLLGACTIGGPILVITEYCCYGDLLNFL-----RRKRESFLTLEDLLSFSYQVAK 152

Query: 210 -IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPA-YVAP 265
            + +      +HRD+   N+LLT    +K+ DFGLA  I N     + G A  P  ++AP
Sbjct: 153 GMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAP 212

Query: 266 E-VLSGNYSEKVDIWSAGVLL 285
           E + +  Y+ + D+WS G+LL
Sbjct: 213 ESIFNCVYTFESDVWSYGILL 233

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 47/211 (22%), Positives = 84/211 (39%), Gaps = 29/211 (13%)

Query: 103 DDHTKVEVIGHGKFGSVWL--CRSKASGAEF---ACKTLRKG-----EETVHREVEIMQH 152
           D       +G G FG V+L  C       +    A KTL++       +   RE E++ +
Sbjct: 5   DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGG--------------RLIDQMVEVGQYSEQR 198
              H  +V  + V  E D   +V E    G               L      +G+ +  +
Sbjct: 65  F-QHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQ 123

Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGL 256
              I   +   + Y      VHRD+   N L+     +K+ DFG++  +  ++   + G 
Sbjct: 124 LLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGH 183

Query: 257 AGSPA-YVAPE-VLSGNYSEKVDIWSAGVLL 285
              P  ++ PE ++   ++ + D+WS GV+L
Sbjct: 184 TMLPIRWMPPESIMYRKFTTESDVWSFGVVL 214

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 1e-10
 Identities = 55/225 (24%), Positives = 87/225 (38%), Gaps = 30/225 (13%)

Query: 111 IGHGKFGSVWL-----CRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +G G FG V+                A KT+ +      R     E  +M+  + H  VV
Sbjct: 14  LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHH-VV 72

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF------KDVMWVIK--- 211
            L  V        +VMEL + G L   +    +  E             K +    +   
Sbjct: 73  RLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKFIQMAAEIAD 130

Query: 212 ---YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-YVAP 265
              Y      VHRD+   N ++     +K+ DFG+   I  ++     G    P  ++AP
Sbjct: 131 GMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAP 190

Query: 266 EVL-SGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIK 308
           E L  G ++ K D+WS GV+L  +  +A  P++G S E V   + 
Sbjct: 191 ESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVI 235

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 61.6 bits (149), Expect = 2e-10
 Identities = 45/187 (24%), Positives = 91/187 (48%), Gaps = 27/187 (14%)

Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQY 194
           E+E+M+ +  H  ++ L     +    ++++E  S G L           ++   ++ + 
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARV 129

Query: 195 SEQRAANIFKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI 247
            +++    FKD++         ++Y      +HRD+   N+L+T +  +K+ADFGLA  +
Sbjct: 130 PDEQMT--FKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDV 187

Query: 248 SN----GQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLE 301
           +N     +T +G      ++APE L    Y+ + D+WS GVL+  +  +   P+ G  +E
Sbjct: 188 NNIDYYKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 246

Query: 302 AVFDAIK 308
            +F  +K
Sbjct: 247 ELFKLLK 253

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 60.0 bits (145), Expect = 5e-10
 Identities = 74/283 (26%), Positives = 120/283 (42%), Gaps = 48/283 (16%)

Query: 109 EVIGHGKFGSVWLCRSKA-------SGAEF-------ACKTLRKGEETVHR-----EVEI 149
           E +G G+FG V LC ++           EF       A K LR       R     E++I
Sbjct: 11  EKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKI 70

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE-QRAANI----FK 204
           M  L  +  ++ L  V    D   ++ E    G L   + +    S    A NI      
Sbjct: 71  MSRLK-NPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129

Query: 205 DVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSG 255
           +++++       +KY   +  VHRD+   N L+     IK+ADFG++  + +G    + G
Sbjct: 130 NLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQG 189

Query: 256 LAGSPA-YVAPE-VLSGNYSEKVDIWSAGVLLHAL--LVAALPFKGDSLEAVFDAIKNVK 311
            A  P  ++A E +L G ++   D+W+ GV L  +  L    P+   S E V   I+N  
Sbjct: 190 RAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQV---IENTG 246

Query: 312 LDFHS-GVWETVSK------PARDLMARMLTRDVSARITADEV 347
             F + G    +S+      P   LM R  +RD+  R T +++
Sbjct: 247 EFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKI 289

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 58/219 (26%), Positives = 101/219 (46%), Gaps = 21/219 (9%)

Query: 107 KVEVIGHGKFGSV----WLCRSKASGAEFACKTL--RKGEETVHREVEIMQHLSG----- 155
           K++++G G FG+V    W+    +     A KT+  R G +T     EI  H+       
Sbjct: 11  KLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQ---EITDHMLAMGSLD 67

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCH 214
           H  +V L  +   A    LV +L   G L+D + +       QR  N    +   + Y  
Sbjct: 68  HAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLE 126

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSP-AYVAPE-VLSG 270
           +  +VHR++   NILL +   +++ADFG+A  +   + +       +P  ++A E +L G
Sbjct: 127 EHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFG 186

Query: 271 NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIK 308
            Y+ + D+WS GV +  ++   A P+ G     V D ++
Sbjct: 187 RYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLE 225

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 63/247 (25%), Positives = 108/247 (43%), Gaps = 51/247 (20%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAE-------FACKTLRKGEETVH------REVEI 149
           D  T  + +G G FG V   +++A G +        A K L K + T         E+E+
Sbjct: 12  DRLTLGKPLGEGAFGQVV--KAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEM 68

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE---VGQYSEQRAANI---- 202
           M+ +  H  ++ L  V  +    ++V+E  + G L D +      G+Y+           
Sbjct: 69  MKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEET 128

Query: 203 --FKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI------ 247
              KD++         +++      +HRD+   N+L+T    +K+ADFGLA  I      
Sbjct: 129 LTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYY 188

Query: 248 ---SNGQTLSGLAGSPA-YVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLE 301
              +NG+        P  ++APE L    Y+ + D+WS GVLL  +  +   P+ G  +E
Sbjct: 189 RKTTNGRL-------PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 241

Query: 302 AVFDAIK 308
            +F  +K
Sbjct: 242 ELFKLLK 248

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 59/233 (25%), Positives = 106/233 (45%), Gaps = 31/233 (13%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEF--ACKTLRK-GEETVHR----EVEIMQHLSG 155
           +D    +VIG G FG V     K  G +   A K L++   E  HR    E+E++  L  
Sbjct: 2   EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGH 61

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLID-----QMVEV-----------GQYSEQRA 199
           H  ++ L    E     ++ +E    G L+D     +++E               + Q+ 
Sbjct: 62  HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM--RISNGQTLSGLA 257
                DV   ++Y  +   +HRD+   N+L+  +   K+ADFGL+    +   +T+  L 
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVKKTMGRL- 180

Query: 258 GSPA-YVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAI 307
             P  ++A E L+ + Y+ K D+WS GVLL  ++ +   P+ G +   +++ +
Sbjct: 181 --PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKL 231

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 57.6 bits (139), Expect = 4e-09
 Identities = 41/114 (35%), Positives = 59/114 (51%), Gaps = 13/114 (11%)

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF--GLAMRISNGQT 252
           SE   A I + V+  + Y H MG VHR +K  +IL++  GK+ L+     L+M I++GQ 
Sbjct: 99  SELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSM-INHGQR 157

Query: 253 LSGLAGSPAY-------VAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFK 296
           L  +   P Y       ++PEVL  N   Y  K DI+S G+    L    +PFK
Sbjct: 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 57.3 bits (138), Expect = 4e-09
 Identities = 60/228 (26%), Positives = 98/228 (42%), Gaps = 33/228 (14%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHR----EVEIMQHLSGHTGVVT 161
           +VIG G FG V   R K  G        R  E   +  HR    E+E++  L  H  ++ 
Sbjct: 13  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 72

Query: 162 LHSVYEEADCFHLVMELCSGGRLID-----QMVEV-----------GQYSEQRAANIFKD 205
           L    E     +L +E    G L+D     +++E               S Q+  +   D
Sbjct: 73  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 132

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPA- 261
           V   + Y      +HRD+   NIL+  +   K+ADFGL    S GQ +     +   P  
Sbjct: 133 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLPVR 188

Query: 262 YVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAI 307
           ++A E L+ + Y+   D+WS GVLL  ++ +   P+ G +   +++ +
Sbjct: 189 WMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 236

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 57.3 bits (138), Expect = 6e-09
 Identities = 48/187 (25%), Positives = 88/187 (47%), Gaps = 27/187 (14%)

Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQY 194
           E+E+M+ +  H  ++ L     +    ++++E  S G L           +D   +  + 
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKL 126

Query: 195 SEQRAANIFKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI 247
            E++    FKD++         ++Y      +HRD+   N+L+T    +K+ADFGLA  +
Sbjct: 127 PEEQLT--FKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDV 184

Query: 248 SN----GQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLE 301
            N     +T +G      ++APE L    Y+ + D+WS GVLL  +  +   P+ G  +E
Sbjct: 185 HNIDYYKKTTNGRL-PVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE 243

Query: 302 AVFDAIK 308
            +F  +K
Sbjct: 244 ELFKLLK 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 58/241 (24%), Positives = 106/241 (43%), Gaps = 53/241 (21%)

Query: 111 IGHGKFGSVWLCRSKASGAE---------FACKTLR-----KGEETVHREVEIMQHLSGH 156
           +G G FG V   R++A G +          A K L+     K    +  E+E+M+ +  H
Sbjct: 20  LGEGCFGQV--VRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKH 77

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKD 205
             ++ L  V  +    ++++E  + G L            D   ++ +  E++ +  FKD
Sbjct: 78  KNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLS--FKD 135

Query: 206 -------VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA---------MRISN 249
                  V   ++Y      +HRD+   N+L+T    +K+ADFGLA          + SN
Sbjct: 136 LVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSN 195

Query: 250 GQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAI 307
           G+          ++APE L    Y+ + D+WS G+L+  +  +   P+ G  +E +F  +
Sbjct: 196 GRL------PVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLL 249

Query: 308 K 308
           +
Sbjct: 250 R 250

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 54/244 (22%), Positives = 107/244 (43%), Gaps = 52/244 (21%)

Query: 110 VIGHGKFGSV-----WLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSGHTGV 159
            +G G+FG V     +  + +A     A K L++   +        E  +++ ++ H  V
Sbjct: 7   TLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHV 65

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVE--------VGQYSEQRAANIF-------- 203
           + L+    +     L++E    G L   + E        +G    + ++ +         
Sbjct: 66  IKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALT 125

Query: 204 -KDVM---WVI----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA---------MR 246
             D++   W I    +Y  +M +VHRD+   N+L+    K+K++DFGL+         ++
Sbjct: 126 MGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVK 185

Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
            S G+          ++A E L  + Y+ + D+WS GVLL  ++ +   P+ G + E +F
Sbjct: 186 RSKGRI------PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF 239

Query: 305 DAIK 308
           + +K
Sbjct: 240 NLLK 243

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 56.2 bits (135), Expect = 1e-08
 Identities = 57/232 (24%), Positives = 99/232 (42%), Gaps = 35/232 (15%)

Query: 111 IGHGKFGSVWLCRSKASGAE-------FACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +     E        A K L+     K    +  E+E+M+ +  H  
Sbjct: 26  LGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 85

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM----------------VEVGQYSEQRAANI 202
           ++ L     +    ++++E  S G L + +                V   Q S +   + 
Sbjct: 86  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSC 145

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 146 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL- 204

Query: 259 SPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS GVLL  +  +   P+ G  +E +F  +K
Sbjct: 205 PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 256

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 57.2 bits (138), Expect = 1e-08
 Identities = 49/198 (24%), Positives = 82/198 (41%), Gaps = 21/198 (10%)

Query: 127 SGAEFACKTLR----KGEETV---HREVEIMQHLSGHTGVVTLHSVYEEADCFHL-VMEL 178
           +G E A K LR    + E       RE  +   L  H  +V L    E        V E 
Sbjct: 2   TGHEVAIKLLRTDAPEEEHQRARFRRETALCARLY-HPNIVALLDSGEAPPGLLFAVFEY 60

Query: 179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---K 235
             G  L + +   G         +   V+  +   H+ G+VHRD+KP+NI+++ +G    
Sbjct: 61  VPGRTLREVLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPH 120

Query: 236 IKLADFGLAMRISNGQ-------TLSG-LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLH 286
            K+ DFG+   +   +       T +  + G+P Y APE L G   +   D+++ G++  
Sbjct: 121 AKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFL 180

Query: 287 ALLVAALPFKGDSLEAVF 304
             L      +G S+  + 
Sbjct: 181 ECLTGQRVVQGASVAEIL 198

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

 Score = 54.9 bits (132), Expect = 2e-08
 Identities = 46/193 (23%), Positives = 81/193 (41%), Gaps = 16/193 (8%)

Query: 107 KVE-VIGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           K+E ++G G+FG +    L          A  TLR G     R     E   +     H+
Sbjct: 8   KIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HS 66

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHD 215
            +V L  V    +   +V E  S G L D  +    GQ    +   +   +   +KY  +
Sbjct: 67  NIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLVAGQLMGMLPGLASGMKYLSE 125

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG-SPA-YVAPEVLS-GNY 272
           MG VH+ +    +L+ +    K++ F       +    + ++G SP  + APE +   ++
Sbjct: 126 MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHF 185

Query: 273 SEKVDIWSAGVLL 285
           S   D+WS G+++
Sbjct: 186 SSASDVWSFGIVM 198

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 55.2 bits (133), Expect = 2e-08
 Identities = 58/231 (25%), Positives = 99/231 (42%), Gaps = 32/231 (13%)

Query: 109 EVIGHGKFGSVW-----LCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTG 158
           E +G G FG V+         + S    A KTL++      ++   +E E+M  L  H  
Sbjct: 11  EELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPN 69

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMV------EVGQYSEQRAA----------NI 202
           +V L  V  +     ++ E  + G L + +V      +VG  S               +I
Sbjct: 70  IVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHI 129

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP-- 260
              +   ++Y      VHRD+   N L+     +K++DFGL+  I +       + S   
Sbjct: 130 AIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLP 189

Query: 261 -AYVAPE-VLSGNYSEKVDIWSAGVLLHALLVAAL-PFKGDSLEAVFDAIK 308
             ++ PE +L G ++ + DIWS GV+L  +    L P+ G S + V + I+
Sbjct: 190 VRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIR 240

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 53.9 bits (129), Expect = 5e-08
 Identities = 56/226 (24%), Positives = 97/226 (42%), Gaps = 29/226 (12%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEF--ACKTLRK-GEETVHR----EVEIMQHLSGHTGVVT 161
           +VIG G FG V   R K  G     A K +++   +  HR    E+E++  L  H  ++ 
Sbjct: 1   DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 60

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMV-------------EVGQYSEQRAANIFK---D 205
           L    E     +L +E    G L+D +                   S   +  +     D
Sbjct: 61  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 120

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM--RISNGQTLSGLAGSPAYV 263
           V   + Y      +HRD+   NIL+  +   K+ADFGL+    +   +T+  L     ++
Sbjct: 121 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRL--PVRWM 178

Query: 264 APEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAI 307
           A E L+ + Y+   D+WS GVLL  ++ +   P+ G +   +++ +
Sbjct: 179 AIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKL 224

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 53.9 bits (130), Expect = 5e-08
 Identities = 71/285 (24%), Positives = 113/285 (39%), Gaps = 49/285 (17%)

Query: 108 VEVIGHGKFGSVWLCR--------------SKASGAE--FACKTLRKGE-----ETVHRE 146
           VE +G G+FG V LC               +  + A    A K LR        E   +E
Sbjct: 10  VEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKE 69

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL-------IDQMVEVGQYSEQRA 199
           V+I+  LS    +  L  V        ++ME    G L       + +   +   S+  +
Sbjct: 70  VKILSRLS-DPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLS 128

Query: 200 ANIFKDVMWVI----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTL 253
            +    +   I    +Y   +  VHRD+   N L+  +  IK+ADFG++  +  S+   +
Sbjct: 129 FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRV 188

Query: 254 SGLAGSPA-YVAPE-VLSGNYSEKVDIWSAGVLLHALLVAA--LPFKGDSLEAVFDAIKN 309
            G A  P  ++A E VL G ++ K D+W+ GV L  +L      P+  + L      I+N
Sbjct: 189 QGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY--EHLTD-QQVIEN 245

Query: 310 VKLDFH-SGVWETVSKPAR------DLMARMLTRDVSARITADEV 347
               F   G    + +P        +LM     RD   R T  E+
Sbjct: 246 AGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI 290

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 53.5 bits (128), Expect = 8e-08
 Identities = 56/216 (25%), Positives = 93/216 (43%), Gaps = 27/216 (12%)

Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 6   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 59

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 60  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 118

Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  +  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 119 AKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178

Query: 264 APE-VLSGNYSEKVDIWSAGVLLHALLVAAL-PFKG 297
           A E +L   Y+ + D+WS GV +  L+     P+ G
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 55/210 (26%), Positives = 93/210 (44%), Gaps = 15/210 (7%)

Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  KV+V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 6   ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANK-EILDEAYVMA 64

Query: 158 GVVTLHSVYEEADCF----HLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKY 212
           GV + +       C      LV +L   G L+D + E   +   Q   N    +   + Y
Sbjct: 65  GVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY 124

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YVAPE-VL 268
             ++ +VHRD+   N+L+ +   +K+ DFGLA  +   +T     G      ++A E +L
Sbjct: 125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184

Query: 269 SGNYSEKVDIWSAGVLLHALLV-AALPFKG 297
              ++ + D+WS GV +  L+   A P+ G
Sbjct: 185 HRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 51.3 bits (123), Expect = 7e-07
 Identities = 68/294 (23%), Positives = 107/294 (36%), Gaps = 90/294 (30%)

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLA--MRISNGQTLSGLAG 258
           I + +++ +   H  G+VHRD+KP+NI+ +  SG  K+ D G A  +R+           
Sbjct: 260 IMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLL 319

Query: 259 SPAYVAPE------------------VLSG-----NYSEKVDIWSAGVLLHALLVAALP- 294
            P Y APE                   LS      N  ++ DI+SAG++    L  A P 
Sbjct: 320 DPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSAGLI---FLQMAFPN 376

Query: 295 ---------FK------GDSLEAVFDAIKNVK----------LDFHSGV-WETVSKPARD 328
                    F          L A    ++             LD   G  WE        
Sbjct: 377 LRSDSNLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWE-------- 428

Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVE 388
           L+  M+      RI+A   L HP   ++    L  L++   L+ Q+              
Sbjct: 429 LLKSMMRFKGRQRISAKAALAHP---YFDREGLLGLSVMQNLRLQL-------------- 471

Query: 389 SDENKIDRGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKR 442
                  R ++ D   A +    L ++S  + EGGF +A    +  +R  EPK+
Sbjct: 472 ------FRATQQDYGEAAAWVVFLMAKSGTEKEGGFTEA---QLQELREKEPKK 516

Length = 566

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 50.1 bits (119), Expect = 9e-07
 Identities = 48/201 (23%), Positives = 87/201 (43%), Gaps = 27/201 (13%)

Query: 111 IGHGKFGSVWLCRSKASGAE-----FACKTLRKGEETV----HREVEIMQHLSGHTGVVT 161
           +G G FG V+L        E      A KTL+   +      HRE E++ +L  H  +V 
Sbjct: 13  LGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVK 71

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVG-------------QYSEQRAANIFKDVMW 208
            + V  E D   +V E    G L   +   G             + ++ +  +I + +  
Sbjct: 72  FYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAA 131

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-YVAP 265
            + Y      VHRD+   N L+  +  +K+ DFG++  +  ++   + G    P  ++ P
Sbjct: 132 GMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPP 191

Query: 266 E-VLSGNYSEKVDIWSAGVLL 285
           E ++   ++ + D+WS GV+L
Sbjct: 192 ESIMYRKFTTESDVWSLGVVL 212

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 49.6 bits (118), Expect = 1e-06
 Identities = 51/207 (24%), Positives = 87/207 (42%), Gaps = 37/207 (17%)

Query: 111 IGHGKFGSVWL--CRSKASGAE---FACKTLRKGEETV----HREVEIMQHLSGHTGVVT 161
           +G G FG V+L  C +     +    A K L++  E+      RE E++  L  H  +V 
Sbjct: 13  LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVR 71

Query: 162 LHSVYEEADCFHLVMELCSGG-------------RLID--QMVEVGQYSEQRAANIFKDV 206
            + V  E     +V E    G             +++   + V  GQ +  +   I   +
Sbjct: 72  FYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQI 131

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-------GQTLSGLAGS 259
              + Y   +  VHRD+   N L+     +K+ DFG++  I +       G+T+  +   
Sbjct: 132 ASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWM 191

Query: 260 PAYVAPE-VLSGNYSEKVDIWSAGVLL 285
           P    PE +L   ++ + DIWS GV+L
Sbjct: 192 P----PESILYRKFTTESDIWSFGVVL 214

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 50.3 bits (120), Expect = 2e-06
 Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 6/109 (5%)

Query: 244 AMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEA 302
           A  +   + L    G+P Y+APE+L G  +   VD W+ GV L   L    PF  ++ + 
Sbjct: 532 AAPVEGERIL----GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQ 587

Query: 303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           VF  I N  + +  G  E +S  A++ +  +LT D + R    E+ +HP
Sbjct: 588 VFQNILNRDIPWPEGE-EKLSVNAQNAIEILLTMDPTKRAGLKELKQHP 635

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|165211 PHA02882, PHA02882, putative serine/threonine kinase; Provisional

 Score = 49.6 bits (118), Expect = 2e-06
 Identities = 20/59 (33%), Positives = 38/59 (64%), Gaps = 1/59 (1%)

Query: 194 YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQ 251
            +++   NI KD++  ++Y H+ G+ H DIKPENI++  + +  + D+G+A   I +G+
Sbjct: 123 KNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGK 181

Length = 294

>gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

 Score = 47.4 bits (113), Expect = 2e-06
 Identities = 31/145 (21%), Positives = 59/145 (40%), Gaps = 15/145 (10%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--ETVHREVEIMQHLSGHTGVV-TLHS 164
           ++++  G    V+L  +K    ++  K     E      REV I+Q L+     V  + +
Sbjct: 3   IKLLKGGLTNRVYLLGTK--DEDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLA 60

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM---GVVHR 221
             E     +L+ME   G  L        + SE+   +I + +  ++   H +    + H 
Sbjct: 61  SGESDGWSYLLMEWIEGETL-------DEVSEEEKEDIAEQLAELLAKLHQLPLLVLCHG 113

Query: 222 DIKPENILLTTSGKIKLADFGLAMR 246
           D+ P NIL+     + + D+  A  
Sbjct: 114 DLHPGNILVDDGKILGIIDWEYAGY 138

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 32/91 (35%), Positives = 51/91 (56%), Gaps = 5/91 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPA-YVAPE-VLSGNYSE 274
           +HRD+   NILLT     K+ DFGLA  I N     + G A  P  ++APE + +  Y+ 
Sbjct: 236 IHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTF 295

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
           + D+WS G+LL  +  + + P+ G  +++ F
Sbjct: 296 ESDVWSYGILLWEIFSLGSSPYPGMPVDSKF 326

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.5 bits (118), Expect = 2e-06
 Identities = 28/71 (39%), Positives = 40/71 (56%), Gaps = 4/71 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPA-YVAPE-VLSGNYSE 274
           +HRD+   N+LLT     K+ DFGLA  I N     + G A  P  ++APE +    Y+ 
Sbjct: 234 IHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTV 293

Query: 275 KVDIWSAGVLL 285
           + D+WS G+LL
Sbjct: 294 QSDVWSYGILL 304

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 49.2 bits (117), Expect = 2e-06
 Identities = 32/91 (35%), Positives = 48/91 (52%), Gaps = 5/91 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AYVAPE-VLSGNYSE 274
           +HRD+   NILL+ +  +K+ DFGLA  I         G A  P  ++APE +    Y+ 
Sbjct: 196 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTT 255

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
           + D+WS GVLL  +  + A P+ G  +   F
Sbjct: 256 QSDVWSFGVLLWEIFSLGASPYPGVQINEEF 286

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 48.3 bits (115), Expect = 4e-06
 Identities = 31/84 (36%), Positives = 46/84 (54%), Gaps = 5/84 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AYVAPE-VLSGNYSE 274
           +HRD+   NILL+ +  +K+ DFGLA  I         G A  P  ++APE +    Y+ 
Sbjct: 195 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTT 254

Query: 275 KVDIWSAGVLLHALL-VAALPFKG 297
           + D+WS GVLL  +  + A P+ G
Sbjct: 255 QSDVWSFGVLLWEIFSLGASPYPG 278

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 48.1 bits (114), Expect = 4e-06
 Identities = 57/232 (24%), Positives = 102/232 (43%), Gaps = 30/232 (12%)

Query: 108 VEVIGHGKFGSVWLCR--SKASGAE---FACKTLRKGEETVHREV----EIMQHLSGHTG 158
           +E +G  +FG V+       A G +    A KTL+   E   RE      +M+    H  
Sbjct: 10  MEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPN 69

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMV------EVGQYSEQRAA----------NI 202
           +V L  V  +     ++   CS   L + +V      +VG   + +            +I
Sbjct: 70  IVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHI 129

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSP 260
              +   +++     VVH+D+   N+L+     +K++D GL   +  ++   L G +  P
Sbjct: 130 VTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLP 189

Query: 261 A-YVAPE-VLSGNYSEKVDIWSAGVLLHALLVAAL-PFKGDSLEAVFDAIKN 309
             +++PE ++ G +S   DIWS GV+L  +    L P+ G S + V + I+N
Sbjct: 190 IRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRN 241

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 47.6 bits (113), Expect = 6e-06
 Identities = 55/216 (25%), Positives = 96/216 (44%), Gaps = 43/216 (19%)

Query: 109 EVIGHGKFGSVWLCRSKASGAE------------------FACKTLRKGEETVHR----- 145
           E +G G+FG V LC  +A G E                   A K LR+      R     
Sbjct: 11  EKLGEGQFGEVHLC--EAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLK 68

Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA-ANI-- 202
           E++IM  L     ++ L +V   +D   ++ E    G L +Q +   +  E    A++  
Sbjct: 69  EIKIMSRLK-DPNIIRLLAVCITSDPLCMITEYMENGDL-NQFLSRHEPQEAAEKADVVT 126

Query: 203 --FKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-- 251
             +  ++++       +KY   +  VHRD+   N L+  +  IK+ADFG++  + +G   
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY 186

Query: 252 TLSGLAGSPA-YVAPE-VLSGNYSEKVDIWSAGVLL 285
            + G A  P  +++ E +L G ++   D+W+ GV L
Sbjct: 187 RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTL 222

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 47.7 bits (113), Expect = 8e-06
 Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 5/91 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-YVAPEVLSGN-YSE 274
           VHRD+   N+LL     +K+ DFGLA  I   +     G    P  ++APE +  N Y+ 
Sbjct: 259 VHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTT 318

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
             D+WS G+LL  +  +   P+ G  +++ F
Sbjct: 319 LSDVWSYGILLWEIFSLGGTPYPGMIVDSTF 349

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 59/213 (27%), Positives = 92/213 (43%), Gaps = 39/213 (18%)

Query: 109 EVIGHGKFGSVW---LCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTG 158
            VIG G FG V+   L  S       A K+L +  +    EVE       IM+  S H  
Sbjct: 1   RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDL--EEVEQFLKEGIIMKDFS-HPN 57

Query: 159 VVTLHSVYEEADCFHLVM--ELCSGGRLIDQMVEVGQY--SEQRAANIFKDVMWV----- 209
           V++L  +   ++   LV+   +  G        ++  +  SE     + KD++       
Sbjct: 58  VLSLLGICLPSEGSPLVVLPYMKHG--------DLRNFIRSETHNPTV-KDLIGFGLQVA 108

Query: 210 --IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-----GLAGSPAY 262
             ++Y      VHRD+   N +L  S  +K+ADFGLA  I + +  S     G      +
Sbjct: 109 KGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKW 168

Query: 263 VAPEVL-SGNYSEKVDIWSAGVLLHALLVAALP 294
           +A E L +  ++ K D+WS GVLL  L+    P
Sbjct: 169 MALESLQTQKFTTKSDVWSFGVLLWELMTRGAP 201

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 47.0 bits (111), Expect = 9e-06
 Identities = 53/218 (24%), Positives = 90/218 (41%), Gaps = 31/218 (14%)

Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIMQH 152
           E +  +V+V+G G FG+V    W+   +      A K L      K       E  IM  
Sbjct: 6   ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMAS 65

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM--WVI 210
           +  H  +V L  V   +    LV +L   G L+        Y  +   NI   ++  W +
Sbjct: 66  MD-HPHLVRLLGVCL-SPTIQLVTQLMPHGCLL-------DYVHEHKDNIGSQLLLNWCV 116

Query: 211 K------YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---A 261
           +      Y  +  +VHRD+   N+L+ +   +K+ DFGLA  +   +      G      
Sbjct: 117 QIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIK 176

Query: 262 YVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKG 297
           ++A E +    ++ + D+WS GV +  L+     P+ G
Sbjct: 177 WMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 47.3 bits (112), Expect = 1e-05
 Identities = 30/75 (40%), Positives = 41/75 (54%), Gaps = 12/75 (16%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLA---MR----ISNGQTLSGLAGSPAYVAPEVLSGN 271
           VHRD+   N+L+     +K+ DFGLA   MR    IS G T   L     ++APE +  N
Sbjct: 261 VHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPL----KWMAPESIFNN 316

Query: 272 -YSEKVDIWSAGVLL 285
            Y+   D+WS G+LL
Sbjct: 317 LYTTLSDVWSFGILL 331

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 46.5 bits (110), Expect = 1e-05
 Identities = 48/204 (23%), Positives = 88/204 (43%), Gaps = 30/204 (14%)

Query: 111 IGHGKFGSVWL--CRSKASGAE---FACKTLR----KGEETVHREVEIMQHLSGHTGVVT 161
           +G G FG V+L  C + +   +    A K L+       +   RE E++ +L  H  +V 
Sbjct: 13  LGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVK 71

Query: 162 LHSVYEEADCFHLVMELCSGGRL--------IDQMVEV--------GQYSEQRAANIFKD 205
            + V  + D   +V E    G L         D M+ V        G+    +  +I   
Sbjct: 72  FYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQ 131

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-Y 262
           +   + Y      VHRD+   N L+  +  +K+ DFG++  +  ++   + G    P  +
Sbjct: 132 IASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRW 191

Query: 263 VAPE-VLSGNYSEKVDIWSAGVLL 285
           + PE ++   ++ + D+WS GV+L
Sbjct: 192 MPPESIMYRKFTTESDVWSFGVIL 215

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 46.6 bits (110), Expect = 1e-05
 Identities = 32/91 (35%), Positives = 49/91 (53%), Gaps = 5/91 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AYVAPE-VLSGNYSE 274
           +HRD+   NILL+ +  +K+ DFGLA  I         G A  P  ++APE +    Y+ 
Sbjct: 201 IHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTI 260

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
           + D+WS GVLL  +  + A P+ G  ++  F
Sbjct: 261 QSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 291

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 46.0 bits (109), Expect = 2e-05
 Identities = 59/234 (25%), Positives = 97/234 (41%), Gaps = 36/234 (15%)

Query: 111 IGHGKFGSVWL--CRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH 163
           IG+G FG V L       S A    K LR       +    +EV+  + L+ H  V+   
Sbjct: 3   IGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCL 61

Query: 164 SVYEEADCFHLVMELCSGGRLIDQM----VEVGQYSEQR-----AANIFKDVMWVIKYCH 214
               E+  + LV+E C  G L + +      V Q +++      A  +   ++W+    H
Sbjct: 62  GQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL----H 117

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEV---- 267
               +H D+   N  LT    +K+ D+GLA+         T    A    ++APE+    
Sbjct: 118 QADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIR 177

Query: 268 ----LSGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAI---KNVKLD 313
               L  + ++K +IWS GV +  L   A  P+   S E V   +   +++KL 
Sbjct: 178 GQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLP 231

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 31/117 (26%), Positives = 55/117 (47%), Gaps = 5/117 (4%)

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG- 255
           Q       D+   ++Y      +HRD+   N +L  +  + +ADFGL+ +I NG      
Sbjct: 112 QMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQG 171

Query: 256 -LAGSPA-YVAPEVLSGN-YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIK 308
            +A  P  ++A E L+   Y+ K D+WS GV +  +      P+ G     ++D ++
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLR 228

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 45.6 bits (108), Expect = 2e-05
 Identities = 65/290 (22%), Positives = 104/290 (35%), Gaps = 47/290 (16%)

Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKA--SGAEF---ACKTLRKGEET-----VHREV 147
           +N IE     V  IG G FG V+  R+        F   A K L++           RE 
Sbjct: 4   RNNIE----YVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREA 59

Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVME------------------LCSGGRLIDQMV 189
            +M     H  +V L  V        L+ E                   CS         
Sbjct: 60  ALMAEFD-HPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSAR 118

Query: 190 EVGQ----YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM 245
           + G      S      I K V   + Y  +   VHRD+   N L+  +  +K+ADFGL+ 
Sbjct: 119 KCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSR 178

Query: 246 RISNGQTLSGLAGSPA----YVAPE-VLSGNYSEKVDIWSAGVLLHALLVAAL-PFKGDS 299
            I +       + + A    ++ PE +    Y+ + D+W+ GV+L  +    + P+ G +
Sbjct: 179 NIYS-ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237

Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
            E V   I  V+        +       +LM    ++  S R +   + R
Sbjct: 238 HEEV---IYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSFASINR 284

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 39/144 (27%), Positives = 67/144 (46%), Gaps = 14/144 (9%)

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPA-YVAPE 266
           +KY   +  VHRD+   N L+  +  IK+ADFG++  +  G    + G A  P  ++A E
Sbjct: 151 MKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWE 210

Query: 267 -VLSGNYSEKVDIWSAGVLLHALLV--AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
            +L G ++   D+W+ GV L  +L+     P+   + E V +       D    V+  + 
Sbjct: 211 CILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY--LF 268

Query: 324 KPA------RDLMARMLTRDVSAR 341
           +P        +LM +  +RD   R
Sbjct: 269 RPPPCPQGLYELMLQCWSRDCRER 292

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.6 bits (105), Expect = 5e-05
 Identities = 56/219 (25%), Positives = 94/219 (42%), Gaps = 26/219 (11%)

Query: 111 IGHGKFGSVW--LCRSKASG---AEFACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +G G FG V+    R    G      A KT+ +      R     E  +M+  + H  VV
Sbjct: 14  LGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHH-VV 72

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ---RAANIFKDVMWV-------I 210
            L  V  +     +VMEL + G L   +  +   +E    R     ++++ +       +
Sbjct: 73  RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-YVAPEV 267
            Y +    VHRD+   N ++     +K+ DFG+   I  ++     G    P  ++APE 
Sbjct: 133 AYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPES 192

Query: 268 LS-GNYSEKVDIWSAGVLLHAL-LVAALPFKGDSLEAVF 304
           L  G ++   D+WS GV+L  +  +A  P++G S E V 
Sbjct: 193 LKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVL 231

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 44.3 bits (104), Expect = 6e-05
 Identities = 53/219 (24%), Positives = 90/219 (41%), Gaps = 26/219 (11%)

Query: 111 IGHGKFGSVWLCRSKA-----SGAEFACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +G G FG V+   +K           A KT+ +      R     E  +M+  + H  VV
Sbjct: 14  LGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH-VV 72

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK--------- 211
            L  V  +     ++MEL + G L   +  +    E         +  +I+         
Sbjct: 73  RLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGM 132

Query: 212 -YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPA-YVAPEV 267
            Y +    VHRD+   N ++     +K+ DFG+   I  ++     G    P  +++PE 
Sbjct: 133 AYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPES 192

Query: 268 LS-GNYSEKVDIWSAGVLLHAL-LVAALPFKGDSLEAVF 304
           L  G ++   D+WS GV+L  +  +A  P++G S E V 
Sbjct: 193 LKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVL 231

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 44.2 bits (104), Expect = 9e-05
 Identities = 40/162 (24%), Positives = 70/162 (43%), Gaps = 15/162 (9%)

Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLV---MELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           ++ H   H  ++T  +V+       ++   M   S   L+      G  SE    NI   
Sbjct: 51  VLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGM-SEALIGNILFG 109

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG-LAMRISNGQTLSGLAGSPAY-- 262
            +  + Y H  G +HR+IK  +IL++  G + L+    L   + NGQ    +   P +  
Sbjct: 110 ALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFST 169

Query: 263 -----VAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFK 296
                ++PE+L  +   Y+ K DI+S G+    L    +PF+
Sbjct: 170 SVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQ 211

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 43.5 bits (102), Expect = 1e-04
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 5/99 (5%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS--PA-YVAPE-VLSGNYSE 274
           VH+D+   NIL+     +K++D GL+  I +         S  P  ++ PE ++ G +S 
Sbjct: 146 VHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205

Query: 275 KVDIWSAGVLLHALLVAAL-PFKGDSLEAVFDAIKNVKL 312
             DIWS GV+L  +    L P+ G S + V + ++  +L
Sbjct: 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQL 244

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|223554 COG0478, COG0478, RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

 Score = 43.5 bits (103), Expect = 1e-04
 Identities = 27/103 (26%), Positives = 41/103 (39%), Gaps = 20/103 (19%)

Query: 145 REVEIMQHLSGHTGVV------TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           RE E +Q L      V        H+V         VME   G  L    ++V    E  
Sbjct: 158 REFEALQRLYPEGVKVPKPIAWNRHAV---------VMEYIEGVELYRLRLDVENPDE-- 206

Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF 241
              I   ++  ++  +  G+VH D+   NIL+T  G I + D+
Sbjct: 207 ---ILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIVVIDW 246

Length = 304

>gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional

 Score = 42.6 bits (101), Expect = 2e-04
 Identities = 32/110 (29%), Positives = 51/110 (46%), Gaps = 10/110 (9%)

Query: 136 LRKGEETVHREVEIMQHLSGHT-GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY 194
           +R+ E T  RE  IM        GV      + + + F +VME   G  L D +   G  
Sbjct: 41  IRR-ERTR-REARIMSRA--RKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM- 95

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA 244
                  + +++  ++   H  G++H D+   N++L+  GKI L DFGLA
Sbjct: 96  ---EELELSREIGRLVGKLHSAGIIHGDLTTSNMILSG-GKIYLIDFGLA 141

Length = 211

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 42.5 bits (100), Expect = 2e-04
 Identities = 63/285 (22%), Positives = 109/285 (38%), Gaps = 64/285 (22%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHREVE-------IMQHLSGHTG 158
           +++G G+FGSV   +           A KT+ K +   + E+E        M+    H  
Sbjct: 5   KILGEGEFGSVMEGQLSQDDGSQLKVAVKTM-KLDIHTYSEIEEFLSEAACMKDFD-HPN 62

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMV-----------------EVGQYSE----Q 197
           V+ L  V     CF    E  S  ++   MV                  +G   E    Q
Sbjct: 63  VMKLIGV-----CF----EASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQ 113

Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----QTL 253
                  D+   ++Y  +   +HRD+   N +L     + +ADFGL+ +I +G    Q  
Sbjct: 114 TLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGR 173

Query: 254 SGLAGSPA-YVAPEVLSGN-YSEKVDIWSAGVLLHALLVAAL-PFKGDSLEAVFDAIKN- 309
             +A  P  ++A E L+   Y+ K D+W+ GV +  +      P+ G     ++D +++ 
Sbjct: 174 --IAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHG 231

Query: 310 VKL----DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
            +L    D    ++        DLM      D   R T  ++   
Sbjct: 232 NRLKQPEDCLDELY--------DLMYSCWRADPKDRPTFTKLREV 268

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 42.3 bits (99), Expect = 4e-04
 Identities = 68/307 (22%), Positives = 123/307 (40%), Gaps = 58/307 (18%)

Query: 42  KRCKEDAGTQPIGSFKSRLAGIAT-APPCGASSSLVPAGRGLKRKIGC------------ 88
           KR +E A +   G  KS      T       ++++  A    K+K+              
Sbjct: 57  KRDRETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHF 116

Query: 89  -------IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSV---WLCRSKASGAEFACKTLRK 138
                  IDV TQ   + KI      + ++G G FG V   W  + K   A    + + K
Sbjct: 117 YVVLGEDIDVSTQ---RFKI------LSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK 167

Query: 139 GEETVHREVEIMQ--HLSGHTGVVTLHSV--YEEADCFHLVMELCSGGR-LIDQMVEVGQ 193
                  E++ M+    +       L  +  Y + +  H+ + +   G  L+D +++ G 
Sbjct: 168 YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGP 227

Query: 194 YSEQRAANIFKDVMWVIKYCH-DMGVVHRDIKPENILLTTSG----------------KI 236
           +S +  A I       + Y H ++ ++H D+KPENIL+ TS                 ++
Sbjct: 228 FSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRV 287

Query: 237 KLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPF 295
           ++ D G      + +T   +  +  Y +PEV+ G  +    D+WS G +++ L    L +
Sbjct: 288 RICDLGGCCDERHSRT--AIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLY 345

Query: 296 KG-DSLE 301
              D+LE
Sbjct: 346 DTHDNLE 352

Length = 467

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 40.7 bits (95), Expect = 0.001
 Identities = 50/206 (24%), Positives = 84/206 (40%), Gaps = 32/206 (15%)

Query: 111 IGHGKFGSVWL--CRSKASGAEFACKTLRKG---EETVH--REVEIMQHLSGHTGVVTLH 163
           IG+G FG V L    S  + A+   K LR     +E +    E +  + L  H+ ++   
Sbjct: 3   IGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCL 61

Query: 164 SVYEEADCFHLVMELCSGG---------RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
               E   + LVME C  G         R  + M       ++ A  I   ++    + H
Sbjct: 62  GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLL----HLH 117

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLA---MRISNGQTLSGLAGSPAYVAPEVLS-- 269
               +H D+   N LLT    +K+ D+GL+    +     T   L     ++APE++   
Sbjct: 118 KNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEV 177

Query: 270 -GNY-----SEKVDIWSAGVLLHALL 289
            GN      +++ ++WS GV +  L 
Sbjct: 178 HGNLLVVDQTKESNVWSLGVTIWELF 203

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain

 Score = 39.3 bits (92), Expect = 0.001
 Identities = 26/72 (36%), Positives = 37/72 (51%), Gaps = 7/72 (9%)

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVD 277
           +HR  K  NILLT  G +KL            +        P ++APEV+ G +Y+EK D
Sbjct: 33  LHRQAKSGNILLTWDGLLKLDGSVAFKTPEQSR------PDPYFMAPEVIQGQSYTEKAD 86

Query: 278 IWSAGVLLHALL 289
           I+S G+ L+  L
Sbjct: 87  IYSLGITLYEAL 98

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 39.9 bits (93), Expect = 0.001
 Identities = 24/85 (28%), Positives = 43/85 (50%), Gaps = 4/85 (4%)

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---A 261
           D+   ++Y      +HRD+   N +L  +  + +ADFGL+ +I +G        S     
Sbjct: 121 DIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVK 180

Query: 262 YVAPEVLSGN-YSEKVDIWSAGVLL 285
           ++A E L+ N Y+   D+W+ GV +
Sbjct: 181 WLALESLADNVYTTHSDVWAFGVTM 205

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

 Score = 40.1 bits (94), Expect = 0.002
 Identities = 27/91 (29%), Positives = 44/91 (48%), Gaps = 5/91 (5%)

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSP-AYVAPE 266
           + Y H  GV+H+DI   N ++    ++K+ D  L+  +   +   L      P  ++A E
Sbjct: 130 MSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALE 189

Query: 267 VLSGN-YSEKVDIWSAGVLLHALL-VAALPF 295
            L    YS   D+WS GVLL  L+ +   P+
Sbjct: 190 SLVNKEYSSASDVWSFGVLLWELMTLGQTPY 220

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	469
KOG0615	475	consensus Serine/threonine protein kinase Chk2 and	100.0
KOG0598	357	consensus Ribosomal protein S6 kinase and related	100.0
KOG0575	592	consensus Polo-like serine/threonine protein kinas	100.0
KOG0616	355	consensus cAMP-dependent protein kinase catalytic	100.0
KOG0592	604	consensus 3-phosphoinositide-dependent protein kin	100.0
KOG0581	364	consensus Mitogen-activated protein kinase kinase	100.0
KOG0033	355	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0605	550	consensus NDR and related serine/threonine kinases	100.0
KOG0694	694	consensus Serine/threonine protein kinase [Signal	100.0
KOG0588	786	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0583	370	consensus Serine/threonine protein kinase [Signal	100.0
KOG0595	429	consensus Serine/threonine-protein kinase involved	100.0
KOG0593	396	consensus Predicted protein kinase KKIAMRE [Genera	100.0
KOG0032	382	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0599	411	consensus Phosphorylase kinase gamma subunit [Carb	100.0
KOG0604	400	consensus MAP kinase-activated protein kinase 2 [S	100.0
KOG0661	538	consensus MAPK related serine/threonine protein ki	100.0
KOG0607	463	consensus MAP kinase-interacting kinase and relate	100.0
KOG0610	459	consensus Putative serine/threonine protein kinase	100.0
KOG0600	560	consensus Cdc2-related protein kinase [Cell cycle	100.0
KOG0659	318	consensus Cdk activating kinase (CAK)/RNA polymera	100.0
KOG0580	281	consensus Serine/threonine protein kinase [Cell cy	100.0
KOG0690	516	consensus Serine/threonine protein kinase [Signal	100.0
KOG0585	576	consensus Ca2+/calmodulin-dependent protein kinase	100.0
KOG0663	419	consensus Protein kinase PITSLRE and related kinas	100.0
KOG0198	313	consensus MEKK and related serine/threonine protei	100.0
KOG0578	550	consensus p21-activated serine/threonine protein k	100.0
KOG0597	808	consensus Serine-threonine protein kinase FUSED [G	100.0
KOG0582	516	consensus Ste20-like serine/threonine protein kina	100.0
KOG0611	668	consensus Predicted serine/threonine protein kinas	100.0
KOG0201	467	consensus Serine/threonine protein kinase [Signal	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0591	375	consensus NIMA (never in mitosis)-related G2-speci	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
KOG0660	359	consensus Mitogen-activated protein kinase [Signal	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0594	323	consensus Protein kinase PCTAIRE and related kinas	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
KOG0658	364	consensus Glycogen synthase kinase-3 [Carbohydrate	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG4717	864	consensus Serine/threonine protein kinase [Signal	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
KOG0574	502	consensus STE20-like serine/threonine kinase MST [	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
KOG0192	362	consensus Tyrosine kinase specific for activated (	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0612	1317	consensus Rho-associated, coiled-coil containing p	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
KOG0577	948	consensus Serine/threonine protein kinase [Signal	100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
KOG0589	426	consensus Serine/threonine protein kinase [General	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
KOG0986	591	consensus G protein-coupled receptor kinase [Signa	100.0
KOG0667	586	consensus Dual-specificity tyrosine-phosphorylatio	100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
KOG0696	683	consensus Serine/threonine protein kinase [Signal	100.0
KOG0579	1187	consensus Ste20-like serine/threonine protein kina	100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
KOG4236	888	consensus Serine/threonine protein kinase PKC mu/P	100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
KOG0586	596	consensus Serine/threonine protein kinase [General	100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
KOG0695	593	consensus Serine/threonine protein kinase [Signal	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
KOG0614	732	consensus cGMP-dependent protein kinase [Signal tr	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
KOG0197	468	consensus Tyrosine kinases [Signal transduction me	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
KOG0662	292	consensus Cyclin-dependent kinase CDK5 [Intracellu	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
KOG4279	1226	consensus Serine/threonine protein kinase [Signal	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
KOG0608	1034	consensus Warts/lats-like serine threonine kinases	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
KOG0983	391	consensus Mitogen-activated protein kinase (MAPK)	100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
KOG4721	904	consensus Serine/threonine protein kinase, contain	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
KOG0666	438	consensus Cyclin C-dependent kinase CDK8 [Transcri	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
KOG1989	738	consensus ARK protein kinase family [Signal transd	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	100.0
KOG0584	632	consensus Serine/threonine protein kinase [General	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
KOG0596	677	consensus Dual specificity; serine/threonine and t	100.0
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
KOG0587	953	consensus Traf2- and Nck-interacting kinase and re	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
KOG4645	1509	consensus MAPKKK (MAP kinase kinase kinase) SSK2 a	100.0
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	100.0
KOG0669	376	consensus Cyclin T-dependent kinase CDK9 [Cell cyc	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	100.0
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	100.0
KOG0193	678	consensus Serine/threonine protein kinase RAF [Sig	100.0
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	100.0
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	100.0
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	100.0
KOG0671	415	consensus LAMMER dual specificity kinases [Signal	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
KOG2345	302	consensus Serine/threonine protein kinase/TGF-beta	100.0
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	100.0
KOG0668	338	consensus Casein kinase II, alpha subunit [Signal	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	100.0
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	100.0
KOG1151	775	consensus Tousled-like protein kinase [Signal tran	100.0
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	100.0
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	100.0
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
KOG1026	774	consensus Nerve growth factor receptor TRKA and re	100.0
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	100.0
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	100.0
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	100.0
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
KOG1187	361	consensus Serine/threonine protein kinase [Signal	100.0
KOG0194	474	consensus Protein tyrosine kinase [Signal transduc	100.0
PHA02882	294	putative serine/threonine kinase; Provisional	100.0
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	100.0
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	100.0
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	100.0
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	100.0
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	100.0
KOG1006	361	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG4250	732	consensus TANK binding protein kinase TBK1 [Signal	100.0
KOG1095	1025	consensus Protein tyrosine kinase [Signal transduc	100.0
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	100.0
KOG0670	752	consensus U4/U6-associated splicing factor PRP4 [R	100.0
PLN03224	507	probable serine/threonine protein kinase; Provisio	100.0
KOG0199	1039	consensus ACK and related non-receptor tyrosine ki	100.0
KOG0576	829	consensus Mitogen-activated protein kinase kinase	100.0
KOG0665	369	consensus Jun-N-terminal kinase (JNK) [Signal tran	100.0
KOG1094	807	consensus Discoidin domain receptor DDR1 [Signal t	100.0
KOG0664	449	consensus Nemo-like MAPK-related serine/threonine	100.0
KOG4257	974	consensus Focal adhesion tyrosine kinase FAK, cont	100.0
KOG4278	1157	consensus Protein tyrosine kinase [Signal transduc	100.0
KOG1027	903	consensus Serine/threonine protein kinase and endo	100.0
KOG0196	996	consensus Tyrosine kinase, EPH (ephrin) receptor f	100.0
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	100.0
KOG1290	590	consensus Serine/threonine protein kinase [Signal	100.0
KOG2052	513	consensus Activin A type IB receptor, serine/threo	100.0
KOG0984	282	consensus Mitogen-activated protein kinase (MAPK)	100.0
KOG1152	772	consensus Signal transduction serine/threonine kin	100.0
KOG0200	609	consensus Fibroblast/platelet-derived growth facto	100.0
KOG1167	418	consensus Serine/threonine protein kinase of the C	100.0
KOG3653	534	consensus Transforming growth factor beta/activin	100.0
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	100.0
KOG1025	1177	consensus Epidermal growth factor receptor EGFR an	100.0
KOG1345	378	consensus Serine/threonine kinase [Signal transduc	99.98
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.98
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.96
KOG0603	612	consensus Ribosomal protein S6 kinase [Signal tran	99.96
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.96
KOG1024	563	consensus Receptor-like protein tyrosine kinase RY	99.95
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.95
PRK09188	365	serine/threonine protein kinase; Provisional	99.95
KOG1164	322	consensus Casein kinase (serine/threonine/tyrosine	99.95
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.94
KOG1165	449	consensus Casein kinase (serine/threonine/tyrosine	99.93
KOG1163	341	consensus Casein kinase (serine/threonine/tyrosine	99.93
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.92
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.91
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.91
KOG4158	598	consensus BRPK/PTEN-induced protein kinase [Signal	99.9
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.9
PRK12274	218	serine/threonine protein kinase; Provisional	99.9
KOG1240	1431	consensus Protein kinase containing WD40 repeats [	99.88
PRK10345	210	hypothetical protein; Provisional	99.87
smart00090	237	RIO RIO-like kinase.	99.85
KOG0195	448	consensus Integrin-linked kinase [Signal transduct	99.83
PRK14879	211	serine/threonine protein kinase; Provisional	99.83
KOG1166	974	consensus Mitotic checkpoint serine/threonine prot	99.83
KOG0590	601	consensus Checkpoint kinase and related serine/thr	99.82
KOG1033	516	consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati	99.81
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.8
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.8
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.79
KOG1023	484	consensus Natriuretic peptide receptor, guanylate	99.76
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.75
KOG0606	1205	consensus Microtubule-associated serine/threonine	99.73
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.72
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.7
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.69
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	99.59
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	99.58
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.56
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	99.55
KOG0601	524	consensus Cyclin-dependent kinase WEE1 [Cell cycle	99.48
KOG1266	458	consensus Protein kinase [Signal transduction mech	99.44
KOG1243	690	consensus Protein kinase [General function predict	99.41
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	99.37
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	99.32
KOG3087	229	consensus Serine/threonine protein kinase [General	99.3
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	99.18
KOG3741	655	consensus Poly(A) ribonuclease subunit [RNA proces	99.14
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	99.13
COG0478	304	RIO-like serine/threonine protein kinase fused to	99.08
KOG2137	700	consensus Protein kinase [Signal transduction mech	99.01
COG4248	637	Uncharacterized protein with protein kinase and he	98.98
KOG0576	829	consensus Mitogen-activated protein kinase kinase	98.97
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.87
COG0661	517	AarF Predicted unusual protein kinase [General fun	98.84
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.77
PRK09902	216	hypothetical protein; Provisional	98.73
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	98.71
PF01636	239	APH: Phosphotransferase enzyme family This family	98.66
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	98.63
KOG1035	1351	consensus eIF-2alpha kinase GCN2 [Translation, rib	98.63
COG2112	201	Predicted Ser/Thr protein kinase [Signal transduct	98.61
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	98.5
KOG1235	538	consensus Predicted unusual protein kinase [Genera	98.48
PF13095	207	FTA2: Kinetochore Sim4 complex subunit FTA2	98.43
PLN02876	822	acyl-CoA dehydrogenase	98.36
cd05157	235	ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes.	98.22
cd05155	235	APH_ChoK_like_1 Uncharacterized bacterial proteins	98.21
PRK09550	401	mtnK methylthioribose kinase; Reviewed	98.2
PRK10593	297	hypothetical protein; Provisional	98.18
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	98.13
KOG2268	465	consensus Serine/threonine protein kinase [Signal	98.11
TIGR02721	256	ycfN_thiK thiamine kinase. Members of this family	98.09
cd05153	296	HomoserineK_II Homoserine Kinase, type II. Homoser	98.04
cd05156	302	ChoK_euk Choline Kinase (ChoK) in eukaryotes. The	97.93
TIGR00938	307	thrB_alt homoserine kinase, Neisseria type. Homose	97.92
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.91
KOG1826	2724	consensus Ras GTPase activating protein RasGAP/neu	97.79
TIGR02906	313	spore_CotS spore coat protein, CotS family. Member	97.72
PRK05231	319	homoserine kinase; Provisional	97.67
TIGR01767	370	MTRK 5-methylthioribose kinase. This enzyme is inv	97.56
cd05152	276	MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH	97.54
KOG2270	520	consensus Serine/threonine protein kinase involved	97.53
PLN02236	344	choline kinase	97.46
PLN02421	330	phosphotransferase, alcohol group as acceptor/kina	97.43
TIGR02904	309	spore_ysxE spore coat protein YsxE. Members of thi	97.23
PRK12396	409	5-methylribose kinase; Reviewed	97.07
PLN02756	418	S-methyl-5-thioribose kinase	97.06
COG3173	321	Predicted aminoglycoside phosphotransferase [Gener	96.98
PF03881	288	Fructosamin_kin: Fructosamine kinase; InterPro: IP	96.94
KOG1093	725	consensus Predicted protein kinase (contains TBC a	96.93
PF01633	211	Choline_kinase: Choline/ethanolamine kinase; Inter	96.85
PTZ00384	383	choline kinase; Provisional	96.63
PRK11768	325	serine/threonine protein kinase; Provisional	96.4
PTZ00296	442	choline kinase; Provisional	96.15
KOG1236	565	consensus Predicted unusual protein kinase [Genera	96.12
COG5072	488	ALK1 Serine/threonine kinase of the haspin family	96.02
PRK06148	1013	hypothetical protein; Provisional	95.93
PF00036	29	EF-hand_1: EF hand; InterPro: IPR018248 Many calci	95.7
PF07387	308	Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099	95.4

>KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=7.6e-64  Score=483.80  Aligned_cols=261  Identities=36%  Similarity=0.602  Sum_probs=241.4

Q ss_pred             cCCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----------hHHHHHHHHHHHHhhCCCCeeEEE
Q 012170           95 MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----------EETVHREVEIMQHLSGHTGVVTLH  163 (469)
Q Consensus        95 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----------~~~~~~E~~il~~l~~hpnIv~l~  163 (469)
                      ......+.+.|.+.+.||+|+||.|-+|..+.||+.||||++.+.           ...+.+|++||++|. |||||+++
T Consensus       164 ~~~pks~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~-HP~IV~~~  242 (475)
T KOG0615|consen  164 KVPPKSFNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLS-HPNIVRIK  242 (475)
T ss_pred             cCccchhcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcC-CCCEEEEe
Confidence            334445788899999999999999999999999999999999652           134679999999997 99999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEe
Q 012170          164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLAD  240 (469)
Q Consensus       164 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~D  240 (469)
                      ++|+..+..||||||++||+|++.+..++.+.+...+.+++|++.|+.|||++||+||||||+|||++.+   ..+||+|
T Consensus       243 d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItD  322 (475)
T KOG0615|consen  243 DFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITD  322 (475)
T ss_pred             eeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999877   5799999


Q ss_pred             ccceeeecCCCcccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQTLSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEA-VFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~~~  315 (469)
                      ||+|+.......+.++||||.|.|||++.+.    |..++|+|||||+||.+|+|.+||.+..... +.++|..+.+.|.
T Consensus       323 FGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~  402 (475)
T KOG0615|consen  323 FGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFG  402 (475)
T ss_pred             cchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCccHHHHHhcCccccc
Confidence            9999999888889999999999999999653    5569999999999999999999999876655 8899999999999


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +..|..+|.++.+||.+||..||++|||+.|+|+||||...
T Consensus       403 p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~  443 (475)
T KOG0615|consen  403 PLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDA  443 (475)
T ss_pred             ChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcc
Confidence            99999999999999999999999999999999999999543

>KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-60  Score=456.25  Aligned_cols=267  Identities=34%  Similarity=0.628  Sum_probs=242.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|+++++||+|+||+||+++.++|++.||+|++++.       ......|..||..++ ||+||.++..|++.+.+||
T Consensus        24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~-hPFiv~l~ysFQt~~kLyl  102 (357)
T KOG0598|consen   24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIK-HPFIVKLIYSFQTEEKLYL  102 (357)
T ss_pred             hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCC-CCcEeeeEEecccCCeEEE
Confidence            47899999999999999999999999999999999753       356788999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee-ecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~-~~~~~~~  253 (469)
                      |+||+.||.|+.+|++.+.|+|..++.++.+|+.||.|||++|||||||||+|||+|.+|+|+|+||||++. ...+...
T Consensus       103 Vld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~~~t  182 (357)
T KOG0598|consen  103 VLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDGDAT  182 (357)
T ss_pred             EEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999984 4445566


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .++|||+.|||||++.+ .|+.++||||||+++|+|++|.+||.+.+...+++.|...+...+.   ..++.++++||++
T Consensus       183 ~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~~~k~~~~p---~~ls~~ardll~~  259 (357)
T KOG0598|consen  183 RTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKILKGKLPLPP---GYLSEEARDLLKK  259 (357)
T ss_pred             ccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHhcCcCCCCC---ccCCHHHHHHHHH
Confidence            77899999999999976 5999999999999999999999999999999999999998855443   3479999999999


Q ss_pred             hchhhhcCCC----CHHHHHcCCCccccccccchhchhhHHhhhhcCCCCCC
Q 012170          333 MLTRDVSARI----TADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHH  380 (469)
Q Consensus       333 ~L~~dP~~Rp----sa~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (469)
                      +|++||++|.    ++.+|.+||||..        ++|...++....++..+
T Consensus       260 LL~rdp~~RLg~~~d~~~ik~HpfF~~--------inW~~l~~k~l~PpF~P  303 (357)
T KOG0598|consen  260 LLKRDPRQRLGGPGDAEEIKRHPFFKG--------INWEKLLAKKLSPPFKP  303 (357)
T ss_pred             HhccCHHHhcCCCCChHHhhcCccccc--------CCHHHHHhcCCCCCeec
Confidence            9999999996    6899999999954        45666666666654443

>KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.7e-58  Score=465.51  Aligned_cols=246  Identities=32%  Similarity=0.583  Sum_probs=235.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+|...++||+|||+.||.+++..+|+.||+|++.+       ..+.+.+|++|.+.|. |||||+++.+|++.+++|||
T Consensus        18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~-HpnIV~f~~~FEDs~nVYiv   96 (592)
T KOG0575|consen   18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLK-HPNIVQFYHFFEDSNNVYIV   96 (592)
T ss_pred             ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcC-CCcEEeeeeEeecCCceEEE
Confidence            579999999999999999999999999999999965       2477899999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      +|+|..++|..++.+++.++|.+++.+++||+.||.|||+++|+|||||..|+|++++-+|||+|||||...... ....
T Consensus        97 LELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~Erk~  176 (592)
T KOG0575|consen   97 LELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGERKK  176 (592)
T ss_pred             EEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999988754 6778


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      +.||||.|+|||++.. .++..+||||+|||||.||+|.|||...+..+.+..|+...+.+|.    .+|.++++||.+|
T Consensus       177 TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~P~----~ls~~A~dLI~~l  252 (592)
T KOG0575|consen  177 TLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSMPS----HLSAEAKDLIRKL  252 (592)
T ss_pred             eecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccccc----ccCHHHHHHHHHH
Confidence            8999999999999976 4999999999999999999999999999999999999999999884    7899999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |+.||.+|||+++||.|+||
T Consensus       253 L~~~P~~Rpsl~~vL~h~Ff  272 (592)
T KOG0575|consen  253 LRPNPSERPSLDEVLDHPFF  272 (592)
T ss_pred             hcCCcccCCCHHHHhcCHhh
Confidence            99999999999999999999

>KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-57  Score=423.72  Aligned_cols=265  Identities=32%  Similarity=0.616  Sum_probs=242.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||.|+||+|.+++++.+|..||+|++++..       +...+|..+|+.+. ||+++++++.|.+.+.+||
T Consensus        43 l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~-~PFlv~l~~t~~d~~~lym  121 (355)
T KOG0616|consen   43 LQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVS-HPFLVKLYGTFKDNSNLYM  121 (355)
T ss_pred             hhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhcc-CceeEEEEEeeccCCeEEE
Confidence            478999999999999999999999999999999997643       56778999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||||++||.|+.++.+.++|++..++.++.||+.||+|||+++|++|||||+|||+|.+|.+||+|||+|+.....  +.
T Consensus       122 vmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r--T~  199 (355)
T KOG0616|consen  122 VMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR--TW  199 (355)
T ss_pred             EEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc--EE
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999987654  67


Q ss_pred             ccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      +.||||.|+|||++..+ |+.++|+|||||++|||+.|.+||.+.++..+++.|..+++.||    ..++++++|||+++
T Consensus       200 TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~~~v~fP----~~fs~~~kdLl~~L  275 (355)
T KOG0616|consen  200 TLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILEGKVKFP----SYFSSDAKDLLKKL  275 (355)
T ss_pred             EecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHhCcccCC----cccCHHHHHHHHHH
Confidence            78999999999999774 99999999999999999999999999999999999999999998    47899999999999


Q ss_pred             chhhhcCCC-----CHHHHHcCCCccccccccchhchhhHHhhhhcCCCCCCC
Q 012170          334 LTRDVSARI-----TADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP  381 (469)
Q Consensus       334 L~~dP~~Rp-----sa~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (469)
                      |+.|-.+|.     ...+|.+||||..        +.|...+...+.++..+|
T Consensus       276 L~vD~t~R~gnlknG~~dIk~H~wF~~--------v~W~~i~~r~ie~P~~pp  320 (355)
T KOG0616|consen  276 LQVDLTKRFGNLKNGVEDIKNHPWFKG--------VDWEAILQRKIEPPFEPP  320 (355)
T ss_pred             HhhhhHhhhcCcCCCccccccCccccc--------ccHHHHhhccccCCCCCc
Confidence            999999995     5789999999954        445555555555555443

>KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms]

Probab=100.00  E-value=7.8e-58  Score=455.27  Aligned_cols=259  Identities=34%  Similarity=0.601  Sum_probs=238.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .-..+|.+++.||+|+|++|++|+++.++..||||++.+.       ...+.+|-.+|.+|.+||.|++|+..|+|+..+
T Consensus        70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL  149 (604)
T KOG0592|consen   70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL  149 (604)
T ss_pred             CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence            3457999999999999999999999999999999999653       245788999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+|+||+++|+|+++|.+.|.|++..++.++.||+.||+|||++|||||||||+|||++.+++++|+|||.|+.+.....
T Consensus       150 YFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~  229 (604)
T KOG0592|consen  150 YFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQK  229 (604)
T ss_pred             EEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999987653221


Q ss_pred             --------------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          253 --------------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       253 --------------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                                    ..+++||..|.+||+|.+. .+..+|+|+||||+|.|+.|.+||.+.+.--+++.|....+.|+  
T Consensus       230 ~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp--  307 (604)
T KOG0592|consen  230 SQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFP--  307 (604)
T ss_pred             cccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCC--
Confidence                          1458999999999999875 68899999999999999999999999999999999999999998  


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccch
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR  362 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~  362 (469)
                        +.+++.++|||+++|..||.+|+|++||.+||||...++.++.
T Consensus       308 --~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~Vdw~nlw  350 (604)
T KOG0592|consen  308 --EGFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEGVDWENLW  350 (604)
T ss_pred             --CCCCHHHHHHHHHHHccCccccccHHHHhhCcccccCChhhhh
Confidence              4678999999999999999999999999999999777666543

>KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms]

Probab=100.00  E-value=2.7e-57  Score=435.44  Aligned_cols=258  Identities=29%  Similarity=0.516  Sum_probs=231.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-eEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-CFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-~~~l  174 (469)
                      ...+.+.++.||+|+.|+||+|+++.|++.+|+|++...     ..++.+|++|++.+. |||||.+|+.|..+. .++|
T Consensus        77 ~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~-spyIV~~ygaF~~~~~~isI  155 (364)
T KOG0581|consen   77 SLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQ-SPYIVGFYGAFYSNGEEISI  155 (364)
T ss_pred             CHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCC-CCCeeeEeEEEEeCCceEEe
Confidence            345777889999999999999999999999999999432     356889999999995 999999999999988 5999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+||+|.+.+...+.++|.....++.+|++||.|||+ ++||||||||+||||+..|+|||||||.+..+.+. ..
T Consensus       156 ~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-~a  234 (364)
T KOG0581|consen  156 CMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-IA  234 (364)
T ss_pred             ehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh-hc
Confidence            99999999999999988999999999999999999999995 99999999999999999999999999999887666 66


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCcC-CCCCCcccCCCHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-----SLEAVFDAIKNVKL-DFHSGVWETVSKPA  326 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~~~~~~s~~~  326 (469)
                      .+++||..|||||.+.+ .|+.++||||||++++||++|+.||...     +..+++..|....+ .++..   .+|+++
T Consensus       235 ~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~fS~ef  311 (364)
T KOG0581|consen  235 NTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG---EFSPEF  311 (364)
T ss_pred             ccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc---cCCHHH
Confidence            78999999999999988 5999999999999999999999999874     67788888887543 33322   479999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCccccccccchh
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWILFYTERTLRT  363 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~~  363 (469)
                      ++||..||++||.+|||+.|+|+|||+..+.......
T Consensus       312 ~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~~~~vd~  348 (364)
T KOG0581|consen  312 RSFVSCCLRKDPSERPSAKQLLQHPFIKKFEDPNVDM  348 (364)
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcCHHHhhcccccccH
Confidence            9999999999999999999999999998877655443

>KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-59  Score=422.13  Aligned_cols=275  Identities=39%  Similarity=0.710  Sum_probs=253.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.+.|++.+.||+|.|+.||+|.+..||+.||+|++..      +.+.+.+|+.|.+.|+ ||||++|.+.+...+..|
T Consensus         8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~Lq-HP~IvrL~~ti~~~~~~y   86 (355)
T KOG0033|consen    8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY   86 (355)
T ss_pred             ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcC-CCcEeehhhhhcccceeE
Confidence            477899999999999999999999999999999998842      4578999999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~DFgla~~~~~~  250 (469)
                      ||+|++.|++|..-|..+-.++|..+..+++||++||.|||.+||||||+||+|+|+-+..   -+||+|||+|....++
T Consensus        87 lvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g  166 (355)
T KOG0033|consen   87 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG  166 (355)
T ss_pred             EEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc
Confidence            9999999999999898888899999999999999999999999999999999999996543   5999999999999988


Q ss_pred             CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ....+++|||.|||||++.. .|+..+|||+.|+|||.||.|.+||.+.+...+++.|..+.++++...|..+++++++|
T Consensus       167 ~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~is~~Ak~L  246 (355)
T KOG0033|consen  167 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDTVTPEAKSL  246 (355)
T ss_pred             cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCcCCHHHHHH
Confidence            88889999999999999966 69999999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccccc-----------ccchhchhhHHhhhhcC
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFYTE-----------RTLRTLTIKSKLKNQVG  375 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~~~-----------~~~~~~~~~~~~~~~~~  375 (469)
                      |++||..||.+|+|+.|+|+|||+.....           ..++.+....+++..+.
T Consensus       247 vrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H~~dtvd~lrkfNarRKLKgavL  303 (355)
T KOG0033|consen  247 IRRMLTVNPKKRITADEALKHPWICNRERVASAIHRQDTVDCLKKFNARRKLKGAIL  303 (355)
T ss_pred             HHHHhccChhhhccHHHHhCCchhcchHHHHHHhhhHHHHHHHHHhhHHHHHHHHHH
Confidence            99999999999999999999999965432           24556666777776553

>KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only]

Probab=100.00  E-value=2.8e-56  Score=444.50  Aligned_cols=263  Identities=32%  Similarity=0.558  Sum_probs=234.8

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..-.++|+++..||+|+||.||+|+.+.||..||+|++++..       ..+..|-.||... ++|+||+||..|++.++
T Consensus       137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~-ds~~vVKLyYsFQD~~~  215 (550)
T KOG0605|consen  137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEV-DSPWVVKLYYSFQDKEY  215 (550)
T ss_pred             cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhc-CCCcEEEEEEEecCCCe
Confidence            335689999999999999999999999999999999998753       5677899999996 49999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      +||||||++||++..+|.+.+.|+++.++.++.+++.|+.-||+.|+|||||||+|+|||..|++||+||||+...... 
T Consensus       216 LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~  295 (550)
T KOG0605|consen  216 LYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKH  295 (550)
T ss_pred             eEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhh
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999998432110 


Q ss_pred             -----------------------C-----c-------------------ccccCCCCcccCceeccCC-CCCccchHHHH
Q 012170          251 -----------------------Q-----T-------------------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAG  282 (469)
Q Consensus       251 -----------------------~-----~-------------------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG  282 (469)
                                             .     .                   ....+|||.|||||++.+. |+..+|+||||
T Consensus       296 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG  375 (550)
T KOG0605|consen  296 RIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLG  375 (550)
T ss_pred             hhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHH
Confidence                                   0     0                   0124699999999999885 99999999999


Q ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC---HHHHHcCCCccccccc
Q 012170          283 VLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT---ADEVLRHPWILFYTER  359 (469)
Q Consensus       283 ~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~~~  359 (469)
                      |||||||.|.+||.+.++.+++.+|.+....+..+.-..++++++|||.+||. ||.+|+.   ++||.+||||....+.
T Consensus       376 ~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~v~W~  454 (550)
T KOG0605|consen  376 CIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKGVDWD  454 (550)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCccccCCcc
Confidence            99999999999999999999999999888554444446789999999999999 9999995   9999999999877776


Q ss_pred             cchh
Q 012170          360 TLRT  363 (469)
Q Consensus       360 ~~~~  363 (469)
                      .+..
T Consensus       455 ~l~~  458 (550)
T KOG0605|consen  455 HLRE  458 (550)
T ss_pred             hhhc
Confidence            6654

>KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-55  Score=449.49  Aligned_cols=269  Identities=33%  Similarity=0.594  Sum_probs=244.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .-.++|.++++||+|+||+|+++..+.+++.||||+++++.       +....|..|+..+..||+++.++.+|+..+++
T Consensus       365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l  444 (694)
T KOG0694|consen  365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL  444 (694)
T ss_pred             ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence            34689999999999999999999999999999999998753       56778999999998899999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~  251 (469)
                      |+||||+.||++ .++...+.|++..+..++.+|+.||+|||++||||||||.+|||+|.+|++||+|||+++..- .+.
T Consensus       445 ~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g~  523 (694)
T KOG0694|consen  445 FFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQGD  523 (694)
T ss_pred             EEEEEecCCCcE-EEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCCC
Confidence            999999999994 345566899999999999999999999999999999999999999999999999999998543 566


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .++++||||.|||||++.+ .|+.++|||||||+|||||.|..||.|++.+++++.|.+..+.+|    ..+|.++.+++
T Consensus       524 ~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP----~~ls~ea~~il  599 (694)
T KOG0694|consen  524 RTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSKEAIAIM  599 (694)
T ss_pred             ccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCC----CcccHHHHHHH
Confidence            7889999999999999987 599999999999999999999999999999999999999988887    46899999999


Q ss_pred             HHhchhhhcCCCC-----HHHHHcCCCccccccccchhchhhHHhhhhcCCCCCCC
Q 012170          331 ARMLTRDVSARIT-----ADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP  381 (469)
Q Consensus       331 ~~~L~~dP~~Rps-----a~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (469)
                      ++||.+||++|+.     +++|..||||        +.+.|...+.+.+.++..+.
T Consensus       600 ~~ll~k~p~kRLG~~e~d~~~i~~hpFF--------r~i~w~~L~~r~i~PPf~P~  647 (694)
T KOG0694|consen  600 RRLLRKNPEKRLGSGERDAEDIKKHPFF--------RSIDWDDLLNRRIKPPFVPT  647 (694)
T ss_pred             HHHhccCcccccCCCCCCchhhhhCCcc--------ccCCHHHHhhccCCCCCCcc
Confidence            9999999999995     5899999999        45567777777777666543

>KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=2.8e-55  Score=445.09  Aligned_cols=252  Identities=37%  Similarity=0.656  Sum_probs=239.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..-|.+++.||.|+.|.|.+|++..||+.+|||++.+.       ...+.+|+-||+-|. ||||+++|+++++...+|+
T Consensus        11 iGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~-HpnVl~LydVwe~~~~lyl   89 (786)
T KOG0588|consen   11 IGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIE-HPNVLRLYDVWENKQHLYL   89 (786)
T ss_pred             ccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhc-CCCeeeeeeeeccCceEEE
Confidence            35688999999999999999999999999999999765       357899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      |+||++||.|++++.+.|++++.+++++++||+.|+.|||..+|+||||||+|+|++..++|||+|||+|..-..+....
T Consensus        90 vlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklLe  169 (786)
T KOG0588|consen   90 VLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLLE  169 (786)
T ss_pred             EEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999998877888888


Q ss_pred             ccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      +.||+|.|.|||++.|. | +.++||||+|||||.||+|++||.+.+...++..++.+.+..|    ..+|.++++||.+
T Consensus       170 TSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP----s~Is~eaQdLLr~  245 (786)
T KOG0588|consen  170 TSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP----SNISSEAQDLLRR  245 (786)
T ss_pred             ccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC----CcCCHHHHHHHHH
Confidence            99999999999999985 5 6789999999999999999999999999999999999998887    5789999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ||..||++|+|.+||++|||+..+..
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~  271 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTS  271 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCC
Confidence            99999999999999999999988764

>KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.1e-54  Score=434.16  Aligned_cols=252  Identities=38%  Similarity=0.697  Sum_probs=234.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      .....|.+++.||+|+||+|++|.+..+|..||+|++.+.         .+.+.+|+.+++.+..||||+++++++....
T Consensus        14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~   93 (370)
T KOG0583|consen   14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT   93 (370)
T ss_pred             cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence            4567899999999999999999999999999999987552         3456789999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeee-c
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRI-S  248 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~-~  248 (469)
                      .+|+|||||.||+|++++...+++.|.+++.+++||+.|++|||++||+||||||+|||++.+ +++||+|||++... .
T Consensus        94 ~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~~  173 (370)
T KOG0583|consen   94 KIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISPG  173 (370)
T ss_pred             eEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccCC
Confidence            999999999999999999999999999999999999999999999999999999999999999 99999999999887 4


Q ss_pred             CCCcccccCCCCcccCceeccCC--C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC-CH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSGN--Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV-SK  324 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~~--~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~-s~  324 (469)
                      ......+.|||+.|+|||++.+.  | +.++|||||||+||.|++|..||.+.+...++..|..+.+.++.    .+ |+
T Consensus       174 ~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~p~----~~~S~  249 (370)
T KOG0583|consen  174 EDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKIPS----YLLSP  249 (370)
T ss_pred             CCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccCCC----CcCCH
Confidence            56677889999999999999873  6 47899999999999999999999999999999999999888873    45 99


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ++++||.+||..||.+|+|+.+|+.||||+.
T Consensus       250 ~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  250 EARSLIEKMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence            9999999999999999999999999999975

>KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-54  Score=419.10  Aligned_cols=254  Identities=33%  Similarity=0.569  Sum_probs=233.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ...+|.+.+.||+|+||+||+|+++.++..||||.+.+.      .+.+..|+.||+.|+ |||||.++++++.++.+||
T Consensus         8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~-H~nIV~l~d~~~~~~~i~l   86 (429)
T KOG0595|consen    8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELK-HPNIVRLLDCIEDDDFIYL   86 (429)
T ss_pred             ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcC-CcceeeEEEEEecCCeEEE
Confidence            457899999999999999999999999999999999654      356788999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC------CcEEEEeccceeeec
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS------GKIKLADFGLAMRIS  248 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~------~~vkL~DFgla~~~~  248 (469)
                      |||||+||+|.++|..++.++|..++.++.||+.||++||+++||||||||+||||+..      -.+||+|||+|+...
T Consensus        87 VMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~  166 (429)
T KOG0595|consen   87 VMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQ  166 (429)
T ss_pred             EEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCC
Confidence            99999999999999999999999999999999999999999999999999999999875      459999999999999


Q ss_pred             CCCcccccCCCCcccCceec-cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          249 NGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      +.....+.||+|.|||||++ ..+|+.|+|+||+|+|+|+|++|++||...+..+++..++.+....+.. ...++++..
T Consensus       167 ~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~~-~~~~s~~~~  245 (429)
T KOG0595|consen  167 PGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPVL-PAELSNPLR  245 (429)
T ss_pred             chhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCch-hhhccCchh
Confidence            88888999999999999999 5679999999999999999999999999999999999888776554432 246788888


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +|+..+|..+|.+|.+..+-+.|+++...
T Consensus       246 ~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~  274 (429)
T KOG0595|consen  246 ELLISLLQRNPKDRISFEDFFDHPFLAAN  274 (429)
T ss_pred             hhhhHHHhcCccccCchHHhhhhhhcccC
Confidence            99999999999999999999999998543

>KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only]

Probab=100.00  E-value=3.9e-55  Score=408.35  Aligned_cols=255  Identities=29%  Similarity=0.555  Sum_probs=223.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +.|+.+..+|+|+||.||+|+++.||+.||||.+..++      .-..+|+++|++|. |||+|.|+++|.....++||+
T Consensus         2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLk-H~NLVnLiEVFrrkrklhLVF   80 (396)
T KOG0593|consen    2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLK-HENLVNLIEVFRRKRKLHLVF   80 (396)
T ss_pred             cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcc-cchHHHHHHHHHhcceeEEEe
Confidence            57889999999999999999999999999999996543      23678999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~  254 (469)
                      |||+. ++.+.+.+. ..++++.+..++.|++.|+.|||+++++||||||+||||+.+|.+||||||+|+... ++...+
T Consensus        81 E~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd~YT  159 (396)
T KOG0593|consen   81 EYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGDNYT  159 (396)
T ss_pred             eecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCcchhh
Confidence            99987 555556554 568999999999999999999999999999999999999999999999999999877 666777


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  313 (469)
                      .++.|.||+|||.+.|  +|+..+||||+||++.||++|.+.|+|.+..+.+..|...-.+                   
T Consensus       160 DYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~  239 (396)
T KOG0593|consen  160 DYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVR  239 (396)
T ss_pred             hhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeee
Confidence            8999999999999988  5999999999999999999999999999888777766433211                   


Q ss_pred             CC--------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          314 FH--------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       314 ~~--------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      +|        ...++.++.-+.||++.||..||.+|++.+|+|.||||..+.++
T Consensus       240 lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~~~er  293 (396)
T KOG0593|consen  240 LPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDGFIER  293 (396)
T ss_pred             cCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhcChHHHHHHHH
Confidence            11        11234578889999999999999999999999999999766554

>KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-53  Score=426.13  Aligned_cols=258  Identities=45%  Similarity=0.824  Sum_probs=243.0

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ...+...|++.+.||+|.||.||+|+.+.||+.||+|++.+.       ...+.+|+.||+++.+|||||.++++|++.+
T Consensus        30 ~~~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~  109 (382)
T KOG0032|consen   30 SEDIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPD  109 (382)
T ss_pred             cccccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCC
Confidence            345778999999999999999999999999999999999653       2589999999999988999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC----CcEEEEeccceee
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLAMR  246 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~----~~vkL~DFgla~~  246 (469)
                      .+++|||+|.||+|++.+... .+++..+..+++||+.++.|||+.||+||||||+|+|+...    +.+|++|||++..
T Consensus       110 ~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~  188 (382)
T KOG0032|consen  110 SVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKF  188 (382)
T ss_pred             eEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceE
Confidence            999999999999999999887 59999999999999999999999999999999999999654    4799999999998


Q ss_pred             ecCCCcccccCCCCcccCceecc-CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ..........+||+.|+|||++. ..|+..+||||+|+++|.|++|.+||.+.+....+..|..+.+.|..+.|..++..
T Consensus       189 ~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~is~~  268 (382)
T KOG0032|consen  189 IKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDDISES  268 (382)
T ss_pred             ccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccccCHH
Confidence            88777788899999999999998 47999999999999999999999999999999999999999999999999999999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +++||++||..||.+|+|+.++|+|||+...
T Consensus       269 akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  269 AKDFIRKLLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             HHHHHHHhcccCcccCCCHHHHhcCccccCC
Confidence            9999999999999999999999999999765

>KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism]

Probab=100.00  E-value=3.2e-54  Score=396.90  Aligned_cols=256  Identities=34%  Similarity=0.606  Sum_probs=239.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------------EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      +-..|.-.+.||.|..++|.+|.++.||..+|+|++...            .+.-.+|+.||+++.+||+|+++.++|+.
T Consensus        15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes   94 (411)
T KOG0599|consen   15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES   94 (411)
T ss_pred             HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence            445677778999999999999999999999999998521            13456799999999999999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      +..+++|+|.|+.|.|+|+|...-.++|...+.|++|+++|+.|||.++||||||||+|||++++-+++|+|||+++.+.
T Consensus        95 ~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~  174 (411)
T KOG0599|consen   95 DAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLE  174 (411)
T ss_pred             cchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccceeeccC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             CCCcccccCCCCcccCceeccC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      .+......||||+|+|||.+..       .|+..+|+|++|+|||.||.|.+||......-++..|..+++.|.++.|.+
T Consensus       175 ~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWad  254 (411)
T KOG0599|consen  175 PGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWAD  254 (411)
T ss_pred             CchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhh
Confidence            9999999999999999999842       388899999999999999999999998888888999999999999999999


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +|...+|||.+||+.||.+|+|++|+|.||||.+.
T Consensus       255 is~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~  289 (411)
T KOG0599|consen  255 ISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI  289 (411)
T ss_pred             ccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence            99999999999999999999999999999999543

>KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-53  Score=396.87  Aligned_cols=259  Identities=36%  Similarity=0.644  Sum_probs=236.2

Q ss_pred             CcccccCCeeee-eeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCe
Q 012170           97 RKNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE----ADC  171 (469)
Q Consensus        97 ~~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~  171 (469)
                      .+..+.++|.+- ++||-|-.|.|..|.++.||+.||+|++.. ....++|+++-....+|||||.++++|+.    ..+
T Consensus        55 k~~~itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~D-s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkc  133 (400)
T KOG0604|consen   55 KEYSITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLD-SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKC  133 (400)
T ss_pred             hcccchhhheehhhhhccccCCceEEEEeccchhhhHHHHHhc-CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCcee
Confidence            445688999984 589999999999999999999999999964 56789999999999999999999999864    467


Q ss_pred             EEEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceee
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMR  246 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~  246 (469)
                      +.+|||.++||+|+..++.++.  |+|.++..|++||..|+.|||+++|.||||||+|+|....   ..+||+|||+|+.
T Consensus       134 LLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~  213 (400)
T KOG0604|consen  134 LLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKE  213 (400)
T ss_pred             eEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecccccccc
Confidence            8999999999999999998876  9999999999999999999999999999999999999764   4699999999998


Q ss_pred             ecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcCCCCCCcccC
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      ......+.+.|.||+|.|||++.. +|+..+|+||+||+||.||+|++||....    ...+-..|..+.+.|+.+.|..
T Consensus       214 t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs~  293 (400)
T KOG0604|consen  214 TQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWSC  293 (400)
T ss_pred             cCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHhH
Confidence            777777888999999999999965 69999999999999999999999997543    3466778999999999999999


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +|++++|+|+.||..+|.+|+|++++++|||+..+
T Consensus       294 VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~  328 (400)
T KOG0604|consen  294 VSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQY  328 (400)
T ss_pred             HHHHHHHHHHHHhcCCchhheeHHHhhcCchhccc
Confidence            99999999999999999999999999999999554

>KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.3e-54  Score=421.99  Aligned_cols=256  Identities=32%  Similarity=0.467  Sum_probs=227.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-eEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD-CFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-~~~  173 (469)
                      .+.++|.+++.||.|+||.||+|+.+.+|..||||.+++.-     -.-.||+..|++|..|||||+|.+++.+.+ .+|
T Consensus         7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~   86 (538)
T KOG0661|consen    7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILY   86 (538)
T ss_pred             hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEe
Confidence            46789999999999999999999999999999999997642     234589999999988999999999999888 999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +|||||+. +|..++..+ ..|++..++.|+.||+.||+|+|.+|+.|||+||+||||..+..|||+|||+|+.+.....
T Consensus        87 fVfE~Md~-NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpP  165 (538)
T KOG0661|consen   87 FVFEFMDC-NLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPP  165 (538)
T ss_pred             eeHHhhhh-hHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccccccCCC
Confidence            99999976 888888665 4699999999999999999999999999999999999999989999999999999988888


Q ss_pred             ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-----------------
Q 012170          253 LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----------------  313 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  313 (469)
                      .+.++.|.||+|||++..  .|+.++||||+|||++|+++-++.|.|.+..+.+..|...-..                 
T Consensus       166 YTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mn  245 (538)
T KOG0661|consen  166 YTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMN  245 (538)
T ss_pred             cchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhc
Confidence            999999999999999954  5999999999999999999999999999988888777543221                 


Q ss_pred             --CCCC-------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 --FHSG-------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 --~~~~-------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                        ++..       .....+.++.+||.+||..||.+||||.|+|+||||+..
T Consensus       246 f~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  246 FRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             cCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcCcccccc
Confidence              1111       123478999999999999999999999999999999654

>KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-53  Score=400.30  Aligned_cols=258  Identities=34%  Similarity=0.639  Sum_probs=234.4

Q ss_pred             ccccCCeee-eeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           99 NKIEDDHTK-VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..+.+.|.+ .+.||+|+||.|--|+...||..||||++.+.    +.++.+|++++.++++|+||++|+++|+++..+|
T Consensus        73 g~F~d~YkLt~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FY  152 (463)
T KOG0607|consen   73 GKFEDMYKLTSELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFY  152 (463)
T ss_pred             chHHHHHHhHHHHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEE
Confidence            346777887 46899999999999999999999999999764    4678999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgla~~~~~~  250 (469)
                      ||||.|.||+|+.+|.++..|+|.++.+++++|+.||.|||.+||.||||||+|||......   ||||||.|...+...
T Consensus       153 LVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~  232 (463)
T KOG0607|consen  153 LVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLN  232 (463)
T ss_pred             EEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccC
Confidence            99999999999999999999999999999999999999999999999999999999987654   899999998654322


Q ss_pred             --------CcccccCCCCcccCceecc---C---CCCCccchHHHHHHHHHHHhCCCCCCCCC---------------HH
Q 012170          251 --------QTLSGLAGSPAYVAPEVLS---G---NYSEKVDIWSAGVLLHALLVAALPFKGDS---------------LE  301 (469)
Q Consensus       251 --------~~~~~~~gt~~y~aPE~l~---~---~~~~~~DiwSlG~il~elltG~~Pf~~~~---------------~~  301 (469)
                              ....+.+|+..|||||+..   +   .|+.++|.||||+|+|.||.|++||.|..               .+
T Consensus       233 ~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~  312 (463)
T KOG0607|consen  233 NDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQN  312 (463)
T ss_pred             CCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHH
Confidence                    1234578999999999873   3   39999999999999999999999997642               57


Q ss_pred             HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       302 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .++..|+.+.+.||...|..+|.+++|||..+|.+|+.+|.++.++++|||+...
T Consensus       313 ~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~~  367 (463)
T KOG0607|consen  313 KLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQRC  367 (463)
T ss_pred             HHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccCCcccccc
Confidence            8899999999999999999999999999999999999999999999999999654

>KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=2.9e-52  Score=403.94  Aligned_cols=256  Identities=32%  Similarity=0.525  Sum_probs=229.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      -.+.|++++.||.|.-|+||+|..+.++..+|+|++.+..       .++..|.+||+.+. ||.+++||..|+.++..|
T Consensus        75 ~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lD-HPFlPTLYa~fet~~~~c  153 (459)
T KOG0610|consen   75 GLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLD-HPFLPTLYASFETDKYSC  153 (459)
T ss_pred             CHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcC-CCccchhhheeeccceeE
Confidence            3468999999999999999999999999999999997642       45677999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC--
Q 012170          174 LVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN--  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~--  249 (469)
                      +|||||+||+|..+++++  +.|++..++.++.+|+.||+|||-+|||+|||||+||||.++|+|.|+||.|+.....  
T Consensus       154 l~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~P  233 (459)
T KOG0610|consen  154 LVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSP  233 (459)
T ss_pred             EEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCC
Confidence            999999999999988775  4699999999999999999999999999999999999999999999999998732110  


Q ss_pred             ---------------------------------C----------------------CcccccCCCCcccCceeccCC-CC
Q 012170          250 ---------------------------------G----------------------QTLSGLAGSPAYVAPEVLSGN-YS  273 (469)
Q Consensus       250 ---------------------------------~----------------------~~~~~~~gt~~y~aPE~l~~~-~~  273 (469)
                                                       .                      .....++||-.|+|||++.|. .+
T Consensus       234 t~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHg  313 (459)
T KOG0610|consen  234 TLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHG  313 (459)
T ss_pred             eeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCC
Confidence                                             0                      001236799999999999985 89


Q ss_pred             CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC----HHHHHc
Q 012170          274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT----ADEVLR  349 (469)
Q Consensus       274 ~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps----a~elL~  349 (469)
                      .++|||+|||++||||.|..||.|.+.++.+.+|....+.|+...  .++..++|||+++|.+||.+|+.    |.||.+
T Consensus       314 sAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~--~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~  391 (459)
T KOG0610|consen  314 SAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEP--EVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKR  391 (459)
T ss_pred             chhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCC--cchhHHHHHHHHHhccChhhhhccccchHHhhc
Confidence            999999999999999999999999999999999999888888653  78999999999999999999998    999999


Q ss_pred             CCCccccccc
Q 012170          350 HPWILFYTER  359 (469)
Q Consensus       350 hp~~~~~~~~  359 (469)
                      ||||....|.
T Consensus       392 HpFF~gVnWa  401 (459)
T KOG0610|consen  392 HPFFEGVNWA  401 (459)
T ss_pred             CccccCCChh
Confidence            9999776654

>KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3e-52  Score=412.32  Aligned_cols=252  Identities=29%  Similarity=0.484  Sum_probs=221.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeC--Ce
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DC  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~  171 (469)
                      ...+.|+.++.||+|+||.||+|++..||+.||+|.++-+.      ....+|+.||++|. ||||++|.++..+.  ..
T Consensus       114 r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~-HpNIikL~eivt~~~~~s  192 (560)
T KOG0600|consen  114 RRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLD-HPNIIKLEEIVTSKLSGS  192 (560)
T ss_pred             cchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcC-CCcccceeeEEEecCCce
Confidence            45678999999999999999999999999999999996543      35779999999996 99999999998766  68


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +|||+|||+. +|.-++... -.|++.+++.++.||+.||+|||++||+|||||.+|||||.+|.+||+|||||+.+...
T Consensus       193 iYlVFeYMdh-DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~  271 (560)
T KOG0600|consen  193 IYLVFEYMDH-DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPS  271 (560)
T ss_pred             EEEEEecccc-hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCC
Confidence            9999999987 676666543 37999999999999999999999999999999999999999999999999999976544


Q ss_pred             C--cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc-------
Q 012170          251 Q--TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW-------  319 (469)
Q Consensus       251 ~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------  319 (469)
                      .  .++..+.|.||+|||++.|  .|+.++|+||+||||.||++|++.|.|.+..+.+..|-+.........|       
T Consensus       272 ~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~  351 (560)
T KOG0600|consen  272 GSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPH  351 (560)
T ss_pred             CCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCc
Confidence            3  5677889999999999988  4999999999999999999999999999998888887544332222222       


Q ss_pred             ------------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          320 ------------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       320 ------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                        ..++..+.+|+..||..||.+|.||.++|+|+||
T Consensus       352 ~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF  403 (560)
T KOG0600|consen  352 ATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQSEYF  403 (560)
T ss_pred             ccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhcCccc
Confidence                              3468889999999999999999999999999999

>KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair]

Probab=100.00  E-value=8.2e-52  Score=380.21  Aligned_cols=251  Identities=30%  Similarity=0.497  Sum_probs=220.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|...+.||+|.||.||+|++..||+.||||.++.++      ....+|++.|+.+. |+||+.++++|...+.+.||+
T Consensus         2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~-h~nIi~LiD~F~~~~~l~lVf   80 (318)
T KOG0659|consen    2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELK-HPNIIELIDVFPHKSNLSLVF   80 (318)
T ss_pred             chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHcc-CcchhhhhhhccCCCceEEEE
Confidence            57888999999999999999999999999999997543      46789999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      ||++. +|...+... ..++..++..++.++++||+|||++.|+||||||.|+||+++|.+||+|||+|+.+..... ..
T Consensus        81 Efm~t-dLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~  159 (318)
T KOG0659|consen   81 EFMPT-DLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQT  159 (318)
T ss_pred             Eeccc-cHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccc
Confidence            99975 788877654 4689999999999999999999999999999999999999999999999999998765443 33


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC---------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG---------------  317 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------  317 (469)
                      ..+.|.||+|||.+.|  .|+..+||||.|||+.||+.|.+-|.|.+.-+.+..|-..-......               
T Consensus       160 ~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~  239 (318)
T KOG0659|consen  160 HQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQ  239 (318)
T ss_pred             cceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHh
Confidence            3478999999999988  49999999999999999999999999998887777764332221111               


Q ss_pred             ---------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          318 ---------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       318 ---------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                               .+...+.++.||+.+||.+||.+|+|+.|+|+|+||..
T Consensus       240 ~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~  286 (318)
T KOG0659|consen  240 QFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKHPYFKS  286 (318)
T ss_pred             cCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcchhhhc
Confidence                     23456788999999999999999999999999999953

>KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=9.6e-53  Score=381.25  Aligned_cols=249  Identities=37%  Similarity=0.641  Sum_probs=233.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|.||.||+|+.+.++-.||+|++.++       ...+.+|++|-..|+ ||||+++|++|.+....|
T Consensus        20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~-hpnilrlY~~fhd~~riy   98 (281)
T KOG0580|consen   20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLR-HPNILRLYGYFHDSKRIY   98 (281)
T ss_pred             chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccC-CccHHhhhhheeccceeE
Confidence            357899999999999999999999999999999999764       356889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          174 LVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |++||..+|+++..|.  ...++++..++.++.|++.||.|||..+|+||||||+|+|++..|.+||+|||.+.... ..
T Consensus        99 LilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p-~~  177 (281)
T KOG0580|consen   99 LILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP-SN  177 (281)
T ss_pred             EEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecC-CC
Confidence            9999999999999998  56789999999999999999999999999999999999999999999999999997654 55


Q ss_pred             cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...+.|||..|.+||+..+. ++..+|+|++|++.||++.|.+||...+..+.+..|......++    ..++.+++|||
T Consensus       178 kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~p----~~is~~a~dlI  253 (281)
T KOG0580|consen  178 KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKFP----STISGGAADLI  253 (281)
T ss_pred             CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccCC----cccChhHHHHH
Confidence            66789999999999999885 99999999999999999999999999999999999999998887    57999999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .+||.++|.+|.+..|++.|||+..
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999954

>KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.9e-52  Score=391.95  Aligned_cols=271  Identities=31%  Similarity=0.564  Sum_probs=246.9

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      .....++|..+++||+|.||+|.+|+.+.+|+.||+|+++++-       ..-..|-++|+..+ ||.+..|...|+..+
T Consensus       163 ~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~-HPFLt~LKYsFQt~d  241 (516)
T KOG0690|consen  163 NKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCR-HPFLTSLKYSFQTQD  241 (516)
T ss_pred             ceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhcc-CcHHHHhhhhhccCc
Confidence            3345689999999999999999999999999999999998742       23446889999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee-ecC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~-~~~  249 (469)
                      .+|+||||+.||.|+.+|.+...|++..++.+-.+|+.||.|||+++||+||||.+|+|+|.+|++||+|||+++. +..
T Consensus       242 rlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~~  321 (516)
T KOG0690|consen  242 RLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIKY  321 (516)
T ss_pred             eEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999974 556


Q ss_pred             CCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      +..+.++||||.|+|||++.. .|+.++|+|.+||+||||++|++||...+.+.++..|....+.||    ..++++++.
T Consensus       322 g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~kLFeLIl~ed~kFP----r~ls~eAkt  397 (516)
T KOG0690|consen  322 GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEKLFELILMEDLKFP----RTLSPEAKT  397 (516)
T ss_pred             cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhHHHHHHHhhhccCC----ccCCHHHHH
Confidence            777889999999999999976 599999999999999999999999999999999999999988888    578999999


Q ss_pred             HHHHhchhhhcCCCC-----HHHHHcCCCccccccccchhchhhHHhhhhcCCCCCCC
Q 012170          329 LMARMLTRDVSARIT-----ADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP  381 (469)
Q Consensus       329 lI~~~L~~dP~~Rps-----a~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  381 (469)
                      |+..+|.+||.+|+.     |.||.+|+||.        .+.|...+.+.+.++..+.
T Consensus       398 LLsGLL~kdP~kRLGgGpdDakEi~~h~FF~--------~v~W~~~~~Kki~PPfKPq  447 (516)
T KOG0690|consen  398 LLSGLLKKDPKKRLGGGPDDAKEIMRHRFFA--------SVDWEATYRKKIEPPFKPQ  447 (516)
T ss_pred             HHHHHhhcChHhhcCCCchhHHHHHhhhhhc--------cCCHHHHHHhccCCCCCCC
Confidence            999999999999994     89999999994        4567777777777666554

>KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=405.23  Aligned_cols=255  Identities=37%  Similarity=0.614  Sum_probs=226.4

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------------------hHHHHHHHHHHHHhhCCCCe
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------------------EETVHREVEIMQHLSGHTGV  159 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------------~~~~~~E~~il~~l~~hpnI  159 (469)
                      .....+.|++++.||+|.||.|.+|++..+++.||||++.+.                  .+.+.+|+.||++|. ||||
T Consensus        92 ~~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~-H~nV  170 (576)
T KOG0585|consen   92 DRKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLH-HPNV  170 (576)
T ss_pred             cceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcC-CcCe
Confidence            345668999999999999999999999999999999999642                  157889999999997 9999


Q ss_pred             eEEEEEEEe--CCeEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          160 VTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       160 v~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      |+|+++..+  .+.+|||+|||..|.+...= ..++ +++.+++.++++++.||+|||.+||+||||||+|+||+++|+|
T Consensus       171 V~LiEvLDDP~s~~~YlVley~s~G~v~w~p-~d~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V  249 (576)
T KOG0585|consen  171 VKLIEVLDDPESDKLYLVLEYCSKGEVKWCP-PDKPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV  249 (576)
T ss_pred             eEEEEeecCcccCceEEEEEeccCCccccCC-CCcccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence            999999976  45799999999999886532 3344 9999999999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCC------CcccccCCCCcccCceeccC---C--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 012170          237 KLADFGLAMRISNG------QTLSGLAGSPAYVAPEVLSG---N--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFD  305 (469)
Q Consensus       237 kL~DFgla~~~~~~------~~~~~~~gt~~y~aPE~l~~---~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  305 (469)
                      ||+|||.+.....+      ......+|||.|+|||.+.+   .  -+.+.||||+||+||.|+.|..||.+....++++
T Consensus       250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~l~~  329 (576)
T KOG0585|consen  250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELELFD  329 (576)
T ss_pred             EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHHHHH
Confidence            99999999765222      22345789999999999965   2  3678999999999999999999999999999999


Q ss_pred             HHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       306 ~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .|.+..+.|+..  +.+..+++|||.+||.+||++|++..+|..|||+...
T Consensus       330 KIvn~pL~fP~~--pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  330 KIVNDPLEFPEN--PEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             HHhcCcccCCCc--ccccHHHHHHHHHHhhcChhheeehhhheecceeccC
Confidence            999999988865  4689999999999999999999999999999999765

>KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only]

Probab=100.00  E-value=1.4e-51  Score=389.12  Aligned_cols=254  Identities=30%  Similarity=0.458  Sum_probs=221.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChH------HHHHHHHHHHHhhCCCCeeEEEEEEE--eCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVTLHSVYE--EADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~E~~il~~l~~hpnIv~l~~~~~--~~~~~  172 (469)
                      -.+.|+.+..|++|+||.||+|+++.|++.||+|.++.+.+      ...+|+.+|.+++ |||||.+-++..  +-+.+
T Consensus        74 sv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~-H~NIV~vkEVVvG~~~d~i  152 (419)
T KOG0663|consen   74 SVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKAR-HPNIVEVKEVVVGSNMDKI  152 (419)
T ss_pred             cHHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcC-CCCeeeeEEEEecccccee
Confidence            44789999999999999999999999999999999976442      4679999999997 999999999875  34579


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      |||||||+. +|...+...+ +|...+++.++.|++.||+|||.+.|+||||||+|+|++..|.+||+|||+|+.+... 
T Consensus       153 y~VMe~~Eh-DLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~  231 (419)
T KOG0663|consen  153 YIVMEYVEH-DLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPL  231 (419)
T ss_pred             eeeHHHHHh-hHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCCc
Confidence            999999987 7888887765 8999999999999999999999999999999999999999999999999999988765 


Q ss_pred             CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc--------
Q 012170          251 QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE--------  320 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~--------  320 (469)
                      ..++..+.|.||+|||++.|  .|+.++|+||+|||+.||+++++.|.|.+..+.++.|-+.........|+        
T Consensus       232 k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~  311 (419)
T KOG0663|consen  232 KPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAV  311 (419)
T ss_pred             ccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchh
Confidence            34677889999999999988  49999999999999999999999999999888888775432221111111        


Q ss_pred             --------------------CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          321 --------------------TVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       321 --------------------~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                          .++....+|+..+|.+||.+|.||.|.|+|+||...
T Consensus       312 k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~  367 (419)
T KOG0663|consen  312 KKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRET  367 (419)
T ss_pred             hccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccC
Confidence                                246889999999999999999999999999999653

>KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-51  Score=401.40  Aligned_cols=252  Identities=30%  Similarity=0.540  Sum_probs=216.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--eEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--CFHLV  175 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--~~~lV  175 (469)
                      ...|..++.||+|+||.||++.+..+|..+|||.+...    .+.+.+|+.+|++|+ |||||++++......  .++++
T Consensus        16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~-~p~IV~~~G~~~~~~~~~~~i~   94 (313)
T KOG0198|consen   16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLN-HPNIVQYYGSSSSRENDEYNIF   94 (313)
T ss_pred             cchhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCC-CCCEEeeCCccccccCeeeEee
Confidence            35688889999999999999999999999999999765    456899999999998 999999999855444  69999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecC----
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISN----  249 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~----  249 (469)
                      |||++||+|.+++.+.+ .+++..+..+.+||+.||.|||++||+||||||+|||++. +|.+||+|||++.....    
T Consensus        95 mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~  174 (313)
T KOG0198|consen   95 MEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTK  174 (313)
T ss_pred             eeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCcccccccccccc
Confidence            99999999999999887 7999999999999999999999999999999999999999 79999999999987653    


Q ss_pred             CCcccccCCCCcccCceeccCCC--CCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          250 GQTLSGLAGSPAYVAPEVLSGNY--SEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~~~--~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ........||+.|||||++...+  ..++|||||||++.||+||.+||.. ......+..|..... .| .....+|.++
T Consensus       175 ~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~~~~-~P-~ip~~ls~~a  252 (313)
T KOG0198|consen  175 SDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGREDS-LP-EIPDSLSDEA  252 (313)
T ss_pred             ccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhccCC-CC-CCCcccCHHH
Confidence            12234578999999999998443  3499999999999999999999987 344443344433331 11 3446799999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++||.+||.+||.+||||.++|+|||....
T Consensus       253 ~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~  282 (313)
T KOG0198|consen  253 KDFLRKCFKRDPEKRPTAEELLEHPFLKQN  282 (313)
T ss_pred             HHHHHHHhhcCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999999998543

>KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-51  Score=414.44  Aligned_cols=252  Identities=32%  Similarity=0.540  Sum_probs=227.5

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ......|.....||+|+.|.||.|+...+++.||||.+..    ..+-+..|+.+|+.+. |+|||.+++.|...+.+|+
T Consensus       269 ~dP~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~-H~NiVnfl~Sylv~deLWV  347 (550)
T KOG0578|consen  269 GDPRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLH-HPNIVNFLDSYLVGDELWV  347 (550)
T ss_pred             CChhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhcc-chHHHHHHHHhcccceeEE
Confidence            3456688889999999999999999999999999999854    2467889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      ||||++||+|.|.+. ...++|.+++.|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||+|..+...+ ..
T Consensus       348 VMEym~ggsLTDvVt-~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~KR  426 (550)
T KOG0578|consen  348 VMEYMEGGSLTDVVT-KTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSKR  426 (550)
T ss_pred             EEeecCCCchhhhhh-cccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccCcc
Confidence            999999999999774 4569999999999999999999999999999999999999999999999999999887665 56


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-cCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV-KLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .+.+|||+|||||++.. .|+.++||||||++++||+-|++||-..++...+..|... .+.+.  .+..+|+.++||+.
T Consensus       427 ~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~P~lk--~~~klS~~~kdFL~  504 (550)
T KOG0578|consen  427 STMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPKLK--NPEKLSPELKDFLD  504 (550)
T ss_pred             ccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCCCCcC--CccccCHHHHHHHH
Confidence            77899999999999976 5999999999999999999999999988877777777543 33333  34789999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcc
Q 012170          332 RMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      +||+.|+.+|++|.|||+||||.
T Consensus       505 ~cL~~dv~~RasA~eLL~HpFl~  527 (550)
T KOG0578|consen  505 RCLVVDVEQRASAKELLEHPFLK  527 (550)
T ss_pred             HHhhcchhcCCCHHHHhcChhhh
Confidence            99999999999999999999993

>KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only]

Probab=100.00  E-value=8.2e-52  Score=412.47  Aligned_cols=247  Identities=30%  Similarity=0.527  Sum_probs=229.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|-+.+.||+|+||.||+|+.+.|.+.||||.+.+.      -..+.+|++|++.|+ |||||.++++|+....+|+|.
T Consensus         2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lk-Hpniv~m~esfEt~~~~~vVt   80 (808)
T KOG0597|consen    2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLK-HPNIVEMLESFETSAHLWVVT   80 (808)
T ss_pred             cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcC-CcchhhHHHhhcccceEEEEe
Confidence            5788899999999999999999999999999999653      235889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |||.| +|+.++...+.++|+.+..++.+++.||.|||+++|+|||+||.|||++..|.+|+||||+|+.+.... ..+.
T Consensus        81 e~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t~vlts  159 (808)
T KOG0597|consen   81 EYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNTSVLTS  159 (808)
T ss_pred             hhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccCceeeee
Confidence            99987 999999999999999999999999999999999999999999999999999999999999999877554 3566


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|||.|||||++.+. |+..+|+||||||+|||+.|.+||...+..++...|......++    ...|..+..||..+|
T Consensus       160 ikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~v~~p----~~~S~~f~nfl~gLL  235 (808)
T KOG0597|consen  160 IKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDPVKPP----STASSSFVNFLQGLL  235 (808)
T ss_pred             ccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCCCCCc----ccccHHHHHHHHHHh
Confidence            7899999999999875 99999999999999999999999999999999999988877666    378999999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccc
Q 012170          335 TRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .+||.+|+|..+++.|||...
T Consensus       236 ~kdP~~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  236 IKDPAQRLTWTDLLGHPFWKG  256 (808)
T ss_pred             hcChhhcccHHHHhcChHHhh
Confidence            999999999999999999854

>KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-50  Score=392.76  Aligned_cols=256  Identities=29%  Similarity=0.464  Sum_probs=224.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++.+.||.|.-++||+|+...+++.||||++.-+     .+.+.+|+..|+.+. ||||++++..|..++.+|+||
T Consensus        25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~-HPNIv~~~~sFvv~~~LWvVm  103 (516)
T KOG0582|consen   25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLID-HPNIVTYHCSFVVDSELWVVM  103 (516)
T ss_pred             ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcC-CCCcceEEEEEEecceeEEee
Confidence            47899999999999999999999999999999999532     367899999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      .||.+|++++++...  ..++|..++.|++++++||.|||.+|.||||||+.||||+.+|.|||+|||.+..+.+...  
T Consensus       104 pfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~  183 (516)
T KOG0582|consen  104 PFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQ  183 (516)
T ss_pred             hhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCcee
Confidence            999999999999764  4599999999999999999999999999999999999999999999999998865543221  


Q ss_pred             ---ccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC------CCCCccc
Q 012170          253 ---LSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD------FHSGVWE  320 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------~~~~~~~  320 (469)
                         ..+++|||+|||||++..   .|+.|+|||||||+..||++|..||....+.+++-.-.++.++      ++.....
T Consensus       184 ~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k  263 (516)
T KOG0582|consen  184 VTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDK  263 (516)
T ss_pred             eEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhh
Confidence               256799999999999643   4999999999999999999999999988887776555554443      2223335


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .++..++.+|..||++||.+||||.++|+|+||.....
T Consensus       264 ~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~  301 (516)
T KOG0582|consen  264 KFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKS  301 (516)
T ss_pred             hhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccc
Confidence            67889999999999999999999999999999976543

>KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=4.7e-51  Score=393.07  Aligned_cols=249  Identities=35%  Similarity=0.626  Sum_probs=234.0

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      -.+..+|++.+.||+|.||+|-+|.....|+.||||.++++.       -.+++|++||..|+ ||||+.+|++|+..+.
T Consensus        49 hnlkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLN-HPhII~IyEVFENkdK  127 (668)
T KOG0611|consen   49 HNLKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLN-HPHIIQIYEVFENKDK  127 (668)
T ss_pred             cchhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcC-CCceeehhhhhcCCce
Confidence            346779999999999999999999999999999999997642       35789999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +.|||||..+|.|.|++.+.+.+++.+++.+++||+.|+.|||.++++|||||.+|||+|.++++||+||||+-.+.+..
T Consensus       128 IvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k  207 (668)
T KOG0611|consen  128 IVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK  207 (668)
T ss_pred             EEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999998888888


Q ss_pred             cccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ...++||+|-|.+||++.|. | ++.+|-|||||+||.|+.|..||.|.+...++.+|.++.+.-+     .-+.++.-|
T Consensus       208 fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP-----~~PSdA~gL  282 (668)
T KOG0611|consen  208 FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRGAYREP-----ETPSDASGL  282 (668)
T ss_pred             HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcccccCC-----CCCchHHHH
Confidence            89999999999999999995 4 6789999999999999999999999999999999999887655     347789999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCc
Q 012170          330 MARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |+.||-.||++|.|+++|-.|=|+
T Consensus       283 IRwmLmVNP~RRATieDiAsHWWv  306 (668)
T KOG0611|consen  283 IRWMLMVNPERRATIEDIASHWWV  306 (668)
T ss_pred             HHHHHhcCcccchhHHHHhhhhee
Confidence            999999999999999999999887

>KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.4e-52  Score=407.25  Aligned_cols=252  Identities=29%  Similarity=0.446  Sum_probs=229.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ....|..++.||+|+||.||+|.+..+++.||+|++.-+     .+++.+|+.+|.++. ++||.++|+.|..+..+|++
T Consensus        11 ~~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~-~~~it~yygsyl~g~~Lwii   89 (467)
T KOG0201|consen   11 PELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCD-SPNITEYYGSYLKGTKLWII   89 (467)
T ss_pred             cccccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcC-cchHHhhhhheeecccHHHH
Confidence            345688889999999999999999999999999999643     367889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      ||||.||++.+.+...+.+.+..+..++++++.||.|||..+.+|||||+.|||+..+|.|||+|||.+........ ..
T Consensus        90 Mey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr~  169 (467)
T KOG0201|consen   90 MEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRRK  169 (467)
T ss_pred             HHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeechhhccc
Confidence            99999999999997777779999999999999999999999999999999999999999999999999988765543 37


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      +++|||+||||||+.+ .|+.++||||||+++|||++|.+||....+..++..|.+..++...   ..+|+.+++||..|
T Consensus       170 tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~PP~L~---~~~S~~~kEFV~~C  246 (467)
T KOG0201|consen  170 TFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAPPRLD---GDFSPPFKEFVEAC  246 (467)
T ss_pred             cccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCCCccc---cccCHHHHHHHHHH
Confidence            8999999999999987 5999999999999999999999999999988888777766554443   36799999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCcccc
Q 012170          334 LTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |++||+.||+|.++|+|+|+...
T Consensus       247 L~k~P~~RpsA~~LLKh~FIk~a  269 (467)
T KOG0201|consen  247 LDKNPEFRPSAKELLKHKFIKRA  269 (467)
T ss_pred             hhcCcccCcCHHHHhhhHHHHhc
Confidence            99999999999999999999763

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.1e-49  Score=399.29  Aligned_cols=249  Identities=29%  Similarity=0.548  Sum_probs=225.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|.+.+.||+|+||.||+|+++.+|+.||||++.+.       ...+.+|+.+|+.+. ||||+++++++.+++.+|
T Consensus        16 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   94 (329)
T PTZ00263         16 KLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELS-HPFIVNMMCSFQDENRVY   94 (329)
T ss_pred             CchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEcCCEEE
Confidence            347899999999999999999999999999999998642       245778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  .
T Consensus        95 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~--~  172 (329)
T PTZ00263         95 FLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR--T  172 (329)
T ss_pred             EEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC--c
Confidence            99999999999999998889999999999999999999999999999999999999999999999999999865433  2


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+......++    ..++..+++||.+
T Consensus       173 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  248 (329)
T PTZ00263        173 FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKILAGRLKFP----NWFDGRARDLVKG  248 (329)
T ss_pred             ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCcCCC----CCCCHHHHHHHHH
Confidence            346799999999999764 88999999999999999999999999888888888887766554    3478999999999


Q ss_pred             hchhhhcCCCC-----HHHHHcCCCcccc
Q 012170          333 MLTRDVSARIT-----ADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rps-----a~elL~hp~~~~~  356 (469)
                      ||+.||.+||+     ++++++||||...
T Consensus       249 ~L~~dP~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        249 LLQTDHTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HhhcCHHHcCCCCCCCHHHHhcCCccCCC
Confidence            99999999997     7999999999654

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-50  Score=395.10  Aligned_cols=248  Identities=32%  Similarity=0.581  Sum_probs=224.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|.+..+|+.||+|++...       ...+.+|+.+|+.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   79 (291)
T cd05612           1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVS-HPFIIRLFWTEHDQRFLYML   79 (291)
T ss_pred             CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCC-CCcHhhhHhhhccCCeEEEE
Confidence            4789999999999999999999999999999998532       245778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  ...
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~--~~~  157 (291)
T cd05612          80 MEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR--TWT  157 (291)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC--ccc
Confidence            999999999999988889999999999999999999999999999999999999999999999999999765432  234


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+....+..+......++    ..++..+++||++||
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  233 (291)
T cd05612         158 LCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKLEFP----RHLDLYAKDLIKKLL  233 (291)
T ss_pred             ccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcCCC----ccCCHHHHHHHHHHc
Confidence            5799999999999764 88999999999999999999999999988888888887766655    356899999999999


Q ss_pred             hhhhcCCCC-----HHHHHcCCCccccc
Q 012170          335 TRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      +.||.+||+     ++++++||||....
T Consensus       234 ~~dp~~R~~~~~~~~~~~l~h~~~~~~~  261 (291)
T cd05612         234 VVDRTRRLGNMKNGADDVKNHRWFKSVD  261 (291)
T ss_pred             CCCHHHccCCccCCHHHHhcCccccCCC
Confidence            999999995     99999999996544

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=3.6e-52  Score=384.98  Aligned_cols=240  Identities=30%  Similarity=0.494  Sum_probs=214.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEE-EEEeCCe-EE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHS-VYEEADC-FH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~-~~~~~~~-~~  173 (469)
                      ..+|++++.||+|+||+||++.+..+|..+|.|.+.-      ..+.+..|+.+|++|+ |||||++++ .|.++.. ++
T Consensus        18 l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~-HpNIVqYy~~~f~~~~evln   96 (375)
T KOG0591|consen   18 LADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLN-HPNIVQYYAHSFIEDNEVLN   96 (375)
T ss_pred             HHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcC-CchHHHHHHHhhhccchhhH
Confidence            4689999999999999999999999999999999852      3467889999999997 999999998 4544444 99


Q ss_pred             EEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHh--cC--eEeccCCCCcEEEccCCcEEEEecccee
Q 012170          174 LVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHD--MG--VVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~--~g--ivHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ||||||.+|+|...++..    +.++|..+|.++.|++.||.+||+  ..  |+||||||.||+|+.+|.|||+||||++
T Consensus        97 ivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r  176 (375)
T KOG0591|consen   97 IVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGR  176 (375)
T ss_pred             HHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHh
Confidence            999999999999888653    469999999999999999999999  55  9999999999999999999999999999


Q ss_pred             eecCCCc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          246 RISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       246 ~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      .+..... ..+++|||+||+||.+.+ .|+.++||||+||++|||+.-.+||.|.+..++-.+|.++.++..  +-..+|
T Consensus       177 ~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~--p~~~YS  254 (375)
T KOG0591|consen  177 FLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPL--PDEHYS  254 (375)
T ss_pred             HhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCC--cHHHhh
Confidence            8765544 456899999999999977 599999999999999999999999999999999999999865422  225679


Q ss_pred             HHHHHHHHHhchhhhcCCCCH
Q 012170          324 KPARDLMARMLTRDVSARITA  344 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa  344 (469)
                      .++..||..|+..||+.||+.
T Consensus       255 ~~l~~li~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  255 TDLRELINMCIAVDPEQRPDT  275 (375)
T ss_pred             hHHHHHHHHHccCCcccCCCc
Confidence            999999999999999999986

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=1.6e-49  Score=403.29  Aligned_cols=255  Identities=27%  Similarity=0.497  Sum_probs=220.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|.++.+++.||||++++.       ...+.+|+.++..+. ||||+++++.+.+.+.+|+|
T Consensus         1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~-~~~iv~~~~~~~~~~~~~lv   79 (363)
T cd05628           1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEAD-SLWVVKMFYSFQDKLNLYLI   79 (363)
T ss_pred             CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCeEEEE
Confidence            4799999999999999999999999999999999652       135778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~  159 (363)
T cd05628          80 MEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEF  159 (363)
T ss_pred             EcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccc
Confidence            9999999999999888999999999999999999999999999999999999999999999999999986542210    


Q ss_pred             --------------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 012170          252 --------------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD  298 (469)
Q Consensus       252 --------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~  298 (469)
                                                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~  239 (363)
T cd05628         160 YRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (363)
T ss_pred             cccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCC
Confidence                                            0124589999999999976 4899999999999999999999999998


Q ss_pred             CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc---CCCCHHHHHcCCCccccccc
Q 012170          299 SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS---ARITADEVLRHPWILFYTER  359 (469)
Q Consensus       299 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~---~Rpsa~elL~hp~~~~~~~~  359 (469)
                      +..+.+..+..............+++++++||.+|+. +|.   .||+++||++||||....+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~~~~  302 (363)
T cd05628         240 TPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGVDWE  302 (363)
T ss_pred             CHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCCCHH
Confidence            8888888887644332222234579999999999875 454   45899999999999765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=1.3e-49  Score=397.52  Aligned_cols=244  Identities=33%  Similarity=0.577  Sum_probs=219.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+|+.||||++++.       ...+.+|+.+|+.+. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~~   79 (323)
T cd05571           1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999998642       134668999999996 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~  159 (323)
T cd05571          80 GELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCCCcccceecCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987532 233344578999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||..||+
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05571         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             cccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHH
Confidence            9999999976 489999999999999999999999999888888888877666554    46899999999999999999


Q ss_pred             CCC-----CHHHHHcCCCccccc
Q 012170          340 ARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +||     ++.++++||||....
T Consensus       236 ~R~~~~~~~~~~ll~h~~f~~~~  258 (323)
T cd05571         236 QRLGGGPEDAKEIMEHRFFASIN  258 (323)
T ss_pred             HcCCCCCCCHHHHHcCCCcCCCC
Confidence            999     899999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-50  Score=387.83  Aligned_cols=258  Identities=28%  Similarity=0.491  Sum_probs=223.0

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEe---
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEE---  168 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~---  168 (469)
                      ...+...|..++.||.|+||.|..|.++.||+.||||.+..      ...+..+|+++|++++ |+||+.+++++..   
T Consensus        17 ~~~i~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~-HeNIi~l~di~~p~~~   95 (359)
T KOG0660|consen   17 LFEIPRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLR-HENIIGLLDIFRPPSR   95 (359)
T ss_pred             EEeccceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhc-CCCcceEEeecccccc
Confidence            34566778888999999999999999999999999999863      2356789999999998 9999999999865   


Q ss_pred             --CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          169 --ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       169 --~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                        -+.+|+|+|+| +.+|...+..+..++++.+..++.||+.||.|+|+.||+||||||.|+|++.+..+||||||+|+.
T Consensus        96 ~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~  174 (359)
T KOG0660|consen   96 DKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLARY  174 (359)
T ss_pred             cccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEeccccceee
Confidence              34699999999 558888887777799999999999999999999999999999999999999999999999999998


Q ss_pred             ecC---CCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC--------
Q 012170          247 ISN---GQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD--------  313 (469)
Q Consensus       247 ~~~---~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------  313 (469)
                      ...   ...++.++.|.||+|||++..  .|+.++||||+|||+.||++|++.|.|.+....+..|......        
T Consensus       175 ~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~  254 (359)
T KOG0660|consen  175 LDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQK  254 (359)
T ss_pred             ccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHH
Confidence            763   455678899999999999854  5999999999999999999999999998876666655332211        


Q ss_pred             ---------------CC----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          314 ---------------FH----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       314 ---------------~~----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                     .+    ...++..++.+.||+.+||..||.+|+|++|+|.|||+..+.
T Consensus       255 i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~h  317 (359)
T KOG0660|consen  255 IRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYH  317 (359)
T ss_pred             hccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhcChhhhhhc
Confidence                           11    123457899999999999999999999999999999996554

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=5.9e-49  Score=385.64  Aligned_cols=248  Identities=31%  Similarity=0.523  Sum_probs=214.2

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      |++.+.||+|+||.||+|.+..+|+.||+|++.+.       ...+.+|+.+|+.+. |+||+++++++.+.+.+++|||
T Consensus         2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~iv~~~~~~~~~~~~~lv~e   80 (285)
T cd05631           2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVN-SRFVVSLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcC-CCcEEEEEEEEccCCeEEEEEE
Confidence            77889999999999999999999999999998542       134678999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...........
T Consensus        81 ~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05631          81 IMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGETVRG  160 (285)
T ss_pred             ecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCeecC
Confidence            99999998887543  3689999999999999999999999999999999999999999999999999987655545556


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH----HHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA----VFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~----~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ..||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.....    +...+.....    .....++.++.+||
T Consensus       161 ~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~s~~~~~li  236 (285)
T cd05631         161 RVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQE----EYSEKFSEDAKSIC  236 (285)
T ss_pred             CCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHhhcccc----cCCccCCHHHHHHH
Confidence            789999999999976 58999999999999999999999998755322    2222322222    23356899999999


Q ss_pred             HHhchhhhcCCCC-----HHHHHcCCCccccc
Q 012170          331 ARMLTRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      .+||+.||.+||+     ++++++||||....
T Consensus       237 ~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         237 RMLLTKNPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             HHHhhcCHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            9999999999997     99999999996554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-49  Score=401.01  Aligned_cols=254  Identities=31%  Similarity=0.551  Sum_probs=222.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|++..+|+.||||++.+.       ...+.+|+.+|+.+. ||||++++++|.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (364)
T cd05599           1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEAD-NPWVVKLYYSFQDENYLYLI   79 (364)
T ss_pred             CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCeEEEE
Confidence            4799999999999999999999999999999999642       134678999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..+....    
T Consensus        80 ~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (364)
T cd05599          80 MEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEF  159 (364)
T ss_pred             ECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987543211    


Q ss_pred             -----------------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCC
Q 012170          252 -----------------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPF  295 (469)
Q Consensus       252 -----------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf  295 (469)
                                                         .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf  239 (364)
T cd05599         160 YRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPF  239 (364)
T ss_pred             cccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCC
Confidence                                               0113469999999999866 5899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC---HHHHHcCCCcccccc
Q 012170          296 KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT---ADEVLRHPWILFYTE  358 (469)
Q Consensus       296 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~~  358 (469)
                      .+.+..+.+..+......+.......+++++++||.+||. +|.+|++   +.++|+||||....+
T Consensus       240 ~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~~~  304 (364)
T cd05599         240 CSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGVDW  304 (364)
T ss_pred             CCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9988888877776655443333334679999999999996 9999998   999999999976543

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=1.1e-48  Score=398.91  Aligned_cols=253  Identities=34%  Similarity=0.546  Sum_probs=221.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+|++++.||+|+||.||+|++..+++.||||++.+.       ...+.+|+.+|+.+. ||||+++++.|.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv   79 (376)
T cd05598           1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFV   79 (376)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCEEEEE
Confidence            3799999999999999999999999999999998642       245778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-----  250 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-----  250 (469)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+...     
T Consensus        80 ~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~  159 (376)
T cd05598          80 MDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  159 (376)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccc
Confidence            999999999999988888999999999999999999999999999999999999999999999999997432100     


Q ss_pred             ---------------------------------------CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh
Q 012170          251 ---------------------------------------QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV  290 (469)
Q Consensus       251 ---------------------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt  290 (469)
                                                             ......+||+.|+|||++.+ .++.++|||||||++|+|++
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~  239 (376)
T cd05598         160 YQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLV  239 (376)
T ss_pred             cccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhh
Confidence                                                   00123579999999999976 48999999999999999999


Q ss_pred             CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCC---CHHHHHcCCCccccc
Q 012170          291 AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI---TADEVLRHPWILFYT  357 (469)
Q Consensus       291 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rp---sa~elL~hp~~~~~~  357 (469)
                      |..||.+.+..+....+...........+..+++++.+||.+|+ .+|.+|+   ++.++++||||....
T Consensus       240 G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~~  308 (376)
T cd05598         240 GQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGID  308 (376)
T ss_pred             CCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCCC
Confidence            99999998887777777655444444444578999999999987 5999999   999999999996543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-49  Score=393.83  Aligned_cols=252  Identities=30%  Similarity=0.532  Sum_probs=223.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|++..+|+.||||++++.       ...+.+|+.++..+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv   79 (333)
T cd05600           1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTK-SEWLVKLLYAFQDDEYLYLA   79 (333)
T ss_pred             CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCC-CCCCccEEEEEEcCCEEEEE
Confidence            3699999999999999999999999999999998642       235678999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  ....
T Consensus        80 ~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--~~~~  157 (333)
T cd05600          80 MEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--YANS  157 (333)
T ss_pred             EeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc--ccCC
Confidence            99999999999998888999999999999999999999999999999999999999999999999999976543  3345


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc----cCCCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW----ETVSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~lI  330 (469)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......+....+    ..++.++.+||
T Consensus       158 ~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li  237 (333)
T cd05600         158 VVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLI  237 (333)
T ss_pred             cccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHH
Confidence            679999999999976 5899999999999999999999999998888887777654332222222    25799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+||..+|.+||++.++++||||....
T Consensus       238 ~~~l~~~~~rr~s~~~ll~h~~~~~~~  264 (333)
T cd05600         238 TKLINDPSRRFGSLEDIKNHPFFKEVD  264 (333)
T ss_pred             HHHhhChhhhcCCHHHHHhCcccCCCC
Confidence            999999999999999999999997543

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-48  Score=386.71  Aligned_cols=241  Identities=31%  Similarity=0.568  Sum_probs=216.6

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||+|+||.||+|.+..+++.||+|++++.       ...+.+|+.+|+++. ||||+++++++...+.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~g~   79 (312)
T cd05585           1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVN-CPFIVPLKFSFQSPEKLYLVLAFINGGE   79 (312)
T ss_pred             CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCcEeceeeEEecCCeEEEEEcCCCCCc
Confidence            79999999999999999999999998642       235678999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccccCCCCcc
Q 012170          184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSPAY  262 (469)
Q Consensus       184 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~~~gt~~y  262 (469)
                      |.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++..... .......+||+.|
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y  159 (312)
T cd05585          80 LFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEY  159 (312)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCCccccccCCccc
Confidence            999998888999999999999999999999999999999999999999999999999999875322 2234456899999


Q ss_pred             cCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCC
Q 012170          263 VAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR  341 (469)
Q Consensus       263 ~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~R  341 (469)
                      +|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......++    ..+++++.+||.+||..||.+|
T Consensus       160 ~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dp~~R  235 (312)
T cd05585         160 LAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFP----DGFDRDAKDLLIGLLSRDPTRR  235 (312)
T ss_pred             CCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHcCCCHHHc
Confidence            99999976 489999999999999999999999999888888888877665554    4689999999999999999999


Q ss_pred             C---CHHHHHcCCCcccc
Q 012170          342 I---TADEVLRHPWILFY  356 (469)
Q Consensus       342 p---sa~elL~hp~~~~~  356 (469)
                      |   ++.++|+||||...
T Consensus       236 ~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         236 LGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             CCCCCHHHHHcCCCcCCC
Confidence            7   58999999999654

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=1.6e-48  Score=389.85  Aligned_cols=244  Identities=34%  Similarity=0.592  Sum_probs=218.2

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+|..||+|++++.       ...+.+|+.+++.+. ||||++++++|...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (323)
T cd05595           1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCFVMEYANG   79 (323)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCEEEEEEeCCCC
Confidence            4699999999999999999999999998642       134567999999996 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .........||+
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  159 (323)
T cd05595          80 GELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTP  159 (323)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCCccccccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987532 223334567999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||..||.
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~  235 (323)
T cd05595         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGLLKKDPK  235 (323)
T ss_pred             CcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCHH
Confidence            9999999965 589999999999999999999999998888888888776665554    46799999999999999999


Q ss_pred             CCC-----CHHHHHcCCCccccc
Q 012170          340 ARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +|+     ++.++++||||....
T Consensus       236 ~R~~~~~~~~~~~l~h~~~~~~~  258 (323)
T cd05595         236 QRLGGGPSDAKEVMEHRFFLSIN  258 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCC
Confidence            998     899999999997654

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=1.7e-48  Score=390.54  Aligned_cols=244  Identities=32%  Similarity=0.565  Sum_probs=217.8

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+|..||+|++.+.       ...+.+|+.+|+.+. ||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~Ey~~~   79 (328)
T cd05593           1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTR-HPFLTSLKYSFQTKDRLCFVMEYVNG   79 (328)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999642       235678999999996 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus        80 g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  159 (328)
T cd05593          80 GELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGTP  159 (328)
T ss_pred             CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcccccccccCCc
Confidence            9999999888889999999999999999999999999999999999999999999999999987532 223344568999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..++.++.+||.+||..||.
T Consensus       160 ~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~~L~~dP~  235 (328)
T cd05593         160 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFP----RTLSADAKSLLSGLLIKDPN  235 (328)
T ss_pred             CccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCC----CCCCHHHHHHHHHHcCCCHH
Confidence            9999999976 589999999999999999999999998888888777766655554    46899999999999999999


Q ss_pred             CCC-----CHHHHHcCCCccccc
Q 012170          340 ARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +|+     ++.++++||||....
T Consensus       236 ~R~~~~~~~~~~il~h~~~~~~~  258 (328)
T cd05593         236 KRLGGGPDDAKEIMRHSFFTGVN  258 (328)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCC
Confidence            997     899999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.3e-48  Score=399.34  Aligned_cols=251  Identities=33%  Similarity=0.537  Sum_probs=219.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +|++++.||+|+||.||+|++..+++.||+|++.+.       ...+.+|+.+++.+. ||||+++++.|.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~-h~~iv~~~~~~~~~~~~~lv~   80 (382)
T cd05625           2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFVM   80 (382)
T ss_pred             CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCC-CCcCCeEEEEEEeCCEEEEEE
Confidence            589999999999999999999999999999998643       245778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC------
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG------  250 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~------  250 (469)
                      |||+||+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~  160 (382)
T cd05625          81 DYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY  160 (382)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccccccc
Confidence            99999999999988888999999999999999999999999999999999999999999999999997532100      


Q ss_pred             ------------------------------------------CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHH
Q 012170          251 ------------------------------------------QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHA  287 (469)
Q Consensus       251 ------------------------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~e  287 (469)
                                                                ......+||+.|+|||++.+ .|+.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~e  240 (382)
T cd05625         161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE  240 (382)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHH
Confidence                                                      00123579999999999976 59999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC---HHHHHcCCCcccc
Q 012170          288 LLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT---ADEVLRHPWILFY  356 (469)
Q Consensus       288 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~  356 (469)
                      |++|.+||.+.+..+....+...........+..+++++.+||.+|+ .+|.+|++   +.++++||||...
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         241 MLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             HHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence            99999999988887777777665444444444678999999999987 59999997   9999999999654

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-49  Score=399.60  Aligned_cols=254  Identities=31%  Similarity=0.519  Sum_probs=218.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+++.||+|+||.||+|.+..+|+.||||++.+.       ...+.+|+++++.+. ||||++++++|.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv   79 (377)
T cd05629           1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESD-SPWVVSLYYSFQDAQYLYLI   79 (377)
T ss_pred             CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCeeEEE
Confidence            4799999999999999999999999999999998542       245678999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+....    
T Consensus        80 ~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~  159 (377)
T cd05629          80 MEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY  159 (377)
T ss_pred             EeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeeccccccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999986321100    


Q ss_pred             --------------------------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHH
Q 012170          252 --------------------------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLH  286 (469)
Q Consensus       252 --------------------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~  286 (469)
                                                                  .....+||+.|+|||++.+ .|+.++|||||||++|
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~  239 (377)
T cd05629         160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMF  239 (377)
T ss_pred             ccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhh
Confidence                                                        0012479999999999976 4899999999999999


Q ss_pred             HHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCC---CCHHHHHcCCCcccccc
Q 012170          287 ALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR---ITADEVLRHPWILFYTE  358 (469)
Q Consensus       287 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~R---psa~elL~hp~~~~~~~  358 (469)
                      +|++|.+||.+.+..+.+..+......+.......++.++++||.+||. +|.+|   +++.+++.||||....+
T Consensus       240 elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~~~  313 (377)
T cd05629         240 ECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGVDW  313 (377)
T ss_pred             hhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCCCH
Confidence            9999999999888877777776543333222334679999999999997 77765   59999999999976543

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=2e-48  Score=391.85  Aligned_cols=250  Identities=26%  Similarity=0.500  Sum_probs=223.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCC-cEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASG-AEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|++++.||+|+||.||+|.++.++ ..||+|++.+.       ...+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus        28 ~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~  106 (340)
T PTZ00426         28 KYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYIN-HPFCVNLYGSFKDESYL  106 (340)
T ss_pred             ChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCCcceEEEEEeCCEE
Confidence            3568999999999999999999877655 68999998532       245778999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus       107 ~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~--  184 (340)
T PTZ00426        107 YLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR--  184 (340)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC--
Confidence            999999999999999998889999999999999999999999999999999999999999999999999999765432  


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+.......+......++    ..+++.++++|+
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~  260 (340)
T PTZ00426        185 TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFP----KFLDNNCKHLMK  260 (340)
T ss_pred             cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHH
Confidence            3456899999999999764 89999999999999999999999999888888888887765554    457999999999


Q ss_pred             HhchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          332 RMLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       332 ~~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +||+.||.+|+     +++++++||||....
T Consensus       261 ~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~~  291 (340)
T PTZ00426        261 KLLSHDLTKRYGNLKKGAQNVKEHPWFGNID  291 (340)
T ss_pred             HHcccCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            99999999996     899999999996543

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=1.9e-48  Score=382.60  Aligned_cols=249  Identities=29%  Similarity=0.509  Sum_probs=212.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||.|+||.||+|.+..++..||+|+++..     ...+.+|+.+++.+. ||||+++++++.+.+.+|+|||
T Consensus         5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e   83 (288)
T cd07871           5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLK-HANIVTLHDIIHTERCLTLVFE   83 (288)
T ss_pred             ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEEEEe
Confidence            5799999999999999999999999999999998632     246778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          178 LCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      |+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus        84 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~~~~~  162 (288)
T cd07871          84 YLDS-DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTKTYSN  162 (288)
T ss_pred             CCCc-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCccccC
Confidence            9975 8888886654 4789999999999999999999999999999999999999999999999999764332 22344


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------C
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------F  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~  314 (469)
                      ..|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+......                   +
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd07871         163 EVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLF  242 (288)
T ss_pred             ceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhcccc
Confidence            578999999999865  4899999999999999999999999988776666554322110                   0


Q ss_pred             CC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.       .....++.++++||.+||+.||.+|||++|+|+||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         243 PQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            00       0123568899999999999999999999999999997

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only]

Probab=100.00  E-value=6e-49  Score=377.32  Aligned_cols=254  Identities=32%  Similarity=0.492  Sum_probs=219.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCC-eeEEEEEEEeCC----
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTG-VVTLHSVYEEAD----  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpn-Iv~l~~~~~~~~----  170 (469)
                      ...|+.+++||+|+||+||+|+.+.+|+.||+|.++-..      ....+|+.+|+.|+ |+| |+.|++++...+    
T Consensus        10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~-~~~~iv~L~dv~~~~~~~~~   88 (323)
T KOG0594|consen   10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLS-HANHIVRLHDVIHTSNNHRG   88 (323)
T ss_pred             HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhC-CCcceEEEEeeeeecccccc
Confidence            456888999999999999999999999999999996432      35689999999997 999 999999998877    


Q ss_pred             --eEEEEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          171 --CFHLVMELCSGGRLIDQMVEVG----QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       171 --~~~lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                        .+++|+||++. +|..++...+    .++...+..+++||+.||+|||++||+||||||+||||+++|.+||+|||+|
T Consensus        89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlA  167 (323)
T KOG0594|consen   89 IGKLYLVFEFLDR-DLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLA  167 (323)
T ss_pred             cceEEEEEEeecc-cHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchH
Confidence              89999999965 8888887765    5778899999999999999999999999999999999999999999999999


Q ss_pred             eeec-CCCcccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc--
Q 012170          245 MRIS-NGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW--  319 (469)
Q Consensus       245 ~~~~-~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~--  319 (469)
                      +... +....+..++|.+|+|||++.|.  |+..+||||+|||++||+++.+.|.|.+..+.+..|-...-......|  
T Consensus       168 ra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~  247 (323)
T KOG0594|consen  168 RAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPG  247 (323)
T ss_pred             HHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCC
Confidence            8665 33446677899999999999874  999999999999999999999999999987777776433221111111  


Q ss_pred             ------------------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          320 ------------------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       320 ------------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                              +..+.+..+++.+||+++|.+|.||+.+|.||||....
T Consensus       248 v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~  309 (323)
T KOG0594|consen  248 VSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTHPYFSELP  309 (323)
T ss_pred             ccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcChhhcccc
Confidence                                    22345899999999999999999999999999996554

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=2.2e-48  Score=397.60  Aligned_cols=253  Identities=31%  Similarity=0.492  Sum_probs=216.9

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .|++++.||+|+||+||+|+++.+++.||||++.+.       ...+.+|+.+|+.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~-h~~iv~l~~~~~~~~~~~lv~   80 (381)
T cd05626           2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEAD-NEWVVKLYYSFQDKDNLYFVM   80 (381)
T ss_pred             CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcC-CCCeeeeEEEEecCCEEEEEE
Confidence            588999999999999999999999999999999642       235778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC------
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG------  250 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~------  250 (469)
                      |||+||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+||||+.+|.+||+|||++......      
T Consensus        81 E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~  160 (381)
T cd05626          81 DYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY  160 (381)
T ss_pred             ecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccc
Confidence            99999999999988889999999999999999999999999999999999999999999999999997532100      


Q ss_pred             ------------------------------------------CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHH
Q 012170          251 ------------------------------------------QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHA  287 (469)
Q Consensus       251 ------------------------------------------~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~e  287 (469)
                                                                ......+||+.|+|||++.+ .|+.++|||||||++|+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~e  240 (381)
T cd05626         161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFE  240 (381)
T ss_pred             cccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHH
Confidence                                                      00123579999999999976 48999999999999999


Q ss_pred             HHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch--hhhcCCCCHHHHHcCCCccccc
Q 012170          288 LLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT--RDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       288 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~--~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      |++|.+||.+.+.......+...........+..+++++.+||.+||.  .+|..|+++.++++||||....
T Consensus       241 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~~  312 (381)
T cd05626         241 MLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEVD  312 (381)
T ss_pred             HHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCCC
Confidence            999999999887776666665443333333445689999999999664  4555599999999999996543

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3.5e-48  Score=387.32  Aligned_cols=250  Identities=29%  Similarity=0.538  Sum_probs=222.6

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +|++++.||+|+||.||+|.+..+++.||||++.+.       .+.+..|+.++..+..|++|+.+++++.+.+.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (324)
T cd05587           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM   80 (324)
T ss_pred             CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence            588999999999999999999999999999998642       2456789999999974567899999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~  255 (469)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~  160 (324)
T cd05587          81 EYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTRT  160 (324)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCCceee
Confidence            999999999999888899999999999999999999999999999999999999999999999999986532 2233445


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+.+..+......++    ..++.++.+||.+||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l  236 (324)
T cd05587         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLL  236 (324)
T ss_pred             ecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence            6899999999999764 89999999999999999999999999998888888887766554    468999999999999


Q ss_pred             hhhhcCCCCH-----HHHHcCCCccccc
Q 012170          335 TRDVSARITA-----DEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rpsa-----~elL~hp~~~~~~  357 (469)
                      ..||.+|+++     +++++||||....
T Consensus       237 ~~~P~~R~~~~~~~~~~~~~hp~~~~~~  264 (324)
T cd05587         237 TKHPAKRLGCGPTGERDIREHAFFRRID  264 (324)
T ss_pred             hcCHHHcCCCCCCCHHHHhcCCCcCCCC
Confidence            9999999976     8999999996543

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=7e-48  Score=384.67  Aligned_cols=245  Identities=33%  Similarity=0.588  Sum_probs=219.0

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+++.||||++.+.       ...+..|..++..+..||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~   80 (320)
T cd05590           1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG   80 (320)
T ss_pred             CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998642       234567888998876799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus        81 g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (320)
T cd05590          81 GDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGTP  160 (320)
T ss_pred             chHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCCCcccccccCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987542 233345568999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++    ..++.++.+||.+||+.||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~L~~dP~  236 (320)
T cd05590         161 DYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLSQDAVDILKAFMTKNPT  236 (320)
T ss_pred             cccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHcccCHH
Confidence            9999999976 489999999999999999999999999999888888887765554    35799999999999999999


Q ss_pred             CCCCH------HHHHcCCCccccc
Q 012170          340 ARITA------DEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rpsa------~elL~hp~~~~~~  357 (469)
                      +||++      +++++||||....
T Consensus       237 ~R~~~~~~~~~~~~~~h~~f~~~~  260 (320)
T cd05590         237 MRLGSLTLGGEEAILRHPFFKELD  260 (320)
T ss_pred             HCCCCCCCCCHHHHHcCCCcCCCC
Confidence            99998      9999999996543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=6.9e-48  Score=384.72  Aligned_cols=246  Identities=30%  Similarity=0.535  Sum_probs=219.6

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+++.||||++++.       ...+..|.+++..+..||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~   80 (321)
T cd05591           1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG   80 (321)
T ss_pred             CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence            4699999999999999999999999998642       134667899998876799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... .......+||+
T Consensus        81 ~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (321)
T cd05591          81 GDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGTP  160 (321)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCccccccccCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875432 23344567999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++    ..++.++.+||.+||+.||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll~~~L~~dp~  236 (321)
T cd05591         161 DYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYP----VWLSKEAVSILKAFMTKNPN  236 (321)
T ss_pred             cccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhccCHH
Confidence            9999999976 589999999999999999999999999999999988887765554    35799999999999999999


Q ss_pred             CCC-------CHHHHHcCCCcccccc
Q 012170          340 ARI-------TADEVLRHPWILFYTE  358 (469)
Q Consensus       340 ~Rp-------sa~elL~hp~~~~~~~  358 (469)
                      +||       ++.++++||||....+
T Consensus       237 ~R~~~~~~~~~~~~~~~hp~~~~~~~  262 (321)
T cd05591         237 KRLGCVASQGGEDAIKQHPFFKEIDW  262 (321)
T ss_pred             HcCCCCCCCCCHHHHhcCCccCCCCH
Confidence            999       9999999999965543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.9e-48  Score=381.59  Aligned_cols=250  Identities=28%  Similarity=0.461  Sum_probs=211.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||.||+|+++.+++.||+|++...      ...+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (287)
T cd07848           1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLK-QENIVELKEAFRRRGKLYLVF   79 (287)
T ss_pred             CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCC-CccccchhhhEecCCEEEEEE
Confidence            4799999999999999999999999999999998642      245778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--ccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~  254 (469)
                      ||+.++.+..+......+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (287)
T cd07848          80 EYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANYT  159 (287)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccccccc
Confidence            999988776555445679999999999999999999999999999999999999999999999999998654322  233


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-------------------
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-------------------  314 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------  314 (469)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+....+.......                   
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07848         160 EYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRF  239 (287)
T ss_pred             ccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhccccc
Confidence            4679999999999976 58999999999999999999999999876655444333211100                   


Q ss_pred             CC---------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HS---------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~---------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.         ..+..+|.++.+||++||++||++|||++|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         240 PAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            00         0112378899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=8.7e-48  Score=384.33  Aligned_cols=250  Identities=29%  Similarity=0.539  Sum_probs=223.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +|.+++.||+|+||.||+|.+..++..||||++.+..       .....|..++..+..||+|+++++++.+.+.+|+||
T Consensus         1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05616           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM   80 (323)
T ss_pred             CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence            5889999999999999999999999999999986431       245668888888876899999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~  255 (469)
                      ||++||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... ......
T Consensus        81 E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~~~~~~  160 (323)
T cd05616          81 EYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTKT  160 (323)
T ss_pred             cCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCCCcccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999975432 233445


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+...++..+......++    ..++.++.+||.+||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~l  236 (323)
T cd05616         161 FCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICKGLM  236 (323)
T ss_pred             CCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CcCCHHHHHHHHHHc
Confidence            789999999999976 489999999999999999999999999998888888887766555    468999999999999


Q ss_pred             hhhhcCCCC-----HHHHHcCCCccccc
Q 012170          335 TRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      +.||.+|++     ..++++||||....
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~~~~~~  264 (323)
T cd05616         237 TKHPGKRLGCGPEGERDIKEHAFFRYID  264 (323)
T ss_pred             ccCHHhcCCCCCCCHHHHhcCCCcCCCC
Confidence            999999998     48999999996544

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2e-48  Score=392.60  Aligned_cols=253  Identities=35%  Similarity=0.620  Sum_probs=223.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+++.||+|+||.||+|.+..+|+.||||++++.       ...+..|+.++..+. ||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (350)
T cd05573           1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADAD-SPWIVKLYYSFQDEEHLYLV   79 (350)
T ss_pred             CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcC-CCCccchhhheecCCeEEEE
Confidence            4799999999999999999999999999999998642       245778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      |||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......    
T Consensus        80 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~  159 (350)
T cd05573          80 MEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREY  159 (350)
T ss_pred             EcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999997654433    


Q ss_pred             --------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 012170          252 --------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF  304 (469)
Q Consensus       252 --------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  304 (469)
                                                ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.....
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~  239 (350)
T cd05573         160 YLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETY  239 (350)
T ss_pred             cccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHH
Confidence                                      2234579999999999976 4899999999999999999999999998888777


Q ss_pred             HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC-HHHHHcCCCccccc
Q 012170          305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT-ADEVLRHPWILFYT  357 (469)
Q Consensus       305 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps-a~elL~hp~~~~~~  357 (469)
                      ..+......+.......+++++.+||.+||. ||.+||+ +.++|+||||....
T Consensus       240 ~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~~  292 (350)
T cd05573         240 NKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGID  292 (350)
T ss_pred             HHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCCC
Confidence            7777633222222234479999999999997 9999999 99999999997654

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=2.7e-48  Score=393.90  Aligned_cols=255  Identities=30%  Similarity=0.531  Sum_probs=220.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|.++.+++.||||++++.       ...+..|+.++..+. ||||+++++.+.+.+.+|+|
T Consensus         1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~~~~lv   79 (360)
T cd05627           1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEAD-GAWVVKMFYSFQDKRNLYLI   79 (360)
T ss_pred             CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            4789999999999999999999999999999998642       245778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++.......    
T Consensus        80 ~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~  159 (360)
T cd05627          80 MEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEF  159 (360)
T ss_pred             EeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCccccccccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999986432110    


Q ss_pred             --------------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC
Q 012170          252 --------------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD  298 (469)
Q Consensus       252 --------------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~  298 (469)
                                                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~  239 (360)
T cd05627         160 YRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE  239 (360)
T ss_pred             ccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCC
Confidence                                            0123579999999999976 4899999999999999999999999998


Q ss_pred             CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCC---CHHHHHcCCCccccccc
Q 012170          299 SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI---TADEVLRHPWILFYTER  359 (469)
Q Consensus       299 ~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rp---sa~elL~hp~~~~~~~~  359 (469)
                      +....+..+..............++.++++||.+|+. ||.+|+   ++.++++||||....+.
T Consensus       240 ~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~~~~  302 (360)
T cd05627         240 TPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGVDWG  302 (360)
T ss_pred             CHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCCCHH
Confidence            8888888777643322222223579999999999874 999998   48999999999765443

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=7.3e-48  Score=392.21  Aligned_cols=254  Identities=35%  Similarity=0.548  Sum_probs=222.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      -.++|++++.||+|+||.||+|.++.++..||+|++.+.       ...+.+|+.+++.+. ||||+++++++.+++.+|
T Consensus        41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~-h~~iv~~~~~~~~~~~~~  119 (370)
T cd05596          41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN-SEWIVQLHYAFQDDKYLY  119 (370)
T ss_pred             CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCcceEEEEEecCCEEE
Confidence            457899999999999999999999999999999998642       234678999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--  251 (469)
                      +||||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~  198 (370)
T cd05596         120 MVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV  198 (370)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc
Confidence            99999999999998754 578999999999999999999999999999999999999999999999999998764332  


Q ss_pred             cccccCCCCcccCceeccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      .....+||+.|+|||++.+     .++.++|||||||++|+|++|.+||.+.+....+..|......+.......+|.++
T Consensus       199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (370)
T cd05596         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLTFPDDIEISKQA  278 (370)
T ss_pred             cCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCCCCCcCCCCHHH
Confidence            2245679999999999854     37889999999999999999999999998888888887654333323334689999


Q ss_pred             HHHHHHhchhhhcC--CCCHHHHHcCCCcccc
Q 012170          327 RDLMARMLTRDVSA--RITADEVLRHPWILFY  356 (469)
Q Consensus       327 ~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~  356 (469)
                      ++||.+||+.+|.+  |+|++++++||||...
T Consensus       279 ~~li~~~L~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         279 KDLICAFLTDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             HHHHHHHccChhhccCCCCHHHHhcCcccCCC
Confidence            99999999999988  9999999999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.6e-47  Score=383.63  Aligned_cols=244  Identities=29%  Similarity=0.530  Sum_probs=211.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+++.||||++++.       ...+.+|..++..+.+||||++++++|.+.+.+|+|||||+|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~   80 (329)
T cd05588           1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG   80 (329)
T ss_pred             CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999752       134678999999997799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee-cCCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~-~~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++... .........+||+
T Consensus        81 g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05588          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCCCccccccCCc
Confidence            999999988889999999999999999999999999999999999999999999999999998642 2233345578999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---------SLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||...         ........+......++    ..++.++.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li  236 (329)
T cd05588         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKASSVL  236 (329)
T ss_pred             cccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHcCCCCCC----CCCCHHHHHHH
Confidence            9999999976 4899999999999999999999999631         12234445555544443    46799999999


Q ss_pred             HHhchhhhcCCCC------HHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARIT------ADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rps------a~elL~hp~~~~~  356 (469)
                      .+||+.||.+|++      +.++++||||...
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~  268 (329)
T cd05588         237 KGFLNKDPKERLGCHPQTGFRDIKSHPFFRNI  268 (329)
T ss_pred             HHHhccCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            9999999999997      7899999999543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=2.4e-47  Score=380.08  Aligned_cols=245  Identities=33%  Similarity=0.598  Sum_probs=215.6

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+++.||||++++.       .+....|..++..+..||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g   80 (316)
T cd05592           1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999998642       133456777887665799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus        81 g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~  160 (316)
T cd05592          81 GDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCCCccccccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999976432 23344568999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+......++    ..++.++.+||.+||..||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~ll~~~l~~~P~  236 (316)
T cd05592         161 DYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP----RWISKEAKDCLSKLFERDPT  236 (316)
T ss_pred             cccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHccCCHH
Confidence            9999999976 489999999999999999999999999998888888876654444    45799999999999999999


Q ss_pred             CCCCH-HHHHcCCCccccc
Q 012170          340 ARITA-DEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rpsa-~elL~hp~~~~~~  357 (469)
                      +||++ .++++||||....
T Consensus       237 ~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05592         237 KRLGVDGDIRQHPFFRGID  255 (316)
T ss_pred             HcCCChHHHHcCcccCCCC
Confidence            99986 5889999996543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.8e-47  Score=381.27  Aligned_cols=245  Identities=32%  Similarity=0.587  Sum_probs=218.8

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+++.||||++++.       ...+.+|..++..+..||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~   80 (318)
T cd05570           1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG   80 (318)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence            4699999999999999999999999999742       234667899998886799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~  160 (318)
T cd05570          81 GDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGTP  160 (318)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCCcccceecCc
Confidence            9999999888899999999999999999999999999999999999999999999999999986532 223334567999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..++.++.+||.+||..||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~dP~  236 (318)
T cd05570         161 DYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP----RWLSKEAKSILKSFLTKNPE  236 (318)
T ss_pred             cccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CcCCHHHHHHHHHHccCCHH
Confidence            9999999976 589999999999999999999999999888888888877665544    45799999999999999999


Q ss_pred             CCCCH-----HHHHcCCCccccc
Q 012170          340 ARITA-----DEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rpsa-----~elL~hp~~~~~~  357 (469)
                      +||++     .+++.||||....
T Consensus       237 ~R~s~~~~~~~~ll~~~~~~~~~  259 (318)
T cd05570         237 KRLGCLPTGEQDIKGHPFFREID  259 (318)
T ss_pred             HcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999     9999999996543

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=1.1e-47  Score=382.63  Aligned_cols=245  Identities=29%  Similarity=0.574  Sum_probs=216.7

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+|..||+|++++.       ......|..++..+.+||||+++++++.+.+.+|+||||+.|
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~   80 (316)
T cd05620           1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG   80 (316)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence            4699999999999999999999999998642       234667888888765699999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.... ........+||+
T Consensus        81 g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05620          81 GDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCCCceeccCCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987532 223345578999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..++.++++||.+||..||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~  236 (316)
T cd05620         161 DYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYP----RWITKESKDILEKLFERDPT  236 (316)
T ss_pred             CccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHHccCCHH
Confidence            9999999976 589999999999999999999999999988888888876655444    35799999999999999999


Q ss_pred             CCCCH-HHHHcCCCccccc
Q 012170          340 ARITA-DEVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rpsa-~elL~hp~~~~~~  357 (469)
                      +||++ +++++||||....
T Consensus       237 ~R~~~~~~~~~h~~f~~~~  255 (316)
T cd05620         237 RRLGVVGNIRGHPFFKTIN  255 (316)
T ss_pred             HcCCChHHHHcCCCcCCCC
Confidence            99997 5899999996543

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=1e-47  Score=384.11  Aligned_cols=244  Identities=32%  Similarity=0.570  Sum_probs=217.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+|..||+|++++.       ...+..|+++++.+. ||||+++++++...+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~-hp~i~~~~~~~~~~~~~~lv~E~~~~   79 (325)
T cd05594           1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLCFVMEYANG   79 (325)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCCceEEEEEcCCEEEEEEeCCCC
Confidence            4699999999999999999999999999642       134567999999996 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGS  259 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt  259 (469)
                      |+|..++...+.+++..+..++.||+.||.|||+ .||+||||||+|||++.+|.+||+|||++.... .........||
T Consensus        80 ~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt  159 (325)
T cd05594          80 GELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGT  159 (325)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCcccccccCC
Confidence            9999999888899999999999999999999997 799999999999999999999999999987533 22334456799


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||+.||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~L~~dP  235 (325)
T cd05594         160 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLSPEAKSLLSGLLKKDP  235 (325)
T ss_pred             cccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhhcCH
Confidence            99999999966 589999999999999999999999999888888888776665554    4679999999999999999


Q ss_pred             cCCC-----CHHHHHcCCCccccc
Q 012170          339 SARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      .+|+     ++.++++||||....
T Consensus       236 ~~R~~~~~~~~~~il~h~~~~~~~  259 (325)
T cd05594         236 KQRLGGGPDDAKEIMQHKFFAGIV  259 (325)
T ss_pred             HHhCCCCCCCHHHHhcCCCcCCCC
Confidence            9997     899999999996543

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=1.2e-47  Score=379.47  Aligned_cols=253  Identities=28%  Similarity=0.464  Sum_probs=208.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++++.||+|+||.||+|.++.+|+.||||++...     ...+.+|+.+++.+. ||||+++++++.+.+..|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~   82 (303)
T cd07869           4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTLVF   82 (303)
T ss_pred             cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCC-CCCcCeEEEEEecCCeEEEEE
Confidence            47899999999999999999999999999999998642     235678999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||+. ++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus        83 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~  161 (303)
T cd07869          83 EYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYS  161 (303)
T ss_pred             ECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCccCC
Confidence            9996 5777777554 56899999999999999999999999999999999999999999999999999754322 2334


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCC--------------CCCC
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLD--------------FHSG  317 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~--------------~~~~  317 (469)
                      ...||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.. ....+..+......              +...
T Consensus       162 ~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (303)
T cd07869         162 NEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPE  241 (303)
T ss_pred             CCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccc
Confidence            5678999999999865  47889999999999999999999998743 22333322110000              0000


Q ss_pred             ------------cc--cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          318 ------------VW--ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       318 ------------~~--~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                  .|  ..+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~  294 (303)
T cd07869         242 RFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDL  294 (303)
T ss_pred             cccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhcCcccccC
Confidence                        01  1245789999999999999999999999999999654

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=1.1e-47  Score=390.69  Aligned_cols=256  Identities=33%  Similarity=0.528  Sum_probs=221.2

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ....++|++++.||+|+||.||+|.++.+++.||+|++.+.       ...+.+|+.+++.+. ||||+++++++.+++.
T Consensus        39 ~~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~  117 (370)
T cd05621          39 QMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFCAFQDDKY  117 (370)
T ss_pred             CCCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCE
Confidence            34567899999999999999999999999999999998641       234778999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......
T Consensus       118 ~~lv~Ey~~gg~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~  196 (370)
T cd05621         118 LYMVMEYMPGGDLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG  196 (370)
T ss_pred             EEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC
Confidence            9999999999999998854 468999999999999999999999999999999999999999999999999998764332


Q ss_pred             c--ccccCCCCcccCceeccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          252 T--LSGLAGSPAYVAPEVLSG-----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      .  ....+||+.|+|||++.+     .++.++|||||||++|+|++|.+||.+.+....+..|......+.......++.
T Consensus       197 ~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~  276 (370)
T cd05621         197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLNFPEDVEISK  276 (370)
T ss_pred             ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccCCCCcccCCH
Confidence            2  245679999999999864     278899999999999999999999999888888888776543333223346799


Q ss_pred             HHHHHHHHhchhhhcC--CCCHHHHHcCCCcccc
Q 012170          325 PARDLMARMLTRDVSA--RITADEVLRHPWILFY  356 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~  356 (469)
                      .++++|.+||..++.+  |+++.|+++||||...
T Consensus       277 ~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         277 HAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             HHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence            9999999999865544  8999999999999653

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism]

Probab=100.00  E-value=8.9e-49  Score=375.80  Aligned_cols=254  Identities=29%  Similarity=0.473  Sum_probs=220.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeC---C--eEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEA---D--CFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~---~--~~~lV  175 (469)
                      ..-.|.-.+++|.|+||.||+|....+++.||||.+-.+...-.+|++||+.+. |||||+|..+|...   +  +..+|
T Consensus        22 ~~i~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~knrEl~im~~l~-HpNIV~L~~~f~~~~~~d~~~lnlV  100 (364)
T KOG0658|consen   22 VEISYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRYKNRELQIMRKLD-HPNIVRLLYFFSSSTESDEVYLNLV  100 (364)
T ss_pred             eEEEEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCcCcHHHHHHHhcC-CcCeeeEEEEEEecCCCchhHHHHH
Confidence            445688889999999999999999999999999999887777788999999996 99999999988632   2  46699


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeeecCC
Q 012170          176 MELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG  250 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~~~~  250 (469)
                      |||++. +|.+.+..    +..++.-.++-+..||++||.|||+.||+||||||.|||+|.+ |.+||||||.|+....+
T Consensus       101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~  179 (364)
T KOG0658|consen  101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKG  179 (364)
T ss_pred             HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccC
Confidence            999976 88888864    4678899999999999999999999999999999999999986 99999999999999888


Q ss_pred             CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc------------CC---
Q 012170          251 QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK------------LD---  313 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------~~---  313 (469)
                      ....++..|..|+|||.+.|  .|+.+.||||.|||+.||+.|.+-|.|.+..+++..|.+.-            +.   
T Consensus       180 epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~  259 (364)
T KOG0658|consen  180 EPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTE  259 (364)
T ss_pred             CCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccccc
Confidence            88888999999999999988  49999999999999999999999999988777766653221            11   


Q ss_pred             -----CCCC-----cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 -----FHSG-----VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 -----~~~~-----~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                           +...     ....+++++.+|+.++|.++|.+|.++.|+|.||||...
T Consensus       260 ~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~h~fFdel  312 (364)
T KOG0658|consen  260 FKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALAHPFFDEL  312 (364)
T ss_pred             ccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhcchhhHHh
Confidence                 1111     224579999999999999999999999999999999543

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=4.9e-48  Score=387.35  Aligned_cols=250  Identities=30%  Similarity=0.550  Sum_probs=215.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      +|++++.||+|+||.||+|++.   .+|..||+|++.+.        .+.+..|+.+|+.+..||||+++++++...+.+
T Consensus         1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (332)
T cd05614           1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL   80 (332)
T ss_pred             CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence            5889999999999999998864   57899999998642        235678999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC--
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG--  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~--  250 (469)
                      |+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  
T Consensus        81 ~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~  160 (332)
T cd05614          81 HLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK  160 (332)
T ss_pred             EEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC
Confidence            999999999999999988889999999999999999999999999999999999999999999999999999764332  


Q ss_pred             CcccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ......+||+.|+|||++.+.  ++.++|||||||++|+|++|..||...    ....+...+......++    ..++.
T Consensus       161 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (332)
T cd05614         161 ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDPPFP----SFIGP  236 (332)
T ss_pred             CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCH
Confidence            223356899999999999763  788999999999999999999999643    23344444544443333    46899


Q ss_pred             HHHHHHHHhchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          325 PARDLMARMLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      .+.+||.+||..||++||     +++++++||||....
T Consensus       237 ~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~~  274 (332)
T cd05614         237 EAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGLD  274 (332)
T ss_pred             HHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCCC
Confidence            999999999999999999     889999999996543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-48  Score=385.10  Aligned_cols=255  Identities=34%  Similarity=0.576  Sum_probs=236.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      +.+..-|.+.+.||+|.|+.|-+|++.-||+.||||++.+.      ...+.+|+..|+-++ |||||+||++......+
T Consensus        14 gkIAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQ-HpNiVRLYEViDTQTKl   92 (864)
T KOG4717|consen   14 GKIAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQ-HPNIVRLYEVIDTQTKL   92 (864)
T ss_pred             cceeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhc-CcCeeeeeehhcccceE
Confidence            45777899999999999999999999999999999999764      256889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-cCCcEEEEeccceeeecCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-~~~~vkL~DFgla~~~~~~  250 (469)
                      |||+|+-++|+|+|+|.++ ..++|+.+..++.||+.|+.|||+..+|||||||+||.+- .-|-|||+|||++-.+.++
T Consensus        93 yLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG  172 (864)
T KOG4717|consen   93 YLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPG  172 (864)
T ss_pred             EEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCc
Confidence            9999999999999999776 5799999999999999999999999999999999998775 4689999999999999999


Q ss_pred             CcccccCCCCcccCceeccCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSGN-YS-EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~~-~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      +...+.||+..|.|||++.|. |+ +++||||||||||-|++|.+||...+..+.+-.|...++..|    ..+|.+++|
T Consensus       173 ~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtvP----shvS~eCrd  248 (864)
T KOG4717|consen  173 KKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTVP----SHVSKECRD  248 (864)
T ss_pred             chhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcccccCc----hhhhHHHHH
Confidence            999999999999999999885 65 689999999999999999999999888899999999998887    578999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ||..||..||.+|.+.++|..|+|++...+
T Consensus       249 LI~sMLvRdPkkRAslEeI~s~~Wlq~~D~  278 (864)
T KOG4717|consen  249 LIQSMLVRDPKKRASLEEIVSTSWLQAGDR  278 (864)
T ss_pred             HHHHHHhcCchhhccHHHHhccccccCCCC
Confidence            999999999999999999999999976643

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=2.4e-47  Score=381.13  Aligned_cols=244  Identities=32%  Similarity=0.563  Sum_probs=213.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHH-HHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVE-IMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~-il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.++.+|+.||||++.+..       ..+..|.. +++.+. ||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (323)
T cd05575           1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTADKLYFVLDYVN   79 (323)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCC-CCCCCCeeEEEEeCCEEEEEEcCCC
Confidence            46999999999999999999999999986421       23444544 456675 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGS  259 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt  259 (469)
                      ||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ........+||
T Consensus        80 ~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (323)
T cd05575          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT  159 (323)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCCccccccCC
Confidence            99999999888899999999999999999999999999999999999999999999999999987532 22334456899


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.......+    ..++..+.+||.+||+.||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p  235 (323)
T cd05575         160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLK----PNISVSARHLLEGLLQKDR  235 (323)
T ss_pred             hhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcCH
Confidence            99999999976 489999999999999999999999999888888888877655443    4579999999999999999


Q ss_pred             cCCCCH----HHHHcCCCccccc
Q 012170          339 SARITA----DEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rpsa----~elL~hp~~~~~~  357 (469)
                      .+||++    .++++||||....
T Consensus       236 ~~R~~~~~~~~~il~~~~~~~~~  258 (323)
T cd05575         236 TKRLGAKDDFLEIKNHVFFSSIN  258 (323)
T ss_pred             HhCCCCCCCHHHHHcCCCcCCCC
Confidence            999987    6999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=7.2e-48  Score=385.83  Aligned_cols=253  Identities=30%  Similarity=0.502  Sum_probs=220.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+.+.||+|+||.||+|.++.+|+.||||++++.       ...+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~-~~~i~~~~~~~~~~~~~~lv   79 (330)
T cd05601           1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISN-SPWIPQLQYAFQDKDNLYLV   79 (330)
T ss_pred             CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCCcceeeEEecCCeEEEE
Confidence            4799999999999999999999999999999999653       235778999999986 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          176 MELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||++||+|.+++... +.+++..+..++.||+.||.|||+.||+||||||+|||++.+|.+||+|||++........  
T Consensus        80 ~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~~  159 (330)
T cd05601          80 MEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMVN  159 (330)
T ss_pred             ECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCcee
Confidence            9999999999999876 6899999999999999999999999999999999999999999999999999987654332  


Q ss_pred             ccccCCCCcccCceeccC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .....||+.|+|||++..       .++.++|||||||++|+|++|..||.+.+....+..+..............++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (330)
T cd05601         160 SKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPEDPKVSSD  239 (330)
T ss_pred             eecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHH
Confidence            223579999999999852       4788999999999999999999999988887777777654322222223468999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +.+||.+||. +|.+|||++++++||||....
T Consensus       240 ~~~li~~ll~-~p~~R~t~~~l~~h~~~~~~~  270 (330)
T cd05601         240 FLDLIQSLLC-GQKERLGYEGLCCHPFFSKID  270 (330)
T ss_pred             HHHHHHHHcc-ChhhCCCHHHHhCCCCcCCCC
Confidence            9999999998 999999999999999997544

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=5.6e-47  Score=378.56  Aligned_cols=245  Identities=32%  Similarity=0.566  Sum_probs=216.9

Q ss_pred             eeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          108 VEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++.||+|+||.||+|++.   .+++.||+|++++.        ...+..|+.+|+.+. ||||++++++|..++.+|+||
T Consensus         1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~iv~~~~~~~~~~~~~lv~   79 (323)
T cd05584           1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVK-HPFIVDLIYAFQTGGKLYLIL   79 (323)
T ss_pred             CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCC-CCchhceeeEEecCCeEEEEE
Confidence            368999999999999864   57899999998642        134668999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~  255 (469)
                      ||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ......
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  159 (323)
T cd05584          80 EYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTHT  159 (323)
T ss_pred             eCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCCcccc
Confidence            9999999999998888999999999999999999999999999999999999999999999999999875432 223345


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++    ..+++++.+||.+||
T Consensus       160 ~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l  235 (323)
T cd05584         160 FCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----PYLTPEARDLLKKLL  235 (323)
T ss_pred             cCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHc
Confidence            679999999999976 488999999999999999999999999888888888877665544    467999999999999


Q ss_pred             hhhhcCCC-----CHHHHHcCCCccccc
Q 012170          335 TRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      .+||++||     +++++++||||....
T Consensus       236 ~~~p~~R~~~~~~~~~~l~~h~~~~~~~  263 (323)
T cd05584         236 KRNPSSRLGAGPGDAAEVQSHPFFRHVN  263 (323)
T ss_pred             ccCHhHcCCCCCCCHHHHhcCCCcCCCC
Confidence            99999999     899999999996543

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=5.3e-47  Score=379.80  Aligned_cols=245  Identities=29%  Similarity=0.539  Sum_probs=211.4

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.+++.||+|++++.       ...+.+|+.++.++.+||||+++++++...+.+|+||||+++
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~   80 (329)
T cd05618           1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG   80 (329)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999752       134678999998886799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~  160 (329)
T cd05618          81 GDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTP  160 (329)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCCccccccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999987532 223344568999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKG---------DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||..         .....+...+......++    ..++.++.+||
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~ll  236 (329)
T cd05618         161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLSVKAASVL  236 (329)
T ss_pred             cccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCCCCCC----CCCCHHHHHHH
Confidence            9999999976 489999999999999999999999952         112334445555544443    46799999999


Q ss_pred             HHhchhhhcCCCC------HHHHHcCCCccccc
Q 012170          331 ARMLTRDVSARIT------ADEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rps------a~elL~hp~~~~~~  357 (469)
                      .+||+.||.+||+      +.++++||||....
T Consensus       237 ~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~  269 (329)
T cd05618         237 KSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  269 (329)
T ss_pred             HHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCC
Confidence            9999999999998      58999999996543

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=7.3e-47  Score=377.80  Aligned_cols=246  Identities=35%  Similarity=0.591  Sum_probs=216.3

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHH---HhhCCCCeeEEEEEEEeCCeEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQ---HLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~---~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      |++++.||+|+||.||+|.+..+|+.||||++++.       .+.+.+|+.++.   .+. ||||+++++++.+.+.+|+
T Consensus         1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~-hp~i~~~~~~~~~~~~~~l   79 (324)
T cd05589           1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER-HPFLVNLFACFQTEDHVCF   79 (324)
T ss_pred             CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccC-CCChhceeeEEEcCCEEEE
Confidence            67889999999999999999999999999999642       234666776664   454 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~  253 (469)
                      ||||++||+|...+. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... .....
T Consensus        80 v~E~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~  158 (324)
T cd05589          80 VMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT  158 (324)
T ss_pred             EEcCCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCCCcc
Confidence            999999999988774 4679999999999999999999999999999999999999999999999999986532 22334


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++    ..++.++.+||.+
T Consensus       159 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  234 (324)
T cd05589         159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEVRYP----RFLSREAISIMRR  234 (324)
T ss_pred             cccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence            45789999999999976 489999999999999999999999999988888888877665554    4679999999999


Q ss_pred             hchhhhcCCC-----CHHHHHcCCCcccc
Q 012170          333 MLTRDVSARI-----TADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rp-----sa~elL~hp~~~~~  356 (469)
                      ||+.||.+||     ++.++++||||...
T Consensus       235 ~L~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         235 LLRRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             HhhcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            9999999999     79999999999654

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=3.5e-47  Score=380.13  Aligned_cols=251  Identities=28%  Similarity=0.514  Sum_probs=222.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +|++.+.||+|+||.||+|.++.+|+.||||++.+.       ...+..|..++..+..|++|+++++++.+.+.+|+||
T Consensus         1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~   80 (323)
T cd05615           1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM   80 (323)
T ss_pred             CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence            477889999999999999999999999999998642       1346678999988876788999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .....
T Consensus        81 Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~~~~~  160 (323)
T cd05615          81 EYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTRT  160 (323)
T ss_pred             cCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCCccccC
Confidence            99999999999988889999999999999999999999999999999999999999999999999998754322 22345


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++    ..++.++.+||.+||
T Consensus       161 ~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l  236 (323)
T cd05615         161 FCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVSYP----KSLSKEAVSICKGLM  236 (323)
T ss_pred             ccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHc
Confidence            679999999999976 489999999999999999999999999988888888877665554    467999999999999


Q ss_pred             hhhhcCCCC-----HHHHHcCCCcccccc
Q 012170          335 TRDVSARIT-----ADEVLRHPWILFYTE  358 (469)
Q Consensus       335 ~~dP~~Rps-----a~elL~hp~~~~~~~  358 (469)
                      .+||.+|++     .+++++||||....+
T Consensus       237 ~~~p~~R~~~~~~~~~~i~~h~~f~~~~~  265 (323)
T cd05615         237 TKHPSKRLGCGPEGERDIREHAFFRRIDW  265 (323)
T ss_pred             ccCHhhCCCCCCCCHHHHhcCcccCCCCH
Confidence            999999997     589999999976543

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=8.9e-47  Score=376.11  Aligned_cols=245  Identities=29%  Similarity=0.549  Sum_probs=216.1

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+++.||||+++..       ......|..++..+..||||+++++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~   80 (316)
T cd05619           1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG   80 (316)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999998643       234567888888765699999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~~~gt~  260 (469)
                      |+|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (316)
T cd05619          81 GDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGTP  160 (316)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCCceeeecCCc
Confidence            99999998888899999999999999999999999999999999999999999999999999875322 22344567999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhc
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS  339 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~  339 (469)
                      .|+|||++.+ .++.++||||+||++|+|++|..||.+.+..+++..+......++    ..++.++++||.+||..||.
T Consensus       161 ~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~P~  236 (316)
T cd05619         161 DYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYP----RWLTREAKDILVKLFVREPE  236 (316)
T ss_pred             cccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHHHhccCHh
Confidence            9999999976 489999999999999999999999999888888888776554443    34799999999999999999


Q ss_pred             CCCCHH-HHHcCCCccccc
Q 012170          340 ARITAD-EVLRHPWILFYT  357 (469)
Q Consensus       340 ~Rpsa~-elL~hp~~~~~~  357 (469)
                      +||++. ++++||||....
T Consensus       237 ~R~~~~~~l~~h~~~~~~~  255 (316)
T cd05619         237 RRLGVKGDIRQHPFFREID  255 (316)
T ss_pred             hcCCChHHHHcCcccCCCC
Confidence            999996 899999996644

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms]

Probab=100.00  E-value=6.4e-50  Score=372.68  Aligned_cols=257  Identities=29%  Similarity=0.415  Sum_probs=227.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++-|.++++||+|+||.||+|.++.+|+.+|||.+.-  +.+.+..|+.||+++. .|++|++|+.|-....+||||||
T Consensus        31 PEEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~sDLQEIIKEISIMQQC~-S~yVVKYYGSYFK~sDLWIVMEY  109 (502)
T KOG0574|consen   31 PEEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDTDLQEIIKEISIMQQCK-SKYVVKYYGSYFKHSDLWIVMEY  109 (502)
T ss_pred             hHHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccchHHHHHHHHHHHHHcC-CchhhhhhhhhccCCceEeehhh
Confidence            45678999999999999999999999999999999854  4578999999999997 99999999999888899999999


Q ss_pred             cCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          179 CSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      |..|++.|.+.. +++++++++..+++..+.||+|||...-+|||||..|||++.+|..||+|||.|..+.+.. ..++.
T Consensus       110 CGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAKRNTV  189 (502)
T KOG0574|consen  110 CGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAKRNTV  189 (502)
T ss_pred             cCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhHHhhCcc
Confidence            999999999854 5789999999999999999999999999999999999999999999999999998776543 35678


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-CCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-DFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .|||.|||||++.. .|+.++||||||++..||..|++||.+-.+...+..|....+ .|.  .+..+|.++.|||++||
T Consensus       190 IGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~PPPTF~--KPE~WS~~F~DFi~~CL  267 (502)
T KOG0574|consen  190 IGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKPPPTFK--KPEEWSSEFNDFIRSCL  267 (502)
T ss_pred             ccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCCCCCCC--ChHhhhhHHHHHHHHHh
Confidence            99999999999977 699999999999999999999999998887766655544332 232  23457999999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCcccccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYTERT  360 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~~~~  360 (469)
                      .++|++|-||.++++|||+....-..
T Consensus       268 iK~PE~R~TA~~L~~H~FiknA~g~~  293 (502)
T KOG0574|consen  268 IKKPEERKTALRLCEHTFIKNAPGCD  293 (502)
T ss_pred             cCCHHHHHHHHHHhhhhhhcCCCccc
Confidence            99999999999999999997654433

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-47  Score=372.46  Aligned_cols=253  Identities=31%  Similarity=0.535  Sum_probs=215.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .|++.+.||+|+||.||++.+..+++.||||++...       ...+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus         1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (285)
T cd05605           1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcC-CCCEeeeeeeecCCCeEEEEE
Confidence            378899999999999999999999999999998642       134667999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||+.||+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||++++++.++|+|||++..........
T Consensus        80 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05605          80 TLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGETIR  159 (285)
T ss_pred             eccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCccc
Confidence            999999999887654  468999999999999999999999999999999999999999999999999998765554445


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||++.+ .++.++||||+||++|+|++|..||.+.........+...........+..++..+.+||.+|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~  239 (285)
T cd05605         160 GRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSEKFSEAARSICRQL  239 (285)
T ss_pred             cccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHhhhcccccCcccCHHHHHHHHHH
Confidence            5689999999999965 488999999999999999999999987665433333222111112222346899999999999


Q ss_pred             chhhhcCCC-----CHHHHHcCCCccccc
Q 012170          334 LTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       334 L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      |..||.+||     +++++++||||....
T Consensus       240 l~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05605         240 LTKDPGFRLGCRGEGAEEVKAHPFFRTAN  268 (285)
T ss_pred             ccCCHHHhcCCCCCCHHHHhcCcCccCCC
Confidence            999999999     999999999996544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.7e-46  Score=375.85  Aligned_cols=245  Identities=28%  Similarity=0.506  Sum_probs=212.1

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+..+++.||+|++++.       ...+.+|+.++.++..||||+.+++++.+.+.+|+||||++|
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   80 (327)
T cd05617           1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG   80 (327)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence            4699999999999999999999999999753       134678999999997799999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~  260 (469)
                      |+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||+
T Consensus        81 ~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~  160 (327)
T cd05617          81 GDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGTP  160 (327)
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCCCceecccCCc
Confidence            9999999888899999999999999999999999999999999999999999999999999997532 233345578999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-------SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .|+|||++.+ .++.++|||||||++|+|++|..||...       ........+......++    ..++..+.++|.+
T Consensus       161 ~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~~~~li~~  236 (327)
T cd05617         161 NYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKPIRIP----RFLSVKASHVLKG  236 (327)
T ss_pred             ccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCCCCCC----CCCCHHHHHHHHH
Confidence            9999999976 5899999999999999999999999532       22344455554444333    4679999999999


Q ss_pred             hchhhhcCCCC------HHHHHcCCCccccc
Q 012170          333 MLTRDVSARIT------ADEVLRHPWILFYT  357 (469)
Q Consensus       333 ~L~~dP~~Rps------a~elL~hp~~~~~~  357 (469)
                      ||..||.+|++      +.++++||||....
T Consensus       237 ~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~  267 (327)
T cd05617         237 FLNKDPKERLGCQPQTGFSDIKSHTFFRSID  267 (327)
T ss_pred             HhccCHHHcCCCCCCCCHHHHHcCCCCCCCC
Confidence            99999999998      57999999996544

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=2.3e-47  Score=396.85  Aligned_cols=253  Identities=24%  Similarity=0.375  Sum_probs=211.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--------CeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEA--------DCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--------~~~~  173 (469)
                      ..+|.+++.||+|+||.||+|.+..+++.||||++........+|+.+|+.+. ||||++++++|...        ..++
T Consensus        65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~l~  143 (440)
T PTZ00036         65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLN-HINIIFLKDYYYTECFKKNEKNIFLN  143 (440)
T ss_pred             CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHhcC-CCCCcceeeeEeecccccCCCceEEE
Confidence            46899999999999999999999999999999999776666778999999997 99999999887432        2577


Q ss_pred             EEEeccCCCchHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeec
Q 012170          174 LVMELCSGGRLIDQMV----EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRIS  248 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~  248 (469)
                      +||||+++ +|.+++.    ....+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++....
T Consensus       144 lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~  222 (440)
T PTZ00036        144 VVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL  222 (440)
T ss_pred             EEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhcc
Confidence            99999975 6666554    245789999999999999999999999999999999999999765 69999999998766


Q ss_pred             CCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc---------------
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK---------------  311 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------  311 (469)
                      .........||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+....               
T Consensus       223 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~  302 (440)
T PTZ00036        223 AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNY  302 (440)
T ss_pred             CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhh
Confidence            5555556789999999999865  48999999999999999999999999877655554443211               


Q ss_pred             --CCCCCC--------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 --LDFHSG--------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 --~~~~~~--------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                        ..++..        .....+.++.+||.+||++||.+|||+.|+|+||||...
T Consensus       303 ~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        303 ADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             hcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence              011110        112467899999999999999999999999999999543

>KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms]

Probab=100.00  E-value=4.6e-47  Score=379.98  Aligned_cols=242  Identities=29%  Similarity=0.457  Sum_probs=210.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcE-EEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-eEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAE-FACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-CFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~-vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-~~~l  174 (469)
                      +...+.+.||.|+||+||+|.+.  |+. ||+|++...      ...+.+|+.+|.+|+ |||||++++++.... .++|
T Consensus        41 ~~l~~~~~iG~G~~g~V~~~~~~--g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~f~G~~~~~~~~~~i  117 (362)
T KOG0192|consen   41 DELPIEEVLGSGSFGTVYKGKWR--GTDVVAVKIISDPDFDDESRKAFRREASLLSRLR-HPNIVQFYGACTSPPGSLCI  117 (362)
T ss_pred             HHhhhhhhcccCCceeEEEEEeC--CceeEEEEEecchhcChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCceEE
Confidence            34445567999999999999998  566 999999753      247999999999997 999999999998887 7999


Q ss_pred             EEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcC-eEeccCCCCcEEEccCC-cEEEEeccceeeecCC
Q 012170          175 VMELCSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMG-VVHRDIKPENILLTTSG-KIKLADFGLAMRISNG  250 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~g-ivHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~  250 (469)
                      ||||+++|+|.+++..  .+.++...+..++.||+.||.|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus       118 VtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~  197 (362)
T KOG0192|consen  118 VTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS  197 (362)
T ss_pred             EEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence            9999999999999988  578999999999999999999999999 99999999999999998 9999999999876654


Q ss_pred             -CcccccCCCCcccCceeccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          251 -QTLSGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       251 -~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                       ...+...||+.|||||++.+.   |+.++||||||+++|||+||..||.+....++...+.........  ...+++.+
T Consensus       198 ~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~--p~~~~~~l  275 (362)
T KOG0192|consen  198 KTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPI--PKECPPHL  275 (362)
T ss_pred             cccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CccCCHHH
Confidence             444557899999999999853   999999999999999999999999998887666666433322221  13489999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..||.+||..||.+||+..+++.
T Consensus       276 ~~l~~~CW~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  276 SSLMERCWLVDPSRRPSFLEIVS  298 (362)
T ss_pred             HHHHHHhCCCCCCcCCCHHHHHH
Confidence            99999999999999999999875

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.1e-47  Score=380.78  Aligned_cols=250  Identities=26%  Similarity=0.423  Sum_probs=208.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----CeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA-----DCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----~~~  172 (469)
                      +|++.+.||+|+||.||+|++..+|..||||.+...      ...+.+|+.+|+.++ ||||+++++++...     ..+
T Consensus         1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~   79 (338)
T cd07859           1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLR-HPDIVEIKHIMLPPSRREFKDI   79 (338)
T ss_pred             CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCC-CCCEeeecceEeccCCCCCceE
Confidence            589999999999999999999999999999998632      235778999999997 99999999988543     358


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      |+|||||. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        80 ~lv~e~~~-~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~  158 (338)
T cd07859          80 YVVFELME-SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTP  158 (338)
T ss_pred             EEEEecCC-CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCccccccccccC
Confidence            99999995 6899999888889999999999999999999999999999999999999999999999999997543221 


Q ss_pred             ---cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC---------------
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV---------------  310 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~---------------  310 (469)
                         ......||+.|+|||++.+   .++.++|||||||++|+|++|.+||.+.+....+..+...               
T Consensus       159 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  238 (338)
T cd07859         159 TAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNE  238 (338)
T ss_pred             ccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhh
Confidence               1234679999999999854   5899999999999999999999999876654433222110               


Q ss_pred             ------------cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          311 ------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       311 ------------~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                                  ........+..+++++.+||.+||..||++|||+.|+|+||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~hp~f~~  295 (338)
T cd07859         239 KARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALADPYFKG  295 (338)
T ss_pred             hHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcCchhhh
Confidence                        000111123457889999999999999999999999999999954

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.9e-49  Score=417.55  Aligned_cols=258  Identities=34%  Similarity=0.562  Sum_probs=231.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      -.++|.++++||+|+||.|.+++++.|++.||+|++.+-       ..-|..|-.||.... .+-|++++..|+++.++|
T Consensus        73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LY  151 (1317)
T KOG0612|consen   73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLY  151 (1317)
T ss_pred             CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceE
Confidence            357999999999999999999999999999999999652       245778999998875 889999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      +||||++||+|..++.+.+++++..++.++.+|+.||.-||++|+|||||||+|||||..|+|||+|||.|..+..+.. 
T Consensus       152 lVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V  231 (1317)
T KOG0612|consen  152 LVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV  231 (1317)
T ss_pred             EEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999988774433 


Q ss_pred             -ccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--cCCCCCCcccCCC
Q 012170          253 -LSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV--KLDFHSGVWETVS  323 (469)
Q Consensus       253 -~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~~s  323 (469)
                       ....+|||.|++||++.      |.|+..+||||+||++|||+.|..||+..+..+.+..|.+.  .+.||  .-..+|
T Consensus       232 ~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP--~~~~VS  309 (1317)
T KOG0612|consen  232 RSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESLSFP--DETDVS  309 (1317)
T ss_pred             EeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhcCCC--cccccC
Confidence             34568999999999993      35999999999999999999999999999999999999877  45555  234599


Q ss_pred             HHHHHHHHHhchhhhcCCCC---HHHHHcCCCccccccccch
Q 012170          324 KPARDLMARMLTRDVSARIT---ADEVLRHPWILFYTERTLR  362 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~~~~~~  362 (469)
                      .++++||.++| -+|+.|+.   ++++.+||||....|.+++
T Consensus       310 eeakdLI~~ll-~~~e~RLgrngiedik~HpFF~g~~W~~iR  350 (1317)
T KOG0612|consen  310 EEAKDLIEALL-CDREVRLGRNGIEDIKNHPFFEGIDWDNIR  350 (1317)
T ss_pred             HHHHHHHHHHh-cChhhhcccccHHHHHhCccccCCChhhhh
Confidence            99999999999 57889998   9999999999777665544

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=1.5e-46  Score=376.80  Aligned_cols=254  Identities=23%  Similarity=0.392  Sum_probs=217.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++++.||+|+||.||+|++..+|..||+|++...     ...+.+|+++|+++. ||||+++++++..++.+++||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   82 (331)
T cd06649           4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISICM   82 (331)
T ss_pred             cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEEe
Confidence            57899999999999999999999999999999998643     246889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      ||++||+|.+++...+.+++..+..++.|++.||.|||+. +|+||||||+|||++.++.++|+|||++...... ....
T Consensus        83 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~~~  161 (331)
T cd06649          83 EHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANS  161 (331)
T ss_pred             ecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc-cccc
Confidence            9999999999998888899999999999999999999986 6999999999999999999999999999765432 2345


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC----------------------
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL----------------------  312 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~----------------------  312 (469)
                      ..||+.|+|||++.+ .++.++|||||||++|+|++|..||......++...+.....                      
T Consensus       162 ~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (331)
T cd06649         162 FVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVS  241 (331)
T ss_pred             CCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCccccccccccc
Confidence            679999999999976 489999999999999999999999987665544333221100                      


Q ss_pred             ----------------------CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          313 ----------------------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       313 ----------------------~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                            ..+......+++++++||.+||..||++|||+.+||+||||....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  308 (331)
T cd06649         242 GHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSE  308 (331)
T ss_pred             ccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence                                  000001124688999999999999999999999999999996543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=8.9e-47  Score=384.36  Aligned_cols=253  Identities=34%  Similarity=0.528  Sum_probs=219.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++.+.       ...+.+|+.+++.+. ||||+++++++.+++.+|
T Consensus        41 ~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~-hp~iv~~~~~~~~~~~~~  119 (371)
T cd05622          41 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY  119 (371)
T ss_pred             chhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence            347999999999999999999999999999999998542       234678999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--  251 (469)
                      +|||||+||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.......  
T Consensus       120 lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~  198 (371)
T cd05622         120 MVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  198 (371)
T ss_pred             EEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc
Confidence            99999999999998854 568999999999999999999999999999999999999999999999999998764332  


Q ss_pred             cccccCCCCcccCceeccC-----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      .....+||+.|+|||++.+     .++.++|||||||++|+|++|.+||.+.+....+..|......+.......++..+
T Consensus       199 ~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  278 (371)
T cd05622         199 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  278 (371)
T ss_pred             cccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCcccCCCcCCCCHHH
Confidence            2235679999999999864     27899999999999999999999999999888888887654333333345789999


Q ss_pred             HHHHHHhchhhhcC--CCCHHHHHcCCCccc
Q 012170          327 RDLMARMLTRDVSA--RITADEVLRHPWILF  355 (469)
Q Consensus       327 ~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~  355 (469)
                      ++||.+||..++.+  |++++++++||||..
T Consensus       279 ~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~  309 (371)
T cd05622         279 KNLICAFLTDREVRLGRNGVEEIKRHLFFKN  309 (371)
T ss_pred             HHHHHHHcCChhhhcCCCCHHHHhcCcccCC
Confidence            99999999844443  789999999999965

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-47  Score=382.51  Aligned_cols=244  Identities=31%  Similarity=0.516  Sum_probs=214.2

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      ||+|+||.||+|+++.+|+.||||++.+..       .....|..++..+.  +||||+.+++++.+.+.+|+||||+.+
T Consensus         1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~   80 (330)
T cd05586           1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG   80 (330)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence            799999999999999999999999986421       22445667776664  699999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcccccCCCC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~~~~~gt~  260 (469)
                      |+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..... .......+||+
T Consensus        81 g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~  160 (330)
T cd05586          81 GELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGTT  160 (330)
T ss_pred             ChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCCCccCccCCc
Confidence            99999998888999999999999999999999999999999999999999999999999999875332 23344578999


Q ss_pred             cccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          261 AYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       261 ~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      .|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+......++.   ..+++++.+||.+||..||
T Consensus       161 ~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~~L~~~P  237 (330)
T cd05586         161 EYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK---NVLSDEGRQFVKGLLNRNP  237 (330)
T ss_pred             cccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCC---ccCCHHHHHHHHHHcCCCH
Confidence            9999999865  3789999999999999999999999999888888888777665553   3479999999999999999


Q ss_pred             cCCC----CHHHHHcCCCccccc
Q 012170          339 SARI----TADEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rp----sa~elL~hp~~~~~~  357 (469)
                      .+||    ++.++++||||....
T Consensus       238 ~~R~~~~~~~~~ll~h~~~~~~~  260 (330)
T cd05586         238 QHRLGAHRDAVELKEHPFFADID  260 (330)
T ss_pred             HHCCCCCCCHHHHhcCccccCCC
Confidence            9998    799999999996543

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=9.8e-47  Score=370.00  Aligned_cols=250  Identities=31%  Similarity=0.452  Sum_probs=208.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECC-CCcEEEEEEcccC------hHHHHHHHHHHHHhh--CCCCeeEEEEEEE-----e
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKG------EETVHREVEIMQHLS--GHTGVVTLHSVYE-----E  168 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~------~~~~~~E~~il~~l~--~hpnIv~l~~~~~-----~  168 (469)
                      ++|++++.||+|+||.||+|++.. +|..||+|+++..      ...+.+|+.+++.+.  .||||+++++++.     .
T Consensus         1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~   80 (290)
T cd07862           1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR   80 (290)
T ss_pred             CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence            478999999999999999999854 4688999988532      235667888888774  4999999999885     3


Q ss_pred             CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ...+++||||+. ++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        81 ~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~  159 (290)
T cd07862          81 ETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARI  159 (290)
T ss_pred             CCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEe
Confidence            456899999996 5888888654  3589999999999999999999999999999999999999999999999999987


Q ss_pred             ecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC---------
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS---------  316 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~---------  316 (469)
                      ...........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+.........         
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  239 (290)
T cd07862         160 YSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVAL  239 (290)
T ss_pred             ccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcc
Confidence            665544556789999999999865 5899999999999999999999999988777666665432110000         


Q ss_pred             --------------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          317 --------------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       317 --------------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                    .....++..+++||.+||+.||++|||+.|+|+||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         240 PRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             cchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence                          0113578889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.1e-47  Score=380.67  Aligned_cols=244  Identities=30%  Similarity=0.575  Sum_probs=217.3

Q ss_pred             eeeeccCCeEEEEEEE---CCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          109 EVIGHGKFGSVWLCRS---KASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      +.||+|+||.||++.+   ..+|+.||+|++.+.      ...+.+|+++|+++. ||||+++++++.+++.+|+||||+
T Consensus         2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~~   80 (318)
T cd05582           2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVN-HPFIVKLHYAFQTEGKLYLILDFL   80 (318)
T ss_pred             ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCEEEEEEcCC
Confidence            6799999999999876   467899999999642      234667999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-CcccccCC
Q 012170          180 SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAG  258 (469)
Q Consensus       180 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~~~g  258 (469)
                      ++|+|.+++.+...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......+|
T Consensus        81 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g  160 (318)
T cd05582          81 RGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG  160 (318)
T ss_pred             CCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCCceecccC
Confidence            99999999988888999999999999999999999999999999999999999999999999999765433 23445689


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      |+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+......++    ..+++++.+||.+||+.|
T Consensus       161 ~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         161 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             ChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHhhcC
Confidence            999999999976 488999999999999999999999999888888888877665544    457999999999999999


Q ss_pred             hcCCCC-----HHHHHcCCCccccc
Q 012170          338 VSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       338 P~~Rps-----a~elL~hp~~~~~~  357 (469)
                      |.+||+     +.++++||||....
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~~~  261 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFSTID  261 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCCCC
Confidence            999999     78899999997653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=5.2e-48  Score=386.44  Aligned_cols=252  Identities=29%  Similarity=0.487  Sum_probs=222.4

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----h---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----E---ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      +.+.+..|.-++.||.|+||.||-|++..|.+.||||.+.-.    .   .++..||..|++|. |||+|.+.++|..+.
T Consensus        21 k~DPEklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~-HPntieYkgCyLre~   99 (948)
T KOG0577|consen   21 KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLR-HPNTIEYKGCYLREH   99 (948)
T ss_pred             cCCHHHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhcc-CCCcccccceeeccc
Confidence            345677888999999999999999999999999999998532    1   46889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ..|||||||-| +-.|++. ..+++.+.+++.|+.+.+.||.|||+++.||||||..|||+++.|.|||+|||.|.... 
T Consensus       100 TaWLVMEYClG-SAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~-  177 (948)
T KOG0577|consen  100 TAWLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA-  177 (948)
T ss_pred             hHHHHHHHHhc-cHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcC-
Confidence            99999999955 7777773 45789999999999999999999999999999999999999999999999999997654 


Q ss_pred             CCcccccCCCCcccCceec----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-CcCCCCCCcccCCCH
Q 012170          250 GQTLSGLAGSPAYVAPEVL----SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN-VKLDFHSGVWETVSK  324 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-~~~~~~~~~~~~~s~  324 (469)
                        +.++++|||+||||||+    .|.|+.++|||||||+..+|.-.+||+...+....+..|.. ..+.+..+.|   |.
T Consensus       178 --PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQNesPtLqs~eW---S~  252 (948)
T KOG0577|consen  178 --PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQSNEW---SD  252 (948)
T ss_pred             --chhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHhcCCCCCCCchh---HH
Confidence              45668999999999998    36799999999999999999999999887777766666654 4455665555   99


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .++.||..||++-|.+|||.+++|+|+|++...
T Consensus       253 ~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~R  285 (948)
T KOG0577|consen  253 YFRNFVDSCLQKIPQERPTSEELLKHRFVLRER  285 (948)
T ss_pred             HHHHHHHHHHhhCcccCCcHHHHhhcchhccCC
Confidence            999999999999999999999999999996543

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=1.3e-46  Score=376.24  Aligned_cols=244  Identities=30%  Similarity=0.547  Sum_probs=212.9

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHH-HHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEI-MQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~i-l~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.++.+|+.||+|++.+.       ...+..|..+ ++.+. ||||+++++++...+.+|+||||+.
T Consensus         1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-hp~iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05604           1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVK-HPFLVGLHYSFQTTEKLYFVLDFVN   79 (325)
T ss_pred             CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCC-CCCCccEEEEEecCCEEEEEEcCCC
Confidence            4699999999999999999999999998642       1234455554 56675 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGS  259 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt  259 (469)
                      ||+|..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ........+||
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt  159 (325)
T cd05604          80 GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT  159 (325)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCCCcccccCC
Confidence            99999999888899999999999999999999999999999999999999999999999999987532 22334456899


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+++..+........    ..++..+.++|.+||..||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~ll~~ll~~~p  235 (325)
T cd05604         160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLR----PGASLTAWSILEELLEKDR  235 (325)
T ss_pred             hhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCC----CCCCHHHHHHHHHHhccCH
Confidence            99999999976 489999999999999999999999999888888888877654443    3578999999999999999


Q ss_pred             cCCCCH----HHHHcCCCccccc
Q 012170          339 SARITA----DEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rpsa----~elL~hp~~~~~~  357 (469)
                      .+||++    .++++||||....
T Consensus       236 ~~R~~~~~~~~~i~~h~~f~~~~  258 (325)
T cd05604         236 QRRLGAKEDFLEIQEHPFFESLS  258 (325)
T ss_pred             HhcCCCCCCHHHHhcCCCcCCCC
Confidence            999976    5999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-46  Score=375.59  Aligned_cols=253  Identities=31%  Similarity=0.543  Sum_probs=216.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|++..+++.||+|++.+.       ...+.+|+.++..+. ||||++++++|.+++.+|+|
T Consensus         1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (331)
T cd05597           1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGD-RRWITNLHYAFQDENNLYLV   79 (331)
T ss_pred             CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCC-CCCCCceEEEEecCCeEEEE
Confidence            4799999999999999999999999999999998641       234778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          176 MELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||++||+|.+++.+ ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........  
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~  159 (331)
T cd05597          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTVQ  159 (331)
T ss_pred             EecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCcc
Confidence            999999999999976 45799999999999999999999999999999999999999999999999999976544332  


Q ss_pred             ccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC--CCCCCcccCCCH
Q 012170          253 LSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL--DFHSGVWETVSK  324 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--~~~~~~~~~~s~  324 (469)
                      ....+||+.|+|||++.      +.++.++|||||||++|+|++|..||.+.+..+.+..+.....  .++. ....++.
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~  238 (331)
T cd05597         160 SNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTDVSE  238 (331)
T ss_pred             ccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-ccCCCCH
Confidence            22356999999999986      2478899999999999999999999998888777777755432  2222 2345899


Q ss_pred             HHHHHHHHhchhhhcC--CCCHHHHHcCCCccccc
Q 012170          325 PARDLMARMLTRDVSA--RITADEVLRHPWILFYT  357 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~~  357 (469)
                      ++++||.+||..++.+  |+++.++|+||||....
T Consensus       239 ~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~~~  273 (331)
T cd05597         239 EAKDLIRRLICSPETRLGRNGLQDFKDHPFFEGID  273 (331)
T ss_pred             HHHHHHHHHccCcccccCCCCHHHHhcCCCCCCCC
Confidence            9999999999764444  78999999999996544

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=3e-46  Score=377.83  Aligned_cols=250  Identities=26%  Similarity=0.449  Sum_probs=206.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...+|+.++.||+|+||.||+|.+..+|+.||||++...     ...+.+|+++|+.+. |+||+++++++...+.+|+|
T Consensus        72 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv  150 (353)
T PLN00034         72 SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVN-HPNVVKCHDMFDHNGEIQVL  150 (353)
T ss_pred             CHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCC-CCCcceeeeEeccCCeEEEE
Confidence            346788899999999999999999999999999998543     245789999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      |||+.+|+|.+.    ....+..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+.... ...
T Consensus       151 ~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~~~~  226 (353)
T PLN00034        151 LEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN  226 (353)
T ss_pred             EecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccccccc
Confidence            999999988543    345788889999999999999999999999999999999999999999999997654332 234


Q ss_pred             ccCCCCcccCceeccC-----C-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-----N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-----~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      ...||+.|+|||++..     . ++.++|||||||++|+|++|..||...........+..............++.++++
T Consensus       227 ~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  306 (353)
T PLN00034        227 SSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRH  306 (353)
T ss_pred             ccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCCCCCccCHHHHH
Confidence            5679999999999843     2 346899999999999999999999743322222222111111122223567999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||.+||..||++|||+.|+|+||||..
T Consensus       307 li~~~l~~~P~~Rpt~~ell~hp~~~~  333 (353)
T PLN00034        307 FISCCLQREPAKRWSAMQLLQHPFILR  333 (353)
T ss_pred             HHHHHccCChhhCcCHHHHhcCccccc
Confidence            999999999999999999999999954

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=3.6e-46  Score=372.27  Aligned_cols=244  Identities=32%  Similarity=0.540  Sum_probs=212.3

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHH-HHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVE-IMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~-il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|++..+|+.||+|++.+.       ...+..|.. +++.+. ||||+++++++.+.+.+|+||||++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e~~~   79 (321)
T cd05603           1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLK-HPFLVGLHYSFQTAEKLYFVLDYVN   79 (321)
T ss_pred             CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCEEEEEEcCCC
Confidence            4699999999999999999999999998642       123445554 567775 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGS  259 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt  259 (469)
                      ||+|...+...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ........+||
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt  159 (321)
T cd05603          80 GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT  159 (321)
T ss_pred             CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCCccccccCC
Confidence            99999999888889999999999999999999999999999999999999999999999999987532 22334456899


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+.......+......++    ...+.++.++|.+||+.||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p  235 (321)
T cd05603         160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLP----GGKTVAACDLLVGLLHKDQ  235 (321)
T ss_pred             cccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHccCCH
Confidence            99999999976 489999999999999999999999999988888888877655444    4578899999999999999


Q ss_pred             cCCCCH----HHHHcCCCccccc
Q 012170          339 SARITA----DEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rpsa----~elL~hp~~~~~~  357 (469)
                      .+||++    .++++||||....
T Consensus       236 ~~R~~~~~~~~~~~~~~~~~~~~  258 (321)
T cd05603         236 RRRLGAKADFLEIKNHVFFSPIN  258 (321)
T ss_pred             hhcCCCCCCHHHHhCCCCcCCCC
Confidence            999975    5999999996543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>KOG0589 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=1.3e-47  Score=382.92  Aligned_cols=252  Identities=31%  Similarity=0.521  Sum_probs=231.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe-EEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADC-FHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~-~~l  174 (469)
                      .+.|..++.+|+|+||.+++++++.++..|++|.+.-      .+....+|+.+++++. |||||.+.+.|.++++ ++|
T Consensus         3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~-hP~iv~y~ds~~~~~~~l~I   81 (426)
T KOG0589|consen    3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLL-HPNIVEYKDSFEEDGQLLCI   81 (426)
T ss_pred             cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhcc-CCCeeeeccchhcCCceEEE
Confidence            3679999999999999999999999999999999853      2357889999999997 9999999999999888 999


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          175 VMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      ||+||+||++.+.|.+.+  .|+++.+..|+.|++.|+.|||+++|+|||||+.||+++.++.|+|+|||+|+.+.... 
T Consensus        82 vm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~  161 (426)
T KOG0589|consen   82 VMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS  161 (426)
T ss_pred             EEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCchh
Confidence            999999999999997654  58999999999999999999999999999999999999999999999999999888776 


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...+.+|||.||.||++.+ .|+.++|||||||++|||++-+++|.+.+...+...|.+......   ...++.+++.+|
T Consensus       162 ~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Pl---p~~ys~el~~lv  238 (426)
T KOG0589|consen  162 LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKINRGLYSPL---PSMYSSELRSLV  238 (426)
T ss_pred             hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHhhccCCCC---CccccHHHHHHH
Confidence            6778999999999999988 599999999999999999999999999999999999988774333   256799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +.||..+|..||++.++|.+|.+..+.
T Consensus       239 ~~~l~~~P~~RPsa~~LL~~P~l~~~~  265 (426)
T KOG0589|consen  239 KSMLRKNPEHRPSALELLRRPHLLRYL  265 (426)
T ss_pred             HHHhhcCCccCCCHHHHhhChhhhhHH
Confidence            999999999999999999999886543

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=6.6e-46  Score=389.20  Aligned_cols=253  Identities=22%  Similarity=0.391  Sum_probs=207.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhh-----CCCCeeEEEEEEEeC-Ce
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLS-----GHTGVVTLHSVYEEA-DC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~-----~hpnIv~l~~~~~~~-~~  171 (469)
                      ..++|.+++.||+|+||+||+|.+..+++.||||+++..   ......|+.+++.+.     .|++++.++++|... ..
T Consensus       127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~  206 (467)
T PTZ00284        127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGH  206 (467)
T ss_pred             CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchhhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCce
Confidence            357899999999999999999999999999999999642   345667888888875     234588999998764 57


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCC----------------
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSG----------------  234 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~----------------  234 (469)
                      +|+|||++ |++|.+++.+.+.+++..+..++.||+.||.|||+ .||+||||||+|||++.++                
T Consensus       207 ~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~  285 (467)
T PTZ00284        207 MCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPC  285 (467)
T ss_pred             EEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCc
Confidence            89999998 77899999888899999999999999999999998 5999999999999998765                


Q ss_pred             cEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC
Q 012170          235 KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       235 ~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                      .+||+|||++....  ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+......
T Consensus       286 ~vkl~DfG~~~~~~--~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~  363 (467)
T PTZ00284        286 RVRICDLGGCCDER--HSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGR  363 (467)
T ss_pred             eEEECCCCccccCc--cccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCC
Confidence            49999999885432  23345789999999999977 4999999999999999999999999987766555444332111


Q ss_pred             CCCCc------------------------------------c--cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          314 FHSGV------------------------------------W--ETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       314 ~~~~~------------------------------------~--~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ++...                                    +  ...++.+.|||.+||++||.+|||++|+|+||||..
T Consensus       364 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        364 LPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             CCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            11000                                    0  011456789999999999999999999999999965


Q ss_pred             c
Q 012170          356 Y  356 (469)
Q Consensus       356 ~  356 (469)
                      +
T Consensus       444 ~  444 (467)
T PTZ00284        444 Y  444 (467)
T ss_pred             c
Confidence            4

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=2e-46  Score=366.73  Aligned_cols=241  Identities=29%  Similarity=0.524  Sum_probs=205.3

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||+|+||+||+|.++.+|+.||+|++.+..       +.+..|+.+|+.+. ||||+++++++...+.+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~g~   79 (280)
T cd05608           1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVH-SRFIVSLAYAFQTKTDLCLVMTIMNGGD   79 (280)
T ss_pred             CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCC-CCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence            699999999999999999999999986421       34567999999996 9999999999999999999999999999


Q ss_pred             hHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-ccccCC
Q 012170          184 LIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAG  258 (469)
Q Consensus       184 L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~~~~g  258 (469)
                      |.+.+..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........ .....|
T Consensus        80 L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~g  159 (280)
T cd05608          80 LRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYAG  159 (280)
T ss_pred             HHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCccccccCC
Confidence            9887743    34689999999999999999999999999999999999999999999999999976544332 334679


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE----AVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      |+.|+|||++.+ .++.++|||||||++|+|++|..||......    .....+.....    .....++.++.+||.+|
T Consensus       160 ~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~  235 (280)
T cd05608         160 TPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV----TYPDKFSPASKSFCEAL  235 (280)
T ss_pred             CcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC----CCcccCCHHHHHHHHHH
Confidence            999999999976 5889999999999999999999999865432    22222322222    22346899999999999


Q ss_pred             chhhhcCCC-----CHHHHHcCCCcccc
Q 012170          334 LTRDVSARI-----TADEVLRHPWILFY  356 (469)
Q Consensus       334 L~~dP~~Rp-----sa~elL~hp~~~~~  356 (469)
                      |+.||++||     +++++++||||...
T Consensus       236 l~~~P~~R~~~~~~~~~~~l~h~~~~~~  263 (280)
T cd05608         236 LAKDPEKRLGFRDGNCDGLRTHPLFRDL  263 (280)
T ss_pred             hcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence            999999999     88999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=8.1e-46  Score=371.49  Aligned_cols=255  Identities=29%  Similarity=0.499  Sum_probs=218.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+++.||+|+||.||+|+++.+++.||+|++.+.       ...+..|+.++..+. |+||+++++++.+.+.+|+|
T Consensus         1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~l~~~~~~~~~~~lv   79 (331)
T cd05624           1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGD-CQWITTLHYAFQDENYLYLV   79 (331)
T ss_pred             CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCEEEEE
Confidence            5799999999999999999999999999999998642       234677899999886 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          176 MELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||+.||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus        80 ~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~  159 (331)
T cd05624          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTVQ  159 (331)
T ss_pred             EeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCcee
Confidence            999999999999977 46799999999999999999999999999999999999999999999999999976654332  


Q ss_pred             ccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC-CCcccCCCHH
Q 012170          253 LSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH-SGVWETVSKP  325 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~  325 (469)
                      ....+||+.|+|||++.+      .++.++|||||||++|+|++|..||.+.+..+.+..+......++ ...+..++.+
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~  239 (331)
T cd05624         160 SSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQFPSHITDVSEE  239 (331)
T ss_pred             eccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHHHHHcCCCcccCCCccccCCHH
Confidence            233579999999999863      478899999999999999999999998888887777765432221 1223467999


Q ss_pred             HHHHHHHhchhhhcC--CCCHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSA--RITADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~~~  358 (469)
                      +++||.+||..++.+  |++++++++||||....+
T Consensus       240 ~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~~~~  274 (331)
T cd05624         240 AKDLIQRLICSRERRLGQNGIEDFKKHAFFEGIDW  274 (331)
T ss_pred             HHHHHHHHccCchhhcCCCCHHHHhcCCCcCCCCH
Confidence            999999999876654  568999999999976543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=4.7e-46  Score=364.56  Aligned_cols=249  Identities=31%  Similarity=0.472  Sum_probs=208.1

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhh--CCCCeeEEEEEEEe-----CC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLS--GHTGVVTLHSVYEE-----AD  170 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~--~hpnIv~l~~~~~~-----~~  170 (469)
                      +|++++.||+|+||.||+|.++.+|+.||+|.++..      .....+|+.+++.+.  +||||+++++++..     ..
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~   80 (288)
T cd07863           1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET   80 (288)
T ss_pred             CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence            588999999999999999999999999999998642      135667888888774  49999999998864     34


Q ss_pred             eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          171 CFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      .+++||||+.+ +|.+++...  ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....
T Consensus        81 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~  159 (288)
T cd07863          81 KVTLVFEHVDQ-DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYS  159 (288)
T ss_pred             eEEEEEccccc-CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcccccc
Confidence            58999999975 788887654  348999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-----C---------
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-----D---------  313 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~---------  313 (469)
                      .........||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+......+..+.....     .         
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07863         160 CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPR  239 (288)
T ss_pred             CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccc
Confidence            4444455678999999999865 589999999999999999999999988776655544432110     0         


Q ss_pred             --CC-------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 --FH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 --~~-------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                        +.       ......++..+.+||.+||++||.+|||+.|+|.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         240 GAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             cccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence              00       01123578889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.5e-46  Score=383.36  Aligned_cols=252  Identities=22%  Similarity=0.323  Sum_probs=208.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      ...+|.+++.||+|+||.||+|.+..+++.||+|....  ..+.+|+++|++|. ||||++++++|...+..++|||++.
T Consensus        90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~--~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~lv~e~~~  166 (391)
T PHA03212         90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR--GGTATEAHILRAIN-HPSIIQLKGTFTYNKFTCLILPRYK  166 (391)
T ss_pred             ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh--hhhHHHHHHHHhCC-CCCCCCEeEEEEECCeeEEEEecCC
Confidence            34689999999999999999999999999999998653  45789999999997 9999999999999999999999995


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC--CcccccCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG--QTLSGLAG  258 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~--~~~~~~~g  258 (469)
                       ++|..++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ......+|
T Consensus       167 -~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g  245 (391)
T PHA03212        167 -TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDINANKYYGWAG  245 (391)
T ss_pred             -CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCcccccccccccccccccC
Confidence             688888888888999999999999999999999999999999999999999999999999999653221  22345689


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCc-------------------
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------LEAVFDAIKNVK-------------------  311 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~i~~~~-------------------  311 (469)
                      |+.|+|||++.+ .|+.++|||||||++|+|++|..||.+..       ....+..+....                   
T Consensus       246 t~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~  325 (391)
T PHA03212        246 TIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIY  325 (391)
T ss_pred             ccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHH
Confidence            999999999966 58999999999999999999998775321       111111111100                   


Q ss_pred             -------C--CCCCCcc---cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 -------L--DFHSGVW---ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 -------~--~~~~~~~---~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                             .  ......|   ..++.++.+||.+||+.||.+||||.|+|+||||...
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~  382 (391)
T PHA03212        326 IGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDI  382 (391)
T ss_pred             HHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhcChhhccC
Confidence                   0  0000111   1356789999999999999999999999999999653

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=2.1e-46  Score=374.65  Aligned_cols=245  Identities=33%  Similarity=0.549  Sum_probs=212.7

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHH-HHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVE-IMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~-il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|++..+++.||+|++.+..       ..+..|.. +++.+. ||||+++++++...+.+|+||||++
T Consensus         1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~-h~~Iv~~~~~~~~~~~~~lv~e~~~   79 (325)
T cd05602           1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKLYFVLDYIN   79 (325)
T ss_pred             CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCC-CCCCCceeEEEEcCCeEEEEEeCCC
Confidence            46999999999999999999999999986421       23344444 456675 9999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGS  259 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt  259 (469)
                      ||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.... ........+||
T Consensus        80 ~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt  159 (325)
T cd05602          80 GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT  159 (325)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCCCcccccCC
Confidence            99999999888889999999999999999999999999999999999999999999999999987533 23334556899


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+..+.+..+......+.    ..++..+.++|.+||+.||
T Consensus       160 ~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li~~~l~~~p  235 (325)
T cd05602         160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLLEGLLQKDR  235 (325)
T ss_pred             ccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCC----CCCCHHHHHHHHHHcccCH
Confidence            99999999976 489999999999999999999999999888888888776554433    4689999999999999999


Q ss_pred             cCCCCHH----HHHcCCCcccccc
Q 012170          339 SARITAD----EVLRHPWILFYTE  358 (469)
Q Consensus       339 ~~Rpsa~----elL~hp~~~~~~~  358 (469)
                      .+|+++.    ++++|+||....+
T Consensus       236 ~~R~~~~~~~~~i~~~~~~~~~~~  259 (325)
T cd05602         236 TKRLGAKDDFMEIKNHIFFSPINW  259 (325)
T ss_pred             HHCCCCCCCHHHHhcCcccCCCCH
Confidence            9999865    8999999965543

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=5.7e-46  Score=372.70  Aligned_cols=255  Identities=30%  Similarity=0.521  Sum_probs=218.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+++++.+++.||+|++.+.       ...+..|+.++..+. |+||+++++++.+.+.+|+|
T Consensus         1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (332)
T cd05623           1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-NQWITTLHYAFQDENNLYLV   79 (332)
T ss_pred             CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCEEEEE
Confidence            4799999999999999999999999999999998542       134678999999986 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          176 MELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||++||+|.+++.+ .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus        80 ~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~~  159 (332)
T cd05623          80 MDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQ  159 (332)
T ss_pred             EeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCcce
Confidence            999999999999977 46789999999999999999999999999999999999999999999999999976543222  


Q ss_pred             ccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC-CCcccCCCHH
Q 012170          253 LSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH-SGVWETVSKP  325 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~  325 (469)
                      ....+||+.|+|||++.      +.++.++|||||||++|+|++|..||.+.+..+.+..+......+. ...+..++++
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~s~~  239 (332)
T cd05623         160 SSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPAQVTDVSED  239 (332)
T ss_pred             ecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCccccCCCccccCCHH
Confidence            23457999999999985      2488999999999999999999999999888888888766543222 1223468999


Q ss_pred             HHHHHHHhchhhhcC--CCCHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSA--RITADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~~~  358 (469)
                      +++||.+||..++.+  |+++.++++||||....+
T Consensus       240 ~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~~~~  274 (332)
T cd05623         240 AKDLIRRLICSREHRLGQNGIEDFKQHPFFTGIDW  274 (332)
T ss_pred             HHHHHHHHccChhhhcCCCCHHHHhCCCCcCCCCH
Confidence            999999999765544  789999999999975543

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=3.8e-46  Score=377.89  Aligned_cols=253  Identities=28%  Similarity=0.490  Sum_probs=208.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC---
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD---  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~---  170 (469)
                      .+.++|++++.||+|+||.||+|.+..+|..||||++...      ...+.+|+.+++.+. ||||+++++++...+   
T Consensus        18 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   96 (359)
T cd07876          18 TVLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKNIISLLNVFTPQKSLE   96 (359)
T ss_pred             hhhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCCcc
Confidence            4668999999999999999999999999999999998642      345778999999996 999999999986543   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          171 ---CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       171 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                         .+|+||||+.+ +|...+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...
T Consensus        97 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~  173 (359)
T cd07876          97 EFQDVYLVMELMDA-NLCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  173 (359)
T ss_pred             ccceeEEEEeCCCc-CHHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCCcccc
Confidence               57999999976 4555553  35889999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHc-----------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN-----------------  309 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~-----------------  309 (469)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+..                 
T Consensus       174 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  253 (359)
T cd07876         174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTV  253 (359)
T ss_pred             ccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHH
Confidence            54444555689999999999976 589999999999999999999999987664433222111                 


Q ss_pred             -----CcCCCCC----------------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          310 -----VKLDFHS----------------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       310 -----~~~~~~~----------------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                           ....++.                ......++++++||.+||..||++|||+.|+|+||||..+
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  321 (359)
T cd07876         254 RNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVW  321 (359)
T ss_pred             HHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcCchhhhh
Confidence                 0001000                0111246789999999999999999999999999999643

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.8e-47  Score=371.02  Aligned_cols=265  Identities=31%  Similarity=0.514  Sum_probs=231.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+.|..-++||+|+||.||-|+.+.||..||+|.+.+       ++.....|..||.++. .+.||.+-..|+..+.+++
T Consensus       184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~-s~FiVslaYAfeTkd~LCl  262 (591)
T KOG0986|consen  184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVS-SPFIVSLAYAFETKDALCL  262 (591)
T ss_pred             ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhc-cCcEEEEeeeecCCCceEE
Confidence            4577888999999999999999999999999999843       3456778999999997 8999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          175 VMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      ||..|+||+|..+|...+  .|++..+..++.+|+-||++||+.+||+|||||+|||+|+.|+|+|+|.|||..+..++.
T Consensus       263 VLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~~  342 (591)
T KOG0986|consen  263 VLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGKP  342 (591)
T ss_pred             EEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCCc
Confidence            999999999999887766  799999999999999999999999999999999999999999999999999999999999


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL----EAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      ..+.+||.+|||||++.+ .|+..+|+|||||++|+|+.|+.||.....    +++-..+.+....+    ...+|++++
T Consensus       343 ~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eEvdrr~~~~~~ey----~~kFS~eak  418 (591)
T KOG0986|consen  343 IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREEVDRRTLEDPEEY----SDKFSEEAK  418 (591)
T ss_pred             cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHHHHHHHhcchhhc----ccccCHHHH
Confidence            888899999999999976 599999999999999999999999976432    34444444444444    367899999


Q ss_pred             HHHHHhchhhhcCCC-----CHHHHHcCCCccccccccchhchhhHHhhhhcCCCCC
Q 012170          328 DLMARMLTRDVSARI-----TADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHH  379 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~  379 (469)
                      +|.+.+|++||.+|+     +++++.+||||...        .|+........++..
T Consensus       419 slc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~l--------nw~rleagml~PPfi  467 (591)
T KOG0986|consen  419 SLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDL--------NWRRLEAGMLEPPFI  467 (591)
T ss_pred             HHHHHHHccCHHHhccCCCcCcchhhhCcccccC--------CHhHHhccCCCCCCC
Confidence            999999999999998     47899999999654        444444444444443

>KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only]

Probab=100.00  E-value=2.3e-46  Score=382.70  Aligned_cols=255  Identities=28%  Similarity=0.426  Sum_probs=216.0

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChH---HHHHHHHHHHHhhCC-----CCeeEEEEEEEeC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGH-----TGVVTLHSVYEEA  169 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~E~~il~~l~~h-----pnIv~l~~~~~~~  169 (469)
                      .+.+.-+|.++++||+|+||.|.+|.+..|++.||||+++....   ....|+.||..|+.|     -|||+++++|...
T Consensus       181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr  260 (586)
T KOG0667|consen  181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR  260 (586)
T ss_pred             cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc
Confidence            34455589999999999999999999999999999999987654   345699999999733     4799999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC--cEEEEecccee
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG--KIKLADFGLAM  245 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~--~vkL~DFgla~  245 (469)
                      +++|||+|++. -+|.+++..++  +|+...++.++.||+.||.+||+.||||+|||||||||.+.+  .|||+|||.++
T Consensus       261 ~HlciVfELL~-~NLYellK~n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc  339 (586)
T KOG0667|consen  261 NHLCIVFELLS-TNLYELLKNNKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSC  339 (586)
T ss_pred             cceeeeehhhh-hhHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeEEeccccc
Confidence            99999999995 59999997764  588999999999999999999999999999999999998754  69999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-----------
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----------  313 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  313 (469)
                      .....  ..+++.+..|+|||++.| .|+.+.||||||||++||++|.+.|.|.+..+.+..|......           
T Consensus       340 ~~~q~--vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~  417 (586)
T KOG0667|consen  340 FESQR--VYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKK  417 (586)
T ss_pred             ccCCc--ceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccc
Confidence            75433  337889999999999988 6999999999999999999999999999988888777332110           


Q ss_pred             ----CCC---------------------------------------Ccc-----cCCCHHHHHHHHHhchhhhcCCCCHH
Q 012170          314 ----FHS---------------------------------------GVW-----ETVSKPARDLMARMLTRDVSARITAD  345 (469)
Q Consensus       314 ----~~~---------------------------------------~~~-----~~~s~~~~~lI~~~L~~dP~~Rpsa~  345 (469)
                          |..                                       ..+     ..-...+.|||++||..||.+|+|+.
T Consensus       418 ~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~  497 (586)
T KOG0667|consen  418 AHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPA  497 (586)
T ss_pred             cceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHH
Confidence                000                                       000     01134678999999999999999999


Q ss_pred             HHHcCCCccc
Q 012170          346 EVLRHPWILF  355 (469)
Q Consensus       346 elL~hp~~~~  355 (469)
                      |+|+||||..
T Consensus       498 qal~Hpfl~~  507 (586)
T KOG0667|consen  498 QALNHPFLTG  507 (586)
T ss_pred             HHhcCccccc
Confidence            9999999963

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=6.8e-46  Score=368.04  Aligned_cols=252  Identities=29%  Similarity=0.488  Sum_probs=212.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|.+++.||+|+||.||+|.++.++..||+|.++..     ...+.+|+.+++.+. ||||+++++++..++.+|+|||
T Consensus         6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   84 (309)
T cd07872           6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIVHTDKSLTLVFE   84 (309)
T ss_pred             CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCC-CCCcceEEEEEeeCCeEEEEEe
Confidence            6799999999999999999999999999999998642     235778999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          178 LCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |+.+ +|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        85 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~  163 (309)
T cd07872          85 YLDK-DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTKTYSN  163 (309)
T ss_pred             CCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCcccccc
Confidence            9975 7877776544 58999999999999999999999999999999999999999999999999997643322 2334


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-------------------CC
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-------------------DF  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~  314 (469)
                      ..+|+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.....                   .+
T Consensus       164 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (309)
T cd07872         164 EVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNF  243 (309)
T ss_pred             ccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhc
Confidence            578999999999865  488999999999999999999999988776655544432110                   00


Q ss_pred             CC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 HS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 ~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.       .....++.++++||.+||..||.+|||+.|+|+||||...
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~  292 (309)
T cd07872         244 PKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHAYFRSL  292 (309)
T ss_pred             CccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhcChhhhhc
Confidence            10       1123578899999999999999999999999999999643

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=3.8e-46  Score=358.78  Aligned_cols=248  Identities=37%  Similarity=0.680  Sum_probs=213.3

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChH------HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~------~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      |++++.||+|+||.||+|++..+++.||+|++.....      ...+|+.+++++. ||||+++++++.+.+..++||||
T Consensus         1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~v~~~   79 (260)
T PF00069_consen    1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLR-HPNIVQILDVFQDDNYLYIVMEY   79 (260)
T ss_dssp             EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHT-BTTBCHEEEEEEESSEEEEEEEE
T ss_pred             CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccc-ccccccccccccccccccccccc
Confidence            7889999999999999999999999999999976431      2345999999995 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee-cCCCcccccC
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA  257 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~-~~~~~~~~~~  257 (469)
                      +.+++|.+++...+.+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||.+... ..........
T Consensus        80 ~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  159 (260)
T PF00069_consen   80 CPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSENNENFNPFV  159 (260)
T ss_dssp             ETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTSTTSEBSSSS
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999988899999999999999999999999999999999999999999999999999999763 3334455678


Q ss_pred             CCCcccCceecc-C-CCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          258 GSPAYVAPEVLS-G-NYSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       258 gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      +++.|+|||++. + .++.++||||||+++|+|++|..||....   ....+..............+...+.++.++|.+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~  239 (260)
T PF00069_consen  160 GTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKK  239 (260)
T ss_dssp             SSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccccccchhHHHHHHHHHH
Confidence            999999999997 4 58999999999999999999999999873   333333333322222222222234899999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCc
Q 012170          333 MLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||+.||++||++.++++||||
T Consensus       240 ~l~~~p~~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  240 MLSKDPEQRPSAEELLKHPWF  260 (260)
T ss_dssp             HSSSSGGGSTTHHHHHTSGGG
T ss_pred             HccCChhHCcCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-47  Score=364.89  Aligned_cols=253  Identities=30%  Similarity=0.542  Sum_probs=230.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..+|.++.+||+|+||+|-+|..+.|.+.||||+++++-       +--..|.++|.-....|.+++++.+|+.-+.+|+
T Consensus       348 ~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyF  427 (683)
T KOG0696|consen  348 ATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYF  427 (683)
T ss_pred             ecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheee
Confidence            468999999999999999999999999999999998742       2234688888777668899999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee-ecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~-~~~~~~~  253 (469)
                      ||||+.||+|..+|+..+.|-|..+..++.+|+-||-+||++||++||||.+|||++.+|+|||+|||+++. +.++..+
T Consensus       428 VMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~~TT  507 (683)
T KOG0696|consen  428 VMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDGVTT  507 (683)
T ss_pred             EEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeecccccccccCCcce
Confidence            999999999999999999999999999999999999999999999999999999999999999999999974 4456667


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .++||||.|+|||++.- .|+..+||||+||+||||+.|.+||.|.+..+++..|..-...++    ..+|.++.++.+.
T Consensus       508 kTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ehnvsyP----KslSkEAv~ickg  583 (683)
T KOG0696|consen  508 KTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIMEHNVSYP----KSLSKEAVAICKG  583 (683)
T ss_pred             eeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHccCcCc----ccccHHHHHHHHH
Confidence            88999999999999965 599999999999999999999999999999999999998888777    6789999999999


Q ss_pred             hchhhhcCCCC-----HHHHHcCCCcccccc
Q 012170          333 MLTRDVSARIT-----ADEVLRHPWILFYTE  358 (469)
Q Consensus       333 ~L~~dP~~Rps-----a~elL~hp~~~~~~~  358 (469)
                      +|.+.|.+|+.     -.+|-.||||....+
T Consensus       584 ~ltK~P~kRLGcg~~ge~di~~H~FFR~iDW  614 (683)
T KOG0696|consen  584 LLTKHPGKRLGCGPEGERDIREHPFFRRIDW  614 (683)
T ss_pred             HhhcCCccccCCCCccccchhhCcchhhccH
Confidence            99999999996     378999999954443

>KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-48  Score=387.64  Aligned_cols=256  Identities=28%  Similarity=0.442  Sum_probs=226.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-C---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-G---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...+-|.++..||.|+||.||+|.++.++...|.|++.. +   -+++.-|++||..|. ||+||+|++.|..++.+||+
T Consensus        29 nP~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~Cd-HP~ivkLl~ayy~enkLwil  107 (1187)
T KOG0579|consen   29 NPRDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECD-HPVIVKLLSAYYFENKLWIL  107 (1187)
T ss_pred             CHHHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCC-ChHHHHHHHHHhccCceEEE
Confidence            345779999999999999999999999999999999853 2   256778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee-cCCCcc
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTL  253 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~-~~~~~~  253 (469)
                      .|||.||-+...+..-+ .+.+.++..+++|++.||.|||+++|||||||..|||++-+|.|+|+|||.+... ...+..
T Consensus       108 iEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~qkR  187 (1187)
T KOG0579|consen  108 IEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQKR  187 (1187)
T ss_pred             EeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchhHHhhh
Confidence            99999999988887654 6999999999999999999999999999999999999999999999999997543 233456


Q ss_pred             cccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .++.|||+|||||++..      .|+.++||||||++|.+|..+.+|....++..++-.|.+..++... .+..++..+.
T Consensus       188 DsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKiaKSePPTLl-qPS~Ws~~F~  266 (1187)
T KOG0579|consen  188 DSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTLL-QPSHWSRSFS  266 (1187)
T ss_pred             ccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHHhhcCCCccc-CcchhhhHHH
Confidence            77999999999999732      4999999999999999999999999999999998888776554322 2356799999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ||+.+||.+||..||++.++|+||||+...
T Consensus       267 DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~  296 (1187)
T KOG0579|consen  267 DFLKRCLVKNPRNRPPAAQLLKHPFVQNAP  296 (1187)
T ss_pred             HHHHHHHhcCCccCCCHHHHhhCcccccCC
Confidence            999999999999999999999999997543

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=1e-45  Score=362.85  Aligned_cols=249  Identities=33%  Similarity=0.559  Sum_probs=211.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .|++.+.||+|+||.||+|.+..+++.||+|.+...       ...+.+|+.+++.+. |+||+.+++.+.+.+.+|+||
T Consensus         1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~   79 (285)
T cd05630           1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVN-SRFVVSLAYAYETKDALCLVL   79 (285)
T ss_pred             CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCC-CCCeeeeeEEEecCCEEEEEE
Confidence            367889999999999999999999999999998542       134668999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          177 ELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||++|++|.+++...+  .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++|+|||++..........
T Consensus        80 e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  159 (285)
T cd05630          80 TLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIK  159 (285)
T ss_pred             EecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcccc
Confidence            9999999998886543  58999999999999999999999999999999999999999999999999997665444444


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE---AVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...|++.|+|||++.+ .++.++||||+|+++|+|++|..||.+....   .....+..   .........+++++.+||
T Consensus       160 ~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~li  236 (285)
T cd05630         160 GRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK---EVQEEYSEKFSPDARSLC  236 (285)
T ss_pred             CCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhhh---hhhhhcCccCCHHHHHHH
Confidence            5689999999999966 5899999999999999999999999864321   11221111   111122356799999999


Q ss_pred             HHhchhhhcCCCC-----HHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARIT-----ADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rps-----a~elL~hp~~~~~  356 (469)
                      .+||+.||.+|||     ++|+++||||...
T Consensus       237 ~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~~  267 (285)
T cd05630         237 KMLLCKDPKERLGCQGGGAREVKEHPLFKQI  267 (285)
T ss_pred             HHHhhcCHHHccCCCCCchHHHHcChhhhcc
Confidence            9999999999999     9999999999543

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=2e-45  Score=359.22  Aligned_cols=242  Identities=29%  Similarity=0.509  Sum_probs=206.1

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||+|+||.||++.++.+|+.||+|.+...       ...+..|+++++++. ||||++++++++.+..+|+||||++||+
T Consensus         1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~i~~~~~~~~~~~~~~lv~e~~~g~~   79 (277)
T cd05607           1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVN-SPFIVNLAYAFESKTHLCLVMSLMNGGD   79 (277)
T ss_pred             CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcC-CCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence            79999999999999999999999998532       234567999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCc
Q 012170          184 LIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA  261 (469)
Q Consensus       184 L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~  261 (469)
                      |.+++...+  .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++.............|++.
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05607          80 LKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKTITQRAGTNG  159 (277)
T ss_pred             HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCceeeccCCCCC
Confidence            998886543  588899999999999999999999999999999999999999999999999987665544445679999


Q ss_pred             ccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          262 YVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL----EAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       262 y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~----~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      |+|||++.+ .++.++|||||||++|+|++|..||.+...    ..+...+......+.   ...++.++++||.+||++
T Consensus       160 y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKFE---HQNFTEESKDICRLFLAK  236 (277)
T ss_pred             ccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhccccccc---cccCCHHHHHHHHHHhcc
Confidence            999999865 489999999999999999999999976432    233333333332222   236799999999999999


Q ss_pred             hhcCCCCH----HHHHcCCCcccc
Q 012170          337 DVSARITA----DEVLRHPWILFY  356 (469)
Q Consensus       337 dP~~Rpsa----~elL~hp~~~~~  356 (469)
                      ||.+||++    +++++||||...
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~~  260 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKTI  260 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcCC
Confidence            99999999    778899999654

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=6.3e-45  Score=357.07  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=215.7

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      |+..+.||.|+||+||+|.+..+++.||+|++...       ...+.+|+++|+.+. |+||+.+++.+..++.+|+|||
T Consensus         2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~-~~~i~~~~~~~~~~~~~~lv~e   80 (285)
T cd05632           2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVN-SQFVVNLAYAYETKDALCLVLT   80 (285)
T ss_pred             ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcC-CcCceeEEEEEecCCEEEEEEE
Confidence            67789999999999999999999999999998642       134678999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++...........
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (285)
T cd05632          81 IMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIRG  160 (285)
T ss_pred             eccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCcccC
Confidence            99999999888654  3699999999999999999999999999999999999999999999999999976554444445


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|++.|+|||++.+ .++.++|+|||||++|+|++|..||.+.........+..............++.++.+||.+||
T Consensus       161 ~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l  240 (285)
T cd05632         161 RVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSAKFSEEAKSICKMLL  240 (285)
T ss_pred             CCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhhccccccCccCCHHHHHHHHHHc
Confidence            679999999999965 5899999999999999999999999877654444444332222222233568999999999999


Q ss_pred             hhhhcCCCC-----HHHHHcCCCccccc
Q 012170          335 TRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      +.||.+||+     +.++++||||....
T Consensus       241 ~~~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         241 TKDPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             cCCHhHcCCCcccChHHHHcChhhhcCC
Confidence            999999999     89999999996553

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=2.4e-45  Score=368.44  Aligned_cols=252  Identities=24%  Similarity=0.411  Sum_probs=214.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..++|++.+.||.|+||.||+|.+..+|..+|+|++...     ...+.+|+++|+.+. ||||++++++|.+++.+|+|
T Consensus         3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   81 (333)
T cd06650           3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISIC   81 (333)
T ss_pred             chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCC-CCcccceeEEEEECCEEEEE
Confidence            357899999999999999999999999999999998643     245789999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      |||+.||+|.+++...+.+++..+..++.||+.||.|||+. +++||||||+|||++.+|.+||+|||++...... ...
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~-~~~  160 (333)
T cd06650          82 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN  160 (333)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-ccc
Confidence            99999999999998888899999999999999999999975 7999999999999999999999999998755332 234


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-------------------------
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIK-------------------------  308 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~-------------------------  308 (469)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++|..||...........+.                         
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (333)
T cd06650         161 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSS  240 (333)
T ss_pred             cCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhh
Confidence            4679999999999976 48899999999999999999999998655443322111                         


Q ss_pred             -------------------cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          309 -------------------NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       309 -------------------~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                         +...  +......++.++++||.+||++||.+|||+.|+|.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~  305 (333)
T cd06650         241 YGPDSRPPMAIFELLDYIVNEPP--PKLPSGVFGAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRS  305 (333)
T ss_pred             hcccccccccHHHHHHHHhcCCC--ccCCCCCcCHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcC
Confidence                               0000  000012367899999999999999999999999999999654

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=2.5e-45  Score=372.59  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=210.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++...      ...+.+|+.+++.+. ||||+++++++...    
T Consensus        21 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~~~~~~~   99 (364)
T cd07875          21 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE   99 (364)
T ss_pred             chhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcC-CCCccccceeeccccccc
Confidence            3568999999999999999999999999999999998642      245778999999996 99999999988643    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       100 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~  176 (364)
T cd07875         100 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  176 (364)
T ss_pred             ccCeEEEEEeCCCC-CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCCcccc
Confidence              357999999975 6666664  35889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC--------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL--------------  312 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------------  312 (469)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+.....              
T Consensus       177 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  256 (364)
T cd07875         177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  256 (364)
T ss_pred             CCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHH
Confidence            55544556789999999999976 489999999999999999999999998776555544422100              


Q ss_pred             --------CC----------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 --------DF----------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 --------~~----------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                              .+                ........+.++++||.+||..||.+|||+.|+|+||||..+
T Consensus       257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~~  324 (364)
T cd07875         257 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  324 (364)
T ss_pred             HHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcCcccccc
Confidence                    00                001111245688999999999999999999999999999543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=1.2e-45  Score=376.01  Aligned_cols=251  Identities=29%  Similarity=0.451  Sum_probs=213.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----eE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----CF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----~~  172 (469)
                      +|++++.||+|+||.||+|.+..+|+.||||.+...      ...+.+|+.+|+.++ ||||+++++++...+     .+
T Consensus         1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   79 (372)
T cd07853           1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFK-HDNVLSALDILQPPHIDPFEEI   79 (372)
T ss_pred             CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCC-CCCcCCHhheecCCCccccceE
Confidence            477889999999999999999999999999998642      245788999999997 999999999998776     78


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC--
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG--  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~--  250 (469)
                      |+||||+. ++|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  
T Consensus        80 ~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~  158 (372)
T cd07853          80 YVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES  158 (372)
T ss_pred             EEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc
Confidence            99999996 578888877888999999999999999999999999999999999999999999999999999765432  


Q ss_pred             CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-----------------
Q 012170          251 QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-----------------  311 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-----------------  311 (469)
                      .......+|+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+....+..|....                 
T Consensus       159 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~  238 (372)
T cd07853         159 KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARA  238 (372)
T ss_pred             ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHH
Confidence            22334578999999999976  37899999999999999999999999887766655543211                 


Q ss_pred             ------CCCCC-----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 ------LDFHS-----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 ------~~~~~-----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                            ...+.     ......++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  294 (372)
T cd07853         239 HILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAHPYLDEG  294 (372)
T ss_pred             HHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcCHhhCCC
Confidence                  00000     1123468899999999999999999999999999999654

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=8.1e-45  Score=350.63  Aligned_cols=248  Identities=28%  Similarity=0.515  Sum_probs=215.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +.|.+.+.||.|++|.||+|.+..++..||+|.+...         ...+.+|+++++++. ||||+++++++.+.+.+|
T Consensus         2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   80 (263)
T cd06625           2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ-HERIVQYYGCLRDDETLS   80 (263)
T ss_pred             CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEccCCeEE
Confidence            4688999999999999999999999999999998532         135778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.........
T Consensus        81 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~  160 (263)
T cd06625          81 IFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSS  160 (263)
T ss_pred             EEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccccccc
Confidence            99999999999999988888999999999999999999999999999999999999999999999999999765432111


Q ss_pred             ----cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          254 ----SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       254 ----~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                          ....|+..|+|||++.+. ++.++||||||+++|+|++|..||...........+.......  .....++.++.+
T Consensus       161 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  238 (263)
T cd06625         161 GTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTNP--QLPSHVSPDARN  238 (263)
T ss_pred             cccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHHhccCCCC--CCCccCCHHHHH
Confidence                235688999999999764 8899999999999999999999998766555544444332221  223568999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||.+||..+|.+|||+.++|+||||
T Consensus       239 li~~~l~~~p~~Rpt~~~ll~~~~~  263 (263)
T cd06625         239 FLRRTFVENAKKRPSAEELLRHFFV  263 (263)
T ss_pred             HHHHHhhcCcccCCCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.2e-45  Score=371.61  Aligned_cols=253  Identities=28%  Similarity=0.476  Sum_probs=209.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..+++.||||.+...      ...+.+|+.+++.+. ||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   92 (355)
T cd07874          14 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKSLE   92 (355)
T ss_pred             hhhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhC-CCchhceeeeeecccccc
Confidence            3568999999999999999999999999999999998642      245678999999996 99999999998644    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+||||+++ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        93 ~~~~~~lv~e~~~~-~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~  169 (355)
T cd07874          93 EFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  169 (355)
T ss_pred             ccceeEEEhhhhcc-cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcccccC
Confidence              357999999976 5666554  35889999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc---------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK---------------  311 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------  311 (469)
                      ..........||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+....               
T Consensus       170 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (355)
T cd07874         170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  249 (355)
T ss_pred             CCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHH
Confidence            55544556789999999999976 48999999999999999999999998876544333221100               


Q ss_pred             -------CC-----C-----------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 -------LD-----F-----------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 -------~~-----~-----------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                             ..     +           ........+.++++||.+||..||++|||+.|+|+||||..+
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~hp~~~~~  317 (355)
T cd07874         250 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQHPYINVW  317 (355)
T ss_pred             HHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcCcchhcc
Confidence                   00     0           001112346788999999999999999999999999999644

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-47  Score=373.32  Aligned_cols=254  Identities=33%  Similarity=0.636  Sum_probs=231.1

Q ss_pred             cccCCeee--eeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          100 KIEDDHTK--VEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       100 ~~~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ++..-|++  .++||.|.||+||-|+++.+|+.||||++.+      .+..++.|+.||+++. ||.||.+--.|+..+.
T Consensus       559 d~stvYQif~devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~-HPGiV~le~M~ET~er  637 (888)
T KOG4236|consen  559 DISTVYQIFADEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLH-HPGIVNLECMFETPER  637 (888)
T ss_pred             hHHHHHHhhhHhhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcC-CCCeeEEEEeecCCce
Confidence            45556666  4789999999999999999999999999964      4578999999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHH--HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceee
Q 012170          172 FHLVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMR  246 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~--~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~  246 (469)
                      +++|||.+.| +.++.|.  +.+++++.....++.||+.||.|||-+||+|+||||+|||+.+.   .++||||||+|+.
T Consensus       638 vFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARi  716 (888)
T KOG4236|consen  638 VFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARI  716 (888)
T ss_pred             EEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceee
Confidence            9999999965 5555553  35789999999999999999999999999999999999999765   3799999999999


Q ss_pred             ecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      +.......+.+|||.|+|||++.. .|+..-|+||+|+|+|.-|.|..||+..  +++.++|++..+.++...|..++.+
T Consensus       717 IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMyPp~PW~eis~~  794 (888)
T KOG4236|consen  717 IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMYPPNPWSEISPE  794 (888)
T ss_pred             cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhccccccCCCchhhcCHH
Confidence            998888888999999999999977 4999999999999999999999999754  5788899999999999999999999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +.|||..+|+..-.+|.|.++.|.|||++.+.
T Consensus       795 AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq  826 (888)
T KOG4236|consen  795 AIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ  826 (888)
T ss_pred             HHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence            99999999999999999999999999998763

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=4e-45  Score=361.05  Aligned_cols=256  Identities=27%  Similarity=0.482  Sum_probs=214.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|.+++.||.|+||.||+|.++.++..||+|.++..     ...+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus         5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~nI~~~~~~~~~~~~~~lv~   83 (301)
T cd07873           5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVF   83 (301)
T ss_pred             ccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcC-CCCcceEEEEEecCCeEEEEE
Confidence            36799999999999999999999999999999998632     245778999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      ||+. ++|.+++... ..+++..+..++.||+.||.|||++||+|+||||+|||++.++.++|+|||++....... ...
T Consensus        84 e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  162 (301)
T cd07873          84 EYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYS  162 (301)
T ss_pred             eccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCCccc
Confidence            9997 5888877654 468999999999999999999999999999999999999999999999999997543222 233


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  313 (469)
                      ...+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+....+......                   
T Consensus       163 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (301)
T cd07873         163 NEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYN  242 (301)
T ss_pred             ccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccc
Confidence            4567999999999865  3788999999999999999999999987766555443321110                   


Q ss_pred             CCC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          314 FHS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       314 ~~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      ++.       .....+++++++||.+||+.||.+|||+.|+|+||||....++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~~~~~  295 (301)
T cd07873         243 YPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMKHPYFHCLGER  295 (301)
T ss_pred             cCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccch
Confidence            000       1113578899999999999999999999999999999766543

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=1.8e-44  Score=354.42  Aligned_cols=248  Identities=34%  Similarity=0.614  Sum_probs=222.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.+..+++.||+|++...       ...+.+|+++|+++. ||||+++++++.+++.+|+|
T Consensus         1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   79 (290)
T cd05580           1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIR-HPFLVNLYGSFQDDSNLYLV   79 (290)
T ss_pred             CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCC-CCCccceeeEEEcCCeEEEE
Confidence            4789999999999999999999999999999998642       245778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|.|||++.++.++|+|||++......  ...
T Consensus        80 ~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~--~~~  157 (290)
T cd05580          80 MEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR--TYT  157 (290)
T ss_pred             EecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--CCC
Confidence            999999999999988889999999999999999999999999999999999999999999999999999776544  344


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|++.|+|||.+.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++..++++|.+||
T Consensus       158 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l  233 (290)
T cd05580         158 LCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFP----SFFSPDAKDLIRNLL  233 (290)
T ss_pred             CCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCccCC----ccCCHHHHHHHHHHc
Confidence            579999999999865 478899999999999999999999998887777777776655444    356899999999999


Q ss_pred             hhhhcCCC-----CHHHHHcCCCccccc
Q 012170          335 TRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      ..||.+|+     +++++++||||....
T Consensus       234 ~~~p~~R~~~~~~~~~~l~~~~~~~~~~  261 (290)
T cd05580         234 QVDLTKRLGNLKNGVNDIKNHPWFAGID  261 (290)
T ss_pred             cCCHHHccCcccCCHHHHHcCcccccCC
Confidence            99999999     999999999995543

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-45  Score=371.34  Aligned_cols=252  Identities=27%  Similarity=0.515  Sum_probs=210.6

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||.|+||.||+|.+..++..||||++...      ...+.+|+.+|+.+. ||||+++++++...    
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07878          12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMK-HENVIGLLDVFTPATSIE   90 (343)
T ss_pred             hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcC-CCchhhhhhhhccccccc
Confidence            4668999999999999999999999999999999998653      245678999999997 99999999988643    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|++||++ +++|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        91 ~~~~~~~~~~~~-~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~  168 (343)
T cd07878          91 NFNEVYLVTNLM-GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQA  168 (343)
T ss_pred             ccCcEEEEeecC-CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCccceec
Confidence              3578999998 77887766 4567999999999999999999999999999999999999999999999999999865


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD------------  313 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------  313 (469)
                      ..  ......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+....+..+......            
T Consensus       169 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07878         169 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSE  246 (343)
T ss_pred             CC--CcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchh
Confidence            43  2345679999999999876  4889999999999999999999999887655544443221100            


Q ss_pred             -----------CCC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 -----------FHS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 -----------~~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                 .+.    ..+...++.+.+||.+||..||.+|||+.|+|+||||..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~  304 (343)
T cd07878         247 HARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAHPYFSQY  304 (343)
T ss_pred             hHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhcc
Confidence                       000    0123457788999999999999999999999999999643

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.6e-45  Score=381.55  Aligned_cols=250  Identities=26%  Similarity=0.448  Sum_probs=219.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCC-CcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKAS-GAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ...|.+.+.||+|+||.||+|....+ +..||+|.+....    ..+.+|+.+|+.+. ||||+++++++...+.+||||
T Consensus        66 ~~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~-Hpniv~~~~~~~~~~~~~lv~  144 (478)
T PTZ00267         66 EHMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACD-HFGIVKHFDDFKSDDKLLLIM  144 (478)
T ss_pred             ceeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEECCEEEEEE
Confidence            34599999999999999999998877 7889999874322    35678999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          177 ELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       177 E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      ||++||+|.+++..    ..++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       145 E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~  224 (478)
T PTZ00267        145 EYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS  224 (478)
T ss_pred             ECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence            99999999987753    3468999999999999999999999999999999999999999999999999998765432 


Q ss_pred             --cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          252 --TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       252 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                        .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+++..+........   ...++.++.+
T Consensus       225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~  301 (478)
T PTZ00267        225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYDPF---PCPVSSGMKA  301 (478)
T ss_pred             cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---CccCCHHHHH
Confidence              2345679999999999976 489999999999999999999999999888888887766544321   2467899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||.+||..||.+||++.++|.|||+..
T Consensus       302 li~~~L~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        302 LLDPLLSKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             HHHHHhccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999999999854

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=4.1e-45  Score=363.43  Aligned_cols=244  Identities=26%  Similarity=0.414  Sum_probs=193.2

Q ss_pred             eeeeeccCCeEEEEEEEC--CCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEEEeccCC
Q 012170          108 VEVIGHGKFGSVWLCRSK--ASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLVMELCSG  181 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV~E~~~g  181 (469)
                      ...||+|+||.||+|+++  .++..||+|.+...  ...+.+|+.+|+++. ||||+++++++..  +..+|+||||+.+
T Consensus         6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07868           6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEH   84 (317)
T ss_pred             ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCcHHHHHHHHHHHhcC-CCCCcceeeeEecCCCcEEEEEEeccCC
Confidence            368999999999999976  46789999998653  356789999999996 9999999999854  4578999999964


Q ss_pred             CchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE----ccCCcEEEEeccceeeec
Q 012170          182 GRLIDQMVEV---------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       182 g~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl----~~~~~vkL~DFgla~~~~  248 (469)
                       +|.+++...         ..+++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07868          85 -DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccC
Confidence             787776432         258899999999999999999999999999999999999    456789999999997654


Q ss_pred             CCC----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHHHHHcCcCC
Q 012170          249 NGQ----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSL---------EAVFDAIKNVKLD  313 (469)
Q Consensus       249 ~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~---------~~~~~~i~~~~~~  313 (469)
                      ...    ......||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+...         ...+..+......
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07868         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGF  243 (317)
T ss_pred             CCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCC
Confidence            322    2345678999999999865  389999999999999999999999975331         1111111110000


Q ss_pred             C----------------------------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 F----------------------------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 ~----------------------------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .                                  ........+.++.+||.+||+.||.+|||++|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         244 PADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             CChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            0                                  000011235678999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.2e-44  Score=369.38  Aligned_cols=256  Identities=25%  Similarity=0.412  Sum_probs=210.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEEC--CCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSK--ASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .+..+|.+++.||.|+||.||+|...  .++..||+|.+... ....+|+++|+.+. ||||+++++++...+.+|+|||
T Consensus        89 ~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-~~~~~E~~il~~l~-h~~iv~~~~~~~~~~~~~lv~e  166 (392)
T PHA03207         89 VVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-KTPGREIDILKTIS-HRAIINLIHAYRWKSTVCMVMP  166 (392)
T ss_pred             hccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-ccHHHHHHHHHhcC-CCCccceeeeEeeCCEEEEEeh
Confidence            35568999999999999999999764  35678999998753 45678999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---cc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~  254 (469)
                      ++. ++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........   ..
T Consensus       167 ~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~  245 (392)
T PHA03207        167 KYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY  245 (392)
T ss_pred             hcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccccccCccccccccc
Confidence            995 58888887778899999999999999999999999999999999999999999999999999976543322   23


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHH----HcCcCCCCCC---------
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL---EAVFDAI----KNVKLDFHSG---------  317 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i----~~~~~~~~~~---------  317 (469)
                      ...||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+...   ...+..+    ......++..         
T Consensus       246 ~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~  325 (392)
T PHA03207        246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHF  325 (392)
T ss_pred             ccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHH
Confidence            4679999999999976 589999999999999999999999976432   1111111    1111111100         


Q ss_pred             --------------c---ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          318 --------------V---WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       318 --------------~---~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                                    .   ...++.++.+||.+||..||.+|||+.++|+||||.....
T Consensus       326 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~p~f~~~~~  383 (392)
T PHA03207        326 KQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSLPLFTKEPI  383 (392)
T ss_pred             HhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhCchhhccch
Confidence                          0   0235678999999999999999999999999999965443

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=1.1e-44  Score=381.60  Aligned_cols=252  Identities=27%  Similarity=0.463  Sum_probs=218.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD----  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~----  170 (469)
                      ..++|.+.+.||+|+||.||+|++..+|+.||||++...      ...+.+|+.+|..+. |+||++++..+...+    
T Consensus        30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~-h~~iv~~~~~~~~~~~~~~  108 (496)
T PTZ00283         30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCD-FFSIVKCHEDFAKKDPRNP  108 (496)
T ss_pred             cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCC-CCcEEEeecceecccccCc
Confidence            447999999999999999999999999999999998542      245678999999996 999999988775432    


Q ss_pred             ----eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecc
Q 012170          171 ----CFHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG  242 (469)
Q Consensus       171 ----~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFg  242 (469)
                          .+++||||+++|+|.+++...    ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||
T Consensus       109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG  188 (496)
T PTZ00283        109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG  188 (496)
T ss_pred             ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence                378999999999999988653    468999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCC---CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          243 LAMRISNG---QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       243 la~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      +++.....   ......+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..+.......   .
T Consensus       189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~---~  265 (496)
T PTZ00283        189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDP---L  265 (496)
T ss_pred             cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCC---C
Confidence            99765432   22345689999999999976 48999999999999999999999999998888887776654432   2


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ...+++++.+||.+||..||.+||++.++|+|||+..+
T Consensus       266 ~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~  303 (496)
T PTZ00283        266 PPSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF  303 (496)
T ss_pred             CCCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence            24689999999999999999999999999999998644

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=2.7e-44  Score=356.64  Aligned_cols=252  Identities=24%  Similarity=0.406  Sum_probs=214.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++.+.||+|+||.||++.+..+|..+|+|.+...     ...+.+|+++++++. ||||+++++++.+++.+|+|||
T Consensus         1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   79 (308)
T cd06615           1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECN-SPYIVGFYGAFYSDGEISICME   79 (308)
T ss_pred             CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCEEEEEee
Confidence            4689999999999999999999999999999998643     245778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |++|++|.+++...+.+++..+..++.||+.||.|||+ .+++||||||+|||++.++.++|+|||++...... .....
T Consensus        80 y~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~~~~  158 (308)
T cd06615          80 HMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MANSF  158 (308)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc-ccccC
Confidence            99999999999888899999999999999999999997 59999999999999999999999999998765332 23456


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC---------------------
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF---------------------  314 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~---------------------  314 (469)
                      .|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+.......                     
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (308)
T cd06615         159 VGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMA  238 (308)
T ss_pred             CCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhh
Confidence            79999999999876 48899999999999999999999997655444333222111000                     


Q ss_pred             -------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 -------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 -------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                   +......++.++++||.+||..||++|||+.++++||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~  293 (308)
T cd06615         239 IFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKHPFIKRA  293 (308)
T ss_pred             HHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhhc
Confidence                         000112368899999999999999999999999999999654

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=2.4e-44  Score=351.69  Aligned_cols=250  Identities=29%  Similarity=0.544  Sum_probs=213.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++.+.||+|+||.||+|.++.+|+.||+|++...      ...+.+|+.+++.+. ||||+++++++...+.+++||
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v~   79 (286)
T cd07847           1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLK-HPNLVNLIEVFRRKRKLHLVF   79 (286)
T ss_pred             CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCC-CCCEeeeeeEEeeCCEEEEEE
Confidence            4799999999999999999999999999999988532      245678999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||++++.|..++.....+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07847          80 EYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDDYTD  159 (286)
T ss_pred             eccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcccccC
Confidence            999998888777666789999999999999999999999999999999999999999999999999998765433 2334


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-------------------CC
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-------------------DF  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~~  314 (469)
                      ..++..|+|||++.+  .++.++||||||+++|+|++|.+||.+.+..+....+.....                   ..
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07847         160 YVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSI  239 (286)
T ss_pred             cccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccC
Confidence            568899999999865  478999999999999999999999988766554444322100                   00


Q ss_pred             CC--------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HS--------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~--------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.        ..+..++..+.+||.+||+.||++||++.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         240 PEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLEHPYF  286 (286)
T ss_pred             CCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhcCCCC
Confidence            00        0124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>KOG0586 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3e-45  Score=371.04  Aligned_cols=252  Identities=37%  Similarity=0.610  Sum_probs=231.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .-...|.+...||+|.|+.|.+|++..||..||||++++..      ..+.+|+++|+.|. |||||+++.+.+....+|
T Consensus        53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~-HPnIvkl~~v~~t~~~ly  131 (596)
T KOG0586|consen   53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLN-HPNIVKLFSVIETEATLY  131 (596)
T ss_pred             ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcC-CcceeeeeeeeeecceeE
Confidence            34568999999999999999999999999999999997642      45789999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+.+|.+++++.+++...+..+..++.|++.|++|||+++|||||||++|||++.+-++||+|||++..+......
T Consensus       132 lV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~l  211 (596)
T KOG0586|consen  132 LVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLML  211 (596)
T ss_pred             EEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeecccccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999988888


Q ss_pred             cccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .++||++.|.|||++.|. | ++.+|+||+|+++|.|+.|.+||.|.+..+.-.....+++..+    ..++.+..++|+
T Consensus       212 qt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl~gk~rIp----~~ms~dce~lLr  287 (596)
T KOG0586|consen  212 QTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVLRGKYRIP----FYMSCDCEDLLR  287 (596)
T ss_pred             cccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchheeeeeccc----ceeechhHHHHH
Confidence            999999999999999884 4 6889999999999999999999999887776666655555544    357899999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++|..+|.+|++.++++.|+|+...
T Consensus       288 k~lvl~Pskr~~~dqim~~~W~n~~  312 (596)
T KOG0586|consen  288 KFLVLNPSKRGPCDQIMKDRWRNDL  312 (596)
T ss_pred             HhhccCccccCCHHHhhhhcccchh
Confidence            9999999999999999999998543

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=1.5e-44  Score=350.02  Aligned_cols=250  Identities=29%  Similarity=0.480  Sum_probs=213.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++|.+.+.||+|+||.||+|.+..+++.||+|+++..    ...+.+|+.+++.+. ||||+++++++...+.+|+|||
T Consensus         8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~-h~~ii~~~~~~~~~~~~~lv~e   86 (267)
T cd06645           8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCK-HSNIVAYFGSYLRRDKLWICME   86 (267)
T ss_pred             HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCeeeEEEEEEeCCEEEEEEe
Confidence            45899999999999999999999999999999998643    235678999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++....... .....
T Consensus        87 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~  166 (267)
T cd06645          87 FCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIAKRKSF  166 (267)
T ss_pred             ccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcccccccc
Confidence            99999999999888899999999999999999999999999999999999999999999999999987654322 23445


Q ss_pred             CCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-CcccCCCHHHHHHHH
Q 012170          257 AGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-GVWETVSKPARDLMA  331 (469)
Q Consensus       257 ~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~lI~  331 (469)
                      .|++.|+|||++.    +.++.++|+|||||++|+|++|.+||...........+.......+. .....++..+.+||.
T Consensus       167 ~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  246 (267)
T cd06645         167 IGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVK  246 (267)
T ss_pred             cCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHH
Confidence            7999999999973    34889999999999999999999999765544444333333222111 111246889999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCC
Q 012170          332 RMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~  352 (469)
                      +||..+|++||++.++++|||
T Consensus       247 ~~l~~~P~~R~~~~~ll~~~~  267 (267)
T cd06645         247 MALTKNPKKRPTAEKLLQHPF  267 (267)
T ss_pred             HHccCCchhCcCHHHHhcCCC
Confidence            999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.1e-45  Score=346.82  Aligned_cols=303  Identities=25%  Similarity=0.431  Sum_probs=251.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      -.++|.++++||+|+|++|.+++++.|.+.||+|+++++.       +-++.|..+..+..+||.+|-++.+|+.+..++
T Consensus       248 ~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlf  327 (593)
T KOG0695|consen  248 GLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLF  327 (593)
T ss_pred             ccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEE
Confidence            4679999999999999999999999999999999997631       346789999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee-ecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~-~~~~~~  252 (469)
                      +|.||++||+|.-+++++..++++.++.+..+|..||.|||++||++||||.+|||++..|++||+|+|+++. +.++..
T Consensus       328 fvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~gd~  407 (593)
T KOG0695|consen  328 FVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPGDT  407 (593)
T ss_pred             EEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCCCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999974 456677


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCC--------CCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKG--------DSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~--------~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ++++||||.|.|||++.|. |+..+|||+||++|+||+.|..||.-        +....+++.|.......+    ..+|
T Consensus       408 tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedylfqvilekqirip----rsls  483 (593)
T KOG0695|consen  408 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIP----RSLS  483 (593)
T ss_pred             cccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHHHHHHHhhhccccc----ceee
Confidence            8899999999999999985 99999999999999999999999951        234456666766666555    5678


Q ss_pred             HHHHHHHHHhchhhhcCCCC------HHHHHcCCCccccccccchhchhhHHhhhhcCCCCCCCCccCCcccccccccCC
Q 012170          324 KPARDLMARMLTRDVSARIT------ADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRG  397 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rps------a~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (469)
                      -.+..+++..|++||.+|+.      ..++..|+||...        +|...-++++.++.+ |.+.+....+   ..+.
T Consensus       484 vkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~i--------dwd~leqk~v~ppf~-p~i~~d~~l~---~fd~  551 (593)
T KOG0695|consen  484 VKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSI--------DWDLLEQKQVLPPFQ-PQITDDYGLD---NFDT  551 (593)
T ss_pred             hhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhC--------CHHHHhhcccCCCCC-CccccccCcc---cccc
Confidence            89999999999999999984      7899999999544        444444556655554 3333322222   3334


Q ss_pred             CCCCCCccCCCccccCCCcccc
Q 012170          398 SRNDESHALSSSESLNSESEVQ  419 (469)
Q Consensus       398 ~~~~~~~~~~~~~~~~~~~~~~  419 (469)
                      +..++..++++.+.......+|
T Consensus       552 qft~e~~qltpdd~d~i~ridq  573 (593)
T KOG0695|consen  552 QFTSEPVQLTPDDEDAIKRIDQ  573 (593)
T ss_pred             ccccCCcccCCCCHHHHHhcch
Confidence            5556666666665555444454

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=3.2e-44  Score=348.47  Aligned_cols=251  Identities=27%  Similarity=0.451  Sum_probs=212.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC------Ce
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEA------DC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~------~~  171 (469)
                      ....|++.+.||+|+||.||+|.+..+++.||+|++...   ...+.+|+.+++.+..||||+++++++...      ..
T Consensus         4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (272)
T cd06637           4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQ   83 (272)
T ss_pred             hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcE
Confidence            346788899999999999999999999999999998543   456889999999996699999999998753      46


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          172 FHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +|+||||+.+|+|.+++...  ..+++..+..++.|++.||.|||++||+||||||+||+++.++.++|+|||++.....
T Consensus        84 ~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~  163 (272)
T cd06637          84 LWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  163 (272)
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccc
Confidence            89999999999999998764  3689999999999999999999999999999999999999999999999999976543


Q ss_pred             C-CcccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          250 G-QTLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      . .......|++.|+|||++.+      .|+.++||||+||++|+|++|..||...........+....  ........+
T Consensus       164 ~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~  241 (272)
T cd06637         164 TVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNP--APRLKSKKW  241 (272)
T ss_pred             ccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHHHhcCC--CCCCCCCCc
Confidence            2 22344679999999999852      47889999999999999999999998766554444443322  111223467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.++.+||.+||..||.+|||+.++++||||
T Consensus       242 ~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         242 SKKFQSFIESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=3.6e-44  Score=350.46  Aligned_cols=248  Identities=32%  Similarity=0.490  Sum_probs=206.8

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||.|+||.||+|.+..+|..||||+++..      ...+.+|+.+++.+. ||||+++++++.+++.+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (285)
T cd07861           1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQ-HPNIVCLQDVLMQESRLYLIFE   79 (285)
T ss_pred             CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcC-CCCEeeeEEEEeeCCeEEEEEe
Confidence            588999999999999999999999999999998532      246788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          178 LCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      |+. ++|.+++...   ..+++..+..++.||+.||.|||+.|++||||+|+|||++.+|.++|+|||++....... ..
T Consensus        80 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~  158 (285)
T cd07861          80 FLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVY  158 (285)
T ss_pred             cCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcccc
Confidence            997 5788777543   468999999999999999999999999999999999999999999999999997553322 22


Q ss_pred             cccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc--------------------
Q 012170          254 SGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--------------------  311 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--------------------  311 (469)
                      ....+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.........+....                    
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (285)
T cd07861         159 THEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT  238 (285)
T ss_pred             cCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh
Confidence            33467899999999865  37889999999999999999999998765443322211100                    


Q ss_pred             -----CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          312 -----LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       312 -----~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                           .......+..+++++++||.+||..||.+|||+.+|++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         239 FPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             ccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhcCCCC
Confidence                 000011124578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=9.3e-44  Score=347.44  Aligned_cols=251  Identities=23%  Similarity=0.413  Sum_probs=210.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||+|+||.||+|.+..+++.||+|++...     ...+.+|+++++++. ||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   79 (279)
T cd06619           1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCD-SPYIIGFYGAFFVENRISICTE   79 (279)
T ss_pred             CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEECCEEEEEEe
Confidence            4688899999999999999999999999999998643     245778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccC
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      |+++++|..+    ..+++..+..++.|++.||.|||+.||+|+||||+|||++.++.++|+|||++...... ......
T Consensus        80 ~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-~~~~~~  154 (279)
T cd06619          80 FMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-IAKTYV  154 (279)
T ss_pred             cCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc-cccCCC
Confidence            9999988543    46789999999999999999999999999999999999999999999999999765433 334568


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC-------HHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------LEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~-------~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ||+.|+|||++.+ .++.++|+||||+++|+|++|..||....       .......+......  ......+++++.+|
T Consensus       155 ~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l  232 (279)
T cd06619         155 GTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPP--VLPVGQFSEKFVHF  232 (279)
T ss_pred             CChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHHHHhccCCC--CCCCCcCCHHHHHH
Confidence            9999999999976 48999999999999999999999996422       12223333222111  11124578899999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCccccccccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~  361 (469)
                      |.+||..||.+||+++++++||||........
T Consensus       233 i~~~l~~~P~~Rp~~~eil~~~~~~~~~~~~~  264 (279)
T cd06619         233 ITQCMRKQPKERPAPENLMDHPFIVQYNDGNA  264 (279)
T ss_pred             HHHHhhCChhhCCCHHHHhcCcccccccCccH
Confidence            99999999999999999999999977654443

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-46  Score=371.49  Aligned_cols=259  Identities=30%  Similarity=0.555  Sum_probs=237.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+++++..||-|+||.|-++..+.....+|+|++++.       .+.+..|-.||..++ .|.||++|..|.++.++|++
T Consensus       420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~-s~fIvrLYrTfrd~kyvYmL  498 (732)
T KOG0614|consen  420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECR-SDFIVRLYRTFRDSKYVYML  498 (732)
T ss_pred             hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcC-chHHHHHHHHhccchhhhhh
Confidence            4667778899999999999988766667999999752       467889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      ||-|-||.|+..|.+++.|.+..++.++..+++|++|||++|||+|||||+|.|++.+|.+||.|||+|+.+..+..+.+
T Consensus       499 mEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~KTwT  578 (732)
T KOG0614|consen  499 MEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGRKTWT  578 (732)
T ss_pred             HHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCCceee
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999999


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc--CCCCCCcccCCCHHHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      +||||.|.|||++.. ..+.++|.||||+++||||+|.+||.+.++...++.|.++-  ..+|    ..++..+.+||++
T Consensus       579 FcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~ILkGid~i~~P----r~I~k~a~~Lik~  654 (732)
T KOG0614|consen  579 FCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLILKGIDKIEFP----RRITKTATDLIKK  654 (732)
T ss_pred             ecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHhhhhhhhcc----cccchhHHHHHHH
Confidence            999999999999866 58999999999999999999999999999999999998764  3333    6789999999999


Q ss_pred             hchhhhcCCCC-----HHHHHcCCCccccccccchhchh
Q 012170          333 MLTRDVSARIT-----ADEVLRHPWILFYTERTLRTLTI  366 (469)
Q Consensus       333 ~L~~dP~~Rps-----a~elL~hp~~~~~~~~~~~~~~~  366 (469)
                      +...+|.+|+.     +.+|.+|.||..+.+..++.-.+
T Consensus       655 LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~L  693 (732)
T KOG0614|consen  655 LCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRTL  693 (732)
T ss_pred             HHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhccC
Confidence            99999999996     89999999999888877765433

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=1.9e-44  Score=365.46  Aligned_cols=250  Identities=25%  Similarity=0.367  Sum_probs=203.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      ...|.+++.||+|+||.||+|.+..++..||+|+....  ....|+.+++++. ||||+++++++...+..++||||+. 
T Consensus        65 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~--~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~-  140 (357)
T PHA03209         65 SLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG--TTLIEAMLLQNVN-HPSVIRMKDTLVSGAITCMVLPHYS-  140 (357)
T ss_pred             hcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc--ccHHHHHHHHhCC-CCCCcChhheEEeCCeeEEEEEccC-
Confidence            35799999999999999999999999999999987543  3467999999997 9999999999999999999999995 


Q ss_pred             CchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          182 GRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                      ++|.+++.. ...+++..+..|+.||+.||.|||++||+||||||+|||++.++.++|+|||++..........+..||+
T Consensus       141 ~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~  220 (357)
T PHA03209        141 SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAGTV  220 (357)
T ss_pred             CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccCcccccccccc
Confidence            578777755 4579999999999999999999999999999999999999999999999999997544444445678999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCC-CCCCCC----------HHHHHHHHHcCc---CCCC----------
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAAL-PFKGDS----------LEAVFDAIKNVK---LDFH----------  315 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~-Pf~~~~----------~~~~~~~i~~~~---~~~~----------  315 (469)
                      .|+|||++.+ .|+.++|||||||++|+|+++.. +|.+..          ...+...+....   ..++          
T Consensus       221 ~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  300 (357)
T PHA03209        221 ETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRG  300 (357)
T ss_pred             cccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHH
Confidence            9999999976 58999999999999999998554 443321          111111111110   0111          


Q ss_pred             ----------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          316 ----------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       316 ----------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                                      ......++.++.+||.+||+.||.+||||.|+|+||||..
T Consensus       301 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        301 FIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             HHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence                            0001245778889999999999999999999999999953

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=3.6e-44  Score=347.41  Aligned_cols=251  Identities=27%  Similarity=0.430  Sum_probs=213.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ...+|++++.||+|+||.||+|.+..+++.||+|++...    ...+.+|+.+++.+. ||||+++++++...+.+|+||
T Consensus         7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~-h~~ii~~~~~~~~~~~~~iv~   85 (267)
T cd06646           7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK-HCNIVAYFGSYLSREKLWICM   85 (267)
T ss_pred             chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcC-CCCeeeeeEEEEeCCEEEEEE
Confidence            346899999999999999999999999999999998642    245778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||+++++|.+++...+.+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... ....
T Consensus        86 e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~~  165 (267)
T cd06646          86 EYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIAKRKS  165 (267)
T ss_pred             eCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeecccccccCc
Confidence            999999999999888889999999999999999999999999999999999999999999999999998664322 2344


Q ss_pred             cCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-CcccCCCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-GVWETVSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~lI  330 (469)
                      ..|++.|+|||.+.+    .++.++||||+||++|+|++|..||...........+.......+. .....++..+.+||
T Consensus       166 ~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  245 (267)
T cd06646         166 FIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFV  245 (267)
T ss_pred             cccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHH
Confidence            578999999998842    3788999999999999999999999765544333333222222111 11135789999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCC
Q 012170          331 ARMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~  352 (469)
                      .+||..||++|||++++|+|+|
T Consensus       246 ~~~l~~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         246 KISLTKNPKKRPTAERLLTHLF  267 (267)
T ss_pred             HHHhhCChhhCcCHHHHhcCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=1e-43  Score=349.28  Aligned_cols=260  Identities=28%  Similarity=0.437  Sum_probs=219.8

Q ss_pred             cCCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           95 MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        95 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      +++.-...+.|++++.||.|+||.||+|.+..++..||+|++....    ..+.+|+.+++.+. ||||+++++++..++
T Consensus         4 ~~~~~~~~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   82 (292)
T cd06644           4 VRRDLDPNEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCN-HPYIVKLLGAFYWDG   82 (292)
T ss_pred             hhcccCcchhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCcEeeeEEEEEeCC
Confidence            3344455678999999999999999999999999999999986533    45778999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      .+|+||||++|++|..++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.....
T Consensus        83 ~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~  162 (292)
T cd06644          83 KLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVK  162 (292)
T ss_pred             eEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceeccc
Confidence            99999999999999887754 45689999999999999999999999999999999999999999999999999875433


Q ss_pred             C-CcccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          250 G-QTLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      . .......+++.|+|||++.+      .++.++|||||||++|+|++|.+||...+....+..+....... ......+
T Consensus       163 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~  241 (292)
T cd06644         163 TLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LSQPSKW  241 (292)
T ss_pred             cccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHHHhcCCCcc-CCCCccc
Confidence            2 22344578999999999842      36789999999999999999999998877666665554433221 1122467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.++.+||.+||..||++||+++++++||||...
T Consensus       242 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  275 (292)
T cd06644         242 SMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSV  275 (292)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCcccccc
Confidence            8899999999999999999999999999999543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=3.5e-44  Score=360.26  Aligned_cols=245  Identities=24%  Similarity=0.378  Sum_probs=201.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-C
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA-D  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-~  170 (469)
                      .++|++++.||+|+||.||+|.+     ..++..||||+++..     ...+.+|+.+|..+..||||+++++++... +
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (338)
T cd05102           6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG   85 (338)
T ss_pred             hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence            46899999999999999999975     245678999999642     245788999999995699999999988654 4


Q ss_pred             eEEEEEeccCCCchHHHHHHh-----------------------------------------------------------
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-----------------------------------------------------------  191 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------------  191 (469)
                      .+|+||||+++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (338)
T cd05102          86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD  165 (338)
T ss_pred             ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence            689999999999999988653                                                           


Q ss_pred             ---CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCc
Q 012170          192 ---GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAP  265 (469)
Q Consensus       192 ---~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aP  265 (469)
                         .++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........   .....+++.|+||
T Consensus       166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aP  245 (338)
T cd05102         166 LWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAP  245 (338)
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCc
Confidence               2377888999999999999999999999999999999999999999999999976533221   1233467889999


Q ss_pred             eeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCC
Q 012170          266 EVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEA-VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI  342 (469)
Q Consensus       266 E~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rp  342 (469)
                      |++.+ .++.++|||||||++|+|++ |..||.+....+ ....+.......   ....+++++.+||.+||..||.+||
T Consensus       246 E~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~cl~~dp~~RP  322 (338)
T cd05102         246 ESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMR---APENATPEIYRIMLACWQGDPKERP  322 (338)
T ss_pred             HHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCC---CCCCCCHHHHHHHHHHccCChhhCc
Confidence            99865 58999999999999999997 999998765433 334444332211   1246789999999999999999999


Q ss_pred             CHHHHHc
Q 012170          343 TADEVLR  349 (469)
Q Consensus       343 sa~elL~  349 (469)
                      |+.++++
T Consensus       323 s~~el~~  329 (338)
T cd05102         323 TFSALVE  329 (338)
T ss_pred             CHHHHHH
Confidence            9999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=8.5e-44  Score=370.25  Aligned_cols=249  Identities=26%  Similarity=0.367  Sum_probs=206.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      ...|.+.+.||+|+||.||+|.+..+++.||||....  ..+.+|+++|++|. ||||+++++++..++..++|||++. 
T Consensus       168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~--~~~~~E~~iL~~L~-HpnIv~l~~~~~~~~~~~lv~e~~~-  243 (461)
T PHA03211        168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY--ASSVHEARLLRRLS-HPAVLALLDVRVVGGLTCLVLPKYR-  243 (461)
T ss_pred             cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc--cCHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEEEccC-
Confidence            4579999999999999999999999999999997542  34678999999997 9999999999999999999999995 


Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---cccccC
Q 012170          182 GRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLA  257 (469)
Q Consensus       182 g~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~~~~~~  257 (469)
                      ++|.+++... +.+++..+..|+.||+.||.|||++||+||||||+||||+.++.++|+|||++.......   ......
T Consensus       244 ~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~  323 (461)
T PHA03211        244 SDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIA  323 (461)
T ss_pred             CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccC
Confidence            6888877654 469999999999999999999999999999999999999999999999999997654322   123467


Q ss_pred             CCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCC--------CHHHHHHHHHcCcCC---C-----------
Q 012170          258 GSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGD--------SLEAVFDAIKNVKLD---F-----------  314 (469)
Q Consensus       258 gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~--------~~~~~~~~i~~~~~~---~-----------  314 (469)
                      ||+.|+|||++.+. ++.++|||||||++|+|++|..|+...        ....+...+......   +           
T Consensus       324 GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~  403 (461)
T PHA03211        324 GTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQ  403 (461)
T ss_pred             CCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHH
Confidence            99999999999764 899999999999999999987654321        223344444332211   1           


Q ss_pred             -------------CCCccc---CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          315 -------------HSGVWE---TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       315 -------------~~~~~~---~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                                   ....|.   .++.++.+||.+||+.||.+|||+.|||+||||.
T Consensus       404 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~  459 (461)
T PHA03211        404 YRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRLPLFQ  459 (461)
T ss_pred             HHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhCcccC
Confidence                         111122   4567899999999999999999999999999995

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=7.3e-44  Score=348.40  Aligned_cols=254  Identities=27%  Similarity=0.466  Sum_probs=216.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +.|++++.||.|+||.||+|.+..++..+|+|.+....    ..+.+|+++++.+. ||||+++++++...+..|+||||
T Consensus         5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~~v~e~   83 (282)
T cd06643           5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILIEF   83 (282)
T ss_pred             HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCC-CCCeeeEEEEEeeCCEEEEEEEe
Confidence            44788899999999999999999999999999986432    45778999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccccc
Q 012170          179 CSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~~  256 (469)
                      +++++|..++.. ..++++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++...... ......
T Consensus        84 ~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  163 (282)
T cd06643          84 CAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSF  163 (282)
T ss_pred             cCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccccccccc
Confidence            999999887755 457999999999999999999999999999999999999999999999999998754332 223446


Q ss_pred             CCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          257 AGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       257 ~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .|++.|+|||++..      .++.++|||||||++|+|++|.+||...+..+....+....... ......++.++.+||
T Consensus       164 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li  242 (282)
T cd06643         164 IGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPT-LAQPSRWSSEFKDFL  242 (282)
T ss_pred             cccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHHhhcCCCC-CCCccccCHHHHHHH
Confidence            78999999999842      37789999999999999999999999877766666665433221 112245789999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .+||..||.+||++.++++||||.....
T Consensus       243 ~~~l~~~p~~Rp~~~~il~~~~~~~~~~  270 (282)
T cd06643         243 KKCLEKNVDARWTTTQLLQHPFVTVNSN  270 (282)
T ss_pred             HHHccCChhhCcCHHHHhcCCCEeccCC
Confidence            9999999999999999999999975543

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=2.1e-44  Score=352.19  Aligned_cols=248  Identities=29%  Similarity=0.524  Sum_probs=206.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||.|+||.||+|++..+|..||+|.++..      ...+.+|+.+++.+. ||||+++++++.+.+.+|+|+|
T Consensus         1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   79 (284)
T cd07839           1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLYDVLHSDKKLTLVFE   79 (284)
T ss_pred             CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcC-CCCeeeHHHHhccCCceEEEEe
Confidence            488999999999999999999999999999998642      245778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |+.+ +|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++....... ....
T Consensus        80 ~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (284)
T cd07839          80 YCDQ-DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYSA  158 (284)
T ss_pred             cCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCCCcCC
Confidence            9975 77777755 5679999999999999999999999999999999999999999999999999997654322 2234


Q ss_pred             cCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCcC-----------------CC-
Q 012170          256 LAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKL-----------------DF-  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf-~~~~~~~~~~~i~~~~~-----------------~~-  314 (469)
                      ..+++.|+|||++.+.  ++.++|||||||++|+|++|..|| .+.+..+.+..+.....                 .+ 
T Consensus       159 ~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07839         159 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYP  238 (284)
T ss_pred             CccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccC
Confidence            5678999999998663  789999999999999999988774 55554444443321100                 00 


Q ss_pred             --C-----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 --H-----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 --~-----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                        .     ......+++++++||.+||..||.+|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         239 MYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhcCCCC
Confidence              0     00113578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=2e-43  Score=339.79  Aligned_cols=246  Identities=27%  Similarity=0.518  Sum_probs=213.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-ADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~~~~lV~  176 (469)
                      .|++++.||.|++|.||++.++.+++.||+|.+...      ...+.+|+++++++. |||++++++.+.. +..+|+||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~   79 (257)
T cd08223           1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLK-HPNIVAYRESWEGEDGLLYIVM   79 (257)
T ss_pred             CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeecCCCCEEEEEe
Confidence            489999999999999999999999999999998532      245788999999996 9999999998864 44689999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      ||+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++....... ..
T Consensus        80 e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~~~  159 (257)
T cd08223          80 GFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA  159 (257)
T ss_pred             cccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccCCcc
Confidence            999999999988763  458999999999999999999999999999999999999999999999999998664322 23


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....|++.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......   ....+++++.+||.+
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~  236 (257)
T cd08223         160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKLPP---MPKDYSPELGELIAT  236 (257)
T ss_pred             ccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCC---CccccCHHHHHHHHH
Confidence            34578999999999876 48899999999999999999999999887777666665543321   224688999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCc
Q 012170          333 MLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||+.||.+|||+.++++||||
T Consensus       237 ~l~~~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         237 MLSKRPEKRPSVKSILRQPYI  257 (257)
T ss_pred             HhccCcccCCCHHHHhcCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.5e-43  Score=340.09  Aligned_cols=246  Identities=24%  Similarity=0.409  Sum_probs=216.6

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|.+.+.||+|+||.||+|.+..+|..|++|.+..      ....+.+|+++++.+. ||||+++++++.+.+.+|+|||
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08529           1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLD-SSYIIRYYESFLDKGKLNIVME   79 (256)
T ss_pred             CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcC-CCCeehheeeeccCCEEEEEEE
Confidence            47888999999999999999999999999999853      2356778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      |++|++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~~~  159 (256)
T cd08529          80 YAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN  159 (256)
T ss_pred             eCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccchhh
Confidence            99999999998774  5689999999999999999999999999999999999999999999999999986654322 33


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+........   ...++.++.++|.+|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~  236 (256)
T cd08529         160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFPPV---SQMYSQQLAQLIDQC  236 (256)
T ss_pred             ccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHHHHHH
Confidence            4578999999999866 488999999999999999999999998887777766665443222   236789999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |+.+|++||++.++++|||+
T Consensus       237 l~~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         237 LTKDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             ccCCcccCcCHHHHhhCCCC
Confidence            99999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=1.1e-43  Score=343.00  Aligned_cols=250  Identities=32%  Similarity=0.513  Sum_probs=215.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||.|+||.||+|.+..++..+|+|++...     ...+.+|+++|+.+. |+||+++++.+...+.+|+|||
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~e   79 (267)
T cd06610           1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCN-HPNVVKYYTSFVVGDELWLVMP   79 (267)
T ss_pred             CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcC-CCCEEEEEEEEeeCCEEEEEEe
Confidence            4799999999999999999999999999999998642     356889999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          178 LCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |++|++|.+++...   ..+++..+..++.||+.||.|||+.|++||||+|+||++++++.++|+|||++........  
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~  159 (267)
T cd06610          80 YLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRT  159 (267)
T ss_pred             ccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCcccc
Confidence            99999999999764   4589999999999999999999999999999999999999999999999999876543322  


Q ss_pred             ---ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-CCCC-cccCCCHH
Q 012170          253 ---LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-FHSG-VWETVSKP  325 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~~~-~~~~~s~~  325 (469)
                         .....|++.|+|||++..  .++.++|+||||+++|+|++|..||...+....+..+...... +... .+..++++
T Consensus       160 ~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (267)
T cd06610         160 RKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKS  239 (267)
T ss_pred             ccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHH
Confidence               234568999999999865  4889999999999999999999999887766555554443222 2111 12467899


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.+||.+||..||.+||++.++++||||
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         240 FRKMISLCLQKDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.1e-43  Score=343.76  Aligned_cols=246  Identities=30%  Similarity=0.534  Sum_probs=213.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------------ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      +|.+...||.|+||.||+|.+..++..||+|.+....             +.+.+|+.+++++. ||||+++++++...+
T Consensus         1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   79 (267)
T cd06628           1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQ-HENIVQYLGSSLDAD   79 (267)
T ss_pred             CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEeCC
Confidence            4778899999999999999999999999999885321             35778999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++......
T Consensus        80 ~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~  159 (267)
T cd06628          80 HLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEAN  159 (267)
T ss_pred             ccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccc
Confidence            99999999999999999988888999999999999999999999999999999999999999999999999998765421


Q ss_pred             C-------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          251 Q-------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       251 ~-------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      .       ......|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+....+..+.....   ......+
T Consensus       160 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (267)
T cd06628         160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIGENAS---PEIPSNI  236 (267)
T ss_pred             cccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHHHHHHHhccCC---CcCCccc
Confidence            1       1123468899999999866 488899999999999999999999987665555444443211   1222467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +..+.++|.+||+.||.+||++.++++||||
T Consensus       237 ~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         237 SSEAIDFLEKTFEIDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence            9999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2e-44  Score=361.23  Aligned_cols=241  Identities=28%  Similarity=0.439  Sum_probs=212.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ..+.+++.||+|-||.||.|.+.. ...||+|.++..   .+.+.+|+++|++|+ |+|||++++++..++.+|||||||
T Consensus       206 ~~l~l~~~LG~G~FG~V~~g~~~~-~~~vavk~ik~~~m~~~~f~~Ea~iMk~L~-H~~lV~l~gV~~~~~piyIVtE~m  283 (468)
T KOG0197|consen  206 EELKLIRELGSGQFGEVWLGKWNG-STKVAVKTIKEGSMSPEAFLREAQIMKKLR-HEKLVKLYGVCTKQEPIYIVTEYM  283 (468)
T ss_pred             HHHHHHHHhcCCccceEEEEEEcC-CCcccceEEeccccChhHHHHHHHHHHhCc-ccCeEEEEEEEecCCceEEEEEec
Confidence            456668899999999999999984 347999999753   477889999999998 999999999999988999999999


Q ss_pred             CCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccC
Q 012170          180 SGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       180 ~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      +.|+|.++|..  .+.+...+...++.||++|++||+++++|||||.+.||||++++.+||+|||||+.+.++.......
T Consensus       284 ~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~  363 (468)
T KOG0197|consen  284 PKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG  363 (468)
T ss_pred             ccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCCCceeecCC
Confidence            99999999987  4568999999999999999999999999999999999999999999999999999666555533322


Q ss_pred             --CCCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          258 --GSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       258 --gt~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                        -...|.|||++. +.++.++|||||||+||||+| |..||.+.+..++++.+.++..-..   +..+|+++.+++..|
T Consensus       364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~---P~~CP~~vY~lM~~C  440 (468)
T KOG0197|consen  364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPR---PEGCPDEVYELMKSC  440 (468)
T ss_pred             CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCC---CCCCCHHHHHHHHHH
Confidence              245699999995 579999999999999999998 9999999999999999988754333   357899999999999


Q ss_pred             chhhhcCCCCHHHHH
Q 012170          334 LTRDVSARITADEVL  348 (469)
Q Consensus       334 L~~dP~~Rpsa~elL  348 (469)
                      +..+|++|||++.+.
T Consensus       441 W~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  441 WHEDPEDRPTFETLR  455 (468)
T ss_pred             hhCCcccCCCHHHHH
Confidence            999999999998654

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=1.7e-43  Score=350.12  Aligned_cols=253  Identities=31%  Similarity=0.572  Sum_probs=220.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||++.+..+++.||+|.+...       ...+.+|+++++.+. ||||+++++.+..++.+|+|
T Consensus         1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv   79 (305)
T cd05609           1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAE-NPFVVSMFCSFETKRHLCMV   79 (305)
T ss_pred             CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCC-CCCeeeeEEEEecCCEEEEE
Confidence            4689999999999999999999999999999998643       235668999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      |||++|++|.+++...+.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.......    
T Consensus        80 ~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~  159 (305)
T cd05609          80 MEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNL  159 (305)
T ss_pred             EecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccc
Confidence            9999999999999888889999999999999999999999999999999999999999999999999986311000    


Q ss_pred             ------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          252 ------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       252 ------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                                  ......|+..|+|||.+.+ .++.++|+|||||++|+|++|..||.+....+++..+.......+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~  239 (305)
T cd05609         160 YEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEGD  239 (305)
T ss_pred             cccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence                        1112467889999999865 589999999999999999999999999888888887776655544433


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCC---HHHHHcCCCccccc
Q 012170          319 WETVSKPARDLMARMLTRDVSARIT---ADEVLRHPWILFYT  357 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~  357 (469)
                      + .++.++.++|.+||..||++||+   +.++|+||||....
T Consensus       240 ~-~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         240 E-ALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             c-cCCHHHHHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            2 67999999999999999999998   89999999996544

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.6e-44  Score=353.41  Aligned_cols=252  Identities=36%  Similarity=0.598  Sum_probs=218.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.+..++..||+|.+....       ..+..|+++++.+. ||||+++++.+...+..|+|
T Consensus         1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   79 (316)
T cd05574           1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLD-HPFLPTLYASFQTETYLCLV   79 (316)
T ss_pred             CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCC-CCCchhheeeeecCCEEEEE
Confidence            47899999999999999999999999999999986432       35778999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--
Q 012170          176 MELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--  251 (469)
                      |||+.|++|.+++...  ..+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~  159 (316)
T cd05574          80 MDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPP  159 (316)
T ss_pred             EEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccc
Confidence            9999999999988754  468999999999999999999999999999999999999999999999999986542211  


Q ss_pred             ----------------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH
Q 012170          252 ----------------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA  302 (469)
Q Consensus       252 ----------------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~  302 (469)
                                                  ......||..|+|||++.+ .++.++||||||+++|+|++|..||.+.+...
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~  239 (316)
T cd05574         160 VSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDE  239 (316)
T ss_pred             cccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHH
Confidence                                        1123468999999999976 48889999999999999999999999888777


Q ss_pred             HHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC----HHHHHcCCCccccc
Q 012170          303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT----ADEVLRHPWILFYT  357 (469)
Q Consensus       303 ~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps----a~elL~hp~~~~~~  357 (469)
                      .+..+......++..  ..++.++.++|.+||..||++|||    ++++|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~~  296 (316)
T cd05574         240 TFSNILKKEVTFPGS--PPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGVN  296 (316)
T ss_pred             HHHHHhcCCccCCCc--cccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcCC
Confidence            777766554444322  237999999999999999999999    99999999996544

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-44  Score=345.95  Aligned_cols=253  Identities=29%  Similarity=0.482  Sum_probs=219.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++.+.||.|+||.||+|.+..+++.||+|++....     ..+.+|+++++.+. ||||+++++++.++..+|+|+|
T Consensus         1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (274)
T cd06609           1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCR-SPYITKYYGSFLKGSKLWIIME   79 (274)
T ss_pred             ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcC-CCCeeeeeEEEEECCeEEEEEE
Confidence            46888999999999999999999999999999986432     45788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~~  256 (469)
                      |+++++|.+++... ++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... ......
T Consensus        80 ~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (274)
T cd06609          80 YCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNTF  158 (274)
T ss_pred             eeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccccccccc
Confidence            99999999988654 8899999999999999999999999999999999999999999999999999876544 233456


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      .|++.|+|||++.+ .++.++||||||+++|+|++|.+||...+.......+.........  ...++.++.++|.+||.
T Consensus       159 ~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~~l~  236 (274)
T cd06609         159 VGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLE--GNKFSKPFKDFVSLCLN  236 (274)
T ss_pred             cCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCCCCCc--ccccCHHHHHHHHHHhh
Confidence            78999999999876 4899999999999999999999999887766666555544322211  11278999999999999


Q ss_pred             hhhcCCCCHHHHHcCCCccccccc
Q 012170          336 RDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       336 ~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      .+|++|||++++++||||......
T Consensus       237 ~~p~~Rpt~~~il~~~~~~~~~~~  260 (274)
T cd06609         237 KDPKERPSAKELLKHKFIKKAKKT  260 (274)
T ss_pred             CChhhCcCHHHHhhChhhcCCCcc
Confidence            999999999999999999765443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-43  Score=342.35  Aligned_cols=245  Identities=33%  Similarity=0.546  Sum_probs=213.7

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||.|+||.||+|.+..+|+.||+|++.+..       ..+..|..++....+||||+++++++..++.+|+||||++|
T Consensus         2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~   81 (260)
T cd05611           2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG   81 (260)
T ss_pred             ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence            57899999999999999999999999986532       22445655555554699999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCc
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA  261 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~  261 (469)
                      ++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....   .....|++.
T Consensus        82 ~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~---~~~~~~~~~  158 (260)
T cd05611          82 GDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE---NKKFVGTPD  158 (260)
T ss_pred             CCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc---cccCCCCcC
Confidence            99999998888899999999999999999999999999999999999999999999999999875433   234568999


Q ss_pred             ccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcC
Q 012170          262 YVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA  340 (469)
Q Consensus       262 y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~  340 (469)
                      |+|||.+.+. ++.++||||||+++|+|++|.+||...+....+..+......++......++.++.++|.+||+.||++
T Consensus       159 y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~  238 (260)
T cd05611         159 YLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEVKEFCSPEAVDLINRLLCMDPAK  238 (260)
T ss_pred             ccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcccccCCHHHHHHHHHHccCCHHH
Confidence            9999998764 789999999999999999999999988888888877766665555555578999999999999999999


Q ss_pred             CCC---HHHHHcCCCcccc
Q 012170          341 RIT---ADEVLRHPWILFY  356 (469)
Q Consensus       341 Rps---a~elL~hp~~~~~  356 (469)
                      ||+   ++|+|.||||...
T Consensus       239 R~~~~~~~~~l~~~~~~~~  257 (260)
T cd05611         239 RLGANGYQEIKSHPFFKSI  257 (260)
T ss_pred             ccCCCcHHHHHcChHhhcC
Confidence            995   5799999999654

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.9e-44  Score=350.13  Aligned_cols=255  Identities=23%  Similarity=0.429  Sum_probs=214.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||+|+||.||+|.+..+|..||+|.++..     ...+.+|+.+++++. ||||+++++.+...+.+|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e   79 (286)
T cd06622           1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAV-SPYIVDFYGAFFIEGAVYMCME   79 (286)
T ss_pred             ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcC-CCcHHhhhhheecCCeEEEEEe
Confidence            4688999999999999999999999999999988642     246778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          178 LCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      |++|++|..++...   ..+++..+..++.||+.||.|||+ .|++||||||+||+++.++.++|+|||++...... ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-~~  158 (286)
T cd06622          80 YMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS-LA  158 (286)
T ss_pred             ecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC-cc
Confidence            99999998887653   378999999999999999999997 59999999999999999999999999999765332 22


Q ss_pred             cccCCCCcccCceeccC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ....|++.|+|||++.+       .++.++|+|||||++|+|++|..||...........+.......+...+..++.++
T Consensus       159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd06622         159 KTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTLPSGYSDDA  238 (286)
T ss_pred             ccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCCCcccCHHH
Confidence            34568899999999854       25789999999999999999999997665555444433221111222334589999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      .+||.+||..+|.+||++.++++||||..+...
T Consensus       239 ~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~~~  271 (286)
T cd06622         239 QDFVAKCLNKIPNRRPTYAQLLEHPWLVKYKNA  271 (286)
T ss_pred             HHHHHHHcccCcccCCCHHHHhcChhhhhccCC
Confidence            999999999999999999999999999766544

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.9e-44  Score=348.02  Aligned_cols=253  Identities=29%  Similarity=0.456  Sum_probs=218.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++|++++.||.|+||.||+|.+..++..||+|++....    +.+.+|+++++.+. ||||+++++++...+.+|+|||
T Consensus         4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   82 (280)
T cd06611           4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECK-HPNIVGLYEAYFYENKLWILIE   82 (280)
T ss_pred             hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEecCCeEEEEee
Confidence            467999999999999999999999899999999986432    45778999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          178 LCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      |+++++|.+++... ..+++..+..++.|++.||.|||+.||+|+||+|+||+++.++.++|+|||++...... .....
T Consensus        83 ~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~  162 (280)
T cd06611          83 FCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDT  162 (280)
T ss_pred             ccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccccccce
Confidence            99999999988764 46999999999999999999999999999999999999999999999999998654332 22344


Q ss_pred             cCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ..|++.|+|||++..      .++.++|+||||+++|+|++|.+||.+.+....+..+........ .....++.++.+|
T Consensus       163 ~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l  241 (280)
T cd06611         163 FIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL-DQPSKWSSSFNDF  241 (280)
T ss_pred             eecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHHHhcCCCCCc-CCcccCCHHHHHH
Confidence            578999999999742      367799999999999999999999998877776666665433211 1224578999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||..+|.+||++.++|+||||...
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~  268 (280)
T cd06611         242 LKSCLVKDPDDRPTAAELLKHPFVSDQ  268 (280)
T ss_pred             HHHHhccChhhCcCHHHHhcChhhccc
Confidence            999999999999999999999999654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=1.6e-43  Score=342.36  Aligned_cols=247  Identities=30%  Similarity=0.477  Sum_probs=211.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +|++.+.||.|+||.||+|.+. +|+.+|+|.+...          ...+.+|+++|+.+. |+||+++++++.+.+.+|
T Consensus         1 ~~~~~~~ig~g~~~~v~~~~~~-~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~   78 (265)
T cd06631           1 EWTKGEVLGKGAYGTVYCGLTN-QGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLK-HVNIVQYLGTCLDDNTIS   78 (265)
T ss_pred             CccccceEeccCCeEEEEEEEc-CCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcC-CCCEeeEeeEeecCCeEE
Confidence            4788899999999999999864 7899999988532          135778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC----
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~----  249 (469)
                      +||||++|++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....    
T Consensus        79 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~  158 (265)
T cd06631          79 IFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLH  158 (265)
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhcccc
Confidence            9999999999999998888899999999999999999999999999999999999999999999999999865421    


Q ss_pred             ---CCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          250 ---GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       250 ---~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                         ........|+..|+|||++.+ .++.++||||||+++|+|++|..||...+.......+.......+ .....++.+
T Consensus       159 ~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  237 (265)
T cd06631         159 GTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGLMP-RLPDSFSAA  237 (265)
T ss_pred             ccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHHHHhhhccCCCC-CCCCCCCHH
Confidence               111234568999999999976 488999999999999999999999987665554444433321111 123468999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.+||.+||..+|.+||++.++|+||||
T Consensus       238 ~~~~i~~~l~~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         238 AIDFVTSCLTRDQHERPSALQLLRHDFL  265 (265)
T ss_pred             HHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            9999999999999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=8.3e-44  Score=388.82  Aligned_cols=253  Identities=26%  Similarity=0.481  Sum_probs=213.3

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CC
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE--AD  170 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~  170 (469)
                      ....++|.+++.||.|+||.||+|.+..++..||+|++...      ...+..|+.+|+.|. |||||+++++|.+  ..
T Consensus         9 e~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~-HPNIVrl~d~f~de~~~   87 (1021)
T PTZ00266          9 ESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELK-HKNIVRYIDRFLNKANQ   87 (1021)
T ss_pred             ccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEecCCC
Confidence            44668999999999999999999999999999999998632      245788999999997 9999999998854  45


Q ss_pred             eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhc-------CeEeccCCCCcEEEcc-------
Q 012170          171 CFHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDM-------GVVHRDIKPENILLTT-------  232 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~-------givHrDlkp~NILl~~-------  232 (469)
                      .+||||||+++|+|.++|...    +.+++..++.|+.||+.||.|||+.       +|+||||||+||||+.       
T Consensus        88 ~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~  167 (1021)
T PTZ00266         88 KLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGK  167 (1021)
T ss_pred             EEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccc
Confidence            799999999999999988653    5799999999999999999999985       4999999999999964       


Q ss_pred             ----------CCcEEEEeccceeeecCCCcccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 012170          233 ----------SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDS  299 (469)
Q Consensus       233 ----------~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~  299 (469)
                                .+.+||+|||++..+..........||+.|+|||++.+   .++.++||||||||||+|++|..||....
T Consensus       168 i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~  247 (1021)
T PTZ00266        168 ITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN  247 (1021)
T ss_pred             ccccccccCCCCceEEccCCccccccccccccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence                      23599999999987654444455689999999999854   38899999999999999999999997654


Q ss_pred             H-HHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          300 L-EAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       300 ~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      . ..++..+... +.++   ....+.++.+||..||..+|.+||++.|+|.||||...
T Consensus       248 ~~~qli~~lk~~-p~lp---i~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~i  301 (1021)
T PTZ00266        248 NFSQLISELKRG-PDLP---IKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKNV  301 (1021)
T ss_pred             cHHHHHHHHhcC-CCCC---cCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhhc
Confidence            3 4444444433 2222   23568999999999999999999999999999999644

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=1.4e-43  Score=346.19  Aligned_cols=248  Identities=29%  Similarity=0.483  Sum_probs=211.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||.|+||.||+|.+..+|..||+|++...      ...+.+|+.+++++. ||||+++++++...+.+|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e   79 (286)
T cd07832           1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQ-HPYVVKLLDVFPHGSGFVLVME   79 (286)
T ss_pred             CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCC-CCCCcceeeEEecCCeeEEEec
Confidence            588999999999999999999999999999998643      246889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--ccc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~  254 (469)
                      |+ +++|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+||+++.++.++|+|||++.......  ...
T Consensus        80 ~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  158 (286)
T cd07832          80 YM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYS  158 (286)
T ss_pred             cc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCCCccc
Confidence            99 9999998865 3568999999999999999999999999999999999999999999999999997665432  234


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-------------------C
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-------------------D  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------------~  313 (469)
                      ...|+..|+|||++.+  .++.++||||+|+++|+|++|.+||.+......+..+.....                   .
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (286)
T cd07832         159 HQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKIT  238 (286)
T ss_pred             cccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhccc
Confidence            4578999999999865  368999999999999999999999987766554444322100                   0


Q ss_pred             CCC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 FHS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 ~~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ++.       .....++.++.+||.+||..||.+|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~h~~~  285 (286)
T cd07832         239 FPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALRHPYF  285 (286)
T ss_pred             CCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhhCcCc
Confidence            000       1123567899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms]

Probab=100.00  E-value=1.1e-44  Score=315.64  Aligned_cols=253  Identities=28%  Similarity=0.537  Sum_probs=216.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..|...++||+|.||+||+|+++.+++.||+|.++-++      ....+|+-+|+.|. |.|||+++++...+..+-+|+
T Consensus         2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelk-hknivrl~dvlhsdkkltlvf   80 (292)
T KOG0662|consen    2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_pred             cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhh-hcceeehhhhhccCceeEEeH
Confidence            45777899999999999999999999999999986533      46889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          177 ELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      |||.. +|..+... ++.++.+.++.++.|+++||.+||++++.||||||.|+||+.+|++||+|||+++.+.-+-. .+
T Consensus        81 e~cdq-dlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgipvrcys  159 (292)
T KOG0662|consen   81 EFCDQ-DLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS  159 (292)
T ss_pred             HHhhH-HHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee
Confidence            99965 66666644 57799999999999999999999999999999999999999999999999999987654432 34


Q ss_pred             ccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcc------------
Q 012170          255 GLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVW------------  319 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~------------  319 (469)
                      ..+.|.+|++|.++.|.  |+...|+||.|||+.|+.. |.+.|+|.+..+.+..|-..........|            
T Consensus       160 aevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~y  239 (292)
T KOG0662|consen  160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPY  239 (292)
T ss_pred             ceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCccc
Confidence            45789999999999884  9999999999999999986 88999999988888877543322222222            


Q ss_pred             -------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          320 -------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       320 -------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                   +.++...+||++++|.-+|.+|++|+++|+||||..+.
T Consensus       240 p~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalqhpyf~d~s  290 (292)
T KOG0662|consen  240 PIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDFS  290 (292)
T ss_pred             CCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhcCccccccC
Confidence                         23355678999999999999999999999999996543

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.1e-43  Score=345.39  Aligned_cols=254  Identities=30%  Similarity=0.459  Sum_probs=212.1

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEE-----eCC
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYE-----EAD  170 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~-----~~~  170 (469)
                      ....++|++++.||+|+||.||+|.+..+++.||+|++...   ...+..|+.+++.+.+||||+++++++.     .++
T Consensus        14 ~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~   93 (286)
T cd06638          14 PDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGD   93 (286)
T ss_pred             CCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccchHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCC
Confidence            34678999999999999999999999999999999998642   3567889999999966999999999873     456


Q ss_pred             eEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          171 CFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      .+|+||||++|++|.+++..    ...+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++..
T Consensus        94 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~  173 (286)
T cd06638          94 QLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQ  173 (286)
T ss_pred             eEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceee
Confidence            79999999999999987753    34688999999999999999999999999999999999999999999999999976


Q ss_pred             ecCCC-cccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc
Q 012170          247 ISNGQ-TLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       247 ~~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      ..... ......|++.|+|||++..      .++.++|||||||++|+|++|..||........+..+...... .....
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~  252 (286)
T cd06638         174 LTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMRALFKIPRNPPP-TLHQP  252 (286)
T ss_pred             cccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhHHHhhccccCCC-cccCC
Confidence            54332 2234579999999998742      3788999999999999999999999877654444333222111 11112


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ..++..+.+||.+||..||++|||+.|||+|+||
T Consensus       253 ~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         253 ELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             CCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence            3468899999999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-44  Score=368.42  Aligned_cols=246  Identities=33%  Similarity=0.551  Sum_probs=221.7

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ..+.+.|++...+|.|+|+.|-.|.+..+++.+++|++.+...+..+|+.++....+||||+++++.+.++...|+|||+
T Consensus       318 ~~~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~  397 (612)
T KOG0603|consen  318 APFTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMEL  397 (612)
T ss_pred             CCcchhhccccccCCCCccceeeeeccccccchhheeccccccccccccchhhhhcCCCcceeecceecCCceeeeeehh
Confidence            34678999999999999999999999999999999999887778889999999999999999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE-ccCCcEEEEeccceeeecCCCcccccC
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl-~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      +.|+.+.+.+...+.+. .++..|+.+|+.|+.|||++|+|||||||+|||+ ++.|+++|+|||.+......  ..+.+
T Consensus       398 l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~--~~tp~  474 (612)
T KOG0603|consen  398 LDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS--CDTPA  474 (612)
T ss_pred             ccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh--hcccc
Confidence            99999999998777666 8888999999999999999999999999999999 68999999999999876544  44567


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      -|..|.|||++.. .|+.++||||||++||+||+|..||...... ++...|..+...      ..+|.++++||.+||+
T Consensus       475 ~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~~~~~s------~~vS~~AKdLl~~LL~  548 (612)
T KOG0603|consen  475 LTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQMPKFS------ECVSDEAKDLLQQLLQ  548 (612)
T ss_pred             hhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhcCCccc------cccCHHHHHHHHHhcc
Confidence            8899999999986 4999999999999999999999999865544 566666554433      5789999999999999


Q ss_pred             hhhcCCCCHHHHHcCCCc
Q 012170          336 RDVSARITADEVLRHPWI  353 (469)
Q Consensus       336 ~dP~~Rpsa~elL~hp~~  353 (469)
                      .||.+||++.+++.||||
T Consensus       549 ~dP~~Rl~~~~i~~h~w~  566 (612)
T KOG0603|consen  549 VDPALRLGADEIGAHPWF  566 (612)
T ss_pred             CChhhCcChhhhccCcch
Confidence            999999999999999999

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=2.4e-43  Score=347.82  Aligned_cols=255  Identities=29%  Similarity=0.474  Sum_probs=217.1

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .....+|++++.||+|+||.||+|.+..++..||+|.+...    ...+.+|+.+++.+. ||||+++++.+......|+
T Consensus        16 ~~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~v~~~~~~~~~~~~~~l   94 (296)
T cd06654          16 GDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWV   94 (296)
T ss_pred             CCcccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCC-CCCEeeEEEEEEeCCEEEE
Confidence            34567999999999999999999999999999999998642    356788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      ||||++|++|.+++. ...+++..+..++.|++.||.|||+.||+||||||+|||++.++.++|+|||++....... ..
T Consensus        95 v~e~~~~~~L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~  173 (296)
T cd06654          95 VMEYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  173 (296)
T ss_pred             eecccCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhcccccccc
Confidence            999999999999884 4578999999999999999999999999999999999999999999999999987543322 22


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....|++.|+|||.+.+. ++.++|||||||++|+|++|.+||...........+..... ........++..+.+||.+
T Consensus       174 ~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~  252 (296)
T cd06654         174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNR  252 (296)
T ss_pred             CcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC-CCCCCccccCHHHHHHHHH
Confidence            345789999999998764 78999999999999999999999988766544433332221 1112234688999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||..||.+||++.++++||||...
T Consensus       253 ~l~~~p~~Rpt~~eil~~~~~~~~  276 (296)
T cd06654         253 CLDMDVEKRGSAKELLQHQFLKIA  276 (296)
T ss_pred             HCcCCcccCcCHHHHhhChhhhcc
Confidence            999999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=5.8e-43  Score=343.58  Aligned_cols=254  Identities=28%  Similarity=0.446  Sum_probs=214.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----Ce
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEA-----DC  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----~~  171 (469)
                      ...++|.+.+.||+|+||.||+|.+..+++.+|+|++...   ...+.+|+.+++++.+||||+++++++...     +.
T Consensus        19 ~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~   98 (291)
T cd06639          19 DPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQ   98 (291)
T ss_pred             CCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCe
Confidence            4568899999999999999999999999999999999643   356778999999996699999999998753     36


Q ss_pred             EEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          172 FHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      +|+||||++||+|.+++..    ...+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++...
T Consensus        99 ~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~  178 (291)
T cd06639          99 LWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL  178 (291)
T ss_pred             eEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhc
Confidence            8999999999999988753    357899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-cccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          248 SNGQ-TLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       248 ~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .... ......|+..|+|||++..      .++.++|||||||++|+|++|.+||........+..+........ ....
T Consensus       179 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  257 (291)
T cd06639         179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTL-LHPE  257 (291)
T ss_pred             ccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCC-Cccc
Confidence            4322 2234578999999999853      267899999999999999999999988776555555544322111 1123


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      .++..+.+||.+||..+|++||++.++++||||+
T Consensus       258 ~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         258 KWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             ccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence            5678999999999999999999999999999983

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.1e-43  Score=339.10  Aligned_cols=250  Identities=30%  Similarity=0.497  Sum_probs=216.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++|++.+.||.|+||.||+|.+..++..+|+|++...    ...+.+|+++++.+. ||||+++++++.+.+.+|+|||
T Consensus         2 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l~~e   80 (262)
T cd06613           2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECR-HPNIVAYFGSYLRRDKLWIVME   80 (262)
T ss_pred             ccceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCC-CCChhceEEEEEeCCEEEEEEe
Confidence            36899999999999999999999999999999998643    356889999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          178 LCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |+.+++|.+++... ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        81 ~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~  160 (262)
T cd06613          81 YCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIAKRKS  160 (262)
T ss_pred             CCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhhhcccc
Confidence            99999999998776 789999999999999999999999999999999999999999999999999987654332 2344


Q ss_pred             cCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-CcccCCCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-GVWETVSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~lI  330 (469)
                      ..++..|+|||.+.+    .++.++|+||||+++|+|++|.+||.+.+.......+......... .....++.++.+||
T Consensus       161 ~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  240 (262)
T cd06613         161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFI  240 (262)
T ss_pred             ccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHH
Confidence            678999999999854    4788999999999999999999999887766655555444222111 11235678999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCC
Q 012170          331 ARMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~  352 (469)
                      .+||..+|.+|||+.+++.|||
T Consensus       241 ~~~l~~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         241 KKCLTKDPKKRPTATKLLQHPF  262 (262)
T ss_pred             HHHcCCChhhCCCHHHHhcCCC
Confidence            9999999999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=1.4e-43  Score=354.47  Aligned_cols=249  Identities=24%  Similarity=0.346  Sum_probs=203.5

Q ss_pred             eeeeeecc--CCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          107 KVEVIGHG--KFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       107 ~~~~lG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ++++||+|  +||+||++.++.+|+.||+|.++..      ...+.+|+.+++.+. ||||+++++++..++..|+||||
T Consensus         2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e~   80 (327)
T cd08227           2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELWVVTSF   80 (327)
T ss_pred             hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEEECCEEEEEEec
Confidence            46789999  7789999999999999999999643      135778999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-C----
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-Q----  251 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~----  251 (469)
                      +++|+|.+++..+  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.++++||+.+...... .    
T Consensus        81 ~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~  160 (327)
T cd08227          81 MAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRV  160 (327)
T ss_pred             cCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccc
Confidence            9999999998653  45899999999999999999999999999999999999999999999999865432211 1    


Q ss_pred             ---cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-----------
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-----------  314 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  314 (469)
                         ......++..|+|||++.+   .|+.++|||||||++|+|++|..||.+.................           
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (327)
T cd08227         161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEE  240 (327)
T ss_pred             cccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhh
Confidence               0122356788999999964   48899999999999999999999998765444333322211100           


Q ss_pred             -------------------------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 -------------------------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 -------------------------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                                     .......+++++.+||.+||+.||++|||+.|+|+||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~  313 (327)
T cd08227         241 LTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQI  313 (327)
T ss_pred             cccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhc
Confidence                                           000112457889999999999999999999999999999543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2e-43  Score=344.42  Aligned_cols=247  Identities=30%  Similarity=0.460  Sum_probs=208.0

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeEEEEEe
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHLVME  177 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~~lV~E  177 (469)
                      |.+++.||+|+||.||+|.+..++..||+|++++..     ....+|+.++.++.+||||+++++++.+.  +.+++|||
T Consensus         1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e   80 (282)
T cd07831           1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE   80 (282)
T ss_pred             CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence            678899999999999999999999999999986521     23457999999997799999999999987  89999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |+.+ +|.+.+... +.+++..+..++.||+.||.|||+.|++||||+|+||+++. +.+||+|||++............
T Consensus        81 ~~~~-~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~~~~  158 (282)
T cd07831          81 LMDM-NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPYTEY  158 (282)
T ss_pred             cCCc-cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccCCCcCCC
Confidence            9975 777777653 57899999999999999999999999999999999999999 99999999999876555444556


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc------------------CCCCC
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK------------------LDFHS  316 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------~~~~~  316 (469)
                      .+++.|+|||++..  .++.++|||||||++|+|++|.+||.+.+..+.+..+....                  ..++.
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07831         159 ISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPS  238 (282)
T ss_pred             CCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcc
Confidence            78999999998743  47889999999999999999999999877666555443211                  11111


Q ss_pred             C-------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          317 G-------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       317 ~-------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .       ....++.++.+||.+||.++|.+||++.++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~~~~  282 (282)
T cd07831         239 KKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALRHPYF  282 (282)
T ss_pred             cccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhhCCCC
Confidence            0       012568999999999999999999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=8.2e-44  Score=343.10  Aligned_cols=245  Identities=30%  Similarity=0.542  Sum_probs=215.8

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .|++.+.||.|+||.||+|.+..++..||+|++.+.       ...+.+|+++++++. ||||+++++++..++.+|+||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (258)
T cd05578           1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELN-HPFLVNLWYSFQDEENMYLVV   79 (258)
T ss_pred             CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCC-CCChHHHHHhhcCCCeEEEEE
Confidence            488999999999999999999999999999998642       356788999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      ||+.|++|.+++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++............
T Consensus        80 e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~  159 (258)
T cd05578          80 DLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST  159 (258)
T ss_pred             eCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcccccc
Confidence            99999999999987779999999999999999999999999999999999999999999999999999776554444556


Q ss_pred             CCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          257 AGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       257 ~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .|+..|+|||++.+. ++.++|+||||+++|+|++|..||...+   ...+..........+    ...++.++.++|.+
T Consensus       160 ~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~  235 (258)
T cd05578         160 SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETADVLY----PATWSTEAIDAINK  235 (258)
T ss_pred             CCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccccccC----cccCcHHHHHHHHH
Confidence            789999999998764 7999999999999999999999998766   344443333222222    24678999999999


Q ss_pred             hchhhhcCCCCH--HHHHcCCCc
Q 012170          333 MLTRDVSARITA--DEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa--~elL~hp~~  353 (469)
                      ||..||.+||++  .|+++||||
T Consensus       236 ~l~~~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         236 LLERDPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             HccCChhHcCCccHHHHhcCCCC
Confidence            999999999999  999999997

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=2.1e-43  Score=339.14  Aligned_cols=250  Identities=28%  Similarity=0.435  Sum_probs=216.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      +++|++.+.||.|+||.||+|.+..++..||+|.+...  .+.+.+|+++++.+. ||||+++++++.+...+|+|+||+
T Consensus         2 ~~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~   80 (256)
T cd06612           2 EEVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEEDLQEIIKEISILKQCD-SPYIVKYYGSYFKNTDLWIVMEYC   80 (256)
T ss_pred             cccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHHHHHHHHHHHHHHhCC-CCcEeeeeeeeecCCcEEEEEecC
Confidence            46899999999999999999999998999999998753  367889999999995 999999999999999999999999


Q ss_pred             CCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccccC
Q 012170          180 SGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLA  257 (469)
Q Consensus       180 ~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~~  257 (469)
                      .+++|.+++.. ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......
T Consensus        81 ~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~  160 (256)
T cd06612          81 GAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKRNTVI  160 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcccccccc
Confidence            99999999865 3568999999999999999999999999999999999999999999999999998665433 233456


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      |+..|+|||++.+ .++.++||||||+++|+|++|..||...........+....... ......++.++.++|.+||..
T Consensus       161 ~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         161 GTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKPPPT-LSDPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             CCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCCCCC-CCchhhcCHHHHHHHHHHHhc
Confidence            8999999999876 48899999999999999999999998776655444443322211 111235788999999999999


Q ss_pred             hhcCCCCHHHHHcCCCc
Q 012170          337 DVSARITADEVLRHPWI  353 (469)
Q Consensus       337 dP~~Rpsa~elL~hp~~  353 (469)
                      ||.+|||+.|+|.||||
T Consensus       240 ~P~~Rps~~~il~~~~~  256 (256)
T cd06612         240 DPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ChhhCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=1.8e-43  Score=351.23  Aligned_cols=244  Identities=26%  Similarity=0.435  Sum_probs=191.7

Q ss_pred             eeeeeccCCeEEEEEEECC--CCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEE--eCCeEEEEEeccCC
Q 012170          108 VEVIGHGKFGSVWLCRSKA--SGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYE--EADCFHLVMELCSG  181 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~--~~~~~~lV~E~~~g  181 (469)
                      ...||+|+||.||+|.++.  ++..||+|.+...  ...+.+|+.+|+.+. ||||+++++++.  .+..+|+||||+.+
T Consensus         6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~lv~e~~~~   84 (317)
T cd07867           6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGISMSACREIALLRELK-HPNVIALQKVFLSHSDRKVWLLFDYAEH   84 (317)
T ss_pred             ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCcHHHHHHHHHHHhCC-CCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence            3589999999999999764  5688999998653  346788999999997 999999999885  45678999999965


Q ss_pred             CchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE----ccCCcEEEEeccceeeec
Q 012170          182 GRLIDQMVEV---------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       182 g~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl----~~~~~vkL~DFgla~~~~  248 (469)
                       +|.+++...         ..+++..+..++.||+.||.|||+.||+||||||+|||+    +.++.+||+|||++....
T Consensus        85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~  163 (317)
T cd07867          85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFN  163 (317)
T ss_pred             -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccC
Confidence             777766422         247899999999999999999999999999999999999    456789999999998654


Q ss_pred             CCC----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------HHHHHHHcCcC-
Q 012170          249 NGQ----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLE---------AVFDAIKNVKL-  312 (469)
Q Consensus       249 ~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------~~~~~i~~~~~-  312 (469)
                      ...    ......||+.|+|||++.+  .++.++|||||||++|+|++|.+||......         ..+..+..... 
T Consensus       164 ~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (317)
T cd07867         164 SPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGF  243 (317)
T ss_pred             CCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCC
Confidence            332    2334578999999999865  3789999999999999999999999753311         11111100000 


Q ss_pred             -------------C-------C-------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          313 -------------D-------F-------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       313 -------------~-------~-------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                   .       +             ........+..+.+||.+||..||.+|||+.|+|+||||
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         244 PADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             CChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence                         0       0             000011245678899999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=4.7e-43  Score=345.91  Aligned_cols=253  Identities=30%  Similarity=0.507  Sum_probs=217.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ....+|++++.||.|+||.||+|.+..+|+.||+|.+...    ...+.+|+.+++.+. ||||+++++++...+.+|+|
T Consensus        16 ~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv   94 (296)
T cd06655          16 DPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELK-NPNIVNFLDSFLVGDELFVV   94 (296)
T ss_pred             CCcceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcC-CCceeeeeeeEecCceEEEE
Confidence            3456899999999999999999999999999999988532    356788999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      |||+.+++|..++.. ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++........ ..
T Consensus        95 ~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~  173 (296)
T cd06655          95 MEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRS  173 (296)
T ss_pred             EEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccccCC
Confidence            999999999988754 5789999999999999999999999999999999999999999999999999876543322 23


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||.+.+ .++.++|||||||++|+|++|..||.+.+.......+...... ....+..++..+.+||.+|
T Consensus       174 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  252 (296)
T cd06655         174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSPIFRDFLNRC  252 (296)
T ss_pred             CcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCc-ccCCcccCCHHHHHHHHHH
Confidence            4578999999999876 4889999999999999999999999987766555544433221 1122356899999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCccc
Q 012170          334 LTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      |..||.+||++.+++.||||..
T Consensus       253 l~~dp~~Rpt~~~il~~~~~~~  274 (296)
T cd06655         253 LEMDVEKRGSAKELLQHPFLKL  274 (296)
T ss_pred             hhcChhhCCCHHHHhhChHhhh
Confidence            9999999999999999999953

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=7.3e-43  Score=335.88  Aligned_cols=246  Identities=28%  Similarity=0.458  Sum_probs=218.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||.|+||.||.+++..++..+++|.+...      ...+.+|+++++++. |+||+++++++.+.+.+++|||
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~~~e   79 (256)
T cd08221           1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQ-HPNIIAYYNHFMDDNTLLIEME   79 (256)
T ss_pred             CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCC-CCCeeEEEeEEecCCeEEEEEE
Confidence            588999999999999999999999999999987532      245788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      |+++|+|.+++...  ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++....... ...
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~~~~  159 (256)
T cd08221          80 YANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAE  159 (256)
T ss_pred             ecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEccccccccc
Confidence            99999999999765  468999999999999999999999999999999999999999999999999997654433 234


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||++.+ .++.++||||||+++|+|++|..||......+....+........   ...++.++.++|.+|
T Consensus       160 ~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~  236 (256)
T cd08221         160 TVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV---VSVYSSELISLVHSL  236 (256)
T ss_pred             ccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC---ccccCHHHHHHHHHH
Confidence            4678999999999876 478899999999999999999999998888887777766544332   256799999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |..+|.+||++.++|+|||+
T Consensus       237 l~~~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         237 LQQDPEKRPTADEVLDQPLL  256 (256)
T ss_pred             cccCcccCCCHHHHhhCcCC
Confidence            99999999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=2.5e-43  Score=344.38  Aligned_cols=251  Identities=27%  Similarity=0.446  Sum_probs=211.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEE------eCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYE------EADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~------~~~~  171 (469)
                      ....|++.+.||.|+||.||+|.+..+++.||+|++...   ...+..|+.+++++.+||||+++++++.      ..+.
T Consensus        14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   93 (282)
T cd06636          14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQ   93 (282)
T ss_pred             hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCE
Confidence            346789999999999999999999999999999998643   3467789999999977999999999985      3567


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          172 FHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +|+||||+.+|+|.+++...  ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        94 ~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~  173 (282)
T cd06636          94 LWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR  173 (282)
T ss_pred             EEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhc
Confidence            89999999999999988654  3588899999999999999999999999999999999999999999999999875432


Q ss_pred             C-CcccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          250 G-QTLSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      . .......|++.|+|||++.      ..++.++|||||||++|+|++|..||...........+.....  .......+
T Consensus       174 ~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~  251 (282)
T cd06636         174 TVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP--PKLKSKKW  251 (282)
T ss_pred             cccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC--CCCccccc
Confidence            2 2234467999999999984      2478899999999999999999999987665444444333221  11122457


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.++.+||.+||..||.+|||+.|||+||||
T Consensus       252 ~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         252 SKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence            8999999999999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=3.2e-43  Score=348.69  Aligned_cols=253  Identities=28%  Similarity=0.442  Sum_probs=211.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~  172 (469)
                      ..++|++.+.||.|+||.||+|.+..+|+.||+|+++...      ..+.+|+.+++++. |+||+++++++...  +.+
T Consensus         5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (309)
T cd07845           5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLR-HPNIVELKEVVVGKHLDSI   83 (309)
T ss_pred             cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCC-CCCCcceEEEEecCCCCeE
Confidence            4578999999999999999999999999999999986321      24568999999997 99999999998755  568


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+.+ +|.+++.. ...+++..+..++.||+.||.|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~  162 (309)
T cd07845          84 FLVMEYCEQ-DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA  162 (309)
T ss_pred             EEEEecCCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc
Confidence            999999965 78777765 3678999999999999999999999999999999999999999999999999998765432


Q ss_pred             -cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC---------------
Q 012170          252 -TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD---------------  313 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------------  313 (469)
                       ......+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+......               
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (309)
T cd07845         163 KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLV  242 (309)
T ss_pred             CCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhccccc
Confidence             2233456888999999865  4789999999999999999999999988877777666542111               


Q ss_pred             ----CCCC-------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          314 ----FHSG-------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       314 ----~~~~-------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                          ....       ....+++++.+||.+||..||++|||+.++|+||||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~  295 (309)
T cd07845         243 GKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALESSYFKE  295 (309)
T ss_pred             ccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcc
Confidence                0000       01235889999999999999999999999999999954

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=4.2e-43  Score=342.60  Aligned_cols=252  Identities=23%  Similarity=0.388  Sum_probs=207.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||+|+||.||+|.++.+|..||||+++..     ...+..|+.++.+..+||||+++++++..++.+|+|||
T Consensus         1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e   80 (283)
T cd06617           1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME   80 (283)
T ss_pred             CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence            4789999999999999999999999999999998643     23456677765555569999999999999999999999


Q ss_pred             ccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          178 LCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |++ |+|.+++..    ...+++..+..++.||+.||.|||++ +++||||||+|||++.++.+||+|||++........
T Consensus        81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~  159 (283)
T cd06617          81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA  159 (283)
T ss_pred             hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccccc
Confidence            997 577766654    24689999999999999999999997 999999999999999999999999999987654444


Q ss_pred             ccccCCCCcccCceeccC-----CCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-----NYSEKVDIWSAGVLLHALLVAALPFKGD--SLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .....|+..|+|||++.+     .++.++|+|||||++|+|++|..||...  ........+......++   ...+|.+
T Consensus       160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (283)
T cd06617         160 KTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEEPSPQLP---AEKFSPE  236 (283)
T ss_pred             cccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhcCCCCCC---ccccCHH
Confidence            444678999999998854     3688999999999999999999999642  22333333322222222   1357899


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +.+||.+||..+|.+||++.+++.||||.....
T Consensus       237 l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         237 FQDFVNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            999999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=2.9e-43  Score=340.09  Aligned_cols=243  Identities=33%  Similarity=0.620  Sum_probs=213.5

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||.|+||.||+|.+..+++.||+|++.+.       ...+.+|+.+++.+. ||||+++++++.+++.+|+||||+++++
T Consensus         1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (262)
T cd05572           1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECN-HPFIVKLYRTFKDKKYIYMLMEYCLGGE   79 (262)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCC-CCCEeeeeeeEEcCCccEEEEecCCCCc
Confidence            69999999999999999999999998642       246888999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCccc
Q 012170          184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV  263 (469)
Q Consensus       184 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~  263 (469)
                      |.+++.+...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.............|++.|+
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~  159 (262)
T cd05572          80 LWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYV  159 (262)
T ss_pred             HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCcccccccccCCcCcc
Confidence            99999888889999999999999999999999999999999999999999999999999998765543344467899999


Q ss_pred             CceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHc--CcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          264 APEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS--LEAVFDAIKN--VKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       264 aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~--~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      |||.+.+ .++.++|+||+|+++|+|++|..||....  .......+..  ....++    ..++.++.++|.+||..||
T Consensus       160 ~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p  235 (262)
T cd05572         160 APEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRRNP  235 (262)
T ss_pred             ChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHccCCh
Confidence            9999865 48899999999999999999999998776  5666666653  222222    3458999999999999999


Q ss_pred             cCCCC-----HHHHHcCCCcccccc
Q 012170          339 SARIT-----ADEVLRHPWILFYTE  358 (469)
Q Consensus       339 ~~Rps-----a~elL~hp~~~~~~~  358 (469)
                      .+||+     ++|+++||||..+.+
T Consensus       236 ~~R~~~~~~~~~~l~~~~~~~~~~~  260 (262)
T cd05572         236 EERLGNLKGGIKDIKKHKWFNGFDW  260 (262)
T ss_pred             hhCcCCcccCHHHHhcChhhhCCCC
Confidence            99999     999999999976543

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-43  Score=340.46  Aligned_cols=252  Identities=30%  Similarity=0.482  Sum_probs=213.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC------e
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEAD------C  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~------~  171 (469)
                      ..++|++.+.||.|+||.||+|.++.+++.|++|++...   .+.+.+|+.+++++..||||+++++++....      .
T Consensus         4 ~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~   83 (275)
T cd06608           4 PTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQ   83 (275)
T ss_pred             chhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCchhHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceE
Confidence            357899999999999999999999999999999998653   3568899999999966999999999997644      5


Q ss_pred             EEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          172 FHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      +|+||||+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...
T Consensus        84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~  163 (275)
T cd06608          84 LWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQL  163 (275)
T ss_pred             EEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceec
Confidence            89999999999999988653    47899999999999999999999999999999999999999999999999998765


Q ss_pred             cCCC-cccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          248 SNGQ-TLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       248 ~~~~-~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .... ......|++.|+|||++..      .++.++||||||+++|+|++|.+||...........+........ ....
T Consensus       164 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~  242 (275)
T cd06608         164 DSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTL-KSPE  242 (275)
T ss_pred             ccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCC-Cchh
Confidence            4322 2334578999999998743      367889999999999999999999987665555555544322111 1112


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .++.++++||.+||..||.+|||+.++++|||+
T Consensus       243 ~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         243 NWSKKFNDFISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             hcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence            368899999999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=6e-45  Score=369.69  Aligned_cols=253  Identities=27%  Similarity=0.477  Sum_probs=218.3

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchH
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLI  185 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~  185 (469)
                      +||+|.||+||.|++..|...+|||.+...    .+-++.|+.+-++|+ |.|||++++.+..++.+-|.||-++||+|.
T Consensus       582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~Lr-HkNIVrYLGs~senGf~kIFMEqVPGGSLS  660 (1226)
T KOG4279|consen  582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLR-HKNIVRYLGSVSENGFFKIFMEQVPGGSLS  660 (1226)
T ss_pred             EeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHh-hHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence            699999999999999999999999999542    245889999999998 999999999999999999999999999999


Q ss_pred             HHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCC-CcccccCCCC
Q 012170          186 DQMVEV-GQY--SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNG-QTLSGLAGSP  260 (469)
Q Consensus       186 ~~l~~~-~~l--~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~-~~~~~~~gt~  260 (469)
                      +++... |++  +|..+..+.+||++||.|||++.|||||||-+||||+. .|.+||+|||.+++...- ..+.++.||.
T Consensus       661 sLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~TETFTGTL  740 (1226)
T KOG4279|consen  661 SLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPCTETFTGTL  740 (1226)
T ss_pred             HHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCCccccccccch
Confidence            999765 677  88999999999999999999999999999999999975 689999999999876543 3356789999


Q ss_pred             cccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          261 AYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       261 ~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      -|||||++..   .|+.++|||||||++.||.||++||.... +...+.  +-+.+..+++.+..+|.+++.||.+|+.+
T Consensus       741 QYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMF--kVGmyKvHP~iPeelsaeak~FilrcFep  818 (1226)
T KOG4279|consen  741 QYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMF--KVGMYKVHPPIPEELSAEAKNFILRCFEP  818 (1226)
T ss_pred             hhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhh--hhcceecCCCCcHHHHHHHHHHHHHHcCC
Confidence            9999999953   49999999999999999999999997532 222222  22445556666788999999999999999


Q ss_pred             hhcCCCCHHHHHcCCCccccccccchhch
Q 012170          337 DVSARITADEVLRHPWILFYTERTLRTLT  365 (469)
Q Consensus       337 dP~~Rpsa~elL~hp~~~~~~~~~~~~~~  365 (469)
                      ||.+||+|.++|.+||++....+.-..+.
T Consensus       819 d~~~R~sA~~LL~DpFlq~~~kk~r~~ls  847 (1226)
T KOG4279|consen  819 DPCDRPSAKDLLQDPFLQHNNKKPRPKLS  847 (1226)
T ss_pred             CcccCccHHHhccCcccccCCCCCCCCCC
Confidence            99999999999999999776554444444

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.1e-43  Score=342.00  Aligned_cols=248  Identities=27%  Similarity=0.438  Sum_probs=204.1

Q ss_pred             cCCeeeeeee--eccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          102 EDDHTKVEVI--GHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       102 ~~~y~~~~~l--G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .+.|++.+.+  |.|+||.||++.++.++..+|+|++....- ...|+.+...+.+||||+++++.|...+.+|+||||+
T Consensus        13 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~e~~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~   91 (267)
T PHA03390         13 LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF-NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYI   91 (267)
T ss_pred             HHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhc-chhhHHHHHHhhcCCCEEEEEEEEecCCeeEEEEEcC
Confidence            3566666665  999999999999999999999999865321 1124444444446999999999999999999999999


Q ss_pred             CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCCcccccCC
Q 012170          180 SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAG  258 (469)
Q Consensus       180 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~~~~~~~g  258 (469)
                      ++|+|.+++...+.+++..+..++.||+.||.|||+.|++||||||+||+++.++ .++|+|||++......   ....|
T Consensus        92 ~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~---~~~~~  168 (267)
T PHA03390         92 KDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP---SCYDG  168 (267)
T ss_pred             CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC---ccCCC
Confidence            9999999998878999999999999999999999999999999999999999998 9999999998765432   23468


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAV-FDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      +..|+|||++.+ .++.++||||+|+++|+|++|..||........ ...+.... ......+..+++.+.+||.+||+.
T Consensus       169 ~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~  247 (267)
T PHA03390        169 TLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ-QKKLPFIKNVSKNANDFVQSMLKY  247 (267)
T ss_pred             CCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-cccCCcccccCHHHHHHHHHHhcc
Confidence            999999999976 588999999999999999999999986543321 11111111 112223356899999999999999


Q ss_pred             hhcCCCC-HHHHHcCCCcc
Q 012170          337 DVSARIT-ADEVLRHPWIL  354 (469)
Q Consensus       337 dP~~Rps-a~elL~hp~~~  354 (469)
                      ||.+||+ ++++|+||||.
T Consensus       248 ~p~~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        248 NINYRLTNYNEIIKHPFLK  266 (267)
T ss_pred             ChhhCCchHHHHhcCCccc
Confidence            9999996 59999999994

>KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=4.1e-44  Score=360.71  Aligned_cols=254  Identities=33%  Similarity=0.540  Sum_probs=221.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .-|..++.||-|+||.|.+++..+|...||+|.+++.+       ..+..|-.||.... .+-||+||..|++.+++|+|
T Consensus       629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEAD-n~WVVrLyySFQDkdnLYFV  707 (1034)
T KOG0608|consen  629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEAD-NEWVVRLYYSFQDKDNLYFV  707 (1034)
T ss_pred             cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcC-CcceEEEEEEeccCCceEEE
Confidence            45888899999999999999999999999999997643       35677999999985 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC---Cc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---QT  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~---~~  252 (469)
                      |+|++||++..+|.+.+-|.|+.++.++.++..|+++.|.+|+|||||||+|||||.+|+|||+|||||..+...   ..
T Consensus       708 MdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskY  787 (1034)
T KOG0608|consen  708 MDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKY  787 (1034)
T ss_pred             EeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceecccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999643210   00


Q ss_pred             ----------------------------------------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhC
Q 012170          253 ----------------------------------------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVA  291 (469)
Q Consensus       253 ----------------------------------------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG  291 (469)
                                                              ....+||+.|+|||++.. .|+.-+||||.|||||+|+.|
T Consensus       788 Yq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g  867 (1034)
T KOG0608|consen  788 YQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVG  867 (1034)
T ss_pred             ccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhC
Confidence                                                    012359999999999966 599999999999999999999


Q ss_pred             CCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC---HHHHHcCCCcccccc
Q 012170          292 ALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT---ADEVLRHPWILFYTE  358 (469)
Q Consensus       292 ~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~~  358 (469)
                      .+||....+.+.-..+.+....++......+|+++.+||.++. .+++.|+.   ++||..||||.....
T Consensus       868 ~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc-~sad~RLGkng~d~vKaHpfFkgIDf  936 (1034)
T KOG0608|consen  868 QPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLC-CSADSRLGKNGADQVKAHPFFKGIDF  936 (1034)
T ss_pred             CCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHh-cChhhhhcccchhhhhcCccccccch
Confidence            9999988877766667666655666666789999999999876 67888884   788999999965543

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=4.9e-43  Score=344.39  Aligned_cols=251  Identities=32%  Similarity=0.446  Sum_probs=206.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe-----
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC-----  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~-----  171 (469)
                      ++|++.+.||.|+||.||+|.+..+|+.||||+++..      ...+.+|+.+++.+..||||+++++++...+.     
T Consensus         1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~   80 (295)
T cd07837           1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS   80 (295)
T ss_pred             CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence            4689999999999999999999999999999998542      24578899999999767999999999987665     


Q ss_pred             EEEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEecccee
Q 012170          172 FHLVMELCSGGRLIDQMVEV-----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAM  245 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~  245 (469)
                      +|+||||+++ +|.+++...     ..+++..+..++.||+.||.|||++|++||||+|+||+++. ++.++|+|||++.
T Consensus        81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~  159 (295)
T cd07837          81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR  159 (295)
T ss_pred             EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence            8999999986 788877543     35799999999999999999999999999999999999998 8899999999997


Q ss_pred             eecCC-CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC---------
Q 012170          246 RISNG-QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD---------  313 (469)
Q Consensus       246 ~~~~~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---------  313 (469)
                      ..... .......+++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+.......+......         
T Consensus       160 ~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (295)
T cd07837         160 AFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGV  239 (295)
T ss_pred             ecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcch
Confidence            65332 22233467889999998865  3789999999999999999999999887655444333221000         


Q ss_pred             --------CC-------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          314 --------FH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       314 --------~~-------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                              ++       ......++.++.+||.+||.+||.+||++.|+|.||||.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         240 SKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             hhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhcCCCcC
Confidence                    00       001135789999999999999999999999999999983

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=2.3e-43  Score=348.23  Aligned_cols=255  Identities=31%  Similarity=0.492  Sum_probs=216.6

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .....+|++++.||.|+||.||+|.+..+|+.||+|.+...    .+.+.+|+.+++.+. ||||+++++++..++.+|+
T Consensus        15 ~~~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   93 (297)
T cd06656          15 GDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWV   93 (297)
T ss_pred             CChhhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCEEEE
Confidence            44668999999999999999999999999999999998542    356778999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-c
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-L  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~  253 (469)
                      ||||+++++|.+++.+ ..+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ .
T Consensus        94 v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~~  172 (297)
T cd06656          94 VMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR  172 (297)
T ss_pred             eecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCccCc
Confidence            9999999999998854 5689999999999999999999999999999999999999999999999999976543322 2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....|++.|+|||.+.+ .++.++|+|||||++|+|++|..||.+.+.......+.... .........++..+.+||.+
T Consensus       173 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~  251 (297)
T cd06656         173 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG-TPELQNPERLSAVFRDFLNR  251 (297)
T ss_pred             CcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCC-CCCCCCccccCHHHHHHHHH
Confidence            34578999999999876 48899999999999999999999998766544333222211 11111234678899999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||..||.+||++.++++||||...
T Consensus       252 ~l~~~p~~Rps~~~il~~~~~~~~  275 (297)
T cd06656         252 CLEMDVDRRGSAKELLQHPFLKLA  275 (297)
T ss_pred             HccCChhhCcCHHHHhcCchhccc
Confidence            999999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=2.1e-43  Score=341.77  Aligned_cols=250  Identities=26%  Similarity=0.484  Sum_probs=210.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .|+..+.||+|+||.||+|.+..+++.||+|++...          ...+.+|+.+++.++ ||||+++++++.+.+.++
T Consensus         1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (268)
T cd06630           1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLN-HPHIIRMLGATCEDSHFN   79 (268)
T ss_pred             CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcC-CCceehhhceeccCCeEE
Confidence            477889999999999999999999999999998642          246788999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCC-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~-  251 (469)
                      +||||+.|++|.+++...+++++..+..++.||+.||.|||++|++|+||+|+||+++.++ .++|+|||++....... 
T Consensus        80 ~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~  159 (268)
T cd06630          80 LFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGT  159 (268)
T ss_pred             EEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccc
Confidence            9999999999999998888999999999999999999999999999999999999998876 59999999987654321 


Q ss_pred             ----cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-CCCCCCcccCCCHH
Q 012170          252 ----TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-LDFHSGVWETVSKP  325 (469)
Q Consensus       252 ----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~  325 (469)
                          ......|+..|+|||++.+ .++.++|+||||+++|+|++|..||...........+.... ..........++++
T Consensus       160 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (268)
T cd06630         160 GAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPG  239 (268)
T ss_pred             cCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHH
Confidence                1223568899999999866 48899999999999999999999997544322222221111 11112222457899


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      +.++|.+||..+|.+||++.++++||||.
T Consensus       240 ~~~~i~~~l~~~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         240 LRDVTLRCLELQPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             HHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence            99999999999999999999999999983

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.9e-43  Score=344.66  Aligned_cols=246  Identities=34%  Similarity=0.578  Sum_probs=208.3

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||+|+||.||+|.+..+|+.||+|++.+.       ...+..|+++|+.++ ||||+++++++...+.+|+||||++|++
T Consensus         1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (277)
T cd05577           1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVS-SRFIVSLAYAFETKDDLCLVMTLMNGGD   79 (277)
T ss_pred             CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCC-CCCEeeeeeEEecCCeEEEEEecCCCCc
Confidence            69999999999999999999999998542       234568999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCc
Q 012170          184 LIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA  261 (469)
Q Consensus       184 L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~  261 (469)
                      |.+++...+  .+++..+..++.|++.||.|||+.|++||||+|+||+++.++.++|+|||++.............++..
T Consensus        80 L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~  159 (277)
T cd05577          80 LKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIKGRAGTPG  159 (277)
T ss_pred             HHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCccccccCCCC
Confidence            999997766  799999999999999999999999999999999999999999999999999876554444445678899


Q ss_pred             ccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcC
Q 012170          262 YVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA  340 (469)
Q Consensus       262 y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~  340 (469)
                      |+|||++.+ .++.++||||||+++|+|++|..||...........+.......+......+++.+.++|.+||+.||.+
T Consensus       160 y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~  239 (277)
T cd05577         160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEYPDKFSPEAKDLCEALLQKDPEK  239 (277)
T ss_pred             cCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccCCccCCHHHHHHHHHHccCChhH
Confidence            999999865 4888999999999999999999999765432222222222222222333567999999999999999999


Q ss_pred             CC-----CHHHHHcCCCccccc
Q 012170          341 RI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       341 Rp-----sa~elL~hp~~~~~~  357 (469)
                      ||     ++.++++||||....
T Consensus       240 R~~~~~~~~~~ll~h~~~~~~~  261 (277)
T cd05577         240 RLGCRGGSADEVREHPLFKDLN  261 (277)
T ss_pred             ccCCCcccHHHHHhChhhhcCC
Confidence            99     899999999996544

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=2.1e-43  Score=347.69  Aligned_cols=251  Identities=29%  Similarity=0.454  Sum_probs=212.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      +|++.+.||.|+||.||+|.+..+|+.||||.++...         ..+..|+++++.+. |+||+++++++.+.+..|+
T Consensus         1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (298)
T cd07841           1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK-HPNIIGLLDVFGHKSNINL   79 (298)
T ss_pred             CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcC-CCCChhhhheeecCCEEEE
Confidence            4788899999999999999999999999999986432         34668999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-c
Q 012170          175 VMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-T  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~  252 (469)
                      ||||+ +|+|.+++.... .+++..+..++.||+.||.|||++|++|+||+|+|||++.+|.++|+|||++....... .
T Consensus        80 v~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~~  158 (298)
T cd07841          80 VFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNRK  158 (298)
T ss_pred             EEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCcc
Confidence            99999 889999997766 79999999999999999999999999999999999999999999999999998765432 2


Q ss_pred             ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC----------------
Q 012170          253 LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF----------------  314 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------  314 (469)
                      .....+++.|+|||.+.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.......                
T Consensus       159 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (298)
T cd07841         159 MTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVE  238 (298)
T ss_pred             ccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhccccccccc
Confidence            333467889999999854  47899999999999999999999998776655444442211000                


Q ss_pred             --------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 --------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 --------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                              ....+..++.++.+||.+||..||++|||+.|+|+||||...
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~  288 (298)
T cd07841         239 FKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEHPYFSND  288 (298)
T ss_pred             ccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhCccccCC
Confidence                    001123457899999999999999999999999999999654

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=9.2e-43  Score=335.19  Aligned_cols=246  Identities=28%  Similarity=0.519  Sum_probs=216.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||+|+||.||++.+..+|+.||+|.+...      ...+.+|+.+++.+. ||||+++++++...+..|+|||
T Consensus         1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08218           1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMK-HPNIVQYQESFEENGNLYIVMD   79 (256)
T ss_pred             CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCC-CCCeeeeEeeecCCCeEEEEEe
Confidence            588999999999999999999999999999988531      246888999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          178 LCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      |+.+++|.+.+....  .+++..+..++.|++.||.|||++|++|+||+|+|||++.++.++|+|||++........ ..
T Consensus        80 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~  159 (256)
T cd08218          80 YCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVELAR  159 (256)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhhhh
Confidence            999999999887643  578999999999999999999999999999999999999999999999999976544322 22


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||++.+ .++.++|+|||||++|+|++|..||......+....+........   ...++.++.++|.+|
T Consensus       160 ~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  236 (256)
T cd08218         160 TCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPV---SSHYSYDLRNLVSQL  236 (256)
T ss_pred             hccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCCCCCC---cccCCHHHHHHHHHH
Confidence            3468899999999876 478899999999999999999999988887777777665543221   246789999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |+.+|.+||++.++|+||||
T Consensus       237 l~~~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         237 FKRNPRDRPSVNSILEKNFI  256 (256)
T ss_pred             hhCChhhCcCHHHHhhCcCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.8e-43  Score=339.13  Aligned_cols=248  Identities=28%  Similarity=0.518  Sum_probs=209.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~  171 (469)
                      .+|+..+.||+|+||.||+|.+..++..||+|.+...         ...+.+|+.+++.++ ||||+++++++.+  ...
T Consensus         2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (266)
T cd06651           2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQ-HERIVQYYGCLRDRAEKT   80 (266)
T ss_pred             CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcC-CCCeeeEEEEEEcCCCCE
Confidence            4688899999999999999999999999999988532         135778999999996 9999999999875  367


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +++||||+++++|.+++...+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~  160 (266)
T cd06651          81 LTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTIC  160 (266)
T ss_pred             EEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccc
Confidence            89999999999999999888889999999999999999999999999999999999999999999999999987543211


Q ss_pred             ----cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 ----TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ----~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                          ......++..|+|||++.+. ++.++||||+||++|+|++|..||...........+......  ......+++.+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  238 (266)
T cd06651         161 MSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQPTN--PQLPSHISEHA  238 (266)
T ss_pred             ccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHHHHhcCCCC--CCCchhcCHHH
Confidence                12235688999999999764 889999999999999999999999876655544443322211  11224578899


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ++|| +||..+|++||+++|+++||||.
T Consensus       239 ~~li-~~~~~~p~~Rp~~~eil~hp~~~  265 (266)
T cd06651         239 RDFL-GCIFVEARHRPSAEELLRHPFAQ  265 (266)
T ss_pred             HHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence            9999 57778999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=2e-43  Score=345.44  Aligned_cols=250  Identities=28%  Similarity=0.491  Sum_probs=211.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||.||+|.+..+++.||+|.+.+.      .+.+.+|+++++.+. ||||+++++++..++.+|+||
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   79 (286)
T cd07846           1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLR-HENLVNLIEVFRRKKRLYLVF   79 (286)
T ss_pred             CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcC-CcchhhHHHhcccCCeEEEEE
Confidence            4689999999999999999999999999999998542      245778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||++++.|..+......+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++....... ....
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (286)
T cd07846          80 EFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYTD  159 (286)
T ss_pred             ecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCccccCc
Confidence            999999888877666679999999999999999999999999999999999999999999999999997654332 2334


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------C
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------F  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~  314 (469)
                      ..++..|+|||++.+  .++.++||||||+++|+|++|.+||.+....+....+......                   .
T Consensus       160 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T cd07846         160 YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRL  239 (286)
T ss_pred             ccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhcccc
Confidence            568999999999865  3788999999999999999999999876654433332211000                   0


Q ss_pred             C--------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 H--------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~--------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +        ...+..++..+.+||.+||..+|.+||++.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         240 PEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             ccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhcCCCC
Confidence            0        01124578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=4.7e-43  Score=342.86  Aligned_cols=250  Identities=33%  Similarity=0.549  Sum_probs=211.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++.+.||+|+||.||+|.+..+++.||+|+++..      ...+.+|+++++.+. |+||+++++++...+.+|+||
T Consensus         1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~iv~   79 (288)
T cd07833           1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLR-HENIVNLKEAFRRKGRLYLVF   79 (288)
T ss_pred             CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcC-CCCeeehhheEEECCEEEEEE
Confidence            3699999999999999999999999999999998642      256889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--ccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~  254 (469)
                      ||++++.+..++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......  ...
T Consensus        80 e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~~~~  159 (288)
T cd07833          80 EYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLT  159 (288)
T ss_pred             ecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcccccc
Confidence            999987777666666779999999999999999999999999999999999999999999999999997665433  334


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  313 (469)
                      ...++..|+|||++.+  .++.++||||||+++|+|++|.+||.+.+..+.+..+......                   
T Consensus       160 ~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (288)
T cd07833         160 DYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVA  239 (288)
T ss_pred             CcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccc
Confidence            5678999999999865  4788999999999999999999999877655444333221000                   


Q ss_pred             CCC---------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 FHS---------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 ~~~---------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ++.         .....++.++.+||++||..+|++|||+.++++||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~f  288 (288)
T cd07833         240 FPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQHPYF  288 (288)
T ss_pred             cCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhcCCCC
Confidence            000         0112348899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=6.3e-43  Score=341.96  Aligned_cols=246  Identities=29%  Similarity=0.478  Sum_probs=201.1

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      .||+|+||.||++.+..+|+.||+|++.+..       ....+|..+++.+.  .||||+.+++++...+..|+||||++
T Consensus         1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~   80 (279)
T cd05633           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN   80 (279)
T ss_pred             CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence            4899999999999999999999999885421       22344544444332  49999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                      ||+|.+++...+.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++....... .....|++
T Consensus        81 ~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~  159 (279)
T cd05633          81 GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK-PHASVGTH  159 (279)
T ss_pred             CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC-ccCcCCCc
Confidence            99999999888899999999999999999999999999999999999999999999999999987554332 23457999


Q ss_pred             cccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          261 AYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       261 ~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      .|+|||.+.+  .++.++||||+||++|+|++|..||.+....... .+...........+..++.++.++|.+||..||
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p  238 (279)
T cd05633         160 GYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNVELPDSFSPELKSLLEGLLQRDV  238 (279)
T ss_pred             CccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCcCCccccCHHHHHHHHHHhcCCH
Confidence            9999999853  4789999999999999999999999754321111 111111122222335689999999999999999


Q ss_pred             cCCC-----CHHHHHcCCCccccc
Q 012170          339 SARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       339 ~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      .+||     ++.++++||||....
T Consensus       239 ~~R~~~~~~~~~~~~~h~~~~~~~  262 (279)
T cd05633         239 SKRLGCLGRGAQEVKEHVFFKGID  262 (279)
T ss_pred             HHhcCCCCCCHHHHHhCccccCCC
Confidence            9999     699999999996643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=4.3e-43  Score=342.93  Aligned_cols=248  Identities=33%  Similarity=0.509  Sum_probs=207.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++++.||.|+||.||+|++..+|+.||||.+...      ...+.+|+++++++. ||||+++++++.+.+..|+|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (284)
T cd07860           1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVFE   79 (284)
T ss_pred             CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcC-CCCCcchhhhcccCCcEEEEee
Confidence            488899999999999999999999999999998642      246788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          178 LCSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      |+. ++|.+++..  ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ...
T Consensus        80 ~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~~~~  158 (284)
T cd07860          80 FLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  158 (284)
T ss_pred             ccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCccccc
Confidence            996 578888755  3568999999999999999999999999999999999999999999999999987554322 223


Q ss_pred             ccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-C-----------------CC
Q 012170          255 GLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-L-----------------DF  314 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~-----------------~~  314 (469)
                      ...+++.|+|||++.+.  ++.++||||||+++|+|++|..||.+.+.......+.... .                 .+
T Consensus       159 ~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07860         159 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSF  238 (284)
T ss_pred             cccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhc
Confidence            34678999999998653  6889999999999999999999998776544333322110 0                 01


Q ss_pred             CC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.       .....++.+++++|.+||+.||.+|||++++|+||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         239 PKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAALAHPFF  284 (284)
T ss_pred             ccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHHhcCCCC
Confidence            00       0123478899999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=1.3e-42  Score=333.74  Aligned_cols=246  Identities=27%  Similarity=0.481  Sum_probs=215.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++.+.||+|+||.||+|.+..+++.+|+|.+...      ...+.+|+++|+.+. ||||+++++.+..++.+++|||
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e   79 (256)
T cd08220           1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLS-HPNIIEYYENFLEDKALMIVME   79 (256)
T ss_pred             CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCC-CCchhheeeeEecCCEEEEEEe
Confidence            588999999999999999999999999999998542      246788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCCccc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~~~~  254 (469)
                      |++|++|.+++...  ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++ .++|+|||++..........
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (256)
T cd08220          80 YAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAY  159 (256)
T ss_pred             cCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcccc
Confidence            99999999999764  3489999999999999999999999999999999999998654 58999999998776554445


Q ss_pred             ccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...|++.|+|||.+.+. ++.++||||||+++|+|++|..||.+.+.......+.......   ....++.++.++|.+|
T Consensus       160 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~  236 (256)
T cd08220         160 TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAP---ISDRYSPDLRQLILSM  236 (256)
T ss_pred             ccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhcCCCC---CCCCcCHHHHHHHHHH
Confidence            56789999999999764 7889999999999999999999998877766666665433221   2245799999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      |..||.+|||+.|+++||||
T Consensus       237 l~~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         237 LNLDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             ccCChhhCCCHHHHhhCCCC
Confidence            99999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=1e-42  Score=337.02  Aligned_cols=247  Identities=29%  Similarity=0.527  Sum_probs=209.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--Ce
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~  171 (469)
                      .+|++.+.||+|+||.||+|.+..+|..||||.+...         ...+.+|+.+++.+. ||||+++++++.+.  ..
T Consensus         2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (265)
T cd06652           2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLL-HERIVQYYGCLRDPMERT   80 (265)
T ss_pred             CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcC-CCCeeeEEeEeccCCCce
Confidence            5789999999999999999999999999999987421         135778999999996 99999999998763  57


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      +++||||++|++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~  160 (265)
T cd06652          81 LSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTIC  160 (265)
T ss_pred             EEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccccccc
Confidence            8899999999999999988788999999999999999999999999999999999999999999999999998754321 


Q ss_pred             ---CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          251 ---QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       251 ---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                         .......|+..|+|||++.+ .++.++|||||||++|+|++|..||.+......+..+......  ......++..+
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  238 (265)
T cd06652         161 LSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQPTN--PVLPPHVSDHC  238 (265)
T ss_pred             ccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHHHHhcCCCC--CCCchhhCHHH
Confidence               11233568999999999866 4889999999999999999999999876555544444322211  11234678899


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .++|.+||. +|.+||+++++++|||+
T Consensus       239 ~~~i~~~l~-~p~~Rp~~~~il~~~~~  264 (265)
T cd06652         239 RDFLKRIFV-EAKLRPSADELLRHTFV  264 (265)
T ss_pred             HHHHHHHhc-ChhhCCCHHHHhcCccc
Confidence            999999994 99999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=9.7e-43  Score=338.25  Aligned_cols=249  Identities=27%  Similarity=0.473  Sum_probs=212.7

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      +|.+.+.||.|+||.||+|.+..+|+.||+|.++..              .+.+.+|+.+++.+. ||||+++++++...
T Consensus         2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~   80 (272)
T cd06629           2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLD-HLNIVQYLGFETTE   80 (272)
T ss_pred             ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcC-CCCcceEEEEeccC
Confidence            578889999999999999999999999999987531              134678999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +.+++||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~  160 (272)
T cd06629          81 EYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDD  160 (272)
T ss_pred             CceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccccccc
Confidence            99999999999999999998888999999999999999999999999999999999999999999999999999975432


Q ss_pred             CC---cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC--cCCCCCCcccC
Q 012170          250 GQ---TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV--KLDFHSGVWET  321 (469)
Q Consensus       250 ~~---~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~--~~~~~~~~~~~  321 (469)
                      ..   ......|+..|+|||++..   .++.++|+||||+++|+|++|..||...........+...  ...++......
T Consensus       161 ~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (272)
T cd06629         161 IYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMN  240 (272)
T ss_pred             cccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHHHHHHhhccccCCcCCcccccc
Confidence            21   1234568999999999864   2788999999999999999999999765554433333222  22333334456


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ++.++.+||.+||..+|.+|||++++|+||||
T Consensus       241 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~  272 (272)
T cd06629         241 LSPVALDFLNACFTINPDNRPTARELLQHPFI  272 (272)
T ss_pred             CCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence            79999999999999999999999999999996

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=8.4e-43  Score=335.10  Aligned_cols=247  Identities=31%  Similarity=0.494  Sum_probs=214.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      +|+..+.||+|+||.||+|.+..++..|++|.+...         ...+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus         1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~l   79 (258)
T cd06632           1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQ-HPNIVQYLGTEREEDNLYI   79 (258)
T ss_pred             CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcC-CCCchheeeeEecCCeEEE
Confidence            477789999999999999999989999999988542         245788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||||+++++|.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.+||+|||++..........
T Consensus        80 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~~~~  159 (258)
T cd06632          80 FLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK  159 (258)
T ss_pred             EEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccccccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999998765444445


Q ss_pred             ccCCCCcccCceeccC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...|++.|+|||.+.. . ++.++|+||||+++|+|++|..||...........+....  .....+..++.++.+||.+
T Consensus       160 ~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~li~~  237 (258)
T cd06632         160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSK--ELPPIPDHLSDEAKDFILK  237 (258)
T ss_pred             ccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhcc--cCCCcCCCcCHHHHHHHHH
Confidence            5679999999999855 3 7899999999999999999999998766544444443311  1112234678999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCc
Q 012170          333 MLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||..+|.+||++.+++.|||+
T Consensus       238 ~l~~~p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         238 CLQRDPSLRPTAAELLEHPFV  258 (258)
T ss_pred             HhhcCcccCcCHHHHhcCCCC
Confidence            999999999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.5e-43  Score=341.51  Aligned_cols=252  Identities=29%  Similarity=0.475  Sum_probs=217.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ...|+.++.||.|+||.||+|.+..++..||+|++...     ...+.+|+.+++.+. ||||+++++++.+++.+|+||
T Consensus         3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06640           3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEEEEE
Confidence            35688889999999999999999999999999998643     245788999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||++||+|.+++. .+++++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06640          82 EYLGGGSALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             ecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCcccccc
Confidence            9999999999885 4678999999999999999999999999999999999999999999999999997654432 2233


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..++..|+|||++.+ .++.++|+|||||++|+|++|.+||.+.........+.....   ......++..+.+||.+||
T Consensus       161 ~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l  237 (277)
T cd06640         161 FVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP---PTLTGEFSKPFKEFIDACL  237 (277)
T ss_pred             ccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC---CCCchhhhHHHHHHHHHHc
Confidence            568899999999866 478999999999999999999999988777666665543322   2223457889999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCcccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ..+|.+||++.++++||||.....
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06640         238 NKDPSFRPTAKELLKHKFIVKNAK  261 (277)
T ss_pred             ccCcccCcCHHHHHhChHhhhcch
Confidence            999999999999999999965543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=9.5e-43  Score=341.89  Aligned_cols=250  Identities=30%  Similarity=0.495  Sum_probs=205.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++.+.||.|+||.||+|.++.+++.||||.+...     ...+.+|+++++.+. ||||+++++++.+.+..|+||
T Consensus         4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   82 (291)
T cd07844           4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLK-HANIVTLHDIIHTKKTLTLVF   82 (291)
T ss_pred             ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCC-CcceeeEEEEEecCCeEEEEE
Confidence            36899999999999999999999999999999998542     234678999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||+.+ +|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++...... ....
T Consensus        83 e~~~~-~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~  161 (291)
T cd07844          83 EYLDT-DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSKTYS  161 (291)
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCCcccc
Confidence            99975 898888664 46899999999999999999999999999999999999999999999999998654322 1222


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCC------------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLD------------------  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~------------------  313 (469)
                      ...+++.|+|||++.+  .++.++||||+|+++|+|++|..||.+.. ..+.+..+......                  
T Consensus       162 ~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (291)
T cd07844         162 NEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPY  241 (291)
T ss_pred             ccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccc
Confidence            3457889999999865  47899999999999999999999997654 33333222111000                  


Q ss_pred             -CC-------CCcccCCC--HHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 -FH-------SGVWETVS--KPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 -~~-------~~~~~~~s--~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                       +.       ......++  .++.++|.+||..+|.+|||+.++|.||||
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         242 SFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMKHPYF  291 (291)
T ss_pred             cccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence             00       00112344  888999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=2.3e-43  Score=340.86  Aligned_cols=250  Identities=30%  Similarity=0.496  Sum_probs=213.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++.+.||.|+||.||+|.++.+++.||+|.+...     ...+.+|+++++.+. ||||+++++++...+.+++|+|
T Consensus         1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e   79 (265)
T cd06605           1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCN-SPYIVGFYGAFYNNGDISICME   79 (265)
T ss_pred             CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCC-CCchhhhheeeecCCEEEEEEE
Confidence            3688889999999999999999999999999998643     245788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |+.+++|.+++... ..+++..+..++.|++.||.|||+ .|++|+||+|+||+++.++.++|+|||.+.......... 
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~-  158 (265)
T cd06605          80 YMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKT-  158 (265)
T ss_pred             ecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhhc-
Confidence            99999999999776 789999999999999999999999 999999999999999999999999999987654332222 


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCcC-CCCCCcccCCCHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-----SLEAVFDAIKNVKL-DFHSGVWETVSKPARD  328 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~  328 (469)
                      ..|+..|+|||.+.+ .++.++||||||+++|+|++|..||...     ........+..... ..+   ...++.++.+
T Consensus       159 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  235 (265)
T cd06605         159 FVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQYIVNEPPPRLP---SGKFSPDFQD  235 (265)
T ss_pred             ccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHHHhcCCCCCCC---hhhcCHHHHH
Confidence            678999999999876 4889999999999999999999999754     23333333333221 111   1127899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ||.+||..||.+|||+.+++.||||+.+.
T Consensus       236 li~~~l~~~p~~Rpt~~~ll~~~~~~~~~  264 (265)
T cd06605         236 FVNLCLIKDPRERPSYKELLEHPFIKKYE  264 (265)
T ss_pred             HHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence            99999999999999999999999997653

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms]

Probab=100.00  E-value=2e-43  Score=325.71  Aligned_cols=256  Identities=26%  Similarity=0.446  Sum_probs=218.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++.+++..||.|+-|.|++++.+.+|...|||.+.+.     ..++...+.++....+.|+||+.+++|..+..+++.||
T Consensus        92 ndl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMe  171 (391)
T KOG0983|consen   92 NDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICME  171 (391)
T ss_pred             HHhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHH
Confidence            3456678899999999999999999999999999652     34677788888777778999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      .|. ..+..++.+ .++++|..+-.+...++.||.||.+ +||+|||+||+|||+|+.|+|||||||.+.++.+....+.
T Consensus       172 lMs-~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAhtr  250 (391)
T KOG0983|consen  172 LMS-TCAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAHTR  250 (391)
T ss_pred             HHH-HHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeeccccccc
Confidence            984 344444433 4689999999999999999999985 6899999999999999999999999999999988888888


Q ss_pred             cCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ..|-+.|||||.+.-    .|+.++||||||++++||+||..||.+. ...+++..|.+..++... .-..+|+.+++|+
T Consensus       251 sAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~-~~~gFSp~F~~fv  329 (391)
T KOG0983|consen  251 SAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLP-GHMGFSPDFQSFV  329 (391)
T ss_pred             ccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCC-cccCcCHHHHHHH
Confidence            899999999999953    4999999999999999999999999974 345677777765442222 2234899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYTERT  360 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~  360 (469)
                      ..||++|+.+||...++|+|||+..+....
T Consensus       330 ~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~a~  359 (391)
T KOG0983|consen  330 KDCLTKDHRKRPKYNKLLEHPFIKRYETAE  359 (391)
T ss_pred             HHHhhcCcccCcchHHHhcCcceeecchhh
Confidence            999999999999999999999998776543

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=6.7e-43  Score=342.77  Aligned_cols=234  Identities=17%  Similarity=0.233  Sum_probs=204.0

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC---h----HHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEEEEEe
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG---E----ETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVME  177 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~----~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~lV~E  177 (469)
                      ..||+|++|.||+|..  +|+.||||.++..   .    +.+.+|+.+|+++. ||||+++++++.+    ...+++|||
T Consensus        26 ~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~~~~~~~~~~lv~E  102 (283)
T PHA02988         26 VLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRID-SNNILKIYGFIIDIVDDLPRLSLILE  102 (283)
T ss_pred             eEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcC-CCCEEEEeeeEEecccCCCceEEEEE
Confidence            5799999999999988  5899999999643   1    45669999999997 9999999999876    457899999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |++||+|.+++...+.+++.....++.|++.||.|||+ .+++||||||+|||++.++.+||+|||++.......  ...
T Consensus       103 y~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~--~~~  180 (283)
T PHA02988        103 YCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP--FKN  180 (283)
T ss_pred             eCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc--ccc
Confidence            99999999999888889999999999999999999998 499999999999999999999999999987554322  235


Q ss_pred             CCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          257 AGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       257 ~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      .|++.|+|||++.+   .|+.++|||||||++|+|++|..||.+.+..+++..+......++.  ...+++++++||.+|
T Consensus       181 ~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~~l~~li~~c  258 (283)
T PHA02988        181 VNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKL--PLDCPLEIKCIVEAC  258 (283)
T ss_pred             cCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCC--CCcCcHHHHHHHHHH
Confidence            68999999999964   5899999999999999999999999998888888777544433332  135799999999999


Q ss_pred             chhhhcCCCCHHHHHc
Q 012170          334 LTRDVSARITADEVLR  349 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~  349 (469)
                      |+.||.+|||+.++++
T Consensus       259 l~~dp~~Rps~~ell~  274 (283)
T PHA02988        259 TSHDSIKRPNIKEILY  274 (283)
T ss_pred             hcCCcccCcCHHHHHH
Confidence            9999999999999985

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.3e-42  Score=334.59  Aligned_cols=246  Identities=31%  Similarity=0.522  Sum_probs=215.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLV  175 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV  175 (469)
                      +|++++.||.|+||.||+|.+..+|..||+|++...      .+.+..|+++++.+. ||||+++++++..  ...+|+|
T Consensus         1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (265)
T cd08217           1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELK-HPNIVRYYDRIIDRSNQTLYIV   79 (265)
T ss_pred             CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcC-CCccceeeeeeecCCCCEEEEE
Confidence            588899999999999999999999999999998532      245778999999997 9999999998753  4568999


Q ss_pred             EeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHH-----hcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          176 MELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCH-----DMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH-----~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      |||+++++|.+++...    ..+++..+..++.||+.||.|||     +.+++|+||+|+||+++.++.++|+|||++..
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~  159 (265)
T cd08217          80 MEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKI  159 (265)
T ss_pred             ehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEeccccccc
Confidence            9999999999998663    57899999999999999999999     99999999999999999999999999999987


Q ss_pred             ecCCCc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          247 ISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       247 ~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ...... .....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+.......   ....++.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~  236 (265)
T cd08217         160 LGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFRR---IPYRYSS  236 (265)
T ss_pred             ccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCC---CccccCH
Confidence            654433 345678999999999866 47889999999999999999999999888777777776654322   2246789


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ++.++|.+||..+|.+||++.+||+|||+
T Consensus       237 ~~~~l~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         237 ELNEVIKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence            99999999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=4.1e-43  Score=343.93  Aligned_cols=256  Identities=25%  Similarity=0.367  Sum_probs=209.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|+..+.||+|+||.||++.+..+|+.||+|.+...     ...+.+|+.++.++.+||||+++++++..++..++|||
T Consensus         4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e   83 (288)
T cd06616           4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICME   83 (288)
T ss_pred             HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEe
Confidence            4667788999999999999999999999999998642     24577899999999779999999999999999999999


Q ss_pred             ccCCCchHHHH---H--HhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          178 LCSGGRLIDQM---V--EVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       178 ~~~gg~L~~~l---~--~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+.+ ++.++.   .  ..+.+++..+..++.|++.||.|||+. |++||||||+|||++.++.++|+|||++.......
T Consensus        84 ~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~  162 (288)
T cd06616          84 LMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI  162 (288)
T ss_pred             cccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC
Confidence            9864 444432   2  236799999999999999999999975 99999999999999999999999999997655444


Q ss_pred             cccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-cCCCCCCcccCCCHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNV-KLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~~s~~  325 (469)
                      ......|++.|+|||++.+    .++.++|||||||++|+|++|.+||..... .+.+..+... ........+..++.+
T Consensus       163 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd06616         163 AKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPS  242 (288)
T ss_pred             ccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHH
Confidence            4444578999999999865    388999999999999999999999976541 1222222211 122222233458999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      +.+||.+||..||.+|||++++++||||..+..+
T Consensus       243 l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~~~  276 (288)
T cd06616         243 FVNFINLCLIKDESKRPKYKELLEHPFIKDYEER  276 (288)
T ss_pred             HHHHHHHHccCChhhCcCHHHHhcChhhhchhhc
Confidence            9999999999999999999999999999766543

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=5.2e-43  Score=354.14  Aligned_cols=253  Identities=28%  Similarity=0.469  Sum_probs=208.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..+|..||||++.+.      ...+.+|+.+++.+. ||||++++++|...    
T Consensus        13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (353)
T cd07850          13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVN-HKNIIGLLNVFTPQKSLE   91 (353)
T ss_pred             hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcC-CCCCcceeeeeccCCCcc
Confidence            3568899999999999999999999999999999998642      235678999999996 99999999998644    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ...|+||||+.+ +|.+.+...  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        92 ~~~~~~lv~e~~~~-~l~~~~~~~--l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~  168 (353)
T cd07850          92 EFQDVYLVMELMDA-NLCQVIQMD--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  168 (353)
T ss_pred             ccCcEEEEEeccCC-CHHHHHhhc--CCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCccceeC
Confidence              357999999964 787777543  899999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------  313 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------  313 (469)
                      ..........|++.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......             
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (353)
T cd07850         169 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTV  248 (353)
T ss_pred             CCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhh
Confidence            55444445678999999999976 4899999999999999999999999877654443333211000             


Q ss_pred             ---------C---------CCC--------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 ---------F---------HSG--------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 ---------~---------~~~--------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                               .         +..        .+...+..+++||.+||..||.+|||+.|+|+||||..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~~~~~~~  317 (353)
T cd07850         249 RNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQHPYINVW  317 (353)
T ss_pred             hHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcChhHhhc
Confidence                     0         000        011346678999999999999999999999999999543

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms]

Probab=100.00  E-value=1.4e-44  Score=360.55  Aligned_cols=235  Identities=28%  Similarity=0.491  Sum_probs=211.6

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHH
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQ  187 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  187 (469)
                      ++-||.|+.|.||+|+..  ++.||||.++.   .-..+++-|++|+ ||||+.+.++|....++|||||||..|-|...
T Consensus       129 LeWlGSGaQGAVF~Grl~--netVAVKKV~e---lkETdIKHLRkLk-H~NII~FkGVCtqsPcyCIiMEfCa~GqL~~V  202 (904)
T KOG4721|consen  129 LEWLGSGAQGAVFLGRLH--NETVAVKKVRE---LKETDIKHLRKLK-HPNIITFKGVCTQSPCYCIIMEFCAQGQLYEV  202 (904)
T ss_pred             hhhhccCcccceeeeecc--CceehhHHHhh---hhhhhHHHHHhcc-CcceeeEeeeecCCceeEEeeeccccccHHHH
Confidence            577999999999999887  78999998863   3456889999997 99999999999999999999999999999999


Q ss_pred             HHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCcee
Q 012170          188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV  267 (469)
Q Consensus       188 l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~  267 (469)
                      |.....++......|..+|+.|+.|||.+.|||||||.-||||+.+..|||+|||.++...+....-.++||..|||||+
T Consensus       203 Lka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEv  282 (904)
T KOG4721|consen  203 LKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEV  282 (904)
T ss_pred             HhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHH
Confidence            99999999999999999999999999999999999999999999999999999999988777767778999999999999


Q ss_pred             ccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHH
Q 012170          268 LSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADE  346 (469)
Q Consensus       268 l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~e  346 (469)
                      +... .+.++|||||||||||||||..||.+.+...++.-+-...+.++  .+..+++-++-||+.||+-.|..||++.+
T Consensus       283 IrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL~Lp--vPstcP~GfklL~Kqcw~sKpRNRPSFrq  360 (904)
T KOG4721|consen  283 IRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSLHLP--VPSTCPDGFKLLLKQCWNSKPRNRPSFRQ  360 (904)
T ss_pred             hhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCccccc--CcccCchHHHHHHHHHHhcCCCCCccHHH
Confidence            9875 79999999999999999999999998776665554444333333  34678999999999999999999999999


Q ss_pred             HHcC
Q 012170          347 VLRH  350 (469)
Q Consensus       347 lL~h  350 (469)
                      ||.|
T Consensus       361 il~H  364 (904)
T KOG4721|consen  361 ILLH  364 (904)
T ss_pred             HHHH
Confidence            9998

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=6.6e-43  Score=343.51  Aligned_cols=249  Identities=31%  Similarity=0.488  Sum_probs=209.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~~l  174 (469)
                      ++|++.+.||.|+||.||+|.+..+++.+|+|.++...      ..+.+|+.+++++. ||||+++++++...  +.+|+
T Consensus         5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~~~l   83 (293)
T cd07843           5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQ-HPNIVTVKEVVVGSNLDKIYM   83 (293)
T ss_pred             hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcC-CCCEEEEEEEEEecCCCcEEE
Confidence            57999999999999999999999999999999996422      24568999999997 99999999998877  89999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cc
Q 012170          175 VMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QT  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~  252 (469)
                      ||||+.+ +|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++...... ..
T Consensus        84 v~e~~~~-~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~  162 (293)
T cd07843          84 VMEYVEH-DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP  162 (293)
T ss_pred             EehhcCc-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc
Confidence            9999975 8888886644 5899999999999999999999999999999999999999999999999999876544 23


Q ss_pred             ccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-----------------
Q 012170          253 LSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----------------  313 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------------  313 (469)
                      .....+++.|+|||++.+.  ++.++|+||||+++|+|++|.+||...+....+..+......                 
T Consensus       163 ~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (293)
T cd07843         163 YTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKK  242 (293)
T ss_pred             cccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcc
Confidence            3445688999999998653  688999999999999999999999887765555443221100                 


Q ss_pred             --C-------CCCcccC--CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 --F-------HSGVWET--VSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 --~-------~~~~~~~--~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                        +       ....+..  +++.+.+||.+||+.||++|||+.|+|.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~~~~f  293 (293)
T cd07843         243 KTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF  293 (293)
T ss_pred             cccccccchhhhccccccCCChHHHHHHHHHhccCccccCCHHHHhcCCCC
Confidence              0       0001111  58889999999999999999999999999997

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.9e-42  Score=334.10  Aligned_cols=248  Identities=30%  Similarity=0.481  Sum_probs=212.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|.+.+.||+|+||.||+|.+..++..||+|+++..      ...+.+|+.+++.+. |+||+++++++...+.+++|+|
T Consensus         1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06626           1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLK-HPNLVKYYGVEVHREKVYIFME   79 (264)
T ss_pred             CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCC-CCChhheeeeEecCCEEEEEEe
Confidence            588999999999999999999999999999998643      246788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-----
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-----  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-----  252 (469)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.+||+|||++........     
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~  159 (264)
T cd06626          80 YCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEE  159 (264)
T ss_pred             cCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCccccc
Confidence            999999999998877899999999999999999999999999999999999999999999999999977644322     


Q ss_pred             ccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .....+++.|+|||++.+.    ++.++||||||+++|+|++|..||.... .......+... .......+..++..+.
T Consensus       160 ~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~  238 (264)
T cd06626         160 VQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFHVGAG-HKPPIPDSLQLSPEGK  238 (264)
T ss_pred             ccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHHHhcC-CCCCCCcccccCHHHH
Confidence            1235688999999998652    6889999999999999999999997653 33333333332 2222223345689999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +||.+||+.+|.+|||+.+++.|||+
T Consensus       239 ~li~~~l~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         239 DFLDRCLESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             HHHHHHccCCcccCCCHHHHhcCCCC
Confidence            99999999999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=2.3e-42  Score=337.69  Aligned_cols=243  Identities=29%  Similarity=0.488  Sum_probs=202.4

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      .||+|+||.||+|.+..+++.||+|++.+..       .....|..+++.+.  .||||+.+++++...+.+|+||||+.
T Consensus         1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~   80 (278)
T cd05606           1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN   80 (278)
T ss_pred             CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence            4899999999999999999999999986421       12334444433332  49999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                      ||+|.+++...+.+++..+..++.|++.||.|||+.+++||||||+||+++.++.++|+|||++...... ......|+.
T Consensus        81 g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~  159 (278)
T cd05606          81 GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-KPHASVGTH  159 (278)
T ss_pred             CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCcc-CCcCcCCCc
Confidence            9999999988888999999999999999999999999999999999999999999999999998755332 223457999


Q ss_pred             cccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          261 AYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGD---SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       261 ~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      .|+|||++.+  .++.++||||+|+++|+|++|..||.+.   ........+......+    +..++.++.++|.+||.
T Consensus       160 ~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~s~~~~~li~~~l~  235 (278)
T cd05606         160 GYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVEL----PDSFSPELRSLLEGLLQ  235 (278)
T ss_pred             CCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCCC----CCcCCHHHHHHHHHHhh
Confidence            9999999964  4889999999999999999999999876   3333333333222222    24579999999999999


Q ss_pred             hhhcCCC-----CHHHHHcCCCccccc
Q 012170          336 RDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       336 ~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      .+|.+||     ++.++++||||....
T Consensus       236 ~~p~~R~~~~~~~~~~ll~~~~~~~~~  262 (278)
T cd05606         236 RDVNRRLGCLGRGAQEVKEHPFFRSLD  262 (278)
T ss_pred             cCHHhccCCCCCCHHHHHhCccccCCC
Confidence            9999999     999999999996554

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.4e-43  Score=345.50  Aligned_cols=252  Identities=29%  Similarity=0.460  Sum_probs=216.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .+.|+.++.||.|+||.||+|.+..++..||+|++...     ...+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus         3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   81 (277)
T cd06642           3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYITRYYGSYLKGTKLWIIM   81 (277)
T ss_pred             HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCC-CCccHhhhcccccCCceEEEE
Confidence            35688889999999999999999999999999998642     245788999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||+++++|.+++. .+.+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06642          82 EYLGGGSALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EccCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCcchhhhc
Confidence            9999999998874 4678999999999999999999999999999999999999999999999999997654332 2233


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|+..|+|||++.+ .++.++|+|||||++|+|++|..||...........+.......   ....++.++.++|.+||
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l  237 (277)
T cd06642         161 FVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPT---LEGQYSKPFKEFVEACL  237 (277)
T ss_pred             ccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCCCC---CCcccCHHHHHHHHHHc
Confidence            568999999999976 48889999999999999999999998766665555544332211   12357889999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCcccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ..+|.+||++.++++||||..+..
T Consensus       238 ~~~p~~Rp~~~~il~~~~~~~~~~  261 (277)
T cd06642         238 NKDPRFRPTAKELLKHKFITRYTK  261 (277)
T ss_pred             cCCcccCcCHHHHHHhHHHHHHhh
Confidence            999999999999999999976554

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.2e-42  Score=339.43  Aligned_cols=248  Identities=30%  Similarity=0.530  Sum_probs=208.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +|++++.||.|++|.||+|.+..+|..||||+++..     ...+.+|+.+++.+. ||||+++++++.+.+.+++||||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   79 (284)
T cd07836           1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELK-HENIVRLHDVIHTENKLMLVFEY   79 (284)
T ss_pred             CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhc-CCCEeeeeeeEeeCCcEEEEEec
Confidence            588999999999999999999999999999998643     346778999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          179 CSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      +++ +|.+++...+   .+++..+..++.||+.||.|||+.|++||||+|+||++++++.++|+|||++....... ...
T Consensus        80 ~~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (284)
T cd07836          80 MDK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVNTFS  158 (284)
T ss_pred             CCc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCccccc
Confidence            985 7888776543   58999999999999999999999999999999999999999999999999997543322 223


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC------------------CC
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL------------------DF  314 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------------~~  314 (469)
                      ...+++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+..+....+.....                  .+
T Consensus       159 ~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (284)
T cd07836         159 NEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTF  238 (284)
T ss_pred             cccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccc
Confidence            3567899999999865  378899999999999999999999988776554444322100                  00


Q ss_pred             CC-------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HS-------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~-------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +.       .....++..+.++|.+||+.||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         239 PRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence            00       0112468889999999999999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=2.3e-42  Score=337.08  Aligned_cols=251  Identities=29%  Similarity=0.474  Sum_probs=216.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .+-|++++.||.|+||.||+|.+..++..||||++...     ...+.+|+.+++.+. ||||+++++++..++.+|+||
T Consensus         3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   81 (277)
T cd06641           3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWIIM   81 (277)
T ss_pred             HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcC-CCCEeEEEEEEEeCCeEEEEE
Confidence            34578889999999999999999999999999997642     246778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||+++++|.+++. .+.+++..+..++.|++.|+.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~l~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06641          82 EYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT  160 (277)
T ss_pred             EeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccchhhhcc
Confidence            9999999998875 4578999999999999999999999999999999999999999999999999987654322 2234


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|+..|+|||.+.+ .++.++|+|||||++|+|++|..||...........+.......   ....++.++.++|.+||
T Consensus       161 ~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~~l  237 (277)
T cd06641         161 FVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEACL  237 (277)
T ss_pred             ccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCCC---CCcccCHHHHHHHHHHc
Confidence            568999999999865 47889999999999999999999998877766666654433221   12457899999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..+|.+||++.++++||||....
T Consensus       238 ~~~p~~Rp~~~~~l~~~~~~~~~  260 (277)
T cd06641         238 NKEPSFRPTAKELLKHKFIVRFA  260 (277)
T ss_pred             cCChhhCcCHHHHHhCHHHhhhh
Confidence            99999999999999999996654

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=1.4e-42  Score=334.77  Aligned_cols=250  Identities=30%  Similarity=0.501  Sum_probs=218.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++.+.||.|++|.||+|.+..++..||+|++...     ...+.+|+.++..+. ||||+++++++...+..++|||
T Consensus         1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   79 (264)
T cd06623           1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCE-SPYVVKCYGAFYKEGEISIVLE   79 (264)
T ss_pred             CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEccCCeEEEEEE
Confidence            3688999999999999999999999999999998654     356889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc-cc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~-~~  255 (469)
                      |+++++|.+++.....+++..+..++.||+.||.|||+ .|++|+||+|+||+++.++.++|+|||++......... ..
T Consensus        80 ~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~  159 (264)
T cd06623          80 YMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQCNT  159 (264)
T ss_pred             ecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcccc
Confidence            99999999999888899999999999999999999999 99999999999999999999999999999866543332 24


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCCCCCCcccC-CCHHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---SLEAVFDAIKNVKLDFHSGVWET-VSKPARDLM  330 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~-~s~~~~~lI  330 (469)
                      ..++..|+|||.+.+ .++.++|+||||+++|+|++|..||...   ...+....+.......   .... ++..+.++|
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  236 (264)
T cd06623         160 FVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGPPPS---LPAEEFSPEFRDFI  236 (264)
T ss_pred             eeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC---CCcccCCHHHHHHH
Confidence            578999999999866 4788999999999999999999999776   4455555555332211   1123 789999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..+|++||++.++++||||...
T Consensus       237 ~~~l~~~p~~R~~~~~ll~~~~~~~~  262 (264)
T cd06623         237 SACLQKDPKKRPSAAELLQHPFIKKA  262 (264)
T ss_pred             HHHccCChhhCCCHHHHHhCHHHHhc
Confidence            99999999999999999999999543

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=8.9e-43  Score=355.31  Aligned_cols=247  Identities=21%  Similarity=0.324  Sum_probs=203.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++++.||+|+||.||+|++..+     +..||+|+++..     ...+.+|+.+|+.+..||||+++++++...+
T Consensus        36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~  115 (374)
T cd05106          36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGG  115 (374)
T ss_pred             cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCC
Confidence            346899999999999999999986543     357999999643     2457789999999955999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh-----------------------------------------------------------
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-----------------------------------------------------------  191 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------------  191 (469)
                      .+|+|||||++|+|.+++...                                                           
T Consensus       116 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (374)
T cd05106         116 PVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSS  195 (374)
T ss_pred             CeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccc
Confidence            999999999999999988542                                                           


Q ss_pred             -----------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---ccccC
Q 012170          192 -----------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLA  257 (469)
Q Consensus       192 -----------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~  257 (469)
                                 .++++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........   .....
T Consensus       196 ~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~  275 (374)
T cd05106         196 DSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR  275 (374)
T ss_pred             cccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCC
Confidence                       2467888999999999999999999999999999999999999999999999976543322   11233


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      +++.|+|||++.+ .++.++|||||||++|+|++ |..||........+..+........  ....+++++.++|.+||+
T Consensus       276 ~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~cl~  353 (374)
T cd05106         276 LPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMS--RPDFAPPEIYSIMKMCWN  353 (374)
T ss_pred             CccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCcc--CCCCCCHHHHHHHHHHcC
Confidence            5678999999865 58999999999999999997 9999987655443333333222221  123468999999999999


Q ss_pred             hhhcCCCCHHHHHc
Q 012170          336 RDVSARITADEVLR  349 (469)
Q Consensus       336 ~dP~~Rpsa~elL~  349 (469)
                      .||.+|||+.++++
T Consensus       354 ~dp~~RPs~~~l~~  367 (374)
T cd05106         354 LEPTERPTFSQISQ  367 (374)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription]

Probab=100.00  E-value=2.7e-44  Score=336.67  Aligned_cols=254  Identities=28%  Similarity=0.436  Sum_probs=206.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-C
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-A  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~  169 (469)
                      ....|+.+..||+|+||.||+|..++++.    .||||.++.+      .....+|+.+++.|+ ||||+.|..+|.. +
T Consensus        22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~-h~nvi~Lv~Vfl~~d  100 (438)
T KOG0666|consen   22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELK-HPNVISLVKVFLSHD  100 (438)
T ss_pred             HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhc-CCcchhHHHHHhccC
Confidence            45689999999999999999997665543    6899999754      256889999999997 9999999999877 7


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC----CcEEEEe
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV-----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS----GKIKLAD  240 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~----~~vkL~D  240 (469)
                      ..+|+++||.+. +|...|.-+     +.++...+..|+.||+.|+.|||++-|+||||||.||||..+    |.|||+|
T Consensus       101 ~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaD  179 (438)
T KOG0666|consen  101 KKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIAD  179 (438)
T ss_pred             ceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeec
Confidence            899999999987 777777533     458899999999999999999999999999999999999888    8999999


Q ss_pred             ccceeeecCCCc----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH---------HHHHH
Q 012170          241 FGLAMRISNGQT----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSL---------EAVFD  305 (469)
Q Consensus       241 Fgla~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~---------~~~~~  305 (469)
                      ||+++.+.+.-.    ....+.|.||+|||++.|  .|+.++|||++|||+.||++-.+.|.+...         .+.++
T Consensus       180 lGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~  259 (438)
T KOG0666|consen  180 LGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLD  259 (438)
T ss_pred             ccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHH
Confidence            999987765422    234678999999999988  499999999999999999999998876421         12233


Q ss_pred             HHHcCcCCCCCCc---------------------c------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCC
Q 012170          306 AIKNVKLDFHSGV---------------------W------------ETVSKPARDLMARMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       306 ~i~~~~~~~~~~~---------------------~------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~  352 (469)
                      .|-+.........                     |            ..-++.+.+|+.+||++||.+|+|++|+|+|+|
T Consensus       260 rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~y  339 (438)
T KOG0666|consen  260 RIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPY  339 (438)
T ss_pred             HHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccc
Confidence            3322211111111                     1            112556889999999999999999999999999


Q ss_pred             cccc
Q 012170          353 ILFY  356 (469)
Q Consensus       353 ~~~~  356 (469)
                      |..-
T Consensus       340 F~~d  343 (438)
T KOG0666|consen  340 FTED  343 (438)
T ss_pred             cccC
Confidence            9654

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=1.5e-42  Score=342.91  Aligned_cols=251  Identities=29%  Similarity=0.448  Sum_probs=205.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD----  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~----  170 (469)
                      ..++|++++.||+|+||.||+|.+..+++.||||.+...      ...+.+|+.+++++. ||||+++++++...+    
T Consensus        10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   88 (310)
T cd07865          10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPYN   88 (310)
T ss_pred             hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCC-CCCccceEEEEeccccccc
Confidence            446799999999999999999999999999999988532      124568999999996 999999999986543    


Q ss_pred             ----eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          171 ----CFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       171 ----~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                          ..|+||||+.+ +|.+.+.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.+||+|||++.
T Consensus        89 ~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~  167 (310)
T cd07865          89 RYKGSFYLVFEFCEH-DLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLAR  167 (310)
T ss_pred             CCCceEEEEEcCCCc-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCCcc
Confidence                46999999965 7777775543 68999999999999999999999999999999999999999999999999997


Q ss_pred             eecCCC-----cccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          246 RISNGQ-----TLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       246 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      ......     ......++..|+|||++.+.  ++.++||||||+++|+|++|.+||.+.+.......+......++...
T Consensus       168 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~  247 (310)
T cd07865         168 AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEV  247 (310)
T ss_pred             cccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhh
Confidence            654322     12345678899999998663  78899999999999999999999988776655444433211111000


Q ss_pred             ----------------------------ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          319 ----------------------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       319 ----------------------------~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                                  ....+..+.+||.+||..||.+|||++++|+||||
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~h~~f  310 (310)
T cd07865         248 WPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF  310 (310)
T ss_pred             cccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhcCCCC
Confidence                                        01135778899999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=9.6e-43  Score=341.00  Aligned_cols=248  Identities=25%  Similarity=0.427  Sum_probs=211.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|++++.||+|+||.||+|.+..+|..||+|++...     ...+.+|+++++.+. ||||+++++++...+.+|+|||
T Consensus         5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   83 (284)
T cd06620           5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECR-SPYIVSFYGAFLNENNICMCME   83 (284)
T ss_pred             HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcC-CCCcceEeeeEecCCEEEEEEe
Confidence            6789999999999999999999999999999987542     246789999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |+++++|.+++...+.+++..+..++.|++.||.|||+ .|++||||+|+||+++.++.++|+|||++...... .....
T Consensus        84 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-~~~~~  162 (284)
T cd06620          84 FMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-IADTF  162 (284)
T ss_pred             cCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhh-ccCcc
Confidence            99999999999888889999999999999999999997 69999999999999999999999999998654322 22345


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-----------HHHHHHHcCc-CCCCCCcccCCC
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE-----------AVFDAIKNVK-LDFHSGVWETVS  323 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-----------~~~~~i~~~~-~~~~~~~~~~~s  323 (469)
                      .|+..|+|||++.+ .++.++|+|||||++|+|++|..||......           +.+..+.... ..++   ...++
T Consensus       163 ~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  239 (284)
T cd06620         163 VGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLP---SSDFP  239 (284)
T ss_pred             ccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCC---chhcC
Confidence            79999999999854 5889999999999999999999999865431           2222222211 1111   12378


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .++.+||.+||..||.+|||+.|+++||||..
T Consensus       240 ~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~  271 (284)
T cd06620         240 EDLRDFVDACLLKDPTERPTPQQLCAMPPFIQ  271 (284)
T ss_pred             HHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            89999999999999999999999999999954

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=3.1e-42  Score=331.55  Aligned_cols=243  Identities=28%  Similarity=0.490  Sum_probs=213.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +|++.+.||.|+||.||++.+..++..||+|.++..     .+.+.+|+.+++.+. ||||+++++.+.+.+.+|+||||
T Consensus         1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   79 (255)
T cd08219           1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMK-HPNIVAFKESFEADGHLYIVMEY   79 (255)
T ss_pred             CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEEee
Confidence            588999999999999999999999999999998532     256778999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      +++|+|.+++...  ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++....... ....
T Consensus        80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  159 (255)
T cd08219          80 CDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT  159 (255)
T ss_pred             CCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccccccc
Confidence            9999999988653  458999999999999999999999999999999999999999999999999997664432 2334


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+........   ...++..+.+||.+||
T Consensus       160 ~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l  236 (255)
T cd08219         160 YVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSYKPL---PSHYSYELRSLIKQMF  236 (255)
T ss_pred             ccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCCCCCC---CcccCHHHHHHHHHHH
Confidence            678999999999976 488999999999999999999999998887777777665543322   2457899999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      +.||.+||++.+++.-
T Consensus       237 ~~~P~~Rp~~~~il~~  252 (255)
T cd08219         237 KRNPRSRPSATTILSR  252 (255)
T ss_pred             hCCcccCCCHHHHhhc
Confidence            9999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-42  Score=336.58  Aligned_cols=251  Identities=29%  Similarity=0.504  Sum_probs=214.8

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .|++++.||.|+||.||+|.+..++..||+|+++..     ...+.+|+.+++.+.  .|||++++++++..+..+|+||
T Consensus         2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~   81 (277)
T cd06917           2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM   81 (277)
T ss_pred             hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence            578889999999999999999999999999998542     246788999999996  5999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||++|++|.+++.. +.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ....
T Consensus        82 e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~  160 (277)
T cd06917          82 EYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSSKRST  160 (277)
T ss_pred             ecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcccccc
Confidence            99999999998854 589999999999999999999999999999999999999999999999999997765432 2334


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..|+..|+|||.+.+  .++.++|+||||+++|+|++|..||.+.........+.....  +......++.++.++|.+|
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~  238 (277)
T cd06917         161 FVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKP--PRLEDNGYSKLLREFVAAC  238 (277)
T ss_pred             ccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccCCC--CCCCcccCCHHHHHHHHHH
Confidence            578999999999865  368899999999999999999999988776555544433321  1111224789999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCccccc
Q 012170          334 LTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      |..||.+||++.++++||||....
T Consensus       239 l~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         239 LDEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             cCCCcccCcCHHHHhhChHhhccc
Confidence            999999999999999999996544

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=5.5e-43  Score=344.75  Aligned_cols=254  Identities=32%  Similarity=0.521  Sum_probs=216.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..+.|.....||.|+||.||++.+..++..||||.+...    .+.+.+|+.+++.+. ||||+++++.+...+..|+||
T Consensus        20 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~ii~~~~~~~~~~~~~lv~   98 (292)
T cd06658          20 PREYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HENVVDMYNSYLVGDELWVVM   98 (292)
T ss_pred             hHHHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCC-CCcHHHHHHheecCCeEEEEE
Confidence            445666678899999999999999999999999998643    245778999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      ||+++++|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++.++|+|||++...... .....
T Consensus        99 e~~~~~~L~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~  177 (292)
T cd06658          99 EFLEGGALTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKS  177 (292)
T ss_pred             eCCCCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccccCce
Confidence            999999999877 4467899999999999999999999999999999999999999999999999998654322 22234


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..|++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+....+..+....... ......++..+.+||.+||
T Consensus       178 ~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l  256 (292)
T cd06658         178 LVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLPPR-VKDSHKVSSVLRGFLDLML  256 (292)
T ss_pred             eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCc-cccccccCHHHHHHHHHHc
Confidence            578999999999866 58899999999999999999999999887766666555432111 1122357889999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..||.+|||++++++||||....
T Consensus       257 ~~~P~~Rpt~~~il~~~~~~~~~  279 (292)
T cd06658         257 VREPSQRATAQELLQHPFLKLAG  279 (292)
T ss_pred             cCChhHCcCHHHHhhChhhhccC
Confidence            99999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=1.6e-42  Score=338.75  Aligned_cols=244  Identities=23%  Similarity=0.333  Sum_probs=211.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCC-----cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASG-----AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ++|++++.||+|+||.||+|.+...+     ..||+|.++..     ...+.+|+.++..+. ||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~   83 (283)
T cd05048           5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ-HPNIVCLLGVCTKEQPT   83 (283)
T ss_pred             HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcC-CcccceEEEEEcCCCce
Confidence            57899999999999999999876555     67999998643     245788999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          173 HLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      |++|||+++|+|.+++...                ..+++..+..++.||+.||.|||++|++|+||||+||+++.++.+
T Consensus        84 ~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~  163 (283)
T cd05048          84 CMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTV  163 (283)
T ss_pred             EEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcE
Confidence            9999999999999999765                457888999999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc
Q 012170          237 KLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK  311 (469)
Q Consensus       237 kL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  311 (469)
                      +|+|||++.......   ......+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+..++...+....
T Consensus       164 ~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05048         164 KISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQ  243 (283)
T ss_pred             EECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999997653322   1233467889999998864 68999999999999999998 999999988888888877654


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...   ....++.++.+|+.+||+.||.+||++.+|+++
T Consensus       244 ~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         244 LLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             cCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            332   225689999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=3.8e-42  Score=337.79  Aligned_cols=249  Identities=30%  Similarity=0.474  Sum_probs=202.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|.+++.||+|+||.||+|.+..+|..||+|++...     ...+.+|+.+++.+. |+||+++++++..++..|+|||
T Consensus         5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~lv~e   83 (291)
T cd07870           5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLK-HANIVLLHDIIHTKETLTFVFE   83 (291)
T ss_pred             ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcC-CCCEeEEEEEEecCCeEEEEEe
Confidence            6899999999999999999999999999999998542     235778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      |+. ++|.+.+.. ...+++..+..++.||+.||.|||+.||+|+||||+|||++.++.++|+|||++...... .....
T Consensus        84 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  162 (291)
T cd07870          84 YMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSS  162 (291)
T ss_pred             ccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCCCCCCC
Confidence            996 567666644 356788999999999999999999999999999999999999999999999998754322 22334


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-c-------------CCC----
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNV-K-------------LDF----  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~-~-------------~~~----  314 (469)
                      ..+++.|+|||++.+  .++.++||||||+++|+|++|..||.+... .+.+..+... .             ..+    
T Consensus       163 ~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (291)
T cd07870         163 EVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEW  242 (291)
T ss_pred             ccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchh
Confidence            567999999999865  478899999999999999999999976542 1222221110 0             000    


Q ss_pred             -----C---CCccc--CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 -----H---SGVWE--TVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 -----~---~~~~~--~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                           +   ...|.  ..+.++.++|.+||..||.+|||+.|+|.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         243 FLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALLHPYF  291 (291)
T ss_pred             ccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhcCCCC
Confidence                 0   00011  136789999999999999999999999999997

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-42  Score=348.53  Aligned_cols=253  Identities=27%  Similarity=0.476  Sum_probs=207.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----C
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA-----D  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----~  170 (469)
                      +.++|++.+.||+|+||.||+|.+..+|+.||||++...     ...+.+|+.+++.++ ||||+++++++...     .
T Consensus         3 ~~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~~   81 (336)
T cd07849           3 VGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFK-HENIIGILDIIRPPSFESFN   81 (336)
T ss_pred             cccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCC-CCCcCchhheeecccccccc
Confidence            457899999999999999999999999999999998531     245778999999997 99999999887654     3


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ..|+||||+.+ +|.+.+ ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~-~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~  159 (336)
T cd07849          82 DVYIVQELMET-DLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPE  159 (336)
T ss_pred             eEEEEehhccc-CHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECcccceeecccc
Confidence            58999999965 777766 4567999999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-----------
Q 012170          251 QT----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----------  313 (469)
Q Consensus       251 ~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----------  313 (469)
                      ..    .....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+......           
T Consensus       160 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (336)
T cd07849         160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIIS  239 (336)
T ss_pred             ccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhc
Confidence            21    233578999999998754  4889999999999999999999999876544433322110000           


Q ss_pred             -----------C-CC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 -----------F-HS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 -----------~-~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                 . ..    .....++.++.+||.+||+.||.+|||+.|+++||||..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~hp~~~~~  298 (336)
T cd07849         240 LRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAHPYLEQY  298 (336)
T ss_pred             hhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcCcccccc
Confidence                       0 00    0113468889999999999999999999999999999644

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=1.9e-42  Score=339.73  Aligned_cols=251  Identities=30%  Similarity=0.564  Sum_probs=214.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .|++.+.||.|+||.||+|.+.   .+|..||+|+++..        .+.+.+|+.+|+.+.+|+||+.++++++.+..+
T Consensus         1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~   80 (290)
T cd05613           1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL   80 (290)
T ss_pred             CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence            4788999999999999999875   47899999998642        245778999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      |+||||+++++|.+++.....+++..+..++.||+.||.|||+.|++||||+|+|||++.++.++|+|||++....... 
T Consensus        81 ~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~  160 (290)
T cd05613          81 HLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV  160 (290)
T ss_pred             EEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc
Confidence            9999999999999999888889999999999999999999999999999999999999999999999999997654322 


Q ss_pred             -cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcCCCCCCcccCCC
Q 012170          252 -TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                       ......|+..|+|||.+.+   .++.++||||||+++|+|++|..||....    ...+...+......++    ..++
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~  236 (290)
T cd05613         161 ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QEMS  236 (290)
T ss_pred             cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHHHHHHhhccCCCCC----ccCC
Confidence             2234578999999999864   36789999999999999999999996432    3334444433333332    4578


Q ss_pred             HHHHHHHHHhchhhhcCCC-----CHHHHHcCCCcccccc
Q 012170          324 KPARDLMARMLTRDVSARI-----TADEVLRHPWILFYTE  358 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~~  358 (469)
                      ..+.+||.+||..||.+||     ++++++.||||....+
T Consensus       237 ~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~~  276 (290)
T cd05613         237 ALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKINW  276 (290)
T ss_pred             HHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCCH
Confidence            9999999999999999997     8999999999976653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=3.1e-42  Score=340.86  Aligned_cols=247  Identities=22%  Similarity=0.310  Sum_probs=202.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC----------------CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCee
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA----------------SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVV  160 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv  160 (469)
                      .++|.+.+.||+|+||.||+|.+..                ++..||+|++...     ...+.+|+.+|.++. ||||+
T Consensus         4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv   82 (304)
T cd05096           4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLK-DPNII   82 (304)
T ss_pred             hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcC-CCCee
Confidence            4689999999999999999998642                3457999998653     246789999999996 99999


Q ss_pred             EEEEEEEeCCeEEEEEeccCCCchHHHHHHhC-------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEec
Q 012170          161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHR  221 (469)
Q Consensus       161 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-------------------~l~~~~~~~i~~qil~aL~yLH~~givHr  221 (469)
                      ++++++.+.+.+++||||+.+|+|.+++....                   .+++..+..++.||+.||.|||+.||+||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH~  162 (304)
T cd05096          83 RLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHR  162 (304)
T ss_pred             EEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence            99999999999999999999999999886532                   35778899999999999999999999999


Q ss_pred             cCCCCcEEEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh--CCCCC
Q 012170          222 DIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV--AALPF  295 (469)
Q Consensus       222 Dlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt--G~~Pf  295 (469)
                      ||||+|||++.++.+||+|||++........   .....++..|+|||++.+ .++.++||||||+++|+|++  +..||
T Consensus       163 dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~  242 (304)
T cd05096         163 DLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPY  242 (304)
T ss_pred             CcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCC
Confidence            9999999999999999999999976543322   223456788999999864 58999999999999999986  66889


Q ss_pred             CCCCHHHHHHHHHcC----cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          296 KGDSLEAVFDAIKNV----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       296 ~~~~~~~~~~~i~~~----~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+.+..+.+..+...    ...........++..+.+||.+||..||.+|||+.+|.+
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~  300 (304)
T cd05096         243 GELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFSDIHA  300 (304)
T ss_pred             CcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHHHHHH
Confidence            877766665544321    111111122457899999999999999999999999953

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=1.9e-42  Score=353.11  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=203.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++.+.||+|+||.||+|.+     ..++..||||+++..     .+.+.+|+.+|..+..||||+++++++.+.+.
T Consensus        34 ~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~  113 (375)
T cd05104          34 RNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGP  113 (375)
T ss_pred             hHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCc
Confidence            45799999999999999999974     356778999998642     24577899999999559999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-----------------------------------------------------------
Q 012170          172 FHLVMELCSGGRLIDQMVEVG-----------------------------------------------------------  192 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------------  192 (469)
                      .++|||||+||+|.+++....                                                           
T Consensus       114 ~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~  193 (375)
T cd05104         114 TLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGS  193 (375)
T ss_pred             ceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccce
Confidence            999999999999999886432                                                           


Q ss_pred             ----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---c
Q 012170          193 ----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---L  253 (469)
Q Consensus       193 ----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~  253 (469)
                                      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........   .
T Consensus       194 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~  273 (375)
T cd05104         194 YIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVK  273 (375)
T ss_pred             ecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCccccccc
Confidence                            367788999999999999999999999999999999999999999999999976543322   1


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.... .....+......   ..+...+.++.+||
T Consensus       274 ~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  350 (375)
T cd05104         274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRM---LSPECAPSEMYDIM  350 (375)
T ss_pred             CCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccC---CCCCCCCHHHHHHH
Confidence            12345667999999966 58999999999999999998 89999876543 334444433211   11235688999999


Q ss_pred             HHhchhhhcCCCCHHHHHcC
Q 012170          331 ARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+||+.||++|||+.+|++.
T Consensus       351 ~~cl~~dP~~RPs~~eil~~  370 (375)
T cd05104         351 KSCWDADPLKRPTFKQIVQL  370 (375)
T ss_pred             HHHccCChhHCcCHHHHHHH
Confidence            99999999999999999864

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.5e-42  Score=338.57  Aligned_cols=252  Identities=31%  Similarity=0.460  Sum_probs=208.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++.+.||.|++|.||+|.++.+|+.||+|.+...      ...+.+|+++++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~   80 (294)
T PLN00009          2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQ-HGNIVRLQDVVHSEKRLYLVF   80 (294)
T ss_pred             CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhcc-CCCEeeEEEEEecCCeEEEEE
Confidence            5799999999999999999999999999999998542      245788999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC-c
Q 012170          177 ELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ-T  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~-~  252 (469)
                      ||++ ++|.+.+.....  +++..+..++.||+.||.|||++|++|+||+|+||+++. ++.+||+|||++....... .
T Consensus        81 e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~~  159 (294)
T PLN00009         81 EYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRT  159 (294)
T ss_pred             eccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCccc
Confidence            9996 578777765443  578889999999999999999999999999999999985 4579999999997553322 2


Q ss_pred             ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC----------------
Q 012170          253 LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF----------------  314 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------------  314 (469)
                      .....|++.|+|||++.+  .++.++||||||+++|+|++|.+||.+....+.+..+.......                
T Consensus       160 ~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (294)
T PLN00009        160 FTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKS  239 (294)
T ss_pred             cccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhh
Confidence            234567899999999865  37889999999999999999999998776655444432210000                


Q ss_pred             -----CC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 -----HS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 -----~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                           ..    .....++.++.++|.+||+.+|++||++.++|+||||...
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        240 AFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             hcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhcCchHhHH
Confidence                 00    0123578899999999999999999999999999999644

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=2e-42  Score=338.02  Aligned_cols=247  Identities=33%  Similarity=0.480  Sum_probs=207.6

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      |++.+.||.|++|.||+|.++.+|..||+|++...      ...+.+|+++++.+. ||||+++++++.+.+..|+||||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~iv~~~~~~~~~~~~~iv~e~   79 (283)
T cd07835           1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELN-HPNIVRLLDVVHSENKLYLVFEF   79 (283)
T ss_pred             CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcC-CCCccCHhheeccCCeEEEEEec
Confidence            67789999999999999999999999999998642      245788999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          179 CSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       179 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ++ ++|.+++....  .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++|+|||++....... ....
T Consensus        80 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~~~~  158 (283)
T cd07835          80 LD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTH  158 (283)
T ss_pred             cC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCccccCc
Confidence            95 68998887765  68999999999999999999999999999999999999999999999999997543222 2233


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc----------------------
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK----------------------  311 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------------------  311 (469)
                      ..+++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+....+..+....                      
T Consensus       159 ~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd07835         159 EVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFP  238 (283)
T ss_pred             cccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcc
Confidence            467899999998865  36889999999999999999999998776544333322110                      


Q ss_pred             ---CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          312 ---LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       312 ---~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                         ..........++.++.++|.+||+.||.+|||++|++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         239 KWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhcCCCC
Confidence               000111224578899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=3.2e-42  Score=334.23  Aligned_cols=243  Identities=19%  Similarity=0.285  Sum_probs=207.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+|++.+.||+|+||.||+|.++   ..+..||+|.++..     ...+.+|+.+++++. ||||+++++++...+..|+
T Consensus         5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l   83 (266)
T cd05064           5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFD-HSNIVRLEGVITRGNTMMI   83 (266)
T ss_pred             HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEecCCCcEE
Confidence            57999999999999999999865   45678999998753     235778999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      ||||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.++++|||.+.........
T Consensus        84 v~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~  163 (266)
T cd05064          84 VTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY  163 (266)
T ss_pred             EEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccchh
Confidence            99999999999998764 57899999999999999999999999999999999999999999999999987654322211


Q ss_pred             c--ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 S--GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 ~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .  ...++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+.......   ....++..+.++
T Consensus       164 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l  240 (266)
T cd05064         164 TTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP---APRNCPNLLHQL  240 (266)
T ss_pred             cccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHH
Confidence            1  2345678999999865 58999999999999999775 999999988888877776653221   235689999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+||..+|.+||++.+|++
T Consensus       241 i~~c~~~~p~~RP~~~~i~~  260 (266)
T cd05064         241 MLDCWQKERGERPRFSQIHS  260 (266)
T ss_pred             HHHHcCCCchhCCCHHHHHH
Confidence            99999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=6.9e-42  Score=335.56  Aligned_cols=252  Identities=32%  Similarity=0.526  Sum_probs=216.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ..|...+.||.|++|.||++.+..+++.+|+|.+...    ...+.+|+.+++.+. ||||+++++++...+..|+|+||
T Consensus        19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~-h~~vv~~~~~~~~~~~~~~v~e~   97 (285)
T cd06648          19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HPNIVEMYSSYLVGDELWVVMEF   97 (285)
T ss_pred             HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcC-CCChheEEEEEEcCCeEEEEEec
Confidence            3455568999999999999999999999999988532    345788999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccccC
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLA  257 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~~  257 (469)
                      +.|++|.+++.. +.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... ......
T Consensus        98 ~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~~~~~~~  176 (285)
T cd06648          98 LEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVPRRKSLV  176 (285)
T ss_pred             cCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCCccccccc
Confidence            999999998866 779999999999999999999999999999999999999999999999999886543322 223356


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      |++.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........ .....++..+.+||.+||..
T Consensus       177 ~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~  255 (285)
T cd06648         177 GTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPPKL-KNLHKVSPRLRSFLDRMLVR  255 (285)
T ss_pred             CCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCCCC-cccccCCHHHHHHHHHHccc
Confidence            8999999999876 488999999999999999999999988877777776665532221 12234789999999999999


Q ss_pred             hhcCCCCHHHHHcCCCccccc
Q 012170          337 DVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       337 dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +|.+||++.++++||||....
T Consensus       256 ~p~~Rpt~~~il~~~~~~~~~  276 (285)
T cd06648         256 DPAQRATAAELLNHPFLAKAG  276 (285)
T ss_pred             ChhhCcCHHHHccCcccccCC
Confidence            999999999999999996554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.7e-42  Score=336.94  Aligned_cols=247  Identities=30%  Similarity=0.583  Sum_probs=218.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+.+.||.|+||.||+|.+..+|+.||+|++.+.       ...+.+|+++++++.+||||+++++++...+.+++|
T Consensus         1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv   80 (280)
T cd05581           1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV   80 (280)
T ss_pred             CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence            4789999999999999999999999999999998642       245778999999996699999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC----
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~----  251 (469)
                      |||+.+++|.+++.+.+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++.......    
T Consensus        81 ~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~  160 (280)
T cd05581          81 LEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPES  160 (280)
T ss_pred             EcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcccccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999987654322    


Q ss_pred             -----------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC
Q 012170          252 -----------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       252 -----------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                                       ......|+..|+|||++.+ .++.++|+||||+++++|++|..||...+....+..+......
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~  240 (280)
T cd05581         161 NKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYS  240 (280)
T ss_pred             CCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCC
Confidence                             1223467899999999865 4788999999999999999999999988776666666655444


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCH----HHHHcCCCc
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITA----DEVLRHPWI  353 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa----~elL~hp~~  353 (469)
                      ++    ..+++.+.+||.+||+.+|.+||++    +++|+||||
T Consensus       241 ~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         241 FP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             CC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            44    4568999999999999999999999    999999997

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.1e-41  Score=324.78  Aligned_cols=247  Identities=32%  Similarity=0.548  Sum_probs=214.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      +|+..+.||.|++|.||++.+..++..|++|++....    ..+.+|+++++.+. ||||+++++++...+..++|+||+
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~l~~e~~   79 (253)
T cd05122           1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCK-HPNIVKYYGSYLKKDELWIVMEFC   79 (253)
T ss_pred             CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEEEecC
Confidence            5888999999999999999999899999999996543    56889999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCC
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG  258 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~g  258 (469)
                      +|++|.+++... ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||.+.............|
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~  159 (253)
T cd05122          80 SGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG  159 (253)
T ss_pred             CCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeeccccccccccccccceec
Confidence            999999998776 5899999999999999999999999999999999999999999999999999977655432445678


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      +..|+|||.+.+ .++.++|+||||+++|+|++|..||...+.......+........ .....++..+.++|.+||+.|
T Consensus       160 ~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~i~~~l~~~  238 (253)
T cd05122         160 TPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPPGL-RNPEKWSDEFKDFLKKCLQKN  238 (253)
T ss_pred             CCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCCCCc-CcccccCHHHHHHHHHHccCC
Confidence            999999999876 478899999999999999999999988755554444433221111 111234899999999999999


Q ss_pred             hcCCCCHHHHHcCCC
Q 012170          338 VSARITADEVLRHPW  352 (469)
Q Consensus       338 P~~Rpsa~elL~hp~  352 (469)
                      |.+|||+.++|+|||
T Consensus       239 p~~R~t~~~~l~~~~  253 (253)
T cd05122         239 PEKRPTAEQLLKHPF  253 (253)
T ss_pred             hhhCCCHHHHhcCCC
Confidence            999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=2.4e-42  Score=332.70  Aligned_cols=242  Identities=34%  Similarity=0.601  Sum_probs=213.7

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||.|+||.||+|.+..+|+.||+|++...       ...+.+|+++++++. ||||+++++.+...+.+|+||||+.+++
T Consensus         1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (265)
T cd05579           1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQ-SPYVVKLYYSFQGKKNLYLVMEYLPGGD   79 (265)
T ss_pred             CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCC-CcchhHHHHheecCcEEEEEEecCCCCc
Confidence            68999999999999999999999998643       246788999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---------ccc
Q 012170          184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---------TLS  254 (469)
Q Consensus       184 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---------~~~  254 (469)
                      |.+++.+.+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......         ...
T Consensus        80 L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~  159 (265)
T cd05579          80 LASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDK  159 (265)
T ss_pred             HHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccccccc
Confidence            99999887899999999999999999999999999999999999999999999999999987543321         223


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...+++.|+|||++.+ .++.++||||||+++|+|++|..||......+.+..+......++..  ..++..+.+||.+|
T Consensus       160 ~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~  237 (265)
T cd05579         160 RIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKIEWPED--VEVSDEAIDLISKL  237 (265)
T ss_pred             CcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCcCCCcc--ccCCHHHHHHHHHH
Confidence            4568899999999865 48889999999999999999999999888888888877655544422  23589999999999


Q ss_pred             chhhhcCCCCH---HHHHcCCCccc
Q 012170          334 LTRDVSARITA---DEVLRHPWILF  355 (469)
Q Consensus       334 L~~dP~~Rpsa---~elL~hp~~~~  355 (469)
                      |+.+|.+|||+   .++|+||||..
T Consensus       238 l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         238 LVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             hcCCHhhcCCCccHHHHhcCccccC
Confidence            99999999999   99999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=8.1e-42  Score=338.49  Aligned_cols=250  Identities=30%  Similarity=0.455  Sum_probs=212.7

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ......|.+.+.||+|+||.||+|.+..+|+.||+|++...       ...+.+|+++++.+. ||||+++++++.+.+.
T Consensus        11 ~~~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~niv~~~~~~~~~~~   89 (307)
T cd06607          11 DDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLR-HPNTIEYKGCYLREHT   89 (307)
T ss_pred             CCcchhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEEeCCe
Confidence            34567899999999999999999999999999999998532       135778999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .|+||||+.| ++.+.+.. .+.+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++......
T Consensus        90 ~~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~  168 (307)
T cd06607          90 AWLVMEYCLG-SASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA  168 (307)
T ss_pred             EEEEHHhhCC-CHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence            9999999975 66666643 457899999999999999999999999999999999999999999999999998654322


Q ss_pred             CcccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-CCCCCCcccCCCHH
Q 012170          251 QTLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-LDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~  325 (469)
                         ....|++.|+|||++.    +.++.++||||||+++|+|++|.+||.+.+.......+.... ....   ...++..
T Consensus       169 ---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  242 (307)
T cd06607         169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSPTLS---SNDWSDY  242 (307)
T ss_pred             ---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHhcCCCCCCC---chhhCHH
Confidence               3457889999999984    348899999999999999999999998877666555554332 2221   2346889


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.++|.+||..||.+||++.+++.||||...
T Consensus       243 ~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~  273 (307)
T cd06607         243 FRNFVDSCLQKIPQDRPSSEELLKHRFVLRE  273 (307)
T ss_pred             HHHHHHHHhcCChhhCcCHHHHhcChhhccc
Confidence            9999999999999999999999999999643

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.8e-43  Score=366.65  Aligned_cols=243  Identities=32%  Similarity=0.467  Sum_probs=206.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-C---hHHHHHHHHHHHHhhCCCCeeEEEE-EEEe----C--Ce
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-G---EETVHREVEIMQHLSGHTGVVTLHS-VYEE----A--DC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~---~~~~~~E~~il~~l~~hpnIv~l~~-~~~~----~--~~  171 (469)
                      .++++.+.|.+|||+.||+|.+...|..||+|.+-- +   ...+++|+++|+.|.+|+|||.+++ ....    .  -.
T Consensus        37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E  116 (738)
T KOG1989|consen   37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE  116 (738)
T ss_pred             EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence            467888999999999999999998889999998742 2   2568899999999999999999999 3321    1  24


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          172 FHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      ++|.||||.||.|.|+|..+  ..|++.++.+|+.|+++|+.+||...  |||||||-|||||+.+|++||||||.|...
T Consensus       117 vllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~  196 (738)
T KOG1989|consen  117 VLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTK  196 (738)
T ss_pred             EEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccc
Confidence            78999999999999999743  56999999999999999999999998  999999999999999999999999999753


Q ss_pred             cCCCc-cc---------ccCCCCcccCceecc---C-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC
Q 012170          248 SNGQT-LS---------GLAGSPAYVAPEVLS---G-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       248 ~~~~~-~~---------~~~gt~~y~aPE~l~---~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                      ..... ..         ....|+-|+|||++.   + ..++|+|||+|||+||.|+....||.+...    -.|.++.+.
T Consensus       197 ~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~----laIlng~Y~  272 (738)
T KOG1989|consen  197 ILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESGK----LAILNGNYS  272 (738)
T ss_pred             cCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCcc----eeEEecccc
Confidence            32221 10         124799999999984   3 389999999999999999999999987643    356777887


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      ||..  ..++..+++||+.||+.||.+||++.|++.+-
T Consensus       273 ~P~~--p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  273 FPPF--PNYSDRLKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             CCCC--ccHHHHHHHHHHHHhccCcccCCCHHHHHHHH
Confidence            7753  57899999999999999999999999988653

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=1.3e-42  Score=348.40  Aligned_cols=254  Identities=26%  Similarity=0.479  Sum_probs=211.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE----AD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~  170 (469)
                      +.++|++.+.||.|+||.||+|.++.+|..||+|++...      ...+.+|+.+|+.+. ||||+++++++..    ..
T Consensus         3 ~~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~   81 (334)
T cd07855           3 VGSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFK-HDNIIAIRDILRPPGADFK   81 (334)
T ss_pred             hhhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcC-CCCccCHHHhccccCCCCc
Confidence            457899999999999999999999999999999998643      245678999999997 9999999998763    45


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .+|+||||+. |+|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.+|.+||+|||++......
T Consensus        82 ~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~  160 (334)
T cd07855          82 DVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSS  160 (334)
T ss_pred             eEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEecccccceeeccc
Confidence            7899999995 589888877788999999999999999999999999999999999999999999999999999765432


Q ss_pred             Cc-----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc------------
Q 012170          251 QT-----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK------------  311 (469)
Q Consensus       251 ~~-----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------  311 (469)
                      ..     .....|+..|+|||++.+  .++.++|||||||++|+|++|.+||.+.+....+..+....            
T Consensus       161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~  240 (334)
T cd07855         161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIG  240 (334)
T ss_pred             CcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhc
Confidence            21     234578999999999854  48899999999999999999999998766544333222110            


Q ss_pred             -----------CCCCCC----cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 -----------LDFHSG----VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 -----------~~~~~~----~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                 ......    .+..++.++.++|.+||+.+|.+|||+.+++.||||...
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~~~~~~~~  300 (334)
T cd07855         241 SDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQHPFLAQY  300 (334)
T ss_pred             hhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHhChhhhhc
Confidence                       000001    124578999999999999999999999999999999644

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=9.2e-42  Score=326.97  Aligned_cols=246  Identities=30%  Similarity=0.549  Sum_probs=217.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|.+.+.||.|+||.||++.+..++..||+|++...      ...+.+|+++++.++ |||++++++.+...+..++|+|
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~~~~~~~~~~lv~e   79 (258)
T cd08215           1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLN-HPNIIKYYESFEEKGKLCIVME   79 (258)
T ss_pred             CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcC-CCChhheEEEEecCCEEEEEEE
Confidence            588899999999999999999999999999998642      246788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-c
Q 012170          178 LCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-T  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~  252 (469)
                      |+++++|.+++...    ..+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... .
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~  159 (258)
T cd08215          80 YADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDL  159 (258)
T ss_pred             ecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCcce
Confidence            99999999998764    679999999999999999999999999999999999999999999999999997665443 2


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||...+...+...+........   ...++.++.++|.
T Consensus       160 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~  236 (258)
T cd08215         160 AKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPI---PSQYSSELRNLVS  236 (258)
T ss_pred             ecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCCC---CCCCCHHHHHHHH
Confidence            334578999999999866 488999999999999999999999988877777776655443222   2367899999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCc
Q 012170          332 RMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +||..+|.+|||+.++|+||||
T Consensus       237 ~~l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         237 SLLQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             HHcCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=2e-42  Score=347.61  Aligned_cols=253  Identities=26%  Similarity=0.469  Sum_probs=211.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA-----  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----  169 (469)
                      +..+|.+.+.||+|+||.||+|.+..+|..||||.+...      ...+.+|+.+++.+. ||||+++++++...     
T Consensus         3 ~~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~ni~~~~~~~~~~~~~~~   81 (337)
T cd07858           3 VDTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLD-HENVIAIKDIMPPPHREAF   81 (337)
T ss_pred             cccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcC-CCCccchHHheeccccccc
Confidence            456899999999999999999999999999999998642      245678999999996 99999999988654     


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ...|+||||+. ++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.....
T Consensus        82 ~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~  160 (337)
T cd07858          82 NDVYIVYELMD-TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSE  160 (337)
T ss_pred             CcEEEEEeCCC-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCccccccCC
Confidence            34899999995 68988888888899999999999999999999999999999999999999999999999999976543


Q ss_pred             C-CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC--------------
Q 012170          250 G-QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL--------------  312 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~--------------  312 (469)
                      . .......|+..|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+.....              
T Consensus       161 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (337)
T cd07858         161 KGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEK  240 (337)
T ss_pred             CcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchh
Confidence            3 22344578999999998853  588999999999999999999999987664443332221100              


Q ss_pred             -------------CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          313 -------------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       313 -------------~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                                   ......+..+++++.+||.+||+.||.+|||+.++|+||||..
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h~~~~~  296 (337)
T cd07858         241 ARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAHPYLAS  296 (337)
T ss_pred             hhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcCcchhh
Confidence                         0001123467899999999999999999999999999999953

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=2.1e-42  Score=341.36  Aligned_cols=252  Identities=33%  Similarity=0.541  Sum_probs=216.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ...|.....||+|+||.||+|.+..++..||+|++..    ....+.+|+.+++.+. ||||+++++++..++..|+|||
T Consensus        20 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~iv~e   98 (297)
T cd06659          20 RSLLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HQNVVEMYKSYLVGEELWVLME   98 (297)
T ss_pred             hhhHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCC-CCchhhhhhheeeCCeEEEEEe
Confidence            3445556789999999999999999999999999853    2356788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      |+++++|..++ ....+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++....... .....
T Consensus        99 ~~~~~~L~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~~~~~~  177 (297)
T cd06659          99 FLQGGALTDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSL  177 (297)
T ss_pred             cCCCCCHHHHH-hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhcccccccccce
Confidence            99999998866 44678999999999999999999999999999999999999999999999999986543322 23346


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      .|++.|+|||++.+ .++.++|||||||++|+|++|..||...+....+..+....... ...+..++..+.++|.+||+
T Consensus       178 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~~i~~~l~  256 (297)
T cd06659         178 VGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPK-LKNAHKISPVLRDFLERMLT  256 (297)
T ss_pred             ecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCC-ccccCCCCHHHHHHHHHHhc
Confidence            78999999999976 58899999999999999999999998877777666665443222 22334678999999999999


Q ss_pred             hhhcCCCCHHHHHcCCCcccc
Q 012170          336 RDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       336 ~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+|.+||++.++++||||...
T Consensus       257 ~~P~~Rps~~~ll~~~~~~~~  277 (297)
T cd06659         257 REPQERATAQELLDHPFLLQT  277 (297)
T ss_pred             CCcccCcCHHHHhhChhhccC
Confidence            999999999999999999644

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=4e-42  Score=344.87  Aligned_cols=254  Identities=28%  Similarity=0.421  Sum_probs=212.1

Q ss_pred             ccCCeee-eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------------HHHHHHHHHHHHhhCCCCeeE
Q 012170          101 IEDDHTK-VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------------ETVHREVEIMQHLSGHTGVVT  161 (469)
Q Consensus       101 ~~~~y~~-~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------------~~~~~E~~il~~l~~hpnIv~  161 (469)
                      +.++|.. .+.||.|+||.||+|.+..+++.||||+++...                  ..+.+|+++++.+. ||||++
T Consensus         6 ~~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~   84 (335)
T PTZ00024          6 ISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIK-HENIMG   84 (335)
T ss_pred             cccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCC-Ccceee
Confidence            5567765 467999999999999999999999999985421                  14678999999997 999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEec
Q 012170          162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF  241 (469)
Q Consensus       162 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DF  241 (469)
                      +++++...+..|+||||+. |+|.+++.....+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+||
T Consensus        85 ~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl~df  163 (335)
T PTZ00024         85 LVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADF  163 (335)
T ss_pred             eeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEECCc
Confidence            9999999999999999997 589999988888999999999999999999999999999999999999999999999999


Q ss_pred             cceeeecCC---------------CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 012170          242 GLAMRISNG---------------QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF  304 (469)
Q Consensus       242 gla~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  304 (469)
                      |++......               .......+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~~~~  243 (335)
T PTZ00024        164 GLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQL  243 (335)
T ss_pred             cceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence            999765411               11223457889999999866  3789999999999999999999999988766655


Q ss_pred             HHHHcCcCC-----CC-------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          305 DAIKNVKLD-----FH-------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       305 ~~i~~~~~~-----~~-------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ..+......     ++                   .......+.++.+||.+||+.+|++|||++++|.||||..+
T Consensus       244 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~~~~~~~~  319 (335)
T PTZ00024        244 GRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSD  319 (335)
T ss_pred             HHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhcCcccCCC
Confidence            544321100     00                   00113457889999999999999999999999999999654

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=1.2e-41  Score=333.91  Aligned_cols=253  Identities=30%  Similarity=0.497  Sum_probs=209.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV  175 (469)
                      ++|...+.||.|++|.||+|.+..+++.||+|.+...     ...+.+|+++++.+. ||||++++++|.+  .+.+|+|
T Consensus         1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~lv   79 (287)
T cd06621           1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCK-SPYIVKYYGAFLDESSSSIGIA   79 (287)
T ss_pred             CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCC-CCCeeeeeeEEEccCCCeEEEE
Confidence            4688999999999999999999999999999998643     246889999999996 9999999998865  3478999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          176 MELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |||++|++|.+++..    ...+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.......
T Consensus        80 ~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~  159 (287)
T cd06621          80 MEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL  159 (287)
T ss_pred             EEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc
Confidence            999999999887653    3458999999999999999999999999999999999999999999999999986543322


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCcCC-CCCCcc--cCC
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-----SLEAVFDAIKNVKLD-FHSGVW--ETV  322 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~~-~~~~~~--~~~  322 (469)
                       .....++..|+|||.+.+ .++.++||||||+++|+|++|..||...     ...+....+...... ......  ..+
T Consensus       160 -~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd06621         160 -AGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKW  238 (287)
T ss_pred             -cccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCch
Confidence             224568899999999865 5899999999999999999999999765     234444444442211 111111  235


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ++.+.+||.+||..+|.+|||+.|+++||||....
T Consensus       239 ~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         239 SEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HHHHHHHHHHHcCCCcccCCCHHHHHhCccccccc
Confidence            78899999999999999999999999999995443

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=6.8e-42  Score=334.00  Aligned_cols=247  Identities=30%  Similarity=0.496  Sum_probs=209.2

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeEEEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHLVM  176 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~~lV~  176 (469)
                      |++++.||.|+||.||+|.+..+|+.||+|.+...      ...+.+|+++++.+. |||++++++++.+.  +..|+||
T Consensus         1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv~   79 (287)
T cd07840           1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLR-HPNIVRLKEIVTSKGKGSIYMVF   79 (287)
T ss_pred             CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCeeeheeeEecCCCCcEEEEe
Confidence            67889999999999999999999999999999754      245778999999997 99999999999888  8999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--cc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~  253 (469)
                      ||+++ +|.+++... ..+++..+..++.||+.||.|||+.|++|+||+|+||++++++.++|+|||++.......  ..
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~~~  158 (287)
T cd07840          80 EYMDH-DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADY  158 (287)
T ss_pred             ccccc-cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcccc
Confidence            99975 888887665 579999999999999999999999999999999999999999999999999998765443  23


Q ss_pred             cccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc-------------
Q 012170          254 SGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV-------------  318 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~-------------  318 (469)
                      ....++..|+|||.+.+  .++.++||||||+++|+|++|..||...+....+..+...........             
T Consensus       159 ~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (287)
T cd07840         159 TNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENL  238 (287)
T ss_pred             cccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhc
Confidence            34567889999998765  478999999999999999999999988776665555433211111000             


Q ss_pred             -------------ccC-CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          319 -------------WET-VSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       319 -------------~~~-~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                   ... ++.++.++|.+||..+|.+||++.+++.||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         239 KPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQHEYF  287 (287)
T ss_pred             cccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhhCcCC
Confidence                         112 38899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=1.2e-41  Score=330.00  Aligned_cols=243  Identities=28%  Similarity=0.493  Sum_probs=202.4

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ...||+|+||.||+|.+..++..||+|.+...    ...+.+|+.+++.++ |+||+++++++..++.+++||||+++++
T Consensus        13 ~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~~   91 (268)
T cd06624          13 RVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLK-HRNIVQYLGSDSENGFFKIFMEQVPGGS   91 (268)
T ss_pred             eEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcC-CCCeeeeeeeeccCCEEEEEEecCCCCC
Confidence            46899999999999999999999999988643    246789999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHh-CCC--CHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC-cccccCC
Q 012170          184 LIDQMVEV-GQY--SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ-TLSGLAG  258 (469)
Q Consensus       184 L~~~l~~~-~~l--~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~-~~~~~~g  258 (469)
                      |.+++... ..+  ++..+..++.||+.||.|||++||+||||||+||+++. ++.++|+|||++....... ......|
T Consensus        92 L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  171 (268)
T cd06624          92 LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINPCTETFTG  171 (268)
T ss_pred             HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCCccccCCC
Confidence            99998764 455  78889999999999999999999999999999999976 6799999999987654322 2334568


Q ss_pred             CCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          259 SPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       259 t~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ++.|+|||++.+   .++.++||||+|+++|+|++|.+||...... .....+..  ..........++.++++||.+||
T Consensus       172 ~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l  249 (268)
T cd06624         172 TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKNFILRCF  249 (268)
T ss_pred             CccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHHHHHHHc
Confidence            999999999854   2788999999999999999999999754322 11111111  11111223467899999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCc
Q 012170          335 TRDVSARITADEVLRHPWI  353 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~  353 (469)
                      ..+|.+|||+.|++.||||
T Consensus       250 ~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         250 EPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             CCCchhCCCHHHHHhCCCC
Confidence            9999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=4.3e-42  Score=334.96  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=210.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ++|.+.+.||+|+||.||+|.+..     ++..||+|+++..     ...+.+|+++|+.+. ||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~   83 (280)
T cd05049           5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQ-HENIVKFYGVCTEGDPP   83 (280)
T ss_pred             HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcC-CCCchheeeEEecCCCe
Confidence            568889999999999999998753     4678999998643     356889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          173 HLVMELCSGGRLIDQMVEVG--------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      |+||||+++|+|.+++...+              .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl  163 (280)
T cd05049          84 IMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKI  163 (280)
T ss_pred             EEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEE
Confidence            99999999999999997643              3788899999999999999999999999999999999999999999


Q ss_pred             EeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCC
Q 012170          239 ADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       239 ~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                      +|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+....+......
T Consensus       164 ~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~  243 (280)
T cd05049         164 GDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLL  243 (280)
T ss_pred             CCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcC
Confidence            99999976433221   223346788999999865 58999999999999999998 99999988888888888765543


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..   ...++..+.+||.+||..||.+||++.|+++
T Consensus       244 ~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         244 QR---PRTCPSEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             CC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            32   2467999999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.7e-42  Score=341.28  Aligned_cols=248  Identities=27%  Similarity=0.469  Sum_probs=202.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECC--CCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKA--SGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~  172 (469)
                      +|.+.+.||+|+||.||+|.+..  ++..||+|.+...       ...+.+|+.+++.+. ||||+++++++.+.  +.+
T Consensus         1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   79 (316)
T cd07842           1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELK-HENVVSLVEVFLEHADKSV   79 (316)
T ss_pred             CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcC-CCCccceEEEEeCCCCceE
Confidence            48889999999999999999988  8999999999762       256788999999996 99999999999988  889


Q ss_pred             EEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc----CCcEEEEeccc
Q 012170          173 HLVMELCSGGRLIDQMVEV-----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT----SGKIKLADFGL  243 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~----~~~vkL~DFgl  243 (469)
                      |+||||+.+ +|.+.+...     ..+++..+..++.||+.||.|||+.||+||||||+|||++.    ++.+||+|||+
T Consensus        80 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~  158 (316)
T cd07842          80 YLLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL  158 (316)
T ss_pred             EEEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCcc
Confidence            999999975 666666432     26899999999999999999999999999999999999999    89999999999


Q ss_pred             eeeecCCCc----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH---------HHHHHH
Q 012170          244 AMRISNGQT----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA---------VFDAIK  308 (469)
Q Consensus       244 a~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~---------~~~~i~  308 (469)
                      +........    .....+++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.....         .+..+.
T Consensus       159 ~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (316)
T cd07842         159 ARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIF  238 (316)
T ss_pred             ccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHH
Confidence            976543221    234578999999998865  37899999999999999999999997654321         111110


Q ss_pred             c--------------------------CcCCCC-------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          309 N--------------------------VKLDFH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       309 ~--------------------------~~~~~~-------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .                          ....++       ...+...+.++.++|.+||..||++|||+.|+++||||
T Consensus       239 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         239 EVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            0                          000000       00011567889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=3.9e-42  Score=340.38  Aligned_cols=245  Identities=24%  Similarity=0.338  Sum_probs=205.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcE--EEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAE--FACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.++.++..  +|+|.++..     ...+.+|+.++.++.+||||+++++++..++.+|+|
T Consensus         7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv   86 (303)
T cd05088           7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   86 (303)
T ss_pred             hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence            5889999999999999999999887765  577776532     245778999999995599999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEE
Q 012170          176 MELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA  239 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~  239 (469)
                      |||+++|+|.+++...+                .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+
T Consensus        87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~  166 (303)
T cd05088          87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  166 (303)
T ss_pred             EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeC
Confidence            99999999999986543                47889999999999999999999999999999999999999999999


Q ss_pred             eccceeeecCCCcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          240 DFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       240 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      |||++.............++..|+|||++.+. ++.++|||||||++|+|++ |.+||.+.+..+....+....   ...
T Consensus       167 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~---~~~  243 (303)
T cd05088         167 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLE  243 (303)
T ss_pred             ccccCcccchhhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCC---cCC
Confidence            99998643211111222346679999998664 7899999999999999998 999999888777776665432   111


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+..+++++.+||.+||+.+|.+||++.++|.+
T Consensus       244 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         244 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            224578999999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.8e-42  Score=328.42  Aligned_cols=246  Identities=28%  Similarity=0.542  Sum_probs=213.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|.+.+.||.|+||.||+|.++.+|..||+|.+..      ..+.+.+|+.+++.++ |+||+++++.+...+..|+|+|
T Consensus         1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~-h~~i~~~~~~~~~~~~~~lv~e   79 (257)
T cd08225           1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMK-HPNIVTFFASFQENGRLFIVME   79 (257)
T ss_pred             CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCC-CCChhhhhheeccCCeEEEEEe
Confidence            58889999999999999999999999999999853      2356779999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc-EEEEeccceeeecCCCc-c
Q 012170          178 LCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK-IKLADFGLAMRISNGQT-L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~-vkL~DFgla~~~~~~~~-~  253 (469)
                      |+++++|.+++....  .+++..+..++.||+.||.|||+.+++|+||+|+||+++.++. ++|+|||.+........ .
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~~  159 (257)
T cd08225          80 YCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELA  159 (257)
T ss_pred             cCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcccc
Confidence            999999999987654  4789999999999999999999999999999999999998864 69999999976544322 2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....|++.|+|||++.+ .++.++|+||||+++|+|++|..||...+..+....+.......   ....++.++.++|.+
T Consensus       160 ~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~~  236 (257)
T cd08225         160 YTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAP---ISPNFSRDLRSLISQ  236 (257)
T ss_pred             cccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcccCCC---CCCCCCHHHHHHHHH
Confidence            23468999999999865 58899999999999999999999998877766666555443222   124578999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCc
Q 012170          333 MLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||..+|++|||+.++++||||
T Consensus       237 ~l~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         237 LFKVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             HhccChhhCcCHHHHhhCCCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=2.4e-41  Score=323.88  Aligned_cols=247  Identities=32%  Similarity=0.562  Sum_probs=214.7

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHLV  175 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~~lV  175 (469)
                      +|.+.+.||+|++|.||+|.+..++..|++|++...      .+.+.+|+.+++++. ||||+++++.+...  +.+++|
T Consensus         1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~lv   79 (260)
T cd06606           1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQ-HPNIVRYYGSERDEEKNTLNIF   79 (260)
T ss_pred             CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcC-CCCEeeEEEEEecCCCCeEEEE
Confidence            478889999999999999999999999999998643      356888999999997 99999999999988  899999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---  252 (469)
                      |||+++++|.+++.....+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||.+........   
T Consensus        80 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  159 (260)
T cd06606          80 LEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEG  159 (260)
T ss_pred             EEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccccc
Confidence            99999999999998888999999999999999999999999999999999999999999999999999987765543   


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....++..|+|||.+.+. ++.++||||||+++|+|++|..||.... .......+...  .........++..+.+||
T Consensus       160 ~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~~i  237 (260)
T cd06606         160 TGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSS--GEPPEIPEHLSEEAKDFL  237 (260)
T ss_pred             ccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcccc--CCCcCCCcccCHHHHHHH
Confidence            3456789999999998764 8899999999999999999999998765 22333333221  111222345689999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCc
Q 012170          331 ARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .+||..||.+||++.++++||||
T Consensus       238 ~~~l~~~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         238 RKCLRRDPKKRPTADELLQHPFL  260 (260)
T ss_pred             HHhCcCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=6.3e-42  Score=361.47  Aligned_cols=259  Identities=25%  Similarity=0.413  Sum_probs=196.9

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCC-cEEEEE------------------EcccC---hHHHHHHHHHHHHhhC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASG-AEFACK------------------TLRKG---EETVHREVEIMQHLSG  155 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vAvK------------------~~~~~---~~~~~~E~~il~~l~~  155 (469)
                      ...+.++|++++.||+|+||.||+|..+... ..+++|                  .+...   ...+.+|+.+|+++. 
T Consensus       143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~-  221 (501)
T PHA03210        143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLN-  221 (501)
T ss_pred             chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCC-
Confidence            3456789999999999999999998765322 222222                  11111   235778999999996 


Q ss_pred             CCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHh-----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE
Q 012170          156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL  230 (469)
Q Consensus       156 hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl  230 (469)
                      ||||+++++++...+..|+|+|++. ++|.+++...     .......+..++.||+.||.|||++||+||||||+|||+
T Consensus       222 HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl  300 (501)
T PHA03210        222 HENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFL  300 (501)
T ss_pred             CCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9999999999999999999999995 4677766432     223466788899999999999999999999999999999


Q ss_pred             ccCCcEEEEeccceeeecCCCc--ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCC-CCCCC--CH-HHH
Q 012170          231 TTSGKIKLADFGLAMRISNGQT--LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAAL-PFKGD--SL-EAV  303 (469)
Q Consensus       231 ~~~~~vkL~DFgla~~~~~~~~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~-Pf~~~--~~-~~~  303 (469)
                      +.+|.+||+|||++..+.....  ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.. ||.+.  .. ..+
T Consensus       301 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~  380 (501)
T PHA03210        301 NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL  380 (501)
T ss_pred             CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence            9999999999999987654322  334689999999999976 48999999999999999999875 44322  12 222


Q ss_pred             HHHHHcCc---CCCCCC------------------------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          304 FDAIKNVK---LDFHSG------------------------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       304 ~~~i~~~~---~~~~~~------------------------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ...+....   ..++..                        ....++.++.++|.+||++||.+|||+.|+|.||||...
T Consensus       381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~hp~f~~~  460 (501)
T PHA03210        381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLALPLFSAE  460 (501)
T ss_pred             HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhhChhhhcC
Confidence            22222111   011100                        001356778899999999999999999999999999665


Q ss_pred             cc
Q 012170          357 TE  358 (469)
Q Consensus       357 ~~  358 (469)
                      ..
T Consensus       461 ~~  462 (501)
T PHA03210        461 EE  462 (501)
T ss_pred             Cc
Confidence            43

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=1.5e-41  Score=327.17  Aligned_cols=242  Identities=27%  Similarity=0.433  Sum_probs=209.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ++|++.+.||+|+||.||++.++. +..+|+|.+...   ...+.+|+.+|+.+. ||||+++++++...+.+|+||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~a~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~iv~e~~   81 (256)
T cd05114           4 SELTFMKELGSGQFGVVHLGKWRA-QIKVAIKAINEGAMSEEDFIEEAKVMMKLS-HPKLVQLYGVCTQQKPLYIVTEFM   81 (256)
T ss_pred             HHcEEeeEecCCcCceEEEEEecc-CceEEEEecccCCccHHHHHHHHHHHHHCC-CCCceeEEEEEccCCCEEEEEEcC
Confidence            568899999999999999998764 568999998643   357888999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--ccc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~~~  256 (469)
                      ++|+|.+++... +.+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........  ...
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05114          82 ENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTSSSGA  161 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCceeccCCC
Confidence            999999988653 56899999999999999999999999999999999999999999999999998765433222  223


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .++..|+|||++.+ .++.++||||||+++|+|++ |.+||...+..+.+..+.........   ...+..+.++|.+||
T Consensus       162 ~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~---~~~~~~~~~li~~c~  238 (256)
T cd05114         162 KFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMISRGFRLYRP---KLASMTVYEVMYSCW  238 (256)
T ss_pred             CCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCCCCCC---CCCCHHHHHHHHHHc
Confidence            45668999999875 58899999999999999999 99999988888888888765433222   346889999999999


Q ss_pred             hhhhcCCCCHHHHHc
Q 012170          335 TRDVSARITADEVLR  349 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~  349 (469)
                      ..+|.+||++.++++
T Consensus       239 ~~~p~~Rps~~~l~~  253 (256)
T cd05114         239 HEKPEGRPTFAELLR  253 (256)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-41  Score=327.58  Aligned_cols=247  Identities=28%  Similarity=0.513  Sum_probs=210.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--Ce
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~  171 (469)
                      .+|.+.+.||+|+||.||+|.+..+|..||+|.+...         ...+.+|+++++++. ||||+++++++.+.  +.
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~~~~~~~~~~~   80 (264)
T cd06653           2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR-HDRIVQYYGCLRDPEEKK   80 (264)
T ss_pred             CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcC-CCCcceEEEEEEcCCCCE
Confidence            5799999999999999999999999999999987421         135778999999996 99999999998764  56


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      +++||||+++++|.+++...+.+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++...... 
T Consensus        81 ~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~  160 (264)
T cd06653          81 LSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTIC  160 (264)
T ss_pred             EEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccc
Confidence            8899999999999999988788999999999999999999999999999999999999999999999999999765321 


Q ss_pred             ---CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          251 ---QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       251 ---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                         .......|+..|+|||++.+ .++.++|+|||||++|+|++|.+||........+..+.....  ....+..+++++
T Consensus       161 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~~p~~~~~~~  238 (264)
T cd06653         161 MSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIATQPT--KPMLPDGVSDAC  238 (264)
T ss_pred             ccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHHHHHcCCC--CCCCCcccCHHH
Confidence               12234568999999999976 488999999999999999999999987765555444433221  122335789999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .++|.+||. +|..||++.+++.|||+
T Consensus       239 ~~~i~~~l~-~~~~r~~~~~~~~~~~~  264 (264)
T cd06653         239 RDFLKQIFV-EEKRRPTAEFLLRHPFV  264 (264)
T ss_pred             HHHHHHHhc-CcccCccHHHHhcCCCC
Confidence            999999998 57999999999999985

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.3e-42  Score=343.64  Aligned_cols=252  Identities=28%  Similarity=0.466  Sum_probs=215.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----eE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----CF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----~~  172 (469)
                      +|++.+.||.|+||.||+|.+..+|..||||.+...      ...+.+|+.+++.+. ||||+++++++...+     .+
T Consensus         1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~~~~   79 (330)
T cd07834           1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLR-HENIIGLLDILRPPSPEDFNDV   79 (330)
T ss_pred             CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcC-CcchhhhhhhhcccCcccccce
Confidence            588999999999999999999999999999998652      246888999999997 999999999998775     78


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      |+||||+. ++|.+++.....+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++....... 
T Consensus        80 ~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~  158 (330)
T cd07834          80 YIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDED  158 (330)
T ss_pred             EEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccc
Confidence            99999997 4888888777789999999999999999999999999999999999999999999999999998765543 


Q ss_pred             ---cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC---------
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG---------  317 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------  317 (469)
                         ......+++.|+|||++.+  .++.++|+||||+++|+|++|.+||.+.+..+.+..+..........         
T Consensus       159 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  238 (330)
T cd07834         159 EKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEK  238 (330)
T ss_pred             ccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccc
Confidence               2345678999999999965  47889999999999999999999999888766665554321111100         


Q ss_pred             ------------------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          318 ------------------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       318 ------------------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                        ....++.++.+||.+||..+|.+||++.++|+||||....
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         239 ARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             hhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhCccHHhhc
Confidence                              1124688999999999999999999999999999996443

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=7.8e-42  Score=336.63  Aligned_cols=252  Identities=31%  Similarity=0.502  Sum_probs=214.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++|.+++.||.|+||.||++.+..++..||+|.+...    .+.+.+|+.+++.+. ||||+++++++...+..|+|+|
T Consensus        18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-hp~i~~~~~~~~~~~~~~lv~e   96 (293)
T cd06647          18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENK-HPNIVNYLDSYLVGDELWVVME   96 (293)
T ss_pred             hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcC-CCCeeehhheeeeCCcEEEEEe
Confidence            47899999999999999999999989999999998532    346788999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      |+++++|.+++.+ ..+++..+..++.|++.||.|||++|++|+||+|+||+++.++.++|+|||++....... .....
T Consensus        97 ~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~~~~~  175 (293)
T cd06647          97 YLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTM  175 (293)
T ss_pred             cCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceecccccccccccc
Confidence            9999999998854 468899999999999999999999999999999999999999999999999987554332 23345


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      .|++.|+|||.+.+ .++.++|+||||+++|+|++|..||...+....+..+..... .....+..++..+.++|.+||.
T Consensus       176 ~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~  254 (293)
T cd06647         176 VGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT-PELQNPEKLSAIFRDFLNRCLE  254 (293)
T ss_pred             cCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCCC-CCCCCccccCHHHHHHHHHHcc
Confidence            78999999999865 488999999999999999999999987665444333322211 1112234578899999999999


Q ss_pred             hhhcCCCCHHHHHcCCCcccc
Q 012170          336 RDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       336 ~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+|.+||++.+++.||||...
T Consensus       255 ~~p~~Rp~~~~il~h~~~~~~  275 (293)
T cd06647         255 MDVEKRGSAKELLQHPFLKIA  275 (293)
T ss_pred             CChhhCcCHHHHhcCHHHhcC
Confidence            999999999999999999543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.5e-41  Score=322.80  Aligned_cols=246  Identities=29%  Similarity=0.504  Sum_probs=215.0

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++.+.||+|++|.||++.+..+++.||+|.+....      ..+.+|+++++++. |||++++++++.+.+..++|||
T Consensus         1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   79 (254)
T cd06627           1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLK-HPNIVKYIGSIETSDSLYIILE   79 (254)
T ss_pred             CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCC-CCCccEEEEEEEeCCEEEEEEe
Confidence            5888999999999999999999999999999986532      45789999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~~~  256 (469)
                      |+++++|.+++...+.+++..+..++.|++.||.|||++|++||||+|+||+++.++.++|+|||++........ ....
T Consensus        80 ~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (254)
T cd06627          80 YAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASV  159 (254)
T ss_pred             cCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCccccccc
Confidence            999999999998888999999999999999999999999999999999999999999999999999987654332 2345


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      .++..|+|||.+.+ .++.++||||+|+++|+|++|..||...........+.....   ......++..+.++|.+||.
T Consensus       160 ~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~  236 (254)
T cd06627         160 VGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDH---PPLPEGISPELKDFLMQCFQ  236 (254)
T ss_pred             ccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCC---CCCCCCCCHHHHHHHHHHHh
Confidence            78999999999865 378899999999999999999999987665444444432221   12234678999999999999


Q ss_pred             hhhcCCCCHHHHHcCCCc
Q 012170          336 RDVSARITADEVLRHPWI  353 (469)
Q Consensus       336 ~dP~~Rpsa~elL~hp~~  353 (469)
                      .+|++|||+.+++.||||
T Consensus       237 ~~p~~R~~~~~~l~~~~~  254 (254)
T cd06627         237 KDPNLRPTAKQLLKHPWI  254 (254)
T ss_pred             CChhhCcCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=1.7e-41  Score=333.01  Aligned_cols=243  Identities=23%  Similarity=0.362  Sum_probs=209.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ++|.+.+.||+|+||.||++.+.     .++..+|+|.+...    ...+.+|+.+++++. ||||+++++++...+.+|
T Consensus         5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   83 (288)
T cd05093           5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPLI   83 (288)
T ss_pred             HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccE
Confidence            57889999999999999999853     35567999998653    245788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          174 LVMELCSGGRLIDQMVEVG-------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                      +||||+++++|.+++...+             .+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~d  163 (288)
T cd05093          84 MVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGD  163 (288)
T ss_pred             EEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEecc
Confidence            9999999999999987654             389999999999999999999999999999999999999999999999


Q ss_pred             ccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      ||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |.+||...........+........
T Consensus       164 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~  243 (288)
T cd05093         164 FGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR  243 (288)
T ss_pred             CCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999976533221   122345778999999876 48999999999999999998 9999998888888888877653322


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                         ...++.++.+||.+||+.||.+|||+.+++.
T Consensus       244 ---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         244 ---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             ---CCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence               2357899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=1.6e-41  Score=328.49  Aligned_cols=243  Identities=24%  Similarity=0.366  Sum_probs=210.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .+|.+.+.||+|+||.||+|.++.++..||+|++....   ..+.+|+++++.+. ||||+++++++..++.+++||||+
T Consensus         6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~   84 (263)
T cd05052           6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFM   84 (263)
T ss_pred             HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCchHHHHHHHHHHHHHhCC-CCChhheEEEEcCCCCcEEEEEeC
Confidence            56889999999999999999999999999999987543   45788999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--cc
Q 012170          180 SGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SG  255 (469)
Q Consensus       180 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~~  255 (469)
                      ++++|.+++....  .+++..+..++.|++.||.|||++|++||||||+|||+++++.+||+|||++.........  ..
T Consensus        85 ~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~~~~  164 (263)
T cd05052          85 TYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAG  164 (263)
T ss_pred             CCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccceeeccCC
Confidence            9999999986643  5889999999999999999999999999999999999999999999999999765443221  12


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+++.|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+..+....+.....   ......++.++.++|.+|
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~c  241 (263)
T cd05052         165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKGYR---MERPEGCPPKVYELMRAC  241 (263)
T ss_pred             CCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CCCCCCCCHHHHHHHHHH
Confidence            234668999999865 48899999999999999998 9999998888877777765321   122356899999999999


Q ss_pred             chhhhcCCCCHHHHHc
Q 012170          334 LTRDVSARITADEVLR  349 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~  349 (469)
                      |..||++|||+.++++
T Consensus       242 l~~~p~~Rp~~~~l~~  257 (263)
T cd05052         242 WQWNPSDRPSFAEIHQ  257 (263)
T ss_pred             ccCCcccCCCHHHHHH
Confidence            9999999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=100.00  E-value=1.4e-41  Score=329.01  Aligned_cols=245  Identities=27%  Similarity=0.425  Sum_probs=208.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|++..+++.||||.+...       ...+.+|+.+++.+. ||||+++++++.+.+..|+|
T Consensus         2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08228           2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLN-HPNVIKYLDSFIEDNELNIV   80 (267)
T ss_pred             cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCC-CcceeeeeeeEEECCeEEEE
Confidence            5799999999999999999999999999999987431       235778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          176 MELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |||+++|+|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~  160 (267)
T cd08228          81 LELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence            999999999888753    2458999999999999999999999999999999999999999999999999987654332


Q ss_pred             c-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 T-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS--LEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      . .....|++.|+|||.+.+ .++.++|+||+|+++|+|++|..||....  .......+....  ++......++..+.
T Consensus       161 ~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  238 (267)
T cd08228         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD--YPPLPTEHYSEKLR  238 (267)
T ss_pred             HHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC--CCCCChhhcCHHHH
Confidence            2 234578999999999865 48889999999999999999999996543  344445544432  22222345788999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcC
Q 012170          328 DLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ++|.+||..+|.+||++.++++.
T Consensus       239 ~li~~cl~~~p~~Rp~~~~vl~~  261 (267)
T cd08228         239 ELVSMCIYPDPDQRPDIGYVHQI  261 (267)
T ss_pred             HHHHHHCCCCcccCcCHHHHHHH
Confidence            99999999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>KOG0584 consensus Serine/threonine protein kinase [General function prediction only]

Probab=100.00  E-value=3.8e-43  Score=356.19  Aligned_cols=243  Identities=22%  Similarity=0.456  Sum_probs=213.7

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcc------cCh--HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe--EEEEEe
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGE--ETVHREVEIMQHLSGHTGVVTLHSVYEEADC--FHLVME  177 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~------~~~--~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~--~~lV~E  177 (469)
                      .++||+|+|-+||+|.+..+|..||.-.++      ...  +.+..|+.+|+.|+ ||||+++|+++.+.+.  +.+|+|
T Consensus        45 ~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~-H~NIirfy~SW~d~~n~~in~iTE  123 (632)
T KOG0584|consen   45 DEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLK-HPNIIRFYDSWVDTDNKTINFITE  123 (632)
T ss_pred             hhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCC-CCceeeeeeheecCCCceeeeeee
Confidence            478999999999999999999999854432      222  67899999999997 9999999999987655  889999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccC-CcEEEEeccceeeecCCCccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~-~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ++.+|+|..|+.+.+..+...+..|++|||+||.|||++.  |+|||||.+||+|+.+ |.|||+|+|||......... 
T Consensus       124 L~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~ak-  202 (632)
T KOG0584|consen  124 LFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSHAK-  202 (632)
T ss_pred             cccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhccccc-
Confidence            9999999999999999999999999999999999999885  9999999999999875 89999999999876544443 


Q ss_pred             ccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+|||.|||||++...|+..+||||||+.|.||+|+..||. ..++.++++.+..+..+-..  ..--.+++++||.+|
T Consensus       203 svIGTPEFMAPEmYEE~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~SGiKP~sl--~kV~dPevr~fIekC  280 (632)
T KOG0584|consen  203 SVIGTPEFMAPEMYEENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVTSGIKPAAL--SKVKDPEVREFIEKC  280 (632)
T ss_pred             eeccCccccChHHHhhhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHHcCCCHHHh--hccCCHHHHHHHHHH
Confidence            379999999999999999999999999999999999999996 57788888888776543221  122378999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCccc
Q 012170          334 LTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      |.. .+.|||+.|+|+||||..
T Consensus       281 l~~-~~~R~sa~eLL~d~Ff~~  301 (632)
T KOG0584|consen  281 LAT-KSERLSAKELLKDPFFDE  301 (632)
T ss_pred             hcC-chhccCHHHHhhChhhcc
Confidence            999 999999999999999965

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=1.1e-41  Score=335.86  Aligned_cols=245  Identities=22%  Similarity=0.309  Sum_probs=206.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCc--EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGA--EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.++.++.  .+++|.++..     .+.+.+|+.++.++..||||+++++++...+.+|+|
T Consensus         2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv   81 (297)
T cd05089           2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA   81 (297)
T ss_pred             ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence            578999999999999999999887775  4688888642     246788999999996699999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEE
Q 012170          176 MELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA  239 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~  239 (469)
                      |||+++|+|.+++....                .+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+
T Consensus        82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~  161 (297)
T cd05089          82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIA  161 (297)
T ss_pred             EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEEC
Confidence            99999999999996542                47889999999999999999999999999999999999999999999


Q ss_pred             eccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          240 DFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       240 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      |||++..............+..|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+.....   ..
T Consensus       162 dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~---~~  238 (297)
T cd05089         162 DFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---ME  238 (297)
T ss_pred             CcCCCccccceeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCC---CC
Confidence            9999864322111122233557999999865 48999999999999999997 9999998888887777655421   11


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....++.++.+||.+||..+|.+|||++++++.
T Consensus       239 ~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         239 KPRNCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            224689999999999999999999999999765

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=330.19  Aligned_cols=248  Identities=30%  Similarity=0.495  Sum_probs=207.9

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCe-----
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLS--GHTGVVTLHSVYEEADC-----  171 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~-----  171 (469)
                      |++++.||.|+||.||+|.++.++..||+|.++..      ...+.+|+.+++++.  .||||+++++++...+.     
T Consensus         1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~   80 (287)
T cd07838           1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK   80 (287)
T ss_pred             CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence            67889999999999999999989999999999632      134667888888775  49999999999988776     


Q ss_pred             EEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          172 FHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +++||||+.+ +|.+++....  .+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.....
T Consensus        81 ~~l~~e~~~~-~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~  159 (287)
T cd07838          81 LTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSF  159 (287)
T ss_pred             eEEEehhccc-CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccC
Confidence            9999999975 7888886643  489999999999999999999999999999999999999999999999999987655


Q ss_pred             CCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-----C----------
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-----D----------  313 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-----~----------  313 (469)
                      ........+++.|+|||++.+ .++.++|+|||||++|+|++|.+||.+.+..+.+..+.....     .          
T Consensus       160 ~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (287)
T cd07838         160 EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRS  239 (287)
T ss_pred             CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchh
Confidence            544445568999999999976 488999999999999999999999998876665555432110     0          


Q ss_pred             -CC-------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          314 -FH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       314 -~~-------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                       ++       ......++..+.+||.+||+.||.+||++.+++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         240 SFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             hcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhcCcCC
Confidence             00       00112456888999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1.6e-41  Score=330.91  Aligned_cols=246  Identities=22%  Similarity=0.285  Sum_probs=207.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++.+.||+|+||.||+|.+.     .++..||+|.+...     ...+.+|+.+++.+. ||||+++++++....
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~iv~~~~~~~~~~   82 (277)
T cd05062           4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQ   82 (277)
T ss_pred             cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence            4578999999999999999999865     24567999998542     235778999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG----------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                      ..++||||+++|+|.+++....          .++...+..++.|++.||.|||+.|++||||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~d  162 (277)
T cd05062          83 PTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD  162 (277)
T ss_pred             CeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECC
Confidence            9999999999999999986532          256778899999999999999999999999999999999999999999


Q ss_pred             ccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      ||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+.......+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (277)
T cd05062         163 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDK  242 (277)
T ss_pred             CCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC
Confidence            999875433221   112345778999999865 58999999999999999999 7899998888887777665543222


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                         ...++..+.++|.+||+.||.+|||+.|++++
T Consensus       243 ---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         243 ---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               24578899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.7e-41  Score=331.52  Aligned_cols=251  Identities=23%  Similarity=0.298  Sum_probs=209.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++.+.||+|+||.||+|.++.     .+..||+|.+....     ..+.+|+.+++.+. ||||+++++++.+.+
T Consensus         4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~   82 (288)
T cd05061           4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFT-CHHVVRLLGVVSKGQ   82 (288)
T ss_pred             cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCC
Confidence            35789999999999999999997652     35579999986432     34678999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG----------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                      ..|+||||+.+|+|.+++...+          .++...+..++.||+.||.|||++||+||||||+|||++.++.++|+|
T Consensus        83 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~D  162 (288)
T cd05061          83 PTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGD  162 (288)
T ss_pred             CcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECc
Confidence            9999999999999999997532          245678889999999999999999999999999999999999999999


Q ss_pred             ccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      ||+++.......   .....++..|+|||.+.+ .++.++|+|||||++|+|++ |..||.+....+....+........
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~  242 (288)
T cd05061         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQ  242 (288)
T ss_pred             CCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence            999875433221   112345678999999865 58999999999999999998 7899999888887777665432211


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc------CCCccc
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLR------HPWILF  355 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~------hp~~~~  355 (469)
                         ...++..+.++|.+||+.||.+|||+.++++      ||||..
T Consensus       243 ---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         243 ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             ---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence               1356889999999999999999999999987      898854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-41  Score=332.42  Aligned_cols=248  Identities=33%  Similarity=0.492  Sum_probs=209.7

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      |.+.+.||.|+||.||+|....+++.||||.+...     .....+|+..++++.+||||+++++++.+++..|+||||+
T Consensus         1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~   80 (283)
T cd07830           1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM   80 (283)
T ss_pred             CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence            67889999999999999999999999999998643     2244579999999977999999999999999999999999


Q ss_pred             CCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccC
Q 012170          180 SGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       180 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                       +|+|.+.+....  .+++..+..++.|++.+|.|||++|++|+||+|+||+++.++.++|+|||++.............
T Consensus        81 -~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~  159 (283)
T cd07830          81 -EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPYTDYV  159 (283)
T ss_pred             -CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCcCCCC
Confidence             789998887765  78999999999999999999999999999999999999999999999999998766554445567


Q ss_pred             CCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-------------------C-
Q 012170          258 GSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-------------------H-  315 (469)
Q Consensus       258 gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------------~-  315 (469)
                      |+..|+|||++.+  .++.++|+||||+++++|++|.+||.+....+.+..+.......                   + 
T Consensus       160 ~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (283)
T cd07830         160 STRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQ  239 (283)
T ss_pred             CcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccc
Confidence            8999999998854  47899999999999999999999998876655444332211000                   0 


Q ss_pred             ------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          316 ------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       316 ------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                            .......+.++.+||.+||..||.+|||+.|++.||||
T Consensus       240 ~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         240 FAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQHPYF  283 (283)
T ss_pred             cccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhhCCCC
Confidence                  00112346889999999999999999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=2.5e-41  Score=331.09  Aligned_cols=255  Identities=30%  Similarity=0.501  Sum_probs=220.6

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ....+.|+..+.||.|+||.||+|.+..++..||+|++...   ...+.+|+++++.+. |+||+++++++...+..|+|
T Consensus        15 ~~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv   93 (286)
T cd06614          15 GDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQNKELIINEILIMKDCK-HPNIVDYYDSYLVGDELWVV   93 (286)
T ss_pred             CCccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCchhHHHHHHHHHHHHHCC-CCCeeEEEEEEEECCEEEEE
Confidence            34667899999999999999999999989999999999754   356788999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      +||++|++|.+++.... .+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ..
T Consensus        94 ~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~  173 (286)
T cd06614          94 MEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKR  173 (286)
T ss_pred             EeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchhhh
Confidence            99999999999998877 89999999999999999999999999999999999999999999999999986543321 22


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....+++.|+|||++.+ .++.++|+||||+++|+|++|..||...+.......+....... ......++.++.+||.+
T Consensus       174 ~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~  252 (286)
T cd06614         174 NSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIPP-LKNPEKWSPEFKDFLNK  252 (286)
T ss_pred             ccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCC-CcchhhCCHHHHHHHHH
Confidence            34568899999999866 48999999999999999999999999877666555554432221 11223478999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCccc
Q 012170          333 MLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||+.+|.+||++.++|+||||..
T Consensus       253 ~l~~~p~~Rpt~~~il~~~~~~~  275 (286)
T cd06614         253 CLVKDPEKRPSAEELLQHPFLKK  275 (286)
T ss_pred             HhccChhhCcCHHHHhhChHhhc
Confidence            99999999999999999999965

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=1.5e-41  Score=340.61  Aligned_cols=253  Identities=25%  Similarity=0.452  Sum_probs=208.9

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCC--CcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKAS--GAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE----ADC  171 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~  171 (469)
                      +|.+.+.||+|+||.||+|.+..+  +..||+|.+...      ...+.+|+.+++++.+||||+++++.+..    ...
T Consensus         1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~   80 (332)
T cd07857           1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE   80 (332)
T ss_pred             CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence            488899999999999999999988  899999998642      24577899999999779999999987543    245


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+++||+. ++|.+++.....+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus        81 ~~~~~e~~~-~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~  159 (332)
T cd07857          81 LYLYEELME-ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENP  159 (332)
T ss_pred             EEEEEeccc-CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceeccccc
Confidence            789999995 6899988888889999999999999999999999999999999999999999999999999997654322


Q ss_pred             -----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC------------
Q 012170          252 -----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL------------  312 (469)
Q Consensus       252 -----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~------------  312 (469)
                           ......||+.|+|||++.+  .++.++||||+|+++|+|++|.+||.+.+....+..+.....            
T Consensus       160 ~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (332)
T cd07857         160 GENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGS  239 (332)
T ss_pred             ccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhh
Confidence                 1234578999999998865  488999999999999999999999987665444433222100            


Q ss_pred             ---------------CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          313 ---------------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       313 ---------------~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                     ......+..++..+.+||.+||+.||.+|||+.+++.|||+..+.
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~~~~~~~~~  299 (332)
T cd07857         240 PKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALEHPYLAIWH  299 (332)
T ss_pred             hhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhhhhc
Confidence                           000112234688999999999999999999999999999996554

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=2.5e-41  Score=330.70  Aligned_cols=244  Identities=21%  Similarity=0.291  Sum_probs=208.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ++|++.+.||+|+||.||+|.+.    .++..||+|.+...     ...+.+|+.+++.+. ||||+++++++...+..|
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~   83 (283)
T cd05090           5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELH-HPNIVCLLGVVTQEQPVC   83 (283)
T ss_pred             hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCCeeeEEEEEecCCceE
Confidence            57889999999999999999853    45678999999642     245788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          174 LVMELCSGGRLIDQMVEVG-----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~-----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      +||||+.+|+|.+++....                 .+++..+..++.||+.||.|||++|++||||||+|||++.++.+
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~  163 (283)
T cd05090          84 MLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHV  163 (283)
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcE
Confidence            9999999999999885432                 36788899999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc
Q 012170          237 KLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK  311 (469)
Q Consensus       237 kL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  311 (469)
                      ||+|||++.......   ......++..|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+...+...+....
T Consensus       164 kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~  243 (283)
T cd05090         164 KISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ  243 (283)
T ss_pred             EeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            999999997654322   1233456778999999865 58999999999999999998 999999888777777666544


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...   .+..+++.+.++|.+||+.||.+||++.+|+++
T Consensus       244 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         244 LLP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             cCC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            221   235679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=2.7e-41  Score=325.88  Aligned_cols=243  Identities=24%  Similarity=0.380  Sum_probs=209.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ++|++++.||+|+||.||+|.+.. +..+|+|.+...   .+.+.+|+.+++.+. ||||+++++++...+.+|+||||+
T Consensus         4 ~~~~~~~~lg~G~~~~vy~~~~~~-~~~~aik~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05113           4 KDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIEEAKVMMKLS-HEKLVQLYGVCTKQRPIYIVTEYM   81 (256)
T ss_pred             HHeEEeeEecCcccceEEEEEecC-CCcEEEEEcCCCcccHHHHHHHHHHHhcCC-CCCeeeEEEEEccCCCcEEEEEcC
Confidence            578999999999999999998764 456999998753   356889999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--ccc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~~~  256 (469)
                      .+|+|.+++... ..+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++.........  ...
T Consensus        82 ~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05113          82 SNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTSSVGS  161 (256)
T ss_pred             CCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCceeecCCC
Confidence            999999998764 46899999999999999999999999999999999999999999999999998765443321  123


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .++..|+|||++.+ .++.++||||||+++|+|++ |..||...+.......+.+....+..   ...+..+.++|.+||
T Consensus       162 ~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~cl  238 (256)
T cd05113         162 KFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRP---HLASEKVYAIMYSCW  238 (256)
T ss_pred             ccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHhcCCCCCCC---CCCCHHHHHHHHHHc
Confidence            45678999999975 58999999999999999998 99999988877777777665443322   346899999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      ..||.+||++.+|+.+
T Consensus       239 ~~~p~~Rp~~~~ll~~  254 (256)
T cd05113         239 HEKAEERPTFQQLLSS  254 (256)
T ss_pred             CCCcccCCCHHHHHHh
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.4e-41  Score=335.18  Aligned_cols=251  Identities=32%  Similarity=0.531  Sum_probs=208.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD----  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~----  170 (469)
                      ..++|++.+.||.|+||.||+|.++.+|+.||+|+++..      ...+.+|+++++.++ ||||+++++++.+..    
T Consensus         5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~~i~~~~~~~~~~~~~~~   83 (302)
T cd07864           5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLN-HRNIVNLKEIVTDKQDALD   83 (302)
T ss_pred             hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCC-CCCeeeeeheecCcchhhh
Confidence            457899999999999999999999999999999999642      245678999999996 999999999987654    


Q ss_pred             ------eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          171 ------CFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       171 ------~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                            .+|+||||+++ ++...+... ..+++..+..++.||+.||.|||+.||+|+||+|+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~  162 (302)
T cd07864          84 FKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGL  162 (302)
T ss_pred             ccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEeCcccc
Confidence                  79999999986 666666543 4689999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC----
Q 012170          244 AMRISNGQ--TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH----  315 (469)
Q Consensus       244 a~~~~~~~--~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----  315 (469)
                      +.......  ......+++.|+|||++.+  .++.++|||||||++|+|++|.+||...+....+..+........    
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (302)
T cd07864         163 ARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELAQLELISRLCGSPCPAVW  242 (302)
T ss_pred             cccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            97654332  2233456888999998864  378899999999999999999999987766555544433211000    


Q ss_pred             ----------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          316 ----------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       316 ----------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                                            ...+..++..+.++|.+||..||.+||++.+++.||||
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         243 PDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             ccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhcCCCC
Confidence                                  01123578999999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=2.2e-41  Score=325.01  Aligned_cols=237  Identities=27%  Similarity=0.394  Sum_probs=201.1

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      +.||+|+||.||+|.++.+++.||+|.+...     ...+.+|+++++.+. ||||+++++++...+.+|+||||+.+++
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   79 (252)
T cd05084           1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGD   79 (252)
T ss_pred             CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEcCCCCeEEEEeeccCCc
Confidence            4689999999999999999999999987642     246889999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc---ccCCC
Q 012170          184 LIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGS  259 (469)
Q Consensus       184 L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~---~~~gt  259 (469)
                      |.+++...+ .+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+|||++..........   ...++
T Consensus        80 L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~  159 (252)
T cd05084          80 FLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIP  159 (252)
T ss_pred             HHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCc
Confidence            999987654 58999999999999999999999999999999999999999999999999987544322111   11234


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      ..|+|||.+.+ .++.++||||||+++|+|++ |.+||...........+......   .....++..+.+||.+||+.+
T Consensus       160 ~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~  236 (252)
T cd05084         160 VKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRL---PCPELCPDAVYRLMERCWEYD  236 (252)
T ss_pred             eeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCC---CCcccCCHHHHHHHHHHcCCC
Confidence            56999999865 58999999999999999997 99999877776666666543221   123467899999999999999


Q ss_pred             hcCCCCHHHHHc
Q 012170          338 VSARITADEVLR  349 (469)
Q Consensus       338 P~~Rpsa~elL~  349 (469)
                      |.+|||+.++++
T Consensus       237 p~~Rps~~~~~~  248 (252)
T cd05084         237 PGQRPSFSTVHQ  248 (252)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=6.8e-42  Score=341.38  Aligned_cols=249  Identities=26%  Similarity=0.404  Sum_probs=199.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcc-cC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~-~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..|++++.||.||.+.||++...+. +.||+|.+. ..     ...+..|+..|.+|++|.+||+|++|-..++.+||||
T Consensus       361 ~~Yeilk~iG~GGSSkV~kV~~s~~-~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvm  439 (677)
T KOG0596|consen  361 REYEILKQIGSGGSSKVFKVLNSDK-QIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVM  439 (677)
T ss_pred             chhhHHHhhcCCCcceeeeeecCCC-cchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEe
Confidence            4699999999999999999987654 556666543 21     2458899999999999999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCC-CHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---
Q 012170          177 ELCSGGRLIDQMVEVGQY-SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l-~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---  252 (469)
                      ||=+ -+|..+|...... +.-.++.+..|+|.|+.++|.+||||.||||.|+|+ -.|.+||+|||.|..+..+..   
T Consensus       440 E~Gd-~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl-VkG~LKLIDFGIA~aI~~DTTsI~  517 (677)
T KOG0596|consen  440 ECGD-IDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL-VKGRLKLIDFGIANAIQPDTTSIV  517 (677)
T ss_pred             eccc-ccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE-EeeeEEeeeechhcccCcccccee
Confidence            9964 4888888776543 335889999999999999999999999999999998 568999999999987765432   


Q ss_pred             ccccCCCCcccCceeccC------------CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCc--CCCCCC
Q 012170          253 LSGLAGSPAYVAPEVLSG------------NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVK--LDFHSG  317 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~--~~~~~~  317 (469)
                      ..+.+||+.||+||.+..            +.+.++||||||||||+|+.|++||..-. ...-+..|....  ++|+.-
T Consensus       518 kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~  597 (677)
T KOG0596|consen  518 KDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI  597 (677)
T ss_pred             eccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC
Confidence            345789999999999842            14678999999999999999999996432 222333343332  233321


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                         .-..++.++++.||.+||.+||+..++|+|||++.+.
T Consensus       598 ---~~~~~li~~mK~CL~rdPkkR~si~eLLqhpFl~~~~  634 (677)
T KOG0596|consen  598 ---PENDELIDVMKCCLARDPKKRWSIPELLQHPFLQIQP  634 (677)
T ss_pred             ---CCchHHHHHHHHHHhcCcccCCCcHHHhcCccccccc
Confidence               1123499999999999999999999999999997654

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=100.00  E-value=9.1e-42  Score=334.59  Aligned_cols=251  Identities=31%  Similarity=0.546  Sum_probs=210.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      +|++.+.||+|+||.||+|.+.   .++..||||++++.        ...+.+|+.++.++.+||||+++++.+..++.+
T Consensus         1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~   80 (288)
T cd05583           1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL   80 (288)
T ss_pred             CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence            4788999999999999999864   46789999998642        235678999999997799999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||+.+|+|.+++.....+++..+..++.|++.||.|||+.|++||||+|.||+++.++.++|+|||++........
T Consensus        81 ~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~  160 (288)
T cd05583          81 HLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE  160 (288)
T ss_pred             EEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECccccccccccc
Confidence            99999999999999998878899999999999999999999999999999999999999999999999999876543322


Q ss_pred             --ccccCCCCcccCceeccCC---CCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcCCCCCCcccCCC
Q 012170          253 --LSGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       253 --~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                        .....|++.|+|||.+.+.   ++.++|+||||+++|+|++|..||....    ..+....+.......    ...++
T Consensus       161 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~  236 (288)
T cd05583         161 ERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKSKPPF----PKTMS  236 (288)
T ss_pred             cccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHHHHHHHHccCCCC----CcccC
Confidence              2335689999999998653   6789999999999999999999996432    223333333332222    24578


Q ss_pred             HHHHHHHHHhchhhhcCCCC---HHHHHcCCCcccccc
Q 012170          324 KPARDLMARMLTRDVSARIT---ADEVLRHPWILFYTE  358 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rps---a~elL~hp~~~~~~~  358 (469)
                      .++.++|.+||+.||++|||   +.++|+||||....+
T Consensus       237 ~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~~~  274 (288)
T cd05583         237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGIDW  274 (288)
T ss_pred             HHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccCCH
Confidence            99999999999999999998   577899999966543

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=5.8e-42  Score=345.19  Aligned_cols=253  Identities=29%  Similarity=0.513  Sum_probs=213.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe--
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC--  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~--  171 (469)
                      .+.++|++.+.||.|+||.||+|++..++..||+|++...      ...+.+|+.+++.+. ||||+++++++...+.  
T Consensus        12 ~~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07851          12 EVPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMD-HENVIGLLDVFTPASSLE   90 (343)
T ss_pred             cccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhcc-CCCHHHHHHHhhcccccc
Confidence            4678999999999999999999999999999999998642      245668999999996 9999999998876654  


Q ss_pred             ----EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          172 ----FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       172 ----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                          +|+|+||+ +++|.+++.. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~  168 (343)
T cd07851          91 DFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARHT  168 (343)
T ss_pred             ccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEccccccccc
Confidence                89999999 6689887754 67999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC----------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH----------  315 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------  315 (469)
                      ...  .....+++.|+|||++.+  .++.++|||||||++|+|++|..||.+......+..+.......+          
T Consensus       169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  246 (343)
T cd07851         169 DDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSE  246 (343)
T ss_pred             ccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccch
Confidence            432  344578999999999865  478899999999999999999999988776665555433211000          


Q ss_pred             -----------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          316 -----------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       316 -----------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                       ...+..++.++.+||.+||..||.+|||+.+||+||||..+.
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~h~~~~~~~  305 (343)
T cd07851         247 SARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALAHPYLAEYH  305 (343)
T ss_pred             hHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhcCCCccccC
Confidence                             011234689999999999999999999999999999997554

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=100.00  E-value=2.6e-41  Score=367.72  Aligned_cols=143  Identities=31%  Similarity=0.541  Sum_probs=134.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|.+++.||+|+||.||+|.+..+++.||||+++...       ..+..|+.++..+. ||||+++++++...+.+||
T Consensus         3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l   81 (669)
T cd05610           3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSK-SPFIVHLYYSLQSANNVYL   81 (669)
T ss_pred             cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcC-CCCcCeEEEEEEECCEEEE
Confidence            368999999999999999999999999999999997532       56788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ||||+.|++|.+++...+.+++..++.++.||+.||.|||.+||+||||||+||||+.++.++|+|||+++
T Consensus        82 VmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610          82 VMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999875

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3e-41  Score=332.61  Aligned_cols=255  Identities=27%  Similarity=0.425  Sum_probs=210.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++.+.||.|+||.||+|.+..+++.||||.++..     ...+..|+.++..+.+||||+++++++.+...+|+||
T Consensus        14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~   93 (296)
T cd06618          14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM   93 (296)
T ss_pred             cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence            46799999999999999999999999999999998642     2345667877777767999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          177 ELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||+. ++|.+++.. .+.+++..+..++.||+.||.|||+ .||+||||+|+||+++.++.++|+|||++..+.......
T Consensus        94 e~~~-~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~~  172 (296)
T cd06618          94 ELMS-TCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKT  172 (296)
T ss_pred             eccC-cCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCCccc
Confidence            9985 467666654 4578999999999999999999997 599999999999999999999999999997765544444


Q ss_pred             ccCCCCcccCceeccCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          255 GLAGSPAYVAPEVLSGN-----YSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      ...+++.|+|||.+.+.     ++.++||||||+++|+|++|..||..... .+.+..+........ .....++.++.+
T Consensus       173 ~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~  251 (296)
T cd06618         173 RSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSL-PPNEGFSPDFCS  251 (296)
T ss_pred             CCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCCCCC-CCCCCCCHHHHH
Confidence            45688999999998643     78899999999999999999999975332 333444333321111 111247899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ||.+||..||.+||+++++++||||..+..
T Consensus       252 li~~~l~~~p~~Rp~~~~il~~~~~~~~~~  281 (296)
T cd06618         252 FVDLCLTKDHRKRPKYRELLQHPFIRRYET  281 (296)
T ss_pred             HHHHHccCChhhCCCHHHHhcChhhhccch
Confidence            999999999999999999999999976543

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=3.6e-41  Score=345.84  Aligned_cols=249  Identities=21%  Similarity=0.337  Sum_probs=204.6

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEE
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYE  167 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~  167 (469)
                      ...-.++|.+++.||+|+||.||+|.+...     +..||||+++..     .+.+.+|+++|+++..||||+++++++.
T Consensus        32 ~~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~  111 (400)
T cd05105          32 WEFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACT  111 (400)
T ss_pred             eeccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEc
Confidence            334467899999999999999999987433     346999999642     2467889999999966999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHh--------------------------------------------------------
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEV--------------------------------------------------------  191 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~--------------------------------------------------------  191 (469)
                      +.+.+|||||||++|+|.+++...                                                        
T Consensus       112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  191 (400)
T cd05105         112 KSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPM  191 (400)
T ss_pred             cCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchh
Confidence            999999999999999999988543                                                        


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc
Q 012170          192 ----------------------------------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT  231 (469)
Q Consensus       192 ----------------------------------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~  231 (469)
                                                              ..+++..+..++.||+.||.|||+.||+||||||+|||++
T Consensus       192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~  271 (400)
T cd05105         192 LEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLA  271 (400)
T ss_pred             hhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEe
Confidence                                                    1367788899999999999999999999999999999999


Q ss_pred             cCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHH-HH
Q 012170          232 TSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAV-FD  305 (469)
Q Consensus       232 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~-~~  305 (469)
                      .++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+...... ..
T Consensus       272 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~  351 (400)
T cd05105         272 QGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYN  351 (400)
T ss_pred             CCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHH
Confidence            999999999999976543222   223457788999999866 58999999999999999997 9999987544333 33


Q ss_pred             HHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       306 ~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+... ....  ....++.++.++|.+||..||++|||+.++.+
T Consensus       352 ~~~~~-~~~~--~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         352 KIKSG-YRMA--KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             HHhcC-CCCC--CCccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            33333 1111  22467899999999999999999999998875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=2.1e-41  Score=341.19  Aligned_cols=252  Identities=29%  Similarity=0.499  Sum_probs=210.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC---
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD---  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~---  170 (469)
                      .+.++|++++.||+|+||.||+|.+..+|..||||++...      ...+.+|+.+|+.+. ||||+++++++....   
T Consensus        12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   90 (343)
T cd07880          12 EVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMK-HENVIGLLDVFTPDLSLD   90 (343)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCccceeeeecCCcccc
Confidence            3678899999999999999999999999999999998542      245778999999996 999999999987654   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          171 ---CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       171 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                         .+++||||+ |++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        91 ~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~  168 (343)
T cd07880          91 RFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQT  168 (343)
T ss_pred             ccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccccccc
Confidence               468999999 778887764 468999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-----------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-----------  314 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  314 (469)
                      ..  ......+++.|+|||++.+  .++.++|+||||+++|+|++|.+||.+.+....+..+.......           
T Consensus       169 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (343)
T cd07880         169 DS--EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSE  246 (343)
T ss_pred             cc--CccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcch
Confidence            33  2234578999999999865  47889999999999999999999998776544443332211110           


Q ss_pred             ------------C----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 ------------H----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 ------------~----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                  .    ...+..++.++.++|.+||..||.+|||+.+++.||||..+
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         247 DAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhcCccHhhh
Confidence                        0    01124578899999999999999999999999999999544

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=3.7e-41  Score=325.13  Aligned_cols=243  Identities=25%  Similarity=0.408  Sum_probs=209.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|.+. ++..||+|.+...   .+.+.+|+.+++.+. ||||+++++++.+.+..|+||||
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~-~~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05072           5 RESIKLVKKLGAGQFGEVWMGYYN-NSTKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYAVVTKEEPIYIITEY   82 (261)
T ss_pred             hHHeEEeeecCCcCCceEEEEEec-CCceEEEEEccCCchhHHHHHHHHHHHHhCC-CCCeeeEEEEEcCCCCcEEEEec
Confidence            468999999999999999999875 4677999998643   356788999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      +++|+|.+++...  ..++...+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  ..
T Consensus        83 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05072          83 MAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYTARE  162 (261)
T ss_pred             CCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCceeccC
Confidence            9999999998654  4688899999999999999999999999999999999999999999999999987654322  12


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+..... +  .....++.++.++|.+
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~  239 (261)
T cd05072         163 GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYR-M--PRMENCPDELYDIMKT  239 (261)
T ss_pred             CCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCC-C--CCCCCCCHHHHHHHHH
Confidence            3345678999999865 58889999999999999998 9999998888777777765432 1  2234688999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||..+|++||+++++++
T Consensus       240 ~l~~~p~~Rp~~~~i~~  256 (261)
T cd05072         240 CWKEKAEERPTFDYLQS  256 (261)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-41  Score=323.57  Aligned_cols=238  Identities=37%  Similarity=0.694  Sum_probs=212.7

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ||.|+||.||+|.+..+++.||+|++.+.       ...+..|+.+++.+. ||||+++++.++.++..|+||||+++++
T Consensus         1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e~~~~~~   79 (250)
T cd05123           1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRIN-HPFIVKLHYAFQTEEKLYLVLEYAPGGE   79 (250)
T ss_pred             CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcC-CCcHHHHHHHeecCCeeEEEEecCCCCc
Confidence            69999999999999989999999998653       236788999999997 9999999999999999999999999999


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-CcccccCCCCcc
Q 012170          184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAY  262 (469)
Q Consensus       184 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~~~gt~~y  262 (469)
                      |.+++...+.+++..+..++.|++.||.|||+.+++|+||+|+||+++.++.++|+|||++...... .......++..|
T Consensus        80 L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (250)
T cd05123          80 LFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY  159 (250)
T ss_pred             HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCCCcccCCcCCccc
Confidence            9999988888999999999999999999999999999999999999999999999999999765443 234456789999


Q ss_pred             cCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCC
Q 012170          263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR  341 (469)
Q Consensus       263 ~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~R  341 (469)
                      +|||.+.+. ++.++|+||||+++|+|++|..||...+.......+......++    ..++..+.++|.+||..||.+|
T Consensus       160 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~~i~~~l~~~p~~R  235 (250)
T cd05123         160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFP----EFLSPEARDLISGLLQKDPTKR  235 (250)
T ss_pred             cChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCC----CCCCHHHHHHHHHHhcCCHhhC
Confidence            999998764 78899999999999999999999988877777777766444443    4568999999999999999999


Q ss_pred             CCH---HHHHcCCCc
Q 012170          342 ITA---DEVLRHPWI  353 (469)
Q Consensus       342 psa---~elL~hp~~  353 (469)
                      |++   +++++||||
T Consensus       236 ~~~~~~~~l~~~~~f  250 (250)
T cd05123         236 LGSGGAEEIKAHPFF  250 (250)
T ss_pred             CCcccHHHHHhCCCC
Confidence            999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=2.5e-41  Score=336.48  Aligned_cols=244  Identities=23%  Similarity=0.356  Sum_probs=205.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcE----EEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..+|++.+.||+|+||.||+|.+..+|..    ||+|+++..     ...+.+|+.+++.+. ||||+++++++... ..
T Consensus         6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~g~~~~~-~~   83 (316)
T cd05108           6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TV   83 (316)
T ss_pred             hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEcCC-Cc
Confidence            46799999999999999999998766664    899998642     246778999999996 99999999998764 56


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ++|+||+++|+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~  163 (316)
T cd05108          84 QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE  163 (316)
T ss_pred             eeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEccccccccccCCC
Confidence            7999999999999999774 368899999999999999999999999999999999999999999999999998765333


Q ss_pred             cc---cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TL---SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ..   ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+.... .++.  ...++.++
T Consensus       164 ~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~  240 (316)
T cd05108         164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGE-RLPQ--PPICTIDV  240 (316)
T ss_pred             cceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC--CCCCCHHH
Confidence            21   22334678999999865 58999999999999999997 999999887766655544332 2221  24578899


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcC
Q 012170          327 RDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++|.+||..||.+||++.+++.+
T Consensus       241 ~~li~~cl~~~p~~Rps~~~l~~~  264 (316)
T cd05108         241 YMIMVKCWMIDADSRPKFRELIIE  264 (316)
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=3.8e-41  Score=323.43  Aligned_cols=238  Identities=28%  Similarity=0.409  Sum_probs=209.8

Q ss_pred             eeeeccCCeEEEEEEECCC---CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKAS---GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.+...   +..||+|++...     ...+.+|+++++.+. |+||+++++++.+...+++||||++
T Consensus         1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~   79 (262)
T cd00192           1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLG-HPNVVRLLGVCTEEEPLYLVLEYME   79 (262)
T ss_pred             CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcC-CCChheeeeeecCCCceEEEEEecc
Confidence            4689999999999999866   889999999653     356788999999997 9999999999999999999999999


Q ss_pred             CCchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          181 GGRLIDQMVEV---------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       181 gg~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +++|.+++...         ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||.+.......
T Consensus        80 ~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~  159 (262)
T cd00192          80 GGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD  159 (262)
T ss_pred             CCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEccccccccccccc
Confidence            99999999875         779999999999999999999999999999999999999999999999999998765432


Q ss_pred             ---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                         ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.....+...+......   .....++.++
T Consensus       160 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~  236 (262)
T cd00192         160 YYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL---PKPEYCPDEL  236 (262)
T ss_pred             ccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCccCChHH
Confidence               2334568899999999865 58999999999999999999 69999998888888887763321   2234679999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcC
Q 012170          327 RDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++|.+||..+|.+|||+.++++|
T Consensus       237 ~~li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         237 YELMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHHHccCCcccCcCHHHHHHh
Confidence            999999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.9e-41  Score=335.12  Aligned_cols=250  Identities=27%  Similarity=0.411  Sum_probs=204.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA------  169 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~------  169 (469)
                      .++|.+.+.||.|+||.||+|.++.+++.||||++...      ...+.+|+++++.++ ||||+++++++.+.      
T Consensus         7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   85 (311)
T cd07866           7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLK-HPNVVPLIDMAVERPDKSKR   85 (311)
T ss_pred             cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcC-CCCccchhhheecccccccc
Confidence            57999999999999999999999999999999988432      235678999999996 99999999987443      


Q ss_pred             --CeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                        ..+|+||||+.+ +|...+.. ...+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++..
T Consensus        86 ~~~~~~lv~~~~~~-~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~  164 (311)
T cd07866          86 KRGSVYMVTPYMDH-DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARP  164 (311)
T ss_pred             cCceEEEEEecCCc-CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCccchh
Confidence              357999999975 56666654 35799999999999999999999999999999999999999999999999999975


Q ss_pred             ecCCCc------------ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC
Q 012170          247 ISNGQT------------LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL  312 (469)
Q Consensus       247 ~~~~~~------------~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~  312 (469)
                      ......            .....|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+.....
T Consensus       165 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~  244 (311)
T cd07866         165 YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCG  244 (311)
T ss_pred             ccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhC
Confidence            543221            123457889999998865  378999999999999999999999998776655544432110


Q ss_pred             CCC--------------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          313 DFH--------------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       313 ~~~--------------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ...                          ...+..++..+.+||.+||..||.+|||+.+++.||||
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         245 TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhcCCCC
Confidence            000                          00123456788999999999999999999999999997

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=100.00  E-value=1.8e-41  Score=328.27  Aligned_cols=244  Identities=26%  Similarity=0.434  Sum_probs=206.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|.+.+.||.|+||.||+|.+..+|..||||.+...       ...+.+|+.+++.+. ||||+++++++..++.+++|
T Consensus         2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~~~~~~~v   80 (267)
T cd08229           2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELNIV   80 (267)
T ss_pred             chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHcc-CCchhhhhheeEeCCeEEEE
Confidence            4688899999999999999999999999999987531       246778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          176 MELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |||++|++|.+++..    ...+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~  160 (267)
T cd08229          81 LELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence            999999999998864    3468999999999999999999999999999999999999999999999999987654332


Q ss_pred             -cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 -TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL--EAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       ......|++.|+|||++.+ .++.++|+||||+++|+|++|..||.+...  ......+....  ++...+..++.++.
T Consensus       161 ~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~  238 (267)
T cd08229         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCD--YPPLPSDHYSEELR  238 (267)
T ss_pred             cccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhhcCC--CCCCCcccccHHHH
Confidence             2234578999999999966 488899999999999999999999976543  33333443322  22223346789999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHc
Q 012170          328 DLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +||.+||..||.+|||+.+|++
T Consensus       239 ~li~~~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         239 QLVNMCINPDPEKRPDITYVYD  260 (267)
T ss_pred             HHHHHhcCCCcccCCCHHHHHH
Confidence            9999999999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4e-41  Score=324.39  Aligned_cols=243  Identities=25%  Similarity=0.394  Sum_probs=207.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .+|++.+.||+|+||.||+|.++ ++..+|+|++.+.   ...+.+|+++++.+. ||||+++++++...+..|+||||+
T Consensus         4 ~~~~~~~~lg~G~~~~v~~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~   81 (256)
T cd05059           4 SELTFLKELGSGQFGVVHLGKWR-GKIDVAIKMIREGAMSEDDFIEEAKVMMKLS-HPNLVQLYGVCTKQRPIFIVTEYM   81 (256)
T ss_pred             HHcchhhhhccCCCceEEEeEec-CCccEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEEEEEEEEcCCCceEEEEecC
Confidence            46888999999999999999886 4678999998653   356788999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc--cc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~--~~  256 (469)
                      +|++|.+++... +.+++..+..++.||+.||.|||+.|++||||||+||+++.++.+||+|||++....+.....  ..
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~~~~~  161 (256)
T cd05059          82 ANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT  161 (256)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccccccCCC
Confidence            999999998764 468999999999999999999999999999999999999999999999999997654332211  12


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .++..|+|||.+.+ .++.++||||||+++|+|++ |.+||.+.+..+....+......   .....++.++.+++.+||
T Consensus       162 ~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl  238 (256)
T cd05059         162 KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVSAGYRL---YRPKLAPTEVYTIMYSCW  238 (256)
T ss_pred             CCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHh
Confidence            23457999999865 58999999999999999999 89999888777777766654221   122457999999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      ..+|++|||+.++++.
T Consensus       239 ~~~p~~Rpt~~~~l~~  254 (256)
T cd05059         239 HEKPEDRPAFKKLLSQ  254 (256)
T ss_pred             cCChhhCcCHHHHHHH
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=4.1e-41  Score=322.97  Aligned_cols=245  Identities=26%  Similarity=0.450  Sum_probs=215.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +|++.+.||.|+||.||++.+..+++.||+|.+...      ...+.+|+++++.+. ||||+++++++.+....|+|||
T Consensus         1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e   79 (256)
T cd08530           1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVN-HPNIISYKEAFLDGNKLCIVME   79 (256)
T ss_pred             CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCC-CCCchhhhhhhccCCEEEEEeh
Confidence            588999999999999999999999999999998642      235678999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          178 LCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      |+++++|.+++.+    ...+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++...... ..
T Consensus        80 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~-~~  158 (256)
T cd08530          80 YAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN-MA  158 (256)
T ss_pred             hcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC-Cc
Confidence            9999999998866    356899999999999999999999999999999999999999999999999999766544 33


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....|++.|+|||.+.+. ++.++|+||||+++|+|++|..||...+..+....+........   ...++.+++++|.+
T Consensus       159 ~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~  235 (256)
T cd08530         159 KTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPPI---PPIYSQDLQNFIRS  235 (256)
T ss_pred             ccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCC---chhhCHHHHHHHHH
Confidence            345689999999999764 78899999999999999999999998887777666655443322   23678999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCc
Q 012170          333 MLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      ||..+|.+||++.++++||++
T Consensus       236 ~l~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         236 MLQVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             HcCCCcccCCCHHHHhcCCCC
Confidence            999999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=6.3e-41  Score=324.66  Aligned_cols=244  Identities=25%  Similarity=0.376  Sum_probs=208.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ++|++.+.||+|+||.||+|.++.+   ...||+|.++..     ...+.+|+.+++.+. ||||+++++++...+..|+
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~i   82 (266)
T cd05033           4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFD-HPNIIRLEGVVTKSRPVMI   82 (266)
T ss_pred             HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCcceEeEEEecCCceEE
Confidence            5789999999999999999998754   457999998643     245778999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-c
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-T  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~  252 (469)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||++||+|+||||+|||++.++.++|+|||++....... .
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (266)
T cd05033          83 ITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT  162 (266)
T ss_pred             EEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccc
Confidence            99999999999998764 478999999999999999999999999999999999999999999999999998764211 1


Q ss_pred             --ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          253 --LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       253 --~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                        .....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||...........+.......   ....++..+.+
T Consensus       163 ~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~  239 (266)
T cd05033         163 YTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYRLP---PPMDCPSALYQ  239 (266)
T ss_pred             eeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHH
Confidence              112345678999999875 58999999999999999998 999998887777777776543221   12467899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcC
Q 012170          329 LMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      |+.+||+.+|++||++.+++++
T Consensus       240 li~~cl~~~p~~Rp~~~ei~~~  261 (266)
T cd05033         240 LMLDCWQKDRNERPTFSQIVST  261 (266)
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=100.00  E-value=4.2e-41  Score=366.27  Aligned_cols=246  Identities=26%  Similarity=0.421  Sum_probs=203.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||.||+|.+..+|+.||||++...       ...+.+|+++++.+. ||||+++++++.+++..|+|
T Consensus         2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~-HPNIVkl~~v~~d~~~lyLV   80 (932)
T PRK13184          2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLI-HPGIVPVYSICSDGDPVYYT   80 (932)
T ss_pred             CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCC-CcCcCeEEEEEeeCCEEEEE
Confidence            5799999999999999999999999999999998642       245788999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-----------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          176 MELCSGGRLIDQMVEV-----------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-----------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      |||++||+|.+++...           ..++...+..++.||+.||.|||++||+||||||+|||++.+|.++|+|||++
T Consensus        81 MEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLA  160 (932)
T PRK13184         81 MPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAA  160 (932)
T ss_pred             EEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcc
Confidence            9999999999988642           23456678899999999999999999999999999999999999999999999


Q ss_pred             eeecCCC-------------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH
Q 012170          245 MRISNGQ-------------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF  304 (469)
Q Consensus       245 ~~~~~~~-------------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~  304 (469)
                      .......                   .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.......+.
T Consensus       161 k~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~  240 (932)
T PRK13184        161 IFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKIS  240 (932)
T ss_pred             eecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhh
Confidence            7652110                   0123579999999999976 4899999999999999999999999876544433


Q ss_pred             HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       305 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....... ......+..+++.+.+++.+||..||++|++..+.+.+
T Consensus       241 ~~~~i~~-P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        241 YRDVILS-PIEVAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             hhhhccC-hhhccccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2211111 11112235789999999999999999999876655543

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.7e-41  Score=339.67  Aligned_cols=252  Identities=27%  Similarity=0.495  Sum_probs=208.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||+|++...      ...+.+|+.++++++ ||||+++++++...    
T Consensus        14 ~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~iv~~~~~~~~~~~~~   92 (345)
T cd07877          14 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE   92 (345)
T ss_pred             hccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcC-CCcccceeeeeeeccccc
Confidence            4668999999999999999999999999999999998643      245678999999997 99999999988643    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+|++++ |++|.+++. ...+++..+..++.||+.||.|||+.||+||||||+||+++.++.++|+|||++...
T Consensus        93 ~~~~~~lv~~~~-~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~  170 (345)
T cd07877          93 EFNDVYLVTHLM-GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  170 (345)
T ss_pred             ccccEEEEehhc-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccccccc
Confidence              3478888887 778887764 457999999999999999999999999999999999999999999999999998764


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD------------  313 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------  313 (469)
                      ..  ......|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+....+..+......            
T Consensus       171 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  248 (345)
T cd07877         171 DD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  248 (345)
T ss_pred             cc--cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccH
Confidence            32  2344578999999999865  4788999999999999999999999876655444333221100            


Q ss_pred             -----------CC----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 -----------FH----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 -----------~~----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                 .+    ...+...++++.+||.+||..||.+||++.++|+||||..+
T Consensus       249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h~~f~~~  306 (345)
T cd07877         249 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  306 (345)
T ss_pred             hHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcChhhhhc
Confidence                       00    01112468899999999999999999999999999999654

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=3.2e-41  Score=332.22  Aligned_cols=251  Identities=31%  Similarity=0.500  Sum_probs=213.7

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .|+....||+|+||.||++.+..+|..||||.+...    ...+.+|+.+++.+. ||||+++++++...+..|+||||+
T Consensus        21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~   99 (292)
T cd06657          21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVVMEFL   99 (292)
T ss_pred             HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcC-CcchhheeeEEEeCCEEEEEEecC
Confidence            344457899999999999999999999999998532    345788999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccccCC
Q 012170          180 SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAG  258 (469)
Q Consensus       180 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~~g  258 (469)
                      ++++|.+++ ..+.+++..+..++.|++.||.|||+.|++|+||+|+||+++.++.++|+|||++....... ......|
T Consensus       100 ~~~~L~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~  178 (292)
T cd06657         100 EGGALTDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVG  178 (292)
T ss_pred             CCCcHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccccccccccc
Confidence            999998876 45678999999999999999999999999999999999999999999999999987654322 2234578


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      ++.|+|||.+.+ .++.++|+||+|+++|+|++|.+||.+.........+........ .....++..+.++|.+||..|
T Consensus       179 ~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         179 TPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPKL-KNLHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             CccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCccc-CCcccCCHHHHHHHHHHHhCC
Confidence            999999999865 578999999999999999999999998777666655544322111 122457899999999999999


Q ss_pred             hcCCCCHHHHHcCCCccccc
Q 012170          338 VSARITADEVLRHPWILFYT  357 (469)
Q Consensus       338 P~~Rpsa~elL~hp~~~~~~  357 (469)
                      |.+||++.++|.||||....
T Consensus       258 P~~R~~~~~ll~~~~~~~~~  277 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAG  277 (292)
T ss_pred             cccCcCHHHHhcChHHhccC
Confidence            99999999999999996554

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.5e-41  Score=354.44  Aligned_cols=254  Identities=28%  Similarity=0.472  Sum_probs=224.9

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEE-----eCCe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYE-----EADC  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~-----~~~~  171 (469)
                      ...+.|++.+.||.|.+|.||+++++.+++..|+|+...   .++++..|.+||+.+..|||++.+|++|.     .++.
T Consensus        16 dp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~Dq   95 (953)
T KOG0587|consen   16 DPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQ   95 (953)
T ss_pred             CCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCe
Confidence            345789999999999999999999999999999999864   35788999999999999999999999985     3678


Q ss_pred             EEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          172 FHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +|||||||.||+..|++...  ..+.|..++.|++.++.||.+||.+.++|||||-.|||++.+|.|||+|||++.....
T Consensus        96 LWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds  175 (953)
T KOG0587|consen   96 LWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS  175 (953)
T ss_pred             EEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec
Confidence            99999999999999988654  4689999999999999999999999999999999999999999999999999987764


Q ss_pred             C-CcccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          250 G-QTLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      . ....+.+|||.|||||++..      .|+..+|+||||++..||.-|.+|+-+..+...+..|....++ ....|..+
T Consensus       176 T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmraLF~IpRNPPP-kLkrp~kW  254 (953)
T KOG0587|consen  176 TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPPP-KLKRPKKW  254 (953)
T ss_pred             ccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhhhccCCCCCCc-cccchhhH
Confidence            4 34567899999999999943      3788999999999999999999999998887777666554322 22345678


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      +.++.+||..||.+|-.+||+..++|+|||+.
T Consensus       255 s~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi~  286 (953)
T KOG0587|consen  255 SKKFNDFISTCLVKDYEQRPSTEELLKHPFIT  286 (953)
T ss_pred             HHHHHHHHHHHHhhccccCcchhhhccCCccc
Confidence            99999999999999999999999999999996

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=2.2e-41  Score=330.01  Aligned_cols=247  Identities=32%  Similarity=0.527  Sum_probs=209.0

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      |.+++.||.|++|.||+|.+..+|+.+|+|.+...      ...+.+|+++|+.+. ||||+++++++.+++.+++||||
T Consensus         1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~   79 (283)
T cd05118           1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELN-HPNIIKLLDVFRHKGDLYLVFEF   79 (283)
T ss_pred             CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhc-CCCcchHHHhhccCCCEEEEEec
Confidence            56788999999999999999999999999998643      245778999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          179 CSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      +++ +|.+.+... ..+++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||.+....... .....
T Consensus        80 ~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~~~~~~  158 (283)
T cd05118          80 MDT-DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHY  158 (283)
T ss_pred             cCC-CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcccccCc
Confidence            975 787777663 589999999999999999999999999999999999999999999999999997765443 23345


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------CC
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------FH  315 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------~~  315 (469)
                      .++..|+|||.+.+  .++.++|+||||+++|+|++|..||.+.+..+.+..+......                   ++
T Consensus       159 ~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (283)
T cd05118         159 VVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFP  238 (283)
T ss_pred             cCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhc
Confidence            68889999999865  4788999999999999999999999887765554443221000                   00


Q ss_pred             -------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          316 -------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       316 -------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                             ...+..++.++.+||.+||..||.+||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         239 KKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALAHPYF  283 (283)
T ss_pred             cccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhhCCCC
Confidence                   01223578899999999999999999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=2e-41  Score=339.10  Aligned_cols=246  Identities=20%  Similarity=0.303  Sum_probs=199.2

Q ss_pred             eeeecc--CCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHG--KFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      ..||.|  +||+||+|.+..+|+.||+|++...      .+.+.+|+.+++.+. ||||++++++|..++.+|+||||+.
T Consensus         4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~~~~~~v~e~~~   82 (328)
T cd08226           4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFR-HPNIMTSWTVFTTGSWLWVISPFMA   82 (328)
T ss_pred             HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcceEeeeEecCCceEEEEeccc
Confidence            456666  9999999999999999999998642      245788999999996 9999999999999999999999999


Q ss_pred             CCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc------
Q 012170          181 GGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT------  252 (469)
Q Consensus       181 gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~------  252 (469)
                      +++|.+++...  ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++++||+.+........      
T Consensus        83 ~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~  162 (328)
T cd08226          83 YGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVY  162 (328)
T ss_pred             CCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccc
Confidence            99999988764  3589999999999999999999999999999999999999999999999986533221110      


Q ss_pred             --ccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-------------
Q 012170          253 --LSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-------------  314 (469)
Q Consensus       253 --~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------------  314 (469)
                        .....++..|+|||++.+   .++.++|||||||++|+|++|.+||.+.........+.......             
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (328)
T cd08226         163 DFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESR  242 (328)
T ss_pred             cccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhh
Confidence              011235667999999965   37899999999999999999999998766544433332211100             


Q ss_pred             ------------------------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          315 ------------------------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       315 ------------------------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                                                    .......+++.+.+||.+||..||.+|||+.|+|+||||..
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         243 MKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence                                          00112245778999999999999999999999999999943

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=2.5e-41  Score=339.92  Aligned_cols=246  Identities=24%  Similarity=0.351  Sum_probs=201.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-AD  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~  170 (469)
                      .++|++++.||+|+||.||+|.+..     +++.||+|+++..     ...+.+|+.++.++..||||+++++++.. +.
T Consensus         6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~   85 (337)
T cd05054           6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGG   85 (337)
T ss_pred             HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCC
Confidence            3589999999999999999997543     4578999998642     23567899999999669999999998764 46


Q ss_pred             eEEEEEeccCCCchHHHHHHh-----------------------------------------------------------
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-----------------------------------------------------------  191 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------------  191 (469)
                      .+++||||+++|+|.+++...                                                           
T Consensus        86 ~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (337)
T cd05054          86 PLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDEL  165 (337)
T ss_pred             CEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHH
Confidence            789999999999999988542                                                           


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCce
Q 012170          192 --GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPE  266 (469)
Q Consensus       192 --~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE  266 (469)
                        ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++..+.....   .....++..|+|||
T Consensus       166 ~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE  245 (337)
T cd05054         166 YKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE  245 (337)
T ss_pred             hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence              2578899999999999999999999999999999999999999999999999976543221   22345677899999


Q ss_pred             eccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCC
Q 012170          267 VLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVF-DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT  343 (469)
Q Consensus       267 ~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps  343 (469)
                      ++.+ .++.++|||||||++|+|++ |..||.+....+.+ ..+.......   ....+++++.+++.+||+.+|++||+
T Consensus       246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~cl~~~p~~RPs  322 (337)
T cd05054         246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMR---APEYATPEIYSIMLDCWHNNPEDRPT  322 (337)
T ss_pred             HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCC---CCccCCHHHHHHHHHHccCChhhCcC
Confidence            8866 58999999999999999998 99999875543333 3333322211   12357899999999999999999999


Q ss_pred             HHHHHcC
Q 012170          344 ADEVLRH  350 (469)
Q Consensus       344 a~elL~h  350 (469)
                      +.|+++|
T Consensus       323 ~~ell~~  329 (337)
T cd05054         323 FSELVEI  329 (337)
T ss_pred             HHHHHHH
Confidence            9999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=9.4e-41  Score=332.08  Aligned_cols=251  Identities=28%  Similarity=0.433  Sum_probs=211.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .+.+.|...+.||+|+||.||+|++..+|..||+|++...       ...+.+|+++++.++ |||++++++++.+.+..
T Consensus        18 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   96 (313)
T cd06633          18 DPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLK-HPNTIEYKGCYLKEHTA   96 (313)
T ss_pred             CHHHHhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEE
Confidence            3455677788999999999999999999999999998532       135778999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+.| ++.+.+.. ..++++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||++....   
T Consensus        97 ~lv~e~~~~-~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~---  172 (313)
T cd06633          97 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS---  172 (313)
T ss_pred             EEEEecCCC-CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccC---
Confidence            999999964 67776654 4568999999999999999999999999999999999999999999999999985432   


Q ss_pred             cccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      ......|+..|+|||++.    +.++.++|||||||++|+|++|.+||...+.......+......  ......++..++
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~  250 (313)
T cd06633         173 PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNDSP--TLQSNEWTDSFR  250 (313)
T ss_pred             CCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCHHHH
Confidence            233467899999999984    34888999999999999999999999887765555555443221  112245688999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +||.+||+.+|.+||++.++++||||....
T Consensus       251 ~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         251 GFVDYCLQKIPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             HHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999999999999996543

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=5.5e-41  Score=327.38  Aligned_cols=245  Identities=26%  Similarity=0.353  Sum_probs=207.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .+.|.+.+.||+|+||.||+|.+..     ++..||+|.+...     ...+.+|+.+++.+. |+||+++++++.+.+.
T Consensus         5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~   83 (277)
T cd05036           5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFN-HQNIVRLIGVSFERLP   83 (277)
T ss_pred             HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCC
Confidence            3679999999999999999999987     7789999998632     245788999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEEec
Q 012170          172 FHLVMELCSGGRLIDQMVEVG-------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADF  241 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~DF  241 (469)
                      .++||||+.|++|.+++...+       .+++..+..++.||+.||.|||++|++||||||+|||++.++   .+||+||
T Consensus        84 ~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~df  163 (277)
T cd05036          84 RFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADF  163 (277)
T ss_pred             cEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEeccC
Confidence            999999999999999987654       488999999999999999999999999999999999998765   5999999


Q ss_pred             cceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCC
Q 012170          242 GLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHS  316 (469)
Q Consensus       242 gla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  316 (469)
                      |++........   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.........+......   
T Consensus       164 g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---  240 (277)
T cd05036         164 GMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGGGRL---  240 (277)
T ss_pred             ccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcC---
Confidence            99976532221   112233567999999865 59999999999999999997 99999988877777666543221   


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .....++..+.++|.+||+.+|++|||+.++|+|
T Consensus       241 ~~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         241 DPPKGCPGPVYRIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            1124678999999999999999999999999987

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=5.7e-41  Score=329.84  Aligned_cols=247  Identities=23%  Similarity=0.320  Sum_probs=207.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCC----------------cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCee
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASG----------------AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVV  160 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~----------------~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv  160 (469)
                      ..+|++++.||+|+||.||+|.+..++                ..||+|.+...     ...+.+|+++++.+. ||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~   82 (296)
T cd05051           4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLS-DPNIA   82 (296)
T ss_pred             hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcC-CCCEe
Confidence            368999999999999999999876544                45899998653     246778999999997 99999


Q ss_pred             EEEEEEEeCCeEEEEEeccCCCchHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEE
Q 012170          161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-----------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL  229 (469)
Q Consensus       161 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NIL  229 (469)
                      ++++++..++.+++||||+.+++|.+++....           .+++..+..++.|++.||.|||++|++||||||+||+
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Nil  162 (296)
T cd05051          83 RLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCL  162 (296)
T ss_pred             EEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhcee
Confidence            99999999999999999999999999997765           6899999999999999999999999999999999999


Q ss_pred             EccCCcEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 012170          230 LTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV--AALPFKGDSLEAV  303 (469)
Q Consensus       230 l~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~  303 (469)
                      ++.++.++|+|||++.......   ......+++.|+|||++.+ .++.++|||||||++|+|++  |..||...+....
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05051         163 VGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQQV  242 (296)
T ss_pred             ecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChHHH
Confidence            9999999999999997654332   1223456788999999865 68999999999999999998  7889987776666


Q ss_pred             HHHHHcC----cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          304 FDAIKNV----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       304 ~~~i~~~----~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +..+...    ...........++.++.+||.+||+.||.+|||+.++++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         243 IENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence            6665433    111111112356899999999999999999999999965

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=3.1e-41  Score=339.75  Aligned_cols=253  Identities=26%  Similarity=0.409  Sum_probs=205.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-------
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEA-------  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-------  169 (469)
                      +..+|.+.+.||.|+||.||+|.+..+|..||+|.+...    ...+.+|+++++.++ ||||+++++++...       
T Consensus         3 ~~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~   81 (342)
T cd07854           3 LGSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVYEVLGPSGSDLTED   81 (342)
T ss_pred             cCcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcC-CCcchhhHhhhcccccccccc
Confidence            457899999999999999999999999999999998542    345788999999996 99999999876543       


Q ss_pred             -------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEec
Q 012170          170 -------DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADF  241 (469)
Q Consensus       170 -------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DF  241 (469)
                             ...|+||||+. ++|.+.+. .+.+++..+..++.||+.||.|||+.|++||||||+||+++. ++.++|+||
T Consensus        82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~kl~df  159 (342)
T cd07854          82 VGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDF  159 (342)
T ss_pred             cccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCc
Confidence                   35899999997 48877774 457999999999999999999999999999999999999975 557899999


Q ss_pred             cceeeecCCCc----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC--
Q 012170          242 GLAMRISNGQT----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD--  313 (469)
Q Consensus       242 gla~~~~~~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--  313 (469)
                      |++........    .....|+..|+|||++.+  .++.++|||||||++|+|++|..||.+.+.......+......  
T Consensus       160 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  239 (342)
T cd07854         160 GLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVR  239 (342)
T ss_pred             ccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCC
Confidence            99976533211    122467889999998754  4788999999999999999999999877655544433221100  


Q ss_pred             --------------------CC----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 --------------------FH----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 --------------------~~----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                          ..    ......++.++.+||.+||+.||.+|||+.++|.||||..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         240 EEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             hHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhCCCccccc
Confidence                                00    00113578899999999999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=5.7e-41  Score=332.41  Aligned_cols=247  Identities=23%  Similarity=0.330  Sum_probs=208.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-------CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..++|.+.+.||+|+||.||+|.+..       ++..+|+|.++..     ...+.+|+.+++.+.+||||+++++++..
T Consensus        16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~   95 (307)
T cd05098          16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   95 (307)
T ss_pred             ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEec
Confidence            34689999999999999999998643       3357999999753     13577899999999669999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+.+|+||||+.+|+|.+++...+                .++...+..++.||+.||.|||++|++||||||+|||++.
T Consensus        96 ~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~  175 (307)
T cd05098          96 DGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  175 (307)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcC
Confidence            999999999999999999997642                3788899999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+
T Consensus       176 ~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~  255 (307)
T cd05098         176 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  255 (307)
T ss_pred             CCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence            99999999999876543221   112234578999999876 48999999999999999998 89999988888877777


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ......   .....++.++.+||.+||..+|.+|||+.+++++
T Consensus       256 ~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         256 KEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             HcCCCC---CCCCcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            654321   2234678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.4e-41  Score=339.67  Aligned_cols=255  Identities=29%  Similarity=0.482  Sum_probs=210.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--Ce
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEA--DC  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~  171 (469)
                      .+.++|++.+.||+|+||.||+|.+..+|..||+|.+.+      ....+.+|+.+++++.+||||+++++++...  ..
T Consensus         4 ~~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~   83 (337)
T cd07852           4 HILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD   83 (337)
T ss_pred             hhhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence            467899999999999999999999999999999998843      1245678999999994499999999998653  46


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+||||+. ++|..++... .+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||++.......
T Consensus        84 ~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~  161 (337)
T cd07852          84 IYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE  161 (337)
T ss_pred             EEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhcccccc
Confidence            899999997 4888887654 88999999999999999999999999999999999999999999999999997654322


Q ss_pred             ------cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc------------
Q 012170          252 ------TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK------------  311 (469)
Q Consensus       252 ------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------  311 (469)
                            ......|++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.........+....            
T Consensus       162 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (337)
T cd07852         162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIK  241 (337)
T ss_pred             ccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHH
Confidence                  2234578999999998854  47889999999999999999999998766544433321111            


Q ss_pred             ---------------CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 ---------------LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 ---------------~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                     ..........++.++.+||.+||+.||.+|||+.++++||||..+
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         242 SPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             hhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhChhhhhh
Confidence                           001111223478999999999999999999999999999999654

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=7e-41  Score=325.87  Aligned_cols=245  Identities=23%  Similarity=0.286  Sum_probs=208.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++.+.||+|+||.||+|.++..     +..||+|.+....     ..+.+|+.+|+.+. ||||+++++++...+
T Consensus         4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~   82 (277)
T cd05032           4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSTGQ   82 (277)
T ss_pred             chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCC-CCceeEEEEEEcCCC
Confidence            357899999999999999999988644     3789999986432     35778999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC----------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG----------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~----------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                      ..|+||||+++|+|.+++....          .+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|
T Consensus        83 ~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~d  162 (277)
T cd05032          83 PTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGD  162 (277)
T ss_pred             CcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEECC
Confidence            9999999999999999986532          367788999999999999999999999999999999999999999999


Q ss_pred             ccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      ||++........   .....++..|+|||.+.+ .++.++|||||||++|+|++ |.+||.+.+.......+....... 
T Consensus       163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-  241 (277)
T cd05032         163 FGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLD-  241 (277)
T ss_pred             cccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCC-
Confidence            999876543321   223456789999999864 58999999999999999998 999999888888887777443211 


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                        ....++.++.+||.+||+.+|++|||+.+++.
T Consensus       242 --~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         242 --LPENCPDKLLELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             --CCCCCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence              12356899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.7e-40  Score=320.77  Aligned_cols=243  Identities=24%  Similarity=0.348  Sum_probs=208.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++.+.||+|+||.||+|.+.. +..||+|.++..   ...+.+|+.+++++. ||||+++++++...+..|+||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   82 (261)
T cd05068           5 RTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTMDPKDFLAEAQIMKKLR-HPKLIQLYAVCTLEEPIYIVTEL   82 (261)
T ss_pred             hhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcccHHHHHHHHHHHHHCC-CCCccceeEEEecCCCeeeeeec
Confidence            4679999999999999999998764 578999999753   356889999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--c
Q 012170          179 CSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--S  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~  254 (469)
                      +.+++|.+++....  .+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........  .
T Consensus        83 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~  162 (261)
T cd05068          83 MKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE  162 (261)
T ss_pred             ccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcccccC
Confidence            99999999997654  6899999999999999999999999999999999999999999999999999876533221  1


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      +..++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+..... .  .....++..+.++|.+
T Consensus       163 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~li~~  239 (261)
T cd05068         163 GAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYR-M--PCPPGCPKELYDIMLD  239 (261)
T ss_pred             CCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC-C--CCCCcCCHHHHHHHHH
Confidence            1223457999999876 58899999999999999999 9999998888777777765422 1  1224678999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||+.+|.+||++.++++
T Consensus       240 ~l~~~P~~Rp~~~~l~~  256 (261)
T cd05068         240 CWKEDPDDRPTFETLQW  256 (261)
T ss_pred             HhhcCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=8.2e-41  Score=322.40  Aligned_cols=235  Identities=28%  Similarity=0.374  Sum_probs=200.9

Q ss_pred             eeeccCCeEEEEEEE--CCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          110 VIGHGKFGSVWLCRS--KASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      .||+|+||.||+|.+  ..++..+|+|+++..      .+.+..|+.+++.+. ||||+++++++. .+.+++||||+++
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~-~~~~~lv~e~~~~   79 (257)
T cd05116           2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLD-NPYIVRMIGICE-AESWMLVMELAEL   79 (257)
T ss_pred             cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCC-CCCcceEEEEEc-CCCcEEEEecCCC
Confidence            589999999999965  467889999998643      246788999999996 999999999885 4567899999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc----ccccC
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGLA  257 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~----~~~~~  257 (469)
                      |+|.+++...+.+++..+..++.|++.||.|||++|++||||||.|||++.++.++|+|||++........    .....
T Consensus        80 ~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05116          80 GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGK  159 (257)
T ss_pred             CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCC
Confidence            99999998888899999999999999999999999999999999999999999999999999976543322    12223


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      +++.|+|||++.. .++.++|||||||++|+|++ |.+||.+....++...+.......   ....+++++.+||.+||+
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~~li~~~~~  236 (257)
T cd05116         160 WPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERME---CPQRCPPEMYDLMKLCWT  236 (257)
T ss_pred             CCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHhc
Confidence            4678999999865 58889999999999999998 999999888888888877654311   224689999999999999


Q ss_pred             hhhcCCCCHHHHHc
Q 012170          336 RDVSARITADEVLR  349 (469)
Q Consensus       336 ~dP~~Rpsa~elL~  349 (469)
                      .||.+||++.+|..
T Consensus       237 ~~p~~Rp~~~~i~~  250 (257)
T cd05116         237 YGVDERPGFAVVEL  250 (257)
T ss_pred             cCchhCcCHHHHHH
Confidence            99999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=5.4e-41  Score=329.73  Aligned_cols=246  Identities=24%  Similarity=0.349  Sum_probs=208.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++.+.||+|+||.||++.+...     ...+|+|.+....     ..+.+|+.+++.+.+||||+++++++...+.
T Consensus        11 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~   90 (293)
T cd05053          11 RDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGP   90 (293)
T ss_pred             HhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCC
Confidence            46799999999999999999987643     3689999986431     3577899999999559999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc
Q 012170          172 FHLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK  235 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~  235 (469)
                      +|+||||+++|+|.+++...                +.+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus        91 ~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~  170 (293)
T cd05053          91 LYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHV  170 (293)
T ss_pred             eEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCe
Confidence            99999999999999998643                35788999999999999999999999999999999999999999


Q ss_pred             EEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 012170          236 IKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNV  310 (469)
Q Consensus       236 vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~  310 (469)
                      +||+|||++........   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+...
T Consensus       171 ~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~  250 (293)
T cd05053         171 MKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEG  250 (293)
T ss_pred             EEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcC
Confidence            99999999976543321   122335678999999865 58999999999999999997 99999988888877777654


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...   .....++.++.+||.+||..||.+|||+.+++++
T Consensus       251 ~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         251 YRM---EKPQNCTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CcC---CCCCCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            321   1224678999999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=9.8e-41  Score=328.09  Aligned_cols=243  Identities=22%  Similarity=0.342  Sum_probs=208.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+|.+.+.||+|+||.||+|.+.     .++..+++|.+....    ..+.+|+.+++.+. ||||+++++++...+..+
T Consensus         5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   83 (291)
T cd05094           5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEHIVKFYGVCGDGDPLI   83 (291)
T ss_pred             HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCceE
Confidence            46888999999999999999854     345679999986542    46889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEE
Q 012170          174 LVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vk  237 (469)
                      +||||+++++|.+++...+                .+++..+..++.||+.||.|||++|++||||||+|||++.++.++
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~  163 (291)
T cd05094          84 MVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVK  163 (291)
T ss_pred             EEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence            9999999999999997643                378899999999999999999999999999999999999999999


Q ss_pred             EEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcC
Q 012170          238 LADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKL  312 (469)
Q Consensus       238 L~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~  312 (469)
                      |+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||...+..+..+.+.....
T Consensus       164 l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~  243 (291)
T cd05094         164 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRV  243 (291)
T ss_pred             ECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCC
Confidence            999999975543221   233456888999999876 58899999999999999998 9999988888887777766543


Q ss_pred             CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       313 ~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ...   ...++..+.++|.+||..||.+|||+.++++
T Consensus       244 ~~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         244 LER---PRVCPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCC---CccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            322   2356899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=1.6e-40  Score=330.96  Aligned_cols=252  Identities=29%  Similarity=0.434  Sum_probs=213.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .+...|...+.||+|+||.||+|++..+|..||+|++...       ...+.+|+++++.+. |||++++++++.+++..
T Consensus        22 ~~~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~  100 (317)
T cd06635          22 DPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIK-HPNSIEYKGCYLREHTA  100 (317)
T ss_pred             CchhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCeE
Confidence            3556688899999999999999999999999999998632       135778999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+.| +|.+.+.. ..++++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||++.....  
T Consensus       101 ~lv~e~~~g-~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--  177 (317)
T cd06635         101 WLVMEYCLG-SASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--  177 (317)
T ss_pred             EEEEeCCCC-CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence            999999975 67776644 45789999999999999999999999999999999999999999999999999865432  


Q ss_pred             cccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       .....|++.|+|||++.    +.++.++|||||||++|+|++|.+||.+.........+........  ....+++.++
T Consensus       178 -~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  254 (317)
T cd06635         178 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTL--QSNEWSDYFR  254 (317)
T ss_pred             -cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhccCCCC--CCccccHHHH
Confidence             23457899999999973    3588999999999999999999999988776666665554432211  1235788999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +||.+||+.+|.+||++.++++|+|+.....
T Consensus       255 ~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         255 NFVDSCLQKIPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             HHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999999999999965443

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=1.3e-40  Score=333.50  Aligned_cols=254  Identities=30%  Similarity=0.514  Sum_probs=209.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEE-ADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~~  171 (469)
                      ..+.++|++++.||.|+||.||+|.+..+|..||||++.+      ....+.+|+.+++.+. ||||++++++|.. ...
T Consensus         6 ~~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   84 (328)
T cd07856           6 FEITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLR-HENIISLSDIFISPLED   84 (328)
T ss_pred             eccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcC-CCCeeeEeeeEecCCCc
Confidence            4567899999999999999999999999999999998753      2356778999999997 9999999999865 567


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      .|+||||+ +++|..++. ...+++..+..++.||+.||.|||++|++||||+|.|||++.++.++|+|||++.....  
T Consensus        85 ~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~--  160 (328)
T cd07856          85 IYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP--  160 (328)
T ss_pred             EEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC--
Confidence            89999999 568877664 45788999999999999999999999999999999999999999999999999875432  


Q ss_pred             cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC-------------------
Q 012170          252 TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV-------------------  310 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~-------------------  310 (469)
                      ......+++.|+|||++.+  .++.++||||||+++|+|++|.+||.+.........+.+.                   
T Consensus       161 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (328)
T cd07856         161 QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLR  240 (328)
T ss_pred             CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHH
Confidence            2234568899999999865  4899999999999999999999999876653332222110                   


Q ss_pred             -----cCC--CC-CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          311 -----KLD--FH-SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       311 -----~~~--~~-~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                           ...  .+ ......++.++.++|.+||+.+|++|||+.+++.||||..+.
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~~~~~~~~  295 (328)
T cd07856         241 FVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAHPYLAPYH  295 (328)
T ss_pred             HHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCCcccccc
Confidence                 000  00 011235788999999999999999999999999999996443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.1e-40  Score=323.26  Aligned_cols=242  Identities=22%  Similarity=0.311  Sum_probs=203.5

Q ss_pred             eeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe----
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC----  171 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~----  171 (469)
                      |.+++.||+|+||.||+|....+   +..||+|.++..      ...+.+|+.+++.+. ||||+++++++...+.    
T Consensus         1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   79 (273)
T cd05035           1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFD-HPNVMKLIGVCFEASSLQKI   79 (273)
T ss_pred             CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCC-CCCeeeEEeeeccCCccccC
Confidence            56789999999999999987653   478999998643      145788999999996 9999999998865543    


Q ss_pred             --EEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          172 --FHLVMELCSGGRLIDQMVEV------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       172 --~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                        .++||||+++|+|..++...      ..+++..+..++.|++.||.|||++|++||||||+||++++++.+||+|||+
T Consensus        80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  159 (273)
T cd05035          80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL  159 (273)
T ss_pred             cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence              79999999999999888543      2588999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCcc---cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          244 AMRISNGQTL---SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       244 a~~~~~~~~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      +.........   ....++..|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+.++.+.......   .
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~  236 (273)
T cd05035         160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK---Q  236 (273)
T ss_pred             eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---C
Confidence            9865433221   12335678999999865 48999999999999999999 999999888888877776553221   2


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...++.++.++|.+||+.||.+|||+.+++++
T Consensus       237 ~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         237 PEDCLDELYDLMYSCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             CcCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            24679999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=4.5e-41  Score=338.62  Aligned_cols=251  Identities=31%  Similarity=0.536  Sum_probs=207.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|.+.+.||+|+||.||+|.+..+|+.||||++.+.      ...+.+|+.+++.+. ||||+++++++...    
T Consensus        12 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~~~~~~~~~~~~~   90 (342)
T cd07879          12 ELPERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQ-HENVIGLLDVFTSAVSGD   90 (342)
T ss_pred             ccccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcC-CCCccchhheecccccCC
Confidence            4567899999999999999999999999999999998642      235778999999996 99999999998754    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+||||+.+ +|..++  ...+++..+..++.|++.||.|||++|++||||||+|||++.++.++|+|||++...
T Consensus        91 ~~~~~~lv~e~~~~-~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~  167 (342)
T cd07879          91 EFQDFYLVMPYMQT-DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHA  167 (342)
T ss_pred             CCceEEEEeccccc-CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCC
Confidence              346999999964 665544  346899999999999999999999999999999999999999999999999998754


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-------------  312 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  312 (469)
                      ..  ......|++.|+|||++.+  .++.++|||||||++|+|++|..||.+.+....+..+.....             
T Consensus       168 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (342)
T cd07879         168 DA--EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDK  245 (342)
T ss_pred             CC--CCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhccc
Confidence            32  2334578899999999865  488999999999999999999999998776554444332110             


Q ss_pred             ----------CCCC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 ----------DFHS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 ----------~~~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                ..+.    ..+..++.++.+||.+||+.||.+||++.++|.||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~  303 (342)
T cd07879         246 AAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF  303 (342)
T ss_pred             chHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence                      0010    1123568889999999999999999999999999999544

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=100.00  E-value=1.7e-40  Score=320.86  Aligned_cols=244  Identities=27%  Similarity=0.459  Sum_probs=207.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.+..+|+.||+|.++.       ....+.+|+++++++. |+||+++++++...+..++|
T Consensus         2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~-~~~i~~~~~~~~~~~~~~lv   80 (267)
T cd08224           2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD-HPNVIKYLASFIENNELNIV   80 (267)
T ss_pred             CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCC-CCCeeeeeeeeecCCeEEEE
Confidence            579999999999999999999999999999998853       1356889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          176 MELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |||+++|+|.+++...    ..+++..+..++.||+.||.|||+.|++||||+|+||+++.++.++|+|||++.......
T Consensus        81 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~  160 (267)
T cd08224          81 LELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT  160 (267)
T ss_pred             EecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence            9999999999988642    458999999999999999999999999999999999999999999999999987654322


Q ss_pred             -cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 -TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS--LEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~--~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       ......|++.|+|||.+.+ .++.++|+||||+++|+|++|..||....  .....+.+......  ......++.++.
T Consensus       161 ~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~  238 (267)
T cd08224         161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEKCDYP--PLPADHYSEELR  238 (267)
T ss_pred             cccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhhcCCCC--CCChhhcCHHHH
Confidence             2234578999999999866 48999999999999999999999996543  33444444443221  112236788999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHc
Q 012170          328 DLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++|.+||..+|.+|||+.+|++
T Consensus       239 ~~i~~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         239 DLVSRCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHHHHHcCCCcccCCCHHHHHH
Confidence            9999999999999999999875

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=4e-41  Score=328.99  Aligned_cols=244  Identities=21%  Similarity=0.306  Sum_probs=208.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .+|.+++.||.|+||.||+|.+..+     +..||+|+++...     +.+.+|+.++..+. ||||+++++++...+..
T Consensus         5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~   83 (283)
T cd05091           5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQ-HPNIVCLLGVVTKEQPL   83 (283)
T ss_pred             HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEcCCCce
Confidence            4578889999999999999987543     5789999997432     45778999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          173 HLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      ++++||+.+++|.+++...                ..+++..+..++.|++.||.|||++||+||||||+|||+++++.+
T Consensus        84 ~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~  163 (283)
T cd05091          84 SMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNV  163 (283)
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCce
Confidence            9999999999999988532                347888899999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc
Q 012170          237 KLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK  311 (469)
Q Consensus       237 kL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  311 (469)
                      ||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....+....+....
T Consensus       164 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~  243 (283)
T cd05091         164 KISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQ  243 (283)
T ss_pred             EecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC
Confidence            9999999876543222   223456789999999854 68999999999999999998 889999988888888887765


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....   ...++..+.+||.+||+.+|.+||++.+|+..
T Consensus       244 ~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         244 VLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             cCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            4322   24689999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1.5e-40  Score=324.50  Aligned_cols=243  Identities=24%  Similarity=0.341  Sum_probs=205.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .++|++++.||.|+||.||+|.+..+|.    .||+|+++..     ...+.+|+.+++.+. ||||+++++++.. ...
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~-~~~   83 (279)
T cd05109           6 ETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVG-SPYVCRLLGICLT-STV   83 (279)
T ss_pred             hhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcC-CCCCceEEEEEcC-CCc
Confidence            4689999999999999999999877776    4899998642     245778999999996 9999999999875 456


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +++|||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~  163 (279)
T cd05109          84 QLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDE  163 (279)
T ss_pred             EEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCceeeccccc
Confidence            7999999999999998764 568999999999999999999999999999999999999999999999999998764332


Q ss_pred             cc---cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TL---SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ..   ....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||...........+.......   ....++.++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  240 (279)
T cd05109         164 TEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREIPDLLEKGERLP---QPPICTIDV  240 (279)
T ss_pred             ceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCC---CCccCCHHH
Confidence            21   22345678999999865 58999999999999999998 999998877777766666543222   124678999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .++|.+||..||.+||++.+++.
T Consensus       241 ~~li~~~l~~dp~~Rp~~~~l~~  263 (279)
T cd05109         241 YMIMVKCWMIDSECRPRFRELVD  263 (279)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.8e-40  Score=319.85  Aligned_cols=236  Identities=25%  Similarity=0.350  Sum_probs=201.3

Q ss_pred             eeeeccCCeEEEEEEECCCC---cEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASG---AEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.+..++   ..||+|.+....     ..+.+|+.+++.+. ||||+++++++. .+.+++||||++
T Consensus         1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~~~v~e~~~   78 (257)
T cd05060           1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLD-HPCIVRLIGVCK-GEPLMLVMELAP   78 (257)
T ss_pred             CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcC-CCCeeeEEEEEc-CCceEEEEEeCC
Confidence            46999999999999876554   789999987433     46778999999996 999999999876 456789999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc----ccc
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL----SGL  256 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~----~~~  256 (469)
                      +|+|.+++...+.+++..+..++.|++.||.|||+.|++|+||||+|||++.++.++|+|||++.........    ...
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~  158 (257)
T cd05060          79 LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAG  158 (257)
T ss_pred             CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCc
Confidence            9999999988888999999999999999999999999999999999999999999999999999866433221    112


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .++..|+|||.+.+ .++.++||||||+++|+|++ |.+||...+..++...+......   .....++..++++|.+||
T Consensus       159 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~cl  235 (257)
T cd05060         159 RWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERL---PRPEECPQEIYSIMLSCW  235 (257)
T ss_pred             cccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC---CCCCCCCHHHHHHHHHHh
Confidence            23467999999865 58999999999999999998 99999988877777777665432   223567899999999999


Q ss_pred             hhhhcCCCCHHHHHc
Q 012170          335 TRDVSARITADEVLR  349 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~  349 (469)
                      ..+|.+||++.++++
T Consensus       236 ~~~p~~Rp~~~~l~~  250 (257)
T cd05060         236 KYRPEDRPTFSELES  250 (257)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=1.6e-40  Score=328.68  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=209.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-------CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-------ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..++|.+.+.||+|+||.||+|++.       .++..||+|.+...     ...+.+|+.+++.+.+||||+++++++..
T Consensus        13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~   92 (304)
T cd05101          13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   92 (304)
T ss_pred             cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence            4578999999999999999999753       23457999998642     24678999999999569999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+..|+||||+.+|+|.+++....                .++...+..++.||+.||.|||++|++||||||+|||++.
T Consensus        93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~  172 (304)
T cd05101          93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTE  172 (304)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcC
Confidence            999999999999999999997642                3677889999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.+||+|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++...+
T Consensus       173 ~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~  252 (304)
T cd05101         173 NNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  252 (304)
T ss_pred             CCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHH
Confidence            99999999999986643221   223346778999999866 48999999999999999998 88999998888888877


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .......   ....++.++.+||.+||..+|.+|||+.++++.
T Consensus       253 ~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         253 KEGHRMD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             HcCCcCC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            6554221   224678999999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=4.1e-41  Score=324.63  Aligned_cols=243  Identities=23%  Similarity=0.349  Sum_probs=210.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..+|++++.||.|+||.||+|.+.. +..+|+|++...    ...+..|+.+++.++ ||||+++++++.+.+.+++|||
T Consensus         5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e   82 (261)
T cd05148           5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDDLLKQQDFQKEVQALKRLR-HKHLISLFAVCSVGEPVYIITE   82 (261)
T ss_pred             HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccchhhHHHHHHHHHHHhcCC-CcchhheeeeEecCCCeEEEEe
Confidence            4579999999999999999999987 889999998653    346788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-cc
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~  254 (469)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||++|++|+||+|+||+++.++.+||+|||++........ ..
T Consensus        83 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~~  162 (261)
T cd05148          83 LMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSS  162 (261)
T ss_pred             ecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcccccc
Confidence            99999999999753  4589999999999999999999999999999999999999999999999999976543322 22


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+.+..+..... .  .....++..+.++|.+
T Consensus       163 ~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~i~~  239 (261)
T cd05148         163 DKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYR-M--PCPAKCPQEIYKIMLE  239 (261)
T ss_pred             CCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHhCCc-C--CCCCCCCHHHHHHHHH
Confidence            3346778999999865 58899999999999999998 8999998888777777764321 1  1235779999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||+.||.+|||+.++++
T Consensus       240 ~l~~~p~~Rpt~~~l~~  256 (261)
T cd05148         240 CWAAEPEDRPSFKALRE  256 (261)
T ss_pred             HcCCCchhCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=1.2e-40  Score=323.79  Aligned_cols=238  Identities=24%  Similarity=0.340  Sum_probs=199.6

Q ss_pred             eeeeccCCeEEEEEEECCCCcE--EEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAE--FACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.++.++..  +|+|.++..     ...+.+|++++.++..||||+++++++...+.+|+||||+++
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~   80 (270)
T cd05047           1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH   80 (270)
T ss_pred             CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence            3689999999999999888764  688988642     246778999999996699999999999999999999999999


Q ss_pred             CchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          182 GRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       182 g~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      |+|.+++....                .+++..+..++.|++.||.|||+.|++||||||+|||++.++.+||+|||++.
T Consensus        81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~  160 (270)
T cd05047          81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSR  160 (270)
T ss_pred             CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCcc
Confidence            99999987543                47889999999999999999999999999999999999999999999999985


Q ss_pred             eecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      .............+..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+.+..+.....   ......++
T Consensus       161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~  237 (270)
T cd05047         161 GQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LEKPLNCD  237 (270)
T ss_pred             ccchhhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCC---CCCCCcCC
Confidence            3321111112234567999999865 48899999999999999997 9999988887777776655321   11224578


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .++.+||.+||..||.+|||+.+++.
T Consensus       238 ~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         238 DEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             HHHHHHHHHHcccChhhCCCHHHHHH
Confidence            99999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=1.5e-40  Score=328.99  Aligned_cols=247  Identities=23%  Similarity=0.352  Sum_probs=205.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+.+.||+|+||.||+|.+     ..++..||+|+++...     +.+.+|+.+++++.+||||+++++++...+
T Consensus        33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  112 (302)
T cd05055          33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGG  112 (302)
T ss_pred             cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCC
Confidence            346899999999999999999975     3355689999986532     457889999999955999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ..|+||||+.+|+|.+++....  .+++..+..++.||+.||.|||++|++|+||||+|||++.++.++|+|||++....
T Consensus       113 ~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~  192 (302)
T cd05055         113 PILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIM  192 (302)
T ss_pred             ceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCccccccc
Confidence            9999999999999999987643  38999999999999999999999999999999999999999999999999997654


Q ss_pred             CCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          249 NGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       249 ~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ....   .....+++.|+|||++.+ .++.++||||+||++|+|++ |..||.+......+..........  .....++
T Consensus       193 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~  270 (302)
T cd05055         193 NDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRM--AQPEHAP  270 (302)
T ss_pred             CCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchHHHHHHHHcCCcC--CCCCCCC
Confidence            3221   122346788999999865 58999999999999999998 999998766554443333222221  1224578


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .++.+||.+||..+|++|||+.|+++
T Consensus       271 ~~~~~li~~cl~~~p~~Rpt~~ell~  296 (302)
T cd05055         271 AEIYDIMKTCWDADPLKRPTFKQIVQ  296 (302)
T ss_pred             HHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms]

Probab=100.00  E-value=4e-43  Score=377.96  Aligned_cols=250  Identities=29%  Similarity=0.469  Sum_probs=217.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.-+|+...+||.|.||.||-|.+..||+..|+|.++-      .-..+.+|..+|..+. |||+|++|++-.+.+..+
T Consensus      1232 nV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~ln-HpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1232 NVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLN-HPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred             cceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhcc-CccccccCceeecHHHHH
Confidence            356678888999999999999999999999999998742      2356789999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--  251 (469)
                      |.||||+||+|.+.+...+..+|.....+..|++.|+.|||++|||||||||+||+++.+|.+|++|||.|..+....  
T Consensus      1311 IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~ 1390 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQT 1390 (1509)
T ss_pred             HHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchhc
Confidence            999999999999998777777888888899999999999999999999999999999999999999999998776542  


Q ss_pred             ---cccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCc-CCCCCCcccCC
Q 012170          252 ---TLSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVK-LDFHSGVWETV  322 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~-~~~~~~~~~~~  322 (469)
                         ......|||.|||||++.|.    ...++||||||||+.||+||+.||...+ .-.++..+..+. +.+|    ..+
T Consensus      1391 ~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P----~~l 1466 (1509)
T KOG4645|consen 1391 MPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHVAAGHKPQIP----ERL 1466 (1509)
T ss_pred             CCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHHhccCCCCCc----hhh
Confidence               24567899999999999763    5678999999999999999999997543 344555554443 2333    459


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      |.+.+|||.+||..||++|+++.|||.|.|-.
T Consensus      1467 s~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~ 1498 (1509)
T KOG4645|consen 1467 SSEGRDFLEHCLEQDPKMRWTASQLLEHAFGK 1498 (1509)
T ss_pred             hHhHHHHHHHHHhcCchhhhHHHHHHHhhccc
Confidence            99999999999999999999999999999864

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=100.00  E-value=1.7e-40  Score=321.49  Aligned_cols=242  Identities=26%  Similarity=0.396  Sum_probs=205.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++.+.||+|+||.||+|.+..+ ..||+|+++..   ...+.+|+++++.+. ||||+++++++.. +..|+||||
T Consensus         5 ~~~~~~~~~lg~g~~~~v~~~~~~~~-~~valK~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv~e~   81 (262)
T cd05071           5 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEY   81 (262)
T ss_pred             hHHeeEeeecCCCCCCcEEEEEecCC-ceEEEEecccCccCHHHHHHHHHHHHhCC-CCCcceEEEEECC-CCcEEEEEc
Confidence            46799999999999999999998765 46999999753   356889999999996 9999999998854 567899999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--c
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--S  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~  254 (469)
                      +++|+|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++.........  .
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~~~  161 (262)
T cd05071          82 MSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  161 (262)
T ss_pred             CCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccccccc
Confidence            9999999999763  35789999999999999999999999999999999999999999999999999766433221  2


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...++..|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+..... .+  ....++..+.+||.+
T Consensus       162 ~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~  238 (262)
T cd05071         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYR-MP--CPPECPESLHDLMCQ  238 (262)
T ss_pred             CCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHHHhcCCC-CC--CccccCHHHHHHHHH
Confidence            3346778999999865 58999999999999999999 8999988877777776654321 11  124678999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||+.||.+||++.+++.
T Consensus       239 ~l~~~p~~Rp~~~~~~~  255 (262)
T cd05071         239 CWRKEPEERPTFEYLQA  255 (262)
T ss_pred             HccCCcccCCCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning]

Probab=100.00  E-value=1.4e-43  Score=323.37  Aligned_cols=253  Identities=30%  Similarity=0.505  Sum_probs=213.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-------  168 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-------  168 (469)
                      ...|+.+.+||+|.||.||+|+.+.+|+.||+|++--+      -....+|+++|..|. |+|++.+++++..       
T Consensus        16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lk-Henv~nliEic~tk~Tp~~r   94 (376)
T KOG0669|consen   16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKATPTNR   94 (376)
T ss_pred             chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhc-chhHHHHHHHHhhccCCccc
Confidence            35677788999999999999999999999999876321      146789999999997 9999999887742       


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          169 -ADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                       ...+|+||.+|+. +|.-++... .+|+..++..++.+++.||.|+|.+.|+|||+||+||||+.+|.+||+|||+++.
T Consensus        95 ~r~t~ylVf~~ceh-DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~  173 (376)
T KOG0669|consen   95 DRATFYLVFDFCEH-DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARA  173 (376)
T ss_pred             ccceeeeeHHHhhh-hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccc
Confidence             3459999999976 777777554 5799999999999999999999999999999999999999999999999999976


Q ss_pred             ecCCC-----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc
Q 012170          247 ISNGQ-----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       247 ~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      +....     ..+..+.|.+|++||.+.|  .|+++.|||..||||.+|++|.+-|.+++....+..|......+..+.|
T Consensus       174 fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevW  253 (376)
T KOG0669|consen  174 FSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVW  253 (376)
T ss_pred             eecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccC
Confidence            65332     2344567999999999987  4999999999999999999999999999988888887655443333333


Q ss_pred             cCC-------------------------------CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          320 ETV-------------------------------SKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       320 ~~~-------------------------------s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.+                               ++++.||+.+||..||.+|+++.++|+|.||..-
T Consensus       254 P~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kd  321 (376)
T KOG0669|consen  254 PNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKD  321 (376)
T ss_pred             CCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcC
Confidence            321                               3478899999999999999999999999999543

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=2e-40  Score=329.72  Aligned_cols=245  Identities=22%  Similarity=0.336  Sum_probs=207.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-------CCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      .++|.+++.||+|+||.||+|.+..       ....+|+|.++...     ..+.+|+.+++.+..||||+++++++.+.
T Consensus        11 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~   90 (314)
T cd05099          11 RDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQE   90 (314)
T ss_pred             HHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccC
Confidence            4689999999999999999998632       34579999987432     35778999999996699999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~  233 (469)
                      +.+|+||||+++|+|.+++...                ..++...+..++.||+.||.|||++|++||||||+|||++.+
T Consensus        91 ~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~  170 (314)
T cd05099          91 GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTED  170 (314)
T ss_pred             CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCC
Confidence            9999999999999999999663                247888999999999999999999999999999999999999


Q ss_pred             CcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 012170          234 GKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIK  308 (469)
Q Consensus       234 ~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~  308 (469)
                      +.+||+|||+++.......   .....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+.+..+.
T Consensus       171 ~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~  250 (314)
T cd05099         171 NVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLR  250 (314)
T ss_pred             CcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999976543211   112234567999999865 48999999999999999999 899999988888888776


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .....   .....++.++++||.+||..||.+|||+.++++
T Consensus       251 ~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         251 EGHRM---DKPSNCTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             cCCCC---CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            64321   122467889999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=1.6e-40  Score=324.76  Aligned_cols=243  Identities=22%  Similarity=0.309  Sum_probs=206.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+|.+.+.||+|+||.||+|...     .++..+|+|.+...    ...+.+|+++++.+. ||||+++++++.+.+..|
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   83 (280)
T cd05092           5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQ-HQHIVRFYGVCTEGRPLL   83 (280)
T ss_pred             HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCC-CCCCceEEEEEecCCceE
Confidence            56788899999999999999743     35678999998643    246889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC---------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          174 LVMELCSGGRLIDQMVEVG---------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~---------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      +||||+++|+|.+++...+               .+++..+..++.||+.||.|||+.|++||||||+|||+++++.++|
T Consensus        84 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL  163 (280)
T cd05092          84 MVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKI  163 (280)
T ss_pred             EEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEE
Confidence            9999999999999987653               4788999999999999999999999999999999999999999999


Q ss_pred             EeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCC
Q 012170          239 ADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       239 ~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                      +|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |.+||......+....+......
T Consensus       164 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  243 (280)
T cd05092         164 GDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGREL  243 (280)
T ss_pred             CCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccC
Confidence            99999976543221   122345788999998865 58999999999999999998 99999887777777766554322


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .   ....+++.+.+||.+||+.||.+||++.+|+.
T Consensus       244 ~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         244 E---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1   12467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=1.2e-40  Score=330.40  Aligned_cols=249  Identities=27%  Similarity=0.424  Sum_probs=210.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ....|+..+.||+|+||.||+|+++.++..+|+|.+...       ...+.+|+++++.+. |+|++++++++...+..|
T Consensus        13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   91 (308)
T cd06634          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (308)
T ss_pred             cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCcccEEEEEEcCCeeE
Confidence            456688889999999999999999999999999998531       135678999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+. |++.+.+.. ...+++..+..++.|++.||.|||+.|++||||+|+|||++.++.++|+|||++......  
T Consensus        92 lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~--  168 (308)
T cd06634          92 LVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA--  168 (308)
T ss_pred             EEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecCc--
Confidence            9999996 577776644 456899999999999999999999999999999999999999999999999998765432  


Q ss_pred             ccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                       ....|++.|+|||++.    +.++.++|||||||++|+|++|..||...........+........  ....++..+.+
T Consensus       169 -~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~  245 (308)
T cd06634         169 -NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRN  245 (308)
T ss_pred             -ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHhhcCCCCc--CcccccHHHHH
Confidence             3456899999999974    3578899999999999999999999987665555544443322211  12357899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+||..+|.+||++.++++|||+...
T Consensus       246 li~~cl~~~P~~Rp~~~~ll~~~~~~~~  273 (308)
T cd06634         246 FVDSCLQKIPQDRPTSEVLLKHRFVLRE  273 (308)
T ss_pred             HHHHHhhCCcccCCCHHHHhhCcccccc
Confidence            9999999999999999999999999654

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=1.5e-40  Score=322.67  Aligned_cols=241  Identities=21%  Similarity=0.290  Sum_probs=201.2

Q ss_pred             eeeeeeeccCCeEEEEEEECCCCc--EEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC------Ce
Q 012170          106 TKVEVIGHGKFGSVWLCRSKASGA--EFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA------DC  171 (469)
Q Consensus       106 ~~~~~lG~G~~g~Vy~~~~~~~~~--~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~------~~  171 (469)
                      .+.+.||+|+||.||+|.+..++.  .||+|.++..      .+.+.+|+.+++.++ ||||+++++++...      ..
T Consensus         2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~   80 (272)
T cd05075           2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFD-HPNVMRLIGVCLQTVESEGYPS   80 (272)
T ss_pred             ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEccCCcccCCCC
Confidence            467899999999999999887775  5999988542      245778999999996 99999999976421      24


Q ss_pred             EEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          172 FHLVMELCSGGRLIDQMVEV------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      .++||||+.+|+|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.
T Consensus        81 ~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~  160 (272)
T cd05075          81 PVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK  160 (272)
T ss_pred             cEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCccc
Confidence            68999999999999887432      347899999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          246 RISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       246 ~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .+.....   .....+++.|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+.......   ...
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~  237 (272)
T cd05075         161 KIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLK---QPP  237 (272)
T ss_pred             ccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC---CCC
Confidence            6543322   122346778999999876 48999999999999999999 899999888888777777654321   124


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++..+.++|.+||+.||.+|||+.+|+++
T Consensus       238 ~~~~~~~~li~~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         238 DCLDGLYSLMSSCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             CCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            678999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.8e-40  Score=318.09  Aligned_cols=239  Identities=26%  Similarity=0.375  Sum_probs=208.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ++|++.+.||.|+||.||+|...  |+.||+|.++...   ..+.+|+.+++.+. |+||+++++++.+.+..|+||||+
T Consensus         6 ~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~   82 (256)
T cd05039           6 KELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDSTAAQAFLAEASVMTTLR-HPNLVQLLGVVLQGNPLYIVTEYM   82 (256)
T ss_pred             hhccceeeeecCCCceEEEEEec--CcEEEEEEeccchhHHHHHHHHHHHHHhcC-CcceeeeEEEEcCCCCeEEEEEec
Confidence            57889999999999999999875  7899999997653   46888999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccC
Q 012170          180 SGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       180 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      ++++|.+++....  .+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........  ...
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~--~~~  160 (256)
T cd05039          83 AKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD--SGK  160 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEcccccccccccccc--cCC
Confidence            9999999997765  689999999999999999999999999999999999999999999999999976633222  334


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      ++..|+|||.+.+ .++.++||||||+++|+|++ |..||.......+...+.....   ......+++++.++|.+||.
T Consensus       161 ~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~  237 (256)
T cd05039         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHVEKGYR---MEAPEGCPPEVYKVMKDCWE  237 (256)
T ss_pred             CcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhcCCC---CCCccCCCHHHHHHHHHHhc
Confidence            5667999998864 58889999999999999997 9999998888777776655422   11224678999999999999


Q ss_pred             hhhcCCCCHHHHHc
Q 012170          336 RDVSARITADEVLR  349 (469)
Q Consensus       336 ~dP~~Rpsa~elL~  349 (469)
                      .+|.+|||+.++++
T Consensus       238 ~~p~~Rp~~~~l~~  251 (256)
T cd05039         238 LDPAKRPTFKQLRE  251 (256)
T ss_pred             cChhhCcCHHHHHH
Confidence            99999999999986

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=6.5e-41  Score=326.47  Aligned_cols=247  Identities=33%  Similarity=0.538  Sum_probs=209.2

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      |++.+.||.|+||.||+|++..+++.||+|++...      ...+..|+.+++.+. |+||+++++++.+.+.+++||||
T Consensus         1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~~~~~~v~e~   79 (282)
T cd07829           1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELK-HPNIVKLLDVIHTERKLYLVFEY   79 (282)
T ss_pred             CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcC-CCCHHHHHhhhhcCCceEEEecC
Confidence            56778999999999999999999999999998753      245778999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccccc
Q 012170          179 CSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~  256 (469)
                      +. ++|.+++... ..+++..+..++.|++.||.|||+.||+||||+|+||+++.++.++|+|||++....... .....
T Consensus        80 ~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~~~~~  158 (282)
T cd07829          80 CD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTHE  158 (282)
T ss_pred             cC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCccccCcc
Confidence            97 5899999776 589999999999999999999999999999999999999999999999999997654332 23345


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc------------------CCCC-
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK------------------LDFH-  315 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~------------------~~~~-  315 (469)
                      .++..|+|||++.+  .++.++||||||+++|+|++|.+||.+.+....+..+....                  ..++ 
T Consensus       159 ~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (282)
T cd07829         159 VVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPK  238 (282)
T ss_pred             ccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccc
Confidence            56888999999854  47889999999999999999999998877655544432210                  0000 


Q ss_pred             ------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          316 ------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       316 ------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                            ...+..++..+.++|.+||..||++||++.++++||||
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         239 FPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             cCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHHhhCcCC
Confidence                  01123457899999999999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=2.3e-40  Score=318.84  Aligned_cols=239  Identities=25%  Similarity=0.388  Sum_probs=205.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEE-EeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVY-EEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~-~~~~~~~lV~E~~  179 (469)
                      ++|++.+.||+|+||.||++...  |..||+|.++..  ...+.+|+.+++.+. |+|++++++++ ..++..|+||||+
T Consensus         6 ~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~lv~e~~   82 (256)
T cd05082           6 KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEYM   82 (256)
T ss_pred             HhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCchHHHHHHHHHHHHhCC-CCCeeeEEEEEEcCCCceEEEEECC
Confidence            57899999999999999999765  788999998754  346889999999996 99999999875 4566789999999


Q ss_pred             CCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccC
Q 012170          180 SGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       180 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      ++++|.+++...+  .+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  ....
T Consensus        83 ~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~--~~~~  160 (256)
T cd05082          83 AKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTGK  160 (256)
T ss_pred             CCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC--CCCc
Confidence            9999999987654  37899999999999999999999999999999999999999999999999987644322  2334


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      ++..|+|||++.+ .++.++|||||||++|+|++ |.+||...........+.....   ......+++.+.++|.+||.
T Consensus       161 ~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~  237 (256)
T cd05082         161 LPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPVVYDVMKQCWH  237 (256)
T ss_pred             cceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCCCCCCHHHHHHHHHHhc
Confidence            5678999999866 48899999999999999997 9999998888777777765422   22235679999999999999


Q ss_pred             hhhcCCCCHHHHHc
Q 012170          336 RDVSARITADEVLR  349 (469)
Q Consensus       336 ~dP~~Rpsa~elL~  349 (469)
                      .+|++|||+.++++
T Consensus       238 ~~p~~Rpt~~~l~~  251 (256)
T cd05082         238 LDAATRPSFLQLRE  251 (256)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=2.5e-40  Score=319.41  Aligned_cols=243  Identities=26%  Similarity=0.406  Sum_probs=206.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|.+. ++..+|+|.+...   .+.+.+|+.+++++. ||||+++++++.. +..|+|||
T Consensus         4 ~~~~~~~~~~ig~g~~~~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~-~~~~lv~e   80 (260)
T cd05070           4 PRESLQLIKKLGNGQFGEVWMGTWN-GNTKVAVKTLKPGTMSPESFLEEAQIMKKLR-HDKLVQLYAVVSE-EPIYIVTE   80 (260)
T ss_pred             chHHhhhhheeccccCceEEEEEec-CCceeEEEEecCCCCCHHHHHHHHHHHHhcC-CCceEEEEeEECC-CCcEEEEE
Confidence            4578999999999999999999876 4677999998653   457889999999996 9999999998854 56789999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+++++|.+++...  ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05070          81 YMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccccc
Confidence            99999999998753  3589999999999999999999999999999999999999999999999999976543322  1


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....++..|+|||++.+ .++.++|+||||+++|+|++ |.+||.+.+..+....+......   ......+..+.+||.
T Consensus       161 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~  237 (260)
T cd05070         161 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRM---PCPQDCPISLHELML  237 (260)
T ss_pred             cCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCcCCHHHHHHHH
Confidence            22345668999999865 58899999999999999999 99999988887777777654211   122467899999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..+|.+|||+.+++.
T Consensus       238 ~~l~~~p~~Rpt~~~l~~  255 (260)
T cd05070         238 QCWKKDPEERPTFEYLQS  255 (260)
T ss_pred             HHcccCcccCcCHHHHHH
Confidence            999999999999999864

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=2.2e-40  Score=321.26  Aligned_cols=243  Identities=25%  Similarity=0.393  Sum_probs=207.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+|++++.||+|+||.||+|.++.++.   .+|+|.++..     ...+.+|+.+++.+. ||||+++++++..++..|+
T Consensus         4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   82 (267)
T cd05066           4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSKPVMI   82 (267)
T ss_pred             HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEecCCccEE
Confidence            578899999999999999999875543   7999998643     246788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      ||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+|||++.++.++|+|||++........ 
T Consensus        83 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~  162 (267)
T cd05066          83 VTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA  162 (267)
T ss_pred             EEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCcccccccccce
Confidence            99999999999999765 4689999999999999999999999999999999999999999999999999976543321 


Q ss_pred             ---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 ---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                         .....++..|+|||++.+ .++.++|+||||+++|+|++ |..||.+....+....+..... ++  ....++..+.
T Consensus       163 ~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~  239 (267)
T cd05066         163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYR-LP--APMDCPAALH  239 (267)
T ss_pred             eeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHHHHHHHhCCCc-CC--CCCCCCHHHH
Confidence               112234568999999975 58999999999999999886 9999988877777777765421 22  2246789999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHc
Q 012170          328 DLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +++.+||+.+|.+||++.++++
T Consensus       240 ~li~~~l~~~p~~Rp~~~~i~~  261 (267)
T cd05066         240 QLMLDCWQKDRNERPKFEQIVS  261 (267)
T ss_pred             HHHHHHcccCchhCCCHHHHHH
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=100.00  E-value=2.9e-40  Score=317.14  Aligned_cols=241  Identities=28%  Similarity=0.403  Sum_probs=209.6

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCC----cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASG----AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      +++.+.||.|+||.||+|.+..++    ..||+|++...     ...+..|+.+++.+. |+||+++++++.+.+..|+|
T Consensus         1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~i   79 (258)
T smart00219        1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLD-HPNIVKLLGVCTEEEPLMIV   79 (258)
T ss_pred             CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCeeEEE
Confidence            356789999999999999998766    89999999653     346888999999995 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          176 MELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      |||+++++|.+++.....  +++..+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++.........
T Consensus        80 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~  159 (258)
T smart00219       80 MEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY  159 (258)
T ss_pred             EeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc
Confidence            999999999999976554  999999999999999999999999999999999999999999999999999776544222


Q ss_pred             c--ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 S--GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 ~--~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .  ...+++.|+|||.+.+ .++.++||||||+++|+|++ |.+||...+.......+........   ...++.++.++
T Consensus       160 ~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  236 (258)
T smart00219      160 KKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEYLKKGYRLPK---PENCPPEIYKL  236 (258)
T ss_pred             ccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHHH
Confidence            1  2337789999999855 58999999999999999998 8999998888888887776543322   23479999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      |.+||..||++|||+.|+++
T Consensus       237 i~~~l~~~p~~Rpt~~~ll~  256 (258)
T smart00219      237 MLQCWAEDPEDRPTFSELVE  256 (258)
T ss_pred             HHHHCcCChhhCcCHHHHHh
Confidence            99999999999999999986

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=100.00  E-value=1e-40  Score=318.47  Aligned_cols=228  Identities=27%  Similarity=0.392  Sum_probs=192.6

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCC
Q 012170          114 GKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ  193 (469)
Q Consensus       114 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~  193 (469)
                      |.||.||+|+++.+|+.||+|.+.... ...+|...+.... ||||+++++++...+.+|+||||++||+|.+++.+...
T Consensus         4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-~~~~~~~~~~~~~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~   81 (237)
T cd05576           4 GVIDKVLLVMDTRTQQTFILKGLRKSS-EYSRERLTIIPHC-VPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLN   81 (237)
T ss_pred             cccceEEEEEEccCCcEEEEEeecchh-hhhhHHHHHHhcC-CCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcC
Confidence            899999999999999999999997643 3445555555554 99999999999999999999999999999999988888


Q ss_pred             CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC-CC
Q 012170          194 YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NY  272 (469)
Q Consensus       194 l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~  272 (469)
                      +++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++......  .....++..|+|||.+.+ .+
T Consensus        82 l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~  159 (237)
T cd05576          82 IPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS--CDGEAVENMYCAPEVGGISEE  159 (237)
T ss_pred             CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhccccc--cccCCcCccccCCcccCCCCC
Confidence            999999999999999999999999999999999999999999999999987654432  234567788999999865 48


Q ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCH-----HHH
Q 012170          273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITA-----DEV  347 (469)
Q Consensus       273 ~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa-----~el  347 (469)
                      +.++|+||+|+++|+|++|..||......     +.. ...+  .....+++.+++||.+||+.||.+||++     +++
T Consensus       160 ~~~~DvwslG~il~el~~g~~~~~~~~~~-----~~~-~~~~--~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~  231 (237)
T cd05576         160 TEACDWWSLGAILFELLTGKTLVECHPSG-----INT-HTTL--NIPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDI  231 (237)
T ss_pred             CchhhHHHHHHHHHHHHHCcchhhcCchh-----ccc-cccc--CCcccCCHHHHHHHHHHccCCHHHhcCCCccchHHH
Confidence            89999999999999999999988643211     100 0011  1124578999999999999999999985     999


Q ss_pred             HcCCCc
Q 012170          348 LRHPWI  353 (469)
Q Consensus       348 L~hp~~  353 (469)
                      ++||||
T Consensus       232 ~~h~~~  237 (237)
T cd05576         232 KSHPFF  237 (237)
T ss_pred             HcCCCC
Confidence            999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms]

Probab=100.00  E-value=2e-41  Score=341.78  Aligned_cols=244  Identities=23%  Similarity=0.374  Sum_probs=208.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..+...+.+.||+|.||+||+|+|..   .||||++...      .+.|+.||.+|++-+ |-||+-+.+++..... .|
T Consensus       390 p~~ev~l~~rIGsGsFGtV~Rg~whG---dVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTR-H~NIlLFMG~~~~p~~-AI  464 (678)
T KOG0193|consen  390 PPEEVLLGERIGSGSFGTVYRGRWHG---DVAVKLLNVDDPTPEQLQAFKNEVAVLKKTR-HENILLFMGACMNPPL-AI  464 (678)
T ss_pred             CHHHhhccceeccccccceeeccccc---ceEEEEEecCCCCHHHHHHHHHHHHHHhhcc-hhhheeeehhhcCCce-ee
Confidence            44456667899999999999999974   4999999643      367899999999998 9999999999988777 89


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee---ecCC
Q 012170          175 VMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR---ISNG  250 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~---~~~~  250 (469)
                      |..+|+|-+|+.++.- ...|.......|++||+.|+.|||.++|||||||..||++.++++|||+||||+..   +...
T Consensus       465 iTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~  544 (678)
T KOG0193|consen  465 ITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGE  544 (678)
T ss_pred             eehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeeeeeccc
Confidence            9999999999998854 34688899999999999999999999999999999999999999999999999964   2233


Q ss_pred             CcccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC-CCcccCCCHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH-SGVWETVSKP  325 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~~s~~  325 (469)
                      .......|...|||||++..    .|+..+|||||||++|||++|..||...+.++++..+-.+..... ......++++
T Consensus       545 ~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~  624 (678)
T KOG0193|consen  545 QQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKA  624 (678)
T ss_pred             cccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHH
Confidence            34455678889999999953    389999999999999999999999998888887777666633222 2233567889


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHc
Q 012170          326 ARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +++|+..||.+++++||.+.+||.
T Consensus       625 mk~Ll~~C~~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  625 MKRLLSDCWKFDREERPLFPQLLS  648 (678)
T ss_pred             HHHHHHHHHhcCcccCccHHHHHH
Confidence            999999999999999999999986

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-40  Score=323.26  Aligned_cols=242  Identities=23%  Similarity=0.351  Sum_probs=195.4

Q ss_pred             CCe-eeeeeeeccCCeEEEEEE----ECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CC
Q 012170          103 DDH-TKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE--AD  170 (469)
Q Consensus       103 ~~y-~~~~~lG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~  170 (469)
                      ++| ++++.||+|+||+||++.    ...++..||+|+++..     ...+.+|+++|+.+. ||||+++++++..  ..
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (283)
T cd05080           3 KRYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLY-HENIVKYKGCCSEQGGK   81 (283)
T ss_pred             hhhceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCc
Confidence            455 889999999999998865    3457889999998643     346778999999996 9999999998765  34


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .+|+||||+++|+|.+++.. ..+++..+..++.|++.||.|||++||+||||||+|||++.++.++|+|||++......
T Consensus        82 ~~~lv~e~~~~~~l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~  160 (283)
T cd05080          82 GLQLIMEYVPLGSLRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEG  160 (283)
T ss_pred             eEEEEecCCCCCCHHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeecccccccCCc
Confidence            68999999999999998865 46999999999999999999999999999999999999999999999999999765433


Q ss_pred             Cc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHH-------------HHHHcC
Q 012170          251 QT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE--AVF-------------DAIKNV  310 (469)
Q Consensus       251 ~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~--~~~-------------~~i~~~  310 (469)
                      ..    .....++..|+|||++.+ .++.++||||||+++|+|++|..||......  +..             ..+...
T Consensus       161 ~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (283)
T cd05080         161 HEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERG  240 (283)
T ss_pred             chhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcC
Confidence            22    122345677999999865 5899999999999999999999998643211  111             011110


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                         ........++.++.+++.+||..||++|||+.+++.
T Consensus       241 ---~~~~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~  276 (283)
T cd05080         241 ---MRLPCPKNCPQEVYILMKNCWETEAKFRPTFRSLIP  276 (283)
T ss_pred             ---CCCCCCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence               111112457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=3.4e-40  Score=322.38  Aligned_cols=242  Identities=23%  Similarity=0.324  Sum_probs=203.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ++|++++.||+|+||.||+|.+..+|.    .+++|.+...     ...+..|+.++.++. ||||+++++++. +...+
T Consensus         7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~-h~~iv~~~~~~~-~~~~~   84 (279)
T cd05111           7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLD-HAYIVRLLGICP-GASLQ   84 (279)
T ss_pred             hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCC-CCCcceEEEEEC-CCccE
Confidence            578899999999999999999987776    4777877532     135667788888886 999999999875 45678


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +|+||+++|+|.+++... +.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........
T Consensus        85 ~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~  164 (279)
T cd05111          85 LVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK  164 (279)
T ss_pred             EEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc
Confidence            999999999999999764 5789999999999999999999999999999999999999999999999999986543321


Q ss_pred             ---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 ---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                         .....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+.......+.+........   ...++.++.
T Consensus       165 ~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~  241 (279)
T cd05111         165 KYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHEVPDLLEKGERLAQ---PQICTIDVY  241 (279)
T ss_pred             ccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHCCCcCCC---CCCCCHHHH
Confidence               233457788999999865 58999999999999999998 9999998887777666665443322   234678899


Q ss_pred             HHHHHhchhhhcCCCCHHHHHc
Q 012170          328 DLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +++.+||..||.+|||+.|+++
T Consensus       242 ~li~~c~~~~p~~Rps~~el~~  263 (279)
T cd05111         242 MVMVKCWMIDENVRPTFKELAN  263 (279)
T ss_pred             HHHHHHcCCCcccCcCHHHHHH
Confidence            9999999999999999999976

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.4e-40  Score=318.89  Aligned_cols=244  Identities=25%  Similarity=0.385  Sum_probs=208.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|+..+.||+|+||.||+|.++.++.   .+|+|.++..     .+.+..|+++++.+. ||||+++++++...+..|
T Consensus         4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (268)
T cd05063           4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFS-HHNIIRLEGVVTKFKPAM   82 (268)
T ss_pred             hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CCCeeEEEEEEccCCCcE
Confidence            3578889999999999999999876665   7999998653     245788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+++++|.+++... +.+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........
T Consensus        83 lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~  162 (268)
T cd05063          83 IITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE  162 (268)
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceecccccc
Confidence            999999999999998764 5789999999999999999999999999999999999999999999999999976543221


Q ss_pred             c----cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          253 L----SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       253 ~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      .    .....++.|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+......   .....++.++
T Consensus       163 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~  239 (268)
T cd05063         163 GTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRL---PAPMDCPSAV  239 (268)
T ss_pred             cceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhcCCCC---CCCCCCCHHH
Confidence            1    11223457999999865 58999999999999999997 99999888887888777654321   1224578999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .++|.+||..+|.+||++.++++
T Consensus       240 ~~li~~c~~~~p~~Rp~~~~i~~  262 (268)
T cd05063         240 YQLMLQCWQQDRARRPRFVDIVN  262 (268)
T ss_pred             HHHHHHHcCCCcccCcCHHHHHH
Confidence            99999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=100.00  E-value=2.4e-40  Score=324.47  Aligned_cols=244  Identities=24%  Similarity=0.326  Sum_probs=207.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||.||+|.+..     ++..||+|++...     ...+.+|+.+++.+. ||||+++++++.+++.
T Consensus         4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~iv~~~~~~~~~~~   82 (288)
T cd05050           4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-HPNIVKLLGVCAVGKP   82 (288)
T ss_pred             hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcC-CCchheEEEEEcCCCc
Confidence            4689999999999999999998753     6788999998653     245788999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEE
Q 012170          172 FHLVMELCSGGRLIDQMVEVG----------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL  229 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~----------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NIL  229 (469)
                      +|+||||+++|+|.+++....                      .+++..+..++.||+.||.|||++|++||||||+|||
T Consensus        83 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil  162 (288)
T cd05050          83 MCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCL  162 (288)
T ss_pred             cEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheE
Confidence            999999999999999986532                      3678889999999999999999999999999999999


Q ss_pred             EccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 012170          230 LTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVF  304 (469)
Q Consensus       230 l~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  304 (469)
                      ++.++.++|+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..+..
T Consensus       163 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~  242 (288)
T cd05050         163 VGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVI  242 (288)
T ss_pred             ecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence            99999999999999875433221   122345677999999865 58999999999999999997 88999888888888


Q ss_pred             HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       305 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+........   ...++.++.+||.+||+.||.+|||+.|+++
T Consensus       243 ~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         243 YYVRDGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             HHHhcCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence            77776543221   2357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=100.00  E-value=4.5e-40  Score=317.62  Aligned_cols=243  Identities=23%  Similarity=0.374  Sum_probs=207.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|..+ +++.||+|.+...   ...+.+|+.+++.+. ||||+++++++. .+.+|+|||
T Consensus         4 ~~~~~~~~~~ig~G~~g~v~~~~~~-~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e   80 (260)
T cd05067           4 PRETLKLVKKLGAGQFGEVWMGYYN-GHTKVAIKSLKQGSMSPEAFLAEANLMKQLQ-HPRLVRLYAVVT-QEPIYIITE   80 (260)
T ss_pred             chHHceeeeeeccCccceEEeeecC-CCceEEEEEecCCCCcHHHHHHHHHHHHhcC-CcCeeeEEEEEc-cCCcEEEEE
Confidence            4578999999999999999999865 5788999998653   357889999999996 999999999875 456899999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+.+++|.+++...  ..+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~  160 (260)
T cd05067          81 YMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYTAR  160 (260)
T ss_pred             cCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcccc
Confidence            99999999988654  3588999999999999999999999999999999999999999999999999976542222  2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....++..|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+..+....+.....   ......++.++.++|.
T Consensus       161 ~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~  237 (260)
T cd05067         161 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYR---MPRPDNCPEELYELMR  237 (260)
T ss_pred             cCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHHHHcCCC---CCCCCCCCHHHHHHHH
Confidence            23446778999999865 58899999999999999999 9999998887777776655422   1223467899999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..+|++||++++++.
T Consensus       238 ~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05067         238 LCWKEKPEERPTFEYLRS  255 (260)
T ss_pred             HHccCChhhCCCHHHHHH
Confidence            999999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=4.6e-40  Score=317.70  Aligned_cols=242  Identities=26%  Similarity=0.389  Sum_probs=204.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|.+.+.||+|+||.||+|.+..+ ..+|+|.+...   .+.+.+|+.+++.+. |||++++++++. .+..|+||||
T Consensus         5 ~~~~~~~~~ig~g~~~~v~~~~~~~~-~~~~lK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~-~~~~~~v~e~   81 (260)
T cd05069           5 RESLRLDVKLGQGCFGEVWMGTWNGT-TKVAIKTLKPGTMMPEAFLQEAQIMKKLR-HDKLVPLYAVVS-EEPIYIVTEF   81 (260)
T ss_pred             hHHeeeeeeecCcCCCeEEEEEEcCC-ceEEEEEcccCCccHHHHHHHHHHHHhCC-CCCeeeEEEEEc-CCCcEEEEEc
Confidence            36799999999999999999988764 46999988653   356788999999996 999999999885 4567899999


Q ss_pred             cCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          179 CSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      +.+|+|.+++....  .+++..+..++.||+.||.|||+.|++|+||||+||++++++.++|+|||++........  ..
T Consensus        82 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~~~  161 (260)
T cd05069          82 MGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQ  161 (260)
T ss_pred             CCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcccccC
Confidence            99999999997643  478999999999999999999999999999999999999999999999999976543322  12


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...++..|+|||.+.+ .++.++||||||+++|+|++ |.+||.+....+....+.....   ...+..++..+.++|.+
T Consensus       162 ~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~  238 (260)
T cd05069         162 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYR---MPCPQGCPESLHELMKL  238 (260)
T ss_pred             CCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCcccCHHHHHHHHH
Confidence            2346678999998865 58899999999999999999 9999998887777777655421   12234678999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||..||.+||+++++++
T Consensus       239 ~l~~~p~~Rp~~~~i~~  255 (260)
T cd05069         239 CWKKDPDERPTFEYIQS  255 (260)
T ss_pred             HccCCcccCcCHHHHHH
Confidence            99999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=1.2e-40  Score=322.29  Aligned_cols=240  Identities=31%  Similarity=0.489  Sum_probs=200.6

Q ss_pred             eeeeeeeccCCeEEEEEEEC----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          106 TKVEVIGHGKFGSVWLCRSK----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       106 ~~~~~lG~G~~g~Vy~~~~~----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .+.+.||.|+||.||+|.+.    ..+..|+||.++..     .+.+.+|++++++++ ||||+++++++...+.+++||
T Consensus         2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~g~~~~~~~~~lv~   80 (259)
T PF07714_consen    2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLR-HPNIVKLYGFCIENEPLFLVM   80 (259)
T ss_dssp             EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHS-BTTBE-EEEEEESSSSEEEEE
T ss_pred             EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeeccccccccc-ccccccccccccccccccccc
Confidence            45689999999999999988    45678999999542     357889999999995 999999999999888899999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||++|+|.+++...  ..+++..+..|+.||+.||.|||+++++|+||++.|||++.++.+||+|||++........  
T Consensus        81 e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~  160 (259)
T PF07714_consen   81 EYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYK  160 (259)
T ss_dssp             E--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEE
T ss_pred             cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence            999999999999887  6799999999999999999999999999999999999999999999999999977632211  


Q ss_pred             -ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          253 -LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       253 -~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                       .....+...|+|||++.+ .++.++||||||+++|||++ |..||.+.+..++...+........   ...++..+.++
T Consensus       161 ~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l  237 (259)
T PF07714_consen  161 NDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEKLKQGQRLPI---PDNCPKDIYSL  237 (259)
T ss_dssp             ESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHHHHTTEETTS---BTTSBHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccee---ccchhHHHHHH
Confidence             223446778999999965 48999999999999999999 7899999888888888866554222   24679999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      |..||..||.+|||+.+|++
T Consensus       238 i~~C~~~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  238 IQQCWSHDPEKRPSFQEILQ  257 (259)
T ss_dssp             HHHHT-SSGGGS--HHHHHH
T ss_pred             HHHHcCCChhhCcCHHHHHh
Confidence            99999999999999999975

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=6.1e-40  Score=315.54  Aligned_cols=243  Identities=29%  Similarity=0.436  Sum_probs=209.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .+|++.+.||.|+||.||+|.+. ++..+|+|.+...   ...+.+|+++++++. ||||+++++++.....+|+||||+
T Consensus         4 ~~~~~~~~ig~g~~g~v~~~~~~-~~~~~~~k~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~   81 (256)
T cd05112           4 SELTLVQEIGSGQFGLVWLGYWL-EKRKVAIKTIREGAMSEEDFIEEAQVMMKLS-HPKLVQLYGVCTERSPICLVFEFM   81 (256)
T ss_pred             hHeEEEeeecCcccceEEEEEEe-CCCeEEEEECCCCCCCHHHHHHHHHHHHhCC-CCCeeeEEEEEccCCceEEEEEcC
Confidence            47889999999999999999886 4778999998753   357889999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cccc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~~~  256 (469)
                      .+++|.+++... +.+++..+..++.|++.||.|||+.|++|+||||+||+++.++.++|+|||++........  ....
T Consensus        82 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~~~~~  161 (256)
T cd05112          82 EHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTSSTGT  161 (256)
T ss_pred             CCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcccccCCC
Confidence            999999988764 4689999999999999999999999999999999999999999999999999976543322  1223


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .++..|+|||++.+ .++.++||||||+++|+|++ |..||...........+......+..   ...+..+.+|+.+||
T Consensus       162 ~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~~~l  238 (256)
T cd05112         162 KFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYKP---RLASQSVYELMQHCW  238 (256)
T ss_pred             ccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHc
Confidence            45678999999875 58899999999999999998 99999988888888777654322221   346899999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      ..+|.+|||+.+++++
T Consensus       239 ~~~p~~Rp~~~~~l~~  254 (256)
T cd05112         239 KERPEDRPSFSLLLHQ  254 (256)
T ss_pred             ccChhhCCCHHHHHHh
Confidence            9999999999999864

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=1.2e-40  Score=321.33  Aligned_cols=245  Identities=30%  Similarity=0.529  Sum_probs=208.1

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      +|.+.+.||+|+||.||++.+..++..+++|+++.         ....+..|+.+++.+. ||||+++++++.+.+..++
T Consensus         1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~l   79 (260)
T cd08222           1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLD-HPAIVKFHASFLERDAFCI   79 (260)
T ss_pred             CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCC-CCcHHHHHHHHhcCCceEE
Confidence            58899999999999999999988887787777643         1234667999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          175 VMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ||||+++++|.+++..    ...+++..+..++.|++.||.|||++|++|+||+|+||+++. +.++|+|||++......
T Consensus        80 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~  158 (260)
T cd08222          80 ITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS  158 (260)
T ss_pred             EEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence            9999999999988854    346899999999999999999999999999999999999975 67999999999765433


Q ss_pred             Cc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          251 QT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       251 ~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      .. .....|++.|+|||.+.+ .++.++|+||||+++|+|++|..||.+.........+.......   ....++.++.+
T Consensus       159 ~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~  235 (260)
T cd08222         159 CDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPS---LPETYSRQLNS  235 (260)
T ss_pred             cccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCC---CcchhcHHHHH
Confidence            22 334568999999999865 47889999999999999999999998777666666654433221   12467899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +|.+||..||++||++.++++||||
T Consensus       236 li~~~l~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         236 IMQSMLNKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             HHHHHhcCChhhCcCHHHHhhCCCC
Confidence            9999999999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=3.2e-40  Score=324.09  Aligned_cols=242  Identities=22%  Similarity=0.340  Sum_probs=204.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +|++.+.||+|+||.||+|.+..     ....+|+|.+....     ..+.+|+.+++.+. ||||+++++.+...+..|
T Consensus         1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   79 (290)
T cd05045           1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVN-HPHVIKLYGACSQDGPLL   79 (290)
T ss_pred             CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCC-CCCEeeEEEEEecCCCcE
Confidence            47888999999999999998753     23569999886432     45778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEE
Q 012170          174 LVMELCSGGRLIDQMVEV------------------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL  229 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NIL  229 (469)
                      +||||+.+|+|.+++...                        ..+++..+..++.|++.||.|||++|++||||||+|||
T Consensus        80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nil  159 (290)
T cd05045          80 LIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVL  159 (290)
T ss_pred             EEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEE
Confidence            999999999999988642                        24778899999999999999999999999999999999


Q ss_pred             EccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 012170          230 LTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVF  304 (469)
Q Consensus       230 l~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  304 (469)
                      +++++.++|+|||++........   .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.....+.
T Consensus       160 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~  239 (290)
T cd05045         160 VAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLF  239 (290)
T ss_pred             EcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHH
Confidence            99999999999999976533221   223346778999998865 48999999999999999998 99999988888877


Q ss_pred             HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       305 ~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+..... .  .....++.++.+||.+||+.+|.+||++.++++
T Consensus       240 ~~~~~~~~-~--~~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         240 NLLKTGYR-M--ERPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             HHHhCCCC-C--CCCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence            76654321 1  123467899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=1.7e-40  Score=329.71  Aligned_cols=242  Identities=22%  Similarity=0.334  Sum_probs=195.3

Q ss_pred             CCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHH
Q 012170          115 KFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM  188 (469)
Q Consensus       115 ~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l  188 (469)
                      ++|.||.++...++..||||++...      ...+.+|+++++.++ ||||+++++++.+.+..|++|||+++|+|.+++
T Consensus        12 ~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~-h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l   90 (314)
T cd08216          12 DLMIVHLAKHKPTNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQ-HPNILPYVTSFIVDSELYVVSPLMAYGSCEDLL   90 (314)
T ss_pred             CCceEEEEEecCCCCEEEEEEEeccccchhHHHHHHHHHHHHHhcC-CcchhhhhheeecCCeEEEEEeccCCCCHHHHH
Confidence            5566777777778999999998643      246889999999997 999999999999999999999999999999998


Q ss_pred             HHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--------ccccCC
Q 012170          189 VEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--------LSGLAG  258 (469)
Q Consensus       189 ~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--------~~~~~g  258 (469)
                      ...  ..+++..+..++.||+.||.|||++||+||||||+||+++.+|.++|+|||.+........        .....+
T Consensus        91 ~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (314)
T cd08216          91 KTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVK  170 (314)
T ss_pred             HHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccc
Confidence            764  4689999999999999999999999999999999999999999999999999875432211        223457


Q ss_pred             CCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCcCC---------------------
Q 012170          259 SPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF-DAIKNVKLD---------------------  313 (469)
Q Consensus       259 t~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~~~~---------------------  313 (469)
                      +..|+|||++.+   .|+.++||||+||++|+|++|..||......... ..+......                     
T Consensus       171 ~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  250 (314)
T cd08216         171 NLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSN  250 (314)
T ss_pred             cccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccc
Confidence            888999999865   3889999999999999999999999876543332 222111000                     


Q ss_pred             --------CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          314 --------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       314 --------~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                              ........++.++.+||.+||..||++|||++++|+||||....
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         251 EHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             cccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence                    00001123456889999999999999999999999999996543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=100.00  E-value=2.9e-40  Score=321.44  Aligned_cols=245  Identities=24%  Similarity=0.414  Sum_probs=210.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ++|+++..||.|+||.||+|+.+.     +...||+|.+....     ..+.+|+++++++. ||||+++++++.+.+..
T Consensus         5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   83 (275)
T cd05046           5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLS-HKNVVRLLGLCREAEPH   83 (275)
T ss_pred             HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcC-CcceeeeEEEECCCCcc
Confidence            678999999999999999999764     34679999986432     45889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC---------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          173 HLVMELCSGGRLIDQMVEVG---------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~---------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                      |+||||+++|+|.+++....         .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||+
T Consensus        84 ~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~  163 (275)
T cd05046          84 YMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSL  163 (275)
T ss_pred             eEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccccc
Confidence            99999999999999997766         689999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCC--cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcc
Q 012170          244 AMRISNGQ--TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       244 a~~~~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      +.......  ......+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+......+..+......+..  .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~  241 (275)
T cd05046         164 SKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQAGKLELPV--P  241 (275)
T ss_pred             ccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchHHHHHHHHcCCcCCCC--C
Confidence            86443221  2233456778999999865 57889999999999999998 88999887777777777765544332  2


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ..++..+.++|.+||..+|.+|||+.+++.+
T Consensus       242 ~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         242 EGCPSRLYKLMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             CCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence            4678999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=100.00  E-value=4.9e-40  Score=329.82  Aligned_cols=247  Identities=23%  Similarity=0.329  Sum_probs=208.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-------CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ...+|++++.||+|+||.||+|.+..       .+..||+|+++..     ...+.+|+++++++.+||||+++++++..
T Consensus        10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~   89 (334)
T cd05100          10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ   89 (334)
T ss_pred             CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEcc
Confidence            34579999999999999999998643       2246999988642     24678899999999569999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+.+|+||||+++|+|.+++....                .++...+..++.||+.||.|||++|++||||||+|||++.
T Consensus        90 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~  169 (334)
T cd05100          90 DGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTE  169 (334)
T ss_pred             CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcC
Confidence            999999999999999999987542                3677888999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.+||+|||+++.......   .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+
T Consensus       170 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~  249 (334)
T cd05100         170 DNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLL  249 (334)
T ss_pred             CCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence            99999999999976543321   122334567999999866 48999999999999999998 89999998888888777


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ......   .....++.++.+||.+||..+|.+|||+.+++++
T Consensus       250 ~~~~~~---~~~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         250 KEGHRM---DKPANCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             HcCCCC---CCCCCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            654321   1224678899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.7e-40  Score=324.66  Aligned_cols=246  Identities=23%  Similarity=0.342  Sum_probs=202.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCC--------------cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASG--------------AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLH  163 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~--------------~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~  163 (469)
                      .+|++.+.||+|+||.||+|.+..++              ..||+|.++..     ...+.+|+++|+++. ||||++++
T Consensus         5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~-h~~i~~~~   83 (295)
T cd05097           5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLK-NPNIIRLL   83 (295)
T ss_pred             HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCcCeEE
Confidence            58999999999999999999875432              35899998653     245788999999997 99999999


Q ss_pred             EEEEeCCeEEEEEeccCCCchHHHHHHhC------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc
Q 012170          164 SVYEEADCFHLVMELCSGGRLIDQMVEVG------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT  231 (469)
Q Consensus       164 ~~~~~~~~~~lV~E~~~gg~L~~~l~~~~------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~  231 (469)
                      +++...+..|+||||+.+++|.+++....            .+++..+..++.|++.||.|||++|++||||||+|||++
T Consensus        84 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nill~  163 (295)
T cd05097          84 GVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG  163 (295)
T ss_pred             EEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhEEEc
Confidence            99999999999999999999999886532            367888999999999999999999999999999999999


Q ss_pred             cCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh--CCCCCCCCCHHHHHH
Q 012170          232 TSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV--AALPFKGDSLEAVFD  305 (469)
Q Consensus       232 ~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~~~  305 (469)
                      .++.+||+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++  |..||...+..+.+.
T Consensus       164 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~  243 (295)
T cd05097         164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIE  243 (295)
T ss_pred             CCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHHHHH
Confidence            999999999999976533221   122345678999998865 58999999999999999988  778998877666655


Q ss_pred             HHHcCc----CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          306 AIKNVK----LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       306 ~i~~~~----~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+....    ..........+++.+.+||.+||..||.+|||+.+|++
T Consensus       244 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         244 NTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence            543211    11111122457899999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.5e-40  Score=315.84  Aligned_cols=244  Identities=25%  Similarity=0.383  Sum_probs=209.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|.+.+.||+|+||.||+|.+. ++..||||.+...   ...+.+|+.+++.+. ||||+++++++.....+++|||
T Consensus         4 ~~~~~~i~~~ig~g~~~~v~~~~~~-~~~~~~vK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   81 (261)
T cd05034           4 PRESLKLERKLGAGQFGEVWMGTWN-GTTKVAVKTLKPGTMSPEAFLQEAQIMKKLR-HDKLVQLYAVCSEEEPIYIVTE   81 (261)
T ss_pred             chhheeeeeeeccCcceEEEEEEEc-CCceEEEEEecCCccCHHHHHHHHHHHhhCC-CCCEeeeeeeeecCCceEEEEe
Confidence            3578999999999999999999976 4578999998753   357889999999997 9999999999999899999999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+++++|.+++....  .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++........  .
T Consensus        82 ~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~  161 (261)
T cd05034          82 YMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAR  161 (261)
T ss_pred             ccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhhhhh
Confidence            999999999997653  689999999999999999999999999999999999999999999999999976543221  1


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....++..|+|||.+.+ .++.++|+||||+++|+|++ |..||.+......+..+.....   .......+.++.++|.
T Consensus       162 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~i~  238 (261)
T cd05034         162 EGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYR---MPRPPNCPEELYDLML  238 (261)
T ss_pred             hccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHH
Confidence            22335678999999876 48889999999999999998 9999998888777777765421   1122456899999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..+|.+||++++++.
T Consensus       239 ~~l~~~p~~Rp~~~~l~~  256 (261)
T cd05034         239 QCWDKDPEERPTFEYLQS  256 (261)
T ss_pred             HHcccCcccCCCHHHHHH
Confidence            999999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=100.00  E-value=2.2e-40  Score=333.82  Aligned_cols=246  Identities=24%  Similarity=0.356  Sum_probs=199.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-AD  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~  170 (469)
                      .++|.+++.||+|+||.||+|.+     ..+++.||||+++..     ...+.+|+.+|.++..||||+++++++.. +.
T Consensus         6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~   85 (343)
T cd05103           6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   85 (343)
T ss_pred             hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCC
Confidence            46899999999999999999985     346788999999642     23577899999999768999999998754 45


Q ss_pred             eEEEEEeccCCCchHHHHHHh-----------------------------------------------------------
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-----------------------------------------------------------  191 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-----------------------------------------------------------  191 (469)
                      .+++|||||++|+|.+++...                                                           
T Consensus        86 ~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  165 (343)
T cd05103          86 PLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEE  165 (343)
T ss_pred             ceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhh
Confidence            689999999999999988643                                                           


Q ss_pred             --------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---ccccCCCC
Q 012170          192 --------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSP  260 (469)
Q Consensus       192 --------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~  260 (469)
                              ..++...+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........   .....+++
T Consensus       166 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~  245 (343)
T cd05103         166 AEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL  245 (343)
T ss_pred             hhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCc
Confidence                    1356778889999999999999999999999999999999999999999999976533221   12234567


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      .|+|||++.+ .++.++||||||+++|+|++ |..||.+.... .....+...... ..  ...+++++.+++.+||..|
T Consensus       246 ~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~~~cl~~~  322 (343)
T cd05103         246 KWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM-RA--PDYTTPEMYQTMLDCWHGE  322 (343)
T ss_pred             ceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCC-CC--CCCCCHHHHHHHHHHccCC
Confidence            8999999865 58999999999999999997 99999875433 333333333221 11  1346889999999999999


Q ss_pred             hcCCCCHHHHHcC
Q 012170          338 VSARITADEVLRH  350 (469)
Q Consensus       338 P~~Rpsa~elL~h  350 (469)
                      |.+|||+.+|++|
T Consensus       323 p~~Rps~~eil~~  335 (343)
T cd05103         323 PSQRPTFSELVEH  335 (343)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999986

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=100.00  E-value=6.1e-40  Score=318.28  Aligned_cols=243  Identities=25%  Similarity=0.389  Sum_probs=206.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+|.+.+.||+|+||.||+|.++.++.   .||||++...     ...+..|+.+++.+. ||||+++++++.+++.+++
T Consensus         4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~~l   82 (269)
T cd05065           4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNIIHLEGVVTKSRPVMI   82 (269)
T ss_pred             HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CcCcceEEEEECCCCceEE
Confidence            468899999999999999999887665   5999998653     246788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      ||||+++|+|.+++... +.+++..+..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~  162 (269)
T cd05065          83 ITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD  162 (269)
T ss_pred             EEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccccCccc
Confidence            99999999999988754 56899999999999999999999999999999999999999999999999998755432211


Q ss_pred             ---cc-c--CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          254 ---SG-L--AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       254 ---~~-~--~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                         .. .  .++..|+|||.+.+ .++.++|||||||++|+|++ |..||.+.+.......+.... ..  .....++..
T Consensus       163 ~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~~~~~~i~~~~-~~--~~~~~~~~~  239 (269)
T cd05065         163 PTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY-RL--PPPMDCPTA  239 (269)
T ss_pred             cccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCC-cC--CCcccCCHH
Confidence               11 1  12457999999865 58999999999999999886 999999888777777775432 11  223467899


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHc
Q 012170          326 ARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+++.+||..+|.+||++.+|+.
T Consensus       240 ~~~li~~~l~~~p~~Rp~~~~i~~  263 (269)
T cd05065         240 LHQLMLDCWQKDRNARPKFGQIVS  263 (269)
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHH
Confidence            999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.9e-41  Score=325.89  Aligned_cols=258  Identities=26%  Similarity=0.422  Sum_probs=210.7

Q ss_pred             cCCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCC-CC----eeEEEEEE
Q 012170           95 MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGH-TG----VVTLHSVY  166 (469)
Q Consensus        95 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~h-pn----Iv~l~~~~  166 (469)
                      ....+.+..+|.++..+|+|+||.|..|.+..++..||||+++.   -.+...-|+++|+++..+ |+    +|.+.++|
T Consensus        81 ~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wF  160 (415)
T KOG0671|consen   81 YQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWF  160 (415)
T ss_pred             EEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhh
Confidence            33445678999999999999999999999999999999999964   345667799999999532 33    78899999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-----------
Q 012170          167 EEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-----------  233 (469)
Q Consensus       167 ~~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-----------  233 (469)
                      +..+..|||+|.+ |-++++.|..++  +|+...++.+..|++.++.|||+.+++|.||||+|||+.+.           
T Consensus       161 dyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~  239 (415)
T KOG0671|consen  161 DYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKK  239 (415)
T ss_pred             hccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCc
Confidence            9999999999999 779999997764  68999999999999999999999999999999999999431           


Q ss_pred             ---------CcEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-
Q 012170          234 ---------GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA-  302 (469)
Q Consensus       234 ---------~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-  302 (469)
                               ..|+|+|||.|....  +..+..+.|..|+|||++.| .++.++||||+||||+||.+|...|...+..+ 
T Consensus       240 ~~~~r~~ks~~I~vIDFGsAtf~~--e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EH  317 (415)
T KOG0671|consen  240 VCFIRPLKSTAIKVIDFGSATFDH--EHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLEH  317 (415)
T ss_pred             cceeccCCCcceEEEecCCcceec--cCcceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHHH
Confidence                     258999999997643  33467789999999999988 79999999999999999999999998766444 


Q ss_pred             --HHHHHHcC------------------cCCCCCCccc------------------C---CCHHHHHHHHHhchhhhcCC
Q 012170          303 --VFDAIKNV------------------KLDFHSGVWE------------------T---VSKPARDLMARMLTRDVSAR  341 (469)
Q Consensus       303 --~~~~i~~~------------------~~~~~~~~~~------------------~---~s~~~~~lI~~~L~~dP~~R  341 (469)
                        +++.|...                  .++++.....                  .   .-.++.|||++||.+||.+|
T Consensus       318 LaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~R  397 (415)
T KOG0671|consen  318 LAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARR  397 (415)
T ss_pred             HHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCcccc
Confidence              33333221                  1111110000                  0   12357799999999999999


Q ss_pred             CCHHHHHcCCCccc
Q 012170          342 ITADEVLRHPWILF  355 (469)
Q Consensus       342 psa~elL~hp~~~~  355 (469)
                      +|+.|+|.||||..
T Consensus       398 iTl~EAL~HpFF~~  411 (415)
T KOG0671|consen  398 ITLREALSHPFFAR  411 (415)
T ss_pred             ccHHHHhcCHHhhc
Confidence            99999999999953

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=7.7e-40  Score=316.07  Aligned_cols=235  Identities=26%  Similarity=0.348  Sum_probs=197.6

Q ss_pred             eeeccCCeEEEEEEEC--CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 012170          110 VIGHGKFGSVWLCRSK--ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      .||+|+||.||+|.+.  .++..||+|++...     .+.+.+|+.+++++. ||||++++++++ .+.+++||||+++|
T Consensus         2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~ii~~~~~~~-~~~~~lv~e~~~~~   79 (257)
T cd05115           2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLD-NPYIVRMIGVCE-AEALMLVMEMASGG   79 (257)
T ss_pred             ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcC-CCCeEEEEEEEc-CCCeEEEEEeCCCC
Confidence            3899999999999775  44567999998653     245789999999996 999999999986 45788999999999


Q ss_pred             chHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc----ccccC
Q 012170          183 RLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGLA  257 (469)
Q Consensus       183 ~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~----~~~~~  257 (469)
                      +|.+++.. ...+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++........    .....
T Consensus        80 ~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~  159 (257)
T cd05115          80 PLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGK  159 (257)
T ss_pred             CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCC
Confidence            99998875 45789999999999999999999999999999999999999999999999999975543221    11223


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhch
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT  335 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~  335 (469)
                      +++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+.......   ....+++++.++|.+||.
T Consensus       160 ~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~c~~  236 (257)
T cd05115         160 WPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKRLD---CPAECPPEMYALMKDCWI  236 (257)
T ss_pred             CCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCCCC---CCCCCCHHHHHHHHHHcC
Confidence            4578999999865 58899999999999999996 999999888877777776554321   124578999999999999


Q ss_pred             hhhcCCCCHHHHHc
Q 012170          336 RDVSARITADEVLR  349 (469)
Q Consensus       336 ~dP~~Rpsa~elL~  349 (469)
                      .||++||++.++++
T Consensus       237 ~~~~~Rp~~~~i~~  250 (257)
T cd05115         237 YKWEDRPNFAKVEE  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999875

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms]

Probab=100.00  E-value=7.2e-42  Score=311.79  Aligned_cols=246  Identities=26%  Similarity=0.365  Sum_probs=205.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcc----cChHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----CeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR----KGEETVHREVEIMQHLSGHTGVVTLHSVYEEA-----DCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~----~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----~~~  172 (469)
                      .++|.+.+.||+|||+.||+++...++..||+|.+.    .+.+...+|++..+++. ||||++++++...+     ...
T Consensus        20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~-s~~vl~l~dh~l~~~~D~~~~~   98 (302)
T KOG2345|consen   20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFN-SPNVLRLVDHQLREEKDGKHEA   98 (302)
T ss_pred             CceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhC-CcchHHHHHHHHHhhccCceeE
Confidence            578999999999999999999999999999999884    34567889999999997 99999998876433     359


Q ss_pred             EEEEeccCCCchHHHHHHh---C-CCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          173 HLVMELCSGGRLIDQMVEV---G-QYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~---~-~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ||++.|...|+|.+.+...   + .++|.++..|+.+|++||++||+..  ++||||||.|||+.+.+.++|.|||.+..
T Consensus        99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~  178 (302)
T KOG2345|consen   99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQ  178 (302)
T ss_pred             EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccc
Confidence            9999999999999998654   2 6899999999999999999999999  99999999999999999999999999875


Q ss_pred             ecCC----------CcccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcC
Q 012170          247 ISNG----------QTLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSL--EAVFDAIKNV  310 (469)
Q Consensus       247 ~~~~----------~~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~  310 (469)
                      ..-.          +.......|..|+|||.+.-    ..++++|||||||++|.|+.|..||...-.  ..+--.+.+.
T Consensus       179 a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv~n~  258 (302)
T KOG2345|consen  179 APIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAVQNA  258 (302)
T ss_pred             cceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEeeecc
Confidence            4211          11223457999999999854    378999999999999999999999953211  0111234455


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+.+|..  ..+|..+.+||+.||+.||.+||++.+++.+
T Consensus       259 q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  259 QISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             ccccCCC--CCccHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            5666654  3489999999999999999999999999875

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=100.00  E-value=3.7e-41  Score=361.32  Aligned_cols=253  Identities=30%  Similarity=0.520  Sum_probs=209.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-----
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-----  168 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-----  168 (469)
                      .+...+|+.+++||+||||.||+|+++-+|+.||||.+.-.     ...+.+|+..|.+|. |||||++|..+.+     
T Consensus       475 SRY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLn-HpNVVRYysAWVEs~~~~  553 (1351)
T KOG1035|consen  475 SRYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLN-HPNVVRYYSAWVESTAEL  553 (1351)
T ss_pred             hhHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcC-CcceeeeehhhhccCCcc
Confidence            34677899999999999999999999999999999998542     346889999999997 9999999764311     


Q ss_pred             --------------------------------------------------------------------------------
Q 012170          169 --------------------------------------------------------------------------------  168 (469)
Q Consensus       169 --------------------------------------------------------------------------------  168 (469)
                                                                                                      
T Consensus       554 ~~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~t  633 (1351)
T KOG1035|consen  554 TVLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNT  633 (1351)
T ss_pred             ccccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccc
Confidence                                                                                            


Q ss_pred             --------------------------C--------CeEEEEEeccCCCchHHHHHHhCCC-CHHHHHHHHHHHHHHHHHH
Q 012170          169 --------------------------A--------DCFHLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVMWVIKYC  213 (469)
Q Consensus       169 --------------------------~--------~~~~lV~E~~~gg~L~~~l~~~~~l-~~~~~~~i~~qil~aL~yL  213 (469)
                                                +        ..+||-||||+...+.+++.++... ....++++++||+.||.|+
T Consensus       634 S~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYI  713 (1351)
T KOG1035|consen  634 SDSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYI  713 (1351)
T ss_pred             cccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHH
Confidence                                      0        2478999999987777766555444 4788999999999999999


Q ss_pred             HhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-------------------CCCcccccCCCCcccCceeccC----
Q 012170          214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-------------------NGQTLSGLAGSPAYVAPEVLSG----  270 (469)
Q Consensus       214 H~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-------------------~~~~~~~~~gt~~y~aPE~l~~----  270 (469)
                      |++|||||||||.||++++++.|||+|||+|....                   +....++.+||.-|+|||++.+    
T Consensus       714 H~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~  793 (1351)
T KOG1035|consen  714 HDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSN  793 (1351)
T ss_pred             HhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccc
Confidence            99999999999999999999999999999997611                   1123456789999999999964    


Q ss_pred             CCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          271 NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       271 ~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .|+.|+||||||||++||+.   ||.. .....++..++.+.++++...+..--+.-..+|+.||+.||.+||||.|+|+
T Consensus       794 ~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~  870 (1351)
T KOG1035|consen  794 KYNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLN  870 (1351)
T ss_pred             cccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhh
Confidence            49999999999999999984   5653 3345667777777777765555555567778999999999999999999999


Q ss_pred             CCCccc
Q 012170          350 HPWILF  355 (469)
Q Consensus       350 hp~~~~  355 (469)
                      +.||..
T Consensus       871 s~llpp  876 (1351)
T KOG1035|consen  871 SELLPP  876 (1351)
T ss_pred             ccCCCc
Confidence            999964

>KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription]

Probab=100.00  E-value=1.8e-41  Score=305.69  Aligned_cols=252  Identities=26%  Similarity=0.491  Sum_probs=211.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--eEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--CFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--~~~lV~E  177 (469)
                      -.++|++++.+|+|.|+.||.|+...+++.++||+++.- ...+.+|+.||+.|.+||||++|+++..+..  ...||+|
T Consensus        36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE  115 (338)
T KOG0668|consen   36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFE  115 (338)
T ss_pred             ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhh
Confidence            467999999999999999999999999999999999763 4679999999999999999999999997654  5779999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |+++.+...+   ...++.-++..++.|++.||.|||++||+|||+||.|++||.. ..++|+|+|+|.....+...+-.
T Consensus       116 ~v~n~Dfk~l---y~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eYnVR  192 (338)
T KOG0668|consen  116 YVNNTDFKQL---YPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVR  192 (338)
T ss_pred             hhccccHHHH---hhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCceeeee
Confidence            9988665433   3568889999999999999999999999999999999999975 46999999999988888877778


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHH-------------cCcCCC------
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFDAIK-------------NVKLDF------  314 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~-------------~~~~~~------  314 (469)
                      +.+..|-.||.+..  .|+..-|+|||||++..|+..+.||- |.+..+.+-.|.             +-...+      
T Consensus       193 VASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~  272 (338)
T KOG0668|consen  193 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFED  272 (338)
T ss_pred             eehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhh
Confidence            88999999999965  59999999999999999999888874 444333332221             111111      


Q ss_pred             -----CCCcc---------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          315 -----HSGVW---------ETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       315 -----~~~~~---------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                           ....|         .-+++++.|||.++|.+|..+|+||.|++.||||..
T Consensus       273 i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~HpyF~~  327 (338)
T KOG0668|consen  273 ILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMAHPYFAP  327 (338)
T ss_pred             HhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhcCchHHH
Confidence                 11112         235799999999999999999999999999999943

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=8.3e-40  Score=314.79  Aligned_cols=237  Identities=24%  Similarity=0.376  Sum_probs=202.2

Q ss_pred             eeeeccCCeEEEEEEECC-CCc--EEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKA-SGA--EFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~-~~~--~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.+.. .+.  .||||.+....     ..+.+|+.+++++. ||||+++++++.. ..+++||||++
T Consensus         1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~-~~~~~v~e~~~   78 (257)
T cd05040           1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLD-HENLIRLYGVVLT-HPLMMVTELAP   78 (257)
T ss_pred             CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcC-CCCccceeEEEcC-CeEEEEEEecC
Confidence            468999999999999865 333  69999997543     36788999999997 9999999999988 88999999999


Q ss_pred             CCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc----cc
Q 012170          181 GGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LS  254 (469)
Q Consensus       181 gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~----~~  254 (469)
                      +|+|.+++....  .+++..+..++.|++.||.|||++|++|+||+|+||+++.++.+||+|||++........    ..
T Consensus        79 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~  158 (257)
T cd05040          79 LGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEE  158 (257)
T ss_pred             CCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccceeccc
Confidence            999999997764  689999999999999999999999999999999999999999999999999976643211    12


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...++..|+|||.+.+ .++.++|||||||++|+|++ |..||...+..+....+........  ....++..+.++|.+
T Consensus       159 ~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~  236 (257)
T cd05040         159 HLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDKEGERLE--RPEACPQDIYNVMLQ  236 (257)
T ss_pred             CCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCcCC--CCccCCHHHHHHHHH
Confidence            3457788999999876 58999999999999999998 9999988888777777664332222  224578999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||..+|.+||++.++++
T Consensus       237 ~l~~~p~~Rps~~~~~~  253 (257)
T cd05040         237 CWAHNPADRPTFAALRE  253 (257)
T ss_pred             HCCCCcccCCCHHHHHH
Confidence            99999999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=100.00  E-value=8e-40  Score=335.89  Aligned_cols=247  Identities=21%  Similarity=0.337  Sum_probs=203.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|.+++.||+|+||.||+|++.     .++..||+|+++..     ...+.+|+.+|..+..||||+++++++...+.
T Consensus        36 ~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~  115 (401)
T cd05107          36 RDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGP  115 (401)
T ss_pred             HHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCC
Confidence            457888999999999999999864     34568999999743     13577899999999669999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC-----------------------------------------------------------
Q 012170          172 FHLVMELCSGGRLIDQMVEVG-----------------------------------------------------------  192 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~-----------------------------------------------------------  192 (469)
                      +++|||||.+|+|.+++...+                                                           
T Consensus       116 ~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  195 (401)
T cd05107         116 IYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDM  195 (401)
T ss_pred             cEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcc
Confidence            999999999999999986532                                                           


Q ss_pred             ---------------------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC
Q 012170          193 ---------------------------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       193 ---------------------------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~  233 (469)
                                                             .+++..+..++.||+.||.|||+.|++||||||+|||++.+
T Consensus       196 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~  275 (401)
T cd05107         196 KGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEG  275 (401)
T ss_pred             hhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCC
Confidence                                                   25667788899999999999999999999999999999999


Q ss_pred             CcEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 012170          234 GKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIK  308 (469)
Q Consensus       234 ~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~  308 (469)
                      +.++|+|||++.......   ......+++.|+|||++.+ .++.++|||||||++|+|++ |..||......+......
T Consensus       276 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~  355 (401)
T cd05107         276 KLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAI  355 (401)
T ss_pred             CEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHH
Confidence            999999999997643222   1223457889999999865 48899999999999999998 899998765544433332


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ......  ..+..++.++.+||.+||..+|.+||++.+|++.
T Consensus       356 ~~~~~~--~~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         356 KRGYRM--AKPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             HcCCCC--CCCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            222211  1234578999999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=2e-39  Score=310.87  Aligned_cols=237  Identities=22%  Similarity=0.355  Sum_probs=200.8

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ++||+|+||.||+|... ++..||+|++...     ...+.+|+++++.+. ||||+++++++...+..++||||+++++
T Consensus         1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~~~~~~   78 (250)
T cd05085           1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDLPQELKIKFLSEARILKQYD-HPNIVKLIGVCTQRQPIYIVMELVPGGD   78 (250)
T ss_pred             CccCCCCCceEEEEEec-CCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCCcCeEEEEEecCCccEEEEECCCCCc
Confidence            46899999999999865 6889999998653     235778999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc--cccCCCC
Q 012170          184 LIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP  260 (469)
Q Consensus       184 L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~--~~~~gt~  260 (469)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||||+||+++.++.++|+|||++.........  ....+++
T Consensus        79 L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (250)
T cd05085          79 FLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPI  158 (250)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccccCCCCCCcc
Confidence            99988654 46789999999999999999999999999999999999999999999999999754332221  1123466


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhh
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP  338 (469)
                      .|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+......   .....++..+.+||.+||..+|
T Consensus       159 ~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p  235 (250)
T cd05085         159 KWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRM---SCPQKCPDDVYKVMQRCWDYKP  235 (250)
T ss_pred             cccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHcccCc
Confidence            7999999865 58899999999999999998 99999988777776666544221   2234678999999999999999


Q ss_pred             cCCCCHHHHHcC
Q 012170          339 SARITADEVLRH  350 (469)
Q Consensus       339 ~~Rpsa~elL~h  350 (469)
                      .+||++.++++.
T Consensus       236 ~~Rp~~~~l~~~  247 (250)
T cd05085         236 ENRPKFSELQKE  247 (250)
T ss_pred             ccCCCHHHHHHH
Confidence            999999999763

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=100.00  E-value=1.1e-39  Score=321.52  Aligned_cols=247  Identities=23%  Similarity=0.333  Sum_probs=200.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC----------------CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCee
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA----------------SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVV  160 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~----------------~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv  160 (469)
                      .++|++.+.||+|+||.||+|.+..                ++..||+|++...     ...+.+|+.+|+.+. ||||+
T Consensus         4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~   82 (296)
T cd05095           4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLK-DPNII   82 (296)
T ss_pred             hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcc
Confidence            3579999999999999999986432                3457999999743     246789999999996 99999


Q ss_pred             EEEEEEEeCCeEEEEEeccCCCchHHHHHHhC-----------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEE
Q 012170          161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-----------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL  229 (469)
Q Consensus       161 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~-----------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NIL  229 (469)
                      ++++++...+..|+||||+.+|+|.+++....           .+++..+..++.||+.||.|||+.|++||||||+|||
T Consensus        83 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Nil  162 (296)
T cd05095          83 RLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCL  162 (296)
T ss_pred             eEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheEE
Confidence            99999999999999999999999999987643           3667789999999999999999999999999999999


Q ss_pred             EccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceecc-CCCCCccchHHHHHHHHHHHh--CCCCCCCCCHHHH
Q 012170          230 LTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV--AALPFKGDSLEAV  303 (469)
Q Consensus       230 l~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt--G~~Pf~~~~~~~~  303 (469)
                      ++.++.++|+|||++..+.....   .....+++.|+|||+.. +.++.++|||||||++|+|++  |..||...+..+.
T Consensus       163 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~~  242 (296)
T cd05095         163 VGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQV  242 (296)
T ss_pred             EcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHHH
Confidence            99999999999999976543221   12234467899999875 468999999999999999998  7899987766655


Q ss_pred             HHHHHc----CcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          304 FDAIKN----VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       304 ~~~i~~----~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.....    ............+++.+.+||.+||..||.+||++.+|++
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         243 IENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            543321    0000111112357899999999999999999999999875

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-39  Score=316.09  Aligned_cols=243  Identities=24%  Similarity=0.349  Sum_probs=206.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..+|++++.||+|+||.||+|.++.+|.    .||+|.+....     ..+.+|+.+++.+. ||||+++++++.. ...
T Consensus         6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~   83 (279)
T cd05057           6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVD-HPHVVRLLGICLS-SQV   83 (279)
T ss_pred             HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEec-Cce
Confidence            3678999999999999999999877765    58999886532     46778999999996 9999999999987 788


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ++||||+++|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.++|+|||++.......
T Consensus        84 ~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~  163 (279)
T cd05057          84 QLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDE  163 (279)
T ss_pred             EEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcc
Confidence            9999999999999998764 468999999999999999999999999999999999999999999999999997654332


Q ss_pred             cc---cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TL---SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~---~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ..   ....++..|+|||.+.. .++.++|+||||+++|+|++ |..||.+....++...+........   ....+.++
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  240 (279)
T cd05057         164 KEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEIPDLLEKGERLPQ---PPICTIDV  240 (279)
T ss_pred             cceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhCCCCCCC---CCCCCHHH
Confidence            21   12224568999998864 58899999999999999998 9999999888887777765432211   23468899


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+++.+||..||..||++.++++
T Consensus       241 ~~~~~~~l~~~p~~Rp~~~~l~~  263 (279)
T cd05057         241 YMVLVKCWMIDAESRPTFKELIN  263 (279)
T ss_pred             HHHHHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999999865

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.7e-41  Score=327.76  Aligned_cols=260  Identities=27%  Similarity=0.470  Sum_probs=220.0

Q ss_pred             cCCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----------hHHHHHHHHHHHHhhCCCCeeEEE
Q 012170           95 MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----------EETVHREVEIMQHLSGHTGVVTLH  163 (469)
Q Consensus        95 ~~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----------~~~~~~E~~il~~l~~hpnIv~l~  163 (469)
                      +.....+.++|.++.+||+|+|+.||+|.+....+.||||+-.-.           .....+|..|-+.|. ||.||++|
T Consensus       455 FkDHptLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLD-HpRIVKlY  533 (775)
T KOG1151|consen  455 FKDHPTLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELD-HPRIVKLY  533 (775)
T ss_pred             hccCcchHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccC-cceeeeee
Confidence            444456788999999999999999999999988999999986321           134678999999996 99999999


Q ss_pred             EEEE-eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc--CeEeccCCCCcEEEcc---CCcEE
Q 012170          164 SVYE-EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM--GVVHRDIKPENILLTT---SGKIK  237 (469)
Q Consensus       164 ~~~~-~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--givHrDlkp~NILl~~---~~~vk  237 (469)
                      ++|. +.+.+|-|+|||+|.+|..+|..++.+++.+++.|+.||+.||.||.+.  .|||-||||.|||+-.   -|.+|
T Consensus       534 DyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIK  613 (775)
T KOG1151|consen  534 DYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIK  613 (775)
T ss_pred             eeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeE
Confidence            9996 6678999999999999999999999999999999999999999999976  4999999999999954   47899


Q ss_pred             EEeccceeeecCCCc--------ccccCCCCcccCceecc-C----CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHH
Q 012170          238 LADFGLAMRISNGQT--------LSGLAGSPAYVAPEVLS-G----NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAV  303 (469)
Q Consensus       238 L~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~-~----~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~  303 (469)
                      |+||||++.+.+...        ++...||.||++||++. +    +.+.++||||+|||+|.++.|+-||..+. ..++
T Consensus       614 ITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQdI  693 (775)
T KOG1151|consen  614 ITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQDI  693 (775)
T ss_pred             eeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHHH
Confidence            999999988765432        35578999999999983 3    37899999999999999999999997543 3333


Q ss_pred             HHH---HHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          304 FDA---IKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       304 ~~~---i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +..   ++.....|+..  +.++.++++||++||.+--++|..+.++-.||||..+.
T Consensus       694 LqeNTIlkAtEVqFP~K--PvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllPh~  748 (775)
T KOG1151|consen  694 LQENTILKATEVQFPPK--PVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLPHI  748 (775)
T ss_pred             HhhhchhcceeccCCCC--CccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccchh
Confidence            322   23344556654  46899999999999999999999999999999996543

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=100.00  E-value=3.1e-39  Score=311.92  Aligned_cols=243  Identities=24%  Similarity=0.395  Sum_probs=206.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|.+.+.||+|+||.||+|.+. .+..+|+|.+....   ..+.+|+.+++.+. |+||+++++++.. ...|+|||
T Consensus         4 ~~~~~~~~~~lg~g~~~~vy~~~~~-~~~~~~iK~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~-~~~~~v~e   80 (260)
T cd05073           4 PRESLKLEKKLGAGQFGEVWMATYN-KHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVTK-EPIYIITE   80 (260)
T ss_pred             cccceeEEeEecCccceEEEEEEec-CCccEEEEecCCChhHHHHHHHHHHHHHhcC-CCCcceEEEEEcC-CCeEEEEE
Confidence            4578999999999999999999865 45679999987543   46788999999996 9999999999987 77899999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+++|+|.+++...  ..++...+..++.||+.||.|||+.|++|+||+|+||+++.++.++|+|||++........  .
T Consensus        81 ~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~  160 (260)
T cd05073          81 FMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAR  160 (260)
T ss_pred             eCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCcccc
Confidence            99999999999764  3578888999999999999999999999999999999999999999999999976543322  1


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....++..|+|||++.+ .++.++|+|||||++|+|++ |.+||.+.+.......+......   .....++.++.+++.
T Consensus       161 ~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~i~  237 (260)
T cd05073         161 EGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPEELYNIMM  237 (260)
T ss_pred             cCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCC---CCcccCCHHHHHHHH
Confidence            22345677999999865 48889999999999999998 99999988877777766654321   223567899999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||+.+|++||++.+++.
T Consensus       238 ~~l~~~p~~Rp~~~~l~~  255 (260)
T cd05073         238 RCWKNRPEERPTFEYIQS  255 (260)
T ss_pred             HHcccCcccCcCHHHHHH
Confidence            999999999999998864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=100.00  E-value=2.2e-39  Score=316.27  Aligned_cols=244  Identities=20%  Similarity=0.245  Sum_probs=205.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-ADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~~  171 (469)
                      .++|.+.+.||+|+||.||+|.+..    ++..|++|.+...     ...+.+|+.+++.+. ||||+++++++.. ...
T Consensus         5 ~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~-h~ni~~~~~~~~~~~~~   83 (280)
T cd05043           5 RDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLS-HQNILPILHVCIEDGEP   83 (280)
T ss_pred             hhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCCC
Confidence            3689999999999999999999876    3578999988643     245778999999996 9999999998765 567


Q ss_pred             EEEEEeccCCCchHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          172 FHLVMELCSGGRLIDQMVEV--------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                      .++++||+.+|+|.+++...        ..+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||+
T Consensus        84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~  163 (280)
T cd05043          84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNAL  163 (280)
T ss_pred             CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCC
Confidence            89999999999999998654        3588999999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          244 AMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       244 a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      ++.+.....   .....++..|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+..+....+..... +.  .
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~-~~--~  240 (280)
T cd05043         164 SRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYR-LA--Q  240 (280)
T ss_pred             cccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCC-CC--C
Confidence            976543221   122346778999999866 48999999999999999998 9999998887777666655421 11  2


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ...+++++.++|.+||..||++|||+.++++
T Consensus       241 ~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         241 PINCPDELFAVMACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             CCcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            3457899999999999999999999999985

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=9e-40  Score=319.97  Aligned_cols=243  Identities=23%  Similarity=0.372  Sum_probs=198.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEE----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRS----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~  172 (469)
                      -|++++.||+|+||.||+|..    ..++..||+|.++..     ...+.+|+.+++.+. ||||+++++++.+.  ..+
T Consensus         5 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~   83 (284)
T cd05079           5 FLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGNGI   83 (284)
T ss_pred             hhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCCce
Confidence            468899999999999999974    467889999998643     246788999999996 99999999998775  578


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ++||||++|++|.+++.+.. .+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......
T Consensus        84 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~  163 (284)
T cd05079          84 KLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDK  163 (284)
T ss_pred             EEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCccccccccCc
Confidence            99999999999999986653 58999999999999999999999999999999999999999999999999997654332


Q ss_pred             c----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHHcCc
Q 012170          252 T----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---------------SLEAVFDAIKNVK  311 (469)
Q Consensus       252 ~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---------------~~~~~~~~i~~~~  311 (469)
                      .    .....|+..|+|||++.+ .++.++||||||+++|+|+++..|+...               ........+....
T Consensus       164 ~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (284)
T cd05079         164 EYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGK  243 (284)
T ss_pred             cceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCc
Confidence            1    223557778999999865 5889999999999999999987665321               1111222222221


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                         ....+..++..+.+||.+||+.||.+|||+.+++++
T Consensus       244 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~  279 (284)
T cd05079         244 ---RLPRPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG  279 (284)
T ss_pred             ---cCCCCCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence               122345689999999999999999999999999874

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.7e-39  Score=310.09  Aligned_cols=236  Identities=25%  Similarity=0.381  Sum_probs=200.8

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      +.||.|+||.||+|.+.. ++.||+|.+...     ...+.+|+++++++. ||||+++++++.+....|+||||+.|++
T Consensus         1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~-~~~i~~~~~~~~~~~~~~~v~e~~~~~~   78 (251)
T cd05041           1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLPPDLKRKFLQEAEILKQYD-HPNIVKLIGVCVQKQPIYIVMELVPGGS   78 (251)
T ss_pred             CccccCCCceEEEEEEeC-CCcEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence            468999999999999887 999999998642     246788999999996 9999999999999999999999999999


Q ss_pred             hHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc---cccCCC
Q 012170          184 LIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGS  259 (469)
Q Consensus       184 L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~---~~~~gt  259 (469)
                      |.+++... ..+++..+..++.|++.||.|||++|++||||+|+|||++.++.++|+|||++.........   ....++
T Consensus        79 l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~  158 (251)
T cd05041          79 LLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIP  158 (251)
T ss_pred             HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcce
Confidence            99998664 46889999999999999999999999999999999999999999999999999755422111   112345


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD  337 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~d  337 (469)
                      ..|+|||.+.+ .++.++|+||||+++|+|++ |..||.+.........+.... ..  .....++.++.++|.+||..+
T Consensus       159 ~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~  235 (251)
T cd05041         159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGY-RM--PAPQLCPEEIYRLMLQCWAYD  235 (251)
T ss_pred             eccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCC-CC--CCCccCCHHHHHHHHHHhccC
Confidence            67999999865 58999999999999999999 899998887766666665432 11  122467899999999999999


Q ss_pred             hcCCCCHHHHHc
Q 012170          338 VSARITADEVLR  349 (469)
Q Consensus       338 P~~Rpsa~elL~  349 (469)
                      |.+|||+.|+|+
T Consensus       236 p~~Rp~~~ell~  247 (251)
T cd05041         236 PENRPSFSEIYN  247 (251)
T ss_pred             hhhCcCHHHHHH
Confidence            999999999986

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.2e-40  Score=317.78  Aligned_cols=233  Identities=21%  Similarity=0.306  Sum_probs=193.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcE-------EEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          109 EVIGHGKFGSVWLCRSKASGAE-------FACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~-------vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +.||.|+||.||+|.+..++..       ||+|.+....    +.+..|+.+++.+. ||||+++++++..++..++|||
T Consensus         1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~-h~~iv~~~~~~~~~~~~~lv~e   79 (258)
T cd05078           1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLS-HKHLVLNYGVCVCGDESIMVQE   79 (258)
T ss_pred             CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCC-CCChhheeeEEEeCCCcEEEEe
Confidence            4689999999999998765543       8888886432    45778999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc--------EEEEeccceeeec
Q 012170          178 LCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK--------IKLADFGLAMRIS  248 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~--------vkL~DFgla~~~~  248 (469)
                      |+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.        ++++|||++....
T Consensus        80 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~  159 (258)
T cd05078          80 YVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVL  159 (258)
T ss_pred             cCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccccccccC
Confidence            999999999997654 5899999999999999999999999999999999999988765        6999999986543


Q ss_pred             CCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .   .....+++.|+|||++.+  .++.++||||||+++|+|++| .+||............. ....++    ...+.+
T Consensus       160 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~  231 (258)
T cd05078         160 P---KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKKLQFYE-DRHQLP----APKWTE  231 (258)
T ss_pred             C---chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHHHHHHH-ccccCC----CCCcHH
Confidence            2   233568899999999975  478999999999999999998 57776665544433322 222233    245688


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||+.||++|||++++++.
T Consensus       232 ~~~li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         232 LANLINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHHHHhccChhhCCCHHHHHHh
Confidence            9999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=3.5e-39  Score=313.09  Aligned_cols=244  Identities=25%  Similarity=0.327  Sum_probs=205.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|.+.+.||+|+||.||+|.+...   ...||||.....     .+.+.+|+.+++.+. ||||+++++++.+ +..|
T Consensus         5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~-h~~i~~~~~~~~~-~~~~   82 (270)
T cd05056           5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFD-HPHIVKLIGVITE-NPVW   82 (270)
T ss_pred             hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCC-CCchhceeEEEcC-CCcE
Confidence            35688999999999999999987654   356999988643     246788999999996 9999999999875 4578


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+++|+|.+++.... .+++..+..++.||+.||.|||+.|++|+||||+|||++.++.++|+|||++........
T Consensus        83 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~  162 (270)
T cd05056          83 IVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY  162 (270)
T ss_pred             EEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeecccccc
Confidence            9999999999999997644 589999999999999999999999999999999999999999999999999976544322


Q ss_pred             c--cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          253 L--SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       253 ~--~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      .  ....+++.|+|||.+.+ .++.++||||||+++|+|++ |..||.+.+..+....+.+....   ..+..++..+.+
T Consensus       163 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~  239 (270)
T cd05056         163 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYS  239 (270)
T ss_pred             eecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCcC---CCCCCCCHHHHH
Confidence            1  12234568999999865 48899999999999999986 99999988877777776654322   123567999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcC
Q 012170          329 LMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +|.+||..+|.+|||+.+++..
T Consensus       240 li~~~l~~~P~~Rpt~~~~~~~  261 (270)
T cd05056         240 LMTKCWAYDPSKRPRFTELKAQ  261 (270)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999998864

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport]

Probab=100.00  E-value=1.5e-40  Score=348.52  Aligned_cols=243  Identities=25%  Similarity=0.393  Sum_probs=213.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ...+....+.||+|+||+||+|+...     ..+.||||.++..     ..+|++|+++|..|. |||||+|++++.+++
T Consensus       484 ~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~-H~nIVrLlGVC~~~~  562 (774)
T KOG1026|consen  484 PRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQ-HPNIVRLLGVCREGD  562 (774)
T ss_pred             chhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhcc-CCCeEEEEEEEccCC
Confidence            34566778899999999999997542     3457999999753     357999999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC--------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG--------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~--------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      .+|+|+|||..|+|..+|..+.              +++..+...|+.||+.|+.||-++.+|||||...|+||.++-.|
T Consensus       563 P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~V  642 (774)
T KOG1026|consen  563 PLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVV  642 (774)
T ss_pred             eeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEE
Confidence            9999999999999999997542              27788999999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCCCccc---ccCCCCcccCceec-cCCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc
Q 012170          237 KLADFGLAMRISNGQTLS---GLAGSPAYVAPEVL-SGNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK  311 (469)
Q Consensus       237 kL~DFgla~~~~~~~~~~---~~~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  311 (469)
                      ||+||||++.+....+..   ...-..+|||||.+ .++|+.++||||+||+|||+++ |..||.+.+.+++++.|.++.
T Consensus       643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~  722 (774)
T KOG1026|consen  643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQ  722 (774)
T ss_pred             EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCC
Confidence            999999998765443322   22335689999988 5689999999999999999997 999999999999999999998


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHH
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEV  347 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~el  347 (469)
                      . ++  ..+.++.++.+|+..|++.+|.+||++.||
T Consensus       723 l-L~--~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI  755 (774)
T KOG1026|consen  723 L-LS--CPENCPTEVYSLMLECWNENPKRRPSFKEI  755 (774)
T ss_pred             c-cc--CCCCCCHHHHHHHHHHhhcCcccCCCHHHH
Confidence            7 33  236899999999999999999999999987

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=100.00  E-value=2.5e-39  Score=311.29  Aligned_cols=238  Identities=28%  Similarity=0.378  Sum_probs=203.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      ++|++.+.||+|+||.||++..  ++..||+|.++..  ...+.+|+.+++.+. ||||+++++++..+ ..++||||+.
T Consensus         6 ~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~~~~~~~~e~~~l~~~~-~~~i~~~~~~~~~~-~~~~v~e~~~   81 (254)
T cd05083           6 QKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDVTAQAFLEETAVMTKLH-HKNLVRLLGVILHN-GLYIVMELMS   81 (254)
T ss_pred             HHceeeeeeccCCCCceEeccc--CCCceEEEeecCcchHHHHHHHHHHHHhCC-CCCcCeEEEEEcCC-CcEEEEECCC
Confidence            5799999999999999999864  6889999998653  356889999999996 99999999998765 4789999999


Q ss_pred             CCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCC
Q 012170          181 GGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG  258 (469)
Q Consensus       181 gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~g  258 (469)
                      +++|.+++....  .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++......  ......
T Consensus        82 ~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~--~~~~~~  159 (254)
T cd05083          82 KGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMG--VDNSKL  159 (254)
T ss_pred             CCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceecccc--CCCCCC
Confidence            999999987654  4789999999999999999999999999999999999999999999999999764322  222345


Q ss_pred             CCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          259 SPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       259 t~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      +..|+|||.+.+ .++.++|+||||+++|+|++ |.+||.+.+..+....+......   .....++..+.++|.+||+.
T Consensus       160 ~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~  236 (254)
T cd05083         160 PVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECVEKGYRM---EPPEGCPADVYVLMTSCWET  236 (254)
T ss_pred             CceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhCCCCC---CCCCcCCHHHHHHHHHHcCC
Confidence            678999999865 58899999999999999997 99999988887777776654221   12346789999999999999


Q ss_pred             hhcCCCCHHHHHc
Q 012170          337 DVSARITADEVLR  349 (469)
Q Consensus       337 dP~~Rpsa~elL~  349 (469)
                      +|.+||++.+++.
T Consensus       237 ~p~~Rp~~~~l~~  249 (254)
T cd05083         237 EPKKRPSFHKLRE  249 (254)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=100.00  E-value=3e-39  Score=313.26  Aligned_cols=245  Identities=27%  Similarity=0.447  Sum_probs=208.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECC-CCcEEEEEEcccC--------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKG--------------EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~--------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      .|++.+.||+|+||.||+|.+.. ++..+|+|.+...              ...+.+|+.++.+..+||||+++++++..
T Consensus         1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~   80 (269)
T cd08528           1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE   80 (269)
T ss_pred             CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence            47888999999999999999987 6889999987421              13466788888764459999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                      ++..|+||||++|++|.+++..    ...+++..++.++.|++.||.|||+ .|++|+||+|+|||++.++.++|+|||+
T Consensus        81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~  160 (269)
T cd08528          81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGL  160 (269)
T ss_pred             CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEecccc
Confidence            9999999999999999988743    3468999999999999999999996 7899999999999999999999999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      +.............|+..|+|||++.+ .++.++|+||||+++|+|++|.+||...........+........  ....+
T Consensus       161 ~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~  238 (269)
T cd08528         161 AKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL--PEGMY  238 (269)
T ss_pred             eeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC--CcccC
Confidence            987655544456679999999999976 488999999999999999999999988877776666655443221  12357


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.++.++|.+||..||++||++.|+..+
T Consensus       239 ~~~l~~li~~cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         239 SEDVTDVITSCLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             CHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence            8999999999999999999999998754

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.8e-39  Score=312.36  Aligned_cols=231  Identities=21%  Similarity=0.264  Sum_probs=192.9

Q ss_pred             eeeeccCCeEEEEEEECCCC----------cEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          109 EVIGHGKFGSVWLCRSKASG----------AEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~----------~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      +.||+|+||.||+|.+..++          ..+++|++...   ...+.+|+.+|+.+. ||||+++++++.. +..++|
T Consensus         1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~-~~~~lv   78 (259)
T cd05037           1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLS-HKHLVKLYGVCVR-DENIMV   78 (259)
T ss_pred             CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhhHHHHHHHHHHHHcCC-CcchhheeeEEec-CCcEEE
Confidence            46899999999999998777          45888987643   356888999999996 9999999999887 778999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-------cEEEEeccceeee
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-------KIKLADFGLAMRI  247 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-------~vkL~DFgla~~~  247 (469)
                      |||+++|+|.+++...+ .++...+..++.||+.||.|||++||+||||||+|||++.++       .++|+|||++...
T Consensus        79 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~  158 (259)
T cd05037          79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV  158 (259)
T ss_pred             EEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccc
Confidence            99999999999998766 789999999999999999999999999999999999999888       7999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ..   .....++..|+|||++.+   .++.++||||||+++|+|++ |..||...+............ ..+    ....
T Consensus       159 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~~~-~~~----~~~~  230 (259)
T cd05037         159 LS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQDQH-RLP----MPDC  230 (259)
T ss_pred             cc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhcCC-CCC----CCCc
Confidence            43   223457788999999865   37899999999999999999 688887765444333332211 111    1224


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+.++|.+||..+|.+|||+.++++
T Consensus       231 ~~~~~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         231 AELANLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             hHHHHHHHHHhccChhhCCCHHHHHH
Confidence            79999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=100.00  E-value=3.9e-39  Score=312.81  Aligned_cols=239  Identities=22%  Similarity=0.300  Sum_probs=192.6

Q ss_pred             eeeeccCCeEEEEEEEC--CCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          109 EVIGHGKFGSVWLCRSK--ASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      +.||+|+||.||+|.+.  .++..+|+|.++...     ..+.+|+.+++.+. ||||+++++++.+...+++||||+++
T Consensus         1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~   79 (269)
T cd05087           1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQ-HSNLLQCLGQCTEVTPYLLVMEFCPL   79 (269)
T ss_pred             CcccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCCcEEEEECCCC
Confidence            36899999999999864  355679999986432     35778999999996 99999999999999999999999999


Q ss_pred             CchHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---c
Q 012170          182 GRLIDQMVEVG-----QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---L  253 (469)
Q Consensus       182 g~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~  253 (469)
                      |+|.+++....     ..++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||++........   .
T Consensus        80 g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~  159 (269)
T cd05087          80 GDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTP  159 (269)
T ss_pred             CcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeecC
Confidence            99999986532     356678889999999999999999999999999999999999999999999865433221   1


Q ss_pred             cccCCCCcccCceeccC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-HcCcCCCCCCc-ccCC
Q 012170          254 SGLAGSPAYVAPEVLSG--------NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI-KNVKLDFHSGV-WETV  322 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~~-~~~~  322 (469)
                      ....|++.|+|||++.+        .++.++||||||+++|+|++ |..||......+..... ......++.+. ....
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (269)
T cd05087         160 DQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPL  239 (269)
T ss_pred             CCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCC
Confidence            23467888999999853        25789999999999999996 99999876655544332 22222222221 1246


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++.+.+++.+|+ .+|.+|||+++|+.
T Consensus       240 ~~~~~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         240 SDRWYEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             ChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence            888999999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=2.9e-39  Score=313.11  Aligned_cols=233  Identities=22%  Similarity=0.269  Sum_probs=190.4

Q ss_pred             eeeeccCCeEEEEEEECCC------------CcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          109 EVIGHGKFGSVWLCRSKAS------------GAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~------------~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      +.||+|+||.||+|.....            ...+|+|++....    ..+..|+.+++.+. ||||+++++++......
T Consensus         1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~-hp~iv~~~~~~~~~~~~   79 (262)
T cd05077           1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVS-HKHIVLLYGVCVRDVEN   79 (262)
T ss_pred             CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCC
Confidence            4689999999999985422            2358999886432    35678899999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc-------EEEEeccce
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK-------IKLADFGLA  244 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~-------vkL~DFgla  244 (469)
                      ++||||+++|+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.       ++++|||++
T Consensus        80 ~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~  159 (262)
T cd05077          80 IMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIP  159 (262)
T ss_pred             EEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCC
Confidence            9999999999998887653 56899999999999999999999999999999999999987664       899999998


Q ss_pred             eeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      .....   .....|+..|+|||++.+  .++.++|||||||++|+|+ .|..||......+..... ......    ...
T Consensus       160 ~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~-~~~~~~----~~~  231 (262)
T cd05077         160 ITVLS---RQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEKERFY-EGQCML----VTP  231 (262)
T ss_pred             ccccC---cccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHHHHHH-hcCccC----CCC
Confidence            65432   223468889999999853  4899999999999999998 589999876554443322 222211    123


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+.++.+||.+||+.||.+||++.+|+++
T Consensus       232 ~~~~~~~li~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         232 SCKELADLMTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             ChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence            46789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2e-39  Score=316.42  Aligned_cols=232  Identities=22%  Similarity=0.301  Sum_probs=190.3

Q ss_pred             eeeccCCeEEEEEEECCC------------------------CcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeE
Q 012170          110 VIGHGKFGSVWLCRSKAS------------------------GAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVT  161 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~------------------------~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~  161 (469)
                      .||+|+||.||+|....+                        ...||+|++....    ..+.+|+.+++.+. ||||++
T Consensus         2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~-h~niv~   80 (274)
T cd05076           2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVS-HIHLAF   80 (274)
T ss_pred             CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCC-CCCeee
Confidence            589999999999975322                        2358999986532    35678899999996 999999


Q ss_pred             EEEEEEeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC------
Q 012170          162 LHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG------  234 (469)
Q Consensus       162 l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~------  234 (469)
                      +++++......|+||||+++|+|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++..+      
T Consensus        81 ~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~~~~~~~  160 (274)
T cd05076          81 VHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLGLAEGTS  160 (274)
T ss_pred             EEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccCcccCcc
Confidence            99999999999999999999999988865 46789999999999999999999999999999999999998654      


Q ss_pred             -cEEEEeccceeeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcC
Q 012170          235 -KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNV  310 (469)
Q Consensus       235 -~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~i~~~  310 (469)
                       .++++|||++......   ....++..|+|||.+.+  .++.++|||||||++|+|+ +|..||.+....+....+.. 
T Consensus       161 ~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~-  236 (274)
T cd05076         161 PFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPSEKERFYEK-  236 (274)
T ss_pred             ceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChHHHHHHHHh-
Confidence             3899999998543221   22457889999998865  4889999999999999995 69999987766554433332 


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...++    ...++++.++|.+||+.+|++|||+.++|++
T Consensus       237 ~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         237 KHRLP----EPSCKELATLISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             ccCCC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence            22222    2356789999999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=7.4e-40  Score=329.76  Aligned_cols=247  Identities=29%  Similarity=0.382  Sum_probs=198.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-eEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-CFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-~~~lV  175 (469)
                      .++.|.-...||+|+||.||+|...+ |..||||.+...    ..+|.+|+.+|.+++ |||+|+|++||.+.+ ..+||
T Consensus        73 AT~~Fs~~~~ig~Ggfg~VYkG~l~~-~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~-H~Nlv~LlGyC~e~~~~~~LV  150 (361)
T KOG1187|consen   73 ATNNFSESNLIGEGGFGTVYKGVLSD-GTVVAVKRLSSNSGQGEREFLNEVEILSRLR-HPNLVKLLGYCLEGGEHRLLV  150 (361)
T ss_pred             HHhCCchhcceecCCCeEEEEEEECC-CCEEEEEEecCCCCcchhHHHHHHHHHhcCC-CcCcccEEEEEecCCceEEEE
Confidence            45788888999999999999999875 489999988642    356999999999998 999999999999888 59999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcC---eEeccCCCCcEEEccCCcEEEEeccceeeecC-
Q 012170          176 MELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMG---VVHRDIKPENILLTTSGKIKLADFGLAMRISN-  249 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~g---ivHrDlkp~NILl~~~~~vkL~DFgla~~~~~-  249 (469)
                      +||+++|+|.++|....  .+++.....|+.+++.||.|||...   |+||||||+|||+|++.+.||+|||+|..... 
T Consensus       151 YEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~  230 (361)
T KOG1187|consen  151 YEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG  230 (361)
T ss_pred             EEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc
Confidence            99999999999997765  8999999999999999999999854   99999999999999999999999999965543 


Q ss_pred             CCccccc-CCCCcccCceecc-CCCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHH----HHHHcCcCC--CCCCc
Q 012170          250 GQTLSGL-AGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVF----DAIKNVKLD--FHSGV  318 (469)
Q Consensus       250 ~~~~~~~-~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~----~~i~~~~~~--~~~~~  318 (469)
                      ....... .||.+|+|||.+. +..+.++||||||++|.||++|+.|.....   .....    ..+.+....  .....
T Consensus       231 ~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l  310 (361)
T KOG1187|consen  231 DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRL  310 (361)
T ss_pred             ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCc
Confidence            3333333 8999999999985 679999999999999999999998876432   11111    122222111  01111


Q ss_pred             c-cCCC-----HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          319 W-ETVS-----KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       319 ~-~~~s-----~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      . ...+     ..+..+..+|++.+|..||++.|+++
T Consensus       311 ~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~  347 (361)
T KOG1187|consen  311 KEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK  347 (361)
T ss_pred             cCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence            1 1222     22556788999999999999999754

>KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=4.9e-40  Score=334.26  Aligned_cols=246  Identities=27%  Similarity=0.359  Sum_probs=208.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCc---E-EEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGA---E-FACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~-vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ..++-.+.+.||+|+||.||+|..+..+.   . ||+|..+.+       ...+.+|+++|++++ |||||++||+....
T Consensus       155 ~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~-H~NVVr~yGVa~~~  233 (474)
T KOG0194|consen  155 SHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLN-HPNVVRFYGVAVLE  233 (474)
T ss_pred             eccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEcCC
Confidence            34555667899999999999998775432   3 899988741       256889999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ..++||||+|.||+|.++|.+.+. ++..+...++.+.+.||+|||+++++||||...|+|++.++.+||+|||+++.-.
T Consensus       234 ~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~  313 (474)
T KOG0194|consen  234 EPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGS  313 (474)
T ss_pred             CccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccCCc
Confidence            999999999999999999999874 9999999999999999999999999999999999999999999999999987543


Q ss_pred             CCCccc-ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          249 NGQTLS-GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       249 ~~~~~~-~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ...... ...-...|+|||.+.. .|+.++||||+||++||+.+ |..||.+....++...|....+..+.  ....+.+
T Consensus       314 ~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~--~~~~p~~  391 (474)
T KOG0194|consen  314 QYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPI--PSKTPKE  391 (474)
T ss_pred             ceeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHHHHHHHHHhcCccCCC--CCCCHHH
Confidence            111112 1124568999999965 69999999999999999998 89999999999999888544333322  2367889


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHc
Q 012170          326 ARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +..++.+|+..||++||++.++.+
T Consensus       392 ~~~~~~~c~~~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  392 LAKVMKQCWKKDPEDRPTMSTIKK  415 (474)
T ss_pred             HHHHHHHhccCChhhccCHHHHHH
Confidence            999999999999999999999865

>PHA02882 putative serine/threonine kinase; Provisional

Probab=100.00  E-value=4.4e-39  Score=317.29  Aligned_cols=242  Identities=18%  Similarity=0.265  Sum_probs=189.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccChHHHHH---------------HHHHHHHhhCCCCeeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKGEETVHR---------------EVEIMQHLSGHTGVVTL  162 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~~~~~---------------E~~il~~l~~hpnIv~l  162 (469)
                      ...+|.+.+.||+|+||.||+|.+..+   +..+|+|+.......+..               +...+..+. |+||+++
T Consensus        10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~   88 (294)
T PHA02882         10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNID-HLGIPKY   88 (294)
T ss_pred             CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCC-CCCCCcE
Confidence            457899999999999999999999877   667888875432222222               223334454 9999999


Q ss_pred             EEEEEeCC----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          163 HSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       163 ~~~~~~~~----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      ++++....    ..+++||++. .++.+.+.....+++..+..++.||+.||.|||+.+|+||||||+|||++.++.++|
T Consensus        89 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~~~~~~~l  167 (294)
T PHA02882         89 YGCGSFKRCRMYYRFILLEKLV-ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVDGNNRGYI  167 (294)
T ss_pred             EEeeeEecCCceEEEEEEehhc-cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCcEEE
Confidence            99876543    4578888874 366666666566789999999999999999999999999999999999999999999


Q ss_pred             EeccceeeecCCC--------cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCH-HH------
Q 012170          239 ADFGLAMRISNGQ--------TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSL-EA------  302 (469)
Q Consensus       239 ~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~------  302 (469)
                      +|||+++.+....        ......||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+... ..      
T Consensus       168 ~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~~~~~~~~  247 (294)
T PHA02882        168 IDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNGNLIHAAK  247 (294)
T ss_pred             EEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccchHHHHHhH
Confidence            9999997653221        12235799999999998764 89999999999999999999999987632 11      


Q ss_pred             --HHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          303 --VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       303 --~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                        .+..+......+     ...++++.+++..|+..+|++||++.++++
T Consensus       248 ~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~  291 (294)
T PHA02882        248 CDFIKRLHEGKIKI-----KNANKFIYDFIECVTKLSYEEKPDYDALIK  291 (294)
T ss_pred             HHHHHHhhhhhhcc-----CCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence              223333332222     356899999999999999999999999875

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=100.00  E-value=3.7e-39  Score=318.94  Aligned_cols=244  Identities=23%  Similarity=0.339  Sum_probs=204.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .++|+..+.||+|+||.||+|.+..+|.    .||+|.+....     ..+.+|+.+++.+. ||||+++++++... ..
T Consensus         6 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~-h~niv~~~~~~~~~-~~   83 (303)
T cd05110           6 ETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMD-HPHLVRLLGVCLSP-TI   83 (303)
T ss_pred             hhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEcCC-Cc
Confidence            3578889999999999999999987776    47889886532     35778999999996 99999999998754 46


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ++|+||+++|+|.+++.... .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        84 ~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~  163 (303)
T cd05110          84 QLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDE  163 (303)
T ss_pred             eeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccccccCcc
Confidence            79999999999999987654 68999999999999999999999999999999999999999999999999997654322


Q ss_pred             c---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 T---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      .   .....++..|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+...... +  .+...+..+
T Consensus       164 ~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~  240 (303)
T cd05110         164 KEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTREIPDLLEKGERL-P--QPPICTIDV  240 (303)
T ss_pred             cccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC-C--CCCCCCHHH
Confidence            2   223445778999999875 48899999999999999997 99999887766666666543322 1  124568899


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcC
Q 012170          327 RDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++|.+||..+|++||++.++++.
T Consensus       241 ~~li~~c~~~~p~~Rp~~~~l~~~  264 (303)
T cd05110         241 YMVMVKCWMIDADSRPKFKELAAE  264 (303)
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHH
Confidence            999999999999999999999874

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=4.7e-39  Score=314.51  Aligned_cols=244  Identities=25%  Similarity=0.369  Sum_probs=196.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEE----CCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRS----KASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEE--ADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~  171 (469)
                      .++|++++.||+|+||.||+|..    ..++..||+|.+....    ..+.+|+++++.+. ||||+++++++..  ...
T Consensus         3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   81 (284)
T cd05081           3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRRN   81 (284)
T ss_pred             cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEccCCCCc
Confidence            35789999999999999999974    4578899999986532    46788999999996 9999999998643  356


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +++||||+++|+|.+++... ..+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++......
T Consensus        82 ~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~  161 (284)
T cd05081          82 LRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQD  161 (284)
T ss_pred             eEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccccccCC
Confidence            89999999999999998764 46899999999999999999999999999999999999999999999999999865433


Q ss_pred             Ccc----cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHHc
Q 012170          251 QTL----SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE----------------AVFDAIKN  309 (469)
Q Consensus       251 ~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----------------~~~~~i~~  309 (469)
                      ...    ....++..|+|||++.+ .++.++||||||+++|+|++|..|+......                .....+..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (284)
T cd05081         162 KEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKN  241 (284)
T ss_pred             CcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhc
Confidence            221    11234456999999876 4889999999999999999988776433211                01111111


Q ss_pred             CcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       310 ~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      . ..++  ....++.++.+||.+||..+|++|||+.++++
T Consensus       242 ~-~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05081         242 N-GRLP--APPGCPAEIYAIMKECWNNDPSQRPSFSELAL  278 (284)
T ss_pred             C-CcCC--CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            1 1111  22467899999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=6e-39  Score=311.31  Aligned_cols=238  Identities=25%  Similarity=0.324  Sum_probs=191.6

Q ss_pred             eeeccCCeEEEEEEECC--CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 012170          110 VIGHGKFGSVWLCRSKA--SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      .||+|+||.||+|....  ....+|+|.+...     ...+.+|+.+++.+. ||||+++++.+...+.+|+||||+++|
T Consensus         2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~nii~~~~~~~~~~~~~lv~e~~~~g   80 (269)
T cd05042           2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELN-HPNVLQCLGQCIESIPYLLVLEFCPLG   80 (269)
T ss_pred             cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCC-CCCcceEEEEECCCCceEEEEEeCCCC
Confidence            58999999999996533  3457899987532     235678999999996 999999999999999999999999999


Q ss_pred             chHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc---cc
Q 012170          183 RLIDQMVEVG-----QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LS  254 (469)
Q Consensus       183 ~L~~~l~~~~-----~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~---~~  254 (469)
                      +|.+++....     .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........   ..
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~  160 (269)
T cd05042          81 DLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKD  160 (269)
T ss_pred             cHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheeccC
Confidence            9999987643     246778899999999999999999999999999999999999999999999865332211   12


Q ss_pred             ccCCCCcccCceeccC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH-HcCcCCCCCC-cccCCC
Q 012170          255 GLAGSPAYVAPEVLSG--------NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI-KNVKLDFHSG-VWETVS  323 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i-~~~~~~~~~~-~~~~~s  323 (469)
                      ...+++.|+|||++..        .++.++|||||||++|+|++ |.+||......+.+..+ ......++.. ....++
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (269)
T cd05042         161 CHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYS  240 (269)
T ss_pred             CCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCC
Confidence            3346778999998742        36789999999999999999 88999877665555443 3333333322 224678


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+.+++..|+ .||++|||+++|++
T Consensus       241 ~~~~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         241 DRWYEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHHHHHHh-cCcccccCHHHHHH
Confidence            89999999998 59999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=3.5e-39  Score=312.59  Aligned_cols=237  Identities=27%  Similarity=0.393  Sum_probs=199.3

Q ss_pred             eeeeccCCeEEEEEEECCCC------cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          109 EVIGHGKFGSVWLCRSKASG------AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~------~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +.||+|+||.||+|.++...      ..+|+|.+...     ...+.+|+.+++.+. ||||+++++++...+..++|||
T Consensus         1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~e   79 (269)
T cd05044           1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFN-HPNIVKLLGVCLLNEPQYIIME   79 (269)
T ss_pred             CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcC-CCCeeeEeeeecCCCCeEEEEe
Confidence            36899999999999886544      68999988543     346788999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-----cEEEEecccee
Q 012170          178 LCSGGRLIDQMVEV-------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-----KIKLADFGLAM  245 (469)
Q Consensus       178 ~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-----~vkL~DFgla~  245 (469)
                      |+++++|.+++...       ..+++..+..++.||+.||.|||+.+++|+||||+||+++.++     .++|+|||++.
T Consensus        80 ~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~  159 (269)
T cd05044          80 LMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR  159 (269)
T ss_pred             ccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccc
Confidence            99999999998653       2478899999999999999999999999999999999999887     89999999997


Q ss_pred             eecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          246 RISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       246 ~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .......   .....++..|+|||++.+ .++.++|||||||++|+|++ |..||...+..+....+......   ..+.
T Consensus       160 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~---~~~~  236 (269)
T cd05044         160 DIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGGRL---QKPE  236 (269)
T ss_pred             ccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCCcc---CCcc
Confidence            6543321   122345788999999865 58999999999999999998 99999887777776666543211   1224


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .++..+.+||.+||..+|.+||++.++++
T Consensus       237 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         237 NCPDKIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             cchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            67899999999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=6e-39  Score=309.69  Aligned_cols=238  Identities=25%  Similarity=0.306  Sum_probs=194.6

Q ss_pred             eeeeccCCeEEEEEEECC---CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEE-eCCeEEEEEecc
Q 012170          109 EVIGHGKFGSVWLCRSKA---SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYE-EADCFHLVMELC  179 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~-~~~~~~lV~E~~  179 (469)
                      +.||+|+||.||+|.+..   .+..||+|.+...     ...+.+|+.+++.+. ||||+++++++. .++..++||||+
T Consensus         1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~~   79 (262)
T cd05058           1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFS-HPNVLSLLGICLPSEGSPLVVLPYM   79 (262)
T ss_pred             CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCC-CCCcceEEEEeecCCCCcEEEEecC
Confidence            468999999999998653   3457999998532     246778999999996 999999999765 456688999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-----cc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TL  253 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-----~~  253 (469)
                      .+|+|.+++... ..+++..+..++.||+.||.|||+.|++||||||+|||++.++.+||+|||++.......     ..
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~  159 (262)
T cd05058          80 KHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNH  159 (262)
T ss_pred             CCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeeccc
Confidence            999999998764 346778888999999999999999999999999999999999999999999997553321     11


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+++.|+|||.+.+ .++.++|||||||++|+|++ |.+||...+.......+........   ...++..+.+++.
T Consensus       160 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~  236 (262)
T cd05058         160 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLLQ---PEYCPDPLYEVML  236 (262)
T ss_pred             ccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCC---CCcCCHHHHHHHH
Confidence            23456778999999865 58899999999999999999 5778887777666666654432211   2356889999999


Q ss_pred             HhchhhhcCCCCHHHHHcC
Q 012170          332 RMLTRDVSARITADEVLRH  350 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~h  350 (469)
                      +||..+|++||++.++++.
T Consensus       237 ~cl~~~p~~Rp~~~~il~~  255 (262)
T cd05058         237 SCWHPKPEMRPTFSELVSR  255 (262)
T ss_pred             HHcCCChhhCCCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=100.00  E-value=1.2e-38  Score=310.75  Aligned_cols=243  Identities=25%  Similarity=0.400  Sum_probs=199.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECC----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~  171 (469)
                      .+|++.+.||+|+||.||+|.+..    ++..||||++...     ...+.+|+++++.+. ||||+++++++..  ...
T Consensus         4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~-~~~i~~~~~~~~~~~~~~   82 (284)
T cd05038           4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLD-HENIVKYKGVCEKPGGRS   82 (284)
T ss_pred             hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCC-CCChheEEeeeecCCCCc
Confidence            467888999999999999998653    4789999999653     346889999999996 9999999999877  567


Q ss_pred             EEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .++||||+++++|.+++.... .+++..+..++.||+.||.|||++|++|+||||+||+++.++.++|+|||++......
T Consensus        83 ~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~  162 (284)
T cd05038          83 LRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPED  162 (284)
T ss_pred             eEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccC
Confidence            999999999999999997654 5899999999999999999999999999999999999999999999999999876532


Q ss_pred             Ccc----cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHHHcC
Q 012170          251 QTL----SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE---------------AVFDAIKNV  310 (469)
Q Consensus       251 ~~~----~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~i~~~  310 (469)
                      ...    ....++..|+|||.+.+ .++.++||||||+++|+|++|..||......               .....+...
T Consensus       163 ~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (284)
T cd05038         163 KDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEG  242 (284)
T ss_pred             CcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccccccccccHHHHHHHHHcC
Confidence            221    12345567999998865 5888999999999999999999998653221               122222222


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                       ..++  ....++.++.+|+.+||..+|.+|||+.++++
T Consensus       243 -~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~  278 (284)
T cd05038         243 -ERLP--RPPSCPDEVYDLMKLCWEAEPQDRPSFADLIL  278 (284)
T ss_pred             -CcCC--CCccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence             1111  12456789999999999999999999999986

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=100.00  E-value=2.1e-38  Score=307.74  Aligned_cols=242  Identities=21%  Similarity=0.302  Sum_probs=199.6

Q ss_pred             eeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----
Q 012170          105 HTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----  170 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----  170 (469)
                      |.+.+.||+|+||.||+|.+.   .+++.||||++...      .+.+.+|+++++.+. ||||+++++++...+     
T Consensus         1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   79 (273)
T cd05074           1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFD-HPNVIKLIGVSLRSRAKGRL   79 (273)
T ss_pred             CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCC-CCCcceEEEEEccCCCCCcc
Confidence            567789999999999999864   35789999998643      235778999999996 999999999886532     


Q ss_pred             -eEEEEEeccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          171 -CFHLVMELCSGGRLIDQMVEV------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       171 -~~~lV~E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                       ..++++||+.+|+|.+++...      ..++...+..++.||+.||.|||++||+||||||+||+++.++.++|+|||+
T Consensus        80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~  159 (273)
T cd05074          80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL  159 (273)
T ss_pred             cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence             347899999999998877532      1478899999999999999999999999999999999999999999999999


Q ss_pred             eeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          244 AMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       244 a~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      +........   .....+++.|++||.+.+ .++.++|||||||++|+|++ |.+||.+.........+........   
T Consensus       160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~---  236 (273)
T cd05074         160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQ---  236 (273)
T ss_pred             cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCC---
Confidence            976543221   122345678999999865 47889999999999999999 8999998887777776665432111   


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....+..+.+++.+||..+|.+||++.+++.+
T Consensus       237 ~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~  268 (273)
T cd05074         237 PPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ  268 (273)
T ss_pred             CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            13568899999999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=100.00  E-value=3.8e-39  Score=343.17  Aligned_cols=254  Identities=22%  Similarity=0.339  Sum_probs=180.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCC----CcEEEEEEcccChHHHHHHHHHHHHhh--CCCCeeEEEEE------EE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKAS----GAEFACKTLRKGEETVHREVEIMQHLS--GHTGVVTLHSV------YE  167 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vAvK~~~~~~~~~~~E~~il~~l~--~hpnIv~l~~~------~~  167 (469)
                      .-.++|.+.+.||+|+||.||+|.+..+    +..||+|.+.....   .|+.+...+.  .+.++..++..      ..
T Consensus       129 ~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~---~e~~~~e~l~~~~~~~~~~~~~~~~~~~~~~  205 (566)
T PLN03225        129 FKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA---VEIWMNERVRRACPNSCADFVYGFLEPVSSK  205 (566)
T ss_pred             CccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch---hHHHHHHHHHhhchhhHHHHHHhhhcccccc
Confidence            3467899999999999999999999988    99999999864321   1222222221  12222222211      24


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCC--------------------CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCc
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVGQ--------------------YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPEN  227 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~~--------------------l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~N  227 (469)
                      ..+.+++||||+.+++|.+++.....                    ..+..+..++.||+.||.|||++||+||||||+|
T Consensus       206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~N  285 (566)
T PLN03225        206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQN  285 (566)
T ss_pred             cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHH
Confidence            56679999999999999998865421                    1234567899999999999999999999999999


Q ss_pred             EEEcc-CCcEEEEeccceeeecCC--CcccccCCCCcccCceeccC-----------------------CCCCccchHHH
Q 012170          228 ILLTT-SGKIKLADFGLAMRISNG--QTLSGLAGSPAYVAPEVLSG-----------------------NYSEKVDIWSA  281 (469)
Q Consensus       228 ILl~~-~~~vkL~DFgla~~~~~~--~~~~~~~gt~~y~aPE~l~~-----------------------~~~~~~DiwSl  281 (469)
                      ||++. ++.+||+|||++..+...  .....++||+.|+|||.+..                       .++.++|||||
T Consensus       286 ILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVwSl  365 (566)
T PLN03225        286 IIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIYSA  365 (566)
T ss_pred             EEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccHHH
Confidence            99986 579999999999765332  22345789999999996532                       23456799999


Q ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-------CC----------CcccCCCHHHHHHHHHhchhhhcCCCCH
Q 012170          282 GVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-------HS----------GVWETVSKPARDLMARMLTRDVSARITA  344 (469)
Q Consensus       282 G~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-------~~----------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa  344 (469)
                      ||++|+|+++..|+... .......+.....++       ..          ......+...++||.+||++||.+|||+
T Consensus       366 GviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR~ta  444 (566)
T PLN03225        366 GLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQRISA  444 (566)
T ss_pred             HHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccCCCH
Confidence            99999999977665432 122222222211110       00          0011123456699999999999999999


Q ss_pred             HHHHcCCCccccc
Q 012170          345 DEVLRHPWILFYT  357 (469)
Q Consensus       345 ~elL~hp~~~~~~  357 (469)
                      .|+|+||||....
T Consensus       445 ~e~L~Hpff~~~~  457 (566)
T PLN03225        445 KAALAHPYFDREG  457 (566)
T ss_pred             HHHhCCcCcCCCC
Confidence            9999999996543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=100.00  E-value=4.8e-38  Score=305.30  Aligned_cols=238  Identities=21%  Similarity=0.278  Sum_probs=190.4

Q ss_pred             eeeccCCeEEEEEEECCC--CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 012170          110 VIGHGKFGSVWLCRSKAS--GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~--~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      .||+|+||.||+|....+  ...+++|.+...     ...+.+|+.+++.+. ||||+++++.+.+....|+||||+++|
T Consensus         2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-h~~iv~~~~~~~~~~~~~lv~e~~~~~   80 (268)
T cd05086           2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQ-HPNILQCLGQCVEAIPYLLVFEYCELG   80 (268)
T ss_pred             cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccC-CcchhheEEEecCCCccEEEEecCCCC
Confidence            589999999999975433  235677776532     256888999999996 999999999999999999999999999


Q ss_pred             chHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---cccc
Q 012170          183 RLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSG  255 (469)
Q Consensus       183 ~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~~~~  255 (469)
                      +|.+++...    ..+++..+..++.||+.||.|||+.+++||||||+|||++.++.++|+|||++.......   ....
T Consensus        81 ~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~  160 (268)
T cd05086          81 DLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDD  160 (268)
T ss_pred             cHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccC
Confidence            999998754    235667788999999999999999999999999999999999999999999985432211   1234


Q ss_pred             cCCCCcccCceeccC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC-cCCCC-CCcccCCCH
Q 012170          256 LAGSPAYVAPEVLSG--------NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNV-KLDFH-SGVWETVSK  324 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~-~~~~~-~~~~~~~s~  324 (469)
                      .+|++.|+|||++..        .++.++||||||+++|+|++ |.+||......+.+..+... ..... ......+++
T Consensus       161 ~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (268)
T cd05086         161 KCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSE  240 (268)
T ss_pred             CcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcH
Confidence            578899999999742        25778999999999999997 57899877766666554322 22222 122235788


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          325 PARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+.++|..|+ .+|.+||++.+|++
T Consensus       241 ~~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         241 RWYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHHh-hCcccCCCHHHHHH
Confidence            9999999999 68999999999975

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-40  Score=305.97  Aligned_cols=255  Identities=24%  Similarity=0.351  Sum_probs=209.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++.+-+..||.|+||+|++..++.+|+..|||.++.     +..++..|.+...+-.+.||||++|+..-.++-.||.||
T Consensus        64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME  143 (361)
T KOG1006|consen   64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME  143 (361)
T ss_pred             chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence            345557789999999999999999999999999963     346788899888888889999999998777777789999


Q ss_pred             ccCCCchHHHH-----HHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          178 LCSGGRLIDQM-----VEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       178 ~~~gg~L~~~l-----~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+- +|..+.     .....++|..+..|....+.||.||.. ..|+|||+||+|||++..|.|||||||.+....+.-
T Consensus       144 LMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si  222 (361)
T KOG1006|consen  144 LMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI  222 (361)
T ss_pred             HHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH
Confidence            9953 443222     234679999999999999999999985 589999999999999999999999999998877666


Q ss_pred             cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCC--CcccCCCHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHS--GVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~--~~~~~~s~~  325 (469)
                      ..+.-.|-..|||||.+..   .|+.++||||||++|||++||..||.+-+ ..+.+..+..+.++...  ...-.++..
T Consensus       223 AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~  302 (361)
T KOG1006|consen  223 AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFS  302 (361)
T ss_pred             HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHH
Confidence            6666789999999999954   39999999999999999999999997632 33334444444433211  111357999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +..||.-||.+|-..||...+++++||+..+..
T Consensus       303 ~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~  335 (361)
T KOG1006|consen  303 MVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV  335 (361)
T ss_pred             HHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence            999999999999999999999999999976654

>KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-39  Score=333.22  Aligned_cols=238  Identities=31%  Similarity=0.467  Sum_probs=194.7

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC------eE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEAD------CF  172 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~------~~  172 (469)
                      -|..-+.||+|+||.||+++++.||+.||||.+++     ..+...+|+++|++|. |||||+++++-++..      ..
T Consensus        14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLn-h~NIVk~f~iee~~~~~~~~~~~   92 (732)
T KOG4250|consen   14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLN-HPNIVKLFDIEETKFLGLVTRLP   92 (732)
T ss_pred             ceeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcC-chhhhhhcccCCccccCcccccc
Confidence            45566899999999999999999999999999965     3467889999999997 999999999866543      46


Q ss_pred             EEEEeccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--CC--cEEEEecccee
Q 012170          173 HLVMELCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SG--KIKLADFGLAM  245 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--~~--~vkL~DFgla~  245 (469)
                      .+|||||.||+|...|.+.   ..+++.+...++.++..||.|||++||+||||||.||++-.  +|  ..||+|||.|+
T Consensus        93 vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Ar  172 (732)
T KOG4250|consen   93 VLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAAR  172 (732)
T ss_pred             eEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccc
Confidence            7999999999999999653   46999999999999999999999999999999999999843  34  38999999999


Q ss_pred             eecCCCcccccCCCCcccCceecc--CCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcC-------
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLS--GNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKL-------  312 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~-------  312 (469)
                      ..+++....+++||+.|++||++.  +.|+..+|.|||||++|+++||..||....    ..++...+...++       
T Consensus       173 el~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~  252 (732)
T KOG4250|consen  173 ELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGA  252 (732)
T ss_pred             cCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEee
Confidence            999999999999999999999997  469999999999999999999999995321    1223333322211       


Q ss_pred             --------CC--CCCcccCCCHH----HHHHHHHhchhhhcCCC
Q 012170          313 --------DF--HSGVWETVSKP----ARDLMARMLTRDVSARI  342 (469)
Q Consensus       313 --------~~--~~~~~~~~s~~----~~~lI~~~L~~dP~~Rp  342 (469)
                              .+  ..+....+++.    +-..+..+|..+|.+|.
T Consensus       253 ~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~  296 (732)
T KOG4250|consen  253 QEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRG  296 (732)
T ss_pred             ecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhC
Confidence                    11  01111233433    34578889999999999

>KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=2.8e-38  Score=342.18  Aligned_cols=242  Identities=26%  Similarity=0.379  Sum_probs=207.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCC-C----cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKAS-G----AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~----~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..-++.+.||+|+||.||.|....- |    ..||+|.+++.     ..+|.+|..+|+++. |||||++++++-+....
T Consensus       692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~-HpNiv~liGv~l~~~~~  770 (1025)
T KOG1095|consen  692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFD-HPNIVSLIGVCLDSGPP  770 (1025)
T ss_pred             hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCC-CcceeeEEEeecCCCCc
Confidence            4566788999999999999986543 2    24999999753     357889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          173 HLVMELCSGGRLIDQMVEV-------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      +|++|||+||+|..+|.+.       ..++..+...++.||++|+.||+++++|||||...|+|++....|||+|||+|+
T Consensus       771 ~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlAr  850 (1025)
T KOG1095|consen  771 LILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLAR  850 (1025)
T ss_pred             EEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhH
Confidence            9999999999999999876       248889999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCccc-ccCC--CCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc-CCCCCCcc
Q 012170          246 RISNGQTLS-GLAG--SPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK-LDFHSGVW  319 (469)
Q Consensus       246 ~~~~~~~~~-~~~g--t~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~  319 (469)
                      .+....... ...+  ...|||||.+. +.++.++|||||||++||+++ |..||.+.+..+++.....+. ++.+    
T Consensus       851 Diy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P----  926 (1025)
T KOG1095|consen  851 DIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPP----  926 (1025)
T ss_pred             hhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCC----
Confidence            554433321 1122  35799999996 579999999999999999998 999999999888888554443 3333    


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..++..+.+++..||+.+|++||++..|++
T Consensus       927 ~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  927 SYCPEKLYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             CCCChHHHHHHHHHccCChhhCccHHHHHh
Confidence            578999999999999999999999999987

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=100.00  E-value=2.6e-37  Score=292.39  Aligned_cols=237  Identities=42%  Similarity=0.745  Sum_probs=209.2

Q ss_pred             CCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHH
Q 012170          115 KFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV  189 (469)
Q Consensus       115 ~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~  189 (469)
                      +||.||+|.+..+|+.+|+|++...     ...+.+|++.++++. |+||+++++++......++||||+.+++|.+++.
T Consensus         1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~   79 (244)
T smart00220        1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLK-HPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLK   79 (244)
T ss_pred             CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCC-CCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHH
Confidence            5899999999999999999999653     467889999999995 9999999999999999999999999999999997


Q ss_pred             HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceecc
Q 012170          190 EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS  269 (469)
Q Consensus       190 ~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~  269 (469)
                      ....++...+..++.+++.++.|||+.|++|+||+|.||+++.++.++|+|||.+.............++..|+|||.+.
T Consensus        80 ~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~  159 (244)
T smart00220       80 KRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLL  159 (244)
T ss_pred             hccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeeccccccccccCCcCCCCHHHHc
Confidence            77668999999999999999999999999999999999999999999999999998776554555667899999999986


Q ss_pred             C-CCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHH
Q 012170          270 G-NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEV  347 (469)
Q Consensus       270 ~-~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~el  347 (469)
                      + .++.++||||||+++|+|++|..||.. .........+......... .+..++.++.+++.+||..+|.+||++.++
T Consensus       160 ~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~  238 (244)
T smart00220      160 GKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPP-PEWKISPEAKDLIRKLLVKDPEKRLTAEEA  238 (244)
T ss_pred             cCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCcc-ccccCCHHHHHHHHHHccCCchhccCHHHH
Confidence            4 588899999999999999999999987 6666666666655444332 122278999999999999999999999999


Q ss_pred             HcCCCc
Q 012170          348 LRHPWI  353 (469)
Q Consensus       348 L~hp~~  353 (469)
                      ++||||
T Consensus       239 ~~~~~~  244 (244)
T smart00220      239 LQHPFF  244 (244)
T ss_pred             hhCCCC
Confidence            999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification]

Probab=100.00  E-value=3.1e-39  Score=319.74  Aligned_cols=255  Identities=28%  Similarity=0.446  Sum_probs=215.6

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhC-----CCCeeEEEEEEEeC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSG-----HTGVVTLHSVYEEA  169 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~-----hpnIv~l~~~~~~~  169 (469)
                      .+.+-.+|.+....|+|-||+|..|.+..-|+.||||+|+..+   ..-..|++||++|..     --|+++|+..|...
T Consensus       427 gE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk  506 (752)
T KOG0670|consen  427 GELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK  506 (752)
T ss_pred             hhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence            3456678999999999999999999999999999999998765   334579999999973     34689999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEecccee
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAM  245 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~  245 (469)
                      +++|||+|-+ ..+|.+.|.+.|   .+....+..++.|++.||..|-..||+|.||||+|||+++.. .+||||||.|.
T Consensus       507 nHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~  585 (752)
T KOG0670|consen  507 NHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSAS  585 (752)
T ss_pred             ceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCcccc
Confidence            9999999998 458999998776   478889999999999999999999999999999999999864 68999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc-----
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW-----  319 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-----  319 (469)
                      ....... +.+..+..|.|||++.| .|+...|+||+||+||||.||+..|+|.+.+.++......+..|+....     
T Consensus       586 ~~~enei-tPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF  664 (752)
T KOG0670|consen  586 FASENEI-TPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQF  664 (752)
T ss_pred             ccccccc-cHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcch
Confidence            8766554 33556788999999999 5999999999999999999999999999888888766444433331100     


Q ss_pred             ---------------------------------------------------cCCCHHHHHHHHHhchhhhcCCCCHHHHH
Q 012170          320 ---------------------------------------------------ETVSKPARDLMARMLTRDVSARITADEVL  348 (469)
Q Consensus       320 ---------------------------------------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL  348 (469)
                                                                         ..+-..+++|+.+||..||++|.|..|+|
T Consensus       665 ~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL  744 (752)
T KOG0670|consen  665 KDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQAL  744 (752)
T ss_pred             hhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHh
Confidence                                                               00113578999999999999999999999


Q ss_pred             cCCCcc
Q 012170          349 RHPWIL  354 (469)
Q Consensus       349 ~hp~~~  354 (469)
                      +||||+
T Consensus       745 ~HpFi~  750 (752)
T KOG0670|consen  745 KHPFIT  750 (752)
T ss_pred             cCCccc
Confidence            999995

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=100.00  E-value=3.3e-37  Score=321.40  Aligned_cols=251  Identities=25%  Similarity=0.388  Sum_probs=188.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC----------------CCCcEEEEEEcccCh------------------HHHHHH
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK----------------ASGAEFACKTLRKGE------------------ETVHRE  146 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~----------------~~~~~vAvK~~~~~~------------------~~~~~E  146 (469)
                      -.++|.+.++||+|+||.||+|...                ..++.||||.+....                  +....|
T Consensus       143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE  222 (507)
T PLN03224        143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE  222 (507)
T ss_pred             cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence            4678999999999999999999752                245679999985421                  122346


Q ss_pred             HHHHHHhhCCCCe-----eEEEEEEEe--------CCeEEEEEeccCCCchHHHHHHhC---------------------
Q 012170          147 VEIMQHLSGHTGV-----VTLHSVYEE--------ADCFHLVMELCSGGRLIDQMVEVG---------------------  192 (469)
Q Consensus       147 ~~il~~l~~hpnI-----v~l~~~~~~--------~~~~~lV~E~~~gg~L~~~l~~~~---------------------  192 (469)
                      +.++.++. |.++     ++++++|..        .+..||||||+++|+|.+++....                     
T Consensus       223 ~~~l~~l~-~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~  301 (507)
T PLN03224        223 AYMCAKIK-RNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNM  301 (507)
T ss_pred             HHHHHHhh-cccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhc
Confidence            77777776 5443     566666642        356899999999999999885421                     


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc--cCCCCcccCcee
Q 012170          193 ---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG--LAGSPAYVAPEV  267 (469)
Q Consensus       193 ---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~--~~gt~~y~aPE~  267 (469)
                         .+++..+..++.|++.+|.|||+.+|+||||||+|||++.++.+||+|||++...........  ..+|+.|+|||+
T Consensus       302 ~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~Y~aPE~  381 (507)
T PLN03224        302 PQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEE  381 (507)
T ss_pred             ccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCccCccccCCCcceeChhh
Confidence               234567889999999999999999999999999999999999999999999976544332222  235899999998


Q ss_pred             ccCC---------------------CC--CccchHHHHHHHHHHHhCCC-CCCCCCHH-----------HHHHHHHcCcC
Q 012170          268 LSGN---------------------YS--EKVDIWSAGVLLHALLVAAL-PFKGDSLE-----------AVFDAIKNVKL  312 (469)
Q Consensus       268 l~~~---------------------~~--~~~DiwSlG~il~elltG~~-Pf~~~~~~-----------~~~~~i~~~~~  312 (469)
                      +...                     |+  ...||||+||++|+|++|.. ||.+....           .....+....+
T Consensus       382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~~~~  461 (507)
T PLN03224        382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKGQKY  461 (507)
T ss_pred             hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcccCC
Confidence            7431                     11  24799999999999999985 77542111           11112222333


Q ss_pred             CCCCCcccCCCHHHHHHHHHhchhhh---cCCCCHHHHHcCCCcc
Q 012170          313 DFHSGVWETVSKPARDLMARMLTRDV---SARITADEVLRHPWIL  354 (469)
Q Consensus       313 ~~~~~~~~~~s~~~~~lI~~~L~~dP---~~Rpsa~elL~hp~~~  354 (469)
                      .+.  .+..+++.++|||.+||..+|   .+|+|+.|+|+||||.
T Consensus       462 ~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        462 DFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             Ccc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            333  467789999999999999876   6899999999999995

>KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=1.8e-37  Score=316.06  Aligned_cols=244  Identities=23%  Similarity=0.336  Sum_probs=210.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCC---cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +++..+.++||+|+||.|++|.|+..+   ..||||+++.+     ..+|.+|+.+|.+|. |||+++||++..+ ....
T Consensus       109 ee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~-H~hliRLyGvVl~-qp~m  186 (1039)
T KOG0199|consen  109 EEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQ-HPHLIRLYGVVLD-QPAM  186 (1039)
T ss_pred             HHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhcc-CcceeEEeeeecc-chhh
Confidence            456677899999999999999987533   35899999754     468999999999997 9999999999987 6677


Q ss_pred             EEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          174 LVMELCSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|||++++|+|++.|.+  ...|.......++.||+.|+.||.++++|||||...|||+-....|||+||||.+.+....
T Consensus       187 MV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ne  266 (1039)
T KOG0199|consen  187 MVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENE  266 (1039)
T ss_pred             HHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence            99999999999999977  3468888899999999999999999999999999999999999999999999998776555


Q ss_pred             cccccC----CCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          252 TLSGLA----GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~----gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .+..+.    -...|+|||.+.- .++.++|||++||++|||++ |+.||.|.....++..|..+..-..   ...++.+
T Consensus       267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~qIL~~iD~~erLpR---Pk~csed  343 (1039)
T KOG0199|consen  267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGIQILKNIDAGERLPR---PKYCSED  343 (1039)
T ss_pred             cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHHHHHHhccccccCCC---CCCChHH
Confidence            443322    3456999999964 79999999999999999998 8899999999999999985543222   2568999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+++..||..+|.+|||+..|...
T Consensus       344 IY~imk~cWah~paDRptFsair~~  368 (1039)
T KOG0199|consen  344 IYQIMKNCWAHNPADRPTFSAIRED  368 (1039)
T ss_pred             HHHHHHHhccCCccccccHHHHHHh
Confidence            9999999999999999999888543

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-39  Score=325.03  Aligned_cols=257  Identities=28%  Similarity=0.461  Sum_probs=229.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...++|+++..+|.|+||.||+++++.+++..|+|+++-+    ...+++|+-+++.++ |||||.+++.|-..+.+|++
T Consensus        12 nP~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~-h~nivay~gsylr~dklwic   90 (829)
T KOG0576|consen   12 NPQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCR-HPNIVAYFGSYLRRDKLWIC   90 (829)
T ss_pred             CCccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCC-CcChHHHHhhhhhhcCcEEE
Confidence            4678999999999999999999999999999999999753    356788999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||||.||+|.+.-.-.+++++.++..++++.+.||.|||++|-+|||||-.|||+++.|.+||+|||.+..+... ....
T Consensus        91 MEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitati~Krk  170 (829)
T KOG0576|consen   91 MEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITATIAKRK  170 (829)
T ss_pred             EEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhhhhhhh
Confidence            999999999998888899999999999999999999999999999999999999999999999999998766533 2345


Q ss_pred             ccCCCCcccCceec----cCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-CcccCCCHHHHHH
Q 012170          255 GLAGSPAYVAPEVL----SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-GVWETVSKPARDL  329 (469)
Q Consensus       255 ~~~gt~~y~aPE~l----~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-~~~~~~s~~~~~l  329 (469)
                      .+.|||+|||||+-    .+.|+..+|||++|++..|+.--.+|-.+..+...+..+.+..+..+. .....+++.+-+|
T Consensus       171 sfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~f  250 (829)
T KOG0576|consen  171 SFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNF  250 (829)
T ss_pred             cccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHH
Confidence            68999999999986    467999999999999999999999998888888888777665544332 2234579999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ++.+|.++|++||+++.+|.|||+....
T Consensus       251 vK~altknpKkRptaeklL~h~fvs~~l  278 (829)
T KOG0576|consen  251 VKGALTKNPKKRPTAEKLLQHPFVSQTL  278 (829)
T ss_pred             HHHHhcCCCccCCChhhheeceeeccch
Confidence            9999999999999999999999997663

>KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms]

Probab=100.00  E-value=8.1e-38  Score=294.65  Aligned_cols=250  Identities=29%  Similarity=0.487  Sum_probs=209.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC---
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEAD---  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~---  170 (469)
                      .+..+|..+..+|.|+- .|..|.+.-++++||+|.+..      ...+..+|..++..+. |+||++++.+|....   
T Consensus        14 tv~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~-~~nii~l~n~ftP~~~l~   91 (369)
T KOG0665|consen   14 TVPKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVN-HKNIISLLNVFTPQKTLE   91 (369)
T ss_pred             eeeeeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhc-ccceeeeeeccCccccHH
Confidence            35678999999999999 888899999999999998743      2356889999999997 999999999996443   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          171 ---CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       171 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                         .+|+|||||.. +|...+.  -.++...+..++.|++.|+.|||+.||+||||||+||+++.++.+||.|||+|+..
T Consensus        92 ~~~e~y~v~e~m~~-nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e  168 (369)
T KOG0665|consen   92 EFQEVYLVMELMDA-NLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTE  168 (369)
T ss_pred             HHHhHHHHHHhhhh-HHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhhccc
Confidence               58999999965 7777665  45778899999999999999999999999999999999999999999999999877


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc---------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK---------------  311 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~---------------  311 (469)
                      .....++.++.|..|.|||++.+ .|...+||||+||++.||++|...|.|.+.-+.+..+....               
T Consensus       169 ~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~  248 (369)
T KOG0665|consen  169 DTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTV  248 (369)
T ss_pred             CcccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHH
Confidence            66666778899999999999977 49999999999999999999999999876554444331110               


Q ss_pred             ----------------CCCCCCccc-------CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          312 ----------------LDFHSGVWE-------TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       312 ----------------~~~~~~~~~-------~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                                      ..|+...|.       .-+..+++++.+||..||++|.+++++|+||||.
T Consensus       249 r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  249 RNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence                            011222221       1245689999999999999999999999999995

>KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-36  Score=304.73  Aligned_cols=248  Identities=23%  Similarity=0.343  Sum_probs=209.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..+...+++.||+|-||.|.+|.... +..||+|.++.+     ..+|.+|+++|.+|+ ||||+.|+++|..++.+++|
T Consensus       536 PRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLk-hPNIveLvGVC~~DePicmI  613 (807)
T KOG1094|consen  536 PRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDATKNARNDFLKEIKILSRLK-HPNIVELLGVCVQDDPLCMI  613 (807)
T ss_pred             chhheehhhhhcCcccceeEEEEecC-ceEEEEeecCcccchhHHHHHHHHHHHHhccC-CCCeeEEEeeeecCCchHHH
Confidence            44567788999999999999998653 689999999753     367999999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          176 MELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||+++|+|..++.++.  .........|+.||+.|++||.+.++|||||.+.|+|++.++++||+|||+++....+...
T Consensus       614 ~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy  693 (807)
T KOG1094|consen  614 TEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY  693 (807)
T ss_pred             HHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccccccCCce
Confidence            99999999999998873  3345566779999999999999999999999999999999999999999999865444332


Q ss_pred             ---cccCCCCcccCceec-cCCCCCccchHHHHHHHHHHH--hCCCCCCCCCHHHHHHHHHcCcCCCCC----CcccCCC
Q 012170          254 ---SGLAGSPAYVAPEVL-SGNYSEKVDIWSAGVLLHALL--VAALPFKGDSLEAVFDAIKNVKLDFHS----GVWETVS  323 (469)
Q Consensus       254 ---~~~~gt~~y~aPE~l-~~~~~~~~DiwSlG~il~ell--tG~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~s  323 (469)
                         ...+-..+|||||.+ .|+++.++|+|++|+++||++  +...||...+.+++.++..........    ..+.-++
T Consensus       694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp  773 (807)
T KOG1094|consen  694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACP  773 (807)
T ss_pred             eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCc
Confidence               223456789999987 678999999999999999985  588999998888888876544322111    1234678


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ..+.+++.+|+.+|.++||+++++-.|
T Consensus       774 ~~lyelml~Cw~~es~~RPsFe~lh~~  800 (807)
T KOG1094|consen  774 QGLYELMLRCWRRESEQRPSFEQLHLF  800 (807)
T ss_pred             HHHHHHHHHHhchhhhcCCCHHHHHHH
Confidence            999999999999999999999998543

>KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.2e-38  Score=293.90  Aligned_cols=250  Identities=27%  Similarity=0.445  Sum_probs=209.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----e
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----C  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----~  171 (469)
                      .+.+-.+.||-|+||.||.+.+..+|+.||+|.+..-      ...+.+|+++|...+ |.|++..+++.+..+     .
T Consensus        53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFk-HdNVLSaLDILQPph~dfFqE  131 (449)
T KOG0664|consen   53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFR-HDNVLSLLDILQPANPSFFQE  131 (449)
T ss_pred             ccCCCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhc-cccHHHHHHhcCCCCchHHHH
Confidence            3444458899999999999999999999999988542      357889999999997 999999988877554     4


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+|+|++.. +|..+|.....++.+.++.++.||++||.|||+.||.||||||.|+|++++..+||||||+++......
T Consensus       132 iYV~TELmQS-DLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~  210 (449)
T KOG0664|consen  132 LYVLTELMQS-DLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRD  210 (449)
T ss_pred             HHHHHHHHHh-hhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccchhh
Confidence            6789999954 898889999999999999999999999999999999999999999999999999999999998765433


Q ss_pred             --cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC--------------
Q 012170          252 --TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD--------------  313 (469)
Q Consensus       252 --~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  313 (469)
                        .++..+.|-+|+|||++.|  .|+.++||||+|||+.||+-.+..|...++.+.++.|......              
T Consensus       211 ~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk  290 (449)
T KOG0664|consen  211 RLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAK  290 (449)
T ss_pred             hhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhH
Confidence              3556678999999999987  4999999999999999999999999888877777666332111              


Q ss_pred             ---------CCCC-------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          314 ---------FHSG-------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       314 ---------~~~~-------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                               .+..       ....-..+..+++..||..||.+|.+.++++.|+|.-
T Consensus       291 ~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkris~~~A~~~~~~~  347 (449)
T KOG0664|consen  291 NHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRISVEEALQHRYLE  347 (449)
T ss_pred             HHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccccHhhhccccccc
Confidence                     0000       0112345788999999999999999999999999973

>KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=308.90  Aligned_cols=241  Identities=25%  Similarity=0.353  Sum_probs=205.6

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCC----CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKAS----GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~----~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++.+.||.|-||.||+|....-    .-.||||..+.+     .+.|.+|.-+|+.+. |||||+|++++.+ ...||
T Consensus       390 ~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfd-HphIikLIGv~~e-~P~Wi  467 (974)
T KOG4257|consen  390 LITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFD-HPHIIKLIGVCVE-QPMWI  467 (974)
T ss_pred             hccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCC-Ccchhheeeeeec-cceeE
Confidence            344457899999999999986432    335899998763     467999999999996 9999999999965 46789


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      |||+++-|.|..+++.++ .++.....-++.||..||.|||+.++|||||...|||+.+..-|||+|||+++.+.+....
T Consensus       468 vmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yY  547 (974)
T KOG4257|consen  468 VMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYY  547 (974)
T ss_pred             EEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchhhhccccchh
Confidence            999999999999998765 6888899999999999999999999999999999999999999999999999988776654


Q ss_pred             cccCC--CCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 SGLAG--SPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 ~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ....|  ..-|||||.+. ..++.++|||.|||.|||++. |..||.|....+++-.|.++....   .++.+++.+..|
T Consensus       548 kaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP---~P~nCPp~LYsl  624 (974)
T KOG4257|consen  548 KASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDVIGHIENGERLP---CPPNCPPALYSL  624 (974)
T ss_pred             hccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccceEEEecCCCCCC---CCCCCChHHHHH
Confidence            43344  34599999995 469999999999999999886 999999988888887777765332   236789999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+||.++|.+||.+.+|..
T Consensus       625 mskcWayeP~kRPrftei~~  644 (974)
T KOG4257|consen  625 MSKCWAYEPSKRPRFTEIKA  644 (974)
T ss_pred             HHHHhccCcccCCcHHHHHH
Confidence            99999999999999877643

>KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms]

Probab=100.00  E-value=1.6e-36  Score=305.22  Aligned_cols=242  Identities=24%  Similarity=0.358  Sum_probs=211.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .+.....+||-|.||.||.|.|+...-.||||.++.+   -++|..|+.+|+.+. |||+|+|+++|..+..+|||.|||
T Consensus       267 tdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtMeveEFLkEAAvMKeik-HpNLVqLLGVCT~EpPFYIiTEfM  345 (1157)
T KOG4278|consen  267 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTHEPPFYIITEFM  345 (1157)
T ss_pred             hheeeeeccCCCcccceeeeeeeccceeeehhhhhhcchhHHHHHHHHHHHHhhc-CccHHHHhhhhccCCCeEEEEecc
Confidence            3455567899999999999999999999999999864   367899999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc--c
Q 012170          180 SGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--G  255 (469)
Q Consensus       180 ~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~--~  255 (469)
                      ..|+|+++|.+..  .++.-....++.||..|+.||..+++|||||...|+|+.++..||++||||++.+..+.+..  +
T Consensus       346 ~yGNLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHAG  425 (1157)
T KOG4278|consen  346 CYGNLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHAG  425 (1157)
T ss_pred             cCccHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCceecccC
Confidence            9999999998754  36667788899999999999999999999999999999999999999999998876544322  1


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..-..-|.|||.+.- .++.++|||+|||+|||+.| |-.||.|-+..+++..+.++.   .......+++....|++.|
T Consensus       426 AKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqVY~LLEkgy---RM~~PeGCPpkVYeLMraC  502 (1157)
T KOG4278|consen  426 AKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYGLLEKGY---RMDGPEGCPPKVYELMRAC  502 (1157)
T ss_pred             ccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHHHHHHhccc---cccCCCCCCHHHHHHHHHH
Confidence            223456999999954 59999999999999999998 889999999999988877653   3334478999999999999


Q ss_pred             chhhhcCCCCHHHHH
Q 012170          334 LTRDVSARITADEVL  348 (469)
Q Consensus       334 L~~dP~~Rpsa~elL  348 (469)
                      |+..|.+||++.|+-
T Consensus       503 W~WsPsDRPsFaeiH  517 (1157)
T KOG4278|consen  503 WNWSPSDRPSFAEIH  517 (1157)
T ss_pred             hcCCcccCccHHHHH
Confidence            999999999998874

>KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms]

Probab=100.00  E-value=2e-37  Score=322.31  Aligned_cols=244  Identities=28%  Similarity=0.458  Sum_probs=198.5

Q ss_pred             eeeeeccCCeE-EEEEEECCCCcEEEEEEcccCh-HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchH
Q 012170          108 VEVIGHGKFGS-VWLCRSKASGAEFACKTLRKGE-ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLI  185 (469)
Q Consensus       108 ~~~lG~G~~g~-Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~  185 (469)
                      -+++|.|+-|+ ||+|...  |+.||||.+-.+. ....+|+..|+.-..|||||++|+.-.+....||..|.|.. +|.
T Consensus       514 ~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~-sL~  590 (903)
T KOG1027|consen  514 KEILGYGSNGTVVFRGVYE--GREVAVKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCAC-SLQ  590 (903)
T ss_pred             HHHcccCCCCcEEEEEeeC--CceehHHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhhh-hHH
Confidence            46799999985 7999876  7899999986543 57889999999999999999999999999999999999965 899


Q ss_pred             HHHHHhCC----CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CC--cEEEEeccceeeecCCCc----
Q 012170          186 DQMVEVGQ----YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SG--KIKLADFGLAMRISNGQT----  252 (469)
Q Consensus       186 ~~l~~~~~----l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~--~vkL~DFgla~~~~~~~~----  252 (469)
                      +++...+.    ........++.|++.||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..+..    
T Consensus       591 dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r  670 (903)
T KOG1027|consen  591 DLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSR  670 (903)
T ss_pred             HHHhccccchhhcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhc
Confidence            99866311    111456789999999999999999999999999999987   34  689999999998765432    


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ..+..||-+|+|||++... -+.++|||||||++|+.++| ..||.+....+  .+|..+.+....-.. ....++.|||
T Consensus       671 ~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~--~NIl~~~~~L~~L~~-~~d~eA~dLI  747 (903)
T KOG1027|consen  671 LSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQ--ANILTGNYTLVHLEP-LPDCEAKDLI  747 (903)
T ss_pred             ccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhh--hhhhcCccceeeecc-CchHHHHHHH
Confidence            4567899999999999764 56799999999999999986 89997654333  345555544322111 1112899999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+||+++|..||+|.++|.||||....
T Consensus       748 ~~ml~~dP~~RPsa~~VL~HPlFW~~e  774 (903)
T KOG1027|consen  748 SRMLNPDPQLRPSATDVLNHPLFWDSE  774 (903)
T ss_pred             HHhcCCCcccCCCHHHHhCCCccCChH
Confidence            999999999999999999999996554

>KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms]

Probab=100.00  E-value=5.8e-37  Score=316.07  Aligned_cols=243  Identities=25%  Similarity=0.390  Sum_probs=213.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...+.++||.|.||.|++|+.+..|+   .||||.++.+     ..+|..|+.||-+.. ||||++|.++......+.||
T Consensus       630 ~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFd-HPNIIrLEGVVTks~PvMIi  708 (996)
T KOG0196|consen  630 CVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFD-HPNIIRLEGVVTKSKPVMII  708 (996)
T ss_pred             heEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCC-CCcEEEEEEEEecCceeEEE
Confidence            44566799999999999999987774   5999999754     467899999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          176 MELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      .|||++|+|..+|..+ +.|+.-++..+++.|+.|+.||-++|+|||||...|||++.+-.+|++||||++.+.++..  
T Consensus       709 TEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~  788 (996)
T KOG0196|consen  709 TEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA  788 (996)
T ss_pred             hhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccceeecccCCCcc
Confidence            9999999999999765 6799999999999999999999999999999999999999999999999999998765542  


Q ss_pred             ccccCC--CCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          253 LSGLAG--SPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       253 ~~~~~g--t~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      .++..|  ..+|.|||.+. ++++.++||||+||+|||.++ |..||.+.+..++++.|..+..-.   .+-+++..+.+
T Consensus       789 ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdVIkaIe~gyRLP---pPmDCP~aL~q  865 (996)
T KOG0196|consen  789 YTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVIKAIEQGYRLP---PPMDCPAALYQ  865 (996)
T ss_pred             ccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHHHHHHHhccCCC---CCCCCcHHHHH
Confidence            222222  46799999995 579999999999999999875 999999999999999998764322   23578999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcC
Q 012170          329 LMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      |+..|+++|-..||.+.||+.+
T Consensus       866 LMldCWqkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  866 LMLDCWQKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHHHHHHHhhcCCCHHHHHHH
Confidence            9999999999999999999874

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=100.00  E-value=2.1e-35  Score=335.73  Aligned_cols=240  Identities=23%  Similarity=0.304  Sum_probs=189.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      ..|...+.||+|+||.||+|.+..+|..||||.+.........|++++++++ |||||++++++.+.+..|+||||+++|
T Consensus       690 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~l~~l~-HpnIv~~~~~~~~~~~~~lv~Ey~~~g  768 (968)
T PLN00113        690 SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIADMGKLQ-HPNIVKLIGLCRSEKGAYLIHEYIEGK  768 (968)
T ss_pred             hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccccHHHHHHHhhCC-CCCcceEEEEEEcCCCCEEEEeCCCCC
Confidence            3455567899999999999999999999999999765555567899999996 999999999999999999999999999


Q ss_pred             chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH---hcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCC
Q 012170          183 RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH---DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS  259 (469)
Q Consensus       183 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH---~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt  259 (469)
                      +|.+++.   .+++..+..++.||+.||.|||   +.+|+||||||+||+++.++..++. ||.......   .....||
T Consensus       769 ~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~---~~~~~~t  841 (968)
T PLN00113        769 NLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT---DTKCFIS  841 (968)
T ss_pred             cHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc---CCCcccc
Confidence            9999984   4789999999999999999999   6799999999999999998888776 665543221   1234689


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHc----Cc------CCCCC--CcccCCCH
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL--EAVFDAIKN----VK------LDFHS--GVWETVSK  324 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~----~~------~~~~~--~~~~~~s~  324 (469)
                      +.|+|||++.+ .|+.++|||||||++|||++|+.||.....  ..+......    ..      .....  ........
T Consensus       842 ~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  921 (968)
T PLN00113        842 SAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIV  921 (968)
T ss_pred             ccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHH
Confidence            99999999976 599999999999999999999999853210  111111100    00      00000  00011223


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          325 PARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ++.+++.+||+.||++|||+.|+++.
T Consensus       922 ~~~~l~~~Cl~~~P~~RPt~~evl~~  947 (968)
T PLN00113        922 EVMNLALHCTATDPTARPCANDVLKT  947 (968)
T ss_pred             HHHHHHHhhCcCCchhCcCHHHHHHH
Confidence            56789999999999999999999864

>KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.4e-34  Score=282.72  Aligned_cols=132  Identities=23%  Similarity=0.429  Sum_probs=115.9

Q ss_pred             cccc-CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCC-------CCeeEEEEEEE
Q 012170           99 NKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGH-------TGVVTLHSVYE  167 (469)
Q Consensus        99 ~~~~-~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~h-------pnIv~l~~~~~  167 (469)
                      +.+. .+|-+.++||.|.|++||+|.+..+.+.||+|+++...   +....|+++|++++.+       .+||+|++.|.
T Consensus        73 D~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~Fk  152 (590)
T KOG1290|consen   73 DVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFK  152 (590)
T ss_pred             ccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccce
Confidence            4455 79999999999999999999999999999999997643   5677899999999742       35999999997


Q ss_pred             e----CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEc
Q 012170          168 E----ADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLT  231 (469)
Q Consensus       168 ~----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~  231 (469)
                      .    +.++|||+|++ |..|+.+|...  +.++...++.|++|||.||.|||. .||||.||||+|||+.
T Consensus       153 hsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvLl~  222 (590)
T KOG1290|consen  153 HSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVLLC  222 (590)
T ss_pred             ecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceeeee
Confidence            4    45899999999 77898888764  579999999999999999999996 5999999999999994

>KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms]

Probab=100.00  E-value=3.1e-34  Score=280.52  Aligned_cols=243  Identities=26%  Similarity=0.427  Sum_probs=193.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHH--hhCCCCeeEEEEEEEeCC----eEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQH--LSGHTGVVTLHSVYEEAD----CFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~--l~~hpnIv~l~~~~~~~~----~~~  173 (469)
                      +..+..+++.||+|.||.||+|.++  |+.||||++.. ++..+.+|.+|.+.  |+ |+||+.+++.-..+.    ++|
T Consensus       209 iarqI~L~e~IGkGRyGEVwrG~wr--Ge~VAVKiF~srdE~SWfrEtEIYqTvmLR-HENILgFIaaD~~~~gs~TQLw  285 (513)
T KOG2052|consen  209 IARQIVLQEIIGKGRFGEVWRGRWR--GEDVAVKIFSSRDERSWFRETEIYQTVMLR-HENILGFIAADNKDNGSWTQLW  285 (513)
T ss_pred             hhheeEEEEEecCccccceeecccc--CCceEEEEecccchhhhhhHHHHHHHHHhc-cchhhhhhhccccCCCceEEEE
Confidence            5667888999999999999999998  89999999964 56789999999875  55 999999998754332    689


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc--------CeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM--------GVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ||.+|.+.|+|+|+|.+ ..++.+....++.-++.||.|||..        .|+|||||..||||..+|.+-|+|+|||.
T Consensus       286 LvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv  364 (513)
T KOG2052|consen  286 LVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  364 (513)
T ss_pred             EeeecccCCcHHHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeE
Confidence            99999999999999977 6889999999999999999999953        49999999999999999999999999997


Q ss_pred             eecCCC-----cccccCCCCcccCceeccCCCC-------CccchHHHHHHHHHHHhC----------CCCCCC-----C
Q 012170          246 RISNGQ-----TLSGLAGSPAYVAPEVLSGNYS-------EKVDIWSAGVLLHALLVA----------ALPFKG-----D  298 (469)
Q Consensus       246 ~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~-------~~~DiwSlG~il~elltG----------~~Pf~~-----~  298 (469)
                      ......     ..+..+||.+|||||++....+       ..+||||||.|+||++..          .+||.+     .
T Consensus       365 ~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DP  444 (513)
T KOG2052|consen  365 RHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDP  444 (513)
T ss_pred             EecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCC
Confidence            665431     2355789999999999976422       358999999999999742          378864     3


Q ss_pred             CHHHHHHHHHcC--cCCCCCCcccCCC--HHHHHHHHHhchhhhcCCCCHHHHH
Q 012170          299 SLEAVFDAIKNV--KLDFHSGVWETVS--KPARDLMARMLTRDVSARITADEVL  348 (469)
Q Consensus       299 ~~~~~~~~i~~~--~~~~~~~~~~~~s--~~~~~lI~~~L~~dP~~Rpsa~elL  348 (469)
                      +.+++.+-+...  .+.++ ..|...+  ..+-.+++.|+..||.-|.||--|.
T Consensus       445 s~eeMrkVVCv~~~RP~ip-nrW~s~~~l~~m~klMkeCW~~Np~aRltALriK  497 (513)
T KOG2052|consen  445 SFEEMRKVVCVQKLRPNIP-NRWKSDPALRVMAKLMKECWYANPAARLTALRIK  497 (513)
T ss_pred             CHHHHhcceeecccCCCCC-cccccCHHHHHHHHHHHHhhcCCchhhhHHHHHH
Confidence            445554443222  22222 2343221  2345689999999999999987664

>KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms]

Probab=100.00  E-value=1.3e-34  Score=257.76  Aligned_cols=211  Identities=25%  Similarity=0.404  Sum_probs=179.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .-.++...+..||+|+||.|-+.++..+|+..|+|.++.     ....+.+|+.+..+...+|++|.+|+.+......||
T Consensus        43 V~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwI  122 (282)
T KOG0984|consen   43 VPADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWI  122 (282)
T ss_pred             cchhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEE
Confidence            344566667899999999999999999999999999853     345677899998888889999999999989999999


Q ss_pred             EEeccCCCchHHH----HHHhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          175 VMELCSGGRLIDQ----MVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       175 V~E~~~gg~L~~~----l~~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      .||.|.- +|..+    +...+.++|..+-+|+..++.||.|||++ .++|||+||+||||+.+|+||+||||.+....+
T Consensus       123 cME~M~t-Sldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d  201 (282)
T KOG0984|consen  123 CMELMDT-SLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVD  201 (282)
T ss_pred             eHHHhhh-hHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence            9999954 55433    33456799999999999999999999975 799999999999999999999999999988777


Q ss_pred             CCcccccCCCCcccCceeccC-----CCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCc
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG-----NYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFDAIKNVK  311 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~-----~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~~~~  311 (469)
                      .-..+-..|--.|||||.+..     .|+-++||||||++++||.+++.||. ..++.+.+.++....
T Consensus       202 SiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkqvVeep  269 (282)
T KOG0984|consen  202 SIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQVVEEP  269 (282)
T ss_pred             hhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHHHhcCC
Confidence            666555678889999999854     48999999999999999999999996 356667777765543

>KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms]

Probab=100.00  E-value=5.4e-35  Score=293.00  Aligned_cols=194  Identities=35%  Similarity=0.558  Sum_probs=175.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------HHHHHHHHHHHHhh--CCCCeeEEEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------ETVHREVEIMQHLS--GHTGVVTLHSVYEE  168 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------~~~~~E~~il~~l~--~hpnIv~l~~~~~~  168 (469)
                      .+|+.+..+|.|+||.|++|.++.+...|+||.+.+++            -.+-.|++||..|.  .|+||++++++|++
T Consensus       561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd  640 (772)
T KOG1152|consen  561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED  640 (772)
T ss_pred             ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence            35999999999999999999999999999999998754            13456999999996  48999999999999


Q ss_pred             CCeEEEEEecc-CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          169 ADCFHLVMELC-SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       169 ~~~~~lV~E~~-~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      ++++||+||-. +|-+|+++|.....++|.++..|++||+.|+++||+.||||||||-+||.++.+|-+||+|||.+...
T Consensus       641 dd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~  720 (772)
T KOG1152|consen  641 DDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYT  720 (772)
T ss_pred             CCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeeccchhhh
Confidence            99999999965 46799999999999999999999999999999999999999999999999999999999999998654


Q ss_pred             cCCCcccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCC
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKG  297 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~  297 (469)
                       .......++||..|.|||++.|. | +..-|||+||++||.++....||..
T Consensus       721 -ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn  771 (772)
T KOG1152|consen  721 -KSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             -cCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence             34556778999999999999884 4 7789999999999999999999863

>KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.5e-33  Score=301.31  Aligned_cols=243  Identities=25%  Similarity=0.370  Sum_probs=205.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEEC----C---CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSK----A---SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~----~---~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ...+.+.||+|+||.|++|...    .   ....||||.++..     .+.+..|+++|+.+..||||+.+++++...+.
T Consensus       297 ~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~  376 (609)
T KOG0200|consen  297 NLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGP  376 (609)
T ss_pred             hccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCc
Confidence            3455679999999999998643    1   1457999998642     36788999999999999999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc
Q 012170          172 FHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK  235 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~  235 (469)
                      +++|+||+..|+|.+++...+                .++..+...++.||+.|++||++.+++||||...|||+..+..
T Consensus       377 ~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~  456 (609)
T KOG0200|consen  377 LYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKV  456 (609)
T ss_pred             eEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCE
Confidence            999999999999999997765                3888999999999999999999999999999999999999999


Q ss_pred             EEEEeccceeeecCCCcc--cccCCCC--cccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCC-HHHHHHHHH
Q 012170          236 IKLADFGLAMRISNGQTL--SGLAGSP--AYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDS-LEAVFDAIK  308 (469)
Q Consensus       236 vkL~DFgla~~~~~~~~~--~~~~gt~--~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~-~~~~~~~i~  308 (469)
                      +||+|||+|+...+....  ....|+.  .|||||.+.. .|+.++||||+||+|||+++ |..||.+.. ..++++.+.
T Consensus       457 ~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~  536 (609)
T KOG0200|consen  457 IKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLK  536 (609)
T ss_pred             EEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHh
Confidence            999999999865544332  2223323  4999999987 59999999999999999998 889999855 666677677


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+.....   +..++.++.++++.|++.+|++||+..++.+
T Consensus       537 ~G~r~~~---P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  537 EGNRMEQ---PEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             cCCCCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            6654322   2567999999999999999999999999875

>KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair]

Probab=100.00  E-value=1.4e-34  Score=282.04  Aligned_cols=253  Identities=28%  Similarity=0.430  Sum_probs=201.8

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECC---CCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKA---SGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..+.+.|..+++||.|+|++||++.+..   .+..||+|.+..  .-..+..|+++|..+.++.||+++.+++..++...
T Consensus        32 p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~  111 (418)
T KOG1167|consen   32 PFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVA  111 (418)
T ss_pred             hhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeE
Confidence            4567889999999999999999998876   678899999854  34779999999999999999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~-  251 (469)
                      +||||++.....++..   .++...+..+++.++.||.++|.+|||||||||.|+|.+. .+.-.|+|||+|....... 
T Consensus       112 ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~  188 (418)
T KOG1167|consen  112 IVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQ  188 (418)
T ss_pred             EEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhh
Confidence            9999999988877764   4678899999999999999999999999999999999986 4779999999996211000 


Q ss_pred             -------------c-------------------------------ccccCCCCcccCceeccC--CCCCccchHHHHHHH
Q 012170          252 -------------T-------------------------------LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLL  285 (469)
Q Consensus       252 -------------~-------------------------------~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il  285 (469)
                                   .                               .....||++|+|||++..  .-++++||||.|+|+
T Consensus       189 ~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~  268 (418)
T KOG1167|consen  189 TEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVIL  268 (418)
T ss_pred             hhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeecccee
Confidence                         0                               011359999999999976  468899999999999


Q ss_pred             HHHHhCCCCCCCCC-HHHHHHHH--------------HcCc----------------CC----------------CCCCc
Q 012170          286 HALLVAALPFKGDS-LEAVFDAI--------------KNVK----------------LD----------------FHSGV  318 (469)
Q Consensus       286 ~elltG~~Pf~~~~-~~~~~~~i--------------~~~~----------------~~----------------~~~~~  318 (469)
                      ..++++..||-... ....+..|              ..+.                ..                .....
T Consensus       269 Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~  348 (418)
T KOG1167|consen  269 LSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREI  348 (418)
T ss_pred             ehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhcccccccceeecc
Confidence            99999999984321 00000000              0000                00                01111


Q ss_pred             cc-CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          319 WE-TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       319 ~~-~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      |. ..+..+.||+.+||..||.+|+||+++|+||||.
T Consensus       349 ~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~  385 (418)
T KOG1167|consen  349 GSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFD  385 (418)
T ss_pred             ccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCc
Confidence            22 2355889999999999999999999999999995

>KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=2.3e-33  Score=276.29  Aligned_cols=241  Identities=25%  Similarity=0.446  Sum_probs=190.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHHhh-CCCCeeEEEEEEEeCC----eEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQHLS-GHTGVVTLHSVYEEAD----CFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~l~-~hpnIv~l~~~~~~~~----~~~lV~  176 (469)
                      ...++.++||+|.||.||+|...  ++.||||++.. +.+.+..|.+|..... .|+||+++++.-+...    .++||+
T Consensus       210 ~pl~l~eli~~Grfg~V~KaqL~--~~~VAVKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt  287 (534)
T KOG3653|consen  210 DPLQLLELIGRGRFGCVWKAQLD--NRLVAVKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVT  287 (534)
T ss_pred             CchhhHHHhhcCccceeehhhcc--CceeEEEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEe
Confidence            34566789999999999999876  69999999975 4567888988887543 4999999999876555    799999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc---------CeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM---------GVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      ||.+.|+|.++|.. ..+++....+++.-+++||+|||+.         .|+|||||..||||..|++..|+|||||..+
T Consensus       288 ~fh~kGsL~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~  366 (534)
T KOG3653|consen  288 EFHPKGSLCDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRL  366 (534)
T ss_pred             eeccCCcHHHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEe
Confidence            99999999999954 5789999999999999999999963         5999999999999999999999999999988


Q ss_pred             cCCCc---ccccCCCCcccCceeccCCC--C-----CccchHHHHHHHHHHHhCC------------CCCC-----CCCH
Q 012170          248 SNGQT---LSGLAGSPAYVAPEVLSGNY--S-----EKVDIWSAGVLLHALLVAA------------LPFK-----GDSL  300 (469)
Q Consensus       248 ~~~~~---~~~~~gt~~y~aPE~l~~~~--~-----~~~DiwSlG~il~elltG~------------~Pf~-----~~~~  300 (469)
                      ..+..   .-+.+||.+|||||++.|..  .     .+.||||+|.|||||++.-            +||.     ..+.
T Consensus       367 ~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~  446 (534)
T KOG3653|consen  367 EPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTL  446 (534)
T ss_pred             cCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCH
Confidence            75433   33478999999999998853  2     3589999999999998643            2332     1223


Q ss_pred             HHHHHHHH--cCcCCCCCCcccC--CCHHHHHHHHHhchhhhcCCCCHHHH
Q 012170          301 EAVFDAIK--NVKLDFHSGVWET--VSKPARDLMARMLTRDVSARITADEV  347 (469)
Q Consensus       301 ~~~~~~i~--~~~~~~~~~~~~~--~s~~~~~lI~~~L~~dP~~Rpsa~el  347 (469)
                      +++...+.  +..+.++ ..|..  --.-+++.|..|++.||+.|+||.=+
T Consensus       447 e~mq~~VV~kK~RP~~p-~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv  496 (534)
T KOG3653|consen  447 EEMQELVVRKKQRPKIP-DAWRKHAGMAVLCETIEECWDHDAEARLTAGCV  496 (534)
T ss_pred             HHHHHHHHhhccCCCCh-hhhhcCccHHHHHHHHHHHcCCchhhhhhhHHH
Confidence            33333332  2223333 23322  24567899999999999999998654

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=100.00  E-value=7.6e-32  Score=248.31  Aligned_cols=205  Identities=45%  Similarity=0.799  Sum_probs=185.5

Q ss_pred             eeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchH
Q 012170          111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLI  185 (469)
Q Consensus       111 lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~  185 (469)
                      ||.|++|.||++....+|+.+++|++....     ..+.+|+++++.+. |++|+++++++......++||||+.|++|.
T Consensus         1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~-~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~   79 (215)
T cd00180           1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLN-HPNIVKLYGVFEDENHLYLVMEYCEGGSLK   79 (215)
T ss_pred             CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcC-CCCeeeEeeeeecCCeEEEEEecCCCCcHH
Confidence            689999999999998889999999997653     56899999999997 999999999999999999999999999999


Q ss_pred             HHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC-cccccCCCCcc
Q 012170          186 DQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ-TLSGLAGSPAY  262 (469)
Q Consensus       186 ~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~-~~~~~~gt~~y  262 (469)
                      +++... ..++...+..++.+++.+|.|||+.|++|+||+|.||+++. ++.++|+|||.+....... ......+...|
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~  159 (215)
T cd00180          80 DLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAY  159 (215)
T ss_pred             HHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcchhhcccCCCCc
Confidence            998765 57899999999999999999999999999999999999999 8999999999997654432 13345688899


Q ss_pred             cCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcC
Q 012170          263 VAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA  340 (469)
Q Consensus       263 ~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~  340 (469)
                      ++||.+..  .++.+.|+|++|+++++|                                   ..+.++|.+||..||.+
T Consensus       160 ~~pe~~~~~~~~~~~~D~~~lg~~~~~l-----------------------------------~~~~~~l~~~l~~~p~~  204 (215)
T cd00180         160 MAPEVLLGKGYYSEKSDIWSLGVILYEL-----------------------------------PELKDLIRKMLQKDPEK  204 (215)
T ss_pred             cChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------------HHHHHHHHHHhhCCccc
Confidence            99999866  678899999999999999                                   68899999999999999


Q ss_pred             CCCHHHHHcCC
Q 012170          341 RITADEVLRHP  351 (469)
Q Consensus       341 Rpsa~elL~hp  351 (469)
                      ||++.++++|+
T Consensus       205 R~~~~~l~~~~  215 (215)
T cd00180         205 RPSAKEILEHL  215 (215)
T ss_pred             CcCHHHHhhCC
Confidence            99999999885

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms]

Probab=100.00  E-value=6.7e-33  Score=287.04  Aligned_cols=240  Identities=25%  Similarity=0.348  Sum_probs=204.9

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCc----EEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ....++||.|+||+||+|.+-..|+    +||+|++..     ....+..|+-+|.+|. |||+++|++++.... +-||
T Consensus       698 lkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masld-Hpnl~RLLgvc~~s~-~qlv  775 (1177)
T KOG1025|consen  698 LKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLD-HPNLLRLLGVCMLST-LQLV  775 (1177)
T ss_pred             hhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCC-CchHHHHhhhcccch-HHHH
Confidence            3446789999999999999865554    588998853     3467889999999996 999999999998766 7799


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc-
Q 012170          176 MELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-  253 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~-  253 (469)
                      ++|+++|.|.|+++.+ ..+.......|..||++|+.|||.++++||||...||||.+-..+||+|||+++........ 
T Consensus       776 tq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey  855 (1177)
T KOG1025|consen  776 TQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEY  855 (1177)
T ss_pred             HHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCcccccc
Confidence            9999999999999765 47889999999999999999999999999999999999999999999999999876544332 


Q ss_pred             --cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 --SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 --~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                        .+..-.+-|||-|.+.. .|+.++||||+||++||++| |..||.+...+++-+.+..+.. +.  .++.++-++..+
T Consensus       856 ~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle~geR-Ls--qPpiCtiDVy~~  932 (1177)
T KOG1025|consen  856 SAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLEKGER-LS--QPPICTIDVYMV  932 (1177)
T ss_pred             cccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHhcccc-CC--CCCCccHHHHHH
Confidence              22233556999998854 69999999999999999998 9999999999999888877654 22  235789999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+||-.|+..||+++++-.
T Consensus       933 mvkCwmid~~~rp~fkel~~  952 (1177)
T KOG1025|consen  933 MVKCWMIDADSRPTFKELAE  952 (1177)
T ss_pred             HHHHhccCcccCccHHHHHH
Confidence            99999999999999988743

>KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms]

Probab=99.98  E-value=4.2e-33  Score=257.27  Aligned_cols=252  Identities=25%  Similarity=0.401  Sum_probs=200.1

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEE-EEeCCeEE
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSV-YEEADCFH  173 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~-~~~~~~~~  173 (469)
                      +-.+.+.|.+.+.||+|.||.+-+|.++.+++.+++|.+.+.   ..++.+|...--.|..|.||+.-|++ |+..+.++
T Consensus        19 kv~l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv   98 (378)
T KOG1345|consen   19 KVDLEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV   98 (378)
T ss_pred             ccchhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence            345788999999999999999999999999999999999764   46788999888888889999988875 78889999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--CCcEEEEeccceeeecCCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--~~~vkL~DFgla~~~~~~~  251 (469)
                      ++|||++-|+|.+-+.. ..+.|.....++.|++.|+.|||++++||||||.+||||-.  ..+|||||||+.+..+.  
T Consensus        99 F~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~--  175 (378)
T KOG1345|consen   99 FVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGT--  175 (378)
T ss_pred             EeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeecccccccCc--
Confidence            99999999999887744 56789999999999999999999999999999999999954  34799999999875432  


Q ss_pred             cccccCCCCcccCceecc----CC--CCCccchHHHHHHHHHHHhCCCCCCCCC-----HHHHHHHHHcCcCCCCCCccc
Q 012170          252 TLSGLAGSPAYVAPEVLS----GN--YSEKVDIWSAGVLLHALLVAALPFKGDS-----LEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~----~~--~~~~~DiwSlG~il~elltG~~Pf~~~~-----~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .......+..|.+||++.    +.  .++.+|+|.||+++|.++||.+||....     .-+.... ......-.+..+.
T Consensus       176 tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w-~~rk~~~~P~~F~  254 (378)
T KOG1345|consen  176 TVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQW-LKRKNPALPKKFN  254 (378)
T ss_pred             eehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHH-hcccCccCchhhc
Confidence            222233456799999873    22  4678999999999999999999997432     1222222 2222222334456


Q ss_pred             CCCHHHHHHHHHhchhhhcCCC---CHHHHHcCCCc
Q 012170          321 TVSKPARDLMARMLTRDVSARI---TADEVLRHPWI  353 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rp---sa~elL~hp~~  353 (469)
                      .+++.+..+.++-|..+|++|-   ++..-...-|.
T Consensus       255 ~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  255 PFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             ccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHH
Confidence            7899999999999999999994   44444444443

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.98  E-value=5.7e-31  Score=246.87  Aligned_cols=207  Identities=42%  Similarity=0.689  Sum_probs=183.0

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      |.+.+.||.|++|.||+|.+..++..+|+|.+...     ...+.+|++.++.+. |+|++++++++...+..++|+||+
T Consensus         1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~-~~~i~~~~~~~~~~~~~~~v~e~~   79 (225)
T smart00221        1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLK-HPNIVKLYGVFEDPEPLYLVMEYC   79 (225)
T ss_pred             CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCChhhheeeeecCCceEEEEecc
Confidence            56788999999999999999988999999999753     457888999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--ccccc
Q 012170          180 SGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~~~  256 (469)
                      .+++|.+++..... +++..+..++.+++.++.|||+.+++|+||+|.||+++.++.++|+|||++.......  .....
T Consensus        80 ~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~~~~~~  159 (225)
T smart00221       80 EGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAALLKTV  159 (225)
T ss_pred             CCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccccccce
Confidence            99999999987766 8999999999999999999999999999999999999999999999999998765543  33456


Q ss_pred             CCCCcccCceec-cC-CCCCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHcCcC
Q 012170          257 AGSPAYVAPEVL-SG-NYSEKVDIWSAGVLLHALLVAALPFKG--DSLEAVFDAIKNVKL  312 (469)
Q Consensus       257 ~gt~~y~aPE~l-~~-~~~~~~DiwSlG~il~elltG~~Pf~~--~~~~~~~~~i~~~~~  312 (469)
                      .++..|++||.+ .. .++.++|+|+||+++++|++|..||..  .+...+.+.|..+.+
T Consensus       160 ~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~~~~  219 (225)
T smart00221      160 KGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSFGVP  219 (225)
T ss_pred             eccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhcCCc
Confidence            788999999998 33 477799999999999999999999977  455577777777653

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=2.6e-31  Score=295.50  Aligned_cols=194  Identities=16%  Similarity=0.172  Sum_probs=145.3

Q ss_pred             CCeeEEEEEE-------EeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcE
Q 012170          157 TGVVTLHSVY-------EEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI  228 (469)
Q Consensus       157 pnIv~l~~~~-------~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NI  228 (469)
                      +||..++++|       ...+.++++|||+ +++|.++|.. ...+++.++..++.||+.||.|||++||+||||||+||
T Consensus        33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrDlKP~Ni  111 (793)
T PLN00181         33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHNVRPSCF  111 (793)
T ss_pred             HHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeeccCCchhE
Confidence            5777777776       2345688889988 6699999965 34699999999999999999999999999999999999


Q ss_pred             EEccC-------------------CcEEEEeccceeeecCC-----------------CcccccCCCCcccCceeccC-C
Q 012170          229 LLTTS-------------------GKIKLADFGLAMRISNG-----------------QTLSGLAGSPAYVAPEVLSG-N  271 (469)
Q Consensus       229 Ll~~~-------------------~~vkL~DFgla~~~~~~-----------------~~~~~~~gt~~y~aPE~l~~-~  271 (469)
                      ||+..                   +.+|++|||+++.....                 ......+||++|||||++.+ .
T Consensus       112 Ll~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~  191 (793)
T PLN00181        112 VMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSS  191 (793)
T ss_pred             EEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCC
Confidence            99654                   44566666666432110                 00112468999999999876 5


Q ss_pred             CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          272 YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       272 ~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      |+.++|||||||+||||++|.+|+....  ..+..+.....  +.. +....+...+++.+||.+||.+||++.|+|+||
T Consensus       192 ~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~--~~~-~~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~  266 (793)
T PLN00181        192 SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL--PPQ-ILLNWPKEASFCLWLLHPEPSCRPSMSELLQSE  266 (793)
T ss_pred             CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc--Chh-hhhcCHHHHHHHHHhCCCChhhCcChHHHhhch
Confidence            9999999999999999999999876422  22222222111  111 112245677999999999999999999999999


Q ss_pred             Ccccc
Q 012170          352 WILFY  356 (469)
Q Consensus       352 ~~~~~  356 (469)
                      ||...
T Consensus       267 ~~~~~  271 (793)
T PLN00181        267 FINEP  271 (793)
T ss_pred             hhhhh
Confidence            99653

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.96  E-value=2.1e-30  Score=275.80  Aligned_cols=257  Identities=29%  Similarity=0.496  Sum_probs=204.4

Q ss_pred             cccCCe-eeeeeeeccCCeEEEEEEECCCCcEEEEEEcc----cCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          100 KIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR----KGE------ETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       100 ~~~~~y-~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~----~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      .+.+.| ...+++|.|++|.|+.+........++.|.++    ...      ..+..|+-+-..+. |||++..+..+.+
T Consensus       314 ~~~~~y~~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~-h~~~~e~l~~~~~  392 (601)
T KOG0590|consen  314 GFSEKYGKPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLS-HPNIIETLDIVQE  392 (601)
T ss_pred             ccccccCCccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeeccccc-CCchhhhHHHHhh
Confidence            344555 34678999999999998887777777777654    221      12455666677786 9999888887777


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ....+-+||||++ +|+.++...+.++..++-.++.|++.||.|||++||.||||||+|++++.+|.+||+|||.+....
T Consensus       393 ~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~  471 (601)
T KOG0590|consen  393 IDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFR  471 (601)
T ss_pred             cccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeec
Confidence            7766677999999 999999888899999999999999999999999999999999999999999999999999997665


Q ss_pred             CCC-----cccccCCCCcccCceeccCC-CC-CccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHH-cCc---CCCCC
Q 012170          249 NGQ-----TLSGLAGSPAYVAPEVLSGN-YS-EKVDIWSAGVLLHALLVAALPFKGDSLEAVF-DAIK-NVK---LDFHS  316 (469)
Q Consensus       249 ~~~-----~~~~~~gt~~y~aPE~l~~~-~~-~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~-~~~---~~~~~  316 (469)
                      ...     ...+.+|+..|+|||++.+. |+ ..+||||.|++++.|++|+.||......+.. .... ...   ..-+.
T Consensus       472 ~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~~~~~~~~~~~  551 (601)
T KOG0590|consen  472 YPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYSDQRNIFEGPN  551 (601)
T ss_pred             cCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccccccccccChH
Confidence            332     34578999999999999874 65 4689999999999999999999754433221 1111 111   11122


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ..+..++.+.+.+|.+||+.||.+|.|+++|++.+||+....
T Consensus       552 ~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~~  593 (601)
T KOG0590|consen  552 RLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIEC  593 (601)
T ss_pred             HHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcce
Confidence            345678999999999999999999999999999999976543

>KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms]

Probab=99.96  E-value=2.7e-30  Score=263.71  Aligned_cols=246  Identities=28%  Similarity=0.495  Sum_probs=213.0

Q ss_pred             eeeccCCeEEEEEE---ECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          110 VIGHGKFGSVWLCR---SKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~---~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      .+|+|+||.|++++   -...|..||+|++++.      ......|..++..+.+||.+++++..|+.+...++++++..
T Consensus         1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~r   80 (612)
T KOG0603|consen    1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLR   80 (612)
T ss_pred             CCCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcc
Confidence            37999999999864   3356788999998652      12345688999999889999999999999999999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                      ||.|+..+.....+.+...+.+...++.+++++|+.|++|||+|++||+++.+|++++.|||+++..-.....   |||.
T Consensus        81 gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~~---cgt~  157 (612)
T KOG0603|consen   81 GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKIA---CGTY  157 (612)
T ss_pred             cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhhc---ccch
Confidence            9999999988888999999999999999999999999999999999999999999999999999765443332   9999


Q ss_pred             cccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcC
Q 012170          261 AYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA  340 (469)
Q Consensus       261 ~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~  340 (469)
                      .|||||++. ....++|+||+|+++++|++|..||.+    ++...|....+.++    ..++..+++++..|+..+|.+
T Consensus       158 eymApEI~~-gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p----~~l~~~a~~~~~~l~~r~p~n  228 (612)
T KOG0603|consen  158 EYRAPEIIN-GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMP----RELSAEARSLFRQLFKRNPEN  228 (612)
T ss_pred             hhhhhHhhh-ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCc----hhhhHHHHHHHHHHHhhCHHH
Confidence            999999998 567889999999999999999999987    67777777666665    567899999999999999999


Q ss_pred             CCC-----HHHHHcCCCccccccccchhchhh
Q 012170          341 RIT-----ADEVLRHPWILFYTERTLRTLTIK  367 (469)
Q Consensus       341 Rps-----a~elL~hp~~~~~~~~~~~~~~~~  367 (469)
                      |..     +.|+++|+||+...+..+.....+
T Consensus       229 rLg~~~~~~~eik~h~f~~~i~~~~l~~r~~~  260 (612)
T KOG0603|consen  229 RLGAGPDGVDEIKQHEFFQSIDWNELEARSRP  260 (612)
T ss_pred             HhccCcchhHHHhccchheeeeHhhHhhcCCC
Confidence            985     589999999988776655444333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.96  E-value=8.3e-29  Score=224.93  Aligned_cols=161  Identities=28%  Similarity=0.320  Sum_probs=129.1

Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          182 GRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       182 g~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                      |+|.+++... +++++..++.++.||+.||.|||+.+      ||+|||++.++.+++  ||++.......    ..||+
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----~~g~~   68 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----SRVDP   68 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc----CCCcc
Confidence            6899999774 46999999999999999999999999      999999999999999  99997654432    26899


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCcCCC-CC--CcccCCCH--HHHHHHHHh
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNVKLDF-HS--GVWETVSK--PARDLMARM  333 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~-~~--~~~~~~s~--~~~~lI~~~  333 (469)
                      .|+|||++.+ .|+.++|||||||++|+|++|..||..... ...+..+....... +.  .....++.  ++.++|.+|
T Consensus        69 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~c  148 (176)
T smart00750       69 YFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRVC  148 (176)
T ss_pred             cccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHHH
Confidence            9999999976 589999999999999999999999976433 22333332221111 10  11123344  699999999


Q ss_pred             chhhhcCCCCHHHHHcCCCcc
Q 012170          334 LTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      |..||.+||++.|+++|+|+.
T Consensus       149 l~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      149 ASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             HhcccccccCHHHHHHHHHHH
Confidence            999999999999999999974

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms]

Probab=99.95  E-value=7.2e-28  Score=232.31  Aligned_cols=245  Identities=17%  Similarity=0.198  Sum_probs=200.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCC-----cEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEE-eC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASG-----AEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYE-EA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-----~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~-~~  169 (469)
                      -..+++..-++-+|.||.||.|.+.+..     +.|-+|.++...     ..+..|.-.|..+. |||+..+.++.. +.
T Consensus       282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~s-H~nll~V~~V~ie~~  360 (563)
T KOG1024|consen  282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGAS-HPNLLSVLGVSIEDY  360 (563)
T ss_pred             hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCc-CCCccceeEEEeecc
Confidence            3456777788999999999999876432     345677776533     34567888888887 999999998864 55


Q ss_pred             CeEEEEEeccCCCchHHHHHHh--------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEec
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV--------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF  241 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~--------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DF  241 (469)
                      +..++++.++.-|+|..++.-.        ..++..+...++.|+..|++|||++||||.||...|.+|++.-+|||+|=
T Consensus       361 ~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDs  440 (563)
T KOG1024|consen  361 ATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDS  440 (563)
T ss_pred             CcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEeccc
Confidence            6778899999999999988722        23667788889999999999999999999999999999999999999999


Q ss_pred             cceeeecCCCccc---ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCC
Q 012170          242 GLAMRISNGQTLS---GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHS  316 (469)
Q Consensus       242 gla~~~~~~~~~~---~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  316 (469)
                      .+++...+.....   +......||+||.+.. .|+.++|+||||++||||+| |+.||..-++.++...++.+..--  
T Consensus       441 aLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRla--  518 (563)
T KOG1024|consen  441 ALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLA--  518 (563)
T ss_pred             hhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHHHHHhccceec--
Confidence            9998765544321   1123456999999976 59999999999999999998 999999999999998888775322  


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                       .+-.+++++..++.-||..+|++||+.+|+..
T Consensus       519 -QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~  550 (563)
T KOG1024|consen  519 -QPFNCPDELFTVMACCWALLPEERPSFSQLVI  550 (563)
T ss_pred             -CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHH
Confidence             22578999999999999999999999999863

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.95  E-value=1.9e-26  Score=225.20  Aligned_cols=246  Identities=36%  Similarity=0.596  Sum_probs=205.9

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCC-CeeEEEEEEEeCCeEEEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHT-GVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hp-nIv~l~~~~~~~~~~~lV~  176 (469)
                      |.+...||.|+||.||++.+.   ..+++|.+...       ...+.+|+.++..+. |+ +|+++++++......++++
T Consensus         2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~   77 (384)
T COG0515           2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLN-HPPNIVKLYDFFQDEGSLYLVM   77 (384)
T ss_pred             ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHHcc-CCcceeeEEEEEecCCEEEEEE
Confidence            778899999999999999987   78999998542       356889999999997 66 7999999998888889999


Q ss_pred             eccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCC-
Q 012170          177 ELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~-  251 (469)
                      +|+.++++.+.+....   .+.+..+..++.|++.++.|+|+.|++||||||+||+++..+ .++++|||.+....... 
T Consensus        78 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~  157 (384)
T COG0515          78 EYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS  157 (384)
T ss_pred             ecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence            9999999997776664   799999999999999999999999999999999999999998 79999999997554433 


Q ss_pred             ------cccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcCC-CCC
Q 012170          252 ------TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLD-FHS  316 (469)
Q Consensus       252 ------~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~-~~~  316 (469)
                            ......||..|+|||.+.+    .+....|+||+|++++++++|..||....    .......+...... ...
T Consensus       158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  237 (384)
T COG0515         158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLAS  237 (384)
T ss_pred             cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCccccc
Confidence                  2456789999999999975    57889999999999999999999988765    35555655554433 222


Q ss_pred             CcccCC----CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          317 GVWETV----SKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       317 ~~~~~~----s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ......    ...+.+++..++..+|..|.+..+...++|..
T Consensus       238 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~  279 (384)
T COG0515         238 PLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHDLLA  279 (384)
T ss_pred             ccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhchHhh
Confidence            111111    25789999999999999999999999887663

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.95  E-value=3.2e-27  Score=236.88  Aligned_cols=168  Identities=22%  Similarity=0.277  Sum_probs=133.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECC-CCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeE-EEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVT-LHSVYEE  168 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~-l~~~~~~  168 (469)
                      .+.++|.+.+.||+|+||+||+|.++. +++.||||++...         ...+.+|+++|++|. |+||+. ++++   
T Consensus        15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~-h~~iv~~l~~~---   90 (365)
T PRK09188         15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVR-GIGVVPQLLAT---   90 (365)
T ss_pred             cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhcc-CCCCCcEEEEc---
Confidence            466789999999999999999999876 6788899986422         245889999999997 999884 5432   


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccC-CCCcEEEccCCcEEEEeccceeee
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI-KPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDl-kp~NILl~~~~~vkL~DFgla~~~  247 (469)
                       +..|+|||||+|++|.. +.   ...   ...++.|++.+|.|||++||+|||| ||+|||++.++.++|+|||+|+.+
T Consensus        91 -~~~~LVmE~~~G~~L~~-~~---~~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~  162 (365)
T PRK09188         91 -GKDGLVRGWTEGVPLHL-AR---PHG---DPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVF  162 (365)
T ss_pred             -CCcEEEEEccCCCCHHH-hC---ccc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECccceec
Confidence             45799999999999962 21   111   2468899999999999999999999 999999999999999999999866


Q ss_pred             cCCCc---------ccccCCCCcccCceeccCC-------CCCccchH
Q 012170          248 SNGQT---------LSGLAGSPAYVAPEVLSGN-------YSEKVDIW  279 (469)
Q Consensus       248 ~~~~~---------~~~~~gt~~y~aPE~l~~~-------~~~~~Diw  279 (469)
                      .....         ..+..+++.|+|||.+...       .+...|-|
T Consensus       163 ~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~~~~~~~~~~~~~dgW  210 (365)
T PRK09188        163 RRRGALYRIAAYEDLRHLLKHKRTYAPDALTPRERKILARKSLPSRIW  210 (365)
T ss_pred             ccCcchhhhhhhhhhhhhhccCccCCcccCChhhhccccccccccCcE
Confidence            44321         2346788999999998542       33446666

>KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.95  E-value=1.9e-26  Score=230.44  Aligned_cols=246  Identities=22%  Similarity=0.301  Sum_probs=194.7

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCC-cEEEEEEcccCh----HHHHHHHHHHHHhh---CCCCeeEEEEEE-EeCCeEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASG-AEFACKTLRKGE----ETVHREVEIMQHLS---GHTGVVTLHSVY-EEADCFHL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~~----~~~~~E~~il~~l~---~hpnIv~l~~~~-~~~~~~~l  174 (469)
                      .|.+.+.||+|+||.||+|.+..++ ..+|+|+.....    ..+..|+.+|..+.   +.+++..+++.+ .....-|+
T Consensus        19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i   98 (322)
T KOG1164|consen   19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI   98 (322)
T ss_pred             ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence            8999999999999999999988775 679999876421    26889999999997   246899999999 57888999


Q ss_pred             EEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-----CcEEEEecccee--
Q 012170          175 VMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-----GKIKLADFGLAM--  245 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-----~~vkL~DFgla~--  245 (469)
                      ||+.+ |.+|.++....  +.|+...+..|+.|++.+|++||+.|++||||||+|+++...     ..+.|.|||+++  
T Consensus        99 VM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~  177 (322)
T KOG1164|consen   99 VMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRF  177 (322)
T ss_pred             EEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccc
Confidence            99999 88999977554  579999999999999999999999999999999999999865     359999999998  


Q ss_pred             eecCCC--------c-ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          246 RISNGQ--------T-LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       246 ~~~~~~--------~-~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      .+....        . ...+.||..|+++.+..+. .+.+.|+||++.++.+|+.|.+||.+.........+........
T Consensus       178 ~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~  257 (322)
T KOG1164|consen  178 KYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLL  257 (322)
T ss_pred             cccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhc
Confidence            321111        1 2345699999999998774 88999999999999999999999977553222222222221111


Q ss_pred             CC-cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          316 SG-VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       316 ~~-~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .. .....+.++..+...+-..+...+|....+...
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~  293 (322)
T KOG1164|consen  258 TDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL  293 (322)
T ss_pred             cccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence            11 223356778888887777889999998877654

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.94  E-value=1.1e-27  Score=255.39  Aligned_cols=226  Identities=31%  Similarity=0.579  Sum_probs=183.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ...+.+|..++.|..|+||.||.++++.+.+.||+|+-++ ..-+++   ||... +.|.+|                  
T Consensus        79 ~p~e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~lilRn---ilt~a-~npfvv------------------  135 (1205)
T KOG0606|consen   79 APSESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-NLILRN---ILTFA-GNPFVV------------------  135 (1205)
T ss_pred             CCCccccceeEeeccCCCCceeeeeccccccchhhccccc-chhhhc---ccccc-CCccee------------------
Confidence            3467899999999999999999999999999999955433 222222   33333 255444                  


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc------
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT------  252 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~------  252 (469)
                         |+-...+...++++.+.        +.+++|||+-||+|||+||+|++|+.-|++|++|||+.+.......      
T Consensus       136 ---gDc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg  204 (1205)
T KOG0606|consen  136 ---GDCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEG  204 (1205)
T ss_pred             ---chhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhc
Confidence               44444455555665554        7789999999999999999999999999999999999864321110      


Q ss_pred             ----------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          253 ----------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       253 ----------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                                -.+.||||.|+||||+.. .|+..+|||++|+|+|+.+.|..||.++.+++++.........++... ..
T Consensus       205 ~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~d-ea  283 (1205)
T KOG0606|consen  205 HIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEED-EA  283 (1205)
T ss_pred             chHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccC-cC
Confidence                      134689999999999866 599999999999999999999999999999999999988888888874 47


Q ss_pred             CCHHHHHHHHHhchhhhcCCC---CHHHHHcCCCccccccc
Q 012170          322 VSKPARDLMARMLTRDVSARI---TADEVLRHPWILFYTER  359 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rp---sa~elL~hp~~~~~~~~  359 (469)
                      ++++++++|.++|+.+|..|.   .+-++.+|+||+...+.
T Consensus       284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LDw~  324 (1205)
T KOG0606|consen  284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLDWK  324 (1205)
T ss_pred             CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecccc
Confidence            899999999999999999997   57889999999766554

>KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.4e-25  Score=211.27  Aligned_cols=240  Identities=23%  Similarity=0.323  Sum_probs=191.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcc--cChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~--~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      -.|.++++||+|+||..|.|.+.-+++.||||.-.  .+...++.|....+.|.+.++|+..|.+.+++-+-.||||++ 
T Consensus        28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-  106 (449)
T KOG1165|consen   28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-  106 (449)
T ss_pred             ccceeccccccCcceeeecccccccCceEEEEeccccCCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-
Confidence            46889999999999999999999999999999863  345689999999999998999999999999998888999999 


Q ss_pred             CCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-----cEEEEeccceeeecCCCc--
Q 012170          181 GGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-----KIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       181 gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-----~vkL~DFgla~~~~~~~~--  252 (469)
                      |.+|.|++.-. ..|+...+..++.|++.-++|+|++.+|+|||||+|+||...+     .|.|+|||+|+.+.+..+  
T Consensus       107 GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~Tkq  186 (449)
T KOG1165|consen  107 GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQ  186 (449)
T ss_pred             CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccc
Confidence            88998887655 4699999999999999999999999999999999999997544     499999999998766543  


Q ss_pred             ------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCCCCC-CcccC
Q 012170          253 ------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGD---SLEAVFDAIKNVKLDFHS-GVWET  321 (469)
Q Consensus       253 ------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~-~~~~~  321 (469)
                            ..+..||.+||+--...|. -+.+.|+-|||-++++.|-|.+||.|.   +..+-++.|-..+...+. .....
T Consensus       187 HIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g  266 (449)
T KOG1165|consen  187 HIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEG  266 (449)
T ss_pred             cCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhc
Confidence                  2456799999998777664 678899999999999999999999874   344555666444332221 12234


Q ss_pred             CCHHHHHHHHHhchhhhcCCCC
Q 012170          322 VSKPARDLMARMLTRDVSARIT  343 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rps  343 (469)
                      ++.++...+.-.=..+-.+-|.
T Consensus       267 ~P~efa~Yl~yvR~L~F~E~PD  288 (449)
T KOG1165|consen  267 FPEEFATYLRYVRRLDFFETPD  288 (449)
T ss_pred             CHHHHHHHHHHHHhcCcccCCC
Confidence            5555554444333333333343

>KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms]

Probab=99.93  E-value=2.5e-25  Score=202.82  Aligned_cols=243  Identities=24%  Similarity=0.323  Sum_probs=200.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +...|.+++.||.|+||.+|+|....+|+.||||+-+..  ...+..|..+.+.|++...|+.+..++.+.++-.+||++
T Consensus        13 v~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdL   92 (341)
T KOG1163|consen   13 VGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKHPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDL   92 (341)
T ss_pred             eccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCCcchhHHHHHHHHhccCCCCchhhhhccccccceeeeec
Confidence            457899999999999999999999999999999998643  457888999999999888999999999999999999999


Q ss_pred             cCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceeeecCCCc--
Q 012170          179 CSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       179 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~~~~~~~--  252 (469)
                      + |.+|.+++.- ...|+...+.-++-|++.-++|+|.++++||||||+|+|+.-+   ..+.|+|||+|+.+.+...  
T Consensus        93 L-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~  171 (341)
T KOG1163|consen   93 L-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQ  171 (341)
T ss_pred             c-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccc
Confidence            9 8899888754 3579999999999999999999999999999999999999643   4699999999987654322  


Q ss_pred             ------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCCCC-cccC
Q 012170          253 ------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFHSG-VWET  321 (469)
Q Consensus       253 ------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~~~-~~~~  321 (469)
                            -....||..|.+--...+. -+.+.|+-|+|.+|.++..|.+||.|..   ..+-++.|...+...+.. ....
T Consensus       172 HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G  251 (341)
T KOG1163|consen  172 HIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKG  251 (341)
T ss_pred             cCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCC
Confidence                  2346799999987766653 5778999999999999999999998854   345556666555444322 2356


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCH
Q 012170          322 VSKPARDLMARMLTRDVSARITA  344 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa  344 (469)
                      +|.++.-.+.-|=..--++-|..
T Consensus       252 ~P~EF~myl~Y~R~L~F~E~Pdy  274 (341)
T KOG1163|consen  252 FPAEFAMYLNYCRGLGFEEKPDY  274 (341)
T ss_pred             CcHHHHHHHHHHhhcCCCCCCcH
Confidence            78899888888866666666764

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.92  E-value=1.2e-24  Score=200.61  Aligned_cols=136  Identities=21%  Similarity=0.322  Sum_probs=111.0

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------------HH-----------------HHHHHHHHHHhhCCC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------------ET-----------------VHREVEIMQHLSGHT  157 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------------~~-----------------~~~E~~il~~l~~hp  157 (469)
                      .+.||+|+||.||+|.+. +|+.||||+++.+.             ..                 ...|+++|.++. ++
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05147           2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLV-TA   79 (190)
T ss_pred             CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHH-HC
Confidence            368999999999999987 89999999996531             11                 234999999997 77


Q ss_pred             CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhcCeEeccCCCCcEEEccCCcE
Q 012170          158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC-HDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       158 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~givHrDlkp~NILl~~~~~v  236 (469)
                      ++.....+... + .+|||||++|+++...+...+.+++..+..++.|++.+|.|| |+.||+||||||+|||++ ++.+
T Consensus        80 ~v~~p~~~~~~-~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~~~v  156 (190)
T cd05147          80 GIPCPEPILLK-S-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-DGKL  156 (190)
T ss_pred             CCCCCcEEEec-C-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-CCcE
Confidence            76443333222 2 379999999987766655667899999999999999999999 799999999999999998 5789


Q ss_pred             EEEeccceeeec
Q 012170          237 KLADFGLAMRIS  248 (469)
Q Consensus       237 kL~DFgla~~~~  248 (469)
                      +|+|||+|....
T Consensus       157 ~LiDFG~a~~~~  168 (190)
T cd05147         157 YIIDVSQSVEHD  168 (190)
T ss_pred             EEEEccccccCC
Confidence            999999997543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.91  E-value=1.5e-23  Score=193.61  Aligned_cols=137  Identities=23%  Similarity=0.315  Sum_probs=113.1

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------------------------HHHHHHHHHHHHhhCCC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------------------------ETVHREVEIMQHLSGHT  157 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------------------------~~~~~E~~il~~l~~hp  157 (469)
                      .+.||+|+||.||+|.+. +|+.||||+++...                              ....+|.+.+.++. |+
T Consensus         2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~   79 (190)
T cd05145           2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLY-EA   79 (190)
T ss_pred             CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHH-hC
Confidence            468999999999999987 89999999987531                              11357899999997 88


Q ss_pred             CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcE
Q 012170          158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       158 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~v  236 (469)
                      +|.....+....  .||||||++|+++.........++...+..++.|++.+|.+||+ .||+||||||+|||++ ++.+
T Consensus        80 ~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~-~~~~  156 (190)
T cd05145          80 GVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH-DGKP  156 (190)
T ss_pred             CCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-CCCE
Confidence            875544443332  37999999988665544455678899999999999999999999 9999999999999998 8899


Q ss_pred             EEEeccceeeecC
Q 012170          237 KLADFGLAMRISN  249 (469)
Q Consensus       237 kL~DFgla~~~~~  249 (469)
                      +|+|||++.....
T Consensus       157 ~liDFG~a~~~~~  169 (190)
T cd05145         157 YIIDVSQAVELDH  169 (190)
T ss_pred             EEEEcccceecCC
Confidence            9999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.91  E-value=3.3e-24  Score=206.86  Aligned_cols=227  Identities=26%  Similarity=0.378  Sum_probs=144.8

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhC---------CCCeeEEEEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSG---------HTGVVTLHSVYE  167 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~---------hpnIv~l~~~~~  167 (469)
                      .+...+.||.|+++.||.+.+..||+.+|+|++...       -+.+.+|.-....+.+         |-.++..++...
T Consensus        13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~   92 (288)
T PF14531_consen   13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR   92 (288)
T ss_dssp             EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred             EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence            456678999999999999999999999999998421       1334444433222211         212333333221


Q ss_pred             ---------eC---C-----eEEEEEeccCCCchHHHHH---HhCCC--CHH--HHHHHHHHHHHHHHHHHhcCeEeccC
Q 012170          168 ---------EA---D-----CFHLVMELCSGGRLIDQMV---EVGQY--SEQ--RAANIFKDVMWVIKYCHDMGVVHRDI  223 (469)
Q Consensus       168 ---------~~---~-----~~~lV~E~~~gg~L~~~l~---~~~~l--~~~--~~~~i~~qil~aL~yLH~~givHrDl  223 (469)
                               ..   .     +.+++|+-+. ++|.+.+.   .....  ...  ....+..|+++.+++||..|++|+||
T Consensus        93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi  171 (288)
T PF14531_consen   93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDI  171 (288)
T ss_dssp             ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-
T ss_pred             EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEeccc
Confidence                     11   1     2367888774 47766643   33322  122  22445589999999999999999999


Q ss_pred             CCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC---------CCCCccchHHHHHHHHHHHhCCCC
Q 012170          224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG---------NYSEKVDIWSAGVLLHALLVAALP  294 (469)
Q Consensus       224 kp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DiwSlG~il~elltG~~P  294 (469)
                      +|+|++++.+|.++|+||+...........  ...+..|.+||....         .++.+.|.|+||+++|.|+||..|
T Consensus       172 ~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lP  249 (288)
T PF14531_consen  172 KPENFLLDQDGGVFLGDFSSLVRAGTRYRC--SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLP  249 (288)
T ss_dssp             SGGGEEE-TTS-EEE--GGGEEETTEEEEG--GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-S
T ss_pred             ceeeEEEcCCCCEEEcChHHHeecCceeec--cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCC
Confidence            999999999999999999988764432222  345678999997632         278899999999999999999999


Q ss_pred             CCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCC
Q 012170          295 FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR  341 (469)
Q Consensus       295 f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~R  341 (469)
                      |..........      ..|...  ..++..+++||..||++||.+|
T Consensus       250 f~~~~~~~~~~------~~f~~C--~~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  250 FGLSSPEADPE------WDFSRC--RDMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             TCCCGGGSTSG------GGGTTS--S---HHHHHHHHHHT-SSGGGS
T ss_pred             CCCCCcccccc------ccchhc--CCcCHHHHHHHHHHccCCcccC
Confidence            98654322111      123322  3789999999999999999988

>KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms]

Probab=99.90  E-value=2.5e-24  Score=208.46  Aligned_cols=188  Identities=26%  Similarity=0.389  Sum_probs=140.4

Q ss_pred             hhCCCCeeEEEEEEEe---------------------------CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHH
Q 012170          153 LSGHTGVVTLHSVYEE---------------------------ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD  205 (469)
Q Consensus       153 l~~hpnIv~l~~~~~~---------------------------~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~q  205 (469)
                      |..|||||++..+|.+                           ...+|+||.-... +|..++.. ...+.....-++.|
T Consensus       272 La~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~-~~~s~r~~~~~laQ  349 (598)
T KOG4158|consen  272 LAKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWT-RHRSYRTGRVILAQ  349 (598)
T ss_pred             cCCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhc-CCCchHHHHHHHHH
Confidence            3469999999887743                           3468999997755 78887744 45677788889999


Q ss_pred             HHHHHHHHHhcCeEeccCCCCcEEEcc--CC--cEEEEeccceeeecCC-------CcccccCCCCcccCceeccCCC--
Q 012170          206 VMWVIKYCHDMGVVHRDIKPENILLTT--SG--KIKLADFGLAMRISNG-------QTLSGLAGSPAYVAPEVLSGNY--  272 (469)
Q Consensus       206 il~aL~yLH~~givHrDlkp~NILl~~--~~--~vkL~DFgla~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~--  272 (469)
                      +++|+.|||.+||.|||+|.+||||.-  |+  .+.|+|||.+-.-...       ...-...|....||||+.....  
T Consensus       350 lLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp  429 (598)
T KOG4158|consen  350 LLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGP  429 (598)
T ss_pred             HHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCC
Confidence            999999999999999999999999953  33  5899999988432211       1112245888899999985421  


Q ss_pred             -----CCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHH
Q 012170          273 -----SEKVDIWSAGVLLHALLVAALPFKGDSLEAVF-DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITAD  345 (469)
Q Consensus       273 -----~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~  345 (469)
                           -.++|.|+.|.+.||++....||.+....-+- ...++..   .+.....+++.+++|+..+|+.||++|+++.
T Consensus       430 ~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~q---LPalp~~vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  430 NAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQ---LPALPSRVPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             ceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhh---CCCCcccCChHHHHHHHHHhcCCccccCCcc
Confidence                 25799999999999999999999874322110 1111211   1223467899999999999999999999853

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.90  E-value=9.9e-24  Score=197.79  Aligned_cols=168  Identities=17%  Similarity=0.218  Sum_probs=132.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hH----H------HHHHHHHHHHhhCCCCeeEEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EE----T------VHREVEIMQHLSGHTGVVTLHSVY  166 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~----~------~~~E~~il~~l~~hpnIv~l~~~~  166 (469)
                      -+..+|..+++||.|+||.||++..  ++..+|+|+++..   .+    .      +.+|+..+.+|. ||+|+.+..++
T Consensus        28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~-~~GI~~~~d~~  104 (232)
T PRK10359         28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVR-SEGLASLNDFY  104 (232)
T ss_pred             HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHH-HCCCCcceEee
Confidence            3678999999999999999999655  4678999999632   11    1      578999999997 99999999887


Q ss_pred             EeC--------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          167 EEA--------DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       167 ~~~--------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      .+.        +..+|||||++|.+|.+..    .+++    ....+++.+|..||..|++|||+||+||+++.+| ++|
T Consensus       105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~----~~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~~g-i~l  175 (232)
T PRK10359        105 LLAERKTLRYAHTYIMLIEYIEGVELNDMP----EISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSKNG-LRI  175 (232)
T ss_pred             eecccccccccCCeEEEEEEECCccHHHhh----hccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeCCC-EEE
Confidence            644        3588999999999997763    2333    2466999999999999999999999999999998 999


Q ss_pred             EeccceeeecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHH
Q 012170          239 ADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALL  289 (469)
Q Consensus       239 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~ell  289 (469)
                      +|||.............          =++...|+.++|+||||+++..+.
T Consensus       176 iDfg~~~~~~e~~a~d~----------~vler~y~~~~di~~lg~~~~~~~  216 (232)
T PRK10359        176 IDLSGKRCTAQRKAKDR----------IDLERHYGIKNEIKDLGYYLLIYK  216 (232)
T ss_pred             EECCCcccccchhhHHH----------HHHHhHhcccccccceeEeehHHH
Confidence            99998865432222111          012334778999999999887654

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.90  E-value=3.7e-23  Score=190.22  Aligned_cols=181  Identities=20%  Similarity=0.240  Sum_probs=140.9

Q ss_pred             eeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       106 ~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++..|++|+||+||.+..  .+..++.+.+....        ..+.+|+++|++|.+|++|++++++    +..|++||
T Consensus         5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme   78 (218)
T PRK12274          5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS   78 (218)
T ss_pred             ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence            3467899999999997765  57888877775432        2478999999999867899999886    34689999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccC-CCCcEEEccCCcEEEEeccceeeecCCCcc---
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI-KPENILLTTSGKIKLADFGLAMRISNGQTL---  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDl-kp~NILl~~~~~vkL~DFgla~~~~~~~~~---  253 (469)
                      |+.|.+|...+..      . ...++.|++.+|.+||+.||+|||| ||+|||++.+|.++|+|||++.........   
T Consensus        79 yI~G~~L~~~~~~------~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~  151 (218)
T PRK12274         79 YLAGAAMYQRPPR------G-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRL  151 (218)
T ss_pred             eecCccHHhhhhh------h-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHH
Confidence            9999988654321      1 2357889999999999999999999 799999999999999999999854433211   


Q ss_pred             -----------cccCCCCcccCceeccC--CCC-CccchHHHHHHHHHHHhCCCCCCCCC
Q 012170          254 -----------SGLAGSPAYVAPEVLSG--NYS-EKVDIWSAGVLLHALLVAALPFKGDS  299 (469)
Q Consensus       254 -----------~~~~gt~~y~aPE~l~~--~~~-~~~DiwSlG~il~elltG~~Pf~~~~  299 (469)
                                 .....++.|++|+...-  ..+ .+.++++.|+-+|.++|+..|+.++.
T Consensus       152 L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~  211 (218)
T PRK12274        152 LAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN  211 (218)
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence                       01236788888875422  233 56799999999999999999886543

>KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms]

Probab=99.88  E-value=8.8e-24  Score=225.92  Aligned_cols=238  Identities=24%  Similarity=0.336  Sum_probs=177.8

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHH---HHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVH---REVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~---~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+...+.||.+.|=+|.+|++.. |. |+||++-+..     ..+.   .|++ . .+..+||++.+.-+...+..-|||
T Consensus        24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~-~l~~~pn~lPfqk~~~t~kAAylv   99 (1431)
T KOG1240|consen   24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIK-F-ALMKAPNCLPFQKVLVTDKAAYLV   99 (1431)
T ss_pred             ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHH-H-HhhcCCcccchHHHHHhhHHHHHH
Confidence            67778999999999999998874 55 9999985432     2233   3333 3 333599999999888888888999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee--c--CCC
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--S--NGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~--~--~~~  251 (469)
                      -+|+.. +|+|.+..++.+..-+.+.|+.||+.||.-||..||+|+|||.+||||+.-+-+.|+||..-+..  .  ++.
T Consensus       100 Rqyvkh-nLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPa  178 (1431)
T KOG1240|consen  100 RQYVKH-NLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPA  178 (1431)
T ss_pred             HHHHhh-hhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCCCcc
Confidence            999965 89999988888888999999999999999999999999999999999999999999999865422  1  111


Q ss_pred             ccccc----CCCCcccCceeccC------------CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCC
Q 012170          252 TLSGL----AGSPAYVAPEVLSG------------NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDF  314 (469)
Q Consensus       252 ~~~~~----~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  314 (469)
                      ....+    .--.+|+|||.+..            ..+++.||||+||+++||++ |.+||.-   .+++ ..+.+.-..
T Consensus       179 df~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L---SQL~-aYr~~~~~~  254 (1431)
T KOG1240|consen  179 DFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL---SQLL-AYRSGNADD  254 (1431)
T ss_pred             cceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH---HHHH-hHhccCccC
Confidence            11112    22346999998732            14678999999999999988 7899942   1221 111111100


Q ss_pred             CCCccc-CCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          315 HSGVWE-TVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       315 ~~~~~~-~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +....+ --+..++.||..|++.||++|.+|++.|+.
T Consensus       255 ~e~~Le~Ied~~~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  255 PEQLLEKIEDVSLRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHhCcCccHHHHHHHHHccCchhccCHHHHHHh
Confidence            000001 124578999999999999999999999986

>PRK10345 hypothetical protein; Provisional

Probab=99.87  E-value=1.7e-21  Score=181.71  Aligned_cols=131  Identities=17%  Similarity=0.274  Sum_probs=107.2

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhh----CCCCeeEEEEEEEeCC---e-EEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLS----GHTGVVTLHSVYEEAD---C-FHLV  175 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~----~hpnIv~l~~~~~~~~---~-~~lV  175 (469)
                      .+.||+|+||.||.  +..++.. +||++...    .+.+.+|+.+++.+.    .||||++++++++++.   . +.+|
T Consensus         7 ~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I   83 (210)
T PRK10345          7 QSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVI   83 (210)
T ss_pred             cceecCCCceEEEE--CCCCcCe-EEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEE
Confidence            47899999999995  7777666 69988653    467899999999994    3799999999999874   4 3478


Q ss_pred             Eec--cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHhcCeEeccCCCCcEEEccC----CcEEEEeccce
Q 012170          176 MEL--CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI-KYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLA  244 (469)
Q Consensus       176 ~E~--~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL-~yLH~~givHrDlkp~NILl~~~----~~vkL~DFgla  244 (469)
                      |||  +.+|+|.+++.+ +.+++.  ..++.|++.++ .|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus        84 ~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345         84 ADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             ecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            999  557999999955 456666  46688888887 99999999999999999999743    37999995444

>smart00090 RIO RIO-like kinase

Probab=99.85  E-value=4.2e-21  Score=183.03  Aligned_cols=138  Identities=24%  Similarity=0.273  Sum_probs=113.6

Q ss_pred             CeeeeeeeeccCCeEEEEEE-ECCCCcEEEEEEcccCh----------------------------HHHHHHHHHHHHhh
Q 012170          104 DHTKVEVIGHGKFGSVWLCR-SKASGAEFACKTLRKGE----------------------------ETVHREVEIMQHLS  154 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~-~~~~~~~vAvK~~~~~~----------------------------~~~~~E~~il~~l~  154 (469)
                      .|.+.+.||+|+||.||+|. +..+|+.||||+++...                            ..+.+|+.++.++.
T Consensus        29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~  108 (237)
T smart00090       29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLY  108 (237)
T ss_pred             hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            47788999999999999998 67789999999986431                            12467999999997


Q ss_pred             CCC--CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC-eEeccCCCCcEEEc
Q 012170          155 GHT--GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG-VVHRDIKPENILLT  231 (469)
Q Consensus       155 ~hp--nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g-ivHrDlkp~NILl~  231 (469)
                       +.  .++++++.   . ..++||||+.|++|...+.....+....+..++.||+.+|.+||+.| ++||||||+||+++
T Consensus       109 -~~~i~~p~~~~~---~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NIli~  183 (237)
T smart00090      109 -EAGVPVPKPIAW---R-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNILVH  183 (237)
T ss_pred             -hcCCCCCeeeEe---c-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhEEEE
Confidence             43  34455543   2 34799999999888766545566777778899999999999999999 99999999999999


Q ss_pred             cCCcEEEEeccceeee
Q 012170          232 TSGKIKLADFGLAMRI  247 (469)
Q Consensus       232 ~~~~vkL~DFgla~~~  247 (469)
                       ++.++|+|||.+...
T Consensus       184 -~~~i~LiDFg~a~~~  198 (237)
T smart00090      184 -DGKVVIIDVSQSVEL  198 (237)
T ss_pred             -CCCEEEEEChhhhcc
Confidence             889999999998654

>KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms]

Probab=99.83  E-value=2.9e-21  Score=179.01  Aligned_cols=234  Identities=18%  Similarity=0.280  Sum_probs=185.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      +..++.+|.+...|..|+|++.  |..+++|++.-.      ..+|..|.-.|+-.. ||||+.+++.+....++.++..
T Consensus       191 ~lnl~tkl~e~hsgelwrgrwq--gndivakil~vr~~t~risrdfneefp~lrifs-hpnilpvlgacnsppnlv~isq  267 (448)
T KOG0195|consen  191 SLNLITKLAESHSGELWRGRWQ--GNDIVAKILNVREVTARISRDFNEEFPALRIFS-HPNILPVLGACNSPPNLVIISQ  267 (448)
T ss_pred             hhhhhhhhccCCCccccccccc--CcchhhhhhhhhhcchhhcchhhhhCcceeeec-CCchhhhhhhccCCCCceEeee
Confidence            3445667889999999999998  556777777432      256788888888886 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEE--EeccceeeecCCC
Q 012170          178 LCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKL--ADFGLAMRISNGQ  251 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL--~DFgla~~~~~~~  251 (469)
                      ||+.|+|+..+.....  .+..++.+++.+|++|+.|||+..  |.---|....|+||++-+.+|  +|--++.+     
T Consensus       268 ~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarismad~kfsfq-----  342 (448)
T KOG0195|consen  268 YMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ-----  342 (448)
T ss_pred             eccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheecccceeeee-----
Confidence            9999999999977654  567889999999999999999875  444468889999999876554  44333321     


Q ss_pred             cccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       ..+..-.|.||+||.+...    .-.++|+|||++++|||.|...||.+.++.+.-..|.-..+.  ...++.++..+.
T Consensus       343 -e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecgmkialeglr--v~ippgis~hm~  419 (448)
T KOG0195|consen  343 -EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECGMKIALEGLR--VHIPPGISRHMN  419 (448)
T ss_pred             -ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhhhhhhhcccc--ccCCCCccHHHH
Confidence             1223457899999999764    235799999999999999999999998888766555433222  223367899999


Q ss_pred             HHHHHhchhhhcCCCCHHHHH
Q 012170          328 DLMARMLTRDVSARITADEVL  348 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL  348 (469)
                      .|+.-|++.||.+||.+..|.
T Consensus       420 klm~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  420 KLMNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHHHhcCCCCcCCCcceeh
Confidence            999999999999999988764

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.83  E-value=1.7e-19  Score=168.90  Aligned_cols=130  Identities=27%  Similarity=0.408  Sum_probs=111.9

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG------------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +.||+|++|.||+|.+  +|..+++|+....            ...+.+|+.++..+. |++|+....++.+.+..++||
T Consensus         2 ~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~   78 (211)
T PRK14879          2 KLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRAR-KAGVNVPAVYFVDPENFIIVM   78 (211)
T ss_pred             cccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHH-HCCCCCCeEEEEeCCCCEEEE
Confidence            6799999999999987  5788999976421            134678999999997 898887777777778889999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ||++|++|.+.+.....    ....++.+++.+|.+||+.|++|+|++|.|||++ ++.++|+|||++..
T Consensus        79 e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879         79 EYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             EEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            99999999998865332    7888999999999999999999999999999999 78999999999854

>KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning]

Probab=99.83  E-value=1.8e-20  Score=204.17  Aligned_cols=190  Identities=22%  Similarity=0.346  Sum_probs=157.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-HHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-ETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .+.|.+-+.||+|+||+||+|...+ |+.||||+-+... -++.--.+++.+|+  --+.|..+...+.-.+.-+||+||
T Consensus       697 ~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~lv~ey  775 (974)
T KOG1166|consen  697 GEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLKPQMLPSIMHISSAHVFQNASVLVSEY  775 (974)
T ss_pred             ceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhchhhhcchHHHHHHHccCCcceeeeec
Confidence            4578888999999999999999887 9999999976532 22222223333332  235577777776667777899999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-------CCcEEEEeccceeee---c
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-------SGKIKLADFGLAMRI---S  248 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-------~~~vkL~DFgla~~~---~  248 (469)
                      .+.|+|++++...+.+++..+..++.|++..+++||..+|||+||||+|.||..       .--++|+|||.+..+   .
T Consensus       776 ~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp  855 (974)
T KOG1166|consen  776 SPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFP  855 (974)
T ss_pred             cccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcC
Confidence            999999999998889999999999999999999999999999999999999953       224999999998654   3


Q ss_pred             CCCcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCC
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAA  292 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~  292 (469)
                      ++......++|-.+--+|++.|. |+..+|.|.|+.+++.||.|+
T Consensus       856 ~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~  900 (974)
T KOG1166|consen  856 DGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGK  900 (974)
T ss_pred             CCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHH
Confidence            44466778899999999999985 999999999999999999986

>KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning]

Probab=99.82  E-value=4.7e-22  Score=212.06  Aligned_cols=253  Identities=32%  Similarity=0.491  Sum_probs=207.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCC-CcEEEEEEcccC---h---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKAS-GAEFACKTLRKG---E---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~---~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..|.+.+.||+|+|+.|-++....+ ...+|+|.+...   .   .....|..+-+.+.+|+|++.+++.....+..+++
T Consensus        20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~   99 (601)
T KOG0590|consen   20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS   99 (601)
T ss_pred             ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence            4566777899999999999877543 345677766432   2   34455888888887799999999999999999999


Q ss_pred             EeccCCCchHHHH-HHhC-CCCHHHHHHHHHHHHHHHHHHH-hcCeEeccCCCCcEEEccCC-cEEEEeccceeeecC-C
Q 012170          176 MELCSGGRLIDQM-VEVG-QYSEQRAANIFKDVMWVIKYCH-DMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISN-G  250 (469)
Q Consensus       176 ~E~~~gg~L~~~l-~~~~-~l~~~~~~~i~~qil~aL~yLH-~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~-~  250 (469)
                      ++|..|+++++-+ .... ..+...+..++.|+..++.|+| ..++.||||||+|.+++..+ .++++|||+|..+.. .
T Consensus       100 ~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~~  179 (601)
T KOG0590|consen  100 LSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNKN  179 (601)
T ss_pred             cCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhccccccC
Confidence            9999999999988 4444 6788899999999999999999 99999999999999999999 999999999987655 2


Q ss_pred             C---cccccCC-CCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-HHHHcCcCCCCCCcccCCC
Q 012170          251 Q---TLSGLAG-SPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF-DAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       251 ~---~~~~~~g-t~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-~~i~~~~~~~~~~~~~~~s  323 (469)
                      .   .....+| ++.|+|||...+  ......|+||+|+++..+++|..||......... .........+....|..++
T Consensus       180 g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  259 (601)
T KOG0590|consen  180 GAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKGRFTQLPWNSIS  259 (601)
T ss_pred             CcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeecccccccccCccccCC
Confidence            2   2344678 999999999987  3577899999999999999999999754432211 1112222334566788999


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ....+++.++|..+|..|.+.+++..+||+..
T Consensus       260 ~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  260 DQAHDLLHKILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             hhhhhcccccccCCchhccccccccccccccc
Confidence            99999999999999999999999999999976

>KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis]

Probab=99.81  E-value=1.1e-20  Score=190.25  Aligned_cols=175  Identities=28%  Similarity=0.485  Sum_probs=140.4

Q ss_pred             CeEEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      .++||.|++|.-.+|.++|.+...   .+......++.|+..|++|   +|.+|||+||.||++..+..+||.|||+...
T Consensus       329 ~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~ts  405 (516)
T KOG1033|consen  329 VYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVTS  405 (516)
T ss_pred             cchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhheee
Confidence            368999999999999999975543   5667889999999999999   9999999999999999999999999999987


Q ss_pred             ecCCC-------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          247 ISNGQ-------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       247 ~~~~~-------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      .....       ..+...||.+||+||.+.+ .|+.++||||||+||+||+. -..+|   .....+..+..+.++  ..
T Consensus       406 ~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~---er~~t~~d~r~g~ip--~~  480 (516)
T KOG1033|consen  406 QDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQF---ERIATLTDIRDGIIP--PE  480 (516)
T ss_pred             cccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHH---HHHHhhhhhhcCCCC--hH
Confidence            76555       4567789999999999987 59999999999999999997 22222   223334445544433  22


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .+.. .++-.+|+.+||.+.|.+||++.+.--|+|.
T Consensus       481 ~~~d-~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  481 FLQD-YPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             Hhhc-CcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            2222 3455689999999999999988888778774

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.80  E-value=3.1e-19  Score=165.74  Aligned_cols=132  Identities=23%  Similarity=0.282  Sum_probs=107.3

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------------------------HHHHHHHHHHHHhhCCC-
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------------------------ETVHREVEIMQHLSGHT-  157 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------------------------~~~~~E~~il~~l~~hp-  157 (469)
                      |.+.+.||.|+||.||+|... +|+.||||+++.+.                          .....|..++..+. |+ 
T Consensus        17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~   94 (198)
T cd05144          17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALY-EEG   94 (198)
T ss_pred             hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHH-HcC
Confidence            777899999999999999875 79999999865321                          12567899999996 66 


Q ss_pred             -CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          158 -GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       158 -nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                       .++..++    ....++||||++|++|.....      ......++.+++.++.++|+.||+||||||+||+++.++.+
T Consensus        95 i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~~~~  164 (198)
T cd05144          95 FPVPKPID----WNRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDDEKI  164 (198)
T ss_pred             CCCCceee----cCCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCCCcE
Confidence             3444443    244589999999998866432      14467788999999999999999999999999999999999


Q ss_pred             EEEeccceeeec
Q 012170          237 KLADFGLAMRIS  248 (469)
Q Consensus       237 kL~DFgla~~~~  248 (469)
                      +|+|||++....
T Consensus       165 ~liDfg~~~~~~  176 (198)
T cd05144         165 YIIDWPQMVSTD  176 (198)
T ss_pred             EEEECCccccCC
Confidence            999999996544

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.80  E-value=4.9e-19  Score=164.24  Aligned_cols=126  Identities=25%  Similarity=0.357  Sum_probs=104.0

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccC------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG------------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .||+|+||.||+|.+  +|..+++|+....            ...+.+|++++..+. |+++.....++...+..++|||
T Consensus         1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~~~~~lv~e   77 (199)
T TIGR03724         1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRAR-KAGVNTPVVYDVDPDNKTIVME   77 (199)
T ss_pred             CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHH-HCCCCCCEEEEEECCCCEEEEE
Confidence            489999999999985  5788999985321            144668999999997 7765555545556667789999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      |++|++|.+.+.....       .++.+++.+|.+||+.|++|+|++|.||+++ ++.++++|||++..
T Consensus        78 ~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~  138 (199)
T TIGR03724        78 YIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKY  138 (199)
T ss_pred             EECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcC
Confidence            9999999987754321       7899999999999999999999999999999 88999999999865

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.79  E-value=3.3e-18  Score=182.38  Aligned_cols=133  Identities=20%  Similarity=0.287  Sum_probs=109.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEc--cc---C-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL--RK---G-------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~--~~---~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ...|...+.||+|+||.||+|.+...  .+++|+.  +.   .       .+.+.+|+++++.+. |++++....++.+.
T Consensus       332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~--~~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~p~~~~~~~  408 (535)
T PRK09605        332 KRRKIPDHLIGKGAEADIKKGEYLGR--DAVIKERVPKGYRHPELDERLRTERTRAEARLLSEAR-RAGVPTPVIYDVDP  408 (535)
T ss_pred             ccccCccceeccCCcEEEEEEeecCc--cceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhc-ccCCCeeEEEEEeC
Confidence            44556678999999999999987643  3444432  11   0       135778999999997 99998888777777


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      +..++||||++|++|.+++.        ....++.|++.+|.|||+.|++||||||+|||+ .++.++|+|||+++.
T Consensus       409 ~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~  476 (535)
T PRK09605        409 EEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY  476 (535)
T ss_pred             CCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence            77889999999999998875        356789999999999999999999999999999 678999999999965

>KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms]

Probab=99.76  E-value=2.2e-18  Score=176.54  Aligned_cols=199  Identities=20%  Similarity=0.316  Sum_probs=158.3

Q ss_pred             HHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCe-EeccCCCCc
Q 012170          150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGV-VHRDIKPEN  227 (469)
Q Consensus       150 l~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~gi-vHrDlkp~N  227 (469)
                      |+.+. |.|+.++++.+.++...++|.+||.-|+|.|.+.. .-.++.--...++++|+.||.|||...| .|+.|++.|
T Consensus         1 l~~l~-h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~n   79 (484)
T KOG1023|consen    1 LRQLD-HDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSN   79 (484)
T ss_pred             Ccccc-hhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeecccc
Confidence            35675 99999999999999999999999999999999966 3457777788899999999999998776 999999999


Q ss_pred             EEEccCCcEEEEeccceeeecCC---CcccccCCCCcccCceeccCC--------CCCccchHHHHHHHHHHHhCCCCCC
Q 012170          228 ILLTTSGKIKLADFGLAMRISNG---QTLSGLAGSPAYVAPEVLSGN--------YSEKVDIWSAGVLLHALLVAALPFK  296 (469)
Q Consensus       228 ILl~~~~~vkL~DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~~--------~~~~~DiwSlG~il~elltG~~Pf~  296 (469)
                      .+++....+||+|||+.......   .......-..-|.|||.+.+.        .+.+.|+||+|++++|+++...||.
T Consensus        80 Clvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~  159 (484)
T KOG1023|consen   80 CLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFD  159 (484)
T ss_pred             ceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCccc
Confidence            99999999999999998665321   111111234459999999763        4667999999999999999999997


Q ss_pred             CC----CHHHHHHHHHc-CcCCCCCCcc--cCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          297 GD----SLEAVFDAIKN-VKLDFHSGVW--ETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       297 ~~----~~~~~~~~i~~-~~~~~~~~~~--~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..    ...+++..+.+ ....+.+..+  ..+.+++..++..|+..+|..||+++++-.
T Consensus       160 ~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  160 LRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS  219 (484)
T ss_pred             cccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence            52    33456666666 3333333333  145668999999999999999999988743

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.75  E-value=7.6e-18  Score=154.58  Aligned_cols=135  Identities=23%  Similarity=0.340  Sum_probs=100.3

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HH----------------------HHHHHHHHHHhhCC-CC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ET----------------------VHREVEIMQHLSGH-TG  158 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~----------------------~~~E~~il~~l~~h-pn  158 (469)
                      .+.||+|+||.||+|.+. +|+.||||+++...      ..                      ...|...+..+..+ -.
T Consensus         2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~   80 (187)
T cd05119           2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP   80 (187)
T ss_pred             CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence            467999999999999987 79999999986421      11                      13566777777522 22


Q ss_pred             eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEE
Q 012170          159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       159 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vk  237 (469)
                      +++++++.    ..++||||++|+.+........... ..+..++.+++.++.++|. .||+||||||+||+++ ++.++
T Consensus        81 ~~~~~~~~----~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~-~~~~~  154 (187)
T cd05119          81 VPKPIDLN----RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD-DGKVY  154 (187)
T ss_pred             CCceEecC----CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-CCcEE
Confidence            45555432    3589999999954432111111111 6788999999999999999 9999999999999999 89999


Q ss_pred             EEeccceeeecC
Q 012170          238 LADFGLAMRISN  249 (469)
Q Consensus       238 L~DFgla~~~~~  249 (469)
                      |+|||.+.....
T Consensus       155 liDfg~a~~~~~  166 (187)
T cd05119         155 IIDVPQAVEIDH  166 (187)
T ss_pred             EEECcccccccC
Confidence            999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only]

Probab=99.73  E-value=6.7e-19  Score=188.79  Aligned_cols=259  Identities=25%  Similarity=0.381  Sum_probs=212.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+.+.+.+-+-.|++|.++.+.-..+|..+++|+....       -+...++-.++-.-. +|.++.....+.-....+|
T Consensus       803 ~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~-~P~v~~~~~s~~~rsP~~L  881 (1205)
T KOG0606|consen  803 PDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPR-SPAVVRSFPSFPCRSPLPL  881 (1205)
T ss_pred             CccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCC-CCceecccCCCCCCCCcch
Confidence            35677778889999999999988888877777776432       233344444443333 5666666666666778999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC----
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----  250 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~----  250 (469)
                      |++|+.|++|...+..-+..+++-++..+..+..+++|||+..+.|||++|.|+|+..+|+.+++|||........    
T Consensus       882 ~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~  961 (1205)
T KOG0606|consen  882 VGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTT  961 (1205)
T ss_pred             hhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCccccccccccccCcC
Confidence            9999999999999988888899999999999999999999999999999999999999999999999844221100    


Q ss_pred             ----------------------------CcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH
Q 012170          251 ----------------------------QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLE  301 (469)
Q Consensus       251 ----------------------------~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~  301 (469)
                                                  .......||+.|.+||.+.+. ....+|+|++|+++++.++|.+||+.....
T Consensus       962 ~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq 1041 (1205)
T KOG0606|consen  962 DLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQ 1041 (1205)
T ss_pred             CcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchh
Confidence                                        001124689999999999874 788999999999999999999999999999


Q ss_pred             HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHH---HHHcCCCccccccccch
Q 012170          302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITAD---EVLRHPWILFYTERTLR  362 (469)
Q Consensus       302 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~---elL~hp~~~~~~~~~~~  362 (469)
                      .++++|.+....++... ...+.++++++.++|..+|.+|..+.   ++-.||||+...+.++.
T Consensus      1042 ~~f~ni~~~~~~~p~g~-~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~~~~~~~l~ 1104 (1205)
T KOG0606|consen 1042 QIFENILNRDIPWPEGP-EEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQDVDWENLA 1104 (1205)
T ss_pred             hhhhccccCCCCCCCCc-cccChhhhhhhhhhhccCchhccCcccccccccCCccCCCCccccc
Confidence            99999999888777654 46899999999999999999999987   99999999888776654

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.72  E-value=5.4e-17  Score=142.02  Aligned_cols=131  Identities=24%  Similarity=0.312  Sum_probs=113.5

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh--HHHHHHHHHHHHhhCC-CCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--ETVHREVEIMQHLSGH-TGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~E~~il~~l~~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      +++.||.|.++.||++....  ..+++|......  ..+.+|+.+++.+..+ .++++++.++...+..|++|||+.|+.
T Consensus         2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~   79 (155)
T cd05120           2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREKGADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGET   79 (155)
T ss_pred             cceecccccccceEEEEecC--CeEEEEecCCCCchhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCee
Confidence            45789999999999999753  789999997654  4789999999999844 689999999988889999999999887


Q ss_pred             hHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc---CeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM---GVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       184 L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      +..+       +......++.+++.+|.+||..   +++|+||+|.||+++..+.++++|||.+..
T Consensus        80 ~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120          80 LDEV-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             cccC-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            7643       5566777899999999999985   799999999999999989999999999853

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.70  E-value=2.5e-16  Score=150.42  Aligned_cols=130  Identities=25%  Similarity=0.428  Sum_probs=102.7

Q ss_pred             eeee-ccCCeEEEEEEECCCCcEEEEEEcccC-----------------hHHHHHHHHHHHHhhCCCCe--eEEEEEEEe
Q 012170          109 EVIG-HGKFGSVWLCRSKASGAEFACKTLRKG-----------------EETVHREVEIMQHLSGHTGV--VTLHSVYEE  168 (469)
Q Consensus       109 ~~lG-~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----------------~~~~~~E~~il~~l~~hpnI--v~l~~~~~~  168 (469)
                      ..|| .|+.|+||.+...  +..++||.+...                 ...+.+|+.++..|. |++|  +..+++...
T Consensus        37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~-~~gi~vP~pl~~~~~  113 (239)
T PRK01723         37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLY-EAGLPVPRPIAARVV  113 (239)
T ss_pred             ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHH-hCCCCCceeEeeeee
Confidence            4677 8889999988764  778999877421                 134678999999997 7774  677776443


Q ss_pred             C-Ce---EEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          169 A-DC---FHLVMELCSG-GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       169 ~-~~---~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                      . ..   .++|||+++| .+|.+++.. ..+++.    .+.||+.+|.+||+.||+||||||+|||++.++.++|+|||.
T Consensus       114 ~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~  188 (239)
T PRK01723        114 RHGLFYRADILIERIEGARDLVALLQE-APLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDR  188 (239)
T ss_pred             ecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCC
Confidence            2 22   2599999997 688877643 456654    367899999999999999999999999999999999999999


Q ss_pred             eee
Q 012170          244 AMR  246 (469)
Q Consensus       244 a~~  246 (469)
                      +..
T Consensus       189 ~~~  191 (239)
T PRK01723        189 GEL  191 (239)
T ss_pred             ccc
Confidence            865

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.69  E-value=1.3e-17  Score=170.95  Aligned_cols=250  Identities=24%  Similarity=0.301  Sum_probs=202.9

Q ss_pred             ccCCeeeeeeeec--cCCeEEEEEEE--CCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGH--GKFGSVWLCRS--KASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~--G~~g~Vy~~~~--~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      +...+.+...+|.  |.+|.||.+..  ..++..+|+|.-+.      ....-.+|+...+.+..|+|.++.+..++..+
T Consensus       112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~  191 (524)
T KOG0601|consen  112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSG  191 (524)
T ss_pred             hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCC
Confidence            4566777889999  99999999988  88999999998421      22344578888888888999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHH----HHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccce
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMW----VIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLA  244 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~----aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla  244 (469)
                      ..|+-+|+|. .+|..+...... +++..++..+.+...    ||.++|+.+++|-|+||.||++..+ ...+++|||+.
T Consensus       192 ~lfiqtE~~~-~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v  270 (524)
T KOG0601|consen  192 ILFIQTELCG-ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLV  270 (524)
T ss_pred             cceeeecccc-chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCcccccccchhheecccccceeecCCccee
Confidence            9999999995 688777766554 888999999999999    9999999999999999999999999 78999999999


Q ss_pred             eeecCCCccc------ccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc
Q 012170          245 MRISNGQTLS------GLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       245 ~~~~~~~~~~------~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~  318 (469)
                      ..+.+.....      ...|...|++||++.+-++...|++++|.++.+-.+|..++...-. .....+.+..  .+...
T Consensus       271 ~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~-~~W~~~r~~~--ip~e~  347 (524)
T KOG0601|consen  271 SKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKN-SSWSQLRQGY--IPLEF  347 (524)
T ss_pred             EEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCC-CCcccccccc--Cchhh
Confidence            9887655322      2257888999999999999999999999999999988766543210 1111122211  23333


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ....+.++...+..|++.+|..|++++.+++|+++.
T Consensus       348 ~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  348 CEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             hcCcchhhhhHHHHhcCcchhhhhHHHHHhcccccc
Confidence            455677788899999999999999999999999985

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=99.59  E-value=5.5e-15  Score=155.18  Aligned_cols=140  Identities=24%  Similarity=0.331  Sum_probs=97.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------------------------------------H-
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------------------------------------E-  141 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------------------------------------~-  141 (469)
                      +...|+. +.||.|++|.||+|+.+.+|+.||||+++.+.                                      . 
T Consensus       118 ~F~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~  196 (537)
T PRK04750        118 WFDDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKT  196 (537)
T ss_pred             HHHhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHH
Confidence            3445666 78999999999999999889999999997541                                      0 


Q ss_pred             -----HHHHHHHHHHHhh---CCCCeeEEEEEEE-eCCeEEEEEeccCCCchHHH--HHHhC----CCCHHHHHHHHHHH
Q 012170          142 -----TVHREVEIMQHLS---GHTGVVTLHSVYE-EADCFHLVMELCSGGRLIDQ--MVEVG----QYSEQRAANIFKDV  206 (469)
Q Consensus       142 -----~~~~E~~il~~l~---~hpnIv~l~~~~~-~~~~~~lV~E~~~gg~L~~~--l~~~~----~l~~~~~~~i~~qi  206 (469)
                           ++.+|+.-+.++.   .+.+.+.+-.+|. .....+|||||+.|+.+.+.  +...+    .+.+..+..++.|+
T Consensus       197 l~~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi  276 (537)
T PRK04750        197 LHDELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV  276 (537)
T ss_pred             HHHhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH
Confidence                 1223333333332   1222233223332 24456799999999999764  33333    24445555555665


Q ss_pred             HHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccceeeec
Q 012170          207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRIS  248 (469)
Q Consensus       207 l~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgla~~~~  248 (469)
                      +       ..|++|+|+||.||+++.+|    .++++|||++..++
T Consensus       277 f-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~  315 (537)
T PRK04750        277 F-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN  315 (537)
T ss_pred             H-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence            4       58999999999999999988    99999999997764

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=99.58  E-value=1.6e-14  Score=149.71  Aligned_cols=137  Identities=25%  Similarity=0.338  Sum_probs=97.4

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh-H-------------------------------------------HHH
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-E-------------------------------------------TVH  144 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~-------------------------------------------~~~  144 (469)
                      +.||.|++|.||+|+.+ +|+.||||+.+.+. +                                           ++.
T Consensus       123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~  201 (437)
T TIGR01982       123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR  201 (437)
T ss_pred             cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence            57999999999999976 69999999986541 1                                           123


Q ss_pred             HHHHHHHHhh----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHH-HHHHHHhcCe
Q 012170          145 REVEIMQHLS----GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMW-VIKYCHDMGV  218 (469)
Q Consensus       145 ~E~~il~~l~----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~-aL~yLH~~gi  218 (469)
                      +|+..+.++.    ++++|.-..-+.......+|||||++|++|.+..... ....   ...++.+++. .+..+|..|+
T Consensus       202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~g~  278 (437)
T TIGR01982       202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRDGF  278 (437)
T ss_pred             HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhCCc
Confidence            3444444443    2444332222223344568999999999998876432 1222   3345555555 4688999999


Q ss_pred             EeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          219 VHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       219 vHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +|+|+||.||+++.+|.++|+|||++..+..
T Consensus       279 ~H~D~hPgNilv~~~g~i~liDfG~~~~l~~  309 (437)
T TIGR01982       279 FHADLHPGNIFVLKDGKIIALDFGIVGRLSE  309 (437)
T ss_pred             eeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence            9999999999999999999999999977653

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.56  E-value=5.8e-14  Score=129.03  Aligned_cols=136  Identities=16%  Similarity=0.257  Sum_probs=103.9

Q ss_pred             eeeeccCCeEEEEEEECC------CCcEEEEEEcccC-------------h-------------HH----HHHHHHHHHH
Q 012170          109 EVIGHGKFGSVWLCRSKA------SGAEFACKTLRKG-------------E-------------ET----VHREVEIMQH  152 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~-------------~-------------~~----~~~E~~il~~  152 (469)
                      ..||.|.-+.||.|....      .+..+|||+.+..             .             ..    ..+|+..|++
T Consensus         3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r   82 (197)
T cd05146           3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR   82 (197)
T ss_pred             CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence            578999999999998653      3578999997421             0             11    2379999999


Q ss_pred             hhCC-CCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhcCeEeccCCCCcEEE
Q 012170          153 LSGH-TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC-HDMGVVHRDIKPENILL  230 (469)
Q Consensus       153 l~~h-pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~givHrDlkp~NILl  230 (469)
                      |... -++++++.+    ..-+|||||+.++.+.....+...+++..+..+..+++.+|..| |..|++|+||++.|||+
T Consensus        83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDLs~~NIL~  158 (197)
T cd05146          83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLVHADLSEYNMLW  158 (197)
T ss_pred             HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence            9743 467777765    34569999997754433333344566677788899999999998 89999999999999999


Q ss_pred             ccCCcEEEEeccceeeecC
Q 012170          231 TTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       231 ~~~~~vkL~DFgla~~~~~  249 (469)
                      + ++.+.|+|||.+.....
T Consensus       159 ~-~~~v~iIDF~qav~~~h  176 (197)
T cd05146         159 H-DGKVWFIDVSQSVEPTH  176 (197)
T ss_pred             E-CCcEEEEECCCceeCCC
Confidence            7 57899999999976543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05151 ChoK Choline Kinase (ChoK)

Probab=99.55  E-value=3.2e-14  Score=128.08  Aligned_cols=125  Identities=17%  Similarity=0.221  Sum_probs=98.3

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCch
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL  184 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  184 (469)
                      ++.|+.|.++.||++...  +..|++|+.....   ..+.+|+.+++.+.....+++++.+..  ...++||||++|.++
T Consensus         3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~G~~l   78 (170)
T cd05151           3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTELLINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIEGSEL   78 (170)
T ss_pred             eeecCCcccCceEEEEEC--CeEEEEEeCCCCcccccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecCCCcc
Confidence            467899999999999865  7889999986543   457889999999974333556665543  334799999999887


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCe-----EeccCCCCcEEEccCCcEEEEecccee
Q 012170          185 IDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV-----VHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       185 ~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~gi-----vHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ...        ......++.+++.+|..||..++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        79 ~~~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          79 LTE--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             ccc--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            643        11123467899999999999985     9999999999999 6789999999985

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning]

Probab=99.48  E-value=1.8e-14  Score=148.16  Aligned_cols=244  Identities=22%  Similarity=0.217  Sum_probs=188.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEEC-CCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSK-ASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ....+|..+..||.|.|+.|+.+... .++..|++|.+.+..      ..-..|+.+...+..|.+++.++..+...+..
T Consensus       262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~  341 (524)
T KOG0601|consen  262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQG  341 (524)
T ss_pred             eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence            45668889999999999999998755 678899999886543      23346888888888899999999888888888


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~~~~~  251 (469)
                      |+-.|||+++++...+.-...+.+...+.+..|++.++.++|++.++|+|+||+||++..+ +..++.|||.+..+.-. 
T Consensus       342 ~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~-  420 (524)
T KOG0601|consen  342 YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS-  420 (524)
T ss_pred             cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhcccccccccccee-
Confidence            8999999999887766555678899999999999999999999999999999999999886 78899999998652211 


Q ss_pred             cccccCCCCccc-CceeccC--CCCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 TLSGLAGSPAYV-APEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~~~~~~gt~~y~-aPE~l~~--~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       .....+.-++. .+|++..  .+..++|++|||..+++.++|.+. ..+...    ..|..+.....    .....++.
T Consensus       421 -~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~~~----~~i~~~~~p~~----~~~~~~~q  491 (524)
T KOG0601|consen  421 -SGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGVQS----LTIRSGDTPNL----PGLKLQLQ  491 (524)
T ss_pred             -cccccccccccccchhhccccccccccccccccccccccccCcccCcccccc----eeeecccccCC----CchHHhhh
Confidence             11223444455 3566544  367899999999999999998743 332221    22222222221    23447889


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .+.+.++..++..|+.+.++..|+=|
T Consensus       492 ~~~kv~~~~~~~~~~l~~~l~~~~~~  517 (524)
T KOG0601|consen  492 VLLKVMINPDRKRRPSAVELSLHSEF  517 (524)
T ss_pred             hhhhhhcCCccccchhhhhhcccchh
Confidence            99999999999999999999888754

>KOG1266 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.44  E-value=9.1e-14  Score=132.78  Aligned_cols=228  Identities=18%  Similarity=0.296  Sum_probs=157.7

Q ss_pred             EEEEEEECCCCcEEEEEEcc--------cChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----eEEEEEeccCCCch
Q 012170          118 SVWLCRSKASGAEFACKTLR--------KGEETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----CFHLVMELCSGGRL  184 (469)
Q Consensus       118 ~Vy~~~~~~~~~~vAvK~~~--------~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----~~~lV~E~~~gg~L  184 (469)
                      .||++-+...|.+|+--.+.        ...+....=..-|-++. |.|||+++.|+.+..     ...++.||++.|++
T Consensus        81 ~v~lamd~e~g~evvwneVq~~~rK~~~~qeek~~~vFdnllqlv-HsnlvkfH~yw~d~K~~e~~rviFiteymssgs~  159 (458)
T KOG1266|consen   81 DVYLAMDTEEGVEVVWNEVQFSERKNPKEQEEKRRAVFDNLLQLV-HSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL  159 (458)
T ss_pred             HHHHHhhhccCchhhHHHHHHHHhcChhhCHHHHHHHHHHHHHHH-HHHHHHHHHhhcccccccccceEEEEecccchhH
Confidence            45555555555555433221        11122222233344565 999999999886543     47899999999999


Q ss_pred             HHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccceeeec-----CCCcc
Q 012170          185 IDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMRIS-----NGQTL  253 (469)
Q Consensus       185 ~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla~~~~-----~~~~~  253 (469)
                      ..+|++.    ..+......+|+.||+.||.|||+..  |+|+++..+-|++..+|-||+.--.....-.     .....
T Consensus       160 ~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek  239 (458)
T KOG1266|consen  160 KQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEK  239 (458)
T ss_pred             HHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhh
Confidence            9998764    34778888999999999999999864  9999999999999999988876322111000     00011


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ..-.+-++|.|||.=.- +.+.++|||++|....+|..|..- -.+.+....-..|.+......       ..--+++|.
T Consensus       240 ~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le-------n~lqr~~i~  312 (458)
T KOG1266|consen  240 SVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE-------NGLQRGSIT  312 (458)
T ss_pred             hccccCCccccCCcCcccccccchhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc-------CccccCcCc
Confidence            22346788999996432 467789999999999999988753 444444444444544433222       223457899


Q ss_pred             HhchhhhcCCCCHHHHHcCCCc
Q 012170          332 RMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +||+..|..||+|.++|.||..
T Consensus       313 kcl~~eP~~rp~ar~llfHpll  334 (458)
T KOG1266|consen  313 KCLEGEPNGRPDARLLLFHPLL  334 (458)
T ss_pred             ccccCCCCCCcchhhhhcCcee
Confidence            9999999999999999999976

>KOG1243 consensus Protein kinase [General function prediction only]

Probab=99.41  E-value=4.7e-12  Score=131.65  Aligned_cols=165  Identities=20%  Similarity=0.330  Sum_probs=126.2

Q ss_pred             EEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCH
Q 012170          121 LCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE  196 (469)
Q Consensus       121 ~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~  196 (469)
                      .|..+.++.+|.|.+.+...    +...+-++-|+.++ ||||+++++.++.++.+|||+|-+.  .|..++.+.+   .
T Consensus        30 ~~t~k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlR-HP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~---~  103 (690)
T KOG1243|consen   30 DGTRKADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLR-HPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG---K  103 (690)
T ss_pred             ccceeccCCceEEEEEeCCCchhhHHHHHHHHHhhhcc-CchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH---H
Confidence            46667788888888876432    34677889999998 9999999999999999999999885  5555665544   6


Q ss_pred             HHHHHHHHHHHHHHHHHH-hcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-ccccCCCCcccCceeccCCCCC
Q 012170          197 QRAANIFKDVMWVIKYCH-DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGNYSE  274 (469)
Q Consensus       197 ~~~~~i~~qil~aL~yLH-~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~  274 (469)
                      ..+..-+.||+.||.||| +.+++|++|....|+|+..|+.||++|.++........ .....---.|..|+.+... .-
T Consensus       104 ~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s-~~  182 (690)
T KOG1243|consen  104 EEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS-EW  182 (690)
T ss_pred             HHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc-cc
Confidence            777788899999999997 66899999999999999999999999999865432221 1111112235555543211 13


Q ss_pred             ccchHHHHHHHHHHHhCC
Q 012170          275 KVDIWSAGVLLHALLVAA  292 (469)
Q Consensus       275 ~~DiwSlG~il~elltG~  292 (469)
                      ..|.|-|||++++++.|.
T Consensus       183 s~D~~~Lg~li~el~ng~  200 (690)
T KOG1243|consen  183 SIDSWGLGCLIEELFNGS  200 (690)
T ss_pred             chhhhhHHHHHHHHhCcc
Confidence            469999999999999883

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=99.37  E-value=7.2e-12  Score=111.85  Aligned_cols=127  Identities=27%  Similarity=0.371  Sum_probs=99.7

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEc-ccC-----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTL-RKG-----------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~-~~~-----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..+++|+-+.+|.+.+.  |..+++|.= .+.           .....+|+.+|.++. --.|...+-++.+.+...|+|
T Consensus         2 ~~i~~GAEa~i~~~~~~--g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~-~~GV~~P~v~dvD~~~~~I~m   78 (204)
T COG3642           2 DLIKQGAEAIIYLTDFL--GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAR-EAGVPVPIVYDVDPDNGLIVM   78 (204)
T ss_pred             chhhCCcceeEEeeecc--CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHH-HcCCCCCeEEEEcCCCCEEEE
Confidence            45789999999999764  555777753 221           245668999999997 556655555555667777999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ||++|..|.+.+...       ...+++.+-..+.-||..||+|+||.++||++..++ +.++||||+..
T Consensus        79 e~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642          79 EYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             EEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            999998888888664       256778888888999999999999999999997764 99999999964

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=99.32  E-value=1.3e-11  Score=115.77  Aligned_cols=136  Identities=21%  Similarity=0.325  Sum_probs=105.3

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCC-CCeeEEEEEEEeC---CeEEEEEecc
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGH-TGVVTLHSVYEEA---DCFHLVMELC  179 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~h-pnIv~l~~~~~~~---~~~~lV~E~~  179 (469)
                      +.||.|.++.||++.... |..|++|+....     ...+.+|+++++.+..+ .++++++.+....   +..++||||+
T Consensus         4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i   82 (223)
T cd05154           4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERV   82 (223)
T ss_pred             eecCCCccceEEEEEecC-CcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEe
Confidence            678999999999998753 688999998653     35688999999999742 3467777776654   3678999999


Q ss_pred             CCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------------------------------------------
Q 012170          180 SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD--------------------------------------------  215 (469)
Q Consensus       180 ~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------------------------------------------  215 (469)
                      +|.++.+.+.. ..+++.....++.+++.+|.+||+                                            
T Consensus        83 ~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  161 (223)
T cd05154          83 DGRVLRDRLLR-PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLL  161 (223)
T ss_pred             CCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHH
Confidence            99888665421 356666666777777777777763                                            


Q ss_pred             ------------cCeEeccCCCCcEEEcc--CCcEEEEeccceee
Q 012170          216 ------------MGVVHRDIKPENILLTT--SGKIKLADFGLAMR  246 (469)
Q Consensus       216 ------------~givHrDlkp~NILl~~--~~~vkL~DFgla~~  246 (469)
                                  ..++|+|++|.||+++.  ++.+.|+||+.+..
T Consensus       162 ~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~  206 (223)
T cd05154         162 RWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL  206 (223)
T ss_pred             HHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence                        24799999999999998  66789999998853

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>KOG3087 consensus Serine/threonine protein kinase [General function prediction only]

Probab=99.30  E-value=4.4e-11  Score=106.46  Aligned_cols=137  Identities=21%  Similarity=0.290  Sum_probs=106.7

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcc-c-----------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLR-K-----------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~-~-----------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+.+|-+|+-+.|+++.+.  |+.+.||.-. +           ...+..+|+++|.++. --.|.-..-+|.+...-.|
T Consensus        11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~-~~GI~~P~l~~~D~~~~~i   87 (229)
T KOG3087|consen   11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCR-ALGIPAPRLIFIDTYGGQI   87 (229)
T ss_pred             cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHH-HhCCCCceEEEEecCCCeE
Confidence            5688999999999999876  8888888632 2           1245778999999997 4466555556666666679


Q ss_pred             EEeccCC-CchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccceee
Q 012170          175 VMELCSG-GRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMR  246 (469)
Q Consensus       175 V~E~~~g-g~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgla~~  246 (469)
                      +|||++| .++.+++....  .........++++|-..+.-||.++|+|+||..+||++..+|.   +.|+|||++..
T Consensus        88 ~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen   88 YMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             EEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999987 46777776543  2333344789999999999999999999999999999987763   58999999854

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=99.18  E-value=2.2e-10  Score=104.89  Aligned_cols=123  Identities=27%  Similarity=0.368  Sum_probs=83.3

Q ss_pred             EEEEEEECCCCcEEEEEEcccC------------------------------hHHHHHHHHHHHHhhCC-CCeeEEEEEE
Q 012170          118 SVWLCRSKASGAEFACKTLRKG------------------------------EETVHREVEIMQHLSGH-TGVVTLHSVY  166 (469)
Q Consensus       118 ~Vy~~~~~~~~~~vAvK~~~~~------------------------------~~~~~~E~~il~~l~~h-pnIv~l~~~~  166 (469)
                      .||.|... .|..+|||+.+.+                              .....+|++.|.++... -++++++.+.
T Consensus         1 ~Vy~~~~~-~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~   79 (188)
T PF01163_consen    1 DVYHAIDP-DGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN   79 (188)
T ss_dssp             EEEEEEEC-TTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred             CEEEEECC-CCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence            48999875 4789999997431                              02356899999999743 2577777553


Q ss_pred             EeCCeEEEEEeccC--CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHH-HHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          167 EEADCFHLVMELCS--GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY-CHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       167 ~~~~~~~lV~E~~~--gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~y-LH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                        .  -+|||||++  |..+.. +... .++......++.+++..+.. +|..||+|+||.+.|||++++ .+.|+|||.
T Consensus        80 --~--~~ivME~I~~~G~~~~~-l~~~-~~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~q  152 (188)
T PF01163_consen   80 --R--NVIVMEYIGEDGVPLPR-LKDV-DLSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQ  152 (188)
T ss_dssp             --T--TEEEEE--EETTEEGGC-HHHC-GGGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTT
T ss_pred             --C--CEEEEEecCCCccchhh-HHhc-cccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEEecCc
Confidence              2  249999998  655543 4332 22245667788888885555 689999999999999999887 999999999


Q ss_pred             eeeec
Q 012170          244 AMRIS  248 (469)
Q Consensus       244 a~~~~  248 (469)
                      +....
T Consensus       153 av~~~  157 (188)
T PF01163_consen  153 AVDSS  157 (188)
T ss_dssp             EEETT
T ss_pred             ceecC
Confidence            97644

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification]

Probab=99.14  E-value=1.5e-09  Score=110.00  Aligned_cols=207  Identities=19%  Similarity=0.245  Sum_probs=156.2

Q ss_pred             CeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEE----eCCeEEEEEeccCC-CchHH
Q 012170          116 FGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYE----EADCFHLVMELCSG-GRLID  186 (469)
Q Consensus       116 ~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~----~~~~~~lV~E~~~g-g~L~~  186 (469)
                      -.+.|+|....+|..|++|.+.-.+    .....-+++++++. |+|||++.++|.    .+..+++|++|.++ ++|.+
T Consensus       289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~-h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d  367 (655)
T KOG3741|consen  289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLC-HTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYD  367 (655)
T ss_pred             cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhc-cCceeehhhhhhhhccCcceEEEEEecCCCCchHHH
Confidence            4578999999999999999993221    12345688999997 999999999987    34578999999986 56766


Q ss_pred             HHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          187 QMVEV---------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       187 ~l~~~---------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +.-..               ...+|..+|.++.|+..||.++|+.|+.-+-|.|.+||++.+-+++|.-.|.......+.
T Consensus       368 ~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~  447 (655)
T KOG3741|consen  368 LYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP  447 (655)
T ss_pred             HHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC
Confidence            54221               236789999999999999999999999999999999999998889998888776554333


Q ss_pred             cccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAV-FDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~-~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .             +-+.  --.+-|.=.||.++..|.||..- +........ +..|.           ..+|.+++++
T Consensus       448 ~-------------~~le--~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~-----------~~yS~D~rn~  501 (655)
T KOG3741|consen  448 T-------------EPLE--SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT-----------TTYSTDLRNV  501 (655)
T ss_pred             C-------------cchh--HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh-----------hhhhHHHHHH
Confidence            0             0010  12456888999999999999643 222222222 23332           3579999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcC
Q 012170          330 MARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~h  350 (469)
                      |.-+...++++ -+.+++|.|
T Consensus       502 v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  502 VEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHhcCccc-ccHHHHHHH
Confidence            99999999887 688888876

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=99.13  E-value=1.6e-09  Score=105.03  Aligned_cols=128  Identities=19%  Similarity=0.149  Sum_probs=94.9

Q ss_pred             CCeEEEEEEECCCCcEEEEEEcccCh---------------HHHHHHHHHHHHhhCCCC--eeEEEEEEEe-----CCeE
Q 012170          115 KFGSVWLCRSKASGAEFACKTLRKGE---------------ETVHREVEIMQHLSGHTG--VVTLHSVYEE-----ADCF  172 (469)
Q Consensus       115 ~~g~Vy~~~~~~~~~~vAvK~~~~~~---------------~~~~~E~~il~~l~~hpn--Iv~l~~~~~~-----~~~~  172 (469)
                      ....|+++..  .|+.|.||......               ..+.+|...+..|. .-+  ++.++.+++.     ...-
T Consensus        34 ~~rrvvr~~~--~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~-~~GIptP~pVa~~e~~~~~~~~~s  110 (268)
T PRK15123         34 EGRRTLRFEL--AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLH-EVGVDTMTGVAFGERGSNPATRTS  110 (268)
T ss_pred             CCceEEEEEE--CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHH-HcCCCCCCeeEEEEecCCCcccee
Confidence            3344666544  36788888653211               13779999999886 333  3445555543     2346


Q ss_pred             EEEEeccCCC-chHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-------CCcEEEEecc
Q 012170          173 HLVMELCSGG-RLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-------SGKIKLADFG  242 (469)
Q Consensus       173 ~lV~E~~~gg-~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-------~~~vkL~DFg  242 (469)
                      +||||++++. +|.+++..  ....+......++.+++..+.-||..||+|+||++.|||++.       ++.+.|+||+
T Consensus       111 ~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~  190 (268)
T PRK15123        111 FIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLH  190 (268)
T ss_pred             EEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECC
Confidence            7999999886 78887754  345667788899999999999999999999999999999975       4679999999


Q ss_pred             cee
Q 012170          243 LAM  245 (469)
Q Consensus       243 la~  245 (469)
                      .+.
T Consensus       191 r~~  193 (268)
T PRK15123        191 RAQ  193 (268)
T ss_pred             ccc
Confidence            885

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=99.08  E-value=1e-09  Score=103.75  Aligned_cols=133  Identities=26%  Similarity=0.334  Sum_probs=102.1

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--------------------------hHHHHHHHHHHHHhhCC-C
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------------------------EETVHREVEIMQHLSGH-T  157 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------------------------~~~~~~E~~il~~l~~h-p  157 (469)
                      +.++..||.|.-|.||.|.+. .|.++|||.-+-+                          .....+|.++|..|..+ -
T Consensus        93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~  171 (304)
T COG0478          93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV  171 (304)
T ss_pred             HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence            345689999999999999987 5899999975321                          13467899999999744 3


Q ss_pred             CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEE
Q 012170          158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       158 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vk  237 (469)
                      .|++.+++    +...+||||++|-.|...     +++.+.+..++..|+.-+.-+=..|+||+|+.+-||+++++|.+.
T Consensus       172 ~VP~P~~~----nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~dg~~~  242 (304)
T COG0478         172 KVPKPIAW----NRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTEDGDIV  242 (304)
T ss_pred             CCCCcccc----ccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecCCCEE
Confidence            57777654    455699999999766432     223455566666666666666689999999999999999999999


Q ss_pred             EEeccceeee
Q 012170          238 LADFGLAMRI  247 (469)
Q Consensus       238 L~DFgla~~~  247 (469)
                      ++||-.+...
T Consensus       243 vIDwPQ~v~~  252 (304)
T COG0478         243 VIDWPQAVPI  252 (304)
T ss_pred             EEeCcccccC
Confidence            9999887543

>KOG2137 consensus Protein kinase [Signal transduction mechanisms]

Probab=99.01  E-value=1.4e-10  Score=121.24  Aligned_cols=156  Identities=23%  Similarity=0.331  Sum_probs=113.1

Q ss_pred             HHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc----------ccCCCCcccCceeccCC-C
Q 012170          205 DVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS----------GLAGSPAYVAPEVLSGN-Y  272 (469)
Q Consensus       205 qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~----------~~~gt~~y~aPE~l~~~-~  272 (469)
                      +++.|+.|+|. .++||+.|.|++|.++.+|..||+-|+++..........          ...-...|.|||++.+. .
T Consensus       107 ~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~~  186 (700)
T KOG2137|consen  107 NVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTTN  186 (700)
T ss_pred             cccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccccc
Confidence            34489999995 589999999999999999999999999986544321111          11235579999999874 6


Q ss_pred             CCccchHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHcCcCCC-CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          273 SEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDF-HSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       273 ~~~~DiwSlG~il~ell-tG~~Pf~~~~~~~~~~~i~~~~~~~-~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.++|+||+|+++|.+. .|+.-+...+...... ........ .......++.++++=|.++|..++.-||++.+++.-
T Consensus       187 ~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~-~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp~~~~l~~~  265 (700)
T KOG2137|consen  187 TPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYS-FSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRPTLDLLLSI  265 (700)
T ss_pred             cccccceeeeeEEEEEecCCcchhhccCCcchhh-hhhcccccccccccccCcHHHHHHHHHHhcCCcccCcchhhhhcc
Confidence            78999999999999998 5665555432221111 11111111 111225789999999999999999999999999999


Q ss_pred             CCccccccccc
Q 012170          351 PWILFYTERTL  361 (469)
Q Consensus       351 p~~~~~~~~~~  361 (469)
                      |||....-+++
T Consensus       266 ~ff~D~~~~aL  276 (700)
T KOG2137|consen  266 PFFSDPGLKAL  276 (700)
T ss_pred             cccCCchhhhh
Confidence            99976544443

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.98  E-value=1.2e-08  Score=101.39  Aligned_cols=236  Identities=15%  Similarity=0.150  Sum_probs=157.7

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-HHHHHHHHHHHHhhCCCCeeEEEEEE-------EeCCeEEEEEecc
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-ETVHREVEIMQHLSGHTGVVTLHSVY-------EEADCFHLVMELC  179 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il~~l~~hpnIv~l~~~~-------~~~~~~~lV~E~~  179 (469)
                      .+.||+|+.+.+|-.-..   ...+.|++.+-- ..-.+-+..|.....||-+-.-+.+=       .......++|..+
T Consensus        16 gr~LgqGgea~ly~l~e~---~d~VAKIYh~Pppa~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflmP~v   92 (637)
T COG4248          16 GRPLGQGGEADLYTLGEV---RDQVAKIYHAPPPAAQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLMPKV   92 (637)
T ss_pred             CccccCCccceeeecchh---hchhheeecCCCchHHHHHHHHhccCCCCcchhhhhcccHHHhhCCCccceeEEecccC
Confidence            467999999999965332   123457775422 22223344455554566443312211       1223377889988


Q ss_pred             CCCch-HHHH---HH---hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          180 SGGRL-IDQM---VE---VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       180 ~gg~L-~~~l---~~---~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      .|..- .+++   .+   ...+.+.-+.++.+.|+.+..-||..|.+-+|+.++|+|+.+++.|.|.|-..-..-.++..
T Consensus        93 ~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~ng~~  172 (637)
T COG4248          93 SGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINANGTL  172 (637)
T ss_pred             CCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEcccceeeccCCce
Confidence            87532 2222   11   23467788999999999999999999999999999999999999999998654433345555


Q ss_pred             ccccCCCCcccCceecc-C-----CCCCccchHHHHHHHHHHHhC-CCCCCCCCH-----HHHHHHHHcCc---------
Q 012170          253 LSGLAGSPAYVAPEVLS-G-----NYSEKVDIWSAGVLLHALLVA-ALPFKGDSL-----EAVFDAIKNVK---------  311 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~-~-----~~~~~~DiwSlG~il~elltG-~~Pf~~~~~-----~~~~~~i~~~~---------  311 (469)
                      ....+|.+.|.+||.-. +     .-+...|.|.||+++++||.| ..||.|-..     ...-..|..+.         
T Consensus       173 ~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g~f~ya~~~~~  252 (637)
T COG4248         173 HLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHGRFAYASDQRR  252 (637)
T ss_pred             EecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcceeeechhccC
Confidence            66778999999999865 2     246679999999999999997 899976321     01111221111         


Q ss_pred             ---CCCCCCcccCCCHHHHHHHHHhchhh--hcCCCCHHH
Q 012170          312 ---LDFHSGVWETVSKPARDLMARMLTRD--VSARITADE  346 (469)
Q Consensus       312 ---~~~~~~~~~~~s~~~~~lI~~~L~~d--P~~Rpsa~e  346 (469)
                         .......|..+++++..|..+|+..-  +.-|||++.
T Consensus       253 g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a  292 (637)
T COG4248         253 GLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA  292 (637)
T ss_pred             CCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence               12223456778999999999998643  567999753

>KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms]

Probab=98.97  E-value=3e-11  Score=124.82  Aligned_cols=243  Identities=19%  Similarity=0.105  Sum_probs=175.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCC-eeEEEEEEEeCCeEEEEEeccCCC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG-VVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpn-Iv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      -+...+.+++|+++++++.+...+...+ .+++... ....-++++|.+++ ||| .+..++-++.++..+++|+++.++
T Consensus       243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~-l~~rl~~eLLdK~n-~P~~~v~~~~d~~~E~~~~i~~~i~s~~  319 (829)
T KOG0576|consen  243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT-LSRRLAIELLDKVN-NPNPVVRYLEDYDGEDYLWIPMRICSTG  319 (829)
T ss_pred             chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc-hhhHHHHHHHHHcc-CCCCcccccccCCcccccchhhhhhcCC
Confidence            4455677899999999999887765555 7776553 56677999999997 999 777888888889999999999987


Q ss_pred             -chHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCC
Q 012170          183 -RLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP  260 (469)
Q Consensus       183 -~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~  260 (469)
                       +....+ ...-.+.+-+...+.+.-+++++|||+.--+|||    ||+..+ +..++.||+....+.......+..+|+
T Consensus       320 rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~~~~t~~~~~  394 (829)
T KOG0576|consen  320 RSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTMKPRTAIGTP  394 (829)
T ss_pred             ccccccCChhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-cccccccccCCcccCcccccccCCCCC
Confidence             222211 1222344555667778888999999998888998    877755 689999999998776665667788999


Q ss_pred             cccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH-HHHHHHhchhhh
Q 012170          261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA-RDLMARMLTRDV  338 (469)
Q Consensus       261 ~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~-~~lI~~~L~~dP  338 (469)
                      .|+|||+..+ .+....|+|++|.-..+|.-|.+|-..  +......+-+....+....-...++.. .++...|+..-|
T Consensus       395 ~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~~--P~~~~~~~g~~p~s~~L~~~~aw~~~~~~~~~~~~~~g~P  472 (829)
T KOG0576|consen  395 EPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRSS--PPAVLPMIGNGPNSPMLTDKSAWSPVFHRDFPAPCLNGLP  472 (829)
T ss_pred             CCCCchhhcccccccCCCccCCCcchhhcCCCCCCCCC--CccccCCCCCCCCccccchhhhcCcccccCCcccccCCCC
Confidence            9999998865 589999999999988888888877543  111111111111111100000111122 258888999999


Q ss_pred             cCCCCHHHHHcCCCcccc
Q 012170          339 SARITADEVLRHPWILFY  356 (469)
Q Consensus       339 ~~Rpsa~elL~hp~~~~~  356 (469)
                      ..|+.+-.++.|.+|...
T Consensus       473 ~~pkv~mgacfsKvfngC  490 (829)
T KOG0576|consen  473 PTPKVHMGACFSKVFNGC  490 (829)
T ss_pred             CCCcchhhHHHHHHhccC
Confidence            999999999999888544

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.87  E-value=2.4e-08  Score=93.29  Aligned_cols=106  Identities=23%  Similarity=0.298  Sum_probs=86.7

Q ss_pred             hHHHHHHHHHHHHhhCCCC--eeEEEEEEEeC----CeEEEEEeccCCC-chHHHHHHhCCCCHHHHHHHHHHHHHHHHH
Q 012170          140 EETVHREVEIMQHLSGHTG--VVTLHSVYEEA----DCFHLVMELCSGG-RLIDQMVEVGQYSEQRAANIFKDVMWVIKY  212 (469)
Q Consensus       140 ~~~~~~E~~il~~l~~hpn--Iv~l~~~~~~~----~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qil~aL~y  212 (469)
                      .....+|...+..|. .-+  ++.++++.+..    ...+||+|+++|. +|.+++......+......++.+++..+.-
T Consensus        55 ~~ra~~E~~~~~~L~-~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~  133 (206)
T PF06293_consen   55 RSRAKREWRNLQRLR-EAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK  133 (206)
T ss_pred             chHHHHHHHHHHHHH-HcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence            356788999888886 333  45666666542    2458999999884 788888765557788889999999999999


Q ss_pred             HHhcCeEeccCCCCcEEEccCC---cEEEEeccceee
Q 012170          213 CHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMR  246 (469)
Q Consensus       213 LH~~givHrDlkp~NILl~~~~---~vkL~DFgla~~  246 (469)
                      ||..||+|+|+++.|||++.++   .+.|+||+.+..
T Consensus       134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            9999999999999999999887   899999998865

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>COG0661 AarF Predicted unusual protein kinase [General function prediction only]

Probab=98.84  E-value=2.3e-08  Score=104.76  Aligned_cols=139  Identities=24%  Similarity=0.327  Sum_probs=96.3

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------------------------------------------HHHH
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------------------------------------------ETVH  144 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------------------------------------------~~~~  144 (469)
                      +.|+.++-|.||+|+.+. |+.||||+.+.+-                                            -++.
T Consensus       131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~  209 (517)
T COG0661         131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR  209 (517)
T ss_pred             CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence            679999999999999885 9999999986531                                            0133


Q ss_pred             HHHHHHHHhh----CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHH-HHhCCCCHHHHHHHHHHHHHHHHHHHhcCeE
Q 012170          145 REVEIMQHLS----GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVV  219 (469)
Q Consensus       145 ~E~~il~~l~----~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l-~~~~~l~~~~~~~i~~qil~aL~yLH~~giv  219 (469)
                      +|..-+.+++    +.|+|.-..=+.+....-.|+|||++|-.+.+.. .+...++...+.....++.  +..+=..|++
T Consensus       210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~f--~~q~~~dgff  287 (517)
T COG0661         210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRAF--LRQLLRDGFF  287 (517)
T ss_pred             HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHHH--HHHHHhcCcc
Confidence            4555554443    3555544444444445566999999999888874 2224555444333332222  2233358999


Q ss_pred             eccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          220 HRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       220 HrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      |.|.+|.||+++.+|++.+.|||+...++..
T Consensus       288 HaDpHpGNi~v~~~g~i~~lDfGi~g~l~~~  318 (517)
T COG0661         288 HADPHPGNILVRSDGRIVLLDFGIVGRLDPK  318 (517)
T ss_pred             ccCCCccceEEecCCcEEEEcCcceecCCHH
Confidence            9999999999999999999999999776543

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.77  E-value=1.4e-07  Score=87.63  Aligned_cols=134  Identities=20%  Similarity=0.266  Sum_probs=91.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------------HHHHHHHHHHHHhhC--CCCeeEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------------ETVHREVEIMQHLSG--HTGVVTLHSV  165 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------------~~~~~E~~il~~l~~--hpnIv~l~~~  165 (469)
                      +..+|.+.+++-......|.+..-  +|..+++|..+...             ....+++..+..+..  -.....++.+
T Consensus        29 ~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~  106 (229)
T PF06176_consen   29 LDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLA  106 (229)
T ss_pred             HhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceee
Confidence            456788888888877777776654  47899999986532             123344444445531  2222232222


Q ss_pred             -----EEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          166 -----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       166 -----~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                           +......++||||++|..|.+...    +++    .+...|..++.-||+.|++|+|.+|.|++++.+ .++++|
T Consensus       107 ~ekk~~~~~~~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~-~i~iID  177 (229)
T PF06176_consen  107 AEKKIFRYTSSYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN-GIRIID  177 (229)
T ss_pred             eeeeeccceeEEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC-cEEEEE
Confidence                 223345679999999988866431    222    244667788999999999999999999999855 599999


Q ss_pred             cccee
Q 012170          241 FGLAM  245 (469)
Q Consensus       241 Fgla~  245 (469)
                      |+..+
T Consensus       178 ~~~k~  182 (229)
T PF06176_consen  178 TQGKR  182 (229)
T ss_pred             Ccccc
Confidence            98764

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>PRK09902 hypothetical protein; Provisional

Probab=98.73  E-value=2.3e-07  Score=85.80  Aligned_cols=132  Identities=22%  Similarity=0.229  Sum_probs=99.0

Q ss_pred             eccCCeEEEEEEECCCCcEEEEEEcc----------cChHHHHHHHHHHHHhhCC-CCeeEEEEEEE-e----CCeEEEE
Q 012170          112 GHGKFGSVWLCRSKASGAEFACKTLR----------KGEETVHREVEIMQHLSGH-TGVVTLHSVYE-E----ADCFHLV  175 (469)
Q Consensus       112 G~G~~g~Vy~~~~~~~~~~vAvK~~~----------~~~~~~~~E~~il~~l~~h-pnIv~l~~~~~-~----~~~~~lV  175 (469)
                      |+||-+.|+.....  |..|-+|.-.          -+...+.+|+..|++|... -.++++. ++. .    .-.-+||
T Consensus        27 ~rgG~SgV~r~~~~--g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV  103 (216)
T PRK09902         27 RRNGMSGVQCVERN--GKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV  103 (216)
T ss_pred             CCCCcceEEEEEeC--CcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence            56888888887654  4467788653          2457899999999999732 1255555 332 1    1236799


Q ss_pred             EeccCC-CchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc--EEEEeccceee
Q 012170          176 MELCSG-GRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK--IKLADFGLAMR  246 (469)
Q Consensus       176 ~E~~~g-g~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~--vkL~DFgla~~  246 (469)
                      +|-+.| -+|.+++...  .+.++.....++.+|+.++.-||..|+.|+|+.+.|||++.+|.  |.++||.-++.
T Consensus       104 Te~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        104 TEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             EEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            997764 4777777552  34577777899999999999999999999999999999987777  99999987754

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=98.71  E-value=2.9e-07  Score=87.19  Aligned_cols=132  Identities=19%  Similarity=0.203  Sum_probs=87.1

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCC-eeEEEEEEEeCCeEEEEEeccCCCc-h
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTG-VVTLHSVYEEADCFHLVMELCSGGR-L  184 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpn-Iv~l~~~~~~~~~~~lV~E~~~gg~-L  184 (469)
                      ..||.|..+.||+.    .|..+++|.....  ...+.+|.++++.+....- +++.+.+..+.+..++|||+++|.. +
T Consensus         7 ~~i~~G~t~~~y~~----~~~~~VlR~~~~~~~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~~   82 (226)
T TIGR02172         7 TQTGEGGNGESYTH----KTGKWMLKLYNPGFDKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRSF   82 (226)
T ss_pred             eeecCCCCcceeEe----cCCCEEEEeCCCCCCHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccch
Confidence            67899999999984    2556889998653  3568999999999974432 6788888888888899999999863 1


Q ss_pred             H--------------HHHHH-----h----CCCCHHH-HHHHHHH----------HHHH-HHHHH----hcCeEeccCCC
Q 012170          185 I--------------DQMVE-----V----GQYSEQR-AANIFKD----------VMWV-IKYCH----DMGVVHRDIKP  225 (469)
Q Consensus       185 ~--------------~~l~~-----~----~~l~~~~-~~~i~~q----------il~a-L~yLH----~~givHrDlkp  225 (469)
                      .              ..+..     +    ....... ...+..+          +... ..+|.    ...++|+|+.|
T Consensus        83 ~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~~  162 (226)
T TIGR02172        83 SRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQI  162 (226)
T ss_pred             hhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCCC
Confidence            1              11111     0    0111110 1111111          1111 12222    12478999999


Q ss_pred             CcEEEccCCcEEEEecccee
Q 012170          226 ENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       226 ~NILl~~~~~vkL~DFgla~  245 (469)
                      .||++++++ +.|+||+.+.
T Consensus       163 ~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       163 GNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             CcEEEcCCC-cEEEechhcC
Confidence            999999888 9999999884

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily

Probab=98.66  E-value=6.2e-07  Score=84.38  Aligned_cols=137  Identities=20%  Similarity=0.320  Sum_probs=85.5

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCC-CeeEEEEEEE---eCCeEEEEEeccCC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHT-GVVTLHSVYE---EADCFHLVMELCSG  181 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hp-nIv~l~~~~~---~~~~~~lV~E~~~g  181 (469)
                      ++.|+.|..+.||++....  ..+++|+....  ...+.+|+.+++.|..+. .+++++....   .....+++|++++|
T Consensus         2 i~~l~~G~~n~~~~v~~~~--~~~vlK~~~~~~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g   79 (239)
T PF01636_consen    2 IRPLSGGFSNRVYRVTTDD--GRYVLKFYRPPDAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPG   79 (239)
T ss_dssp             EEEEEESSSSEEEEEEETT--SEEEEEEESSHHHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESS
T ss_pred             CccCCCCCeeeEEEEEECC--cEEEEEEeCCCCCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEecc
Confidence            5789999999999998775  48999998664  467889999999997442 3667776443   33457899999999


Q ss_pred             CchHH----------------HHH---Hh-CC---CCH-H--------HHHHH------------HHHHHH-HHHHHH--
Q 012170          182 GRLID----------------QMV---EV-GQ---YSE-Q--------RAANI------------FKDVMW-VIKYCH--  214 (469)
Q Consensus       182 g~L~~----------------~l~---~~-~~---l~~-~--------~~~~i------------~~qil~-aL~yLH--  214 (469)
                      ..+..                .+.   .. ..   +.. .        .....            ...+.. .+..++  
T Consensus        80 ~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  159 (239)
T PF01636_consen   80 RPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEAL  159 (239)
T ss_dssp             EEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHhh
Confidence            87766                111   11 01   010 0        00000            111222 233333  


Q ss_pred             -----hcCeEeccCCCCcEEEc-cCCcEEEEeccceee
Q 012170          215 -----DMGVVHRDIKPENILLT-TSGKIKLADFGLAMR  246 (469)
Q Consensus       215 -----~~givHrDlkp~NILl~-~~~~vkL~DFgla~~  246 (469)
                           ...++|+|+.|.|||++ .++.+-|+||+.+..
T Consensus       160 ~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~  197 (239)
T PF01636_consen  160 LPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW  197 (239)
T ss_dssp             HHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred             hccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence                 24599999999999999 667778999998854

; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B ....

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=98.63  E-value=3.4e-07  Score=86.05  Aligned_cols=135  Identities=22%  Similarity=0.306  Sum_probs=96.4

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh----------------------------HHHHHHHHHHHHhh-CCCCe
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------------------------ETVHREVEIMQHLS-GHTGV  159 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------------------------~~~~~E~~il~~l~-~hpnI  159 (469)
                      ..|..|.-+.||+|.. .++..+|+|+++...                            .-..+|+.-|+++. .+=.+
T Consensus        54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv  132 (268)
T COG1718          54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV  132 (268)
T ss_pred             eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence            4677888899999975 458899999985321                            01345788788776 23446


Q ss_pred             eEEEEEEEeCCeEEEEEeccCCCch-HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEE
Q 012170          160 VTLHSVYEEADCFHLVMELCSGGRL-IDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       160 v~l~~~~~~~~~~~lV~E~~~gg~L-~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vk  237 (469)
                      ++.+.+...    .|||||+....+ .-.|.. -++...++..+..+++..+.-|=. .|+||+||..-|||+. ++.+.
T Consensus       133 P~Pi~~~~n----VLvMEfIg~~g~pAP~LkD-v~~e~~e~~~~~~~~v~~~~~l~~~a~LVHgDLSEyNiL~~-~~~p~  206 (268)
T COG1718         133 PEPIAFRNN----VLVMEFIGDDGLPAPRLKD-VPLELEEAEGLYEDVVEYMRRLYKEAGLVHGDLSEYNILVH-DGEPY  206 (268)
T ss_pred             CCceeecCC----eEEEEeccCCCCCCCCccc-CCcCchhHHHHHHHHHHHHHHHHHhcCcccccchhhheEEE-CCeEE
Confidence            667766542    499999964311 112222 233344788888899988887766 8999999999999999 88999


Q ss_pred             EEeccceeeecCC
Q 012170          238 LADFGLAMRISNG  250 (469)
Q Consensus       238 L~DFgla~~~~~~  250 (469)
                      |+|||.|....++
T Consensus       207 iID~~QaV~~~hp  219 (268)
T COG1718         207 IIDVSQAVTIDHP  219 (268)
T ss_pred             EEECccccccCCC
Confidence            9999999765533

>KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis]

Probab=98.63  E-value=2.6e-07  Score=102.05  Aligned_cols=202  Identities=20%  Similarity=0.252  Sum_probs=148.0

Q ss_pred             HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE----EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012170          142 TVHREVEIMQHLSGHTGVVTLHSVYEEADCF----HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG  217 (469)
Q Consensus       142 ~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~----~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g  217 (469)
                      ...-|...+.++. |+|++.++.+-......    .+..++|...++...+..-+..+...++.+..+++.||.|+|+..
T Consensus       228 ~~E~e~~~l~k~~-~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h~~~  306 (1351)
T KOG1035|consen  228 TTEIELESLSKIA-HDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLHSLS  306 (1351)
T ss_pred             HHHHHHHHHHhhc-cccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHHHhc
Confidence            3455777788886 99999999886544332    345579999999999999999999999999999999999999996


Q ss_pred             eEeccCCCC---cEEEccCCcEEEE--eccceeeecCCCcccccCCCCcccCceeccCC-C--CCccchHHHHHHHHHHH
Q 012170          218 VVHRDIKPE---NILLTTSGKIKLA--DFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-Y--SEKVDIWSAGVLLHALL  289 (469)
Q Consensus       218 ivHrDlkp~---NILl~~~~~vkL~--DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~--~~~~DiwSlG~il~ell  289 (469)
                      ..|.-|...   +-.++..+.+.++  ||+......+........-+..|.+||....+ +  ....|+|.+|..+..+.
T Consensus       307 l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~  386 (1351)
T KOG1035|consen  307 LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLS  386 (1351)
T ss_pred             cceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHhhhh
Confidence            666555554   4444555667766  89888776665554445566778889888654 3  33469999999999998


Q ss_pred             hCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          290 VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       290 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .|..+-...   .+...+..          .....+..+++.+|+..++++|+++.+++.|||.....
T Consensus       387 ~~~~i~~~~---~~~~~~l~----------~~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~  441 (1351)
T KOG1035|consen  387 QGEDISEKS---AVPVSLLD----------VLSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPT  441 (1351)
T ss_pred             hcCcccccc---cchhhhhc----------cccchhhhhhhhhhcchhhhhccchhhhhhchhccccc
Confidence            876543211   11111100          11122788999999999999999999999999986554

>COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms]

Probab=98.61  E-value=2.1e-07  Score=82.91  Aligned_cols=128  Identities=20%  Similarity=0.236  Sum_probs=94.2

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCch
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL  184 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L  184 (469)
                      ..+.||+|.+|.||+|.+.  |..+|+|+-+.+  ...+..|+++|..+.+-.--+++|.+..+.    +.|||+.|-.|
T Consensus        26 v~~~L~KG~~s~Vyl~~~~--~~~~a~Kvrr~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~~----i~me~i~G~~L   99 (201)
T COG2112          26 VEKELAKGTTSVVYLGEWR--GGEVALKVRRRDSPRRNLEKEAKILEILAGEGVTPEVYFYGEDF----IRMEYIDGRPL   99 (201)
T ss_pred             hhhhhhcccccEEEEeecc--CceEEEEEecCCcchhhHHHHHHHHHHhhhcCCCceEEEechhh----hhhhhhcCcch
Confidence            3578999999999999887  679999988654  467999999999998555556777765543    56999999888


Q ss_pred             HHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCC-CCcEEEccCCcEEEEeccceeee
Q 012170          185 IDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK-PENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       185 ~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlk-p~NILl~~~~~vkL~DFgla~~~  247 (469)
                      .+.-...   .    ..-+..+++.-.-|-..||-|..|. |..++|-.++.+.|+||..|+.-
T Consensus       100 ~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~~~~iIDFd~At~k  156 (201)
T COG2112         100 GKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDRDVYIIDFDSATFK  156 (201)
T ss_pred             hhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence            6654211   2    2234455566566778899999987 44444445559999999999743

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=98.50  E-value=1.8e-06  Score=82.68  Aligned_cols=134  Identities=17%  Similarity=0.168  Sum_probs=87.0

Q ss_pred             eeeccCC-eEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHH
Q 012170          110 VIGHGKF-GSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQ  187 (469)
Q Consensus       110 ~lG~G~~-g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~  187 (469)
                      .|-.|.. +.||++...  +..+.+|+.... ...+.+|+++++.+..+--+++++.+...++..++|||+++|.++...
T Consensus         5 ~~~~g~~~~~v~~~~~~--~~~~~vk~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~   82 (244)
T cd05150           5 RVTEGQSGATVYRLDGK--NPGLYLKIAPSGPTYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL   82 (244)
T ss_pred             ecCCCCCcCeEEEEcCC--CCcEEEEecCCCcccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence            3445555 789998653  467899988542 245788999999998665577888888877778899999999766532


Q ss_pred             H----------------HHhC-------CCCHH---HHHHH---HH----------------HHHHHHHHH-------Hh
Q 012170          188 M----------------VEVG-------QYSEQ---RAANI---FK----------------DVMWVIKYC-------HD  215 (469)
Q Consensus       188 l----------------~~~~-------~l~~~---~~~~i---~~----------------qil~aL~yL-------H~  215 (469)
                      .                .+-.       ++...   .....   +.                .+...+..|       ..
T Consensus        83 ~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~  162 (244)
T cd05150          83 WEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAEED  162 (244)
T ss_pred             hcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCcCc
Confidence            1                0000       11100   00000   00                011112222       12


Q ss_pred             cCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          216 MGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       216 ~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ..++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             eEEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            349999999999999998778899999874

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>KOG1235 consensus Predicted unusual protein kinase [General function prediction only]

Probab=98.48  E-value=8e-07  Score=93.10  Aligned_cols=136  Identities=24%  Similarity=0.276  Sum_probs=90.3

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----------------------------------HHHHHHHHHHH--
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------------------------------ETVHREVEIMQ--  151 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----------------------------------~~~~~E~~il~--  151 (469)
                      +.||..+.|.||+|+.+. |+.||||+-+.+-                                   +.+..|+..++  
T Consensus       167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA  245 (538)
T KOG1235|consen  167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA  245 (538)
T ss_pred             chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence            579999999999999886 9999999976431                                   11222333322  


Q ss_pred             ----Hhh---CCCC------eeEEEEEEEeCCeEEEEEeccCCCchHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhcC
Q 012170          152 ----HLS---GHTG------VVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMG  217 (469)
Q Consensus       152 ----~l~---~hpn------Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~g  217 (469)
                          +++   .|-+      |+++|..+.  ..-.|+||||+|..+.|.-. +...++...+...+.++..  .-+=..|
T Consensus       246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~--~qIf~~G  321 (538)
T KOG1235|consen  246 KNAERFRENFKDFSLLTYVLVPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYL--EQIFKTG  321 (538)
T ss_pred             HhHHHHHHHHHhcccccceeCCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHH--HHHHhcC
Confidence                221   1444      555554443  34569999999988766431 2334555544444333322  2333678


Q ss_pred             eEeccCCCCcEEEcc----CCcEEEEeccceeeecC
Q 012170          218 VVHRDIKPENILLTT----SGKIKLADFGLAMRISN  249 (469)
Q Consensus       218 ivHrDlkp~NILl~~----~~~vkL~DFgla~~~~~  249 (469)
                      ++|.|=+|.||+++.    ++.+.+.|||+...+..
T Consensus       322 ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is~  357 (538)
T KOG1235|consen  322 FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVISH  357 (538)
T ss_pred             CccCCCCCCcEEEecCCCCCccEEEEcccccccccH
Confidence            999999999999994    56899999999976653

>PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2

Probab=98.43  E-value=8.6e-06  Score=74.90  Aligned_cols=122  Identities=26%  Similarity=0.395  Sum_probs=90.2

Q ss_pred             CCeeeeeeeeccCC-eEEEEEEECCCCcEEEEEEccc--------------C-----------hHHHHHHHHHHHHhhC-
Q 012170          103 DDHTKVEVIGHGKF-GSVWLCRSKASGAEFACKTLRK--------------G-----------EETVHREVEIMQHLSG-  155 (469)
Q Consensus       103 ~~y~~~~~lG~G~~-g~Vy~~~~~~~~~~vAvK~~~~--------------~-----------~~~~~~E~~il~~l~~-  155 (469)
                      .+++.++.||.|.. |.||++...  |..||+|+++.              .           ...+..|.+..-+|.. 
T Consensus        37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~  114 (207)
T PF13095_consen   37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA  114 (207)
T ss_pred             CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence            78999999999999 999999876  78999999321              0           0235678777776652 


Q ss_pred             -CCCe--eEEEEEEEeC------------------CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH
Q 012170          156 -HTGV--VTLHSVYEEA------------------DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH  214 (469)
Q Consensus       156 -hpnI--v~l~~~~~~~------------------~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH  214 (469)
                       +.++  |+.+++..-.                  -.+.||.||++...         .++..    -+.+|++-+.-+|
T Consensus       115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~----~~~~~~~dl~~~~  181 (207)
T PF13095_consen  115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIR----DIPQMLRDLKILH  181 (207)
T ss_pred             cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchh----HHHHHHHHHHHHH
Confidence             4455  8999987322                  12468888887654         22233    3456777788999


Q ss_pred             hcCeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          215 DMGVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       215 ~~givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      ..||+-+|+++.|..     .-+|+|||.+
T Consensus       182 k~gI~~~Dv~~~ny~-----~G~lvDfs~~  206 (207)
T PF13095_consen  182 KLGIVPRDVKPRNYR-----GGKLVDFSSS  206 (207)
T ss_pred             HCCeeeccCcccccc-----CCEEEecccC
Confidence            999999999999976     3589999875

>PLN02876 acyl-CoA dehydrogenase

Probab=98.36  E-value=5.5e-06  Score=93.06  Aligned_cols=139  Identities=21%  Similarity=0.428  Sum_probs=91.3

Q ss_pred             eeeeeccCCeEEEEEEECCCC--cEEEEEEccc-----ChHHHHHHHHHHHHhhCCCCe--eEEEEEEEeC---CeEEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASG--AEFACKTLRK-----GEETVHREVEIMQHLSGHTGV--VTLHSVYEEA---DCFHLV  175 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~--~~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnI--v~l~~~~~~~---~~~~lV  175 (469)
                      ++.|+.|.++.+|+......+  ..+++|+...     ....+.+|+++|+.|..|++|  ++++.++.+.   +..|+|
T Consensus        43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV  122 (822)
T PLN02876         43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI  122 (822)
T ss_pred             EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence            577899999999998765432  4688887643     235688999999999656654  7888887664   467899


Q ss_pred             EeccCCCchHH--------------------HHHHhCC----------------CCHHHHHHHHHH--------------
Q 012170          176 MELCSGGRLID--------------------QMVEVGQ----------------YSEQRAANIFKD--------------  205 (469)
Q Consensus       176 ~E~~~gg~L~~--------------------~l~~~~~----------------l~~~~~~~i~~q--------------  205 (469)
                      |||++|..+.+                    .+..-..                +...++..|..+              
T Consensus       123 ME~v~G~~~~~~~~~~~~~~~r~~l~~~l~~~La~LH~vd~~~~gl~~~g~~~~~~~~~l~~w~~~~~~~~~~~~~~~~~  202 (822)
T PLN02876        123 MEYLEGRIFVDPKLPGVAPERRRAIYRATAKVLAALHSADVDAIGLGKYGRRDNYCKRQVERWAKQYLASTGEGKPPRNP  202 (822)
T ss_pred             EEecCCcccCCccCCCCCHHHHHHHHHHHHHHHHHHhCCCchhcChhhcCCCCchHHHHHHHHHHHHHHhhcccCCCCCh
Confidence            99999864321                    1110000                111233322222              


Q ss_pred             -HHHHHHHHHh-----------cCeEeccCCCCcEEEccC-Cc-EEEEeccceee
Q 012170          206 -VMWVIKYCHD-----------MGVVHRDIKPENILLTTS-GK-IKLADFGLAMR  246 (469)
Q Consensus       206 -il~aL~yLH~-----------~givHrDlkp~NILl~~~-~~-vkL~DFgla~~  246 (469)
                       +...+.+|..           ..+||+|+++.|||++.+ +. +-|.||+++..
T Consensus       203 ~~~~l~~wL~~~~P~~~~~~~~~~LvHGD~~~~Nvl~~~~~~~v~aVLDWE~a~~  257 (822)
T PLN02876        203 KMLELIDWLRENIPAEDSTGAGTGIVHGDFRIDNLVFHPTEDRVIGILDWELSTL  257 (822)
T ss_pred             hHHHHHHHHHhcCCCccccCCCcceEecCcccccEEEcCCCCeEEEEEeeecccc
Confidence             2233556632           359999999999999853 34 57999998854

>cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes

Probab=98.22  E-value=1.4e-05  Score=75.82  Aligned_cols=73  Identities=18%  Similarity=0.204  Sum_probs=52.3

Q ss_pred             eeeeeccCCeEEEEEEECC-CCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          108 VEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      ++.|..|-...||++.... .+..|++|+.....   ....+|+.+++.+..+.-.++++..+..    .+||||++|.+
T Consensus         3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~~~d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i~G~~   78 (235)
T cd05157           3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTELIIDRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFIPGRT   78 (235)
T ss_pred             EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccceecHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEeeCCCc
Confidence            4678888889999997543 35789999886532   2345899999999755555666655432    37999999866


Q ss_pred             h
Q 012170          184 L  184 (469)
Q Consensus       184 L  184 (469)
                      +
T Consensus        79 l   79 (235)
T cd05157          79 L   79 (235)
T ss_pred             C
Confidence            5

ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo

>cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members

Probab=98.21  E-value=8.4e-06  Score=77.63  Aligned_cols=71  Identities=15%  Similarity=0.141  Sum_probs=48.3

Q ss_pred             eeeeccCCe-EEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCC--CeeEEEEEEEeC---CeEEEEEeccC
Q 012170          109 EVIGHGKFG-SVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHT--GVVTLHSVYEEA---DCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hp--nIv~l~~~~~~~---~~~~lV~E~~~  180 (469)
                      +.|+.|+.. .||+.     +..+++|+....  ...+.+|+++|..|..+-  -++++++.....   ...|+||++++
T Consensus         3 ~~~~~gG~~n~vy~~-----~~~~VlR~~~~~~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~   77 (235)
T cd05155           3 EPVDSGGTDNATFRL-----GDDMSVRLPSAAGYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLE   77 (235)
T ss_pred             eeccCCCcccceEEc-----CCceEEEcCCccchHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeec
Confidence            567766666 59976     235888987652  357889999999987431  355555554332   23578999999


Q ss_pred             CCch
Q 012170          181 GGRL  184 (469)
Q Consensus       181 gg~L  184 (469)
                      |.++
T Consensus        78 G~~l   81 (235)
T cd05155          78 GETA   81 (235)
T ss_pred             CCCC
Confidence            9666

The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista

>PRK09550 mtnK methylthioribose kinase; Reviewed

Probab=98.20  E-value=6.6e-05  Score=76.75  Aligned_cols=74  Identities=18%  Similarity=0.150  Sum_probs=54.8

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEccc-----------ChHHHHHHHHHHHHhhCC--CCeeEEEEEEEeCCeEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----------GEETVHREVEIMQHLSGH--TGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----------~~~~~~~E~~il~~l~~h--pnIv~l~~~~~~~~~~~l  174 (469)
                      .+.||.|.+..||++.....++.|+||.-..           ..+....|.+.|+.+..+  .++++++.+  +.+..++
T Consensus        31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l  108 (401)
T PRK09550         31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT  108 (401)
T ss_pred             eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence            3679999999999999865446899998431           234567899999887543  457778777  3455679


Q ss_pred             EEeccCCCc
Q 012170          175 VMELCSGGR  183 (469)
Q Consensus       175 V~E~~~gg~  183 (469)
                      ||||+++..
T Consensus       109 VME~L~~~~  117 (401)
T PRK09550        109 VMEDLSDHK  117 (401)
T ss_pred             EEecCCCcc
Confidence            999998743

>PRK10593 hypothetical protein; Provisional

Probab=98.18  E-value=3.4e-05  Score=76.20  Aligned_cols=76  Identities=17%  Similarity=0.179  Sum_probs=58.5

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCC--CCeeEEEEEEEe---CCeEEEEEecc
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGH--TGVVTLHSVYEE---ADCFHLVMELC  179 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~h--pnIv~l~~~~~~---~~~~~lV~E~~  179 (469)
                      -.+.||.|..+.||.....+ + .+.+|..+..  ...+..|...|+.|..+  -.++++++++.+   .+..+||||++
T Consensus        18 ~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i   95 (297)
T PRK10593         18 RVECISEQPYAALWALYDSQ-G-NPMPLMARSFSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERL   95 (297)
T ss_pred             eeeecCCccceeEEEEEcCC-C-CEEEEEecccccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEecc
Confidence            35789999999999986432 3 5777886542  35889999999999754  358889988754   36689999999


Q ss_pred             CCCch
Q 012170          180 SGGRL  184 (469)
Q Consensus       180 ~gg~L  184 (469)
                      +|+++
T Consensus        96 ~G~~~  100 (297)
T PRK10593         96 RGVSV  100 (297)
T ss_pred             CCEec
Confidence            98754

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=98.13  E-value=6.9e-05  Score=69.32  Aligned_cols=124  Identities=22%  Similarity=0.326  Sum_probs=92.2

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------------------HHHHHHHHHHHHhh-----CCCCeeEEE
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------------------ETVHREVEIMQHLS-----GHTGVVTLH  163 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------------------~~~~~E~~il~~l~-----~hpnIv~l~  163 (469)
                      ..||+|+.-.||.-  . ......||+.....                    ....+|+.....+.     .+.+|.+++
T Consensus         7 ~~i~~G~~R~cy~H--P-~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~   83 (199)
T PF10707_consen    7 DLIAQGGERDCYQH--P-DDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRFY   83 (199)
T ss_pred             cccccCCCceEEEC--C-CCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccEe
Confidence            57999999999954  3 24457889886544                    56677887776664     267899999


Q ss_pred             EEEEeCCeEEEEEeccCC------CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---
Q 012170          164 SVYEEADCFHLVMELCSG------GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---  234 (469)
Q Consensus       164 ~~~~~~~~~~lV~E~~~g------g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---  234 (469)
                      ++.+++-...+|+|.+..      -+|.+++ ..+.+++ ...   ..+-+-..||-+++|+.+||+|.||++...+   
T Consensus        84 G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l-~~~~~~~-~~~---~~L~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~  158 (199)
T PF10707_consen   84 GFVETNLGLGLVVELIRDADGNISPTLEDYL-KEGGLTE-ELR---QALDEFKRYLLDHHIVIRDLNPHNIVVQRRDSGE  158 (199)
T ss_pred             EEEecCCceEEEEEEEECCCCCcCccHHHHH-HcCCccH-HHH---HHHHHHHHHHHHcCCeecCCCcccEEEEecCCCc
Confidence            999999999999998753      2566666 4556666 333   3344456788999999999999999996543   


Q ss_pred             -cEEEEe
Q 012170          235 -KIKLAD  240 (469)
Q Consensus       235 -~vkL~D  240 (469)
                       .+.|+|
T Consensus       159 ~~lvlID  165 (199)
T PF10707_consen  159 FRLVLID  165 (199)
T ss_pred             eEEEEEe
Confidence             578887

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only]

Probab=98.11  E-value=2.8e-06  Score=82.56  Aligned_cols=134  Identities=23%  Similarity=0.296  Sum_probs=100.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh--------------------------HHHHHHHHHHHHhhCCC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--------------------------ETVHREVEIMQHLSGHT  157 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--------------------------~~~~~E~~il~~l~~hp  157 (469)
                      -+.+++.||-|.-+.||.+.+. .|.++++|+-+-++                          -...+|+..|+.|..|.
T Consensus        93 v~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~g  171 (465)
T KOG2268|consen   93 VESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERG  171 (465)
T ss_pred             hhhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcC
Confidence            3566789999999999999876 48899999743211                          23457999999997553


Q ss_pred             C-eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          158 G-VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       158 n-Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      . |++.+++    +..++|||++.|-.|...-      ....+..+...++.-+--|-.+|+||+|+.-=||+|++++.+
T Consensus       172 fpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm~~Iv~la~~GlIHgDFNEFNimv~dd~~i  241 (465)
T KOG2268|consen  172 FPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLMGLIVRLANHGLIHGDFNEFNIMVKDDDKI  241 (465)
T ss_pred             CCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHHHHHHHHHHcCceecccchheeEEecCCCE
Confidence            3 5555544    4577999999987774422      122344566666677778889999999999999999999999


Q ss_pred             EEEeccceeeec
Q 012170          237 KLADFGLAMRIS  248 (469)
Q Consensus       237 kL~DFgla~~~~  248 (469)
                      +++||-.+...+
T Consensus       242 ~vIDFPQmvS~s  253 (465)
T KOG2268|consen  242 VVIDFPQMVSTS  253 (465)
T ss_pred             EEeechHhhccC
Confidence            999998765443

>TIGR02721 ycfN_thiK thiamine kinase

Probab=98.09  E-value=1.7e-05  Score=76.50  Aligned_cols=130  Identities=22%  Similarity=0.287  Sum_probs=80.3

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccChH----HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchH
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEE----TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLI  185 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~----~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~  185 (469)
                      .+..|-.+.+|+..  .++..+++|+......    ...+|..+++.+..+.-.++++....    -++||||++|..+.
T Consensus         3 ~~~~G~tn~~y~~~--~~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~   76 (256)
T TIGR02721         3 TLSGGLTNRSWRIE--HPGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVIT   76 (256)
T ss_pred             cCCCcCcCCeEEEE--eCCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCcccc
Confidence            35568888999886  3467899998754322    45789999999975433455555432    25899999986653


Q ss_pred             HH----------H----HH---hC----CCCH-HHHHHHHHHH---------HHHHHHHHh--------cCeEeccCCCC
Q 012170          186 DQ----------M----VE---VG----QYSE-QRAANIFKDV---------MWVIKYCHD--------MGVVHRDIKPE  226 (469)
Q Consensus       186 ~~----------l----~~---~~----~l~~-~~~~~i~~qi---------l~aL~yLH~--------~givHrDlkp~  226 (469)
                      ..          +    .+   ..    +++. ..+..+..++         ...+..+-.        ..++|+|+.|.
T Consensus        77 ~~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~  156 (256)
T TIGR02721        77 LDQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAY  156 (256)
T ss_pred             cccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcC
Confidence            11          1    11   00    1111 1222222121         111222221        25899999999


Q ss_pred             cEEEccCCcEEEEeccceee
Q 012170          227 NILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       227 NILl~~~~~vkL~DFgla~~  246 (469)
                      ||+++.++ +.|+||..+..
T Consensus       157 Nil~~~~~-~~lIDwE~a~~  175 (256)
T TIGR02721       157 NLVVTPQG-LKLIDWEYASD  175 (256)
T ss_pred             cEEEeCCC-CEEEeccccCc
Confidence            99999877 78999998843

Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function.

>cd05153 HomoserineK_II Homoserine Kinase, type II

Probab=98.04  E-value=5.5e-05  Score=74.49  Aligned_cols=136  Identities=16%  Similarity=0.160  Sum_probs=87.0

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHHhhCCC-CeeEEEEE------EEeCCeEEEEEecc
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQHLSGHT-GVVTLHSV------YEEADCFHLVMELC  179 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~l~~hp-nIv~l~~~------~~~~~~~~lV~E~~  179 (469)
                      ++.|..|....+|++...  +..+++|+... ....+..|+.++..|..+- .+++++..      ....+..++|++|+
T Consensus        19 i~~i~~G~~n~~y~v~~~--~~~~vLr~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i   96 (296)
T cd05153          19 FEGISAGIENTNYFVTTD--SGRYVLTLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFL   96 (296)
T ss_pred             eecccCccccceEEEEeC--CCcEEEEEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeC
Confidence            567888888899998643  45799999874 3466788999999996332 25555442      23455678999999


Q ss_pred             CCCchHH----H---H-------HHh-CCCCH--------HHHH------------HHHHHHHHHHHHHHh-------cC
Q 012170          180 SGGRLID----Q---M-------VEV-GQYSE--------QRAA------------NIFKDVMWVIKYCHD-------MG  217 (469)
Q Consensus       180 ~gg~L~~----~---l-------~~~-~~l~~--------~~~~------------~i~~qil~aL~yLH~-------~g  217 (469)
                      +|..+..    .   +       ... ..+..        ....            .....+..++.++..       .+
T Consensus        97 ~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~  176 (296)
T cd05153          97 AGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRG  176 (296)
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCc
Confidence            9866421    0   1       100 00100        0000            011122334445443       47


Q ss_pred             eEeccCCCCcEEEccCCcEEEEecccee
Q 012170          218 VVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       218 ivHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ++|+|+.|.|||++.++.+.|+||+.+.
T Consensus       177 l~HgD~~~~Nil~~~~~~~~iIDfe~a~  204 (296)
T cd05153         177 VIHADLFRDNVLFDGDELSGVIDFYFAC  204 (296)
T ss_pred             CCccCcCcccEEEeCCceEEEeehhhhc
Confidence            9999999999999988777899999884

Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine.

>cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes

Probab=97.93  E-value=7.9e-05  Score=73.67  Aligned_cols=74  Identities=15%  Similarity=0.142  Sum_probs=52.9

Q ss_pred             eeeeeccCCeEEEEEEECC------CCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          108 VEVIGHGKFGSVWLCRSKA------SGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~------~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ++.|..|-...||++....      ++..|++|+.....   ....+|++++..+..+.-.++++.++..    .+|+||
T Consensus         3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~   78 (302)
T cd05156           3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF   78 (302)
T ss_pred             EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCcceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence            3566677778999887543      36789999986532   4568899999999755445667766642    368999


Q ss_pred             cCCCchH
Q 012170          179 CSGGRLI  185 (469)
Q Consensus       179 ~~gg~L~  185 (469)
                      ++|..+.
T Consensus        79 i~G~~l~   85 (302)
T cd05156          79 IPSRTLT   85 (302)
T ss_pred             eCCCcCC
Confidence            9987653

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer

>TIGR00938 thrB_alt homoserine kinase, Neisseria type

Probab=97.92  E-value=9.3e-05  Score=73.44  Aligned_cols=136  Identities=18%  Similarity=0.190  Sum_probs=84.8

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCC-CeeEEEEE------EEeCCeEEEEEec
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHT-GVVTLHSV------YEEADCFHLVMEL  178 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hp-nIv~l~~~------~~~~~~~~lV~E~  178 (469)
                      ++.++.|....||++...  +..+++|+....  ...+..|++++..|..+- .+++++..      ....+..++||+|
T Consensus        27 i~~~~~G~~n~~y~v~t~--~~~~vLK~~~~~~~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e~  104 (307)
T TIGR00938        27 LKGIAEGVENSNYLLTTD--VGRYILTLYEKRVKAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVEF  104 (307)
T ss_pred             ccccCCccccceEEEEeC--CCcEEEEEecCCCCHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEEe
Confidence            566778888899988643  346889987653  466778899998886321 24455442      2235667899999


Q ss_pred             cCCCchH----HH----------HHHh-CCCC--------HHH-----HH----------HHHHHHHHHHHHHH------
Q 012170          179 CSGGRLI----DQ----------MVEV-GQYS--------EQR-----AA----------NIFKDVMWVIKYCH------  214 (469)
Q Consensus       179 ~~gg~L~----~~----------l~~~-~~l~--------~~~-----~~----------~i~~qil~aL~yLH------  214 (469)
                      ++|..+.    +.          +... ..++        ...     ..          .....+...++++.      
T Consensus       105 i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~~  184 (307)
T TIGR00938       105 LQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPRD  184 (307)
T ss_pred             CCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhhc
Confidence            9985431    10          1110 1110        000     00          00112233455553      


Q ss_pred             -hcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          215 -DMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       215 -~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                       ..+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       185 ~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~  216 (307)
T TIGR00938       185 LPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC  216 (307)
T ss_pred             CCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence             2689999999999999998877899999874

Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase.

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.91  E-value=3.8e-05  Score=70.57  Aligned_cols=100  Identities=19%  Similarity=0.212  Sum_probs=81.4

Q ss_pred             HHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHH---HHHhCCCCHHHHHHHHHHHHHHHHHHHh---cC
Q 012170          144 HREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQ---MVEVGQYSEQRAANIFKDVMWVIKYCHD---MG  217 (469)
Q Consensus       144 ~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~---l~~~~~l~~~~~~~i~~qil~aL~yLH~---~g  217 (469)
                      ..|.-+|+.+.+.+++++++|++-.    ++|.||...+++...   +..--..++.....|+.+++..+.+|+.   ..
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~   82 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF   82 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence            3588899999866799999999843    479999987766421   2222345889999999999999999997   45


Q ss_pred             eEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          218 VVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       218 ivHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      +.-.|++|+|+-++++|++|++|...+...
T Consensus        83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            889999999999999999999999887543

Proteins in this uncharacterised family are described as transmembrane proteins.

>KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms]

Probab=97.79  E-value=2.3e-06  Score=96.53  Aligned_cols=206  Identities=13%  Similarity=-0.000  Sum_probs=143.1

Q ss_pred             HHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhc
Q 012170          143 VHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDM  216 (469)
Q Consensus       143 ~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~  216 (469)
                      ...|...++.+. |+++...+.-...  ....|.+++|+.+|.+++.|.+.    ..+.+.-+.....+.+.+..-+|+.
T Consensus      1276 ll~e~de~~~~~-h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~ 1354 (2724)
T KOG1826|consen 1276 LLSERDELREAK-HYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSL 1354 (2724)
T ss_pred             hhhhhhhhhhhh-ceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhc
Confidence            344555666666 9988877665543  34578999999999999998653    2334444444444546666666643


Q ss_pred             -----CeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHH
Q 012170          217 -----GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALL  289 (469)
Q Consensus       217 -----givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ell  289 (469)
                           -.+|++||+-|.+|..+..++++++|+.+... .........+++.|++|++... .++.++|+|..|+-+|.+-
T Consensus      1355 tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs 1434 (2724)
T KOG1826|consen 1355 TNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRS 1434 (2724)
T ss_pred             ccCCccchhhhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHh
Confidence                 28899999999999999999999999998322 2223445678899999998866 5888899999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHcCcCCCCC--CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          290 VAALPFKGDSLEAVFDAIKNVKLDFHS--GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       290 tG~~Pf~~~~~~~~~~~i~~~~~~~~~--~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      .|..+|..     ..+.+.++...-..  ......|.++......+|-..-..||.-..++.-+.|-
T Consensus      1435 ~~n~~fi~-----flq~~Lkgiidn~tf~sIe~l~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a 1496 (2724)
T KOG1826|consen 1435 DGNAYFIF-----FLQPALKGIIDNHTFFSIEKLKPGDANVEALHRLLWKYMERPGQYISLSRDHFA 1496 (2724)
T ss_pred             cccHHHHH-----HHHHHHcCcccccccccccccCCCcccHHHHHHHHHHhhhcchhhhhccccccc
Confidence            88887732     22222222221110  00112345566666777777778999999999888774

>TIGR02906 spore_CotS spore coat protein, CotS family

Probab=97.72  E-value=0.005  Score=60.93  Aligned_cols=65  Identities=11%  Similarity=0.113  Sum_probs=44.1

Q ss_pred             EEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCC-CeeEEEEE------EEeCCeEEEEEeccCCCch
Q 012170          118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT-GVVTLHSV------YEEADCFHLVMELCSGGRL  184 (469)
Q Consensus       118 ~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hp-nIv~l~~~------~~~~~~~~lV~E~~~gg~L  184 (469)
                      .||++...  +..+++|++......+..|+.++..|..+. .+++++..      ...++..|+|++|++|..+
T Consensus        11 ~v~~v~t~--~g~~~LK~~~~~~~~~~~~~~~~~~L~~~g~~vp~~i~t~~g~~~~~~~~~~~~l~~~i~G~~~   82 (313)
T TIGR02906        11 NVYKVETD--SGNKCLKKINYPPERLLFILGAQEHLRKNGFNIPKILKTKDGELYVKYNGDLYVLTEWIEGREC   82 (313)
T ss_pred             cEEEEEeC--CCCeEEEEcCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEehhccCcCC
Confidence            48888643  336999998765666777888888886321 34444432      2346678999999998544

Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers.

>PRK05231 homoserine kinase; Provisional

Probab=97.67  E-value=0.00098  Score=66.37  Aligned_cols=135  Identities=17%  Similarity=0.220  Sum_probs=79.7

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHHhhCC-CCeeEEEE------EEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQHLSGH-TGVVTLHS------VYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~l~~h-pnIv~l~~------~~~~~~~~~lV~E~~~  180 (469)
                      +.|+.|....+|.+...  +..+++|++.. ....+..|+.++..|..+ -.+++++.      +....+..+++++|++
T Consensus        28 ~~l~~G~~n~~y~v~t~--~g~~vLK~~~~~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~~l~  105 (319)
T PRK05231         28 KGIAEGIENSNFFLTTT--QGEYVLTLFERLTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVTFLE  105 (319)
T ss_pred             chhccccccceEEEEeC--CCcEEEEEeccCChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEEecC
Confidence            55677888899998754  33699998852 335566788888888622 11444442      2234567889999999


Q ss_pred             CCchH-----------HHHH---Hh-CCC--------C--H-HH-HH-----------HHHHH-HHHHHHHHH-------
Q 012170          181 GGRLI-----------DQMV---EV-GQY--------S--E-QR-AA-----------NIFKD-VMWVIKYCH-------  214 (469)
Q Consensus       181 gg~L~-----------~~l~---~~-~~l--------~--~-~~-~~-----------~i~~q-il~aL~yLH-------  214 (469)
                      |..+.           ..+.   .. ..+        .  . .. ..           ..+.+ +-..+..+.       
T Consensus       106 G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~l  185 (319)
T PRK05231        106 GKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAWPAL  185 (319)
T ss_pred             CCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhccccccC
Confidence            86431           1111   00 011        0  0 00 00           11111 111122332       


Q ss_pred             hcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          215 DMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       215 ~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      ..+++|+|+.|.|||++.+...-|+||+.+.
T Consensus       186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~  216 (319)
T PRK05231        186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFAC  216 (319)
T ss_pred             CcccCCCCCCCCcEEEECCceEEEEeccccc
Confidence            2489999999999999866556899999884

>TIGR01767 MTRK 5-methylthioribose kinase

Probab=97.56  E-value=0.0012  Score=66.31  Aligned_cols=71  Identities=15%  Similarity=0.124  Sum_probs=49.1

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEccc-----------ChHHHHHHHHHHHHhhCC-C-CeeEEEEEEEeCCeEEEEE
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-----------GEETVHREVEIMQHLSGH-T-GVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----------~~~~~~~E~~il~~l~~h-p-nIv~l~~~~~~~~~~~lV~  176 (469)
                      .||.|....||++.+...+..|+||.-..           ..++..-|...|+..... | .++++|.+  +.+...+||
T Consensus         2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM   79 (370)
T TIGR01767         2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM   79 (370)
T ss_pred             cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence            47999999999999864446899997421           124566788888877543 3 35555544  445556999


Q ss_pred             eccCCC
Q 012170          177 ELCSGG  182 (469)
Q Consensus       177 E~~~gg  182 (469)
                      |+++..
T Consensus        80 EdL~~~   85 (370)
T TIGR01767        80 EDLSHH   85 (370)
T ss_pred             hhCccc
Confidence            999653

This enzyme is involved in the methionine salvage pathway in certain bacteria.

>cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2')

Probab=97.54  E-value=0.0008  Score=65.74  Aligned_cols=46  Identities=15%  Similarity=0.216  Sum_probs=31.8

Q ss_pred             eeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCC
Q 012170          110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGH  156 (469)
Q Consensus       110 ~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~h  156 (469)
                      ..+.|-...||.+. ..+|..+++|.-+..  ...+.+|+++|+.|..+
T Consensus        18 ~~~~g~~~~v~~i~-~~~g~~~VlR~p~~~~~~~~l~rE~~vL~~L~~~   65 (276)
T cd05152          18 LNESGLDFQVVFAK-DTDGVPWVLRIPRRPDVSERAAAEKRVLALVRKH   65 (276)
T ss_pred             ecCCcceeEEEEEE-cCCCCeEEEEecCCHHHHHHHHHHHHHHHHHHhc
Confidence            34455555666553 234788999988652  35688999999999754

MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported

>KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning]

Probab=97.53  E-value=0.00069  Score=67.32  Aligned_cols=135  Identities=19%  Similarity=0.346  Sum_probs=95.3

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC------h--------------------H----HHHHHHHHHHHhhCCCC
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG------E--------------------E----TVHREVEIMQHLSGHTG  158 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~--------------------~----~~~~E~~il~~l~~hpn  158 (469)
                      ..|..|.-+.||.|... +|..+|||+++.+      +                    .    -...|++-|+++. ...
T Consensus       150 GCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~-~aG  227 (520)
T KOG2270|consen  150 GCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLN-NAG  227 (520)
T ss_pred             cccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHH-hcC
Confidence            46788999999999765 6888999997531      1                    0    1346888888886 555


Q ss_pred             eeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHH-HhcCeEeccCCCCcEEEccCCcEE
Q 012170          159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC-HDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       159 Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yL-H~~givHrDlkp~NILl~~~~~vk  237 (469)
                      |+..--+...  ...|||+|+.....-.-..+.-.++...+..+-.|++.-+.-| |..++||.||.--|+|+ .+|.+.
T Consensus       228 IP~PePIlLk--~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHADLSEfN~Ly-hdG~ly  304 (520)
T KOG2270|consen  228 IPCPEPILLK--NHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHADLSEFNLLY-HDGKLY  304 (520)
T ss_pred             CCCCCceeee--cceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccchhhhhheE-ECCEEE
Confidence            5443333322  2359999996432222223445678888888888888777655 57799999999999998 567999


Q ss_pred             EEeccceeeec
Q 012170          238 LADFGLAMRIS  248 (469)
Q Consensus       238 L~DFgla~~~~  248 (469)
                      |+|.+.+....
T Consensus       305 iIDVSQSVE~D  315 (520)
T KOG2270|consen  305 IIDVSQSVEHD  315 (520)
T ss_pred             EEEccccccCC
Confidence            99998875443

>PLN02236 choline kinase

Probab=97.46  E-value=0.0015  Score=65.98  Aligned_cols=135  Identities=19%  Similarity=0.239  Sum_probs=85.0

Q ss_pred             eeeeeeccCCeEEEEEEECC----CCcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          107 KVEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~----~~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      -+..|-.|-...+|++....    ++..|++|+.....+   +..+|..+++.+..+.--+++++.+..+    .|.+|+
T Consensus        40 ~i~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~idR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi  115 (344)
T PLN02236         40 QVIPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFFDRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFI  115 (344)
T ss_pred             EEEEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeeechHHHHHHHHHHHHcCCCCceEEEECCc----eEEEee
Confidence            34566668888999987532    346899999865432   2467999999998655556777777443    589999


Q ss_pred             CCCchHHH----------H----HH---hC-C----C-CHHHHHHHHHHHH-----------------HHHHHH----H-
Q 012170          180 SGGRLIDQ----------M----VE---VG-Q----Y-SEQRAANIFKDVM-----------------WVIKYC----H-  214 (469)
Q Consensus       180 ~gg~L~~~----------l----~~---~~-~----l-~~~~~~~i~~qil-----------------~aL~yL----H-  214 (469)
                      +|.++...          +    .+   .. +    + ....+..++.++.                 ..+..|    . 
T Consensus       116 ~g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~  195 (344)
T PLN02236        116 HARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSG  195 (344)
T ss_pred             CCCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhcc
Confidence            87665311          1    00   00 0    1 1223333332211                 111112    1 


Q ss_pred             ---hcCeEeccCCCCcEEEcc-CCcEEEEecccee
Q 012170          215 ---DMGVVHRDIKPENILLTT-SGKIKLADFGLAM  245 (469)
Q Consensus       215 ---~~givHrDlkp~NILl~~-~~~vkL~DFgla~  245 (469)
                         ...++|+|+++.|||+++ ++.+.|+||..+.
T Consensus       196 ~~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~  230 (344)
T PLN02236        196 DDQEIGFCHNDLQYGNIMIDEETRAITIIDYEYAS  230 (344)
T ss_pred             cCCCceEEeCCCCcCcEEEeCCCCcEEEEeehhcc
Confidence               236899999999999986 4689999999884

>PLN02421 phosphotransferase, alcohol group as acceptor/kinase

Probab=97.43  E-value=0.0015  Score=65.49  Aligned_cols=134  Identities=16%  Similarity=0.193  Sum_probs=82.0

Q ss_pred             eeeeeccCCeEEEEEEECCC---CcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          108 VEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      ++.|..|=...+|++.....   +..|++|+.....+   +..+|..+++.+..+.--+++++++..+    +|.+|++|
T Consensus        19 i~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g   94 (330)
T PLN02421         19 VERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDYVIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA   94 (330)
T ss_pred             EEEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCeEechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence            45666688888998865432   34799998865433   3467999999998554446777776422    58999987


Q ss_pred             CchHH----------HH----HH--hCC------C-CHHHHHHHHHHH----------------------HHHHHH----
Q 012170          182 GRLID----------QM----VE--VGQ------Y-SEQRAANIFKDV----------------------MWVIKY----  212 (469)
Q Consensus       182 g~L~~----------~l----~~--~~~------l-~~~~~~~i~~qi----------------------l~aL~y----  212 (469)
                      ..|..          .+    .+  ...      + ....+..++.++                      ..-+..    
T Consensus        95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~  174 (330)
T PLN02421         95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI  174 (330)
T ss_pred             CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence            65421          11    10  001      1 112222222222                      111222    


Q ss_pred             HHhc----CeEeccCCCCcEEEcc-CCcEEEEecccee
Q 012170          213 CHDM----GVVHRDIKPENILLTT-SGKIKLADFGLAM  245 (469)
Q Consensus       213 LH~~----givHrDlkp~NILl~~-~~~vkL~DFgla~  245 (469)
                      +...    -++|.||.+.|||+++ ++.++++||..|.
T Consensus       175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag  212 (330)
T PLN02421        175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGS  212 (330)
T ss_pred             hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccC
Confidence            2122    2899999999999975 4789999999984

>TIGR02904 spore_ysxE spore coat protein YsxE

Probab=97.23  E-value=0.0049  Score=61.22  Aligned_cols=67  Identities=18%  Similarity=0.157  Sum_probs=45.9

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCC--CCeeEEEE------EEEeCCeEEEEEeccCCC
Q 012170          114 GKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGH--TGVVTLHS------VYEEADCFHLVMELCSGG  182 (469)
Q Consensus       114 G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~h--pnIv~l~~------~~~~~~~~~lV~E~~~gg  182 (469)
                      |.-|.||++.-.  +..+++|.+....+.+...+.++..|..+  +++++++-      +...++..|+||++++|.
T Consensus        17 ~~~~~v~~v~T~--~G~~~Lk~~~~~~~~l~~~~~~~~~L~~~G~~~~~~~~~t~~G~~~~~~~~~~~~L~~wi~G~   91 (309)
T TIGR02904        17 QVTGKLFKVYTD--QGVFALKKLYADRNTIESFVSQIQVLSEKGFSRIVPVYPTKDGSYYLFHGHFLYYLMPWLDIE   91 (309)
T ss_pred             cccCcEEEEEeC--CCCEEEEEeccchHhHHHHHHHHHHHHHcCCCcCCceeecCCCCeeeEECCEEEEEeCCcccc
Confidence            335689998653  44699999986666777777788887522  34555533      234466679999999884

Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat.

>PRK12396 5-methylribose kinase; Reviewed

Probab=97.07  E-value=0.0047  Score=62.91  Aligned_cols=72  Identities=17%  Similarity=0.128  Sum_probs=51.4

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcc----c------ChHHHHHHHHHHHHhhCC-C-CeeEEEEEEEeCCeEEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR----K------GEETVHREVEIMQHLSGH-T-GVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~----~------~~~~~~~E~~il~~l~~h-p-nIv~l~~~~~~~~~~~lV  175 (469)
                      ++.||.|.-.-||++.+...+..|+||.-.    .      ..++..-|.++|+.+... | .++++|.+  +.+...+|
T Consensus        34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v  111 (409)
T PRK12396         34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV  111 (409)
T ss_pred             eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence            578899999999999985445679999742    1      235677788999877542 3 45666655  44556689


Q ss_pred             EeccCC
Q 012170          176 MELCSG  181 (469)
Q Consensus       176 ~E~~~g  181 (469)
                      ||+++.
T Consensus       112 MEdL~~  117 (409)
T PRK12396        112 MEDLSD  117 (409)
T ss_pred             HHhCcc
Confidence            999965

>PLN02756 S-methyl-5-thioribose kinase

Probab=97.06  E-value=0.0086  Score=61.31  Aligned_cols=70  Identities=14%  Similarity=0.143  Sum_probs=51.0

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcc-----c------ChHHHHHHHHHHHHhhCC--CCeeEEEEEEEeCCeEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR-----K------GEETVHREVEIMQHLSGH--TGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~-----~------~~~~~~~E~~il~~l~~h--pnIv~l~~~~~~~~~~~l  174 (469)
                      .+.||.|....||+..+.  +..|+||.-.     .      ...+...|...|+.+...  .++++++.+..+  ..++
T Consensus        37 ~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~ded--~~vl  112 (418)
T PLN02756         37 IKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDRT--MALI  112 (418)
T ss_pred             EEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECCC--CCEE
Confidence            578899999999998863  4569999764     1      234456677888766532  468888888763  3568


Q ss_pred             EEeccCC
Q 012170          175 VMELCSG  181 (469)
Q Consensus       175 V~E~~~g  181 (469)
                      ||||+++
T Consensus       113 vME~L~~  119 (418)
T PLN02756        113 GMRYLEP  119 (418)
T ss_pred             EEeecCC
Confidence            9999977

>COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only]

Probab=96.98  E-value=0.0051  Score=60.93  Aligned_cols=139  Identities=20%  Similarity=0.238  Sum_probs=82.4

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcc-----cChHHHHHHHHHHHHhhCC-CCeeEEEEEEEeCC--eEEEEEec
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH-TGVVTLHSVYEEAD--CFHLVMEL  178 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~-----~~~~~~~~E~~il~~l~~h-pnIv~l~~~~~~~~--~~~lV~E~  178 (469)
                      +++.+-.|.--.+|.....  ++.+++..-.     .......+|+.+|+.+..- --+...++++.++.  ..|.||+|
T Consensus        29 ~v~~~~~G~sn~t~~~~~~--~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~  106 (321)
T COG3173          29 IVEEISGGWSNDTFRLGDT--GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEW  106 (321)
T ss_pred             eeeeccCCcccceEEEecC--CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEE
Confidence            3344434444445555443  7778888221     1235677899999988532 22445566666555  66899999


Q ss_pred             cCCCch---------H---------HHHHHh--------------CCCCHHHHHHHHHHH--------------HHHHHH
Q 012170          179 CSGGRL---------I---------DQMVEV--------------GQYSEQRAANIFKDV--------------MWVIKY  212 (469)
Q Consensus       179 ~~gg~L---------~---------~~l~~~--------------~~l~~~~~~~i~~qi--------------l~aL~y  212 (469)
                      ++|..+         .         +.|..-              +.+...++..+..+.              ..-..|
T Consensus       107 veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~W  186 (321)
T COG3173         107 VEGEVVWSALPPESLGRQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKW  186 (321)
T ss_pred             ecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHH
Confidence            998322         1         111110              001122222333222              222445


Q ss_pred             HHhc--------CeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          213 CHDM--------GVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       213 LH~~--------givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      |+.+        .++|+|+.+.||+|+.++-+-+.||+++..-
T Consensus       187 l~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG  229 (321)
T COG3173         187 LEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG  229 (321)
T ss_pred             HHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence            5543        4899999999999999999999999998653

>PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein []

Probab=96.94  E-value=0.0061  Score=59.82  Aligned_cols=74  Identities=19%  Similarity=0.261  Sum_probs=50.6

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEEEEeccCCC
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHLVMELCSGG  182 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~lV~E~~~gg  182 (469)
                      ..+.|+.|....+|+..  .++..|.||+-.. ....+..|.+-|+.|.  ..-.+++++.+....+.-||||||++.+
T Consensus        21 ~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~   97 (288)
T PF03881_consen   21 SIEPVSGGDINEAYRLD--TDGGSYFVKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG   97 (288)
T ss_dssp             EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred             eeEecCCCChhheEEEE--CCCccEEEEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence            35788999999999987  5688999998864 2457889999999994  2345788999988777779999999876

Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A.

>KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only]

Probab=96.93  E-value=0.0026  Score=65.83  Aligned_cols=163  Identities=16%  Similarity=0.143  Sum_probs=105.5

Q ss_pred             HHHHHHHHHHHHhhCCCCeeEEEEEEEeC-CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeE
Q 012170          141 ETVHREVEIMQHLSGHTGVVTLHSVYEEA-DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVV  219 (469)
Q Consensus       141 ~~~~~E~~il~~l~~hpnIv~l~~~~~~~-~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~giv  219 (469)
                      ..+.--..+++.+. |+|...++++-... ....+|||++ +.+|.+.+..+. +-.....              .+|+.
T Consensus        27 ~~ilgr~~~lktl~-~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~--------------~~~~~   89 (725)
T KOG1093|consen   27 IQILGRFQYLKSLQ-HDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL--------------AHGVL   89 (725)
T ss_pred             HHHhhhhHHHHhhc-CccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc--------------ccccc
Confidence            34556678899997 99999999887533 3578999999 568988886543 2211111              22222


Q ss_pred             eccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 012170          220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDS  299 (469)
Q Consensus       220 HrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~  299 (469)
                      |     -|       .++.+| -++   ...   ....|               +++||||+|.++.++..|...+....
T Consensus        90 ~-----~~-------~~~~td-~~~---t~~---~~~~~---------------pKsdVwsl~~i~~el~L~~~l~~~~~  135 (725)
T KOG1093|consen   90 H-----LN-------IIYITD-HFL---TKY---PSPIG---------------PKSDVWSLGFIILELYLGISLEAELT  135 (725)
T ss_pred             e-----eh-------hhhccc-ccc---ccC---CCCCC---------------cchhhhhHHHHHHHHHHhhHHHHHHH
Confidence            2     12       233344 111   000   11111               38999999999999999988777666


Q ss_pred             HHHHHHHHHcCcCCCCCC--------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          300 LEAVFDAIKNVKLDFHSG--------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       300 ~~~~~~~i~~~~~~~~~~--------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ..+....|..........        ....++....++..+|+-..|..||...++.+|+-|.
T Consensus       136 ~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~  198 (725)
T KOG1093|consen  136 ESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFT  198 (725)
T ss_pred             HHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHH
Confidence            556655555433221110        1124567788999999999999999999999999874

>PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2

Probab=96.85  E-value=0.0052  Score=57.35  Aligned_cols=115  Identities=21%  Similarity=0.266  Sum_probs=62.3

Q ss_pred             CcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHH-------HH-------HH
Q 012170          128 GAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID-------QM-------VE  190 (469)
Q Consensus       128 ~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~-------~l-------~~  190 (469)
                      ++.|+|++.....   -....|..+++.+..+..-+++++++..+    +|.+|++|..|..       .+       .+
T Consensus         2 ~~~~~~Ri~g~~t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~g----~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~~   77 (211)
T PF01633_consen    2 PEKYLVRIPGEGTENFIDRENENEALKLLSEAGLGPKIIYFFENG----RVEEFIEGRTLSPEDFRNPEILKRIAKLLAK   77 (211)
T ss_dssp             TSEEEEEEEESCGCSHHHHHHHHHHHHHHHHTTSSS-EEEEETTE----EEEE--SSEE--CGGGGSHHHHHHHHHHHHH
T ss_pred             CCEEEEEeCCCCcccccCHHHHHHHHHHHHHcCCCCeEEEEcCCC----cEEEEecccccChhhccChHHHHHHHHHHHH
Confidence            4678888886653   35567999999998666667888876443    5779997755311       11       00


Q ss_pred             -----h-CCC----CHHHHHHH----------------------HHHHHHHHHHHH--------hcCeEeccCCCCcEEE
Q 012170          191 -----V-GQY----SEQRAANI----------------------FKDVMWVIKYCH--------DMGVVHRDIKPENILL  230 (469)
Q Consensus       191 -----~-~~l----~~~~~~~i----------------------~~qil~aL~yLH--------~~givHrDlkp~NILl  230 (469)
                           . ...    -...+..+                      +..+..-+..+.        ...++|+||.|.|||+
T Consensus        78 lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil~  157 (211)
T PF01633_consen   78 LHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNILI  157 (211)
T ss_dssp             HHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEEE
T ss_pred             HhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEEe
Confidence                 0 000    01122222                      111122222222        1359999999999999


Q ss_pred             -ccCCcEEEEeccceee
Q 012170          231 -TTSGKIKLADFGLAMR  246 (469)
Q Consensus       231 -~~~~~vkL~DFgla~~  246 (469)
                       +.++.++|+||..|..
T Consensus       158 ~~~~~~~~lIDfEya~~  174 (211)
T PF01633_consen  158 NNKDGEVKLIDFEYAGY  174 (211)
T ss_dssp             TSSSSCEEE--GTT-EE
T ss_pred             ccCCCeEEEecHHHHhh
Confidence             8889999999999854

7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B ....

>PTZ00384 choline kinase; Provisional

Probab=96.63  E-value=0.032  Score=57.10  Aligned_cols=73  Identities=10%  Similarity=0.101  Sum_probs=49.4

Q ss_pred             eeeeeccCCeEEEEEEECCC-CcE-----EEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          108 VEVIGHGKFGSVWLCRSKAS-GAE-----FACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~-~~~-----vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ++.|..|-...+|++..... +..     |.+.+.....   -+-.+|+.+++.|..+..-+++++.+..    ++|.||
T Consensus        55 i~~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~~----g~l~ef  130 (383)
T PTZ00384         55 IKKMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSSTYNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFGD----FTIQEW  130 (383)
T ss_pred             EEEeCCcccceEEEEEecCCCCCccccceEEEEeccCCCceEeccHHHHHHHHHHHhCCCCCeEEEecCC----EEEEEE
Confidence            45666688889999875432 122     4444432221   1346799999999866677888888853    489999


Q ss_pred             cCCCch
Q 012170          179 CSGGRL  184 (469)
Q Consensus       179 ~~gg~L  184 (469)
                      ++|-.|
T Consensus       131 IeGr~l  136 (383)
T PTZ00384        131 VEGNTM  136 (383)
T ss_pred             eccccC
Confidence            998765

>PRK11768 serine/threonine protein kinase; Provisional

Probab=96.40  E-value=0.081  Score=52.96  Aligned_cols=69  Identities=14%  Similarity=0.122  Sum_probs=45.2

Q ss_pred             cCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCC-CeeEEE---E--EEEeCCeEEEEEeccCCCc
Q 012170          114 GKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHT-GVVTLH---S--VYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       114 G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hp-nIv~l~---~--~~~~~~~~~lV~E~~~gg~  183 (469)
                      +.-..||++... +|..+++|+.+.+   ...+..|++.+..|..+. .++...   +  +...++..+.|+++++|..
T Consensus        36 s~eN~vy~v~~~-~~~~~vlKv~r~~~~~~~~i~~E~~~l~~L~~~gipv~~p~~~~G~~~~~~~g~~~~l~~~~~G~~  113 (325)
T PRK11768         36 SYENRVYQFGDE-DGRRVVAKFYRPERWSDAQILEEHAFALELAEAEIPVVAPLAFNGQTLHEHQGFRFALFPRRGGRA  113 (325)
T ss_pred             cccceEEEEecC-CCCEEEEEEcCcccCCHHHHHHHHHHHHHHHHCCCCCCCCccCCCCEEEEECCEEEEEEeeeCCCC
Confidence            345678988653 4678999998643   466788999998886421 122211   1  2234567889999998754

>PTZ00296 choline kinase; Provisional

Probab=96.15  E-value=0.054  Score=56.50  Aligned_cols=74  Identities=16%  Similarity=0.138  Sum_probs=51.4

Q ss_pred             eeeeeeccCCeEEEEEEECC--------CCcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          107 KVEVIGHGKFGSVWLCRSKA--------SGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      -++.|..|-.-.+|++....        .+..|.+++.-.+.+   ...+|..+++.+..+.--+++++.+. +   +.|
T Consensus       109 ~i~~l~gGlTN~~f~v~~~~~~~~~~~~~~~~~lvRiyG~~te~lIdR~~E~~v~~~ls~~gi~P~l~~~f~-g---g~I  184 (442)
T PTZ00296        109 RVNQILSGLTNQLFEVSLKEETANNYPSIRRRVLFRIYGKDVDELYNPISEFEVYKTMSKYRIAPQLLNTFS-G---GRI  184 (442)
T ss_pred             EEEEecCcccCceEEEEecCCCCccccCcCceEEEEecCCCccceeCHHHHHHHHHHHHHCCCCCceEEEeC-C---CEE
Confidence            46778888888999987542        156899999865443   34569999998874443456776663 2   358


Q ss_pred             EeccCCCch
Q 012170          176 MELCSGGRL  184 (469)
Q Consensus       176 ~E~~~gg~L  184 (469)
                      .||++|-.|
T Consensus       185 ~efi~g~~l  193 (442)
T PTZ00296        185 EEWLYGDPL  193 (442)
T ss_pred             EEeeCCccC
Confidence            899988643

>KOG1236 consensus Predicted unusual protein kinase [General function prediction only]

Probab=96.12  E-value=0.019  Score=58.13  Aligned_cols=61  Identities=20%  Similarity=0.166  Sum_probs=41.5

Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHH-HHHHhcCeEeccCCCCcEEEccC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI-KYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL-~yLH~~givHrDlkp~NILl~~~  233 (469)
                      ..||=+|..|-++..++. ....++.....++.-.+.|+ ..|--.+++|.|++|.||++.-+
T Consensus       320 ~vl~E~~~~Gl~v~~~v~-~~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf~  381 (565)
T KOG1236|consen  320 LVLVETYERGLSVLRFVK-WKSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRFN  381 (565)
T ss_pred             ceeeeeccccccHHhhhh-cccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEec
Confidence            346666888888777663 34445555566665555554 34456789999999999999543

>COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning]

Probab=96.02  E-value=0.032  Score=55.76  Aligned_cols=85  Identities=20%  Similarity=0.264  Sum_probs=60.8

Q ss_pred             CCCeeEEEEEE-EeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccC
Q 012170          156 HTGVVTLHSVY-EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTS  233 (469)
Q Consensus       156 hpnIv~l~~~~-~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~  233 (469)
                      -++..+++-+- ....+.|++|++- |++|.- +   ..-..+++..++.+.+..+.-+..+ ..-|||+...||||+ +
T Consensus       284 ~~~~e~~~vv~~de~~y~yl~~kdh-gt~is~-i---k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLId-~  357 (488)
T COG5072         284 SVFLETLKVVSLDETLYLYLHFKDH-GTPISI-I---KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILID-E  357 (488)
T ss_pred             chhhhcceEEecCCceEEEEEEecC-Cceeee-e---ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceeee-c
Confidence            34444433333 3445678888886 555532 2   2234677888888888877777654 589999999999999 9


Q ss_pred             CcEEEEeccceee
Q 012170          234 GKIKLADFGLAMR  246 (469)
Q Consensus       234 ~~vkL~DFgla~~  246 (469)
                      |+|-|+||-+++.
T Consensus       358 GnvtLIDfklsRl  370 (488)
T COG5072         358 GNVTLIDFKLSRL  370 (488)
T ss_pred             CceEEEEeeeeec
Confidence            9999999999973

>PRK06148 hypothetical protein; Provisional

Probab=95.93  E-value=0.17  Score=58.42  Aligned_cols=136  Identities=17%  Similarity=0.241  Sum_probs=78.8

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccCh--HHHHHHHHHHHHhhCC-CC--eeEEEE--------EEEe-CC--eE
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--ETVHREVEIMQHLSGH-TG--VVTLHS--------VYEE-AD--CF  172 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~--~~~~~E~~il~~l~~h-pn--Iv~l~~--------~~~~-~~--~~  172 (469)
                      +.|+ |.+-.+|++.. .+|..|++|+.....  ..+..|..+|..|..+ +.  +.+++-        .... ++  .+
T Consensus        31 ~~L~-s~~d~nf~v~~-~~g~~yVLKi~~~~~~~~~~~~q~~~L~hL~~~~~glpvP~~i~t~~G~~~~~v~~~~G~~~~  108 (1013)
T PRK06148         31 TPLD-GERDLNFRLTT-DDGADYILKIVNPSEPRVESDFQTAALDHLAAVAPDLPVPRLIPSLSGASLASAQDPDGEPRL  108 (1013)
T ss_pred             eecC-CcCCceEEEEe-CCCCeEEEEEcCCccchhHHHHHHHHHHHHHhhCCCCCcCeeeecCCCCeEEEeecCCCceEE
Confidence            4454 34577888764 357789999997543  3455677788877643 33  333332        1111 22  56


Q ss_pred             EEEEeccCCCchHHH-------HH----------H----h------CCCCH-----------------HHHHHHHHHHHH
Q 012170          173 HLVMELCSGGRLIDQ-------MV----------E----V------GQYSE-----------------QRAANIFKDVMW  208 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~-------l~----------~----~------~~l~~-----------------~~~~~i~~qil~  208 (469)
                      +.+++|++|..+.+.       +.          .    .      ..+.+                 ...+.++.+++.
T Consensus       109 vrLl~~l~G~~l~~~~~~t~~~~~~lG~~larlh~al~~F~~p~~~r~~~Wdl~~~~~l~~~l~~i~d~~~r~~l~~~~~  188 (1013)
T PRK06148        109 LRLLSWLPGTPLAEAAPRTEALLDNLGRALGRLDRALQGFMHPGALRDLDWDLRHAGRARDRLHFIDDPEDRALVERFLA  188 (1013)
T ss_pred             EEEEeccCCCcHHhccCCCHHHHHHHHHHHHHHHHHHhcCCCCCcccccccccccchhhhhhhhhcCCHHHHHHHHHHHH
Confidence            788999999766441       10          0    0      00001                 011122233333


Q ss_pred             HHH-----HHH--hcCeEeccCCCCcEEEccCC--cEE-EEeccceee
Q 012170          209 VIK-----YCH--DMGVVHRDIKPENILLTTSG--KIK-LADFGLAMR  246 (469)
Q Consensus       209 aL~-----yLH--~~givHrDlkp~NILl~~~~--~vk-L~DFgla~~  246 (469)
                      .+.     .+.  ..++||+|+.+.|||++.++  ++. |+|||-+..
T Consensus       189 ~~~~~v~p~l~~Lp~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~  236 (1013)
T PRK06148        189 RFERNVAPRLAALPAQVIHNDANDYNILVDADDGERISGLIDFGDAVH  236 (1013)
T ss_pred             HHHHHHHHHHhcCCcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence            222     121  24799999999999999875  565 999998854

>PF00036 EF-hand_1: EF hand; InterPro: IPR018248 Many calcium-binding proteins belong to the same evolutionary family and share a type of calcium-binding domain known as the EF-hand

Probab=95.70  E-value=0.00078  Score=41.72  Aligned_cols=23  Identities=0%  Similarity=0.045  Sum_probs=20.5

Q ss_pred             CCCcccccccccccCHHHHhhhC
Q 012170          447 GPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       447 ~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .+|+.+|.|+||+|+.+|+++++
T Consensus         4 ~~F~~~D~d~dG~I~~~Ef~~~~   26 (29)
T PF00036_consen    4 EAFREFDKDGDGKIDFEEFKEMM   26 (29)
T ss_dssp             HHHHHHSTTSSSEEEHHHHHHHH
T ss_pred             HHHHHHCCCCCCcCCHHHHHHHH
Confidence            46889999999999999999874

This type of domain consists of a twelve residue loop flanked on both sides by a twelve residue alpha-helical domain. In an EF-hand loop the calcium ion is coordinated in a pentagonal bipyramidal configuration. The six residues involved in the binding are in positions 1, 3, 5, 7, 9 and 12; these residues are denoted by X, Y, Z, -Y, -X and -Z. The invariant Glu or Asp at position 12 provides two oxygens for liganding Ca (bidentate ligand).; PDB: 1BJF_A 1XFW_R 1XFV_O 2K0J_A 2F3Z_A 3BYA_A 1XFU_Q 2R28_B 1ZOT_B 3G43_D ....

>PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length

Probab=95.40  E-value=0.079  Score=49.54  Aligned_cols=86  Identities=17%  Similarity=0.276  Sum_probs=61.4

Q ss_pred             HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--cCe
Q 012170          141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD--MGV  218 (469)
Q Consensus       141 ~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--~gi  218 (469)
                      .-+..+..++.++.   .|+++..-  +.-.+.+++|+|-.....             -..++..=+.+|.-.|+  .+.
T Consensus       103 ~~y~nky~v~Armh---GilrL~ND--n~~~yGvIlE~Cy~~~i~-------------~~N~i~agi~~L~~fH~~~~~~  164 (308)
T PF07387_consen  103 ALYFNKYRVFARMH---GILRLKND--NNYKYGVILERCYKIKIN-------------FSNFITAGIKDLMDFHSENQHC  164 (308)
T ss_pred             hhhhhhhhHHHHhh---heeEeecC--CCceeEEEEeeccCcccc-------------hhHHHHHhHHHHHHhhccCCCe
Confidence            45678899998875   58888733  444678999999542211             01122222466778884  469


Q ss_pred             EeccCCCCcEEEccCCcEEEEeccce
Q 012170          219 VHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       219 vHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      +|+|..|+||+-|..|.+||.|=+..
T Consensus       165 lHGD~np~NiM~D~~G~lKlVDP~~L  190 (308)
T PF07387_consen  165 LHGDCNPDNIMCDKFGYLKLVDPVCL  190 (308)
T ss_pred             ecCCCChhheeecCCCCEEecChhhh
Confidence            99999999999999999999997653

The function of this family is unknown.

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	469
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		2e-45
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		7e-45
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		4e-44
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-44
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		6e-44
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		2e-43
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		2e-43
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		2e-43
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-43
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-43
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		1e-42
3kk8_A	284	Camkii Substrate Complex A Length = 284		1e-42
3kk9_A	282	Camkii Substrate Complex B Length = 282		2e-42
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		2e-42
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		2e-42
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		4e-42
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		5e-42
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		1e-41
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		1e-41
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		2e-41
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		2e-41
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-41
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		2e-41
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		2e-41
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		2e-41
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		2e-41
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		2e-41
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		3e-41
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		3e-41
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		4e-41
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		4e-41
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		6e-41
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		9e-41
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		1e-40
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		1e-40
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		2e-40
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		2e-40
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		2e-40
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		2e-40
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		2e-40
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		2e-40
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		2e-40
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		2e-40
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		2e-40
3soa_A	444	Full-Length Human Camkii Length = 444		5e-40
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		6e-40
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		6e-40
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		9e-40
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-39
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-39
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-38
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		2e-38
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		3e-38
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		3e-38
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		4e-38
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		4e-38
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		4e-38
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		5e-38
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		6e-38
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		7e-38
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		7e-38
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		7e-38
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-38
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		7e-38
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		8e-38
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-38
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		8e-38
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		9e-38
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		9e-38
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		9e-38
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-37
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-37
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		1e-37
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		1e-37
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		1e-37
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		1e-37
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		1e-37
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		1e-37
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		1e-37
3rny_A	346	Crystal Structure Of Human Rsk1 C-Terminal Kinase D		1e-37
2wnt_A	330	Crystal Structure Of The Human Ribosomal Protein S6		2e-37
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		2e-37
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		2e-37
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		2e-37
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		2e-37
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		2e-37
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		3e-37
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		5e-37
2qr8_A	342	2.0a X-ray Structure Of C-terminal Kinase Domain Of		8e-37
2qr7_A	342	2.0a X-Ray Structure Of C-Terminal Kinase Domain Of		3e-36
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		8e-36
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		1e-35
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		1e-34
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		1e-33
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		1e-33
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		2e-33
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-33
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		4e-33
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		4e-33
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-33
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		8e-33
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-32
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		1e-32
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		1e-32
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-32
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		1e-32
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		1e-32
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		1e-32
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		1e-32
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		1e-32
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-32
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		2e-32
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		2e-32
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		2e-32
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		3e-32
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		3e-32
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-32
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		3e-31
2hw6_A	307	Crystal Structure Of Mnk1 Catalytic Domain Length =		5e-31
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		5e-31
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		6e-31
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		7e-31
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		8e-31
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		8e-31
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		9e-31
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		1e-30
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		1e-30
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		1e-30
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		2e-30
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		2e-30
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-30
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		6e-30
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		1e-29
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		1e-29
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		1e-29
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		1e-29
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		1e-29
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-29
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		1e-29
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-29
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-29
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		4e-29
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		5e-29
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		5e-29
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		5e-29
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		5e-29
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		6e-29
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		6e-29
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		6e-29
2oza_A	356	Structure Of P38alpha Complex Length = 356		6e-29
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		7e-29
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		8e-29
2ac5_A	316	Structure Of Human Mnk2 Kinase Domain Mutant D228g		9e-29
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		1e-28
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		1e-28
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		2e-28
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		2e-28
1kob_A	387	Twitchin Kinase Fragment (Aplysia), Autoregulated P		3e-28
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		4e-28
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		5e-28
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		5e-28
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		5e-28
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		5e-28
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		5e-28
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		5e-28
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		5e-28
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		5e-28
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		6e-28
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		6e-28
2ac3_A	316	Structure Of Human Mnk2 Kinase Domain Length = 316		6e-28
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		6e-28
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		6e-28
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		6e-28
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		7e-28
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		7e-28
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		8e-28
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		9e-28
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		1e-27
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-27
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		1e-27
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		1e-27
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		1e-27
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-27
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		1e-27
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		1e-27
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-27
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		2e-27
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-27
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-27
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		2e-27
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		2e-27
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-27
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		2e-27
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-27
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		2e-27
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		3e-27
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		3e-27
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		4e-27
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		5e-27
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		6e-27
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		6e-27
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		7e-27
4ae9_A	343	Structure And Function Of The Human Sperm-specific		7e-27
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		7e-27
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		7e-27
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		8e-27
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		8e-27
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		8e-27
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		8e-27
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		8e-27
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		8e-27
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		9e-27
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		1e-26
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		1e-26
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		2e-26
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-26
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		2e-26
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		2e-26
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		2e-26
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		2e-26
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		3e-26
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-26
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-26
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-26
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-26
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		4e-26
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		5e-26
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		6e-26
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		7e-26
4fie_A	423	Full-Length Human Pak4 Length = 423		7e-26
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		1e-25
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-25
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		2e-25
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-25
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-25
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-25
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		3e-25
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		3e-25
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		3e-25
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		3e-25
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		3e-25
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		3e-25
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		4e-25
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		4e-25
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		6e-25
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		6e-25
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		1e-24
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		2e-24
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		2e-24
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		3e-24
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		4e-24
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		4e-24
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		4e-24
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		4e-24
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		8e-24
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		8e-24
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		8e-24
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-24
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-24
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-24
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-24
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		9e-24
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		9e-24
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-23
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-23
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-23
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-23
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		1e-23
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-23
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-23
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-23
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-23
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-23
3g51_A	325	Structural Diversity Of The Active Conformation Of		2e-23
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		2e-23
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-23
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-23
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		2e-23
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		3e-23
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		3e-23
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		4e-23
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		5e-23
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		6e-23
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		6e-23
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		6e-23
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		7e-23
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		7e-23
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		8e-23
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		8e-23
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		8e-23
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		1e-22
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		1e-22
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		1e-22
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		1e-22
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		1e-22
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		1e-22
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-22
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		1e-22
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		1e-22
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-22
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		2e-22
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-22
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		2e-22
2vd5_A	412	Structure Of Human Myotonic Dystrophy Protein Kinas		2e-22
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		2e-22
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		2e-22
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		3e-22
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-22
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		3e-22
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		4e-22
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-22
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-22
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		5e-22
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		5e-22
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		6e-22
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		6e-22
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		6e-22
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		6e-22
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		6e-22
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		7e-22
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		7e-22
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		7e-22
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		7e-22
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		8e-22
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		9e-22
3kga_A	299	Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe		9e-22
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-21
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		1e-21
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		1e-21
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		1e-21
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		1e-21
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		1e-21
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		1e-21
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		1e-21
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		1e-21
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		1e-21
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		1e-21
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		1e-21
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		1e-21
3a7f_A	303	Human Mst3 Kinase Length = 303		1e-21
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		2e-21
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-21
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-21
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		2e-21
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-21
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		2e-21
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		3e-21
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		3e-21
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		3e-21
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		3e-21
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		3e-21
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		3e-21
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		3e-21
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		3e-21
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		4e-21
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		4e-21
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		4e-21
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		4e-21
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-21
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		5e-21
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		5e-21
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		5e-21
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		5e-21
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		5e-21
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		5e-21
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		7e-21
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		1e-20
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		1e-20
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		1e-20
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		1e-20
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		2e-20
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-20
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		4e-20
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		5e-20
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		5e-20
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-19
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-19
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		1e-19
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-19
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		1e-19
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-19
4exu_A	371	Mapk13, Inactive Form Length = 371		2e-19
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		4e-19
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		5e-19
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		5e-19
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		7e-19
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		9e-19
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-18
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		1e-18
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		1e-18
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		1e-18
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		1e-18
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		1e-18
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-18
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		2e-18
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		2e-18
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		2e-18
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		2e-18
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-18
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		3e-18
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		3e-18
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		3e-18
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		3e-18
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		3e-18
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		4e-18
3aln_A	327	Crystal Structure Of Human Non-Phosphorylated Mkk4		4e-18
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		4e-18
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		5e-18
4gs6_A	315	Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz		5e-18
2eva_A	307	Structural Basis For The Interaction Of Tak1 Kinase		5e-18
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		7e-18
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		8e-18
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		8e-18
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		1e-17
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		1e-17
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		1e-17
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		2e-17
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-17
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-17
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		2e-17
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		2e-17
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		2e-17
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		2e-17
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		2e-17
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-17
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		3e-17
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		3e-17
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		3e-17
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-17
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		3e-17
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		3e-17
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		4e-17
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		4e-17
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		4e-17
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		4e-17
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		4e-17
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		4e-17
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		4e-17
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-17
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		5e-17
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-17
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		5e-17
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		5e-17
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		5e-17
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		5e-17
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		5e-17
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		5e-17
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		5e-17
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-17
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		5e-17
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		6e-17
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-17
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-17
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		6e-17
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-17
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		6e-17
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-17
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		6e-17
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-17
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		7e-17
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		7e-17
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		7e-17
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		7e-17
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		7e-17
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		7e-17
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		7e-17
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		7e-17
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		7e-17
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		7e-17
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		7e-17
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		8e-17
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		8e-17
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		8e-17
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		8e-17
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		8e-17
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		9e-17
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		9e-17
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		9e-17
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		9e-17
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		9e-17
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		9e-17
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-16
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		1e-16
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		1e-16
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-16
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		1e-16
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		1e-16
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-16
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		1e-16
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		1e-16
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		1e-16
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-16
1x8b_A	289	Structure Of Human Wee1a Kinase: Kinase Domain Comp		1e-16
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		1e-16
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		1e-16
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		1e-16
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		1e-16
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		1e-16
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		1e-16
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-16
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		1e-16
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		1e-16
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		1e-16
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		1e-16
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-16
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		1e-16
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		1e-16
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		1e-16
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		2e-16
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		2e-16
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		2e-16
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		2e-16
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		2e-16
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		2e-16
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		2e-16
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		2e-16
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		2e-16
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		2e-16
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		2e-16
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		2e-16
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		2e-16
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		2e-16
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		2e-16
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		2e-16
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		2e-16
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		2e-16
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		2e-16
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		2e-16
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		2e-16
3hec_A	348	P38 In Complex With Imatinib Length = 348		2e-16
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		2e-16
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		2e-16
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		2e-16
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		2e-16
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		2e-16
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		2e-16
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		2e-16
2oza_B	366	Structure Of P38alpha Complex Length = 366		2e-16
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		2e-16
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		2e-16
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		3e-16
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		3e-16
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		3e-16
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		3e-16
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		3e-16
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		3e-16
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		3e-16
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		4e-16
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		4e-16
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		4e-16
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-16
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		5e-16
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		6e-16
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		7e-16
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		9e-16
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		9e-16
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		9e-16
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		9e-16
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		1e-15
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		1e-15
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		2e-15
2z2w_A	285	Humand Wee1 Kinase Complexed With Inhibitor Pf03357		2e-15
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-15
3bi6_A	287	Wee1 Kinase Complex With Inhibitor Pd352396 Length		2e-15
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		2e-15
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		2e-15
2in6_A	287	Wee1 Kinase Complex With Inhibitor Pd311839 Length		2e-15
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		2e-15
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		2e-15
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		3e-15
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		4e-15
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		5e-15
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		5e-15
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		5e-15
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-15
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		6e-15
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		6e-15
2iwi_A	312	Crystal Structure Of The Human Pim2 In Complex With		7e-15
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		8e-15
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		8e-15
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		8e-15
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		9e-15
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		1e-14
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		1e-14
3vn9_A	340	Rifined Crystal Structure Of Non-Phosphorylated Map		2e-14
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		3e-14
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		3e-14
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		4e-14
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		4e-14
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-14
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		5e-14
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		5e-14
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		5e-14
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		5e-14
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		6e-14
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		6e-14
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		6e-14
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		6e-14
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		6e-14
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		6e-14
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		7e-14
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		7e-14
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		7e-14
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		8e-14
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		8e-14
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		8e-14
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		8e-14
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		8e-14
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		8e-14
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-14
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		9e-14
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		9e-14
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-13
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		1e-13
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		1e-13
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		1e-13
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-13
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		1e-13
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-13
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		1e-13
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		1e-13
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		1e-13
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-13
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-13
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-13
3fme_A	290	Crystal Structure Of Human Mitogen-Activated Protei		1e-13
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		2e-13
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		2e-13
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		2e-13
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		2e-13
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		2e-13
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		3e-13
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		3e-13
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		3e-13
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		3e-13
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		3e-13
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		3e-13
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		3e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		4e-13
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		4e-13
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		4e-13
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		4e-13
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		4e-13
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		4e-13
3ppz_A	309	Crystal Structure Of Ctr1 Kinase Domain In Complex		5e-13
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		5e-13
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		5e-13
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		5e-13
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		6e-13
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		6e-13
3p86_A	309	Crystal Structure Of Ctr1 Kinase Domain Mutant D676		6e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		7e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		7e-13
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		7e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		7e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		7e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		7e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		7e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		7e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-13
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		8e-13
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		8e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		8e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		8e-13
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		8e-13
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		9e-13
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		9e-13
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		9e-13
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-12
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		1e-12
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		1e-12
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		1e-12
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-12
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		2e-12
2dyl_A	318	Crystal Structure Of Human Mitogen-Activated Protei		2e-12
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		2e-12
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		3e-12
3a4o_X	286	Lyn Kinase Domain Length = 286		4e-12
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-12
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		6e-12
3enm_A	316	The Structure Of The Map2k Mek6 Reveals An Autoinhi		9e-12
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		2e-11
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		2e-11
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-11
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		3e-11
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		3e-11
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		3e-11
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-11
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-11
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		4e-11
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		4e-11
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		4e-11
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		4e-11
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		4e-11
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		4e-11
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		4e-11
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		5e-11
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		5e-11
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		5e-11
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		5e-11
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		6e-11
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		6e-11
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		6e-11
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		6e-11
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-11
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		6e-11
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		6e-11
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		7e-11
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		7e-11
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		8e-11
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		9e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		9e-11
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		1e-10
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-10
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		1e-10
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		1e-10
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		1e-10
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		1e-10
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		1e-10
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		1e-10
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		1e-10
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		2e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		2e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		2e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		2e-10
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		2e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		2e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		2e-10
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		2e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		2e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		2e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		2e-10
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		2e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		2e-10
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		2e-10
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-10
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		2e-10
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		3e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		3e-10
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		3e-10
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		4e-10
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		4e-10
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		5e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		7e-10
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		7e-10
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		7e-10
3uys_A	296	Crystal Structure Of Apo Human Ck1d Length = 296		8e-10
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-10
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		1e-09
1ckj_A	317	Casein Kinase I Delta Truncation Mutant Containing		1e-09
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		1e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		1e-09
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-09
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-09
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		2e-09
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		2e-09
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		2e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		2e-09
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-09
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		3e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		3e-09
4hni_A	296	Crystal Structure Of Ck1e In Complex With Pf4800567		3e-09
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		3e-09
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-09
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		3e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-09
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		3e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		3e-09
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		3e-09
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		3e-09
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		3e-09
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-09
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-09
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-09
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		4e-09
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		4e-09
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		4e-09
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		4e-09
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		4e-09
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-09
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-09
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		4e-09
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-09
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		5e-09
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-09
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		5e-09
2pzi_A	681	Crystal Structure Of Protein Kinase Pkng From Mycob		5e-09
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		5e-09
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		6e-09
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		6e-09
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		6e-09
4f0f_A	287	Crystal Structure Of The Roco4 Kinase Domain Bound		9e-09
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
3fpq_A	290	Crystal Structure Of The Kinase Domain Of Wnk1 Leng		1e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		1e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		1e-08
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		1e-08
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		1e-08
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		1e-08
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		1e-08
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		1e-08
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-08
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-08
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		1e-08
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-08
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-08
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-08
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		1e-08
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		1e-08
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		2e-08
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		2e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		2e-08
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		2e-08
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		3e-08
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		3e-08
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		4e-08
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		4e-08
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		4e-08
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		4e-08
4f1o_A	287	Crystal Structure Of The L1180t Mutant Roco4 Kinase		4e-08
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		4e-08
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		4e-08
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-08
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		5e-08
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		5e-08
4f1m_A	287	Crystal Structure Of The G1179s Roco4 Kinase Domain		5e-08
4h58_A	275	Braf In Complex With Compound 3 Length = 275		5e-08
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		6e-08
3sxr_A	268	Crystal Structure Of Bmx Non-Receptor Tyrosine Kina		7e-08
3pp0_A	338	Crystal Structure Of The Kinase Domain Of Human Her		8e-08
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		9e-08
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		1e-07
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-07
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		1e-07
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-07
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-07
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		1e-07
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-07
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-07
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-07
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		1e-07
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-07
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-07
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		1e-07
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-07
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-07
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-07
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-07
3b2t_A	311	Structure Of Phosphotransferase Length = 311		2e-07
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-07
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		2e-07
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-07
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		2e-07
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		2e-07
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		2e-07
3sv0_A	483	Crystal Structure Of Casein Kinase-1 Like Protein I		3e-07
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		3e-07
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		3e-07
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		3e-07
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		4e-07
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		4e-07
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		4e-07
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		4e-07
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		5e-07
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		5e-07
2wtk_B	373	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-07
3gni_B	389	Structure Of Strad And Mo25 Length = 389		5e-07
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		6e-07
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		6e-07
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		6e-07
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		6e-07
4h1j_A	293	Crystal Structure Of Pyk2 With The Pyrazole 13a Len		7e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		7e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		7e-07
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		7e-07
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		7e-07
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		7e-07
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-07
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		7e-07
3fzo_A	277	Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin		7e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		8e-07
3cc6_A	281	Crystal Structure Of Kinase Domain Of Protein Tyros		8e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		8e-07
3tl8_A	349	The Avrptob-Bak1 Complex Reveals Two Structurally S		8e-07
1fvr_A	327	Tie2 Kinase Domain Length = 327		9e-07
2oo8_X	317	Synthesis, Structural Analysis, And Sar Studies Of		9e-07
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		9e-07
4fl3_A	635	Structural And Biophysical Characterization Of The		1e-06
4fl2_A	636	Structural And Biophysical Characterization Of The		1e-06
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		1e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		1e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		1e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		1e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		1e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		1e-06
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		1e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		1e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		1e-06
4fnw_A	327	Crystal Structure Of The Apo F1174l Anaplastic Lymp		1e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		1e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		1e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		1e-06
3w2o_A	331	Egfr Kinase Domain T790m/l858r Mutant With Tak-285		1e-06
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		1e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-06
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-06
4i1z_A	329	Crystal Structure Of The Monomeric (v948r) Form Of		2e-06
2yfx_A	327	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
2yhv_A	342	Structure Of L1196m Mutant Anaplastic Lymphoma Kina		2e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		2e-06
4i21_A	329	Crystal Structure Of L858r + T790m Egfr Kinase Doma		2e-06
2yjr_A	342	Structure Of F1174l Mutant Anaplastic Lymphoma Kina		2e-06
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		2e-06
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		2e-06
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		2e-06
3lmg_A	344	Crystal Structure Of The Erbb3 Kinase Domain In Com		2e-06
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		2e-06
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		2e-06
3kex_A	325	Crystal Structure Of The Catalytically Inactive Kin		2e-06
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		2e-06
4fnx_A	327	Crystal Structure Of The Apo R1275q Anaplastic Lymp		2e-06
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		2e-06
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		3e-06
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		3e-06
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		3e-06
2wqb_A	324	Structure Of The Tie2 Kinase Domain In Complex With		3e-06
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		3e-06
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		3e-06
4dce_A	333	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		3e-06
4fob_A	353	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
4fnz_A	327	Crystal Structure Of Human Anaplastic Lymphoma Kina		3e-06
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		4e-06
3aox_A	344	X-Ray Crystal Structure Of Human Anaplastic Lymphom		4e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		4e-06
2xp2_A	327	Structure Of The Human Anaplastic Lymphoma Kinase I		4e-06
2yjs_A	342	Structure Of C1156y Mutant Anaplastic Lymphoma Kina		4e-06
2xb7_A	315	Structure Of Human Anaplastic Lymphoma Kinase In Co		4e-06
3uim_A	326	Structural Basis For The Impact Of Phosphorylation		4e-06
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		5e-06
3lct_A	344	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-06
3l9p_A	367	Crystal Structure Of The Anaplastic Lymphoma Kinase		6e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		6e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		6e-06
4i20_A	329	Crystal Structure Of Monomeric (v948r) Primary Onco		7e-06
2eb3_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (L8		7e-06
2itt_A	327	Crystal Structure Of Egfr Kinase Domain L858r Mutat		8e-06
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		1e-05
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		2e-05
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		2e-05
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-05
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-05
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		2e-05
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-05
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-05
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-05
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		3e-05
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-05
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		3e-05
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		3e-05
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		4e-05
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-05
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		4e-05
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-05
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		4e-05
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-05
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-05
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-05
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		4e-05
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		5e-05
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		5e-05

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score =  179 bits (455), Expect = 2e-45,   Method: Compositional matrix adjust.
 Identities = 92/254 (36%), Positives = 149/254 (58%), Gaps = 10/254 (3%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLH 163
           +EV+G G F  V+L + + +G  FA K ++K     + ++  E+ +++ +  H  +VTL 
Sbjct: 14  MEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLE 72
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            +YE    ++LVM+L SGG L D+++E G Y+E+ A+ + + V+  +KY H+ G+VHRD+
Sbjct: 73  DIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDL 132
Query: 224 KPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           KPEN+L  T   + KI + DFGL+    NG  +S   G+P YVAPEVL+   YS+ VD W
Sbjct: 133 KPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCW 191
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF  ++   +F+ IK    +F S  W+ +S+ A+D +  +L +D +
Sbjct: 192 SIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPN 251
Query: 340 ARITADEVLRHPWI 353
            R T ++ L HPWI
Sbjct: 252 ERYTCEKALSHPWI 265

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score =  178 bits (451), Expect = 7e-45,   Method: Compositional matrix adjust.
 Identities = 95/260 (36%), Positives = 139/260 (53%), Gaps = 10/260 (3%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLH 163
           ++G G FG V  C+ + +  E+A K + K         T+ REVE+++ L  H  ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLF 87
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            + E++  F++V EL +GG L D++++  ++SE  AA I K V   I Y H   +VHRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 224 KPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPENILL +  K   IK+ DFGL+        +    G+  Y+APEVL G Y EK D+WS
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWS 207
Query: 281 XXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                        PF G +   +   ++  K  F    W T+S  A+DL+ +MLT   S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 341 RITADEVLRHPWILFYTERT 360
           RITA + L HPWI  Y+  T
Sbjct: 268 RITATQCLEHPWIQKYSSET 287

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 90/254 (35%), Positives = 141/254 (55%), Gaps = 10/254 (3%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-----TLRKGEETVHREVEIMQHLSGHTGVVTLH 163
           E +G G F  V L   KA+G  FA K      L+  E ++  E+ +++ +  H  +V L 
Sbjct: 28  ETLGTGAFSEVVLAEEKATGKLFAVKCIPKKALKGKESSIENEIAVLRKIK-HENIVALE 86
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            +YE  +  +LVM+L SGG L D++VE G Y+E+ A+ + + V+  + Y H MG+VHRD+
Sbjct: 87  DIYESPNHLYLVMQLVSGGELFDRIVEKGFYTEKDASTLIRQVLDAVYYLHRMGIVHRDL 146
Query: 224 KPENILLTTS---GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           KPEN+L  +     KI ++DFGL+     G  +S   G+P YVAPEVL+   YS+ VD W
Sbjct: 147 KPENLLYYSQDEESKIMISDFGLSKMEGKGDVMSTACGTPGYVAPEVLAQKPYSKAVDCW 206
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF  ++   +F+ I   + +F S  W+ +S  A+D +  ++ +D +
Sbjct: 207 SIGVIAYILLCGYPPFYDENDSKLFEQILKAEYEFDSPYWDDISDSAKDFIRNLMEKDPN 266
Query: 340 ARITADEVLRHPWI 353
            R T ++  RHPWI
Sbjct: 267 KRYTCEQAARHPWI 280

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 138/257 (53%), Gaps = 10/257 (3%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLH 163
           ++G G FG V  C+ + +  E+A K + K         T+ REVE+++ L  H  ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLF 87
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            + E++  F++V EL +GG L D++++  ++SE  AA I K V   I Y H   +VHRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 224 KPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPENILL +  K   IK+ DFGL+        +    G+  Y+APEVL G Y EK D+WS
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWS 207
Query: 281 XXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                        PF G +   +   ++  K  F    W T+S  A+DL+ +MLT   S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 341 RITADEVLRHPWILFYT 357
           RITA + L HPWI  Y+
Sbjct: 268 RITATQCLEHPWIQKYS 284

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score =  174 bits (442), Expect = 6e-44,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 138/257 (53%), Gaps = 10/257 (3%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLH 163
           ++G G FG V  C+ + +  E+A K + K         T+ REVE+++ L  H  ++ L 
Sbjct: 29  MLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLF 87
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            + E++  F++V EL +GG L D++++  ++SE  AA I K V   I Y H   +VHRD+
Sbjct: 88  EILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDL 147
Query: 224 KPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
           KPENILL +  K   IK+ DFGL+        +    G+  Y+APEVL G Y EK D+WS
Sbjct: 148 KPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRGTYDEKCDVWS 207
Query: 281 XXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                        PF G +   +   ++  K  F    W T+S  A+DL+ +MLT   S 
Sbjct: 208 AGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLTFHPSL 267
Query: 341 RITADEVLRHPWILFYT 357
           RITA + L HPWI  Y+
Sbjct: 268 RITATQCLEHPWIQKYS 284

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 96/269 (35%), Positives = 145/269 (53%), Gaps = 11/269 (4%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVE 148
           M    K  D++   E +G G F  V  C  K +G EFA K +   +      + + RE  
Sbjct: 21  MNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREAR 80
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I + L  H  +V LH   +E    +LV +L +GG L + +V    YSE  A++  + ++ 
Sbjct: 81  ICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILE 139
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            I YCH  G+VHR++KPEN+LL +  K   +KLADFGLA+ +++ +   G AG+P Y++P
Sbjct: 140 SIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSP 199
Query: 266 EVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           EVL  + YS+ VDIW+             PF  +    ++  IK    D+ S  W+TV+ 
Sbjct: 200 EVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTP 259
Query: 325 PARDLMARMLTRDVSARITADEVLRHPWI 353
            A+ L+  MLT +   RITAD+ L+ PWI
Sbjct: 260 EAKSLIDSMLTVNPKKRITADQALKVPWI 288

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 144/262 (54%), Gaps = 11/262 (4%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V LC+ K +G E A K + K        +E++ REV++++ L  H  ++ L
Sbjct: 56  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 114
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  I Y H   +VHRD
Sbjct: 115 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 174
Query: 223 IKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIW 279
           +KPEN+LL +  K   I++ DFGL+      + +    G+  Y+APEVL G Y EK D+W
Sbjct: 175 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVW 234
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF G +   +   ++  K  F    W+ VS+ A+DL+ +MLT   S
Sbjct: 235 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 294
Query: 340 ARITADEVLRHPWILFYTERTL 361
            RI+A + L H WI  YT+  +
Sbjct: 295 MRISARDALDHEWIQTYTKEQI 316

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 144/262 (54%), Gaps = 11/262 (4%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V LC+ K +G E A K + K        +E++ REV++++ L  H  ++ L
Sbjct: 57  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 115
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  I Y H   +VHRD
Sbjct: 116 YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 175
Query: 223 IKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIW 279
           +KPEN+LL +  K   I++ DFGL+      + +    G+  Y+APEVL G Y EK D+W
Sbjct: 176 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVW 235
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF G +   +   ++  K  F    W+ VS+ A+DL+ +MLT   S
Sbjct: 236 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 295
Query: 340 ARITADEVLRHPWILFYTERTL 361
            RI+A + L H WI  YT+  +
Sbjct: 296 MRISARDALDHEWIQTYTKEQI 317

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 93/262 (35%), Positives = 144/262 (54%), Gaps = 11/262 (4%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V LC+ K +G E A K + K        +E++ REV++++ L  H  ++ L
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKL 91
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  I Y H   +VHRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRD 151
Query: 223 IKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIW 279
           +KPEN+LL +  K   I++ DFGL+      + +    G+  Y+APEVL G Y EK D+W
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTYDEKCDVW 211
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF G +   +   ++  K  F    W+ VS+ A+DL+ +MLT   S
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPS 271
Query: 340 ARITADEVLRHPWILFYTERTL 361
            RI+A + L H WI  YT+  +
Sbjct: 272 MRISARDALDHEWIQTYTKEQI 293

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score =  172 bits (436), Expect = 4e-43,   Method: Compositional matrix adjust.
 Identities = 94/266 (35%), Positives = 145/266 (54%), Gaps = 11/266 (4%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           D +    V+G G FG V LC+ K +G E A K + K +       E++ REV++++ L  
Sbjct: 32  DRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ L+  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  I Y H 
Sbjct: 91  HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHK 150
Query: 216 MGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY 272
             +VHRD+KPEN+LL +  K   I++ DFGL+      + +    G+  Y+APEVL G Y
Sbjct: 151 NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHGTY 210
Query: 273 SEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
            EK D+WS             PF G +   +   ++  K  F    W+ VS+ A+DL+ +
Sbjct: 211 DEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRK 270
Query: 333 MLTRDVSARITADEVLRHPWILFYTE 358
           MLT   S RI+A + L H WI  YT+
Sbjct: 271 MLTYVPSMRISARDALDHEWIQTYTK 296

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score =  171 bits (432), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQH 152
            K  D++   E +G G F  V  C  K +G EFA K +   +      + + RE  I + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  +V LH   +E    +LV +L +GG L + +V    YSE  A++  + ++  I Y
Sbjct: 62  LQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           CH  G+VHR++KPEN+LL +  K   +KLADFGLA+ +++ +   G AG+P Y++PEVL 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            + YS+ VDIW+             PF  +    ++  IK    D+ S  W+TV+  A+ 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+  MLT +   RITAD+ L+ PWI
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score =  170 bits (431), Expect = 1e-42,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQH 152
            K  D++   E +G G F  V  C  K +G EFA K +   +      + + RE  I + 
Sbjct: 2   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 61
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  +V LH   +E    +LV +L +GG L + +V    YSE  A++  + ++  I Y
Sbjct: 62  LQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 120
Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           CH  G+VHR++KPEN+LL +  K   +KLADFGLA+ +++ +   G AG+P Y++PEVL 
Sbjct: 121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 180
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            + YS+ VDIW+             PF  +    ++  IK    D+ S  W+TV+  A+ 
Sbjct: 181 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 240
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+  MLT +   RITAD+ L+ PWI
Sbjct: 241 LIDSMLTVNPKKRITADQALKVPWI 265

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/265 (35%), Positives = 144/265 (54%), Gaps = 11/265 (4%)
Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQH 152
            K  D++   E +G G F  V  C  K +G EFA K +   +      + + RE  I + 
Sbjct: 1   TKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRK 60
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  +V LH   +E    +LV +L +GG L + +V    YSE  A++  + ++  I Y
Sbjct: 61  LQ-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAY 119
Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           CH  G+VHR++KPEN+LL +  K   +KLADFGLA+ +++ +   G AG+P Y++PEVL 
Sbjct: 120 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLK 179
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            + YS+ VDIW+             PF  +    ++  IK    D+ S  W+TV+  A+ 
Sbjct: 180 KDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKS 239
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+  MLT +   RITAD+ L+ PWI
Sbjct: 240 LIDSMLTVNPKKRITADQALKVPWI 264

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 91/266 (34%), Positives = 143/266 (53%), Gaps = 10/266 (3%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIM 150
           +K  + + + +V+ +G G +G V LCR K +  E A K +RK          +  EV ++
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + L  H  ++ L+  +E+   ++LVME   GG L D+++   +++E  AA I K V+  +
Sbjct: 91  KLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149
Query: 211 KYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            Y H   +VHRD+KPEN+LL +  K   IK+ DFGL+    N + +    G+  Y+APEV
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209
Query: 268 LSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
           L   Y EK D+WS             PF G + + +   ++  K  F S  W+ VS+ A+
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+ +ML  D   RI+A + L HPWI
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWI 295

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score =  170 bits (430), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/273 (34%), Positives = 146/273 (53%), Gaps = 15/273 (5%)
Query: 96  GRKN----KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VH 144
           GR+N     + D + +V+ +G G +G V LC+ K +GAE A K ++K   T       + 
Sbjct: 10  GRENLYFQGLSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALL 69
Query: 145 REVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK 204
            EV +++ L  H  ++ L+  +E+   ++LVME+  GG L D+++   ++SE  AA I K
Sbjct: 70  DEVAVLKQLD-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMK 128
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPA 261
            V+    Y H   +VHRD+KPEN+LL +  +   IK+ DFGL+     G  +    G+  
Sbjct: 129 QVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAY 188
Query: 262 YVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           Y+APEVL   Y EK D+WS             PF G + + +   ++  K  F    W  
Sbjct: 189 YIAPEVLRKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQ 248
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS  A+ L+  MLT + S RI+A+E L HPWI+
Sbjct: 249 VSDEAKQLVKLMLTYEPSKRISAEEALNHPWIV 281

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score =  169 bits (427), Expect = 4e-42,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 142/264 (53%), Gaps = 11/264 (4%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHREVEIMQHL 153
           + D + +V+ +G G +G V LC+ K +GAE A K ++K   T       +  EV +++ L
Sbjct: 2   LSDRYQRVKKLGSGAYGEVLLCKDKLTGAERAIKIIKKSSVTTTSNSGALLDEVAVLKQL 61
Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
             H  ++ L+  +E+   ++LVME+  GG L D+++   ++SE  AA I K V+    Y 
Sbjct: 62  D-HPNIMKLYEFFEDKRNYYLVMEVYRGGELFDEIILRQKFSEVDAAVIMKQVLSGTTYL 120
Query: 214 HDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
           H   +VHRD+KPEN+LL +  +   IK+ DFGL+     G  +    G+  Y+APEVL  
Sbjct: 121 HKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVGGKMKERLGTAYYIAPEVLRK 180
Query: 271 NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
            Y EK D+WS             PF G + + +   ++  K  F    W  VS  A+ L+
Sbjct: 181 KYDEKCDVWSCGVILYILLCGYPPFGGQTDQEILKRVEKGKFSFDPPDWTQVSDEAKQLV 240
Query: 331 ARMLTRDVSARITADEVLRHPWIL 354
             MLT + S RI+A+E L HPWI+
Sbjct: 241 KLMLTYEPSKRISAEEALNHPWIV 264

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score =  168 bits (426), Expect = 5e-42,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 141/262 (53%), Gaps = 11/262 (4%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V LC+ K +G E A K + K        +E++ REV++++ L  H  +  L
Sbjct: 33  VLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIXKL 91
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  I Y H   +VHRD
Sbjct: 92  YEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYXHKNKIVHRD 151
Query: 223 IKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIW 279
           +KPEN+LL +  K   I++ DFGL+      +      G+  Y+APEVL G Y EK D+W
Sbjct: 152 LKPENLLLESKSKDANIRIIDFGLSTHFEASKKXKDKIGTAYYIAPEVLHGTYDEKCDVW 211
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S             PF G +   +   ++  K  F    W+ VS+ A+DL+ + LT   S
Sbjct: 212 STGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKXLTYVPS 271
Query: 340 ARITADEVLRHPWILFYTERTL 361
            RI+A + L H WI  YT+  +
Sbjct: 272 XRISARDALDHEWIQTYTKEQI 293

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score =  167 bits (423), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 95/264 (35%), Positives = 144/264 (54%), Gaps = 12/264 (4%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLS 154
           + D++   E IG G F  V  C    +G E+A K +       +  + + RE  I + L 
Sbjct: 2   MTDEYQLYEDIGKGAFSVVRRCVKLCTGHEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            H+ +V LH    E    +LV +L +GG L + +V    YSE  A++  + ++  + +CH
Sbjct: 62  -HSNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCH 120
Query: 215 DMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG 270
            MGVVHRD+KPEN+LL +  K   +KLADFGLA+ +  + Q   G AG+P Y++PEVL  
Sbjct: 121 QMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 271 N-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
             Y + VDIW+             PF  +    ++  IK    DF S  W+TV+  A++L
Sbjct: 181 EAYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYDFPSPEWDTVTPEAKNL 240
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +MLT + + RITA E L+HPW+
Sbjct: 241 INQMLTINPAKRITAHEALKHPWV 264

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score =  167 bits (422), Expect = 1e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 141/262 (53%), Gaps = 10/262 (3%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSG 155
           I D +   +V+G G F  V L   K +    A K + K      E ++  E+ ++ H   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVL-HKIK 74
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L  +YE     +L+M+L SGG L D++VE G Y+E+ A+ +   V+  +KY HD
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 216 MGVVHRDIKPENIL---LTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           +G+VHRD+KPEN+L   L    KI ++DFGL+     G  LS   G+P YVAPEVL+   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           YS+ VD WS             PF  ++   +F+ I   + +F S  W+ +S  A+D + 
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 332 RMLTRDVSARITADEVLRHPWI 353
            ++ +D   R T ++ L+HPWI
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 141/262 (53%), Gaps = 10/262 (3%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSG 155
           I D +   +V+G G F  V L   K +    A K + K      E ++  E+ ++ H   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL-HKIK 74
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L  +YE     +L+M+L SGG L D++VE G Y+E+ A+ +   V+  +KY HD
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 216 MGVVHRDIKPENIL---LTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           +G+VHRD+KPEN+L   L    KI ++DFGL+     G  LS   G+P YVAPEVL+   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           YS+ VD WS             PF  ++   +F+ I   + +F S  W+ +S  A+D + 
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 332 RMLTRDVSARITADEVLRHPWI 353
            ++ +D   R T ++ L+HPWI
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 141/262 (53%), Gaps = 10/262 (3%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSG 155
           I D +   +V+G G F  V L   K +    A K + K      E ++  E+ ++ H   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL-HKIK 74
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L  +YE     +L+M+L SGG L D++VE G Y+E+ A+ +   V+  +KY HD
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 216 MGVVHRDIKPENIL---LTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           +G+VHRD+KPEN+L   L    KI ++DFGL+     G  LS   G+P YVAPEVL+   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           YS+ VD WS             PF  ++   +F+ I   + +F S  W+ +S  A+D + 
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 332 RMLTRDVSARITADEVLRHPWI 353
            ++ +D   R T ++ L+HPWI
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 142/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I +V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score =  167 bits (422), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 141/262 (53%), Gaps = 10/262 (3%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSG 155
           I D +   +V+G G F  V L   K +    A K + K      E ++  E+ ++ H   
Sbjct: 16  IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKEALEGKEGSMENEIAVL-HKIK 74
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L  +YE     +L+M+L SGG L D++VE G Y+E+ A+ +   V+  +KY HD
Sbjct: 75  HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHD 134
Query: 216 MGVVHRDIKPENIL---LTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           +G+VHRD+KPEN+L   L    KI ++DFGL+     G  LS   G+P YVAPEVL+   
Sbjct: 135 LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKP 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           YS+ VD WS             PF  ++   +F+ I   + +F S  W+ +S  A+D + 
Sbjct: 195 YSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDFIR 254
Query: 332 RMLTRDVSARITADEVLRHPWI 353
            ++ +D   R T ++ L+HPWI
Sbjct: 255 HLMEKDPEKRFTCEQALQHPWI 276

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I  V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 143/264 (54%), Gaps = 12/264 (4%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLS 154
           + D++   E +G G F  V  C    +G E+A K +       +  + + RE  I + L 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            H  +V LH    E    +LV +L +GG L + +V    YSE  A++  + ++  + +CH
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 215 DMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG 270
             G+VHRD+KPEN+LL +  K   +KLADFGLA+ +  + Q   G AG+P Y++PEVL  
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 271 N-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           + Y + VD+W+             PF  +    ++  IK    DF S  W+TV+  A+DL
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +MLT + + RITA E L+HPWI
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 142/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I +V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score =  166 bits (421), Expect = 2e-41,   Method: Compositional matrix adjust.
 Identities = 92/274 (33%), Positives = 141/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  ++TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I  V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score =  166 bits (420), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 142/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I +V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score =  166 bits (419), Expect = 3e-41,   Method: Compositional matrix adjust.
 Identities = 93/274 (33%), Positives = 141/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K +          E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVLHH-NVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     I  V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + ++L ++   R+T  E LRHPWI
Sbjct: 243 SQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 140/274 (51%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+PA+
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPAF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score =  165 bits (418), Expect = 4e-41,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 143/264 (54%), Gaps = 12/264 (4%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLS 154
           + D++   E +G G F  V  C    +G E+A K +       +  + + RE  I + L 
Sbjct: 2   MTDEYQLFEELGKGAFSVVRRCMKIPTGQEYAAKIINTKKLSARDHQKLEREARICRLLK 61
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            H  +V LH    E    +LV +L +GG L + +V    YSE  A++  + ++  + +CH
Sbjct: 62  -HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEADASHCIQQILESVNHCH 120
Query: 215 DMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG 270
             G+VHRD+KPEN+LL +  K   +KLADFGLA+ +  + Q   G AG+P Y++PEVL  
Sbjct: 121 LNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEVQGDQQAWFGFAGTPGYLSPEVLRK 180
Query: 271 N-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           + Y + VD+W+             PF  +    ++  IK    DF S  W+TV+  A+DL
Sbjct: 181 DPYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDL 240
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +MLT + + RITA E L+HPWI
Sbjct: 241 INKMLTINPAKRITASEALKHPWI 264

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score =  165 bits (417), Expect = 6e-41,   Method: Compositional matrix adjust.
 Identities = 92/277 (33%), Positives = 140/277 (50%), Gaps = 21/277 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------------- 140
           ++ KI + + KV  +G G +G V LC+ K   +E A K ++K +                
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89
Query: 141 -ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA 199
            E ++ E+ +++ L  H  ++ L  V+E+   F+LV E   GG L +Q++   ++ E  A
Sbjct: 90  HEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMRISNGQTLSGL 256
           ANI K ++  I Y H   +VHRDIKPENILL        IK+ DFGL+   S    L   
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208
Query: 257 AGSPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHS 316
            G+  Y+APEVL   Y+EK D+WS             PF G + + +   ++  K  F  
Sbjct: 209 LGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268
Query: 317 GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             W+ +S  A++L+  MLT D + R TA+E L   WI
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score =  164 bits (415), Expect = 9e-41,   Method: Compositional matrix adjust.
 Identities = 94/256 (36%), Positives = 139/256 (54%), Gaps = 12/256 (4%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLSGHTGVVTL 162
           E +G G F  V  C    +G E+A K +       +  + + RE  I + L  H  +V L
Sbjct: 28  EELGKGAFSVVRRCVKVLAGQEYAAKIINTKKLSARDHQKLEREARICRLLK-HPNIVRL 86
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           H    E    +L+ +L +GG L + +V    YSE  A++  + ++  + +CH MGVVHRD
Sbjct: 87  HDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRD 146
Query: 223 IKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +KPEN+LL +  K   +KLADFGLA+ +    Q   G AG+P Y++PEVL  + Y + VD
Sbjct: 147 LKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVD 206
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           +W+             PF  +    ++  IK    DF S  W+TV+  A+DL+ +MLT +
Sbjct: 207 LWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKDLINKMLTIN 266
Query: 338 VSARITADEVLRHPWI 353
            S RITA E L+HPWI
Sbjct: 267 PSKRITAAEALKHPWI 282

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score =  164 bits (415), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 88/274 (32%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G GKF  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGKFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score =  164 bits (414), Expect = 1e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score =  163 bits (413), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 183 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 183 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 240
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 241 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score =  163 bits (412), Expect = 2e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 139/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 92/266 (34%), Positives = 142/266 (53%), Gaps = 12/266 (4%)
Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQH 152
            +  +++   E +G G F  V  C    +G E+A   +       +  + + RE  I + 
Sbjct: 7   TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  +V LH    E    +L+ +L +GG L + +V    YSE  A++  + ++  + +
Sbjct: 67  LK-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLH 125
Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL 268
           CH MGVVHR++KPEN+LL +  K   +KLADFGLA+ +    Q   G AG+P Y++PEVL
Sbjct: 126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVL 185
Query: 269 SGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
             + Y + VD+W+             PF  +    ++  IK    DF S  W+TV+  A+
Sbjct: 186 RKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAK 245
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+ +MLT + S RITA E L+HPWI
Sbjct: 246 DLINKMLTINPSKRITAAEALKHPWI 271

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 107/348 (30%), Positives = 174/348 (50%), Gaps = 36/348 (10%)
Query: 47  DAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHT 106
           D GT+ +  F+S  +  A+A P   ++SLVP            D       ++ + D   
Sbjct: 12  DLGTENL-YFQSMSSVTASAAP--GTASLVP------------DYWIDGSNRDALSDFFE 56
Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHS 164
               +G G    V+ C+ K +   +A K L+K   ++ V  E+ ++  LS H  ++ L  
Sbjct: 57  VESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKE 115
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           ++E      LV+EL +GG L D++VE G YSE+ AA+  K ++  + Y H+ G+VHRD+K
Sbjct: 116 IFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLK 175
Query: 225 PENILLTTS---GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
           PEN+L  T      +K+ADFGL+  + +   +  + G+P Y APE+L G  Y  +VD+WS
Sbjct: 176 PENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWS 235
Query: 281 XXXXXXXXXXXXXPF---KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
                        PF   +GD    +F  I N +  F S  W+ VS  A+DL+ +++  D
Sbjct: 236 VGIITYILLCGFEPFYDERGDQF--MFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLD 293
Query: 338 VSARITADEVLRHPWI---------LFYTERTLRTLTIKSKLKNQVGA 376
              R+T  + L+HPW+         +   ++ L+    + KLK  V A
Sbjct: 294 PKKRLTTFQALQHPWVTGKAANFVHMDTAQKKLQEFNARRKLKAAVKA 341

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score =  161 bits (408), Expect = 6e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGVFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score =  161 bits (407), Expect = 9e-40,   Method: Compositional matrix adjust.
 Identities = 87/274 (31%), Positives = 138/274 (50%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L+ EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILIGELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF GD+ +     +  V  +F    +
Sbjct: 184 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYF 241
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 242 SNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 275

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score =  160 bits (404), Expect = 2e-39,   Method: Compositional matrix adjust.
 Identities = 94/280 (33%), Positives = 146/280 (52%), Gaps = 13/280 (4%)
Query: 86  IGCIDVHTQ-MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------K 138
           +G  +++ Q M    +  DD+   E +G G F  V  C  K    E+A K +       +
Sbjct: 13  LGTENLYFQXMATCTRFTDDYQLFEELGKGAFSVVRRCVKKTPTQEYAAKIINTKKLSAR 72
Query: 139 GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
             + + RE  I + L  H  +V LH    E    +LV +L +GG L + +V    YSE  
Sbjct: 73  DHQKLEREARICRLLK-HPNIVRLHDSISEEGFHYLVFDLVTGGELFEDIVAREYYSEAD 131
Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLS 254
           A++    ++  + + H   +VHRD+KPEN+LL +  K   +KLADFGLA+ +    Q   
Sbjct: 132 ASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEVQGEQQAWF 191
Query: 255 GLAGSPAYVAPEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G AG+P Y++PEVL  + Y + VDIW+             PF  +    ++  IK    D
Sbjct: 192 GFAGTPGYLSPEVLRKDPYGKPVDIWACGVILYILLVGYPPFWDEDQHKLYQQIKAGAYD 251
Query: 314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           F S  W+TV+  A++L+ +MLT + + RITAD+ L+HPW+
Sbjct: 252 FPSPEWDTVTPEAKNLINQMLTINPAKRITADQALKHPWV 291

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score =  158 bits (400), Expect = 5e-39,   Method: Compositional matrix adjust.
 Identities = 94/271 (34%), Positives = 133/271 (49%), Gaps = 8/271 (2%)
Query: 90  DVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHR--- 145
           +++ Q   K  I   +T    IG G +G V +   K +    A K + K   E V R   
Sbjct: 13  NLYFQGSTKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQ 72
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E+EIM+ L  H  ++ L+  +E+    +LVMELC+GG L +++V    + E  AA I KD
Sbjct: 73  EIEIMKSLD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKD 131
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           V+  + YCH + V HRD+KPEN L  T      +KL DFGLA R   G+ +    G+P Y
Sbjct: 132 VLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYY 191
Query: 263 VAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           V+P+VL G Y  + D WS             PF   +   V   I+     F    W  V
Sbjct: 192 VSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNV 251
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S  A  L+ R+LT+    RIT+ + L H W 
Sbjct: 252 SPQAESLIRRLLTKSPKQRITSLQALEHEWF 282

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score =  157 bits (396), Expect = 1e-38,   Method: Compositional matrix adjust.
 Identities = 88/279 (31%), Positives = 137/279 (49%), Gaps = 20/279 (7%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHREVEIM 150
           +ED +   E +G G+F  V  CR K +G E+A K ++K            E + REV I+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + +  H  ++TLH ++E      L++EL SGG L D + E    +E  A    K ++  +
Sbjct: 63  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121
Query: 211 KYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
            Y H   + H D+KPENI+L      + +IKL DFG+A +I  G     + G+P +VAPE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181
Query: 267 VLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           ++  NY     + D+WS             PF G++ +     I  V  DF    +   S
Sbjct: 182 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 239
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           + A+D + R+L +D   R+T  + L H WI     R +R
Sbjct: 240 ELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVR 278

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score =  156 bits (394), Expect = 2e-38,   Method: Compositional matrix adjust.
 Identities = 93/263 (35%), Positives = 129/263 (49%), Gaps = 8/263 (3%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHR---EVEIMQHL 153
           K  I   +T    IG G +G V +   K +    A K + K   E V R   E+EIM+ L
Sbjct: 4   KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
             H  ++ L+  +E+    +LVMELC+GG L +++V    + E  AA I KDV+  + YC
Sbjct: 64  D-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYC 122
Query: 214 HDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
           H + V HRD+KPEN L  T      +KL DFGLA R   G+ +    G+P YV+P+VL G
Sbjct: 123 HKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEG 182
Query: 271 NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
            Y  + D WS             PF   +   V   I+     F    W  VS  A  L+
Sbjct: 183 LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVMLKIREGTFTFPEKDWLNVSPQAESLI 242
Query: 331 ARMLTRDVSARITADEVLRHPWI 353
            R+LT+    RIT+ + L H W 
Sbjct: 243 RRLLTKSPKQRITSLQALEHEWF 265

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 88/267 (32%), Positives = 143/267 (53%), Gaps = 14/267 (5%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREV 147
           MG +    +D      +G GKFG+V+L R K S    A K L K        E  + REV
Sbjct: 3   MGSRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREV 62
Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
           EI  HL  H  ++ L+  + +A   +L++E    G +  ++ ++ ++ EQR A    ++ 
Sbjct: 63  EIQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELA 121
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             + YCH   V+HRDIKPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE+
Sbjct: 122 NALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-AALCGTLDYLPPEM 180
Query: 268 LSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           + G  + EKVD+WS             PF+ ++ +  +  I  V+  F     + V++ A
Sbjct: 181 IEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGA 236
Query: 327 RDLMARMLTRDVSARITADEVLRHPWI 353
           RDL++R+L  + S R    EVL HPWI
Sbjct: 237 RDLISRLLKHNPSQRPMLREVLEHPWI 263

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score =  155 bits (393), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 254
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 255 MLREVLEHPWI 265

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 86/274 (31%), Positives = 135/274 (49%), Gaps = 20/274 (7%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  +ED +   E +G G+F  V  CR K +G E+A K ++K            E + RE
Sbjct: 6   RQEDVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIERE 65
Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  ++TLH ++E      L++EL SGG L D + E    +E  A    K +
Sbjct: 66  VNILREIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 124
Query: 207 MWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L      + +IKL DFG+A +I  G     + G+P +
Sbjct: 125 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 184
Query: 263 VAPEVLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           VAPE++  NY     + D+WS             PF G++ +     I  V  DF    +
Sbjct: 185 VAPEIV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYF 242
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              S+ A+D + R+L +D   R+   + L H WI
Sbjct: 243 SNTSELAKDFIRRLLVKDPKRRMXIAQSLEHSWI 276

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 100
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 275
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 276 MLREVLEHPWI 286

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score =  155 bits (393), Expect = 4e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 80  GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR-XXLXGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 254
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 255 MLREVLEHPWI 265

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score =  155 bits (391), Expect = 5e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 33  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 91
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 92  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 151
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 152 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 210
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 211 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 266
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 267 MLREVLEHPWI 277

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score =  155 bits (391), Expect = 6e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 139/251 (55%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R + S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 78
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+  + +  +  I  V+  F     + V++ ARDL++R+L  + S R+
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRLLKHNASQRL 253
Query: 343 TADEVLRHPWI 353
           T  EVL HPWI
Sbjct: 254 TLAEVLEHPWI 264

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 252
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 253 MLREVLEHPWI 263

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 42  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 100
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 101 GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 160
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 161 KPENLLLGSAGELKIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 219
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 220 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 275
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 276 MLREVLEHPWI 286

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 75
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 250
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 251 MLREVLEHPWI 261

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-AALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 254
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 255 MLREVLEHPWI 265

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 87/279 (31%), Positives = 136/279 (48%), Gaps = 20/279 (7%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHREVEIM 150
           +ED +   E +G G+F  V  CR K +G E+A K ++K            E + REV I+
Sbjct: 24  VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLXSSRRGVSREEIEREVNIL 83
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + +  H  ++TLH ++E      L++EL SGG L D + E    +E  A    K ++  +
Sbjct: 84  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 142
Query: 211 KYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
            Y H   + H D+KPENI+L      + +IKL DFG+A +I  G     + G+P +VAPE
Sbjct: 143 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 202
Query: 267 VLSGNYSE---KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           ++  NY     + D+WS             PF G++ +     I  V  DF    +   S
Sbjct: 203 IV--NYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTS 260
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           + A+D + R+L +D   R+   + L H WI     R +R
Sbjct: 261 ELAKDFIRRLLVKDPKRRMXIAQSLEHSWIKAIRRRNVR 299

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 198
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 254
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 255 MLREVLEHPWI 265

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score =  154 bits (390), Expect = 8e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score =  154 bits (390), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 75
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG +    + +  + L+G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 136 KPENLLLGSAGELKIADFGWSCHAPSSRR-TTLSGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 250
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 251 MLREVLEHPWI 261

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score =  154 bits (389), Expect = 9e-38,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-TDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-TELCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R + S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 20  LGKGKFGNVYLARERQSKFILALKVLFKTQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 78
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSRFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 139 KPENLLLGSNGELKIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+  + +  +  I  V+  F     + V++ ARDL++R+L  + S R+
Sbjct: 198 VLCYEFLVGMPPFEAHTYQETYRRISRVEFTFP----DFVTEGARDLISRLLKHNASQRL 253
Query: 343 TADEVLRHPWI 353
           T  EVL HPWI
Sbjct: 254 TLAEVLEHPWI 264

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 21  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 80  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 139
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE + G  + EKVD+WS  
Sbjct: 140 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEXIEGRXHDEKVDLWSLG 198
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 199 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 254
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 255 XLREVLEHPWI 265

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 20  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 78
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 79  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 138
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 139 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 197
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 198 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 253
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 254 MLREVLEHPWI 264

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 143/266 (53%), Gaps = 14/266 (5%)
Query: 96  GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVE 148
           G++    +D      +G GKFG+V+L R K S    A K L K        E  + REVE
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I  HL  H  ++ L+  + +A   +L++E    G +  ++ ++ ++ EQR A    ++  
Sbjct: 61  IQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
            + YCH   V+HRDIKPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-TXLCGTLDYLPPEMI 178
Query: 269 SGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
            G  + EKVD+WS             PF+ ++ +  +  I  V+  F     + V++ AR
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGAR 234
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL++R+L  + S R    EVL HPWI
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 76
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 137 KPENLLLGSAGELKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 251
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 252 MLREVLEHPWI 262

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  154 bits (389), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 252
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 253 MLREVLEHPWI 263

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 15  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 73
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 74  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 133
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 134 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 192
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 193 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 248
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 249 MLREVLEHPWI 259

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 17  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 75
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 76  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 135
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 136 KPENLLLGSAGELKIADFGWSVHAPSSRR-DTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 194
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 195 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 250
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 251 MLREVLEHPWI 261

>pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 137/265 (51%), Gaps = 15/265 (5%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVV 160
             D +   E IG G +     C  KA+  E+A K + K +     E+EI+     H  ++
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNII 84
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
           TL  VY++    +LV EL  GG L+D+++    +SE+ A+ +   +   ++Y H  GVVH
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 221 RDIKPENIL-LTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAY----VAPEVLS-GN 271
           RD+KP NIL +  SG    +++ DFG A ++   +  +GL  +P Y    VAPEVL    
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPF---KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           Y E  DIWS             PF     D+ E +   I + K     G W TVS+ A+D
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+++ML  D   R+TA +VL+HPW+
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 91/265 (34%), Positives = 137/265 (51%), Gaps = 15/265 (5%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVV 160
             D +   E IG G +     C  KA+  E+A K + K +     E+EI+     H  ++
Sbjct: 25  FSDGYVVKETIGVGSYSECKRCVHKATNMEYAVKVIDKSKRDPSEEIEILLRYGQHPNII 84
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
           TL  VY++    +LV EL  GG L+D+++    +SE+ A+ +   +   ++Y H  GVVH
Sbjct: 85  TLKDVYDDGKHVYLVTELMRGGELLDKILRQKFFSEREASFVLHTIGKTVEYLHSQGVVH 144
Query: 221 RDIKPENIL-LTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAY----VAPEVLS-GN 271
           RD+KP NIL +  SG    +++ DFG A ++   +  +GL  +P Y    VAPEVL    
Sbjct: 145 RDLKPSNILYVDESGNPECLRICDFGFAKQL---RAENGLLMTPCYTANFVAPEVLKRQG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG---DSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           Y E  DIWS             PF     D+ E +   I + K     G W TVS+ A+D
Sbjct: 202 YDEGCDIWSLGILLYTMLAGYTPFANGPSDTPEEILTRIGSGKFTLSGGNWNTVSETAKD 261
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+++ML  D   R+TA +VL+HPW+
Sbjct: 262 LVSKMLHVDPHQRLTAKQVLQHPWV 286

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 87/266 (32%), Positives = 142/266 (53%), Gaps = 14/266 (5%)
Query: 96  GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVE 148
           G++    +D      +G GKFG+V+L R K S    A K L K        E  + REVE
Sbjct: 1   GKRQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVE 60
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I  HL  H  ++ L+  + +A   +L++E    G +  ++ ++ ++ EQR A    ++  
Sbjct: 61  IQSHLR-HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELAN 119
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
            + YCH   V+HRDIKPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++
Sbjct: 120 ALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMI 178
Query: 269 SGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
            G  + EKVD+WS             PF+ ++ +  +  I  V+  F     + V++ AR
Sbjct: 179 EGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGAR 234
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL++R+L  + S R    EVL HPWI
Sbjct: 235 DLISRLLKHNPSQRPMLREVLEHPWI 260

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score =  153 bits (387), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR-DDLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 252
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 253 MLREVLEHPWI 263

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 85/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +    L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 138 KPENLLLGSAGELKIADFGWSVHAPSSRR-XXLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 252
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 253 MLREVLEHPWI 263

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 18  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 76
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 77  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 136
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+A+FG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 137 KPENLLLGSAGELKIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 195
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 196 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 251
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 252 MLREVLEHPWI 262

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score =  153 bits (386), Expect = 2e-37,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 16  LGKGKFGNVYLAREKNSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + ++   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 75  GYFHDSTRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKKVIHRDI 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 135 KPENLLLGSAGELKIADFGWSVHAPSSRR-AALCGTLDYLPPEMIEGRMHDEKVDLWSLG 193
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 194 VLCYEFLVGKPPFEANTYQDTYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 249
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 250 MLREVLEHPWI 260

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score =  152 bits (385), Expect = 3e-37,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 138/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 19  LGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 78  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 137
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+A+FG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 138 KPENLLLGSAGELKIANFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 196
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 197 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 252
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 253 MLREVLEHPWI 263

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score =  152 bits (383), Expect = 5e-37,   Method: Compositional matrix adjust.
 Identities = 84/251 (33%), Positives = 137/251 (54%), Gaps = 14/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G GKFG+V+L R K      A K L K        E  + REVEI  HL  H  ++ L+
Sbjct: 13  LGKGKFGNVYLAREKQRKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLY 71
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRDI
Sbjct: 72  GYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDI 131
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXX 282
           KPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + EKVD+WS  
Sbjct: 132 KPENLLLGSAGELKIADFGWSVHAPSSRR-TTLCGTLDYLPPEMIEGRMHDEKVDLWSLG 190
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L  + S R 
Sbjct: 191 VLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLLKHNPSQRP 246
Query: 343 TADEVLRHPWI 353
              EVL HPWI
Sbjct: 247 MLREVLEHPWI 257

>pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342

Iteration: 1
 Score =  151 bits (381), Expect = 8e-37,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 146/288 (50%), Gaps = 16/288 (5%)
Query: 84  RKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET 142
           + +G   +  Q+ R + +  D +   E IG G +     C  KA+  EFA K + K +  
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61
Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
              E+EI+     H  ++TL  VY++    ++V EL  GG L+D+++    +SE+ A+ +
Sbjct: 62  PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV 121
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENIL-LTTSGK---IKLADFGLAMRISNGQTLSGLAG 258
              +   ++Y H  GVVHRD+KP NIL +  SG    I++ DFG A ++   +  +GL  
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLM 178
Query: 259 SPAY----VAPEVLS-GNYSEKVDIWSXXXXXXXXXXXXXPFKG---DSLEAVFDAIKNV 310
           +P Y    VAPEVL    Y    DIWS             PF     D+ E +   I + 
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSG 238
Query: 311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
           K     G W +VS  A+DL+++ML  D   R+TA  VLRHPWI+ + +
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342

Iteration: 1
 Score =  149 bits (376), Expect = 3e-36,   Method: Compositional matrix adjust.
 Identities = 95/288 (32%), Positives = 146/288 (50%), Gaps = 16/288 (5%)
Query: 84  RKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET 142
           + +G   +  Q+ R + +  D +   E IG G +     C  KA+  EFA K + K +  
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNXEFAVKIIDKSKRD 61
Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
              E+EI+     H  ++TL  VY++    ++V EL  GG L+D+++    +SE+ A+ +
Sbjct: 62  PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELXKGGELLDKILRQKFFSEREASAV 121
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENIL-LTTSGK---IKLADFGLAMRISNGQTLSGLAG 258
              +   ++Y H  GVVHRD+KP NIL +  SG    I++ DFG A ++   +  +GL  
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL---RAENGLLX 178
Query: 259 SPAY----VAPEVLS-GNYSEKVDIWSXXXXXXXXXXXXXPFKG---DSLEAVFDAIKNV 310
           +P Y    VAPEVL    Y    DIWS             PF     D+ E +   I + 
Sbjct: 179 TPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTXLTGYTPFANGPDDTPEEILARIGSG 238
Query: 311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
           K     G W +VS  A+DL+++ L  D   R+TA  VLRHPWI+ + +
Sbjct: 239 KFSLSGGYWNSVSDTAKDLVSKXLHVDPHQRLTAALVLRHPWIVHWDQ 286

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score =  148 bits (373), Expect = 8e-36,   Method: Compositional matrix adjust.
 Identities = 83/264 (31%), Positives = 132/264 (50%), Gaps = 19/264 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKT------------LRKGEETVHREVEIMQHLSGH 156
           +VIG G    V  C  +A+G EFA K             L +  E   RE  I++ ++GH
Sbjct: 100 DVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGH 159
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++TL   YE +    LV +L   G L D + E    SE+   +I + ++  + + H  
Sbjct: 160 PHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHAN 219
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN----- 271
            +VHRD+KPENILL  + +I+L+DFG +  +  G+ L  L G+P Y+APE+L  +     
Sbjct: 220 NIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETH 279
Query: 272 --YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
             Y ++VD+W+             PF       +   I   +  F S  W+  S   +DL
Sbjct: 280 PGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDL 339
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           ++R+L  D  AR+TA++ L+HP+ 
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFF 363

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score =  147 bits (371), Expect = 1e-35,   Method: Compositional matrix adjust.
 Identities = 97/306 (31%), Positives = 148/306 (48%), Gaps = 31/306 (10%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------ETVHREVEIMQ 151
            ED +   EVIG G F  V  C ++ +G +FA K +   +         E + RE  I  
Sbjct: 22  FEDVYELCEVIGKGAFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVM 207
           H+  H  +V L   Y      ++V E   G  L  ++V+       YSE  A++  + ++
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRI-SNGQTLSGLAGSPAYV 263
             ++YCHD  ++HRD+KPEN+LL +   S  +KL DFG+A+++  +G    G  G+P ++
Sbjct: 141 EALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 264 APEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           APEV+    Y + VD+W              PF G + E +F+ I   K   +   W  +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHI 259
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI-----------LFYTERTLRTLTIKSKLK 371
           S+ A+DL+ RML  D + RIT  E L HPW+           L  T   LR    + KLK
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319
Query: 372 NQVGAS 377
             V A+
Sbjct: 320 GAVLAA 325

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 89/304 (29%), Positives = 148/304 (48%), Gaps = 25/304 (8%)
Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
           S LA    APP      +V A +G       +                +K E++G G+FG
Sbjct: 60  SALAVDIPAPPAPFDHRIVTAKQGAVNSFYTV----------------SKTEILGGGRFG 103
Query: 118 SVWLCRSKASGAEFACKTLR----KGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH 173
            V  C   A+G + A K ++    K +E V  E+ +M  L  H  ++ L+  +E  +   
Sbjct: 104 QVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIV 162
Query: 174 LVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT 232
           LVME   GG L D+++ E    +E       K +   I++ H M ++H D+KPENIL   
Sbjct: 163 LVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVN 222
Query: 233 --SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY-SEKVDIWSXXXXXXXXX 289
             + +IK+ DFGLA R    + L    G+P ++APEV++ ++ S   D+WS         
Sbjct: 223 RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
Query: 290 XXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
               PF GD+     + I   + D     ++ +S+ A++ ++++L ++ S RI+A E L+
Sbjct: 283 SGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALK 342
Query: 350 HPWI 353
           HPW+
Sbjct: 343 HPWL 346

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 20/280 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------------RKGEETVHREVEI 149
           +++   E++G G    V  C  K +  E+A K +             ++  E   +EV+I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
           ++ +SGH  ++ L   YE    F LV +L   G L D + E    SE+    I + ++ V
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           I   H + +VHRD+KPENILL     IKL DFG + ++  G+ L  + G+P+Y+APE++ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLRSVCGTPSYLAPEIIE 196
Query: 270 GN-------YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
            +       Y ++VD+WS             PF       +   I +    F S  W+  
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           S   +DL++R L      R TA+E L HP+   Y    +R
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score =  140 bits (353), Expect = 1e-33,   Method: Compositional matrix adjust.
 Identities = 82/277 (29%), Positives = 140/277 (50%), Gaps = 14/277 (5%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHR 145
            +M ++    DD   V  +G GKFG+V+L R K +    A K L K        E  + R
Sbjct: 4   AEMPKRKFTIDDFDIVRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 63
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E+EI  HL  H  ++ +++ + +    +L++E    G L  ++ + G++ EQR+A   ++
Sbjct: 64  EIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 122
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
           +   + YCH+  V+HRDIKPEN+L+   G++K+ADFG ++   + +    + G+  Y+ P
Sbjct: 123 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RXMCGTLDYLPP 181
Query: 266 EVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           E++ G  + EKVD+W              PF   S       I NV L F       +S 
Sbjct: 182 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSD 237
Query: 325 PARDLMARMLTRDVSARITADEVLRHPWILFYTERTL 361
            ++DL++++L      R+    V+ HPW+   + R L
Sbjct: 238 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 274

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score =  140 bits (352), Expect = 2e-33,   Method: Compositional matrix adjust.
 Identities = 83/280 (29%), Positives = 132/280 (47%), Gaps = 20/280 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------------RKGEETVHREVEI 149
           +++   E++G G    V  C  K +  E+A K +             ++  E   +EV+I
Sbjct: 17  ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
           ++ +SGH  ++ L   YE    F LV +L   G L D + E    SE+    I + ++ V
Sbjct: 77  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 136
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           I   H + +VHRD+KPENILL     IKL DFG + ++  G+ L  + G+P+Y+APE++ 
Sbjct: 137 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 196
Query: 270 GN-------YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
            +       Y ++VD+WS             PF       +   I +    F S  W+  
Sbjct: 197 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 256
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           S   +DL++R L      R TA+E L HP+   Y    +R
Sbjct: 257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score =  139 bits (351), Expect = 3e-33,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 144/306 (47%), Gaps = 31/306 (10%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------ETVHREVEIMQ 151
            ED +   EVIG G F  V  C ++ +G +FA K +   +         E + RE  I  
Sbjct: 24  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 82
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVM 207
           H+  H  +V L   Y      ++V E   G  L  ++V+       YSE  A++  + ++
Sbjct: 83  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 142
Query: 208 WVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRI-SNGQTLSGLAGSPAYV 263
             ++YCHD  ++HRD+KP  +LL +   S  +KL  FG+A+++  +G    G  G+P ++
Sbjct: 143 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 202
Query: 264 APEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           APEV+    Y + VD+W              PF G   E +F+ I   K   +   W  +
Sbjct: 203 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 261
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI-----------LFYTERTLRTLTIKSKLK 371
           S+ A+DL+ RML  D + RIT  E L HPW+           L  T   LR    + KLK
Sbjct: 262 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 321
Query: 372 NQVGAS 377
             V A+
Sbjct: 322 GAVLAA 327

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score =  139 bits (350), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 82/274 (29%), Positives = 130/274 (47%), Gaps = 20/274 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------------RKGEETVHREVEI 149
           +++   E++G G    V  C  K +  E+A K +             ++  E   +EV+I
Sbjct: 4   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 63
Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
           ++ +SGH  ++ L   YE    F LV +L   G L D + E    SE+    I + ++ V
Sbjct: 64  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 123
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           I   H + +VHRD+KPENILL     IKL DFG + ++  G+ L  + G+P+Y+APE++ 
Sbjct: 124 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 183
Query: 270 GN-------YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
            +       Y ++VD+WS             PF       +   I +    F S  W+  
Sbjct: 184 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 243
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
           S   +DL++R L      R TA+E L HP+   Y
Sbjct: 244 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 277

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score =  139 bits (349), Expect = 4e-33,   Method: Compositional matrix adjust.
 Identities = 94/306 (30%), Positives = 144/306 (47%), Gaps = 31/306 (10%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------ETVHREVEIMQ 151
            ED +   EVIG G F  V  C ++ +G +FA K +   +         E + RE  I  
Sbjct: 22  FEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC- 80
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVM 207
           H+  H  +V L   Y      ++V E   G  L  ++V+       YSE  A++  + ++
Sbjct: 81  HMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRI-SNGQTLSGLAGSPAYV 263
             ++YCHD  ++HRD+KP  +LL +   S  +KL  FG+A+++  +G    G  G+P ++
Sbjct: 141 EALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFM 200
Query: 264 APEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           APEV+    Y + VD+W              PF G   E +F+ I   K   +   W  +
Sbjct: 201 APEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSHI 259
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI-----------LFYTERTLRTLTIKSKLK 371
           S+ A+DL+ RML  D + RIT  E L HPW+           L  T   LR    + KLK
Sbjct: 260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKLK 319
Query: 372 NQVGAS 377
             V A+
Sbjct: 320 GAVLAA 325

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score =  138 bits (347), Expect = 8e-33,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score =  137 bits (346), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    G+P Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 81/277 (29%), Positives = 139/277 (50%), Gaps = 14/277 (5%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHR 145
            +M ++    DD      +G GKFG+V+L R K +    A K L K        E  + R
Sbjct: 5   AEMPKRKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRR 64
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E+EI  HL  H  ++ +++ + +    +L++E    G L  ++ + G++ EQR+A   ++
Sbjct: 65  EIEIQSHLR-HPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEE 123
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
           +   + YCH+  V+HRDIKPEN+L+   G++K+ADFG ++   + +    + G+  Y+ P
Sbjct: 124 LADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRR-RXMCGTLDYLPP 182
Query: 266 EVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           E++ G  + EKVD+W              PF   S       I NV L F       +S 
Sbjct: 183 EMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSD 238
Query: 325 PARDLMARMLTRDVSARITADEVLRHPWILFYTERTL 361
            ++DL++++L      R+    V+ HPW+   + R L
Sbjct: 239 GSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVL 275

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 101 IEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRKGEE--TVHREVE 148
           + D++   + +G G  G V L      C+  A    S  +FA  + R+ +    V  E+E
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 266 EVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIKNVKLDFHSGVWE 320
           EVL    +  Y+  VD WS             PF     +    D I + K +F   VW 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 101 IEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRKGEE--TVHREVE 148
           + D++   + +G G  G V L      C+  A    S  +FA  + R+ +    V  E+E
Sbjct: 7   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 66
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++ 
Sbjct: 67  ILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 124
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+AP
Sbjct: 125 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 184
Query: 266 EVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIKNVKLDFHSGVWE 320
           EVL    +  Y+  VD WS             PF     +    D I + K +F   VW 
Sbjct: 185 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 244
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 245 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 277

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 101 IEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRKGEE--TVHREVE 148
           + D++   + +G G  G V L      C+  A    S  +FA  + R+ +    V  E+E
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 266 EVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIKNVKLDFHSGVWE 320
           EVL    +  Y+  VD WS             PF     +    D I + K +F   VW 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 101 IEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRKGEE--TVHREVE 148
           + D++   + +G G  G V L      C+  A    S  +FA  + R+ +    V  E+E
Sbjct: 8   LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 67
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++ 
Sbjct: 68  ILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 125
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+AP
Sbjct: 126 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 185
Query: 266 EVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIKNVKLDFHSGVWE 320
           EVL    +  Y+  VD WS             PF     +    D I + K +F   VW 
Sbjct: 186 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 245
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 246 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score =  137 bits (345), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H 
Sbjct: 13  NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HP 71
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +L+ME  SGG + D +V  G+  E+ A + F+ ++  ++YCH   
Sbjct: 72  NIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKR 131
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 132 IVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDTFCGSPPYAAPELFQGKKYDGPE 191
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ R 
Sbjct: 192 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKRF 245
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  +   R T +++++  WI
Sbjct: 246 LVLNPIKRGTLEQIMKDRWI 265

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score =  137 bits (344), Expect = 1e-32,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 140/273 (51%), Gaps = 22/273 (8%)
Query: 101 IEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRKGEE--TVHREVE 148
           + D++   + +G G  G V L      C+  A    S  +FA  + R+ +    V  E+E
Sbjct: 14  LRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIE 73
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           I++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++ 
Sbjct: 74  ILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLL 131
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
            ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+AP
Sbjct: 132 AVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAP 191
Query: 266 EVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIKNVKLDFHSGVWE 320
           EVL    +  Y+  VD WS             PF     +    D I + K +F   VW 
Sbjct: 192 EVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVWA 251
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 252 EVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 284

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A + + K +      + + REV IM+ L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score =  137 bits (344), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 82/276 (29%), Positives = 135/276 (48%), Gaps = 24/276 (8%)
Query: 88  CIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------E 141
           C D    +G       ++  ++ IG G F  V L R   +G E A K + K +      +
Sbjct: 7   CADEQPHIG-------NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQ 59
Query: 142 TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
            + REV IM+ L+ H  +V L  V E     +L+ME  SGG + D +V  G+  E+ A +
Sbjct: 60  KLFREVRIMKILN-HPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARS 118
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA 261
            F+ ++  ++YCH   +VHRD+K EN+LL     IK+ADFG +   + G  L    G+P 
Sbjct: 119 KFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPP 178
Query: 262 YVAPEVLSGNYSE--KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSG 317
           Y APE+  G   +  +VD+WS             PF G +L+ + + +     ++ F+  
Sbjct: 179 YAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY-- 236
Query: 318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
               +S    +L+ R L  +   R T +++++  WI
Sbjct: 237 ----MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWI 268

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 79/260 (30%), Positives = 131/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A + + K +      + + REV IM+ L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVRIIDKTQLNSSSLQKLFREVRIMKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDEFCGSPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 248 LILNPSKRGTLEQIMKDRWM 267

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score =  136 bits (343), Expect = 2e-32,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 143/285 (50%), Gaps = 22/285 (7%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRK 138
           + V  Q      + D++   + +G G  G V L      C+  A    S  +FA  + R+
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180
Query: 139 GEE--TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE 196
            +    V  E+EI++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E
Sbjct: 181 ADPALNVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 238
Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL 253
                 F  ++  ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298
Query: 254 SGLAGSPAYVAPEVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIK 308
             L G+P Y+APEVL    +  Y+  VD WS             PF     +    D I 
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + K +F   VW  VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 86/285 (30%), Positives = 143/285 (50%), Gaps = 22/285 (7%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWL------CRSKA----SGAEFACKTLRK 138
           + V  Q      + D++   + +G G  G V L      C+  A    S  +FA  + R+
Sbjct: 135 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 194
Query: 139 GEE--TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE 196
            +    V  E+EI++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E
Sbjct: 195 ADPALNVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 252
Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL 253
                 F  ++  ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +
Sbjct: 253 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 312
Query: 254 SGLAGSPAYVAPEVL----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF-DAIK 308
             L G+P Y+APEVL    +  Y+  VD WS             PF     +    D I 
Sbjct: 313 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 372
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + K +F   VW  VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 373 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 417

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score =  136 bits (342), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 80/260 (30%), Positives = 130/260 (50%), Gaps = 17/260 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H 
Sbjct: 8   NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIMKVLN-HP 66
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LVME  SGG + D +V  G   E+ A   F+ ++  ++YCH   
Sbjct: 67  NIVKLFEVIETEKTLYLVMEYASGGEVFDYLVAHGWMKEKEARAKFRQIVSAVQYCHQKF 126
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +
Sbjct: 127 IVHRDLKAENLLLDADMNIKIADFGFSNEFTFGNKLDTFCGSPPYAAPELFQGKKYDGPE 186
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+      +S    +L+ + 
Sbjct: 187 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY------MSTDCENLLKKF 240
Query: 334 LTRDVSARITADEVLRHPWI 353
           L  + S R T +++++  W+
Sbjct: 241 LILNPSKRGTLEQIMKDRWM 260

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score =  135 bits (340), Expect = 5e-32,   Method: Compositional matrix adjust.
 Identities = 90/279 (32%), Positives = 134/279 (48%), Gaps = 27/279 (9%)
Query: 96  GRKN-----KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHR 145
           GR+N      I+D       +G G FG V L   ++SG E   KT+ K       E +  
Sbjct: 10  GRENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEA 69
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAAN 201
           E+E+++ L  H  ++ +  V+E+    ++VME C GG L++++V         SE   A 
Sbjct: 70  EIEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAE 128
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAG 258
           + K +M  + Y H   VVH+D+KPENIL   +     IK+ DFGLA    + +  +  AG
Sbjct: 129 LMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG 188
Query: 259 SPAYVAPEVLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV 318
           +  Y+APEV   + + K DIWS             PF G SLE V       K  +    
Sbjct: 189 TALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV-----QQKATYKEPN 243
Query: 319 WETVSKP----ARDLMARMLTRDVSARITADEVLRHPWI 353
           +    +P    A DL+ +MLT+D   R +A +VL H W 
Sbjct: 244 YAVECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/311 (29%), Positives = 144/311 (46%), Gaps = 60/311 (19%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE---------ETVHREVEIMQHLSGHTGVVT 161
           IG G +G V +     + A  A K + K +         E +  EV +M+ L  H  +  
Sbjct: 34  IGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIAR 92
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQM------------VEVGQYS-------------- 195
           L+ VYE+     LVMELC GG L+D++            ++V +                
Sbjct: 93  LYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAING 152
Query: 196 --------------EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SGKIKLA 239
                         E+  +NI + +   + Y H+ G+ HRDIKPEN L +T  S +IKL 
Sbjct: 153 SIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLV 212
Query: 240 DFGLA---MRISNGQT--LSGLAGSPAYVAPEVLSG---NYSEKVDIWSXXXXXXXXXXX 291
           DFGL+    +++NG+   ++  AG+P +VAPEVL+    +Y  K D WS           
Sbjct: 213 DFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMG 272
Query: 292 XXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
             PF G +       + N KL F +  +  +S  ARDL++ +L R+V  R  A   L+HP
Sbjct: 273 AVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHP 332
Query: 352 WILFYTERTLR 362
           WI  ++++  +
Sbjct: 333 WISQFSDKIYK 343

>pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 83/281 (29%), Positives = 139/281 (49%), Gaps = 36/281 (12%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHS 164
           E++G G +  V    S  +G E+A K + K        V REVE +    G+  ++ L  
Sbjct: 19  ELLGEGAYAKVQGAVSLQNGKEYAVKIIEKQAGHSRSRVFREVETLYQCQGNKNILELIE 78
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +E+   F+LV E   GG ++  + +   ++E+ A+ + +DV   + + H  G+ HRD+K
Sbjct: 79  FFEDDTRFYLVFEKLQGGSILAHIQKQKHFNEREASRVVRDVAAALDFLHTKGIAHRDLK 138
Query: 225 PENILLTTSGK---IKLADFGL--AMRISNGQT------LSGLAGSPAYVAPEVL----- 268
           PENIL  +  K   +K+ DF L   M+++N  T      L+   GS  Y+APEV+     
Sbjct: 139 PENILCESPEKVSPVKICDFDLGSGMKLNNSCTPITTPELTTPCGSAEYMAPEVVEVFTD 198
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG--------DSLEA-------VFDAIKNVKL 312
            +  Y ++ D+WS             PF G        D  E        +F++I+  K 
Sbjct: 199 QATFYDKRCDLWSLGVVLYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGKY 258
Query: 313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           +F    W  +S  A+DL++++L RD   R++A +VL+HPW+
Sbjct: 259 EFPDKDWAHISSEAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 79/256 (30%), Positives = 126/256 (49%), Gaps = 13/256 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVHREVEIMQHLSGHTGVVTLHSVYEEA 169
           +G G F     C  K S   FA K + ++ E    +E+  ++   GH  +V LH V+ + 
Sbjct: 19  LGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQ 78
Query: 170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENIL 229
               LVMEL +GG L +++ +   +SE  A+ I + ++  + + HD+GVVHRD+KPEN+L
Sbjct: 79  LHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLL 138
Query: 230 LTTSG---KIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXXXX 284
            T      +IK+ DFG A ++  + Q L     +  Y APE+L+ N Y E  D+WS    
Sbjct: 139 FTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVI 198
Query: 285 XXXXXXXXXPFKG-------DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
                    PF+         S   +   IK     F    W+ VS+ A+DL+  +LT D
Sbjct: 199 LYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVD 258
Query: 338 VSARITADEVLRHPWI 353
            + R+    +  + W+
Sbjct: 259 PNKRLKMSGLRYNEWL 274

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score =  132 bits (331), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 83/272 (30%), Positives = 138/272 (50%), Gaps = 25/272 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL---RKGE----ETVHREVEIMQHLSGHTGVVTLH 163
           +G GKF  V  C SK++G E+A K L   R+G+    E +H E+ +++       V+ LH
Sbjct: 37  LGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILH-EIAVLELAKSCPRVINLH 95
Query: 164 SVYEEADCFHLVMELCSGGRLIDQ-MVEVGQY-SEQRAANIFKDVMWVIKYCHDMGVVHR 221
            VYE      L++E  +GG +    + E+ +  SE     + K ++  + Y H   +VH 
Sbjct: 96  EVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHL 155
Query: 222 DIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY---SEK 275
           D+KP+NILL++    G IK+ DFG++ +I +   L  + G+P Y+APE+L  NY   +  
Sbjct: 156 DLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEIL--NYDPITTA 213
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
            D+W+             PF G+  +  +  I  V +D+    + +VS+ A D +  +L 
Sbjct: 214 TDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLV 273
Query: 336 RDVSARITADEVLRHPWI-------LFYTERT 360
           ++   R TA+  L H W+       LF+ E T
Sbjct: 274 KNPEKRPTAEICLSHSWLQQWDFENLFHPEET 305

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score =  131 bits (330), Expect = 7e-31,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 21/262 (8%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH 156
           ++  V+ +G G FG V L     +G + A K + K        +  + RE+  ++ L  H
Sbjct: 14  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 72
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++ L+ V +  D   +V+E  +G  L D +V+  + SEQ A   F+ ++  ++YCH  
Sbjct: 73  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 131
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SE 274
            +VHRD+KPEN+LL     +K+ADFGL+  +++G  L    GSP Y APEV+SG      
Sbjct: 132 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 191
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMA 331
           +VD+WS             PF  +S+  +F  I N       GV+   + +S  A  L+ 
Sbjct: 192 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVYTLPKFLSPGAAGLIK 244
Query: 332 RMLTRDVSARITADEVLRHPWI 353
           RML  +   RI+  E+++  W 
Sbjct: 245 RMLIVNPLNRISIHEIMQDDWF 266

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 21/262 (8%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH 156
           ++  V+ +G G FG V L     +G + A K + K        +  + RE+  ++ L  H
Sbjct: 5   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++ L+ V +  D   +V+E  +G  L D +V+  + SEQ A   F+ ++  ++YCH  
Sbjct: 64  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 122
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SE 274
            +VHRD+KPEN+LL     +K+ADFGL+  +++G  L    GSP Y APEV+SG      
Sbjct: 123 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 182
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMA 331
           +VD+WS             PF  +S+  +F  I N       GV+   + +S  A  L+ 
Sbjct: 183 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVYTLPKFLSPGAAGLIK 235
Query: 332 RMLTRDVSARITADEVLRHPWI 353
           RML  +   RI+  E+++  W 
Sbjct: 236 RMLIVNPLNRISIHEIMQDDWF 257

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 21/262 (8%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH 156
           ++  V+ +G G FG V L     +G + A K + K        +  + RE+  ++ L  H
Sbjct: 15  NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 73
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++ L+ V +  D   +V+E  +G  L D +V+  + SEQ A   F+ ++  ++YCH  
Sbjct: 74  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 132
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SE 274
            +VHRD+KPEN+LL     +K+ADFGL+  +++G  L    GSP Y APEV+SG      
Sbjct: 133 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 192
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMA 331
           +VD+WS             PF  +S+  +F  I N       GV+   + +S  A  L+ 
Sbjct: 193 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVYTLPKFLSPGAAGLIK 245
Query: 332 RMLTRDVSARITADEVLRHPWI 353
           RML  +   RI+  E+++  W 
Sbjct: 246 RMLIVNPLNRISIHEIMQDDWF 267

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score =  131 bits (329), Expect = 9e-31,   Method: Compositional matrix adjust.
 Identities = 82/262 (31%), Positives = 133/262 (50%), Gaps = 21/262 (8%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH 156
           ++  V+ +G G FG V L     +G + A K + K        +  + RE+  ++ L  H
Sbjct: 9   NYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-H 67
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++ L+ V +  D   +V+E  +G  L D +V+  + SEQ A   F+ ++  ++YCH  
Sbjct: 68  PHIIKLYDVIKSKDEIIMVIEY-AGNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRH 126
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SE 274
            +VHRD+KPEN+LL     +K+ADFGL+  +++G  L    GSP Y APEV+SG      
Sbjct: 127 KIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGP 186
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMA 331
           +VD+WS             PF  +S+  +F  I N       GV+   + +S  A  L+ 
Sbjct: 187 EVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISN-------GVYTLPKFLSPGAAGLIK 239
Query: 332 RMLTRDVSARITADEVLRHPWI 353
           RML  +   RI+  E+++  W 
Sbjct: 240 RMLIVNPLNRISIHEIMQDDWF 261

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 95/306 (31%), Positives = 145/306 (47%), Gaps = 33/306 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-----TLRKGEE--TVHREVEIMQHLSGHTGVVT 161
           E +G G FG V L     +  + A K      L+K +    V RE+  ++ L  H  ++ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIK 73
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V        +V+E  +GG L D +VE  + +E      F+ ++  I+YCH   +VHR
Sbjct: 74  LYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SEKVDIW 279
           D+KPEN+LL  +  +K+ADFGL+  +++G  L    GSP Y APEV++G      +VD+W
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKN---VKLDFHSGVWETVSKPARDLMARMLTR 336
           S             PF  + +  +F  + +   V  DF       +S  A+ L+ RM+  
Sbjct: 193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF-------LSPGAQSLIRRMIVA 245
Query: 337 DVSARITADEVLRHPWILFYTERTLRTLT----------IKSKLKNQVGASHHHPAILSG 386
           D   RIT  E+ R PW        LR +           I SKL   +G S  +  I+  
Sbjct: 246 DPMQRITIQEIRRDPWFNVNLPDYLRPMEEVQGSYADSRIVSKLGEAMGFSEDY--IVEA 303
Query: 387 VESDEN 392
           + SDEN
Sbjct: 304 LRSDEN 309

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score =  130 bits (328), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 77/259 (29%), Positives = 126/259 (48%), Gaps = 17/259 (6%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHT 157
           ++  ++ IG G F  V L R   +G E A K + K +      + + REV I + L+ H 
Sbjct: 15  NYRLLKTIGKGNFAKVKLARHILTGKEVAVKIIDKTQLNSSSLQKLFREVRIXKVLN-HP 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V L  V E     +LV E  SGG + D +V  G+  E+ A   F+ ++  ++YCH   
Sbjct: 74  NIVKLFEVIETEKTLYLVXEYASGGEVFDYLVAHGRXKEKEARAKFRQIVSAVQYCHQKF 133
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--K 275
           +VHRD+K EN+LL     IK+ADFG +   + G  L    G+P Y APE+  G   +  +
Sbjct: 134 IVHRDLKAENLLLDADXNIKIADFGFSNEFTFGNKLDAFCGAPPYAAPELFQGKKYDGPE 193
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPARDLMARM 333
           VD+WS             PF G +L+ + + +     ++ F+       S    +L+ + 
Sbjct: 194 VDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFYX------STDCENLLKKF 247
Query: 334 LTRDVSARITADEVLRHPW 352
           L  + S R T +++ +  W
Sbjct: 248 LILNPSKRGTLEQIXKDRW 266

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score =  130 bits (327), Expect = 1e-30,   Method: Compositional matrix adjust.
 Identities = 91/252 (36%), Positives = 135/252 (53%), Gaps = 13/252 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V L R K SG + A K   LRK +  E +  EV IM+    H  VV ++  Y
Sbjct: 53  IGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSY 111
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              +   ++ME   GG L D + +V + +E++ A + + V+  + Y H  GV+HRDIK +
Sbjct: 112 LVGEELWVLMEFLQGGALTDIVSQV-RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSD 170
Query: 227 NILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   +IS +      L G+P ++APEV+S + Y+ +VDIWS    
Sbjct: 171 SILLTLDGRVKLSDFGFCAQISKDVPKRKXLVGTPYWMAPEVISRSLYATEVDIWSLGIM 230
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWET--VSKPARDLMARMLTRDVSARI 342
                    P+  DS      A+K ++      +  +  VS   RD + RML RD   R 
Sbjct: 231 VIEMVDGEPPYFSDS---PVQAMKRLRDSPPPKLKNSHKVSPVLRDFLERMLVRDPQERA 287
Query: 343 TADEVLRHPWIL 354
           TA E+L HP++L
Sbjct: 288 TAQELLDHPFLL 299

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 20/257 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
           + +G G FG V +   + +G + A K L + +         + RE++ ++ L  H  ++ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHPHIIK 75
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V      F +VME  SGG L D + + G+  E  A  +F+ ++  + YCH   VVHR
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SEKVDIW 279
           D+KPEN+LL      K+ADFGL+  +S+G+ L    GSP Y APEV+SG      +VDIW
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRDSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMARMLTR 336
           S             PF  + +  +F  I+        GV+   E +++    L+  ML  
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGVFYIPEYLNRSVATLLMHMLQV 248
Query: 337 DVSARITADEVLRHPWI 353
           D   R T  ++  H W 
Sbjct: 249 DPLKRATIKDIREHEWF 265

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score =  130 bits (327), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 81/257 (31%), Positives = 126/257 (49%), Gaps = 20/257 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
           + +G G FG V +   + +G + A K L + +         + RE++ ++ L  H  ++ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHPHIIK 75
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V      F +VME  SGG L D + + G+  E  A  +F+ ++  + YCH   VVHR
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SEKVDIW 279
           D+KPEN+LL      K+ADFGL+  +S+G+ L    GSP Y APEV+SG      +VDIW
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW---ETVSKPARDLMARMLTR 336
           S             PF  + +  +F  I+        GV+   E +++    L+  ML  
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKKIR-------GGVFYIPEYLNRSVATLLMHMLQV 248
Query: 337 DVSARITADEVLRHPWI 353
           D   R T  ++  H W 
Sbjct: 249 DPLKRATIKDIREHEWF 265

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score =  130 bits (326), Expect = 2e-30,   Method: Compositional matrix adjust.
 Identities = 72/203 (35%), Positives = 104/203 (51%), Gaps = 9/203 (4%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTL 162
           + IG G F  V L R   +G E A K + K +      + + REV IM+ L+ H  +V L
Sbjct: 21  KTIGKGNFAKVKLARHVLTGREVAVKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKL 79
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
             V E     +LVME  SGG + D +V  G+  E+ A   F+ ++  ++YCH   +VHRD
Sbjct: 80  FEVIETEKTLYLVMEYASGGEVFDYLVAHGRMKEKEARAKFRQIVSAVQYCHQKYIVHRD 139
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWS 280
           +K EN+LL     IK+ADFG +   + G  L    GSP Y APE+  G   +  +VD+WS
Sbjct: 140 LKAENLLLDGDMNIKIADFGFSNEFTVGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWS 199
Query: 281 XXXXXXXXXXXXXPFKGDSLEAV 303
                        PF G +L+ +
Sbjct: 200 LGVILYTLVSGSLPFDGQNLKEL 222

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score =  128 bits (322), Expect = 6e-30,   Method: Compositional matrix adjust.
 Identities = 84/310 (27%), Positives = 146/310 (47%), Gaps = 28/310 (9%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE------IMQHLSGHT 157
           D   +  +G G FG V L RS+ +G  +A K L+K      ++VE      +M  +  H 
Sbjct: 7   DFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHP 66
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            ++ +   +++A    ++M+   GG L   + +  ++    A     +V   ++Y H   
Sbjct: 67  FIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKD 126
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKV 276
           +++RD+KPENILL  +G IK+ DFG A  + +      L G+P Y+APEV+S   Y++ +
Sbjct: 127 IIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTYXLCGTPDYIAPEVVSTKPYNKSI 184
Query: 277 DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D WS             PF   +    ++ I N +L F     E V    +DL++R++TR
Sbjct: 185 DWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV----KDLLSRLITR 240
Query: 337 DVSARI-----TADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDE 391
           D+S R+       ++V  HPW             +  KL ++   + + P I  G + D 
Sbjct: 241 DLSQRLGNLQNGTEDVKNHPWF---------KEVVWEKLLSRNIETPYEPPIQQG-QGDT 290
Query: 392 NKIDRGSRND 401
           ++ D+    D
Sbjct: 291 SQFDKYPEED 300

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 8   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 66
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 67  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 126
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 127 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 186
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 187 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGL 242
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 243 LKKDPKQRLGGGPSDAKEVMEHRFFL 268

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score =  127 bits (320), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 63
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGL 239
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 63
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGL 239
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 63
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGL 239
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 63
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAGL 239
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 79/257 (30%), Positives = 126/257 (49%), Gaps = 20/257 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVT 161
           + +G G FG V + + + +G + A K L + +         + RE++ ++ L  H  ++ 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHPHIIK 80
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V        +VME  SGG L D + + G+  E+ +  +F+ ++  + YCH   VVHR
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY--SEKVDIW 279
           D+KPEN+LL      K+ADFGL+  +S+G+ L    GSP Y APEV+SG      +VDIW
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRXSCGSPNYAAPEVISGRLYAGPEVDIW 200
Query: 280 SXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWET---VSKPARDLMARMLTR 336
           S             PF  D +  +F  I +       G++ T   ++     L+  ML  
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKICD-------GIFYTPQYLNPSVISLLKHMLQV 253
Query: 337 DVSARITADEVLRHPWI 353
           D   R T  ++  H W 
Sbjct: 254 DPMKRATIKDIREHEWF 270

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 10  NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 68
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 69  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 128
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 129 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 188
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 189 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGL 244
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 245 LKKDPKQRLGGGPSDAKEVMEHRFFL 270

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 86/266 (32%), Positives = 131/266 (49%), Gaps = 19/266 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHR--EVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+ + 
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQN-TR 63
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKXFCGTPEYLAPEVLEDNDYG 183
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W              PF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGL 239
Query: 334 LTRDVSARI-----TADEVLRHPWIL 354
           L +D   R+      A EV+ H + L
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFFL 265

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 85/274 (31%), Positives = 140/274 (51%), Gaps = 14/274 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSG 155
           DD      +G GKFG+V+L R K S    A K L K        E  + RE+EI  HL  
Sbjct: 23  DDFEIGRPLGKGKFGNVYLAREKKSHFIVALKVLFKSQIEKEGVEHQLRREIEIQAHLH- 81
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ L++ + +    +L++E    G L  ++ +   + EQR A I +++   + YCH 
Sbjct: 82  HPNILRLYNYFYDRRRIYLILEYAPRGELYKELQKSCTFDEQRTATIMEELADALMYCHG 141
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
             V+HRDIKPEN+LL   G++K+ADFG ++   + +    + G+  Y+ PE++ G  ++E
Sbjct: 142 KKVIHRDIKPENLLLGLKGELKIADFGWSVHAPSLRR-KTMCGTLDYLPPEMIEGRMHNE 200
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           KVD+W              PF+  S    +  I  V L F +    +V   A+DL++++L
Sbjct: 201 KVDLWCIGVLCYELLVGNPPFESASHNETYRRIVKVDLKFPA----SVPTGAQDLISKLL 256
Query: 335 TRDVSARITADEVLRHPWILFYTERTLRTLTIKS 368
             + S R+   +V  HPW+   + R L    ++S
Sbjct: 257 RHNPSERLPLAQVSAHPWVRANSRRVLPPSALQS 290

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score =  125 bits (314), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 113
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 326

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 17  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 75
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 76  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 135
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 136 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 195
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 196 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 255
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 256 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 288

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 67
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 187
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 248 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 25  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 83
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 84  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 143
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 144 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 203
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 204 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 263
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 264 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 296

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score =  125 bits (314), Expect = 5e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 61  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 119
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 120 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 179
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 180 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 239
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 240 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 299
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 300 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 332

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 10  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 68
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 69  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 128
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 129 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 188
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 189 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 248
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 249 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 281

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score =  125 bits (314), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 15  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 73
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 74  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 133
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 134 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 193
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 194 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 253
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 254 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 286

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 69
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 250 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score =  125 bits (313), Expect = 6e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 69
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 189
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 190 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 249
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 250 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 282

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score =  125 bits (313), Expect = 7e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 16  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 74
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 75  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 134
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 135 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 194
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 195 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 254
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 255 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 287

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score =  124 bits (312), Expect = 8e-29,   Method: Compositional matrix adjust.
 Identities = 84/273 (30%), Positives = 135/273 (49%), Gaps = 16/273 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 9   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 67
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 68  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 127
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 128 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTEPCYTPYYVAPE 187
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           VL    Y +  D+WS             PF  +   A+   +K      + +F +  W  
Sbjct: 188 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 247
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           VS+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 248 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 280

>pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316

Iteration: 1
 Score =  124 bits (312), Expect = 9e-29,   Method: Compositional matrix adjust.
 Identities = 87/281 (30%), Positives = 137/281 (48%), Gaps = 36/281 (12%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHS 164
           +V+G G    V  C +  +  E+A K + K        V REVE++    GH  V+ L  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +EE D F+LV E   GG ++  + +   ++E  A+ + +DV   + + H+ G+ HRD+K
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 225 PENILLTTSGK---IKLADFGLAMRIS-NGQT-------LSGLAGSPAYVAPEVL----- 268
           PENIL     +   +K+ DFGL   I  NG         L    GS  Y+APEV+     
Sbjct: 139 PENILCEHPNQVSPVKICDFGLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG--------DSLEA-------VFDAIKNVKL 312
            +  Y ++ D+WS             PF G        D  EA       +F++I+  K 
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           +F    W  +S  A+DL++++L RD   R++A +VL+HPW+
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 133/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   LAG+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LAGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 126/259 (48%), Gaps = 10/259 (3%)
Query: 104 DHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTG 158
           DH  + E +G G FG V     +A+G  FA K +       +ETV +E++ M  L  H  
Sbjct: 51  DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 109
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V LH  +E+ +   ++ E  SGG L +++  E  + SE  A    + V   + + H+  
Sbjct: 110 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 169
Query: 218 VVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
            VH D+KPENI+ TT  S ++KL DFGL   +   Q++    G+  + APEV  G     
Sbjct: 170 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 229
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
             D+WS             PF G++ +     +K+   +     +  +S+  +D + ++L
Sbjct: 230 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 289
Query: 335 TRDVSARITADEVLRHPWI 353
             D + R+T  + L HPW+
Sbjct: 290 LADPNTRMTIHQALEHPWL 308

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 76/259 (29%), Positives = 126/259 (48%), Gaps = 10/259 (3%)
Query: 104 DHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTG 158
           DH  + E +G G FG V     +A+G  FA K +       +ETV +E++ M  L  H  
Sbjct: 157 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPT 215
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V LH  +E+ +   ++ E  SGG L +++  E  + SE  A    + V   + + H+  
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENN 275
Query: 218 VVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
            VH D+KPENI+ TT  S ++KL DFGL   +   Q++    G+  + APEV  G     
Sbjct: 276 YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGY 335
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
             D+WS             PF G++ +     +K+   +     +  +S+  +D + ++L
Sbjct: 336 YTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIRKLL 395
Query: 335 TRDVSARITADEVLRHPWI 353
             D + R+T  + L HPW+
Sbjct: 396 LADPNTRMTIHQALEHPWL 414

>pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387

Iteration: 1
 Score =  122 bits (307), Expect = 3e-28,   Method: Compositional matrix adjust.
 Identities = 75/268 (27%), Positives = 128/268 (47%), Gaps = 15/268 (5%)
Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
           ++  + D +  +E +G G FG V  C  KA+G  F  K +       + TV  E+ IM  
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIK 211
           L  H  ++ LH  +E+     L++E  SGG L D++  E  + SE    N  +     +K
Sbjct: 105 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163
Query: 212 YCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           + H+  +VH DIKPENI+  T  +  +K+ DFGLA +++  + +     +  + APE++ 
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223
Query: 270 ----GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
               G Y+   D+W+             PF G+        +K    +F    + +VS  
Sbjct: 224 REPVGFYT---DMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPE 280
Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
           A+D +  +L ++   R+T  + L HPW+
Sbjct: 281 AKDFIKNLLQKEPRKRLTVHDALEHPWL 308

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LXGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYQMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score =  122 bits (306), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 73/263 (27%), Positives = 128/263 (48%), Gaps = 18/263 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE------IMQHLSGH 156
           D   ++  +G G FG V L + K +G  +A K L K +    +++E       +Q     
Sbjct: 42  DQFERIRTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRIQQAVNF 101
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V L   +++    ++V+E   GG +   +  +G++SE  A      ++   +Y H +
Sbjct: 102 PFLVKLEFSFKDNSNLYMVLEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSL 161
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSEK 275
            +++RD+KPEN+L+   G IK+ADFG A R+  G+T   L G+P Y+APE +LS  Y++ 
Sbjct: 162 DLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNKA 219
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L 
Sbjct: 220 VDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLLQ 275
Query: 336 RDVSARI-----TADEVLRHPWI 353
            D++ R        +++  H W 
Sbjct: 276 VDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G T + L G+P Y+APE +LS  Y++
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GATWT-LCGTPEYLAPEIILSKGYNK 238
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 294
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 295 QVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 75/262 (28%), Positives = 126/262 (48%), Gaps = 11/262 (4%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           D+   + V+G G FG V L R K +G  +A K L+K         E    E  I+     
Sbjct: 23  DNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARN 82
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L+  + +  ++ E RA     +++  + + HD
Sbjct: 83  HPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YS 273
            G+++RD+K +N+LL   G  KLADFG+    I NG T +   G+P Y+APE+L    Y 
Sbjct: 143 KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYG 202
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W+             PF+ ++ + +F+AI N ++ + + + E  +   +  M + 
Sbjct: 203 PAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKN 262
Query: 334 LTRDVSARITADE--VLRHPWI 353
            T  + +     E  +LRHP+ 
Sbjct: 263 PTMRLGSLTQGGEHAILRHPFF 284

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLPNGVNDIKNHKWF 297

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  FA K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 5e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  FA K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  FA K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHKETGNHFAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEYSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 86/281 (30%), Positives = 135/281 (48%), Gaps = 36/281 (12%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHS 164
           +V+G G    V  C +  +  E+A K + K        V REVE++    GH  V+ L  
Sbjct: 19  DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIE 78
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +EE D F+LV E   GG ++  + +   ++E  A+ + +DV   + + H+ G+ HRD+K
Sbjct: 79  FFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLK 138
Query: 225 PENILLTTSGK---IKLADFGLAMRIS-NGQT-------LSGLAGSPAYVAPEVLSGN-- 271
           PENIL     +   +K+ DF L   I  NG         L    GS  Y+APEV+     
Sbjct: 139 PENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSE 198
Query: 272 ----YSEKVDIWSXXXXXXXXXXXXXPFKG--------DSLEA-------VFDAIKNVKL 312
               Y ++ D+WS             PF G        D  EA       +F++I+  K 
Sbjct: 199 EASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKY 258
Query: 313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           +F    W  +S  A+DL++++L RD   R++A +VL+HPW+
Sbjct: 259 EFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADEPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ IG G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G IK+ADFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score =  122 bits (305), Expect = 6e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 133/272 (48%), Gaps = 17/272 (6%)
Query: 97  RKNKIEDDHT-KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +K  + DD+    +V+G G  G V  C  + +G + A K L    +   +EV+     SG
Sbjct: 3   KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-RQEVDHHWQASG 61
Query: 156 HTGVVTLHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  ++ME   GG L  ++ E G   ++E+ AA I +D+   
Sbjct: 62  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 121
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I++ H   + HRD+KPEN+L T+  K   +KL DFG A   +    L     +P YVAPE
Sbjct: 122 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPE 180
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK-NVKL---DFHSGVWET 321
           VL    Y +  D+WS             PF  ++ +A+   +K  ++L    F +  W  
Sbjct: 181 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 240
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           VS+ A+ L+  +L  D + R+T  + + HPWI
Sbjct: 241 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 272

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score =  121 bits (304), Expect = 7e-28,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 133/272 (48%), Gaps = 17/272 (6%)
Query: 97  RKNKIEDDHT-KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +K  + DD+    +V+G G  G V  C  + +G + A K L    +   +EV+     SG
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPKA-RQEVDHHWQASG 80
Query: 156 HTGVVTLHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  ++ME   GG L  ++ E G   ++E+ AA I +D+   
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I++ H   + HRD+KPEN+L T+  K   +KL DFG A   +    L     +P YVAPE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPE 199
Query: 267 VLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK-NVKL---DFHSGVWET 321
           VL    Y +  D+WS             PF  ++ +A+   +K  ++L    F +  W  
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           VS+ A+ L+  +L  D + R+T  + + HPWI
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWI 291

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score =  121 bits (304), Expect = 8e-28,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 28  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 86
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 87  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 146
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 147 LDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 204
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 205 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 260
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 261 QVDLTKRFGNLKNGVNDIKNHKWF 284

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score =  121 bits (303), Expect = 9e-28,   Method: Compositional matrix adjust.
 Identities = 87/253 (34%), Positives = 130/253 (51%), Gaps = 17/253 (6%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   K +G + A K   LRK +  E +  EV IM+    H  VV ++S Y
Sbjct: 53  IGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYH-HDNVVDMYSSY 111
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  + Y H+ GV+HRDIK +
Sbjct: 112 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSD 170
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT+ G+IKL+DFG   ++S        L G+P ++APEV+S   Y  +VDIWS    
Sbjct: 171 SILLTSDGRIKLSDFGFCAQVSKEVPKRKXLVGTPYWMAPEVISRLPYGTEVDIWSLGIM 230
Query: 285 XXXXXXXXXPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
                    P+  +    ++  + D++     D H      VS   R  +  ML R+ S 
Sbjct: 231 VIEMIDGEPPYFNEPPLQAMRRIRDSLPPRVKDLHK-----VSSVLRGFLDLMLVREPSQ 285
Query: 341 RITADEVLRHPWI 353
           R TA E+L HP++
Sbjct: 286 RATAQELLGHPFL 298

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 74/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +E+E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFGLA R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ IG G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G IK+ADFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score =  121 bits (303), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ IG G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTIGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYMPGGDMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G IK+ADFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIKVADFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIXNHKWF 298

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 78/252 (30%), Positives = 117/252 (46%), Gaps = 13/252 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIMQHLSGH 156
           D   ++VIG G FG V L R KA    +A K L       +K E+ +  E  ++     H
Sbjct: 39  DFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKH 98
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LH  ++ AD  + V++  +GG L   +     + E RA     ++   + Y H +
Sbjct: 99  PFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSL 158
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAM-RISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
            +V+RD+KPENILL + G I L DFGL    I +  T S   G+P Y+APEVL    Y  
Sbjct: 159 NIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDR 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W              PF   +   ++D I N  L         ++  AR L+  +L
Sbjct: 219 TVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLL 274
Query: 335 TRDVSARITADE 346
            +D + R+ A +
Sbjct: 275 QKDRTKRLGAKD 286

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G+++E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score =  120 bits (302), Expect = 1e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 62  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 180
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 238
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 294
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 295 QVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 62  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 120
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 121 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 180
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 181 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 238
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 239 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 294
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 295 QVDLTKRFGNLKNGVNDIKNHKWF 318

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  120 bits (301), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 92
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 152
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 210
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 266
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 267 QVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 132/264 (50%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G I++ DFG A R+  G+T   L G+P Y+APE ++S  Y++
Sbjct: 160 LDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIIISKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 36  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 94
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 95  FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 154
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 155 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 212
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 213 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 268
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 269 QVDLTKRFGNLKNGVNDIKNHKWF 292

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score =  120 bits (300), Expect = 2e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +E+E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKEIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G I++ DFGLA R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGLAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (299), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+AP  +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPAIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score =  119 bits (298), Expect = 3e-27,   Method: Compositional matrix adjust.
 Identities = 90/288 (31%), Positives = 131/288 (45%), Gaps = 15/288 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-GHTG 158
           D +  V+ IG G FG   L R K S    A K + +GE   E V RE  I+ H S  H  
Sbjct: 18  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKRE--IINHRSLRHPN 75
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V    V        +VME  SGG L +++   G++SE  A   F+ ++  + YCH M V
Sbjct: 76  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 135
Query: 219 VHRDIKPENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYSEK 275
            HRD+K EN LL  + + ++K+ DFG +             G+PAY+APEV L   Y  K
Sbjct: 136 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 195
Query: 276 V-DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMAR 332
           V D+WS             PF+       F    +  L+    +  +  +S   R L++R
Sbjct: 196 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 255
Query: 333 MLTRDVSARITADEVLRHPWILFYTERTL---RTLTIKSKLKNQVGAS 377
           +   D + RI+  E+  H W L      L    T+T +    +Q G S
Sbjct: 256 IFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFAASDQPGQS 303

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++          +++  H W 
Sbjct: 274 QVDLTKAFGNLKNGVNDIKNHKWF 297

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score =  119 bits (297), Expect = 5e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T + L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score =  118 bits (296), Expect = 6e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 84/272 (30%), Positives = 131/272 (48%), Gaps = 16/272 (5%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKXLQDCPK-ARREVELHWRASQ 113
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +V E   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVXECLDGGELFSRIQDRGDQAFTEREASEIXKSIGEA 173
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233
Query: 267 VLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDA----IKNVKLDFHSGVWET 321
           VL    Y +  D WS             PF  +   A+       I+  + +F +  W  
Sbjct: 234 VLGPEKYDKSCDXWSLGVIXYILLCGYPPFYSNHGLAISPGXKTRIRXGQYEFPNPEWSE 293
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           VS+  + L+  +L  + + R T  E   HPWI
Sbjct: 294 VSEEVKXLIRNLLKTEPTQRXTITEFXNHPWI 325

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score =  118 bits (296), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 34  DQFERIKTLGTGSFGRVMLVKHKETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 92
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 93  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 152
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 153 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 210
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 211 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 266
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 267 QVDLTKRFGNLKNGVNDIKNHKWF 290

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 27  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 85
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 86  FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 145
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T + L G+P Y+APE +LS  Y++
Sbjct: 146 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWT-LCGTPEYLAPEIILSKGYNK 203
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 204 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 259
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 260 QVDLTKRFGNLKDGVNDIKNHKWF 283

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG------EETVHREVE--IMQHLSG 155
           + V+G G +G V+  R K +GA     FA K L+K       ++T H + E  I++ +  
Sbjct: 22  LRVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK- 79
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L   ++     +L++E  SGG L  Q+   G + E  A     ++   + + H 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVL-SGNYS 273
            G+++RD+KPENI+L   G +KL DFGL    I +G       G+  Y+APE+L    ++
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHXFCGTIEYMAPEILMRSGHN 199
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD WS             PF G++ +   D I   KL+        +++ ARDL+ ++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKL 255
Query: 334 LTRDVSARI-----TADEVLRHPWI 353
           L R+ ++R+      A EV  HP+ 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 79/265 (29%), Positives = 130/265 (49%), Gaps = 25/265 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG------EETVHREVE--IMQHLSG 155
           + V+G G +G V+  R K +GA     FA K L+K       ++T H + E  I++ +  
Sbjct: 22  LRVLGKGGYGKVFQVR-KVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK- 79
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +V L   ++     +L++E  SGG L  Q+   G + E  A     ++   + + H 
Sbjct: 80  HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQ 139
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVL-SGNYS 273
            G+++RD+KPENI+L   G +KL DFGL    I +G       G+  Y+APE+L    ++
Sbjct: 140 KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHN 199
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD WS             PF G++ +   D I   KL+        +++ ARDL+ ++
Sbjct: 200 RAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPP----YLTQEARDLLKKL 255
Query: 334 LTRDVSARI-----TADEVLRHPWI 353
           L R+ ++R+      A EV  HP+ 
Sbjct: 256 LKRNAASRLGAGPGDAGEVQAHPFF 280

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKDGVNDIKNHKWF 297

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 73/264 (27%), Positives = 131/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P  +APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEALAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score =  118 bits (295), Expect = 9e-27,   Method: Compositional matrix adjust.
 Identities = 87/286 (30%), Positives = 131/286 (45%), Gaps = 11/286 (3%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQHLS-GHTGVV 160
           D +  V+ IG G FG   L R K S    A K + +GE+   + + EI+ H S  H  +V
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIAANVKREIINHRSLRHPNIV 78
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
               V        +VME  SGG L +++   G++SE  A   F+ ++  + YCH M V H
Sbjct: 79  RFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQVCH 138
Query: 221 RDIKPENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYSEKV- 276
           RD+K EN LL  + + ++K+ DFG +             G+PAY+APEV L   Y  KV 
Sbjct: 139 RDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGKVA 198
Query: 277 DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARML 334
           D+WS             PF+       F    +  L+    +  +  +S   R L++R+ 
Sbjct: 199 DVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISRIF 258
Query: 335 TRDVSARITADEVLRHPWILFYTERTL---RTLTIKSKLKNQVGAS 377
             D + RI+  E+  H W L      L    T+T +    +Q G S
Sbjct: 259 VADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQS 304

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 99  NKIED------DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHR 145
           NKI D      D+  V+VIG G FG V L R K++   +A K L K E            
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E +IM   +    VV L   +++    ++VME   GG L++ M       E+ A     +
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAE 181
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYV 263
           V+  +   H MG +HRD+KP+N+LL  SG +KLADFG  M+++    +      G+P Y+
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 264 APEVL-----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV 318
           +PEVL      G Y  + D WS             PF  DSL   +  I N K       
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 301
Query: 319 WETVSKPARDLMARMLT-RDVS-ARITADEVLRHPWILFY 356
              +SK A++L+   LT R+V   R   +E+ RH   LF+
Sbjct: 302 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH---LFF 338

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score =  117 bits (293), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 130/264 (49%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score =  117 bits (293), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 99  NKIED------DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHR 145
           NKI D      D+  V+VIG G FG V L R K++   +A K L K E            
Sbjct: 59  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 118
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E +IM   +    VV L   +++    ++VME   GG L++ M       E+ A     +
Sbjct: 119 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAE 176
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYV 263
           V+  +   H MG +HRD+KP+N+LL  SG +KLADFG  M+++    +      G+P Y+
Sbjct: 177 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 236
Query: 264 APEVL-----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV 318
           +PEVL      G Y  + D WS             PF  DSL   +  I N K       
Sbjct: 237 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 296
Query: 319 WETVSKPARDLMARMLT-RDVS-ARITADEVLRHPWILFY 356
              +SK A++L+   LT R+V   R   +E+ RH   LF+
Sbjct: 297 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH---LFF 333

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +  L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +  L   +++    ++VME   GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 91/280 (32%), Positives = 131/280 (46%), Gaps = 27/280 (9%)
Query: 99  NKIED------DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           NKI D      D+  V+VIG G FG V L R K++   +A K L K E            
Sbjct: 64  NKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWE 123
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E +IM   +    VV L   +++    ++VME   GG L++ M       E+ A     +
Sbjct: 124 ERDIMA-FANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNY-DVPEKWARFYTAE 181
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYV 263
           V+  +   H MG +HRD+KP+N+LL  SG +KLADFG  M+++    +      G+P Y+
Sbjct: 182 VVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYI 241
Query: 264 APEVL-----SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV 318
           +PEVL      G Y  + D WS             PF  DSL   +  I N K       
Sbjct: 242 SPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD 301
Query: 319 WETVSKPARDLMARMLT-RDVS-ARITADEVLRHPWILFY 356
              +SK A++L+   LT R+V   R   +E+ RH   LF+
Sbjct: 302 DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH---LFF 338

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 85/263 (32%), Positives = 127/263 (48%), Gaps = 14/263 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-GHTG 158
           D +  V+ IG G FG   L R K +    A K + +GE   E V RE  I+ H S  H  
Sbjct: 19  DRYELVKDIGAGNFGVARLMRDKQANELVAVKYIERGEKIDENVKRE--IINHRSLRHPN 76
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V    V        +VME  SGG L +++   G++SE  A   F+ ++  + Y H M V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYAHAMQV 136
Query: 219 VHRDIKPENILL--TTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEV-LSGNYSE 274
            HRD+K EN LL  + + ++K+ADFG +   + + Q  S + G+PAY+APEV L   Y  
Sbjct: 137 AHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQPKSAV-GTPAYIAPEVLLKKEYDG 195
Query: 275 KV-DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMA 331
           KV D+WS             PF+       F    +  L+    +  +  +S   R L++
Sbjct: 196 KVADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLIS 255
Query: 332 RMLTRDVSARITADEVLRHPWIL 354
           R+   D + RI+  E+  H W L
Sbjct: 256 RIFVADPAKRISIPEIRNHEWFL 278

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 85/267 (31%), Positives = 126/267 (47%), Gaps = 18/267 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHREVEIMQHLSG 155
           +D+  V+VIG G FG V L R KAS   +A K L K E            E +IM   + 
Sbjct: 75  EDYDVVKVIGRGAFGEVQLVRHKASQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FAN 133
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              VV L   +++    ++VME   GG L++ M       E+ A     +V+  +   H 
Sbjct: 134 SPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHS 192
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYVAPEVL----- 268
           MG++HRD+KP+N+LL   G +KLADFG  M++     +      G+P Y++PEVL     
Sbjct: 193 MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMVHCDTAVGTPDYISPEVLKSQGG 252
Query: 269 SGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            G Y  + D WS             PF  DSL   +  I + K          +SK A++
Sbjct: 253 DGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLCFPEDAEISKHAKN 312
Query: 329 LMARMLT-RDVS-ARITADEVLRHPWI 353
           L+   LT R+V   R   +E+ +HP+ 
Sbjct: 313 LICAFLTDREVRLGRNGVEEIKQHPFF 339

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 41  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 159
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 217
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 273
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 129/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 101 FPFLVKLEFSFKDNSNLYMVMEYVPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 130/288 (45%), Gaps = 15/288 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-GHTG 158
           D +  V+ IG G FG   L R K S    A K + +GE   E V RE  I+ H S  H  
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKRE--IINHRSLRHPN 76
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V    V        +VME  SGG L +++   G++SE  A   F+ ++  + YCH M V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 219 VHRDIKPENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYSEK 275
            HRD+K EN LL  + + ++K+  FG +             G+PAY+APEV L   Y  K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKSTVGTPAYIAPEVLLKKEYDGK 196
Query: 276 V-DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMAR 332
           V D+WS             PF+       F    +  L+    +  +  +S   R L++R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 333 MLTRDVSARITADEVLRHPWILFYTERTL---RTLTIKSKLKNQVGAS 377
           +   D + RI+  E+  H W L      L    T+T +    +Q G S
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQS 304

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 89/288 (30%), Positives = 130/288 (45%), Gaps = 15/288 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-GHTG 158
           D +  V+ IG G FG   L R K S    A K + +GE   E V RE  I+ H S  H  
Sbjct: 19  DRYELVKDIGSGNFGVARLMRDKQSNELVAVKYIERGEKIDENVKRE--IINHRSLRHPN 76
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V    V        +VME  SGG L +++   G++SE  A   F+ ++  + YCH M V
Sbjct: 77  IVRFKEVILTPTHLAIVMEYASGGELFERICNAGRFSEDEARFFFQQLISGVSYCHAMQV 136
Query: 219 VHRDIKPENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYSEK 275
            HRD+K EN LL  + + ++K+  FG +             G+PAY+APEV L   Y  K
Sbjct: 137 CHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQPKDTVGTPAYIAPEVLLKKEYDGK 196
Query: 276 V-DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMAR 332
           V D+WS             PF+       F    +  L+    +  +  +S   R L++R
Sbjct: 197 VADVWSCGVTLYVMLVGAYPFEDPEEPKNFRKTIHRILNVQYAIPDYVHISPECRHLISR 256
Query: 333 MLTRDVSARITADEVLRHPWILFYTERTL---RTLTIKSKLKNQVGAS 377
           +   D + RI+  E+  H W L      L    T+T +    +Q G S
Sbjct: 257 IFVADPAKRISIPEIRNHEWFLKNLPADLMNDNTMTTQFDESDQPGQS 304

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 16/272 (5%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREV 147
           + R+   ++   +  V+G G FG V  C+ +A+G  +ACK L K       GE     E 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKD 205
           +I++ ++    VV+L   YE  D   LV+ L +GG L   +  +GQ  + E RA     +
Sbjct: 236 QILEKVNSRF-VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
           +   ++  H   +V+RD+KPENILL   G I+++D GLA+ +  GQT+ G  G+  Y+AP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 266 EVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           EV+    Y+   D W+             PF+    +   + ++ +  +      E  S 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 325 PARDLMARMLTRDVSARI-----TADEVLRHP 351
            AR L +++L +D + R+     +A EV  HP
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score =  115 bits (288), Expect = 6e-26,   Method: Compositional matrix adjust.
 Identities = 81/272 (29%), Positives = 134/272 (49%), Gaps = 16/272 (5%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREV 147
           + R+   ++   +  V+G G FG V  C+ +A+G  +ACK L K       GE     E 
Sbjct: 176 LERQPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEK 235
Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKD 205
           +I++ ++    VV+L   YE  D   LV+ L +GG L   +  +GQ  + E RA     +
Sbjct: 236 QILEKVNSRF-VVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAE 294
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
           +   ++  H   +V+RD+KPENILL   G I+++D GLA+ +  GQT+ G  G+  Y+AP
Sbjct: 295 ICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAP 354
Query: 266 EVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
           EV+    Y+   D W+             PF+    +   + ++ +  +      E  S 
Sbjct: 355 EVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSERFSP 414
Query: 325 PARDLMARMLTRDVSARI-----TADEVLRHP 351
            AR L +++L +D + R+     +A EV  HP
Sbjct: 415 QARSLCSQLLCKDPAERLGCRGGSAREVKEHP 446

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 70/264 (26%), Positives = 128/264 (48%), Gaps = 20/264 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
           D   +++ +G G FG V L +   +G  +A K L K +    +++E       I+Q ++ 
Sbjct: 42  DQFERIKTLGTGSFGRVMLVKHMETGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 100
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +  L   +++    ++VME   GG +   +  +G++ E  A      ++   +Y H 
Sbjct: 101 FPFLTKLEFSFKDNSNLYMVMEYAPGGEMFSHLRRIGRFXEPHARFYAAQIVLTFEYLHS 160
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE-VLSGNYSE 274
           + +++RD+KPEN+++   G IK+ DFG A R+  G+T   L G+P Y+APE +LS  Y++
Sbjct: 161 LDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-GRTWX-LCGTPEYLAPEIILSKGYNK 218
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 219 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPS----HFSSDLKDLLRNLL 274
Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 275 QVDLTKRFGNLKNGVNDIKNHKWF 298

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 159 IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 217
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 218 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 276
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 277 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 336
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 337 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 393
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 394 TAAELLKHPFL 404

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score =  114 bits (284), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 82  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 140
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 141 LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 199
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 200 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 259
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 260 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 316
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 317 TAAELLKHPFL 327

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score =  114 bits (284), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 39  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 97
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 98  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 156
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 157 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 216
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 217 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 273
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 274 TAAELLKHPFL 284

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 130/256 (50%), Gaps = 11/256 (4%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQVIH 139
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 279 WSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS             P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMD 257
Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 37  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 95
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 96  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 154
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 155 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 214
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 215 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 271
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 272 TAAELLKHPFL 282

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 130/256 (50%), Gaps = 11/256 (4%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQVIH 139
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 279 WSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS             P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLDMD 257
Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score =  113 bits (283), Expect = 2e-25,   Method: Compositional matrix adjust.
 Identities = 78/256 (30%), Positives = 130/256 (50%), Gaps = 11/256 (4%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 22  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 80
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 81  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQVIH 139
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSEMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 279 WSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS             P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLDMD 257
Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+L+H ++
Sbjct: 258 VEKRGSAKELLQHQFL 273

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 28  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 86
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 87  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 145
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 146 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 205
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 206 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 262
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 263 TAAELLKHPFL 273

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score =  113 bits (282), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 82/251 (32%), Positives = 128/251 (50%), Gaps = 13/251 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHTGVVTLHSVY 166
           IG G  G V +   ++SG   A K   LRK +  E +  EV IM+    H  VV +++ Y
Sbjct: 32  IGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSY 90
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
              D   +VME   GG L D +V   + +E++ A +   V+  +   H  GV+HRDIK +
Sbjct: 91  LVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSD 149
Query: 227 NILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXX 284
           +ILLT  G++KL+DFG   ++S        L G+P ++APE++S   Y  +VDIWS    
Sbjct: 150 SILLTHDGRVKLSDFGFCAQVSKEVPRRKXLVGTPYWMAPELISRLPYGPEVDIWSLGIM 209
Query: 285 XXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV--WETVSKPARDLMARMLTRDVSARI 342
                    P+     E    A+K ++ +    +     VS   +  + R+L RD + R 
Sbjct: 210 VIEMVDGEPPYFN---EPPLKAMKMIRDNLPPRLKNLHKVSPSLKGFLDRLLVRDPAQRA 266
Query: 343 TADEVLRHPWI 353
           TA E+L+HP++
Sbjct: 267 TAAELLKHPFL 277

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 125/258 (48%), Gaps = 20/258 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVV 160
           ++++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  + 
Sbjct: 156 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 214
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVV 219
            L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV
Sbjct: 215 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 274
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD
Sbjct: 275 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 334
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            W              PF     E +F+ I   ++ F      T+   A+ L++ +L +D
Sbjct: 335 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKD 390
Query: 338 VSARI-----TADEVLRH 350
              R+      A E+++H
Sbjct: 391 PKQRLGGGSEDAKEIMQH 408

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 20/261 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVV 160
           ++++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  + 
Sbjct: 15  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 73
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVV 219
            L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV
Sbjct: 74  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 133
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD
Sbjct: 134 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 193
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            W              PF     E +F+ I   ++ F      T+   A+ L++ +L +D
Sbjct: 194 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKD 249
Query: 338 VSARI-----TADEVLRHPWI 353
              R+      A E+++H + 
Sbjct: 250 PKQRLGGGSEDAKEIMQHRFF 270

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/258 (30%), Positives = 125/258 (48%), Gaps = 20/258 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVV 160
           ++++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  + 
Sbjct: 153 LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 211
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVV 219
            L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV
Sbjct: 212 ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 271
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD
Sbjct: 272 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVD 331
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            W              PF     E +F+ I   ++ F      T+   A+ L++ +L +D
Sbjct: 332 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPR----TLGPEAKSLLSGLLKKD 387
Query: 338 VSARI-----TADEVLRH 350
              R+      A E+++H
Sbjct: 388 PKQRLGGGSEDAKEIMQH 405

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 20/261 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVV 160
           ++++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  + 
Sbjct: 14  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVV 219
            L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV
Sbjct: 73  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 132
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD
Sbjct: 133 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 192
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            W              PF     E +F+ I   ++ F      T+   A+ L++ +L +D
Sbjct: 193 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKD 248
Query: 338 VSARI-----TADEVLRHPWI 353
              R+      A E+++H + 
Sbjct: 249 PKQRLGGGSEDAKEIMQHRFF 269

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score =  112 bits (281), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 79/261 (30%), Positives = 126/261 (48%), Gaps = 20/261 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVE--IMQHLSGHTGVV 160
           ++++G G FG V L + KA+G  +A K L+K      +E  H   E  ++Q+ S H  + 
Sbjct: 13  LKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLT 71
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVV 219
            L   ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV
Sbjct: 72  ALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVV 131
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
           +RD+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD
Sbjct: 132 YRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKXFCGTPEYLAPEVLEDNDYGRAVD 191
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
            W              PF     E +F+ I   ++ F      T+   A+ L++ +L +D
Sbjct: 192 WWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKD 247
Query: 338 VSARI-----TADEVLRHPWI 353
              R+      A E+++H + 
Sbjct: 248 PKQRLGGGSEDAKEIMQHRFF 268

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 77/256 (30%), Positives = 130/256 (50%), Gaps = 11/256 (4%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 81
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQVIH 140
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 141 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSXMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 279 WSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS             P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMD 258
Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+++H ++
Sbjct: 259 VEKRGSAKELIQHQFL 274

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 80/288 (27%), Positives = 137/288 (47%), Gaps = 41/288 (14%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------------------- 140
           + +T  + IG G +G V L  ++     +A K L K +                      
Sbjct: 13  NQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGG 72
Query: 141 --------ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHLVMELCSGGRLIDQMVE 190
                   E V++E+ I++ L  H  VV L  V ++   D  ++V EL + G ++ ++  
Sbjct: 73  CIQPRGPIEQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVM-EVPT 130
Query: 191 VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG 250
           +   SE +A   F+D++  I+Y H   ++HRDIKP N+L+   G IK+ADFG++      
Sbjct: 131 LKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGS 190
Query: 251 QT-LSGLAGSPAYVAPEVLSGN---YSEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFD 305
              LS   G+PA++APE LS     +S K +D+W+             PF  + +  +  
Sbjct: 191 DALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHS 250
Query: 306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            IK+  L+F       +++  +DL+ RML ++  +RI   E+  HPW+
Sbjct: 251 KIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 131/267 (49%), Gaps = 12/267 (4%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEETV--HREVEIMQHLSGHTGVVTLHSV 165
           E +G G+FG V  C   +S   +  K ++ KG + V   +E+ I+ +++ H  ++ LH  
Sbjct: 11  EDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISIL-NIARHRNILHLHES 69
Query: 166 YEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           +E  +   ++ E  SG  + +++     + +E+   +    V   +++ H   + H DI+
Sbjct: 70  FESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIR 129
Query: 225 PENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY-SEKVDIWSX 281
           PENI+  T  S  IK+ +FG A ++  G     L  +P Y APEV   +  S   D+WS 
Sbjct: 130 PENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSL 189
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF  ++ + + + I N +  F    ++ +S  A D + R+L ++  +R
Sbjct: 190 GTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249
Query: 342 ITADEVLRHPWILFYTER----TLRTL 364
           +TA E L+HPW+    ER     +RTL
Sbjct: 250 MTASEALQHPWLKQKIERVSTKVIRTL 276

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score =  110 bits (275), Expect = 1e-24,   Method: Compositional matrix adjust.
 Identities = 76/256 (29%), Positives = 130/256 (50%), Gaps = 11/256 (4%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVV 160
           +T+ E IG G  G+V+     A+G E A + +    +  +E +  E+ +M+  + +  +V
Sbjct: 23  YTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRE-NKNPNIV 81
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
                Y   D   +VME  +GG L D + E      Q AA + ++ +  +++ H   V+H
Sbjct: 82  NYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAA-VCRECLQALEFLHSNQVIH 140
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           R+IK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  KVDI
Sbjct: 141 RNIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDI 200
Query: 279 WSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           WS             P+  ++ L A++    N   +  +   E +S   RD + R L  D
Sbjct: 201 WSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP--EKLSAIFRDFLNRCLEMD 258
Query: 338 VSARITADEVLRHPWI 353
           V  R +A E+++H ++
Sbjct: 259 VEKRGSAKELIQHQFL 274

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score =  110 bits (275), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 79/264 (29%), Positives = 120/264 (45%), Gaps = 16/264 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLS-GHTG 158
           D +  V+ IG G FG   L R K +    A K + +G   +E V RE  I+ H S  H  
Sbjct: 20  DRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQRE--IINHRSLRHPN 77
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +V    V        ++ME  SGG L +++   G++SE  A   F+ ++  + YCH M +
Sbjct: 78  IVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQI 137
Query: 219 VHRDIKPENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYSEK 275
            HRD+K EN LL  + + ++K+ DFG +             G+PAY+APEV L   Y  K
Sbjct: 138 CHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGK 197
Query: 276 V-DIWSXXXXXXXXXXXXXPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           + D+WS             PF+              I +VK      +   +S     L+
Sbjct: 198 IADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDI--RISPECCHLI 255
Query: 331 ARMLTRDVSARITADEVLRHPWIL 354
           +R+   D + RI+  E+  H W L
Sbjct: 256 SRIFVADPATRISIPEIKTHSWFL 279

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score =  110 bits (274), Expect = 2e-24,   Method: Compositional matrix adjust.
 Identities = 75/265 (28%), Positives = 136/265 (51%), Gaps = 18/265 (6%)
Query: 100 KIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQ 151
           KIED   KV  ++G G F  V+   S  +G E A K + K         + V  EV+I  
Sbjct: 9   KIED--FKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC 66
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVI 210
            L  H  ++ L++ +E+++  +LV+E+C  G +   +   V  +SE  A +    ++  +
Sbjct: 67  QLK-HPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGM 125
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLS 269
            Y H  G++HRD+   N+LLT +  IK+ADFGLA ++    +    L G+P Y++PE+ +
Sbjct: 126 LYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIAT 185
Query: 270 -GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
              +  + D+WS             PF  D+++   + +  V  D+    + ++   A+D
Sbjct: 186 RSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKV--VLADYEMPSFLSIE--AKD 241
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
           L+ ++L R+ + R++   VL HP++
Sbjct: 242 LIHQLLRRNPADRLSLSSVLDHPFM 266

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score =  109 bits (273), Expect = 3e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 15/264 (5%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IM 150
           K KIED     +++G G FG V+L   K +   FA K L+K    +  +VE       ++
Sbjct: 14  KLKIEDFELH-KMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 72
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
                H  +  +   ++  +    VME  +GG L+  +    ++   RA     +++  +
Sbjct: 73  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 132
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLS 269
           ++ H  G+V+RD+K +NILL   G IK+ADFG+      G   +    G+P Y+APE+L 
Sbjct: 133 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNEFCGTPDYIAPEILL 192
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y+  VD WS             PF G   E +F +I+ +   F+   W  + K A+D
Sbjct: 193 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPFYPR-W--LEKEAKD 248
Query: 329 LMARMLTRDVSARI-TADEVLRHP 351
           L+ ++  R+   R+    ++ +HP
Sbjct: 249 LLVKLFVREPEKRLGVRGDIRQHP 272

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 66/248 (26%), Positives = 124/248 (50%), Gaps = 13/248 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGH 156
           D   + V+G G FG V L   K +   +A K L+K       +VE       ++  L   
Sbjct: 20  DFNFLMVLGKGSFGKVMLADRKGTEELYAIKILKKDVVIQDDDVECTMVEKRVLALLDKP 79
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +  LHS ++  D  + VME  +GG L+  + +VG++ E +A     ++   + + H  
Sbjct: 80  PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISIGLFFLHKR 139
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           G+++RD+K +N++L + G IK+ADFG+    + +G T     G+P Y+APE+++   Y +
Sbjct: 140 GIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMMDGVTTREFCGTPDYIAPEIIAYQPYGK 199
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF G+  + +F +I    ++ +    +++SK A  +   ++
Sbjct: 200 SVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI----MEHNVSYPKSLSKEAVSICKGLM 255
Query: 335 TRDVSARI 342
           T+  + R+
Sbjct: 256 TKHPAKRL 263

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 75/264 (28%), Positives = 127/264 (48%), Gaps = 15/264 (5%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IM 150
           K KIED     +++G G FG V+L   K +   FA K L+K    +  +VE       ++
Sbjct: 13  KLKIED-FILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
                H  +  +   ++  +    VME  +GG L+  +    ++   RA     +++  +
Sbjct: 72  SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGL 131
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLS 269
           ++ H  G+V+RD+K +NILL   G IK+ADFG+      G   +    G+P Y+APE+L 
Sbjct: 132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNXFCGTPDYIAPEILL 191
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y+  VD WS             PF G   E +F +I+ +   F+   W  + K A+D
Sbjct: 192 GQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR-MDNPFYPR-W--LEKEAKD 247
Query: 329 LMARMLTRDVSARI-TADEVLRHP 351
           L+ ++  R+   R+    ++ +HP
Sbjct: 248 LLVKLFVREPEKRLGVRGDIRQHP 271

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score =  109 bits (272), Expect = 4e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEIXINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 8e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSXQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 240
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 241 HKILVENPSARITIPDIKKDRW 262

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  108 bits (269), Expect = 9e-24,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 130/273 (47%), Gaps = 22/273 (8%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------KGEETVHREVEIMQHLSGH 156
           + + +++ IG G FG   L +S   G ++  K +       K  E   REV ++ ++  H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-H 82
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVG-QYSEQRAANIFKDVMWVIKYCH 214
             +V     +EE    ++VM+ C GG L  ++  + G  + E +  + F  +   +K+ H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSGN-Y 272
           D  ++HRDIK +NI LT  G ++L DFG+A  +++   L+    G+P Y++PE+     Y
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202
Query: 273 SEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV----SKPARD 328
           + K DIW+              F+  S+       KN+ L   SG +  V    S   R 
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSM-------KNLVLKIISGSFPPVSLHYSYDLRS 255
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERTL 361
           L++++  R+   R + + +L   +I    E+ L
Sbjct: 256 LVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFL 288

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score =  107 bits (268), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/248 (30%), Positives = 123/248 (49%), Gaps = 16/248 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQH-----LSGHT 157
           +D   ++VIG G FG V + + K +   FA K L K E     E    +      ++G +
Sbjct: 74  EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 158 G-VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD 215
             + TLH  +++ +  +LVM+   GG L+  + +   +  E+ A     +++  I   H 
Sbjct: 134 KWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQ 193
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLA-GSPAYVAPEVLS---- 269
           +  VHRDIKP+NIL+  +G I+LADFG  +++  +G   S +A G+P Y++PE+L     
Sbjct: 194 LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEG 253
Query: 270 --GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWET-VSKPA 326
             G Y  + D WS             PF  +SL   +  I N K  F      T VS+ A
Sbjct: 254 GKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPTQVTDVSENA 313
Query: 327 RDLMARML 334
           +DL+ R++
Sbjct: 314 KDLIRRLI 321

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMXGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score =  107 bits (267), Expect = 1e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 125/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT---YLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 122/248 (49%), Gaps = 13/248 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ------HLSGHT 157
           D   + V+G G FG V L   K +   +A K L+K       +VE          L G  
Sbjct: 342 DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 401
Query: 158 GVVT-LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +T LHS ++  D  + VME  +GG L+  + +VG++ E  A     ++   + +    
Sbjct: 402 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           G+++RD+K +N++L + G IK+ADFG+    I +G T     G+P Y+APE+++   Y +
Sbjct: 462 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK 521
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF+G+  + +F +I    ++ +    +++SK A  +   ++
Sbjct: 522 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPKSMSKEAVAICKGLM 577
Query: 335 TRDVSARI 342
           T+    R+
Sbjct: 578 TKHPGKRL 585

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 135/283 (47%), Gaps = 23/283 (8%)
Query: 88  CIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKGEETV 143
            I  H + G +         ++V+G G FG V+L + K SG++    +A K L+K    V
Sbjct: 9   AITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKV 67
Query: 144 HREV------EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
              V      +I+  ++ H  +V LH  ++     +L+++   GG L  ++ +   ++E+
Sbjct: 68  RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGL 256
                  ++   + + H +G+++RD+KPENILL   G IKL DFGL+   I + +     
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFH 315
            G+  Y+APEV++   +++  D WS             PF+G   +     I   KL   
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--- 243
Query: 316 SGVWETVSKPARDLMARMLTRDVSARITA-----DEVLRHPWI 353
            G+ + +S  A+ L+  +  R+ + R+ A     +E+ RH + 
Sbjct: 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 75/266 (28%), Positives = 129/266 (48%), Gaps = 24/266 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKGEETVHREV------EIMQHLSGHTG 158
           ++V+G G FG V+L R      SG  +A K L+K    V   V      +I+  ++ H  
Sbjct: 33  LKVLGQGSFGKVFLVRKVTRPDSGHLYAMKVLKKATLKVRDRVRTKMERDILADVN-HPF 91
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           VV LH  ++     +L+++   GG L  ++ +   ++E+       ++   + + H +G+
Sbjct: 92  VVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALGLDHLHSLGI 151
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLS-GNYSEKV 276
           ++RD+KPENILL   G IKL DFGL+   I + +      G+  Y+APEV++   +S   
Sbjct: 152 IYRDLKPENILLDEEGHIKLTDFGLSKEAIDHEKKAYSFCGTVEYMAPEVVNRQGHSHSA 211
Query: 277 DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D WS             PF+G   +     I   KL    G+ + +S  A+ L+  +  R
Sbjct: 212 DWWSYGVLMFEMLTGSLPFQGKDRKETMTLILKAKL----GMPQFLSTEAQSLLRALFKR 267
Query: 337 DVSARI-----TADEVLRHPWILFYT 357
           + + R+      A+E+ RH   +FY+
Sbjct: 268 NPANRLGSGPDGAEEIKRH---VFYS 290

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 71/270 (26%), Positives = 129/270 (47%), Gaps = 24/270 (8%)
Query: 108 VEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKGE--------ETVHREVEIMQHLSGH 156
           ++V+G G +G V+L R  +   +G  +A K L+K          E    E ++++H+   
Sbjct: 59  LKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQS 118
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +VTLH  ++     HL+++  +GG L   + +  +++E        +++  +++ H +
Sbjct: 119 PFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKL 178
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG--LAGSPAYVAPEVLSG---N 271
           G+++RDIK ENILL ++G + L DFGL+      +T       G+  Y+AP+++ G    
Sbjct: 179 GIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSG 238
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + + VD WS             PF  D  +     I    L       + +S  A+DL+ 
Sbjct: 239 HDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQ 298
Query: 332 RMLTRDVSARI-----TADEVLRHPWILFY 356
           R+L +D   R+      ADE+  H   LF+
Sbjct: 299 RLLMKDPKKRLGCGPRDADEIKEH---LFF 325

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I   L+ H 
Sbjct: 7   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINAMLN-HE 65
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 66  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 125
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 126 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 185
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 186 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 242
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 243 HKILVENPSARITIPDIKKDRW 264

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score =  106 bits (265), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 68/248 (27%), Positives = 123/248 (49%), Gaps = 13/248 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEI------MQHLSGHT 157
           D   + V+G G FG V L   K +   +A K L+K       +VE       +  L G  
Sbjct: 21  DFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKP 80
Query: 158 GVVT-LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +T LHS ++  D  + VME  +GG L+  + +VG++ E  A     ++   + +    
Sbjct: 81  PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 140
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           G+++RD+K +N++L + G IK+ADFG+    I +G T     G+P Y+APE+++   Y +
Sbjct: 141 GIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKXFCGTPDYIAPEIIAYQPYGK 200
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+             PF+G+  + +F +I    ++ +    +++SK A  +   ++
Sbjct: 201 SVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSI----MEHNVAYPKSMSKEAVAICKGLM 256
Query: 335 TRDVSARI 342
           T+    R+
Sbjct: 257 TKHPGKRL 264

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 135/283 (47%), Gaps = 23/283 (8%)
Query: 88  CIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKGEETV 143
            I  H + G +         ++V+G G FG V+L + K SG++    +A K L+K    V
Sbjct: 9   AITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKV 67
Query: 144 HREV------EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
              V      +I+  ++ H  +V LH  ++     +L+++   GG L  ++ +   ++E+
Sbjct: 68  RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGL 256
                  ++   + + H +G+++RD+KPENILL   G IKL DFGL+   I + +     
Sbjct: 127 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 186
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFH 315
            G+  Y+APEV++   +++  D WS             PF+G   +     I   KL   
Sbjct: 187 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--- 243
Query: 316 SGVWETVSKPARDLMARMLTRDVSARITA-----DEVLRHPWI 353
            G+ + +S  A+ L+  +  R+ + R+ A     +E+ RH + 
Sbjct: 244 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 285

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 74/283 (26%), Positives = 135/283 (47%), Gaps = 23/283 (8%)
Query: 88  CIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKGEETV 143
            I  H + G +         ++V+G G FG V+L + K SG++    +A K L+K    V
Sbjct: 10  AITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVK-KISGSDARQLYAMKVLKKATLKV 68
Query: 144 HREV------EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
              V      +I+  ++ H  +V LH  ++     +L+++   GG L  ++ +   ++E+
Sbjct: 69  RDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEE 127
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGL 256
                  ++   + + H +G+++RD+KPENILL   G IKL DFGL+   I + +     
Sbjct: 128 DVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF 187
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFH 315
            G+  Y+APEV++   +++  D WS             PF+G   +     I   KL   
Sbjct: 188 CGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKL--- 244
Query: 316 SGVWETVSKPARDLMARMLTRDVSARITA-----DEVLRHPWI 353
            G+ + +S  A+ L+  +  R+ + R+ A     +E+ RH + 
Sbjct: 245 -GMPQFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFF 286

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 76/262 (29%), Positives = 124/262 (47%), Gaps = 16/262 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHT 157
           +D   V+ +G G  G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 6   EDWDLVQTLGEGAAGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 65  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQ-TLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA   R +N +  L+ + G+  YVAPE+L     +
Sbjct: 125 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 184
Query: 273 SEKVDIWSXXXXXXXXXXXXXPF--KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +E VD+WS             P+    DS +   D  +      +   W+ +      L+
Sbjct: 185 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEK---KTYLNPWKKIDSAPLALL 241
Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  + SARIT  ++ +  W
Sbjct: 242 HKILVENPSARITIPDIKKDRW 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score =  105 bits (262), Expect = 5e-23,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 35  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 93
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 94  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 153
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 154 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 213
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF +  +      ARDL+ 
Sbjct: 214 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPAAFFPK----ARDLVE 269
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 270 KLLVLDATKRLGCEEM 285

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIM 150
           + K  +D    +++G G F +V L R  A+  E+A K L K           V RE ++M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             L  H   V L+  +++ +  +  +     G L+  + ++G + E        +++  +
Sbjct: 63  SRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEV 267
           +Y H  G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 181
Query: 268 LSGNYSEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           L+   + K  D+W+             PF+  +   +F  I  ++ DF     E     A
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 237
Query: 327 RDLMARMLTRDVSARITADEV 347
           RDL+ ++L  D + R+  +E+
Sbjct: 238 RDLVEKLLVLDATKRLGCEEM 258

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score =  105 bits (262), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIM 150
           + K  +D    +++G G F +V L R  A+  E+A K L K           V RE ++M
Sbjct: 4   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 63
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             L  H   V L+  +++ +  +  +     G L+  + ++G + E        +++  +
Sbjct: 64  SRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 122
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEV 267
           +Y H  G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+
Sbjct: 123 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 182
Query: 268 LSGNYSEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           L+   + K  D+W+             PF+  +   +F  I  ++ DF     E     A
Sbjct: 183 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 238
Query: 327 RDLMARMLTRDVSARITADEV 347
           RDL+ ++L  D + R+  +E+
Sbjct: 239 RDLVEKLLVLDATKRLGCEEM 259

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score =  105 bits (261), Expect = 6e-23,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIM 150
           + K  +D    +++G G F +V L R  A+  E+A K L K           V RE ++M
Sbjct: 5   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 64
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             L  H   V L+  +++ +  +  +     G L+  + ++G + E        +++  +
Sbjct: 65  SRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 123
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEV 267
           +Y H  G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+
Sbjct: 124 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 183
Query: 268 LSGNYSEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           L+   + K  D+W+             PF+  +   +F  I  ++ DF     E     A
Sbjct: 184 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 239
Query: 327 RDLMARMLTRDVSARITADEV 347
           RDL+ ++L  D + R+  +E+
Sbjct: 240 RDLVEKLLVLDATKRLGCEEM 260

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 69/261 (26%), Positives = 122/261 (46%), Gaps = 16/261 (6%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIM 150
           + K  +D    +++G G F +V L R  A+  E+A K L K           V RE ++M
Sbjct: 2   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 61
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             L  H   V L+  +++ +  +  +     G L+  + ++G + E        +++  +
Sbjct: 62  SRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 120
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEV 267
           +Y H  G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+
Sbjct: 121 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPEL 180
Query: 268 LSGNYSEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           L+   + K  D+W+             PF+  +   +F  I  ++ DF     E     A
Sbjct: 181 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKA 236
Query: 327 RDLMARMLTRDVSARITADEV 347
           RDL+ ++L  D + R+  +E+
Sbjct: 237 RDLVEKLLVLDATKRLGCEEM 257

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAFVGTAQYVSPELLTEKS 208
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 264
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 265 KLLVLDATKRLGCEEM 280

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score =  105 bits (261), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 91
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 211
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 267
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 268 KLLVLDATKRLGCEEM 283

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 121/256 (47%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGCLLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLS-GN 271
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+  +
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 210
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
            S+  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 ASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score =  104 bits (260), Expect = 8e-23,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 AXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 264
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 265 KLLVLDATKRLGCEEM 280

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 33  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 91
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 92  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 151
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 152 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 211
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 212 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 267
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 268 KLLVLDATKRLGCEEM 283

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 30  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 264
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 265 KLLVLDATKRLGCEEM 280

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 87
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKS 207
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 263
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 264 KLLVLDATKRLGCEEM 279

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 130/260 (50%), Gaps = 19/260 (7%)
Query: 93  TQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ 151
           TQ+ ++ ++  +D   ++VIG G FG V + + K +   +A K L K E     E    +
Sbjct: 79  TQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR 138
Query: 152 H-----LSGHTGVVT-LHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFK 204
                 ++G    +T LH  +++ +  +LVM+   GG L+  + +   +  E  A     
Sbjct: 139 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 198
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAY 262
           +++  I   H +  VHRDIKP+N+LL  +G I+LADFG  +++++  T+  S   G+P Y
Sbjct: 199 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 258
Query: 263 VAPEVLS------GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKN--VKLDF 314
           ++PE+L       G Y  + D WS             PF  +SL   +  I N   +  F
Sbjct: 259 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 318
Query: 315 HSGVWETVSKPARDLMARML 334
            S V + VS+ A+DL+ R++
Sbjct: 319 PSHVTD-VSEEAKDLIQRLI 337

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  104 bits (259), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E  S    + +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KPEN+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  103 bits (258), Expect = 1e-22,   Method: Compositional matrix adjust.
 Identities = 86/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 62
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E  S    + +D     G       + +F+ ++  + +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLSMDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KPEN+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 242 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 37  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 95
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 96  HPFFVKLYFCFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 155
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 156 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 215
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 216 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 271
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 272 KLLVLDATKRLGCEEM 287

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 14  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 72
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 73  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 132
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 133 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 192
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 193 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 248
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 249 KLLVLDATKRLGCEEM 264

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 29  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 87
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 88  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 147
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 148 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 207
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 208 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 263
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 264 KLLVLDATKRLGCEEM 279

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score =  103 bits (258), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 76/260 (29%), Positives = 129/260 (49%), Gaps = 19/260 (7%)
Query: 93  TQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQ 151
           TQ+ ++ ++  +D   ++VIG G FG V + + K +   +A K L K E     E    +
Sbjct: 63  TQLVKEMQLHREDFEIIKVIGRGAFGEVAVVKMKNTERIYAMKILNKWEMLKRAETACFR 122
Query: 152 H-----LSGHTGVVT-LHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFK 204
                 ++G    +T LH  +++ +  +LVM+   GG L+  + +   +  E  A     
Sbjct: 123 EERDVLVNGDCQWITALHYAFQDENHLYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIG 182
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAY 262
           +++  I   H +  VHRDIKP+N+LL  +G I+LADFG  +++++  T+  S   G+P Y
Sbjct: 183 EMVLAIDSIHQLHYVHRDIKPDNVLLDVNGHIRLADFGSCLKMNDDGTVQSSVAVGTPDY 242
Query: 263 VAPEVLS------GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKN--VKLDF 314
           ++PE+L       G Y  + D WS             PF  +SL   +  I N   +  F
Sbjct: 243 ISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHEERFQF 302
Query: 315 HSGVWETVSKPARDLMARML 334
            S V   VS+ A+DL+ R++
Sbjct: 303 PSHV-TDVSEEAKDLIQRLI 321

>pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 74/250 (29%), Positives = 117/250 (46%), Gaps = 18/250 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT------LRKGEETVHREVEIMQHLSGH 156
           DD   ++VIG G F  V + + K +G  +A K       L++GE +  RE   +      
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMWVIKYCHD 215
             +  LH  +++ +  +LVME   GG L+  + + G+      A  +  +++  I   H 
Sbjct: 121 RWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHR 180
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL--AGSPAYVAPEVLSG--- 270
           +G VHRDIKP+NILL   G I+LADFG  +++    T+  L   G+P Y++PE+L     
Sbjct: 181 LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGG 240
Query: 271 -----NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFH-SGVWETVSK 324
                +Y  + D W+             PF  DS    +  I + K       V E V +
Sbjct: 241 GPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPE 300
Query: 325 PARDLMARML 334
            ARD + R+L
Sbjct: 301 EARDFIQRLL 310

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 68/256 (26%), Positives = 120/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +V L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 32  EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 90
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 91  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 150
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 151 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 210
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 211 ACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLVE 266
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 267 KLLVLDATKRLGCEEM 282

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score =  103 bits (257), Expect = 2e-22,   Method: Compositional matrix adjust.
 Identities = 75/250 (30%), Positives = 126/250 (50%), Gaps = 22/250 (8%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETV---HREVEIMQHLSGHTGVV 160
           V+ +G G   +V+L        + A K +    R+ EET+    REV     LS H  +V
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIV 74
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
           ++  V EE DC++LVME   G  L + +   G  S   A N    ++  IK+ HDM +VH
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISN---GQTLSGLAGSPAYVAPEVLSGNYSEK-V 276
           RDIKP+NIL+ ++  +K+ DFG+A  +S     QT + + G+  Y +PE   G  +++  
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQT-NHVLGTVQYFSPEQAKGEATDECT 193
Query: 277 DIWSXXXXXXXXXXXXXPFKGDS-----LEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           DI+S             PF G++     ++ + D++ NV  D    + +++S    +++ 
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLS----NVIL 249
Query: 332 RMLTRDVSAR 341
           R   +D + R
Sbjct: 250 RATEKDKANR 259

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score =  103 bits (256), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGH 156
           D   + VIG G +  V L R K +   +A K ++K         + V  E  + +  S H
Sbjct: 21  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 80
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LHS ++       V+E  +GG L+  M    +  E+ A     ++   + Y H+ 
Sbjct: 81  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 140
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
           G+++RD+K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE+L G +Y  
Sbjct: 141 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 200
Query: 275 KVDIWSXXXXXXXXXXXXXPF 295
            VD W+             PF
Sbjct: 201 SVDWWALGVLMFEMMAGRSPF 221

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGH 156
           D   + VIG G +  V L R K +   +A K ++K         + V  E  + +  S H
Sbjct: 6   DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LHS ++       V+E  +GG L+  M    +  E+ A     ++   + Y H+ 
Sbjct: 66  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 125
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
           G+++RD+K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE+L G +Y  
Sbjct: 126 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 185
Query: 275 KVDIWSXXXXXXXXXXXXXPF 295
            VD W+             PF
Sbjct: 186 SVDWWALGVLMFEMMAGRSPF 206

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score =  102 bits (255), Expect = 3e-22,   Method: Compositional matrix adjust.
 Identities = 67/256 (26%), Positives = 119/256 (46%), Gaps = 16/256 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G F +  L R  A+  E+A K L K           V RE ++M  L  
Sbjct: 30  EDFKFGKILGEGSFSTTVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD- 88
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H   V L+  +++ +  +  +     G L+  + ++G + E        +++  ++Y H 
Sbjct: 89  HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHG 148
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSGNY 272
            G++HRD+KPENILL     I++ DFG A  +   S     +   G+  YV+PE+L+   
Sbjct: 149 KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXFVGTAQYVSPELLTEKS 208
Query: 273 SEK-VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K  D+W+             PF+  +   +F  I  ++ DF     E     ARDL+ 
Sbjct: 209 ACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLVE 264
Query: 332 RMLTRDVSARITADEV 347
           ++L  D + R+  +E+
Sbjct: 265 KLLVLDATKRLGCEEM 280

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score =  102 bits (255), Expect = 4e-22,   Method: Compositional matrix adjust.
 Identities = 60/201 (29%), Positives = 96/201 (47%), Gaps = 9/201 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGH 156
           D   + VIG G +  V L R K +   +A K ++K         + V  E  + +  S H
Sbjct: 10  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNH 69
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LHS ++       V+E  +GG L+  M    +  E+ A     ++   + Y H+ 
Sbjct: 70  PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
           G+++RD+K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE+L G +Y  
Sbjct: 130 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSXFCGTPNYIAPEILRGEDYGF 189
Query: 275 KVDIWSXXXXXXXXXXXXXPF 295
            VD W+             PF
Sbjct: 190 SVDWWALGVLMFEMMAGRSPF 210

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KPEN+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 123 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 243 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  102 bits (254), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 184
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 245 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 62
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KPEN+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 122 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 242 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 5e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN-- 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 68
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN-- 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGXKY 187
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 248 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 10  ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 68
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 69  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 127
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 128 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 187
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 188 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 247
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 248 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 294

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLSFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  102 bits (253), Expect = 6e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 62
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 181
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 242 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 14/253 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGH 156
           D   + VIG G +  V L R K +   +A + ++K         + V  E  + +  S H
Sbjct: 53  DFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNH 112
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LHS ++       V+E  +GG L+  M    +  E+ A     ++   + Y H+ 
Sbjct: 113 PFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
           G+++RD+K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE+L G +Y  
Sbjct: 173 GIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGF 232
Query: 275 KVDIWSXXXXXXXXXXXXXPF-----KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
            VD W+             PF       +  +   D +  V L+    +  ++S  A  +
Sbjct: 233 SVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASV 292
Query: 330 MARMLTRDVSARI 342
           +   L +D   R+
Sbjct: 293 LKSFLNKDPKERL 305

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  102 bits (253), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  101 bits (252), Expect = 7e-22,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 131/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  101 bits (252), Expect = 8e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGR--LIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E  S      +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  101 bits (252), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGR--LIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E  S      +D     G       + +F+ ++  + +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLSMDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 243 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299

Iteration: 1
 Score =  101 bits (251), Expect = 9e-22,   Method: Compositional matrix adjust.
 Identities = 76/272 (27%), Positives = 122/272 (44%), Gaps = 35/272 (12%)
Query: 97  RKNKIEDDH-TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPKA-RREVELHWRASQ 69
Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129
Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG                     A E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AKE 169
Query: 267 VLSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWETV 322
                Y +  D+WS             PF  +   A+   +K      + +F +  W  V
Sbjct: 170 TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           S+  + L+  +L  + + R+T  E + HPWI+
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIM 261

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 243 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 5   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 64  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 122
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 123 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 182
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 183 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 242
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 243 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 289

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 7   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 66  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 124
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 125 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 184
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 185 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 244
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 245 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 291

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  101 bits (251), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 62
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 242 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 4   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 62
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 63  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 121
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 122 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 181
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 182 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 241
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 242 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 288

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score =  100 bits (250), Expect = 1e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +         E + +E+ ++      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 80
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 81  Y-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 138
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 198
Query: 275 KVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS             P  +   ++ +F   KN             SKP ++ +   
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG----NYSKPLKEFVEAC 254
Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L ++ S R TA E+L+H +IL   ++T
Sbjct: 255 LNKEPSFRPTAKELLKHKFILRNAKKT 281

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 85/288 (29%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGR--LIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E         +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKDFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KPEN+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +         E + +E+ ++      
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 66  Y-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 183
Query: 275 KVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS             P  +   ++ +F   KN             SKP ++ +   
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGN----YSKPLKEFVEAC 239
Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L ++ S R TA E+L+H +IL   ++T
Sbjct: 240 LNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score =  100 bits (249), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +         E + +E+ ++      
Sbjct: 6   EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 66  Y-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 123
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 124 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDS 183
Query: 275 KVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS             P  +   ++ +F   KN             SKP ++ +   
Sbjct: 184 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG----NYSKPLKEFVEAC 239
Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L ++ S R TA E+L+H +IL   ++T
Sbjct: 240 LNKEPSFRPTAKELLKHKFILRNAKKT 266

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/267 (28%), Positives = 128/267 (47%), Gaps = 14/267 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K +         E + +E+ ++      
Sbjct: 26  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSP 85
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 86  Y-VTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 143
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 144 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 203
Query: 275 KVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS             P  +   ++ +F   KN             SKP ++ +   
Sbjct: 204 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEG----NYSKPLKEFVEAC 259
Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L ++ S R TA E+L+H +IL   ++T
Sbjct: 260 LNKEPSFRPTAKELLKHKFILRNAKKT 286

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 75/279 (26%), Positives = 133/279 (47%), Gaps = 30/279 (10%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +    A K +  K EE +     E++I+     H  +V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS-CDHPNIVKLLDAF 103
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
              +   +++E C+GG +   M+E+ +  +E +   + K  +  + Y HD  ++HRD+K 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 226 ENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEVLSGN------YSEKV 276
            NIL T  G IKLADFG++ +  N +T+       G+P ++APEV+         Y  K 
Sbjct: 164 GNILFTLDGDIKLADFGVSAK--NTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKA 221
Query: 277 DIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR------DLM 330
           D+WS             P     L  +      V L        T+++P+R      D +
Sbjct: 222 DVWSLGITLIEMAEIEPPHH--ELNPM-----RVLLKIAKSEPPTLAQPSRWSSNFKDFL 274
Query: 331 ARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSK 369
            + L ++V AR T  ++L+HP++   + + +R L  ++K
Sbjct: 275 KKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 313

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 133/283 (46%), Gaps = 41/283 (14%)
Query: 111 IGHGKFGSVWLCRSKASGAEF-ACKTLR--KGEE----TVHREVEIMQHLSG--HTGVVT 161
           IG G +G V+  R   +G  F A K +R   GEE    +  REV +++HL    H  VV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 LHSV-----YEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           L  V      +      LV E         +D++ E G  +E     +F+ ++  + + H
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLH 137
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYS 273
              VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y APEV L  +Y+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---------KNVKLD---FHSG 317
             VD+WS              F+G    D L  + D I         ++V L    FHS 
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 257
Query: 318 VWETVSK-------PARDLMARMLTRDVSARITADEVLRHPWI 353
             + + K         +DL+ + LT + + RI+A   L HP+ 
Sbjct: 258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +    A K +  K EE +     E++I+     H  +V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS-CDHPNIVKLLDAF 103
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
              +   +++E C+GG +   M+E+ +  +E +   + K  +  + Y HD  ++HRD+K 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 226 ENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN------YSEKVDI 278
            NIL T  G IKLADFG++ + +   Q      G+P ++APEV+         Y  K D+
Sbjct: 164 GNILFTLDGDIKLADFGVSAKNTRXIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADV 223
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR------DLMAR 332
           WS             P     L  +      V L        T+++P+R      D + +
Sbjct: 224 WSLGITLIEMAEIEPPHH--ELNPM-----RVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276
Query: 333 MLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSK 369
            L ++V AR T  ++L+HP++   + + +R L  ++K
Sbjct: 277 CLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 313

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 129/288 (44%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E         +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEFLHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 6   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 64
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 65  PNIVKLLDVIHTENKLYLVFEHVDQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 123
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T      +  Y APE+L G   
Sbjct: 124 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYXHEVVTLWYRAPEILLGCKY 183
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 184 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 243
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 244 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 290

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A   +R   ET        RE+ +++ L+ H
Sbjct: 3   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 62  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 120
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 121 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 180
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 181 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 240
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 287

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 83/288 (28%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A   +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALXKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E       + +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 29  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 87
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 88  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 147
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 148 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSI 207
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 208 GCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAASLIQKMLQTDPTAR 263
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 264 PTINELL 270

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 133/283 (46%), Gaps = 41/283 (14%)
Query: 111 IGHGKFGSVWLCRSKASGAEF-ACKTLR--KGEE----TVHREVEIMQHLSG--HTGVVT 161
           IG G +G V+  R   +G  F A K +R   GEE    +  REV +++HL    H  VV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 LHSV-----YEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           L  V      +      LV E         +D++ E G  +E     +F+ ++  + + H
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLH 137
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYS 273
              VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y APEV L  +Y+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---------KNVKLD---FHSG 317
             VD+WS              F+G    D L  + D I         ++V L    FHS 
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 257
Query: 318 VWETVSK-------PARDLMARMLTRDVSARITADEVLRHPWI 353
             + + K         +DL+ + LT + + RI+A   L HP+ 
Sbjct: 258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 99.8 bits (247), Expect = 3e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 144 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSI 203
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAASLIQKMLQTDPTAR 259
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 260 PTINELL 266

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 25  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 83
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 84  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 143
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 144 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKTLCGTPNYIAPEVLSKKGHSFEVDVWSI 203
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 204 GCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAASLIQKMLQTDPTAR 259
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 260 PTINELL 266

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 131/277 (47%), Gaps = 26/277 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL-RKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +    A K +  K EE +     E++I+     H  +V L   +
Sbjct: 45  LGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILAS-CDHPNIVKLLDAF 103
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
              +   +++E C+GG +   M+E+ +  +E +   + K  +  + Y HD  ++HRD+K 
Sbjct: 104 YYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKA 163
Query: 226 ENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSGN------YSEKVDI 278
            NIL T  G IKLADFG++ + +   Q      G+P ++APEV+         Y  K D+
Sbjct: 164 GNILFTLDGDIKLADFGVSAKNTRXIQRRDXFIGTPYWMAPEVVMCETSKDRPYDYKADV 223
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR------DLMAR 332
           WS             P     L  +      V L        T+++P+R      D + +
Sbjct: 224 WSLGITLIEMAEIEPPHH--ELNPM-----RVLLKIAKSEPPTLAQPSRWSSNFKDFLKK 276
Query: 333 MLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSK 369
            L ++V AR T  ++L+HP++   + + +R L  ++K
Sbjct: 277 CLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 313

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 103 DDHTKVEVIGHGKFGSVW--LCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG--HTG 158
           DD+   EVIG G    V    C  K          L K + ++   ++ +Q +S   H  
Sbjct: 15  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 74
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--------GQYSEQRAANIFKDVMWVI 210
           +V+ ++ +   D   LVM+L SGG ++D +  +        G   E   A I ++V+  +
Sbjct: 75  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 134
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS------GLAGSPAYVA 264
           +Y H  G +HRD+K  NILL   G +++ADFG++  ++ G  ++         G+P ++A
Sbjct: 135 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 194
Query: 265 PEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWE- 320
           PEV+     Y  K DIWS             P+ K   ++ +   ++N      +GV + 
Sbjct: 195 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 254
Query: 321 ----TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                  K  R +++  L +D   R TA E+LRH + 
Sbjct: 255 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 90/283 (31%), Positives = 133/283 (46%), Gaps = 41/283 (14%)
Query: 111 IGHGKFGSVWLCRSKASGAEF-ACKTLR--KGEE----TVHREVEIMQHLSG--HTGVVT 161
           IG G +G V+  R   +G  F A K +R   GEE    +  REV +++HL    H  VV 
Sbjct: 19  IGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVR 78
Query: 162 LHSV-----YEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           L  V      +      LV E         +D++ E G  +E     +F+ ++  + + H
Sbjct: 79  LFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ-LLRGLDFLH 137
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV-LSGNYS 273
              VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y APEV L  +Y+
Sbjct: 138 SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYA 197
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---------KNVKLD---FHSG 317
             VD+WS              F+G    D L  + D I         ++V L    FHS 
Sbjct: 198 TPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSK 257
Query: 318 VWETVSK-------PARDLMARMLTRDVSARITADEVLRHPWI 353
             + + K         +DL+ + LT + + RI+A   L HP+ 
Sbjct: 258 SAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 300

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 99.4 bits (246), Expect = 4e-21,   Method: Compositional matrix adjust.
 Identities = 68/265 (25%), Positives = 124/265 (46%), Gaps = 22/265 (8%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR---KGEETVHREVEIMQHLSGHTGVVTLHS 164
           VE++G+G +G V+  R   +G   A K +      EE + +E+ +++  S H  + T + 
Sbjct: 29  VELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYG 88
Query: 165 VYEEA------DCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDM 216
            + +       D   LVME C  G + D +         E+  A I ++++  + + H  
Sbjct: 89  AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQH 148
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLS------ 269
            V+HRDIK +N+LLT + ++KL DFG++ ++       +   G+P ++APEV++      
Sbjct: 149 KVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPD 208
Query: 270 GNYSEKVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
             Y  K D+WS             P      + A+F   +N      S  W   SK  + 
Sbjct: 209 ATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW---SKKFQS 265
Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
            +   L ++ S R   +++++HP+I
Sbjct: 266 FIESCLVKNHSQRPATEQLMKHPFI 290

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 47  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 105
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 106 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 165
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 166 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 225
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 226 GCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAASLIQKMLQTDPTAR 281
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 282 PTINELL 288

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 75/277 (27%), Positives = 127/277 (45%), Gaps = 26/277 (9%)
Query: 103 DDHTKVEVIGHGKFGSVW--LCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG--HTG 158
           DD+   EVIG G    V    C  K          L K + ++   ++ +Q +S   H  
Sbjct: 10  DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCHHPN 69
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--------GQYSEQRAANIFKDVMWVI 210
           +V+ ++ +   D   LVM+L SGG ++D +  +        G   E   A I ++V+  +
Sbjct: 70  IVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGL 129
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS------GLAGSPAYVA 264
           +Y H  G +HRD+K  NILL   G +++ADFG++  ++ G  ++         G+P ++A
Sbjct: 130 EYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMA 189
Query: 265 PEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLDFHSGV--- 318
           PEV+     Y  K DIWS             P+ K   ++ +   ++N      +GV   
Sbjct: 190 PEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDK 249
Query: 319 --WETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              +   K  R +++  L +D   R TA E+LRH + 
Sbjct: 250 EMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 286

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 49  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 107
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 108 GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 167
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 168 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 227
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 228 GCIMYTLLVGKPPFETSCLKETYLRIKKNEY----SIPKHINPVAASLIQKMLQTDPTAR 283
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 284 PTINELL 290

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 84/288 (29%), Positives = 130/288 (45%), Gaps = 40/288 (13%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R   ET        RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V L  V    +  +LV E         +D     G       + +F+ ++  + +CH
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEHVHQDLKTFMDASALTGIPLPLIKSYLFQ-LLQGLAFCH 119
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG--N 271
              V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   
Sbjct: 120 SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKY 179
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNV-------------------- 310
           YS  VDIWS              F GDS ++ +F   + +                    
Sbjct: 180 YSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS 239
Query: 311 -----KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                + DF S V   + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 240 FPKWARQDF-SKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 99.0 bits (245), Expect = 5e-21,   Method: Compositional matrix adjust.
 Identities = 70/260 (26%), Positives = 111/260 (42%), Gaps = 17/260 (6%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK----TLRKGEETVHREVEIMQH--LS 154
            +    ++  +GHG +G V+  RSK  G  +A K      R  ++   +  E+  H  + 
Sbjct: 55  FQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVG 114
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKY 212
            H   V L   +EE    +L  ELC  G  + Q  E       E +     +D +  + +
Sbjct: 115 QHPCCVRLEQAWEEGGILYLQTELC--GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAH 172
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNY 272
            H  G+VH D+KP NI L   G+ KL DFGL + +          G P Y+APE+L G+Y
Sbjct: 173 LHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSY 232
Query: 273 SEKVDIWSXXXXXXXXX-XXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
               D++S              P  G+  + +      +  +F +G    +S   R ++ 
Sbjct: 233 GTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGY--LPPEFTAG----LSSELRSVLV 286
Query: 332 RMLTRDVSARITADEVLRHP 351
            ML  D   R TA+ +L  P
Sbjct: 287 MMLEPDPKLRATAEALLALP 306

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 98.6 bits (244), Expect = 7e-21,   Method: Compositional matrix adjust.
 Identities = 70/247 (28%), Positives = 117/247 (47%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV  H
Sbjct: 23  LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFH 81
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HRD+
Sbjct: 82  GFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDL 141
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSX 281
           K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS 
Sbjct: 142 KLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSI 201
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      + + ++  A  L+ +ML  D +AR
Sbjct: 202 GCIMYTLLVGKPPFETSCLKETYLRIKKNE----YSIPKHINPVAASLIQKMLQTDPTAR 257
Query: 342 ITADEVL 348
            T +E+L
Sbjct: 258 PTINELL 264

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLS 154
           ED      V+G G FG V+ C+ KA+G  +ACK L K       G +    E +I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVI 210
               +V+L   +E      LVM + +GG +   +  V +    + E RA      ++  +
Sbjct: 244 SRF-IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLS 269
           ++ H   +++RD+KPEN+LL   G ++++D GLA+ +  GQT + G AG+P ++APE+L 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 270 G-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y   VD ++             PF+    +     +K   L+      +  S  ++D
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 329 LMARMLTRDVSARI-----TADEVLRHP 351
               +L +D   R+     + D +  HP
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLS 154
           ED      V+G G FG V+ C+ KA+G  +ACK L K       G +    E +I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVI 210
               +V+L   +E      LVM + +GG +   +  V +    + E RA      ++  +
Sbjct: 244 SRF-IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLS 269
           ++ H   +++RD+KPEN+LL   G ++++D GLA+ +  GQT + G AG+P ++APE+L 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 270 G-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y   VD ++             PF+    +     +K   L+      +  S  ++D
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 329 LMARMLTRDVSARI-----TADEVLRHP 351
               +L +D   R+     + D +  HP
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLS 154
           ED      V+G G FG V+ C+ KA+G  +ACK L K       G +    E +I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVI 210
               +V+L   +E      LVM + +GG +   +  V +    + E RA      ++  +
Sbjct: 244 SRF-IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLS 269
           ++ H   +++RD+KPEN+LL   G ++++D GLA+ +  GQT + G AG+P ++APE+L 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 270 G-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y   VD ++             PF+    +     +K   L+      +  S  ++D
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 329 LMARMLTRDVSARI-----TADEVLRHP 351
               +L +D   R+     + D +  HP
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 97.8 bits (242), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 19/268 (7%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLS 154
           ED      V+G G FG V+ C+ KA+G  +ACK L K       G +    E +I+  + 
Sbjct: 184 EDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH 243
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVI 210
               +V+L   +E      LVM + +GG +   +  V +    + E RA      ++  +
Sbjct: 244 SRF-IVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGL 302
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLS 269
           ++ H   +++RD+KPEN+LL   G ++++D GLA+ +  GQT + G AG+P ++APE+L 
Sbjct: 303 EHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLL 362
Query: 270 G-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G  Y   VD ++             PF+    +     +K   L+      +  S  ++D
Sbjct: 363 GEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYPDKFSPASKD 422
Query: 329 LMARMLTRDVSARI-----TADEVLRHP 351
               +L +D   R+     + D +  HP
Sbjct: 423 FCEALLQKDPEKRLGFRDGSCDGLRTHP 450

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 77/272 (28%), Positives = 128/272 (47%), Gaps = 14/272 (5%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACK--TLRKGEETVHREVEIMQHLSGHTGVVTLHSV 165
           +E +G G +GSV+    K +G   A K   +    + + +E+ IMQ       V    S 
Sbjct: 34  LEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCDSPHVVKYYGSY 93
Query: 166 YEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           ++  D + +VME C  G + D + +     +E   A I +  +  ++Y H M  +HRDIK
Sbjct: 94  FKNTDLW-IVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIK 152
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSXX 282
             NILL T G  KLADFG+A ++++     + + G+P ++APEV+    Y+   DIWS  
Sbjct: 153 AGNILLNTEGHAKLADFGVAGQLTDXMAKRNXVIGTPFWMAPEVIQEIGYNCVADIWSLG 212
Query: 283 XXXXXXXXXXXPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                      P+     + A+F    N    F     E  S    D + + L +    R
Sbjct: 213 ITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKP--ELWSDNFTDFVKQCLVKSPEQR 270
Query: 342 ITADEVLRHPWILFYTERTLRTLTIKSKLKNQ 373
            TA ++L+HP++     R+ + ++I   L N+
Sbjct: 271 ATATQLLQHPFV-----RSAKGVSILRDLINE 297

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 97.4 bits (241), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 74/263 (28%), Positives = 124/263 (47%), Gaps = 24/263 (9%)
Query: 109 EVIGHGKFGSV-------WLCRSKASGAEFACKTLR-KGEETVHREVEIMQHLSGHTGVV 160
           +++G G +G V        LCR      +         GE  V +E+++++ L  H  V+
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVI 69
Query: 161 TLHSVY--EEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            L  V   EE    ++VME C  G   ++D + E  ++   +A   F  ++  ++Y H  
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ 128
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQTLSGLAGSPAYVAPEVLSG--N 271
           G+VH+DIKP N+LLTT G +K++  G+A  +   +   T     GSPA+  PE+ +G   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188
Query: 272 YSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +S  KVDIWS             PF+GD++  +F+ I          +      P  DL+
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSY----AIPGDCGPPLSDLL 244
Query: 331 ARMLTRDVSARITADEVLRHPWI 353
             ML  + + R +  ++ +H W 
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWF 267

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 97.1 bits (240), Expect = 2e-20,   Method: Compositional matrix adjust.
 Identities = 77/280 (27%), Positives = 132/280 (47%), Gaps = 25/280 (8%)
Query: 96  GRKNKIEDDH---TKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREV 147
           G +N I D     TK+E IG G FG V+      +    A K +         E + +E+
Sbjct: 13  GMQNNIADPEELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEI 72
Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
            ++      + V   +  Y +     ++ME   GG  +D ++  G + E + A + K+++
Sbjct: 73  TVLSQCDS-SYVTKYYGSYLKGSKLWIIMEYLGGGSALD-LLRAGPFDEFQIATMLKEIL 130
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPE 266
             + Y H    +HRDIK  N+LL+  G +KLADFG+A ++++ Q   +   G+P ++APE
Sbjct: 131 KGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPE 190
Query: 267 VLSGN-YSEKVDIWSXXXXXXXXXXXXXPFKG-DSLEAVFDAIKN----VKLDFHSGVWE 320
           V+  + Y  K DIWS             P      +  +F   KN    +  DF      
Sbjct: 191 VIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNPPTLVGDF------ 244
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERT 360
             +K  ++ +   L +D S R TA E+L+H +I+  +++T
Sbjct: 245 --TKSFKEFIDACLNKDPSFRPTAKELLKHKFIVKNSKKT 282

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 77/294 (26%), Positives = 125/294 (42%), Gaps = 46/294 (15%)
Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHTGVVT 161
           ++E +G+G + +V+   +K +G   A K ++   E     T  RE+ +M+ L  H  +V 
Sbjct: 9   QLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVR 67
Query: 162 LHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVI----KYCHD 215
           L+ V    +   LV E       + +D    VG        N+ K   W +     +CH+
Sbjct: 68  LYDVIHTENKLTLVFEFMDNDLKKYMDSRT-VGNTPRGLELNLVKYFQWQLLQGLAFCHE 126
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--Y 272
             ++HRD+KP+N+L+   G++KL DFGLA        T S    +  Y AP+VL G+  Y
Sbjct: 127 NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTY 186
Query: 273 SEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK-------- 324
           S  +DIWS              F G + E     I ++    +  +W +V+K        
Sbjct: 187 STSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNI 246
Query: 325 ---PARDL-------------------MARMLTRDVSARITADEVLRHPWILFY 356
              P RDL                   +  +L  +   R++A + L HPW   Y
Sbjct: 247 QQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEY 300

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 73/267 (27%), Positives = 124/267 (46%), Gaps = 14/267 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-----RKGEETVHREVEIMQHLSGH 156
           E+  TK++ IG G FG V+      +    A K +         E + +E+ ++      
Sbjct: 18  EELFTKLDRIGKGSFGEVYKGIDNHTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS- 76
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +      Y ++    ++ME   GG  +D +++ G   E   A I ++++  + Y H  
Sbjct: 77  PYITRYFGSYLKSTKLWIIMEYLGGGSALD-LLKPGPLEETYIATILREILKGLDYLHSE 135
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
             +HRDIK  N+LL+  G +KLADFG+A ++++ Q   +   G+P ++APEV+  + Y  
Sbjct: 136 RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNXFVGTPFWMAPEVIKQSAYDF 195
Query: 275 KVDIWSXXXXXXXXXXXXXPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K DIWS             P      +  +F   KN             SKP ++ +   
Sbjct: 196 KADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEG----QHSKPFKEFVEAC 251
Query: 334 LTRDVSARITADEVLRHPWILFYTERT 360
           L +D   R TA E+L+H +I  YT++T
Sbjct: 252 LNKDPRFRPTAKELLKHKFITRYTKKT 278

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score = 95.5 bits (236), Expect = 5e-20,   Method: Compositional matrix adjust.
 Identities = 77/292 (26%), Positives = 123/292 (42%), Gaps = 47/292 (16%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           + + K+  IG G +G V+ CR++ +G   A K   + E+         RE+ +++ L  H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-H 61
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW----VIKY 212
             +V L  V+      HLV E C    L     E+ +Y      ++ K + W     + +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVL----HELDRYQRGVPEHLVKSITWQTLQAVNF 117
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPAYVAPEVLSG 270
           CH    +HRD+KPENIL+T    IKL DFG A R+  G +        +  Y +PE+L G
Sbjct: 118 CHKHNCIHRDVKPENILITKHSVIKLCDFGFA-RLLTGPSDYYDDEVATRWYRSPELLVG 176
Query: 271 N--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD-------------FH 315
           +  Y   VD+W+              + G S       I+    D             + 
Sbjct: 177 DTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYF 236
Query: 316 SGV--------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           SGV              +  +S PA  L+   L  D + R+T +++L HP+ 
Sbjct: 237 SGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYF 288

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 134/306 (43%), Gaps = 25/306 (8%)
Query: 52  PIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVI 111
           P+GS  + +A  +  P    S+ + P    LK     +     M R       + +   +
Sbjct: 2   PLGSMSAAIAKPSAKP----SAHVDPKSAPLKEIPDVLVDPRTMKR-------YMRGRFL 50
Query: 112 GHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHS 164
           G G F   +      +   FA K + K        +E +  E+ I + L  +  VV  H 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHG 109
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +E+ D  ++V+E+C    L++        +E  A    +  +  ++Y H+  V+HRD+K
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 225 PENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWSXX 282
             N+ L     +K+ DFGLA +I  +G+    L G+P Y+APEVL    +S +VDIWS  
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+   L+  +  IK  +      V   ++  A  L+ RML  D + R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEY----SVPRHINPVASALIRRMLHADPTLRP 285
Query: 343 TADEVL 348
           +  E+L
Sbjct: 286 SVAELL 291

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 75/286 (26%), Positives = 129/286 (45%), Gaps = 41/286 (14%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVV 160
           D  ++ V+G G FG V   R+      +A K +R  EE   T+  EV ++  L+ H  VV
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVV 65
Query: 161 TLHSVYEEADCF-------------HLVMELCSGGRLIDQMVEVGQYSEQRAA--NIFKD 205
             ++ + E   F              + ME C  G L D ++     ++QR     +F+ 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS--------NGQTLSGLA 257
           ++  + Y H  G++HRD+KP NI +  S  +K+ DFGLA  +         + Q L G +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 258 -------GSPAYVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFK-GDSLEAVFDAI 307
                  G+  YVA EVL  +G+Y+EK+D++S             PF  G     +   +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS---LGIIFFEMIYPFSTGMERVNILKKL 241
Query: 308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           ++V ++F     +   K  + ++  ++  D + R  A  +L   W+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 134/306 (43%), Gaps = 25/306 (8%)
Query: 52  PIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVI 111
           P+GS  + +A  +  P    S+ + P    LK     +     M R       + +   +
Sbjct: 2   PLGSMSAAIAKPSAKP----SAHVDPKSAPLKEIPDVLVDPRTMKR-------YMRGRFL 50
Query: 112 GHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHS 164
           G G F   +      +   FA K + K        +E +  E+ I + L  +  VV  H 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHG 109
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +E+ D  ++V+E+C    L++        +E  A    +  +  ++Y H+  V+HRD+K
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 225 PENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWSXX 282
             N+ L     +K+ DFGLA +I  +G+    L G+P Y+APEVL    +S +VDIWS  
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKXLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+   L+  +  IK  +      V   ++  A  L+ RML  D + R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEY----SVPRHINPVASALIRRMLHADPTLRP 285
Query: 343 TADEVL 348
           +  E+L
Sbjct: 286 SVAELL 291

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 80/306 (26%), Positives = 134/306 (43%), Gaps = 25/306 (8%)
Query: 52  PIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVI 111
           P+GS  + +A  +  P    S+ + P    LK     +     M R       + +   +
Sbjct: 2   PLGSMSAAIAKPSAKP----SAHVDPKSAPLKEIPDVLVDPRTMKR-------YMRGRFL 50
Query: 112 GHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHS 164
           G G F   +      +   FA K + K        +E +  E+ I + L  +  VV  H 
Sbjct: 51  GKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFHG 109
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
            +E+ D  ++V+E+C    L++        +E  A    +  +  ++Y H+  V+HRD+K
Sbjct: 110 FFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLK 169
Query: 225 PENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWSXX 282
             N+ L     +K+ DFGLA +I  +G+    L G+P Y+APEVL    +S +VDIWS  
Sbjct: 170 LGNLFLNDDMDVKIGDFGLATKIEFDGERKKTLCGTPNYIAPEVLCKKGHSFEVDIWSLG 229
Query: 283 XXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
                      PF+   L+  +  IK  +      V   ++  A  L+ RML  D + R 
Sbjct: 230 CILYTLLVGKPPFETSCLKETYIRIKKNEY----SVPRHINPVASALIRRMLHADPTLRP 285
Query: 343 TADEVL 348
           +  E+L
Sbjct: 286 SVAELL 291

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 69/247 (27%), Positives = 114/247 (46%), Gaps = 14/247 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F   +      +   FA K + K        +E +  E+ I + L  +  VV  H
Sbjct: 34  LGKGGFAKCYEITDMDTKEVFAGKVVPKSMLLKPHQKEKMSTEIAIHKSLD-NPHVVGFH 92
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
             +E+ D  ++V+E+C    L++        +E  A    +  +  ++Y H+  V+HRD+
Sbjct: 93  GFFEDDDFVYVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDL 152
Query: 224 KPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWSX 281
           K  N+ L     +K+ DFGLA +I  +G+    L G+P Y+APEVL    +S +VDIWS 
Sbjct: 153 KLGNLFLNDDMDVKIGDFGLATKIEFDGERKKDLCGTPNYIAPEVLCKKGHSFEVDIWSL 212
Query: 282 XXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
                       PF+   L+  +  IK  +      V   ++  A  L+ RML  D + R
Sbjct: 213 GCILYTLLVGKPPFETSCLKETYIRIKKNEY----SVPRHINPVASALIRRMLHADPTLR 268
Query: 342 ITADEVL 348
            +  E+L
Sbjct: 269 PSVAELL 275

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 133/300 (44%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           + +++ IG G  G V        G   A K L +  +        +RE+ +++ ++ H  
Sbjct: 24  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKN 82
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++ + +   +R + +   ++  IK+
Sbjct: 83  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM-ELDHERMSYLLYQMLCGIKH 139
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA   S    ++    +  Y APEV+ G  
Sbjct: 140 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTASTNFMMTPYVVTRYYRAPEVILGMG 199
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F+G    D    V + +     +F + +  TV     
Sbjct: 200 YKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 259
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D   RI+ DE LRHP+I
Sbjct: 260 NRPAYPGIAFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 319

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 92/324 (28%), Positives = 145/324 (44%), Gaps = 55/324 (16%)
Query: 75  LVPAG-RGLKRKIGCIDVHTQMGRKNKIEDDHTKVEV--IGHGKFGSVWLCRSKASGAEF 131
           LVP G   L RK G    + Q   K   E   T V    +G G +GSV     K SG + 
Sbjct: 14  LVPRGSMSLIRKKG---FYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKV 70
Query: 132 ACKTLRKGEET------VHREVEIMQHLSGHTGVVTLHSVYEEADC------FHLVMELC 179
           A K L +  ++       +RE+ +++H+  H  V+ L  V+  A        F+LVM   
Sbjct: 71  AIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLRNFYDFYLVMPFM 129
Query: 180 SGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA 239
                  Q +   ++SE++   +   ++  +KY H  GVVHRD+KP N+ +    ++K+ 
Sbjct: 130 QTDL---QKIMGMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKIL 186
Query: 240 DFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG 297
           DFGLA R ++ + ++G   +  Y APEV+    +Y++ VDIWS              FKG
Sbjct: 187 DFGLA-RHADAE-MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKG 244
Query: 298 -DSLEAVFDAIK---------------------------NVKLDFHSGVWETVSKPARDL 329
            D L+ +   +K                             + DF + ++   S  A DL
Sbjct: 245 KDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDF-TQLFPRASPQAADL 303
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +ML  DV  R+TA + L HP+ 
Sbjct: 304 LEKMLELDVDKRLTAAQALTHPFF 327

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 131/285 (45%), Gaps = 49/285 (17%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTLHS 164
           +G G +GSV     K SG + A K L +  ++       +RE+ +++H+  H  V+ L  
Sbjct: 32  VGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLD 90
Query: 165 VYEEADC------FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V+  A        F+LVM          Q +   ++SE++   +   ++  +KY H  GV
Sbjct: 91  VFTPASSLRNFYDFYLVMPFMQTDL---QKIMGLKFSEEKIQYLVYQMLKGLKYIHSAGV 147
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKV 276
           VHRD+KP N+ +    ++K+ DFGLA R ++ + ++G   +  Y APEV+    +Y++ V
Sbjct: 148 VHRDLKPGNLAVNEDCELKILDFGLA-RHADAE-MTGYVVTRWYRAPEVILSWMHYNQTV 205
Query: 277 DIWSXXXXXXXXXXXXXPFKG-DSLEAVFDAIK--------------------------- 308
           DIWS              FKG D L+ +   +K                           
Sbjct: 206 DIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQ 265
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             + DF + ++   S  A DL+ +ML  DV  R+TA + L HP+ 
Sbjct: 266 TPRKDF-TQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFF 309

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 92.4 bits (228), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIM 150
           K+  E   + +  IGHG FG+V+  R   +    A K +        +  + + +EV  +
Sbjct: 49  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 108
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMW 208
           Q L  H   +     Y       LVME C G      ++EV +    E   A +    + 
Sbjct: 109 QKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQ 165
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
            + Y H   ++HRD+K  NILL+  G +KL DFG A  ++     +   G+P ++APEV+
Sbjct: 166 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVI 222
Query: 269 ----SGNYSEKVDIWSXXXXXXXXXXXXXP-FKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
                G Y  KVD+WS             P F  +++ A++   +N      SG W   S
Sbjct: 223 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 279
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWIL 354
           +  R+ +   L +    R T++ +L+H ++L
Sbjct: 280 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 310

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 92.0 bits (227), Expect = 5e-19,   Method: Compositional matrix adjust.
 Identities = 73/271 (26%), Positives = 121/271 (44%), Gaps = 23/271 (8%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTL-------RKGEETVHREVEIM 150
           K+  E   + +  IGHG FG+V+  R   +    A K +        +  + + +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMW 208
           Q L  H   +     Y       LVME C G      ++EV +    E   A +    + 
Sbjct: 70  QKLR-HPNTIQYRGCYLREHTAWLVMEYCLGS--ASDLLEVHKKPLQEVEIAAVTHGALQ 126
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
            + Y H   ++HRD+K  NILL+  G +KL DFG A  ++     +   G+P ++APEV+
Sbjct: 127 GLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVI 183
Query: 269 ----SGNYSEKVDIWSXXXXXXXXXXXXXP-FKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
                G Y  KVD+WS             P F  +++ A++   +N      SG W   S
Sbjct: 184 LAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---S 240
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWIL 354
           +  R+ +   L +    R T++ +L+H ++L
Sbjct: 241 EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 91.7 bits (226), Expect = 7e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +GA  A K +  K EE +     E+EI+     H  +V L   Y
Sbjct: 27  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILA-TCDHPYIVKLLGAY 85
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
                  +++E C GG +   M+E+ +  +E +   + + ++  + + H   ++HRD+K 
Sbjct: 86  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 145
Query: 226 ENILLTTSGKIKLADFGL-AMRISNGQTLSGLAGSPAYVAPEVL------SGNYSEKVDI 278
            N+L+T  G I+LADFG+ A  +   Q      G+P ++APEV+         Y  K DI
Sbjct: 146 GNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 205
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD----FHSGVWETVSKPARDLMARML 334
           WS             P     L  +   +K  K D         W   S   RD +   L
Sbjct: 206 WSLGITLIEMAQIEPPHH--ELNPMRVLLKIAKSDPPTLLTPSKW---SVEFRDFLKIAL 260
Query: 335 TRDVSARITADEVLRHPWILFYT-ERTLRTLTIKSK 369
            ++   R +A ++L HP++   T  + LR L  ++K
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAK 296

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 91.7 bits (226), Expect = 9e-19,   Method: Compositional matrix adjust.
 Identities = 76/276 (27%), Positives = 126/276 (45%), Gaps = 23/276 (8%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V+  ++K +GA  A K +  K EE +     E+EI+     H  +V L   Y
Sbjct: 19  LGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILAT-CDHPYIVKLLGAY 77
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
                  +++E C GG +   M+E+ +  +E +   + + ++  + + H   ++HRD+K 
Sbjct: 78  YHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKA 137
Query: 226 ENILLTTSGKIKLADFGL-AMRISNGQTLSGLAGSPAYVAPEVL------SGNYSEKVDI 278
            N+L+T  G I+LADFG+ A  +   Q      G+P ++APEV+         Y  K DI
Sbjct: 138 GNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADI 197
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD----FHSGVWETVSKPARDLMARML 334
           WS             P     L  +   +K  K D         W   S   RD +   L
Sbjct: 198 WSLGITLIEMAQIEPPHH--ELNPMRVLLKIAKSDPPTLLTPSKW---SVEFRDFLKIAL 252
Query: 335 TRDVSARITADEVLRHPWILFYT-ERTLRTLTIKSK 369
            ++   R +A ++L HP++   T  + LR L  ++K
Sbjct: 253 DKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAK 288

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 91.3 bits (225), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 74/286 (25%), Positives = 128/286 (44%), Gaps = 41/286 (14%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVV 160
           D  ++ V+G G FG V   R+      +A K +R  EE   T+  EV ++  L+ H  VV
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVV 65
Query: 161 TLHSVYEEADCF-------------HLVMELCSGGRLIDQMVEVGQYSEQRAA--NIFKD 205
             ++ + E   F              + ME C    L D ++     ++QR     +F+ 
Sbjct: 66  RYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS--------NGQTLSGLA 257
           ++  + Y H  G++HRD+KP NI +  S  +K+ DFGLA  +         + Q L G +
Sbjct: 125 ILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 258 -------GSPAYVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFK-GDSLEAVFDAI 307
                  G+  YVA EVL  +G+Y+EK+D++S             PF  G     +   +
Sbjct: 185 DNLTSAIGTAMYVATEVLDGTGHYNEKIDMYS---LGIIFFEMIYPFSTGMERVNILKKL 241
Query: 308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           ++V ++F     +   K  + ++  ++  D + R  A  +L   W+
Sbjct: 242 RSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 94/189 (49%), Gaps = 13/189 (6%)
Query: 104 DHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           DH ++   IG G FG V + +   +   +A K + K +         V +E++IMQ L  
Sbjct: 15  DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              V   +S  +E D F +V++L  GG L   + +   + E+       +++  + Y  +
Sbjct: 75  PFLVNLWYSFQDEEDMF-MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQN 133
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS----GN 271
             ++HRD+KP+NILL   G + + DF +A  +     ++ +AG+  Y+APE+ S      
Sbjct: 134 QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAG 193
Query: 272 YSEKVDIWS 280
           YS  VD WS
Sbjct: 194 YSFAVDWWS 202

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVT 161
           +E IG G +G V+  ++   G  FA K +R  +E      T  RE+ I++ L  H+ +V 
Sbjct: 7   LEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVK 64
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           L+ V        LV E       + ++++V  G      A +    ++  I YCHD  V+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YSEKV 276
           HRD+KP+N+L+   G++K+ADFGLA       +  +    +  Y AP+VL G+  YS  +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI--------KNV----KLDFHSGV-- 318
           DIWS              F G    D L  +F  +         NV    K D +  V  
Sbjct: 183 DIWSVGCIFAEMVNGAPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 319 ---WETVSK----PARDLMARMLTRDVSARITADEVLRHPWI 353
              WE+  K       DL+++ML  D + RITA + L H + 
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           +D+  +  IG G +G     R K+ G     K L  G  T      +  EV +++ L  H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 157 TGVVTLHS--VYEEADCFHLVMELCSGGRL---IDQMVEVGQY-SEQRAANIFKDVMWVI 210
             +V  +   +       ++VME C GG L   I +  +  QY  E+    +   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 211 KYCH---DMG--VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPAYV 263
           K CH   D G  V+HRD+KP N+ L     +KL DFGLA RI N  T       G+P Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKAFVGTPYYM 183
Query: 264 APEVLS-GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           +PE ++  +Y+EK DIWS             PF   S + +   I+  K      +    
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYRY 240
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           S    +++ RML      R + +E+L +P IL
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVT 161
           +E IG G +G V+  ++   G  FA K +R  +E      T  RE+ I++ L  H+ +V 
Sbjct: 7   LEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVK 64
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           L+ V        LV E       + ++++V  G      A +    ++  I YCHD  V+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YSEKV 276
           HRD+KP+N+L+   G++K+ADFGLA       +  +    +  Y AP+VL G+  YS  +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEVVTLWYRAPDVLMGSKKYSTTI 182
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI--------KNV----KLDFHSGV-- 318
           DIWS              F G    D L  +F  +         NV    K D +  V  
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 319 ---WETVSK----PARDLMARMLTRDVSARITADEVLRHPWI 353
              WE+  K       DL+++ML  D + RITA + L H + 
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ +  H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.9 bits (224), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ +  H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 129/282 (45%), Gaps = 40/282 (14%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVT 161
           +E IG G +G V+  ++   G  FA K +R  +E      T  RE+ I++ L  H+ +V 
Sbjct: 7   LEKIGEGTYGVVYKAQNNY-GETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVK 64
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           L+ V        LV E       + ++++V  G      A +    ++  I YCHD  V+
Sbjct: 65  LYDVIHTKKRLVLVFEHLDQD--LKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVL 122
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YSEKV 276
           HRD+KP+N+L+   G++K+ADFGLA       +  +    +  Y AP+VL G+  YS  +
Sbjct: 123 HRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTI 182
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI--------KNV----KLDFHSGV-- 318
           DIWS              F G    D L  +F  +         NV    K D +  V  
Sbjct: 183 DIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYE 242
Query: 319 ---WETVSK----PARDLMARMLTRDVSARITADEVLRHPWI 353
              WE+  K       DL+++ML  D + RITA + L H + 
Sbjct: 243 PLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 93/373 (24%), Positives = 154/373 (41%), Gaps = 83/373 (22%)
Query: 40  LKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKN 99
           LK+   ED   +P G  K        A P   ++S+      L  K    DV   +G   
Sbjct: 6   LKEEDGEDGSAEPPGPVK--------AEPAHTAASVAAKNLALL-KARSFDVTFDVG--- 53
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHL 153
              D++  +E IG+G +G V   R + +G + A K +    + V       RE++I++H 
Sbjct: 54  ---DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF 110
Query: 154 SGHTGVVTLHSV------YEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDV 206
             H  ++ +  +      Y E    ++V++L      + Q++   Q  + +        +
Sbjct: 111 K-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQL 167
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA----- 261
           +  +KY H   V+HRD+KP N+L+  + ++K+ DFG+A          GL  SPA     
Sbjct: 168 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA---------RGLCTSPAEHQYF 218
Query: 262 ---------YVAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSL---------- 300
                    Y APE++     Y++ +D+WS              F G +           
Sbjct: 219 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 278
Query: 301 -----EAVFDAI--KNVKLDFHS------GVWETV----SKPARDLMARMLTRDVSARIT 343
                 AV  A+  + V+    S        WETV     + A  L+ RML  + SARI+
Sbjct: 279 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 338
Query: 344 ADEVLRHPWILFY 356
           A   LRHP++  Y
Sbjct: 339 AAAALRHPFLAKY 351

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 79/272 (29%), Positives = 121/272 (44%), Gaps = 25/272 (9%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           +D+  +  IG G +G     R K+ G     K L  G  T      +  EV +++ L  H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 157 TGVVTLHS--VYEEADCFHLVMELCSGGRL---IDQMVEVGQY-SEQRAANIFKDVMWVI 210
             +V  +   +       ++VME C GG L   I +  +  QY  E+    +   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 211 KYCH---DMG--VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPAYV 263
           K CH   D G  V+HRD+KP N+ L     +KL DFGLA RI N  T       G+P Y+
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA-RILNHDTSFAKTFVGTPYYM 183
Query: 264 APEVLS-GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           +PE ++  +Y+EK DIWS             PF   S + +   I+  K      +    
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYRY 240
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWIL 354
           S    +++ RML      R + +E+L +P IL
Sbjct: 241 SDELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 59/199 (29%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTGVVTLH 163
           ++G G +G V  CR+K +G   A K   + ++         RE+++++ L  H  +V L 
Sbjct: 32  LVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLL 90
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            V ++   ++LV E      L D  +       Q        ++  I +CH   ++HRDI
Sbjct: 91  EVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDI 150
Query: 224 KPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWS 280
           KPENIL++ SG +KL DFG A  ++  G+       +  Y APE+L G+  Y + VD+W+
Sbjct: 151 KPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWA 210
Query: 281 XXXXXXXXXXXXXPFKGDS 299
                         F GDS
Sbjct: 211 IGCLVTEMFMGEPLFPGDS 229

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 74/292 (25%), Positives = 130/292 (44%), Gaps = 37/292 (12%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K++ +G G + +V+  +SK +    A K +R   E     T  REV +++ L  H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HA 60
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK-DVMWVIKYCHDM 216
            +VTLH +        LV E      L   + + G         +F   ++  + YCH  
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKD-LKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQ 119
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSG--NYS 273
            V+HRD+KP+N+L+   G++KLADFGLA   S   +T      +  Y  P++L G  +YS
Sbjct: 120 KVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYS 179
Query: 274 EKVDIWSXXXXXXXXXXXXXPFKGDSLEA----VFDAIKNVKLDFHSGV-----WETVSK 324
            ++D+W               F G ++E     +F  +     +   G+     ++T + 
Sbjct: 180 TQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY 239
Query: 325 P-----------------ARDLMARMLTRDVSARITADEVLRHPWILFYTER 359
           P                   DL+ ++L  +   RI+A++ ++HP+ L   ER
Sbjct: 240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGER 291

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ +  H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ +  H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMK-VVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 90.1 bits (222), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 122/271 (45%), Gaps = 23/271 (8%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGH 156
           +D+  +  IG G +G     R K+ G     K L  G  T      +  EV +++ L  H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64
Query: 157 TGVVTLHS--VYEEADCFHLVMELCSGGRL---IDQMVEVGQY-SEQRAANIFKDVMWVI 210
             +V  +   +       ++VME C GG L   I +  +  QY  E+    +   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124
Query: 211 KYCH---DMG--VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVA 264
           K CH   D G  V+HRD+KP N+ L     +KL DFGLA  +++ +  +    G+P Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDEDFAKEFVGTPYYMS 184
Query: 265 PEVLS-GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           PE ++  +Y+EK DIWS             PF   S + +   I+  K      +    S
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKF---RRIPYRYS 241
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWIL 354
               +++ RML      R + +E+L +P IL
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLIL 272

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 83/289 (28%), Positives = 132/289 (45%), Gaps = 39/289 (13%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   S  E A K + + +   +RE++IM+ +  H  VV 
Sbjct: 39  EIAYTNCKVIGNGSFGVVFQAKLVESD-EVAIKKVLQDKRFKNRELQIMR-IVKHPNVVD 96
Query: 162 LHSV-YEEAD-----CFHLVMELC--SGGRLIDQMVEVGQYSEQRAANIFK-DVMWVIKY 212
           L +  Y   D       +LV+E    +  R      ++ Q        ++   ++  + Y
Sbjct: 97  LKAFFYSNGDKKDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H +G+ HRDIKP+N+LL   SG +KL DFG A  +  G+       S  Y APE++ G 
Sbjct: 157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSXICSRYYRAPELIFGA 216
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIK-------------------- 308
            NY+  +DIWS              F G+S ++ + + IK                    
Sbjct: 217 TNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEH 276
Query: 309 ---NVKLDFHSGVWETVSKP-ARDLMARMLTRDVSARITADEVLRHPWI 353
               ++    S V+   + P A DL++R+L    SAR+TA E L HP+ 
Sbjct: 277 KFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFF 325

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score = 89.7 bits (221), Expect = 3e-18,   Method: Compositional matrix adjust.
 Identities = 93/373 (24%), Positives = 154/373 (41%), Gaps = 83/373 (22%)
Query: 40  LKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKN 99
           LK+   ED   +P G  K        A P   ++S+      L  K    DV   +G   
Sbjct: 7   LKEEDGEDGSAEPPGPVK--------AEPAHTAASVAAKNLAL-LKARSFDVTFDVG--- 54
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHL 153
              D++  +E IG+G +G V   R + +G + A K +    + V       RE++I++H 
Sbjct: 55  ---DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHF 111
Query: 154 SGHTGVVTLHSV------YEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDV 206
             H  ++ +  +      Y E    ++V++L      + Q++   Q  + +        +
Sbjct: 112 K-HDNIIAIKDILRPTVPYGEFKSVYVVLDLMESD--LHQIIHSSQPLTLEHVRYFLYQL 168
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA----- 261
           +  +KY H   V+HRD+KP N+L+  + ++K+ DFG+A          GL  SPA     
Sbjct: 169 LRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMA---------RGLCTSPAEHQYF 219
Query: 262 ---------YVAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSL---------- 300
                    Y APE++     Y++ +D+WS              F G +           
Sbjct: 220 MTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMV 279
Query: 301 -----EAVFDAI--KNVKLDFHS------GVWETV----SKPARDLMARMLTRDVSARIT 343
                 AV  A+  + V+    S        WETV     + A  L+ RML  + SARI+
Sbjct: 280 LGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARIS 339
Query: 344 ADEVLRHPWILFY 356
           A   LRHP++  Y
Sbjct: 340 AAAALRHPFLAKY 352

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 79/300 (26%), Positives = 135/300 (45%), Gaps = 41/300 (13%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH-S 164
           IG G +GSV     K SG   A K +R     K ++ +  +++++   S    +V  + +
Sbjct: 30  IGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 165 VYEEADCFHLVMELCSGG---------RLIDQMVE---VGQ--YSEQRAANIFKDVMWVI 210
           ++ E DC+ + MEL S            ++D ++    +G+   +  +A N  K+     
Sbjct: 90  LFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKE----- 143
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
               ++ ++HRDIKP NILL  SG IKL DFG++ ++ +    +  AG   Y+APE +  
Sbjct: 144 ----NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDP 199
Query: 271 N-----YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV----KLDFHSGVWET 321
           +     Y  + D+WS             P+      +VFD +  V         +     
Sbjct: 200 SASRQGYDVRSDVWSLGITLYELATGRFPYP--KWNSVFDQLTQVVKGDPPQLSNSEERE 257
Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP 381
            S    + +   LT+D S R    E+L+HP+IL Y ER +       K+ +Q+ A+   P
Sbjct: 258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYVCKILDQMPATPSSP 317

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 76/305 (24%), Positives = 134/305 (43%), Gaps = 55/305 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           + +++ IG G  G V        G   A K L +  +        +RE+ +++ ++ H  
Sbjct: 26  YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++ + +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIHM-ELDHERMSYLLYQMLCGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y+  VDIWS              F+G    D    V + +     +F + +  TV     
Sbjct: 202 YAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVIEQLGTPSAEFMAALQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D   RI+ DE LRHP+I
Sbjct: 262 NRPKYPGIKFEELFPDWIFPSESERDKIKTSQARDLLSKMLVIDPDKRISVDEALRHPYI 321
Query: 354 LFYTE 358
             + +
Sbjct: 322 TVWYD 326

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 82/326 (25%), Positives = 138/326 (42%), Gaps = 71/326 (21%)
Query: 95  MGRKNKIEDDHTKVEV----------------IGHGKFGSVWLCRSKASGAEFACKTLRK 138
           MG K+K+++    VEV                IG G  G V            A K L +
Sbjct: 1   MGSKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 60
Query: 139 GEET------VHREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLID 186
             +        +RE+ +M+ ++ H  +++L +V+      EE    +LVMEL      + 
Sbjct: 61  PFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LC 117
Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR 246
           Q++++ +   +R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA  
Sbjct: 118 QVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLE 301
                 ++    +  Y APEV+ G  Y E VDIWS              F G    D   
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 236
Query: 302 AVFDAIKNVKLDFHSGVWETV-----SKP-----------------------------AR 327
            V + +     +F   +  TV     ++P                             AR
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 296
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+++ML  D + RI+ D+ L+HP+I
Sbjct: 297 DLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 114/251 (45%), Gaps = 18/251 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS--GHTGVVTLHSVY 166
           EV+G G FG V  C++K    + A K +    E     VE+ Q LS   H  +V L+   
Sbjct: 15  EVVGRGAFGVV--CKAKWRAKDVAIKQIESESERKAFIVELRQ-LSRVNHPNIVKLYGAC 71
Query: 167 EEADCFHLVMELCSGGRLIDQM---VEVGQYSEQRAANIFKDVMWVIKYCHDM---GVVH 220
               C  LVME   GG L + +     +  Y+   A +        + Y H M    ++H
Sbjct: 72  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 129
Query: 221 RDIKPENILLTTSGKI-KLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDI 278
           RD+KP N+LL   G + K+ DFG A  I    T +   GS A++APEV  G NYSEK D+
Sbjct: 130 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFEGSNYSEKCDV 187
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           +S             PF      A F  +  V       + + + KP   LM R  ++D 
Sbjct: 188 FSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP 246
Query: 339 SARITADEVLR 349
           S R + +E+++
Sbjct: 247 SQRPSMEEIVK 257

>pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307

Iteration: 1
 Score = 89.0 bits (219), Expect = 5e-18,   Method: Compositional matrix adjust.
 Identities = 78/251 (31%), Positives = 114/251 (45%), Gaps = 18/251 (7%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS--GHTGVVTLHSVY 166
           EV+G G FG V  C++K    + A K +    E     VE+ Q LS   H  +V L+   
Sbjct: 14  EVVGRGAFGVV--CKAKWRAKDVAIKQIESESERKAFIVELRQ-LSRVNHPNIVKLYGAC 70
Query: 167 EEADCFHLVMELCSGGRLIDQM---VEVGQYSEQRAANIFKDVMWVIKYCHDM---GVVH 220
               C  LVME   GG L + +     +  Y+   A +        + Y H M    ++H
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128
Query: 221 RDIKPENILLTTSGKI-KLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDI 278
           RD+KP N+LL   G + K+ DFG A  I    T +   GS A++APEV  G NYSEK D+
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTACDIQTHMTNN--KGSAAWMAPEVFEGSNYSEKCDV 186
Query: 279 WSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDV 338
           +S             PF      A F  +  V       + + + KP   LM R  ++D 
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPA-FRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDP 245
Query: 339 SARITADEVLR 349
           S R + +E+++
Sbjct: 246 SQRPSMEEIVK 256

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 88.6 bits (218), Expect = 7e-18,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 127/286 (44%), Gaps = 41/286 (14%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVV 160
           D  ++ V+G G FG V   R+      +A K +R  EE   T+  EV ++  L+ H  VV
Sbjct: 7   DFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVXLLASLN-HQYVV 65
Query: 161 TLHSVYEEADCF-------------HLVMELCSGGRLIDQMVEVGQYSEQRAA--NIFKD 205
             ++ + E   F              +  E C    L D ++     ++QR     +F+ 
Sbjct: 66  RYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYD-LIHSENLNQQRDEYWRLFRQ 124
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS--------NGQTLSGLA 257
           ++  + Y H  G++HR++KP NI +  S  +K+ DFGLA  +         + Q L G +
Sbjct: 125 ILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSS 184
Query: 258 -------GSPAYVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFK-GDSLEAVFDAI 307
                  G+  YVA EVL  +G+Y+EK+D +S             PF  G     +   +
Sbjct: 185 DNLTSAIGTAXYVATEVLDGTGHYNEKIDXYS---LGIIFFEXIYPFSTGXERVNILKKL 241
Query: 308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           ++V ++F     +   K  + ++  ++  D + R  A  +L   W+
Sbjct: 242 RSVSIEFPPDFDDNKXKVEKKIIRLLIDHDPNKRPGARTLLNSGWL 287

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 88.6 bits (218), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LSQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score = 88.2 bits (217), Expect = 8e-18,   Method: Compositional matrix adjust.
 Identities = 73/286 (25%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+E IG G +G+V+  +++ +    A K +R  ++      +  RE+ +++ L  H  
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKN 62
Query: 159 VVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
           +V LH V        LV E C     +  D     G    +   +    ++  + +CH  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YS 273
            V+HRD+KP+N+L+  +G++KLADFGLA       +  S    +  Y  P+VL G   YS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 274 EKVDIWSXXXXXXXXXXXXXP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSK-------- 324
             +D+WS             P F G+ ++     I  +        W +++K        
Sbjct: 181 TSIDMWSAGCIFAELANAARPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 325 --PA---------------RDLMARMLTRDVSARITADEVLRHPWI 353
             PA               RDL+  +L  +   RI+A+E L+HP+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 87.8 bits (216), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM-ELDHERMSYLLYQMLXGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/291 (25%), Positives = 130/291 (44%), Gaps = 48/291 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ +G G +G+V       +GA+ A K L +  ++       +RE+ +++H+  H  
Sbjct: 27  YRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HEN 85
Query: 159 VVTLHSVYEEADC------FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           V+ L  V+   +       F+LVM     G  + ++++  +  E R   +   ++  ++Y
Sbjct: 86  VIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRY 143
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-- 270
            H  G++HRD+KP N+ +    ++K+ DFGLA +  +   + G   +  Y APEV+    
Sbjct: 144 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS--EMXGXVVTRWYRAPEVILNWM 201
Query: 271 NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF----------------DAIKNV 310
            Y++ VDIWS              FKG    D L+ +                 D  KN 
Sbjct: 202 RYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNY 261
Query: 311 --------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                   K DF S +    S  A +L+ +ML  D   R+TA E L HP+ 
Sbjct: 262 MKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 311

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 87.4 bits (215), Expect = 1e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKXVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM-ELDHERMSYLLYQMLCGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 87.4 bits (215), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 110/244 (45%), Gaps = 14/244 (5%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLR-------KGEETVHREVEIMQHLSGHTGVVTLH 163
           IG G+F  V+       G   A K ++       K      +E+++++ L+ H  V+  +
Sbjct: 40  IGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYY 98
Query: 164 SVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAA-NIFKDVMWVIKYCHDMGVV 219
           + + E +  ++V+EL   G   R+I    +  +   +R     F  +   +++ H   V+
Sbjct: 99  ASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVM 158
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVAPEVLSGN-YSEKVD 277
           HRDIKP N+ +T +G +KL D GL    S+  T +  L G+P Y++PE +  N Y+ K D
Sbjct: 159 HRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSD 218
Query: 278 IWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           IWS             PF GD +       K  + D+     +  S+  R L+   +  D
Sbjct: 219 IWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPD 278
Query: 338 VSAR 341
              R
Sbjct: 279 PEKR 282

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPSP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 74/296 (25%), Positives = 128/296 (43%), Gaps = 45/296 (15%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEIMQHLSGHTGVV 160
           +DD+  V  +G GK+  V+   +  +  +   K L+  ++  + RE++I+++L G   ++
Sbjct: 36  QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKNKIKREIKILENLRGGPNII 95
Query: 161 TLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           TL  + ++  +    LV E  +          +  Y          +++  + YCH MG+
Sbjct: 96  TLADIVKDPVSRTPALVFEHVNNTDFKQLYQTLTDYD---IRFYMYEILKALDYCHSMGI 152
Query: 219 VHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEK 275
           +HRD+KP N+++     K++L D+GLA     GQ  +    S  +  PE+L     Y   
Sbjct: 153 MHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYS 212
Query: 276 VDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAIK--NVKLD------ 313
           +D+WS             PF       D L         E ++D I   N++LD      
Sbjct: 213 LDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI 272
Query: 314 ------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
                        HS     VS  A D + ++L  D  +R+TA E + HP+  FYT
Sbjct: 273 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY--FYT 326

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 77
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM-ELDHERMSYLLYQMLXGIKH 134
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LXQVIQM-ELDHERMSYLLYQMLXGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 87.0 bits (214), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + +G+   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M            ++  HPW   +  RT
Sbjct: 246 QIREM--NPNYTEFAFPQIKAHPWTKVFRPRT 275

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 81/326 (24%), Positives = 137/326 (42%), Gaps = 71/326 (21%)
Query: 95  MGRKNKIEDDHTKVEV----------------IGHGKFGSVWLCRSKASGAEFACKTLRK 138
           M  K+K+++    VEV                IG G  G V            A K L +
Sbjct: 1   MASKSKVDNQFYSVEVGDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR 60
Query: 139 GEET------VHREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLID 186
             +        +RE+ +M+ ++ H  +++L +V+      EE    +LVMEL      + 
Sbjct: 61  PFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LC 117
Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR 246
           Q++++ +   +R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA  
Sbjct: 118 QVIQM-ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART 176
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLE 301
                 ++    +  Y APEV+ G  Y E VDIWS              F G    D   
Sbjct: 177 AGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 236
Query: 302 AVFDAIKNVKLDFHSGVWETV-----SKP-----------------------------AR 327
            V + +     +F   +  TV     ++P                             AR
Sbjct: 237 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR 296
Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+++ML  D + RI+ D+ L+HP+I
Sbjct: 297 DLLSKMLVIDPAKRISVDDALQHPYI 322

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 86.7 bits (213), Expect = 2e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 123/272 (45%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + +G+   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 246 QIREMNPNYTEFKF--PQIKAHPWTKVFRPRT 275

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 117/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  +++L +V+      EE    +LVMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKXVN-HKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDP 306
Query: 339 SARITADEVLRHPWI 353
           + RI+ D+ L+HP+I
Sbjct: 307 AKRISVDDALQHPYI 321

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 122
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 179
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 86.7 bits (213), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ET 142
           +++H  M       +D +   +IG G FG V+ CR   +G  +A K L K        ET
Sbjct: 181 LNIHLTM-------NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 233
Query: 143 VHREVEIMQHLSGHTG----VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           +     IM  L   TG    +V +   +   D    +++L +GG L   + + G +SE  
Sbjct: 234 LALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 292
Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
                 +++  +++ H+  VV+RD+KP NILL   G ++++D GLA   S  +  + + G
Sbjct: 293 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-G 351
Query: 259 SPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHS 316
           +  Y+APEVL     Y    D +S             PF+    +   + I  + L    
Sbjct: 352 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV 410
Query: 317 GVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPWI 353
            + ++ S   R L+  +L RDV+ R+      A EV   P+ 
Sbjct: 411 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 452

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ET 142
           +++H  M       +D +   +IG G FG V+ CR   +G  +A K L K        ET
Sbjct: 182 LNIHLTM-------NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234
Query: 143 VHREVEIMQHLSGHTG----VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           +     IM  L   TG    +V +   +   D    +++L +GG L   + + G +SE  
Sbjct: 235 LALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
                 +++  +++ H+  VV+RD+KP NILL   G ++++D GLA   S  +  + + G
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-G 352
Query: 259 SPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHS 316
           +  Y+APEVL     Y    D +S             PF+    +   + I  + L    
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV 411
Query: 317 GVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPWI 353
            + ++ S   R L+  +L RDV+ R+      A EV   P+ 
Sbjct: 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 72  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 127
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 128 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 187
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 188 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 247
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 248 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 307
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 308 SKRISVDEALQHPYI 322

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ET 142
           +++H  M       +D +   +IG G FG V+ CR   +G  +A K L K        ET
Sbjct: 182 LNIHLTM-------NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234
Query: 143 VHREVEIMQHLSGHTG----VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           +     IM  L   TG    +V +   +   D    +++L +GG L   + + G +SE  
Sbjct: 235 LALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
                 +++  +++ H+  VV+RD+KP NILL   G ++++D GLA   S  +  + + G
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-G 352
Query: 259 SPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHS 316
           +  Y+APEVL     Y    D +S             PF+    +   + I  + L    
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV 411
Query: 317 GVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPWI 353
            + ++ S   R L+  +L RDV+ R+      A EV   P+ 
Sbjct: 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 75/282 (26%), Positives = 126/282 (44%), Gaps = 27/282 (9%)
Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ET 142
           +++H  M       +D +   +IG G FG V+ CR   +G  +A K L K        ET
Sbjct: 182 LNIHLTM-------NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGET 234
Query: 143 VHREVEIMQHLSGHTG----VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           +     IM  L   TG    +V +   +   D    +++L +GG L   + + G +SE  
Sbjct: 235 LALNERIMLSLVS-TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAD 293
Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
                 +++  +++ H+  VV+RD+KP NILL   G ++++D GLA   S  +  + + G
Sbjct: 294 MRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV-G 352
Query: 259 SPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHS 316
           +  Y+APEVL     Y    D +S             PF+    +   + I  + L    
Sbjct: 353 THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE-IDRMTLTMAV 411
Query: 317 GVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPWI 353
            + ++ S   R L+  +L RDV+ R+      A EV   P+ 
Sbjct: 412 ELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 73/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + +G+   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQGKAFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPATVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M            ++  HPW   +  RT
Sbjct: 246 QIREM--NPNYTEFAFPQIKAHPWTKVFRPRT 275

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 86.3 bits (212), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 73  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 128
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        +    
Sbjct: 129 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMVPFV 188
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 189 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 248
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 249 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 308
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 309 SKRISVDEALQHPYI 323

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 72/286 (25%), Positives = 125/286 (43%), Gaps = 40/286 (13%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+E IG G +G+V+  +++ +    A K +R  ++      +  RE+ +++ L  H  
Sbjct: 4   YEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKN 62
Query: 159 VVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
           +V LH V        LV E C     +  D     G    +   +    ++  + +CH  
Sbjct: 63  IVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCN--GDLDPEIVKSFLFQLLKGLGFCHSR 120
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YS 273
            V+HRD+KP+N+L+  +G++KLA+FGLA       +  S    +  Y  P+VL G   YS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180
Query: 274 EKVDIWSXXXXXXXXXXXXXP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSK-------- 324
             +D+WS             P F G+ ++     I  +        W +++K        
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240
Query: 325 --PA---------------RDLMARMLTRDVSARITADEVLRHPWI 353
             PA               RDL+  +L  +   RI+A+E L+HP+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 83/298 (27%), Positives = 135/298 (45%), Gaps = 33/298 (11%)
Query: 75  LVPAGRGLKRKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAE 130
           LVP G  +     C D+H T++     K  +E  +    ++G G FGSV+     +    
Sbjct: 14  LVPRGSHMA---PCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLP 70
Query: 131 FACKTLRK------GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELC 179
            A K + K      GE      V  EV +++ +S G +GV+ L   +E  D F L++E  
Sbjct: 71  VAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERP 130
Query: 180 SGGR-LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIK 237
              + L D + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++K
Sbjct: 131 EPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELK 190
Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF 295
           L DFG    + +    +   G+  Y  PE +  +  +     +WS             PF
Sbjct: 191 LIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 249
Query: 296 KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + D      + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 250 EHD------EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 64  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 122
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 123 IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 179
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 239
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 240 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 299
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 300 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 359

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 96  GRKN----KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHR 145
           GR+N     + + + K+E +G G +G V+  +  + G   A K +R   E      T  R
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIF 203
           E+ +++ L  H  +V+L  V     C  LV E       +++D+  + G    Q    ++
Sbjct: 69  EISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLY 126
Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAY 262
           + ++  + +CH   ++HRD+KP+N+L+ + G +KLADFGLA       ++ +    +  Y
Sbjct: 127 Q-LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 263 VAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFD----------- 305
            AP+VL G+  YS  VDIWS              F G    D L  +F            
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 306 AIKNVKL-------DFHSGVWETV----SKPARDLMARMLTRDVSARITADEVLRHPWI 353
            ++ + L        F    W ++     +   DL++ ML  D + RI+A + + HP+ 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 78/299 (26%), Positives = 135/299 (45%), Gaps = 45/299 (15%)
Query: 96  GRKN----KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHR 145
           GR+N     + + + K+E +G G +G V+  +  + G   A K +R   E      T  R
Sbjct: 10  GRENLYFQGLMEKYQKLEKVGEGTYGVVYKAKD-SQGRIVALKRIRLDAEDEGIPSTAIR 68
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG--RLIDQMVEVGQYSEQRAANIF 203
           E+ +++ L  H  +V+L  V     C  LV E       +++D+  + G    Q    ++
Sbjct: 69  EISLLKELH-HPNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDEN-KTGLQDSQIKIYLY 126
Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAY 262
           + ++  + +CH   ++HRD+KP+N+L+ + G +KLADFGLA       ++ +    +  Y
Sbjct: 127 Q-LLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTHEVVTLWY 185
Query: 263 VAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFD----------- 305
            AP+VL G+  YS  VDIWS              F G    D L  +F            
Sbjct: 186 RAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245
Query: 306 AIKNVKL-------DFHSGVWETV----SKPARDLMARMLTRDVSARITADEVLRHPWI 353
            ++ + L        F    W ++     +   DL++ ML  D + RI+A + + HP+ 
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYF 304

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 28  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 87
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 88  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 147
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 208 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 260
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 261 EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 14  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 73
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 74  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 133
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 194 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 246
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 247 EEIIGGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 85.9 bits (211), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 26  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 84
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 85  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 141
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 201
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 202 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 261
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 262 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 321

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 25  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 83
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 84  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 140
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 141 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 200
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 201 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 260
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 261 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 320

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 19  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 77
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 78  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 134
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 135 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 194
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 195 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 254
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 255 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 314

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDVVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 246 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 275

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 13  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 72
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 73  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 132
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 193 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 245
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 246 EEIIGGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 33  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 92
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 93  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 152
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 153 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 212
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 213 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 265
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 266 EEIIRGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 310

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 76  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 131
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 132 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 191
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VD+WS              F G    D    V + +     
Sbjct: 192 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 251
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 252 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 311
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 312 SKRISVDEALQHPYI 326

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 14  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 73
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 74  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 133
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 194 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 246
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 247 EEIIGGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 71/264 (26%), Positives = 113/264 (42%), Gaps = 26/264 (9%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------------VHREVEIMQH 152
           ++ +  +G G FG VW    K    E   K ++K +              V  E+ I+  
Sbjct: 26  YSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSR 85
Query: 153 LSGHTGVVTLHSVYEEADCFHLVMEL-CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
           +  H  ++ +  ++E    F LVME   SG  L   +    +  E  A+ IF+ ++  + 
Sbjct: 86  VE-HANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVG 144
Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN 271
           Y     ++HRDIK ENI++     IKL DFG A  +  G+      G+  Y APEVL GN
Sbjct: 145 YLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGN 204
Query: 272 --YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
                ++++WS             PF  +  E V  AI    L         VSK    L
Sbjct: 205 PYRGPELEMWSLGVTLYTLVFEENPF-CELEETVEAAIHPPYL---------VSKELMSL 254
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           ++ +L      R T ++++  PW+
Sbjct: 255 VSGLLQPVPERRTTLEKLVTDPWV 278

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 13  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 72
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 73  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 132
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 193 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 245
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 246 EEIIRGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 14  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 73
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 74  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 133
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 194 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 246
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 247 EEIIGGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 28  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 87
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 88  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 147
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 148 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 207
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 208 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 260
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 261 EEIIRGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 78
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 135
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 13  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 72
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 73  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 132
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 193 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 245
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 246 EEIIGGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 75/300 (25%), Positives = 130/300 (43%), Gaps = 55/300 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTG 158
           +  ++ IG G  G V            A K L +  +        +RE+ +M+ ++ H  
Sbjct: 20  YQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKN 78
Query: 159 VVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +++L +V+      EE    +LVMEL      + Q++++ +   +R + +   ++  IK+
Sbjct: 79  IISLLNVFTPQKTLEEFQDVYLVMELMDAN--LCQVIQM-ELDHERMSYLLYQMLCGIKH 135
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-N 271
            H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+ G  
Sbjct: 136 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMG 195
Query: 272 YSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDFHSGVWETV----- 322
           Y E VDIWS              F G    D    V + +     +F   +  TV     
Sbjct: 196 YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVE 255
Query: 323 SKP-----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           ++P                             ARDL+++ML  D + RI+ D+ L+HP+I
Sbjct: 256 NRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYI 315

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 13  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 72
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 73  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 132
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 133 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 192
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 193 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 245
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 246 EEIIGGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 290

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L K  +++      +RE+ +++H+
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSKPFQSIIHAKRTYRELRLLKHM 90
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 91  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 205
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 266 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 85.5 bits (210), Expect = 6e-17,   Method: Compositional matrix adjust.
 Identities = 80/289 (27%), Positives = 131/289 (45%), Gaps = 30/289 (10%)
Query: 84  RKIGCIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           R   C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K 
Sbjct: 14  RAAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKD 73
Query: 139 -----GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQ 187
                GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D 
Sbjct: 74  RISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDF 133
Query: 188 MVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMR 246
           + E G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    
Sbjct: 134 ITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL 193
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVF 304
           + +    +   G+  Y  PE +  +  +     +WS             PF+ D      
Sbjct: 194 LKD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------ 246
Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + I   ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 247 EEIIGGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 291

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 85.5 bits (210), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 115/253 (45%), Gaps = 18/253 (7%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSV 165
           V+G G +G V+  R  ++    A K + + +    + +H E+ + +HL  H  +V     
Sbjct: 29  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGS 87
Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           + E     + ME   GG L   +       + +EQ      K ++  +KY HD  +VHRD
Sbjct: 88  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 147
Query: 223 IKPENILLTT-SGKIKLADFGLAMRISN-GQTLSGLAGSPAYVAPEVLSG---NYSEKVD 277
           IK +N+L+ T SG +K++DFG + R++          G+  Y+APE++      Y +  D
Sbjct: 148 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 207
Query: 278 IWSXXXXXXXXXXXXXPFK--GDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           IWS             PF   G+   A+F   K      H  + E++S  A+  + +   
Sbjct: 208 IWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAKAFILKCFE 264
Query: 336 RDVSARITADEVL 348
            D   R  A+++L
Sbjct: 265 PDPDKRACANDLL 277

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVH 144
           M  K  +E  +    ++G G FGSV+     +     A K + K      GE      V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 145 REVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANI 202
            EV +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPA 261
           F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRV 179
Query: 262 YVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           Y  PE +  +  +     +WS             PF+ D      + I   ++ F     
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 229
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + VS   + L+   L    S R T +E+  HPW+
Sbjct: 230 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 65  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 120
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 121 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYV 180
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VD+WS              F G    D    V + +     
Sbjct: 181 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 240
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 241 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 300
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 301 SKRISVDEALQHPYI 315

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/299 (24%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  IG G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 24  EVPERYQNLSPIGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 84  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEI 198
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 259 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 116/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++   
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPEV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNALKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVH 144
           M  K  +E  +    ++G G FGSV+     +     A K + K      GE      V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 145 REVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANI 202
            EV +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPA 261
           F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRV 179
Query: 262 YVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           Y  PE +  +  +     +WS             PF+ D      + I   ++ F     
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 229
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + VS   + L+   L    S R T +E+  HPW+
Sbjct: 230 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 63/269 (23%), Positives = 117/269 (43%), Gaps = 36/269 (13%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLH 163
           D  ++E+IG G FG V+  + +  G  +  K ++   E   REV+ +  L  H  +V  +
Sbjct: 12  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVHYN 70
Query: 164 SVYEEAD----------------CFHLVMELCSGGRLIDQMVEV---GQYSEQRAANIFK 204
             ++  D                C  + ME C  G L +Q +E     +  +  A  +F+
Sbjct: 71  GCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRGEKLDKVLALELFE 129
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVA 264
            +   + Y H   +++RD+KP NI L  + ++K+ DFGL   + N        G+  Y++
Sbjct: 130 QITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRXRSKGTLRYMS 189
Query: 265 PEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKL--DFHSGVWET 321
           PE +S  +Y ++VD+++                 + L     A +  K   D   G+   
Sbjct: 190 PEQISSQDYGKEVDLYALGLIL-----------AELLHVCDTAFETSKFFTDLRDGIISD 238
Query: 322 V-SKPARDLMARMLTRDVSARITADEVLR 349
           +  K  + L+ ++L++    R    E+LR
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILR 267

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 88  CIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----- 138
           C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K     
Sbjct: 5   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 139 -GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEV 191
            GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D + E 
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG 250
           G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 183
Query: 251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              +   G+  Y  PE +  +  +     +WS             PF+ D      + I 
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 237
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 238 RGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 76/274 (27%), Positives = 124/274 (45%), Gaps = 26/274 (9%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVH 144
           M  K  +E  +    ++G G FGSV+     +     A K + K      GE      V 
Sbjct: 1   MKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVP 60
Query: 145 REVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANI 202
            EV +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + 
Sbjct: 61  MEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSF 120
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPA 261
           F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  
Sbjct: 121 FWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRV 179
Query: 262 YVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVW 319
           Y  PE +  +  +     +WS             PF+ D      + I   ++ F     
Sbjct: 180 YSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR---- 229
Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + VS   + L+   L    S R T +E+  HPW+
Sbjct: 230 QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 263

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 111
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 231
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 279
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 280 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 309

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 85.1 bits (209), Expect = 7e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 55  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 113
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 114 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 173
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 174 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 233
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 234 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 281
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 282 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 311

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 57  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 115
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 116 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 175
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 176 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 235
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 236 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 283
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 284 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 313

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 88  CIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----- 138
           C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K     
Sbjct: 4   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 63
Query: 139 -GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEV 191
            GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D + E 
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG 250
           G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + + 
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 182
Query: 251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              +   G+  Y  PE +  +  +     +WS             PF+ D      + I 
Sbjct: 183 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 236
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 237 RGQVFFR----QRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 88  CIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----- 138
           C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K     
Sbjct: 5   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 139 -GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEV 191
            GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D + E 
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG 250
           G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 183
Query: 251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              +   G+  Y  PE +  +  +     +WS             PF+ D      + I 
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 237
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 238 RGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 278

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 85  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEI 199
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 260 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 85.1 bits (209), Expect = 8e-17,   Method: Compositional matrix adjust.
 Identities = 79/285 (27%), Positives = 130/285 (45%), Gaps = 30/285 (10%)
Query: 88  CIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----- 138
           C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K     
Sbjct: 4   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 63
Query: 139 -GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEV 191
            GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D + E 
Sbjct: 64  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 123
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG 250
           G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + + 
Sbjct: 124 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 182
Query: 251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              +   G+  Y  PE +  +  +     +WS             PF+ D      + I 
Sbjct: 183 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 236
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++ F     + VS   + L+   L    S R T +E+  HPW+
Sbjct: 237 RGQVFFR----QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 277

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 85.1 bits (209), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 81  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTDDEMT--GYVATRWYRAPEI 195
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 256 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 L--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +  + +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 76/275 (27%), Positives = 124/275 (45%), Gaps = 26/275 (9%)
Query: 94  QMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETV 143
            M  K  +E  +    ++G G FGSV+     +     A K + K      GE      V
Sbjct: 22  HMKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRV 81
Query: 144 HREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAAN 201
             EV +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A +
Sbjct: 82  PMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARS 141
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSP 260
            F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+ 
Sbjct: 142 FFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTR 200
Query: 261 AYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV 318
            Y  PE +  +  +     +WS             PF+ D      + I   ++ F    
Sbjct: 201 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR--- 251
Query: 319 WETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            + VS   + L+   L    S R T +E+  HPW+
Sbjct: 252 -QRVSXECQHLIRWCLALRPSDRPTFEEIQNHPWM 285

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 98  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 156
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 157 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 216
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 217 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 276
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 277 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 324
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 325 QIREMNPNYTEFKF--PQIKAHPWTKVFRPRT 354

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 47  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 105
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 106 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 165
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 166 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 225
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 226 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 273
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 274 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 303

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 84.7 bits (208), Expect = 9e-17,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 53  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 111
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 112 LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 171
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 231
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 232 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 279
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 280 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 309

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 27  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 85
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 86  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 145
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 146 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 205
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 206 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 253
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 254 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 283

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 67/253 (26%), Positives = 114/253 (45%), Gaps = 18/253 (7%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVVTLHSV 165
           V+G G +G V+  R  ++    A K +     +  + +H E+ + +HL  H  +V     
Sbjct: 15  VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGS 73
Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           + E     + ME   GG L   +       + +EQ      K ++  +KY HD  +VHRD
Sbjct: 74  FSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRD 133
Query: 223 IKPENILLTT-SGKIKLADFGLAMRISN-GQTLSGLAGSPAYVAPEVLSG---NYSEKVD 277
           IK +N+L+ T SG +K++DFG + R++          G+  Y+APE++      Y +  D
Sbjct: 134 IKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAAD 193
Query: 278 IWSXXXXXXXXXXXXXPFK--GDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           IWS             PF   G+   A+F   K      H  + E++S  A+  + +   
Sbjct: 194 IWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVHPEIPESMSAEAKAFILKCFE 250
Query: 336 RDVSARITADEVL 348
            D   R  A+++L
Sbjct: 251 PDPDKRACANDLL 263

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 38  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 96
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 97  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 156
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 157 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 216
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 217 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 264
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 265 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 294

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 24  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 82
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 83  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 142
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 143 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 202
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 203 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 250
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 251 QIREMNPNYTEFKF--PQIKAHPWTKVFRPRT 280

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 70/298 (23%), Positives = 130/298 (43%), Gaps = 46/298 (15%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       SG + A K L +  +++      +RE+ +++H+
Sbjct: 48  EVPERYQTLSPVGSGAYGSVCSSYDVKSGLKIAVKKLSRPFQSIIHAKRTYRELRLLKHM 107
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 108 K-HENVIGLLDVFTPATSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 164
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 165 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 222
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF----------------- 304
           +    +Y+  VDIWS              F G    + L+ +                  
Sbjct: 223 MLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQQIMRLTGTPPASVISRMPSH 282
Query: 305 ------DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                 +++  +     + V+   +  A DL+ +ML  D   RITA E L HP+   Y
Sbjct: 283 EARNYINSLPQMPKRNFADVFIGANPLAVDLLEKMLVLDTDKRITASEALAHPYFSQY 340

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 90  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEI 204
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 265 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score = 84.7 bits (208), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 86  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA   ++  T  G   +  Y APE+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEI 200
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 261 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 89
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 257
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 258 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 287

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 86  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA   ++  T  G   +  Y APE+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEI 200
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 261 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 31  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 89
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 90  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 149
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 150 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 209
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 210 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 257
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 258 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 287

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 86  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA   ++  T  G   +  Y APE+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--GYVATRWYRAPEI 200
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 261 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 32  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 90
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 91  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 150
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 151 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 210
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 211 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 258
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 259 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 288

>pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 79/292 (27%), Positives = 127/292 (43%), Gaps = 42/292 (14%)
Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVE 148
           MG K++   +  ++E IG G+FGSV+ C  +  G  +A K  +K       E+   REV 
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFK 204
               L  H+ VV   S + E D   +  E C+GG L D + E    +  + E    ++  
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLT-----------------TSGKI--KLADFGLAM 245
            V   ++Y H M +VH DIKP NI ++                  S K+  K+ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182
Query: 246 RISNGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWSXXXXXX-XXXXXXXPFKGDSLEA 302
           RIS+ Q      G   ++A EVL  NY+   K DI++              P  GD    
Sbjct: 183 RISSPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236
Query: 303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
            +  I+  +L     + + +S+   +L+  M+  D   R +A  +++H  +L
Sbjct: 237 -WHEIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 284

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 84  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEI 198
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 259 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 91  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 205
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 266 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 99  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 213
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 274 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 31  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 90
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 91  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 147
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 148 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 205
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 206 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 265
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 266 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 323

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCAKLTDDHVQFLIYQIL 131
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 189
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 250 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 246 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 275

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 246 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 275

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 98  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 212
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 273 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 23  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 81
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 82  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 141
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 142 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 201
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 202 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 249
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 250 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 279

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 30  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 89
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 90  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 146
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 147 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 204
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 205 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 264
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 265 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 322

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 19  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 77
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 78  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 138 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 197
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 198 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 245
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 246 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 275

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 81  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 195
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 256 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score = 84.3 bits (207), Expect = 1e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 102 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 216
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 277 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 84  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 198
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 259 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   ++G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 18  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 77
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 78  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 134
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 135 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 192
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 193 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 252
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 253 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 310

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 72/272 (26%), Positives = 122/272 (44%), Gaps = 28/272 (10%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT 161
           E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  H  +V 
Sbjct: 20  EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVR 78
Query: 162 LHSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-KDVMW----VIKY 212
           L   +    E+ D  +L + L      + ++      ++Q    I+ K  M+     + Y
Sbjct: 79  LRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 138
Query: 213 CHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG- 270
            H  G+ HRDIKP+N+LL   +  +KL DFG A ++  G+       S  Y APE++ G 
Sbjct: 139 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSXICSRYYRAPELIFGA 198
Query: 271 -NYSEKVDIWSXXXXXXXXXXXXXPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            +Y+  +D+WS              F GDS ++ + + IK             +  P R+
Sbjct: 199 TDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIK------------VLGTPTRE 246
Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERT 360
            +  M       +    ++  HPW   +  RT
Sbjct: 247 QIREMNPNYTEFKFP--QIKAHPWTKVFRPRT 276

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 26  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 85
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 86  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 142
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 143 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 200
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 201 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 260
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 261 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 318

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 17  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 76
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 77  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 133
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 134 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 191
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 192 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 251
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 252 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 309

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 81  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 195
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 256 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   ++G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREV 147
           K  +E  +    ++G G FGSV+     +     A K + K      GE      V  EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 148 EIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKD 205
            +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERMEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVA 264
           V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 181
Query: 265 PEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           PE +  +  +     +WS             PF+ D      + I   ++ F     + V
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRV 231
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S   + L+   L    S R T +E+  HPW+
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 21  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 80
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 81  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 138 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 195
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 196 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 255
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 256 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 313

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 24  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 83
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 84  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 140
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 141 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 198
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 199 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 258
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 259 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 316

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 76  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 190
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 251 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 85  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 199
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 260 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 38  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 97
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 98  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 154
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 155 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 212
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 213 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 272
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 273 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 330

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKXQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 99  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 213
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 274 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 16  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 75
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 76  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 132
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 133 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 190
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 191 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 250
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 251 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 308

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 189
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 250 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 85  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 199
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 260 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GXVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score = 84.0 bits (206), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 134/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   ++G   +  Y APE+
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMAGFVATRWYRAPEI 189
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 250 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 67/255 (26%), Positives = 115/255 (45%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        +    
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VD+WS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
           +F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 EFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREV 147
           K  +E  +    ++G G FGSV+     +     A K + K      GE      V  EV
Sbjct: 3   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 62
Query: 148 EIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKD 205
            +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  
Sbjct: 63  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 122
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVA 264
           V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  
Sbjct: 123 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 181
Query: 265 PEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           PE +  +  +     +WS             PF+ D      + I   ++ F     + V
Sbjct: 182 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRV 231
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S   + L+   L    S R T +E+  HPW+
Sbjct: 232 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 262

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 25  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 84
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 85  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 141
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 142 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 199
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 200 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 259
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 260 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 317

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 131
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 132 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 189
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 190 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 249
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 250 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 307

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 78/285 (27%), Positives = 129/285 (45%), Gaps = 30/285 (10%)
Query: 88  CIDVH-TQMG---RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----- 138
           C D+H T++     K  +E  +    ++G G FGSV+     +     A K + K     
Sbjct: 5   CNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISD 64
Query: 139 -GE----ETVHREVEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEV 191
            GE      V  EV +++ +S G +GV+ L   +E  D F L++E     + L D + E 
Sbjct: 65  WGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITER 124
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNG 250
           G   E+ A + F  V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + + 
Sbjct: 125 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD- 183
Query: 251 QTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              +   G+  Y  PE +  +  +     +WS             PF+ D      + I 
Sbjct: 184 TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEII 237
Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++ F     + VS   + L+   L      R T +E+  HPW+
Sbjct: 238 RGQVFFR----QRVSXECQHLIRWCLALRPXDRPTFEEIQNHPWM 278

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 29  EVPERYQNLAPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 88
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 89  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 145
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE+
Sbjct: 146 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEI 203
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 204 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 263
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 264 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 321

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 68/255 (26%), Positives = 114/255 (44%), Gaps = 49/255 (19%)
Query: 144 HREVEIMQHLSGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQ 197
           +RE+ +M+ ++ H  ++ L +V+      EE    ++VMEL      + Q++++ +   +
Sbjct: 71  YRELVLMKCVN-HKNIIGLLNVFTPQKSLEEFQDVYIVMELMDAN--LCQVIQM-ELDHE 126
Query: 198 RAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           R + +   ++  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        +    
Sbjct: 127 RMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMEPEV 186
Query: 258 GSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKL 312
            +  Y APEV+ G  Y E VDIWS              F G    D    V + +     
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVIEQLGTPCP 246
Query: 313 DFHSGVWETV-----SKP-----------------------------ARDLMARMLTRDV 338
            F   +  TV     ++P                             ARDL+++ML  D 
Sbjct: 247 AFMKKLQPTVRNYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDA 306
Query: 339 SARITADEVLRHPWI 353
           S RI+ DE L+HP+I
Sbjct: 307 SKRISVDEALQHPYI 321

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 42  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 101
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 102 K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 158
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   + G   +  Y APE+
Sbjct: 159 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMXGYVATRWYRAPEI 216
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 217 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 276
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 277 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 334

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 59/211 (27%), Positives = 96/211 (45%), Gaps = 35/211 (16%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTG 158
           D   ++ +G G FG V+  ++K     +A K +R        E V REV+ +  L  H G
Sbjct: 6   DFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPG 64
Query: 159 VVTLHSVYEEADC------------FHLVMELCSGGRLIDQM---VEVGQYSEQRAANIF 203
           +V   + + E +              ++ M+LC    L D M     + +       +IF
Sbjct: 65  IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---QTL------- 253
             +   +++ H  G++HRD+KP NI  T    +K+ DFGL   +      QT+       
Sbjct: 125 LQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAY 184
Query: 254 ---SGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
              +G  G+  Y++PE + GN YS KVDI+S
Sbjct: 185 ARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 83.2 bits (204), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 75/271 (27%), Positives = 123/271 (45%), Gaps = 26/271 (9%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREV 147
           K  +E  +    ++G G FGSV+     +     A K + K      GE      V  EV
Sbjct: 2   KEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEV 61
Query: 148 EIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKD 205
            +++ +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  
Sbjct: 62  VLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQ 121
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVA 264
           V+  +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  
Sbjct: 122 VLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSP 180
Query: 265 PEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           PE +  +  +     +WS             PF+ D      + I   ++ F     + V
Sbjct: 181 PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRV 230
Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S   + L+   L    S R T +E+  HPW+
Sbjct: 231 SSECQHLIRWCLALRPSDRPTFEEIQNHPWM 261

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 39  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 98
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 99  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 155
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +   + G   +  Y APE+
Sbjct: 156 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD--EMXGXVATRWYRAPEI 213
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 214 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 273
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 274 SARNYIQSLAQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 331

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 76/315 (24%), Positives = 133/315 (42%), Gaps = 48/315 (15%)
Query: 90  DVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH----- 144
           +V    G+   +   +T+++ IG G +G V            A K +   E   +     
Sbjct: 30  EVEMVKGQPFDVGPRYTQLQYIGEGAYGMVSSAYDHVRKTRVAIKKISPFEHQTYCQRTL 89
Query: 145 REVEIMQHLSGHTGVVTLH-----SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA 199
           RE++I+     H  V+ +      S  E     ++V +L      + ++++  Q S    
Sbjct: 90  REIQILLRFR-HENVIGIRDILRASTLEAMRDVYIVQDLMETD--LYKLLKSQQLSNDHI 146
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLS 254
                 ++  +KY H   V+HRD+KP N+L+ T+  +K+ DFGLA RI++ +      L+
Sbjct: 147 CYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLA-RIADPEHDHTGFLT 205
Query: 255 GLAGSPAYVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV----- 303
               +  Y APE++  S  Y++ +DIWS              F G    D L  +     
Sbjct: 206 EXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILG 265
Query: 304 ------FDAIKNVKLDFH------------SGVWETVSKPARDLMARMLTRDVSARITAD 345
                  + I N+K   +            + ++      A DL+ RMLT + + RIT +
Sbjct: 266 SPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPKSDSKALDLLDRMLTFNPNKRITVE 325
Query: 346 EVLRHPWILFYTERT 360
           E L HP++  Y + T
Sbjct: 326 EALAHPYLEQYYDPT 340

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKSQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DFGL     +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 127/301 (42%), Gaps = 66/301 (21%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEE----TVHREVEIMQHLSG--H 156
           +  V  IG G +G+V+  R   SG   A K++R   GEE    +  REV +++ L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ----------------RAA 200
             VV L             M++C+  R  D+ ++V    E                   A
Sbjct: 66  PNVVRL-------------MDVCATSR-TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 201 NIFKDVMWV----IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
              KD+M      + + H   +VHRD+KPENIL+T+ G +KLADFGLA   S    L+ +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALAPV 171
Query: 257 AGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---- 307
             +  Y APEV L   Y+  VD+WS              F G    D L  +FD I    
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 231
Query: 308 -----KNVKLDFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                ++V L   +           V   + +    L+  MLT +   RI+A   L+H +
Sbjct: 232 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291
Query: 353 I 353
           +
Sbjct: 292 L 292

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 133/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ D+GLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 63/282 (22%), Positives = 118/282 (41%), Gaps = 49/282 (17%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLH 163
           D  ++E+IG G FG V+  + +  G  +  + ++   E   REV+ +  L  H  +V  +
Sbjct: 13  DFKEIELIGSGGFGQVFKAKHRIDGKTYVIRRVKYNNEKAEREVKALAKLD-HVNIVHYN 71
Query: 164 SVYEEAD-----------------------------CFHLVMELCSGGRLIDQMVEV--- 191
             ++  D                             C  + ME C  G L +Q +E    
Sbjct: 72  GCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFIQMEFCDKGTL-EQWIEKRRG 130
Query: 192 GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ 251
            +  +  A  +F+ +   + Y H   ++HRD+KP NI L  + ++K+ DFGL   + N  
Sbjct: 131 EKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 190
Query: 252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV 310
             +   G+  Y++PE +S  +Y ++VD+++                 + L     A +  
Sbjct: 191 KRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLIL-----------AELLHVCDTAFETS 239
Query: 311 KL--DFHSGVWETV-SKPARDLMARMLTRDVSARITADEVLR 349
           K   D   G+   +  K  + L+ ++L++    R    E+LR
Sbjct: 240 KFFTDLRDGIISDIFDKKEKTLLQKLLSKKPEDRPNTSEILR 281

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 126/301 (41%), Gaps = 66/301 (21%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEE----TVHREVEIMQHLSG--H 156
           +  V  IG G +G+V+  R   SG   A K++R   GEE    +  REV +++ L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ----------------RAA 200
             VV L             M++C+  R  D+ ++V    E                   A
Sbjct: 66  PNVVRL-------------MDVCATSR-TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 201 NIFKDVMWV----IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
              KD+M      + + H   +VHRD+KPENIL+T+ G +KLADFGLA   S    L  +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALDPV 171
Query: 257 AGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---- 307
             +  Y APEV L   Y+  VD+WS              F G    D L  +FD I    
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 231
Query: 308 -----KNVKLDFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                ++V L   +           V   + +    L+  MLT +   RI+A   L+H +
Sbjct: 232 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291
Query: 353 I 353
           +
Sbjct: 292 L 292

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 82.0 bits (201), Expect = 7e-16,   Method: Compositional matrix adjust.
 Identities = 68/204 (33%), Positives = 92/204 (45%), Gaps = 33/204 (16%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLHSV 165
           V+  G F  V+  +   SG E+A K L   EE  +R    EV  M+ LSGH  +V   S 
Sbjct: 35  VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 166 Y----EEADC----FHLVMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
                EE+D     F L+ ELC G     + +M   G  S      IF      +++ H 
Sbjct: 95  ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 216 M--GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-------------GSP 260
               ++HRD+K EN+LL+  G IKL DFG A  IS+    S  A              +P
Sbjct: 155 QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTP 214
Query: 261 AYVAPEV--LSGNYS--EKVDIWS 280
            Y  PE+  L  N+   EK DIW+
Sbjct: 215 MYRTPEIIDLYSNFPIGEKQDIWA 238

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREVEIM 150
           +E  +    ++G G FGSV+     +     A K + K      GE      V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 151 QHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKDVMW 208
           + +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  V+ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 209 VIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  PE 
Sbjct: 122 AVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEW 180
Query: 268 LSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +  +  +     +WS             PF+ D      + I   ++ F     + VS  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVSXE 230
Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
            + L+   L    S R T +E+  HPW+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 86/301 (28%), Positives = 126/301 (41%), Gaps = 66/301 (21%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR--KGEE----TVHREVEIMQHLSG--H 156
           +  V  IG G +G+V+  R   SG   A K++R   GEE    +  REV +++ L    H
Sbjct: 6   YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGEEGLPISTVREVALLRRLEAFEH 65
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ----------------RAA 200
             VV L             M++C+  R  D+ ++V    E                   A
Sbjct: 66  PNVVRL-------------MDVCATSR-TDREIKVTLVFEHVDQDLRTYLDKAPPPGLPA 111
Query: 201 NIFKDVMWV----IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
              KD+M      + + H   +VHRD+KPENIL+T+ G +KLADFGLA   S    L  +
Sbjct: 112 ETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALFPV 171
Query: 257 AGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI---- 307
             +  Y APEV L   Y+  VD+WS              F G    D L  +FD I    
Sbjct: 172 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 231
Query: 308 -----KNVKLDFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                ++V L   +           V   + +    L+  MLT +   RI+A   L+H +
Sbjct: 232 EDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 291
Query: 353 I 353
           +
Sbjct: 292 L 292

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREVEIM 150
           +E  +    ++G G FGSV+     +     A K + K      GE      V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 151 QHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKDVMW 208
           + +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  V+ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 209 VIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEW 180
Query: 268 LSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +  +  +     +WS             PF+ D      + I   ++ F     + VS  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVSSE 230
Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
            + L+   L    S R T +E+  HPW+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 81.6 bits (200), Expect = 9e-16,   Method: Compositional matrix adjust.
 Identities = 74/268 (27%), Positives = 122/268 (45%), Gaps = 26/268 (9%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GE----ETVHREVEIM 150
           +E  +    ++G G FGSV+     +     A K + K      GE      V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61
Query: 151 QHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKDVMW 208
           + +S G +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  V+ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121
Query: 209 VIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            +++CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEW 180
Query: 268 LSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +  +  +     +WS             PF+ D      + I   ++ F     + VS  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIGGQVFFR----QRVSSE 230
Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
            + L+   L    S R T +E+  HPW+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 73/307 (23%), Positives = 128/307 (41%), Gaps = 54/307 (17%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSG 155
           I  D     ++G G +G V     K +G   A K +   ++ +      RE++I++H   
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK- 67
Query: 156 HTGVVTLHSV-----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           H  ++T+ ++     +E  +  +++ EL      + +++     S+          +  +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-----SNGQTLSGLAGSPAYV-- 263
           K  H   V+HRD+KP N+L+ ++  +K+ DFGLA  I      N +     +G   YV  
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMTEYVAT 185
Query: 264 ----APEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------- 304
               APEV+  S  YS  +D+WS              F G      L  +F         
Sbjct: 186 RWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSD 245
Query: 305 ------------DAIKNVKLDFHSGV---WETVSKPARDLMARMLTRDVSARITADEVLR 349
                       + IK++ +   + +   +  V+    DL+ RML  D + RITA E L 
Sbjct: 246 NDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALE 305
Query: 350 HPWILFY 356
           HP++  Y
Sbjct: 306 HPYLQTY 312

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 19/237 (8%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           + M   + + D +   E++G G    V L R      + A K LR              R
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 146 EVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
           E +    L+ H  +V ++   E         ++VME   G  L D +   G  + +RA  
Sbjct: 62  EAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLA--- 257
           +  D    + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++ G +++  A   
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 258 GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G+  Y++PE   G+  + + D++S             PF GDS ++V  A ++V+ D
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPDSV--AYQHVRED 235

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score = 80.9 bits (198), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+  FGLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 78/289 (26%), Positives = 126/289 (43%), Gaps = 42/289 (14%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQ 151
           K++   +  ++E IG G+FGSV+ C  +  G  +A K  +K       E+   REV    
Sbjct: 2   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 61
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVM 207
            L  H+ VV   S + E D   +  E C+GG L D + E    +  + E    ++   V 
Sbjct: 62  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 121
Query: 208 WVIKYCHDMGVVHRDIKPENILLT-----------------TSGKI--KLADFGLAMRIS 248
             ++Y H M +VH DIKP NI ++                  S K+  K+ D G   RIS
Sbjct: 122 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 181
Query: 249 NGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWSXXXXXXXXX-XXXXPFKGDSLEAVFD 305
           + Q      G   ++A EVL  NY+   K DI++              P  GD     + 
Sbjct: 182 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVXAAGAEPLPRNGDQ----WH 234
Query: 306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
            I+  +L     + + +S+   +L+  M+  D   R +A  +++H  +L
Sbjct: 235 EIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 280

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSG 155
           I  D     ++G G +G V     K +G   A K +   ++ +      RE++I++H   
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK- 67
Query: 156 HTGVVTLHSV-----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           H  ++T+ ++     +E  +  +++ EL      + +++     S+          +  +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---------SNGQTLSGLAGSPA 261
           K  H   V+HRD+KP N+L+ ++  +K+ DFGLA  I           GQ  SG+    A
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ-SGMTEXVA 184
Query: 262 ---YVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF-------- 304
              Y APEV+  S  YS  +D+WS              F G      L  +F        
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 305 -------------DAIKNVKLDFHSGV---WETVSKPARDLMARMLTRDVSARITADEVL 348
                        + IK++ +   + +   +  V+    DL+ RML  D + RITA E L
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 349 RHPWILFY 356
            HP++  Y
Sbjct: 305 EHPYLQTY 312

>pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQ 151
           K++   +  ++E IG G+FGSV+ C  +  G  +A K  +K       E+   REV    
Sbjct: 4   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 63
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVM 207
            L  H+ VV   S + E D   +  E C+GG L D + E    +  + E    ++   V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 208 WVIKYCHDMGVVHRDIKPENILLT-----------------TSGKI--KLADFGLAMRIS 248
             ++Y H M +VH DIKP NI ++                  S K+  K+ D G   RIS
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 249 NGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWSXXXXXX-XXXXXXXPFKGDSLEAVFD 305
           + Q      G   ++A EVL  NY+   K DI++              P  GD     + 
Sbjct: 184 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WH 236
Query: 306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
            I+  +L     + + +S+   +L+  M+  D   R +A  +++H  +L
Sbjct: 237 EIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.5 bits (197), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ D GLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGHRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ DF LA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 77/289 (26%), Positives = 125/289 (43%), Gaps = 42/289 (14%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQ 151
           K++   +  ++E IG G+FGSV+ C  +  G  +A K  +K       E+   REV    
Sbjct: 4   KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHA 63
Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVM 207
            L  H+ VV   S + E D   +  E C+GG L D + E    +  + E    ++   V 
Sbjct: 64  VLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG 123
Query: 208 WVIKYCHDMGVVHRDIKPENILLT-----------------TSGKI--KLADFGLAMRIS 248
             ++Y H M +VH DIKP NI ++                  S K+  K+ D G   RIS
Sbjct: 124 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 183
Query: 249 NGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWSXXXXXX-XXXXXXXPFKGDSLEAVFD 305
           + Q      G   ++A EVL  NY+   K DI++              P  GD     + 
Sbjct: 184 SPQVEE---GDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ----WH 236
Query: 306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
            I+  +L     + + +S+   +L+  M+  D   R +A  +++H  +L
Sbjct: 237 EIRQGRL---PRIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLL 282

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           + M   + + D +   E++G G    V L R      + A K LR              R
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 146 EVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
           E +    L+ H  +V ++   E         ++VME   G  L D +   G  + +RA  
Sbjct: 62  EAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTL---SGLA 257
           +  D    + + H  G++HRD+KP NIL++ +  +K+ DFG+A  I++ G ++   + + 
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGNSVXQTAAVI 180
Query: 258 GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G+  Y++PE   G+  + + D++S             PF GDS  +V  A ++V+ D
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRED 235

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 75/308 (24%), Positives = 129/308 (41%), Gaps = 56/308 (18%)
Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSG 155
           I  D     ++G G +G V     K +G   A K +   ++ +      RE++I++H   
Sbjct: 9   ISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK- 67
Query: 156 HTGVVTLHSV-----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           H  ++T+ ++     +E  +  +++ EL      + +++     S+          +  +
Sbjct: 68  HENIITIFNIQRPDSFENFNEVYIIQELMQTD--LHRVISTQMLSDDHIQYFIYQTLRAV 125
Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---------SNGQTLSGLAGSPA 261
           K  H   V+HRD+KP N+L+ ++  +K+ DFGLA  I           GQ  SG+    A
Sbjct: 126 KVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQ-SGMVEFVA 184
Query: 262 ---YVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF-------- 304
              Y APEV+  S  YS  +D+WS              F G      L  +F        
Sbjct: 185 TRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS 244
Query: 305 -------------DAIKNVKLDFHSGV---WETVSKPARDLMARMLTRDVSARITADEVL 348
                        + IK++ +   + +   +  V+    DL+ RML  D + RITA E L
Sbjct: 245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEAL 304
Query: 349 RHPWILFY 356
            HP++  Y
Sbjct: 305 EHPYLQTY 312

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 80.1 bits (196), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ D GLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 70/299 (23%), Positives = 132/299 (44%), Gaps = 48/299 (16%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +  +++      +RE+ +++H+
Sbjct: 19  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 78
Query: 154 SGHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+      EE +  +LV  L   G  ++ +V+  + ++     +   ++
Sbjct: 79  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLM--GADLNNIVKCQKLTDDHVQFLIYQIL 135
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             +KY H   ++HRD+KP N+ +    ++K+ D GLA    +  T  G   +  Y APE+
Sbjct: 136 RGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTDDEMT--GYVATRWYRAPEI 193
Query: 268 LSG--NYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVF--------DAIKNV--- 310
           +    +Y++ VDIWS              F G    D L+ +         + +K +   
Sbjct: 194 MLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE 253
Query: 311 -------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                        K++F + V+   +  A DL+ +ML  D   RITA + L H +   Y
Sbjct: 254 SARNYIQSLTQMPKMNF-ANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY 311

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           + M   + + D +   E++G G    V L R      + A K LR              R
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 146 EVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
           E +    L+ H  +V ++   E         ++VME   G  L D +   G  + +RA  
Sbjct: 62  EAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLA--- 257
           +  D    + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++ G +++  A   
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 258 GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G+  Y++PE   G+  + + D++S             PF GDS  +V  A ++V+ D
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRED 235

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 109/237 (45%), Gaps = 19/237 (8%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           + M   + + D +   E++G G    V L R      + A K LR              R
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 146 EVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
           E +    L+ H  +V +++  E         ++VME   G  L D +   G  + +RA  
Sbjct: 62  EAQNAAALN-HPAIVAVYATGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLA--- 257
           +  D    + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++ G +++  A   
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 258 GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G+  Y++PE   G+  + + D++S             PF GDS  +V  A ++V+ D
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRED 235

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 46/287 (16%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHLSGHTGVVTLHS 164
           +G G +GSV          + A K L +  +++      +RE+ +++HL  H  V+ L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK-HENVIGLLD 94
Query: 165 VYEEADCF------HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V+  A         +LV  L   G  ++ +V+    S++    +   ++  +KY H  G+
Sbjct: 95  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKV 276
           +HRD+KP N+ +    ++++ DFGLA +    + ++G   +  Y APE++    +Y++ V
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD--EEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDF------------------ 314
           DIWS              F G    D L+ + + +     +                   
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPP 270
Query: 315 -----HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                 S ++   +  A DL+ RML  D   R++A E L H +   Y
Sbjct: 271 MPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 46/287 (16%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHLSGHTGVVTLHS 164
           +G G +GSV          + A K L +  +++      +RE+ +++HL  H  V+ L  
Sbjct: 36  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK-HENVIGLLD 94
Query: 165 VYEEADCF------HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V+  A         +LV  L   G  ++ +V+    S++    +   ++  +KY H  G+
Sbjct: 95  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKSQALSDEHVQFLVYQLLRGLKYIHSAGI 152
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKV 276
           +HRD+KP N+ +    ++++ DFGLA +    + ++G   +  Y APE++    +Y++ V
Sbjct: 153 IHRDLKPSNVAVNEDSELRILDFGLARQAD--EEMTGYVATRWYRAPEIMLNWMHYNQTV 210
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDF------------------ 314
           DIWS              F G    D L+ + + +     +                   
Sbjct: 211 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPP 270
Query: 315 -----HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                 S ++   +  A DL+ RML  D   R++A E L H +   Y
Sbjct: 271 MPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 317

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 82/307 (26%), Positives = 131/307 (42%), Gaps = 56/307 (18%)
Query: 98  KNKIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS-- 154
           +++ E D  +VE + G G FG+V L + K++G   A K + +     +RE++IMQ L+  
Sbjct: 17  RSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVL 76
Query: 155 GHTGVVTLHSVY------EEADCF-HLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKD 205
            H  +V L S +      +  D + ++VME        D +       Y  Q A      
Sbjct: 77  HHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP-----DTLHRCCRNYYRRQVAPPPILI 131
Query: 206 VMWVIKYCHDMG--------VVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGL 256
            +++ +    +G        V HRDIKP N+L+  + G +KL DFG A ++S  +     
Sbjct: 132 KVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAY 191
Query: 257 AGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDS--------------- 299
             S  Y APE++ GN  Y+  VDIWS              F+GD+               
Sbjct: 192 ICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCP 251
Query: 300 ----LEAVFDAIKNVKLDFHSGV-WETV--------SKPARDLMARMLTRDVSARITADE 346
               L  +  +  +V L    G+ W  V        +K A DL++ +L      R+   E
Sbjct: 252 SREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYE 311
Query: 347 VLRHPWI 353
            L HP+ 
Sbjct: 312 ALCHPYF 318

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH 163
           E +G G FG V     + +G + A K  R     K  E    E++IM+ L+ H  VV+  
Sbjct: 20  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAR 78
Query: 164 SVYE------EADCFHLVMELCSGGRL---IDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            V +        D   L ME C GG L   ++Q        E     +  D+   ++Y H
Sbjct: 79  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 138
Query: 215 DMGVVHRDIKPENILLTTSGKI---KLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SG 270
           +  ++HRD+KPENI+L    +    K+ D G A  +  G+  +   G+  Y+APE+L   
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 198
Query: 271 NYSEKVDIWS 280
            Y+  VD WS
Sbjct: 199 KYTVTVDYWS 208

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 79.0 bits (193), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 88/190 (46%), Gaps = 19/190 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH 163
           E +G G FG V     + +G + A K  R     K  E    E++IM+ L+ H  VV+  
Sbjct: 21  ERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAR 79
Query: 164 SVYE------EADCFHLVMELCSGGRL---IDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            V +        D   L ME C GG L   ++Q        E     +  D+   ++Y H
Sbjct: 80  EVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLH 139
Query: 215 DMGVVHRDIKPENILLTTSGKI---KLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SG 270
           +  ++HRD+KPENI+L    +    K+ D G A  +  G+  +   G+  Y+APE+L   
Sbjct: 140 ENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQK 199
Query: 271 NYSEKVDIWS 280
            Y+  VD WS
Sbjct: 200 KYTVTVDYWS 209

>pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312

Iteration: 1
 Score = 78.6 bits (192), Expect = 7e-15,   Method: Compositional matrix adjust.
 Identities = 73/273 (26%), Positives = 115/273 (42%), Gaps = 28/273 (10%)
Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE----------TVHREV 147
           +   E ++    ++G G FG+V+         + A K + +             T   EV
Sbjct: 26  REAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEV 85
Query: 148 EIMQHLS---GHTGVVTLHSVYEEADCFHLVME-LCSGGRLIDQMVEVGQYSEQRAANIF 203
            ++  +    GH GV+ L   +E  + F LV+E       L D + E G   E  +   F
Sbjct: 86  ALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFF 145
Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
             V+  I++CH  GVVHRDIK ENIL+    G  KL DFG    + + +  +   G+  Y
Sbjct: 146 GQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHD-EPYTDFDGTRVY 204
Query: 263 VAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
             PE +S +  ++    +WS             PF+ D        I   +L F +    
Sbjct: 205 SPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFPA---- 254
Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            VS     L+ R L    S+R + +E+L  PW+
Sbjct: 255 HVSPDCCALIRRCLAPKPSSRPSLEEILLDPWM 287

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 62/243 (25%), Positives = 110/243 (45%), Gaps = 19/243 (7%)
Query: 87  GCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET---- 142
           G +   + M   + + D +   E++G G    V L R      + A K LR         
Sbjct: 13  GLVPRGSHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSF 72
Query: 143 ---VHREVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYS 195
                RE +    L+ H  +V ++   E         ++VME   G  L D +   G  +
Sbjct: 73  YLRFRREAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMT 131
Query: 196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLS 254
            +RA  +  D    + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++ G +++
Sbjct: 132 PKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVT 191
Query: 255 GLA---GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV 310
             A   G+  Y++PE   G+  + + D++S             PF GDS  +V  A ++V
Sbjct: 192 QTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHV 249
Query: 311 KLD 313
           + D
Sbjct: 250 RED 252

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 78.6 bits (192), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 61/237 (25%), Positives = 108/237 (45%), Gaps = 19/237 (8%)
Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-------VHR 145
           + M   + + D +   E++G G    V L R      + A K LR              R
Sbjct: 2   SHMTTPSHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRR 61
Query: 146 EVEIMQHLSGHTGVVTLHSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
           E +    L+ H  +V ++   E         ++VME   G  L D +   G  + +RA  
Sbjct: 62  EAQNAAALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIE 120
Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLA--- 257
           +  D    + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++ G +++  A   
Sbjct: 121 VIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVI 180
Query: 258 GSPAYVAPEVLSGNYSE-KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLD 313
           G+  Y++PE   G+  + + D++S             PF GDS  +V  A ++V+ D
Sbjct: 181 GTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVRED 235

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 59/204 (28%), Positives = 96/204 (47%), Gaps = 15/204 (7%)
Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGR-LIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           SG +GV+ L   +E  D F L++E     + L D + E G   E+ A + F  V+  +++
Sbjct: 113 SGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRH 172
Query: 213 CHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN 271
           CH+ GV+HRDIK ENIL+  + G++KL DFG    + +    +   G+  Y  PE +  +
Sbjct: 173 CHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKD-TVYTDFDGTRVYSPPEWIRYH 231
Query: 272 --YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
             +     +WS             PF+ D      + I   ++ F     + VS   + L
Sbjct: 232 RYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFR----QRVSSECQHL 281
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           +   L    S R T +E+  HPW+
Sbjct: 282 IRWCLALRPSDRPTFEEIQNHPWM 305

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 67/264 (25%), Positives = 121/264 (45%), Gaps = 17/264 (6%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 24  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 82
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 83  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 142
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    S   G+ +Y++PE L G +YS 
Sbjct: 143 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSV 201
Query: 275 KVDIWSXXXXXXXXXXXXXPF-KGDSLEAVFDAIKNVKLD----FHSGVWETVSKPARDL 329
           + DIWS             P   G    A+F+ +  +  +      SGV+   S   +D 
Sbjct: 202 QSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDYIVNEPPPKLPSGVF---SLEFQDF 258
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + + L ++ + R    +++ H +I
Sbjct: 259 VNKCLIKNPAERADLKQLMVHAFI 282

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score = 78.2 bits (191), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 83/304 (27%), Positives = 124/304 (40%), Gaps = 69/304 (22%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---------TVHREVEIMQHLSG 155
           +  V  IG G +G+V+  R   SG   A K++R             +  REV +++ L  
Sbjct: 11  YEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEA 70
Query: 156 --HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQ---------------- 197
             H  VV L             M++C+  R  D+ ++V    E                 
Sbjct: 71  FEHPNVVRL-------------MDVCATSR-TDREIKVTLVFEHVDQDLRTYLDKAPPPG 116
Query: 198 RAANIFKDVMWV----IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL 253
             A   KD+M      + + H   +VHRD+KPENIL+T+ G +KLADFGLA   S    L
Sbjct: 117 LPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMAL 176
Query: 254 SGLAGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAI- 307
           + +  +  Y APEV L   Y+  VD+WS              F G    D L  +FD I 
Sbjct: 177 TPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIG 236
Query: 308 --------KNVKLDFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLR 349
                   ++V L   +           V   + +    L+  MLT +   RI+A   L+
Sbjct: 237 LPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQ 296
Query: 350 HPWI 353
           H ++
Sbjct: 297 HSYL 300

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 67/287 (23%), Positives = 123/287 (42%), Gaps = 46/287 (16%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETV------HREVEIMQHLSGHTGVVTLHS 164
           +G G +GSV          + A K L +  +++      +RE+ +++HL  H  V+ L  
Sbjct: 28  VGSGAYGSVCSAYDARLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHLK-HENVIGLLD 86
Query: 165 VYEEADCF------HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V+  A         +LV  L   G  ++ +V+    S++    +   ++  +KY H  G+
Sbjct: 87  VFTPATSIEDFSEVYLVTTLM--GADLNNIVKCQALSDEHVQFLVYQLLRGLKYIHSAGI 144
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKV 276
           +HRD+KP N+ +    ++++ DFGLA +    + ++G   +  Y APE++    +Y++ V
Sbjct: 145 IHRDLKPSNVAVNEDCELRILDFGLARQAD--EEMTGYVATRWYRAPEIMLNWMHYNQTV 202
Query: 277 DIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNVKLDF------------------ 314
           DIWS              F G    D L+ + + +     +                   
Sbjct: 203 DIWSVGCIMAELLQGKALFPGSDYIDQLKRIMEVVGTPSPEVLAKISSEHARTYIQSLPP 262
Query: 315 -----HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
                 S ++   +  A DL+ RML  D   R++A E L H +   Y
Sbjct: 263 MPQKDLSSIFRGANPLAIDLLGRMLVLDSDQRVSAAEALAHAYFSQY 309

>pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 124/273 (45%), Gaps = 19/273 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
           DD   +  +G G +G V   R   SG   A K +R     + ++ +  +++I        
Sbjct: 51  DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 110
Query: 158 GVVTLH-SVYEEADCFHLVMEL--CSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYC 213
             VT + +++ E D + + MEL   S  +   Q+++ GQ   E     I   ++  +++ 
Sbjct: 111 FTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 169
Query: 214 HD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           H  + V+HRD+KP N+L+   G++K+ DFG++  + +    +  AG   Y+APE ++   
Sbjct: 170 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDSVAKTIDAGCKPYMAPERINPEL 229
Query: 272 ----YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV-WETVSKPA 326
               YS K DIWS             P+  DS    F  +K V  +    +  +  S   
Sbjct: 230 NQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKFSAEF 287
Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYTER 359
            D  ++ L ++   R T  E+++HP+   +  +
Sbjct: 288 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 320

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 76/326 (23%), Positives = 129/326 (39%), Gaps = 81/326 (24%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVT 161
           V+ +G G +G VW    + +G   A K +    +         RE+ I+  LSGH  +V 
Sbjct: 14  VKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVN 73
Query: 162 LHSVY---EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           L +V     + D + LV +       +  ++            +   ++ VIKY H  G+
Sbjct: 74  LLNVLRADNDRDVY-LVFDYMETD--LHAVIRANILEPVHKQYVVYQLIKVIKYLHSGGL 130
Query: 219 VHRDIKPENILLTTSGKIKLADFGLA------MRISNGQTLS----------------GL 256
           +HRD+KP NILL     +K+ADFGL+       R++N   LS                  
Sbjct: 131 LHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDY 190
Query: 257 AGSPAYVAPEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDF 314
             +  Y APE+L G+  Y++ +D+WS              F G S     + I  V +DF
Sbjct: 191 VATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGV-IDF 249
Query: 315 HSG----------------------------------VWETV----------SKPARDLM 330
            S                                    W+ +          ++ A DL+
Sbjct: 250 PSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLL 309
Query: 331 ARMLTRDVSARITADEVLRHPWILFY 356
            ++L  + + RI+A++ L+HP++  +
Sbjct: 310 DKLLQFNPNKRISANDALKHPFVSIF 335

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 68/293 (23%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + LV  L   G  + ++++    S          ++  +KY H
Sbjct: 105 GINDIIRAPTIEQMKDVY-LVTHLM--GADLYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 162 SANVLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 333

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 25/264 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +V+GHG  G++ + R      + A K  L +      REV++++    H  V+      +
Sbjct: 30  DVLGHGAEGTI-VYRGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEK 88
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQ--RAANIFKDVMWVIKYCHDMGVVHRDIKP 225
           +    ++ +ELC+    + + VE   ++        + +     + + H + +VHRD+KP
Sbjct: 89  DRQFQYIAIELCAAT--LQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKP 146
Query: 226 ENILLTTS---GKIK--LADFGLAMRISNGQ----TLSGLAGSPAYVAPEVLSGNYSEK- 275
            NIL++     GKIK  ++DFGL  +++ G+      SG+ G+  ++APE+LS +  E  
Sbjct: 147 HNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENP 206
Query: 276 ---VDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIKNV-KLD-FHSGVWETVSKPARDL 329
              VDI+S              PF G SL+   + +     LD  H    E V   AR+L
Sbjct: 207 TYTVDIFSAGCVFYYVISEGSHPF-GKSLQRQANILLGACSLDCLHPEKHEDVI--AREL 263
Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +M+  D   R +A  VL+HP+ 
Sbjct: 264 IEKMIAMDPQKRPSAKHVLKHPFF 287

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/260 (25%), Positives = 119/260 (45%), Gaps = 13/260 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 8   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 66
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 67  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 126
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ + +  +   G+ +Y++PE L G +YS 
Sbjct: 127 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID-EMANEFVGTRSYMSPERLQGTHYSV 185
Query: 275 KVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKN-VKLDFHSGVWETVSKPARDLMARM 333
           + DIWS             P    ++  + D I N       S V+   S   +D + + 
Sbjct: 186 QSDIWSMGLSLVEMAVGRYPRPPMAIFELLDYIVNEPPPKLPSAVF---SLEFQDFVNKC 242
Query: 334 LTRDVSARITADEVLRHPWI 353
           L ++ + R    +++ H +I
Sbjct: 243 LIKNPAERADLKQLMVHAFI 262

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 87  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/298 (22%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLAFRHENII 86
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 87  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTSDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAVFDAIKNV-KLDFHSGV---- 318
            S  Y++ +DIWS              F G    D L  +   + +  + D + G+    
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCGINLKA 262
Query: 319 ------------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
                             +      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLAQYYD 320

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 85  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 85  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score = 75.9 bits (185), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 85  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTXDLKIXDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNXIINLKA 260
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 85  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 313

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 27  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 86
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 87  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 143
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 144 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 202
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 203 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 262
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 263 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 320

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 67  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 125
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 126 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 185
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    S   G+ +Y++PE L G +YS 
Sbjct: 186 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSPERLQGTHYSV 244
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 245 QSDIWS 250

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYXQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTXDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 45  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 104
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 105 GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 161
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 162 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 220
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 221 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 280
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 281 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 338

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 33  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 92
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 93  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 149
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 150 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 208
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 209 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 268
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 269 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 326

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 25  YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 84
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 85  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 141
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 142 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 200
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 201 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 260
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 261 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 318

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+R+G   EE    E E+M  LS H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIREGAMSEEDFIEEAEVMMKLS-HPK 63
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAS 123
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 184 KSDVWS 189

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 90  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 205
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 31  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 90
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 91  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 147
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 148 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 206
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 207 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 266
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 267 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 324

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 22  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 81
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 82  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 138
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 139 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 197
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 198 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 257
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 258 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 315

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 83  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPEQEDLNCIINLKA 258
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score = 75.1 bits (183), Expect = 8e-14,   Method: Compositional matrix adjust.
 Identities = 66/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 23  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 82
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 83  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 139
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 140 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 198
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 199 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 258
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 259 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 311

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 32  DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 90
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 91  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 151 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 209
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 210 QSDIWS 215

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 68/270 (25%), Positives = 122/270 (45%), Gaps = 23/270 (8%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182
Query: 275 KVDIWSXXXXXXXXXXXXXPF-----KGDSLE--AVFDAIKNV----KLDFHSGVWETVS 323
           + DIWS             P      K DS    A+F+ +  +         SGV+   S
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKEDSRPPMAIFELLDYIVNEPPPKLPSGVF---S 239
Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
              +D + + L ++ + R    +++ H +I
Sbjct: 240 LEFQDFVNKCLIKNPAERADLKQLMVHAFI 269

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 126/298 (42%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKCQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 60/190 (31%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++VME  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVMEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V+E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 183 QSDIWS 188

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH 163
           +++G G   +V+  R K +G  FA K        +  +   RE E+++ L+ H  +V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLF 73
Query: 164 SVYEEADCFH--LVMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMGV 218
           ++ EE    H  L+ME C  G L   + E        E     + +DV+  + +  + G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 219 VHRDIKPENIL--LTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL------ 268
           VHR+IKP NI+  +   G+   KL DFG A  + + +    L G+  Y+ P++       
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLR 193
Query: 269 ---SGNYSEKVDIWSXXXXXXXXXXXXXPFK 296
                 Y   VD+WS             PF+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 320
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 321 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 379
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 380 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 439
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 440 RFTIKSDVWS 449

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+R+G   EE    E E+M  LS H  
Sbjct: 8   TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIREGAMSEEDFIEEAEVMMKLS-HPK 61
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 62  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 121
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 122 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 181
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 182 KSDVWS 187

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+R+G   EE    E E+M  LS H  
Sbjct: 10  TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIREGAMSEEDFIEEAEVMMKLS-HPK 63
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 64  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 123
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 124 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 183
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 184 KSDVWS 189

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 183 QSDIWS 188

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 65/293 (22%), Positives = 124/293 (42%), Gaps = 48/293 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A + +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIRKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L+    +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTEYVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             +            + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 317

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 29  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 88
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 89  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 145
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L     +  Y APE++ 
Sbjct: 146 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEIML 204
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 205 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 264
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 265 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 322

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/298 (22%), Positives = 125/298 (41%), Gaps = 48/298 (16%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIM-----QHLS 154
           +T +  IG G +G V       +    A K +   E   +     RE++I+     +++ 
Sbjct: 30  YTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENII 89
Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           G   ++   ++ +  D + +V +L      + ++++    S          ++  +KY H
Sbjct: 90  GINDIIRAPTIEQMKDVY-IVQDLMETD--LYKLLKTQHLSNDHICYFLYQILRGLKYIH 146
Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVL- 268
              V+HRD+KP N+LL T+  +K+ DFGLA R+++        L     +  Y APE++ 
Sbjct: 147 SANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLXEXVATRWYRAPEIML 205
Query: 269 -SGNYSEKVDIWSXXXXXXXXXXXXXPFKG----DSLEAV-----------FDAIKNVKL 312
            S  Y++ +DIWS              F G    D L  +            + I N+K 
Sbjct: 206 NSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKA 265
Query: 313 DFH------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE 358
             +            + ++      A DL+ +MLT +   RI  ++ L HP++  Y +
Sbjct: 266 RNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYD 323

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 183 QSDIWS 188

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 53/186 (28%), Positives = 92/186 (49%), Gaps = 9/186 (4%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++ H    
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVL-HECNS 63
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G +YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182
Query: 275 KVDIWS 280
           + DIWS
Sbjct: 183 QSDIWS 188

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V+E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVIEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 123/273 (45%), Gaps = 19/273 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
           DD   +  +G G +G V   R   SG   A K +R     + ++ +  +++I        
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66
Query: 158 GVVTLH-SVYEEADCFHLVMEL--CSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYC 213
             VT + +++ E D + + MEL   S  +   Q+++ GQ   E     I   ++  +++ 
Sbjct: 67  FTVTFYGALFREGDVW-ICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125
Query: 214 HD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           H  + V+HRD+KP N+L+   G++K+ DFG++  + +       AG   Y+APE ++   
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185
Query: 272 ----YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV-WETVSKPA 326
               YS K DIWS             P+  DS    F  +K V  +    +  +  S   
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKFSAEF 243
Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYTER 359
            D  ++ L ++   R T  E+++HP+   +  +
Sbjct: 244 VDFTSQCLKKNSKERPTYPELMQHPFFTLHESK 276

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+R+G   EE    E E+M  LS H  
Sbjct: 13  TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIREGAMSEEDFIEEAEVMMKLS-HPK 66
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 67  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 126
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 127 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 186
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 187 KSDVWS 192

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 56/211 (26%), Positives = 93/211 (44%), Gaps = 24/211 (11%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTGVVTLH 163
           +++G G   +V+  R K +G  FA K        +  +   RE E+++ L+ H  +V L 
Sbjct: 15  DILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLF 73
Query: 164 SVYEEADCFH--LVMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMGV 218
           ++ EE    H  L+ME C  G L   + E        E     + +DV+  + +  + G+
Sbjct: 74  AIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGI 133
Query: 219 VHRDIKPENIL--LTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL------ 268
           VHR+IKP NI+  +   G+   KL DFG A  + + +    L G+  Y+ P++       
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVXLYGTEEYLHPDMYERAVLR 193
Query: 269 ---SGNYSEKVDIWSXXXXXXXXXXXXXPFK 296
                 Y   VD+WS             PF+
Sbjct: 194 KDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 63/240 (26%), Positives = 102/240 (42%), Gaps = 32/240 (13%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSG 155
           + K++ +G G+F +V+  R K +    A K ++ G           T  RE++++Q LS 
Sbjct: 12  YEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS- 70
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV----IK 211
           H  ++ L   +       LV +        D  V +   S     +  K  M +    ++
Sbjct: 71  HPNIIGLLDAFGHKSNISLVFDFME----TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE 126
Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSG 270
           Y H   ++HRD+KP N+LL  +G +KLADFGLA    S  +       +  Y APE+L G
Sbjct: 127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYXHQVVTRWYRAPELLFG 186
Query: 271 N--YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
              Y   VD+W+                GDS            LD  + ++ET+  P  +
Sbjct: 187 ARMYGVGVDMWAVGCILAELLLRVPFLPGDS-----------DLDQLTRIFETLGTPTEE 235

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 62/186 (33%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+R+G   EE    E E+M  LS H  
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIREGAMSEEDFIEEAEVMMKLS-HPK 64
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 65  LVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 124
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 125 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 184
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 185 KSDVWS 190

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 3   EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 60
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 61  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 119
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 120 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 179
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 180 RFTIKSDVWS 189

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 117/298 (39%), Gaps = 56/298 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+  IG G FG V+  R + +G + A K +    E      T  RE++I+Q L  H  
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HEN 78
Query: 159 VVTL-------HSVYEEAD-CFHLVMELCS---GGRLIDQMVEVGQYSEQRAANIFKDVM 207
           VV L        S Y       +LV + C     G L + +V+      +R   +  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQT--LSGLAGSPAY 262
           +   Y H   ++HRD+K  N+L+T  G +KLADFGLA   S   N Q         +  Y
Sbjct: 139 Y---YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 263 VAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
             PE+L G  +Y   +D+W                +G++ +     I  +       VW 
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 321 TVSK----------------------------PARDLMARMLTRDVSARITADEVLRH 350
            V                               A DL+ ++L  D + RI +D+ L H
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 5   EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 62
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 63  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 121
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 122 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 181
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 182 RFTIKSDVWS 191

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 73.6 bits (179), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 117/298 (39%), Gaps = 56/298 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+  IG G FG V+  R + +G + A K +    E      T  RE++I+Q L  H  
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HEN 78
Query: 159 VVTL-------HSVYEEADC-FHLVMELCS---GGRLIDQMVEVGQYSEQRAANIFKDVM 207
           VV L        S Y       +LV + C     G L + +V+      +R   +  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQT--LSGLAGSPAY 262
           +   Y H   ++HRD+K  N+L+T  G +KLADFGLA   S   N Q         +  Y
Sbjct: 139 Y---YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 263 VAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
             PE+L G  +Y   +D+W                +G++ +     I  +       VW 
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 321 TVSK----------------------------PARDLMARMLTRDVSARITADEVLRH 350
            V                               A DL+ ++L  D + RI +D+ L H
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 357 RFTIKSDVWS 366

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 357 RFTIKSDVWS 366

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 7   EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 64
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 65  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 123
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 124 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 183
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 184 RFTIKSDVWS 193

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 117/298 (39%), Gaps = 56/298 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+  IG G FG V+  R + +G + A K +    E      T  RE++I+Q L  H  
Sbjct: 20  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HEN 78
Query: 159 VVTL-------HSVYEEAD-CFHLVMELCS---GGRLIDQMVEVGQYSEQRAANIFKDVM 207
           VV L        S Y       +LV + C     G L + +V+      +R   +  + +
Sbjct: 79  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 138
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQT--LSGLAGSPAY 262
           +   Y H   ++HRD+K  N+L+T  G +KLADFGLA   S   N Q         +  Y
Sbjct: 139 Y---YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 195
Query: 263 VAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
             PE+L G  +Y   +D+W                +G++ +     I  +       VW 
Sbjct: 196 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 255
Query: 321 TVSK----------------------------PARDLMARMLTRDVSARITADEVLRH 350
            V                               A DL+ ++L  D + RI +D+ L H
Sbjct: 256 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 313

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 43/221 (19%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHL 153
           K+ D++    +IG G +G V+L   K +    A K + +  E       + RE+ I+  L
Sbjct: 25  KVPDNYEIKHLIGRGSYGYVYLAYDKNANKNVAIKKVNRMFEDLIDCKRILREITILNRL 84
Query: 154 SGHTGVVTLHSVYEEADCF-----HLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVM 207
                ++ LH +    D       ++V+E+      + ++ +   + +EQ    I  +++
Sbjct: 85  KSDY-IIRLHDLIIPEDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEQHVKTILYNLL 141
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----------------- 250
              K+ H+ G++HRD+KP N LL     +K+ DFGLA  I++                  
Sbjct: 142 LGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHIVNDLEEKEENEE 201
Query: 251 ---------QTLSGLAGSPAYVAPE--VLSGNYSEKVDIWS 280
                    + L+    +  Y APE  +L  NY+  +DIWS
Sbjct: 202 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWS 242

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVCEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 55/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+L+     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 75/298 (25%), Positives = 117/298 (39%), Gaps = 56/298 (18%)
Query: 105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGHTG 158
           + K+  IG G FG V+  R + +G + A K +    E      T  RE++I+Q L  H  
Sbjct: 19  YEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HEN 77
Query: 159 VVTL-------HSVYEEAD-CFHLVMELCS---GGRLIDQMVEVGQYSEQRAANIFKDVM 207
           VV L        S Y       +LV + C     G L + +V+      +R   +  + +
Sbjct: 78  VVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQT--LSGLAGSPAY 262
           +   Y H   ++HRD+K  N+L+T  G +KLADFGLA   S   N Q         +  Y
Sbjct: 138 Y---YIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYXNRVVTLWY 194
Query: 263 VAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
             PE+L G  +Y   +D+W                +G++ +     I  +       VW 
Sbjct: 195 RPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP 254
Query: 321 TVSK----------------------------PARDLMARMLTRDVSARITADEVLRH 350
            V                               A DL+ ++L  D + RI +D+ L H
Sbjct: 255 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 72.8 bits (177), Expect = 4e-13,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 91/193 (47%), Gaps = 22/193 (11%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLHS 164
           EV+G G FG       + +G     K L + +E   R    EV++M+ L  H  V+    
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIG 74
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
           V  +    + + E   GG L   +  +  QY   +  +  KD+   + Y H M ++HRD+
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDL 134
Query: 224 KPENILLTTSGKIKLADFGLAMRISNGQTLS---------------GLAGSPAYVAPEVL 268
              N L+  +  + +ADFGLA  + + +T                  + G+P ++APE++
Sbjct: 135 NSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMI 194
Query: 269 SG-NYSEKVDIWS 280
           +G +Y EKVD++S
Sbjct: 195 NGRSYDEKVDVFS 207

>pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 61/185 (32%), Positives = 94/185 (50%), Gaps = 16/185 (8%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVH---REVEIMQHLSGHTGVVTL 162
           E IG G FG+V   R++  G++ A K L + +   E V+   REV IM+ L  H  +V  
Sbjct: 43  EKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLF 99
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMG-- 217
                +     +V E  S G L   + + G   Q  E+R  ++  DV   + Y H+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGNYS-EK 275
           +VHRD+K  N+L+     +K+ DFGL+ ++ S        AG+P ++APEVL    S EK
Sbjct: 160 IVHRDLKSPNLLVDKKYTVKVCDFGLSRLKASXFLXSKXAAGTPEWMAPEVLRDEPSNEK 219
Query: 276 VDIWS 280
            D++S
Sbjct: 220 SDVYS 224

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 181 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGNMSPEAFLQEAQVMKKLR- 238
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 239 HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 297
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGL   I + +  +  G      + APE  L G
Sbjct: 298 ERMNYVHRDLRAANILVGENLVCKVADFGLGRLIEDNEYTARQGAKFPIKWTAPEAALYG 357
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 358 RFTIKSDVWS 367

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 237
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 238 HEKLVQLYAVVSE-EPIYIVGEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 296
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 297 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 356
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 357 RFTIKSDVWS 366

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ +  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKIR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 72.4 bits (176), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 98/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGCLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 14  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 71
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  S G L+D +  E+G+Y    +  ++   +   + Y 
Sbjct: 72  HEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYV 130
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD+   NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 131 ERMNYVHRDLAAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 190
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 191 RFTIKSDVWS 200

>pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 60/185 (32%), Positives = 95/185 (51%), Gaps = 16/185 (8%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVH---REVEIMQHLSGHTGVVTL 162
           E IG G FG+V   R++  G++ A K L + +   E V+   REV IM+ L  H  +V  
Sbjct: 43  EKIGAGSFGTV--HRAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLF 99
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMG-- 217
                +     +V E  S G L   + + G   Q  E+R  ++  DV   + Y H+    
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPP 159
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGNYS-EK 275
           +VHR++K  N+L+     +K+ DFGL+ ++ S   +    AG+P ++APEVL    S EK
Sbjct: 160 IVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEK 219
Query: 276 VDIWS 280
            D++S
Sbjct: 220 SDVYS 224

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 96/190 (50%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 4   EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 61
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +   +V E  S G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 62  HEKLVQLYAVVSE-EPIXIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYV 120
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 121 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYG 180
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 181 RFTIKSDVWS 190

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 318 MEHPY--FYT 325

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 72.0 bits (175), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 138 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 257
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 258 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 317
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 318 MEHPY--FYT 325

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 93/182 (51%), Gaps = 13/182 (7%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHS 164
           ++ +G+G+FG VW+     +  + A KTL+ G    E+   E +IM+ L  H  +V L++
Sbjct: 14  IKRLGNGQFGEVWMGTWNGN-TKVAIKTLKPGTMSPESFLEEAQIMKKLK-HDKLVQLYA 71
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---IKYCHDMGVVHR 221
           V  E +  ++V E  + G L+D  ++ G+    +  N+      V   + Y   M  +HR
Sbjct: 72  VVSE-EPIYIVTEYMNKGSLLD-FLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHR 129
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSGNYSEKVDI 278
           D++  NIL+      K+ADFGLA  I + +  +  G      + APE  L G ++ K D+
Sbjct: 130 DLRSANILVGNGLICKIADFGLARLIEDNEXTARQGAKFPIKWTAPEAALYGRFTIKSDV 189
Query: 279 WS 280
           WS
Sbjct: 190 WS 191

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 72/339 (21%), Positives = 138/339 (40%), Gaps = 67/339 (19%)
Query: 68  PCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKAS 127
           P G+   ++     L      I ++  +  K+K  +D+  +  +  GKF  + LC  +  
Sbjct: 2   PLGSMKDILSNYSNL------IYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILC--EKD 53
Query: 128 GAEFACK---------------------TLRKGEETVHREVEIMQHLSGHTGVVTLHSVY 166
              +A K                     +++   +    E++I+  +      +T   + 
Sbjct: 54  NKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEY-CLTCEGII 112
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN------------IFKDVMWVIKYCH 214
              D  +++ E        D +++  +Y      N            I K V+    Y H
Sbjct: 113 TNYDEVYIIYEYMEN----DSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIH 168
Query: 215 D-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYS 273
           +   + HRD+KP NIL+  +G++KL+DFG +  + + + + G  G+  ++ PE  S   S
Sbjct: 169 NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKK-IKGSRGTYEFMPPEFFSNESS 227
Query: 274 ---EKVDIWSXXXXXXXXXXXXXPFKGD-SLEAVFDAI--KNVK--LDFHSGVWETVSKP 325
               KVDIWS             PF    SL  +F+ I  KN++  LD +  ++   +K 
Sbjct: 228 YNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKK 287
Query: 326 AR-----------DLMARMLTRDVSARITADEVLRHPWI 353
           +            D +   L ++ + RIT+++ L+H W+
Sbjct: 288 STCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 319 MEHPY--FYT 326

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 137 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 196
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 316
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 317 MEHPY--FYT 324

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 83/190 (43%), Gaps = 39/190 (20%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 144 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 203
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 204 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 263
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 264 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 323
Query: 348 LRHPWILFYT 357
           + HP+  FYT
Sbjct: 324 MEHPY--FYT 331

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 68
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  + G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 69  HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYG 187
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 188 RFTIKSDVWS 197

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 97/213 (45%), Gaps = 12/213 (5%)
Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGH 156
           +DD  ++  +G G  G V   + + SG   A K +           + RE++++ H    
Sbjct: 15  DDDFERISELGAGNGGVVTKVQHRPSGLIMARKLIHLEIKPAIRNQIIRELQVL-HECNS 73
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + E  +  E+    +   V+  + Y  + 
Sbjct: 74  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREK 133
Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    S   G+ +Y+APE L G +YS 
Sbjct: 134 HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMAPERLQGTHYSV 192
Query: 275 KVDIWSXXXXXXXXXXXXXPFK---GDSLEAVF 304
           + DIWS             P        LEA+F
Sbjct: 193 QSDIWSMGLSLVELAVGRYPIPPPDAKELEAIF 225

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 97/190 (51%), Gaps = 12/190 (6%)
Query: 100 KIEDDHTKVEV-IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSG 155
           +I  +  ++EV +G G FG VW+     +    A KTL+ G    E   +E ++M+ L  
Sbjct: 11  EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR- 68
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSE-QRAANIFKDVMWVIKYC 213
           H  +V L++V  E +  ++V E  + G L+D +  E G+Y    +  ++   +   + Y 
Sbjct: 69  HEKLVQLYAVVSE-EPIYIVTEYMNKGSLLDFLKGETGKYLRLPQLVDMSAQIASGMAYV 127
Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPE-VLSG 270
             M  VHRD++  NIL+  +   K+ADFGLA  I + +  +  G      + APE  L G
Sbjct: 128 ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEWTARQGAKFPIKWTAPEAALYG 187
Query: 271 NYSEKVDIWS 280
            ++ K D+WS
Sbjct: 188 RFTIKSDVWS 197

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 60/186 (32%), Positives = 90/186 (48%), Gaps = 17/186 (9%)
Query: 106 TKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG 158
           T V+ IG G+FG V    WL + K      A KT+++G   E+    E E+M  LS H  
Sbjct: 30  TFVQEIGSGQFGLVHLGYWLNKDKV-----AIKTIKEGSMSEDDFIEEAEVMMKLS-HPK 83
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           +V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  
Sbjct: 84  LVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEAC 143
Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSE 274
           V+HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S   YS 
Sbjct: 144 VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSS 203
Query: 275 KVDIWS 280
           K D+WS
Sbjct: 204 KSDVWS 209

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG-----VVTLHSV 165
           +G G FG V   + K +G + A K +R        EV  ++ L    G     +V L+  
Sbjct: 66  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 118
Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
             E    ++ MEL  GG L   + ++G   E RA       +  ++Y H   ++H D+K 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178
Query: 226 ENILLTTSG-KIKLADFGLAMRIS----NGQTLSG--LAGSPAYVAPEVLSGNYSE-KVD 277
           +N+LL++ G +  L DFG A+ +         L+G  + G+  ++APEV+ G   + KVD
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238
Query: 278 IWS 280
           IWS
Sbjct: 239 IWS 241

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 55/183 (30%), Positives = 89/183 (48%), Gaps = 20/183 (10%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG-----VVTLHSV 165
           +G G FG V   + K +G + A K +R        EV  ++ L    G     +V L+  
Sbjct: 82  VGRGSFGEVHRMKDKQTGFQCAVKKVR-------LEVFRVEELVACAGLSSPRIVPLYGA 134
Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
             E    ++ MEL  GG L   + ++G   E RA       +  ++Y H   ++H D+K 
Sbjct: 135 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 194
Query: 226 ENILLTTSG-KIKLADFGLAMRIS----NGQTLSG--LAGSPAYVAPEVLSGNYSE-KVD 277
           +N+LL++ G +  L DFG A+ +         L+G  + G+  ++APEV+ G   + KVD
Sbjct: 195 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 254
Query: 278 IWS 280
           IWS
Sbjct: 255 IWS 257

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG--VVTLHSVYEE 168
           +G G FG V     K +G + A K +R     V R  E+M   +G T   +V L+    E
Sbjct: 101 LGRGSFGEVHRMEDKQTGFQCAVKKVRL---EVFRAEELMA-CAGLTSPRIVPLYGAVRE 156
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
               ++ MEL  GG L   + E G   E RA       +  ++Y H   ++H D+K +N+
Sbjct: 157 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 216
Query: 229 LLTTSGK-IKLADFGLAMRIS----NGQTLSG--LAGSPAYVAPEVLSGNYSE-KVDIWS 280
           LL++ G    L DFG A+ +         L+G  + G+  ++APEV+ G   + KVD+WS
Sbjct: 217 LLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 276

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 57/180 (31%), Positives = 88/180 (48%), Gaps = 14/180 (7%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG--VVTLHSVYEE 168
           +G G FG V     K +G + A K +R     V R  E+M   +G T   +V L+    E
Sbjct: 82  LGRGSFGEVHRMEDKQTGFQCAVKKVRL---EVFRAEELMA-CAGLTSPRIVPLYGAVRE 137
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
               ++ MEL  GG L   + E G   E RA       +  ++Y H   ++H D+K +N+
Sbjct: 138 GPWVNIFMELLEGGSLGQLVKEQGCLPEDRALYYLGQALEGLEYLHSRRILHGDVKADNV 197
Query: 229 LLTTSGK-IKLADFGLAMRIS----NGQTLSG--LAGSPAYVAPEVLSGNYSE-KVDIWS 280
           LL++ G    L DFG A+ +         L+G  + G+  ++APEV+ G   + KVD+WS
Sbjct: 198 LLSSDGSHAALCDFGHAVCLQPDGLGKDLLTGDYIPGTETHMAPEVVLGRSCDAKVDVWS 257

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 56/180 (31%), Positives = 91/180 (50%), Gaps = 14/180 (7%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTG--VVTLHSVYEE 168
           +G G FG V   + K +G + A K +R     V R VE +   +G +   +V L+    E
Sbjct: 80  LGRGSFGEVHRMKDKQTGFQCAVKKVRL---EVFR-VEELVACAGLSSPRIVPLYGAVRE 135
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
               ++ MEL  GG L   + ++G   E RA       +  ++Y H   ++H D+K +N+
Sbjct: 136 GPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNV 195
Query: 229 LLTTSG-KIKLADFGLAMRIS----NGQTLSG--LAGSPAYVAPEVLSGNYSE-KVDIWS 280
           LL++ G +  L DFG A+ +         L+G  + G+  ++APEV+ G   + KVDIWS
Sbjct: 196 LLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWS 255

>pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 71/267 (26%), Positives = 114/267 (42%), Gaps = 30/267 (11%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTG---VVTLHS 164
           +G G  G VW  R + +G   A K +R+    EE     +++   L  H     V    +
Sbjct: 33  MGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 165 VYEEADCFHLVMELCS--GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHR 221
                D F + MEL      +L  +M   G   E+    +   ++  + Y  +  GV+HR
Sbjct: 93  FITNTDVF-IAMELMGTCAEKLKKRMQ--GPIPERILGKMTVAIVKALYYLKEKHGVIHR 149
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS------GNYSEK 275
           D+KP NILL   G+IKL DFG++ R+ + +     AG  AY+APE +        +Y  +
Sbjct: 150 DVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIR 209
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNV------KLDFHSGVWETVSKPARDL 329
            D+WS             P+K  + +  F+ +  V       L  H G     S   +  
Sbjct: 210 ADVWSLGISLVELATGQFPYK--NCKTDFEVLTKVLQEEPPLLPGHMG----FSGDFQSF 263
Query: 330 MARMLTRDVSARITADEVLRHPWILFY 356
           +   LT+D   R   +++L H +I  Y
Sbjct: 264 VKDCLTKDHRKRPKYNKLLEHSFIKRY 290

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 80/186 (43%), Gaps = 37/186 (19%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  +    S  + 
Sbjct: 139 EILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 198
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++D I
Sbjct: 199 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 258
Query: 308 K--NVKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
              N++LD                   HS     VS  A D + ++L  D  +R+TA E 
Sbjct: 259 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREA 318
Query: 348 LRHPWI 353
           + HP+ 
Sbjct: 319 MEHPYF 324

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 57/211 (27%), Positives = 90/211 (42%), Gaps = 16/211 (7%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           D + ++  +G G +G V+      +    A K +R   E      T  REV +++ L  H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-H 92
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             ++ L SV       HL+ E      L   M +    S +   +    ++  + +CH  
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAEND-LKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSR 151
Query: 217 GVVHRDIKPENILLTTSGK-----IKLADFGLAMRISNG-QTLSGLAGSPAYVAPEVLSG 270
             +HRD+KP+N+LL+ S       +K+ DFGLA       +  +    +  Y  PE+L G
Sbjct: 152 RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLG 211
Query: 271 --NYSEKVDIWSXXXXXXXXXXXXXPFKGDS 299
             +YS  VDIWS              F GDS
Sbjct: 212 SRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 51/181 (28%), Positives = 91/181 (50%), Gaps = 10/181 (5%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHS 164
           V+ +G G+FG VW+     S  + A KTL+ G  +V     E  +M+ L  H  +V L++
Sbjct: 18  VKRLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYA 75
Query: 165 VYEEADCFHLVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V    +  +++ E  + G L+D +   E G+    +  +    +   + Y      +HRD
Sbjct: 76  VVTREEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 135
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  N+L++ S   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 136 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSDVW 195
Query: 280 S 280
           S
Sbjct: 196 S 196

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 50/181 (27%), Positives = 92/181 (50%), Gaps = 10/181 (5%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTLHS 164
           V+ +G G+FG VW+     S  + A KTL+ G  +V     E  +M+ L  H  +V L++
Sbjct: 17  VKKLGAGQFGEVWMGYYNNS-TKVAVKTLKPGTMSVQAFLEEANLMKTLQ-HDKLVRLYA 74
Query: 165 VYEEADCFHLVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E  + G L+D +   E G+    +  +    +   + Y      +HRD
Sbjct: 75  VVTKEEPIYIITEFMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRD 134
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  N+L++ S   K+ADFGLA  I + +  +  G      + APE ++ G ++ K ++W
Sbjct: 135 LRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGCFTIKSNVW 194
Query: 280 S 280
           S
Sbjct: 195 S 195

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 74/262 (28%), Positives = 114/262 (43%), Gaps = 31/262 (11%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLR--------KGEETVHREVEIMQHLSGHTGVV 160
           E+IG G FG V+  R+   G E A K  R        +  E V +E ++   L  H  ++
Sbjct: 13  EIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNII 69
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD---MG 217
            L  V  +     LVME   GG L ++++   +       N    +   + Y HD   + 
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPL-NRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVP 128
Query: 218 VVHRDIKPENILLT-------TSGKI-KLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           ++HRD+K  NIL+         S KI K+ DFGLA        +S  AG+ A++APEV+ 
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSA-AGAYAWMAPEVIR 187
Query: 270 GN-YSEKVDIWSXXXXXXXXXXXXXPFKG-DSLEAVFD-AIKNVKLDFHSGVWETVSKPA 326
            + +S+  D+WS             PF+G D L   +  A+  + L   S    T  +P 
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALPIPS----TCPEPF 243
Query: 327 RDLMARMLTRDVSARITADEVL 348
             LM      D  +R +   +L
Sbjct: 244 AKLMEDCWNPDPHSRPSFTNIL 265

>pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 67/273 (24%), Positives = 120/273 (43%), Gaps = 19/273 (6%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
           DD   +  +G G +G V   R   SG   A K +R     + ++ +  +++I        
Sbjct: 34  DDLEPIXELGRGAYGVVEKXRHVPSGQIXAVKRIRATVNSQEQKRLLXDLDISXRTVDCP 93
Query: 158 GVVTLH-SVYEEADCFHLVMEL--CSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYC 213
             VT + +++ E D + +  EL   S  +   Q+++ GQ   E     I   ++  +++ 
Sbjct: 94  FTVTFYGALFREGDVW-ICXELXDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 152
Query: 214 HD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           H  + V+HRD+KP N+L+   G++K  DFG++  + +       AG   Y APE ++   
Sbjct: 153 HSKLSVIHRDVKPSNVLINALGQVKXCDFGISGYLVDDVAKDIDAGCKPYXAPERINPEL 212
Query: 272 ----YSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGV-WETVSKPA 326
               YS K DIWS             P+  DS    F  +K V  +    +  +  S   
Sbjct: 213 NQKGYSVKSDIWSLGITXIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKFSAEF 270
Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYTER 359
            D  ++ L ++   R T  E+ +HP+   +  +
Sbjct: 271 VDFTSQCLKKNSKERPTYPELXQHPFFTLHESK 303

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 62/236 (26%), Positives = 109/236 (46%), Gaps = 17/236 (7%)
Query: 86  IGCIDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---E 141
           +G  +++ Q   K ++E  D T    +G G++G V++   K      A KTL++     E
Sbjct: 14  LGTENLYFQSMDKWEMERTDITMKHKLGGGQYGEVYVGVWKKYSLTVAVKTLKEDTMEVE 73
Query: 142 TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAAN 201
              +E  +M+ +  H  +V L  V      F++V E    G L+D + E  +  E+  A 
Sbjct: 74  EFLKEAAVMKEIK-HPNLVQLLGVCTLEPPFYIVTEYMPYGNLLDYLRECNR--EEVTAV 130
Query: 202 IF----KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           +       +   ++Y      +HRD+   N L+  +  +K+ADFGL+ R+  G T +  A
Sbjct: 131 VLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLS-RLMTGDTYTAHA 189
Query: 258 GSP---AYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
           G+     + APE L+ N +S K D+W+              P+ G  L  V+D ++
Sbjct: 190 GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYDLLE 245

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 11/188 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHT 157
           +D    E IG G FG V+  R +A     A K+ R+      +    +E  I++  S H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            +V L  V  +    ++VMEL  GG  +  +  E  +   +    +  D    ++Y    
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPA-YVAPEVLS-GNY 272
             +HRD+   N L+T    +K++DFG++   ++G   +  GL   P  + APE L+ G Y
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXAASGGLRQVPVKWTAPEALNYGRY 292
Query: 273 SEKVDIWS 280
           S + D+WS
Sbjct: 293 SSESDVWS 300

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 53/188 (28%), Positives = 88/188 (46%), Gaps = 11/188 (5%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHT 157
           +D    E IG G FG V+  R +A     A K+ R+      +    +E  I++  S H 
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HP 172
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            +V L  V  +    ++VMEL  GG  +  +  E  +   +    +  D    ++Y    
Sbjct: 173 NIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESK 232
Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPA-YVAPEVLS-GNY 272
             +HRD+   N L+T    +K++DFG++   ++G   +  GL   P  + APE L+ G Y
Sbjct: 233 CCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRY 292
Query: 273 SEKVDIWS 280
           S + D+WS
Sbjct: 293 SSESDVWS 300

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 77
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F++++E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 78  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F++++E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 93/179 (51%), Gaps = 13/179 (7%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW+  +     + A KT++ G  +V     E  +M+ L  H  +V LH+V  
Sbjct: 196 LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT 253
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQ---RAANIFKDVMWVIKYCHDMGVVHRDIK 224
           + +  +++ E  + G L+D  ++  + S+Q   +  +    +   + +      +HRD++
Sbjct: 254 K-EPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 311
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIWS 280
             NIL++ S   K+ADFGLA  I + +  +  G      + APE ++ G+++ K D+WS
Sbjct: 312 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 370

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 73
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F++++E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 74  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 192
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 247

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 49/179 (27%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW+  +     + A KT++ G  +V     E  +M+ L  H  +V LH+V  
Sbjct: 23  LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT 80
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---IKYCHDMGVVHRDIK 224
           + +  +++ E  + G L+D  ++  + S+Q    +      +   + +      +HRD++
Sbjct: 81  K-EPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 138
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIWS 280
             NIL++ S   K+ADFGLA  I + +  +  G      + APE ++ G+++ K D+WS
Sbjct: 139 AANILVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWS 197

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 15  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 73
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 74  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 133
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 134 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 192
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 193 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 247

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 74
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAPAGAKFPIKWTAPESLAYNKFSI 193
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 248

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 107/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F++++E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 61/252 (24%), Positives = 110/252 (43%), Gaps = 13/252 (5%)
Query: 87  GCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETV 143
           G +D      +      D T    +G G++G V+    K      A KTL++     E  
Sbjct: 1   GAMDPSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEF 60
Query: 144 HREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF 203
            +E  +M+ +  H  +V L  V      F+++ E  + G L+D + E  +        ++
Sbjct: 61  LKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLY 119
Query: 204 --KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP- 260
               +   ++Y      +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+  
Sbjct: 120 MATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKF 178
Query: 261 --AYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFH 315
              + APE L+ N +S K D+W+              P+ G  L  V++ + K+ +++  
Sbjct: 179 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERP 238
Query: 316 SGVWETVSKPAR 327
            G  E V +  R
Sbjct: 239 EGCPEKVYELMR 250

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/223 (23%), Positives = 99/223 (44%), Gaps = 41/223 (18%)
Query: 96  GRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVE 148
           G KN  + D++    +IG G +G V+L   K +    A K + +  E       + RE+ 
Sbjct: 18  GIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREIT 77
Query: 149 IMQHLSGHTGVVTLHSVYEEADCF-----HLVMELCSGGRLIDQMVEVGQY-SEQRAANI 202
           I+  L     ++ L+ +    D       ++V+E+      + ++ +   + +E+    I
Sbjct: 78  ILNRLKS-DYIIRLYDLIIPDDLLKFDELYIVLEIADSD--LKKLFKTPIFLTEEHIKTI 134
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN------------- 249
             +++    + H+ G++HRD+KP N LL     +K+ DFGLA  I++             
Sbjct: 135 LYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEEN 194
Query: 250 ----------GQTLSGLAGSPAYVAPE--VLSGNYSEKVDIWS 280
                      + L+    +  Y APE  +L  NY++ +DIWS
Sbjct: 195 EEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWS 237

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 77
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 87  GCIDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ET 142
           G +D  +    K ++E  D T    +G G++G V+    K      A KTL++     E 
Sbjct: 1   GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
             +E  +M+ +  H  +V L  V      F+++ E  + G L+D + E  +        +
Sbjct: 61  FLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLL 119
Query: 203 F--KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
           +    +   ++Y      +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+ 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAK 178
Query: 261 ---AYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDF 314
               + APE L+ N +S K D+W+              P+ G  L  V++ + K+ +++ 
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 315 HSGVWETVSKPAR 327
             G  E V +  R
Sbjct: 239 PEGCPEKVYELMR 251

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 74
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 248

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 16  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 74
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 75  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 134
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 135 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 193
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 194 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 248

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 19  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 77
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 78  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 137
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 138 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 196
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 197 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 251

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 63/253 (24%), Positives = 114/253 (45%), Gaps = 14/253 (5%)
Query: 87  GCIDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ET 142
           G +D  +    K ++E  D T    +G G++G V+    K      A KTL++     E 
Sbjct: 1   GAMDPSSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEE 60
Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
             +E  +M+ +  H  +V L  V      F+++ E  + G L+D + E  +        +
Sbjct: 61  FLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLL 119
Query: 203 F--KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
           +    +   ++Y      +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+ 
Sbjct: 120 YMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAK 178
Query: 261 ---AYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDF 314
               + APE L+ N +S K D+W+              P+ G  L  V++ + K+ +++ 
Sbjct: 179 FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMER 238
Query: 315 HSGVWETVSKPAR 327
             G  E V +  R
Sbjct: 239 PEGCPEKVYELMR 251

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 128/282 (45%), Gaps = 40/282 (14%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +++G+G  G+V + +    G   A K  L    +    E++++     H  V+  +    
Sbjct: 39  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET 97
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYS--------EQRAANIFKDVMWVIKYCHDMGVV 219
                ++ +ELC+    +  +VE    S        E    ++ + +   + + H + ++
Sbjct: 98  TDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 155
Query: 220 HRDIKPENILLTTSG-------------KIKLADFGLAMRISNGQ-----TLSGLAGSPA 261
           HRD+KP+NIL++TS              +I ++DFGL  ++ +GQ      L+  +G+  
Sbjct: 156 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSG 215
Query: 262 YVAPEVLSGN----YSEKVDIWSXX-XXXXXXXXXXXPFKGDSLEAVFDAIKNV-KLDFH 315
           + APE+L  +     +  +DI+S              PF GD      + I+ +  LD  
Sbjct: 216 WRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSRESNIIRGIFSLDEM 274
Query: 316 SGVWE-TVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
             + + ++   A DL+++M+  D   R TA +VLRHP  LF+
Sbjct: 275 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP--LFW 314

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 27  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 85
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 86  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 145
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 146 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 204
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 205 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 259

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 52/197 (26%), Positives = 95/197 (48%), Gaps = 14/197 (7%)
Query: 96  GRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEI 149
           G  +K E + T + +   +G G++G V+    K      A KTL++     E   +E  +
Sbjct: 1   GSLDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAV 60
Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVM 207
           M+ +  H  +V L  V      F++++E  + G L+D + E  +        ++    + 
Sbjct: 61  MKEIK-HPNLVQLLGVCTREPPFYIIIEFMTYGNLLDYLRECNRQEVSAVVLLYMATQIS 119
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVA 264
             ++Y      +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + A
Sbjct: 120 SAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTA 178
Query: 265 PEVLSGN-YSEKVDIWS 280
           PE L+ N +S K D+W+
Sbjct: 179 PESLAYNKFSIKSDVWA 195

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 127/281 (45%), Gaps = 42/281 (14%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +++G+G  G+V + +    G   A K  L    +    E++++     H  V+  +    
Sbjct: 21  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYS--------EQRAANIFKDVMWVIKYCHDMGVV 219
                ++ +ELC+    +  +VE    S        E    ++ + +   + + H + ++
Sbjct: 80  TDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 220 HRDIKPENILLTTSG-------------KIKLADFGLAMRISNGQT-----LSGLAGSPA 261
           HRD+KP+NIL++TS              +I ++DFGL  ++ +GQ+     L+  +G+  
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSG 197
Query: 262 YVAPEVL--SGNYSEK------VDIWSXX-XXXXXXXXXXXPFKGDSLEAVFDAIKNV-K 311
           + APE+L  S N   K      +DI+S              PF GD      + I+ +  
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSRESNIIRGIFS 256
Query: 312 LDFHSGVWE-TVSKPARDLMARMLTRDVSARITADEVLRHP 351
           LD    + + ++   A DL+++M+  D   R TA +VLRHP
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 67/282 (23%), Positives = 128/282 (45%), Gaps = 40/282 (14%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +++G+G  G+V + +    G   A K  L    +    E++++     H  V+  +    
Sbjct: 39  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET 97
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYS--------EQRAANIFKDVMWVIKYCHDMGVV 219
                ++ +ELC+    +  +VE    S        E    ++ + +   + + H + ++
Sbjct: 98  TDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 155
Query: 220 HRDIKPENILLTTSG-------------KIKLADFGLAMRISNGQ-----TLSGLAGSPA 261
           HRD+KP+NIL++TS              +I ++DFGL  ++ +GQ      L+  +G+  
Sbjct: 156 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSG 215
Query: 262 YVAPEVLSGN----YSEKVDIWSXX-XXXXXXXXXXXPFKGDSLEAVFDAIKNV-KLDFH 315
           + APE+L  +     +  +DI+S              PF GD      + I+ +  LD  
Sbjct: 216 WRAPELLEESTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSRESNIIRGIFSLDEM 274
Query: 316 SGVWE-TVSKPARDLMARMLTRDVSARITADEVLRHPWILFY 356
             + + ++   A DL+++M+  D   R TA +VLRHP  LF+
Sbjct: 275 KCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP--LFW 314

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 65.5 bits (158), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 59/235 (25%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 14  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 72
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 73  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 132
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 191
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 192 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 246

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 88/186 (47%), Gaps = 11/186 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G+FG V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 12  DITMKHKLGGGQFGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 70
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTXTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 275 KVDIWS 280
           K D+W+
Sbjct: 190 KSDVWA 195

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 65.1 bits (157), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 68/281 (24%), Positives = 126/281 (44%), Gaps = 42/281 (14%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           +++G+G  G+V + +    G   A K  L    +    E++++     H  V+  +    
Sbjct: 21  KILGYGSSGTV-VFQGSFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSET 79
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYS--------EQRAANIFKDVMWVIKYCHDMGVV 219
                ++ +ELC+    +  +VE    S        E    ++ + +   + + H + ++
Sbjct: 80  TDRFLYIALELCNLN--LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKII 137
Query: 220 HRDIKPENILLTTSG-------------KIKLADFGLAMRISNGQ-----TLSGLAGSPA 261
           HRD+KP+NIL++TS              +I ++DFGL  ++ +GQ      L+  +G+  
Sbjct: 138 HRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSG 197
Query: 262 YVAPEVL--SGNYSEK------VDIWSXX-XXXXXXXXXXXPFKGDSLEAVFDAIKNV-K 311
           + APE+L  S N   K      +DI+S              PF GD      + I+ +  
Sbjct: 198 WRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPF-GDKYSRESNIIRGIFS 256
Query: 312 LDFHSGVWE-TVSKPARDLMARMLTRDVSARITADEVLRHP 351
           LD    + + ++   A DL+++M+  D   R TA +VLRHP
Sbjct: 257 LDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHP 297

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 82
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEETSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 277 DIWS 280
           DIW+
Sbjct: 203 DIWA 206

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 25  DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 82
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 83  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 142
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 143 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 202
Query: 277 DIWS 280
           DIW+
Sbjct: 203 DIWA 206

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 11/186 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 12  DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 70
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 71  QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 130
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 131 IHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTFTAHAGAKFPIKWTAPESLAYNKFSI 189
Query: 275 KVDIWS 280
           K D+W+
Sbjct: 190 KSDVWA 195

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 260 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 318
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 319 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 378
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HR++   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 379 IHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 437
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 438 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 492

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 5   DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 62
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 63  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 122
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 123 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 182
Query: 277 DIWS 280
           DIW+
Sbjct: 183 DIWA 186

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 58/235 (24%), Positives = 106/235 (45%), Gaps = 13/235 (5%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVV 160
           D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V
Sbjct: 221 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLV 279
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF--KDVMWVIKYCHDMGV 218
            L  V      F+++ E  + G L+D + E  +        ++    +   ++Y      
Sbjct: 280 QLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNF 339
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP---AYVAPEVLSGN-YSE 274
           +HR++   N L+  +  +K+ADFGL+ R+  G T +  AG+     + APE L+ N +S 
Sbjct: 340 IHRNLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 398
Query: 275 KVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSKPAR 327
           K D+W+              P+ G  L  V++ + K+ +++   G  E V +  R
Sbjct: 399 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRMERPEGCPEKVYELMR 453

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 9   DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 66
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 67  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 126
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 127 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 186
Query: 277 DIWS 280
           DIW+
Sbjct: 187 DIWA 190

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 16  DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 73
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 74  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 133
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 134 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 193
Query: 277 DIWS 280
           DIW+
Sbjct: 194 DIWA 197

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 94/184 (51%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 67
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-PA-YVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S +    P  +  PEVL    +S K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 277 DIWS 280
           DIW+
Sbjct: 188 DIWA 191

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFAC---KTLRKGEETVHR-----EVEIM 150
           +I+  + K+E VIG G+FG V   R KA G + +C   KTL+ G     R     E  IM
Sbjct: 12  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 71
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMW 208
                H  ++ L  V   +    ++ E    G L D  + +  GQ++  +   + + +  
Sbjct: 72  GQFE-HPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIAS 129
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPA--Y 262
            ++Y  +M  VHRD+   NIL+ ++   K++DFGL+  +    S+    S L G     +
Sbjct: 130 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTETSSLGGKIPIRW 189
Query: 263 VAPEVLSG-NYSEKVDIWS 280
            APE ++   ++   D WS
Sbjct: 190 TAPEAIAFRKFTSASDAWS 208

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score = 64.3 bits (155), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/223 (26%), Positives = 96/223 (43%), Gaps = 45/223 (20%)
Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK-TLRKGEETVH-----REVEIMQHL 153
           +I D +    +IG G +G V     K      A K  LR  E+ +      RE+ I+  L
Sbjct: 50  QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRL 109
Query: 154 SGHTGVVTLHSVY-----EEADCFHLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVM 207
           + H  VV +  +      E+ D  ++V+E+        ++     Y +E     +  +++
Sbjct: 110 N-HDHVVKVLDIVIPKDVEKFDELYVVLEIADSD--FKKLFRTPVYLTELHIKTLLYNLL 166
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI---SNGQT------------ 252
             +KY H  G++HRD+KP N L+     +K+ DFGLA  +    NG +            
Sbjct: 167 VGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMN 226
Query: 253 -------------LSGLAGSPAYVAPE--VLSGNYSEKVDIWS 280
                        L+G   +  Y APE  +L  NY+E +D+WS
Sbjct: 227 LVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWS 269

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 24  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 81
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 280 S 280
           S
Sbjct: 201 S 201

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 26  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 83
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 84  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 142
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 143 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 202
Query: 280 S 280
           S
Sbjct: 203 S 203

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 18  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 75
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 280 S 280
           S
Sbjct: 195 S 195

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 20/199 (10%)
Query: 100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFAC---KTLRKGEETVHR-----EVEIM 150
           +I+  + K+E VIG G+FG V   R KA G + +C   KTL+ G     R     E  IM
Sbjct: 10  EIDVSYVKIEEVIGAGEFGEVCRGRLKAPGKKESCVAIKTLKGGYTERQRREFLSEASIM 69
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMW 208
                H  ++ L  V   +    ++ E    G L D  + +  GQ++  +   + + +  
Sbjct: 70  GQFE-HPNIIRLEGVVTNSMPVMILTEFMENGAL-DSFLRLNDGQFTVIQLVGMLRGIAS 127
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPA--Y 262
            ++Y  +M  VHRD+   NIL+ ++   K++DFGL+  +    S+    S L G     +
Sbjct: 128 GMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPTYTSSLGGKIPIRW 187
Query: 263 VAPEVLSG-NYSEKVDIWS 280
            APE ++   ++   D WS
Sbjct: 188 TAPEAIAFRKFTSASDAWS 206

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 27  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 84
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 85  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 143
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 144 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 203
Query: 280 S 280
           S
Sbjct: 204 S 204

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 20  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 77
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 78  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 136
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 137 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 196
Query: 280 S 280
           S
Sbjct: 197 S 197

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 93/184 (50%), Gaps = 9/184 (4%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
           D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +V
Sbjct: 10  DLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLV 67
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
            L+ V  +     ++ E  + G L++ + E+  ++  Q+   + KDV   ++Y      +
Sbjct: 68  QLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFL 127
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVL-SGNYSEKV 276
           HRD+   N L+   G +K++DFGL+  + + +  S  G      +  PEVL    +S K 
Sbjct: 128 HRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSRGSKFPVRWSPPEVLMYSKFSSKS 187
Query: 277 DIWS 280
           DIW+
Sbjct: 188 DIWA 191

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 19  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 76
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 77  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 135
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 136 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 195
Query: 280 S 280
           S
Sbjct: 196 S 196

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 18  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 75
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 280 S 280
           S
Sbjct: 195 S 195

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 13  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 70
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 71  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 129
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 130 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 189
Query: 280 S 280
           S
Sbjct: 190 S 190

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 24  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 81
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 82  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 140
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 141 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 200
Query: 280 S 280
           S
Sbjct: 201 S 201

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 58/190 (30%), Positives = 86/190 (45%), Gaps = 18/190 (9%)
Query: 107 KVE-VIGHGKFGSVWLCRSKASG---AEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           K+E VIG G+FG V   R K  G      A KTL+ G     R     E  IM     H 
Sbjct: 46  KIERVIGAGEFGEVCSGRLKLPGKRDVAVAIKTLKVGYTEKQRRDFLCEASIMGQFD-HP 104
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHD 215
            VV L  V        +V+E    G L D  +    GQ++  +   + + +   ++Y  D
Sbjct: 105 NVVHLEGVVTRGKPVMIVIEFMENGAL-DAFLRKHDGQFTVIQLVGMLRGIAAGMRYLAD 163
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----QTLSGLAGSPAYVAPEVLSG- 270
           MG VHRD+   NIL+ ++   K++DFGL+  I +      T +G      + APE +   
Sbjct: 164 MGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVYTTTGGKIPVRWTAPEAIQYR 223
Query: 271 NYSEKVDIWS 280
            ++   D+WS
Sbjct: 224 KFTSASDVWS 233

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 28  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 85
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 86  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 144
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 145 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 204
Query: 280 S 280
           S
Sbjct: 205 S 205

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 23  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 80
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 81  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 139
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 140 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 199
Query: 280 S 280
           S
Sbjct: 200 S 200

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 54/190 (28%), Positives = 88/190 (46%), Gaps = 16/190 (8%)
Query: 106 TKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKGEETVHR-----EVEIMQHLSGH 156
           T+ +VIG G+FG V+    K S  +     A KTL+ G     R     E  IM   S H
Sbjct: 47  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHH 106
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD 215
             ++ L  V  +     ++ E    G L   + E  G++S  +   + + +   +KY  +
Sbjct: 107 N-IIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 165
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG----QTLSGLAGSPAYVAPEVLSG- 270
           M  VHRD+   NIL+ ++   K++DFGL+  + +      T SG      + APE +S  
Sbjct: 166 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 225
Query: 271 NYSEKVDIWS 280
            ++   D+WS
Sbjct: 226 KFTSASDVWS 235

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 37/186 (19%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH  G++HRD+KP N+++     K++L D+GLA      Q  +    S  + 
Sbjct: 140 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFK 199
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++  +
Sbjct: 200 GPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYL 259
Query: 308 KNVKLDF----------HS-GVWET---------VSKPARDLMARMLTRDVSARITADEV 347
           K   +D           HS   WE          VS  A DL+ ++L  D   R+TA E 
Sbjct: 260 KKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEA 319
Query: 348 LRHPWI 353
           + HP+ 
Sbjct: 320 MEHPYF 325

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 49/261 (18%)
Query: 131 FACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY---EEADC--FHLVMELCSG--GR 183
           F CK        V RE+ ++ H   H  ++ L  ++   EE      +LV EL      +
Sbjct: 71  FLCKR-------VLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 184 LI-DQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG 242
           +I DQ + +   S Q        ++  +   H+ GVVHRD+ P NILL  +  I + DF 
Sbjct: 123 VIHDQRIVI---SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 243 LAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPFKGDSL 300
           LA   +     +       Y APE++     +++ VD+WS              F+G + 
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 301 ----------------------------EAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
                                       + + +++ NV     + V  T    A DL+A+
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299
Query: 333 MLTRDVSARITADEVLRHPWI 353
           ML  +   RI+ ++ LRHP+ 
Sbjct: 300 MLEFNPQRRISTEQALRHPYF 320

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 77/186 (41%), Gaps = 37/186 (19%)
Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAYV 263
           +++  + YCH  G++HRD+KP N+++     K++L D+GLA      Q  +    S  + 
Sbjct: 145 ELLKALDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQEYNVRVASRYFK 204
Query: 264 APEVLSGN--YSEKVDIWSXXXXXXXXXXXXXPF-----KGDSL---------EAVFDAI 307
            PE+L     Y   +D+WS             PF       D L         E ++  +
Sbjct: 205 GPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGTEELYGYL 264
Query: 308 KNVKLDF----------HS-GVWET---------VSKPARDLMARMLTRDVSARITADEV 347
           K   +D           HS   WE          VS  A DL+ ++L  D   R+TA E 
Sbjct: 265 KKYHIDLDPHFNDILGQHSRKRWENFIHSENRHLVSPEALDLLDKLLRYDHQQRLTAKEA 324
Query: 348 LRHPWI 353
           + HP+ 
Sbjct: 325 MEHPYF 330

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 46/181 (25%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 18  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 75
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 280 S 280
           S
Sbjct: 195 S 195

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score = 63.5 bits (153), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 63/261 (24%), Positives = 105/261 (40%), Gaps = 49/261 (18%)
Query: 131 FACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY---EEADC--FHLVMELCSG--GR 183
           F CK        V RE+ ++ H   H  ++ L  ++   EE      +LV EL      +
Sbjct: 71  FLCKR-------VLREIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQ 122
Query: 184 LI-DQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG 242
           +I DQ + +   S Q        ++  +   H+ GVVHRD+ P NILL  +  I + DF 
Sbjct: 123 VIHDQRIVI---SPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFN 179
Query: 243 LAMRISNGQTLSGLAGSPAYVAPEVLS--GNYSEKVDIWSXXXXXXXXXXXXXPFKGDSL 300
           LA   +     +       Y APE++     +++ VD+WS              F+G + 
Sbjct: 180 LAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTF 239
Query: 301 ----------------------------EAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
                                       + + +++ NV     + V  T    A DL+A+
Sbjct: 240 YNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAK 299
Query: 333 MLTRDVSARITADEVLRHPWI 353
           ML  +   RI+ ++ LRHP+ 
Sbjct: 300 MLEFNPQRRISTEQALRHPYF 320

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/186 (29%), Positives = 85/186 (45%), Gaps = 17/186 (9%)
Query: 110 VIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVVT 161
           VIG G+FG V   R K  G      A KTL+ G     R     E  IM     H  ++ 
Sbjct: 29  VIGAGEFGEVCSGRLKLPGKRELPVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIH 87
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVV 219
           L  V  ++    +V E    G L D  ++   GQ++  +   + + +   +KY  DMG V
Sbjct: 88  LEGVVTKSKPVMIVTEYMENGSL-DTFLKKNDGQFTVIQLVGMLRGISAGMKYLSDMGYV 146
Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYSE 274
           HRD+   NIL+ ++   K++DFGL+  + +      T  G      + APE ++   ++ 
Sbjct: 147 HRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAFRKFTS 206
Query: 275 KVDIWS 280
             D+WS
Sbjct: 207 ASDVWS 212

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 91/177 (51%), Gaps = 19/177 (10%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVYE 167
           +G G+FG VW+  +     + A KT++ G  +V     E  +M+ L  H  +V LH+V  
Sbjct: 190 LGAGQFGEVWMA-TYNKHTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT 247
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQ---RAANIFKDVMWVIKYCHDMGVVHRDIK 224
           + +  +++ E  + G L+D  ++  + S+Q   +  +    +   + +      +HRD++
Sbjct: 248 K-EPIYIITEFMAKGSLLD-FLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLR 305
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS-GNYSEKVDIWS 280
             NIL++ S   K+ADFGLA R+       G      + APE ++ G+++ K D+WS
Sbjct: 306 AANILVSASLVCKIADFGLA-RV-------GAKFPIKWTAPEAINFGSFTIKSDVWS 354

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 38/126 (30%), Positives = 60/126 (47%), Gaps = 17/126 (13%)
Query: 172 FHLVMELCSGGRLIDQMVEVGQYSEQR---AANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
            ++ M+LC    L D M       ++      +IF  +   +++ H  G++HRD+KP NI
Sbjct: 136 LYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNI 195
Query: 229 LLTTSGKIKLADFGLAMRISNGQ-------------TLSGLAGSPAYVAPEVLSG-NYSE 274
             T    +K+ DFGL   +   +             T  G  G+  Y++PE + G NYS 
Sbjct: 196 FFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHXGQVGTKLYMSPEQIHGNNYSH 255
Query: 275 KVDIWS 280
           KVDI+S
Sbjct: 256 KVDIFS 261

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/186 (27%), Positives = 81/186 (43%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 32  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 84
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y  A    +V + C G  L   +     ++  ++  +I +     + Y H   ++HR
Sbjct: 85  FMGYSTAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+    S  YS 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 275 KVDIWS 280
           + D+++
Sbjct: 205 QSDVYA 210

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 91/181 (50%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 14  VERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 71
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HR+
Sbjct: 72  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRN 130
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 131 LRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVW 190
Query: 280 S 280
           S
Sbjct: 191 S 191

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score = 62.0 bits (149), Expect = 7e-10,   Method: Compositional matrix adjust.
 Identities = 51/206 (24%), Positives = 92/206 (44%), Gaps = 37/206 (17%)
Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI-KLADFGLAM 245
            ++E G   E+ A      ++  +KY H   V+HRD+KP N+ + T   + K+ DFGLA 
Sbjct: 110 NVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA- 168
Query: 246 RISN------GQTLSGLAGSPAYVAPEVL--SGNYSEKVDIWSXXXXXXXXXXXXXPFKG 297
           RI +      G    GL  +  Y +P +L    NY++ +D+W+              F G
Sbjct: 169 RIMDPHYSHKGHLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAG 227
Query: 298 ----DSLEAVFDA-------------------IKNVKLDFHSGVWET---VSKPARDLMA 331
               + ++ + ++                   I+N   + H  + +    +S+ A D + 
Sbjct: 228 AHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLE 287
Query: 332 RMLTRDVSARITADEVLRHPWILFYT 357
           ++LT     R+TA+E L HP++  Y+
Sbjct: 288 QILTFSPMDRLTAEEALSHPYMSIYS 313

>pdb|3UYS|A Chain A, Crystal Structure Of Apo Human Ck1d Length = 296

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L    A+G E A K   ++     +H E +I + + G  G+ T+     E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV-IKYCHDMGVVHRDIKPEN 227
            D   +VMEL  G  L D      +    +   +  D M   I+Y H    +HRD+KP+N
Sbjct: 77  GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135
Query: 228 ILLTTSGK---IKLADFGLAMRISNGQT 252
            L+    K   + + DFGLA +  + +T
Sbjct: 136 FLMGLGKKGNLVYIIDFGLAKKYRDART 163

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 217 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 277 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 61.6 bits (148), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 99  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 157
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 158 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 216
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 217 VGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 276
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 277 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328

>pdb|1CKJ|A Chain A, Casein Kinase I Delta Truncation Mutant Containing Residues 1-317 Complex With Bound Tungstate Length = 317

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 45/148 (30%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L    A+G E A K   ++     +H E +I + + G  G+ T+     E
Sbjct: 15  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 74
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV-IKYCHDMGVVHRDIKPEN 227
            D   +VMEL  G  L D      +    +   +  D M   I+Y H    +HRD+KP+N
Sbjct: 75  GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 133
Query: 228 ILLTTSGK---IKLADFGLAMRISNGQT 252
            L+    K   + + DFGLA +  + +T
Sbjct: 134 FLMGLGKKGNLVYIIDFGLAKKYRDART 161

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 54/189 (28%), Positives = 84/189 (44%), Gaps = 19/189 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +VIG G+FG V     K  G      A KTL+ G     R     E  IM     H  V+
Sbjct: 39  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVI 97
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    ++ E    G L D  +    GQ++  +   + + +   +KY  DM  
Sbjct: 98  HLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 156
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPA--YVAPEVLSG-N 271
           VHRD+   NIL+ ++   K++DFGL+  +    S+    S L G     + APE +    
Sbjct: 157 VHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 216
Query: 272 YSEKVDIWS 280
           ++   D+WS
Sbjct: 217 FTSASDVWS 225

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 75/331 (22%), Positives = 126/331 (38%), Gaps = 54/331 (16%)
Query: 72  SSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTK------------------VEVIGH 113
           SS LVP G G+K           M   +   DD  K                  ++ IG 
Sbjct: 7   SSGLVPRGSGMKETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGS 66
Query: 114 GKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYE 167
           G    V+   ++     +A K +   E      ++   E+  +  L  H+  +     YE
Sbjct: 67  GGSSKVFQVLNEKKQI-YAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYE 125
Query: 168 EADCF-HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE 226
             D + ++VME C    L   + +          + +K+++  +   H  G+VH D+KP 
Sbjct: 126 ITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPA 184
Query: 227 NILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSGNYSEK-------- 275
           N L+   G +KL DFG+A ++    T        G+  Y+ PE +    S +        
Sbjct: 185 NFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSK 243
Query: 276 ----VDIWSXXXXXXXXXXXXXPFKG-----DSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
                D+WS             PF+        L A+ D   N +++F     +   K  
Sbjct: 244 ISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDP--NHEIEFP----DIPEKDL 297
Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYT 357
           +D++   L RD   RI+  E+L HP++   T
Sbjct: 298 QDVLKCCLKRDPKQRISIPELLAHPYVQIQT 328

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 52  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 110
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 111 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 169
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 170 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 229
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 230 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 281

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           ++ IG G+FG V L   + +     C       +    E  +M  L     V  L  + E
Sbjct: 17  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 76
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---DVMWVIKYCHDMGVVHRDIK 224
           E    ++V E  + G L+D +   G+ S      + K   DV   ++Y      VHRD+ 
Sbjct: 77  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 135
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
             N+L++     K++DFGL    S+ Q    L     + APE L    +S K D+WS
Sbjct: 136 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREAAFSTKSDVWS 190

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 101 IEDDHTK-VEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG----EETVHREVEIMQ 151
            E+ H K +  +G G FGSV LCR       +GA  A K L+      +    RE++I++
Sbjct: 7   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 66
Query: 152 HLSGHTGVVTLH---SVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVM 207
            L  H+  +  +   S         LVME    G L D +     +    R       + 
Sbjct: 67  AL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 124
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQTLSGLAGSPAY-V 263
             ++Y      VHRD+   NIL+ +   +K+ADFGLA  +    +   +     SP +  
Sbjct: 125 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 184
Query: 264 APEVLSGN-YSEKVDIWS 280
           APE LS N +S + D+WS
Sbjct: 185 APESLSDNIFSRQSDVWS 202

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 101 IEDDHTK-VEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG----EETVHREVEIMQ 151
            E+ H K +  +G G FGSV LCR       +GA  A K L+      +    RE++I++
Sbjct: 8   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 67
Query: 152 HLSGHTGVVTLH---SVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVM 207
            L  H+  +  +   S         LVME    G L D +     +    R       + 
Sbjct: 68  AL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 125
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQTLSGLAGSPAY-V 263
             ++Y      VHRD+   NIL+ +   +K+ADFGLA  +    +   +     SP +  
Sbjct: 126 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 185
Query: 264 APEVLSGN-YSEKVDIWS 280
           APE LS N +S + D+WS
Sbjct: 186 APESLSDNIFSRQSDVWS 203

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/181 (24%), Positives = 90/181 (49%), Gaps = 11/181 (6%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHS 164
           VE +G G+ G VW+        + A K+L++G    +    E  +M+ L  H  +V L++
Sbjct: 18  VERLGAGQAGEVWMGYYNGH-TKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYA 75
Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +   +HRD
Sbjct: 76  VVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRD 134
Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLS-GNYSEKVDIW 279
           ++  NIL++ +   K+ADFGLA  I + +  +  G      + APE ++ G ++ K D+W
Sbjct: 135 LRAANILVSDTLSCKIADFGLARLIEDAEXTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 280 S 280
           S
Sbjct: 195 S 195

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           ++ IG G+FG V L   + +     C       +    E  +M  L     V  L  + E
Sbjct: 198 LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---DVMWVIKYCHDMGVVHRDIK 224
           E    ++V E  + G L+D +   G+ S      + K   DV   ++Y      VHRD+ 
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 316
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
             N+L++     K++DFGL    S+ Q    L     + APE L    +S K D+WS
Sbjct: 317 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPVK--WTAPEALREKKFSTKSDVWS 371

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 55  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 113
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 114 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 172
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 173 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 232
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 233 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 284

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 101 IEDDHTK-VEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG----EETVHREVEIMQ 151
            E+ H K +  +G G FGSV LCR       +GA  A K L+      +    RE++I++
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79
Query: 152 HLSGHTGVVTLH---SVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVM 207
            L  H+  +  +   S         LVME    G L D +     +    R       + 
Sbjct: 80  AL--HSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 137
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQTLSGLAGSPAY-V 263
             ++Y      VHRD+   NIL+ +   +K+ADFGLA  +    +   +     SP +  
Sbjct: 138 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWY 197
Query: 264 APEVLSGN-YSEKVDIWS 280
           APE LS N +S + D+WS
Sbjct: 198 APESLSDNIFSRQSDVWS 215

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           ++ IG G+FG V L   + +     C       +    E  +M  L     V  L  + E
Sbjct: 26  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 85
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---DVMWVIKYCHDMGVVHRDIK 224
           E    ++V E  + G L+D +   G+ S      + K   DV   ++Y      VHRD+ 
Sbjct: 86  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 144
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
             N+L++     K++DFGL    S+ Q    L     + APE L    +S K D+WS
Sbjct: 145 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWS 199

>pdb|4HNI|A Chain A, Crystal Structure Of Ck1e In Complex With Pf4800567 Length = 296

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 44/148 (29%), Positives = 70/148 (47%), Gaps = 7/148 (4%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L  + ASG E A K   ++     +H E +  + + G  G+ ++     E
Sbjct: 17  IGSGSFGDIYLGANIASGEEVAIKLECVKTKHPQLHIESKFYKMMQGGVGIPSIKWCGAE 76
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV-IKYCHDMGVVHRDIKPEN 227
            D   +VMEL  G  L D      +    +   +  D M   I+Y H    +HRD+KP+N
Sbjct: 77  GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135
Query: 228 ILLTTSGK---IKLADFGLAMRISNGQT 252
            L+    K   + + DFGLA +  + +T
Sbjct: 136 FLMGLGKKGNLVYIIDFGLAKKYRDART 163

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 19/184 (10%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTLHS 164
           IG G FG+V+  + K  G + A K L+  + T         EV +++  + H  ++ L  
Sbjct: 44  IGSGSFGTVY--KGKWHG-DVAVKILKVVDPTPEQFQAFRNEVAVLRK-TRHVNIL-LFM 98
Query: 165 VYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDI 223
            Y   D   +V + C G  L   + V+  ++   +  +I +     + Y H   ++HRD+
Sbjct: 99  GYMTKDNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDM 158
Query: 224 KPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSEKV 276
           K  NI L     +K+ DFGLA    R S  Q +    GS  ++APEV+    +  +S + 
Sbjct: 159 KSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQS 218
Query: 277 DIWS 280
           D++S
Sbjct: 219 DVYS 222

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 32  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 84
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   +     ++  ++  +I +     + Y H   ++HR
Sbjct: 85  FMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+    S  YS 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204
Query: 275 KVDIWS 280
           + D+++
Sbjct: 205 QSDVYA 210

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 20  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 72
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   +     ++  ++  +I +     + Y H   ++HR
Sbjct: 73  FMGYSTKPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 132
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+    S  YS 
Sbjct: 133 DLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 192
Query: 275 KVDIWS 280
           + D+++
Sbjct: 193 QSDVYA 198

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 57/185 (30%), Positives = 88/185 (47%), Gaps = 19/185 (10%)
Query: 111 IGHGKFGSV--WLCRSKASGAEFACKTLRKGEET-----VHREVEIMQHLSGHTGVVTLH 163
           +G G FGSV   + R +    + A K L++G E      + RE +IM  L  +  +V L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLI 76
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI---FKDVMWVIKYCHDMGVVH 220
            V + A+   LVME+  GG L      VG+  E   +N+      V   +KY  +   VH
Sbjct: 77  GVCQ-AEALMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 133
Query: 221 RDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEK 275
           RD+   N+LL      K++DFGL  A+   +    +  AG     + APE ++   +S +
Sbjct: 134 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 193
Query: 276 VDIWS 280
            D+WS
Sbjct: 194 SDVWS 198

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 119
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 180 PIFWYAPESLTESKFSVASDVWS 202

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 49/177 (27%), Positives = 76/177 (42%), Gaps = 7/177 (3%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYE 167
           ++ IG G+FG V L   + +     C       +    E  +M  L     V  L  + E
Sbjct: 11  LQTIGKGEFGDVMLGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK---DVMWVIKYCHDMGVVHRDIK 224
           E    ++V E  + G L+D +   G+ S      + K   DV   ++Y      VHRD+ 
Sbjct: 71  EKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLA 129
Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL-SGNYSEKVDIWS 280
             N+L++     K++DFGL    S+ Q    L     + APE L    +S K D+WS
Sbjct: 130 ARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTAPEALREKKFSTKSDVWS 184

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 51  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 109
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 110 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 168
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 169 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 228
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 229 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 280

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 10  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 69
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 70  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 123
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 124 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 183
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 184 PIFWYAPESLTESKFSVASDVWS 206

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 59/208 (28%), Positives = 92/208 (44%), Gaps = 28/208 (13%)
Query: 95  MGRKNKIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHR 145
           M    + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       R
Sbjct: 1   MRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFER 60
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF 203
           E+EI++ L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I 
Sbjct: 61  EIEILKSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI- 114
Query: 204 KDVMWVIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL- 256
           K + +  + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    + 
Sbjct: 115 KLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVK 174
Query: 257 --AGSPAY-VAPEVLS-GNYSEKVDIWS 280
               SP +  APE L+   +S   D+WS
Sbjct: 175 EPGESPIFWYAPESLTESKFSVASDVWS 202

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 11  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 70
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 71  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 124
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 125 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 184
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 185 PIFWYAPESLTESKFSVASDVWS 207

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 13  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 72
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 73  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 126
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 127 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 186
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 187 PIFWYAPESLTESKFSVASDVWS 209

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 122
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 183 PIFWYAPESLTESKFSVASDVWS 205

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 51/184 (27%), Positives = 82/184 (44%), Gaps = 17/184 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL--------RKGEETVHREVEIMQHLSGHTGVVTL 162
           +G G FG V+  +   +    A K L         + ++   +E+++M     H  +V L
Sbjct: 39  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVEL 95
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVV 219
                + D   LV      G L+D++  +      S      I +     I + H+   +
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 220 HRDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVLSGNYSEKV 276
           HRDIK  NILL  +   K++DFGLA    + +     S + G+ AY+APE L G  + K 
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXSRIVGTTAYMAPEALRGEITPKS 215
Query: 277 DIWS 280
           DI+S
Sbjct: 216 DIYS 219

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 6   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 65
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 66  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 119
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 179
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 180 PIFWYAPESLTESKFSVASDVWS 202

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 5   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 64
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 65  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 118
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 119 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 178
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 179 PIFWYAPESLTESKFSVASDVWS 201

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 56/238 (23%), Positives = 98/238 (41%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++    T       
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQ 188
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 249 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 88/198 (44%), Gaps = 20/198 (10%)
Query: 101 IEDDHTK-VEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKG----EETVHREVEIMQ 151
            E+ H K +  +G G FGSV LCR       +GA  A K L+      +    RE++I++
Sbjct: 4   FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 63
Query: 152 HLSGHTGVVTLH---SVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVM 207
            L  H+  +  +   S         LVME    G L D +     +    R       + 
Sbjct: 64  AL--HSDFIVKYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQIC 121
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS---NGQTLSGLAGSPAY-V 263
             ++Y      VHRD+   NIL+ +   +K+ADFGLA  +    +   +     SP +  
Sbjct: 122 KGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVVREPGQSPIFWY 181
Query: 264 APEVLSGN-YSEKVDIWS 280
           APE LS N +S + D+WS
Sbjct: 182 APESLSDNIFSRQSDVWS 199

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 78  AGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASG---AEFACK 134
           AGR   R+I    +H +              ++IG G  G V   R +  G      A K
Sbjct: 38  AGRSFTREIEASRIHIE--------------KIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 135 TLRKGEETVHR-----EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV 189
            L+ G     R     E  IM     H  ++ L  V        +V E    G L D  +
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL 141
Query: 190 EV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI 247
               GQ++  +   + + V   ++Y  D+G VHRD+   N+L+ ++   K++DFGL+  +
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 248 SN----GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
            +      T +G      + APE ++   +S   D+WS
Sbjct: 202 EDDPDAAXTTTGGKIPIRWTAPEAIAFRTFSSASDVWS 239

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 37  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 96
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 97  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 150
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 210
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 211 PIFWYAPESLTESKFSVASDVWS 233

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 59.7 bits (143), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 12  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 71
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 72  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 125
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 126 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 185
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 186 PIFWYAPESLTESKFSVASDVWS 208

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 55/218 (25%), Positives = 90/218 (41%), Gaps = 31/218 (14%)
Query: 78  AGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASG---AEFACK 134
           AGR   R+I    +H +              ++IG G  G V   R +  G      A K
Sbjct: 38  AGRSFTREIEASRIHIE--------------KIIGSGDSGEVCYGRLRVPGQRDVPVAIK 83
Query: 135 TLRKGEETVHR-----EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV 189
            L+ G     R     E  IM     H  ++ L  V        +V E    G L D  +
Sbjct: 84  ALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSL-DTFL 141
Query: 190 EV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI 247
               GQ++  +   + + V   ++Y  D+G VHRD+   N+L+ ++   K++DFGL+  +
Sbjct: 142 RTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVL 201
Query: 248 SN----GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWS 280
            +      T +G      + APE ++   +S   D+WS
Sbjct: 202 EDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWS 239

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 4   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 63
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 64  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 117
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 118 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 177
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 178 PIFWYAPESLTESKFSVASDVWS 200

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 107 KVEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKGEETVH-----REVEIMQHLSGHT 157
           ++  +G G FG V LCR       +G + A K+L+      H     +E+EI+++L  H 
Sbjct: 25  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HE 83
Query: 158 GVVTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V    +  E   +   L+ME    G L + + +      +   N+ + + + ++ C  
Sbjct: 84  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-----NKNKINLKQQLKYAVQICKG 138
Query: 216 MGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAY-VAP 265
           M        VHRD+   N+L+ +  ++K+ DFGL   I   +   T+     SP +  AP
Sbjct: 139 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 198
Query: 266 EVL-SGNYSEKVDIWS 280
           E L    +    D+WS
Sbjct: 199 ECLMQSKFYIASDVWS 214

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 84  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 137
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 198 PIFWYAPESLTESKFSVASDVWS 220

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/185 (30%), Positives = 88/185 (47%), Gaps = 19/185 (10%)
Query: 111 IGHGKFGSV--WLCRSKASGAEFACKTLRKGEET-----VHREVEIMQHLSGHTGVVTLH 163
           +G G FGSV   + R +    + A K L++G E      + RE +IM  L  +  +V L 
Sbjct: 344 LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLI 402
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI---FKDVMWVIKYCHDMGVVH 220
            V + A+   LVME+  GG L      VG+  E   +N+      V   +KY  +   VH
Sbjct: 403 GVCQ-AEALMLVMEMAGGGPL--HKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 459
Query: 221 RDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEK 275
           R++   N+LL      K++DFGL  A+   +    +  AG     + APE ++   +S +
Sbjct: 460 RNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 519
Query: 276 VDIWS 280
            D+WS
Sbjct: 520 SDVWS 524

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 24  QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 83
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 84  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 137
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 138 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 197
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 198 PIFWYAPESLTESKFSVASDVWS 220

>pdb|2PZI|A Chain A, Crystal Structure Of Protein Kinase Pkng From Mycobacterium Tuberculosis In Complex With Tetrahydrobenzothiophene Ax20017 Length = 681

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 56/242 (23%), Positives = 98/242 (40%), Gaps = 34/242 (14%)
Query: 51  QPIGSFKSRLAGIATA--PPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKV 108
           +P+G   S   G +    P CG+  S +P                Q+   + +   +   
Sbjct: 42  RPVGRSDSETKGASEGWCPYCGSPYSFLP----------------QLNPGDIVAGQYEVK 85
Query: 109 EVIGHGKFGSVWLCRSK-ASGAEFACKTL-RKGEETVHREVEIMQHLSG---HTGVVTLH 163
             I HG  G ++L   +  +G     K L   G+          +       H  +V + 
Sbjct: 86  GCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIF 145
Query: 164 SVYEEAD-----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +  E  D       ++VME   G  L     +    +E  A     +++  + Y H +G+
Sbjct: 146 NFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQKLPVAE--AIAYLLEILPALSYLHSIGL 203
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDI 278
           V+ D+KPENI+LT   ++KL D G   RI+   +   L G+P + APE++    +   DI
Sbjct: 204 VYNDLKPENIMLTEE-QLKLIDLGAVSRIN---SFGYLYGTPGFQAPEIVRTGPTVATDI 259
Query: 279 WS 280
           ++
Sbjct: 260 YT 261

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 64/250 (25%), Positives = 96/250 (38%), Gaps = 50/250 (20%)
Query: 94  QMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKAS-GAE--FACKTLRKGEETVH--REVE 148
           Q+    KIED       IG G F SV+L  ++   G E   A K L      +    E++
Sbjct: 18  QLSNVFKIEDK------IGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQ 71
Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVM 207
            +    G   V+ +   + + D   + M        +D +  +  Q   +   N+FK   
Sbjct: 72  CLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILNSLSFQEVREYMLNLFK--- 128
Query: 208 WVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLA---------------------- 244
             +K  H  G+VHRD+KP N L      K  L DFGLA                      
Sbjct: 129 -ALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQER 187
Query: 245 -------MRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSXXXXXXXXXXXXXPF 295
                  + +S  Q ++  AG+P + APEVL+   N +  +D+WS             PF
Sbjct: 188 CSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPF 247
Query: 296 --KGDSLEAV 303
               D L A+
Sbjct: 248 YKASDDLTAL 257

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGLA  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 50/196 (25%), Positives = 88/196 (44%), Gaps = 28/196 (14%)
Query: 107 KVEVIGHGKFGSVWLCRSKA----SGAEFACKTLRKGEETVH-----REVEIMQHLSGHT 157
           ++  +G G FG V LCR       +G + A K+L+      H     +E+EI+++L  H 
Sbjct: 13  RIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HE 71
Query: 158 GVVTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V    +  E   +   L+ME    G L + + +      +   N+ + + + ++ C  
Sbjct: 72  NIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPK-----NKNKINLKQQLKYAVQICKG 126
Query: 216 MGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAY-VAP 265
           M        VHRD+   N+L+ +  ++K+ DFGL   I   +   T+     SP +  AP
Sbjct: 127 MDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTVKDDRDSPVFWYAP 186
Query: 266 EVL-SGNYSEKVDIWS 280
           E L    +    D+WS
Sbjct: 187 ECLMQSKFYIASDVWS 202

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 58/203 (28%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 9   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q   +R  +I K + +
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QAHAERIDHI-KLLQY 122
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 183 PIFWYAPESLTESKFSVASDVWS 205

>pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 65/244 (26%), Positives = 107/244 (43%), Gaps = 39/244 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------ETVHREVEIMQHLSGHTGV 159
           IG G FG V   R     +  A K+L  G+           +   REV IM +L+ H  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNI 85
Query: 160 VTLHSVYEEADCFHLVMELCSGG----RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           V L+ +        +VME    G    RL+D+   +    + R   +  D+   I+Y  +
Sbjct: 86  VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR---LMLDIALGIEYMQN 140
Query: 216 MG--VVHRDIKPENILLTTSGK-----IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
               +VHRD++  NI L +  +      K+ADFGL+ +  +  ++SGL G+  ++APE +
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQ--SVHSVSGLLGNFQWMAPETI 198
Query: 269 SG---NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK- 324
                +Y+EK D +S             PF     E  +  IK + +    G+  T+ + 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINMIREEGLRPTIPED 254
Query: 325 -PAR 327
            P R
Sbjct: 255 CPPR 258

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 55/238 (23%), Positives = 97/238 (40%), Gaps = 29/238 (12%)
Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HLVMELCSGGRLIDQMVEVGQYSEQRA 199
           ++   E+  +  L  H+  +     YE  D + ++VME C    L   + +         
Sbjct: 71  DSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWER 129
Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGL 256
            + +K+++  +   H  G+VH D+KP N L+   G +KL DFG+A ++            
Sbjct: 130 KSYWKNMLEAVHTIHQHGIVHSDLKPANFLI-VDGMLKLIDFGIANQMQPDXXXVVKDSQ 188
Query: 257 AGSPAYVAPEVLSGNYSEK------------VDIWSXXXXXXXXXXXXXPFKG-----DS 299
            G+  Y+ PE +    S +             D+WS             PF+        
Sbjct: 189 VGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISK 248
Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
           L A+ D   N +++F     +   K  +D++   L RD   RI+  E+L HP++   T
Sbjct: 249 LHAIIDP--NHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQT 300

>pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/183 (25%), Positives = 82/183 (44%), Gaps = 15/183 (8%)
Query: 111 IGHGKFGSVWLCRSKASGAEFA-C----KTLRKGE-ETVHREVEIMQHLSGHTGVVTLHS 164
           IG G F +V+      +  E A C    + L K E +    E E ++ L  H  +V  + 
Sbjct: 34  IGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEXLKGLQ-HPNIVRFYD 92
Query: 165 VYEEA----DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--V 218
            +E       C  LV EL + G L   +        +   +  + ++  +++ H     +
Sbjct: 93  SWESTVKGKKCIVLVTELXTSGTLKTYLKRFKVXKIKVLRSWCRQILKGLQFLHTRTPPI 152
Query: 219 VHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVD 277
           +HRD+K +NI +T  +G +K+ D GLA  +        + G+P + APE     Y E VD
Sbjct: 153 IHRDLKCDNIFITGPTGSVKIGDLGLAT-LKRASFAKAVIGTPEFXAPEXYEEKYDESVD 211
Query: 278 IWS 280
           +++
Sbjct: 212 VYA 214

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGF 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL--------RKGEETVHREVEIMQHLSGHTGVVTL 162
           +G G FG V+  +   +    A K L         + ++   +E+++M     H  +V L
Sbjct: 33  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVEL 89
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVV 219
                + D   LV      G L+D++  +      S      I +     I + H+   +
Sbjct: 90  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 149
Query: 220 HRDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVLSGNYSEKV 276
           HRDIK  NILL  +   K++DFGLA    + +       + G+ AY+APE L G  + K 
Sbjct: 150 HRDIKSANILLDEAFTAKISDFGLARASEKFAQXVMXXRIVGTTAYMAPEALRGEITPKS 209
Query: 277 DIWS 280
           DI+S
Sbjct: 210 DIYS 213

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFAC---KTLRKGEETVHR-----EVEIM 150
           +I+    K+E VIG G+FG V   R K  G    C   KTL+ G     R     E  IM
Sbjct: 25  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 84
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMW 208
                H  ++ L  V  +     ++ E    G L D  +    G+++  +   + + +  
Sbjct: 85  GQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGS 142
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVA 264
            +KY  DM  VHRD+   NIL+ ++   K++DFG++  + +      T  G      + A
Sbjct: 143 GMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 202
Query: 265 PEVLSG-NYSEKVDIWS 280
           PE ++   ++   D+WS
Sbjct: 203 PEAIAYRKFTSASDVWS 219

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGA 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/184 (27%), Positives = 81/184 (44%), Gaps = 17/184 (9%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTL--------RKGEETVHREVEIMQHLSGHTGVVTL 162
           +G G FG V+  +   +    A K L         + ++   +E+++M     H  +V L
Sbjct: 39  MGEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVEL 95
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVV 219
                + D   LV      G L+D++  +      S      I +     I + H+   +
Sbjct: 96  LGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHI 155
Query: 220 HRDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVLSGNYSEKV 276
           HRDIK  NILL  +   K++DFGLA    + +       + G+ AY+APE L G  + K 
Sbjct: 156 HRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMXXRIVGTTAYMAPEALRGEITPKS 215
Query: 277 DIWS 280
           DI+S
Sbjct: 216 DIYS 219

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 91/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K ++ +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 7   QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 66
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L D +    Q  ++R  +I K + +
Sbjct: 67  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHI-KLLQY 120
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HR++   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 121 TSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 180
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 181 PIFWYAPESLTESKFSVASDVWS 203

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/186 (26%), Positives = 80/186 (43%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 16  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 68
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y  A    +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 69  FMGYSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 275 KVDIWS 280
           + D+++
Sbjct: 189 QSDVYA 194

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 47/216 (21%), Positives = 87/216 (40%), Gaps = 45/216 (20%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY-- 166
           + +G G FG V       SG  FA K + +     +RE++IM+ L  H  ++ L   +  
Sbjct: 13  KTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLD-HVNIIKLVDYFYT 71
Query: 167 ------------------------------------EEADCFHLVMELCSGG--RLIDQM 188
                                                +    +++ME       +++   
Sbjct: 72  TGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLHKVLKSF 131
Query: 189 VEVGQYSEQRAANIF-KDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMR 246
           +  G+       +I+   +   + + H +G+ HRDIKP+N+L+ +    +KL DFG A +
Sbjct: 132 IRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKK 191
Query: 247 ISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWS 280
           +   +       S  Y APE++ G   Y+  +D+WS
Sbjct: 192 LIPSEPSVAXICSRFYRAPELMLGATEYTPSIDLWS 227

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/189 (28%), Positives = 83/189 (43%), Gaps = 19/189 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +VIG G+FG V     K  G      A KTL+ G     R     E  IM     H  V+
Sbjct: 13  QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVI 71
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    ++ E    G L D  +    GQ++  +   + + +   +KY  DM  
Sbjct: 72  HLEGVVTKSTPVMIITEFMENGSL-DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNY 130
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRI----SNGQTLSGLAGSPA--YVAPEVLSG-N 271
           VHR +   NIL+ ++   K++DFGL+  +    S+    S L G     + APE +    
Sbjct: 131 VHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK 190
Query: 272 YSEKVDIWS 280
           ++   D+WS
Sbjct: 191 FTSASDVWS 199

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/203 (28%), Positives = 90/203 (44%), Gaps = 28/203 (13%)
Query: 100 KIEDDHTK-VEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEET----VHREVEIM 150
           + E+ H K +  +G G FGSV +CR       +G   A K L+   E       RE+EI+
Sbjct: 9   QFEERHLKFLRQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEIL 68
Query: 151 QHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
           + L  H  +V    V   A      L+ME    G L + +    Q  ++R  +I K + +
Sbjct: 69  KSLQ-HDNIVKYKGVCYSAGRRNLKLIMEFLPYGSLREYL----QKHKERIDHI-KLLQY 122
Query: 209 VIKYCHDMGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGS 259
             + C  M        +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 123 TSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKVKEPGES 182
Query: 260 PAY-VAPEVLS-GNYSEKVDIWS 280
           P +  APE L+   +S   D+WS
Sbjct: 183 PIFWYAPESLTESKFSVASDVWS 205

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 80
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 81  RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 200 SASDVWS 206

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 49  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 107
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 108 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 166
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 167 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 226
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 227 SASDVWS 233

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFAC---KTLRKGEETVHR-----EVEIM 150
           +I+    K+E VIG G+FG V   R K  G    C   KTL+ G     R     E  IM
Sbjct: 10  EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 69
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMW 208
                H  ++ L  V  +     ++ E    G L D  +    G+++  +   + + +  
Sbjct: 70  GQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGS 127
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVA 264
            +KY  DM  VHRD+   NIL+ ++   K++DFG++  + +      T  G      + A
Sbjct: 128 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 187
Query: 265 PEVLSG-NYSEKVDIWS 280
           PE ++   ++   D+WS
Sbjct: 188 PEAIAYRKFTSASDVWS 204

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 39  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 97
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 98  RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 156
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 157 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 216
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 217 SASDVWS 223

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 22  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 80
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 81  RLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 139
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 140 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 199
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 200 SASDVWS 206

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 84/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEXMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL+  + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 53/197 (26%), Positives = 88/197 (44%), Gaps = 18/197 (9%)
Query: 100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFAC---KTLRKGEETVHR-----EVEIM 150
           +I+    K+E VIG G+FG V   R K  G    C   KTL+ G     R     E  IM
Sbjct: 4   EIDASCIKIEKVIGVGEFGEVCSGRLKVPGKREICVAIKTLKAGYTDKQRRDFLSEASIM 63
Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMW 208
                H  ++ L  V  +     ++ E    G L D  +    G+++  +   + + +  
Sbjct: 64  GQFD-HPNIIHLEGVVTKCKPVMIITEYMENGSL-DAFLRKNDGRFTVIQLVGMLRGIGS 121
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVA 264
            +KY  DM  VHRD+   NIL+ ++   K++DFG++  + +      T  G      + A
Sbjct: 122 GMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAYTTRGGKIPIRWTA 181
Query: 265 PEVLSG-NYSEKVDIWS 280
           PE ++   ++   D+WS
Sbjct: 182 PEAIAYRKFTSASDVWS 198

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 50/187 (26%), Positives = 83/187 (44%), Gaps = 17/187 (9%)
Query: 109 EVIGHGKFGSVWLCRSKASGAE---FACKTLRKGEETVHR-----EVEIMQHLSGHTGVV 160
           +V+G G+FG V   R K    +    A KTL+ G     R     E  IM     H  ++
Sbjct: 51  KVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNII 109
Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGV 218
            L  V  ++    +V E    G L D  +     Q++  +   + + +   +KY  DMG 
Sbjct: 110 RLEGVVTKSKPVMIVTEYMENGSL-DSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGY 168
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAGSPAYVAPEVLSG-NYS 273
           VHRD+   NIL+ ++   K++DFGL   + +      T  G      + +PE ++   ++
Sbjct: 169 VHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFT 228
Query: 274 EKVDIWS 280
              D+WS
Sbjct: 229 SASDVWS 235

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++TL     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 36  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 88
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 89  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 148
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 149 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 208
Query: 275 KVDIWS 280
           + D+++
Sbjct: 209 QSDVYA 214

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 44/182 (24%), Positives = 73/182 (40%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 159 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 218
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L A  +  + 
Sbjct: 219 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNAYLNKYR- 277
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 278 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 337
Query: 352 WI 353
           + 
Sbjct: 338 YF 339

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 43  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 95
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 96  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 155
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 156 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 215
Query: 275 KVDIWS 280
           + D+++
Sbjct: 216 QSDVYA 221

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 44  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 96
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 97  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 275 KVDIWS 280
           + D+++
Sbjct: 217 QSDVYA 222

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 50/183 (27%), Positives = 79/183 (43%), Gaps = 17/183 (9%)
Query: 112 GHGKFGSVWLCRSKASGAEFACK--------TLRKGEETVHREVEIMQHLSGHTGVVTLH 163
           G G FG V+  +   +    A K        T  + ++   +E+++      H  +V L 
Sbjct: 31  GEGGFGVVY--KGYVNNTTVAVKKLAAMVDITTEELKQQFDQEIKVXAKCQ-HENLVELL 87
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVH 220
               + D   LV      G L+D++  +      S      I +     I + H+   +H
Sbjct: 88  GFSSDGDDLCLVYVYXPNGSLLDRLSCLDGTPPLSWHXRCKIAQGAANGINFLHENHHIH 147
Query: 221 RDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVLSGNYSEKVD 277
           RDIK  NILL  +   K++DFGLA    + +     S + G+ AY APE L G  + K D
Sbjct: 148 RDIKSANILLDEAFTAKISDFGLARASEKFAQXVXXSRIVGTTAYXAPEALRGEITPKSD 207
Query: 278 IWS 280
           I+S
Sbjct: 208 IYS 210

>pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------ETVHREVEIMQHLSGHTGV 159
           IG G FG V   R     +  A K+L  G+           +   REV IM +L+ H  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNI 85
Query: 160 VTLHSVYEEADCFHLVMELCSGG----RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           V L+ +        +VME    G    RL+D+   +    + R   +  D+   I+Y  +
Sbjct: 86  VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR---LMLDIALGIEYMQN 140
Query: 216 MG--VVHRDIKPENILLTTSGK-----IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
               +VHRD++  NI L +  +      K+ADFG + +  +  ++SGL G+  ++APE +
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGTSQQ--SVHSVSGLLGNFQWMAPETI 198
Query: 269 SG---NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK- 324
                +Y+EK D +S             PF     E  +  IK + +    G+  T+ + 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINMIREEGLRPTIPED 254
Query: 325 -PAR 327
            P R
Sbjct: 255 CPPR 258

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 44  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 96
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 97  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 156
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 157 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 216
Query: 275 KVDIWS 280
           + D+++
Sbjct: 217 QSDVYA 222

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 16  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 68
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 69  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 275 KVDIWS 280
           + D+++
Sbjct: 189 QSDVYA 194

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 21  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 73
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 74  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 275 KVDIWS 280
           + D+++
Sbjct: 194 QSDVYA 199

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 18  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 70
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 71  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 130
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 131 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 190
Query: 275 KVDIWS 280
           + D+++
Sbjct: 191 QSDVYA 196

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 21  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 73
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 74  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 133
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 134 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 193
Query: 275 KVDIWS 280
           + D+++
Sbjct: 194 QSDVYA 199

>pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 64/244 (26%), Positives = 106/244 (43%), Gaps = 39/244 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------ETVHREVEIMQHLSGHTGV 159
           IG G FG V   R     +  A K+L  G+           +   REV IM +L+ H  +
Sbjct: 27  IGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNI 85
Query: 160 VTLHSVYEEADCFHLVMELCSGG----RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           V L+ +        +VME    G    RL+D+   +    + R   +  D+   I+Y  +
Sbjct: 86  VKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLR---LMLDIALGIEYMQN 140
Query: 216 MG--VVHRDIKPENILLTTSGK-----IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
               +VHRD++  NI L +  +      K+ADF L+ +  +  ++SGL G+  ++APE +
Sbjct: 141 QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFSLSQQ--SVHSVSGLLGNFQWMAPETI 198
Query: 269 SG---NYSEKVDIWSXXXXXXXXXXXXXPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK- 324
                +Y+EK D +S             PF     E  +  IK + +    G+  T+ + 
Sbjct: 199 GAEEESYTEKADTYSFAMILYTILTGEGPFD----EYSYGKIKFINMIREEGLRPTIPED 254
Query: 325 -PAR 327
            P R
Sbjct: 255 CPPR 258

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 49/186 (26%), Positives = 79/186 (42%), Gaps = 23/186 (12%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV--------VTL 162
           IG G FG+V+  + K  G + A K L     T  +    +Q      GV        + L
Sbjct: 16  IGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQ----LQAFKNEVGVLRKTRHVNILL 68
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
              Y       +V + C G  L   + +   ++   +  +I +     + Y H   ++HR
Sbjct: 69  FMGYSTKPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHR 128
Query: 222 DIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+       YS 
Sbjct: 129 DLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSF 188
Query: 275 KVDIWS 280
           + D+++
Sbjct: 189 QSDVYA 194

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 63/278 (22%), Positives = 110/278 (39%), Gaps = 74/278 (26%)
Query: 145 REVEIMQHLSGHTGVVTLHSV--------------YEEADCFHLVMELCSGGRLIDQMVE 190
           RE+ +++ L  H  V++L  V              Y E D +H++ +     +   + V 
Sbjct: 67  REIALLRELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHII-KFHRASKANKKPV- 123
Query: 191 VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT----TSGKIKLADFGLAMR 246
             Q       ++   ++  I Y H   V+HRD+KP NIL+       G++K+AD G A R
Sbjct: 124 --QLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-R 180
Query: 247 ISNGQT-----LSGLAGSPAYVAPEVLSG--NYSEKVDIWS-------------XXXXXX 286
           + N        L  +  +  Y APE+L G  +Y++ +DIW+                   
Sbjct: 181 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 240
Query: 287 XXXXXXXPFKGDSLEAVFDAI-----------------KNVKLDFHSGVWETVS------ 323
                  P+  D L+ +F+ +                   +  DF    +   S      
Sbjct: 241 EDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300
Query: 324 ----KP---ARDLMARMLTRDVSARITADEVLRHPWIL 354
               KP   A  L+ ++LT D   RIT+++ ++ P+ L
Sbjct: 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFL 338

>pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268

Iteration: 1
 Score = 55.5 bits (132), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 87/182 (47%), Gaps = 9/182 (4%)
Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTL 162
           T ++ +G G+FG V L + K    + A K +++G   E+   +E + M  LS H  +V  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKF 68
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE-QRAANIFKDVMWVIKYCHDMGVVHR 221
           + V  +    ++V E  S G L++ +   G+  E  +   +  DV   + +      +HR
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVL-SGNYSEKVDI 278
           D+   N L+     +K++DFG+   + + Q +S  G      + APEV     YS K D+
Sbjct: 129 DLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDV 188
Query: 279 WS 280
           W+
Sbjct: 189 WA 190

>pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 88/198 (44%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  KV+V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 16  ETELRKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAG 75
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDV 206
               ++S   G+    +V        LV +L   G L+D + E  G+   Q   N    +
Sbjct: 76  VGSPYVSRLLGICLTSTV-------QLVTQLMPYGCLLDHVRENRGRLGSQDLLNWCMQI 128
Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
              + Y  D+ +VHRD+   N+L+ +   +K+ DFGLA  +   +T     G      ++
Sbjct: 129 AKGMSYLEDVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWM 188
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   ++ + D+WS
Sbjct: 189 ALESILRRRFTHQSDVWS 206

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 55.1 bits (131), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDXXKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 140 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 199
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 200 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 258
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 259 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 318
Query: 352 WI 353
           + 
Sbjct: 319 YF 320

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/211 (25%), Positives = 94/211 (44%), Gaps = 41/211 (19%)
Query: 109 EVIGHGKFGSVWLCRSKASGA-------EFACKTLRKGEETVHRE-----VEIMQHLSGH 156
           +V+G G FG V    + A G        + A K L++  ++  RE     +++M  L  H
Sbjct: 51  KVLGSGAFGKV--MNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSH 108
Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-----------VEV---GQYSEQRAANI 202
             +V L      +   +L+ E C  G L++ +           +E     +  E+   N+
Sbjct: 109 ENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNV 168
Query: 203 --FKDVMWV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQ 251
             F+D++         +++      VHRD+   N+L+T    +K+ DFGLA  I   +  
Sbjct: 169 LTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNY 228
Query: 252 TLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
            + G A  P  ++APE +  G Y+ K D+WS
Sbjct: 229 VVRGNARLPVKWMAPESLFEGIYTIKSDVWS 259

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 139 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 198
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 199 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 257
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 258 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 352 WI 353
           + 
Sbjct: 318 YF 319

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM---------VE 190
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +          E
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 152
Query: 191 VGQYSEQRAANIFK-DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN 249
            G+  E R    F   V   + +      +HRD+   N+LLT     K+ DFGLA  I N
Sbjct: 153 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 212
Query: 250 --GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
                + G A  P  ++APE +    Y+ + D+WS
Sbjct: 213 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 247

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 52/233 (22%), Positives = 96/233 (41%), Gaps = 37/233 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS- 259
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N           
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKNTTNGR 220
Query: 260 -PA-YVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
            P  ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 89  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 148
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 149 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 206
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 207 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 267 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 319

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 75  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 128 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 184 IKWMALESILHRIYTHQSDVWS 205

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 139 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 198
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 199 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 257
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 258 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 317
Query: 352 WI 353
           + 
Sbjct: 318 YF 319

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 58/215 (26%), Positives = 88/215 (40%), Gaps = 27/215 (12%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 25  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 84
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM---------VE 190
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +          E
Sbjct: 85  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLDKE 144
Query: 191 VGQYSEQRAANIFK-DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN 249
            G+  E R    F   V   + +      +HRD+   N+LLT     K+ DFGLA  I N
Sbjct: 145 DGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 204
Query: 250 --GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
                + G A  P  ++APE +    Y+ + D+WS
Sbjct: 205 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 239

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 39/182 (21%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           + YCH  G++HRD+KP N+++     K++L D+GLA     G+  +    S  +  PE+L
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELL 197
Query: 269 SG--NYSEKVDIWSXXXXXXXXXXXXXPF-----------------KGDSLEAVFDAIKN 309
               +Y   +D+WS             PF                   D L    +  + 
Sbjct: 198 VDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGTDGLNVYLNKYR- 256
Query: 310 VKLD------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           ++LD                   ++     VS  A D + ++L  D   R+TA E + HP
Sbjct: 257 IELDPQLEALVGRHSRKPWLKFMNADNQHLVSPEAIDFLDKLLRYDHQERLTALEAMTHP 316
Query: 352 WI 353
           + 
Sbjct: 317 YF 318

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 54.3 bits (129), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/234 (23%), Positives = 100/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLRKG--EETVH---REVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+    EE +     E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEEDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLH 163
           ++VIG G FG V            A K +R  E+  HR    E+ I++HL       T+ 
Sbjct: 102 LKVIGKGXFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTM- 159
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMV-------EVGQYSEQRAANIFKDVMWVIKYCHDM 216
           +V    + F     +C    L+   +       +   +S          ++  +   H  
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 217 GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYS 273
            ++H D+KPENILL   G+  IK+ DFG +      Q +     S  Y APEV+ G  Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYXXIQSRFYRAPEVILGARYG 277
Query: 274 EKVDIWS 280
             +D+WS
Sbjct: 278 MPIDMWS 284

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 31/95 (32%), Positives = 49/95 (51%), Gaps = 3/95 (3%)
Query: 186 DQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM 245
           +++  V +   +  + + +DV W     H   + HRD K +N+LL +     LADFGLA+
Sbjct: 112 NELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171
Query: 246 RISNGQT---LSGLAGSPAYVAPEVLSGNYSEKVD 277
           R   G+      G  G+  Y+APEVL G  + + D
Sbjct: 172 RFEPGKPPGDTHGQVGTRRYMAPEVLEGAINFQRD 206

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLH 163
           ++VIG G FG V            A K +R  E+  HR    E+ I++HL       T+ 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVR-NEKRFHRQAAEEIRILEHLRKQDKDNTM- 159
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMV-------EVGQYSEQRAANIFKDVMWVIKYCHDM 216
           +V    + F     +C    L+   +       +   +S          ++  +   H  
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 217 GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYS 273
            ++H D+KPENILL   G+  IK+ DFG +      Q +     S  Y APEV+ G  Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYG 277
Query: 274 EKVDIWS 280
             +D+WS
Sbjct: 278 MPIDMWS 284

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 30  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 89
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 90  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 147
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 148 SCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 207
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 208 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 260

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 18/187 (9%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR----EVEIMQHLSGHTGVVTLH 163
           ++VIG G FG V            A K +R  E+  HR    E+ I++HL       T+ 
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRN-EKRFHRQAAEEIRILEHLRKQDKDNTM- 159
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMV-------EVGQYSEQRAANIFKDVMWVIKYCHDM 216
           +V    + F     +C    L+   +       +   +S          ++  +   H  
Sbjct: 160 NVIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKN 219
Query: 217 GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYS 273
            ++H D+KPENILL   G+  IK+ DFG +      Q +     S  Y APEV+ G  Y 
Sbjct: 220 RIIHCDLKPENILLKQQGRSGIKVIDFGSS--CYEHQRVYTXIQSRFYRAPEVILGARYG 277
Query: 274 EKVDIWS 280
             +D+WS
Sbjct: 278 MPIDMWS 284

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +++ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 35  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 94
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 95  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 152
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 153 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 212
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 213 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 265

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 53/234 (22%), Positives = 99/234 (42%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 32  LGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 91
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++E  S G L           ++   ++ +  E++    FKD++
Sbjct: 92  IINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 149
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 150 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 209
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 210 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 262

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 78  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 131 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 186
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 187 IKWMALESILHRIYTHQSDVWS 208

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 74  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 127 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 183 IKWMALESILHRIYTHQSDVWS 204

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 15  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 74
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 75  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 127
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 128 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 183
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 184 IKWMALESILHRIYTHQSDVWS 205

>pdb|3SV0|A Chain A, Crystal Structure Of Casein Kinase-1 Like Protein In Plant Length = 483

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 41/148 (27%), Positives = 68/148 (45%), Gaps = 7/148 (4%)
Query: 111 IGHGKFGSVWLCRSKASGAEFACK--TLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L  +  +  E A K   ++     +  E +I + L G TG+  +     E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74
Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV-IKYCHDMGVVHRDIKPEN 227
            D   LVM+L  G  L D      +    +   +  D M   +++ H    +HRDIKP+N
Sbjct: 75  GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133
Query: 228 ILL---TTSGKIKLADFGLAMRISNGQT 252
            L+     + ++ + DFGLA +  +  T
Sbjct: 134 FLMGLGRRANQVYIIDFGLAKKYRDTST 161

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 76
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 77  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 130 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 185
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 186 IKWMALESILHRIYTHQSDVWS 207

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 54/202 (26%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 76  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 129 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 184
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 185 IKWMALESILHRIYTHQSDVWS 206

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 40/145 (27%), Positives = 65/145 (44%), Gaps = 3/145 (2%)
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           VV +H   E     ++   L +G  L   +   G  +  RA  I + +   +   H  G 
Sbjct: 96  VVPIHDFGEIDGQLYVDXRLINGVDLAAXLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155
Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLSGNYSE-K 275
            HRD+KPENIL++      L DFG+A   ++ +   L    G+  Y APE  S +++  +
Sbjct: 156 THRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYXAPERFSESHATYR 215
Query: 276 VDIWSXXXXXXXXXXXXXPFKGDSL 300
            DI++             P++GD L
Sbjct: 216 ADIYALTCVLYECLTGSPPYQGDQL 240

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 53.1 bits (126), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 54/219 (24%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM----------- 188
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +           
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 189 ---VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM 245
              +     S +   +    V   + +      +HRD+   N+LLT     K+ DFGLA 
Sbjct: 153 AFAIANSTLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 246 RISN--GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
            I N     + G A  P  ++APE +    Y+ + D+WS
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 55/219 (25%), Positives = 86/219 (39%), Gaps = 31/219 (14%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA 199
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +    +  E   
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDP 152
Query: 200 A--------------NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM 245
           A              +    V   + +      +HRD+   N+LLT     K+ DFGLA 
Sbjct: 153 AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR 212
Query: 246 RISN--GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
            I N     + G A  P  ++APE +    Y+ + D+WS
Sbjct: 213 DIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 251

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 56/221 (25%), Positives = 88/221 (39%), Gaps = 33/221 (14%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 33  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 92
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG 192
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +       +E  
Sbjct: 93  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKRPPGLEYS 152
Query: 193 ---------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL 243
                    Q S +   +    V   + +      +HRD+   N+LLT     K+ DFGL
Sbjct: 153 YNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGL 212
Query: 244 AMRISN--GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
           A  I N     + G A  P  ++APE +    Y+ + D+WS
Sbjct: 213 ARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 253

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 120/318 (37%), Gaps = 76/318 (23%)
Query: 108 VEVIGHGKFGSVWLC-RSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLH 163
           V+ +G G FG V  C   KA G   A K ++  +   E    E+++++HL+      T  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 164 SV-----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---YCHD 215
            V     +E      +V EL  G    D + E G +   R  +I K    + K   + H 
Sbjct: 79  CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 216 MGVVHRDIKPENILLTTSG-------------------KIKLADFGLAMRISNGQTLSGL 256
             + H D+KPENIL   S                     IK+ DFG A    + +  S L
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT--YDDEHHSTL 194
Query: 257 AGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG-DSLE--AVFDAI----- 307
             +  Y APEV L+  +S+  D+WS              F   DS E  A+ + I     
Sbjct: 195 VSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254
Query: 308 ---------------KNVKLDFHSGVWETVS---KPAR--------------DLMARMLT 335
                            +  D HS     VS   KP +              DL+ +ML 
Sbjct: 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314
Query: 336 RDVSARITADEVLRHPWI 353
            D + RIT  E L+HP+ 
Sbjct: 315 YDPAKRITLREALKHPFF 332

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 52.8 bits (125), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 28/191 (14%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +IG G FG V     +      A K ++  +  +++   EV +++ ++ H   +  + V+
Sbjct: 42  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 101
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI--KYCHDM-------- 216
            +   F     LC    L+ +M+    Y   R  N F+ V   +  K+   M        
Sbjct: 102 LKRH-FMFRNHLC----LVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLA 155
Query: 217 ----GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
                ++H D+KPENILL    +  IK+ DFG + ++  GQ +     S  Y +PEVL G
Sbjct: 156 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLG 213
Query: 271 -NYSEKVDIWS 280
             Y   +D+WS
Sbjct: 214 MPYDLAIDMWS 224

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 48  ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 165
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 166 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225
Query: 271 NYSEK 275
           + + K
Sbjct: 226 SINMK 230

>pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 43/244 (17%)
Query: 73  SSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFA 132
           SS +P G       GC ++ T +G+              G     +V L R K +G    
Sbjct: 2   SSFLPEG-------GCYELLTVIGK--------------GFEDLMTVNLARYKPTGEYVT 40
Query: 133 CKTLRKGEETVHREVEIMQ---HLS---GHTGVVTLHSVYEEADCFHLVMELCSGGRLID 186
            + +   E   +  V  +Q   H+S    H  +V   + +   +   +V    + G   D
Sbjct: 41  VRRINL-EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 99
Query: 187 QMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF--G 242
            +    +   +E   A I + V+  + Y H MG VHR +K  +IL++  GK+ L+     
Sbjct: 100 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 159
Query: 243 LAMRISNGQTLSGLAGSPAY-------VAPEVLSGN---YSEKVDIWSXXXXXXXXXXXX 292
           L+M IS+GQ    +   P Y       ++PEVL  N   Y  K DI+S            
Sbjct: 160 LSM-ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 218
Query: 293 XPFK 296
            PFK
Sbjct: 219 VPFK 222

>pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 62/244 (25%), Positives = 98/244 (40%), Gaps = 43/244 (17%)
Query: 73  SSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFA 132
           SS +P G       GC ++ T +G+              G     +V L R K +G    
Sbjct: 18  SSFLPEG-------GCYELLTVIGK--------------GFEDLMTVNLARYKPTGEYVT 56
Query: 133 CKTLRKGEETVHREVEIMQ---HLS---GHTGVVTLHSVYEEADCFHLVMELCSGGRLID 186
            + +   E   +  V  +Q   H+S    H  +V   + +   +   +V    + G   D
Sbjct: 57  VRRINL-EACSNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKD 115
Query: 187 QMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF--G 242
            +    +   +E   A I + V+  + Y H MG VHR +K  +IL++  GK+ L+     
Sbjct: 116 LICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSN 175
Query: 243 LAMRISNGQTLSGLAGSPAY-------VAPEVLSGN---YSEKVDIWSXXXXXXXXXXXX 292
           L+M IS+GQ    +   P Y       ++PEVL  N   Y  K DI+S            
Sbjct: 176 LSM-ISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
Query: 293 XPFK 296
            PFK
Sbjct: 235 VPFK 238

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 28/191 (14%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +IG G FG V     +      A K ++  +  +++   EV +++ ++ H   +  + V+
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI--KYCHDM-------- 216
            +   F     LC    L+ +M+    Y   R  N F+ V   +  K+   M        
Sbjct: 121 LKRH-FMFRNHLC----LVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLA 174
Query: 217 ----GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
                ++H D+KPENILL    +  IK+ DFG + ++  GQ +     S  Y +PEVL G
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLG 232
Query: 271 -NYSEKVDIWS 280
             Y   +D+WS
Sbjct: 233 MPYDLAIDMWS 243

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++   S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 52.4 bits (124), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 51/191 (26%), Positives = 86/191 (45%), Gaps = 28/191 (14%)
Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR---EVEIMQHLSGHTGVVTLHSVY 166
           +IG G FG V     +      A K ++  +  +++   EV +++ ++ H   +  + V+
Sbjct: 61  LIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVH 120
Query: 167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI--KYCHDM-------- 216
            +   F     LC    L+ +M+    Y   R  N F+ V   +  K+   M        
Sbjct: 121 LKRH-FMFRNHLC----LVFEMLSYNLYDLLRNTN-FRGVSLNLTRKFAQQMCTALLFLA 174
Query: 217 ----GVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
                ++H D+KPENILL    +  IK+ DFG + ++  GQ +     S  Y +PEVL G
Sbjct: 175 TPELSIIHCDLKPENILLCNPKRXAIKIVDFGSSCQL--GQRIYQXIQSRFYRSPEVLLG 232
Query: 271 -NYSEKVDIWS 280
             Y   +D+WS
Sbjct: 233 MPYDLAIDMWS 243

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 10  ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 67
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 68  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 127
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 128 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 187
Query: 271 NYSEK 275
           + + K
Sbjct: 188 SINMK 192

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 35  ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 92
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 93  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 152
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 153 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 212
Query: 271 NYSEK 275
           + + K
Sbjct: 213 SINMK 217

>pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 25/156 (16%)
Query: 110 VIGHGKFGSVW---LCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVT 161
           ++G G FG V+       K      A KT +K      +E    E  IM++L  H  +V 
Sbjct: 31  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVK 89
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE--QRAANIFKDVMWVIKYCHDMGV- 218
           L  + EE   + ++MEL   G       E+G Y E  + +  +   V++ ++ C  M   
Sbjct: 90  LIGIIEEEPTW-IIMELYPYG-------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 141
Query: 219 -----VHRDIKPENILLTTSGKIKLADFGLAMRISN 249
                VHRDI   NIL+ +   +KL DFGL+  I +
Sbjct: 142 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 177

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 78  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 279 W 279
           W
Sbjct: 196 W 196

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 21  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 80
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 81  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 138
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 139 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 198
Query: 279 W 279
           W
Sbjct: 199 W 199

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 20  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 79
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 80  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 137
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 138 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 197
Query: 279 W 279
           W
Sbjct: 198 W 198

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 15  ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 72
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 73  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 132
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 133 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 192
Query: 271 NYSEK 275
           + + K
Sbjct: 193 SINMK 197

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 9   ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 66
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 67  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 126
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 127 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186
Query: 271 NYSEK 275
           + + K
Sbjct: 187 SINMK 191

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 78  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 279 W 279
           W
Sbjct: 196 W 196

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+ +L   G L+D + E    +G QY       I
Sbjct: 74  VDNPHVCRLLGICLTSTV-------QLITQLMPFGXLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 127 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 183 IKWMALESILHRIYTHQSDVWS 204

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 46  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 105
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 106 GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 163
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 164 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 223
Query: 279 W 279
           W
Sbjct: 224 W 224

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 54/185 (29%), Positives = 84/185 (45%), Gaps = 20/185 (10%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQH-LSGHTGVVTLHSVY 166
           E IG G+FG VW  R K  G E A K     EE +  RE EI Q  +  H  ++   +  
Sbjct: 12  ESIGKGRFGEVW--RGKWRGEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFIAAD 69
Query: 167 EEADC----FHLVMELCSGGRLIDQM------VE-VGQYSEQRAANIFKDVMWVIKYCHD 215
            + +       LV +    G L D +      VE + + +   A+ +    M ++     
Sbjct: 70  NKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK 129
Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPEVLSG 270
             + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APEVL  
Sbjct: 130 PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 189
Query: 271 NYSEK 275
           + + K
Sbjct: 190 SINMK 194

>pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 51/189 (26%), Positives = 86/189 (45%), Gaps = 28/189 (14%)
Query: 110 VIGHGKFGSVW---LCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVT 161
           ++G G FG V+       K      A KT +K      +E    E  IM++L  H  +V 
Sbjct: 15  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVK 73
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE--QRAANIFKDVMWVIKYCHDMGV- 218
           L  + EE   + ++MEL   G       E+G Y E  + +  +   V++ ++ C  M   
Sbjct: 74  LIGIIEEEPTW-IIMELYPYG-------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 125
Query: 219 -----VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPA-YVAPEVLSG- 270
                VHRDI   NIL+ +   +KL DFGL+  I +     + +   P  +++PE ++  
Sbjct: 126 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFR 185
Query: 271 NYSEKVDIW 279
            ++   D+W
Sbjct: 186 RFTTASDVW 194

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 23  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 82
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 83  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 140
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 141 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 200
Query: 279 W 279
           W
Sbjct: 201 W 201

>pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 46/156 (29%), Positives = 71/156 (45%), Gaps = 25/156 (16%)
Query: 110 VIGHGKFGSVW---LCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVT 161
           ++G G FG V+       K      A KT +K      +E    E  IM++L  H  +V 
Sbjct: 19  ILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVK 77
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE--QRAANIFKDVMWVIKYCHDMGV- 218
           L  + EE   + ++MEL   G       E+G Y E  + +  +   V++ ++ C  M   
Sbjct: 78  LIGIIEEEPTW-IIMELYPYG-------ELGHYLERNKNSLKVLTLVLYSLQICKAMAYL 129
Query: 219 -----VHRDIKPENILLTTSGKIKLADFGLAMRISN 249
                VHRDI   NIL+ +   +KL DFGL+  I +
Sbjct: 130 ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIED 165

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 52.0 bits (123), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 48/181 (26%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 15  IGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 74
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V +YS   A+ I     +   + Y      VHR
Sbjct: 75  GVITENPVW-IIMELCTLGEL-RSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHR 132
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 133 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 192
Query: 279 W 279
           W
Sbjct: 193 W 193

>pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 87/193 (45%), Gaps = 19/193 (9%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHT 157
           D+ +   ++G G FG V+  R  A G   A K L++     GE     EVE++  ++ H 
Sbjct: 38  DNFSNKNILGRGGFGKVYKGRL-ADGTLVAVKRLKEERXQGGELQFQTEVEMIS-MAVHR 95
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-------VGQYSEQR-AANIFKDVMWV 209
            ++ L           LV    + G +   + E       +     QR A    + + ++
Sbjct: 96  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 155
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPAYVAPEV 267
             +C D  ++HRD+K  NILL    +  + DFGLA  M   +      + G+  ++APE 
Sbjct: 156 HDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGTIGHIAPEY 214
Query: 268 LS-GNYSEKVDIW 279
           LS G  SEK D++
Sbjct: 215 LSTGKSSEKTDVF 227

>pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV---HR----EVEIMQHLSGHTGVVT 161
           +VIG G FG V   R K  G        R  E      HR    E+E++  L  H  ++ 
Sbjct: 31  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 90
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVE----------------VGQYSEQRAANIFKD 205
           L    E     +L +E    G L+D + +                    S Q+  +   D
Sbjct: 91  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 150
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPA- 261
           V   + Y      +HRD+   NIL+  +   K+ADFGL    S GQ +     +   P  
Sbjct: 151 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLPVR 206
Query: 262 YVAPEVLSGN-YSEKVDIWS 280
           ++A E L+ + Y+   D+WS
Sbjct: 207 WMAIESLNYSVYTTNSDVWS 226

>pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 53/200 (26%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV---HR----EVEIMQHLSGHTGVVT 161
           +VIG G FG V   R K  G        R  E      HR    E+E++  L  H  ++ 
Sbjct: 21  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 80
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVE----------------VGQYSEQRAANIFKD 205
           L    E     +L +E    G L+D + +                    S Q+  +   D
Sbjct: 81  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 140
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPA- 261
           V   + Y      +HRD+   NIL+  +   K+ADFGL    S GQ +     +   P  
Sbjct: 141 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLPVR 196
Query: 262 YVAPEVLSGN-YSEKVDIWS 280
           ++A E L+ + Y+   D+WS
Sbjct: 197 WMAIESLNYSVYTTNSDVWS 216

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 52/234 (22%), Positives = 98/234 (41%), Gaps = 39/234 (16%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V +  +              A K L+     K    +  E+E+M+ +  H  
Sbjct: 43  LGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKN 102
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL-----------IDQMVEVGQYSEQRAANIFKDVM 207
           ++ L     +    ++++   S G L           ++   ++ +  E++    FKD++
Sbjct: 103 IINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDINRVPEEQMT--FKDLV 160
Query: 208 WV-------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGL 256
                    ++Y      +HRD+   N+L+T +  +K+ADFGLA  I+N     +T +G 
Sbjct: 161 SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 220
Query: 257 AGSPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
                ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 221 LPV-KWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLK 273

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L  +  +V +  + E A+ + LVME+   G L   + +     ++    +   
Sbjct: 420 EANVMQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 477
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 478 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 537
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 538 WYAPECINYYKFSSKSDVWS 557

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 67/140 (47%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L  +  +V +  + E A+ + LVME+   G L   + +     ++    +   
Sbjct: 421 EANVMQQLD-NPYIVRMIGICE-AESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 478
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 479 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 538
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 539 WYAPECINYYKFSSKSDVWS 558

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 51.6 bits (122), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 83/318 (26%), Positives = 119/318 (37%), Gaps = 76/318 (23%)
Query: 108 VEVIGHGKFGSVWLC-RSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLH 163
           V+ +G G FG V  C   KA G   A K ++  +   E    E+++++HL+      T  
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLNTTDPNSTFR 78
Query: 164 SV-----YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---YCHD 215
            V     +E      +V EL  G    D + E G +   R  +I K    + K   + H 
Sbjct: 79  CVQMLEWFEHHGHICIVFELL-GLSTYDFIKENG-FLPFRLDHIRKMAYQICKSVNFLHS 136
Query: 216 MGVVHRDIKPENILLTTSG-------------------KIKLADFGLAMRISNGQTLSGL 256
             + H D+KPENIL   S                     IK+ DFG A    + +  S L
Sbjct: 137 NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSAT--YDDEHHSTL 194
Query: 257 AGSPAYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKG-DSLE--AVFDAI----- 307
                Y APEV L+  +S+  D+WS              F   DS E  A+ + I     
Sbjct: 195 VXXRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLP 254
Query: 308 ---------------KNVKLDFHSGVWETVS---KPAR--------------DLMARMLT 335
                            +  D HS     VS   KP +              DL+ +ML 
Sbjct: 255 KHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLE 314
Query: 336 RDVSARITADEVLRHPWI 353
            D + RIT  E L+HP+ 
Sbjct: 315 YDPAKRITLREALKHPFF 332

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 24  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 77
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 78  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 136
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 137 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 196
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 197 ALESILHRIYTHQSDVWS 214

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 39  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 92
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 93  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 151
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 152 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 211
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 212 ALESILHRIYTHQSDVWS 229

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 20  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 73
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 74  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 132
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 133 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 192
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 193 ALESILHRIYTHQSDVWS 210

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 74
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 75  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 194 ALESILHRIYTHQSDVWS 211

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 67
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 68  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 187 ALESILHRIYTHQSDVWS 204

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 84/182 (46%), Gaps = 16/182 (8%)
Query: 111 IGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTL 162
           IG G+FG V    ++     + A  A KT +       RE  + + L+     H  +V L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVH 220
             V  E   + ++MELC+ G L    ++V ++S   A+ I     +   + Y      VH
Sbjct: 457 IGVITENPVW-IIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVD 277
           RDI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D
Sbjct: 515 RDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 278 IW 279
           +W
Sbjct: 575 VW 576

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+ +L   G L+D + E    +G QY       I
Sbjct: 68  VDNPHVCRLLGICLTSTV-------QLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 121 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 176
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 177 IKWMALESILHRIYTHQSDVWS 198

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 70
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 71  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 190 ALESILHRIYTHQSDVWS 207

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 69
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 70  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 189 ALESILHRIYTHQSDVWS 206

>pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 54/199 (27%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+  L+ 
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN- 92
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 213 MPPEAFMEGIFTSKTDTWS 231

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+  G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 80
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 81  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G    
Sbjct: 134 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 189
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 190 IKWMALESILHRIYTHQSDVWS 211

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 70
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 71  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 190 ALESILHRIYTHQSDVWS 207

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 17  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 70
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 71  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 129
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 130 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 189
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 190 ALESILHRIYTHQSDVWS 207

>pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 18  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 77
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 78  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 130
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G    
Sbjct: 131 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 186
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 187 IKWMALESILHRIYTHQSDVWS 208

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/182 (26%), Positives = 83/182 (45%), Gaps = 16/182 (8%)
Query: 111 IGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTL 162
           IG G+FG V    ++     + A  A KT +       RE  + + L+     H  +V L
Sbjct: 398 IGEGQFGDVHQGIYMSPENPAMA-VAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKL 456
Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVH 220
             V  E   + ++MELC+ G L    ++V ++S   A+ I     +   + Y      VH
Sbjct: 457 IGVITENPVW-IIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVH 514
Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVD 277
           RDI   N+L++ +  +KL DFGL+  + +        G     ++APE ++   ++   D
Sbjct: 515 RDIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASD 574
Query: 278 IW 279
           +W
Sbjct: 575 VW 576

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 67
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 68  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 187 ALESILHRIYTHQSDVWS 204

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 81/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V ++S   A+ I     +   + Y      VHR
Sbjct: 78  GVITENPVW-IIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++++  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 136 DIAARNVLVSSNDCVKLGDFGLSRYMEDSTXXKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 279 W 279
           W
Sbjct: 196 W 196

>pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 76  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G    
Sbjct: 129 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 185 IKWMALESILHRIYTHQSDVWS 206

>pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 91
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA-------NIFKDVMW 208
           H  +V    V  ++    ++MEL +GG L   + E      Q ++       ++ +D+  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
             +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 212 MPPEAFMEGIFTSKTDTWS 230

>pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 106
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA-------NIFKDVMW 208
           H  +V    V  ++    ++MEL +GG L   + E      Q ++       ++ +D+  
Sbjct: 107 HQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
             +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 227 MPPEAFMEGIFTSKTDTWS 245

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 52/198 (26%), Positives = 85/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 11  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 64
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 65  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 123
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 124 AEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 183
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 184 ALESILHRIYTHQSDVWS 201

>pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/202 (26%), Positives = 86/202 (42%), Gaps = 34/202 (16%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLR-----KGEETVHREVEIM-- 150
           E +  K++V+G G FG+V    W+   +      A K LR     K  + +  E  +M  
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 75
Query: 151 ---QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VG-QYSEQRAANI 202
               H+    G+    +V        L+M+L   G L+D + E    +G QY       I
Sbjct: 76  VDNPHVCRLLGICLTSTV-------QLIMQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA- 261
            K     + Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G    
Sbjct: 129 AKG----MNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVP 184
Query: 262 --YVAPE-VLSGNYSEKVDIWS 280
             ++A E +L   Y+ + D+WS
Sbjct: 185 IKWMALESILHRIYTHQSDVWS 206

>pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 86/199 (43%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+  L+ 
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKLN- 106
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA-------NIFKDVMW 208
           H  +V    V  ++    +++EL +GG L   + E      Q ++       ++ +D+  
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
             +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 227 MPPEAFMEGIFTSKTDTWS 245

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 51/199 (25%), Positives = 88/199 (44%), Gaps = 29/199 (14%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 161 TL-HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWV---IKYCHD 215
            L  +  +      +++E C  G L   +  +  ++   +  +++KD + +   I Y   
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKPEDLYKDFLTLEHLIXYSFQ 156
Query: 216 MG----------VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AY 262
           +            +HRD+   NILL+    +K+ DFGLA  I         G A  P  +
Sbjct: 157 VAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPLKW 216
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           +APE +    Y+ + D+WS
Sbjct: 217 MAPETIFDRVYTIQSDVWS 235

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 76  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 133
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 134 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 193
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 194 WYAPECINYYKFSSKSDVWS 213

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/181 (25%), Positives = 80/181 (44%), Gaps = 14/181 (7%)
Query: 111 IGHGKFGSV---WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS----GHTGVVTLH 163
           IG G+FG V        +      A KT +       RE  + + L+     H  +V L 
Sbjct: 18  IGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLI 77
Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFK--DVMWVIKYCHDMGVVHR 221
            V  E   + ++MELC+ G L    ++V ++S   A+ I     +   + Y      VHR
Sbjct: 78  GVITENPVW-IIMELCTLGEL-RSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHR 135
Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--YVAPEVLSG-NYSEKVDI 278
           DI   N+L++ +  +KL DFGL+  + +        G     ++APE ++   ++   D+
Sbjct: 136 DIAARNVLVSATDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDV 195
Query: 279 W 279
           W
Sbjct: 196 W 196

>pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTL--RKGEETVHREVEIMQHLSG 155
           E +  K++V+G G FG+V    W+   ++       K +  + G ++     + M  +  
Sbjct: 30  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 89
Query: 156 --HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKY 212
             H  +V L  +        LV +    G L+D + +  G    Q   N    +   + Y
Sbjct: 90  LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 148
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPA-YVAPEVLS 269
             + G+VHR++   N+LL +  ++++ADFG+A  +   + Q L   A +P  ++A E + 
Sbjct: 149 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 208
Query: 270 -GNYSEKVDIWS 280
            G Y+ + D+WS
Sbjct: 209 FGKYTHQSDVWS 220

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 78  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 196 WYAPECINYYKFSSKSDVWS 215

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 78  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 135
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 136 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 195
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 196 WYAPECINYYKFSSKSDVWS 215

>pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/192 (24%), Positives = 89/192 (46%), Gaps = 14/192 (7%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTL--RKGEETVHREVEIMQHLSG 155
           E +  K++V+G G FG+V    W+   ++       K +  + G ++     + M  +  
Sbjct: 12  ETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGS 71
Query: 156 --HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKY 212
             H  +V L  +        LV +    G L+D + +  G    Q   N    +   + Y
Sbjct: 72  LDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY 130
Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPA-YVAPEVLS 269
             + G+VHR++   N+LL +  ++++ADFG+A  +   + Q L   A +P  ++A E + 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190
Query: 270 -GNYSEKVDIWS 280
            G Y+ + D+WS
Sbjct: 191 FGKYTHQSDVWS 202

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 62  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXYKAQTHGKWPVK 179
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 180 WYAPECINYYKFSSKSDVWS 199

>pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 92
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAQDIYRASYYRKGGCAMLPVKW 212
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 213 MPPEAFMEGIFTSKTDTWS 231

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 68  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 125
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 126 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 185
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 186 WYAPECINYYKFSSKSDVWS 205

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 56  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 113
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 114 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 173
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 174 WYAPECINYYKFSSKSDVWS 193

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 62  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 119
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 120 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 179
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 180 WYAPECINYYKFSSKSDVWS 199

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 32/201 (15%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS---------- 154
           V  +G G F +VWL +   +    A K +R  +   E    E++++Q ++          
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 155 GHTGVVTL--HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-----KDVM 207
           G   ++ L  H  ++  +  H+VM     G   + +  + +Y  +    I+     K ++
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGE--NLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 208 WVIKYCHDM-GVVHRDIKPENILLTTSG------KIKLADFGLAMRISNGQTLSGLAGSP 260
             + Y H   G++H DIKPEN+L+          +IK+AD G A       T S    + 
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTR 199
Query: 261 AYVAPEVLSG-NYSEKVDIWS 280
            Y +PEVL G  +    DIWS
Sbjct: 200 EYRSPEVLLGAPWGCGADIWS 220

>pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/200 (26%), Positives = 80/200 (40%), Gaps = 32/200 (16%)
Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV---HR----EVEIMQHLSGHTGVVT 161
           +VIG G FG V   R K  G        R  E      HR    E+E++  L  H  ++ 
Sbjct: 28  DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 87
Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVE----------------VGQYSEQRAANIFKD 205
           L    E     +L +E    G L+D + +                    S Q+  +   D
Sbjct: 88  LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 147
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPA- 261
           V   + Y      +HR++   NIL+  +   K+ADFGL    S GQ +     +   P  
Sbjct: 148 VARGMDYLSQKQFIHRNLAARNILVGENYVAKIADFGL----SRGQEVYVKKTMGRLPVR 203
Query: 262 YVAPEVLSGN-YSEKVDIWS 280
           ++A E L+ + Y+   D+WS
Sbjct: 204 WMAIESLNYSVYTTNSDVWS 223

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/201 (25%), Positives = 88/201 (43%), Gaps = 32/201 (15%)
Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS---------- 154
           V  +G G F +VWL +   +    A K +R  +   E    E++++Q ++          
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83
Query: 155 GHTGVVTL--HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF-----KDVM 207
           G   ++ L  H  ++  +  H+VM     G   + +  + +Y  +    I+     K ++
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVLGE--NLLALIKKYEHRGIPLIYVKQISKQLL 141
Query: 208 WVIKYCHDM-GVVHRDIKPENILLTTSG------KIKLADFGLAMRISNGQTLSGLAGSP 260
             + Y H   G++H DIKPEN+L+          +IK+AD G A       T S    + 
Sbjct: 142 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNS--IQTR 199
Query: 261 AYVAPEVLSG-NYSEKVDIWS 280
            Y +PEVL G  +    DIWS
Sbjct: 200 EYRSPEVLLGAPWGCGADIWS 220

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 41/140 (29%), Positives = 64/140 (45%), Gaps = 7/140 (5%)
Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           E  +MQ L     V  +     EA+ + LVME+   G L   + +     ++    +   
Sbjct: 58  EANVMQQLDNPYIVRMIGIC--EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQ 115
Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL--AMRISNGQTLSGLAGS-PA- 261
           V   +KY  +   VHRD+   N+LL T    K++DFGL  A+R       +   G  P  
Sbjct: 116 VSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVK 175
Query: 262 YVAPEVLS-GNYSEKVDIWS 280
           + APE ++   +S K D+WS
Sbjct: 176 WYAPECINYYKFSSKSDVWS 195

>pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 40  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 98
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 99  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 158
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 159 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 218
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 219 MPPEAFMEGIFTSKTDTWS 237

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 82/196 (41%), Gaps = 30/196 (15%)
Query: 107 KVEVIGHGKFGSVWL-CR---SKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           K+  +G G FG V L C    +  +G   A K L+      HR     E++I++ L  H 
Sbjct: 35  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HE 93
Query: 158 GVVTLHSVYEEADC--FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV------ 209
            ++      E+A      LVME    G L D       Y  + +  + + +++       
Sbjct: 94  HIIKYKGCCEDAGAASLQLVMEYVPLGSLRD-------YLPRHSIGLAQLLLFAQQICEG 146
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGSPAY-VAP 265
           + Y H    +HRD+   N+LL     +K+ DFGLA  +  G     +     SP +  AP
Sbjct: 147 MAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYRVREDGDSPVFWYAP 206
Query: 266 EVL-SGNYSEKVDIWS 280
           E L    +    D+WS
Sbjct: 207 ECLKEYKFYYASDVWS 222

>pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 60  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 118
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 119 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 178
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 179 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 238
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 239 MPPEAFMEGIFTSKTDTWS 257

>pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 34  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 92
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 93  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 152
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 153 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 212
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 213 MPPEAFMEGIFTSKTDTWS 231

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 58/228 (25%), Positives = 88/228 (38%), Gaps = 40/228 (17%)
Query: 93  TQMGRKNKIEDDHTKVEV---IGHGKFGSVWLCRSKASGAE-----FACKTLRKG----- 139
           TQ+    K E     ++    +G G FG V    +   G E      A K L+       
Sbjct: 18  TQLPYNEKWEFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADE 77
Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM----------- 188
           +E +  E++IM HL  H  +V L           ++ E C  G L++ +           
Sbjct: 78  KEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPS 137
Query: 189 -----------VEVGQYSEQRAANIFK-DVMWVIKYCHDMGVVHRDIKPENILLTTSGKI 236
                       E G+  E R    F   V   + +      +HRD+   N+LLT     
Sbjct: 138 LAPGQDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 197
Query: 237 KLADFGLAMRISN--GQTLSGLAGSPA-YVAPE-VLSGNYSEKVDIWS 280
           K+ DFGLA  I N     + G A  P  ++APE +    Y+ + D+WS
Sbjct: 198 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWS 245

>pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 50  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 108
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 109 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 168
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 169 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 228
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 229 MPPEAFMEGIFTSKTDTWS 247

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 26/64 (40%), Positives = 38/64 (59%), Gaps = 3/64 (4%)
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPE 266
           +K  H   + HRDIK +N+LL  +    +ADFGLA++   G++     G  G+  Y+APE
Sbjct: 144 LKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPE 203
Query: 267 VLSG 270
           VL G
Sbjct: 204 VLEG 207

>pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 33  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 91
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA-------NIFKDVMW 208
           H  +V    V  ++    +++EL +GG L   + E      Q ++       ++ +D+  
Sbjct: 92  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 151
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
             +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 152 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 211
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 212 MPPEAFMEGIFTSKTDTWS 230

>pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 48  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVYSEQDELDFLMEALIISKFN- 106
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 107 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 166
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 167 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 226
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 227 MPPEAFMEGIFTSKTDTWS 245

>pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 52/199 (26%), Positives = 85/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 25  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 83
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA-------NIFKDVMW 208
           H  +V    V  ++    +++EL +GG L   + E      Q ++       ++ +D+  
Sbjct: 84  HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 143
Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
             +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 144 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKW 203
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 204 MPPEAFMEGIFTSKTDTWS 222

>pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 53/193 (27%), Positives = 85/193 (44%), Gaps = 19/193 (9%)
Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHT 157
           D+     ++G G FG V+  R  A G   A K L++     GE     EVE++  ++ H 
Sbjct: 30  DNFXNKNILGRGGFGKVYKGRL-ADGXLVAVKRLKEERTQGGELQFQTEVEMIS-MAVHR 87
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-------VGQYSEQR-AANIFKDVMWV 209
            ++ L           LV    + G +   + E       +     QR A    + + ++
Sbjct: 88  NLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYL 147
Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA--MRISNGQTLSGLAGSPAYVAPEV 267
             +C D  ++HRD+K  NILL    +  + DFGLA  M   +      + G   ++APE 
Sbjct: 148 HDHC-DPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDXHVXXAVRGXIGHIAPEY 206
Query: 268 LS-GNYSEKVDIW 279
           LS G  SEK D++
Sbjct: 207 LSTGKSSEKTDVF 219

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A   LR+       + EI+       
Sbjct: 48  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIMELREATSPKANK-EILDE----- 101
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 102 -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 160
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 161 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 220
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 221 ALESILHRIYTHQSDVWS 238

>pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 51  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 109
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 110 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 169
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 170 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 229
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 230 MPPEAFMEGIFTSKTDTWS 248

>pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 53/199 (26%), Positives = 84/199 (42%), Gaps = 25/199 (12%)
Query: 106 TKVEVIGHGKFGSVWLCR-----SKASGAEFACKTL-----RKGEETVHREVEIMQHLSG 155
           T +  +GHG FG V+  +     +  S  + A KTL      + E     E  I+   + 
Sbjct: 74  TLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN- 132
Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  +V    V  ++    +++EL +GG L   + E      Q ++    D++ V +    
Sbjct: 133 HQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIAC 192
Query: 212 ---YCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL--SGLAGSPA-Y 262
              Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  +
Sbjct: 193 GCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKW 252
Query: 263 VAPE-VLSGNYSEKVDIWS 280
           + PE  + G ++ K D WS
Sbjct: 253 MPPEAFMEGIFTSKTDTWS 271

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+  G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 21  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 74
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 75  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 194 ALESILHRIYTHQSDVWS 211

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+  G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 14  ETEFKKIKVLSSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 67
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 68  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 187 ALESILHRIYTHQSDVWS 204

>pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329

Iteration: 1
 Score = 48.9 bits (115), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 16  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 69
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 70  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 128
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G      ++
Sbjct: 129 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 188
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 189 ALESILHRIYTHQSDVWS 206

>pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 21  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 74
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 75  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 133
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G      ++
Sbjct: 134 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 193
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 194 ALESILHRIYTHQSDVWS 211

>pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 84/198 (42%), Gaps = 26/198 (13%)
Query: 102 EDDHTKVEVIGHGKFGSV----WLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHT 157
           E +  K++V+G G FG+V    W+   +      A K LR+       + EI+       
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANK-EILDE----- 67
Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVM--WVIK- 211
               + SV     C  L + L S  +LI Q++  G    Y  +   NI    +  W ++ 
Sbjct: 68  -AYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 126
Query: 212 -----YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---YV 263
                Y  D  +VHRD+   N+L+ T   +K+ DFG A  +   +      G      ++
Sbjct: 127 AKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGRAKLLGAEEKEYHAEGGKVPIKWM 186
Query: 264 APE-VLSGNYSEKVDIWS 280
           A E +L   Y+ + D+WS
Sbjct: 187 ALESILHRIYTHQSDVWS 204

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 52/202 (25%), Positives = 87/202 (43%), Gaps = 33/202 (16%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 37  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 96
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQMV----EVGQYSEQRAANIFKDVMWV------ 209
            L  +  +      +++E C  G L   +     E   Y E    +++KD + +      
Sbjct: 97  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKEA-PEDLYKDFLTLEHLICY 155
Query: 210 -------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP 260
                  +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P
Sbjct: 156 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 215
Query: 261 -AYVAPE-VLSGNYSEKVDIWS 280
             ++APE +    Y+ + D+WS
Sbjct: 216 LKWMAPETIFDRVYTIQSDVWS 237

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/222 (23%), Positives = 87/222 (39%), Gaps = 67/222 (30%)
Query: 104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHREVEIM------------ 150
           D T +E +G G++G VW  R    G   A K    + E++  RE E+             
Sbjct: 9   DITLLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILG 66
Query: 151 --------QHLSGHTGVVT----LHSVYE--------EADCFHLVMELCSGGRLIDQMVE 190
                   +H S    ++T    + S+Y+           C  +V+ + SG  L    +E
Sbjct: 67  FIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASG--LAHLHIE 124
Query: 191 VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG 250
           +     + A                  + HRD+K +NIL+  +G+  +AD GLA+  S  
Sbjct: 125 IFGTQGKPA------------------IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQS 166
Query: 251 QTLSGLAGSP-----AYVAPEVLSGNYS-------EKVDIWS 280
                +  +P      Y+APEVL            ++VDIW+
Sbjct: 167 TNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAE-------FACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +     +        A K L+     K    +  E+E+M+ +  H  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPSHNPEEQLSSKDLVSC 155
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDXXKKTTNGRLP 215
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 216 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      +++E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 214
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 215 KWMAPETIFDRVYTIQSDVWS 235

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      +++E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 86  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 206 KWMAPETIFDRVYTIQSDVWS 226

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      +++E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 214
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 215 KWMAPETIFDRVYTIQSDVWS 235

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 47.0 bits (110), Expect = 2e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 72  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 131
Query: 161 TL-HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      +++E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 132 NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 191
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 192 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 251
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 252 KWMAPETIFDRVYTIQSDVWS 272

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 25  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 84
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 85  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 144
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 145 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 204
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 205 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 255

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 107 KVEVIGHGKFGSVWL-CR---SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHT 157
           K+  +G G FG V L C    +  +G   A K L++G          RE+EI++ L  H 
Sbjct: 13  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY-HE 71
Query: 158 GVVTLHSVYEEA--DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V      E+       LVME    G L D       Y  +    + + +++  + C  
Sbjct: 72  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD-------YLPRHCVGLAQLLLFAQQICEG 124
Query: 216 MGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGSPAY-VAP 265
           M        +HR +   N+LL     +K+ DFGLA  +  G     +     SP +  AP
Sbjct: 125 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 184
Query: 266 EVL-SGNYSEKVDIWS 280
           E L    +    D+WS
Sbjct: 185 ECLKECKFYYASDVWS 200

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 89/201 (44%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      +++E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 154
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 155 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDXVRKGDARLPL 214
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 215 KWMAPETIFDRVYTIQSDVWS 235

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 47.0 bits (110), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 29  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 88
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 89  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 148
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 149 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 208
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 209 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 259

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 52/196 (26%), Positives = 80/196 (40%), Gaps = 30/196 (15%)
Query: 107 KVEVIGHGKFGSVWL-CR---SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHT 157
           K+  +G G FG V L C    +  +G   A K L++G          RE+EI++ L  H 
Sbjct: 12  KIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKEGCGPQLRSGWQREIEILRTLY-HE 70
Query: 158 GVVTLHSVYEEA--DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
            +V      E+       LVME    G L D       Y  +    + + +++  + C  
Sbjct: 71  HIVKYKGCCEDQGEKSVQLVMEYVPLGSLRD-------YLPRHCVGLAQLLLFAQQICEG 123
Query: 216 MGV------VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL---AGSPAY-VAP 265
           M        +HR +   N+LL     +K+ DFGLA  +  G     +     SP +  AP
Sbjct: 124 MAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 183
Query: 266 EVL-SGNYSEKVDIWS 280
           E L    +    D+WS
Sbjct: 184 ECLKECKFYYASDVWS 199

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 216 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAE-------FACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +     +        A K L+     K    +  E+E+M+ +  H  
Sbjct: 28  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 87
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 88  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 147
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 148 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 207
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 208 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 258

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 46.6 bits (109), Expect = 3e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPSHNPEEQLSSKDLVSC 155
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 216 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      ++ E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLPL 205
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 206 KWMAPETIFDRVYTIQSDVWS 226

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      ++ E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 206 KWMAPETIFDRVYTIQSDVWS 226

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 48/204 (23%), Positives = 86/204 (42%), Gaps = 35/204 (17%)
Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHREVEI-----MQHLSGHTGV 159
           T +E +G G++G VW  R    G   A K    + E++  RE E+     ++H +    +
Sbjct: 40  TLLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 97
Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---IKYCH-- 214
            +  +    +    L+      G L D +    Q +     +  + V+ +   + + H  
Sbjct: 98  ASDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIE 153
Query: 215 ------DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP-----AYV 263
                    + HRD+K +NIL+  +G+  +AD GLA+  S       +  +P      Y+
Sbjct: 154 IFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYM 213
Query: 264 APEVLSGNYS-------EKVDIWS 280
           APEVL            ++VDIW+
Sbjct: 214 APEVLDETIQVDCFDSYKRVDIWA 237

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 50/201 (24%), Positives = 88/201 (43%), Gaps = 31/201 (15%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 26  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 85
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAA--NIFKDVMWV------- 209
            L  +  +      ++ E C  G L   +  +  ++   + A  +++KD + +       
Sbjct: 86  NLLGACTKPGGPLMVITEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYS 145
Query: 210 ------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP- 260
                 +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P 
Sbjct: 146 FQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPL 205
Query: 261 AYVAPE-VLSGNYSEKVDIWS 280
            ++APE +    Y+ + D+WS
Sbjct: 206 KWMAPETIFDRVYTIQSDVWS 226

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/198 (25%), Positives = 85/198 (42%), Gaps = 29/198 (14%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---IKYCHDM 216
            L  +  +      +++E C  G L    +   +       +++KD + +   I Y   +
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLIXYSFQV 153
Query: 217 G----------VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AYV 263
                       +HRD+   NILL+    +K+ DFGLA  I         G A  P  ++
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 264 APE-VLSGNYSEKVDIWS 280
           APE +    Y+ + D+WS
Sbjct: 214 APETIFDRVYTIQSDVWS 231

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 21  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 80
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEV---------GQYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 81  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 140
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 141 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 200
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 201 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 251

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 71/326 (21%), Positives = 115/326 (35%), Gaps = 76/326 (23%)
Query: 111 IGHGKFGSVWLCRSKASG-AEFACKTLR---KGEETVHREVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V  C   A G ++ A K +R   K  E    E+ +++ +           V 
Sbjct: 27  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 86
Query: 167 EEADCFHLVMELCSGGRLIDQMV-------EVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
             +D F+    +C    L+ +             Y      ++   +   +++ H+  + 
Sbjct: 87  M-SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLT 145
Query: 220 HRDIKPENILLTTS-------------------GKIKLADFGLAMRISNGQTLSGLAGSP 260
           H D+KPENIL   S                     I++ADFG A    + +  + +  + 
Sbjct: 146 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSA--TFDHEHHTTIVATR 203
Query: 261 AYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDS-------LEAVFDAIKNVKL 312
            Y  PEV L   +++  D+WS              F+          +E +   I +  +
Sbjct: 204 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 263
Query: 313 D-------FHSG--VWETVSKPAR------------------------DLMARMLTRDVS 339
                   F+ G  VW+  S   R                        DLM RML  D +
Sbjct: 264 HRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 323
Query: 340 ARITADEVLRHPWILFYT--ERTLRT 363
            RIT  E L HP+    T  ER+  T
Sbjct: 324 QRITLAEALLHPFFAGLTPEERSFHT 349

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRS-------KASGAEFACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +            + A K L+     K    +  E+E+M+ +  H  
Sbjct: 77  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 136
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEVG---------QYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 137 IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSC 196
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 197 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 256
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSXXXXX-XXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 257 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 307

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 52/220 (23%), Positives = 86/220 (39%), Gaps = 67/220 (30%)
Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVHREVEIM-------------- 150
           T +E +G G++G VW  R    G   A K    + E++  RE E+               
Sbjct: 11  TLLECVGKGRYGEVW--RGSWQGENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68
Query: 151 ------QHLSGHTGVVT----LHSVYE--------EADCFHLVMELCSGGRLIDQMVEVG 192
                 +H S    ++T    + S+Y+           C  +V+ + SG  L    +E+ 
Sbjct: 69  ASDMTSRHSSTQLWLITHYHEMGSLYDYLQLTTLDTVSCLRIVLSIASG--LAHLHIEIF 126
Query: 193 QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT 252
               + A                  + HRD+K +NIL+  +G+  +AD GLA+  S    
Sbjct: 127 GTQGKPA------------------IAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN 168
Query: 253 LSGLAGSP-----AYVAPEVLSGNYS-------EKVDIWS 280
              +  +P      Y+APEVL            ++VDIW+
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWA 208

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 53/232 (22%), Positives = 94/232 (40%), Gaps = 35/232 (15%)
Query: 111 IGHGKFGSVWLCRSKASGAE-------FACKTLR-----KGEETVHREVEIMQHLSGHTG 158
           +G G FG V L  +     +        A K L+     K    +  E+E+M+ +  H  
Sbjct: 36  LGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKN 95
Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQM-------VEV---------GQYSEQRAANI 202
           ++ L     +    ++++E  S G L + +       +E           Q S +   + 
Sbjct: 96  IINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPSHNPEEQLSSKDLVSC 155
Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----GQTLSGLAG 258
              V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     +T +G   
Sbjct: 156 AYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLP 215
Query: 259 SPAYVAPEVLSGN-YSEKVDIWSX-XXXXXXXXXXXXPFKGDSLEAVFDAIK 308
              ++APE L    Y+ + D+WS              P+ G  +E +F  +K
Sbjct: 216 V-KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLK 266

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 46.2 bits (108), Expect = 4e-05,   Method: Compositional matrix adjust.
 Identities = 51/202 (25%), Positives = 87/202 (43%), Gaps = 34/202 (16%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 36  LGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 95
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQM----VEVGQYSEQRAANIFKDVMWV------ 209
            L  +  +      +++E C  G L   +     E   Y  +   +++KD + +      
Sbjct: 96  NLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPY--KTPEDLYKDFLTLEHLICY 153
Query: 210 -------IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN--GQTLSGLAGSP 260
                  +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P
Sbjct: 154 SFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPDXVRKGDARLP 213
Query: 261 -AYVAPE-VLSGNYSEKVDIWS 280
             ++APE +    Y+ + D+WS
Sbjct: 214 LKWMAPETIFDRVYTIQSDVWS 235

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 72/326 (22%), Positives = 113/326 (34%), Gaps = 76/326 (23%)
Query: 111 IGHGKFGSVWLCRSKASG-AEFACKTLR---KGEETVHREVEIMQHLSGHTGVVTLHSVY 166
           +G G FG V  C   A G ++ A K +R   K  E    E+ +++ +           V 
Sbjct: 59  LGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFLCVL 118
Query: 167 EEADCFHLVMELCSGGRLIDQMV-------EVGQYSEQRAANIFKDVMWVIKYCHDMGVV 219
             +D F+    +C    L+ +             Y      ++   +   +++ H+  + 
Sbjct: 119 M-SDWFNFHGHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLT 177
Query: 220 HRDIKPENILLTTS-------------------GKIKLADFGLAMRISNGQTLSGLAGSP 260
           H D+KPENIL   S                     I++ADFG A       T   +  + 
Sbjct: 178 HTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEHHT--TIVATR 235
Query: 261 AYVAPEV-LSGNYSEKVDIWSXXXXXXXXXXXXXPFKGDS-------LEAVFDAIKNVKL 312
            Y  PEV L   +++  D+WS              F+          +E +   I +  +
Sbjct: 236 HYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMI 295
Query: 313 D-------FHSG--VWETVSKPAR------------------------DLMARMLTRDVS 339
                   F+ G  VW+  S   R                        DLM RML  D +
Sbjct: 296 HRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPA 355
Query: 340 ARITADEVLRHPWILFYT--ERTLRT 363
            RIT  E L HP+    T  ER+  T
Sbjct: 356 QRITLAEALLHPFFAGLTPEERSFHT 381

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 45.8 bits (107), Expect = 5e-05,   Method: Compositional matrix adjust.
 Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 29/198 (14%)
Query: 111 IGHGKFGSV-----WLCRSKASGAEFACKTLRKG-EETVHR----EVEIMQHLSGHTGVV 160
           +G G FG V     +     A+    A K L++G   + HR    E++I+ H+  H  VV
Sbjct: 35  LGRGAFGQVIEADAFGIDKTATXRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVV 94
Query: 161 TLH-SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV---------- 209
            L  +  +      +++E C  G L    +   +       +++KD + +          
Sbjct: 95  NLLGACTKPGGPLMVIVEFCKFGNL-STYLRSKRNEFVPYKDLYKDFLTLEHLICYSFQV 153
Query: 210 ---IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSP-AYV 263
              +++      +HRD+   NILL+    +K+ DFGLA  I         G A  P  ++
Sbjct: 154 AKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 213
Query: 264 APE-VLSGNYSEKVDIWS 280
           APE +    Y+ + D+WS
Sbjct: 214 APETIFDRVYTIQSDVWS 231
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	469
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-118
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	1e-118
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	1e-117
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	1e-116
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	1e-115
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	1e-115
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	1e-115
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-114
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	1e-114
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	1e-114
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	1e-114
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	1e-114
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	1e-111
3bhy_A	283	Death-associated protein kinase 3; death associate	1e-111
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-111
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	1e-111
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	1e-110
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	1e-110
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	1e-110
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	1e-110
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	1e-108
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	1e-107
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	1e-107
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	1e-106
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	1e-106
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	1e-106
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	1e-105
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	1e-105
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-105
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	1e-104
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	1e-104
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	1e-103
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	3e-99
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	1e-85
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	1e-84
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	6e-84
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	1e-82
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	5e-82
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	2e-81
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	4e-81
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-81
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	7e-81
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-80
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	3e-77
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	2e-76
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	7e-76
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	3e-75
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	4e-75
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	5e-74
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	7e-74
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	8e-73
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	2e-71
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-71
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	3e-71
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	5e-71
2a19_B	284	Interferon-induced, double-stranded RNA-activated	9e-71
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-70
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	3e-70
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	3e-70
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	9e-70
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	5e-69
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	5e-69
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	6e-69
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	1e-68
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	3e-68
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	4e-67
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	8e-66
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	4e-65
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	1e-64
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	2e-63
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	1e-62
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	2e-62
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	3e-61
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	3e-58
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	1e-56
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	1e-56
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	2e-56
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-56
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	5e-56
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-56
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	2e-55
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	2e-55
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	3e-55
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	3e-55
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	7e-55
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	4e-54
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	2e-53
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	2e-53
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	2e-53
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	5e-53
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	6e-53
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-52
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	1e-52
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	2e-52
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	2e-52
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	3e-52
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	4e-51
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	3e-49
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	4e-47
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	2e-46
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-46
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	5e-46
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	6e-46
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	9e-46
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	2e-45
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	4e-45
3fme_A	290	Dual specificity mitogen-activated protein kinase;	6e-45
3an0_A	340	Dual specificity mitogen-activated protein kinase;	8e-45
3aln_A	327	Dual specificity mitogen-activated protein kinase;	1e-44
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	1e-44
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-44
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	2e-44
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-44
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	6e-44
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	7e-44
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-43
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	3e-43
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	3e-43
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	5e-43
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	1e-42
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	2e-42
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	6e-42
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	9e-42
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	2e-41
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	4e-41
3niz_A	311	Rhodanese family protein; structural genomics, str	3e-40
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	4e-40
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	4e-40
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	7e-40
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	1e-39
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	5e-39
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	9e-39
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	2e-38
3ork_A	311	Serine/threonine protein kinase; structural genomi	2e-38
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-38
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	6e-38
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	6e-37
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	1e-36
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	2e-35
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	3e-35
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-34
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	2e-34
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	8e-34
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	3e-33
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	3e-33
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	3e-33
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	8e-33
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	1e-32
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	1e-32
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	2e-32
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	3e-32
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	3e-31
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	4e-31
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	6e-31
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-31
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	2e-30
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-29
3q4u_A	301	Activin receptor type-1; structural genomics conso	3e-29
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	5e-28
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	5e-28
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-28
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	3e-27
3uqc_A	286	Probable conserved transmembrane protein; structur	4e-27
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	3e-26
3soc_A	322	Activin receptor type-2A; structural genomics cons	3e-25
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	7e-25
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	2e-24
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	2e-24
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	6e-23
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	1e-22
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	1e-22
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	2e-22
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	2e-22
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	2e-22
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	3e-22
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	5e-22
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	6e-22
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	1e-21
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	2e-21
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	2e-21
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	3e-21
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	4e-21
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	5e-21
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	5e-21
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-21
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	6e-21
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	1e-20
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	1e-20
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	1e-20
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	1e-20
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	1e-20
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-20
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	3e-20
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	4e-20
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	5e-20
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	5e-20
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	8e-20
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	1e-19
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-19
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	2e-19
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-19
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-19
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	4e-19
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	4e-19
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	5e-19
3pls_A	298	Macrophage-stimulating protein receptor; protein k	6e-19
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	8e-19
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	8e-19
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	9e-19
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	1e-18
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	6e-04
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	2e-18
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-18
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	3e-18
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	4e-18
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	3e-17
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	4e-17
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	6e-17
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	6e-17
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	7e-17
4aoj_A	329	High affinity nerve growth factor receptor; transf	7e-17
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	9e-17
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	1e-16
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-16
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	3e-16
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-16
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	3e-16
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	5e-16
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	9e-15
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	2e-14
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	5e-14
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	9e-14
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	1e-13
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	1e-13
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	1e-11
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-11
1vt4_I	1221	APAF-1 related killer DARK; drosophila apoptosome,	3e-11
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	3e-09
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	2e-06
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	4e-04

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  347 bits (893), Expect = e-118
 Identities = 91/274 (33%), Positives = 140/274 (51%), Gaps = 14/274 (5%)

Query: 92  HTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHRE 146
              +  +  I+D       +G G FG V L   ++SG E   KT+ K       E +  E
Sbjct: 11  RENLYFQGTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAE 70

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----VGQYSEQRAANI 202
           +E+++ L  H  ++ +  V+E+    ++VME C GG L++++V         SE   A +
Sbjct: 71  IEVLKSLD-HPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAEL 129

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGS 259
            K +M  + Y H   VVH+D+KPENIL         IK+ DFGLA    + +  +  AG+
Sbjct: 130 MKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGT 189

Query: 260 PAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW 319
             Y+APEV   + + K DIWSAGV+++ LL   LPF G SLE V       + ++     
Sbjct: 190 ALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAV-EC 248

Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             ++  A DL+ +MLT+D   R +A +VL H W 
Sbjct: 249 RPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWF 282

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  345 bits (888), Expect = e-118
 Identities = 100/271 (36%), Positives = 149/271 (54%), Gaps = 10/271 (3%)

Query: 92  HTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHR 145
              +  +    + +  V ++G G FG V  C+ + +  E+A K + K         T+ R
Sbjct: 11  RENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILR 70

Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           EVE+++ L  H  ++ L  + E++  F++V EL +GG L D++++  ++SE  AA I K 
Sbjct: 71  EVELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQ 129

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAY 262
           V   I Y H   +VHRD+KPENILL +  K   IK+ DFGL+        +    G+  Y
Sbjct: 130 VFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYY 189

Query: 263 VAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           +APEVL G Y EK D+WSAGV+L+ LL    PF G +   +   ++  K  F    W T+
Sbjct: 190 IAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTI 249

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S  A+DL+ +MLT   S RITA + L HPWI
Sbjct: 250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  344 bits (884), Expect = e-117
 Identities = 95/264 (35%), Positives = 136/264 (51%), Gaps = 8/264 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
            K  I   +T    IG G +G V +   K +    A K + K      +   +E+EIM+ 
Sbjct: 3   TKGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKS 62

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           L  H  ++ L+  +E+    +LVMELC+GG L +++V    + E  AA I KDV+  + Y
Sbjct: 63  LD-HPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAY 121

Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           CH + V HRD+KPEN L  T      +KL DFGLA R   G+ +    G+P YV+P+VL 
Sbjct: 122 CHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLE 181

Query: 270 GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           G Y  + D WSAGV+++ LL    PF   +   V   I+     F    W  VS  A  L
Sbjct: 182 GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESL 241

Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + R+LT+    RIT+ + L H W 
Sbjct: 242 IRRLLTKSPKQRITSLQALEHEWF 265

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  341 bits (877), Expect = e-116
 Identities = 87/293 (29%), Positives = 138/293 (47%), Gaps = 20/293 (6%)

Query: 90  DVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------- 138
                    +   +++   E++G G    V  C  K +  E+A K +             
Sbjct: 4   AALPGSHSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEV 63

Query: 139 --GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE 196
               E   +EV+I++ +SGH  ++ L   YE    F LV +L   G L D + E    SE
Sbjct: 64  QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSE 123

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
           +    I + ++ VI   H + +VHRD+KPENILL     IKL DFG + ++  G+ L  +
Sbjct: 124 KETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREV 183

Query: 257 AGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN 309
            G+P+Y+APE++          Y ++VD+WS GV+++ LL  + PF       +   I +
Sbjct: 184 CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMS 243

Query: 310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
               F S  W+  S   +DL++R L      R TA+E L HP+   Y    +R
Sbjct: 244 GNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVR 296

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  347 bits (892), Expect = e-115
 Identities = 100/270 (37%), Positives = 149/270 (55%), Gaps = 10/270 (3%)

Query: 93  TQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHRE 146
             +  +    + +  V ++G G FG V  C+ + +  E+A K + K         T+ RE
Sbjct: 12  ENLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILRE 71

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           VE+++ L  H  ++ L  + E++  F++V EL +GG L D++++  ++SE  AA I K V
Sbjct: 72  VELLKKLD-HPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQV 130

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYV 263
              I Y H   +VHRD+KPENILL +  K   IK+ DFGL+        +    G+  Y+
Sbjct: 131 FSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYI 190

Query: 264 APEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           APEVL G Y EK D+WSAGV+L+ LL    PF G +   +   ++  K  F    W T+S
Sbjct: 191 APEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTIS 250

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
             A+DL+ +MLT   S RITA + L HPWI
Sbjct: 251 DDAKDLIRKMLTFHPSLRITATQCLEHPWI 280

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  342 bits (880), Expect = e-115
 Identities = 115/368 (31%), Positives = 180/368 (48%), Gaps = 30/368 (8%)

Query: 70  GASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGA 129
           G   + +  G+ + R    +   +      K  D++   E +G G F  V  C  K +G 
Sbjct: 1   GPHMASMTGGQQMGRGSEFMMNAST-----KFSDNYDVKEELGKGAFSVVRRCVHKTTGL 55

Query: 130 EFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR 183
           EFA K +          + + RE  I + L  H  +V LH   +E    +LV +L +GG 
Sbjct: 56  EFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHYLVFDLVTGGE 114

Query: 184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLAD 240
           L + +V    YSE  A++  + ++  I YCH  G+VHR++KPEN+LL +  K   +KLAD
Sbjct: 115 LFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLAD 174

Query: 241 FGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS 299
           FGLA+ +++ +   G AG+P Y++PEVL  + YS+ VDIW+ GV+L+ LLV   PF  + 
Sbjct: 175 FGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234

Query: 300 LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI------ 353
              ++  IK    D+ S  W+TV+  A+ L+  MLT +   RITAD+ L+ PWI      
Sbjct: 235 QHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERV 294

Query: 354 -----LFYTERTLRTLTIKSKLK---NQVGASHHHPAILSGVESDENKIDRGSRNDESHA 405
                   T   L+    + KLK        +  + + L     ++ +    S   ES  
Sbjct: 295 ASAIHRQDTVDCLKKFNARRKLKGAILTTMIATRNLSNLGRNLLNKKEQGPPSTIKESSE 354

Query: 406 LSSSESLN 413
            S +   N
Sbjct: 355 SSQTIDDN 362

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  342 bits (878), Expect = e-115
 Identities = 97/365 (26%), Positives = 155/365 (42%), Gaps = 27/365 (7%)

Query: 8   SETDATEDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAP 67
             +       K+   +R  I        +  R   R   D  +Q               P
Sbjct: 7   HSSGVDNKFNKERRRARREIRHLPNLNREQRRAFIRSLRDDPSQSANLLAEAKKLNDAQP 66

Query: 68  PCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKAS 127
               +      G          D         +    +   +VIG G    V  C  +A+
Sbjct: 67  KGTENLYFQSMGP--------EDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRAT 118

Query: 128 GAEFACKTLRK------------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV 175
           G EFA K +                E   RE  I++ ++GH  ++TL   YE +    LV
Sbjct: 119 GHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLV 178

Query: 176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK 235
            +L   G L D + E    SE+   +I + ++  + + H   +VHRD+KPENILL  + +
Sbjct: 179 FDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQ 238

Query: 236 IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHAL 288
           I+L+DFG +  +  G+ L  L G+P Y+APE+L          Y ++VD+W+ GV+L  L
Sbjct: 239 IRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTL 298

Query: 289 LVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVL 348
           L  + PF       +   I   +  F S  W+  S   +DL++R+L  D  AR+TA++ L
Sbjct: 299 LAGSPPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQAL 358

Query: 349 RHPWI 353
           +HP+ 
Sbjct: 359 QHPFF 363

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  345 bits (888), Expect = e-114
 Identities = 96/277 (34%), Positives = 146/277 (52%), Gaps = 21/277 (7%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----------------G 139
           ++ KI + + KV  +G G +G V LC+ K   +E A K ++K                  
Sbjct: 30  KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKF 89

Query: 140 EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA 199
            E ++ E+ +++ L  H  ++ L  V+E+   F+LV E   GG L +Q++   ++ E  A
Sbjct: 90  HEEIYNEISLLKSLD-HPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDA 148

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGL 256
           ANI K ++  I Y H   +VHRDIKPENILL        IK+ DFGL+   S    L   
Sbjct: 149 ANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDR 208

Query: 257 AGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS 316
            G+  Y+APEVL   Y+EK D+WS GV+++ LL    PF G + + +   ++  K  F  
Sbjct: 209 LGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDF 268

Query: 317 GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             W+ +S  A++L+  MLT D + R TA+E L   WI
Sbjct: 269 NDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWI 305

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  337 bits (867), Expect = e-114
 Identities = 101/264 (38%), Positives = 151/264 (57%), Gaps = 11/264 (4%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHL 153
           K  D++   E +G G F  V  C  K +G EFA K +          + + RE  I + L
Sbjct: 3   KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKL 62

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
             H  +V LH   +E    +LV +L +GG L + +V    YSE  A++  + ++  I YC
Sbjct: 63  Q-HPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYC 121

Query: 214 HDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG 270
           H  G+VHR++KPEN+LL +  K   +KLADFGLA+ +++ +   G AG+P Y++PEVL  
Sbjct: 122 HSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKK 181

Query: 271 N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           + YS+ VDIW+ GV+L+ LLV   PF  +    ++  IK    D+ S  W+TV+  A+ L
Sbjct: 182 DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL 241

Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           +  MLT +   RITAD+ L+ PWI
Sbjct: 242 IDSMLTVNPKKRITADQALKVPWI 265

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  344 bits (885), Expect = e-114
 Identities = 99/273 (36%), Positives = 152/273 (55%), Gaps = 11/273 (4%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEI 149
                 D +    V+G G FG V LC+ K +G E A K + K        +E++ REV++
Sbjct: 20  STAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQL 79

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
           ++ L  H  ++ L+  +E+   F+LV E+ +GG L D+++   ++SE  AA I + V+  
Sbjct: 80  LKQLD-HPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSG 138

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I Y H   +VHRD+KPEN+LL +  K   I++ DFGL+      + +    G+  Y+APE
Sbjct: 139 ITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPE 198

Query: 267 VLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           VL G Y EK D+WS GV+L+ LL    PF G +   +   ++  K  F    W+ VS+ A
Sbjct: 199 VLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESA 258

Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYTER 359
           +DL+ +MLT   S RI+A + L H WI  YT+ 
Sbjct: 259 KDLIRKMLTYVPSMRISARDALDHEWIQTYTKE 291

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  344 bits (885), Expect = e-114
 Identities = 96/266 (36%), Positives = 149/266 (56%), Gaps = 10/266 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIM 150
           +K  + + + +V+ +G G +G V LCR K +  E A K +RK          +  EV ++
Sbjct: 31  KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVL 90

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + L  H  ++ L+  +E+   ++LVME   GG L D+++   +++E  AA I K V+  +
Sbjct: 91  KLLD-HPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGV 149

Query: 211 KYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            Y H   +VHRD+KPEN+LL +  K   IK+ DFGL+    N + +    G+  Y+APEV
Sbjct: 150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEV 209

Query: 268 LSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
           L   Y EK D+WS GV+L  LL    PF G + + +   ++  K  F S  W+ VS+ A+
Sbjct: 210 LRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK 269

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+ +ML  D   RI+A + L HPWI
Sbjct: 270 DLIKQMLQFDSQRRISAQQALEHPWI 295

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  338 bits (870), Expect = e-114
 Identities = 98/307 (31%), Positives = 153/307 (49%), Gaps = 13/307 (4%)

Query: 84  RKIGCIDVHTQMGRKN-KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET 142
           + +G   +  Q+ R + +  D +   E IG G +     C  KA+  EFA K + K +  
Sbjct: 2   QTVGVHSIVQQLHRNSIQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD 61

Query: 143 VHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANI 202
              E+EI+     H  ++TL  VY++    ++V EL  GG L+D+++    +SE+ A+ +
Sbjct: 62  PTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAV 121

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTT----SGKIKLADFGLAMRI-SNGQTLSGLA 257
              +   ++Y H  GVVHRD+KP NIL          I++ DFG A ++ +    L    
Sbjct: 122 LFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPC 181

Query: 258 GSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPF---KGDSLEAVFDAIKNVKLD 313
            +  +VAPEVL    Y    DIWS GVLL+ +L    PF     D+ E +   I + K  
Sbjct: 182 YTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFS 241

Query: 314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE---RTLRTLTIKSKL 370
              G W +VS  A+DL+++ML  D   R+TA  VLRHPWI+ + +     L        +
Sbjct: 242 LSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWDQLPQYQLNRQDAPHLV 301

Query: 371 KNQVGAS 377
           K  + A+
Sbjct: 302 KGAMAAT 308

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  331 bits (851), Expect = e-111
 Identities = 93/309 (30%), Positives = 150/309 (48%), Gaps = 29/309 (9%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 5   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 64

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 65  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTT----SGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183

Query: 263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           VAPE+++      + D+WS GV+ + LL  A PF GD+ +     +  V  +F    +  
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 243

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI-------------LFYTERTLRTLTIKS 368
            S  A+D + R+L +D   R+T  + L+HPWI                     +    + 
Sbjct: 244 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDTQQALSRKASAVNMEKFKKFAARK 303

Query: 369 KLKNQVGAS 377
           K  N  G  
Sbjct: 304 KSNNGSGGG 312

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  329 bits (846), Expect = e-111
 Identities = 91/279 (32%), Positives = 143/279 (51%), Gaps = 16/279 (5%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHREVEIM 150
           +ED +   E +G G+F  V  CR K +G E+A K ++K            E + REV I+
Sbjct: 3   VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNIL 62

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           + +  H  ++TLH ++E      L++EL SGG L D + E    +E  A    K ++  +
Sbjct: 63  REIR-HPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGV 121

Query: 211 KYCHDMGVVHRDIKPENILLTT----SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
            Y H   + H D+KPENI+L      + +IKL DFG+A +I  G     + G+P +VAPE
Sbjct: 122 HYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPE 181

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +++      + D+WS GV+ + LL  A PF G++ +     I  V  DF    +   S+ 
Sbjct: 182 IVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL 241

Query: 326 ARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTL 364
           A+D + R+L +D   R+T  + L H WI     R +R  
Sbjct: 242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIRRRNVRGE 280

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  334 bits (859), Expect = e-111
 Identities = 105/317 (33%), Positives = 162/317 (51%), Gaps = 23/317 (7%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHL 153
           +  +++   E +G G F  V  C    +G E+A   +          + + RE  I + L
Sbjct: 8   RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLL 67

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
             H  +V LH    E    +L+ +L +GG L + +V    YSE  A++  + ++  + +C
Sbjct: 68  K-HPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHC 126

Query: 214 HDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLS 269
           H MGVVHR++KPEN+LL +  K   +KLADFGLA+ +    Q   G AG+P Y++PEVL 
Sbjct: 127 HQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLR 186

Query: 270 GN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            + Y + VD+W+ GV+L+ LLV   PF  +    ++  IK    DF S  W+TV+  A+D
Sbjct: 187 KDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD 246

Query: 329 LMARMLTRDVSARITADEVLRHPWI-----------LFYTERTLRTLTIKSKLKNQVGAS 377
           L+ +MLT + S RITA E L+HPWI              T   L+    + KLK  +   
Sbjct: 247 LINKMLTINPSKRITAAEALKHPWISHRSTVASCMHRQETVDCLKKFNARRKLKGAILTV 306

Query: 378 HHHPAILSGVESDENKI 394
                  S  + +  K+
Sbjct: 307 MLATRNFSVRKQEIIKV 323

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  329 bits (845), Expect = e-111
 Identities = 87/292 (29%), Positives = 140/292 (47%), Gaps = 16/292 (5%)

Query: 97  RKNKIEDD---HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQH 152
           + +          K + +G G F     C  K S   FA K + K  E    +E+  ++ 
Sbjct: 2   KDSPFYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKL 61

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
             GH  +V LH V+ +     LVMEL +GG L +++ +   +SE  A+ I + ++  + +
Sbjct: 62  CEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSH 121

Query: 213 CHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVL 268
            HD+GVVHRD+KPEN+L T       IK+ DFG A     + Q L     +  Y APE+L
Sbjct: 122 MHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELL 181

Query: 269 SGN-YSEKVDIWSAGVLLHALLVAALPFKGD-------SLEAVFDAIKNVKLDFHSGVWE 320
           + N Y E  D+WS GV+L+ +L   +PF+         S   +   IK     F    W+
Sbjct: 182 NQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWK 241

Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKN 372
            VS+ A+DL+  +LT D + R+    +  + W+   ++ +   L     L +
Sbjct: 242 NVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQLSSNPLMTPDILGS 293

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  328 bits (843), Expect = e-110
 Identities = 100/314 (31%), Positives = 157/314 (50%), Gaps = 32/314 (10%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K            E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIERE 65

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVL-HHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTT----SGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           VAPE+++      + D+WS GV+ + LL  A PF GD+ +     I +V  DF    +  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSH 244

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERT-------------LRTLTIKS 368
            S+ A+D + ++L ++   R+T  E LRHPWI     +               R   ++ 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDNQQAMVRRESVVNLENFRKQYVRR 304

Query: 369 KLK---NQVGASHH 379
           + K   + V   +H
Sbjct: 305 RWKLSFSIVSLCNH 318

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  328 bits (842), Expect = e-110
 Identities = 78/293 (26%), Positives = 141/293 (48%), Gaps = 24/293 (8%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTL 162
           + +G GKF  V  C SK++G E+A K L+K          +  E+ +++       V+ L
Sbjct: 35  KELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINL 94

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
           H VYE      L++E  +GG +    +       SE     + K ++  + Y H   +VH
Sbjct: 95  HEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVH 154

Query: 221 RDIKPENILLTTS---GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKV 276
            D+KP+NILL++    G IK+ DFG++ +I +   L  + G+P Y+APE+L+ +  +   
Sbjct: 155 LDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTAT 214

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D+W+ G++ + LL    PF G+  +  +  I  V +D+    + +VS+ A D +  +L +
Sbjct: 215 DMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVK 274

Query: 337 DVSARITADEVLRHPWILFYTERT------------LRTLTIKSKLKNQVGAS 377
           +   R TA+  L H W+  +                 +  +++S       +S
Sbjct: 275 NPEKRPTAEICLSHSWLQQWDFENLFHPEETSSSSQTQDHSVRSSEDKTSKSS 327

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  329 bits (845), Expect = e-110
 Identities = 102/354 (28%), Positives = 165/354 (46%), Gaps = 36/354 (10%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
           ++ K+ED +   E +G G+F  V  CR K++G E+A K ++K            E + RE
Sbjct: 6   KQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIERE 65

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  ++TLH VYE      L++EL SGG L D + +    SE+ A +  K +
Sbjct: 66  VSILRQVL-HPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTT----SGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H   + H D+KPENI+L         IKL DFGLA  I +G     + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184

Query: 263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           VAPE+++      + D+WS GV+ + LL  A PF GD+ +     I  V  DF    +  
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQ 244

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERT-------------LRTLTIKS 368
            S+ A+D + ++L ++   R+T  E LRHPWI     +               +   ++ 
Sbjct: 245 TSELAKDFIRKLLVKETRKRLTIQEALRHPWITPVDTQQAMVRRESVVNLENFKKQYVRR 304

Query: 369 KLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALSSSESLNSESEVQDEG 422
           + K            +S        + +      S  L + ES   E+  + + 
Sbjct: 305 RWKLSFSI-------VSLCNHLTRSLMKKVHLRTSEDLRNCESDTEENIARRKA 351

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  322 bits (828), Expect = e-108
 Identities = 94/315 (29%), Positives = 158/315 (50%), Gaps = 12/315 (3%)

Query: 65  TAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRS 124
                 + ++    G         ID       ++ + D       +G G    V+ C+ 
Sbjct: 19  YFQSMSSVTASAAPGTASLVPDYWIDGS----NRDALSDFFEVESELGRGATSIVYRCKQ 74

Query: 125 KASGAEFACKTL--RKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGG 182
           K +   +A K L     ++ V  E+ ++  LS H  ++ L  ++E      LV+EL +GG
Sbjct: 75  KGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVLELVTGG 133

Query: 183 RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLA 239
            L D++VE G YSE+ AA+  K ++  + Y H+ G+VHRD+KPEN+L  T      +K+A
Sbjct: 134 ELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIA 193

Query: 240 DFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD 298
           DFGL+  + +   +  + G+P Y APE+L G  Y  +VD+WS G++ + LL    PF  +
Sbjct: 194 DFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDE 253

Query: 299 SLEA-VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT 357
             +  +F  I N +  F S  W+ VS  A+DL+ +++  D   R+T  + L+HPW+    
Sbjct: 254 RGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKA 313

Query: 358 ERTLRTLTIKSKLKN 372
              +   T + KL+ 
Sbjct: 314 ANFVHMDTAQKKLQE 328

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  322 bits (827), Expect = e-107
 Identities = 100/329 (30%), Positives = 151/329 (45%), Gaps = 34/329 (10%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------GEETVHREVEIM 150
             ED +   EVIG G F  V  C ++ +G +FA K +             E + RE  I 
Sbjct: 21  LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASIC 80

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDV 206
             L  H  +V L   Y      ++V E   G  L  ++V+       YSE  A++  + +
Sbjct: 81  HMLK-HPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQI 139

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRIS-NGQTLSGLAGSPAY 262
           +  ++YCHD  ++HRD+KP  +LL +   S  +KL  FG+A+++  +G    G  G+P +
Sbjct: 140 LEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHF 199

Query: 263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           +APEV+    Y + VD+W  GV+L  LL   LPF G   E +F+ I   K   +   W  
Sbjct: 200 MAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKMNPRQWSH 258

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI-----------LFYTERTLRTLTIKSKL 370
           +S+ A+DL+ RML  D + RIT  E L HPW+           L  T   LR    + KL
Sbjct: 259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKIHLPETVEQLRKFNARRKL 318

Query: 371 K---NQVGASHHHPAILSGVESDENKIDR 396
           K       +SH   +       +      
Sbjct: 319 KGAVLAAVSSHKFNSFYGDPPEELPDFSE 347

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  322 bits (827), Expect = e-107
 Identities = 92/292 (31%), Positives = 145/292 (49%), Gaps = 16/292 (5%)

Query: 97  RKNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+       REVE+    S 
Sbjct: 55  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQ 113

Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 114 CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 173

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+      +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 233

Query: 267 VLS-GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEA----VFDAIKNVKLDFHSGVWET 321
           VL    Y +  D+WS GV+++ LL    PF  +   A    +   I+  + +F +  W  
Sbjct: 234 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 293

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQ 373
           VS+  + L+  +L  + + R+T  E + HPWI+  T+     L     LK  
Sbjct: 294 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 345

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  317 bits (814), Expect = e-106
 Identities = 73/280 (26%), Positives = 135/280 (48%), Gaps = 8/280 (2%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGH 156
           ++ + +   E +G G+FG V  C   +S   +  K ++     +  V +E+ I+     H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIA-RH 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHD 215
             ++ LH  +E  +   ++ E  SG  + +++     + +E+   +    V   +++ H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 216 MGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-Y 272
             + H DI+PENI+  T  S  IK+ +FG A ++  G     L  +P Y APEV   +  
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
           S   D+WS G L++ LL    PF  ++ + + + I N +  F    ++ +S  A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 333 MLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKN 372
           +L ++  +R+TA E L+HPW+    ER    +    K + 
Sbjct: 241 LLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRR 280

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  317 bits (814), Expect = e-106
 Identities = 85/274 (31%), Positives = 141/274 (51%), Gaps = 22/274 (8%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------------GEETVHREV 147
            + D++   + +G G  G V L   + +  + A K + K                V  E+
Sbjct: 7   ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEI 66

Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
           EI++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E      F  ++
Sbjct: 67  EILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQML 124

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVA 264
             ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +  L G+P Y+A
Sbjct: 125 LAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLA 184

Query: 265 PEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA-VFDAIKNVKLDFHSGVW 319
           PEVL       Y+  VD WS GV+L   L    PF     +  + D I + K +F   VW
Sbjct: 185 PEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW 244

Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 278

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  316 bits (813), Expect = e-106
 Identities = 88/291 (30%), Positives = 142/291 (48%), Gaps = 37/291 (12%)

Query: 100 KIEDDHT-KVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLS 154
           + ED +  + +V+G G    V  C +  +  E+A K + K        V REVE++    
Sbjct: 9   RFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQ 68

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           GH  V+ L   +EE D F+LV E   GG ++  + +   ++E  A+ + +DV   + + H
Sbjct: 69  GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128

Query: 215 DMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNG--------QTLSGLAGSPAYV 263
           + G+ HRD+KPENIL     +   +K+ DF L   I             L    GS  Y+
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188

Query: 264 APEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSL---------------EA 302
           APEV+         Y ++ D+WS GV+L+ LL    PF G                    
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNM 248

Query: 303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           +F++I+  K +F    W  +S  A+DL++++L RD   R++A +VL+HPW+
Sbjct: 249 LFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWV 299

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  317 bits (814), Expect = e-105
 Identities = 87/287 (30%), Positives = 152/287 (52%), Gaps = 14/287 (4%)

Query: 97  RKNKIEDDHT--KVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIM 150
           ++  +   +T  K E++G G+FG V  C   A+G + A K ++      +E V  E+ +M
Sbjct: 81  KQGAVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVM 140

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWV 209
             L  H  ++ L+  +E  +   LVME   GG L D++++     +E       K +   
Sbjct: 141 NQLD-HANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEG 199

Query: 210 IKYCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
           I++ H M ++H D+KPENIL     + +IK+ DFGLA R    + L    G+P ++APEV
Sbjct: 200 IRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEV 259

Query: 268 LSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           ++ +  S   D+WS GV+ + LL    PF GD+     + I   + D     ++ +S+ A
Sbjct: 260 VNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEA 319

Query: 327 RDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQ 373
           ++ ++++L ++ S RI+A E L+HPW+   ++  L +     K KN+
Sbjct: 320 KEFISKLLIKEKSWRISASEALKHPWL---SDHKLHSRLSAQKKKNR 363

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  315 bits (809), Expect = e-105
 Identities = 89/295 (30%), Positives = 142/295 (48%), Gaps = 20/295 (6%)

Query: 97  RKNKIEDDHT-KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +K  + DD+    +V+G G  G V  C  + +G + A K L        +EV+     SG
Sbjct: 22  KKYAVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYD-SPKARQEVDHHWQASG 80

Query: 156 HTGVVTLHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  ++ME   GG L  ++ E G   ++E+ AA I +D+   
Sbjct: 81  GPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTA 140

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I++ H   + HRD+KPEN+L T+  K   +KL DFG A   +    L     +P YVAPE
Sbjct: 141 IQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA-LQTPCYTPYYVAPE 199

Query: 267 VLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWET 321
           VL    Y +  D+WS GV+++ LL    PF  ++       +   I+  +  F +  W  
Sbjct: 200 VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSE 259

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYT---ERTLRTLTIKSKLKNQ 373
           VS+ A+ L+  +L  D + R+T  + + HPWI       +  L T  +  + K+ 
Sbjct: 260 VSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTARVLQEDKDH 314

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  322 bits (827), Expect = e-105
 Identities = 81/284 (28%), Positives = 137/284 (48%), Gaps = 9/284 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
           + + + D +   E +G G FG V     +A+G  FA K +       +ETV +E++ M  
Sbjct: 151 KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 210

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIK 211
           L  H  +V LH  +E+ +   ++ E  SGG L +++  E  + SE  A    + V   + 
Sbjct: 211 LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 269

Query: 212 YCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           + H+   VH D+KPENI+ TT  S ++KL DFGL   +   Q++    G+  + APEV  
Sbjct: 270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 329

Query: 270 G-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G       D+WS GVL + LL    PF G++ +     +K+   +     +  +S+  +D
Sbjct: 330 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 389

Query: 329 LMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKN 372
            + ++L  D + R+T  + L HPW+         +    S+   
Sbjct: 390 FIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQIPSSRYTK 433

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  316 bits (811), Expect = e-104
 Identities = 77/265 (29%), Positives = 130/265 (49%), Gaps = 9/265 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
           ++  + D +  +E +G G FG V  C  KA+G  F  K +       + TV  E+ IM  
Sbjct: 45  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 104

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIK 211
           L  H  ++ LH  +E+     L++E  SGG L D++     + SE    N  +     +K
Sbjct: 105 LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 163

Query: 212 YCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           + H+  +VH DIKPENI+  T  +  +K+ DFGLA +++  + +     +  + APE++ 
Sbjct: 164 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 223

Query: 270 GN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
                   D+W+ GVL + LL    PF G+        +K    +F    + +VS  A+D
Sbjct: 224 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 283

Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
            +  +L ++   R+T  + L HPW+
Sbjct: 284 FIKNLLQKEPRKRLTVHDALEHPWL 308

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  317 bits (813), Expect = e-104
 Identities = 86/285 (30%), Positives = 144/285 (50%), Gaps = 22/285 (7%)

Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------- 138
           + V  Q      + D++   + +G G  G V L   + +  + A + + K          
Sbjct: 121 LTVDDQSVYPKALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSARE 180

Query: 139 --GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE 196
                 V  E+EI++ L+ H  ++ + + ++  D +++V+EL  GG L D++V   +  E
Sbjct: 181 ADPALNVETEIEILKKLN-HPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKE 238

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTL 253
                 F  ++  ++Y H+ G++HRD+KPEN+LL++  +   IK+ DFG +  +     +
Sbjct: 239 ATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLM 298

Query: 254 SGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA-VFDAIK 308
             L G+P Y+APEVL       Y+  VD WS GV+L   L    PF     +  + D I 
Sbjct: 299 RTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQIT 358

Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           + K +F   VW  VS+ A DL+ ++L  D  AR T +E LRHPW+
Sbjct: 359 SGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWL 403

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  310 bits (795), Expect = e-103
 Identities = 100/332 (30%), Positives = 153/332 (46%), Gaps = 60/332 (18%)

Query: 90  DVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------GE 140
           +++ Q G   +++  +     IG G +G V +     + A  A K + K           
Sbjct: 13  NLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDV 72

Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ------- 193
           E +  EV +M+ L  H  +  L+ VYE+     LVMELC GG L+D++            
Sbjct: 73  ERIKTEVRLMKKLH-HPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCA 131

Query: 194 ---------------------------------YSEQRAANIFKDVMWVIKYCHDMGVVH 220
                                              E+  +NI + +   + Y H+ G+ H
Sbjct: 132 MDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICH 191

Query: 221 RDIKPENILLTT--SGKIKLADFGLAMRISN-----GQTLSGLAGSPAYVAPEVLSG--- 270
           RDIKPEN L +T  S +IKL DFGL+             ++  AG+P +VAPEVL+    
Sbjct: 192 RDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNE 251

Query: 271 NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +Y  K D WSAGVLLH LL+ A+PF G +       + N KL F +  +  +S  ARDL+
Sbjct: 252 SYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLL 311

Query: 331 ARMLTRDVSARITADEVLRHPWILFYTERTLR 362
           + +L R+V  R  A   L+HPWI  ++++  +
Sbjct: 312 SNLLNRNVDERFDAMRALQHPWISQFSDKIYK 343

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  298 bits (766), Expect = 3e-99
 Identities = 83/291 (28%), Positives = 131/291 (45%), Gaps = 35/291 (12%)

Query: 97  RKNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+       REVE+    S 
Sbjct: 11  KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQ 69

Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 70  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 129

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+      +KL DFG A                     E
Sbjct: 130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--------------------KE 169

Query: 267 VLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSL----EAVFDAIKNVKLDFHSGVWETV 322
                Y +  D+WS GV+++ LL    PF  +        +   I+  + +F +  W  V
Sbjct: 170 TTGEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEV 229

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQ 373
           S+  + L+  +L  + + R+T  E + HPWI+  T+     L     LK  
Sbjct: 230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTSRVLKED 280

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  268 bits (687), Expect = 1e-85
 Identities = 72/340 (21%), Positives = 141/340 (41%), Gaps = 25/340 (7%)

Query: 79  GRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT-LR 137
           G     +    D  T +    KI       +V+GHG  G++ + R      + A K  L 
Sbjct: 2   GSSPSLEQDDGDEETSVVIVGKIS--FCPKDVLGHGAEGTI-VYRGMFDNRDVAVKRILP 58

Query: 138 KGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSE 196
           +      REV++++    H  V+      ++    ++ +ELC    L + + +    +  
Sbjct: 59  ECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKDFAHLG 117

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-----KIKLADFGLAMRISNGQ 251
                + +     + + H + +VHRD+KP NIL++        K  ++DFGL  +++ G+
Sbjct: 118 LEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGR 177

Query: 252 ----TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEA 302
                 SG+ G+  ++APE+LS     N +  VDI+SAG + + ++   + PF       
Sbjct: 178 HSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQ 237

Query: 303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLR 362
               +    LD      +     AR+L+ +M+  D   R +A  VL+HP+         +
Sbjct: 238 ANILLGACSLDCLH-PEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFF----WSLEK 292

Query: 363 TLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDE 402
            L     + +++        I+  +E     + +    + 
Sbjct: 293 QLQFFQDVSDRIEKESLDGPIVKQLERGGRAVVKMDWREN 332

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  261 bits (669), Expect = 1e-84
 Identities = 71/304 (23%), Positives = 128/304 (42%), Gaps = 37/304 (12%)

Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSG 155
            +   D  ++ V+G G FG V   R+      +A K +R  E    T+  EV ++  L+ 
Sbjct: 2   LRYASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN- 60

Query: 156 HTGVVTLHSVYEEADCFH-------------LVMELCSGGRLIDQMVEVGQY-SEQRAAN 201
           H  VV  ++ + E   F              + ME C  G L D +              
Sbjct: 61  HQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWR 120

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA---------------MR 246
           +F+ ++  + Y H  G++HRD+KP NI +  S  +K+ DFGLA                 
Sbjct: 121 LFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNL 180

Query: 247 ISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF 304
             +   L+   G+  YVA EVL G  +Y+EK+D++S G++   ++       G     + 
Sbjct: 181 PGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--YPFSTGMERVNIL 238

Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTL 364
             +++V ++F     +   K  + ++  ++  D + R  A  +L   W+    +  +   
Sbjct: 239 KKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKE 298

Query: 365 TIKS 368
            +KS
Sbjct: 299 ALKS 302

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  259 bits (663), Expect = 6e-84
 Identities = 92/270 (34%), Positives = 147/270 (54%), Gaps = 14/270 (5%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTL 162
            +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  H  ++ L
Sbjct: 16  PLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRL 74

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +  + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH   V+HRD
Sbjct: 75  YGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRD 134

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSA 281
           IKPEN+LL ++G++K+ADFG ++  +     + L G+  Y+ PE++ G  + EKVD+WS 
Sbjct: 135 IKPENLLLGSAGELKIADFGWSVH-APSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSL 193

Query: 282 GVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
           GVL +  LV   PF+ ++ +  +  I  V+  F       V++ ARDL++R+L  + S R
Sbjct: 194 GVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPD----FVTEGARDLISRLLKHNPSQR 249

Query: 342 ITADEVLRHPWILFYTERTLRTLTIKSKLK 371
               EVL HPWI   + +       +S  K
Sbjct: 250 PMLREVLEHPWITANSSKPSNCQNKESASK 279

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  255 bits (654), Expect = 1e-82
 Identities = 84/260 (32%), Positives = 141/260 (54%), Gaps = 14/260 (5%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTL 162
            +G GKFG+V+L R K +    A K L K        E  + RE+EI  HL  H  ++ +
Sbjct: 21  PLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRM 79

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           ++ + +    +L++E    G L  ++ + G++ EQR+A   +++   + YCH+  V+HRD
Sbjct: 80  YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRD 139

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSA 281
           IKPEN+L+   G++K+ADFG ++   + +  + + G+  Y+ PE++ G  + EKVD+W A
Sbjct: 140 IKPENLLMGYKGELKIADFGWSVHAPSLRRRT-MCGTLDYLPPEMIEGKTHDEKVDLWCA 198

Query: 282 GVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR 341
           GVL +  LV   PF   S       I NV L F       +S  ++DL++++L      R
Sbjct: 199 GVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPP----FLSDGSKDLISKLLRYHPPQR 254

Query: 342 ITADEVLRHPWILFYTERTL 361
           +    V+ HPW+   + R L
Sbjct: 255 LPLKGVMEHPWVKANSRRVL 274

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  255 bits (653), Expect = 5e-82
 Identities = 69/308 (22%), Positives = 117/308 (37%), Gaps = 49/308 (15%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEI 149
           MG ++         +++G G   +V+  R K +G  FA K           +   RE E+
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 150 MQHLSGHTGVVTLHSVYEEADCFH--LVMELCSGGRLIDQMVEVGQ---YSEQRAANIFK 204
           ++ L+ H  +V L ++ EE    H  L+ME C  G L   + E        E     + +
Sbjct: 61  LKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLAMRISNGQTLSGLAGSP 260
           DV+  + +  + G+VHR+IKP NI+           KL DFG A  + + +    L G+ 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 261 AYVAPEVLSG---------NYSEKVDIWSAGVLLHALLVAALPFK----GDSLEAVFDAI 307
            Y+ P++             Y   VD+WS GV  +     +LPF+        + V   I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 308 KN-----------------VKLDFHSGVWETVSKPARDLM----ARMLTRDVSARITADE 346
                              +       V  ++S+  + L+    A +L  D       D+
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 347 VLRHPWIL 354
                  +
Sbjct: 300 FFAETSDI 307

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  257 bits (659), Expect = 2e-81
 Identities = 61/299 (20%), Positives = 123/299 (41%), Gaps = 40/299 (13%)

Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGH 156
           +  +++     +++G+G  G+V        G   A K +     +    E++++     H
Sbjct: 10  EQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDH 68

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYS-------EQRAANIFKDVMWV 209
             V+  +         ++ +ELC    L D +              E    ++ + +   
Sbjct: 69  PNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASG 127

Query: 210 IKYCHDMGVVHRDIKPENILLTTSG-------------KIKLADFGLAMRISNGQ----- 251
           + + H + ++HRD+KP+NIL++TS              +I ++DFGL  ++ +GQ     
Sbjct: 128 VAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRT 187

Query: 252 TLSGLAGSPAYVAPEVLSGN--------YSEKVDIWSAGVLLHALLVAALPFKGDSLEAV 303
            L+  +G+  + APE+L  +         +  +DI+S G + + +L       GD     
Sbjct: 188 NLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE 247

Query: 304 FDAIKNVKLDF---HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER 359
              I                ++   A DL+++M+  D   R TA +VLRHP     +++
Sbjct: 248 -SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPKSKK 305

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  253 bits (647), Expect = 4e-81
 Identities = 69/260 (26%), Positives = 108/260 (41%), Gaps = 15/260 (5%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSG 155
           +    ++  +GHG +G V+  RSK  G  +A K                 EV   + +  
Sbjct: 56  QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQ 115

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY-SEQRAANIFKDVMWVIKYCH 214
           H   V L   +EE    +L  ELC G  L       G    E +     +D +  + + H
Sbjct: 116 HPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLH 174

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE 274
             G+VH D+KP NI L   G+ KL DFGL + +          G P Y+APE+L G+Y  
Sbjct: 175 SQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQGSYGT 234

Query: 275 KVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             D++S G+ +  +     LP  G+  + +       +          +S   R ++  M
Sbjct: 235 AADVFSLGLTILEVACNMELPHGGEGWQQLRQGYLPPEF------TAGLSSELRSVLVMM 288

Query: 334 LTRDVSARITADEVLRHPWI 353
           L  D   R TA+ +L  P +
Sbjct: 289 LEPDPKLRATAEALLALPVL 308

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  252 bits (645), Expect = 4e-81
 Identities = 74/254 (29%), Positives = 123/254 (48%), Gaps = 14/254 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVT 161
             +G G F   +      +   FA K + K         E +  E+ I + L+ H  VV 
Sbjct: 21  RFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVG 79

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
            H  +E+ D   +V+ELC    L++        +E  A    + ++   +Y H   V+HR
Sbjct: 80  FHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHR 139

Query: 222 DIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+K  N+ L    ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+W
Sbjct: 140 DLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVW 199

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S G +++ LLV   PF+   L+  +  IK  +          ++  A  L+ +ML  D +
Sbjct: 200 SIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPT 255

Query: 340 ARITADEVLRHPWI 353
           AR T +E+L   + 
Sbjct: 256 ARPTINELLNDEFF 269

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  250 bits (642), Expect = 7e-81
 Identities = 72/253 (28%), Positives = 134/253 (52%), Gaps = 15/253 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLH 163
           +G G F  V+   S  +G E A K + K         + V  EV+I   L  H  ++ L+
Sbjct: 19  LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELY 77

Query: 164 SVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           + +E+++  +LV+E+C  G +   +   V  +SE  A +    ++  + Y H  G++HRD
Sbjct: 78  NYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRD 137

Query: 223 IKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +   N+LLT +  IK+ADFGLA ++    +    L G+P Y++PE+ + + +  + D+WS
Sbjct: 138 LTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWS 197

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            G + + LL+   PF  D+++   + +     +  S     +S  A+DL+ ++L R+ + 
Sbjct: 198 LGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPS----FLSIEAKDLIHQLLRRNPAD 253

Query: 341 RITADEVLRHPWI 353
           R++   VL HP++
Sbjct: 254 RLSLSSVLDHPFM 266

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  252 bits (646), Expect = 1e-80
 Identities = 81/301 (26%), Positives = 135/301 (44%), Gaps = 15/301 (4%)

Query: 62  GIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWL 121
           G A A P  A    V A           ++   +         + +   +G G F   + 
Sbjct: 1   GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRR-YVRGRFLGKGGFAKCFE 59

Query: 122 CRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL 174
                +   FA K + K         E +  E+ I + L+ H  VV  H  +E+ D   +
Sbjct: 60  ISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVFV 118

Query: 175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG 234
           V+ELC    L++        +E  A    + ++   +Y H   V+HRD+K  N+ L    
Sbjct: 119 VLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDL 178

Query: 235 KIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAA 292
           ++K+ DFGLA ++  +G+    L G+P Y+APEVLS   +S +VD+WS G +++ LLV  
Sbjct: 179 EVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238

Query: 293 LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
            PF+   L+  +  IK  +          ++  A  L+ +ML  D +AR T +E+L   +
Sbjct: 239 PPFETSCLKETYLRIKKNEYSIPK----HINPVAASLIQKMLQTDPTARPTINELLNDEF 294

Query: 353 I 353
            
Sbjct: 295 F 295

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  245 bits (628), Expect = 3e-77
 Identities = 68/306 (22%), Positives = 116/306 (37%), Gaps = 49/306 (16%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEI 149
           MG ++         +++G G   +V+  R K +G  FA K           +   RE E+
Sbjct: 1   MGSQSTSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEV 60

Query: 150 MQHLSGHTGVVTLHSVYEEADCFH--LVMELCSGGRLIDQMVEVGQ---YSEQRAANIFK 204
           ++ L+ H  +V L ++ EE    H  L+ME C  G L   + E        E     + +
Sbjct: 61  LKKLN-HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLR 119

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLAMRISNGQTLSGLAGSP 260
           DV+  + +  + G+VHR+IKP NI+           KL DFG A  + + +    L G+ 
Sbjct: 120 DVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTE 179

Query: 261 AYVAPEVLSGN---------YSEKVDIWSAGVLLHALLVAALPFK----GDSLEAVFDAI 307
            Y+ P++             Y   VD+WS GV  +     +LPF+        + V   I
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKI 239

Query: 308 KN-----------------VKLDFHSGVWETVSKPARD----LMARMLTRDVSARITADE 346
                              +       V  ++S+  +     ++A +L  D       D+
Sbjct: 240 ITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQ 299

Query: 347 VLRHPW 352
                 
Sbjct: 300 FFAETS 305

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  242 bits (619), Expect = 2e-76
 Identities = 67/326 (20%), Positives = 127/326 (38%), Gaps = 53/326 (16%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------------- 139
            K+K  +D+  +  +  GKF  + LC        +A K   K                  
Sbjct: 25  EKDKYINDYRIIRTLNQGKFNKIILCEKD--NKFYALKKYEKSLLEKKRDFTKSNNDKIS 82

Query: 140 ----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ-- 193
                +    E++I+  +  +   +T   +    D  +++ E      ++          
Sbjct: 83  IKSKYDDFKNELQIITDIK-NEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLD 141

Query: 194 ------YSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMR 246
                    Q    I K V+    Y H+   + HRD+KP NIL+  +G++KL+DFG +  
Sbjct: 142 KNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEY 201

Query: 247 ISNGQTLSGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGD-SLEA 302
           + +   + G  G+  ++ PE  S        KVDIWS G+ L+ +    +PF    SL  
Sbjct: 202 MVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVE 260

Query: 303 VFDAIKNVKLDF---------------HSGVWETVSKPARDLMARMLTRDVSARITADEV 347
           +F+ I+   +++                +     +S    D +   L ++ + RIT+++ 
Sbjct: 261 LFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDA 320

Query: 348 LRHPWILFYTERTLRTLTIKSKLKNQ 373
           L+H W+       LR  + +   K +
Sbjct: 321 LKHEWLADTNIEDLREFSKELYKKRK 346

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  239 bits (612), Expect = 7e-76
 Identities = 60/272 (22%), Positives = 113/272 (41%), Gaps = 30/272 (11%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGH-TG 158
           + ++ IG G    V+   ++     +A K +   E      ++   E+  +  L  H   
Sbjct: 31  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 89

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           ++ L+         ++VME C    L   + +          + +K+++  +   H  G+
Sbjct: 90  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 148

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSGN---- 271
           VH D+KP N L+   G +KL DFG+A ++    T        G+  Y+ PE +       
Sbjct: 149 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 207

Query: 272 --------YSEKVDIWSAGVLLHALLVAALPFKG--DSLEAVFDAIKNVKLDFHSGVWET 321
                    S K D+WS G +L+ +     PF+   + +  +  AI +   +      + 
Sbjct: 208 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIE--FPDI 264

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             K  +D++   L RD   RI+  E+L HP++
Sbjct: 265 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  238 bits (610), Expect = 3e-75
 Identities = 68/336 (20%), Positives = 130/336 (38%), Gaps = 30/336 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGH-TG 158
           + ++ IG G    V+   ++     +A K +   E      ++   E+  +  L  H   
Sbjct: 12  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 70

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           ++ L+         ++VME C    L   + +          + +K+++  +   H  G+
Sbjct: 71  IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 129

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG----- 270
           VH D+KP N L+   G +KL DFG+A ++    T        G+  Y+ PE +       
Sbjct: 130 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSR 188

Query: 271 -------NYSEKVDIWSAGVLLHALLVAALPFKG--DSLEAVFDAIKNVKLDFHSGVWET 321
                    S K D+WS G +L+ +     PF+   + +  +  AI +   +      + 
Sbjct: 189 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIE--FPDI 245

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP 381
             K  +D++   L RD   RI+  E+L HP++   T    +     ++    V       
Sbjct: 246 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 305

Query: 382 AILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
              + +      +       ESH  SSS++   +  
Sbjct: 306 NSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 341

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  237 bits (608), Expect = 4e-75
 Identities = 84/251 (33%), Positives = 132/251 (52%), Gaps = 13/251 (5%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHS 164
           IG G F  V L R   +G E A K + K        + + REV IM+ L+ H  +V L  
Sbjct: 23  IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFE 81

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           V E     +L+ME  SGG + D +V  G+  E+ A + F+ ++  ++YCH   +VHRD+K
Sbjct: 82  VIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLK 141

Query: 225 PENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSE--KVDIWSAG 282
            EN+LL     IK+ADFG +   + G  L    G+P Y APE+  G   +  +VD+WS G
Sbjct: 142 AENLLLDADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLG 201

Query: 283 VLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI 342
           V+L+ L+  +LPF G +L+ + + +   K          +S    +L+ R L  +   R 
Sbjct: 202 VILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY----MSTDCENLLKRFLVLNPIKRG 257

Query: 343 TADEVLRHPWI 353
           T +++++  WI
Sbjct: 258 TLEQIMKDRWI 268

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  233 bits (596), Expect = 5e-74
 Identities = 74/270 (27%), Positives = 121/270 (44%), Gaps = 23/270 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGH 156
           +D+  +  IG G +G     R K+ G     K L  G       + +  EV +++ L  H
Sbjct: 6   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 64

Query: 157 TGVVTLHSVY--EEADCFHLVMELCSGG---RLIDQMVEVGQY-SEQRAANIFKDVMWVI 210
             +V  +           ++VME C GG    +I +  +  QY  E+    +   +   +
Sbjct: 65  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124

Query: 211 KYCHDMG-----VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVA 264
           K CH        V+HRD+KP N+ L     +KL DFGLA  +++  +      G+P Y++
Sbjct: 125 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMS 184

Query: 265 PEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           PE ++   Y+EK DIWS G LL+ L     PF   S + +   I+  K      +    S
Sbjct: 185 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYS 241

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
               +++ RML      R + +E+L +P I
Sbjct: 242 DELNEIITRMLNLKDYHRPSVEEILENPLI 271

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  233 bits (597), Expect = 7e-74
 Identities = 81/280 (28%), Positives = 137/280 (48%), Gaps = 41/280 (14%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKG------------------------------E 140
           IG G +G V L  ++     +A K L K                                
Sbjct: 21  IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80

Query: 141 ETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
           E V++E+ I++ L  H  VV L  V ++   D  ++V EL + G +++ +  +   SE +
Sbjct: 81  EQVYQEIAILKKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME-VPTLKPLSEDQ 138

Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL-AMRISNGQTLSGLA 257
           A   F+D++  I+Y H   ++HRDIKP N+L+   G IK+ADFG+      +   LS   
Sbjct: 139 ARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTV 198

Query: 258 GSPAYVAPEVLSGN---YS-EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD 313
           G+PA++APE LS     +S + +D+W+ GV L+  +    PF  + +  +   IK+  L+
Sbjct: 199 GTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALE 258

Query: 314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           F       +++  +DL+ RML ++  +RI   E+  HPW+
Sbjct: 259 FPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWV 296

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  233 bits (597), Expect = 8e-73
 Identities = 68/336 (20%), Positives = 130/336 (38%), Gaps = 30/336 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGH-TG 158
           + ++ IG G    V+   ++     +A K +   E      ++   E+  +  L  H   
Sbjct: 59  SILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDK 117

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           ++ L+         ++VME C    L   + +          + +K+++  +   H  G+
Sbjct: 118 IIRLYDYEITDQYIYMVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGI 176

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG----- 270
           VH D+KP N L+   G +KL DFG+A ++    T        G+  Y+ PE +       
Sbjct: 177 VHSDLKPANFLI-VDGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSR 235

Query: 271 -------NYSEKVDIWSAGVLLHALLVAALPFKG--DSLEAVFDAIKNVKLDFHSGVWET 321
                    S K D+WS G +L+ +     PF+   + +  +  AI +   +      + 
Sbjct: 236 ENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLH-AIIDPNHEIE--FPDI 292

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHP 381
             K  +D++   L RD   RI+  E+L HP++   T    +     ++    V       
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGL 352

Query: 382 AILSGVESDENKIDRGSRNDESHALSSSESLNSESE 417
              + +      +       ESH  SSS++   +  
Sbjct: 353 NSPNSILKAAKTLYEHYSGGESHNSSSSKTFEKKRG 388

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  226 bits (579), Expect = 2e-71
 Identities = 75/257 (29%), Positives = 123/257 (47%), Gaps = 12/257 (4%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTL 162
           V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H  VV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKF 70

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G+ HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA---GSPAYVAPEVLSGN-YS-EKVD 277
           IKPEN+LL     +K++DFGLA           L    G+  YVAPE+L    +  E VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 278 IWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           +WS G++L A+L   LP+     ++  +     +   +   W+ +      L+ ++L  +
Sbjct: 191 VWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249

Query: 338 VSARITADEVLRHPWIL 354
            SARIT  ++ +  W  
Sbjct: 250 PSARITIPDIKKDRWYN 266

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  226 bits (578), Expect = 2e-71
 Identities = 86/254 (33%), Positives = 134/254 (52%), Gaps = 14/254 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVT 161
           + +G G FG V +   + +G + A K L +           + RE++ ++    H  ++ 
Sbjct: 17  DTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIK 75

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V      F +VME  SGG L D + + G+  E  A  +F+ ++  + YCH   VVHR
Sbjct: 76  LYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHR 135

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YS-EKVDIW 279
           D+KPEN+LL      K+ADFGL+  +S+G+ L    GSP Y APEV+SG  Y+  +VDIW
Sbjct: 136 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 195

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S GV+L+ALL   LPF  + +  +F  I+     F+   +  +++    L+  ML  D  
Sbjct: 196 SCGVILYALLCGTLPFDDEHVPTLFKKIR--GGVFYIPEY--LNRSVATLLMHMLQVDPL 251

Query: 340 ARITADEVLRHPWI 353
            R T  ++  H W 
Sbjct: 252 KRATIKDIREHEWF 265

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  228 bits (582), Expect = 3e-71
 Identities = 75/260 (28%), Positives = 115/260 (44%), Gaps = 26/260 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK------------GEETVHREVEIMQHLSGH 156
             +G G FG VW    K    E   K ++K                V  E+ I+  +  H
Sbjct: 30  SPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-H 88

Query: 157 TGVVTLHSVYEEADCFHLVMEL-CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
             ++ +  ++E    F LVME   SG  L   +    +  E  A+ IF+ ++  + Y   
Sbjct: 89  ANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRL 148

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YS- 273
             ++HRDIK ENI++     IKL DFG A  +  G+      G+  Y APEVL GN Y  
Sbjct: 149 KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRG 208

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
            ++++WS GV L+ L+    PF    LE   +A        H      VSK    L++ +
Sbjct: 209 PELEMWSLGVTLYTLVFEENPF--CELEETVEA------AIHPPYL--VSKELMSLVSGL 258

Query: 334 LTRDVSARITADEVLRHPWI 353
           L      R T ++++  PW+
Sbjct: 259 LQPVPERRTTLEKLVTDPWV 278

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score =  228 bits (583), Expect = 5e-71
 Identities = 81/258 (31%), Positives = 125/258 (48%), Gaps = 14/258 (5%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHS 164
           V+ IG G FG   L R K +    A K + +G   +E V RE+   + L  H  +V    
Sbjct: 25  VKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKE 83

Query: 165 VYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           V        ++ME  SGG L +++   G++SE  A   F+ ++  + YCH M + HRD+K
Sbjct: 84  VILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLK 143

Query: 225 PENILL--TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YS-EKVDIWS 280
            EN LL  + + ++K+ DFG +             G+PAY+APEVL    Y  +  D+WS
Sbjct: 144 LENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWS 203

Query: 281 AGVLLHALLVAALPFKGDSLEAVF----DAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
            GV L+ +LV A PF+       +      I +VK      +   +S     L++R+   
Sbjct: 204 CGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDDIR--ISPECCHLISRIFVA 261

Query: 337 DVSARITADEVLRHPWIL 354
           D + RI+  E+  H W L
Sbjct: 262 DPATRISIPEIKTHSWFL 279

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  225 bits (575), Expect = 9e-71
 Identities = 62/273 (22%), Positives = 122/273 (44%), Gaps = 28/273 (10%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV 159
           +   D  ++E+IG G FG V+  + +  G  +  K ++   E   REV+ +  L  H  +
Sbjct: 8   RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNI 66

Query: 160 VTLHSVYEEAD----------------CFHLVMELCSGGRLIDQMVE-VGQY-SEQRAAN 201
           V  +  ++  D                C  + ME C  G L   + +  G+   +  A  
Sbjct: 67  VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALE 126

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA 261
           +F+ +   + Y H   +++RD+KP NI L  + ++K+ DFGL   + N    +   G+  
Sbjct: 127 LFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKGTLR 186

Query: 262 YVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
           Y++PE +S   Y ++VD+++ G++L  LL   +          F  +++  +       +
Sbjct: 187 YMSPEQISSQDYGKEVDLYALGLILAELL--HVCDTAFETSKFFTDLRDGIIS------D 238

Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
              K  + L+ ++L++    R    E+LR   +
Sbjct: 239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV 271

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  235 bits (601), Expect = 2e-70
 Identities = 66/294 (22%), Positives = 109/294 (37%), Gaps = 39/294 (13%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQ 151
              +        E +G G FG V     + +G + A K  R+       E    E++IM+
Sbjct: 8   LPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMK 67

Query: 152 HLSGHTGVVTLHSVYEEADCFH------LVMELCSGGRLIDQMVEVGQ---YSEQRAANI 202
            L+ H  VV+   V +            L ME C GG L   + +        E     +
Sbjct: 68  KLN-HPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTL 126

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQTLSGLAGS 259
             D+   ++Y H+  ++HRD+KPENI+L    +    K+ D G A  +  G+  +   G+
Sbjct: 127 LSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGT 186

Query: 260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV 318
             Y+APE+L    Y+  VD WS G L    +    PF  +     +      K + H  V
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVV 246

Query: 319 WETVSKPAR--------------------DLMARMLTRDVSARITADEVLRHPW 352
           ++ ++   +                      +  ML      R T  +      
Sbjct: 247 YDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGC 300

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  226 bits (577), Expect = 3e-70
 Identities = 72/282 (25%), Positives = 131/282 (46%), Gaps = 14/282 (4%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGH 156
           + + +++ IG G FG   L +S   G ++  K +          E   REV ++ ++  H
Sbjct: 24  EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-H 82

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQY-SEQRAANIFKDVMWVIKYCH 214
             +V     +EE    ++VM+ C GG L  ++    G    E +  + F  +   +K+ H
Sbjct: 83  PNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSGN-Y 272
           D  ++HRDIK +NI LT  G ++L DFG+A  +++   L     G+P Y++PE+     Y
Sbjct: 143 DRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPY 202

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
           + K DIW+ G +L+ L      F+  S++ +   I +        V    S   R L+++
Sbjct: 203 NNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIIS---GSFPPVSLHYSYDLRSLVSQ 259

Query: 333 MLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQV 374
           +  R+   R + + +L   +I    E+ L    I  +   + 
Sbjct: 260 LFKRNPRDRPSVNSILEKGFIAKRIEKFLSPQLIAEEFCLKT 301

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  224 bits (574), Expect = 3e-70
 Identities = 83/309 (26%), Positives = 140/309 (45%), Gaps = 14/309 (4%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTL 162
           V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H  VV  
Sbjct: 12  VQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKF 70

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
           +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G+ HRD
Sbjct: 71  YGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 130

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA---GSPAYVAPEVLSGN-YS-EKVD 277
           IKPEN+LL     +K++DFGLA           L    G+  YVAPE+L    +  E VD
Sbjct: 131 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 190

Query: 278 IWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRD 337
           +WS G++L A+L   LP+     ++  +     +   +   W+ +      L+ ++L  +
Sbjct: 191 VWSCGIVLTAMLAGELPWD-QPSDSCQEYSDWKEKKTYLNPWKKIDSAPLALLHKILVEN 249

Query: 338 VSARITADEVLRHPWILFYTERTLRT--LTIKSKLKNQVGASHHHPAILSGVESDENKID 395
            SARIT  ++ +  W     ++  +   +T     ++  G S H  + L     +     
Sbjct: 250 PSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSASRT 309

Query: 396 RGSRNDESH 404
            GS   + H
Sbjct: 310 PGSGWSKEH 318

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  223 bits (570), Expect = 9e-70
 Identities = 81/308 (26%), Positives = 128/308 (41%), Gaps = 39/308 (12%)

Query: 63  IATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLC 122
           + T P  G  +           K            +   E ++    ++G G FG+V+  
Sbjct: 2   MLTKPLQGPPAPPGTPTPPPGGK-----------DREAFEAEYRLGPLLGKGGFGTVFAG 50

Query: 123 RSKASGAEFACKTLRK----------GEETVHREVEIMQHLS---GHTGVVTLHSVYEEA 169
                  + A K + +             T   EV ++  +    GH GV+ L   +E  
Sbjct: 51  HRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ 110

Query: 170 DCFHLVMEL-CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
           + F LV+E       L D + E G   E  +   F  V+  I++CH  GVVHRDIK ENI
Sbjct: 111 EGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENI 170

Query: 229 LL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YS-EKVDIWSAGVLL 285
           L+    G  KL DFG    + + +  +   G+  Y  PE +S + Y      +WS G+LL
Sbjct: 171 LIDLRRGCAKLIDFGSG-ALLHDEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILL 229

Query: 286 HALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITAD 345
           + ++   +PF+ D        I   +L F +     VS     L+ R L    S+R + +
Sbjct: 230 YDMVCGDIPFERD------QEILEAELHFPAH----VSPDCCALIRRCLAPKPSSRPSLE 279

Query: 346 EVLRHPWI 353
           E+L  PW+
Sbjct: 280 EILLDPWM 287

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  226 bits (578), Expect = 5e-69
 Identities = 85/254 (33%), Positives = 135/254 (53%), Gaps = 14/254 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVT 161
           + +G G FG V + + + +G + A K L +           + RE++ ++    H  ++ 
Sbjct: 22  DTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIK 80

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V        +VME  SGG L D + + G+  E+ +  +F+ ++  + YCH   VVHR
Sbjct: 81  LYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHR 140

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYS-EKVDIW 279
           D+KPEN+LL      K+ADFGL+  +S+G+ L    GSP Y APEV+SG  Y+  +VDIW
Sbjct: 141 DLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIW 200

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S+GV+L+ALL   LPF  D +  +F  I      F++  +  ++     L+  ML  D  
Sbjct: 201 SSGVILYALLCGTLPFDDDHVPTLFKKIC--DGIFYTPQY--LNPSVISLLKHMLQVDPM 256

Query: 340 ARITADEVLRHPWI 353
            R T  ++  H W 
Sbjct: 257 KRATIKDIREHEWF 270

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  222 bits (567), Expect = 6e-69
 Identities = 85/263 (32%), Positives = 135/263 (51%), Gaps = 15/263 (5%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVT 161
           E +G G FG V L     +  + A K + +           V RE+  ++ L  H  ++ 
Sbjct: 15  ETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIK 73

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           L+ V        +V+E   GG L D +VE  + +E      F+ ++  I+YCH   +VHR
Sbjct: 74  LYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHR 132

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYS-EKVDIW 279
           D+KPEN+LL  +  +K+ADFGL+  +++G  L    GSP Y APEV++G  Y+  +VD+W
Sbjct: 133 DLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVW 192

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
           S G++L+ +LV  LPF  + +  +F  +      +    +  +S  A+ L+ RM+  D  
Sbjct: 193 SCGIVLYVMLVGRLPFDDEFIPNLFKKVN--SCVYVMPDF--LSPGAQSLIRRMIVADPM 248

Query: 340 ARITADEVLRHPWILFYTERTLR 362
            RIT  E+ R PW        LR
Sbjct: 249 QRITIQEIRRDPWFNVNLPDYLR 271

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  220 bits (563), Expect = 1e-68
 Identities = 81/278 (29%), Positives = 134/278 (48%), Gaps = 24/278 (8%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK--------GEETVHREVEIMQHLSGHTGVV 160
           +++G G +G V       +    A K L+K        GE  V +E+++++ L  H  V+
Sbjct: 11  DLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVI 69

Query: 161 TLHSVY--EEADCFHLVMELCSGGR--LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            L  V   EE    ++VME C  G   ++D + E  ++   +A   F  ++  ++Y H  
Sbjct: 70  QLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSVPE-KRFPVCQAHGYFCQLIDGLEYLHSQ 128

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLA---MRISNGQTLSGLAGSPAYVAPEVLSGN-- 271
           G+VH+DIKP N+LLTT G +K++  G+A      +   T     GSPA+  PE+ +G   
Sbjct: 129 GIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDT 188

Query: 272 YS-EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
           +S  KVDIWSAGV L+ +     PF+GD++  +F+ I   K  +          P  DL+
Sbjct: 189 FSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIG--KGSYAIPGD--CGPPLSDLL 244

Query: 331 ARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKS 368
             ML  + + R +  ++ +H W           + I  
Sbjct: 245 KGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIPP 282

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  219 bits (561), Expect = 3e-68
 Identities = 77/272 (28%), Positives = 126/272 (46%), Gaps = 26/272 (9%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----------GEETVHRE 146
            K  +E  +    ++G G FGSV+     +     A K + K              V  E
Sbjct: 37  EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME 96

Query: 147 VEIMQHLS-GHTGVVTLHSVYEEADCFHLVMELCSG-GRLIDQMVEVGQYSEQRAANIFK 204
           V +++ +S G +GV+ L   +E  D F L++E       L D + E G   E+ A + F 
Sbjct: 97  VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW 156

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV 263
            V+  +++CH+ GV+HRDIK ENIL+    G++KL DFG    + +    +   G+  Y 
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV-YTDFDGTRVYS 215

Query: 264 APEVLSGN-YS-EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
            PE +  + Y      +WS G+LL+ ++   +PF+ D      + I   ++ F       
Sbjct: 216 PPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFFRQR---- 265

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           VS   + L+   L    S R T +E+  HPW+
Sbjct: 266 VSSECQHLIRWCLALRPSDRPTFEEIQNHPWM 297

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  218 bits (557), Expect = 4e-67
 Identities = 50/349 (14%), Positives = 98/349 (28%), Gaps = 58/349 (16%)

Query: 51  QPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEV 110
           + IG  +        A     ++++ P             V + + +  +       VE 
Sbjct: 20  ELIGYCREEALKEPAAMVEAVTATVWPQNAETT-------VDSLLSQGER---KLKLVEP 69

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHL---------- 153
           +  G    V+L R      +FA K    G        E +H        L          
Sbjct: 70  LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129

Query: 154 -------------SGHTGVVTLHSVYEEADC--FHLVMELCSG------GRLIDQMVEVG 192
                                L    ++     + L+M   S         L    V  G
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189

Query: 193 QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT 252
                    +   ++ +       G+VH    P+N+ +   G++ L D     ++  G  
Sbjct: 190 DEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV--GTR 247

Query: 253 LSGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKN 309
               +    Y   E L+ +   ++  ++ W  G+ ++ +    LPF   +        + 
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307

Query: 310 VKL-----DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                       G    +    + L+ R L  D   R+   E +  P  
Sbjct: 308 SLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEF 356

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  213 bits (544), Expect = 8e-66
 Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 30/276 (10%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVT 161
             ++ +G G F  V L      G  +A K +   E    E   RE ++ +    H  ++ 
Sbjct: 32  LFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLF-NHPNILR 90

Query: 162 LHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVIKYC 213
           L +             L++     G L +++  +       +E +   +   +   ++  
Sbjct: 91  LVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAI 150

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLA----MRISNGQTLSGLA------GSPAYV 263
           H  G  HRD+KP NILL   G+  L D G      + +   +    L        + +Y 
Sbjct: 151 HAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYR 210

Query: 264 APEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEA-VFDAIKNVKLDFHSGV 318
           APE+ S        E+ D+WS G +L+A++    P+     +          +L      
Sbjct: 211 APELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ-- 268

Query: 319 WETVSKPARDLMARMLTRDVSARITADEVLRHPWIL 354
               S     L+  M+T D   R     +L     L
Sbjct: 269 SPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQLEAL 304

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  211 bits (539), Expect = 4e-65
 Identities = 67/265 (25%), Positives = 118/265 (44%), Gaps = 14/265 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
            +    + IG G+F  V+       G   A K ++  +           +E+++++ L+ 
Sbjct: 32  ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN- 90

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGG---RLIDQMVEVGQY-SEQRAANIFKDVMWVIK 211
           H  V+  ++ + E +  ++V+EL   G   R+I    +  +   E+     F  +   ++
Sbjct: 91  HPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALE 150

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSG 270
           + H   V+HRDIKP N+ +T +G +KL D GL    S+  T    L G+P Y++PE +  
Sbjct: 151 HMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHE 210

Query: 271 N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
           N Y+ K DIWS G LL+ +     PF GD +       K  + D+     +  S+  R L
Sbjct: 211 NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQL 270

Query: 330 MARMLTRDVSARITADEVLRHPWIL 354
           +   +  D   R     V      +
Sbjct: 271 VNMCINPDPEKRPDVTYVYDVAKRM 295

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  212 bits (540), Expect = 1e-64
 Identities = 40/296 (13%), Positives = 84/296 (28%), Gaps = 62/296 (20%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHL-------- 153
            V+G     +      + +G  F        E       + +  EV  ++ L        
Sbjct: 79  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 138

Query: 154 ----------------SGHTGVVTLHSVYEEADC--FHLVMELCS------GGRLIDQMV 189
                                ++ +     +        +           G  L+    
Sbjct: 139 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198

Query: 190 EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN 249
                       +   V+ ++   H  G+VH  ++P +I+L   G + L  F   +R   
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 258

Query: 250 GQTLSGLAGSPAYVAPEVLSGN------------YSEKVDIWSAGVLLHALLVAALPFKG 297
               S    S  +  PE+ +               +   D W+ G++++ +  A LP   
Sbjct: 259 RVVSS---VSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315

Query: 298 DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           D+     + I     +        + +P R L+   L      R+   + +  P  
Sbjct: 316 DAALGGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETPEY 363

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  206 bits (527), Expect = 2e-63
 Identities = 64/285 (22%), Positives = 115/285 (40%), Gaps = 40/285 (14%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
            D   ++ +G G FG V+  ++K     +A K +R        E V REV+ +  L  H 
Sbjct: 5   TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HP 63

Query: 158 GVVTLHSVYEEADCF------------HLVMELCSGG---RLIDQMVEVGQYSEQRAANI 202
           G+V   + + E +              ++ M+LC        ++    + +       +I
Sbjct: 64  GIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN------------- 249
           F  +   +++ H  G++HRD+KP NI  T    +K+ DFGL   +               
Sbjct: 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPA 183

Query: 250 GQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIK 308
               +G  G+  Y++PE + GN YS KVDI+S G++L  LL                 ++
Sbjct: 184 YARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLYP--FSTQMERVRTLTDVR 241

Query: 309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           N+K      ++         ++  ML+     R  A  ++ +   
Sbjct: 242 NLKF---PPLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVF 283

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  205 bits (524), Expect = 1e-62
 Identities = 78/311 (25%), Positives = 119/311 (38%), Gaps = 41/311 (13%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVVT 161
               V+  G F  V+  +   SG E+A K L     +    + +EV  M+ LSGH  +V 
Sbjct: 31  RVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQ 90

Query: 162 LHSVYEEADC--------FHLVMELCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVI 210
             S               F L+ ELC G  L++ + ++   G  S      IF      +
Sbjct: 91  FCSAASIGKEESDTGQAEFLLLTELCKGQ-LVEFLKKMESRGPLSCDTVLKIFYQTCRAV 149

Query: 211 KYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA----------- 257
           ++ H     ++HRD+K EN+LL+  G IKL DFG A  IS+    S  A           
Sbjct: 150 QHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEIT 209

Query: 258 --GSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK 311
              +P Y  PE++         EK DIW+ G +L+ L     PF+  +       I N K
Sbjct: 210 RNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKL----RIVNGK 265

Query: 312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLK 371
                   +T       L+  ML  +   R++  EV+     +           I   L+
Sbjct: 266 YSIPP--HDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQLQEIAAARNVNPKSPITELLE 323

Query: 372 NQVGASHHHPA 382
              G      +
Sbjct: 324 QNGGYGSATLS 334

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  203 bits (519), Expect = 2e-62
 Identities = 75/296 (25%), Positives = 124/296 (41%), Gaps = 40/296 (13%)

Query: 95  MGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVE 148
           MG K++   +  ++E IG G+FGSV+ C  +  G  +A K  +K       E+   REV 
Sbjct: 3   MGMKSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVY 62

Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY----SEQRAANIFK 204
               L  H+ VV   S + E D   +  E C+GG L D + E  +      E    ++  
Sbjct: 63  AHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLL 122

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKI-------------------KLADFGLAM 245
            V   ++Y H M +VH DIKP NI ++ +                      K+ D G   
Sbjct: 123 QVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182

Query: 246 RISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAV 303
           RIS+ Q      G   ++A EVL  N  +  K DI++  + +     A    +       
Sbjct: 183 RISSPQV---EEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQ--- 236

Query: 304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTER 359
           +  I+  +L     V    S+   +L+  M+  D   R +A  +++H  +L  + +
Sbjct: 237 WHEIRQGRLPRIPQVL---SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSASRK 289

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score =  201 bits (513), Expect = 3e-61
 Identities = 79/314 (25%), Positives = 133/314 (42%), Gaps = 44/314 (14%)

Query: 60  LAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSV 119
           + G A  P  GA S          RK                 +D    +++G G F +V
Sbjct: 1   MDGTAAEPRPGAGSLQHAQPPPQPRKKRP--------------EDFKFGKILGEGSFSTV 46

Query: 120 WLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF 172
            L R  A+  E+A K L K           V RE ++M  L  H   V L+  +++ +  
Sbjct: 47  VLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKL 105

Query: 173 HLVMELCSGGRLIDQMVEVGQYSEQRA----ANIFKDVMWVIKYCHDMGVVHRDIKPENI 228
           +  +     G L+  + ++G + E       A I    +  ++Y H  G++HRD+KPENI
Sbjct: 106 YFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI----VSALEYLHGKGIIHRDLKPENI 161

Query: 229 LLTTSGKIKLADFGLA---MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVL 284
           LL     I++ DFG A      S     +   G+  YV+PE+L+     +  D+W+ G +
Sbjct: 162 LLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCI 221

Query: 285 LHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARIT- 343
           ++ L+    PF+  +   +F  I  ++ DF           ARDL+ ++L  D + R+  
Sbjct: 222 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPEK----FFPKARDLVEKLLVLDATKRLGC 277

Query: 344 -----ADEVLRHPW 352
                   +  HP+
Sbjct: 278 EEMEGYGPLKAHPF 291

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  196 bits (500), Expect = 3e-58
 Identities = 40/291 (13%), Positives = 86/291 (29%), Gaps = 55/291 (18%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG------ 155
            V+G     +      + +G  F        E       + +  EV  ++ L G      
Sbjct: 84  TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143

Query: 156 ---------------HTGVVTLHSVYEEADCFHLVMEL-------CSGGRLIDQMVEVGQ 193
                                +  V  +     ++           +     + ++    
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203

Query: 194 ----YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI-S 248
                       +   V+ ++   H  G+VH  ++P +I+L   G + L  F   +R  +
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263

Query: 249 NGQTLSGLA-GSPAYVAPEVLSGN------YSEKVDIWSAGVLLHALLVAALPFKGDSLE 301
           +  +  G     P   A  +L          +   D W+ G+ ++ +  A LP   D+  
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323

Query: 302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
              + I     +        + +P R L+   L      R+   + +  P 
Sbjct: 324 GGSEWIFRSCKN--------IPQPVRALLEGFLRYPKEDRLLPLQAMETPE 366

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score =  191 bits (488), Expect = 1e-56
 Identities = 64/258 (24%), Positives = 118/258 (45%), Gaps = 20/258 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTL 162
            IG G FG V + +   +   +A K + K +         V +E++IMQ L  H  +V L
Sbjct: 22  AIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNL 80

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
              +++ +   +V++L  GG L   + +   + E+       +++  + Y  +  ++HRD
Sbjct: 81  WYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRD 140

Query: 223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN----YSEKVDI 278
           +KP+NILL   G + + DF +A  +     ++ +AG+  Y+APE+ S      YS  VD 
Sbjct: 141 MKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDW 200

Query: 279 WSAGVLLHALLVAALPFKG---DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           WS GV  + LL    P+      S + +    +   + + S      S+    L+ ++L 
Sbjct: 201 WSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYPS----AWSQEMVSLLKKLLE 256

Query: 336 RDVSARI-TADEVLRHPW 352
            +   R     +V   P+
Sbjct: 257 PNPDQRFSQLSDVQNFPY 274

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score =  190 bits (485), Expect = 1e-56
 Identities = 72/253 (28%), Positives = 126/253 (49%), Gaps = 14/253 (5%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTL 162
           ++G G FG V+L   K +   FA K L+K    +  +VE       ++     H  +  +
Sbjct: 24  MLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHM 83

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
              ++  +    VME  +GG L+  +    ++   RA     +++  +++ H  G+V+RD
Sbjct: 84  FCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRD 143

Query: 223 IKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +K +NILL   G IK+ADFG+    +      +   G+P Y+APE+L G  Y+  VD WS
Sbjct: 144 LKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWS 203

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+ +L+   PF G   E +F +I+     +       + K A+DL+ ++  R+   
Sbjct: 204 FGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW----LEKEAKDLLVKLFVREPEK 259

Query: 341 RITA-DEVLRHPW 352
           R+    ++ +HP 
Sbjct: 260 RLGVRGDIRQHPL 272

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score =  195 bits (498), Expect = 2e-56
 Identities = 87/262 (33%), Positives = 135/262 (51%), Gaps = 24/262 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTL 162
           V+G G FG V  C+ +A+G  +ACK L K       GE     E +I++ ++    VV+L
Sbjct: 191 VLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSL 249

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVH 220
              YE  D   LV+ L +GG L   +  +GQ  + E RA     ++   ++  H   +V+
Sbjct: 250 AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVY 309

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           RD+KPENILL   G I+++D GLA+ +  GQT+ G  G+  Y+APEV+    Y+   D W
Sbjct: 310 RDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWW 369

Query: 280 SAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           + G LL+ ++    PF+        E V   +K V  ++     E  S  AR L +++L 
Sbjct: 370 ALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQARSLCSQLLC 425

Query: 336 RDVSARI-----TADEVLRHPW 352
           +D + R+     +A EV  HP 
Sbjct: 426 KDPAERLGCRGGSAREVKEHPL 447

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score =  197 bits (502), Expect = 3e-56
 Identities = 72/262 (27%), Positives = 118/262 (45%), Gaps = 24/262 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSG--HTGVV 160
           +IG G FG V+ CR   +G  +A K L K       GE     E  ++  +S      +V
Sbjct: 196 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 255

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            +   +   D    +++L +GG L   + + G +SE        +++  +++ H+  VV+
Sbjct: 256 CMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVY 315

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDI 278
           RD+KP NILL   G ++++D GLA   S  +      G+  Y+APEVL     Y    D 
Sbjct: 316 RDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVAYDSSADW 374

Query: 279 WSAGVLLHALLVAALPF---KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           +S G +L  LL    PF   K      +      + ++      ++ S   R L+  +L 
Sbjct: 375 FSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPELRSLLEGLLQ 430

Query: 336 RDVSARI-----TADEVLRHPW 352
           RDV+ R+      A EV   P+
Sbjct: 431 RDVNRRLGCLGRGAQEVKESPF 452

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score =  188 bits (480), Expect = 5e-56
 Identities = 87/257 (33%), Positives = 133/257 (51%), Gaps = 19/257 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVE--IMQHLSGHTGVVTL 162
           ++G G FG V L R KA+G  +A K LRK      +E  H   E  ++Q+   H  +  L
Sbjct: 12  LLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTAL 70

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
              ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H   VV+RD
Sbjct: 71  KYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRD 130

Query: 223 IKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           IK EN++L   G IK+ DFGL    IS+G T+    G+P Y+APEVL  N Y   VD W 
Sbjct: 131 IKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWG 190

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GV+++ ++   LPF     E +F+ I   ++ F      T+S  A+ L+A +L +D   
Sbjct: 191 LGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPR----TLSPEAKSLLAGLLKKDPKQ 246

Query: 341 RI-----TADEVLRHPW 352
           R+      A EV+ H +
Sbjct: 247 RLGGGPSDAKEVMEHRF 263

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score =  188 bits (481), Expect = 5e-56
 Identities = 72/279 (25%), Positives = 137/279 (49%), Gaps = 19/279 (6%)

Query: 89  IDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREV 147
           +      G +++++  D   + V+G G FG V L   K +   +A K L+K       +V
Sbjct: 5   VSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDV 64

Query: 148 E-------IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA 200
           E       ++        +  LHS ++  D  + VME  +GG L+  + +VG++ E  A 
Sbjct: 65  ECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAV 124

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGS 259
               ++   + +    G+++RD+K +N++L + G IK+ADFG+    I +G T     G+
Sbjct: 125 FYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGT 184

Query: 260 PAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV 318
           P Y+APE+++   Y + VD W+ GVLL+ +L    PF+G+  + +F +I    + +    
Sbjct: 185 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPK-- 242

Query: 319 WETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
             ++SK A  +   ++T+    R+        ++  H +
Sbjct: 243 --SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 279

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score =  189 bits (481), Expect = 2e-55
 Identities = 91/267 (34%), Positives = 132/267 (49%), Gaps = 20/267 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVE--IMQHLSG 155
           +D+  V+VIG G FG V L R K++   +A K L K E     ++     E  IM   + 
Sbjct: 69  EDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN- 127

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              VV L   +++    ++VME   GG L++ M       E+ A     +V+  +   H 
Sbjct: 128 SPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHS 186

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLA-GSPAYVAPEVL----- 268
           MG +HRD+KP+N+LL  SG +KLADFG  M+    G      A G+P Y++PEVL     
Sbjct: 187 MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGG 246

Query: 269 SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
            G Y  + D WS GV L+ +LV   PF  DSL   +  I N K          +SK A++
Sbjct: 247 DGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKN 306

Query: 329 LMARMLTRDVSARIT---ADEVLRHPW 352
           L+   LT D   R+     +E+ RH +
Sbjct: 307 LICAFLT-DREVRLGRNGVEEIKRHLF 332

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score =  187 bits (476), Expect = 2e-55
 Identities = 75/263 (28%), Positives = 135/263 (51%), Gaps = 20/263 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +       E    E  I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+  G+T + L G+P  +APE++    Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-KGRTWT-LCGTPEALAPEIILSKGYNK 217

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+ GVL++ +     PF  D    +++ I + K+ F S      S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSH----FSSDLKDLLRNLL 273

Query: 335 TRDVSARI-----TADEVLRHPW 352
             D++ R        +++  H W
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKW 296

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score =  188 bits (480), Expect = 3e-55
 Identities = 80/272 (29%), Positives = 131/272 (48%), Gaps = 24/272 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVE--IMQHLSG 155
           DD   ++VIG G F  V + + K +G  +A K + K +     E      E  ++ +   
Sbjct: 61  DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD- 119

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCH 214
              +  LH  +++ +  +LVME   GG L+  + + G +   + A     +++  I   H
Sbjct: 120 RRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVH 179

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLA-GSPAYVAPEVL---- 268
            +G VHRDIKP+NILL   G I+LADFG  ++  ++G   S +A G+P Y++PE+L    
Sbjct: 180 RLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVG 239

Query: 269 ----SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-GVWETVS 323
               +G+Y  + D W+ GV  + +     PF  DS    +  I + K       V E V 
Sbjct: 240 GGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVP 299

Query: 324 KPARDLMARMLTRDVSARIT---ADEVLRHPW 352
           + ARD + R+L      R+    A +   HP+
Sbjct: 300 EEARDFIQRLLC-PPETRLGRGGAGDFRTHPF 330

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score =  187 bits (476), Expect = 3e-55
 Identities = 78/258 (30%), Positives = 133/258 (51%), Gaps = 19/258 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTL 162
           V+G G FG V L R K +G  +A K L+K       +VE       I+     H  +  L
Sbjct: 30  VLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQL 89

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRD 222
              ++  D    VME  +GG L+  + +  ++ E RA     +++  + + HD G+++RD
Sbjct: 90  FCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRD 149

Query: 223 IKPENILLTTSGKIKLADFGLAM-RISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWS 280
           +K +N+LL   G  KLADFG+    I NG T +   G+P Y+APE+L    Y   VD W+
Sbjct: 150 LKLDNVLLDHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWA 209

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSA 340
            GVLL+ +L    PF+ ++ + +F+AI N ++ + +     + + A  ++   +T++ + 
Sbjct: 210 MGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW----LHEDATGILKSFMTKNPTM 265

Query: 341 RI------TADEVLRHPW 352
           R+          +LRHP+
Sbjct: 266 RLGSLTQGGEHAILRHPF 283

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score =  190 bits (485), Expect = 7e-55
 Identities = 71/272 (26%), Positives = 128/272 (47%), Gaps = 27/272 (9%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSG 155
           D      V+G G FG V+ C+ KA+G  +ACK L K       G +    E +I+  +  
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH- 243

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ----YSEQRAANIFKDVMWVIK 211
              +V+L   +E      LVM + +GG +   +  V +    + E RA      ++  ++
Sbjct: 244 SRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLAGSPAYVAPEVLSG 270
           + H   +++RD+KPEN+LL   G ++++D GLA+   +      G AG+P ++APE+L G
Sbjct: 304 HLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLG 363

Query: 271 N-YSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKP 325
             Y   VD ++ GV L+ ++ A  PF+        + +   +    + +     +  S  
Sbjct: 364 EEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKFSPA 419

Query: 326 ARDLMARMLTRDVSARI-----TADEVLRHPW 352
           ++D    +L +D   R+     + D +  HP 
Sbjct: 420 SKDFCEALLQKDPEKRLGFRDGSCDGLRTHPL 451

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score =  186 bits (474), Expect = 4e-54
 Identities = 83/281 (29%), Positives = 141/281 (50%), Gaps = 23/281 (8%)

Query: 93  TQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHRE 146
           T   ++ ++  +D   ++VIG G FG V + + K +   FA K L K E     ET    
Sbjct: 63  TSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFR 122

Query: 147 VE--IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIF 203
            E  ++ +      + TLH  +++ +  +LVM+   GG L+  + +   +  E+ A    
Sbjct: 123 EERDVLVNGD-SKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYL 181

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTLSGLA-GSPA 261
            +++  I   H +  VHRDIKP+NIL+  +G I+LADFG  ++ + +G   S +A G+P 
Sbjct: 182 AEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPD 241

Query: 262 YVAPEVLSGN------YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH 315
           Y++PE+L         Y  + D WS GV ++ +L    PF  +SL   +  I N K  F 
Sbjct: 242 YISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQ 301

Query: 316 SGVWET-VSKPARDLMARMLTRDVSARIT---ADEVLRHPW 352
                T VS+ A+DL+ R++      R+     ++  +HP+
Sbjct: 302 FPTQVTDVSENAKDLIRRLICSR-EHRLGQNGIEDFKKHPF 341

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score =  184 bits (470), Expect = 2e-53
 Identities = 81/258 (31%), Positives = 130/258 (50%), Gaps = 20/258 (7%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTL 162
           ++G G FG V L + KA+G  +A K L+K       EV        ++Q+ S H  +  L
Sbjct: 155 LLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTAL 213

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVVHR 221
              ++  D    VME  +GG L   +     +SE RA     +++  + Y H +  VV+R
Sbjct: 214 KYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYR 273

Query: 222 DIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIW 279
           D+K EN++L   G IK+ DFGL    I +G T+    G+P Y+APEVL  N Y   VD W
Sbjct: 274 DLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWW 333

Query: 280 SAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVS 339
             GV+++ ++   LPF     E +F+ I   ++ F      T+   A+ L++ +L +D  
Sbjct: 334 GLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLLSGLLKKDPK 389

Query: 340 ARI-----TADEVLRHPW 352
            R+      A E+++H +
Sbjct: 390 QRLGGGSEDAKEIMQHRF 407

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  181 bits (461), Expect = 2e-53
 Identities = 62/257 (24%), Positives = 105/257 (40%), Gaps = 13/257 (5%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSV 165
           T    +G G FG V   + K +G + A K +R  E     E+     LS    +V L+  
Sbjct: 61  THQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRL-EVFRVEELVACAGLS-SPRIVPLYGA 118

Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
             E    ++ MEL  GG L   + ++G   E RA       +  ++Y H   ++H D+K 
Sbjct: 119 VREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKA 178

Query: 226 ENILLTTSG-KIKLADFGLAMRISNGQTLSGLA------GSPAYVAPEVLSGN-YSEKVD 277
           +N+LL++ G +  L DFG A+ +        L       G+  ++APEV+ G     KVD
Sbjct: 179 DNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVD 238

Query: 278 IWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           IWS+  ++  +L    P+                       +  + +      +   L +
Sbjct: 239 IWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIRE--IPPSCAPLTAQAIQEGLRK 296

Query: 337 DVSARITADEVLRHPWI 353
           +   R +A E+ R    
Sbjct: 297 EPVHRASAMELRRKVGK 313

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score =  180 bits (460), Expect = 2e-53
 Identities = 77/267 (28%), Positives = 139/267 (52%), Gaps = 28/267 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSG 155
            D   +  +G G FG V L RS+ +G  +A K L+K      ++VE       ++  ++ 
Sbjct: 6   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 64

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA----ANIFKDVMWVIK 211
           H  ++ +   +++A    ++M+   GG L   + +  ++    A    A +    +  ++
Sbjct: 65  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV---CL-ALE 120

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN 271
           Y H   +++RD+KPENILL  +G IK+ DFG A  +    T + L G+P Y+APEV+S  
Sbjct: 121 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-PDVTYT-LCGTPDYIAPEVVSTK 178

Query: 272 -YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
            Y++ +D WS G+L++ +L    PF   +    ++ I N +L F        ++  +DL+
Sbjct: 179 PYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF----FNEDVKDLL 234

Query: 331 ARMLTRDVSARI-----TADEVLRHPW 352
           +R++TRD+S R+       ++V  HPW
Sbjct: 235 SRLITRDLSQRLGNLQNGTEDVKNHPW 261

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score =  181 bits (462), Expect = 5e-53
 Identities = 82/260 (31%), Positives = 121/260 (46%), Gaps = 25/260 (9%)

Query: 110 VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTL 162
           VIG G FG V L R KA    +A K L+K      +E +       ++     H  +V L
Sbjct: 45  VIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGL 104

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA----ANIFKDVMWVIKYCHDMGV 218
           H  ++ AD  + V++  +GG L   +     + E RA    A I       + Y H + +
Sbjct: 105 HFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEI----ASALGYLHSLNI 160

Query: 219 VHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKV 276
           V+RD+KPENILL + G I L DFGL    I +  T S   G+P Y+APEVL    Y   V
Sbjct: 161 VYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTV 220

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           D W  G +L+ +L    PF   +   ++D I N  L         ++  AR L+  +L +
Sbjct: 221 DWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN----ITNSARHLLEGLLQK 276

Query: 337 DVSARI----TADEVLRHPW 352
           D + R+       E+  H +
Sbjct: 277 DRTKRLGAKDDFMEIKSHVF 296

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score =  187 bits (477), Expect = 6e-53
 Identities = 81/356 (22%), Positives = 148/356 (41%), Gaps = 18/356 (5%)

Query: 11  DATEDELKQGHDSRTSIIRSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCG 70
           D T      G  S          ++ + +L  + + +    P+    S            
Sbjct: 249 DLTSRNDFMGSLSFGISELQKAGVDGWFKLLSQEEGEYFNVPVPPEGSEGNEELRQKFER 308

Query: 71  ASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAE 130
           A           K             R      D   + V+G G FG V L   K +   
Sbjct: 309 AKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDEL 368

Query: 131 FACKTLRKGEETVHREVE-------IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR 183
           +A K L+K       +VE       ++        +  LHS ++  D  + VME  +GG 
Sbjct: 369 YAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGD 428

Query: 184 LIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL 243
           L+  + +VG++ E  A     ++   + +    G+++RD+K +N++L + G IK+ADFG+
Sbjct: 429 LMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGM 488

Query: 244 AMR-ISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLE 301
               I +G T     G+P Y+APE+++   Y + VD W+ GVLL+ +L    PF+G+  +
Sbjct: 489 CKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548

Query: 302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
            +F +I    + +      ++SK A  +   ++T+    R+        ++  H +
Sbjct: 549 ELFQSIMEHNVAYPK----SMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAF 600

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score =  179 bits (457), Expect = 1e-52
 Identities = 71/282 (25%), Positives = 127/282 (45%), Gaps = 29/282 (10%)

Query: 96  GRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE------ 148
           G  + +   D   + VIG G +  V L R K +   +A K ++K       +++      
Sbjct: 1   GAMDPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEK 60

Query: 149 -IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
            + +  S H  +V LHS ++       V+E  +GG L+  M    +  E+ A     ++ 
Sbjct: 61  HVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEIS 120

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPE 266
             + Y H+ G+++RD+K +N+LL + G IKL D+G+    +  G T S   G+P Y+APE
Sbjct: 121 LALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPE 180

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLVAALPF---------KGDSLEAVFDAIKNVKLDFHS 316
           +L G  Y   VD W+ GVL+  ++    PF           ++ + +F  I   ++    
Sbjct: 181 ILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPR 240

Query: 317 GVWETVSKPARDLMARMLTRDVSARI------TADEVLRHPW 352
                +S  A  ++   L +D   R+         ++  HP+
Sbjct: 241 S----LSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPF 278

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score =  181 bits (460), Expect = 1e-52
 Identities = 72/311 (23%), Positives = 134/311 (43%), Gaps = 29/311 (9%)

Query: 67  PPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSK 125
           P           G G++ +   ++        + +   D   + VIG G +  V L R K
Sbjct: 15  PTTENLYFQGAMGSGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLK 74

Query: 126 ASGAEFACKTLRKGEETVHREVE-------IMQHLSGHTGVVTLHSVYEEADCFHLVMEL 178
            +   +A + ++K       +++       + +  S H  +V LHS ++       V+E 
Sbjct: 75  KTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEY 134

Query: 179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL 238
            +GG L+  M    +  E+ A     ++   + Y H+ G+++RD+K +N+LL + G IKL
Sbjct: 135 VNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKL 194

Query: 239 ADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPF- 295
            D+G+    +  G T S   G+P Y+APE+L G  Y   VD W+ GVL+  ++    PF 
Sbjct: 195 TDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFD 254

Query: 296 --------KGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI----- 342
                     ++ + +F  I   ++         +S  A  ++   L +D   R+     
Sbjct: 255 IVGSSDNPDQNTEDYLFQVILEKQIRIPRS----LSVKAASVLKSFLNKDPKERLGCHPQ 310

Query: 343 -TADEVLRHPW 352
               ++  HP+
Sbjct: 311 TGFADIQGHPF 321

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score =  178 bits (455), Expect = 2e-52
 Identities = 83/284 (29%), Positives = 141/284 (49%), Gaps = 23/284 (8%)

Query: 87  GCIDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCR---SKASGAEFACKTLRK----- 138
           G  +     G +    +    + V+G G +G V+  R      +G  FA K L+K     
Sbjct: 1   GSSETSVNRGPEKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVR 60

Query: 139 -GEETVHREVE--IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYS 195
             ++T H + E  I++ +  H  +V L   ++     +L++E  SGG L  Q+   G + 
Sbjct: 61  NAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFM 119

Query: 196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLS 254
           E  A     ++   + + H  G+++RD+KPENI+L   G +KL DFGL    I +G    
Sbjct: 120 EDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTH 179

Query: 255 GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD 313
              G+  Y+APE+L  + ++  VD WS G L++ +L  A PF G++ +   D I   KL+
Sbjct: 180 TFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLN 239

Query: 314 FHSGVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
                   +++ ARDL+ ++L R+ ++R+      A EV  HP+
Sbjct: 240 LPPY----LTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPF 279

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score =  178 bits (454), Expect = 2e-52
 Identities = 74/280 (26%), Positives = 133/280 (47%), Gaps = 21/280 (7%)

Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCR---SKASGAEFACKTLRKGEETVHR 145
           I  H + G +         ++V+G G FG V+L +      +   +A K L+K    V  
Sbjct: 10  ITHHVKEGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRD 69

Query: 146 EVE------IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRA 199
            V       I+  ++ H  +V LH  ++     +L+++   GG L  ++ +   ++E+  
Sbjct: 70  RVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDV 128

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAG 258
                ++   + + H +G+++RD+KPENILL   G IKL DFGL+   I + +      G
Sbjct: 129 KFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG 188

Query: 259 SPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG 317
           +  Y+APEV++   +++  D WS GVL+  +L   LPF+G   +     I   KL     
Sbjct: 189 TVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248

Query: 318 VWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
               +S  A+ L+  +  R+ + R+       +E+ RH +
Sbjct: 249 ----LSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSF 284

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  179 bits (455), Expect = 3e-52
 Identities = 43/294 (14%), Positives = 101/294 (34%), Gaps = 37/294 (12%)

Query: 109 EVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVV 160
            ++G G F  V+           +  +F  K  +     E  +  ++      S     +
Sbjct: 71  HLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFM 130

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY-----SEQRAANIFKDVMWVIKYCHD 215
             +S +   +   LV EL S G L++ +            +    +    ++++I+  HD
Sbjct: 131 KFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD 190

Query: 216 MGVVHRDIKPENILLTT-----------SGKIKLADFGLAMRIS---NGQTLSGLAGSPA 261
             ++H DIKP+N +L             S  + L D G ++ +     G   +    +  
Sbjct: 191 CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSG 250

Query: 262 YVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
           +   E+LS   ++ ++D +     ++ +L        +            +   H  +W 
Sbjct: 251 FQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGECKPE-GLFRRLPHLDMWN 309

Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTL-TIKSKLKNQ 373
                  +    ML       + + ++LR      + +     +  ++++L   
Sbjct: 310 -------EFFHVMLNIPDCHHLPSLDLLRQKLKKVFQQHYTNKIRALRNRLIVL 356

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  174 bits (443), Expect = 4e-51
 Identities = 71/278 (25%), Positives = 126/278 (45%), Gaps = 18/278 (6%)

Query: 90  DVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK--TLRKGE--ETVHR 145
           D  + +   +   D++    V+G G +G V+  R  ++    A K    R     + +H 
Sbjct: 9   DCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHE 68

Query: 146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANI 202
           E+ + +HL  H  +V     + E     + ME   GG L   +       + +EQ     
Sbjct: 69  EIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFY 127

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQTLS-GLAGSP 260
            K ++  +KY HD  +VHRDIK +N+L+ T SG +K++DFG + R++     +    G+ 
Sbjct: 128 TKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTGTL 187

Query: 261 AYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFK--GDSLEAVFDAIKNVKLDFH 315
            Y+APE++      Y +  DIWS G  +  +     PF   G+   A+F   K      H
Sbjct: 188 QYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMF---KVGMFKVH 244

Query: 316 SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             + E++S  A+  + +    D   R  A+++L   ++
Sbjct: 245 PEIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFL 282

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score =  170 bits (434), Expect = 3e-49
 Identities = 77/291 (26%), Positives = 142/291 (48%), Gaps = 32/291 (10%)

Query: 89  IDVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCR---SKASGAEFACKTLRK------ 138
           +      G   K+  ++   ++V+G G +G V+L R      +G  +A K L+K      
Sbjct: 39  LRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQK 98

Query: 139 GEETVHREVE--IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSE 196
            + T H   E  +++H+     +VTLH  ++     HL+++  +GG L   + +  +++E
Sbjct: 99  AKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTE 158

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA---MRISNGQTL 253
                   +++  +++ H +G+++RDIK ENILL ++G + L DFGL+   +     +  
Sbjct: 159 HEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAY 218

Query: 254 SGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDA 306
               G+  Y+AP+++ G    + + VD WS GVL++ LL  A PF  D    S   +   
Sbjct: 219 D-FCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRR 277

Query: 307 IKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARI-----TADEVLRHPW 352
           I   +  +       +S  A+DL+ R+L +D   R+      ADE+  H +
Sbjct: 278 ILKSEPPYPQE----MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLF 324

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  164 bits (417), Expect = 4e-47
 Identities = 53/283 (18%), Positives = 102/283 (36%), Gaps = 26/283 (9%)

Query: 89  IDVHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVE 148
           +    ++     I             K+            +     +     +    ++ 
Sbjct: 55  VKALAKLEHPG-IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIR 113

Query: 149 IMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRL---IDQMVEVGQYSEQRAANIFKD 205
            M   S    V  L          ++ M+LC    L   +++   +         +IF  
Sbjct: 114 RMDPFSTKNTVGQLQP-SSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQ 172

Query: 206 VMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-------------GQT 252
           +   +++ H  G++HRD+KP NI  T    +K+ DFGL   +                 T
Sbjct: 173 IAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYAT 232

Query: 253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFDAIKNV 310
            +G  G+  Y++PE + G NYS KVDI+S G++L  LL     F        +   ++N+
Sbjct: 233 HTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNL 289

Query: 311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           K      ++         ++  ML+   + R  A +++ +   
Sbjct: 290 KFPL---LFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIF 329

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  161 bits (410), Expect = 2e-46
 Identities = 48/259 (18%), Positives = 110/259 (42%), Gaps = 18/259 (6%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHLSGHTGVVTL 162
             IG G F +V+      +  E A   L      +   +    E E+++ L  H  +V  
Sbjct: 32  IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRF 90

Query: 163 HSVY----EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG- 217
           +  +    +   C  LV EL + G L   +        +   +  + ++  +++ H    
Sbjct: 91  YDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150

Query: 218 -VVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEK 275
            ++HRD+K +NI +T  +G +K+ D GLA         + + G+P ++APE+    Y E 
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA-VIGTPEFMAPEMYEEKYDES 209

Query: 276 VDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           VD+++ G+ +  +  +  P+    +   ++  + +      +   +      ++++   +
Sbjct: 210 VDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCI 267

Query: 335 TRDVSARITADEVLRHPWI 353
            ++   R +  ++L H + 
Sbjct: 268 RQNKDERYSIKDLLNHAFF 286

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score =  162 bits (411), Expect = 3e-46
 Identities = 69/290 (23%), Positives = 123/290 (42%), Gaps = 25/290 (8%)

Query: 90  DVHTQMGRKNKIE-DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETV 143
              T  G++ + E +D   +  +G G  G VW  R + +G   A K +R     +  + +
Sbjct: 11  GYLTIGGQRYQAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRI 70

Query: 144 HREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF 203
             +++++        +V     +       + MEL        +    G   E+    + 
Sbjct: 71  LMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMT 130

Query: 204 KDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
             ++  + Y  +  GV+HRD+KP NILL   G+IKL DFG++ R+ + +     AG  AY
Sbjct: 131 VAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKAKDRSAGCAAY 190

Query: 263 VAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV------ 310
           +APE +        +Y  + D+WS G+ L  L     P+   + +  F+ +  V      
Sbjct: 191 MAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPY--KNCKTDFEVLTKVLQEEPP 248

Query: 311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERT 360
            L  H G +   S   +  +   LT+D   R   +++L H +I  Y    
Sbjct: 249 LLPGHMG-F---SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETLE 294

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  161 bits (410), Expect = 5e-46
 Identities = 90/259 (34%), Positives = 137/259 (52%), Gaps = 11/259 (4%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHT 157
                    IG G  G V L R K SG + A K   LRK +  E +  EV IM+    H 
Sbjct: 44  RLLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HF 102

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV ++  Y   +   ++ME   GG L D +V   + +E++ A + + V+  + Y H  G
Sbjct: 103 NVVEMYKSYLVGEELWVLMEFLQGGALTD-IVSQVRLNEEQIATVCEAVLQALAYLHAQG 161

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEK 275
           V+HRDIK ++ILLT  G++KL+DFG   +IS        L G+P ++APEV+S + Y+ +
Sbjct: 162 VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATE 221

Query: 276 VDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           VDIWS G+++  ++    P+  DS ++A+     +      +     VS   RD + RML
Sbjct: 222 VDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKN--SHKVSPVLRDFLERML 279

Query: 335 TRDVSARITADEVLRHPWI 353
            RD   R TA E+L HP++
Sbjct: 280 VRDPQERATAQELLDHPFL 298

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  160 bits (407), Expect = 6e-46
 Identities = 79/259 (30%), Positives = 135/259 (52%), Gaps = 11/259 (4%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACK--TLRKGE--ETVHREVEIMQHLSGHT 157
           +  +T+ E IG G  G+V+     A+G E A +   L++    E +  E+ +M+    + 
Sbjct: 19  KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NP 77

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            +V     Y   D   +VME  +GG L D +V      E + A + ++ +  +++ H   
Sbjct: 78  NIVNYLDSYLVGDELWVVMEYLAGGSLTD-VVTETCMDEGQIAAVCRECLQALEFLHSNQ 136

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSEK 275
           V+HRDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  K
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPK 196

Query: 276 VDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           VDIWS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R L
Sbjct: 197 VDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIFRDFLNRCL 254

Query: 335 TRDVSARITADEVLRHPWI 353
             DV  R +A E+L+H ++
Sbjct: 255 EMDVEKRGSAKELLQHQFL 273

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  160 bits (407), Expect = 9e-46
 Identities = 78/279 (27%), Positives = 131/279 (46%), Gaps = 28/279 (10%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE---ETVHREVEIMQHLSGH 156
            DD+   EVIG G    V          + A K   L K +   + + +E++ M     H
Sbjct: 14  RDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-H 72

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQM--------VEVGQYSEQRAANIFKDVMW 208
             +V+ ++ +   D   LVM+L SGG ++D +         + G   E   A I ++V+ 
Sbjct: 73  PNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLE 132

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA------GSPAY 262
            ++Y H  G +HRD+K  NILL   G +++ADFG++  ++ G  ++         G+P +
Sbjct: 133 GLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCW 192

Query: 263 VAPEVL--SGNYSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNV--KLDFHSG 317
           +APEV+     Y  K DIWS G+    L   A P+ K   ++ +   ++N    L+    
Sbjct: 193 MAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQ 252

Query: 318 VWETV---SKPARDLMARMLTRDVSARITADEVLRHPWI 353
             E +    K  R +++  L +D   R TA E+LRH + 
Sbjct: 253 DKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFF 291

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  159 bits (405), Expect = 2e-45
 Identities = 77/303 (25%), Positives = 126/303 (41%), Gaps = 71/303 (23%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           + + K+  IG G +G V+ CR++ +G   A K   + E+         RE+ +++ L  H
Sbjct: 3   EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-H 61

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMW----VI 210
             +V L  V+      HLV E C       +D+             ++ K + W     +
Sbjct: 62  PNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRY------QRGVPEHLVKSITWQTLQAV 115

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--------- 261
            +CH    +HRD+KPENIL+T    IKL DFG A R+            P+         
Sbjct: 116 NFCHKHNCIHRDVKPENILITKHSVIKLCDFGFA-RLL---------TGPSDYYDDEVAT 165

Query: 262 --YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI----- 307
             Y +PE+L G   Y   VD+W+ G +  A L++ +P + G S    L  +   +     
Sbjct: 166 RWYRSPELLVGDTQYGPPVDVWAIGCVF-AELLSGVPLWPGKSDVDQLYLIRKTLGDLIP 224

Query: 308 ------------KNVKLDFHSG------VWETVSKPARDLMARMLTRDVSARITADEVLR 349
                         VK+            +  +S PA  L+   L  D + R+T +++L 
Sbjct: 225 RHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLH 284

Query: 350 HPW 352
           HP+
Sbjct: 285 HPY 287

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score =  158 bits (402), Expect = 4e-45
 Identities = 80/263 (30%), Positives = 132/263 (50%), Gaps = 18/263 (6%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE---ETVHREVEIMQHLSGH 156
           E+  TK+E IG G FG V+      +    A K   L + E   E + +E+ ++      
Sbjct: 21  EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-S 79

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             V   +  Y +     ++ME   GG  +D ++E G   E + A I ++++  + Y H  
Sbjct: 80  PYVTKYYGSYLKDTKLWIIMEYLGGGSALD-LLEPGPLDETQIATILREILKGLDYLHSE 138

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLS-GNYSE 274
             +HRDIK  N+LL+  G++KLADFG+A ++++ Q       G+P ++APEV+    Y  
Sbjct: 139 KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDS 198

Query: 275 KVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNV--KLDFHSGVWETVSKPARDLMA 331
           K DIWS G+    L     P  +   ++ +F   KN    L+   G +   SKP ++ + 
Sbjct: 199 KADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLE---GNY---SKPLKEFVE 252

Query: 332 RMLTRDVSARITADEVLRHPWIL 354
             L ++ S R TA E+L+H +IL
Sbjct: 253 ACLNKEPSFRPTAKELLKHKFIL 275

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score =  157 bits (400), Expect = 6e-45
 Identities = 68/277 (24%), Positives = 122/277 (44%), Gaps = 25/277 (9%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-KGEETVH----REVEIMQHLSGHT 157
           DD   +  +G G +G V   R   SG   A K +R             +++I        
Sbjct: 7   DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTVDCP 66

Query: 158 GVVTLH-SVYEEADCFHLVMELCSGG--RLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYC 213
             VT + +++ E D   + MEL      +   Q+++ GQ   E     I   ++  +++ 
Sbjct: 67  FTVTFYGALFREGDV-WICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125

Query: 214 HD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN- 271
           H  + V+HRD+KP N+L+   G++K+ DFG++  + +       AG   Y+APE ++   
Sbjct: 126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPEL 185

Query: 272 ----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD----FHSGVWETVS 323
               YS K DIWS G+ +  L +   P+  DS    F  +K V  +      +  +   S
Sbjct: 186 NQKGYSVKSDIWSLGITMIELAILRFPY--DSWGTPFQQLKQVVEEPSPQLPADKF---S 240

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWILFYTERT 360
               D  ++ L ++   R T  E+++HP+   +  + 
Sbjct: 241 AEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHESKG 277

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score =  158 bits (401), Expect = 1e-44
 Identities = 78/281 (27%), Positives = 131/281 (46%), Gaps = 29/281 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHREVEIMQHLSGHT 157
           +D   +  IG G +GSV     K SG   A K +R     K ++ +  +++++   S   
Sbjct: 22  EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSSDCP 81

Query: 158 GVVTLH-SVYEEADCFHLVMELCSGG--RLIDQMVEV--GQYSEQRAANIFKDVMWVIKY 212
            +V  + +++ E DC+ + MEL S    +    +  V      E+    I    +  + +
Sbjct: 82  YIVQFYGALFREGDCW-ICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140

Query: 213 CHDMG-VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN 271
             +   ++HRDIKP NILL  SG IKL DFG++ ++ +    +  AG   Y+APE +  +
Sbjct: 141 LKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPS 200

Query: 272 -----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV------KL-DFHSGVW 319
                Y  + D+WS G+ L+ L     P+      +VFD +  V      +L +     +
Sbjct: 201 ASRQGYDVRSDVWSLGITLYELATGRFPY--PKWNSVFDQLTQVVKGDPPQLSNSEEREF 258

Query: 320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERT 360
              S    + +   LT+D S R    E+L+HP+IL Y ER 
Sbjct: 259 ---SPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERA 296

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  159 bits (405), Expect = 1e-44
 Identities = 91/343 (26%), Positives = 145/343 (42%), Gaps = 76/343 (22%)

Query: 63  IATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDH-TKVEVIGHGKFGSVWL 121
           ++ AP  G   +       L      I V    G+  +  +   T  +VIG+G FG V+ 
Sbjct: 5   MSNAPLNGVKLN------PLDDPNKVIKVLASDGKTGEQREIAYTNCKVIGNGSFGVVFQ 58

Query: 122 CRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY------EEADCFHLV 175
            +   S  E A K + + +   +RE++IM+ +  H  VV L + +      ++    +LV
Sbjct: 59  AKLVESD-EVAIKKVLQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLNLV 116

Query: 176 MELCSG--GRLIDQMVEVGQ---------YSEQRAANIFKDVMWVIKYCHDMGVVHRDIK 224
           +E       R      ++ Q         Y  Q    + +     + Y H +G+ HRDIK
Sbjct: 117 LEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQ----LLR----SLAYIHSIGICHRDIK 168

Query: 225 PENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV------APEVLSG--NYSEK 275
           P+N+LL   SG +KL DFG A  +  G+         +Y+      APE++ G  NY+  
Sbjct: 169 PQNLLLDPPSGVLKLIDFGSAKILIAGEPNV------SYICSRYYRAPELIFGATNYTTN 222

Query: 276 VDIWSAGVLLHALLVAALP-FKGDS----LEAVF--------DAIKNV------------ 310
           +DIWS G ++ A L+   P F G+S    L  +         + IK +            
Sbjct: 223 IDIWSTGCVM-AELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQI 281

Query: 311 -KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
               F           A DL++R+L    SAR+TA E L HP+
Sbjct: 282 RPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPF 324

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score =  157 bits (399), Expect = 2e-44
 Identities = 70/273 (25%), Positives = 130/273 (47%), Gaps = 26/273 (9%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR---KGEETVHREVEIMQHLSGHTG 158
                 VE++G+G +G V+  R   +G   A K +      EE + +E+ +++  S H  
Sbjct: 23  AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRN 82

Query: 159 VVTLHSVYEEADCFH------LVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVI 210
           + T +  + + +         LVME C  G + D  +  +     E+  A I ++++  +
Sbjct: 83  IATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 142

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS---GLAGSPAYVAPEV 267
            + H   V+HRDIK +N+LLT + ++KL DFG++ ++    T+       G+P ++APEV
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR--TVGRRNTFIGTPYWMAPEV 200

Query: 268 LS------GNYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWE 320
           ++        Y  K D+WS G+    +   A P      + A+F   +N      S  W 
Sbjct: 201 IACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRLKSKKW- 259

Query: 321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
             SK  +  +   L ++ S R   +++++HP+I
Sbjct: 260 --SKKFQSFIESCLVKNHSQRPATEQLMKHPFI 290

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  157 bits (399), Expect = 2e-44
 Identities = 73/305 (23%), Positives = 124/305 (40%), Gaps = 68/305 (22%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
               ++E +G+G + +V+   +K +G   A K ++   E     T  RE+ +M+ L  H 
Sbjct: 5   SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HE 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWV----IK 211
            +V L+ V    +   LV E       + +D               + K   W     + 
Sbjct: 64  NIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLV-KYFQWQLLQGLA 122

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---------- 261
           +CH+  ++HRD+KP+N+L+   G++KL DFGLA             G P           
Sbjct: 123 FCHENKILHRDLKPQNLLINKRGQLKLGDFGLA----------RAFGIPVNTFSSEVVTL 172

Query: 262 -YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI------ 307
            Y AP+VL G   YS  +DIWS G +L A ++   P F G +    L+ +FD +      
Sbjct: 173 WYRAPDVLMGSRTYSTSIDIWSCGCIL-AEMITGKPLFPGTNDEEQLKLIFDIMGTPNES 231

Query: 308 --------------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEV 347
                               ++++        E +     D +  +L  +   R++A + 
Sbjct: 232 LWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQA 291

Query: 348 LRHPW 352
           L HPW
Sbjct: 292 LHHPW 296

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score =  155 bits (394), Expect = 6e-44
 Identities = 69/267 (25%), Positives = 120/267 (44%), Gaps = 20/267 (7%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE--ETVHREVEIMQHLSGHT 157
            +    V  +G G FG V+  ++K +GA  A K    +  E  E    E+EI+     H 
Sbjct: 18  NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HP 76

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDM 216
            +V L   Y       +++E C GG +   M+E+    +E +   + + ++  + + H  
Sbjct: 77  YIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLS------ 269
            ++HRD+K  N+L+T  G I+LADFG++ +            G+P ++APEV+       
Sbjct: 137 RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKD 196

Query: 270 GNYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNV--KLDFHSGVWETVSKPA 326
             Y  K DIWS G+ L  +     P    + +  +    K+    L      W   S   
Sbjct: 197 TPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTLL-TPSKW---SVEF 252

Query: 327 RDLMARMLTRDVSARITADEVLRHPWI 353
           RD +   L ++   R +A ++L HP++
Sbjct: 253 RDFLKIALDKNPETRPSAAQLLEHPFV 279

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  156 bits (397), Expect = 7e-44
 Identities = 72/264 (27%), Positives = 116/264 (43%), Gaps = 19/264 (7%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGE-----ETVHREVEIMQHLS 154
           E   + +  IGHG FG+V+  R   +    A K       +     + + +EV  +Q L 
Sbjct: 53  EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 112

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
            H   +     Y       LVME C G       V      E   A +    +  + Y H
Sbjct: 113 -HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLH 171

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS----G 270
              ++HRD+K  NILL+  G +KL DFG A  ++   +     G+P ++APEV+     G
Sbjct: 172 SHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILAMDEG 228

Query: 271 NYSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
            Y  KVD+WS G+    L     P F  +++ A++   +N      SG W   S+  R+ 
Sbjct: 229 QYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHW---SEYFRNF 285

Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           +   L +    R T++ +L+H ++
Sbjct: 286 VDSCLQKIPQDRPTSEVLLKHRFV 309

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  154 bits (392), Expect = 1e-43
 Identities = 77/302 (25%), Positives = 128/302 (42%), Gaps = 70/302 (23%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
             + K+E IG G +G+V+  +++ +    A K +R  ++      +  RE+ +++ L  H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWV----I 210
             +V LH V        LV E C     +  D        +      I K  ++     +
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSC------NGDLDPEIVKSFLFQLLKGL 114

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--------- 261
            +CH   V+HRD+KP+N+L+  +G++KLA+FGLA R           G P          
Sbjct: 115 GFCHSRNVLHRDLKPQNLLINRNGELKLANFGLA-RAF---------GIPVRCYSAEVVT 164

Query: 262 --YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI----- 307
             Y  P+VL G   YS  +D+WSAG +   L  A  P F G+     L+ +F  +     
Sbjct: 165 LWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTE 224

Query: 308 -----------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                                    + V   ++   RDL+  +L  +   RI+A+E L+H
Sbjct: 225 EQWPSMTKLPDYKPYPMYPATTSLVN-VVPKLNATGRDLLQNLLKCNPVQRISAEEALQH 283

Query: 351 PW 352
           P+
Sbjct: 284 PY 285

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  154 bits (392), Expect = 3e-43
 Identities = 72/295 (24%), Positives = 123/295 (41%), Gaps = 55/295 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           + +  + ++G G +G V  CR+K +G   A K   + ++         RE+++++ L  H
Sbjct: 25  EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-H 83

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMW----VI 210
             +V L  V ++   ++LV E         ++               + +  ++     I
Sbjct: 84  ENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELF------PNGLDYQVVQKYLFQIINGI 137

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI--SNGQTLSGLAGSPAYVAPEVL 268
            +CH   ++HRDIKPENIL++ SG +KL DFG A R   + G+       +  Y APE+L
Sbjct: 138 GFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFA-RTLAAPGEVYDDEVATRWYRAPELL 196

Query: 269 SG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI-------------- 307
            G   Y + VD+W+ G L+   +    P F GDS    L  +   +              
Sbjct: 197 VGDVKYGKAVDVWAIGCLV-TEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKN 255

Query: 308 ---KNVKL-------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                V+L             +  +S+   DL  + L  D   R    E+L H +
Sbjct: 256 PVFAGVRLPEIKEREPLER-RYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDF 309

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  154 bits (390), Expect = 3e-43
 Identities = 74/260 (28%), Positives = 121/260 (46%), Gaps = 13/260 (5%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGV 159
           E+    +E +G G +GSV+    K +G   A K   +    + + +E+ IMQ       V
Sbjct: 28  EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHV 86

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V  +  Y +     +VME C  G + D + +     +E   A I +  +  ++Y H M  
Sbjct: 87  VKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG-LAGSPAYVAPEVLS-GNYSEKV 276
           +HRDIK  NILL T G  KLADFG+A ++++       + G+P ++APEV+    Y+   
Sbjct: 147 IHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVA 206

Query: 277 DIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNV--KLDFHSGVWETVSKPARDLMARM 333
           DIWS G+    +     P      + A+F    N          +W   S    D + + 
Sbjct: 207 DIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFR-KPELW---SDNFTDFVKQC 262

Query: 334 LTRDVSARITADEVLRHPWI 353
           L +    R TA ++L+HP++
Sbjct: 263 LVKSPEQRATATQLLQHPFV 282

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score =  154 bits (391), Expect = 5e-43
 Identities = 66/316 (20%), Positives = 121/316 (38%), Gaps = 50/316 (15%)

Query: 93  TQMGRKNKI-EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR-----KGEETVHRE 146
           TQ  +  ++ +DD  K+  +G G  G V+    K SG   A K +           + RE
Sbjct: 22  TQKQKVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRE 81

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           ++++ H      +V  +  +       + ME   GG L   + + G+  EQ    +   V
Sbjct: 82  LQVL-HECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140

Query: 207 MWVIKYCHDMG-VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
           +  + Y  +   ++HRD+KP NIL+ + G+IKL DFG++ ++ +    S   G+ +Y++P
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANS-FVGTRSYMSP 199

Query: 266 EVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV-- 322
           E L G  YS + DIWS G+ L  + V   P      + +            +        
Sbjct: 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRT 259

Query: 323 --------------------------------------SKPARDLMARMLTRDVSARITA 344
                                                 S   +D + + L ++ + R   
Sbjct: 260 PGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADL 319

Query: 345 DEVLRHPWILFYTERT 360
            +++ H +I       
Sbjct: 320 KQLMVHAFIKRSDAEE 335

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  155 bits (393), Expect = 1e-42
 Identities = 81/347 (23%), Positives = 136/347 (39%), Gaps = 68/347 (19%)

Query: 58  SRLAGIATAPPCGASSSLVPAGRGLKRKIGCIDVHTQMGRKNKIEDDHTKVEVIGHGKFG 117
           S            A  S+  +      K+  +      G     E  +T  +VIG+G FG
Sbjct: 9   SFAESCKPVQQPSAFGSMKVSRDKDGSKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFG 68

Query: 118 SVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVY------EEADC 171
            V+  +   SG   A K + + +   +RE++IM+ L  H  +V L   +      ++   
Sbjct: 69  VVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVY 127

Query: 172 FHLVMEL--CSGGRLIDQMVEVGQ---------YSEQRAANIFKDVMWVIKYCHDMGVVH 220
            +LV++    +  R+        Q         Y  Q    +F+     + Y H  G+ H
Sbjct: 128 LNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQ----LFR----SLAYIHSFGICH 179

Query: 221 RDIKPENILL-TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV------APEVLSG--N 271
           RDIKP+N+LL   +  +KL DFG A ++  G+         +Y+      APE++ G  +
Sbjct: 180 RDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNV------SYICSRYYRAPELIFGATD 233

Query: 272 YSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI------------------- 307
           Y+  +D+WSAG +L A L+   P F GDS    L  +   +                   
Sbjct: 234 YTSSIDVWSAGCVL-AELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFK 292

Query: 308 --KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
             +     +           A  L +R+L    +AR+T  E   H +
Sbjct: 293 FPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSF 339

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  152 bits (386), Expect = 2e-42
 Identities = 75/303 (24%), Positives = 118/303 (38%), Gaps = 68/303 (22%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           D + ++  +G G +G V+      +    A K +R   E      T  REV +++ L  H
Sbjct: 34  DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-H 92

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             ++ L SV       HL+ E       + +D+       S +   +    ++  + +CH
Sbjct: 93  RNIIELKSVIHHNHRLHLIFEYAENDLKKYMDKN---PDVSMRVIKSFLYQLINGVNFCH 149

Query: 215 DMGVVHRDIKPENILLTTS-----GKIKLADFGLAMRISNGQTLSGLAGSPA-------- 261
               +HRD+KP+N+LL+ S       +K+ DFGLA R           G P         
Sbjct: 150 SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA-RAF---------GIPIRQFTHEII 199

Query: 262 ---YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI---- 307
              Y  PE+L G  +YS  VDIWS   +  A ++   P F GDS    L  +F+ +    
Sbjct: 200 TLWYRPPEILLGSRHYSTSVDIWSIACIW-AEMLMKTPLFPGDSEIDQLFKIFEVLGLPD 258

Query: 308 ------------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
                             K         +   +     DL+  ML  D   RI+A   L 
Sbjct: 259 DTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALE 318

Query: 350 HPW 352
           HP+
Sbjct: 319 HPY 321

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  149 bits (379), Expect = 6e-42
 Identities = 84/301 (27%), Positives = 127/301 (42%), Gaps = 70/301 (23%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           + +  +E IG G +G V+  ++   G  FA K +R  +E      T  RE+ I++ L  H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-H 59

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWV----I 210
           + +V L+ V        LV E       +L+D             +   K  +      I
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVC------EGGLESVTAKSFLLQLLNGI 113

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA--------- 261
            YCHD  V+HRD+KP+N+L+   G++K+ADFGLA R           G P          
Sbjct: 114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLA-RAF---------GIPVRKYTHEIVT 163

Query: 262 --YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI----- 307
             Y AP+VL G   YS  +DIWS G +  A +V   P F G S    L  +F  +     
Sbjct: 164 LWYRAPDVLMGSKKYSTTIDIWSVGCIF-AEMVNGTPLFPGVSEADQLMRIFRILGTPNS 222

Query: 308 ---------KNVKLDFH-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
                         +F            + + +   DL+++ML  D + RITA + L H 
Sbjct: 223 KNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHA 282

Query: 352 W 352
           +
Sbjct: 283 Y 283

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score =  149 bits (378), Expect = 9e-42
 Identities = 78/257 (30%), Positives = 132/257 (51%), Gaps = 19/257 (7%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETV---HREVEIMQHLSGHTGVV 160
           V+ +G G   +V+L        + A K +       EET+    REV     LS H  +V
Sbjct: 16  VDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIV 74

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
           ++  V EE DC++LVME   G  L + +   G  S   A N    ++  IK+ HDM +VH
Sbjct: 75  SMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVH 134

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPAYVAPEVLSGNY-SEKV 276
           RDIKP+NIL+ ++  +K+ DFG+A +  +  +L   + + G+  Y +PE   G    E  
Sbjct: 135 RDIKPQNILIDSNKTLKIFDFGIA-KALSETSLTQTNHVLGTVQYFSPEQAKGEATDECT 193

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF---HSGVWETVSKPARDLMARM 333
           DI+S G++L+ +LV   PF G++  ++  AIK+++       + V + + +   +++ R 
Sbjct: 194 DIYSIGIVLYEMLVGEPPFNGETAVSI--AIKHIQDSVPNVTTDVRKDIPQSLSNVILRA 251

Query: 334 LTRDVSAR-ITADEVLR 349
             +D + R  T  E+  
Sbjct: 252 TEKDKANRYKTIQEMKD 268

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  149 bits (378), Expect = 2e-41
 Identities = 70/301 (23%), Positives = 122/301 (40%), Gaps = 69/301 (22%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHT 157
           + + K++ +G G + +V+  +SK +    A K +R   E     T  REV +++ L  H 
Sbjct: 2   ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HA 60

Query: 158 GVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWV----IK 211
            +VTLH +        LV E       + +D    +            K  ++     + 
Sbjct: 61  NIVTLHDIIHTEKSLTLVFEYLDKDLKQYLDDCGNIINMHNV------KLFLFQLLRGLA 114

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA---------- 261
           YCH   V+HRD+KP+N+L+   G++KLADFGLA R             P           
Sbjct: 115 YCHRQKVLHRDLKPQNLLINERGELKLADFGLA-R---------AKSIPTKTYDNEVVTL 164

Query: 262 -YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI------ 307
            Y  P++L G  +YS ++D+W  G +    +    P F G +    L  +F  +      
Sbjct: 165 WYRPPDILLGSTDYSTQIDMWGVGCIF-YEMATGRPLFPGSTVEEQLHFIFRILGTPTEE 223

Query: 308 -----------KNVKLDFHSG-----VWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
                      K      +           +     DL+ ++L  +   RI+A++ ++HP
Sbjct: 224 TWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHP 283

Query: 352 W 352
           +
Sbjct: 284 F 284

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  148 bits (375), Expect = 4e-41
 Identities = 85/298 (28%), Positives = 123/298 (41%), Gaps = 55/298 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---------TVHREVEIMQHL 153
             +  V  IG G +G+V+  R   SG   A K++R             +  REV +++ L
Sbjct: 9   SRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRL 68

Query: 154 SG--HTGVVTLHSV-----YEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFK 204
               H  VV L  V      +      LV E         +D+    G  +E       K
Sbjct: 69  EAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQDLRTYLDKAPPPGLPAET-----IK 123

Query: 205 DVMW----VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
           D+M      + + H   +VHRD+KPENIL+T+ G +KLADFGLA   S    L+ +  + 
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMALTPVVVTL 183

Query: 261 AYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI------- 307
            Y APEVL    Y+  VD+WS G +  A +    P F G+S    L  +FD I       
Sbjct: 184 WYRAPEVLLQSTYATPVDMWSVGCIF-AEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDD 242

Query: 308 -------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                                S V   + +    L+  MLT +   RI+A   L+H +
Sbjct: 243 WPRDVSLPRGAFPPRGPRPVQS-VVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSY 299

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  146 bits (370), Expect = 3e-40
 Identities = 76/298 (25%), Positives = 124/298 (41%), Gaps = 63/298 (21%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
           + + K+E +G G +G V+  +    G   A K +R   E      T  RE+ +++ L  H
Sbjct: 21  EKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-H 78

Query: 157 TGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
             +V+L  V     C  LV E       +++D+        + +       ++  + +CH
Sbjct: 79  PNIVSLIDVIHSERCLTLVFEFMEKDLKKVLDENK--TGLQDSQIKIYLYQLLRGVAHCH 136

Query: 215 DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-----------YV 263
              ++HRD+KP+N+L+ + G +KLADFGLA R           G P            Y 
Sbjct: 137 QHRILHRDLKPQNLLINSDGALKLADFGLA-RAF---------GIPVRSYTHEVVTLWYR 186

Query: 264 APEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI--------- 307
           AP+VL G   YS  VDIWS G +  A ++   P F G +    L  +F  +         
Sbjct: 187 APDVLMGSKKYSTSVDIWSIGCIF-AEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWP 245

Query: 308 --------KNVKLDFHSG-----VWETVSKPARDLMARMLTRDVSARITADEVLRHPW 352
                   K              +     +   DL++ ML  D + RI+A + + HP+
Sbjct: 246 QVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPY 303

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  147 bits (373), Expect = 4e-40
 Identities = 61/363 (16%), Positives = 126/363 (34%), Gaps = 68/363 (18%)

Query: 102 EDDHTKVEVIGHG--KFGSVWLCRSKASGAEFACKTL------RKGEETVHREVEIMQHL 153
              +  + VIG G     +V L R K +G     + +       +    +  E+ + +  
Sbjct: 24  GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIK 211
           + H  +V   + +   +   +V    + G   D +        +E   A I + V+  + 
Sbjct: 84  N-HPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD 142

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--------LSGLAGSPAYV 263
           Y H MG VHR +K  +IL++  GK+ L+     + + +                    ++
Sbjct: 143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWL 202

Query: 264 APEVLSGN---YSEKVDIWSAGVL-------------LHALLVAALPFKGD--------S 299
           +PEVL  N   Y  K DI+S G+              + A  +      G         +
Sbjct: 203 SPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST 262

Query: 300 LEAVFDAIKNVKLDFHSGVWETV---------------------SKPARDLMARMLTRDV 338
           + A    +   +   +SG+ +++                     S      + + L R+ 
Sbjct: 263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNP 322

Query: 339 SARITADEVLRHPWILFYTERTLRTLT----IKSKLKNQVGASHHHPAILSGVESDENKI 394
            AR +A  +L H +      R    L       + + N  G+     + + G+ ++  ++
Sbjct: 323 DARPSASTLLNHSFFKQIKRRASEALPELLRPVTPITNFEGSQSQDHSGIFGLVTNLEEL 382

Query: 395 DRG 397
           +  
Sbjct: 383 EVD 385

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  145 bits (369), Expect = 4e-40
 Identities = 88/295 (29%), Positives = 131/295 (44%), Gaps = 51/295 (17%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEF-ACKTLRKGEE------TVHREVEIMQHLSG 155
             +  V  IG G +G V+  R   +G  F A K +R          +  REV +++HL  
Sbjct: 11  QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLET 70

Query: 156 --HTGVVTLHSV-----YEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDV 206
             H  VV L  V      +      LV E         +D++ E G  +E       KD+
Sbjct: 71  FEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETI-----KDM 125

Query: 207 MW----VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           M+     + + H   VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y
Sbjct: 126 MFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWY 185

Query: 263 VAPEVLSG-NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI--------- 307
            APEVL   +Y+  VD+WS G +  A +    P F+G S    L  + D I         
Sbjct: 186 RAPEVLLQSSYATPVDLWSVGCIF-AEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWP 244

Query: 308 ------KNVKLDFHSGVWETV----SKPARDLMARMLTRDVSARITADEVLRHPW 352
                 +       +   E       +  +DL+ + LT + + RI+A   L HP+
Sbjct: 245 RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPY 299

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  145 bits (369), Expect = 7e-40
 Identities = 76/303 (25%), Positives = 129/303 (42%), Gaps = 71/303 (23%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---------TVHREVEIMQHL 153
             + K++ +G G+F +V+  R K +    A K ++ G           T  RE++++Q L
Sbjct: 10  KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQEL 69

Query: 154 SGHTGVVTLHSVYEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDVMWV-- 209
           S H  ++ L   +       LV +        +I         +    ++I K  M +  
Sbjct: 70  S-HPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNS--LVLTP---SHI-KAYMLMTL 122

Query: 210 --IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA------ 261
             ++Y H   ++HRD+KP N+LL  +G +KLADFGLA +           GSP       
Sbjct: 123 QGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLA-KSF---------GSPNRAYTHQ 172

Query: 262 -----YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDAI-- 307
                Y APE+L G   Y   VD+W+ G +L A L+  +P   GDS    L  +F+ +  
Sbjct: 173 VVTRWYRAPELLFGARMYGVGVDMWAVGCIL-AELLLRVPFLPGDSDLDQLTRIFETLGT 231

Query: 308 ------KNV-KL-DFHS----------GVWETVSKPARDLMARMLTRDVSARITADEVLR 349
                  ++  L D+ +           ++        DL+  +   +  ARITA + L+
Sbjct: 232 PTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291

Query: 350 HPW 352
             +
Sbjct: 292 MKY 294

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score =  144 bits (364), Expect = 1e-39
 Identities = 67/255 (26%), Positives = 114/255 (44%), Gaps = 24/255 (9%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET--VHREVEIMQHLSGHTGVVTLHSVY 166
           EV+G G FG V   ++K    + A K +    E      E+  +  ++ H  +V L+   
Sbjct: 14  EVVGRGAFGVVC--KAKWRAKDVAIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGAC 70

Query: 167 EEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM---GVVH 220
               C  LVME   GG    ++     +  Y+   A +        + Y H M    ++H
Sbjct: 71  LNPVC--LVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIH 128

Query: 221 RDIKPENILLTTSGK-IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDI 278
           RD+KP N+LL   G  +K+ DFG A        ++   GS A++APEV  G+ YSEK D+
Sbjct: 129 RDLKPPNLLLVAGGTVLKICDFGTA-CDIQ-THMTNNKGSAAWMAPEVFEGSNYSEKCDV 186

Query: 279 WSAGVLLHALLVAALPFKG--DSLEAVFDAI-KNVKLDFHSGVWETVSKPARDLMARMLT 335
           +S G++L  ++    PF         +  A+    +      + + +      LM R  +
Sbjct: 187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPPLIKNLPKPI----ESLMTRCWS 242

Query: 336 RDVSARITADEVLRH 350
           +D S R + +E+++ 
Sbjct: 243 KDPSQRPSMEEIVKI 257

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score =  142 bits (360), Expect = 5e-39
 Identities = 68/260 (26%), Positives = 116/260 (44%), Gaps = 28/260 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTL 162
           E IG G FG+V   R++  G++ A K L + +          REV IM+ L  H  +V  
Sbjct: 43  EKIGAGSFGTVH--RAEWHGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLF 99

Query: 163 HSVYEEADCFHLVMELCSGG---RLIDQMVEVGQYSEQRAANIFKDV---MWVIKYCHDM 216
                +     +V E  S G   RL+ +     Q  E+R  ++  DV   M    Y H+ 
Sbjct: 100 MGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM---NYLHNR 156

Query: 217 G--VVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQTLSGLAGSPAYVAPEVLSGN-Y 272
              +VHR++K  N+L+     +K+ DFGL+ ++ S   +    AG+P ++APEVL     
Sbjct: 157 NPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPS 216

Query: 273 SEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFD-AIKNVKLDFHSGVWETVSKPARDLM 330
           +EK D++S GV+L  L     P+   +  + V     K  +L+        ++     ++
Sbjct: 217 NEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIP----RNLNPQVAAII 272

Query: 331 ARMLTRDVSARITADEVLRH 350
               T +   R +   ++  
Sbjct: 273 EGCWTNEPWKRPSFATIMDL 292

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  142 bits (360), Expect = 9e-39
 Identities = 70/316 (22%), Positives = 129/316 (40%), Gaps = 59/316 (18%)

Query: 90  DVHTQMGRK------NKIE----DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK- 138
           DV+T   R+      + +E    DD+  V  +G GK+  V+   +  +  +   K L+  
Sbjct: 13  DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 72

Query: 139 GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV-----MELCSGGRLIDQMVEVGQ 193
            ++ + RE++I+++L G   ++TL  + ++            +      +L   +     
Sbjct: 73  KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQTL----- 127

Query: 194 YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNGQT 252
            ++        +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ 
Sbjct: 128 -TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE 186

Query: 253 LSGLAGSPAYVAPEVL--SGNYSEKVDIWSAGVLLHALLVAALP-FKGDS---------- 299
            +    S  +  PE+L     Y   +D+WS G +L +++    P F G            
Sbjct: 187 YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAK 246

Query: 300 ------LEAVFDAIKNVKLD-----------------FHSGVWETVSKPARDLMARMLTR 336
                 L    D                          HS     VS  A D + ++L  
Sbjct: 247 VLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRY 306

Query: 337 DVSARITADEVLRHPW 352
           D  +R+TA E + HP+
Sbjct: 307 DHQSRLTAREAMEHPY 322

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  141 bits (359), Expect = 2e-38
 Identities = 72/308 (23%), Positives = 127/308 (41%), Gaps = 58/308 (18%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE------TVHREVEIMQHLSGH 156
             + K+  IG G FG V+  R + +G + A K +    E      T  RE++I+Q L  H
Sbjct: 17  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-H 75

Query: 157 TGVVTLHSV--------YEEADCFHLVMELCSG--GRLIDQMVEVGQYSEQRAANIFKDV 206
             VV L  +               +LV + C      L+  ++   +++      + + +
Sbjct: 76  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLV--KFTLSEIKRVMQML 133

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA----- 261
           +  + Y H   ++HRD+K  N+L+T  G +KLADFGLA   S  +       +       
Sbjct: 134 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 193

Query: 262 YVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALP-FKGDS----LEAVFDA-------- 306
           Y  PE+L G  +Y   +D+W AG ++ A +    P  +G++    L  +           
Sbjct: 194 YRPPELLLGERDYGPPIDLWGAGCIM-AEMWTRSPIMQGNTEQHQLALISQLCGSITPEV 252

Query: 307 ---------------IKNVKLDFHSGV-WETVSKPARDLMARMLTRDVSARITADEVLRH 350
                          +K  K      +        A DL+ ++L  D + RI +D+ L H
Sbjct: 253 WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 312

Query: 351 PWILFYTE 358
            +  F+++
Sbjct: 313 DF--FWSD 318

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score =  140 bits (356), Expect = 2e-38
 Identities = 69/261 (26%), Positives = 119/261 (45%), Gaps = 22/261 (8%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLR----KGEETV---HREVEIMQHLSGHTGVV 160
            E++G G    V L R      + A K LR    +         RE +    L+ H  +V
Sbjct: 17  GEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIV 75

Query: 161 TLHSVYEEADCFH----LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
            ++   E          +VME   G  L D +   G  + +RA  +  D    + + H  
Sbjct: 76  AVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQN 135

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLA-GSPAYVAPEVLSGNY 272
           G++HRD+KP NI+++ +  +K+ DFG+A  I++     T +    G+  Y++PE   G+ 
Sbjct: 136 GIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDS 195

Query: 273 -SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH--SGVWETVSKPARDL 329
              + D++S G +L+ +L    PF GDS  +V  A ++V+ D    S   E +S     +
Sbjct: 196 VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV--AYQHVREDPIPPSARHEGLSADLDAV 253

Query: 330 MARMLTRDVSAR-ITADEVLR 349
           + + L ++   R  TA E+  
Sbjct: 254 VLKALAKNPENRYQTAAEMRA 274

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score =  140 bits (355), Expect = 3e-38
 Identities = 53/203 (26%), Positives = 85/203 (41%), Gaps = 11/203 (5%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETV---HREVEIMQHLSGHTGVV 160
             ++G G  G V+           A K + +             RE      L     VV
Sbjct: 39  RRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVV 97

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            +H   E     ++ M L +G  L   +   G  +  RA  I + +   +   H  G  H
Sbjct: 98  PIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATH 157

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLA-GSPAYVAPEVLSGNY-SEKVD 277
           RD+KPENIL++      L DFG+A   +    T  G   G+  Y+APE  S ++ + + D
Sbjct: 158 RDVKPENILVSADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRAD 217

Query: 278 IWSAGVLLHALLVAALPFKGDSL 300
           I++   +L+  L  + P++GD L
Sbjct: 218 IYALTCVLYECLTGSPPYQGDQL 240

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score =  138 bits (351), Expect = 6e-38
 Identities = 63/264 (23%), Positives = 112/264 (42%), Gaps = 27/264 (10%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------ETVHREVEIMQHLSGHT 157
           + IG G FG V   R     +  A K+L  G+           +   REV IM +L+ H 
Sbjct: 25  KQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HP 83

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDM 216
            +V L+ +        +VME    G L  +++ +           +  D+   I+Y  + 
Sbjct: 84  NIVKLYGLMHNPPR--MVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQ 141

Query: 217 G--VVHRDIKPENILLTTSGK-----IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
              +VHRD++  NI L +  +      K+ADFGL+ + S   ++SGL G+  ++APE + 
Sbjct: 142 NPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLS-QQSV-HSVSGLLGNFQWMAPETIG 199

Query: 270 GN---YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
                Y+EK D +S  ++L+ +L    PF   S   +       +      + E      
Sbjct: 200 AEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPEDCPPRL 259

Query: 327 RDLMARMLTRDVSARITADEVLRH 350
           R+++    + D   R     +++ 
Sbjct: 260 RNVIELCWSGDPKKRPHFSYIVKE 283

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score =  143 bits (361), Expect = 6e-37
 Identities = 58/254 (22%), Positives = 99/254 (38%), Gaps = 29/254 (11%)

Query: 108 VEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVT 161
              I HG  G ++L   +  +G     K L              E + +  +  H  +V 
Sbjct: 85  KGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQ 143

Query: 162 LHSVYEEADCF-----HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
           + +  E  D       ++VME   G  L     +  +     A     +++  + Y H +
Sbjct: 144 IFNFVEHTDRHGDPVGYIVMEYVGGQSLKR--SKGQKLPVAEAIAYLLEILPALSYLHSI 201

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKV 276
           G+V+ D+KPENI+LT    +KL D G   RI        L G+P + APE++    +   
Sbjct: 202 GLVYNDLKPENIMLTEEQ-LKLIDLGAVSRI--NSF-GYLYGTPGFQAPEIVRTGPTVAT 257

Query: 277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR 336
           DI++ G  L AL +      G  ++ + +    +K                 L+ R +  
Sbjct: 258 DIYTVGRTLAALTLDLPTRNGRYVDGLPEDDPVLK----------TYDSYGRLLRRAIDP 307

Query: 337 DVSAR-ITADEVLR 349
           D   R  TA+E+  
Sbjct: 308 DPRQRFTTAEEMSA 321

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  137 bits (347), Expect = 1e-36
 Identities = 77/318 (24%), Positives = 120/318 (37%), Gaps = 77/318 (24%)

Query: 96  GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLS- 154
            R  K  D      + G G FG+V L + K++G   A K + +     +RE++IMQ L+ 
Sbjct: 16  ERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAV 75

Query: 155 -GHTGVVTLHSVYEEAD-------CFHLVMEL--CSGGRLIDQMVEVGQ---------YS 195
             H  +V L S +             ++VME    +  R                   + 
Sbjct: 76  LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFL 135

Query: 196 EQ--RAANIFKDVMWVIKYCHD--MGVVHRDIKPENILL-TTSGKIKLADFGLAMRISNG 250
            Q  R+          I   H   + V HRDIKP N+L+    G +KL DFG A ++S  
Sbjct: 136 FQLIRS----------IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPS 185

Query: 251 QTLSGLAGSPAYV------APEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSL-- 300
           +         AY+      APE++ G  +Y+  VDIWS G +   +++    F+GD+   
Sbjct: 186 EPNV------AYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAG 239

Query: 301 -------------EAVFDAIKNVKLDFH-------------SGVWETVSKPARDLMARML 334
                          V   +     D               S      +K A DL++ +L
Sbjct: 240 QLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALL 299

Query: 335 TRDVSARITADEVLRHPW 352
                 R+   E L HP+
Sbjct: 300 QYLPEERMKPYEALCHPY 317

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score =  131 bits (332), Expect = 2e-35
 Identities = 68/222 (30%), Positives = 101/222 (45%), Gaps = 26/222 (11%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET--------VHREVEIMQHLSGHTGVV 160
           E+IG G FG V+  R+   G E A K  R   +         V +E ++   L  H  ++
Sbjct: 13  EIIGIGGFGKVY--RAFWIGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNII 69

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--- 217
            L  V  +     LVME   GG L   +    +       N    +   + Y HD     
Sbjct: 70  ALRGVCLKEPNLCLVMEFARGGPLNRVLSG-KRIPPDILVNWAVQIARGMNYLHDEAIVP 128

Query: 218 VVHRDIKPENILLTTSGK--------IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           ++HRD+K  NIL+    +        +K+ DFGLA R  +  T    AG+ A++APEV+ 
Sbjct: 129 IIHRDLKSSNILILQKVENGDLSNKILKITDFGLA-REWHRTTKMSAAGAYAWMAPEVIR 187

Query: 270 GN-YSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKN 309
            + +S+  D+WS GVLL  LL   +PF+G D L   +    N
Sbjct: 188 ASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMN 229

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  134 bits (338), Expect = 3e-35
 Identities = 62/322 (19%), Positives = 116/322 (36%), Gaps = 70/322 (21%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGV 159
                ++  + +G G FG V       SG  FA K + +     +RE++IM+ L  H  +
Sbjct: 4   TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLD-HVNI 62

Query: 160 VTL----HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV------ 209
           + L    ++  +E        +  +     +  V     S     +  K +  +      
Sbjct: 63  IKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD 122

Query: 210 -------------------------------IKYCHDMGVVHRDIKPENILL-TTSGKIK 237
                                          + + H +G+ HRDIKP+N+L+ +    +K
Sbjct: 123 TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLK 182

Query: 238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVL--SGNYSEKVDIWSAGVLLHALLVAALPF 295
           L DFG A ++   +       S  Y APE++  +  Y+  +D+WS G +   L++    F
Sbjct: 183 LCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF 242

Query: 296 KGDS----LEAVFDAI---------------------KNVKLDFHSGVWETVSKPARDLM 330
            G++    L  +   +                          D+   + E     A DL+
Sbjct: 243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLL 302

Query: 331 ARMLTRDVSARITADEVLRHPW 352
            ++L  +   RI   E + HP+
Sbjct: 303 EQILRYEPDLRINPYEAMAHPF 324

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  130 bits (328), Expect = 1e-34
 Identities = 62/258 (24%), Positives = 111/258 (43%), Gaps = 21/258 (8%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTL 162
           + IG G FG+V+  + K  G + A K L     T         EV +++    H  ++  
Sbjct: 30  QRIGSGSFGTVY--KGKWHG-DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLF 85

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
                      +V + C G  L   +     ++  ++  +I +     + Y H   ++HR
Sbjct: 86  MGYSTA-PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHR 144

Query: 222 DIKPENILLTTSGKIKLADFGLA---MRISNGQTLSGLAGSPAYVAPEVL----SGNYSE 274
           D+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+    S  YS 
Sbjct: 145 DLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSF 204

Query: 275 KVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAI-KNVKLDFHSGVWETVSKPARDLMAR 332
           + D+++ G++L+ L+   LP+   ++ + + + + +       S V     K  + LMA 
Sbjct: 205 QSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAE 264

Query: 333 MLTRDVSARITADEVLRH 350
            L +    R +   +L  
Sbjct: 265 CLKKKRDERPSFPRILAE 282

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  131 bits (331), Expect = 2e-34
 Identities = 75/321 (23%), Positives = 127/321 (39%), Gaps = 74/321 (23%)

Query: 95  MGRKNK--IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REV 147
           M ++    I  D     ++G G +G V     K +G   A K +   ++ +      RE+
Sbjct: 1   MPKRIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREI 60

Query: 148 EIMQHLSGHTGVVTLHSVY--EEADCFH---LVMEL--------CSGGRLIDQMVEVGQY 194
           +I++H   H  ++T+ ++   +  + F+   ++ EL         S   L D  ++   Y
Sbjct: 61  KILKHFK-HENIITIFNIQRPDSFENFNEVYIIQELMQTDLHRVISTQMLSDDHIQYFIY 119

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS 254
              RA          +K  H   V+HRD+KP N+L+ ++  +K+ DFGLA  I      +
Sbjct: 120 QTLRA----------VKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADN 169

Query: 255 GLAGSPA-----YV------APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS-- 299
                       +V      APEV+  S  YS  +D+WS G +L  L +    F G    
Sbjct: 170 SEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYR 229

Query: 300 --------------LEAVFDAIKNV-------------KLDFHSGVWETVSKPARDLMAR 332
                          +     I++                     ++  V+    DL+ R
Sbjct: 230 HQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEK-MFPRVNPKGIDLLQR 288

Query: 333 MLTRDVSARITADEVLRHPWI 353
           ML  D + RITA E L HP++
Sbjct: 289 MLVFDPAKRITAKEALEHPYL 309

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  128 bits (324), Expect = 8e-34
 Identities = 53/266 (19%), Positives = 101/266 (37%), Gaps = 32/266 (12%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTL 162
           E+IG G+FG V+    +  G E A + +    +         REV   +    H  VV  
Sbjct: 39  ELIGKGRFGQVY--HGRWHG-EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLF 94

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
                      ++  LC G  L   +          +   I ++++  + Y H  G++H+
Sbjct: 95  MGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHK 154

Query: 222 DIKPENILLTTSGKIKLADFGLA------MRISNGQTLSGLAGSPAYVAPEVLSGN---- 271
           D+K +N+    +GK+ + DFGL               L    G   ++APE++       
Sbjct: 155 DLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDT 213

Query: 272 ------YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI-KNVKLDFHSGVWETVSK 324
                 +S+  D+++ G + + L     PFK    EA+   +   +K +        + K
Sbjct: 214 EEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ---IGMGK 270

Query: 325 PARDLMARMLTRDVSARITADEVLRH 350
              D++      +   R T  +++  
Sbjct: 271 EISDILLFCWAFEQEERPTFTKLMDM 296

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  127 bits (322), Expect = 3e-33
 Identities = 77/303 (25%), Positives = 127/303 (41%), Gaps = 65/303 (21%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           +   +     +G G +GSV     K SG + A K L +  +  +      RE+ +++H+ 
Sbjct: 22  LPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ 81

Query: 155 GHTGVVTLHSVY---EEADCFH---LVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDV 206
            H  V+ L  V+        F+   LVM        +++       ++SE++   +   +
Sbjct: 82  -HENVIGLLDVFTPASSLRNFYDFYLVMPFMQTDLQKIMGL-----KFSEEKIQYLVYQM 135

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV--- 263
           +  +KY H  GVVHRD+KP N+ +    ++K+ DFGLA       T         YV   
Sbjct: 136 LKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMT--------GYVVTR 187

Query: 264 ---APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI------- 307
              APEV+    +Y++ VDIWS G ++  +L     FKG      L  +           
Sbjct: 188 WYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEF 247

Query: 308 -----------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                            +  + DF   ++   S  A DL+ +ML  DV  R+TA + L H
Sbjct: 248 VQKLNDKAAKSYIQSLPQTPRKDFTQ-LFPRASPQAADLLEKMLELDVDKRLTAAQALTH 306

Query: 351 PWI 353
           P+ 
Sbjct: 307 PFF 309

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  128 bits (324), Expect = 3e-33
 Identities = 68/326 (20%), Positives = 128/326 (39%), Gaps = 71/326 (21%)

Query: 96  GRKNKIEDDHTKV-EVIGHGKFGSVWLCRSK--ASGAEFACKTLRK-GEE-TVHREVEIM 150
             + ++ED        +G G +G V+  + K      ++A K +   G   +  RE+ ++
Sbjct: 13  SERERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALL 72

Query: 151 QHLSGHTGVVTLHSVYEEA--DCFHLVMELCSG--GRLIDQMVEVGQYSEQRA--ANIFK 204
           + L  H  V++L  V+         L+ +        +I          +       + K
Sbjct: 73  RELK-HPNVISLQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVK 131

Query: 205 DVMW----VIKYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLAMRI--SNGQTLS 254
            +++     I Y H   V+HRD+KP NIL+       G++K+AD G A R+  S  + L+
Sbjct: 132 SLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA-RLFNSPLKPLA 190

Query: 255 GLAGSPA---YVAPEVLSG--NYSEKVDIWSAG------VLLHALL-------VAALPFK 296
            L        Y APE+L G  +Y++ +DIW+ G      +    +          + P+ 
Sbjct: 191 DLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYH 250

Query: 297 GDSLEAVFDAI-----------------KNVKLDFHSGVWE-------------TVSKPA 326
            D L+ +F+ +                   +  DF    +                   A
Sbjct: 251 HDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKA 310

Query: 327 RDLMARMLTRDVSARITADEVLRHPW 352
             L+ ++LT D   RIT+++ ++ P+
Sbjct: 311 FHLLQKLLTMDPIKRITSEQAMQDPY 336

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score =  124 bits (314), Expect = 8e-33
 Identities = 41/263 (15%), Positives = 90/263 (34%), Gaps = 35/263 (13%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET------VHREVEIMQHLSGHTGVVTL 162
             +     G +W  + +  G +   K L+  + +       + E   ++  S H  V+ +
Sbjct: 16  TKLNENHSGELW--KGRWQGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPV 72

Query: 163 HSVYEEADCFHL--VMELCSGGRLID--QMVEVGQYSEQRAANIFKDV---MWVIKYCHD 215
               +     H   +      G L +           + +A     D+   M    + H 
Sbjct: 73  LGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGM---AFLHT 129

Query: 216 MG--VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--- 270
           +   +    +   ++++      +++   +     +     G   +PA+VAPE L     
Sbjct: 130 LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS----PGRMYAPAWVAPEALQKKPE 185

Query: 271 -NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFD-AIKNVKLDFHSGVWETVSKPAR 327
                  D+WS  VLL  L+   +PF    ++E     A++ ++      +   +S    
Sbjct: 186 DTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRPT----IPPGISPHVS 241

Query: 328 DLMARMLTRDVSARITADEVLRH 350
            LM   +  D + R   D ++  
Sbjct: 242 KLMKICMNEDPAKRPKFDMIVPI 264

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  125 bits (315), Expect = 1e-32
 Identities = 54/201 (26%), Positives = 93/201 (46%), Gaps = 28/201 (13%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV----HREVEIMQHLSGHTGVVTLHS 164
           EV+G G FG       + +G     K L + +E       +EV++M+ L  H  V+    
Sbjct: 16  EVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIG 74

Query: 165 VYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDV---MWVIKYCHDMGVVH 220
           V  +    + + E   GG L   +     QY   +  +  KD+   M    Y H M ++H
Sbjct: 75  VLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGM---AYLHSMNIIH 131

Query: 221 RDIKPENILLTTSGKIKLADFGLA---------------MRISNGQTLSGLAGSPAYVAP 265
           RD+   N L+  +  + +ADFGLA               ++  + +    + G+P ++AP
Sbjct: 132 RDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAP 191

Query: 266 EVLSGN-YSEKVDIWSAGVLL 285
           E+++G  Y EKVD++S G++L
Sbjct: 192 EMINGRSYDEKVDVFSFGIVL 212

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  126 bits (318), Expect = 1e-32
 Identities = 75/306 (24%), Positives = 128/306 (41%), Gaps = 59/306 (19%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           +   +  ++ IG G  G V            A K L +  +   H     RE+ +M+ + 
Sbjct: 23  VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 81

Query: 155 GHTGVVTLHSVY---EEADCFH---LVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDV 206
            H  ++ L +V+   +  + F    +VMEL   +  ++I       +   +R + +   +
Sbjct: 82  NHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDANLCQVIQM-----ELDHERMSYLLYQM 136

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           +  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APE
Sbjct: 137 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 196

Query: 267 V-LSGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI-------------- 307
           V L   Y E VDIWS G ++  ++   + F G         V + +              
Sbjct: 197 VILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPT 256

Query: 308 ---------KNVKLDFH-----------SGVWETVSKPARDLMARMLTRDVSARITADEV 347
                    K     F            S   +  +  ARDL+++ML  D S RI+ DE 
Sbjct: 257 VRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEA 316

Query: 348 LRHPWI 353
           L+HP+I
Sbjct: 317 LQHPYI 322

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  125 bits (316), Expect = 2e-32
 Identities = 69/303 (22%), Positives = 127/303 (41%), Gaps = 64/303 (21%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           + + +  +  +G G +GSV       +G   A K L +  +  +H     RE+ +++H+ 
Sbjct: 27  VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK 86

Query: 155 GHTGVVTLHSVY---EEADCFH---LVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDV 206
            H  V+ L  V+      + F+   LV  L       ++       + ++     +   +
Sbjct: 87  -HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQ----KLTDDHVQFLIYQI 141

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV--- 263
           +  +KY H   ++HRD+KP N+ +    ++K+ DFGLA   ++  T         YV   
Sbjct: 142 LRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMT--------GYVATR 193

Query: 264 ---APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI------- 307
              APE++    +Y++ VDIWS G ++  LL     F G      L+ +   +       
Sbjct: 194 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAEL 253

Query: 308 -----------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                            +  K++F + V+   +  A DL+ +ML  D   RITA + L H
Sbjct: 254 LKKISSESARNYIQSLTQMPKMNFAN-VFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 312

Query: 351 PWI 353
            + 
Sbjct: 313 AYF 315

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  127 bits (320), Expect = 3e-32
 Identities = 76/306 (24%), Positives = 129/306 (42%), Gaps = 59/306 (19%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           +   +  ++ IG G  G V            A K L +  +   H     RE+ +M+ + 
Sbjct: 60  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCV- 118

Query: 155 GHTGVVTLHSV------YEEADCFHLVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDV 206
            H  +++L +V       EE    +LVMEL   +  ++I       +   +R + +   +
Sbjct: 119 NHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQM-----ELDHERMSYLLYQM 173

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           +  IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APE
Sbjct: 174 LCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPE 233

Query: 267 V-LSGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI-------------- 307
           V L   Y E VDIWS G ++  ++   + F G         V + +              
Sbjct: 234 VILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPT 293

Query: 308 ---------KNVKLDFH-----------SGVWETVSKPARDLMARMLTRDVSARITADEV 347
                    K   L F            S   +  +  ARDL+++ML  D + RI+ D+ 
Sbjct: 294 VRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDA 353

Query: 348 LRHPWI 353
           L+HP+I
Sbjct: 354 LQHPYI 359

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  122 bits (309), Expect = 3e-31
 Identities = 73/309 (23%), Positives = 125/309 (40%), Gaps = 76/309 (24%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           +   +  ++ +G G +G+V       +GA+ A K L +  +  +      RE+ +++H+ 
Sbjct: 23  VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR 82

Query: 155 GHTGVVTLHSVY---EEADCFH---LVMEL--------CSGGRLIDQMVEVGQYSEQRAA 200
            H  V+ L  V+   E  D F    LVM              +L +  ++   Y   +  
Sbjct: 83  -HENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKG- 140

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
                    ++Y H  G++HRD+KP N+ +    ++K+ DFGLA +  +  T        
Sbjct: 141 ---------LRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMT-------- 183

Query: 261 AYV------APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS------------- 299
            YV      APEV+     Y++ VDIWS G ++  ++     FKG               
Sbjct: 184 GYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTG 243

Query: 300 --LEAVFDAIKNV-------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITA 344
                    +++              K DF S +    S  A +L+ +ML  D   R+TA
Sbjct: 244 TPPAEFVQRLQSDEAKNYMKGLPELEKKDFAS-ILTNASPLAVNLLEKMLVLDAEQRVTA 302

Query: 345 DEVLRHPWI 353
            E L HP+ 
Sbjct: 303 GEALAHPYF 311

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  122 bits (307), Expect = 4e-31
 Identities = 65/320 (20%), Positives = 109/320 (34%), Gaps = 86/320 (26%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---------------R 145
           ++  +T    I  G +G+V        G   A K +                       R
Sbjct: 20  MQSPYTVQRFISSGSYGAVCAGVDS-EGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLR 78

Query: 146 EVEIMQHLSGHTGVVTLHSVY--EEADCFH---LVMEL----------CSGGRLIDQMVE 190
           E+ ++ H   H  ++ L  ++   E    H   LV EL               +  Q ++
Sbjct: 79  EIRLLNHFH-HPNILGLRDIFVHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQ 137

Query: 191 VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG 250
              Y               +   H+ GVVHRD+ P NILL  +  I + DF LA   +  
Sbjct: 138 YFMYHILLG----------LHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTAD 187

Query: 251 QTLSGLAGSPAYV------APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS--- 299
              +       YV      APE++     +++ VD+WSAG ++  +      F+G +   
Sbjct: 188 ANKTH------YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYN 241

Query: 300 ------------LEAVFDAIKNV--------------KLDFHSGVWETVSKPARDLMARM 333
                                +                  + + V  T    A DL+A+M
Sbjct: 242 QLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTA-VVPTADPVALDLIAKM 300

Query: 334 LTRDVSARITADEVLRHPWI 353
           L  +   RI+ ++ LRHP+ 
Sbjct: 301 LEFNPQRRISTEQALRHPYF 320

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  121 bits (306), Expect = 6e-31
 Identities = 68/307 (22%), Positives = 120/307 (39%), Gaps = 68/307 (22%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH-----REVEIMQHLSG 155
           +   +T +  IG G +G V       +    A K +   E   +     RE++I+     
Sbjct: 25  VGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 83

Query: 156 HTGVVTLHSVY--EEADCFH---LVMEL--------CSGGRLIDQMVEVGQYSEQRAANI 202
           H  ++ ++ +      +      +V +L             L +  +    Y   R    
Sbjct: 84  HENIIGINDIIRAPTIEQMKDVYIVQDLMETDLYKLLKTQHLSNDHICYFLYQILRG--- 140

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
                  +KY H   V+HRD+KP N+LL T+  +K+ DFGLA R+++         +  Y
Sbjct: 141 -------LKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLA-RVADPDHDHTGFLTE-Y 191

Query: 263 V------APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS--------------- 299
           V      APE++  S  Y++ +DIWS G +L  +L     F G                 
Sbjct: 192 VATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSP 251

Query: 300 LEAVFDAIKN-------------VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADE 346
            +   + I N              K+ ++  ++      A DL+ +MLT +   RI  ++
Sbjct: 252 SQEDLNCIINLKARNYLLSLPHKNKVPWNR-LFPNADSKALDLLDKMLTFNPHKRIEVEQ 310

Query: 347 VLRHPWI 353
            L HP++
Sbjct: 311 ALAHPYL 317

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  121 bits (306), Expect = 9e-31
 Identities = 76/340 (22%), Positives = 125/340 (36%), Gaps = 95/340 (27%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH-----REVEIMQHLS 154
           +   +  V+ +G G +G VW    + +G   A K +    + +       RE+ I+  LS
Sbjct: 7   VLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELS 66

Query: 155 GHTGVVTLHSVYEEADCFH---LVMEL--------CSGGRLIDQMVEVGQYSEQRAANIF 203
           GH  +V L +V   AD      LV +              L        QY       + 
Sbjct: 67  GHENIVNLLNVLR-ADNDRDVYLVFDYMETDLHAVIRANILEPVHK---QY-------VV 115

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPA-- 261
             ++ VIKY H  G++HRD+KP NILL     +K+ADFGL+    N + ++         
Sbjct: 116 YQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINE 175

Query: 262 --------------YV------APEVL--SGNYSEKVDIWSAGVLLHALL---------- 289
                         YV      APE+L  S  Y++ +D+WS G +L  +L          
Sbjct: 176 NTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSS 235

Query: 290 -------------------------------VAALPFK-GDSLEAVFDAIKNVKLDFHSG 317
                                          + +L  K         D     K      
Sbjct: 236 TMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKI 295

Query: 318 VWETVSKP-ARDLMARMLTRDVSARITADEVLRHPWILFY 356
             +      A DL+ ++L  + + RI+A++ L+HP++  +
Sbjct: 296 NPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  118 bits (299), Expect = 2e-30
 Identities = 63/309 (20%), Positives = 120/309 (38%), Gaps = 64/309 (20%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET----VHREVEIMQHLSGH 156
           +   +  ++ +G G  G V+           A K +   +        RE++I++ L  H
Sbjct: 9   LGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-H 67

Query: 157 TGVVTLHSV--------------YEEADCFHLVMEL--CSGGRLIDQMVEVGQYSEQRAA 200
             +V +  +                E +  ++V E        +++Q    G   E+ A 
Sbjct: 68  DNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ----GPLLEEHAR 123

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLAGS 259
                ++  +KY H   V+HRD+KP N+ + T    +K+ DFGLA RI +         S
Sbjct: 124 LFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLA-RIMDPHYSHKGHLS 182

Query: 260 PAYV------APEVL--SGNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAI 307
              +      +P +L    NY++ +D+W+AG +   +L     F G      ++ + ++I
Sbjct: 183 E-GLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESI 241

Query: 308 -----------------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITA 344
                                            +   +S+ A D + ++LT     R+TA
Sbjct: 242 PVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQ-LLPGISREAVDFLEQILTFSPMDRLTA 300

Query: 345 DEVLRHPWI 353
           +E L HP++
Sbjct: 301 EEALSHPYM 309

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  119 bits (299), Expect = 2e-29
 Identities = 72/361 (19%), Positives = 120/361 (33%), Gaps = 121/361 (33%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH------REVEIMQHLS 154
           I D +    +IG G +G V     K      A K + +  E +       RE+ I+  L+
Sbjct: 51  IPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN 110

Query: 155 GHTGVVTLHSVY--EEADCFH---LVMELC---------SGGRLIDQMVEVGQYSEQRAA 200
            H  VV +  +   ++ + F    +V+E+          +   L +  ++   Y+     
Sbjct: 111 -HDHVVKVLDIVIPKDVEKFDELYVVLEIADSDFKKLFRTPVYLTELHIKTLLYNLLVG- 168

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
                    +KY H  G++HRD+KP N L+     +K+ DFGLA  +   +  +      
Sbjct: 169 ---------VKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPIS 219

Query: 261 A----------------------YV------APEVL--SGNYSEKVDIWSAGVLLHALLV 290
                                  +V      APE++    NY+E +D+WS G +   LL 
Sbjct: 220 PREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279

Query: 291 AALP-----------FKGDSL-----------------------------------EAVF 304
                          F G S                                    E   
Sbjct: 280 MIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDI 339

Query: 305 DAIKNV-------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP 351
           +A++                 D     +   S  A  L+ RML  + + RIT +E L HP
Sbjct: 340 EALEKEDAKRYIRIFPKREGTDLAE-RFPASSADAIHLLKRMLVFNPNKRITINECLAHP 398

Query: 352 W 352
           +
Sbjct: 399 F 399

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  115 bits (290), Expect = 3e-29
 Identities = 60/290 (20%), Positives = 108/290 (37%), Gaps = 51/290 (17%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEIMQ-HLSGHTGVVTL- 162
           T +E +G G++G VW    +  G   A K     +E    RE E+    +  H  ++   
Sbjct: 11  TLLECVGKGRYGEVWRGSWQ--GENVAVKIFSSRDEKSWFRETELYNTVMLRHENILGFI 68

Query: 163 ----HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV--------MWVI 210
                S +     + L+      G L D  +++          I   +        + + 
Sbjct: 69  ASDMTSRHSSTQLW-LITHYHEMGSLYD-YLQLTTLDTVSCLRIVLSIASGLAHLHIEIF 126

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-----SGLAGSPAYVAP 265
                  + HRD+K +NIL+  +G+  +AD GLA+  S          +   G+  Y+AP
Sbjct: 127 GTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAP 186

Query: 266 EVLSG-------NYSEKVDIWSAGVLL----------HALLVAALPFKG-----DSLEAV 303
           EVL         +  ++VDIW+ G++L            +     PF        S E +
Sbjct: 187 EVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDM 246

Query: 304 FDAI--KNVKLDFHSGVWETVSKPA--RDLMARMLTRDVSARITADEVLR 349
              +     + +  +  W +         LM     ++ SAR+TA  + +
Sbjct: 247 RKVVCVDQQRPNIPNR-WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK 295

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  112 bits (283), Expect = 5e-28
 Identities = 61/289 (21%), Positives = 113/289 (39%), Gaps = 49/289 (16%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEIMQ-HLSGHTGVVTLH 163
              E IG G+FG VW  + +  G E A K     EE    RE EI Q  +  H  ++   
Sbjct: 45  VLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHENILGFI 102

Query: 164 SVYEEADCFH----LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV--------MWVIK 211
           +   + +       LV +    G L D +      + +    +            M ++ 
Sbjct: 103 AADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVG 161

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA-----GSPAYVAPE 266
                 + HRD+K +NIL+  +G   +AD GLA+R  +      +A     G+  Y+APE
Sbjct: 162 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 221

Query: 267 VLSGN-------YSEKVDIWSAGVLLHALLV----------AALPFKG-----DSLEAVF 304
           VL  +         ++ DI++ G++   +              LP+        S+E + 
Sbjct: 222 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 281

Query: 305 DAI--KNVKLDFHSGVWETVSKPA--RDLMARMLTRDVSARITADEVLR 349
             +  + ++ +  +  W++         +M      + +AR+TA  + +
Sbjct: 282 KVVCEQKLRPNIPNR-WQSCEALRVMAKIMRECWYANGAARLTALRIKK 329

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  114 bits (287), Expect = 6e-28
 Identities = 69/364 (18%), Positives = 133/364 (36%), Gaps = 113/364 (31%)

Query: 91  VHTQMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVH----- 144
           ++ Q  +   + D++    +IG G +G V+L   K +    A K + +  E+ +      
Sbjct: 14  LYFQGIKNVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRIL 73

Query: 145 REVEIMQHLSGHTGVVTLHSVY--EEADCFH---LVMELC---------SGGRLIDQMVE 190
           RE+ I+  L     ++ L+ +   ++   F    +V+E+          +   L ++ ++
Sbjct: 74  REITILNRLK-SDYIIRLYDLIIPDDLLKFDELYIVLEIADSDLKKLFKTPIFLTEEHIK 132

Query: 191 VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG 250
              Y+                + H+ G++HRD+KP N LL     +K+ DFGLA  I++ 
Sbjct: 133 TILYNLLLG----------ENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSE 182

Query: 251 QTLSGLAGSPA-----------------YV------APEVL--SGNYSEKVDIWSAGVLL 285
           +  + +                      +V      APE++    NY++ +DIWS G + 
Sbjct: 183 KDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIF 242

Query: 286 HALLVAALP-----------FKGDS---------------------LEAVFDAI------ 307
             LL                F G S                     L  +F+ I      
Sbjct: 243 AELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTED 302

Query: 308 ------------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
                                 ++     + ++S    +L+  ML  + + RIT D+ L 
Sbjct: 303 DLKNINKPEVIKYIKLFPHRKPINLKQ-KYPSISDDGINLLESMLKFNPNKRITIDQALD 361

Query: 350 HPWI 353
           HP++
Sbjct: 362 HPYL 365

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  111 bits (279), Expect = 3e-27
 Identities = 68/317 (21%), Positives = 119/317 (37%), Gaps = 74/317 (23%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS---------- 154
           V  +G G F +VWL +   +    A K +R  +   E    E++++Q ++          
Sbjct: 24  VRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSM 83

Query: 155 GHTGVVTLHS--VYEEADCFH--LVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMW 208
           G   ++ L     ++  +  H  +V E+  G  L+  + +             I K ++ 
Sbjct: 84  GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLL 142

Query: 209 VIKYCHDM-GVVHRDIKPENILL------TTSGKIKLADFGLAMRISNGQTLSGLAGSPA 261
            + Y H   G++H DIKPEN+L+          +IK+AD G A      +  +    +  
Sbjct: 143 GLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYD--EHYTNSIQTRE 200

Query: 262 YVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------------LEAVFDAI 307
           Y +PEVL G  +    DIWS   L+  L+     F+ D              +  +   +
Sbjct: 201 YRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGEL 260

Query: 308 --------KNVKLDFHS-GVWETVSKPAR----------------------DLMARMLTR 336
                   K  +  F+S G+   +SK                         D ++ ML  
Sbjct: 261 PSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQL 320

Query: 337 DVSARITADEVLRHPWI 353
           D   R  A  ++ HPW+
Sbjct: 321 DPRKRADAGGLVNHPWL 337

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score =  109 bits (274), Expect = 4e-27
 Identities = 38/259 (14%), Positives = 66/259 (25%), Gaps = 53/259 (20%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVV 160
           +   G       W     A   + A   +           +        +  +    GV 
Sbjct: 36  LIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVA 94

Query: 161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVH 220
            +  V        +V E   GG L  ++ +    S   A    + +       H  GV  
Sbjct: 95  RVLDVVHTRAGGLVVAEWIRGGSL-QEVAD-TSPSPVGAIRAMQSLAAAADAAHRAGVAL 152

Query: 221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWS 280
               P  + ++  G + LA                       +         + + DI  
Sbjct: 153 SIDHPSRVRVSIDGDVVLAYPA-------------------TMPDA------NPQDDIRG 187

Query: 281 AGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR----------DLM 330
            G  L+ALLV   P     + +                     +PA            + 
Sbjct: 188 IGASLYALLVNRWPLPEAGVRSGLAPA-------ERDTAGQPIEPADIDRDIPFQISAVA 240

Query: 331 ARMLTRDVSARITADEVLR 349
           AR +  D   R +A  +L 
Sbjct: 241 ARSVQGDGGIR-SASTLLN 258

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  107 bits (270), Expect = 3e-26
 Identities = 58/291 (19%), Positives = 105/291 (36%), Gaps = 53/291 (18%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETV-HREVEIMQ-------HLSGHT 157
             V+ IG G++G VW+ + +  G + A K     EE    RE EI Q       ++ G  
Sbjct: 40  QMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFI 97

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV--------MWV 209
                 +         L+ +    G L D +        +    +              +
Sbjct: 98  AADIKGTGSWTQLY--LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEI 154

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-----SGLAGSPAYVA 264
                   + HRD+K +NIL+  +G   +AD GLA++  +         +   G+  Y+ 
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214

Query: 265 PEVLSGN-------YSEKVDIWSAGVLL----------HALLVAALPFKG-----DSLEA 302
           PEVL  +            D++S G++L            +    LP+        S E 
Sbjct: 215 PEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYED 274

Query: 303 VFDAI--KNVKLDFHSGVWETVSKPA--RDLMARMLTRDVSARITADEVLR 349
           + + +  K ++  F +  W +         LM      + ++R+TA  V +
Sbjct: 275 MREIVCIKKLRPSFPNR-WSSDECLRQMGKLMTECWAHNPASRLTALRVKK 324

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score =  104 bits (261), Expect = 3e-25
 Identities = 58/290 (20%), Positives = 106/290 (36%), Gaps = 51/290 (17%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEI--MQHLSGHTGVVTL 162
             +EV   G+FG VW  +        A K     ++     E E+  +  +  H  ++  
Sbjct: 27  QLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK-HENILQF 83

Query: 163 -----HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM- 216
                     + D + L+      G L    ++    S     +I + +   + Y H+  
Sbjct: 84  IGAEKRGTSVDVDLW-LITAFHEKGSL-SDFLKANVVSWNELCHIAETMARGLAYLHEDI 141

Query: 217 ---------GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGSPAYVA 264
                     + HRDIK +N+LL  +    +ADFGLA++   G++     G  G+  Y+A
Sbjct: 142 PGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMA 201

Query: 265 PEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKG----------------DSLEA 302
           PEVL G      +   ++D+++ G++L  L        G                 SLE 
Sbjct: 202 PEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLED 261

Query: 303 VFDAI--KNVKLDFHSGVWETVSKPA-RDLMARMLTRDVSARITADEVLR 349
           + + +  K  +        +        + +      D  AR++A  V  
Sbjct: 262 MQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGE 311

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score =  106 bits (266), Expect = 7e-25
 Identities = 53/237 (22%), Positives = 101/237 (42%), Gaps = 13/237 (5%)

Query: 85  KIGCIDVHTQMGRKNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-- 139
           K     ++      +K E + T +     +G G++G V+    K      A KTL++   
Sbjct: 199 KRNKPTIYGVSPNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM 258

Query: 140 -EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSE 196
             E   +E  +M+ +  H  +V L  V      F+++ E  + G L+D  +     + S 
Sbjct: 259 EVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSA 317

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
                +   +   ++Y      +HR++   N L+  +  +K+ADFGL+  ++     +  
Sbjct: 318 VVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA 377

Query: 257 AGSPAY--VAPEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
                    APE L+   +S K D+W+ GVLL  +      P+ G  L  V++ ++ 
Sbjct: 378 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 434

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score =  103 bits (259), Expect = 2e-24
 Identities = 62/228 (27%), Positives = 103/228 (45%), Gaps = 19/228 (8%)

Query: 98  KNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHR-----EVEI 149
           K+K   +H  +   E IG G FG V+  R +A     A K+ R+      +     E  I
Sbjct: 106 KDKWVLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARI 165

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDVMW 208
           ++  S H  +V L  V  +    ++VMEL  GG  +  +  E  +   +    +  D   
Sbjct: 166 LKQYS-HPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAA 224

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYV--- 263
            ++Y      +HRD+   N L+T    +K++DFG++   ++G      GL   P  V   
Sbjct: 225 GMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVP--VKWT 282

Query: 264 APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           APE L+ G YS + D+WS G+LL     + A P+   S +   + ++ 
Sbjct: 283 APEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEK 330

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score =  102 bits (256), Expect = 2e-24
 Identities = 43/213 (20%), Positives = 81/213 (38%), Gaps = 40/213 (18%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEIMQ--HLSGHTGVVTL-- 162
           +E+IG G++G+V+  +        A K            E  I +   +  H  +     
Sbjct: 18  LELIGRGRYGAVY--KGSLDERPVAVKVFSFANRQNFINEKNIYRVPLME-HDNIARFIV 74

Query: 163 ----HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-- 216
                +     +   LVME    G L    + +       +  +   V   + Y H    
Sbjct: 75  GDERVTADGRMEYL-LVMEYYPNGSLXK-YLSLHTSDWVSSCRLAHSVTRGLAYLHTELP 132

Query: 217 -------GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---------SGLAGSP 260
                   + HRD+   N+L+   G   ++DFGL+MR++  + +             G+ 
Sbjct: 133 RGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTI 192

Query: 261 AYVAPEVLSG--------NYSEKVDIWSAGVLL 285
            Y+APEVL G        +  ++VD+++ G++ 
Sbjct: 193 RYMAPEVLEGAVNLRDXESALKQVDMYALGLIY 225

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 97.7 bits (244), Expect = 6e-23
 Identities = 58/217 (26%), Positives = 100/217 (46%), Gaps = 18/217 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTL 162
           T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +V L
Sbjct: 16  TMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQL 74

Query: 163 HSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDV---MWVIKYCHDMG 217
             V      F+++ E  + G L+D  +     + S      +   +   M   +Y     
Sbjct: 75  LGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM---EYLEKKN 131

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS--PA-YVAPEVLS-GNYS 273
            +HRD+   N L+  +  +K+ADFGL+ R+  G T +  AG+  P  + APE L+   +S
Sbjct: 132 FIHRDLAARNCLVGENHLVKVADFGLS-RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFS 190

Query: 274 EKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            K D+W+ GVLL  +      P+ G  L  V++ ++ 
Sbjct: 191 IKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK 227

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 97.0 bits (242), Expect = 1e-22
 Identities = 54/207 (26%), Positives = 84/207 (40%), Gaps = 32/207 (15%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEETVH-----REVEIMQH 152
           +    K+  +G G FG V L      +  +G   A K L+      H     +E++I++ 
Sbjct: 30  KRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRT 89

Query: 153 LSGHTGVVTLHSVYEEADC--FHLVMELCSGGRLID-------QMVEVGQYSEQRAANIF 203
           L  H  ++      E+A      LVME    G L D        + ++  +++Q      
Sbjct: 90  LY-HEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRHSIGLAQLLLFAQQICEG-- 146

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSP 260
              M    Y H    +HRD+   N+LL     +K+ DFGLA  +  G     +     SP
Sbjct: 147 ---M---AYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSP 200

Query: 261 -AYVAPEVLS-GNYSEKVDIWSAGVLL 285
             + APE L    +    D+WS GV L
Sbjct: 201 VFWYAPECLKEYKFYYASDVWSFGVTL 227

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 96.7 bits (241), Expect = 1e-22
 Identities = 56/239 (23%), Positives = 102/239 (42%), Gaps = 22/239 (9%)

Query: 95  MGRKNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQ 151
           M  +N +   H KV   IG G FG ++   +  +  + A K    R     +  E    +
Sbjct: 1   MSGQNNVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYK 60

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVI 210
            L+G TG+  ++   +E     LV++L  G  L D +   G ++S +  A   K ++  +
Sbjct: 61  LLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARV 119

Query: 211 KYCHDMGVVHRDIKPENILL-----TTSGKIKLADFGLAMRISNGQTLS--------GLA 257
           +  H+  +V+RDIKP+N L+       +  I + DFG+     +  T           L+
Sbjct: 120 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLS 179

Query: 258 GSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALP---FKGDSLEAVFDAIKNVKL 312
           G+  Y++     G   S + D+ + G +    L  +LP    K  + +  ++ I   K 
Sbjct: 180 GTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ 238

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 55/210 (26%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKGEETVH-----REVEIMQH 152
           +    ++  +G G FG V LCR    G       A K+L+      H     +E+EI+++
Sbjct: 20  KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRN 79

Query: 153 LSGHTGVVTLHSV--YEEADCFHLVMELCSGGRLID------QMVEVGQ---YSEQRAAN 201
           L  H  +V    +   +  +   L+ME    G L +        + + Q   Y+ Q    
Sbjct: 80  LY-HENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKG 138

Query: 202 IFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAG 258
                M    Y      VHRD+   N+L+ +  ++K+ DFGL   I   +   T+     
Sbjct: 139 -----M---DYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRD 190

Query: 259 SP-AYVAPEVLS-GNYSEKVDIWSAGVLLH 286
           SP  + APE L    +    D+WS GV LH
Sbjct: 191 SPVFWYAPECLMQSKFYIASDVWSFGVTLH 220

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 98.3 bits (245), Expect = 2e-22
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 12/216 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGV 159
           +       +G G FG VW+     +    A KTL+ G  +     +E ++M+ L  H  +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 241

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA--NIFKDVMWVIKYCHDMG 217
           V L++V  E +  ++V E  S G L+D +        +     ++   +   + Y   M 
Sbjct: 242 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 300

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY--VAPEVLS-GNYSE 274
            VHRD++  NIL+  +   K+ADFGLA  I + +  +           APE    G ++ 
Sbjct: 301 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 360

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           K D+WS G+LL  L     +P+ G     V D ++ 
Sbjct: 361 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 396

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score = 97.9 bits (244), Expect = 2e-22
 Identities = 71/320 (22%), Positives = 106/320 (33%), Gaps = 83/320 (25%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGH-----TGV 159
           ++VIG G FG V            A K +R  +        E+ I++HL          V
Sbjct: 102 LKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNV 161

Query: 160 VTLHSVYEEADCF----HL--VMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
           + +       + F    H+    EL S     LI +    G +S          ++  + 
Sbjct: 162 IHML------ENFTFRNHICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLD 214

Query: 212 YCHDMGVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
             H   ++H D+KPENILL   G+  IK+ DFG +      Q +     S  Y APEV+ 
Sbjct: 215 ALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYE--HQRVYTYIQSRFYRAPEVIL 272

Query: 270 G-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------LEAVFDAI--------KNVKLD 313
           G  Y   +D+WS G +L  LL       G+        +  +            K  K  
Sbjct: 273 GARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNF 332

Query: 314 FHSGV------------WETVSKPARDLMAR----------------------------M 333
             S                 V    R    +                             
Sbjct: 333 VSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQC 392

Query: 334 LTRDVSARITADEVLRHPWI 353
           L  D + R+T  + LRHPW+
Sbjct: 393 LEWDPAVRMTPGQALRHPWL 412

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 95.4 bits (238), Expect = 3e-22
 Identities = 58/210 (27%), Positives = 88/210 (41%), Gaps = 34/210 (16%)

Query: 101 IEDDH-TKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKGEETVH----REVEIMQ 151
            E+ H   ++ +G G FGSV +CR            A K L+   E       RE+EI++
Sbjct: 7   FEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILK 66

Query: 152 HLSGHTGVVTLHSVYEEADC--FHLVMELCSGGRLID---------QMVEVGQYSEQRAA 200
            L  H  +V    V   A      L+ME    G L D           +++ QY+ Q   
Sbjct: 67  SLQ-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICK 125

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLA 257
                 M   +Y      +HRD+   NIL+    ++K+ DFGL   +   +    +    
Sbjct: 126 G-----M---EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPG 177

Query: 258 GSP-AYVAPEVLS-GNYSEKVDIWSAGVLL 285
            SP  + APE L+   +S   D+WS GV+L
Sbjct: 178 ESPIFWYAPESLTESKFSVASDVWSFGVVL 207

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 95.5 bits (238), Expect = 5e-22
 Identities = 58/208 (27%), Positives = 88/208 (42%), Gaps = 33/208 (15%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEETVH----REVEIMQHL 153
           E     ++ +G G FGSV +CR       +G   A K L+   E       RE+EI++ L
Sbjct: 40  ERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSL 99

Query: 154 SGHTGVVTLHSVYEEADC--FHLVMELCSGGRLID---------QMVEVGQYSEQRAANI 202
             H  +V    V   A      L+ME    G L D           +++ QY+ Q     
Sbjct: 100 Q-HDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKG- 157

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGS 259
               M   +Y      +HRD+   NIL+    ++K+ DFGL   +   +    +     S
Sbjct: 158 ----M---EYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210

Query: 260 P-AYVAPEVLS-GNYSEKVDIWSAGVLL 285
           P  + APE L+   +S   D+WS GV+L
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVL 238

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 97.6 bits (243), Expect = 6e-22
 Identities = 58/216 (26%), Positives = 97/216 (44%), Gaps = 12/216 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGV 159
           +       +G G FG VW+     +    A KTL+ G  +     +E ++M+ L  H  +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 324

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAA--NIFKDVMWVIKYCHDMG 217
           V L++V  E +  ++V E  S G L+D +        +     ++   +   + Y   M 
Sbjct: 325 VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 383

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAY--VAPEVLS-GNYSE 274
            VHRD++  NIL+  +   K+ADFGLA  I + +  +           APE    G ++ 
Sbjct: 384 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 443

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           K D+WS G+LL  L     +P+ G     V D ++ 
Sbjct: 444 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER 479

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 93.0 bits (232), Expect = 1e-21
 Identities = 69/215 (32%), Positives = 101/215 (46%), Gaps = 16/215 (7%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTL 162
           T V+ IG G+FG V L        + A KT+R+G   EE    E E+M  LS H  +V L
Sbjct: 11  TFVQEIGSGQFGLVHLGYWLNKD-KVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQL 68

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDV---MWVIKYCHDMGV 218
           + V  E     LV E    G L D +    G ++ +    +  DV   M    Y  +  V
Sbjct: 69  YGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM---AYLEEACV 125

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPA-YVAPEVLS-GNYSEK 275
           +HRD+   N L+  +  IK++DFG+   + + Q T S     P  + +PEV S   YS K
Sbjct: 126 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 185

Query: 276 VDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            D+WS GVL+  +     +P++  S   V + I  
Sbjct: 186 SDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIST 220

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 94.2 bits (235), Expect = 2e-21
 Identities = 51/207 (24%), Positives = 85/207 (41%), Gaps = 34/207 (16%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKG--EETVH---REVEIMQH 152
           E +  K++V+G G FG+V+       G +     A K LR+    +       E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73

Query: 153 LSGHT------GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKD 205
           +  +       G+    +V        L+ +L   G L+D + E       Q   N    
Sbjct: 74  VD-NPHVCRLLGICLTSTVQ-------LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125

Query: 206 V---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS--P 260
           +   M    Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G   P
Sbjct: 126 IAKGM---NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182

Query: 261 -AYVAPEVLS-GNYSEKVDIWSAGVLL 285
             ++A E +    Y+ + D+WS GV +
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTV 209

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 95.1 bits (237), Expect = 2e-21
 Identities = 57/222 (25%), Positives = 92/222 (41%), Gaps = 34/222 (15%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLH 163
             ++ IG G+FG V L   +  G + A K ++     +    E  +M  L  H+ +V L 
Sbjct: 196 KLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLL 252

Query: 164 SV-YEEADCFHLVMELCSGGRLID-------QMVEVGQ---YSEQRAANIFKDVMWVIKY 212
            V  EE    ++V E  + G L+D        ++       +S           M   +Y
Sbjct: 253 GVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA-----M---EY 304

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV---APEVLS 269
                 VHRD+   N+L++     K++DFGL    S+ Q    L      V   APE L 
Sbjct: 305 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLP-----VKWTAPEALR 359

Query: 270 -GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
              +S K D+WS G+LL  +     +P+    L+ V   ++ 
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 401

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 93.2 bits (232), Expect = 3e-21
 Identities = 62/210 (29%), Positives = 87/210 (41%), Gaps = 34/210 (16%)

Query: 101 IEDDH-TKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGEETVH----REVEIMQ 151
            E+ H   +  +G G FGSV LCR       +GA  A K L+           RE++I++
Sbjct: 20  FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILK 79

Query: 152 HLSGHTGVVTLHSVYEEADC--FHLVMELCSGGRLID---------QMVEVGQYSEQRAA 200
            L     +V    V          LVME    G L D             +  YS Q   
Sbjct: 80  ALH-SDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICK 138

Query: 201 NIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLA 257
                 M   +Y      VHRD+   NIL+ +   +K+ADFGLA  +   +    +    
Sbjct: 139 G-----M---EYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPG 190

Query: 258 GSP-AYVAPEVLS-GNYSEKVDIWSAGVLL 285
            SP  + APE LS   +S + D+WS GV+L
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 91.9 bits (229), Expect = 4e-21
 Identities = 50/220 (22%), Positives = 94/220 (42%), Gaps = 26/220 (11%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTL 162
           T ++ +G G+FG V L + K    + A K +++G   E+   +E + M  LS H  +V  
Sbjct: 11  TLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKF 68

Query: 163 HSVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANIFKDVMWVIKYC 213
           + V  +    ++V E  S G L++         +  ++ +             M    + 
Sbjct: 69  YGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEG-----M---AFL 120

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPA-YVAPEVLS-G 270
                +HRD+   N L+     +K++DFG+   + + Q   S     P  + APEV    
Sbjct: 121 ESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYF 180

Query: 271 NYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            YS K D+W+ G+L+  +  +  +P+   +   V   +  
Sbjct: 181 KYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQ 220

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 91.9 bits (229), Expect = 5e-21
 Identities = 51/220 (23%), Positives = 100/220 (45%), Gaps = 26/220 (11%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTL 162
           T ++ +G G+FG V   + +    + A K +++G  +      E ++M +LS H  +V L
Sbjct: 27  TFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQL 84

Query: 163 HSVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANIFKDVMWVIKYC 213
           + V  +     ++ E  + G L++         Q  ++ +  +          M   +Y 
Sbjct: 85  YGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEA-----M---EYL 136

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPA-YVAPEVLS-G 270
                +HRD+   N L+   G +K++DFGL+  + + + T S  +  P  +  PEVL   
Sbjct: 137 ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYS 196

Query: 271 NYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            +S K DIW+ GVL+  +  +  +P++  +     + I  
Sbjct: 197 KFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQ 236

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 93.2 bits (232), Expect = 5e-21
 Identities = 62/329 (18%), Positives = 109/329 (33%), Gaps = 92/329 (27%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGH----TGVV 160
           +  +G G FG V LC+   +   +A K +R  +    +   E +I++ +         +V
Sbjct: 40  IRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIV 99

Query: 161 TLHSVYEEADCF----HL--VMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKY 212
             H        F    H+  + E   G  L + +       +  +       +++  + Y
Sbjct: 100 KYH------GKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNY 152

Query: 213 CHDMGVVHRDIKPENILLTTSG-------------------------KIKLADFGLAMRI 247
              M + H D+KPENILL                              IKL DFG A   
Sbjct: 153 LRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK 212

Query: 248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS------- 299
           S       +  +  Y APEV+    +    D+WS G +L  L   +L F+          
Sbjct: 213 S--DYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAM 270

Query: 300 LEAV-------------------FDAIKNVKLDFHSGVWETVSKPAR------------- 327
           +E++                   +     +KL +        S                 
Sbjct: 271 MESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHE 330

Query: 328 ---DLMARMLTRDVSARITADEVLRHPWI 353
              D +  +L  D + R +  E+L+H ++
Sbjct: 331 LFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 92.0 bits (229), Expect = 6e-21
 Identities = 57/220 (25%), Positives = 96/220 (43%), Gaps = 19/220 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L    A+G E A K   ++     +H E +I + + G  G+ T+     E
Sbjct: 17  IGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAE 76

Query: 169 ADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPEN 227
            D   +VMEL  G  L D       ++S +    +   ++  I+Y H    +HRD+KP+N
Sbjct: 77  GDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDN 135

Query: 228 ILL---TTSGKIKLADFGLAMRISNGQTLS--------GLAGSPAYVAPEVLSGN-YSEK 275
            L+        + + DFGLA +  + +T           L G+  Y +     G   S +
Sbjct: 136 FLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRR 195

Query: 276 VDIWSAGVLLHALLVAALP---FKGDSLEAVFDAIKNVKL 312
            D+ S G +L    + +LP    K  +    ++ I   K+
Sbjct: 196 DDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM 235

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 91.9 bits (229), Expect = 6e-21
 Identities = 54/203 (26%), Positives = 78/203 (38%), Gaps = 24/203 (11%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVH-------REVEIMQ 151
           E D   +E +G G FG V      A   +    A K L+    +         REV  M 
Sbjct: 17  EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 76

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDV---M 207
            L  H  ++ L+ V        +V EL   G L+D++ +  G +     +     V   M
Sbjct: 77  SLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 134

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSP-AYV 263
               Y      +HRD+   N+LL T   +K+ DFGL   +        +      P A+ 
Sbjct: 135 ---GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 191

Query: 264 APEVLS-GNYSEKVDIWSAGVLL 285
           APE L    +S   D W  GV L
Sbjct: 192 APESLKTRTFSHASDTWMFGVTL 214

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 93.2 bits (232), Expect = 1e-20
 Identities = 57/218 (26%), Positives = 105/218 (48%), Gaps = 22/218 (10%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTL 162
              + +G G+FG VW+        + A KT++ G  +V     E  +M+ L  H  +V L
Sbjct: 191 KLEKKLGAGQFGEVWMATYNKHT-KVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKL 248

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI------KYCHDM 216
           H+V  + +  +++ E  + G L+D +    +  E     + K + +         +    
Sbjct: 249 HAVVTK-EPIYIITEFMAKGSLLDFL----KSDEGSKQPLPKLIDFSAQIAEGMAFIEQR 303

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV---APEVLS-GNY 272
             +HRD++  NIL++ S   K+ADFGLA R+      +   G+   +   APE ++ G++
Sbjct: 304 NYIHRDLRAANILVSASLVCKIADFGLA-RVIEDNEYTAREGAKFPIKWTAPEAINFGSF 362

Query: 273 SEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           + K D+WS G+LL  ++    +P+ G S   V  A++ 
Sbjct: 363 TIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALER 400

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 58/222 (26%), Positives = 93/222 (41%), Gaps = 34/222 (15%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLH 163
             ++ IG G+FG V        G + A K ++     +    E  +M  L  H+ +V L 
Sbjct: 24  KLLQTIGKGEFGDVM--LGDYRGNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLL 80

Query: 164 SV-YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD------- 215
            V  EE    ++V E  + G L+D       Y   R  ++      ++K+  D       
Sbjct: 81  GVIVEEKGGLYIVTEYMAKGSLVD-------YLRSRGRSVLG-GDCLLKFSLDVCEAMEY 132

Query: 216 ---MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV---APEVLS 269
                 VHRD+   N+L++     K++DFGL    S+ Q    L   P  V   APE L 
Sbjct: 133 LEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL---P--VKWTAPEALR 187

Query: 270 -GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
              +S K D+WS G+LL  +     +P+    L+ V   ++ 
Sbjct: 188 EKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK 229

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 92.7 bits (230), Expect = 1e-20
 Identities = 70/362 (19%), Positives = 106/362 (29%), Gaps = 130/362 (35%)

Query: 111 IGHGKFGSVWLCRSKASGAEFA---CKTLRKGEETVHREVEIMQHLS-------GHTGVV 160
           +G G F +VWL          A    K+     ET   E+ +++ +            VV
Sbjct: 45  LGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVV 104

Query: 161 TLHSVYEEADCF--------H--LVMEL--CSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
            L       D F        H  +V E+      + I +              I + V+ 
Sbjct: 105 QLL------DDFKISGVNGTHICMVFEVLGHHLLKWIIKS-NYQGLPLPCVKKIIQQVLQ 157

Query: 209 VIKYCH-DMGVVHRDIKPENILLTTS---------------------------------- 233
            + Y H    ++H DIKPENILL+ +                                  
Sbjct: 158 GLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATA 217

Query: 234 ---------------GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVD 277
                           K+K+AD G A  +   +  +    +  Y + EVL G+ Y+   D
Sbjct: 218 GNFLVNPLEPKNAEKLKVKIADLGNACWVH--KHFTEDIQTRQYRSLEVLIGSGYNTPAD 275

Query: 278 IWSAGVLL-----------------------H-ALLVAAL-PF------KGDSLEAVFDA 306
           IWS   +                        H AL++  L          G   +  F  
Sbjct: 276 IWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFT- 334

Query: 307 IKNVKLDFHSGVWETVS---------------KPARDLMARMLTRDVSARITADEVLRHP 351
            K   L   + +                        D +  ML      R TA E LRHP
Sbjct: 335 -KKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHP 393

Query: 352 WI 353
           W+
Sbjct: 394 WL 395

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 90.7 bits (226), Expect = 1e-20
 Identities = 55/216 (25%), Positives = 106/216 (49%), Gaps = 18/216 (8%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVH---REVEIMQHLSGHTGVVTL 162
             VE +G G+FG VW+        + A K+L++G  +      E  +M+ L  H  +V L
Sbjct: 16  KLVERLGAGQFGEVWMGYYNGHT-KVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRL 73

Query: 163 HSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDV---MWVIKYCHDMG 217
           ++V  + +  +++ E    G L+D  +     + +  +  ++   +   M    +  +  
Sbjct: 74  YAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM---AFIEERN 129

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPA-YVAPEVLS-GNYSE 274
            +HRD++  NIL++ +   K+ADFGLA  I + + T    A  P  + APE ++ G ++ 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 275 KVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           K D+WS G+LL  ++    +P+ G +   V   ++ 
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER 225

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 90.8 bits (226), Expect = 1e-20
 Identities = 52/223 (23%), Positives = 84/223 (37%), Gaps = 53/223 (23%)

Query: 97  RKNKIEDDHTKVE----VIGHGKFGSVW--LCRSKASGAEFACKTLRKG------EETVH 144
           R  ++  D   +      +G G FG+V     + K      A K L+        ++ + 
Sbjct: 7   RPKEVYLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELL 66

Query: 145 REVEIMQHLSGHT------GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQR 198
            E  +MQ L  +       G+    S         LVME+   G L   + +     ++ 
Sbjct: 67  AEANVMQQLD-NPYIVRMIGICEAESWM-------LVMEMAELGPLNKYLQQNRHVKDKN 118

Query: 199 AANIFKDV---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG 255
              +   V   M   KY  +   VHRD+   N+LL T    K++DFGL+  +   +    
Sbjct: 119 IIELVHQVSMGM---KYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN--- 172

Query: 256 LAGSPAYV------------APEVLS-GNYSEKVDIWSAGVLL 285
                 Y             APE ++   +S K D+WS GVL+
Sbjct: 173 -----YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLM 210

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 91.2 bits (227), Expect = 2e-20
 Identities = 67/323 (20%), Positives = 109/323 (33%), Gaps = 86/323 (26%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-ACKTLRKGE---ETVHREVEIMQHL-----SGHTG 158
           V  +G G FG V  C   A G    A K +R      E    E+ +++ +          
Sbjct: 24  VGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIKEKDKENKFL 83

Query: 159 VVTLHSVYEEADCF----HL--VMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVI 210
            V +       D F    H+    EL        + +      Y      ++   +   +
Sbjct: 84  CVLMS------DWFNFHGHMCIAFELLGKNTFEFLKENNFQP-YPLPHVRHMAYQLCHAL 136

Query: 211 KYCHDMGVVHRDIKPENILLTTSG-------------------KIKLADFGLAMRISNGQ 251
           ++ H+  + H D+KPENIL   S                     I++ADFG A      +
Sbjct: 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDH--E 194

Query: 252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------LEAV 303
             + +  +  Y  PEV+    +++  D+WS G +L         F+          +E +
Sbjct: 195 HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKI 254

Query: 304 FDAI--------KNVKLDFHSGV-----------WETVSKPAR--------------DLM 330
              I        +  K  +  G+            +   KP +              DLM
Sbjct: 255 LGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLM 314

Query: 331 ARMLTRDVSARITADEVLRHPWI 353
            RML  D + RIT  E L HP+ 
Sbjct: 315 RRMLEFDPAQRITLAEALLHPFF 337

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 90.4 bits (225), Expect = 3e-20
 Identities = 68/324 (20%), Positives = 112/324 (34%), Gaps = 88/324 (27%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-ACKTLRKGEETVHR----EVEIMQHL-----SGHT 157
           V+ +G G FG V  C    +G    A K ++   +        E+++++HL     +   
Sbjct: 19  VDTLGEGAFGKVVECIDHKAGGRHVAVKIVK-NVDRYCEAARSEIQVLEHLNTTDPNSTF 77

Query: 158 GVVTLHSVYEEADCF----HL--VMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWV 209
             V +       + F    H+  V EL        I +   +  +       +   +   
Sbjct: 78  RCVQML------EWFEHHGHICIVFELLGLSTYDFIKENGFLP-FRLDHIRKMAYQICKS 130

Query: 210 IKYCHDMGVVHRDIKPENILLTTSG-------------------KIKLADFGLAMRISNG 250
           + + H   + H D+KPENIL   S                     IK+ DFG A      
Sbjct: 131 VNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDD-- 188

Query: 251 QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-------LEA 302
           +  S L  +  Y APEV+    +S+  D+WS G +L    +    F           +E 
Sbjct: 189 EHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMER 248

Query: 303 VFDAI--------KNVKLDFHSGV-WETVSKPAR------------------------DL 329
           +   +        +  K   H  + W+  S   R                        DL
Sbjct: 249 ILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDL 308

Query: 330 MARMLTRDVSARITADEVLRHPWI 353
           + +ML  D + RIT  E L+HP+ 
Sbjct: 309 IQKMLEYDPAKRITLREALKHPFF 332

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 90.1 bits (224), Expect = 4e-20
 Identities = 62/244 (25%), Positives = 100/244 (40%), Gaps = 40/244 (16%)

Query: 93  TQMGRKNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF----ACKTLRKGEETVHR 145
            Q   K   E   + V   +VIG G+FG V+    K S  +     A KTL+ G     R
Sbjct: 31  NQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQR 90

Query: 146 -----EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRA 199
                E  IM   S H  ++ L  V  +     ++ E    G L   + E  G++S  + 
Sbjct: 91  VDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQL 149

Query: 200 ANIFKDV---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL 256
             + + +   M   KY  +M  VHRD+   NIL+ ++   K++DFGL+  + +       
Sbjct: 150 VGMLRGIAAGM---KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP----- 201

Query: 257 AGSPAYV-----------APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAV 303
                Y            APE +S   ++   D+WS G+++  ++     P+   S   V
Sbjct: 202 --EATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEV 259

Query: 304 FDAI 307
             AI
Sbjct: 260 MKAI 263

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 90.5 bits (225), Expect = 5e-20
 Identities = 61/243 (25%), Positives = 102/243 (41%), Gaps = 39/243 (16%)

Query: 93  TQMGRKNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHR- 145
           TQ   +   E D T +   +V+G G+FG V   R K    +    A KTL+ G     R 
Sbjct: 32  TQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRR 91

Query: 146 ----EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAA 200
               E  IM     H  ++ L  V  ++    +V E    G L   + +   Q++  +  
Sbjct: 92  DFLGEASIMGQFD-HPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLV 150

Query: 201 NIFKDV---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
            + + +   M   KY  DMG VHRD+   NIL+ ++   K++DFGL   + +        
Sbjct: 151 GMLRGIASGM---KYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP------ 201

Query: 258 GSPAYV-----------APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
              AY            +PE ++   ++   D+WS G++L  ++     P+   S + V 
Sbjct: 202 -EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVI 260

Query: 305 DAI 307
            A+
Sbjct: 261 KAV 263

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 91.8 bits (228), Expect = 5e-20
 Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 43/231 (18%)

Query: 106 TKVEVIGHGKFGSVW---LCRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
                IG G+FG V        +      A KT +       R     E   M+    H 
Sbjct: 393 ELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HP 451

Query: 158 ------GVVTLHSVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANI 202
                 GV+T + V+       ++MELC+ G L            +  +  Y+ Q +   
Sbjct: 452 HIVKLIGVITENPVW-------IIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTA- 503

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG-SPA 261
               +    Y      VHRDI   N+L++++  +KL DFGL+  + +        G  P 
Sbjct: 504 ----L---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556

Query: 262 -YVAPEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            ++APE ++   ++   D+W  GV +  +L     PF+G     V   I+N
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 607

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 89.3 bits (222), Expect = 8e-20
 Identities = 57/245 (23%), Positives = 100/245 (40%), Gaps = 41/245 (16%)

Query: 94  QMGRKNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHR-- 145
           + GR    E + +++   ++IG G  G V   R +  G      A K L+ G     R  
Sbjct: 37  RAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRD 96

Query: 146 ---EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAA 200
              E  IM     H  ++ L  V        +V E    G L    +  + GQ++  +  
Sbjct: 97  FLSEASIMGQFD-HPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD-GQFTIMQLV 154

Query: 201 NIFKDV---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
            + + V   M   +Y  D+G VHRD+   N+L+ ++   K++DFGL+  + +        
Sbjct: 155 GMLRGVGAGM---RYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP------ 205

Query: 258 GSPAYV-----------APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
              AY            APE ++   +S   D+WS GV++  +L     P+   +   V 
Sbjct: 206 -DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVI 264

Query: 305 DAIKN 309
            +++ 
Sbjct: 265 SSVEE 269

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 87.7 bits (218), Expect = 1e-19
 Identities = 54/191 (28%), Positives = 84/191 (43%), Gaps = 21/191 (10%)

Query: 111 IGHGKFGSVW--LCRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHTGVVTLH 163
           +G G FGSV   + R +    + A K L++G E         E +IM  L  +  +V L 
Sbjct: 18  LGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLI 76

Query: 164 SVYEEADCFHLVMELCSGGRLIDQM-VEVGQYSEQRAANIFKDV---MWVIKYCHDMGVV 219
            V +  +   LVME+  GG L   +  +  +      A +   V   M   KY  +   V
Sbjct: 77  GVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM---KYLEEKNFV 132

Query: 220 HRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSP-AYVAPEVLS-GNYSE 274
           HRD+   N+LL      K++DFGL+  +       T       P  + APE ++   +S 
Sbjct: 133 HRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSS 192

Query: 275 KVDIWSAGVLL 285
           + D+WS GV +
Sbjct: 193 RSDVWSYGVTM 203

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 88.2 bits (219), Expect = 2e-19
 Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 23/226 (10%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKG-----EETVHREVEIMQH 152
           E +  K++V+G G FG+V+       G +     A K LR+       + +  E  +M  
Sbjct: 14  ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 73

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDV---MW 208
           +  +  V  L  +        L+ +L   G L+D + E       Q   N    +   M 
Sbjct: 74  VD-NPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGM- 130

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS--P-AYVAP 265
              Y  D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G   P  ++A 
Sbjct: 131 --NYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMAL 188

Query: 266 EVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           E +    Y+ + D+WS GV +  L+   + P+ G     +   ++ 
Sbjct: 189 ESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK 234

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 87.3 bits (217), Expect = 2e-19
 Identities = 55/231 (23%), Positives = 90/231 (38%), Gaps = 43/231 (18%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
                IG G+FG V      +        A KT +       R     E   M+    H 
Sbjct: 18  ELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HP 76

Query: 158 ------GVVTLHSVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANI 202
                 GV+T + V+       ++MELC+ G L            +  +  Y+ Q +   
Sbjct: 77  HIVKLIGVITENPVW-------IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTA- 128

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG-SPA 261
               +    Y      VHRDI   N+L++++  +KL DFGL+  + +        G  P 
Sbjct: 129 ----L---AYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181

Query: 262 -YVAPEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            ++APE ++   ++   D+W  GV +  +L     PF+G     V   I+N
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIEN 232

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 51/222 (22%), Positives = 88/222 (39%), Gaps = 21/222 (9%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKTLRKGEE--TVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG + L ++  +    A K          +H E    + L    G+  ++     
Sbjct: 17  IGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPC 76

Query: 169 ADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPEN 227
                +V+EL  G  L D        +S +    I   ++  ++Y H   +++RD+KPEN
Sbjct: 77  GKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPEN 135

Query: 228 ILL-----TTSGKIKLADFGLAMRISNGQTLS--------GLAGSPAYVAPEVLSGN-YS 273
            L+      T   I + DF LA    + +T           L G+  Y++     G   S
Sbjct: 136 FLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQS 195

Query: 274 EKVDIWSAGVLLHALLVAALP---FKGDSLEAVFDAIKNVKL 312
            + D+ + G +    L  +LP    K D+L+  +  I + K 
Sbjct: 196 RRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKR 237

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 88.9 bits (220), Expect = 3e-19
 Identities = 55/220 (25%), Positives = 95/220 (43%), Gaps = 19/220 (8%)

Query: 111 IGHGKFGSVWLCRSKASGAEFACKT--LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE 168
           IG G FG ++L  +  +  E A K   ++     +  E +I + L G TG+  +     E
Sbjct: 15  IGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVE 74

Query: 169 ADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPEN 227
            D   LVM+L  G  L D      +  S +    +   ++  +++ H    +HRDIKP+N
Sbjct: 75  GDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDN 133

Query: 228 ILL---TTSGKIKLADFGLAMRISNGQTLS--------GLAGSPAYVAPEVLSGN-YSEK 275
            L+     + ++ + DFGLA +  +  T           L G+  Y +     G   S +
Sbjct: 134 FLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRR 193

Query: 276 VDIWSAGVLLHALLVAALP---FKGDSLEAVFDAIKNVKL 312
            D+ S G +L   L  +LP    K  + +  ++ I   K+
Sbjct: 194 DDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKV 233

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 57/238 (23%), Positives = 91/238 (38%), Gaps = 37/238 (15%)

Query: 100 KIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVHR-----EVE 148
            I      V   EVIG G FG V+      +  +    A K+L +  +         E  
Sbjct: 19  VIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGI 78

Query: 149 IMQHLSGHTGVVTLHSV-YEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQR 198
           IM+  S H  V++L  +         +V+     G L +          + ++  +  Q 
Sbjct: 79  IMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQV 137

Query: 199 AANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAG 258
           A       M   KY      VHRD+   N +L     +K+ADFGLA  + + +  S    
Sbjct: 138 AKG-----M---KYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNK 189

Query: 259 SPAYV-----APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           + A +     A E L    ++ K D+WS GVLL  L+   A P+   +   +   +  
Sbjct: 190 TGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 247

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 86.5 bits (215), Expect = 4e-19
 Identities = 47/206 (22%), Positives = 79/206 (38%), Gaps = 42/206 (20%)

Query: 106 TKVEVIGHGKFGSVW---LCRSKASGAEFACKTLRKGEETVHR-----EVEIMQHLSGHT 157
               ++G G FG V+       K      A KT +K     ++     E  IM++L  H 
Sbjct: 15  VLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HP 73

Query: 158 ------GVVTLHSVYEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRAANI 202
                 G++     +       ++MEL   G L           +++ +  YS Q     
Sbjct: 74  HIVKLIGIIEEEPTW-------IIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKA- 125

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS-P- 260
               M    Y   +  VHRDI   NIL+ +   +KL DFGL+  I +           P 
Sbjct: 126 ----M---AYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPI 178

Query: 261 AYVAPEVLS-GNYSEKVDIWSAGVLL 285
            +++PE ++   ++   D+W   V +
Sbjct: 179 KWMSPESINFRRFTTASDVWMFAVCM 204

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 86.6 bits (215), Expect = 5e-19
 Identities = 45/197 (22%), Positives = 80/197 (40%), Gaps = 22/197 (11%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRKGEETVH-----REVEIMQHLSGH 156
            K++V+G G FG+V        G         K +               +  +  L  H
Sbjct: 16  RKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-H 74

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDV---MWVIKY 212
             +V L  +        LV +    G L+D + +  G    Q   N    +   M    Y
Sbjct: 75  AHIVRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGM---YY 130

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS--P-AYVAPEVLS 269
             + G+VHR++   N+LL +  ++++ADFG+A  +         + +  P  ++A E + 
Sbjct: 131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIH 190

Query: 270 -GNYSEKVDIWSAGVLL 285
            G Y+ + D+WS GV +
Sbjct: 191 FGKYTHQSDVWSYGVTV 207

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 86.2 bits (214), Expect = 6e-19
 Identities = 58/237 (24%), Positives = 91/237 (38%), Gaps = 37/237 (15%)

Query: 101 IEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVH-----REVEI 149
           I  +        VIG G FG V+              A K+L +  E        RE  +
Sbjct: 16  IPHERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLL 75

Query: 150 MQHLSGHTGVVTLHSV-YEEADCFHLVMELCSGGRLID---------QMVEVGQYSEQRA 199
           M+ L+ H  V+ L  +        H+++     G L+           + ++  +  Q A
Sbjct: 76  MRGLN-HPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVA 134

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS 259
                  M   +Y  +   VHRD+   N +L  S  +K+ADFGLA  I + +  S     
Sbjct: 135 RG-----M---EYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHR 186

Query: 260 PAYV-----APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            A +     A E L    ++ K D+WS GVLL  LL   A P++      +   +  
Sbjct: 187 HARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQ 243

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 88.5 bits (219), Expect = 8e-19
 Identities = 53/200 (26%), Positives = 84/200 (42%), Gaps = 21/200 (10%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF--ACKTLRKGEETVHR-----EVEIMQHLS 154
           ++       +G G FGSV     +    +   A K L++G E         E +IM  L 
Sbjct: 335 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD 394

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDV---MWVI 210
            +  +V L  V +  +   LVME+  GG L   +V    +      A +   V   M   
Sbjct: 395 -NPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGM--- 449

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSP-AYVAPE 266
           KY  +   VHR++   N+LL      K++DFGL+  +       T       P  + APE
Sbjct: 450 KYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPE 509

Query: 267 VLS-GNYSEKVDIWSAGVLL 285
            ++   +S + D+WS GV +
Sbjct: 510 CINFRKFSSRSDVWSYGVTM 529

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 86.7 bits (215), Expect = 8e-19
 Identities = 61/310 (19%), Positives = 105/310 (33%), Gaps = 38/310 (12%)

Query: 29  RSHYSLEDYSRLKKRCKEDAGTQPIGSFKSRLAGIATAPPCGASSSLVPAGRGLKRKIGC 88
             H+     S               G         +     G+ +        +   +  
Sbjct: 11  HHHHGRRRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSA 70

Query: 89  IDVHT-QMGRKNKIEDDHTKV---EVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEE 141
           ++    Q  +   I      V   EVIG G FG V+      +  +    A K+L +  +
Sbjct: 71  LNPELVQAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD 130

Query: 142 TVHR-----EVEIMQHLSGHTGVVTLHSV-YEEADCFHLVMELCSGGRLID--------- 186
                    E  IM+  S H  V++L  +         +V+     G L +         
Sbjct: 131 IGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNP 189

Query: 187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR 246
            + ++  +  Q A       M   K+      VHRD+   N +L     +K+ADFGLA  
Sbjct: 190 TVKDLIGFGLQVAKG-----M---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD 241

Query: 247 ISNGQTLSGLAGSPAYV-----APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDS 299
           + + +  S    + A +     A E L    ++ K D+WS GVLL  L+   A P+   +
Sbjct: 242 MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 301

Query: 300 LEAVFDAIKN 309
              +   +  
Sbjct: 302 TFDITVYLLQ 311

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 85.4 bits (212), Expect = 9e-19
 Identities = 42/234 (17%), Positives = 74/234 (31%), Gaps = 41/234 (17%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEF-------ACKTLRKG----EETVHREVEIMQHLS 154
              E +G G F  ++    +  G            K L K      E+      +M  LS
Sbjct: 11  IFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS 70

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYC 213
            H  +V  + V    D   LV E    G L   + +     +      + K +   + + 
Sbjct: 71  -HKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFL 129

Query: 214 HDMGVVHRDIKPENILLTTSGK--------IKLADFGLAMRISNGQTLSGLAGSPAY--- 262
            +  ++H ++  +NILL             IKL+D G+++ +                  
Sbjct: 130 EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD----------ILQE 179

Query: 263 ----VAPEVLS--GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
               V PE +    N +   D WS G  L  +      P      +      ++
Sbjct: 180 RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED 233

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 86.3 bits (214), Expect = 1e-18
 Identities = 53/213 (24%), Positives = 87/213 (40%), Gaps = 30/213 (14%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGH-----TGV 159
             +IG G FG V     +      A K ++  +        EV +++ ++ H       +
Sbjct: 59  DSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYI 118

Query: 160 VTLHSVYEEADCF----HL--VMELCSGG--RLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
           V L         F    HL  V E+ S     L+      G  S        + +   + 
Sbjct: 119 VHLK------RHFMFRNHLCLVFEMLSYNLYDLLRNTNFRG-VSLNLTRKFAQQMCTALL 171

Query: 212 YCH--DMGVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
           +    ++ ++H D+KPENILL    +  IK+ DFG + ++  GQ +     S  Y +PEV
Sbjct: 172 FLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQL--GQRIYQYIQSRFYRSPEV 229

Query: 268 LSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS 299
           L G  Y   +D+WS G +L  +      F G +
Sbjct: 230 LLGMPYDLAIDMWSLGCILVEMHTGEPLFSGAN 262

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 10/26 (38%), Positives = 13/26 (50%)

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           DL+ RML  D   RI     L+H + 
Sbjct: 351 DLILRMLDYDPKTRIQPYYALQHSFF 376

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 85.0 bits (211), Expect = 2e-18
 Identities = 51/205 (24%), Positives = 78/205 (38%), Gaps = 30/205 (14%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF--ACKTLRKG--EETVH---REVEIMQHLSGHTGVV 160
            +VIG G FG V   R K  G     A K +++   ++       E+E++  L  H  ++
Sbjct: 30  QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89

Query: 161 TLHSVYEEADCFHLVMELCSGGRLID-------QMVEVGQYSEQRAANIFK-----DVMW 208
            L    E     +L +E    G L+D          +         A+            
Sbjct: 90  NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149

Query: 209 VI----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV- 263
            +     Y      +HRD+   NIL+  +   K+ADFGL+ R         +   P  V 
Sbjct: 150 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS-RGQEVYVKKTMGRLP--VR 206

Query: 264 --APEVLS-GNYSEKVDIWSAGVLL 285
             A E L+   Y+   D+WS GVLL
Sbjct: 207 WMAIESLNYSVYTTNSDVWSYGVLL 231

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 84.7 bits (210), Expect = 2e-18
 Identities = 46/230 (20%), Positives = 80/230 (34%), Gaps = 31/230 (13%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVH------REVEIMQHLSGH-- 156
             ++G G+FGSV   + K     F   A K L+             RE   M+    H  
Sbjct: 28  GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPH 86

Query: 157 ----TGVVTLHSVYEEADCFHLVMELCSGGRLID--QMVEVGQYSEQRAANIFKDVMWVI 210
                GV              +++     G L        +G+             M  I
Sbjct: 87  VAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDI 146

Query: 211 ----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV--- 263
               +Y      +HRD+   N +L     + +ADFGL+ +I +G       G  + +   
Sbjct: 147 ACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR--QGCASKLPVK 204

Query: 264 --APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
             A E L+   Y+   D+W+ GV +  ++     P+ G     +++ +  
Sbjct: 205 WLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIG 254

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 84.6 bits (210), Expect = 3e-18
 Identities = 50/215 (23%), Positives = 82/215 (38%), Gaps = 46/215 (21%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKG-----EETVHREVEIMQHLSGHT 157
            + +G G FG V    +   G E      A K L+       +E +  E++IM HL  H 
Sbjct: 51  GKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHE 110

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLID-------QMVEVGQYSEQRAANIFKDVM--- 207
            +V L           ++ E C  G L++        +     ++   +    +D++   
Sbjct: 111 NIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFS 170

Query: 208 WVI----KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV 263
             +     +      +HRD+   N+LLT     K+ DFGLA  I N            Y+
Sbjct: 171 SQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN---------DSNYI 221

Query: 264 ------------APEVLS-GNYSEKVDIWSAGVLL 285
                       APE +    Y+ + D+WS G+LL
Sbjct: 222 VKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILL 256

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 83.8 bits (208), Expect = 4e-18
 Identities = 49/221 (22%), Positives = 75/221 (33%), Gaps = 54/221 (24%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-------ACKTLRKGEETVHR-----EVEIMQHLSG 155
            + +G G FG V      A G          A K L+       R     E++++ +L  
Sbjct: 28  GKTLGAGAFGKVVEA--TAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGN 85

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLID-----------QMVEVGQYSEQRAANIFK 204
           H  +V L           ++ E C  G L++                    +   A   +
Sbjct: 86  HMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLE 145

Query: 205 D-VMWVI------KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLA 257
           D + +         +      +HRD+   NILLT     K+ DFGLA  I N        
Sbjct: 146 DLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS------ 199

Query: 258 GSPAYV------------APEVLS-GNYSEKVDIWSAGVLL 285
               YV            APE +    Y+ + D+WS G+ L
Sbjct: 200 ---NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFL 237

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 81.6 bits (202), Expect = 3e-17
 Identities = 56/232 (24%), Positives = 92/232 (39%), Gaps = 36/232 (15%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           +  +GHG FG V+  +      +      A KTL +            E  I+   + H 
Sbjct: 35  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQ 93

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLID-------QMVEVGQYSEQRAANIFKDV---M 207
            +V    V  ++    ++MEL +GG L         +  +    +     ++ +D+    
Sbjct: 94  NIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 153

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQ--TLSGLAGSPAY 262
              +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  
Sbjct: 154 ---QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLP-- 208

Query: 263 V---APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           V    PE    G ++ K D WS GVLL  +  +  +P+   S + V + + +
Sbjct: 209 VKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 260

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 81.3 bits (201), Expect = 4e-17
 Identities = 34/165 (20%), Positives = 63/165 (38%), Gaps = 24/165 (14%)

Query: 111 IGHGKFGSVWLCRSKASG---AEFACKTLRKGEETVHREVEIMQHLSG------------ 155
           IG G FG ++L          A    K   +    +  E++  Q ++             
Sbjct: 45  IGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQ 104

Query: 156 --HTGVVTLH----SVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
             + G+   +    + ++      +VME   G  L     + G + +     +   ++ V
Sbjct: 105 LDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDV 163

Query: 210 IKYCHDMGVVHRDIKPENILL--TTSGKIKLADFGLAMRISNGQT 252
           ++Y H+   VH DIK  N+LL      ++ LAD+GL+ R      
Sbjct: 164 LEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 80.4 bits (199), Expect = 6e-17
 Identities = 47/234 (20%), Positives = 84/234 (35%), Gaps = 35/234 (14%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVH----REVEIMQHLSGHTG 158
              +G G FG V+L               A K L+           RE E++ +L  H  
Sbjct: 20  KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQ-HEH 78

Query: 159 VVTLHSVYEEADCFHLVMELCSGG---------RLIDQMVEVGQYSEQRAANIFKDVMWV 209
           +V  + V  + D   +V E    G              ++  GQ  + +       ++ +
Sbjct: 79  IVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 138

Query: 210 I-------KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSP 260
                    Y      VHRD+   N L+  +  +K+ DFG++  + +     + G    P
Sbjct: 139 ASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLP 198

Query: 261 AYV---APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
             +    PE +    ++ + D+WS GV+L  +      P+   S   V + I  
Sbjct: 199 --IRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ 250

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 80.8 bits (200), Expect = 6e-17
 Identities = 52/229 (22%), Positives = 86/229 (37%), Gaps = 30/229 (13%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
              +G G FG V+   +K    +      A KT+ +      R     E  +M+      
Sbjct: 30  SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEF-NCH 88

Query: 158 GVVTLHSVYEEADCFHLVMELCSGG------RLIDQMVEVGQYSEQRAANIFKDVMWVI- 210
            VV L  V  +     ++MEL + G      R +   +         + +    +   I 
Sbjct: 89  HVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148

Query: 211 ---KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYV-- 263
               Y +    VHRD+   N ++     +K+ DFG+   I         G    P  V  
Sbjct: 149 DGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP--VRW 206

Query: 264 -APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            +PE L  G ++   D+WS GV+L  +  +A  P++G S E V   +  
Sbjct: 207 MSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVME 255

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 81.3 bits (201), Expect = 7e-17
 Identities = 53/244 (21%), Positives = 91/244 (37%), Gaps = 51/244 (20%)

Query: 108 VEVIGHGKFGSVWLCR----SKASGAEF---ACKTLRKG---EETVH--REVEIMQHLSG 155
            + +G G FG V L       K         A K L+     ++      E+E+M+ +  
Sbjct: 74  GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK---- 211
           H  ++ L     +    ++++E  S G L + +        + + N   +    +     
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193

Query: 212 ------------YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS 259
                       Y      +HRD+   N+L+T    +K+ADFGLA  I +          
Sbjct: 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY------- 246

Query: 260 PAYV------------APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFD 305
             Y             APE L    Y+ + D+WS GVLL  +  +   P+ G  +E +F 
Sbjct: 247 --YKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFK 304

Query: 306 AIKN 309
            +K 
Sbjct: 305 LLKE 308

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 80.4 bits (199), Expect = 7e-17
 Identities = 52/233 (22%), Positives = 82/233 (35%), Gaps = 34/233 (14%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVH----REVEIMQHLSGHTG 158
              +G G FG V+L        E      A K L++  E+      RE E++  L  H  
Sbjct: 46  KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQH 104

Query: 159 VVTLHSVYEEADCFHLVMELCSGGRL--------IDQMVEVGQYSEQRAANIFKDVMWVI 210
           +V    V  E     +V E    G L         D  +  G             ++ V 
Sbjct: 105 IVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVA 164

Query: 211 -------KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPA 261
                   Y   +  VHRD+   N L+     +K+ DFG++  I +     + G    P 
Sbjct: 165 SQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLP- 223

Query: 262 YV---APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
            +    PE +    ++ + D+WS GV+L  +      P+   S     D I  
Sbjct: 224 -IRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQ 275

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 80.5 bits (199), Expect = 9e-17
 Identities = 58/229 (25%), Positives = 93/229 (40%), Gaps = 30/229 (13%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           +  +GHG FG V+  +      +      A KTL +            E  I+   + H 
Sbjct: 76  IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQ 134

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI------- 210
            +V    V  ++    +++EL +GG L   + E      Q ++    D++ V        
Sbjct: 135 NIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGC 194

Query: 211 KYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNGQ--TLSGLAGSPAYV-- 263
           +Y  +   +HRDI   N LLT  G     K+ DFG+A  I         G A  P  V  
Sbjct: 195 QYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLP--VKW 252

Query: 264 -APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
             PE    G ++ K D WS GVLL  +  +  +P+   S + V + + +
Sbjct: 253 MPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTS 301

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 79.6 bits (197), Expect = 1e-16
 Identities = 49/233 (21%), Positives = 83/233 (35%), Gaps = 38/233 (16%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF---ACKTLRKGEETVH------REVEIMQHLSGH-- 156
            +++G G+FGSV     K         A KT++    +         E   M+  S H  
Sbjct: 39  GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPN 97

Query: 157 ----TGVVTLHSVYEEADCFHLVMELCSGGRLID------QMVEVGQYSEQRAANIFKDV 206
                GV    S         +++     G L                  Q       D+
Sbjct: 98  VIRLLGVCIEMSSQGIPKPM-VILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156

Query: 207 ---MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV 263
              M   +Y  +   +HRD+   N +L     + +ADFGL+ +I +G       G  A +
Sbjct: 157 ALGM---EYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYR--QGRIAKM 211

Query: 264 -----APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
                A E L+   Y+ K D+W+ GV +  +      P+ G     ++D + +
Sbjct: 212 PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLH 264

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 79.3 bits (196), Expect = 2e-16
 Identities = 49/219 (22%), Positives = 82/219 (37%), Gaps = 50/219 (22%)

Query: 108 VEVIGHGKFGSVWLCR----SKASGAEF---ACKTLRKG--EETVH---REVEIMQHLSG 155
            + +G G FG V +       K    E    A K L+    E+ +     E+E+M+ +  
Sbjct: 40  GKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 99

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLID------QMVEVGQYSEQRAANIFKDVMWV 209
           H  ++ L     +    ++++E  S G L +             Y   R          +
Sbjct: 100 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159

Query: 210 IKYCHD----------MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS 259
           +   +              +HRD+   N+L+T +  +K+ADFGLA  I+N          
Sbjct: 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------- 212

Query: 260 PAYV------------APEVLS-GNYSEKVDIWSAGVLL 285
             Y             APE L    Y+ + D+WS GVL+
Sbjct: 213 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLM 249

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 78.0 bits (193), Expect = 3e-16
 Identities = 57/235 (24%), Positives = 93/235 (39%), Gaps = 36/235 (15%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           +E +G  +FG V+                A KTL+   E   R     E  +   L  H 
Sbjct: 14  MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HP 72

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI------- 210
            VV L  V  +     ++   CS G L + +V    +S+  + +  + V   +       
Sbjct: 73  NVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVH 132

Query: 211 ---------KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGS 259
                    +Y     VVH+D+   N+L+     +K++D GL   +       L G +  
Sbjct: 133 LVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLL 192

Query: 260 PAYV---APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKN 309
           P  +   APE +  G +S   DIWS GV+L  +      P+ G S + V + I+N
Sbjct: 193 P--IRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRN 245

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 78.9 bits (195), Expect = 3e-16
 Identities = 52/224 (23%), Positives = 84/224 (37%), Gaps = 55/224 (24%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKG--EETVH---REVEIMQHLSGHT 157
            +V+G G FG V    +            A K L++            E+++M  L  H 
Sbjct: 50  GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLID--------QMVEVGQYSEQRAANIFKDVMWV 209
            +V L      +   +L+ E C  G L++           +  +Y  Q+     +D+  +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169

Query: 210 -----IKYCHD----------MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS 254
                + + +              VHRD+   N+L+T    +K+ DFGLA  I +     
Sbjct: 170 TFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS----- 224

Query: 255 GLAGSPAYV------------APEVLS-GNYSEKVDIWSAGVLL 285
                  YV            APE L  G Y+ K D+WS G+LL
Sbjct: 225 ----DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILL 264

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 78.5 bits (194), Expect = 3e-16
 Identities = 50/218 (22%), Positives = 78/218 (35%), Gaps = 49/218 (22%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKG-----EETVHREVEIMQHLSGHT 157
            + +G G FG V    +            A K L++G        +  E++I+ H+  H 
Sbjct: 32  GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91

Query: 158 GVVTLHSVYEEADC-FHLVMELCSGGRLID------QMVEVGQYSEQRAANIFKDVMWVI 210
            VV L     +      +++E C  G L              + + +     F  +  +I
Sbjct: 92  NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151

Query: 211 KYCHD----------MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSP 260
            Y                +HRD+   NILL+    +K+ DFGLA  I             
Sbjct: 152 CYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-------- 203

Query: 261 AYV------------APEVLS-GNYSEKVDIWSAGVLL 285
            YV            APE +    Y+ + D+WS GVLL
Sbjct: 204 -YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 78.6 bits (194), Expect = 5e-16
 Identities = 54/244 (22%), Positives = 93/244 (38%), Gaps = 51/244 (20%)

Query: 108 VEVIGHGKFGSVWLCR----SKASGAEF---ACKTLRKG--EETVH---REVEIMQHLSG 155
            + +G G FG V +       K    E    A K L+    E+ +     E+E+M+ +  
Sbjct: 86  GKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGK 145

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLID------QMVEVGQYSEQRAANIFKDVMWV 209
           H  ++ L     +    ++++E  S G L +             Y   R          +
Sbjct: 146 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205

Query: 210 IKYCHD----------MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS 259
           +   +              +HRD+   N+L+T +  +K+ADFGLA  I+N          
Sbjct: 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY------- 258

Query: 260 PAYV------------APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFD 305
             Y             APE L    Y+ + D+WS GVL+  +  +   P+ G  +E +F 
Sbjct: 259 --YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFK 316

Query: 306 AIKN 309
            +K 
Sbjct: 317 LLKE 320

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 73.8 bits (182), Expect = 9e-15
 Identities = 47/225 (20%), Positives = 80/225 (35%), Gaps = 57/225 (25%)

Query: 108 VEVIGHGKFGSVWLCR-----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHT 157
            + +G G+FG V          +A     A K L++         +  E  +++ +  H 
Sbjct: 28  GKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQV-NHP 86

Query: 158 GVVTLHSVYEEADCFHLVMELCSGG---------RLIDQMVEVGQYSEQRAANIFKDVMW 208
            V+ L+    +     L++E    G         R +         S   ++    D   
Sbjct: 87  HVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERA 146

Query: 209 V-----IKYCHD----------MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL 253
           +     I +             M +VHRD+   NIL+    K+K++DFGL+  +    + 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS- 205

Query: 254 SGLAGSPAYV------------APEVLS-GNYSEKVDIWSAGVLL 285
                   YV            A E L    Y+ + D+WS GVLL
Sbjct: 206 --------YVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLL 242

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 73.0 bits (180), Expect = 2e-14
 Identities = 33/78 (42%), Positives = 46/78 (58%), Gaps = 5/78 (6%)

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL----AGSPAYVAPEV 267
           + H+   +HRDIK  NILL  +   K++DFGLA R S     + +     G+ AY+APE 
Sbjct: 148 FLHENHHIHRDIKSANILLDEAFTAKISDFGLA-RASEKFAQTVMTSRIVGTTAYMAPEA 206

Query: 268 LSGNYSEKVDIWSAGVLL 285
           L G  + K DI+S GV+L
Sbjct: 207 LRGEITPKSDIYSFGVVL 224

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 72.5 bits (178), Expect = 5e-14
 Identities = 33/168 (19%), Positives = 57/168 (33%), Gaps = 27/168 (16%)

Query: 111 IGHGKFGSVWLCRSK-----ASGAEFACKTLRKGEETVHREVEIMQHLS----------- 154
           IG G FG ++L          S A    K        +  E++  Q  +           
Sbjct: 43  IGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT 102

Query: 155 ---GHTGVVTLH----SVYEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDV 206
               + GV                  ++M+   G  L        + +S +    +   +
Sbjct: 103 RKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRI 161

Query: 207 MWVIKYCHDMGVVHRDIKPENILL--TTSGKIKLADFGLAMRISNGQT 252
           + +++Y H+   VH DIK  N+LL      ++ L D+GLA R      
Sbjct: 162 LDILEYIHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGV 209

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 71.2 bits (175), Expect = 9e-14
 Identities = 50/243 (20%), Positives = 84/243 (34%), Gaps = 44/243 (18%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEF-----ACKTLRKGEETVHR-----EVEIMQHLSGHT 157
           V  IG G FG V+  R+            A K L++      +     E  +M     + 
Sbjct: 52  VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NP 110

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRL-----------------IDQMVEVGQYSEQRAA 200
            +V L  V        L+ E  + G L                  D        S     
Sbjct: 111 NIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPP 170

Query: 201 NIFKDVMWVI-------KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-- 251
               + + +         Y  +   VHRD+   N L+  +  +K+ADFGL+  I +    
Sbjct: 171 LSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYY 230

Query: 252 TLSGLAGSPAYV---APEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDA 306
              G    P  +    PE +    Y+ + D+W+ GV+L  +      P+ G + E V   
Sbjct: 231 KADGNDAIP--IRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYY 288

Query: 307 IKN 309
           +++
Sbjct: 289 VRD 291

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 58/198 (29%), Positives = 87/198 (43%), Gaps = 34/198 (17%)

Query: 110 VIGHGKFGSV---WLCRSKASGAEFACKTL----RKGEETVHREVEIMQHLSGHTGVVTL 162
           +IGHG FG V    L      GA+ A K       +G E    E+E +     H  +V+L
Sbjct: 46  LIGHGVFGKVYKGVL----RDGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSL 100

Query: 163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYS-----EQR------AANIFKDVMWVIK 211
               +E +   L+ +    G L   +      +     EQR      AA         + 
Sbjct: 101 IGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAAR-------GLH 153

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLA-MRISNGQT-LS-GLAGSPAYVAPE-V 267
           Y H   ++HRD+K  NILL  +   K+ DFG++       QT LS  + G+  Y+ PE  
Sbjct: 154 YLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYF 213

Query: 268 LSGNYSEKVDIWSAGVLL 285
           + G  +EK D++S GV+L
Sbjct: 214 IKGRLTEKSDVYSFGVVL 231

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 70.3 bits (173), Expect = 1e-13
 Identities = 26/71 (36%), Positives = 43/71 (60%), Gaps = 3/71 (4%)

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LS-GLAGSPAYVAPE-VLSGNYSE 274
           ++HRD+K  NILL    +  + DFGLA  +    T ++  + G+  ++APE + +G  SE
Sbjct: 155 IIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSE 214

Query: 275 KVDIWSAGVLL 285
           K D++  GV+L
Sbjct: 215 KTDVFGYGVML 225

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 23/162 (14%), Positives = 51/162 (31%), Gaps = 27/162 (16%)

Query: 111 IGHGKFGSVWL--------CRSKASGAEFACK-------------TLRKGEETVHREVEI 149
                 G ++         C S     +F+ K               ++  + +      
Sbjct: 50  QTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKDGRLFNEQNFFQRAAKPLQVNKWK 109

Query: 150 MQHLSGHTGVVTLH-SVYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDV 206
             + +    + T       +     LV+    G  L   +        SE+    +   +
Sbjct: 110 KLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRL 168

Query: 207 MWVIKYCHDMGVVHRDIKPENILL--TTSGKIKLADFGLAMR 246
           +  +++ H+   VH ++  ENI +      ++ LA +G A R
Sbjct: 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFR 210

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 64.1 bits (155), Expect = 2e-11
 Identities = 37/194 (19%), Positives = 60/194 (30%), Gaps = 54/194 (27%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLR------------KGEETVHREVEI 149
            +   + E IG G FG V+   +       A K +             K  E +  E+ I
Sbjct: 19  TEKLQRCEKIGEGVFGEVFQTIAD--HTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76

Query: 150 MQHLSG--------HTGVVTLHSVY------------------------------EEADC 171
            + LS           G + L+SV+                               + D 
Sbjct: 77  SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136

Query: 172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILL 230
             +V+E   GG  ++QM      S   A +I   +   +      +   HRD+   N+LL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLL 195

Query: 231 TTSGKIKLADFGLA 244
             +   KL      
Sbjct: 196 KKTSLKKLHYTLNG 209

>1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221

 Score = 64.9 bits (157), Expect = 3e-11
 Identities = 74/371 (19%), Positives = 118/371 (31%), Gaps = 108/371 (29%)

Query: 136 LRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYS 195
           L K EE V + VE             L   Y+    F L+  + +        +    Y 
Sbjct: 72  LSKQEEMVQKFVE-----------EVLRINYK----F-LMSPIKT--EQRQPSMMTRMYI 113

Query: 196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG 255
           EQR   ++ D     KY +    V R ++P   L     +  L    L +R +    + G
Sbjct: 114 EQR-DRLYNDNQVFAKY-N----VSR-LQPYLKL-----RQAL----LELRPAKNVLIDG 157

Query: 256 LAGS-PAYVAPEVLSGNYSEKVDI-------W-------SAGVLLHALLVAALPFKGD-S 299
           + GS   +VA +V     S KV         W       S   +L  L    L ++ D +
Sbjct: 158 VLGSGKTWVALDVCL---SYKVQCKMDFKIFWLNLKNCNSPETVLEMLQ--KLLYQIDPN 212

Query: 300 LEAVFDAIKNVKLDFHSG----------------------VW--ETVSKPARDLMARML- 334
             +  D   N+KL  HS                       V   +  +  A +L  ++L 
Sbjct: 213 WTSRSDHSSNIKLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAKAWN--AFNLSCKILL 270

Query: 335 -TRD------VSARITADEVLRHPWILFYTERTLRTL-----TIKSKLKNQVGASHHHPA 382
            TR       +SA  T    L H  +    +     L          L  +      +P 
Sbjct: 271 TTRFKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPRE--VLTTNPR 328

Query: 383 ILSGV-ESDENKIDRGSR-----NDE-SHALSSS-ESLNSESEVQDEGGFVDALAVAISN 434
            LS + ES  + +           D+ +  + SS   L    E +    F   L+V   +
Sbjct: 329 RLSIIAESIRDGLATWDNWKHVNCDKLTTIIESSLNVLEPA-EYRKM--FDR-LSVFPPS 384

Query: 435 VRISEPKRSRL 445
             I     S +
Sbjct: 385 AHIPTILLSLI 395

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 57.6 bits (139), Expect = 3e-09
 Identities = 25/78 (32%), Positives = 37/78 (47%), Gaps = 4/78 (5%)

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYV---APEVL 268
           +      +HRD+   NILL+    +K+ DFGLA  I           +   +   APE +
Sbjct: 208 FLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETI 267

Query: 269 S-GNYSEKVDIWSAGVLL 285
               Y+ + D+WS GVLL
Sbjct: 268 FDRVYTIQSDVWSFGVLL 285

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 48.4 bits (115), Expect = 2e-06
 Identities = 31/153 (20%), Positives = 57/153 (37%), Gaps = 17/153 (11%)

Query: 109 EVIGHGKFGSVWLCR-----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTG 158
           + +G G FG V           A+    A K L++G        +  E++I+ H+  H  
Sbjct: 28  KPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLN 87

Query: 159 VVTLHSVYEEADC-FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM- 216
           VV L     +      +++E C  G L   +      S++     +K      +   D  
Sbjct: 88  VVNLLGACTKPGGPLMVIVEFCKFGNLSTYL-----RSKRNEFVPYKTKGARFRQGKDYV 142

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISN 249
           G +  D+K     +T+S     + F     +S+
Sbjct: 143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* Length = 258

 Score = 40.8 bits (95), Expect = 4e-04
 Identities = 27/147 (18%), Positives = 52/147 (35%), Gaps = 9/147 (6%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEET-VHREVEIMQHLSGHTGVVTLHSV 165
           K+  I   +F  +          +    + ++       +E   ++      GV      
Sbjct: 80  KIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERAKEA-GVSVPQPY 138

Query: 166 YEEADCFHLVMELCSG-GRLIDQMVEVG-QYSEQRAANIFKDVMW-VIKYCHDMGVVHRD 222
               +   L+ME           +VE+G +  E     IF DV+  V +   +  +VH D
Sbjct: 139 TYMKNV--LLMEFIGEDELPAPTLVELGRELKELDVEGIFNDVVENVKRLYQEAELVHAD 196

Query: 223 IKPENILLTTSGKIKLADFGLAMRISN 249
           +   NI+     K+   D G A+ + +
Sbjct: 197 LSEYNIMYI--DKVYFIDMGQAVTLRH 221

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	469
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
3uqc_A	286	Probable conserved transmembrane protein; structur	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	100.0
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	100.0
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.95
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.93
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.87
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.78
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	99.54
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	99.4
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	99.29
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	99.25
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	98.97
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	98.88
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	98.79
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	98.69
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	98.59
3ats_A	357	Putative uncharacterized protein; hypothetical pro	98.56
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	98.54
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	98.53
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	98.17
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	98.16
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	98.06
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	98.03
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	97.99
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	97.93
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	97.92
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.84
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	97.79
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	97.78
3f7w_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	97.76
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	97.56
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	97.53
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	97.32
3mes_A	424	Choline kinase; malaria, structural genomics, stru	96.99
3g15_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	95.91
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	90.74
2lhi_A	176	Calmodulin, serine/threonine-protein phosphatase c	89.49
1s6j_A	87	CDPK, calcium-dependent protein kinase SK5; EF-han	88.49
3h4s_E	135	KCBP interacting Ca2+-binding protein; kinesin, mo	88.4
2lmt_A	148	Calmodulin-related protein 97A; spermatogenesis, m	88.13
1yx7_A	83	Calsensin, LAN3-6 antigen; calcium-binding protein	87.78
4ano_A	219	ESSB; membrane protein, membrane secretion, ESS ty	87.66
3pm8_A	197	PFCDPK2, calcium-dependent protein kinase 2; malar	87.43
3i5g_B	153	Myosin regulatory light chain LC-2, mantle muscle;	87.18
3i5g_C	159	Myosin catalytic light chain LC-1, mantle muscle;	86.73
3a4u_B	143	Multiple coagulation factor deficiency protein 2;	85.8
2lv7_A	100	Calcium-binding protein 7; metal binding protein;	84.89
1iq3_A	110	Ralbp1-interacting protein (partner of ralbp1); EF	84.88
2b1u_A	71	Calmodulin-like protein 5; CLSP, calmodulin-like S	84.39
1fi6_A	92	EH domain protein REPS1; EPS15 homology domain, EF	84.3
2l4h_A	214	Calcium and integrin-binding protein 1; metal bind	84.25
3k21_A	191	PFCDPK3, calcium-dependent protein kinase 3; calci	83.53
1c07_A	95	Protein (epidermal growth factor receptor pathway	83.49
1ij5_A	323	Plasmodial specific LAV1-2 protein; fourty kDa cal	83.46
2kyc_A	108	Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand p	82.74
2obh_A	143	Centrin-2; DNA repair complex EF hand superfamily	82.45
1c7v_A	81	CAVP, calcium vector protein; EF-hand family, calc	82.27
1qjt_A	99	EH1, epidermal growth factor receptor substrate su	82.23
1tiz_A	67	Calmodulin-related protein, putative; helix-turn-h	82.0
3mse_B	180	Calcium-dependent protein kinase, putative; CDPKS,	81.82
1s6i_A	188	CDPK, calcium-dependent protein kinase SK5; EF-han	81.73
3ll8_B	155	Calcineurin subunit B type 1; protein-peptide dock	81.7
3li6_A	66	Calcium-binding protein; calcium signaling protein	81.36
4ann_A	215	ESSB; membrane protein, membrane secretion, ESS ty	81.33
2kgr_A	111	Intersectin-1; structure, alternative splicing, ca	81.13
3khe_A	191	Calmodulin-like domain protein kinase isoform 3; c	80.14
2ehb_A	207	Calcineurin B-like protein 4; protein complex, Ca(	80.1
2joj_A	77	Centrin protein; N-terminal domain, centrin soluti	80.01

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=1.3e-66  Score=512.76  Aligned_cols=255  Identities=29%  Similarity=0.522  Sum_probs=234.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.       .+.+.+|+++|+.|+ |||||+++++|++++.+||
T Consensus        31 ~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~yi  109 (311)
T 4aw0_A           31 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF  109 (311)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEEEE
Confidence            36899999999999999999999999999999999642       356889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC---C
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---Q  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~---~  251 (469)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+...   .
T Consensus       110 vmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~  189 (311)
T 4aw0_A          110 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  189 (311)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCC
T ss_pred             EEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999877533   2


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|.+..+.++    ..+|+++++||
T Consensus       190 ~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli  265 (311)
T 4aw0_A          190 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFP----EKFFPKARDLV  265 (311)
T ss_dssp             CBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTCCHHHHHHH
T ss_pred             cccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----cccCHHHHHHH
Confidence            3557899999999999976 499999999999999999999999999999999999999887776    46899999999


Q ss_pred             HHhchhhhcCCCCHHH------HHcCCCccccccccc
Q 012170          331 ARMLTRDVSARITADE------VLRHPWILFYTERTL  361 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~e------lL~hp~~~~~~~~~~  361 (469)
                      .+||++||.+|||++|      |++||||....+..+
T Consensus       266 ~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l  302 (311)
T 4aw0_A          266 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENL  302 (311)
T ss_dssp             HHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTG
T ss_pred             HHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHh
Confidence            9999999999999988      689999977665444

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=7.1e-65  Score=507.44  Aligned_cols=254  Identities=30%  Similarity=0.497  Sum_probs=231.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...+.|++++.||+|+||+||+|+++.||+.||||++..    ..+.+.+|+.+|+.|+ |||||+++++|++++.+|||
T Consensus        71 dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~iv  149 (346)
T 4fih_A           71 DPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWVV  149 (346)
T ss_dssp             CGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCSSGGGGHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ChhHhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            456789999999999999999999999999999999953    3456889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||||+||+|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+... ....
T Consensus       150 mEy~~gg~L~~~l~-~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~~  228 (346)
T 4fih_A          150 MEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRK  228 (346)
T ss_dssp             ECCCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBC
T ss_pred             EeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCCCccc
Confidence            99999999999885 478999999999999999999999999999999999999999999999999999877544 3456


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      +.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|..... .....|..+|+++++||.+|
T Consensus       229 ~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~~  307 (346)
T 4fih_A          229 SLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDRL  307 (346)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC-CCCSCGGGSCHHHHHHHHHH
T ss_pred             ccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCCccccCCHHHHHHHHHH
Confidence            7899999999999976 599999999999999999999999999999999988876533 23345678999999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCcccc
Q 012170          334 LTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |++||.+|||+.|+|+||||...
T Consensus       308 L~~dP~~R~ta~e~l~Hp~~~~~  330 (346)
T 4fih_A          308 LVRDPAQRATAAELLKHPFLAKA  330 (346)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             cCCChhHCcCHHHHhcCHhhcCC
Confidence            99999999999999999999654

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.5e-64  Score=490.89  Aligned_cols=246  Identities=35%  Similarity=0.640  Sum_probs=214.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.       ...+.+|+++|+.|+ |||||+++++|++.+.+|||
T Consensus        13 g~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv   91 (275)
T 3hyh_A           13 GNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLR-HPHIIKLYDVIKSKDEIIMV   91 (275)
T ss_dssp             -CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             eCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEEEE
Confidence            6899999999999999999999999999999999643       246889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      |||| +|+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.........+
T Consensus        92 mEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~~~~  170 (275)
T 3hyh_A           92 IEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKT  170 (275)
T ss_dssp             EECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTCCEEECCSSCC-----------
T ss_pred             EeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCCCccCC
Confidence            9999 789999999999999999999999999999999999999999999999999999999999999988776666677


Q ss_pred             cCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      .+||+.|||||++.+. | +.++|||||||++|+|++|.+||.+.+...++..|.+..+.++    ..+|+++++||.+|
T Consensus       171 ~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~  246 (275)
T 3hyh_A          171 SCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNGVYTLP----KFLSPGAAGLIKRM  246 (275)
T ss_dssp             ----CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHHH
T ss_pred             eeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHH
Confidence            8999999999999874 4 6799999999999999999999999999999999998877665    46899999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCcc
Q 012170          334 LTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      |++||.+|||++|+|+||||+
T Consensus       247 L~~dP~~R~s~~eil~hpw~k  267 (275)
T 3hyh_A          247 LIVNPLNRISIHEIMQDDWFK  267 (275)
T ss_dssp             SCSSGGGSCCHHHHHHCHHHH
T ss_pred             ccCChhHCcCHHHHHcCcccc
Confidence            999999999999999999995

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=4.1e-64  Score=494.44  Aligned_cols=250  Identities=28%  Similarity=0.535  Sum_probs=222.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ++|++++.||+|+||+||+|++.   .+++.||||++++.      ...+.+|+++|++|+ |||||+++++|++++.+|
T Consensus        24 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~  102 (304)
T 3ubd_A           24 SQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVN-HPFIVKLHYAFQTEGKLY  102 (304)
T ss_dssp             GGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEEECC------CCCCCCC-CTTEECEEEEEEETTEEE
T ss_pred             cccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChHHHHHHHHHHHHHHHCC-CCCCCeEEEEEEECCEEE
Confidence            68999999999999999999874   47889999999642      246888999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~  252 (469)
                      ||||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... ...
T Consensus       103 ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~  182 (304)
T 3ubd_A          103 LILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKK  182 (304)
T ss_dssp             EEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----CC
T ss_pred             EEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCcc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999986543 334


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ..+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|.+..+.++    ..+|+++++||.
T Consensus       183 ~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  258 (304)
T 3ubd_A          183 AYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP----QFLSPEAQSLLR  258 (304)
T ss_dssp             CCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CcCCHHHHHHHH
Confidence            566899999999999976 499999999999999999999999999999999999988877665    468999999999


Q ss_pred             HhchhhhcCCCC-----HHHHHcCCCccccc
Q 012170          332 RMLTRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       332 ~~L~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      +||++||.+|||     ++|+|+||||....
T Consensus       259 ~~L~~dP~~R~ta~~~~~~eil~Hp~f~~id  289 (304)
T 3ubd_A          259 MLFKRNPANRLGAGPDGVEEIKRHSFFSTID  289 (304)
T ss_dssp             HHTCSSGGGSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HHcccCHHHCCCCCcCCHHHHHcCccccCCC
Confidence            999999999998     58999999996544

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=4.6e-64  Score=502.34  Aligned_cols=252  Identities=27%  Similarity=0.512  Sum_probs=223.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||++.+.      .+.+.+|+++|++|+ |||||+++++|++++.+||||
T Consensus        24 e~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~yiVm  102 (350)
T 4b9d_A           24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMK-HPNIVQYRESFEENGSLYIVM  102 (350)
T ss_dssp             CCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             cceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHCCHHHHHHHHHHHHHHHHCC-CCCCCcEEEEEEECCEEEEEE
Confidence            6899999999999999999999999999999999643      256889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cc
Q 012170          177 ELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~  253 (469)
                      |||+||+|.++|...+  .+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+...... ..
T Consensus       103 Ey~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  182 (350)
T 4b9d_A          103 DYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA  182 (350)
T ss_dssp             ECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHHHH
T ss_pred             eCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCcccc
Confidence            9999999999997653  57999999999999999999999999999999999999999999999999998765432 24


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .+.+||+.|||||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..|....+..   .+..+|+++++||.+
T Consensus       183 ~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~---~~~~~s~~~~~li~~  259 (350)
T 4b9d_A          183 RACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKIISGSFPP---VSLHYSYDLRSLVSQ  259 (350)
T ss_dssp             HHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSCHHHHHHHHH
T ss_pred             cccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCCCC---CCccCCHHHHHHHHH
Confidence            567899999999999874 9999999999999999999999999999999999998876532   345789999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ||++||.+|||++|+|+||||....+
T Consensus       260 ~L~~dP~~R~s~~e~l~hp~~~~~~~  285 (350)
T 4b9d_A          260 LFKRNPRDRPSVNSILEKGFIAKRIE  285 (350)
T ss_dssp             HTCSSGGGSCCHHHHHTSHHHHTTGG
T ss_pred             HccCChhHCcCHHHHhcCHHhhcCCC
Confidence            99999999999999999999975443

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=5.3e-63  Score=505.69  Aligned_cols=255  Identities=30%  Similarity=0.495  Sum_probs=231.3

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ....+.|++++.||+|+||.||+|+++.+|+.||||++..    ..+.+.+|+.+|+.|+ |||||+++++|++++.+||
T Consensus       147 ~dp~~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIV~l~~~~~~~~~~~i  225 (423)
T 4fie_A          147 GDPRSYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ-HENVVEMYNSYLVGDELWV  225 (423)
T ss_dssp             SCGGGTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCSSGGGHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             CChhHhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCCCceEEEEEECCEEEE
Confidence            3456789999999999999999999999999999999954    2457899999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~  253 (469)
                      |||||+||+|.+++. .+.+++..++.|+.||+.||.|||++||+||||||+||||+.+|.+||+|||+|..+... ...
T Consensus       226 VmEy~~gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~~~  304 (423)
T 4fie_A          226 VMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRR  304 (423)
T ss_dssp             EEECCTTEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCCCB
T ss_pred             EEeCCCCCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCCccc
Confidence            999999999999884 578999999999999999999999999999999999999999999999999999877544 345


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .+.+||+.|||||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|..... .....+..+|+++++||.+
T Consensus       305 ~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~-~~~~~~~~~s~~~~dli~~  383 (423)
T 4fie_A          305 KSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP-PRLKNLHKVSPSLKGFLDR  383 (423)
T ss_dssp             CCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC-CCCSCTTSSCHHHHHHHHH
T ss_pred             cccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC-CCCcccccCCHHHHHHHHH
Confidence            67899999999999976 499999999999999999999999999999999988876533 2234457899999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+||.+|||+.|+|+||||...
T Consensus       384 ~L~~dP~~R~ta~ell~Hp~~~~~  407 (423)
T 4fie_A          384 LLVRDPAQRATAAELLKHPFLAKA  407 (423)
T ss_dssp             HSCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             HcCCChhHCcCHHHHhcCHHhcCC
Confidence            999999999999999999999654

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=2.9e-62  Score=478.68  Aligned_cols=247  Identities=20%  Similarity=0.389  Sum_probs=217.1

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFHL  174 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~l  174 (469)
                      |.+.+.||+|+||+||+|.++.++..||+|++...      .+.+.+|+++|++|+ |||||+++++|++    .+.+||
T Consensus        28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~~~l  106 (290)
T 3fpq_A           28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL  106 (290)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEEETTEEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEeeccCCCcEEEE
Confidence            36677899999999999999999999999998542      246889999999997 9999999999975    356899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~  251 (469)
                      |||||+||+|.+++.+.+.+++..+..|+.||+.||.|||++|  |+||||||+||||+. +|.+||+|||+|+.. ...
T Consensus       107 vmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~-~~~  185 (290)
T 3fpq_A          107 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-RAS  185 (290)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGC-CTT
T ss_pred             EEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeC-CCC
Confidence            9999999999999999999999999999999999999999999  999999999999985 799999999999753 334


Q ss_pred             cccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...+.+||+.|||||++.+.|+.++|||||||++|+|+||.+||.+. +...++..+.....  +...+..+++++++||
T Consensus       186 ~~~~~~GTp~YmAPE~~~~~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li  263 (290)
T 3fpq_A          186 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEII  263 (290)
T ss_dssp             SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHH
T ss_pred             ccCCcccCccccCHHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHHHHcCCC--CCCCCccCCHHHHHHH
Confidence            45668999999999999999999999999999999999999999764 45566666655432  2233456899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .+||.+||.+|||+.|+|+||||+.
T Consensus       264 ~~~L~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          264 EGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHccCChhHCcCHHHHhcCccccC
Confidence            9999999999999999999999964

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=1e-62  Score=490.37  Aligned_cols=254  Identities=26%  Similarity=0.375  Sum_probs=224.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      .+.|++.+.||+|+||.||+|+++.+|+.||||+++... ...+|+.+|+.|+ |||||+++++|++++.+|||||||+|
T Consensus        57 ~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~-~~~~E~~il~~l~-HpnIV~l~~~~~~~~~~~ivmEy~~g  134 (336)
T 4g3f_A           57 VHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEV-FRVEELVACAGLS-SPRIVPLYGAVREGPWVNIFMELLEG  134 (336)
T ss_dssp             TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT-CCTHHHHTTTTCC-CTTBCCEEEEEEETTEEEEEECCCTT
T ss_pred             hhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHH-hHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEEEeccCC
Confidence            357899999999999999999999999999999997643 3457999999997 99999999999999999999999999


Q ss_pred             CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCCc------cc
Q 012170          182 GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQT------LS  254 (469)
Q Consensus       182 g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~~------~~  254 (469)
                      |+|.+++.+.+.+++..+..++.||+.||.|||++||+||||||+||||+.+| ++||+|||+|+.+.....      ..
T Consensus       135 g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~  214 (336)
T 4g3f_A          135 GSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGD  214 (336)
T ss_dssp             CBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------C
T ss_pred             CcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCC
Confidence            99999999999999999999999999999999999999999999999999998 699999999987654321      23


Q ss_pred             ccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+||+.|||||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..|......+. ..+..+|+++.+||.+|
T Consensus       215 ~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~li~~~  293 (336)
T 4g3f_A          215 YIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIASEPPPIR-EIPPSCAPLTAQAIQEG  293 (336)
T ss_dssp             CCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCHHHHHHSCCGGG-GSCTTSCHHHHHHHHHH
T ss_pred             ccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHcCCCCch-hcCccCCHHHHHHHHHH
Confidence            46899999999999875 99999999999999999999999998887777777777654432 23467899999999999


Q ss_pred             chhhhcCCCCHHHH-------------HcCCCcccccc
Q 012170          334 LTRDVSARITADEV-------------LRHPWILFYTE  358 (469)
Q Consensus       334 L~~dP~~Rpsa~el-------------L~hp~~~~~~~  358 (469)
                      |++||.+|||+.|+             |+|||+..+.+
T Consensus       294 L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~  331 (336)
T 4g3f_A          294 LRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKE  331 (336)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCC
T ss_pred             ccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCC
Confidence            99999999999998             57899866543

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.9e-61  Score=490.68  Aligned_cols=256  Identities=25%  Similarity=0.486  Sum_probs=223.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-----  168 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-----  168 (469)
                      .+.++|++++.||+|+||+||+|+++.+|+.||||++++.      ...+.+|+++|+.|+ |||||++++++..     
T Consensus        51 ~i~~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~  129 (398)
T 4b99_A           51 DVGDEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAFDVVTNAKRTLRELKILKHFK-HDNIIAIKDILRPTVPYG  129 (398)
T ss_dssp             CCCSSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSSCTT
T ss_pred             CCCCCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccccchHHHHHHHHHHHHHHhcC-CCCcceEeeeeecccccc
Confidence            3567899999999999999999999999999999999653      245778999999997 9999999999764     


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          169 -ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                       .+.+|||||||+ |+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+
T Consensus       130 ~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~  208 (398)
T 4b99_A          130 EFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGL  208 (398)
T ss_dssp             TCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC
T ss_pred             cCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCccccccCCCCCEEEeecceeeec
Confidence             367899999996 679999988899999999999999999999999999999999999999999999999999999865


Q ss_pred             cCC-----CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC---
Q 012170          248 SNG-----QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG---  317 (469)
Q Consensus       248 ~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---  317 (469)
                      ...     ....+.+||+.|||||++.+  .|+.++||||+|||+|+|++|.+||.+.+..+.+..|......++..   
T Consensus       209 ~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~  288 (398)
T 4b99_A          209 CTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQ  288 (398)
T ss_dssp             -------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC
T ss_pred             ccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhh
Confidence            432     23456899999999999876  37999999999999999999999999999988888876543222211   


Q ss_pred             ------------------------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          318 ------------------------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       318 ------------------------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                              .+..++++++|||.+||.+||.+||||.|+|+||||..+.
T Consensus       289 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  352 (398)
T 4b99_A          289 AVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARISAAAALRHPFLAKYH  352 (398)
T ss_dssp             -----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTC
T ss_pred             hhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCC
Confidence                                    1235799999999999999999999999999999996543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=5.8e-59  Score=496.94  Aligned_cols=259  Identities=30%  Similarity=0.548  Sum_probs=241.3

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..+.++|++++.||+|+||.||+|+++.+|+.||||++...    .+.+.+|+.+|+.|+ |||||+++++|++.+.+||
T Consensus       153 ~~il~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~i  231 (573)
T 3uto_A          153 DHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVM  231 (573)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEECSSEEEE
T ss_pred             CcCccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccchhhHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence            34568999999999999999999999999999999999653    356889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC--CcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS--GKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~--~~vkL~DFgla~~~~~~~  251 (469)
                      |||||+||+|+++|.. .+.+++.++..++.||+.||.|||++||+||||||+|||++.+  |.+||+|||+|+.+....
T Consensus       232 v~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~  311 (573)
T 3uto_A          232 IYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ  311 (573)
T ss_dssp             EEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTS
T ss_pred             EEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCCC
Confidence            9999999999999864 4689999999999999999999999999999999999999864  899999999999888777


Q ss_pred             cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|||||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..|....+.++...|..+|+++++||
T Consensus       312 ~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli  391 (573)
T 3uto_A          312 SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFI  391 (573)
T ss_dssp             EEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGGTTSCHHHHHHH
T ss_pred             ceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccccCCCHHHHHHH
Confidence            77788999999999999875 99999999999999999999999999999999999999988888888889999999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .+||.+||.+|||+.|+|+||||.....
T Consensus       392 ~~~L~~dp~~R~t~~e~l~Hpw~~~~~~  419 (573)
T 3uto_A          392 RKLLLADPNTRMTIHQALEHPWLTPGNA  419 (573)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSTTTSCCCC
T ss_pred             HHHccCChhHCcCHHHHhcCcCcCCCCC
Confidence            9999999999999999999999986654

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=9.6e-59  Score=468.49  Aligned_cols=253  Identities=28%  Similarity=0.473  Sum_probs=212.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+.++|++++.||+|+||+||+|+++   .+++.||||++.+.  ...+.+|+++|+.+.+||||++++++|++.+++||
T Consensus        18 ~l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~l   97 (361)
T 4f9c_A           18 QLSNVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTSHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVI   97 (361)
T ss_dssp             GGGGTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTSCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEE
T ss_pred             CccCcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEccccCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEE
Confidence            46789999999999999999999875   46789999998643  35688999999999779999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeeecCCC--
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~~~~~--  251 (469)
                      |||||+||+|.+++   +.+++.+++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|+...+..  
T Consensus        98 vmE~~~g~~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~  174 (361)
T 4f9c_A           98 AMPYLEHESFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIE  174 (361)
T ss_dssp             EEECCCCCCHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCG
T ss_pred             EEeCCCcccHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccc
Confidence            99999999999988   469999999999999999999999999999999999999877 899999999997654321  


Q ss_pred             ---------------------------cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCC-CCCHH
Q 012170          252 ---------------------------TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFK-GDSLE  301 (469)
Q Consensus       252 ---------------------------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~  301 (469)
                                                 ...+.+||++|+|||++.+  .|+.++||||+||++|+|++|.+||. +.+..
T Consensus       175 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~  254 (361)
T 4f9c_A          175 LLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDL  254 (361)
T ss_dssp             GGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHH
T ss_pred             ccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHH
Confidence                                       2344689999999999976  48999999999999999999999995 44444


Q ss_pred             HHHHHHHcC--------------------------------------cC------------CCCCCcccCCCHHHHHHHH
Q 012170          302 AVFDAIKNV--------------------------------------KL------------DFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       302 ~~~~~i~~~--------------------------------------~~------------~~~~~~~~~~s~~~~~lI~  331 (469)
                      +.+..|...                                      ..            ......|..+|++++|||.
T Consensus       255 ~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~  334 (361)
T 4f9c_A          255 TALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLD  334 (361)
T ss_dssp             HHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC----------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHH
Confidence            444443210                                      00            0112245678999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      +||++||.+||||+|+|+||||..
T Consensus       335 ~lL~~dP~~R~ta~eaL~Hp~f~~  358 (361)
T 4f9c_A          335 KLLDLNPASRITAEEALLHPFFKD  358 (361)
T ss_dssp             HHTCSCTTTSCCHHHHHTSGGGTT
T ss_pred             HHCcCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999953

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=1.8e-58  Score=493.07  Aligned_cols=266  Identities=27%  Similarity=0.444  Sum_probs=228.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHH---HHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREV---EIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~---~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      -.++|++++.||+|+||+||+|+++.+|+.||||++.+.       ...+.+|.   .+++.+. |||||+++++|++.+
T Consensus       187 slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~-HP~IV~l~~~f~~~~  265 (689)
T 3v5w_A          187 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPD  265 (689)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSS
T ss_pred             chHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCC-CCCEeEEEEEEEECC
Confidence            457899999999999999999999999999999999642       23344554   4445554 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .+|||||||+||+|.++|.+.+.+++..++.++.||+.||.|||++|||||||||+||||+.+|++||+|||+|..+...
T Consensus       266 ~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~  345 (689)
T 3v5w_A          266 KLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK  345 (689)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred             EEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999876544


Q ss_pred             CcccccCCCCcccCceecc-C-CCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          251 QTLSGLAGSPAYVAPEVLS-G-NYSEKVDIWSAGVLLHALLVAALPFKGD---SLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      . ..+.+||+.|||||++. + .|+.++|||||||++|+|++|.+||.+.   +...+...+....+.++    ..+|++
T Consensus       346 ~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~~~~p----~~~S~~  420 (689)
T 3v5w_A          346 K-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP----DSFSPE  420 (689)
T ss_dssp             C-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             C-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhhcCCCCCCC----ccCCHH
Confidence            3 45679999999999995 4 4999999999999999999999999763   45566667766665554    578999


Q ss_pred             HHHHHHHhchhhhcCCCC-----HHHHHcCCCccccccccchhchhhHHhhhhcCCCCCC
Q 012170          326 ARDLMARMLTRDVSARIT-----ADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHH  380 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rps-----a~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  380 (469)
                      +++||.+||++||.+|++     ++||++||||...        +|.........++..+
T Consensus       421 a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~i--------dW~~l~~~~~~pP~~P  472 (689)
T 3v5w_A          421 LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL--------DWQMVFLQKYPPPLIP  472 (689)
T ss_dssp             HHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTTC--------CHHHHHTTCSCCSCCC
T ss_pred             HHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccCC--------CHHHHHcCCCCcCccC
Confidence            999999999999999998     8999999999654        4555555555555444

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=2.8e-59  Score=460.50  Aligned_cols=250  Identities=28%  Similarity=0.490  Sum_probs=201.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----  170 (469)
                      +.++|++++.||+|+||+||+|+++.+|+.||||+++..     .+.+.+|+++|++|+ |||||+++++|.+.+     
T Consensus         3 ~l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~E~~il~~l~-HpnIV~~~~~~~~~~~~~~~   81 (299)
T 4g31_A            3 YLTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLEKNTTEKL   81 (299)
T ss_dssp             HHHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECSSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEEC-----
T ss_pred             cchhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEecCccccc
Confidence            346799999999999999999999999999999998642     246789999999996 999999999987654     


Q ss_pred             -------eEEEEEeccCCCchHHHHHHhCCC---CHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          171 -------CFHLVMELCSGGRLIDQMVEVGQY---SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       171 -------~~~lV~E~~~gg~L~~~l~~~~~l---~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                             .+|||||||+||+|.+++...+.+   .+..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|
T Consensus        82 ~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~D  161 (299)
T 4g31_A           82 QPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  161 (299)
T ss_dssp             -----CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC
T ss_pred             cccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcCccccCcHHHeEECCCCcEEEcc
Confidence                   379999999999999999876654   4566889999999999999999999999999999999999999999


Q ss_pred             ccceeeecCCC-------------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q 012170          241 FGLAMRISNGQ-------------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFD  305 (469)
Q Consensus       241 Fgla~~~~~~~-------------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~  305 (469)
                      ||+|+......             ...+.+||+.|||||++.+ .|+.++|||||||++|+|++   ||.+.. ....+.
T Consensus       162 FGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~  238 (299)
T 4g31_A          162 FGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLT  238 (299)
T ss_dssp             CCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             CccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHH
Confidence            99998765432             1234689999999999987 49999999999999999996   786532 223334


Q ss_pred             HHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       306 ~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+....  ++ ..+...++.+.+||.+||++||.+|||+.|+|+||||....
T Consensus       239 ~~~~~~--~p-~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          239 DVRNLK--FP-PLFTQKYPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHTTC--CC-HHHHHHCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHhcCC--CC-CCCcccCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            444332  22 23455678899999999999999999999999999996543

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=3.8e-57  Score=444.98  Aligned_cols=243  Identities=22%  Similarity=0.342  Sum_probs=213.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .++|.+.+.||+|+||+||+|++.     .++..||||+++..    .+.+.+|+++|++|+ |||||++++++.+++.+
T Consensus        12 r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~~~   90 (299)
T 4asz_A           12 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ-HEHIVKFYGVCVEGDPL   90 (299)
T ss_dssp             GGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCCChHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEE
Confidence            368999999999999999999875     36789999999754    356889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEE
Q 012170          173 HLVMELCSGGRLIDQMVEVG-------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA  239 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~  239 (469)
                      |||||||+||+|.++|...+             .+++..+..|+.||+.||.|||+++|+||||||+||||+.++.+||+
T Consensus        91 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~  170 (299)
T 4asz_A           91 IMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIG  170 (299)
T ss_dssp             EEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEEC
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEEC
Confidence            99999999999999997643             68999999999999999999999999999999999999999999999


Q ss_pred             eccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCC
Q 012170          240 DFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDF  314 (469)
Q Consensus       240 DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  314 (469)
                      |||+|+.......   ....+||+.|||||++.+ .|+.++|||||||++|||+| |..||.+.+..+++..+..+....
T Consensus       171 DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~  250 (299)
T 4asz_A          171 DFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQ  250 (299)
T ss_dssp             CCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCC
T ss_pred             CcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            9999976543322   233569999999999965 69999999999999999998 999999999999999988765422


Q ss_pred             CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHH
Q 012170          315 HSGVWETVSKPARDLMARMLTRDVSARITADEVL  348 (469)
Q Consensus       315 ~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL  348 (469)
                         .+..+|+++.+||.+||+.||++|||+.||+
T Consensus       251 ---~p~~~~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          251 ---RPRTCPQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             ---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             ---CCccchHHHHHHHHHHcCCChhHCcCHHHHH
Confidence               2357899999999999999999999999994

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=2.5e-56  Score=444.93  Aligned_cols=245  Identities=21%  Similarity=0.305  Sum_probs=209.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .++|.+.+.||+|+||+||+|+++     .+++.||||+++..    .+.+.+|+++|++|+ |||||++++++.+.+.+
T Consensus        40 ~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~f~~E~~il~~l~-HpnIV~l~g~~~~~~~~  118 (329)
T 4aoj_A           40 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTMLQ-HQHIVRFFGVCTEGRPL  118 (329)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSE
T ss_pred             HHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            467899999999999999999875     36889999999754    256889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh---------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEE
Q 012170          173 HLVMELCSGGRLIDQMVEV---------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~---------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vk  237 (469)
                      |||||||+||+|.+++...               +++++.++..|+.||+.||.|||+++|+||||||+||||+.++.+|
T Consensus       119 ~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~K  198 (329)
T 4aoj_A          119 LMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVK  198 (329)
T ss_dssp             EEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEE
T ss_pred             EEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEE
Confidence            9999999999999998653               3589999999999999999999999999999999999999999999


Q ss_pred             EEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcC
Q 012170          238 LADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKL  312 (469)
Q Consensus       238 L~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~  312 (469)
                      |+|||+++......   .....+||+.|||||++.+ .|+.++|||||||++|||+| |..||.+.+..+++..+..+..
T Consensus       199 i~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~  278 (329)
T 4aoj_A          199 IGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRE  278 (329)
T ss_dssp             ECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCC
T ss_pred             EcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC
Confidence            99999998654332   2345689999999999976 59999999999999999999 9999999999999888877642


Q ss_pred             CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       313 ~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .   ..+..+++++.+||.+||+.||++|||+.||+++
T Consensus       279 ~---~~p~~~~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          279 L---ERPRACPPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             C---CCCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             C---CCcccccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            2   1235789999999999999999999999999864

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=1.5e-56  Score=441.44  Aligned_cols=244  Identities=23%  Similarity=0.369  Sum_probs=202.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+++.+.+.||+|+||+||+|+++.   .||||+++..      .+.+.+|+.+|++|+ |||||++++++.+ +.+|||
T Consensus        35 ~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~-~~~~iV  109 (307)
T 3omv_A           35 ASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVDPTPEQFQAFRNEVAVLRKTR-HVNILLFMGYMTK-DNLAIV  109 (307)
T ss_dssp             TTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECS-SSCEEE
T ss_pred             HHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEC-CeEEEE
Confidence            4688899999999999999998753   5999998632      256889999999997 9999999998854 568999


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC---C
Q 012170          176 MELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---Q  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~---~  251 (469)
                      ||||+||+|.++|... +.+++..+..|+.||+.||.|||++|||||||||+||||++++.+||+|||+|+.....   .
T Consensus       110 mEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~  189 (307)
T 3omv_A          110 TQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQ  189 (307)
T ss_dssp             EECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------
T ss_pred             EEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCcce
Confidence            9999999999999764 57999999999999999999999999999999999999999999999999999765432   2


Q ss_pred             cccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHcCcCC-CCCCcccCCCHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA-VFDAIKNVKLD-FHSGVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~-~~~~i~~~~~~-~~~~~~~~~s~~  325 (469)
                      .....+||+.|||||++.+    .|+.++|||||||++|||+||..||.+.+... +...+...... .....+..++++
T Consensus       190 ~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  269 (307)
T 3omv_A          190 QVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKA  269 (307)
T ss_dssp             ----CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHH
T ss_pred             eecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHH
Confidence            3456789999999999953    48999999999999999999999998765444 44444443222 122345678999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||+.||++|||+.||+++
T Consensus       270 l~~li~~cl~~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          270 MKRLVADCVKKVKEERPLFPQILSS  294 (307)
T ss_dssp             HHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999987543

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5e-56  Score=438.82  Aligned_cols=245  Identities=22%  Similarity=0.313  Sum_probs=215.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..++++++.||+|+||+||+|.+.     .+++.||||+++..     .+.+.+|+.+|++|+ |||||++++++.+++.
T Consensus        25 ~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~~~~~~~~f~~E~~il~~l~-HpNIV~l~g~~~~~~~  103 (308)
T 4gt4_A           25 LSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQ-HPNVVCLLGVVTKDQP  103 (308)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-CCC-CHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSS
T ss_pred             HHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECcccChHHHHHHHHHHHHHHhCC-CCCCCCcceEEEECCE
Confidence            457888999999999999999864     46789999999642     367899999999997 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc
Q 012170          172 FHLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK  235 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~  235 (469)
                      +|||||||++|+|.++|...                ..+++..+..|+.||+.||.|||+++||||||||+||||++++.
T Consensus       104 ~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~  183 (308)
T 4gt4_A          104 LSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLN  183 (308)
T ss_dssp             CEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGC
T ss_pred             EEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCC
Confidence            99999999999999999653                35899999999999999999999999999999999999999999


Q ss_pred             EEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcC
Q 012170          236 IKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNV  310 (469)
Q Consensus       236 vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~  310 (469)
                      +||+|||+++......   .....+||+.|||||++.+ .|+.++|||||||++|||+| |..||.+.+..+++..+...
T Consensus       184 ~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~  263 (308)
T 4gt4_A          184 VKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNR  263 (308)
T ss_dssp             EEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTT
T ss_pred             EEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC
Confidence            9999999998654322   2345689999999999864 69999999999999999998 89999999999999998876


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....   .+..+++++.+||.+||+.||.+|||+.||+++
T Consensus       264 ~~~~---~p~~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          264 QVLP---CPDDCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             CCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC---CcccchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            5322   235789999999999999999999999999875

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=5.9e-56  Score=468.05  Aligned_cols=329  Identities=32%  Similarity=0.554  Sum_probs=273.0

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----------------hHHHHHHHHHHHHhhCCCCee
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----------------EETVHREVEIMQHLSGHTGVV  160 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----------------~~~~~~E~~il~~l~~hpnIv  160 (469)
                      ...+.++|.+++.||+|+||.||+|.++.+++.||||++.+.                 .+.+.+|+.+|+.+. ||||+
T Consensus        31 ~~~i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv  109 (504)
T 3q5i_A           31 EGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLD-HPNII  109 (504)
T ss_dssp             CSCGGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCC-CTTBC
T ss_pred             CCCcccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCC-CCCCC
Confidence            345788999999999999999999999999999999998642                 246789999999996 99999


Q ss_pred             EEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEE
Q 012170          161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIK  237 (469)
Q Consensus       161 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vk  237 (469)
                      ++++++.+.+.+|+|||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+|
T Consensus       110 ~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~k  189 (504)
T 3q5i_A          110 KLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIK  189 (504)
T ss_dssp             CEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESSTTCCSSEE
T ss_pred             eEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCcHHHEEEecCCCCccEE
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999876   699


Q ss_pred             EEeccceeeecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       238 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      |+|||++............+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+.+..+++..+....+.++..
T Consensus       190 l~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~  269 (504)
T 3q5i_A          190 IVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLKKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFN  269 (504)
T ss_dssp             ECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHH
T ss_pred             EEECCCCEEcCCCCccccccCCcCCCCHHHhccCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcc
Confidence            99999998877666667788999999999999899999999999999999999999999999999999999998888877


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccchh--chhhHHhhhhcCCCCCCCCccCCccccccccc
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRT--LTIKSKLKNQVGASHHHPAILSGVESDENKID  395 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  395 (469)
                      .|..+++++++||.+||..||.+|||+.|+|+||||..+.......  ......+.+..                     
T Consensus       270 ~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------  328 (504)
T 3q5i_A          270 DWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKSDQKTLCGALSNMR---------------------  328 (504)
T ss_dssp             HHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCCCCGGGHHHHHHHHHHHH---------------------
T ss_pred             ccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhcccccchhhHHHHHHHHH---------------------
Confidence            8889999999999999999999999999999999996543321100  00000010000                     


Q ss_pred             CCCCCCCCccCCCccccCCCcccccccchHHHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          396 RGSRNDESHALSSSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       396 ~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                                           .-....-+..+....|....+.+.+..++...|..+|.|++|.|+.+||..++
T Consensus       329 ---------------------~~~~~~kl~~a~l~~i~~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l  381 (504)
T 3q5i_A          329 ---------------------KFEGSQKLAQAAILFIGSKLTTLEERKELTDIFKKLDKNGDGQLDKKELIEGY  381 (504)
T ss_dssp             ---------------------HCCCCSHHHHHHHHHHHHHTSCHHHHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred             ---------------------HHHHHHHHHHHHHHHhhccCCcHHHHHHHHHHHHeeCCCCCCeEcHHHHHHHH
Confidence                                 00001112223333333333333456678889999999999999999998753

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=7.8e-56  Score=466.00  Aligned_cols=333  Identities=32%  Similarity=0.562  Sum_probs=271.2

Q ss_pred             CcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           97 RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        97 ~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ....+.++|++++.||+|+||.||+|+++.++..||||++.+.      ...+.+|+.+|+.+. ||||++++++|.+.+
T Consensus        31 ~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~  109 (494)
T 3lij_A           31 KKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLD-HPNIMKLYDFFEDKR  109 (494)
T ss_dssp             CBCCHHHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC-----CTTHHHHHHHHHHTTCC-CTTBCCEEEEEECSS
T ss_pred             CCCchhcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCC
Confidence            3456778999999999999999999999999999999998642      356889999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceeee
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMRI  247 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~~  247 (469)
                      .+|+|||||.||+|.+.+.....+++..++.++.||+.||.|||++||+||||||+|||++..   +.+||+|||++...
T Consensus       110 ~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~  189 (494)
T 3lij_A          110 NYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVF  189 (494)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC
T ss_pred             EEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeEC
Confidence            999999999999999999999999999999999999999999999999999999999999764   45999999999887


Q ss_pred             cCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .........+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+.+..+++..+......++...|..++++++
T Consensus       190 ~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  269 (494)
T 3lij_A          190 ENQKKMKERLGTAYYIAPEVLRKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAK  269 (494)
T ss_dssp             BTTBCBCCCCSCTTTCCHHHHTTCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGTTSCHHHH
T ss_pred             CCCccccccCCCcCeeCHHHHcccCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcccCCHHHH
Confidence            77666677889999999999998899999999999999999999999999999999999999998888888999999999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCccccccccchhchhhHHhhhhcCCCCCCCCccCCcccccccccCCCCCCCCccCC
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALS  407 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (469)
                      +||.+||+.||.+|||+.|+|+||||......          .....    ..+...       +....-          
T Consensus       270 ~li~~~L~~dp~~R~s~~e~l~hp~~~~~~~~----------~~~~~----~~~~~~-------~~~~~~----------  318 (494)
T 3lij_A          270 DLIKQMLQFDSQRRISAQQALEHPWIKEMCSK----------KESGI----ELPSLA-------NAIENM----------  318 (494)
T ss_dssp             HHHHHHTCSSTTTSCCHHHHHTCHHHHHHHHH----------HHC-------CCCCS-------SHHHHH----------
T ss_pred             HHHHHHCCCChhhCccHHHHhcCcccccCccc----------ccccc----cccccH-------HHHHHH----------
Confidence            99999999999999999999999999532110          00000    000000       000000          


Q ss_pred             CccccCCCcccccccchHHHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          408 SSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       408 ~~~~~~~~~~~~~~~g~~~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                              ..-+...-+..++...+......+.+..++...|..||.|++|.|+.+||..+|
T Consensus       319 --------~~~~~~~~l~qa~l~~ia~~~~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~l  372 (494)
T 3lij_A          319 --------RKFQNSQKLAQAALLYMASKLTSQEETKELTDIFRHIDKNGDGQLDRQELIDGY  372 (494)
T ss_dssp             --------HTTTTCCHHHHHHHHHHHHHSCCHHHHHHHHHHHHHHCTTCSSEECHHHHHHTT
T ss_pred             --------HHHHHhHHHHHHHHHHHHHhcccHHHHHHHHHHHHHhCcCCCCeEcHHHHHHHH
Confidence                    000011112223233333333333456678889999999999999999998765

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=4e-56  Score=467.24  Aligned_cols=326  Identities=34%  Similarity=0.580  Sum_probs=269.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++.+      ....+.+|+.+|+++. ||||+++++++.+.+.+|
T Consensus        19 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~   97 (486)
T 3mwu_A           19 TFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSFY   97 (486)
T ss_dssp             HHHHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHBCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChhcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHHHhCC-CCCcCeEEEEEEcCCEEE
Confidence            467899999999999999999999999999999999843      3467889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc---cCCcEEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT---TSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~---~~~~vkL~DFgla~~~~~~  250 (469)
                      +|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        98 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~  177 (486)
T 3mwu_A           98 IVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN  177 (486)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC
T ss_pred             EEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCC
Confidence            9999999999999999999999999999999999999999999999999999999995   4567999999999876666


Q ss_pred             CcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ......+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+....|..+|+++++||
T Consensus       178 ~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  257 (486)
T 3mwu_A          178 TKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLI  257 (486)
T ss_dssp             ----CCTTGGGGCCGGGGGSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGGGGSCHHHHHHH
T ss_pred             CccCCCcCCCCCCCHHHhCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCcccCCCCHHHHHHH
Confidence            66667789999999999999999999999999999999999999999999999999999988888888899999999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccccccccchhchhh---HHhhhhcCCCCCCCCccCCcccccccccCCCCCCCCccCC
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIK---SKLKNQVGASHHHPAILSGVESDENKIDRGSRNDESHALS  407 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  407 (469)
                      .+||..||.+|||+.|+|+||||..............   ..+.+.                                  
T Consensus       258 ~~~L~~dp~~R~t~~~~l~hp~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------------  303 (486)
T 3mwu_A          258 RKMLTFHPSLRITATQCLEHPWIQKYSSETPTISDLPSLESAMTNI----------------------------------  303 (486)
T ss_dssp             HHHTCSSTTTSCCHHHHHHCHHHHHTCCCCCCGGGHHHHHHHHHHH----------------------------------
T ss_pred             HHHcCCChhhCcCHHHHhcCHhhccCcccCccccccccHHHHHHHH----------------------------------
Confidence            9999999999999999999999965432211000000   000000                                  


Q ss_pred             CccccCCCcccccccchHHHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhh
Q 012170          408 SSESLNSESEVQDEGGFVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       408 ~~~~~~~~~~~~~~~g~~~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                              ..-+...-+..++...+....+++....++...|..+|.|++|.|+.+||.++
T Consensus       304 --------~~~~~~~~~~~~~l~~ia~~l~~~~~~~~l~~~F~~~D~d~dG~I~~~El~~~  356 (486)
T 3mwu_A          304 --------RQFQAEKKLAQAALLYMASKLTTLDETKQLTEIFRKLDTNNDGMLDRDELVRG  356 (486)
T ss_dssp             --------HHHHHSCHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred             --------HHHHHHHHHHHHHHHHHHHHhccHHHHHHHHHHHHHhCCCCCceeeHHHHHHH
Confidence                    00001111222333333333333345667888999999999999999999654

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=7.2e-55  Score=440.78  Aligned_cols=258  Identities=37%  Similarity=0.651  Sum_probs=240.6

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++++.          .+.+.+|+.+|+.+. ||||++++++|.+
T Consensus         8 ~~~~~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~   86 (361)
T 2yab_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVL-HPNIITLHDVYEN   86 (361)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEEC
T ss_pred             CChhhceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCC-CcCCCcEEEEEEe
Confidence            45788999999999999999999999999999999998642          256889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccce
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLA  244 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgla  244 (469)
                      .+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a  166 (361)
T 2yab_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (361)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCc
Confidence            999999999999999999998888999999999999999999999999999999999999998877    7999999999


Q ss_pred             eeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ............+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|....+.++...|..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  246 (361)
T 2yab_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVSYDFDEEFFSQTS  246 (361)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTSC
T ss_pred             eEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCchhccCCC
Confidence            88776666677889999999999976 59999999999999999999999999999999999999998888877888999


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +++++||.+||..||.+|||+.|+|+||||....
T Consensus       247 ~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  280 (361)
T 2yab_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (361)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSCSS
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCcCcCCCc
Confidence            9999999999999999999999999999997543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=5.2e-56  Score=465.98  Aligned_cols=257  Identities=38%  Similarity=0.693  Sum_probs=239.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||||++.+       ....+.+|+.+|+++. ||||+++++++.+.+.
T Consensus        22 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~  100 (484)
T 3nyv_A           22 AIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD-HPNIMKLYEFFEDKGY  100 (484)
T ss_dssp             CCHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSE
T ss_pred             CcccCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCE
Confidence            3467899999999999999999999999999999999843       2467889999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeec
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~  248 (469)
                      +|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++....
T Consensus       101 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  180 (484)
T 3nyv_A          101 FYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFE  180 (484)
T ss_dssp             EEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBC
T ss_pred             EEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcc
Confidence            99999999999999999988999999999999999999999999999999999999999   467899999999998776


Q ss_pred             CCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      ........+||+.|+|||++.+.|+.++|||||||++|+|++|.+||.+.+..+++..+....+.+....|..+++++++
T Consensus       181 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  260 (484)
T 3nyv_A          181 ASKKMKDKIGTAYYIAPEVLHGTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKD  260 (484)
T ss_dssp             CCCSHHHHTTGGGTCCHHHHHTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGGGSCHHHHH
T ss_pred             cccccccCCCCccccCceeecCCCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCcccccCCHHHHH
Confidence            66666677899999999999999999999999999999999999999999999999999999888888888999999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+||..||.+|||+.|+|+||||...
T Consensus       261 li~~~L~~dp~~R~s~~e~l~h~~~~~~  288 (484)
T 3nyv_A          261 LIRKMLTYVPSMRISARDALDHEWIQTY  288 (484)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHTSHHHHHH
T ss_pred             HHHHHCCCChhHCcCHHHHhhChhhccc
Confidence            9999999999999999999999999543

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=3.3e-54  Score=434.66  Aligned_cols=252  Identities=31%  Similarity=0.568  Sum_probs=225.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++++.       ...+.+|..+|+.+.+||||+++++++++.+.+|+
T Consensus        22 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  101 (353)
T 3txo_A           22 IDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFF  101 (353)
T ss_dssp             -CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEE
Confidence            47899999999999999999999999999999999642       34577899999998679999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~  253 (469)
                      |||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.... .....
T Consensus       102 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~~~~  181 (353)
T 3txo_A          102 VMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTT  181 (353)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCCccc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999997533 33345


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|......++    ..++.++.+||.+
T Consensus       182 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  257 (353)
T 3txo_A          182 ATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYP----TWLHEDATGILKS  257 (353)
T ss_dssp             ----CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             cccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            56789999999999976 499999999999999999999999999999999999998877766    3589999999999


Q ss_pred             hchhhhcCCCCH------HHHHcCCCccccc
Q 012170          333 MLTRDVSARITA------DEVLRHPWILFYT  357 (469)
Q Consensus       333 ~L~~dP~~Rpsa------~elL~hp~~~~~~  357 (469)
                      ||.+||.+||++      +|+++||||....
T Consensus       258 lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~  288 (353)
T 3txo_A          258 FMTKNPTMRLGSLTQGGEHAILRHPFFKEID  288 (353)
T ss_dssp             HTCSSGGGSTTSGGGTCTHHHHTSGGGTTCC
T ss_pred             HhhhCHHHccCCcccCCHHHHhhCCcccCCC
Confidence            999999999998      8999999996544

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=5.2e-55  Score=439.10  Aligned_cols=247  Identities=23%  Similarity=0.335  Sum_probs=210.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-C
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-A  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~  169 (469)
                      -.++|++++.||+|+||+||+|.+..+     ++.||||.++..     ...+.+|+++|.++..|||||+++++|.+ +
T Consensus        62 ~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~  141 (353)
T 4ase_A           62 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  141 (353)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             cHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEccccChHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecC
Confidence            457899999999999999999997654     367999999653     24688999999999856999999999865 4


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~  233 (469)
                      +.+|||||||++|+|.++|...                ..+++..+..++.||+.||.|||+++||||||||+|||++.+
T Consensus       142 ~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~  221 (353)
T 4ase_A          142 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  221 (353)
T ss_dssp             SCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCC
Confidence            6789999999999999999753                348899999999999999999999999999999999999999


Q ss_pred             CcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHH
Q 012170          234 GKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSL-EAVFDAI  307 (469)
Q Consensus       234 ~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~-~~~~~~i  307 (469)
                      +.+||+|||+|+.......   ....+||+.|||||++.+ .|+.++|||||||++|||+| |..||.+.+. ..+...+
T Consensus       222 ~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i  301 (353)
T 4ase_A          222 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  301 (353)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999986644322   345679999999999965 59999999999999999998 9999988654 4455555


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ..+...   ..+..+++++.+||.+||+.||.+|||+.||++|
T Consensus       302 ~~g~~~---~~p~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          302 KEGTRM---RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             HHTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCC---CCCccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            554321   1225689999999999999999999999999987

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=8.1e-54  Score=427.55  Aligned_cols=251  Identities=34%  Similarity=0.613  Sum_probs=231.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++.+.      ...+.+|+++|+.+. ||||+++++++.+.+.+|
T Consensus        12 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~   90 (328)
T 3fe3_A           12 PHIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILN-HPNIVKLFEVIETEKTLY   90 (328)
T ss_dssp             CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCEEE
Confidence            3457899999999999999999999999999999998642      245779999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........
T Consensus        91 lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~  170 (328)
T 3fe3_A           91 LIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL  170 (328)
T ss_dssp             EEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCGG
T ss_pred             EEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCcc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999877666667


Q ss_pred             cccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ...+||+.|+|||++.+. + +.++|||||||++|+|++|.+||.+.+...+...+......++    ..+++++.+||.
T Consensus       171 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  246 (328)
T 3fe3_A          171 DAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIP----FYMSTDCENLLK  246 (328)
T ss_dssp             GTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            778999999999999764 4 4789999999999999999999999999999999988876655    357999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      +||..||.+|||++|+|+||||..
T Consensus       247 ~~L~~dP~~R~t~~eil~h~~~~~  270 (328)
T 3fe3_A          247 RFLVLNPIKRGTLEQIMKDRWINA  270 (328)
T ss_dssp             HHCCSSTTTSCCHHHHTTCTTTTT
T ss_pred             HHCCCChhHCcCHHHHhcCHhhcC
Confidence            999999999999999999999954

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=3e-53  Score=425.01  Aligned_cols=251  Identities=33%  Similarity=0.582  Sum_probs=229.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++++.       ...+.+|+.+|+.+. ||||+++++++++.+.+|+
T Consensus         4 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~l~~~~~~~~~~~l   82 (337)
T 1o6l_A            4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCC-CCcCcceEEEEEeCCEEEE
Confidence            36899999999999999999999999999999998642       356788999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~  253 (469)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... .....
T Consensus        83 v~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~~  162 (337)
T 1o6l_A           83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCCCcc
Confidence            99999999999999998999999999999999999999999999999999999999999999999999997633 33445


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+...+...+......++    ..+++++++||.+
T Consensus       163 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~  238 (337)
T 1o6l_A          163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG  238 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             cccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            66789999999999976 489999999999999999999999999999999988888776665    4689999999999


Q ss_pred             hchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          333 MLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       333 ~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      ||..||.+||     +++|+++||||....
T Consensus       239 lL~~dP~~R~g~~~~~~~ei~~h~~f~~~~  268 (337)
T 1o6l_A          239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSIN  268 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTCC
T ss_pred             HhhcCHHHhcCCCCCCHHHHHcCCCcCCCC
Confidence            9999999999     999999999996543

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.8e-54  Score=425.89  Aligned_cols=257  Identities=27%  Similarity=0.514  Sum_probs=237.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .+.++|.+++.||+|+||.||+|.+..+|..||+|++...   ...+.+|+.+|+.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~   80 (321)
T 1tki_A            2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             chhhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecCcccHHHHHHHHHHHHhCC-CCCCCeEeEEEecCCEEEEEE
Confidence            4678999999999999999999999999999999998653   345789999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--CCcEEEEeccceeeecCCCcc
Q 012170          177 ELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--~~~vkL~DFgla~~~~~~~~~  253 (469)
                      |||+||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.........
T Consensus        81 e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~  160 (321)
T 1tki_A           81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             EeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc
Confidence            9999999999996654 7999999999999999999999999999999999999987  789999999999887766666


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.+..+++..+......++...|..++.++.+||.+
T Consensus       161 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T 1tki_A          161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             ccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhhccCCHHHHHHHHH
Confidence            677899999999999875 7999999999999999999999999999999999999988888877788999999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCccccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ||..||.+|||+.|+|+||||....
T Consensus       241 ~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          241 LLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             HcCCChhHCcCHHHHhcChhhccCc
Confidence            9999999999999999999996553

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=3.6e-53  Score=433.02  Aligned_cols=252  Identities=28%  Similarity=0.537  Sum_probs=225.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+++.||||++++.       ...+.+|..+|.++.+||||++++++|++.+.+|+
T Consensus        51 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~l  130 (396)
T 4dc2_A           51 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF  130 (396)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEE
Confidence            47899999999999999999999999999999999653       24578899999998669999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee-ecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR-ISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~-~~~~~~~  253 (469)
                      |||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.. .......
T Consensus       131 V~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~~  210 (396)
T 4dc2_A          131 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  210 (396)
T ss_dssp             EEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCB
T ss_pred             EEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCCCcc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999976 3344456


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---------SLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---------~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.         ....+...+....+.++    ..++
T Consensus       211 ~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~s  286 (396)
T 4dc2_A          211 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS  286 (396)
T ss_dssp             CCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CCHHHHHHHHHHCCCCCC----TTSC
T ss_pred             ccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhhHHHHHHHHhccccCCC----CcCC
Confidence            67899999999999977 4999999999999999999999999632         34456677777766665    4689


Q ss_pred             HHHHHHHHHhchhhhcCCCCH------HHHHcCCCccccc
Q 012170          324 KPARDLMARMLTRDVSARITA------DEVLRHPWILFYT  357 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa------~elL~hp~~~~~~  357 (469)
                      .++++||.+||+.||.+||++      +||++||||....
T Consensus       287 ~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~  326 (396)
T 4dc2_A          287 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVD  326 (396)
T ss_dssp             HHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCC
T ss_pred             HHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCC
Confidence            999999999999999999985      8999999996543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.4e-53  Score=431.43  Aligned_cols=257  Identities=39%  Similarity=0.702  Sum_probs=238.3

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ...+.++|++++.||+|+||.||+|.++.+|+.||+|++...      .+.+.+|+.+|+.+. ||||+++++++.+.+.
T Consensus        24 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~  102 (362)
T 2bdw_A           24 STKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESF  102 (362)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSE
T ss_pred             CCCcccCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCE
Confidence            445678999999999999999999999999999999999643      246789999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEEeccceeeec
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMRIS  248 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~DFgla~~~~  248 (469)
                      +|+|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++....
T Consensus       103 ~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~  182 (362)
T 2bdw_A          103 HYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVN  182 (362)
T ss_dssp             EEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCT
T ss_pred             EEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEec
Confidence            999999999999999998888999999999999999999999999999999999999998654   59999999998777


Q ss_pred             CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+...++..+......++...|..++++++
T Consensus       183 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  262 (362)
T 2bdw_A          183 DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAK  262 (362)
T ss_dssp             TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGGGGSCHHHH
T ss_pred             CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHH
Confidence            6666667889999999999977 599999999999999999999999999999999999999988888888899999999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      +||.+||..||.+|||+.|+|+||||..
T Consensus       263 ~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          263 SLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             HHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            9999999999999999999999999964

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.6e-53  Score=422.19  Aligned_cols=258  Identities=34%  Similarity=0.648  Sum_probs=237.7

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..+.++|.+.+.||+|+||.||+|.++.+|+.||+|++...          .+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         7 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~   85 (326)
T 2y0a_A            7 ENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYEN   85 (326)
T ss_dssp             SCHHHHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             CCcccceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEe
Confidence            45678899999999999999999999999999999998642          356889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccce
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLA  244 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgla  244 (469)
                      .+.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        86 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a  165 (326)
T 2y0a_A           86 KTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLA  165 (326)
T ss_dssp             SSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCC
Confidence            999999999999999999998888999999999999999999999999999999999999999887    8999999999


Q ss_pred             eeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ............+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..++
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (326)
T 2y0a_A          166 HKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNTS  245 (326)
T ss_dssp             EECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCCHHHHTTSC
T ss_pred             eECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcCccccccCC
Confidence            88766656667789999999999976 58999999999999999999999999999999988888887777766677899


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..+.+||.+||..||.+|||+.|+|+||||....
T Consensus       246 ~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          246 ALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999999999999997543

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=5.4e-53  Score=438.25  Aligned_cols=255  Identities=38%  Similarity=0.696  Sum_probs=234.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.++|++++.||+|+||.||+|.++.+|+.||+|++...      ...+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus         8 ~~~~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~   86 (444)
T 3soa_A            8 RFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRLLK-HPNIVRLHDSISEEGHHY   86 (444)
T ss_dssp             HHHHHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSCHHHHHHHHHHHHHHHHHCC-BTTBCCEEEEEECSSEEE
T ss_pred             cccCCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CcCCCeEEEEEEECCEEE
Confidence            4678999999999999999999999999999999998643      245789999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc---cCCcEEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT---TSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~---~~~~vkL~DFgla~~~~~~  250 (469)
                      +|||||.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++   .++.+||+|||++......
T Consensus        87 lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~  166 (444)
T 3soa_A           87 LIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE  166 (444)
T ss_dssp             EEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTT
T ss_pred             EEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCC
Confidence            9999999999999999999999999999999999999999999999999999999998   4578999999999776543


Q ss_pred             C-cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          251 Q-TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       251 ~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      . .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+......++...|..+++++++
T Consensus       167 ~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  246 (444)
T 3soa_A          167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWDTVTPEAKD  246 (444)
T ss_dssp             CCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHH
T ss_pred             CceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccccCCHHHHH
Confidence            3 3456789999999999977 5999999999999999999999999999999999999999999988888999999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||.+||..||.+|||+.|+|+||||..
T Consensus       247 li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          247 LINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             HHHHHcCCChhHCCCHHHHhcCccccC
Confidence            999999999999999999999999954

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=5.3e-53  Score=424.55  Aligned_cols=254  Identities=29%  Similarity=0.515  Sum_probs=230.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|.+++.||+|+||.||+|+++.+|+.||||++++.       ...+..|..+|..+..||||+++++++++.+.+|
T Consensus        15 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~   94 (345)
T 1xjd_A           15 KIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLF   94 (345)
T ss_dssp             -CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEE
Confidence            347899999999999999999999999999999999642       3557789999998856999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~  252 (469)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..... ...
T Consensus        95 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  174 (345)
T 1xjd_A           95 FVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK  174 (345)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCCCc
Confidence            9999999999999999889999999999999999999999999999999999999999999999999999976432 334


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|......++    ..+++++++||.
T Consensus       175 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  250 (345)
T 1xjd_A          175 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLV  250 (345)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHhCCCCCC----cccCHHHHHHHH
Confidence            566789999999999977 489999999999999999999999999999999999988776655    458999999999


Q ss_pred             HhchhhhcCCCCHH-HHHcCCCcccccc
Q 012170          332 RMLTRDVSARITAD-EVLRHPWILFYTE  358 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~-elL~hp~~~~~~~  358 (469)
                      +||..||.+||++. +|++||||....+
T Consensus       251 ~lL~~dp~~R~~~~~~i~~hp~f~~~~w  278 (345)
T 1xjd_A          251 KLFVREPEKRLGVRGDIRQHPLFREINW  278 (345)
T ss_dssp             HHSCSSGGGSBTTBSCGGGSGGGTTCCH
T ss_pred             HHhcCCHhHcCCChHHHHcCccccCCCH
Confidence            99999999999998 9999999966544

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=1.6e-53  Score=427.82  Aligned_cols=258  Identities=36%  Similarity=0.628  Sum_probs=235.2

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||||++.+......+|+++|.++..||||+++++++.+.+.+|+||||
T Consensus        18 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~   97 (342)
T 2qr7_A           18 IQFTDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTEL   97 (342)
T ss_dssp             -CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             cCccccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeC
Confidence            35778999999999999999999999999999999999877777788999999996799999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC----CcEEEEeccceeeecCC-Ccc
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS----GKIKLADFGLAMRISNG-QTL  253 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~----~~vkL~DFgla~~~~~~-~~~  253 (469)
                      |+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+..+    +.+||+|||++...... ...
T Consensus        98 ~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~  177 (342)
T 2qr7_A           98 MKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLL  177 (342)
T ss_dssp             CCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCB
T ss_pred             CCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCce
Confidence            9999999999988899999999999999999999999999999999999998543    35999999999876543 334


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKG---DSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ...+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+   ....+++..+......++...|..+++++++|
T Consensus       178 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  257 (342)
T 2qr7_A          178 MTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYWNSVSDTAKDL  257 (342)
T ss_dssp             CCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTTTTSCHHHHHH
T ss_pred             eccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCccccccCCHHHHHH
Confidence            567899999999999764 89999999999999999999999985   56788889999888888888888999999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||..||.+|||+.++|+||||..+
T Consensus       258 i~~~L~~dP~~R~t~~~il~hp~~~~~  284 (342)
T 2qr7_A          258 VSKMLHVDPHQRLTAALVLRHPWIVHW  284 (342)
T ss_dssp             HHHHTCSSTTTSCCHHHHTTSHHHHTG
T ss_pred             HHHHCCCChhHCcCHHHHhcCCeecCc
Confidence            999999999999999999999999654

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=2.3e-52  Score=415.32  Aligned_cols=249  Identities=31%  Similarity=0.593  Sum_probs=228.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||+|++++.       .+.+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus         5 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~Iv~~~~~~~~~~~~~l   83 (318)
T 1fot_A            5 LQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFM   83 (318)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEE
T ss_pred             hHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCC-CCCCceEeEEEEeCCEEEE
Confidence            46899999999999999999999999999999998642       356778999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....  ...
T Consensus        84 v~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~--~~~  161 (318)
T 1fot_A           84 IMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD--VTY  161 (318)
T ss_dssp             EECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS--CBC
T ss_pred             EEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEcCCCCEEEeecCcceecCC--ccc
Confidence            999999999999999889999999999999999999999999999999999999999999999999999987543  334


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....+..|......++    ..++.++++||.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~l  237 (318)
T 1fot_A          162 TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRL  237 (318)
T ss_dssp             CCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHH
T ss_pred             cccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHHHH
Confidence            5789999999999976 489999999999999999999999999999999988888776665    46799999999999


Q ss_pred             chhhhcCCC-----CHHHHHcCCCccccc
Q 012170          334 LTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       334 L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      |..||.+||     +++++++||||....
T Consensus       238 L~~dp~~R~~~~~~~~~~i~~hp~f~~~~  266 (318)
T 1fot_A          238 ITRDLSQRLGNLQNGTEDVKNHPWFKEVV  266 (318)
T ss_dssp             TCSCTTTCTTSSTTTTHHHHTSGGGSSCC
T ss_pred             hccCHHHcCCCcCCCHHHHhcCccccCCC
Confidence            999999999     899999999996544

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.7e-52  Score=430.06  Aligned_cols=256  Identities=34%  Similarity=0.517  Sum_probs=228.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|+++.+++.||+|++++       ....+.+|+.+|+.+. ||||++++++|.+.+.+|
T Consensus        67 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~  145 (410)
T 3v8s_A           67 KAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFAN-SPWVVQLFYAFQDDRYLY  145 (410)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             CccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEE
Confidence            45789999999999999999999999999999999864       2245789999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      +|||||+||+|.+++. ...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++........ 
T Consensus       146 lV~E~~~gg~L~~~l~-~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~  224 (410)
T 3v8s_A          146 MVMEYMPGGDLVNLMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV  224 (410)
T ss_dssp             EEECCCTTEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE
T ss_pred             EEEeCCCCCcHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc
Confidence            9999999999999885 46799999999999999999999999999999999999999999999999999987655432 


Q ss_pred             -ccccCCCCcccCceeccCC-----CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          253 -LSGLAGSPAYVAPEVLSGN-----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       253 -~~~~~gt~~y~aPE~l~~~-----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                       ..+.+||+.|+|||++.+.     |+.++|||||||++|+|++|.+||.+.+....+..|......+....+..+++++
T Consensus       225 ~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~  304 (410)
T 3v8s_A          225 RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPDDNDISKEA  304 (410)
T ss_dssp             ECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCTTCCCCHHH
T ss_pred             cccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCCcccccHHH
Confidence             3467899999999999652     7889999999999999999999999999999999887754333333445789999


Q ss_pred             HHHHHHhchhhhcC--CCCHHHHHcCCCcccccc
Q 012170          327 RDLMARMLTRDVSA--RITADEVLRHPWILFYTE  358 (469)
Q Consensus       327 ~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~~~  358 (469)
                      ++||.+||..+|.+  ||+++||++||||....+
T Consensus       305 ~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~~w  338 (410)
T 3v8s_A          305 KNLICAFLTDREVRLGRNGVEEIKRHLFFKNDQW  338 (410)
T ss_dssp             HHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCSSC
T ss_pred             HHHHHHHccChhhhCCCCCHHHHhcCccccCCCH
Confidence            99999999999998  999999999999976543

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=1.4e-52  Score=422.81  Aligned_cols=253  Identities=28%  Similarity=0.525  Sum_probs=230.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++++.       .+.+..|..+|..+..||||+++++++++.+.+|
T Consensus        18 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~   97 (353)
T 2i0e_A           18 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY   97 (353)
T ss_dssp             -CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEE
T ss_pred             chHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEE
Confidence            347899999999999999999999999999999998642       3557789999998866999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~  252 (469)
                      +||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.... ....
T Consensus        98 lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  177 (353)
T 2i0e_A           98 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  177 (353)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCC
T ss_pred             EEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCCcc
Confidence            999999999999999988999999999999999999999999999999999999999999999999999997643 3344


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|....+.++    ..+++++.+||.
T Consensus       178 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  253 (353)
T 2i0e_A          178 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  253 (353)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHHHHHH
Confidence            566789999999999976 589999999999999999999999999999999999988777665    468999999999


Q ss_pred             HhchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          332 RMLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       332 ~~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +||..||.+||     ++++|++||||....
T Consensus       254 ~lL~~dP~~R~~~~~~~~~~i~~h~~f~~~~  284 (353)
T 2i0e_A          254 GLMTKHPGKRLGCGPEGERDIKEHAFFRYID  284 (353)
T ss_dssp             HHTCSCTTSCTTCSTTHHHHHHTSGGGTTCC
T ss_pred             HHhhcCHHHcCCCCCCCHHHHhcCccccCCC
Confidence            99999999999     479999999996543

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=3.8e-52  Score=418.38  Aligned_cols=253  Identities=28%  Similarity=0.525  Sum_probs=224.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++++.       ...+.+|+.+|+++.+||||+++++++.+.+.+|+
T Consensus         8 ~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~l   87 (345)
T 3a8x_A            8 LQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFF   87 (345)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred             hhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEE
Confidence            46899999999999999999999999999999999653       13477899999998569999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~~  253 (469)
                      ||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.... .....
T Consensus        88 v~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~~~~  167 (345)
T 3a8x_A           88 VIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTT  167 (345)
T ss_dssp             EECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTTCCB
T ss_pred             EEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCCCcc
Confidence            99999999999999988999999999999999999999999999999999999999999999999999997533 33445


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKG---------DSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~---------~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||..         .....+...+......++    ..++
T Consensus       168 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~~~~~~p----~~~s  243 (345)
T 3a8x_A          168 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP----RSLS  243 (345)
T ss_dssp             CCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------CHHHHHHHHHHCCCCCC----TTSC
T ss_pred             cccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCcccccccccccHHHHHHHHHcCCCCCC----CCCC
Confidence            66799999999999977 589999999999999999999999975         344556667777666555    4689


Q ss_pred             HHHHHHHHHhchhhhcCCCCH------HHHHcCCCcccccc
Q 012170          324 KPARDLMARMLTRDVSARITA------DEVLRHPWILFYTE  358 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa------~elL~hp~~~~~~~  358 (469)
                      .++++||.+||..||.+||++      .|+++||||....+
T Consensus       244 ~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w  284 (345)
T 3a8x_A          244 VKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDW  284 (345)
T ss_dssp             HHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCH
Confidence            999999999999999999995      89999999965443

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=4.1e-52  Score=418.93  Aligned_cols=250  Identities=29%  Similarity=0.552  Sum_probs=229.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++.+.       .+.+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus        39 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~  117 (350)
T 1rdq_E           39 QLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLY  117 (350)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             CHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEEcCCEEE
Confidence            457899999999999999999999999999999998542       356788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......  .
T Consensus       118 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~--~  195 (350)
T 1rdq_E          118 MVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--T  195 (350)
T ss_dssp             EEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--B
T ss_pred             EEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEECCCCCEEEcccccceeccCC--c
Confidence            99999999999999999899999999999999999999999999999999999999999999999999999876433  3


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|......++    ..++.++.+||.+
T Consensus       196 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li~~  271 (350)
T 1rdq_E          196 WTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRN  271 (350)
T ss_dssp             CCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHH
T ss_pred             ccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHH
Confidence            45689999999999976 589999999999999999999999999999999999988876665    4689999999999


Q ss_pred             hchhhhcCCCC-----HHHHHcCCCccccc
Q 012170          333 MLTRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       333 ~L~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      ||+.||.+||+     +++|++||||....
T Consensus       272 lL~~dp~~R~~~~~~~~~ei~~h~~f~~~~  301 (350)
T 1rdq_E          272 LLQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             HSCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             HhhcCHHhccCCccCCHHHHHhCcCcCCCC
Confidence            99999999998     99999999996543

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=2.1e-52  Score=428.46  Aligned_cols=257  Identities=33%  Similarity=0.575  Sum_probs=219.2

Q ss_pred             ccccCCeeee-eeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEE
Q 012170           99 NKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~  173 (469)
                      ..+.++|.+. +.||+|+||.||+|.++.+|+.||||+++. ...+.+|+.++.++..||||++++++|..    .+.+|
T Consensus        57 ~~~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~-~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~  135 (400)
T 1nxk_A           57 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL  135 (400)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CcccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCc-chhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEE
Confidence            4566788887 799999999999999999999999999975 46788999998777679999999999876    66799


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEeccceeeec
Q 012170          174 LVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRIS  248 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~~~~  248 (469)
                      ||||||+||+|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus       136 lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~  215 (400)
T 1nxk_A          136 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  215 (400)
T ss_dssp             EEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC
T ss_pred             EEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccC
Confidence            9999999999999997654  5999999999999999999999999999999999999998   7899999999998776


Q ss_pred             CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCcCCCCCCcccCCC
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE----AVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..    .....+....+.++...|..++
T Consensus       216 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  295 (400)
T 1nxk_A          216 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  295 (400)
T ss_dssp             -----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTTTTSC
T ss_pred             CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCcccccCC
Confidence            5555667889999999999965 5999999999999999999999999865432    2455667777777777788899


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .++.+||.+||..||.+|||+.|+|+||||...
T Consensus       296 ~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          296 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999643

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=2.1e-51  Score=418.45  Aligned_cols=253  Identities=25%  Similarity=0.466  Sum_probs=228.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|.++.+|+.||+|++.+.       ...+.+|+.+|+.+. ||||++++++|.+.+.+|
T Consensus        13 ~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~   91 (384)
T 4fr4_A           13 NFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLE-HPFLVNLWYSFQDEEDMF   91 (384)
T ss_dssp             CGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCEEE
Confidence            347899999999999999999999999999999998542       356789999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.........
T Consensus        92 lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~~  171 (384)
T 4fr4_A           92 MVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQI  171 (384)
T ss_dssp             EEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCCB
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCCCce
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999887766667


Q ss_pred             cccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          254 SGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKG---DSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ...+||+.|+|||++.+    .|+.++|||||||++|+|++|..||.+   .....+...+......++    ..++.++
T Consensus       172 ~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~~~p----~~~s~~~  247 (384)
T 4fr4_A          172 TTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP----SAWSQEM  247 (384)
T ss_dssp             CCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCCCCC----TTSCHHH
T ss_pred             eccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHHHHHHHhhcccCCC----CcCCHHH
Confidence            78899999999999953    389999999999999999999999974   345566666666655554    4679999


Q ss_pred             HHHHHHhchhhhcCCCC-HHHHHcCCCcccccc
Q 012170          327 RDLMARMLTRDVSARIT-ADEVLRHPWILFYTE  358 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rps-a~elL~hp~~~~~~~  358 (469)
                      .+||.+||..||.+||+ ++++++||||....+
T Consensus       248 ~~li~~lL~~dP~~R~s~~~~l~~hp~f~~~~w  280 (384)
T 4fr4_A          248 VSLLKKLLEPNPDQRFSQLSDVQNFPYMNDINW  280 (384)
T ss_dssp             HHHHHHHSCSSGGGSCCSHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHhcCCHhHhcccHHHHHcChhhhcCCH
Confidence            99999999999999998 999999999965543

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=3.6e-52  Score=403.92  Aligned_cols=256  Identities=36%  Similarity=0.636  Sum_probs=238.5

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..+.++|++.+.||+|+||.||+|.+..++..||+|++..    ..+.+.+|+++++.+. ||||+++++++.+.+.+|+
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~l   83 (277)
T 3f3z_A            5 GDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSLD-HPNIIRLYETFEDNTDIYL   83 (277)
T ss_dssp             -CHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hhhhhhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhccchHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCeEEE
Confidence            4577899999999999999999999999999999999854    3467889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++.......
T Consensus        84 v~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~  163 (277)
T 3f3z_A           84 VMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK  163 (277)
T ss_dssp             EEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS
T ss_pred             EEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc
Confidence            99999999999999988999999999999999999999999999999999999999   788899999999998877666


Q ss_pred             cccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ......||+.|+|||++.+.++.++||||||+++|+|++|..||.+....+....+......++...+..+++++.+||.
T Consensus       164 ~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~  243 (277)
T 3f3z_A          164 MMRTKVGTPYYVSPQVLEGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDWLNVSPQAESLIR  243 (277)
T ss_dssp             CBCCCCSCTTTCCHHHHTTCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHH
T ss_pred             chhccCCCCCccChHHhcccCCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhhhcCCHHHHHHHH
Confidence            66777899999999999988999999999999999999999999999999999999888887777667789999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      +||..||.+|||+.++|+||||..
T Consensus       244 ~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          244 RLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             HHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             HHccCChhhCcCHHHHhcCHHHhc
Confidence            999999999999999999999954

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=1e-51  Score=401.88  Aligned_cols=256  Identities=39%  Similarity=0.710  Sum_probs=237.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.++|++++.||+|+||.||+|.++.+|+.||+|++...      ...+.+|+.+++++. ||||+++++++.+.+..|
T Consensus         3 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   81 (284)
T 3kk8_A            3 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQ-HPNIVRLHDSIQEESFHY   81 (284)
T ss_dssp             TTTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEE
T ss_pred             hhhhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccCCHHHHHHHHHHHHHHHHcC-CCCcCeEEEEEEcCCEEE
Confidence            4678999999999999999999999999999999998543      245778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgla~~~~~~  250 (469)
                      +||||+.||+|.+.+...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        82 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  161 (284)
T 3kk8_A           82 LVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS  161 (284)
T ss_dssp             EEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSS
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccC
Confidence            99999999999999999899999999999999999999999999999999999999987665   999999999887766


Q ss_pred             CcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .......||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+......++...+..+++++.+|
T Consensus       162 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  241 (284)
T 3kk8_A          162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSL  241 (284)
T ss_dssp             CBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCHHHHHH
T ss_pred             ccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhhcccCHHHHHH
Confidence            666678899999999999774 8999999999999999999999999999999999999888888877788899999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||+.||.+|||+.|+|+||||...
T Consensus       242 i~~~l~~dp~~Rps~~~~l~h~~~~~~  268 (284)
T 3kk8_A          242 IDSMLTVNPKKRITADQALKVPWICNR  268 (284)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTSHHHHSC
T ss_pred             HHHHcccChhhCCCHHHHhcCccccCC
Confidence            999999999999999999999999543

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=6.1e-52  Score=417.33  Aligned_cols=259  Identities=34%  Similarity=0.644  Sum_probs=217.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..+.++|++.+.||+|+||.||+|.+..+++.||||+++..  .+.+.+|+.+|+.+. ||||+++++++.+.+.+|+||
T Consensus        49 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~  127 (349)
T 2w4o_A           49 DALSDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTVDKKIVRTEIGVLLRLS-HPNIIKLKEIFETPTEISLVL  127 (349)
T ss_dssp             SCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC----------CHHHHHCC-CTTBCCEEEEEECSSEEEEEE
T ss_pred             ccccCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccchhHHHHHHHHHHHHhCC-CCCCcceeeeEecCCeEEEEE
Confidence            45778999999999999999999999999999999999753  356788999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEeccceeeecCCCcc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~~~~~~~~~  253 (469)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++.   ++.+||+|||++.........
T Consensus       128 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  207 (349)
T 2w4o_A          128 ELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLM  207 (349)
T ss_dssp             CCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC-----------
T ss_pred             EeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccccc
Confidence            99999999999988888999999999999999999999999999999999999975   889999999999876655555


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ...+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+... ...+..+......+....|..++.++.+||.
T Consensus       208 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  287 (349)
T 2w4o_A          208 KTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWWDEVSLNAKDLVR  287 (349)
T ss_dssp             -----CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTTTTSCHHHHHHHH
T ss_pred             ccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchhhhCCHHHHHHHH
Confidence            66789999999999977 589999999999999999999999976554 4467778877777776777889999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +||..||.+|||+.|+|+||||.....
T Consensus       288 ~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          288 KLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HHccCChhhCcCHHHHhcCcccCCCcc
Confidence            999999999999999999999976543

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=6.6e-52  Score=420.84  Aligned_cols=252  Identities=33%  Similarity=0.551  Sum_probs=220.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHH-HHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEI-MQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~i-l~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|++++.||+|+||.||+|+++.+++.||||++++.       ...+.+|..+ ++.+. ||||++++++|++.+.+
T Consensus        36 ~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~-hp~Iv~l~~~~~~~~~~  114 (373)
T 2r5t_A           36 KPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVK-HPFLVGLHFSFQTADKL  114 (373)
T ss_dssp             CGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCC-CTTBCCEEEEEECSSEE
T ss_pred             ChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCC-CCCCCCEEEEEEeCCEE
Confidence            457899999999999999999999999999999999643       2345567666 35564 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~  251 (469)
                      |+||||++||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.... ...
T Consensus       115 ~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~~  194 (373)
T 2r5t_A          115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNS  194 (373)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCCC
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999997533 334


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|......++    ..++.++++||
T Consensus       195 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~----~~~~~~~~~li  270 (373)
T 2r5t_A          195 TTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLK----PNITNSARHLL  270 (373)
T ss_dssp             CCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHHHSCCCCC----SSSCHHHHHHH
T ss_pred             ccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhcccCCC----CCCCHHHHHHH
Confidence            4566899999999999977 489999999999999999999999999999999999988766655    46899999999


Q ss_pred             HHhchhhhcCCCCH----HHHHcCCCccccc
Q 012170          331 ARMLTRDVSARITA----DEVLRHPWILFYT  357 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa----~elL~hp~~~~~~  357 (469)
                      .+||+.||.+||++    .++++||||....
T Consensus       271 ~~lL~~dp~~R~~~~~~~~~i~~h~~f~~~~  301 (373)
T 2r5t_A          271 EGLLQKDRTKRLGAKDDFMEIKSHVFFSLIN  301 (373)
T ss_dssp             HHHTCSSGGGSTTTTTTHHHHHTSGGGTTCC
T ss_pred             HHHcccCHHhCCCCCCCHHHHhCCccccCCC
Confidence            99999999999986    6999999996543

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=4.3e-52  Score=418.74  Aligned_cols=255  Identities=35%  Similarity=0.645  Sum_probs=227.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------GEETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      .+.++|++++.||+|+||.||+|.++.+|+.||||++..         ..+.+.+|+.+|+.+. ||||+++++++.+.+
T Consensus        21 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~   99 (351)
T 3c0i_A           21 LFEDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLK-HPHIVELLETYSSDG   99 (351)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETT
T ss_pred             ccccceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCC
Confidence            467899999999999999999999999999999999853         2467889999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccc
Q 012170          171 CFHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGL  243 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgl  243 (469)
                      .+|+|||||+||+|.+.+...    ..+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||+
T Consensus       100 ~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~  179 (351)
T 3c0i_A          100 MLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGV  179 (351)
T ss_dssp             EEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTT
T ss_pred             EEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcc
Confidence            999999999999998888654    25899999999999999999999999999999999999987655   99999999


Q ss_pred             eeeecCCCc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          244 AMRISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       244 a~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      +........ ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+. ....+..+......+....|..
T Consensus       180 a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~~~~i~~~~~~~~~~~~~~  258 (351)
T 3c0i_A          180 AIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERLFEGIIKGKYKMNPRQWSH  258 (351)
T ss_dssp             CEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHHHHHHHHTCCCCCHHHHTT
T ss_pred             eeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHHHHHHHcCCCCCCcccccc
Confidence            987665433 445789999999999976 4899999999999999999999999875 4567777777777776667788


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++.++++||.+||..||.+|||+.|+|+||||...
T Consensus       259 ~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  293 (351)
T 3c0i_A          259 ISESAKDLVRRMLMLDPAERITVYEALNHPWLKER  293 (351)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred             CCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence            99999999999999999999999999999999653

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=3.3e-52  Score=411.28  Aligned_cols=245  Identities=23%  Similarity=0.331  Sum_probs=193.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-HHHHH--HHHHHHHhhCCCCeeEEEEEEEeCC----eEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-ETVHR--EVEIMQHLSGHTGVVTLHSVYEEAD----CFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~--E~~il~~l~~hpnIv~l~~~~~~~~----~~~l  174 (469)
                      ..+|.+.+.||+|+||+||+|++  +|+.||||+++... ..+.+  |+..+.+++ |||||++++++.+++    .+||
T Consensus         2 ar~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~~~~~~~e~Ei~~~~~l~-HpNIv~l~g~~~~~~~~~~~~~l   78 (303)
T 3hmm_A            2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhhHHHHHHHHHHhcCC-CCCCCcEEEEEEecCCCceEEEE
Confidence            45789999999999999999988  48999999997543 33444  555556776 999999999997654    6899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc--------CeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM--------GVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      |||||+||+|.+++.. .++++..+..++.|++.||.|||++        +|+||||||+||||+.++.+||+|||+|+.
T Consensus        79 V~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~  157 (303)
T 3hmm_A           79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EecCCCCCcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCcc
Confidence            9999999999999954 5789999999999999999999987        999999999999999999999999999987


Q ss_pred             ecCCCc-----ccccCCCCcccCceeccCC-------CCCccchHHHHHHHHHHHhCCCCCCCC---------------C
Q 012170          247 ISNGQT-----LSGLAGSPAYVAPEVLSGN-------YSEKVDIWSAGVLLHALLVAALPFKGD---------------S  299 (469)
Q Consensus       247 ~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~elltG~~Pf~~~---------------~  299 (469)
                      ......     ....+||+.|||||++.+.       |+.++|||||||++|||+||.+||...               .
T Consensus       158 ~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~  237 (303)
T 3hmm_A          158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccch
Confidence            654432     2346899999999999653       677899999999999999998765321               2


Q ss_pred             HHHHHHHHHcCcCCCCCC-ccc--CCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          300 LEAVFDAIKNVKLDFHSG-VWE--TVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       300 ~~~~~~~i~~~~~~~~~~-~~~--~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ...+...+.........+ .+.  ..+..+.+||.+||+.||++|||+.||++.
T Consensus       238 ~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  291 (303)
T 3hmm_A          238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            334444443333221111 111  234578899999999999999999999864

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=7.2e-52  Score=422.58  Aligned_cols=257  Identities=30%  Similarity=0.540  Sum_probs=235.1

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++...    ...+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus        47 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~l  125 (387)
T 1kob_A           47 GSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVL  125 (387)
T ss_dssp             SCGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEEE
T ss_pred             CccccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccchhhHHHHHHHHHHHHhCC-CcCCCeEEEEEEeCCEEEE
Confidence            45678999999999999999999999999999999999653    346889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--CCcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--~~~vkL~DFgla~~~~~~~  251 (469)
                      |||||.||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.  ++.+||+|||++.......
T Consensus       126 v~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~  205 (387)
T 1kob_A          126 ILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE  205 (387)
T ss_dssp             EEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS
T ss_pred             EEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc
Confidence            999999999999886554 7999999999999999999999999999999999999974  4679999999998876665


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++.+||
T Consensus       206 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li  285 (387)
T 1kob_A          206 IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFI  285 (387)
T ss_dssp             CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHH
T ss_pred             ceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccccCCHHHHHHH
Confidence            5566789999999999976 489999999999999999999999999999899999988888777777788999999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.|+|+||||...
T Consensus       286 ~~~L~~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          286 KNLLQKEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             HTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHHcCCChhHCcCHHHHhhCccccCC
Confidence            99999999999999999999999654

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=2.2e-51  Score=403.89  Aligned_cols=254  Identities=30%  Similarity=0.485  Sum_probs=224.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++..    ..+.+.+|+.+++.+. ||||+++++++...+.+|+|
T Consensus        17 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv   95 (297)
T 3fxz_A           17 DPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVV   95 (297)
T ss_dssp             CGGGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             ChhhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccccHHHHHHHHHHHHhcCC-CCCCCeEeEEEEECCEEEEE
Confidence            456789999999999999999999999999999999853    3466889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      |||++||+|.+++.. ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... ...
T Consensus        96 ~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  174 (297)
T 3fxz_A           96 MEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS  174 (297)
T ss_dssp             EECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBC
T ss_pred             EECCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcccccC
Confidence            999999999998855 579999999999999999999999999999999999999999999999999998765443 345


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.......+...... .......++..+.+||.+|
T Consensus       175 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~  253 (297)
T 3fxz_A          175 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRC  253 (297)
T ss_dssp             CCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSCGGGSCHHHHHHHHHH
T ss_pred             CccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCCCccccCHHHHHHHHHH
Confidence            5789999999999976 5899999999999999999999999988877766655433221 1122357899999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCcccc
Q 012170          334 LTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |..||.+|||+.|+|+||||...
T Consensus       254 l~~dp~~Rps~~ell~h~~~~~~  276 (297)
T 3fxz_A          254 LEMDVEKRGSAKELLQHQFLKIA  276 (297)
T ss_dssp             SCSSTTTSCCHHHHTTCGGGGGC
T ss_pred             ccCChhHCcCHHHHhhChhhccc
Confidence            99999999999999999999654

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=5.9e-52  Score=429.33  Aligned_cols=260  Identities=30%  Similarity=0.513  Sum_probs=230.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|++++.||+|+||+||+|+++.+++.||+|++.+.       ...+.+|+.+|..+. ||||++++++|.+.+.+
T Consensus        71 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~  149 (437)
T 4aw2_A           71 LHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGD-SKWITTLHYAFQDDNNL  149 (437)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEeeCCEE
Confidence            3457999999999999999999999999999999999642       234889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+|||||+||+|.+++.. .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++.......
T Consensus       150 ~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~  229 (437)
T 4aw2_A          150 YLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG  229 (437)
T ss_dssp             EEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCC
Confidence            999999999999999977 4789999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc--CCCCCCcccC
Q 012170          252 T--LSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVWET  321 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~~~  321 (469)
                      .  ....+||+.|+|||++.      +.|+.++|||||||++|+|++|.+||.+.+..+.+..|....  +.++. .+..
T Consensus       230 ~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~  308 (437)
T 4aw2_A          230 TVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT-QVTD  308 (437)
T ss_dssp             CEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCC
T ss_pred             CcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc-cccc
Confidence            3  34468999999999985      348999999999999999999999999999998888886543  33332 2356


Q ss_pred             CCHHHHHHHHHhchhhhcC--CCCHHHHHcCCCccccccccc
Q 012170          322 VSKPARDLMARMLTRDVSA--RITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~--Rpsa~elL~hp~~~~~~~~~~  361 (469)
                      +++++++||.+||..+|.+  |++++|+++||||....+..+
T Consensus       309 ~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~i~w~~l  350 (437)
T 4aw2_A          309 VSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSGIDWDNI  350 (437)
T ss_dssp             SCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTTCCTTTG
T ss_pred             CCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCCCCHHHH
Confidence            8999999999999999988  999999999999987766554

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=1.3e-51  Score=409.35  Aligned_cols=258  Identities=37%  Similarity=0.652  Sum_probs=237.2

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||+|++...          .+.+.+|+.+|+.+. ||||+++++++.+
T Consensus         8 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~   86 (321)
T 2a2a_A            8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVL-HHNVITLHDVYEN   86 (321)
T ss_dssp             SCHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEEC
T ss_pred             hhhhccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCC-CCCcceEEEEEec
Confidence            34678999999999999999999999999999999998642          356889999999997 9999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccce
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLA  244 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgla  244 (469)
                      .+.+|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++    .+||+|||++
T Consensus        87 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~  166 (321)
T 2a2a_A           87 RTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLA  166 (321)
T ss_dssp             SSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTC
T ss_pred             CCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccc
Confidence            999999999999999999998888899999999999999999999999999999999999999888    7999999999


Q ss_pred             eeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      .............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+.+..+......++...+..++
T Consensus       167 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  246 (321)
T 2a2a_A          167 HEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVSYDFDEEFFSHTS  246 (321)
T ss_dssp             EECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHHHHTTCC
T ss_pred             eecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccChhhhcccC
Confidence            88776655666789999999999976 58999999999999999999999999999999999998887777666667889


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..+.+||.+||..||.+|||+.|+|+||||....
T Consensus       247 ~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~~  280 (321)
T 2a2a_A          247 ELAKDFIRKLLVKETRKRLTIQEALRHPWITPVD  280 (321)
T ss_dssp             HHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCSS
T ss_pred             HHHHHHHHHHcCCChhhCcCHHHHhcCccccCCC
Confidence            9999999999999999999999999999997554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=5.9e-51  Score=399.33  Aligned_cols=262  Identities=33%  Similarity=0.597  Sum_probs=237.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------------hHHHHHHHHHHHHhhCCCCeeEEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------------EETVHREVEIMQHLSGHTGVVTLHSVY  166 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------------~~~~~~E~~il~~l~~hpnIv~l~~~~  166 (469)
                      .+.++|++.+.||+|+||.||+|.++.+|+.||||++...             .+.+.+|+.+|+++.+||||+++++++
T Consensus        14 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~   93 (298)
T 1phk_A           14 GFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTY   93 (298)
T ss_dssp             -CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEE
T ss_pred             chhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeee
Confidence            3668999999999999999999999999999999998642             245678999999997799999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       167 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ...+.+|+||||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++..
T Consensus        94 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~  173 (298)
T 1phk_A           94 ETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQ  173 (298)
T ss_dssp             ECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEcCCCcEEEecccchhh
Confidence            99999999999999999999999888999999999999999999999999999999999999999999999999999988


Q ss_pred             ecCCCcccccCCCCcccCceecc-------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLS-------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~-------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      ...........||+.|+|||++.       ..++.++||||||+++|+|++|..||.+.+.......+......++...+
T Consensus       174 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~  253 (298)
T 1phk_A          174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW  253 (298)
T ss_dssp             CCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG
T ss_pred             cCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc
Confidence            76666666678999999999984       24788999999999999999999999999988888888888877777777


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~  361 (469)
                      ..++.++.+||.+||..||.+|||+.|+|+||||.......+
T Consensus       254 ~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~~~  295 (298)
T 1phk_A          254 DDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV  295 (298)
T ss_dssp             GGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC----
T ss_pred             cccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccchhh
Confidence            889999999999999999999999999999999977654433

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=6.4e-52  Score=413.06  Aligned_cols=256  Identities=32%  Similarity=0.565  Sum_probs=212.0

Q ss_pred             ccCCeeee---eeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          101 IEDDHTKV---EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       101 ~~~~y~~~---~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      +.++|++.   +.||+|+||.||+|.++.+|+.||||++.+. ...+.+|+.+++.+.+||||+++++++.+.+..|+||
T Consensus         6 f~~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~   85 (325)
T 3kn6_A            6 FYQHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVM   85 (325)
T ss_dssp             HHHHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEE
T ss_pred             chhccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEE
Confidence            44567764   7899999999999999999999999999754 4678899999999988999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEEeccceeeecCC-Cc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGLAMRISNG-QT  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~DFgla~~~~~~-~~  252 (469)
                      ||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||++...... ..
T Consensus        86 e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~  165 (325)
T 3kn6_A           86 ELLNGGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQP  165 (325)
T ss_dssp             CCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----
T ss_pred             EccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCc
Confidence            9999999999999989999999999999999999999999999999999999998766   8999999999865433 33


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-------SLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-------~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.       ...+++..+......++...|..+++
T Consensus       166 ~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  245 (325)
T 3kn6_A          166 LKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFSFEGEAWKNVSQ  245 (325)
T ss_dssp             ------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCCCCSHHHHTSCH
T ss_pred             ccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCCCCcccccCCCH
Confidence            456789999999999976 4899999999999999999999999764       34577888888888888778888999


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++++||.+||..||.+|||+.|+|+||||...
T Consensus       246 ~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          246 EAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999999999654

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=2.3e-52  Score=418.41  Aligned_cols=250  Identities=33%  Similarity=0.613  Sum_probs=222.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|.+++.||+|+||.||+|.+..+|+.||||++.+.       ...+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus         6 ~~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   84 (336)
T 3h4j_B            6 RHIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLR-HPHIIKLYDVITTPTDI   84 (336)
T ss_dssp             SEETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             cccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCC-CCCCCeEEEEEEeCCEE
Confidence            3457899999999999999999999999999999998542       356889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||+ +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        85 ~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~  163 (336)
T 3h4j_B           85 VMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF  163 (336)
T ss_dssp             EEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT
T ss_pred             EEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc
Confidence            9999999 789999999999999999999999999999999999999999999999999999999999999987766666


Q ss_pred             ccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.........+......++    ..+++++.+||
T Consensus       164 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  239 (336)
T 3h4j_B          164 LKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMP----DFLSPGAQSLI  239 (336)
T ss_dssp             TCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCSSCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCCCCCc----ccCCHHHHHHH
Confidence            6778999999999999875 3 7899999999999999999999987655444433333333322    46899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .+||..||.+|||+.|+++||||..
T Consensus       240 ~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          240 RRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             HTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             HHHcCCChhHCcCHHHHHhChhhcc
Confidence            9999999999999999999999953

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=4.7e-51  Score=407.08  Aligned_cols=252  Identities=31%  Similarity=0.555  Sum_probs=220.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ..++|++++.||+|+||.||+|++.   .+|+.||+|++++.        ...+.+|+.+|+.+. ||||+++++++.+.
T Consensus        15 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~   93 (327)
T 3a62_A           15 RPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVK-HPFIVDLIYAFQTG   93 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCC-CTTBCCEEEEEECS
T ss_pred             CHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCC-CCCccceeEEEEcC
Confidence            4578999999999999999999985   68999999998653        234678999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +.+|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.....
T Consensus        94 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~  173 (327)
T 3a62_A           94 GKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIH  173 (327)
T ss_dssp             SCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC-----
T ss_pred             CEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHHHeEECCCCcEEEEeCCccccccc
Confidence            99999999999999999999889999999999999999999999999999999999999999999999999999975432


Q ss_pred             -CCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          250 -GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       250 -~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       .......+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+....+..+......++    ..++.++.
T Consensus       174 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~  249 (327)
T 3a62_A          174 DGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP----PYLTQEAR  249 (327)
T ss_dssp             -----CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC----TTSCHHHH
T ss_pred             CCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC----CCCCHHHH
Confidence             233455789999999999976 489999999999999999999999999999888888887766655    46799999


Q ss_pred             HHHHHhchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          328 DLMARMLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      +||.+||..||.+||     ++.|+|+||||....
T Consensus       250 ~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~~  284 (327)
T 3a62_A          250 DLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHIN  284 (327)
T ss_dssp             HHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSCC
T ss_pred             HHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCCC
Confidence            999999999999999     899999999996543

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=3e-51  Score=401.02  Aligned_cols=252  Identities=29%  Similarity=0.526  Sum_probs=214.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||.||+|.++.+|+.||||++...      ...+.+|+.+++++. ||||+++++++.+++.+|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   80 (292)
T 3o0g_A            2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             CCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCCcCCcchHHHHHHHHHhcCC-CCCEeeEEeEEEeCCEEEEEE
Confidence            5899999999999999999999999999999998642      256789999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||+.+ ++.+.+.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  159 (292)
T 3o0g_A           81 EFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYS  159 (292)
T ss_dssp             ECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCSCCC
T ss_pred             ecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcccccc
Confidence            99986 55555544 678999999999999999999999999999999999999999999999999999876533 3345


Q ss_pred             ccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHcCcCCCCC---------------
Q 012170          255 GLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHS---------------  316 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~P-f~~~~~~~~~~~i~~~~~~~~~---------------  316 (469)
                      ...||+.|+|||++.+.  ++.++|||||||++|+|++|..| |.+.+....+..+.........               
T Consensus       160 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~  239 (292)
T 3o0g_A          160 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPY  239 (292)
T ss_dssp             SCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCC
T ss_pred             CCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhccccccccc
Confidence            56899999999999663  79999999999999999987766 6677777766666432111111               


Q ss_pred             ----------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          317 ----------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       317 ----------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                .....++.++++||.+||+.||.+|||++|+|+||||..+
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          240 PMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             CCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             ccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHHHHhcCcccccC
Confidence                      1123578999999999999999999999999999999654

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.5e-51  Score=423.22  Aligned_cols=259  Identities=31%  Similarity=0.520  Sum_probs=227.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|++++.||+|+||.||+|+++.+|+.||||++++.       ...+.+|+.+|..+. ||||++++++|++.+.+
T Consensus        58 ~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~-hp~Iv~l~~~~~~~~~~  136 (412)
T 2vd5_A           58 LQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGD-RRWITQLHFAFQDENYL  136 (412)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSC-TTTBCCEEEEEECSSEE
T ss_pred             CChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeeCCEE
Confidence            3457999999999999999999999999999999999642       234788999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+|||||+||+|.+++.+.+ .+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||++.......
T Consensus       137 ~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~  216 (412)
T 2vd5_A          137 YLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADG  216 (412)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS
T ss_pred             EEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCC
Confidence            99999999999999998765 79999999999999999999999999999999999999999999999999998765443


Q ss_pred             c--ccccCCCCcccCceecc--------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc--CCCCCCcc
Q 012170          252 T--LSGLAGSPAYVAPEVLS--------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK--LDFHSGVW  319 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~--------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~--~~~~~~~~  319 (469)
                      .  ....+||+.|+|||++.        +.|+.++|||||||++|+|++|.+||.+.+..+.+..|....  ..++. ..
T Consensus       217 ~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~  295 (412)
T 2vd5_A          217 TVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLPL-VD  295 (412)
T ss_dssp             CEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC----
T ss_pred             ccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCCc-cc
Confidence            3  23468999999999986        348999999999999999999999999999988888887643  22221 23


Q ss_pred             cCCCHHHHHHHHHhchhhhcCC---CCHHHHHcCCCccccccccc
Q 012170          320 ETVSKPARDLMARMLTRDVSAR---ITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~R---psa~elL~hp~~~~~~~~~~  361 (469)
                      ..+|+++++||.+||. +|.+|   ++++|+++||||....+..+
T Consensus       296 ~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~i~w~~l  339 (412)
T 2vd5_A          296 EGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFGLDWDGL  339 (412)
T ss_dssp             -CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTTCCSTTS
T ss_pred             cCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCCCCHHHH
Confidence            5689999999999999 99998   59999999999977666544

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.8e-51  Score=406.58  Aligned_cols=259  Identities=34%  Similarity=0.622  Sum_probs=223.1

Q ss_pred             ccccCCeeee-eeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           99 NKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..+.+.|++. +.||+|+||.||+|.+..+|+.||||++...    ...+.+|+.+|.++.+||||+++++++.+.+.+|
T Consensus         8 ~~~~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~   87 (316)
T 2ac3_A            8 GRFEDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY   87 (316)
T ss_dssp             CCTTTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCSSCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred             cccceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCcchhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence            3467889995 7899999999999999999999999999643    4678899999999766999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgla~~~~~~  250 (469)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++......
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~  167 (316)
T 2ac3_A           88 LVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLN  167 (316)
T ss_dssp             EEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-----
T ss_pred             EEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccC
Confidence            99999999999999998899999999999999999999999999999999999999998776   999999998754321


Q ss_pred             --------CcccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCC---------------HH
Q 012170          251 --------QTLSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDS---------------LE  301 (469)
Q Consensus       251 --------~~~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~---------------~~  301 (469)
                              ......+||+.|+|||++.+      .++.++|||||||++|+|++|..||.+..               ..
T Consensus       168 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  247 (316)
T 2ac3_A          168 GDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQN  247 (316)
T ss_dssp             --------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHH
T ss_pred             CccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHH
Confidence                    11234569999999999863      48899999999999999999999998754               34


Q ss_pred             HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       302 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+...+......++...+..++.++++||.+||..||.+|||+.|+|+||||....
T Consensus       248 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~~  303 (316)
T 2ac3_A          248 MLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGCA  303 (316)
T ss_dssp             HHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC---
T ss_pred             HHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCCC
Confidence            56777777777777666678999999999999999999999999999999996543

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=4e-51  Score=413.90  Aligned_cols=255  Identities=34%  Similarity=0.632  Sum_probs=234.6

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------------hHHHHHHHHHHHHhhCCCCeeEEEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------------EETVHREVEIMQHLSGHTGVVTLHSVYE  167 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------~~~~~~E~~il~~l~~hpnIv~l~~~~~  167 (469)
                      .+.++|.+.+.||.|+||.||+|.++.+|+.||||++...            .+.+.+|+.+++.+.+||||+++++++.
T Consensus        91 ~~~~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~  170 (365)
T 2y7j_A           91 EFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYE  170 (365)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             hhhhhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEe
Confidence            3557899999999999999999999999999999998643            2457789999999966999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      ..+..|+||||++|++|.+++.....+++..+..++.||+.||.|||+.||+||||||+|||++.+|.++|+|||++...
T Consensus       171 ~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~  250 (365)
T 2y7j_A          171 SSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHL  250 (365)
T ss_dssp             BSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             eCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEEecCccccc
Confidence            99999999999999999999988889999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCcccccCCCCcccCceeccC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .........+||+.|+|||++.+       .++.++|||||||++|+|++|..||.+.+....+..+......+....|.
T Consensus       251 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  330 (365)
T 2y7j_A          251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEWD  330 (365)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHHS
T ss_pred             CCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            76666667889999999999853       37889999999999999999999999988888888888887777766778


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      .++..+.+||.+||..||.+|||+.|+|+||||.
T Consensus       331 ~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          331 DRSSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             SSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            8999999999999999999999999999999995

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=4e-51  Score=399.13  Aligned_cols=254  Identities=36%  Similarity=0.616  Sum_probs=221.2

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +.+.++|.+.+.||+|+||.||+|.+..+|..||+|++...     .+.+.+|+++|+.+. ||||+++++++.+.+.+|
T Consensus        18 g~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~   96 (285)
T 3is5_A           18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSLD-HPNIIKIFEVFEDYHNMY   96 (285)
T ss_dssp             SCHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCCSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             CChhhheeecceeccCCCeEEEEEEEccCCceEEEEEeeccccchhHHHHHHHHHHHHhCC-CchHHhHHHheecCCeEE
Confidence            34678999999999999999999999999999999998643     367889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceee
Q 012170          174 LVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMR  246 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~  246 (469)
                      +||||+++|+|.+.+...    ..+++..+..++.||+.||.|||+.||+||||||+|||+   +.++.+||+|||++..
T Consensus        97 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~  176 (285)
T 3is5_A           97 IVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL  176 (285)
T ss_dssp             EEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC
T ss_pred             EEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeeccee
Confidence            999999999999988543    679999999999999999999999999999999999999   4567899999999987


Q ss_pred             ecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ...........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+.......+......+... ...+++++
T Consensus       177 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  255 (285)
T 3is5_A          177 FKSDEHSTNAAGTALYMAPEVFKRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-CRPLTPQA  255 (285)
T ss_dssp             ----------CTTGGGCCHHHHTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC---CCCCHHH
T ss_pred             cCCcccCcCcccccCcCChHHhccCCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-cCcCCHHH
Confidence            66555556678999999999998889999999999999999999999999998888877776655544332 23579999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      .+||.+||..||.+|||+.|+|+||||.
T Consensus       256 ~~li~~~L~~dP~~Rps~~e~l~hp~f~  283 (285)
T 3is5_A          256 VDLLKQMLTKDPERRPSAAQVLHHEWFK  283 (285)
T ss_dssp             HHHHHHHTCSCTTTSCCHHHHHTSGGGG
T ss_pred             HHHHHHHccCChhhCcCHHHHhcCHHhh
Confidence            9999999999999999999999999995

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=2.1e-51  Score=426.82  Aligned_cols=251  Identities=31%  Similarity=0.553  Sum_probs=220.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++.+.       ...+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus       146 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~l~~~~~~~~~~~  224 (446)
T 4ejn_A          146 TMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSR-HPFLTALKYSFQTHDRLC  224 (446)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCS-CTTSCCEEEEEEETTEEE
T ss_pred             ChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCC-CCeEeeEEEEEeeCCEEE
Confidence            457899999999999999999999999999999998642       245678999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQ  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~  251 (469)
                      +||||++||+|.+++...+.+++..+..++.||+.||.|||+ .||+||||||+||||+.+|.+||+|||++.... ...
T Consensus       225 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~  304 (446)
T 4ejn_A          225 FVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA  304 (446)
T ss_dssp             EEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---
T ss_pred             EEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCCc
Confidence            999999999999999999999999999999999999999998 999999999999999999999999999997532 333


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+...+...+......++    ..+++++.+||
T Consensus       305 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~~~~~~~li  380 (446)
T 4ejn_A          305 TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFP----RTLGPEAKSLL  380 (446)
T ss_dssp             --CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHH
T ss_pred             ccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHH
Confidence            4556789999999999966 599999999999999999999999999999999999888776665    46899999999


Q ss_pred             HHhchhhhcCCC-----CHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARI-----TADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rp-----sa~elL~hp~~~~~  356 (469)
                      .+||..||.+||     +++|+|+||||...
T Consensus       381 ~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          381 SGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             HHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999999999     99999999999654

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=6.9e-51  Score=443.04  Aligned_cols=254  Identities=28%  Similarity=0.518  Sum_probs=232.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|+++.+++.||||++++.       .+.+..|..+|..+..||||+.++++|++.+.+|
T Consensus       339 ~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~  418 (674)
T 3pfq_A          339 KLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLY  418 (674)
T ss_dssp             -CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEE
T ss_pred             cccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEE
Confidence            357899999999999999999999999999999998642       3567789999999877999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec-CCCc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~-~~~~  252 (469)
                      |||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.+|++||+|||++.... ....
T Consensus       419 lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~~  498 (674)
T 3pfq_A          419 FVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVT  498 (674)
T ss_dssp             EEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTCC
T ss_pred             EEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCCcc
Confidence            999999999999999998999999999999999999999999999999999999999999999999999998643 3344


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|....+.++    ..+++++++||.
T Consensus       499 ~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~  574 (674)
T 3pfq_A          499 TKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYP----KSMSKEAVAICK  574 (674)
T ss_dssp             BCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHSSCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHHhCCCCCC----ccCCHHHHHHHH
Confidence            567899999999999976 599999999999999999999999999999999999998887776    468999999999


Q ss_pred             HhchhhhcCCCCH-----HHHHcCCCcccccc
Q 012170          332 RMLTRDVSARITA-----DEVLRHPWILFYTE  358 (469)
Q Consensus       332 ~~L~~dP~~Rpsa-----~elL~hp~~~~~~~  358 (469)
                      +||++||.+||++     +||++||||....+
T Consensus       575 ~lL~~dP~~R~~~~~~~~~ei~~h~ff~~i~w  606 (674)
T 3pfq_A          575 GLMTKHPGKRLGCGPEGERDIKEHAFFRYIDW  606 (674)
T ss_dssp             HHSCSSSTTCTTCSTTHHHHHHSSGGGSSCCH
T ss_pred             HHccCCHHHCCCCCCCcHHHHhcCccccCCCH
Confidence            9999999999997     99999999965443

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3.8e-51  Score=407.43  Aligned_cols=262  Identities=29%  Similarity=0.555  Sum_probs=232.6

Q ss_pred             cccccCCeeee-eeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           98 KNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        98 ~~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ...+.++|.+. +.||+|+||.||+|.+..+|+.||+|++...      ...+.+|+.+++.+..||||+++++++.+.+
T Consensus        23 ~~~~~~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~  102 (327)
T 3lm5_A           23 MENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTS  102 (327)
T ss_dssp             HHHHHHHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEETTEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSS
T ss_pred             HHhhhhEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCC
Confidence            44577889998 8999999999999999999999999998642      3578899999999987899999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEecccee
Q 012170          171 CFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAM  245 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~  245 (469)
                      .+|+||||+.||+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++.
T Consensus       103 ~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~  182 (327)
T 3lm5_A          103 EIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSR  182 (327)
T ss_dssp             EEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCE
T ss_pred             eEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCcccc
Confidence            999999999999999988543  67999999999999999999999999999999999999988   7899999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ............||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......++...+..+++
T Consensus       183 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  262 (327)
T 3lm5_A          183 KIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQ  262 (327)
T ss_dssp             EC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTTTSCH
T ss_pred             ccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhcccCH
Confidence            8766655666789999999999976 589999999999999999999999999999998888888888887777788999


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      .+.+||.+||..||.+|||++++|+||||......
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~~  297 (327)
T 3lm5_A          263 LATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDFE  297 (327)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCTT
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHhCCHhhcccccc
Confidence            99999999999999999999999999999766543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-51  Score=401.53  Aligned_cols=250  Identities=32%  Similarity=0.584  Sum_probs=219.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------------------------HHHHHHHHHH
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------------------------ETVHREVEIM  150 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------------------------~~~~~E~~il  150 (469)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++....                              +.+.+|+++|
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l   90 (298)
T 2zv2_A           11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL   90 (298)
T ss_dssp             EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred             eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence            3478999999999999999999999999999999986432                              4578999999


Q ss_pred             HHhhCCCCeeEEEEEEEe--CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcE
Q 012170          151 QHLSGHTGVVTLHSVYEE--ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI  228 (469)
Q Consensus       151 ~~l~~hpnIv~l~~~~~~--~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NI  228 (469)
                      +.+. ||||+++++++.+  .+.+|+||||+++++|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+||
T Consensus        91 ~~l~-h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Ni  168 (298)
T 2zv2_A           91 KKLD-HPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVP-TLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNL  168 (298)
T ss_dssp             HTCC-CTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSS-CSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred             HhCC-CCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHE
Confidence            9996 9999999999986  67899999999999998754 456899999999999999999999999999999999999


Q ss_pred             EEccCCcEEEEeccceeeecCCC-cccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCHHHH
Q 012170          229 LLTTSGKIKLADFGLAMRISNGQ-TLSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSLEAV  303 (469)
Q Consensus       229 Ll~~~~~vkL~DFgla~~~~~~~-~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~  303 (469)
                      |++.++.+||+|||++....... ......||+.|+|||++.+.    ++.++|||||||++|+|++|..||.+......
T Consensus       169 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~  248 (298)
T 2zv2_A          169 LVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCL  248 (298)
T ss_dssp             EECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred             EECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCccHHHH
Confidence            99999999999999998765433 34556899999999999763    37789999999999999999999999888888


Q ss_pred             HHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       304 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ...+......++.  ...+++++.+||.+||..||.+|||+.|+|+||||.
T Consensus       249 ~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          249 HSKIKSQALEFPD--QPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             HHHHHHCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             HHHHhcccCCCCC--ccccCHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            8877776555443  356899999999999999999999999999999984

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=4.1e-51  Score=416.72  Aligned_cols=255  Identities=29%  Similarity=0.509  Sum_probs=209.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--e
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--C  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--~  171 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.+.      ...+.+|+.+|+.+.+||||+++++++...+  .
T Consensus         6 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~   85 (388)
T 3oz6_A            6 HVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRD   85 (388)
T ss_dssp             HHHTTEEEEEC-------CEEEEEETTTCCEEEEEEECC--CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSC
T ss_pred             cccCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEecccccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCE
Confidence            3568999999999999999999999999999999998542      2457789999999977999999999997554  7


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC--
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN--  249 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~--  249 (469)
                      +|+|||||. |+|..++.. +.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||+++....  
T Consensus        86 ~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~  163 (388)
T 3oz6_A           86 VYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIR  163 (388)
T ss_dssp             EEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCC
T ss_pred             EEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccc
Confidence            899999997 588887754 6899999999999999999999999999999999999999999999999999986532  


Q ss_pred             --------------------CCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 012170          250 --------------------GQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI  307 (469)
Q Consensus       250 --------------------~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  307 (469)
                                          .......+||++|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+....+..|
T Consensus       164 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i  243 (388)
T 3oz6_A          164 RVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERI  243 (388)
T ss_dssp             CCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence                                112345689999999999975  5899999999999999999999999999887777766


Q ss_pred             HcCcCCCCC--------------------------------------------CcccCCCHHHHHHHHHhchhhhcCCCC
Q 012170          308 KNVKLDFHS--------------------------------------------GVWETVSKPARDLMARMLTRDVSARIT  343 (469)
Q Consensus       308 ~~~~~~~~~--------------------------------------------~~~~~~s~~~~~lI~~~L~~dP~~Rps  343 (469)
                      ..... ++.                                            ..+..+++++.+||.+||+.||.+|||
T Consensus       244 ~~~~~-~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t  322 (388)
T 3oz6_A          244 IGVID-FPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRIS  322 (388)
T ss_dssp             HHHHC-CCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCC
T ss_pred             HHhcC-CCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCC
Confidence            43211 110                                            011267899999999999999999999


Q ss_pred             HHHHHcCCCccccc
Q 012170          344 ADEVLRHPWILFYT  357 (469)
Q Consensus       344 a~elL~hp~~~~~~  357 (469)
                      +.|+|+||||..+.
T Consensus       323 ~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          323 ANDALKHPFVSIFH  336 (388)
T ss_dssp             HHHHTTSTTTTTTC
T ss_pred             HHHHhCCHHHHHhc
Confidence            99999999996543

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=5.6e-51  Score=412.24  Aligned_cols=253  Identities=33%  Similarity=0.560  Sum_probs=212.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|+++.+|+.||||++...   .+.+.+|+.+++.+. ||||+++++++.+.+.+|+|||
T Consensus        18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv~e   96 (361)
T 3uc3_A           18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDENVQREIINHRSLR-HPNIVRFKEVILTPTHLAIIME   96 (361)
T ss_dssp             CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSCHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEEEE
T ss_pred             CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCccccHHHHHHHHHHHhCC-CCCCCcEEEEEeeCCEEEEEEE
Confidence            347899999999999999999999999999999999653   367889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc--EEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK--IKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~--vkL~DFgla~~~~~~~~~~~  255 (469)
                      |++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.  +||+|||++...........
T Consensus        97 ~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~~~~~  176 (361)
T 3uc3_A           97 YASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKS  176 (361)
T ss_dssp             CCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC-----------
T ss_pred             eCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCccccccccCCCCC
Confidence            9999999999988899999999999999999999999999999999999999987765  99999999976554444556


Q ss_pred             cCCCCcccCceeccC-CCCCc-cchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          256 LAGSPAYVAPEVLSG-NYSEK-VDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~-~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .+||+.|+|||++.+ .++.+ +|||||||++|+|++|..||.+..    ....+..+......++.  ...+++++.+|
T Consensus       177 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~~l  254 (361)
T 3uc3_A          177 TVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPD--DIRISPECCHL  254 (361)
T ss_dssp             ----CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCCCCT--TSCCCHHHHHH
T ss_pred             CcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCCCCC--cCCCCHHHHHH
Confidence            789999999999966 45544 899999999999999999998743    35556666665554443  34689999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||..||.+|||+.|+|+||||...
T Consensus       255 i~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          255 ISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HHHHccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999999654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-51  Score=401.29  Aligned_cols=255  Identities=29%  Similarity=0.400  Sum_probs=218.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhh--CCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLS--GHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~--~hpnIv~l~~~~~~~  169 (469)
                      +.++|++++.||+|+||.||+|++..+|+.||||++...         ...+.+|+.+++.+.  .||||+++++++...
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~   86 (308)
T 3g33_A            7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS   86 (308)
T ss_dssp             ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred             cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence            567999999999999999999999999999999998531         246788999888875  499999999999876


Q ss_pred             C-----eEEEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecc
Q 012170          170 D-----CFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG  242 (469)
Q Consensus       170 ~-----~~~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFg  242 (469)
                      .     .+++||||+. |+|.+++.....  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||
T Consensus        87 ~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg  165 (308)
T 3g33_A           87 RTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFG  165 (308)
T ss_dssp             CSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCS
T ss_pred             CCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCc
Confidence            5     5899999997 599999877654  9999999999999999999999999999999999999999999999999


Q ss_pred             ceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc---
Q 012170          243 LAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV---  318 (469)
Q Consensus       243 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---  318 (469)
                      ++............+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+.......+...   
T Consensus       166 ~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~  245 (308)
T 3g33_A          166 LARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPR  245 (308)
T ss_dssp             CTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCS
T ss_pred             cccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccc
Confidence            9987666666667789999999999965 599999999999999999999999999988887777654321111111   


Q ss_pred             --------------------ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          319 --------------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       319 --------------------~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                          ...+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          246 DVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             SCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence                                23578999999999999999999999999999999643

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=5.3e-51  Score=403.76  Aligned_cols=256  Identities=27%  Similarity=0.472  Sum_probs=214.6

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..+.++|++++.||+|+||.||+|.+. +|+.||+|++...      ...+.+|+++|+.+. ||||+++++++.+.+.+
T Consensus        17 q~l~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~   94 (311)
T 3niz_A           17 QGLMEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDAEDEGIPSTAIREISLLKELH-HPNIVSLIDVIHSERCL   94 (311)
T ss_dssp             ECSSCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC------CHHHHHHHHHHHHHHCC-CTTBCCEEEEECCSSCE
T ss_pred             cchHhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEecccccchhhHHHHHHHHHHHHcC-CCCEeeeeeEEccCCEE
Confidence            347789999999999999999999986 4899999998642      246789999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      |+||||+++ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... 
T Consensus        95 ~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~  173 (311)
T 3niz_A           95 TLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV  173 (311)
T ss_dssp             EEEEECCSE-EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC
T ss_pred             EEEEcCCCC-CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc
Confidence            999999975 777777654 45999999999999999999999999999999999999999999999999999876533 


Q ss_pred             CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC-----------
Q 012170          251 QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG-----------  317 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----------  317 (469)
                      .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+....+.+..+..........           
T Consensus       174 ~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~  253 (311)
T 3niz_A          174 RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLW  253 (311)
T ss_dssp             C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHH
T ss_pred             ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchh
Confidence            33445689999999999865  48999999999999999999999998876655555543211111100           


Q ss_pred             ---------------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          318 ---------------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       318 ---------------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                     ....+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  308 (311)
T 3niz_A          254 KQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD  308 (311)
T ss_dssp             HSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTSC
T ss_pred             hhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHHHhcCcccccCC
Confidence                           1134788999999999999999999999999999996543

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=6.7e-51  Score=395.97  Aligned_cols=255  Identities=35%  Similarity=0.650  Sum_probs=229.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      +.++|++++.||+|+||.||+|.+..+|+.||+|+++..          .+.+.+|+.+|+.+. ||||+++++++.+.+
T Consensus         3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~   81 (283)
T 3bhy_A            3 VEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIR-HPNIITLHDIFENKT   81 (283)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSS
T ss_pred             hhhhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCC-CCCeeehhheecCCC
Confidence            456899999999999999999999999999999998542          467889999999997 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccceee
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMR  246 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgla~~  246 (469)
                      .+|+||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+||+++.++    .+||+|||++..
T Consensus        82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~  161 (283)
T 3bhy_A           82 DVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHK  161 (283)
T ss_dssp             EEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEE
T ss_pred             eEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEecCCCCCCceEEEeccccee
Confidence            9999999999999999998888999999999999999999999999999999999999999877    899999999987


Q ss_pred             ecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ...........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+......++...+..++..
T Consensus       162 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (283)
T 3bhy_A          162 IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVNYDFDEEYFSNTSEL  241 (283)
T ss_dssp             CC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCCHHHHTTCCHH
T ss_pred             ccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCcchhcccCCHH
Confidence            766555566789999999999975 5899999999999999999999999999988888888887777666666788999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.+||.+||..||.+|||+.|+|+||||...
T Consensus       242 ~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~  272 (283)
T 3bhy_A          242 AKDFIRRLLVKDPKRRMTIAQSLEHSWIKAI  272 (283)
T ss_dssp             HHHHHHTTSCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             HHHHHHHHccCCHhHCcCHHHHHhCHHHHHH
Confidence            9999999999999999999999999999644

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=6.4e-51  Score=413.67  Aligned_cols=255  Identities=32%  Similarity=0.569  Sum_probs=225.9

Q ss_pred             ccCCeee--eeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTK--VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~--~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      +...|.+  .+.||+|+||.||+|.+..+|+.||+|+++..    .+.+.+|+.+|+++. ||||+++++++.+.+.+|+
T Consensus        85 ~~~~~~~~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l  163 (373)
T 2x4f_A           85 VNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVKNEISVMNQLD-HANLIQLYDAFESKNDIVL  163 (373)
T ss_dssp             GGGTEEEEEEEECC-----CEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cccceeeecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccccccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEE
Confidence            3445555  67899999999999999999999999999753    356889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE--ccCCcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL--TTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl--~~~~~vkL~DFgla~~~~~~~  251 (469)
                      ||||++||+|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||+  +.++.+||+|||++.......
T Consensus       164 v~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~  243 (373)
T 2x4f_A          164 VMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE  243 (373)
T ss_dssp             EEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC
T ss_pred             EEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc
Confidence            99999999999988664 469999999999999999999999999999999999999  567789999999998877666


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+......++...+..+++++++||
T Consensus       244 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li  323 (373)
T 2x4f_A          244 KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEFQDISEEAKEFI  323 (373)
T ss_dssp             BCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGGTTSCHHHHHHH
T ss_pred             ccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhhccCCHHHHHHH
Confidence            6666789999999999976 488999999999999999999999999999999999988887777777788999999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.|+|+||||...
T Consensus       324 ~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          324 SKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             HTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             HHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            99999999999999999999999654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.1e-51  Score=406.20  Aligned_cols=254  Identities=31%  Similarity=0.536  Sum_probs=220.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++...     .+.+.+|+.+++.+. ||||+++++++.+++..|+
T Consensus         4 ~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l   82 (323)
T 3tki_A            4 PFVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYL   82 (323)
T ss_dssp             TTTTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEE
T ss_pred             cHhhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccccchHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeEEE
Confidence            3668999999999999999999999999999999998543     256889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---  251 (469)
                      |||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   
T Consensus        83 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~  162 (323)
T 3tki_A           83 FLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER  162 (323)
T ss_dssp             EEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEEC
T ss_pred             EEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCccc
Confidence            99999999999999888889999999999999999999999999999999999999999999999999997654322   


Q ss_pred             cccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      .....+||+.|+|||++.+.  ++.++|||||||++|+|++|..||.+.... ..+..+......  ...+..++.++.+
T Consensus       163 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~  240 (323)
T 3tki_A          163 LLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTY--LNPWKKIDSAPLA  240 (323)
T ss_dssp             CBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHHHTTCTT--STTGGGSCHHHHH
T ss_pred             ccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhccccc--CCccccCCHHHHH
Confidence            23457899999999999764  477899999999999999999999875543 223333333222  2335678999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+||..||.+|||+.|+|+||||...
T Consensus       241 li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          241 LLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhccc
Confidence            9999999999999999999999999654

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=2.6e-50  Score=428.05  Aligned_cols=254  Identities=34%  Similarity=0.588  Sum_probs=227.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|.+++.||+|+||.||+|+++.+|+.||||++.+       ....+.+|+.+|+.+. ||||+++++++++.+.+
T Consensus       181 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l  259 (576)
T 2acx_A          181 VTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVN-SRFVVSLAYAYETKDAL  259 (576)
T ss_dssp             CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             ccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcC-CCCEeeEEEEEeeCCEE
Confidence            445789999999999999999999999999999999854       2356789999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      |+||||++||+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus       260 ~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~  339 (576)
T 2acx_A          260 CLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEG  339 (576)
T ss_dssp             EEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTT
T ss_pred             EEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccC
Confidence            999999999999999977554  999999999999999999999999999999999999999999999999999887766


Q ss_pred             CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.    ....+...+......++    ..++++
T Consensus       340 ~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~i~~~i~~~~~~~p----~~~s~~  415 (576)
T 2acx_A          340 QTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYS----ERFSPQ  415 (576)
T ss_dssp             CCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHHHHHHHHHCCCCCC----TTSCHH
T ss_pred             ccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHHHHHHhhcccccCC----ccCCHH
Confidence            66667799999999999977 4899999999999999999999999875    34666677766655554    568999


Q ss_pred             HHHHHHHhchhhhcCCC-----CHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSARI-----TADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~~  358 (469)
                      +++||.+||..||.+||     ++.||++||||....+
T Consensus       416 ~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~i~w  453 (576)
T 2acx_A          416 ARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKKLNF  453 (576)
T ss_dssp             HHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTTCCH
T ss_pred             HHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhccCCH
Confidence            99999999999999999     8999999999965443

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.1e-50  Score=402.30  Aligned_cols=255  Identities=27%  Similarity=0.466  Sum_probs=206.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++|++++.||+|+||.||+|.++.+|+.||+|+++..     ...+.+|+.+|+.+. ||||+++++++.+++.+|+||
T Consensus         4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~   82 (317)
T 2pmi_A            4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGTPSTAIREISLMKELK-HENIVRLYDVIHTENKLTLVF   82 (317)
T ss_dssp             ---------------CEEEEEECSSSCCEEEEEEEECCSTTCSCHHHHHHHHHHTTCC-BTTBCCEEEEECCTTEEEEEE
T ss_pred             ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeecccccccHHHHHHHHHHHHhcC-CCCcceEEEEEEECCeEEEEE
Confidence            36899999999999999999999999999999998642     256889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          177 ELCSGGRLIDQMVEV------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       177 E~~~gg~L~~~l~~~------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ||++ |+|.+++...      ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        83 e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~  161 (317)
T 2pmi_A           83 EFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIP  161 (317)
T ss_dssp             ECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSC
T ss_pred             EecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCC
Confidence            9998 5899888664      35899999999999999999999999999999999999999999999999999876433


Q ss_pred             -CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-----------
Q 012170          251 -QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-----------  316 (469)
Q Consensus       251 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  316 (469)
                       .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+.........           
T Consensus       162 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  241 (317)
T 2pmi_A          162 VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPK  241 (317)
T ss_dssp             CCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTT
T ss_pred             cccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhh
Confidence             23445689999999999975  4899999999999999999999999998887777766432111000           


Q ss_pred             -------------------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          317 -------------------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       317 -------------------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                                         .....++.++.+||.+||+.||.+|||+.|+|+||||..+..
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          242 YNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             cccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence                               011257899999999999999999999999999999976543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=6.6e-51  Score=425.70  Aligned_cols=252  Identities=33%  Similarity=0.576  Sum_probs=231.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|.+++.||+|+||.||+|.+..+|+.||||++.+.       ...+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus        13 ~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~l~~~~~~~~~~   91 (476)
T 2y94_A           13 VKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFR-HPHIIKLYQVISTPSDI   91 (476)
T ss_dssp             CEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEE
T ss_pred             ceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEE
Confidence            3457899999999999999999999999999999999642       246889999999997 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        92 ~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~  171 (476)
T 2y94_A           92 FMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF  171 (476)
T ss_dssp             EEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC
T ss_pred             EEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEEecCCCeEEEeccchhhcccccc
Confidence            99999999999999998888999999999999999999999999999999999999999999999999999988776666


Q ss_pred             ccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ....+||+.|+|||++.+. + +.++|||||||++|+|++|..||.+.+...++..+.......+    ..+++++.+||
T Consensus       172 ~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~Li  247 (476)
T 2y94_A          172 LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTP----QYLNPSVISLL  247 (476)
T ss_dssp             BCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHHHTTCCCCC----TTCCHHHHHHH
T ss_pred             ccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCcCCC----ccCCHHHHHHH
Confidence            6778999999999999875 4 6899999999999999999999999888888888887765544    45799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.|+++||||...
T Consensus       248 ~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          248 KHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             HHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             HHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            99999999999999999999999643

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=3.6e-51  Score=409.44  Aligned_cols=262  Identities=37%  Similarity=0.635  Sum_probs=228.5

Q ss_pred             CCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEE
Q 012170           96 GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVY  166 (469)
Q Consensus        96 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~  166 (469)
                      +....+.++|++++.||+|+||.||+|.+..++..||+|++.+.         .+.+.+|+.+|+.++ ||||+++++++
T Consensus        19 ~~~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~   97 (345)
T 3hko_A           19 GSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLH-HPNIARLYEVY   97 (345)
T ss_dssp             BCHHHHHHHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCC-CTTBCCEEEEE
T ss_pred             chhhhhhhheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCC-CCCcceeehhh
Confidence            33445778999999999999999999999999999999998532         256889999999997 99999999999


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHH----------------------------------------hCCCCHHHHHHHHHHH
Q 012170          167 EEADCFHLVMELCSGGRLIDQMVE----------------------------------------VGQYSEQRAANIFKDV  206 (469)
Q Consensus       167 ~~~~~~~lV~E~~~gg~L~~~l~~----------------------------------------~~~l~~~~~~~i~~qi  206 (469)
                      .+.+.+|+|||||+||+|.+++..                                        ...+++..++.++.||
T Consensus        98 ~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi  177 (345)
T 3hko_A           98 EDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQI  177 (345)
T ss_dssp             ECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHH
T ss_pred             ccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHH
Confidence            999999999999999999988741                                        1123678899999999


Q ss_pred             HHHHHHHHhcCeEeccCCCCcEEEccCC--cEEEEeccceeeecCCC-----cccccCCCCcccCceeccC---CCCCcc
Q 012170          207 MWVIKYCHDMGVVHRDIKPENILLTTSG--KIKLADFGLAMRISNGQ-----TLSGLAGSPAYVAPEVLSG---NYSEKV  276 (469)
Q Consensus       207 l~aL~yLH~~givHrDlkp~NILl~~~~--~vkL~DFgla~~~~~~~-----~~~~~~gt~~y~aPE~l~~---~~~~~~  276 (469)
                      +.||.|||++||+||||||+|||++.++  .+||+|||++..+....     ......||+.|+|||++.+   .++.++
T Consensus       178 ~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  257 (345)
T 3hko_A          178 FSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC  257 (345)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHH
T ss_pred             HHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHH
Confidence            9999999999999999999999998776  89999999998654321     2345679999999999864   588999


Q ss_pred             chHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          277 DIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       277 DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |||||||++|+|++|..||.+.+..+....+......+....+..+++++.+||.+||..||.+|||+.++|+||||..+
T Consensus       258 DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~  337 (345)
T 3hko_A          258 DAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQF  337 (345)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccC
Confidence            99999999999999999999999988888888888777777777899999999999999999999999999999999765


Q ss_pred             cc
Q 012170          357 TE  358 (469)
Q Consensus       357 ~~  358 (469)
                      .+
T Consensus       338 ~~  339 (345)
T 3hko_A          338 SD  339 (345)
T ss_dssp             SS
T ss_pred             hH
Confidence            43

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.1e-50  Score=404.40  Aligned_cols=255  Identities=27%  Similarity=0.444  Sum_probs=212.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||+++...      ..+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus        32 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  110 (329)
T 3gbz_A           32 SIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHEEEGVPGTAIREVSLLKELQ-HRNIIELKSVIHHNHRLHL  110 (329)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC--------CHHHHHHGGGCC-CTTBCCEEEEEEETTEEEE
T ss_pred             chhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEcccccccccchhHHHHHHHHHHcC-CCCcceEEEEEecCCEEEE
Confidence            5578999999999999999999999999999999996432      34678999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-----cCCcEEEEeccceeeecC
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-----TSGKIKLADFGLAMRISN  249 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-----~~~~vkL~DFgla~~~~~  249 (469)
                      ||||+.| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++     .++.+||+|||++.....
T Consensus       111 v~e~~~~-~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~  189 (329)
T 3gbz_A          111 IFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGI  189 (329)
T ss_dssp             EEECCSE-EHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-
T ss_pred             EEecCCC-CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCC
Confidence            9999975 9999999888999999999999999999999999999999999999995     445699999999976543


Q ss_pred             C-CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc-------
Q 012170          250 G-QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW-------  319 (469)
Q Consensus       250 ~-~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~-------  319 (469)
                      . ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+...........|       
T Consensus       190 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (329)
T 3gbz_A          190 PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALP  269 (329)
T ss_dssp             ----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGST
T ss_pred             cccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhh
Confidence            2 23445678999999999976  3899999999999999999999999998887777666432111111111       


Q ss_pred             -------------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          320 -------------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       320 -------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                         ..+++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  326 (329)
T 3gbz_A          270 DWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHND  326 (329)
T ss_dssp             TCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSSC
T ss_pred             hhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCCHHHHhCCcccCCCC
Confidence                               12789999999999999999999999999999996543

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=1.6e-50  Score=395.30  Aligned_cols=250  Identities=30%  Similarity=0.480  Sum_probs=211.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||.||+|.+ .+|+.||+|++...      ...+.+|+.+++.+. ||||+++++++.+.+.+|+||
T Consensus         2 ~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~   79 (288)
T 1ob3_A            2 EKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVF   79 (288)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEE
T ss_pred             ccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEeccccccccchhHHHHHHHHHhcC-CCCEeeeeeEEccCCeEEEEE
Confidence            5799999999999999999998 67999999998542      256789999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||+.+ +|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++...... ....
T Consensus        80 e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  158 (288)
T 1ob3_A           80 EHLDQ-DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYT  158 (288)
T ss_dssp             ECCSE-EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC------
T ss_pred             EecCC-CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccccccc
Confidence            99975 888888654 67999999999999999999999999999999999999999999999999999765432 2334


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC-----------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH-----------------  315 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------  315 (469)
                      ...||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........                 
T Consensus       159 ~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  238 (288)
T 1ob3_A          159 HEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNF  238 (288)
T ss_dssp             ---CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTC
T ss_pred             cccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhccccccccc
Confidence            5679999999999965  489999999999999999999999999887776665543110000                 


Q ss_pred             ----C----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          316 ----S----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       316 ----~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                          .    .....+++++.+||.+||..||.+|||+.|+|+||||..
T Consensus       239 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          239 TVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             ccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence                0    112357999999999999999999999999999999953

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=396.32  Aligned_cols=255  Identities=28%  Similarity=0.493  Sum_probs=215.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+++++. ||||+++++++.+.+.+++|
T Consensus         2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   80 (311)
T 4agu_A            2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESEDDPVIKKIALREIRMLKQLK-HPNLVNLLEVFRRKRRLHLV   80 (311)
T ss_dssp             -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCCC-HHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccccchHHHHHHHHHHHHHHhCC-CCCccchhheeecCCeEEEE
Confidence            47899999999999999999999999999999998543      245678999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      |||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ....
T Consensus        81 ~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  160 (311)
T 4agu_A           81 FEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYD  160 (311)
T ss_dssp             EECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             EEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccccC
Confidence            999999999998887888999999999999999999999999999999999999999999999999999876533 2345


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------------------  313 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------  313 (469)
                      ...||+.|+|||++.+  .++.++||||||+++|+|++|.+||.+.+..+....+......                   
T Consensus       161 ~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (311)
T 4agu_A          161 DEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVK  240 (311)
T ss_dssp             -----GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCC
T ss_pred             CCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCc
Confidence            5689999999999965  4899999999999999999999999998877766655432110                   


Q ss_pred             CCC--------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          314 FHS--------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       314 ~~~--------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+.        ..+..++.++.+||.+||..||.+|||++|+|+||||....
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  292 (311)
T 4agu_A          241 IPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIR  292 (311)
T ss_dssp             CCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             CCCccccchhhhhcccccHHHHHHHHHHccCChhhcCCHHHHhcChHHHhcc
Confidence            000        01246899999999999999999999999999999996543

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.2e-50  Score=423.09  Aligned_cols=253  Identities=27%  Similarity=0.461  Sum_probs=209.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++.+.      ...+.+|+.+|+.+. ||||+++++++...    
T Consensus        59 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~~  137 (464)
T 3ttj_A           59 TVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLE  137 (464)
T ss_dssp             EEETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTT
T ss_pred             eecCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccccChHHHHHHHHHHHHHHhCC-CCCCCcEEEEEccCCccc
Confidence            3568999999999999999999999999999999999642      246779999999996 99999999999654    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+||||+.++ |.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       138 ~~~~~~lv~E~~~~~-l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~  214 (464)
T 3ttj_A          138 EFQDVYLVMELMDAN-LCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  214 (464)
T ss_dssp             TCCEEEEEEECCSEE-HHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCCC---
T ss_pred             cCCeEEEEEeCCCCC-HHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeec
Confidence              4679999999764 655553  45999999999999999999999999999999999999999999999999999887


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF------------  314 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~------------  314 (469)
                      .........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|.......            
T Consensus       215 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~  294 (464)
T 3ttj_A          215 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTV  294 (464)
T ss_dssp             --CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHH
T ss_pred             CCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhh
Confidence            66666677899999999999977 59999999999999999999999999988777776664321110            


Q ss_pred             ----------CCCcc----------------cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 ----------HSGVW----------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 ----------~~~~~----------------~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                ....+                ...++++++||.+||..||.+|||++|+|+||||..+
T Consensus       295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          295 RNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             hhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence                      00000                0015679999999999999999999999999999754

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=3.4e-50  Score=409.96  Aligned_cols=256  Identities=22%  Similarity=0.319  Sum_probs=213.8

Q ss_pred             cCCeeeeeeeecc--CCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHG--KFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G--~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|++++.||+|  +||.||+|+++.+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++.+.+.+|
T Consensus        24 ~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  102 (389)
T 3gni_B           24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLFN-HPNIVPYRATFIADNELW  102 (389)
T ss_dssp             GGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEE
T ss_pred             CCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEecccccChHHHHHHHHHHHHHHhCC-CCCCCcEeEEEEECCEEE
Confidence            3689999999999  9999999999999999999999643      245778999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          174 LVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|||||++|+|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       103 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~  182 (389)
T 3gni_B          103 VVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHG  182 (389)
T ss_dssp             EEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETT
T ss_pred             EEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeecccc
Confidence            999999999999999776  679999999999999999999999999999999999999999999999999986543221


Q ss_pred             --------cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-------
Q 012170          252 --------TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-------  313 (469)
Q Consensus       252 --------~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-------  313 (469)
                              .....+||+.|+|||++.+   .|+.++|||||||++|+|++|.+||.+.+....+..+......       
T Consensus       183 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  262 (389)
T 3gni_B          183 QRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTST  262 (389)
T ss_dssp             EECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCSTTHHHHC-------------
T ss_pred             ccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccc
Confidence                    1223479999999999976   4899999999999999999999999876544433332211110       


Q ss_pred             -----------------------------------CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          314 -----------------------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       314 -----------------------------------~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                                                         .....+..+++++.+||.+||+.||.+|||+.|+|+||||.....
T Consensus       263 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          263 IPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             -------------------------------------------CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             cccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence                                               011133567999999999999999999999999999999976543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=4.9e-50  Score=389.62  Aligned_cols=249  Identities=37%  Similarity=0.660  Sum_probs=223.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|.+..++..||+|++...       ...+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   85 (279)
T 3fdn_A            7 ALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVY   85 (279)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEE
T ss_pred             ecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCC-CCCCcchhheEecCCEEE
Confidence            457899999999999999999999999999999998542       356889999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... ..
T Consensus        86 lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~-~~  164 (279)
T 3fdn_A           86 LILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RR  164 (279)
T ss_dssp             EEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC------
T ss_pred             EEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc-cc
Confidence            99999999999999998899999999999999999999999999999999999999999999999999998654332 23


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+.......+......++    ..++..+.+||.+
T Consensus       165 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~  240 (279)
T 3fdn_A          165 TDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISR  240 (279)
T ss_dssp             ---CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHHHH
T ss_pred             cccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHHhCCCCCC----CcCCHHHHHHHHH
Confidence            456899999999999774 78999999999999999999999999999988888887766655    4579999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCccc
Q 012170          333 MLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||..||.+|||+.|+|+||||..
T Consensus       241 ~l~~~p~~Rps~~e~l~h~~~~~  263 (279)
T 3fdn_A          241 LLKHNPSQRPMLREVLEHPWITA  263 (279)
T ss_dssp             HCCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HhccChhhCCCHHHHhhCccccC
Confidence            99999999999999999999954

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=9.7e-51  Score=422.99  Aligned_cols=257  Identities=28%  Similarity=0.420  Sum_probs=199.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-----  168 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-----  168 (469)
                      .+.++|++++.||+|+||.||+|+++.+|+.||||++.+.      ...+.+|+.+|+.+. ||||+++++++..     
T Consensus        50 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~l~~~~~~~~~~~  128 (458)
T 3rp9_A           50 QIPDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRVFEDLIDCKRILREIAILNRLN-HDHVVKVLDIVIPKDVEK  128 (458)
T ss_dssp             CSCTTEEECCC-------CEEEEEECC--CEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCTTT
T ss_pred             ccCCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechhhcCHHHHHHHHHHHHHHHhCC-CCCCCceEEEEecCCccc
Confidence            4668999999999999999999999999999999998642      246789999999996 9999999999843     


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      .+.+|+||||+ +|+|.+++...+.+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...
T Consensus       129 ~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~  207 (458)
T 3rp9_A          129 FDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVD  207 (458)
T ss_dssp             CCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTT
T ss_pred             CceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhEEECCCCCEeecccccchhcc
Confidence            35799999998 56999999888889999999999999999999999999999999999999999999999999997654


Q ss_pred             CC----------------------------CcccccCCCCcccCceecc-C-CCCCccchHHHHHHHHHHHh--------
Q 012170          249 NG----------------------------QTLSGLAGSPAYVAPEVLS-G-NYSEKVDIWSAGVLLHALLV--------  290 (469)
Q Consensus       249 ~~----------------------------~~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~ellt--------  290 (469)
                      ..                            ......+||++|+|||++. + .|+.++|||||||++|+|++        
T Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~  287 (458)
T 3rp9_A          208 YPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAY  287 (458)
T ss_dssp             SCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSS
T ss_pred             CccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccc
Confidence            22                            1234568999999999863 3 59999999999999999998        


Q ss_pred             ---CCCCCCCCCH--------------------HHHHHHHHcCc---------------------------CCCCCCccc
Q 012170          291 ---AALPFKGDSL--------------------EAVFDAIKNVK---------------------------LDFHSGVWE  320 (469)
Q Consensus       291 ---G~~Pf~~~~~--------------------~~~~~~i~~~~---------------------------~~~~~~~~~  320 (469)
                         |.++|.+.+.                    ...+..|....                           .......+.
T Consensus       288 ~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  367 (458)
T 3rp9_A          288 HADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFP  367 (458)
T ss_dssp             GGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGST
T ss_pred             cccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCC
Confidence               7888877542                    12222221100                           000012235


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .+++++.+||.+||..||.+|||++|+|+||||.....
T Consensus       368 ~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~~  405 (458)
T 3rp9_A          368 ASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVRI  405 (458)
T ss_dssp             TSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTCC
T ss_pred             CCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcCC
Confidence            67999999999999999999999999999999976543

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=4e-50  Score=395.28  Aligned_cols=255  Identities=37%  Similarity=0.710  Sum_probs=232.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+.++|.+++.||+|+||.||+|.+..+|+.||+|+++..    ...+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   84 (304)
T 2jam_A            6 NIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIK-HENIVTLEDIYESTTHYYLV   84 (304)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC------HHHHHHHHHHHCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             chhccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccccchHHHHHHHHHHHhCC-CCCeeehhhhcccCCEEEEE
Confidence            4678999999999999999999999999999999999653    346889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeecCCCc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.++|+|||++..... ..
T Consensus        85 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~-~~  163 (304)
T 2jam_A           85 MQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN-GI  163 (304)
T ss_dssp             ECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCC-BT
T ss_pred             EEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCC-Cc
Confidence            9999999999999888999999999999999999999999999999999999999   7788999999999865432 23


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.........+......++...+..++.++.+||.
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~  243 (304)
T 2jam_A          164 MSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFWDDISESAKDFIC  243 (304)
T ss_dssp             THHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTTTTSCHHHHHHHH
T ss_pred             cccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCccccccCCHHHHHHHH
Confidence            344679999999999976 4899999999999999999999999999999999999888877777777889999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +||..||.+|||+.|+|+||||...
T Consensus       244 ~~l~~dp~~Rps~~~~l~h~~~~~~  268 (304)
T 2jam_A          244 HLLEKDPNERYTCEKALSHPWIDGN  268 (304)
T ss_dssp             HHHCSSTTTSCCHHHHHTSHHHHSS
T ss_pred             HHcCCChhHCcCHHHHhcCccccCC
Confidence            9999999999999999999999644

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.7e-50  Score=399.85  Aligned_cols=253  Identities=27%  Similarity=0.489  Sum_probs=212.1

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChH-----HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-----TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~-----~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++|.+++.||+|+||.||+|.+..+++.||||++.....     .+.+|+.+|+.+. ||||+++++++.+.+.+|+|||
T Consensus         2 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e   80 (324)
T 3mtl_A            2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLK-HANIVTLHDIIHTEKSLTLVFE   80 (324)
T ss_dssp             CSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC------CCCCCCCHHHHSCCC-CTTBCCEEEEEECSSCEEEEEE
T ss_pred             CceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccccccchhHHHHHHHHHhcC-CCCCCeeeeEEeeCCEEEEEec
Confidence            579999999999999999999999999999999964322     3457999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          178 LCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      |+. |+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .....
T Consensus        81 ~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~  159 (324)
T 3mtl_A           81 YLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN  159 (324)
T ss_dssp             CCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECTTCCEEECSSSEEECC---------
T ss_pred             ccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCcccccc
Confidence            997 58888887654 5999999999999999999999999999999999999999999999999999765432 23445


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc---------------
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV---------------  318 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~---------------  318 (469)
                      ..||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+...........               
T Consensus       160 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (324)
T 3mtl_A          160 EVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNY  239 (324)
T ss_dssp             ---CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCC
T ss_pred             ccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhccccc
Confidence            678999999999876  489999999999999999999999999988887777654322111111               


Q ss_pred             -----------ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          319 -----------WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       319 -----------~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                 +..+++++.+||.+||+.||.+|||+.|+|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          240 PKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             ccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence                       135789999999999999999999999999999996544

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=8.5e-50  Score=402.27  Aligned_cols=256  Identities=23%  Similarity=0.393  Sum_probs=220.2

Q ss_pred             CCcccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhh----CCCCeeEEEEEEEe
Q 012170           96 GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS----GHTGVVTLHSVYEE  168 (469)
Q Consensus        96 ~~~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~----~hpnIv~l~~~~~~  168 (469)
                      .....+.++|.+++.||+|+||.||+|++..+++.||||+++...   ..+..|+.+++.+.    .||||+++++++..
T Consensus        28 ~~g~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~  107 (360)
T 3llt_A           28 KKGMLLNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNIKKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMY  107 (360)
T ss_dssp             CTTCEETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCHHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEE
T ss_pred             ecceEecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccchhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeE
Confidence            334457889999999999999999999999999999999997543   45778999999996    49999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--------------
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--------------  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--------------  232 (469)
                      .+.+|+||||+ +++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.              
T Consensus       108 ~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~  186 (360)
T 3llt_A          108 YDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVT  186 (360)
T ss_dssp             TTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTT
T ss_pred             CCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcccEEEccccccccccchhccc
Confidence            99999999999 899999997764  5999999999999999999999999999999999999975              


Q ss_pred             -----------CCcEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH
Q 012170          233 -----------SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL  300 (469)
Q Consensus       233 -----------~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~  300 (469)
                                 ++.+||+|||++.....  ......||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+.
T Consensus       187 ~~~~~~~~~~~~~~~kl~DFG~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~  264 (360)
T 3llt_A          187 DGKKIQIYRTKSTGIKLIDFGCATFKSD--YHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH  264 (360)
T ss_dssp             TCCEEEEEEESCCCEEECCCTTCEETTS--CCCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred             ccccccccccCCCCEEEEeccCceecCC--CCcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence                       78999999999976433  3345689999999999976 599999999999999999999999999888


Q ss_pred             HHHHHHHHcCcCCCCCCc------------------------------------------ccCCCHHHHHHHHHhchhhh
Q 012170          301 EAVFDAIKNVKLDFHSGV------------------------------------------WETVSKPARDLMARMLTRDV  338 (469)
Q Consensus       301 ~~~~~~i~~~~~~~~~~~------------------------------------------~~~~s~~~~~lI~~~L~~dP  338 (469)
                      .+.+..+......++...                                          ....++.+.+||.+||+.||
T Consensus       265 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP  344 (360)
T 3llt_A          265 MEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDP  344 (360)
T ss_dssp             HHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSG
T ss_pred             HHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCCh
Confidence            777766654332222100                                          01124778899999999999


Q ss_pred             cCCCCHHHHHcCCCcc
Q 012170          339 SARITADEVLRHPWIL  354 (469)
Q Consensus       339 ~~Rpsa~elL~hp~~~  354 (469)
                      .+|||+.|+|+||||+
T Consensus       345 ~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          345 TLRPSPAELLKHKFLE  360 (360)
T ss_dssp             GGSCCHHHHTTSGGGC
T ss_pred             hhCCCHHHHhcCcccC
Confidence            9999999999999984

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=7.9e-50  Score=399.30  Aligned_cols=252  Identities=29%  Similarity=0.491  Sum_probs=228.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ....+|.+++.||+|+||.||+|.+..+++.||+|++...       .+.+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus        38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  116 (335)
T 2owb_A           38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFV  116 (335)
T ss_dssp             TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEecCCeE
Confidence            3567899999999999999999999999999999998642       256788999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-C
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-Q  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~  251 (469)
                      |+||||+.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus       117 ~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~  196 (335)
T 2owb_A          117 FVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE  196 (335)
T ss_dssp             EEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred             EEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc
Confidence            999999999999999988889999999999999999999999999999999999999999999999999999876533 3


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+....+.+..+......++    ..++.++.+||
T Consensus       197 ~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li  272 (335)
T 2owb_A          197 RKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLI  272 (335)
T ss_dssp             CBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCC----TTSCHHHHHHH
T ss_pred             cccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhcCCCCCC----ccCCHHHHHHH
Confidence            3445689999999999976 488999999999999999999999999888888888877665554    46799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.|+|+||||...
T Consensus       273 ~~~l~~dp~~Rps~~ell~~~~~~~~  298 (335)
T 2owb_A          273 QKMLQTDPTARPTINELLNDEFFTSG  298 (335)
T ss_dssp             HHHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHHccCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999543

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-49  Score=386.67  Aligned_cols=251  Identities=33%  Similarity=0.614  Sum_probs=227.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|++++.||+|+||.||+|.+..++..||+|++...       ...+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus        11 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   89 (284)
T 2vgo_A           11 FTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLR-HPNILRMYNYFHDRKRI   89 (284)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             hhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCC-CCCEeeEEEEEEcCCEE
Confidence            3457899999999999999999999999999999998532       356889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++...... .
T Consensus        90 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~-~  168 (284)
T 2vgo_A           90 YLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL-R  168 (284)
T ss_dssp             EEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS-C
T ss_pred             EEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc-c
Confidence            999999999999999998899999999999999999999999999999999999999999999999999999765432 3


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...+.......+......++    ..++.++++||.
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  244 (284)
T 2vgo_A          169 RRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFP----PFLSDGSKDLIS  244 (284)
T ss_dssp             BCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHhccccCCC----CcCCHHHHHHHH
Confidence            345689999999999976 489999999999999999999999999888888888877665554    467999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +||..||.+|||+.++|+||||...
T Consensus       245 ~~l~~~p~~Rps~~~ll~h~~~~~~  269 (284)
T 2vgo_A          245 KLLRYHPPQRLPLKGVMEHPWVKAN  269 (284)
T ss_dssp             HHSCSSGGGSCCHHHHHTCHHHHHH
T ss_pred             HHhhcCHhhCCCHHHHhhCHHHHhh
Confidence            9999999999999999999999543

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=2e-49  Score=419.78  Aligned_cols=254  Identities=29%  Similarity=0.511  Sum_probs=225.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...++|.+++.||+|+||.||+|+++.+|+.||||++.+.       ...+.+|+.+|+.+. ||||++++++|++.+.+
T Consensus       182 ~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~-hp~Iv~l~~~~~~~~~l  260 (543)
T 3c4z_A          182 MGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVH-SRFIVSLAYAFETKTDL  260 (543)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-CTTBCCEEEEEECSSEE
T ss_pred             CChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcC-CCCEeeEEEEEeeCCEE
Confidence            3457899999999999999999999999999999999542       356788999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          173 HLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      |+||||++||+|.+++...    ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++....
T Consensus       261 ~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~  340 (543)
T 3c4z_A          261 CLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELK  340 (543)
T ss_dssp             EEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECC
T ss_pred             EEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeecc
Confidence            9999999999999998764    369999999999999999999999999999999999999999999999999998765


Q ss_pred             CCCc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCcCCCCCCcccCC
Q 012170          249 NGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       249 ~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      .... ....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.    ....+...+......++    ..+
T Consensus       341 ~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~~~~~~~i~~~~~~~p----~~~  416 (543)
T 3c4z_A          341 AGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP----DKF  416 (543)
T ss_dssp             TTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCHHHHHHHHHHCCCCCC----TTS
T ss_pred             CCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhHHHHHHHHhhcccCCC----ccc
Confidence            5443 345689999999999977 4999999999999999999999999875    45677777776665554    468


Q ss_pred             CHHHHHHHHHhchhhhcCCCC-----HHHHHcCCCcccccc
Q 012170          323 SKPARDLMARMLTRDVSARIT-----ADEVLRHPWILFYTE  358 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rps-----a~elL~hp~~~~~~~  358 (469)
                      ++++++||.+||..||.+||+     +++|++||||....+
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i~w  457 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRDISW  457 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTTCCH
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccCCCH
Confidence            999999999999999999996     589999999965443

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=8.4e-50  Score=394.99  Aligned_cols=250  Identities=27%  Similarity=0.438  Sum_probs=210.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.++|++++.||+|+||+||+|++..+|+.||||++...      ......|+..+..+..||||+++++++.+.+.+|
T Consensus        54 ~~~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~  133 (311)
T 3p1a_A           54 FFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILY  133 (311)
T ss_dssp             HHHHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEE
T ss_pred             hhhhheeeeheeccCCCeEEEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEE
Confidence            3557899999999999999999999999999999998542      2345566777777756999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       134 lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~  212 (311)
T 3p1a_A          134 LQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA  212 (311)
T ss_dssp             EEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC----
T ss_pred             EEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC
Confidence            999999 668888886654 699999999999999999999999999999999999999999999999999987766555


Q ss_pred             ccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      .....||+.|+|||++.+.++.++|||||||++|+|++|..||.+..   ....+....  .+...+..+++++.+||.+
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~l~~li~~  287 (311)
T 3p1a_A          213 GEVQEGDPRYMAPELLQGSYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQGY--LPPEFTAGLSSELRSVLVM  287 (311)
T ss_dssp             --CCCCCGGGCCGGGGGTCCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTTC--CCHHHHTTSCHHHHHHHHH
T ss_pred             CcccCCCccccCHhHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhccC--CCcccccCCCHHHHHHHHH
Confidence            56678999999999999999999999999999999999977665432   233333322  2222345789999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCccc
Q 012170          333 MLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||..||.+|||+.|+|+||||..
T Consensus       288 ~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          288 MLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             HSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             HcCCChhhCcCHHHHHhCccccC
Confidence            99999999999999999999953

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=1e-49  Score=400.55  Aligned_cols=254  Identities=27%  Similarity=0.471  Sum_probs=218.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-------  168 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-------  168 (469)
                      .++|++++.||+|+||.||+|++..+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++..       
T Consensus        16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   94 (351)
T 3mi9_A           16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNR   94 (351)
T ss_dssp             GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSCSSSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEEC------
T ss_pred             ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccccccchHHHHHHHHHHHhcc-CCCcccHhheeecccccccc
Confidence            47899999999999999999999999999999998532      246789999999997 9999999999987       


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          169 -ADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                       .+.+|+||||+.+ +|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        95 ~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~  173 (351)
T 3mi9_A           95 CKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARA  173 (351)
T ss_dssp             --CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEE
T ss_pred             CCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhccc
Confidence             4568999999976 676666543 6799999999999999999999999999999999999999999999999999987


Q ss_pred             ecCC-----CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcc
Q 012170          247 ISNG-----QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       247 ~~~~-----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      ....     .......||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......+......++...|
T Consensus       174 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~  253 (351)
T 3mi9_A          174 FSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVW  253 (351)
T ss_dssp             CCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTS
T ss_pred             ccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhc
Confidence            6422     22345679999999999965  4899999999999999999999999999988888777654444333333


Q ss_pred             cC----------------------------CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          320 ET----------------------------VSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       320 ~~----------------------------~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..                            .++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       254 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  319 (351)
T 3mi9_A          254 PNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP  319 (351)
T ss_dssp             TTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred             cccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCC
Confidence            22                            278899999999999999999999999999996543

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.8e-50  Score=392.24  Aligned_cols=257  Identities=39%  Similarity=0.698  Sum_probs=234.7

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      +.+.++|++++.||+|+||.||+|.+..+++.||||++..      ....+.+|+++++++. ||||+++++++.+.+.+
T Consensus        18 ~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~   96 (287)
T 2wei_A           18 GTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLD-HPNIMKLFEILEDSSSF   96 (287)
T ss_dssp             HHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGBSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEE
T ss_pred             HHHhhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcc-CCCccEEEEEEeCCCeE
Confidence            3466899999999999999999999999999999999853      2467889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceeeecC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMRISN  249 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~~~~  249 (469)
                      |+||||+.+++|.+.+...+.+++..+..++.||+.||.|||++|++||||||+|||++.+   +.+||+|||++.....
T Consensus        97 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~  176 (287)
T 2wei_A           97 YIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ  176 (287)
T ss_dssp             EEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCC
T ss_pred             EEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecC
Confidence            9999999999999999888999999999999999999999999999999999999999764   4699999999976655


Q ss_pred             CCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          250 GQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ........||+.|+|||++.+.++.++||||||+++|+|++|..||.+.+...+...+......++...+..+++++.+|
T Consensus       177 ~~~~~~~~~~~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  256 (287)
T 2wei_A          177 NTKMKDRIGTAYYIAPEVLRGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDL  256 (287)
T ss_dssp             CSSCSCHHHHHTTCCHHHHTTCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGGTTSCHHHHHH
T ss_pred             CCccccccCcccccChHHhcCCCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchhhhhcCHHHHHH
Confidence            55445567899999999999899999999999999999999999999999988888888887777766777899999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||..||.+|||+.|+|+||||..+
T Consensus       257 i~~~l~~dp~~Rps~~ell~hp~~~~~  283 (287)
T 2wei_A          257 IRKMLTFHPSLRITATQCLEHPWIQKY  283 (287)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHSHHHHHH
T ss_pred             HHHHcccChhhCcCHHHHhcCHHHhcc
Confidence            999999999999999999999999654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.7e-50  Score=406.20  Aligned_cols=252  Identities=29%  Similarity=0.554  Sum_probs=219.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      .++|++++.||+|+||.||+|++.   .+|+.||||++++.        ...+.+|+.+|+.+..||||+++++++...+
T Consensus        53 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  132 (355)
T 1vzo_A           53 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET  132 (355)
T ss_dssp             GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred             ccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCc
Confidence            478999999999999999999984   58999999998642        3567789999999977999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       133 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~  212 (355)
T 1vzo_A          133 KLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD  212 (355)
T ss_dssp             EEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGG
T ss_pred             eEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccC
Confidence            99999999999999999998899999999999999999999999999999999999999999999999999999865432


Q ss_pred             C--cccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHcCcCCCCCCcccC
Q 012170          251 Q--TLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGD----SLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       251 ~--~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~----~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      .  .....+||+.|+|||++.+   .++.++|||||||++|+|++|..||...    ....+...+......++    ..
T Consensus       213 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----~~  288 (355)
T 1vzo_A          213 ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYP----QE  288 (355)
T ss_dssp             GGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCC----TT
T ss_pred             CCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCccchHHHHHHHHhccCCCCC----cc
Confidence            2  2345689999999999975   3788999999999999999999999743    34555555555444443    56


Q ss_pred             CCHHHHHHHHHhchhhhcCCC-----CHHHHHcCCCccccc
Q 012170          322 VSKPARDLMARMLTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      ++..+.+||.+||..||.+||     ++.|+++||||....
T Consensus       289 ~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~~  329 (355)
T 1vzo_A          289 MSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKIN  329 (355)
T ss_dssp             SCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTCC
T ss_pred             cCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcCC
Confidence            899999999999999999999     999999999996554

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=7.7e-50  Score=413.43  Aligned_cols=259  Identities=26%  Similarity=0.432  Sum_probs=211.5

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--  169 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--  169 (469)
                      ...+.++|++++.||+|+||.||+|.++.+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++...  
T Consensus        21 ~~~i~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~nIv~l~~~~~~~~~   99 (432)
T 3n9x_A           21 NVHVPDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRMFEDLIDCKRILREITILNRLK-SDYIIRLYDLIIPDDL   99 (432)
T ss_dssp             GCCCCTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSTTTSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCT
T ss_pred             cceecCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCchhcChHHHHHHHHHHHHHHHcC-CCCcceEEEEEecCCC
Confidence            345778999999999999999999999999999999999652      246789999999997 99999999999766  


Q ss_pred             ---CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          170 ---DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       170 ---~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                         +.+|+||||+. |+|.+++.....+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.
T Consensus       100 ~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NILl~~~~~~kL~DFGla~~  178 (432)
T 3n9x_A          100 LKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLART  178 (432)
T ss_dssp             TTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             CcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHeEECCCCCEEEccCCCccc
Confidence               57999999996 59999998888899999999999999999999999999999999999999999999999999987


Q ss_pred             ecCCC-----------------------cccccCCCCcccCceecc-C-CCCCccchHHHHHHHHHHHh-----------
Q 012170          247 ISNGQ-----------------------TLSGLAGSPAYVAPEVLS-G-NYSEKVDIWSAGVLLHALLV-----------  290 (469)
Q Consensus       247 ~~~~~-----------------------~~~~~~gt~~y~aPE~l~-~-~~~~~~DiwSlG~il~ellt-----------  290 (469)
                      .....                       .....+||++|+|||++. + .|+.++|||||||++|+|++           
T Consensus       179 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~  258 (432)
T 3n9x_A          179 INSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTN  258 (432)
T ss_dssp             C-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGG
T ss_pred             ccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccccc
Confidence            64332                       235678999999999863 3 59999999999999999998           


Q ss_pred             CCCCCCCCC-----------------HHHHHHHH------------------------HcCcCCCCC---CcccCCCHHH
Q 012170          291 AALPFKGDS-----------------LEAVFDAI------------------------KNVKLDFHS---GVWETVSKPA  326 (469)
Q Consensus       291 G~~Pf~~~~-----------------~~~~~~~i------------------------~~~~~~~~~---~~~~~~s~~~  326 (469)
                      |.++|.+.+                 ....+..|                        .......+.   ..+..+++++
T Consensus       259 ~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  338 (432)
T 3n9x_A          259 RFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDG  338 (432)
T ss_dssp             CCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHH
T ss_pred             ccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHH
Confidence            455555543                 11122211                        111111110   1124689999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .+||.+||..||.+|||++|+|+||||....+
T Consensus       339 ~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          339 INLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            99999999999999999999999999976543

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=4.3e-49  Score=391.91  Aligned_cols=251  Identities=34%  Similarity=0.531  Sum_probs=222.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ..|...+.||+|+||.||+|++..+|+.||||++...    .+.+.+|+.+|+.+. ||||+++++++...+..|+||||
T Consensus        45 ~~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~lv~e~  123 (321)
T 2c30_A           45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQ-HFNVVEMYKSYLVGEELWVLMEF  123 (321)
T ss_dssp             HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCSHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEECC
T ss_pred             hhhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccchhHHHHHHHHHHHHHhCC-CCCcceEEEEEEECCEEEEEEec
Confidence            4578888999999999999999999999999998642    356889999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccccC
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSGLA  257 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~~~  257 (469)
                      ++||+|.+++. ...+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ......
T Consensus       124 ~~~~~L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~  202 (321)
T 2c30_A          124 LQGGALTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKRKSLV  202 (321)
T ss_dssp             CCSCBHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCCBCCCC
T ss_pred             CCCCCHHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCcccccccc
Confidence            99999999874 5679999999999999999999999999999999999999999999999999998765432 345578


Q ss_pred             CCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          258 GSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       258 gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      ||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+........ .....+++++.+||.+||..
T Consensus       203 gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          203 GTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKL-KNSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCCCC-TTGGGSCHHHHHHHHHHSCS
T ss_pred             CCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCc-CccccCCHHHHHHHHHHccC
Confidence            9999999999976 489999999999999999999999999888888777766543221 22356899999999999999


Q ss_pred             hhcCCCCHHHHHcCCCcccc
Q 012170          337 DVSARITADEVLRHPWILFY  356 (469)
Q Consensus       337 dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+|||+.|+|+||||...
T Consensus       282 dp~~Rps~~ell~hp~~~~~  301 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQT  301 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGC
T ss_pred             ChhhCcCHHHHhcChhhccC
Confidence            99999999999999999654

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=1.7e-50  Score=416.82  Aligned_cols=256  Identities=33%  Similarity=0.609  Sum_probs=217.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------HHHHHHHHHHHHhhCCCCeeEEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------ETVHREVEIMQHLSGHTGVVTLHSVY  166 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------~~~~~E~~il~~l~~hpnIv~l~~~~  166 (469)
                      ..+.++|.+.+.||+|+||.||+|.+..+++.||||++.+..            ..+.+|+.+|+++. ||||+++++++
T Consensus       131 ~~~~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~  209 (419)
T 3i6u_A          131 KALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFF  209 (419)
T ss_dssp             HHHHTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCC-CTTBCCCCEEE
T ss_pred             hhhhccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            346789999999999999999999999999999999986421            24789999999996 99999999998


Q ss_pred             EeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEEeccc
Q 012170          167 EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLADFGL  243 (469)
Q Consensus       167 ~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~DFgl  243 (469)
                      . .+.+|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++   .+||+|||+
T Consensus       210 ~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~  288 (419)
T 3i6u_A          210 D-AEDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGH  288 (419)
T ss_dssp             E-SSEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSSSCCEEECCSST
T ss_pred             e-cCceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCCCcceEEEeeccc
Confidence            5 456789999999999999998888999999999999999999999999999999999999997654   599999999


Q ss_pred             eeeecCCCcccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCCc
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGV  318 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~~  318 (469)
                      +............+||+.|+|||++.    ..|+.++|||||||++|+|++|.+||.+.. .......+......+....
T Consensus       289 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~~~~~~~~i~~~~~~~~~~~  368 (419)
T 3i6u_A          289 SKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEV  368 (419)
T ss_dssp             TTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSSSCCHHHHHHTTCCCCCHHH
T ss_pred             ceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcchHHHHHHHhcCCCCCCchh
Confidence            98776665566788999999999985    347889999999999999999999997643 2345566777777776667


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |..+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus       369 ~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          369 WAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             hcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence            78899999999999999999999999999999999543

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=6e-50  Score=407.55  Aligned_cols=253  Identities=25%  Similarity=0.420  Sum_probs=216.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe------------
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE------------  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~------------  168 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++........+|+.+|+.+. ||||++++++|..            
T Consensus         5 ~~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~   83 (383)
T 3eb0_A            5 SSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYKNRELDIMKVLD-HVNIIKLVDYFYTTGDEEPKPPQPP   83 (383)
T ss_dssp             -CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHTTCC-CTTBCCEEEEEEEC-----------
T ss_pred             ccceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchHHHHHHHHHHcC-CCCccchhheeeecCcccccccccc
Confidence            457899999999999999999999999999999999877777778999999996 9999999999843            


Q ss_pred             --------------------------CCeEEEEEeccCCCchHHHHH----HhCCCCHHHHHHHHHHHHHHHHHHHhcCe
Q 012170          169 --------------------------ADCFHLVMELCSGGRLIDQMV----EVGQYSEQRAANIFKDVMWVIKYCHDMGV  218 (469)
Q Consensus       169 --------------------------~~~~~lV~E~~~gg~L~~~l~----~~~~l~~~~~~~i~~qil~aL~yLH~~gi  218 (469)
                                                ...+++||||++| +|.+.+.    ..+.+++..+..++.||+.||.|||++||
T Consensus        84 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi  162 (383)
T 3eb0_A           84 DDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGI  162 (383)
T ss_dssp             --------------------------CCEEEEEECCCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred             cccccccccccccccccccccccCCCceEEEEEEecCCc-cHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence                                      3458999999985 7666654    34679999999999999999999999999


Q ss_pred             EeccCCCCcEEEc-cCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCC
Q 012170          219 VHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPF  295 (469)
Q Consensus       219 vHrDlkp~NILl~-~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf  295 (469)
                      +||||||+|||++ .++.+||+|||++.............||+.|+|||++.+  .|+.++|||||||++|+|++|.+||
T Consensus       163 ~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf  242 (383)
T 3eb0_A          163 CHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLF  242 (383)
T ss_dssp             ECSCCCGGGEEEETTTTEEEECCCTTCEECCTTSCCCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSS
T ss_pred             ccCccCHHHEEEcCCCCcEEEEECCCCcccCCCCCCcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCC
Confidence            9999999999998 688999999999988776666677789999999999876  4899999999999999999999999


Q ss_pred             CCCCHHHHHHHHHcCcC-----------------CCC---CC-----cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          296 KGDSLEAVFDAIKNVKL-----------------DFH---SG-----VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       296 ~~~~~~~~~~~i~~~~~-----------------~~~---~~-----~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+.+..+.+..+.....                 .++   ..     ....+++++.+||.+||..||.+|||+.|+|+|
T Consensus       243 ~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~h  322 (383)
T 3eb0_A          243 SGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAH  322 (383)
T ss_dssp             CCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTS
T ss_pred             CCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence            99887777666543110                 111   01     123478999999999999999999999999999


Q ss_pred             CCccc
Q 012170          351 PWILF  355 (469)
Q Consensus       351 p~~~~  355 (469)
                      |||..
T Consensus       323 p~f~~  327 (383)
T 3eb0_A          323 PFFDH  327 (383)
T ss_dssp             GGGHH
T ss_pred             HHHHH
Confidence            99954

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=6.1e-49  Score=390.84  Aligned_cols=253  Identities=26%  Similarity=0.476  Sum_probs=215.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-ChHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-GEETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-~~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|.+..+++.||||+++. ....+.+|+.+|+.+.+||||+++++++.+  ....++|||
T Consensus        34 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e  113 (330)
T 3nsz_A           34 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFE  113 (330)
T ss_dssp             EGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEE
T ss_pred             CCCceEEEEEecccCCeEEEEEEECCCCcEEEEEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEe
Confidence            35789999999999999999999999999999999975 356789999999999879999999999987  678999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCCccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      |+.+++|.+++.   .+++..+..++.||+.||.|||++||+||||||+|||++.++ .+||+|||++............
T Consensus       114 ~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~~~~~  190 (330)
T 3nsz_A          114 HVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVR  190 (330)
T ss_dssp             CCCCCCHHHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCCCCSC
T ss_pred             ccCchhHHHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCccccc
Confidence            999999988773   589999999999999999999999999999999999999777 8999999999887766666677


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHH-------------HHcCcCCC------
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDA-------------IKNVKLDF------  314 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~-------------i~~~~~~~------  314 (469)
                      .||+.|+|||++.+  .++.++|||||||++|+|++|..||.. ....+.+..             +.......      
T Consensus       191 ~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  270 (330)
T 3nsz_A          191 VASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFND  270 (330)
T ss_dssp             CSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHH
T ss_pred             cccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhh
Confidence            89999999999865  489999999999999999999999953 333222222             22111111      


Q ss_pred             --------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 --------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 --------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                    .......+++++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          271 ILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             HHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             hhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence                          111123479999999999999999999999999999999654

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=7.9e-50  Score=411.93  Aligned_cols=255  Identities=29%  Similarity=0.456  Sum_probs=214.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeC------CeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEA------DCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~------~~~~  173 (469)
                      ....+|++++.||+|+||.||+|++..+|+.||||++........+|+++|+.+. ||||++++++|...      .+++
T Consensus        51 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~~~~~~~~~~~~  129 (420)
T 1j1b_A           51 PQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLN  129 (420)
T ss_dssp             CEEEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTSCCHHHHHHHTCC-CTTBCCEEEEEEEEETTTTEEEEE
T ss_pred             cccceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHcC-CCCccceeeEEeccCCCCcceeEE
Confidence            3456899999999999999999999999999999999876666778999999997 99999999988532      2477


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeeec
Q 012170          174 LVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRIS  248 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~~  248 (469)
                      +||||+++ +|.+.+..    ...+++..+..++.||+.||.|||++||+||||||+||||+.+ +.+||+|||+++...
T Consensus       130 lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~  208 (420)
T 1j1b_A          130 LVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLV  208 (420)
T ss_dssp             EEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECC
T ss_pred             eehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcc
Confidence            99999976 56555532    4679999999999999999999999999999999999999965 578999999998876


Q ss_pred             CCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcC----------------
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV----------------  310 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~----------------  310 (469)
                      ........+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..|...                
T Consensus       209 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~  288 (420)
T 1j1b_A          209 RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNY  288 (420)
T ss_dssp             TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCC
T ss_pred             cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhh
Confidence            6655666789999999999965  5899999999999999999999999998876665554321                


Q ss_pred             -cCCCCC---Ccc-----cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          311 -KLDFHS---GVW-----ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       311 -~~~~~~---~~~-----~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                       .+.++.   ..|     ..+++++.+||.+||.+||.+|||+.|+|+||||...
T Consensus       289 ~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          289 TEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             hhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence             011110   111     3568999999999999999999999999999999654

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.8e-50  Score=404.04  Aligned_cols=253  Identities=28%  Similarity=0.489  Sum_probs=212.8

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--  170 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--  170 (469)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++...+  
T Consensus        21 ~~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~l~~~~~~~~~~   99 (367)
T 1cm8_A           21 WEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETL   99 (367)
T ss_dssp             ECCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSST
T ss_pred             eeecceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CcCCCCceeeEecCCcc
Confidence            34678999999999999999999999999999999998542      245779999999997 999999999998653  


Q ss_pred             ----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          171 ----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       171 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                          .+|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus       100 ~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~  177 (367)
T 1cm8_A          100 DDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQ  177 (367)
T ss_dssp             TTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEE
T ss_pred             ccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHHEEEcCCCCEEEEeeecccc
Confidence                469999999 8899988855 7899999999999999999999999999999999999999999999999999987


Q ss_pred             ecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC---------
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH---------  315 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---------  315 (469)
                      ...  .....+||++|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+....+..|.......+         
T Consensus       178 ~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~  255 (367)
T 1cm8_A          178 ADS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQS  255 (367)
T ss_dssp             CCS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSC
T ss_pred             ccc--ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhh
Confidence            543  3455789999999999866  589999999999999999999999999887777666543211110         


Q ss_pred             ------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          316 ------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       316 ------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                        ...+..+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       256 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~  314 (367)
T 1cm8_A          256 DEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESL  314 (367)
T ss_dssp             HHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred             HHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCCCHHHHhcChHHHhh
Confidence                              11234679999999999999999999999999999999644

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=1.6e-49  Score=385.55  Aligned_cols=251  Identities=28%  Similarity=0.527  Sum_probs=197.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus         9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (278)
T 3cok_A            9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLK-HPSILELYNYFEDSNYVY   87 (278)
T ss_dssp             SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBC-CTTBCCEEEEEECSSEEE
T ss_pred             ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCC-CCCeEeEEEEEccCCeEE
Confidence            346899999999999999999999999999999998642       256889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-C
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-Q  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~  251 (469)
                      +||||+++++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... .
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~  167 (278)
T 3cok_A           88 LVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE  167 (278)
T ss_dssp             EEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC----
T ss_pred             EEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC
Confidence            999999999999998765 57999999999999999999999999999999999999999999999999999875432 2


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ......||+.|+|||++.+ .++.++||||||+++|+|++|..||........+..+.......    ...++.++.+||
T Consensus       168 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li  243 (278)
T 3cok_A          168 KHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEM----PSFLSIEAKDLI  243 (278)
T ss_dssp             ------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCSSCCCC----CTTSCHHHHHHH
T ss_pred             cceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhhcccCC----ccccCHHHHHHH
Confidence            2334679999999999976 48899999999999999999999998766555444443333222    246799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.++|+||||...
T Consensus       244 ~~~l~~dp~~Rps~~~~l~h~~~~~~  269 (278)
T 3cok_A          244 HQLLRRNPADRLSLSSVLDHPFMSRN  269 (278)
T ss_dssp             HHHSCSSGGGSCCHHHHTTSTTTC--
T ss_pred             HHHcccCHhhCCCHHHHhcCccccCC
Confidence            99999999999999999999999543

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=5.6e-50  Score=397.66  Aligned_cols=255  Identities=33%  Similarity=0.619  Sum_probs=222.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------HHHHHHHHHHHHhhCCCCeeEEEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------ETVHREVEIMQHLSGHTGVVTLHSVYE  167 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------~~~~~E~~il~~l~~hpnIv~l~~~~~  167 (469)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++....            ..+.+|+.+|+.+. ||||+++++++.
T Consensus         7 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~   85 (322)
T 2ycf_A            7 ALRDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLN-HPCIIKIKNFFD   85 (322)
T ss_dssp             HHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             hhhhceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCC-CCCCceEeeEEc
Confidence            35678999999999999999999999999999999986421            24789999999996 999999999997


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccce
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGLA  244 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgla  244 (469)
                      ..+ +|+||||+++|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.   +||+|||++
T Consensus        86 ~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~  164 (322)
T 2ycf_A           86 AED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHS  164 (322)
T ss_dssp             SSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTC
T ss_pred             CCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEecCCCCCeEEEccCccc
Confidence            665 8999999999999999988889999999999999999999999999999999999999987665   999999999


Q ss_pred             eeecCCCcccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCcCCCCCCcc
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~  319 (469)
                      .............||+.|+|||++.    ..++.++|||||||++|+|++|..||.+... ..+...+......+....+
T Consensus       165 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~  244 (322)
T 2ycf_A          165 KILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGKYNFIPEVW  244 (322)
T ss_dssp             EECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCCCCHHHH
T ss_pred             eecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchHHHHHHHHHhCccccCchhh
Confidence            8776554455668999999999973    3588999999999999999999999976432 2344556666655555556


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ..++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       245 ~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~~  281 (322)
T 2ycf_A          245 AEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE  281 (322)
T ss_dssp             TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCCH
T ss_pred             hhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCCH
Confidence            7889999999999999999999999999999999654

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.7e-49  Score=382.29  Aligned_cols=251  Identities=34%  Similarity=0.602  Sum_probs=218.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|.+++.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus         9 ~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   87 (276)
T 2h6d_A            9 KIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFR-HPHIIKLYQVISTPTDFF   87 (276)
T ss_dssp             EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             eeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCeEE
Confidence            457899999999999999999999999999999998542       246789999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.........
T Consensus        88 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~  167 (276)
T 2h6d_A           88 MVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFL  167 (276)
T ss_dssp             EEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----
T ss_pred             EEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCcce
Confidence            99999999999999998899999999999999999999999999999999999999999999999999999876655555


Q ss_pred             cccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....||+.|+|||++.+. + +.++||||||+++|+|++|..||.+.........+......++    ..++.++.+||.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~  243 (276)
T 2h6d_A          168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIP----EYLNRSVATLLM  243 (276)
T ss_dssp             ---------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHH
T ss_pred             ecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccCc----hhcCHHHHHHHH
Confidence            567899999999999775 3 6799999999999999999999999888888888877655444    457999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +||+.||.+|||+.++++||||...
T Consensus       244 ~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          244 HMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             HHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHccCChhhCCCHHHHHhChhhccC
Confidence            9999999999999999999999543

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=8.3e-50  Score=399.56  Aligned_cols=247  Identities=28%  Similarity=0.480  Sum_probs=218.3

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------HHHHHHHHHHHHhhCCCCeeEEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------ETVHREVEIMQHLSGHTGVVTLHSVY  166 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------~~~~~E~~il~~l~~hpnIv~l~~~~  166 (469)
                      ..+.++|++++.||+|+||.||+|.++.+|+.||||++....            ..+.+|+.+|+.+. ||||+++++++
T Consensus        20 ~~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~Iv~~~~~~   98 (335)
T 3dls_A           20 GEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVE-HANIIKVLDIF   98 (335)
T ss_dssp             THHHHHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCC-CTTBCCEEEEE
T ss_pred             cccccceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEE
Confidence            346789999999999999999999999999999999986532            35678999999996 99999999999


Q ss_pred             EeCCeEEEEEeccCCC-chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          167 EEADCFHLVMELCSGG-RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       167 ~~~~~~~lV~E~~~gg-~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      .+.+.+++||||+.+| +|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.
T Consensus        99 ~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~  178 (335)
T 3dls_A           99 ENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAA  178 (335)
T ss_dssp             ECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             eeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEEEcCCCcEEEeecccce
Confidence            9999999999999776 999999888899999999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ...........+||+.|+|||++.+. + +.++|||||||++|+|++|..||.....      ......    .....++
T Consensus       179 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~------~~~~~~----~~~~~~~  248 (335)
T 3dls_A          179 YLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE------TVEAAI----HPPYLVS  248 (335)
T ss_dssp             ECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG------GTTTCC----CCSSCCC
T ss_pred             ECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH------HHhhcc----CCCcccC
Confidence            87766666678899999999999764 4 7899999999999999999999976321      111111    1224589


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +++.+||.+||..||.+|||+.++|+||||...
T Consensus       249 ~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          249 KELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999999999999654

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=7.1e-49  Score=384.28  Aligned_cols=251  Identities=29%  Similarity=0.490  Sum_probs=227.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|.+++.||+|+||.||+|.+..+++.||+|++...       .+.+.+|+.+++.+. ||||+++++++.+.+..|
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~   91 (294)
T 2rku_A           13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLA-HQHVVGFHGFFEDNDFVF   91 (294)
T ss_dssp             TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCC-CCCEeeeeeeeccCCEEE
Confidence            557899999999999999999999999999999998542       246788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~  252 (469)
                      +||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ..
T Consensus        92 lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~  171 (294)
T 2rku_A           92 VVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGER  171 (294)
T ss_dssp             EEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTCC
T ss_pred             EEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCccc
Confidence            99999999999999988889999999999999999999999999999999999999999999999999999876532 33


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.+....+....+......++    ..++..+.+||.
T Consensus       172 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~  247 (294)
T 2rku_A          172 KKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIP----KHINPVAASLIQ  247 (294)
T ss_dssp             BCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHH
T ss_pred             cccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhccCCCc----cccCHHHHHHHH
Confidence            4456799999999999764 88999999999999999999999999888888888877665544    467999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +||..||.+|||+.|+|+||||...
T Consensus       248 ~~l~~~p~~Rps~~~ll~~~~~~~~  272 (294)
T 2rku_A          248 KMLQTDPTARPTINELLNDEFFTSG  272 (294)
T ss_dssp             HHTCSSGGGSCCGGGGGGSHHHHTS
T ss_pred             HHcccChhhCcCHHHHhhChheecC
Confidence            9999999999999999999999543

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.6e-50  Score=397.27  Aligned_cols=256  Identities=25%  Similarity=0.397  Sum_probs=218.7

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ...+.++|++++.||+|+||.||+|.+..+++.||||++....       ..+.+|+.+++.+. ||||+++++++...+
T Consensus         7 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   85 (311)
T 3ork_A            7 PSHLSDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAET   85 (311)
T ss_dssp             CSEETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCC-CTTBCCEEEEEEEEE
T ss_pred             cceecCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCC-CCCcceEEEeeeccC
Confidence            4457889999999999999999999999999999999996531       35788999999996 999999999987654


Q ss_pred             ----eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          171 ----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       171 ----~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                          ..|+||||++||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..
T Consensus        86 ~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~  165 (311)
T 3ork_A           86 PAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA  165 (311)
T ss_dssp             TTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEETTSCEEECCCSCC--
T ss_pred             CCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccc
Confidence                3599999999999999999889999999999999999999999999999999999999999999999999999976


Q ss_pred             ecCCC----cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          247 ISNGQ----TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       247 ~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      .....    ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.......+...+..
T Consensus       166 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  245 (311)
T 3ork_A          166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEG  245 (311)
T ss_dssp             ----------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCHHHHSTT
T ss_pred             ccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCCCcccccCC
Confidence            54332    2234579999999999976 589999999999999999999999999988887777666554444444467


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      ++.++.+||.+||..||.+||++.++|.|+|+.
T Consensus       246 ~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          246 LSADLDAVVLKALAKNPENRYQTAAEMRADLVR  278 (311)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHH
Confidence            899999999999999999999999999999973

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=2.2e-49  Score=393.29  Aligned_cols=249  Identities=27%  Similarity=0.483  Sum_probs=208.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-----  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-----  170 (469)
                      +.++|++++.||+|+||.||+|+++.+|+.||||+++..     .+.+.+|+.+|++++ ||||++++++|.+.+     
T Consensus         4 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~   82 (332)
T 3qd2_B            4 YLTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLE-HPGIVRYFNAWLETPPEKWQ   82 (332)
T ss_dssp             HHHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCSTTTHHHHHHHHHHHHTSCC-CTTBCCEEEEEEECCSCHHH
T ss_pred             hhhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCCchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEEeccchhh
Confidence            557899999999999999999999999999999998632     356889999999996 999999999986543     


Q ss_pred             ----------------------------------------------------eEEEEEeccCCCchHHHHHHhCC---CC
Q 012170          171 ----------------------------------------------------CFHLVMELCSGGRLIDQMVEVGQ---YS  195 (469)
Q Consensus       171 ----------------------------------------------------~~~lV~E~~~gg~L~~~l~~~~~---l~  195 (469)
                                                                          .+|+|||||+||+|.+++.....   .+
T Consensus        83 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~  162 (332)
T 3qd2_B           83 EEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE  162 (332)
T ss_dssp             HHHHC--------------------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSC
T ss_pred             hhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchh
Confidence                                                                38999999999999999977543   45


Q ss_pred             HHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-------------cccccCCCCcc
Q 012170          196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-------------TLSGLAGSPAY  262 (469)
Q Consensus       196 ~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-------------~~~~~~gt~~y  262 (469)
                      +..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......             .....+||+.|
T Consensus       163 ~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y  242 (332)
T 3qd2_B          163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY  242 (332)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGG
T ss_pred             hHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCc
Confidence            66789999999999999999999999999999999999999999999998765432             23446799999


Q ss_pred             cCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCC
Q 012170          263 VAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSAR  341 (469)
Q Consensus       263 ~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~R  341 (469)
                      +|||++.+ .++.++|||||||++|+|++|..|+..  .......+.....   ...+...++++.+||.+||..||.+|
T Consensus       243 ~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~R  317 (332)
T 3qd2_B          243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKF---PLLFTQKYPQEHMMVQDMLSPSPTER  317 (332)
T ss_dssp             SCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCC---CHHHHHHCHHHHHHHHHHHCSSGGGS
T ss_pred             cChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCC---CcccccCChhHHHHHHHHccCCCCcC
Confidence            99999976 589999999999999999999877632  2233333433322   22234568899999999999999999


Q ss_pred             CCHHHHHcCCCccc
Q 012170          342 ITADEVLRHPWILF  355 (469)
Q Consensus       342 psa~elL~hp~~~~  355 (469)
                      ||+.|+|+||||..
T Consensus       318 ps~~~~l~~~~f~~  331 (332)
T 3qd2_B          318 PEATDIIENAIFEN  331 (332)
T ss_dssp             CCHHHHHHSTTCCC
T ss_pred             CCHHHHhhchhhhc
Confidence            99999999999953

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=1.4e-49  Score=396.51  Aligned_cols=255  Identities=27%  Similarity=0.453  Sum_probs=215.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+++.+. ||||+++++++.+.+.+|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  101 (331)
T 4aaa_A           23 SMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESDDDKMVKKIAMREIKLLKQLR-HENLVNLLEVCKKKKRWYL  101 (331)
T ss_dssp             CGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCSSCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEE
T ss_pred             hhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCCCchHHHHHHHHHHHHHhhCC-CCCEeeEEEEeecCCEEEE
Confidence            457899999999999999999999999999999998543      234678999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~  253 (469)
                      ||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ...
T Consensus       102 v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~  181 (331)
T 4aaa_A          102 VFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVY  181 (331)
T ss_dssp             EEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------
T ss_pred             EEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcccc
Confidence            9999999999888877788999999999999999999999999999999999999999999999999999765433 334


Q ss_pred             cccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC------------------
Q 012170          254 SGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD------------------  313 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~------------------  313 (469)
                      ....||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+......                  
T Consensus       182 ~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  261 (331)
T 4aaa_A          182 DDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGV  261 (331)
T ss_dssp             --CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTC
T ss_pred             CCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccc
Confidence            45689999999999976  4889999999999999999999999988876665554321110                  


Q ss_pred             -CC--------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 -FH--------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 -~~--------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                       .+        ...+..+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       262 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          262 RLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             cCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence             00        00123579999999999999999999999999999999643

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=3.9e-49  Score=400.02  Aligned_cols=253  Identities=27%  Similarity=0.454  Sum_probs=205.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC---
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD---  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~---  170 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+++.+. ||||+++++++...+   
T Consensus        22 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~  100 (371)
T 2xrw_A           22 TVLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIIGLLNVFTPQKSLE  100 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTTSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSCCSTT
T ss_pred             chhhheeEeeeeEecCCEEEEEEEECCCCceEEEEEeccccCChHHHHHHHHHHHHHHhcC-CCCccceEEeeccccccc
Confidence            3568999999999999999999999999999999998642      245778999999996 999999999997665   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          171 ---CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       171 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                         .+|+||||+.+ +|.+.+.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       101 ~~~~~~lv~e~~~~-~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~  177 (371)
T 2xrw_A          101 EFQDVYIVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA  177 (371)
T ss_dssp             TCCEEEEEEECCSE-EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC----
T ss_pred             cccceEEEEEcCCC-CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCCCEEEEEeeccccc
Confidence               78999999975 7877774  56999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCc--------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV--------  318 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--------  318 (469)
                      .........+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+....+..+...........        
T Consensus       178 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~  257 (371)
T 2xrw_A          178 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTV  257 (371)
T ss_dssp             ------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHH
T ss_pred             ccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHH
Confidence            65555566789999999999976 489999999999999999999999999888777766654321110000        


Q ss_pred             ------------------------------ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          319 ------------------------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       319 ------------------------------~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                                    ....+.++++||.+||..||.+|||+.|+|+||||..+
T Consensus       258 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          258 RTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence                                          01125689999999999999999999999999999644

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=2e-49  Score=405.47  Aligned_cols=255  Identities=31%  Similarity=0.435  Sum_probs=213.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC------eEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEEAD------CFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~------~~~  173 (469)
                      ....+|.+++.||+|+||.||+|++..++. ||+|.+........+|+++|+.+. ||||++++++|...+      .+|
T Consensus        37 ~~~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~~~E~~il~~l~-h~niv~l~~~~~~~~~~~~~~~~~  114 (394)
T 4e7w_A           37 QREIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFKNRELQIMRIVK-HPNVVDLKAFFYSNGDKKDEVFLN  114 (394)
T ss_dssp             EEEEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSCCHHHHHHHTCC-CTTBCCEEEEEEEESSSSSCEEEE
T ss_pred             cccceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchHHHHHHHHHhCC-CCCcceEEEEEEecCCCCCceEEE
Confidence            356789999999999999999999987766 888888766666678999999996 999999999985433      388


Q ss_pred             EEEeccCCCchHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-cCCcEEEEeccceeeecC
Q 012170          174 LVMELCSGGRLIDQM---VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAMRISN  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-~~~~vkL~DFgla~~~~~  249 (469)
                      +||||++++.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||++.....
T Consensus       115 lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~  194 (394)
T 4e7w_A          115 LVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA  194 (394)
T ss_dssp             EEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCT
T ss_pred             EEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccC
Confidence            999999875443322   2256799999999999999999999999999999999999999 799999999999988766


Q ss_pred             CCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc----------------
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK----------------  311 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~----------------  311 (469)
                      ........||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..+....                
T Consensus       195 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~  274 (394)
T 4e7w_A          195 GEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYM  274 (394)
T ss_dssp             TCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGS
T ss_pred             CCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhh
Confidence            666667889999999999965  48999999999999999999999999988776666554311                


Q ss_pred             -CCCCC--------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          312 -LDFHS--------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       312 -~~~~~--------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                       ..++.        .....+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       275 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          275 EHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             SSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             hhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence             00110        0113478999999999999999999999999999999644

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=1.2e-48  Score=404.15  Aligned_cols=255  Identities=25%  Similarity=0.380  Sum_probs=217.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhh-----CCCCeeEEEEEEEeCC
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-----GHTGVVTLHSVYEEAD  170 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~-----~hpnIv~l~~~~~~~~  170 (469)
                      ..+..+|++++.||+|+||.||+|.+..+++.||||+++...   ..+.+|+.+++.+.     +|+||+++++++...+
T Consensus        93 ~~~~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~  172 (429)
T 3kvw_A           93 DHVAYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRN  172 (429)
T ss_dssp             CEETTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETT
T ss_pred             CcccCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCccchHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCC
Confidence            456788999999999999999999999999999999997653   45778999999885     4779999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc--EEEEeccceee
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK--IKLADFGLAMR  246 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~--vkL~DFgla~~  246 (469)
                      .+|+||||+. ++|.+++....  .+++..+..++.||+.||.|||++||+||||||+||||+.++.  +||+|||++..
T Consensus       173 ~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~  251 (429)
T 3kvw_A          173 HICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY  251 (429)
T ss_dssp             EEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEE
T ss_pred             eEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeeccccee
Confidence            9999999996 58999887754  4999999999999999999999999999999999999999987  99999999975


Q ss_pred             ecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC----------
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH----------  315 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~----------  315 (469)
                      ..  ......+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+          
T Consensus       252 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~  329 (429)
T 3kvw_A          252 EH--QRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRA  329 (429)
T ss_dssp             TT--CCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTH
T ss_pred             cC--CcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhh
Confidence            43  33445689999999999976 599999999999999999999999999888777666543210000          


Q ss_pred             ----------------------------------------CCc-----ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          316 ----------------------------------------SGV-----WETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       316 ----------------------------------------~~~-----~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                                                              ...     ....++++.+||.+||+.||.+|||+.|+|+|
T Consensus       330 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~H  409 (429)
T 3kvw_A          330 KNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRH  409 (429)
T ss_dssp             HHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred             hhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCC
Confidence                                                    000     01237889999999999999999999999999


Q ss_pred             CCcccc
Q 012170          351 PWILFY  356 (469)
Q Consensus       351 p~~~~~  356 (469)
                      |||...
T Consensus       410 pw~~~~  415 (429)
T 3kvw_A          410 PWLRRR  415 (429)
T ss_dssp             TTTC--
T ss_pred             hhhccC
Confidence            999643

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=7.4e-49  Score=379.87  Aligned_cols=254  Identities=31%  Similarity=0.540  Sum_probs=219.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++...     .+.+.+|+.+++.+. ||||+++++++.+.+..|+|
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   83 (276)
T 2yex_A            5 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLF   83 (276)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGCTTHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             eecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccchhhhHHHHHHHHHHHhcC-CCCceeeeeEEEcCCEEEEE
Confidence            457899999999999999999999999999999998532     256889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---c
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---T  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~  252 (469)
                      |||+++++|.+++.....+++..+..++.||+.||.|||++|++||||||+||+++.++.++|+|||++.......   .
T Consensus        84 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~  163 (276)
T 2yex_A           84 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  163 (276)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhc
Confidence            9999999999999777789999999999999999999999999999999999999999999999999997654322   2


Q ss_pred             ccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .....||+.|+|||++.+.  ++.++||||||+++|+|++|..||.+.... ..+..+.......  ..+..++..+.+|
T Consensus       164 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~l  241 (276)
T 2yex_A          164 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL--NPWKKIDSAPLAL  241 (276)
T ss_dssp             BCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHHHTTCTTS--TTGGGSCHHHHHH
T ss_pred             ccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHhhhccccc--CchhhcCHHHHHH
Confidence            3456899999999999763  377899999999999999999999875432 2333333332222  2356789999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      |.+||..||.+|||+.|+++||||....
T Consensus       242 i~~~l~~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          242 LHKILVENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred             HHHHCCCCchhCCCHHHHhcCccccChh
Confidence            9999999999999999999999996543

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=1.9e-48  Score=380.50  Aligned_cols=249  Identities=20%  Similarity=0.380  Sum_probs=216.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCF  172 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~  172 (469)
                      ..|.+.+.||+|+||.||+|.+..++..||+|++...      ...+.+|+.+|+.+. ||||+++++++..    ...+
T Consensus        26 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~  104 (290)
T 1t4h_A           26 RFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCI  104 (290)
T ss_dssp             CEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEE
T ss_pred             eeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhhCHHHHHHHHHHHHHHHhCC-CCCeeeeeeeeccccCCCceE
Confidence            4688899999999999999999999999999998642      245788999999996 9999999999875    4568


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEc-cCCcEEEEeccceeeecC
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLT-TSGKIKLADFGLAMRISN  249 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~-~~~~vkL~DFgla~~~~~  249 (469)
                      |+||||+++|+|.+++...+.+++..+..++.||+.||.|||+.|  |+||||||+|||++ .++.+||+|||++.....
T Consensus       105 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~  184 (290)
T 1t4h_A          105 VLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA  184 (290)
T ss_dssp             EEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred             EEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccc
Confidence            999999999999999998899999999999999999999999999  99999999999998 789999999999965433


Q ss_pred             CCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          250 GQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                       .......||+.|+|||++.+.++.++||||||+++|+|++|..||.+. ........+.....  +.......++++.+
T Consensus       185 -~~~~~~~~t~~y~aPE~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~l~~  261 (290)
T 1t4h_A          185 -SFAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKE  261 (290)
T ss_dssp             -TSBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHH
T ss_pred             -cccccccCCcCcCCHHHHhccCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHHHHHHhccCC--ccccCCCCCHHHHH
Confidence             333456799999999999988999999999999999999999999874 44555555544322  22233567899999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ||.+||..||.+|||+.|+|+||||..
T Consensus       262 li~~~l~~dp~~Rps~~ell~h~~f~~  288 (290)
T 1t4h_A          262 IIEGCIRQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHTSGGGC-
T ss_pred             HHHHHccCChhhCCCHHHHhhCccccc
Confidence            999999999999999999999999953

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=9.4e-49  Score=394.04  Aligned_cols=252  Identities=27%  Similarity=0.421  Sum_probs=219.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...+.|.+++.||+|+||.||+|++..+|+.||||++...       ...+.+|+++|+.+. ||||+++++++.+.+..
T Consensus        51 ~~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~  129 (348)
T 1u5q_A           51 DPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTA  129 (348)
T ss_dssp             CHHHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEE
T ss_pred             chhhheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCeE
Confidence            4557799999999999999999999999999999998642       145789999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+. |+|.+.+. ..+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....  
T Consensus       130 ~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--  206 (348)
T 1u5q_A          130 WLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--  206 (348)
T ss_dssp             EEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--
T ss_pred             EEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--
Confidence            99999997 57777775 456799999999999999999999999999999999999999999999999999976543  


Q ss_pred             cccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                       ....+||+.|+|||++.    +.++.++|||||||++|+|++|.+||.+.+....+..+........  ....++..+.
T Consensus       207 -~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  283 (348)
T 1u5q_A          207 -ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFR  283 (348)
T ss_dssp             -BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHH
T ss_pred             -CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCCCC--CCCCCCHHHH
Confidence             23468999999999984    3589999999999999999999999998887776666655433221  2246799999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          328 DLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +||.+||..||.+|||+.++|+||||.....
T Consensus       284 ~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~  314 (348)
T 1u5q_A          284 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERP  314 (348)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHTTCHHHHSCCC
T ss_pred             HHHHHHcccChhhCcCHHHHhhChhhhccCC
Confidence            9999999999999999999999999965543

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=2.2e-48  Score=377.77  Aligned_cols=250  Identities=29%  Similarity=0.440  Sum_probs=212.7

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ...+.++|++++.||+|+||.||+|.+..+++.||||++...      ...+.+|+.++..+..||||+++++++.+.+.
T Consensus         6 ~~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~   85 (289)
T 1x8b_A            6 KSRYTTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDH   85 (289)
T ss_dssp             CCHHHHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCTTSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTE
T ss_pred             cccccchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEecccccccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCe
Confidence            345678999999999999999999999999999999998642      35677899999999559999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC--------------
Q 012170          172 FHLVMELCSGGRLIDQMVEV----GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS--------------  233 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~----~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~--------------  233 (469)
                      +|+||||++||+|.+++...    +.+++..+..++.||+.||.|||++||+||||||+|||++.+              
T Consensus        86 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~  165 (289)
T 1x8b_A           86 MLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDD  165 (289)
T ss_dssp             EEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC----------------
T ss_pred             EEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEEEcCCCCCccccccccccc
Confidence            99999999999999999765    679999999999999999999999999999999999999854              


Q ss_pred             -----CcEEEEeccceeeecCCCcccccCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q 012170          234 -----GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDA  306 (469)
Q Consensus       234 -----~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~  306 (469)
                           ..+||+|||++.......   ...||+.|+|||++.+.  ++.++|||||||++|+|++|.+|+....   ....
T Consensus       166 ~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~---~~~~  239 (289)
T 1x8b_A          166 WASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGD---QWHE  239 (289)
T ss_dssp             ----CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSH---HHHH
T ss_pred             ccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchh---HHHH
Confidence                 479999999998765432   34699999999999764  5579999999999999999998876543   2334


Q ss_pred             HHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          307 IKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       307 i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +......   .....+++++.+||.+||..||.+|||+.|+|+||||...
T Consensus       240 ~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          240 IRQGRLP---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             HHTTCCC---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             HHcCCCC---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            4443322   1225689999999999999999999999999999999643

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.2e-49  Score=395.77  Aligned_cols=254  Identities=26%  Similarity=0.404  Sum_probs=213.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...         ...+.+|+.+++.+. ||||+++++++.+.+.
T Consensus         8 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~   86 (346)
T 1ua2_A            8 RAKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSN   86 (346)
T ss_dssp             -----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTC
T ss_pred             HhcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCC-CCCCCeEEEEEeeCCc
Confidence            457899999999999999999999999999999998642         135779999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +|+||||+.+ +|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++......
T Consensus        87 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~  165 (346)
T 1ua2_A           87 ISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSP  165 (346)
T ss_dssp             CEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSC
T ss_pred             eEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCC
Confidence            9999999986 788877654 36899999999999999999999999999999999999999999999999999765433


Q ss_pred             -CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC----------
Q 012170          251 -QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG----------  317 (469)
Q Consensus       251 -~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~----------  317 (469)
                       ......+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+..........          
T Consensus       166 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  245 (346)
T 1ua2_A          166 NRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPD  245 (346)
T ss_dssp             CCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTT
T ss_pred             cccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcc
Confidence             23455689999999999965  38899999999999999999999999988877777664421111111          


Q ss_pred             --------------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          318 --------------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       318 --------------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                    .+..++.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       246 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~  298 (346)
T 1ua2_A          246 YVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSNR  298 (346)
T ss_dssp             CCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSS
T ss_pred             cccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhcChhhhcC
Confidence                          124567999999999999999999999999999999643

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=3.9e-48  Score=380.70  Aligned_cols=254  Identities=29%  Similarity=0.464  Sum_probs=225.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..+.|++++.||+|+||.||+|.+..+++.||||++...     ...+.+|+.+++.+. ||||+++++++.+.+.+|+|
T Consensus        20 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   98 (303)
T 3a7i_A           20 PEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCD-SPYVTKYYGSYLKDTKLWII   98 (303)
T ss_dssp             GGGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTCSTTHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             hHHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEecccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCCeEEEE
Confidence            457899999999999999999999999999999998542     367889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-ccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      |||++|++|.+++. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++....... ...
T Consensus        99 ~e~~~~~~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  177 (303)
T 3a7i_A           99 MEYLGGGSALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRN  177 (303)
T ss_dssp             EECCTTEEHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBCCBC
T ss_pred             EEeCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCCCCEEEeecccceecCccccccC
Confidence            99999999999884 5789999999999999999999999999999999999999999999999999998765443 234


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++|..||...........+.......   ....++.++.+||.+|
T Consensus       178 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~  254 (303)
T 3a7i_A          178 TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPT---LEGNYSKPLKEFVEAC  254 (303)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC---CCSSCCHHHHHHHHHH
T ss_pred             ccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCCCCC---CccccCHHHHHHHHHH
Confidence            5689999999999976 48999999999999999999999999988887777776544322   2356899999999999


Q ss_pred             chhhhcCCCCHHHHHcCCCccccccc
Q 012170          334 LTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      |..||.+|||+.++|+||||......
T Consensus       255 l~~dp~~Rps~~~ll~~~~~~~~~~~  280 (303)
T 3a7i_A          255 LNKEPSFRPTAKELLKHKFILRNAKK  280 (303)
T ss_dssp             CCSSGGGSCCHHHHTTCHHHHHHCCC
T ss_pred             cCCChhhCcCHHHHhhChhhhcCCCc
Confidence            99999999999999999999655443

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.3e-49  Score=390.78  Aligned_cols=252  Identities=25%  Similarity=0.408  Sum_probs=214.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--e
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--C  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--~  171 (469)
                      ..+.++|.+++.||+|+||.||+|.+..+|+.||||++...     .+.+.+|+++|+.+. ||||+++++++...+  .
T Consensus         5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   83 (319)
T 4euu_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRH   83 (319)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCC
T ss_pred             cCCCCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCcceEEEEeecCCCce
Confidence            45678999999999999999999999999999999998642     356789999999997 999999999998765  7


Q ss_pred             EEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE----ccCCcEEEEeccce
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLA  244 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl----~~~~~vkL~DFgla  244 (469)
                      +|+||||++||+|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a  163 (319)
T 4euu_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (319)
T ss_dssp             EEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTC
T ss_pred             EEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCc
Confidence            8999999999999999976543   9999999999999999999999999999999999999    77888999999999


Q ss_pred             eeecCCCcccccCCCCcccCceecc---------CCCCCccchHHHHHHHHHHHhCCCCCCCCC----HHHHHHHHHcCc
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLS---------GNYSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVK  311 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~---------~~~~~~~DiwSlG~il~elltG~~Pf~~~~----~~~~~~~i~~~~  311 (469)
                      .............||+.|+|||++.         ..++.++|||||||++|+|++|..||....    ..+++..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~  243 (319)
T 4euu_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (319)
T ss_dssp             EECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHC
T ss_pred             eecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCC
Confidence            8877666666778999999999985         458999999999999999999999996422    234444443322


Q ss_pred             CC---------------------CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          312 LD---------------------FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       312 ~~---------------------~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      +.                     ........++..+.+||.+||+.||.+|||+.|+|+||
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             CcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            21                     11111234567889999999999999999999999997

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=3.9e-49  Score=399.67  Aligned_cols=253  Identities=27%  Similarity=0.481  Sum_probs=200.6

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++...    
T Consensus        26 ~~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~  104 (367)
T 2fst_X           26 EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLE  104 (367)
T ss_dssp             EEETTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             CCCCceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccccCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCccc
Confidence            4668999999999999999999999999999999999642      246778999999997 99999999999754    


Q ss_pred             --CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          170 --DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                        ..+|+||||+ +++|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       105 ~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~  182 (367)
T 2fst_X          105 EFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHT  182 (367)
T ss_dssp             GCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECC-------
T ss_pred             cCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhEEECCCCCEEEeeccccccc
Confidence              5689999999 7899888754 68999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-----------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-----------  314 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  314 (469)
                      ..  .....+||++|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+....+..|.......           
T Consensus       183 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~  260 (367)
T 2fst_X          183 AD--EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSE  260 (367)
T ss_dssp             ----------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCH
T ss_pred             cc--cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhH
Confidence            43  2445689999999999976  58999999999999999999999999988777766654321110           


Q ss_pred             ------------CC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          315 ------------HS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       315 ------------~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                  +.    ..+..+++++.+||.+||..||.+|||+.|+|+||||..+.
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~  319 (367)
T 2fst_X          261 SARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYH  319 (367)
T ss_dssp             HHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhcc
Confidence                        00    11235689999999999999999999999999999996543

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.5e-48  Score=383.96  Aligned_cols=257  Identities=26%  Similarity=0.431  Sum_probs=217.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEEe------CC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYEE------AD  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~~------~~  170 (469)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++..   ....+.+|+.+++++..||||+++++++..      .+
T Consensus        21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~  100 (326)
T 2x7f_A           21 DPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD  100 (326)
T ss_dssp             CCTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSTTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCC
T ss_pred             CCCCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCcccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccc
Confidence            467899999999999999999999999999999999854   346789999999999669999999999987      56


Q ss_pred             eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          171 CFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      .+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~  180 (326)
T 2x7f_A          101 QLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLD  180 (326)
T ss_dssp             EEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC---
T ss_pred             eEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecC
Confidence            899999999999999999764  579999999999999999999999999999999999999999999999999997654


Q ss_pred             CC-CcccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          249 NG-QTLSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       249 ~~-~~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      .. .......||+.|+|||++.      ..++.++|||||||++|+|++|..||.+.+.......+.......  .....
T Consensus       181 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~  258 (326)
T 2x7f_A          181 RTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPR--LKSKK  258 (326)
T ss_dssp             ----------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC--CSCSC
T ss_pred             cCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcccc--CCccc
Confidence            32 2234567999999999985      348899999999999999999999999888777666665443221  12346


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ++..+.+||.+||..||.+|||+.++|+||||.....
T Consensus       259 ~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          259 WSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             SCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             cCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            7999999999999999999999999999999976543

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-48  Score=398.61  Aligned_cols=249  Identities=23%  Similarity=0.379  Sum_probs=211.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhC-CCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSG-HTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~-hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+|++++.||+|+||.||+|.+.. ++.||||++...      ...+.+|+.+|+.|.. ||||+++++++...+.+|+|
T Consensus        56 ~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv  134 (390)
T 2zmd_A           56 RIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMV  134 (390)
T ss_dssp             EEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccccHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEE
Confidence            469999999999999999999875 899999998643      2567899999999974 69999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---c
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---T  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~  252 (469)
                      || +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++..+....   .
T Consensus       135 ~E-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~  212 (390)
T 2zmd_A          135 ME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVV  212 (390)
T ss_dssp             EE-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC--------
T ss_pred             Ee-cCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCcccc
Confidence            99 56889999999888999999999999999999999999999999999999995 5899999999998664332   2


Q ss_pred             ccccCCCCcccCceeccC------------CCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCcCCCCCCcc
Q 012170          253 LSGLAGSPAYVAPEVLSG------------NYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVW  319 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~  319 (469)
                      ....+||+.|+|||++.+            .|+.++|||||||++|+|++|.+||.+. .....+..+......+...  
T Consensus       213 ~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~--  290 (390)
T 2zmd_A          213 KDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP--  290 (390)
T ss_dssp             -CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC--
T ss_pred             CCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC--
Confidence            345689999999999864            5889999999999999999999999875 3344555555544333222  


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ...+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       291 ~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~  327 (390)
T 2zmd_A          291 DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  327 (390)
T ss_dssp             CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCcccc
Confidence            3458899999999999999999999999999999654

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=1.4e-48  Score=394.60  Aligned_cols=254  Identities=25%  Similarity=0.450  Sum_probs=215.6

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEA-----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----  169 (469)
                      .+.++|++++.||+|+||.||+|.+..++..||||++....     ..+.+|+++|+.+. ||||+++++++...     
T Consensus        24 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~  102 (364)
T 3qyz_A           24 DVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQM  102 (364)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTC
T ss_pred             cccccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccccCcHHHHHHHHHHHHHHhcC-CCCCccceeEEecCCcccc
Confidence            35579999999999999999999999999999999996432     45779999999997 99999999999765     


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ..+|+||||+. |+|.+++. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       103 ~~~~iv~e~~~-~~L~~~l~-~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~  180 (364)
T 3qyz_A          103 KDVYIVQDLME-TDLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP  180 (364)
T ss_dssp             CCEEEEEECCS-EEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCG
T ss_pred             ceEEEEEcccC-cCHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEEECCCCCEEEEeCcceEecCC
Confidence            46899999997 58988875 46799999999999999999999999999999999999999999999999999987643


Q ss_pred             CCc----ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC--------
Q 012170          250 GQT----LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH--------  315 (469)
Q Consensus       250 ~~~----~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~--------  315 (469)
                      ...    ....+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........        
T Consensus       181 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  260 (364)
T 3qyz_A          181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCII  260 (364)
T ss_dssp             GGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCC
T ss_pred             CCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhh
Confidence            322    345689999999998754  389999999999999999999999998876666555532111100        


Q ss_pred             -------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          316 -------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       316 -------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                         ...+..+++++.+||.+||+.||.+|||+.|+|+||||..+
T Consensus       261 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          261 NLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             CHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhc
Confidence                               00124578999999999999999999999999999999655

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=9.1e-49  Score=394.94  Aligned_cols=258  Identities=24%  Similarity=0.402  Sum_probs=220.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ...++|++++.||+|+||.||+|.+..+|..||+|++...     ...+.+|+.+|+.+. ||||+++++++.+++.+|+
T Consensus        30 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  108 (360)
T 3eqc_A           30 LKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISI  108 (360)
T ss_dssp             CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECCCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEETTEEEE
T ss_pred             cccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccccCHHHHHHHHHHHHHHHHCC-CCCEEEEeEEEEECCEEEE
Confidence            3567899999999999999999999999999999998653     256789999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      ||||++||+|.+++...+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++...... ..
T Consensus       109 v~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-~~  187 (360)
T 3eqc_A          109 CMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MA  187 (360)
T ss_dssp             EECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-C-
T ss_pred             EEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc-cc
Confidence            999999999999999989999999999999999999999996 9999999999999999999999999998654322 23


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-------------------------
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI-------------------------  307 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i-------------------------  307 (469)
                      ....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.......+                         
T Consensus       188 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  267 (360)
T 3eqc_A          188 NSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF  267 (360)
T ss_dssp             ---CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHHC------------------------
T ss_pred             cCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCccccc
Confidence            44689999999999976 4899999999999999999999999877655433221                         


Q ss_pred             -----------------HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccc
Q 012170          308 -----------------KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       308 -----------------~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~  361 (469)
                                       .....  +......++.++.+||.+||..||.+|||+.|+|+||||.......+
T Consensus       268 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~  336 (360)
T 3eqc_A          268 GMDSRPPMAIFELLDYIVNEPP--PKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEV  336 (360)
T ss_dssp             ------CCCHHHHHHHHHHSCC--CCCCTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHHHHHSCC
T ss_pred             ccCCCCcccchhhhhHHhccCC--CCCCcccccHHHHHHHHHHhhcChhhCCCHHHHhhChHhhcchHhhh
Confidence                             11111  11112357899999999999999999999999999999976554443

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=1.9e-48  Score=389.70  Aligned_cols=254  Identities=33%  Similarity=0.594  Sum_probs=189.7

Q ss_pred             cccCCeeeee-eeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEEE
Q 012170          100 KIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~l  174 (469)
                      .+.++|.+++ .||+|+||.||+|.++.+|+.||||++..... ..+|+..+.++.+||||+++++++..    ...+|+
T Consensus        25 ~~~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~l  103 (336)
T 3fhr_A           25 AVTDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSPK-ARQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLI  103 (336)
T ss_dssp             CGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSHH-HHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEE
T ss_pred             cccceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcHH-HHHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEE
Confidence            4678999965 69999999999999999999999999976544 44455544444469999999999976    456899


Q ss_pred             EEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEeccceeeecC
Q 012170          175 VMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLADFGLAMRISN  249 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~DFgla~~~~~  249 (469)
                      ||||++||+|.+++...+  .+++..++.++.||+.||.|||++||+||||||+|||++.+   +.+||+|||++.....
T Consensus       104 v~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~  183 (336)
T 3fhr_A          104 IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ  183 (336)
T ss_dssp             EEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC--
T ss_pred             EEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceeccc
Confidence            999999999999997764  69999999999999999999999999999999999999864   4599999999976543


Q ss_pred             CCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCcCCCCCCcccCCCH
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAV----FDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      . .....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+......    ...+......++...|..++.
T Consensus       184 ~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  262 (336)
T 3fhr_A          184 N-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSE  262 (336)
T ss_dssp             ---------------------CHHHHHHHHHHHHHHHHHHHHSSCCC---------------------CCCTTTSTTCCH
T ss_pred             c-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccchhhhhhHHHhhhccccccCchhhccCCH
Confidence            2 3345678999999999965 488999999999999999999999987654433    333444455566666778999


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ++.+||.+||..||.+|||+.|+|+||||..
T Consensus       263 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          263 DAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             HHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             HHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            9999999999999999999999999999954

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=6e-49  Score=403.10  Aligned_cols=258  Identities=26%  Similarity=0.438  Sum_probs=198.3

Q ss_pred             cccccCCeee-eeeeeccCCeEEEEEEEC--CCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CC
Q 012170           98 KNKIEDDHTK-VEVIGHGKFGSVWLCRSK--ASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEE--AD  170 (469)
Q Consensus        98 ~~~~~~~y~~-~~~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~  170 (469)
                      ...+.+.|.+ .++||+|+||.||+|+++  .+++.||||++...  ...+.+|+.+|+.|. ||||+++++++..  ..
T Consensus        15 ~~~~~~~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~   93 (405)
T 3rgf_A           15 RERVEDLFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGISMSACREIALLRELK-HPNVISLQKVFLSHADR   93 (405)
T ss_dssp             CCCHHHHEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSCCHHHHHHHHHHHHCC-CTTBCCCCEEEEETTTT
T ss_pred             hhhhhhhhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCCCHHHHHHHHHHHhcC-CCCeeeEeeEEecCCCC
Confidence            3456778888 458999999999999976  56889999999753  357889999999997 9999999999954  77


Q ss_pred             eEEEEEeccCCCchHHHHHHh---------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE----ccCCcEE
Q 012170          171 CFHLVMELCSGGRLIDQMVEV---------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL----TTSGKIK  237 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~---------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl----~~~~~vk  237 (469)
                      .+|+||||+.+ +|.+++...         ..+++..++.++.||+.||.|||++||+||||||+||||    +.++.+|
T Consensus        94 ~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~k  172 (405)
T 3rgf_A           94 KVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVK  172 (405)
T ss_dssp             EEEEEEECCSE-EHHHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEE
T ss_pred             eEEEEEeCCCC-CHHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEE
Confidence            89999999965 787777532         249999999999999999999999999999999999999    6778999


Q ss_pred             EEeccceeeecCC----CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------H
Q 012170          238 LADFGLAMRISNG----QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLE---------A  302 (469)
Q Consensus       238 L~DFgla~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------~  302 (469)
                      |+|||++......    ......+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+....         +
T Consensus       173 l~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~  252 (405)
T 3rgf_A          173 IADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHD  252 (405)
T ss_dssp             ECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHH
T ss_pred             EEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHH
Confidence            9999999866432    22345789999999999976  3899999999999999999999999865532         3


Q ss_pred             HHHHHHcCcCCCCCCccc----------------------------------CCCHHHHHHHHHhchhhhcCCCCHHHHH
Q 012170          303 VFDAIKNVKLDFHSGVWE----------------------------------TVSKPARDLMARMLTRDVSARITADEVL  348 (469)
Q Consensus       303 ~~~~i~~~~~~~~~~~~~----------------------------------~~s~~~~~lI~~~L~~dP~~Rpsa~elL  348 (469)
                      .+..|...........|.                                  ..+..+.+||.+||..||.+|||+.|+|
T Consensus       253 ~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L  332 (405)
T 3rgf_A          253 QLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAM  332 (405)
T ss_dssp             HHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred             HHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHh
Confidence            333332221111111121                                  1278899999999999999999999999


Q ss_pred             cCCCccccc
Q 012170          349 RHPWILFYT  357 (469)
Q Consensus       349 ~hp~~~~~~  357 (469)
                      +||||....
T Consensus       333 ~hp~f~~~~  341 (405)
T 3rgf_A          333 QDPYFLEDP  341 (405)
T ss_dssp             TSGGGTSSS
T ss_pred             cChhhccCC
Confidence            999997544

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=4.1e-48  Score=379.88  Aligned_cols=259  Identities=27%  Similarity=0.419  Sum_probs=220.6

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .....++|++++.||+|+||.||+|.+..+|..||+|++...    ...+.+|+.+++.+. ||||+++++++.+.+.+|
T Consensus        14 ~~~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   92 (302)
T 2j7t_A           14 DLDPNEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCD-HPYIVKLLGAYYHDGKLW   92 (302)
T ss_dssp             SSCGGGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC----CCHHHHHHHHHHHHHCC-CTTBCCEEEEEECC-CEE
T ss_pred             ccCCccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCCHHHHHHHHHHHHHHhcCC-CCCEeeeeeeeeeCCeEE
Confidence            345678999999999999999999999999999999998642    367889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-C
Q 012170          174 LVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-Q  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~  251 (469)
                      +||||+++++|.+++.. .+.+++..+..++.||+.||.|||++|++||||||+|||++.++.+||+|||++...... .
T Consensus        93 lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (302)
T 2j7t_A           93 IMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQ  172 (302)
T ss_dssp             EEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHHH
T ss_pred             EEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECCCCCEEEEECCCCcccccccc
Confidence            99999999999998866 467999999999999999999999999999999999999999999999999997543211 1


Q ss_pred             cccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          252 TLSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ......||+.|+|||++.      ..++.++||||||+++|+|++|..||.+.+.......+........ .....++.+
T Consensus       173 ~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~  251 (302)
T 2j7t_A          173 KRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSDPPTL-LTPSKWSVE  251 (302)
T ss_dssp             C-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC-SSGGGSCHH
T ss_pred             ccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHhccCCccc-CCccccCHH
Confidence            233457999999999983      3588999999999999999999999999888777776665543221 123567999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      +.+||.+||..||.+|||+.++++||||.....
T Consensus       252 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          252 FRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             HHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            999999999999999999999999999976554

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=4.6e-48  Score=384.52  Aligned_cols=255  Identities=27%  Similarity=0.450  Sum_probs=216.3

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEE-CCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCC------CeeEEEEEEE
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRS-KASGAEFACKTLRKGE---ETVHREVEIMQHLSGHT------GVVTLHSVYE  167 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~-~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hp------nIv~l~~~~~  167 (469)
                      ...+.++|++++.||+|+||.||+|.+ ..+|+.||||+++...   +.+.+|+.+++.+. |+      +|+++++++.
T Consensus         9 g~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~e~~~l~~l~-~~~~~~~~~i~~~~~~~~   87 (339)
T 1z57_A            9 GDVLSARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNVDRYCEAARSEIQVLEHLN-TTDPNSTFRCVQMLEWFE   87 (339)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHH-HHCTTCTTCBCCEEEEEE
T ss_pred             CCCccCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecCCchhHHHHHHHHHHHHhh-hcCCCCceeeEeeecccc
Confidence            345778999999999999999999998 5688999999997643   56788999999987 55      4999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-------------
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-------------  232 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-------------  232 (469)
                      ..+.+|+||||+ +++|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.             
T Consensus        88 ~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~  166 (339)
T 1z57_A           88 HHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKR  166 (339)
T ss_dssp             ETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----C
T ss_pred             cCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCcccc
Confidence            999999999999 889999998765  6899999999999999999999999999999999999987             


Q ss_pred             ------CCcEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q 012170          233 ------SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFD  305 (469)
Q Consensus       233 ------~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~  305 (469)
                            ++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+...
T Consensus       167 ~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~  244 (339)
T 1z57_A          167 DERTLINPDIKVVDFGSATYDDE--HHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLA  244 (339)
T ss_dssp             EEEEESCCCEEECCCSSCEETTS--CCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHH
T ss_pred             ccccccCCCceEeeCcccccCcc--ccccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence                  66899999999976433  3345689999999999976 58999999999999999999999999888776665


Q ss_pred             HHHcCcCCCCCC----------------cc------------------------cCCCHHHHHHHHHhchhhhcCCCCHH
Q 012170          306 AIKNVKLDFHSG----------------VW------------------------ETVSKPARDLMARMLTRDVSARITAD  345 (469)
Q Consensus       306 ~i~~~~~~~~~~----------------~~------------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~  345 (469)
                      .+......++..                .|                        ...++++.+||.+||..||.+|||+.
T Consensus       245 ~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~  324 (339)
T 1z57_A          245 MMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLR  324 (339)
T ss_dssp             HHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHH
T ss_pred             HHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHH
Confidence            554322211110                01                        12356788999999999999999999


Q ss_pred             HHHcCCCcccc
Q 012170          346 EVLRHPWILFY  356 (469)
Q Consensus       346 elL~hp~~~~~  356 (469)
                      |+|+||||...
T Consensus       325 ell~hp~f~~~  335 (339)
T 1z57_A          325 EALKHPFFDLL  335 (339)
T ss_dssp             HHTTSGGGGGG
T ss_pred             HHhcCHHHHHH
Confidence            99999999644

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=5.5e-48  Score=392.95  Aligned_cols=256  Identities=25%  Similarity=0.376  Sum_probs=215.6

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCC-----eeEEEEEEEeC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTG-----VVTLHSVYEEA  169 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpn-----Iv~l~~~~~~~  169 (469)
                      ...+.++|++++.||+|+||.||+|.+..+++.||||+++...   ..+.+|+.+++.+..|++     |+++++++...
T Consensus        49 ~~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~  128 (382)
T 2vx3_A           49 GEKWMDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNKKAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR  128 (382)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSSHHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred             CCEeeeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEeccHHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence            4457789999999999999999999999999999999997653   456789999999875664     99999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHH--hcCeEeccCCCCcEEEc--cCCcEEEEeccc
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCH--DMGVVHRDIKPENILLT--TSGKIKLADFGL  243 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH--~~givHrDlkp~NILl~--~~~~vkL~DFgl  243 (469)
                      +.+|+||||+. |+|.+++...  +.+++..+..++.||+.||.|||  +.||+||||||+|||++  .++.+||+|||+
T Consensus       129 ~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~  207 (382)
T 2vx3_A          129 NHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGS  207 (382)
T ss_dssp             TEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTT
T ss_pred             CceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccC
Confidence            99999999996 5999998765  46999999999999999999999  57999999999999995  477899999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC-------
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH-------  315 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~-------  315 (469)
                      +.....  .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..+.......+       
T Consensus       208 a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  285 (382)
T 2vx3_A          208 SCQLGQ--RIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQA  285 (382)
T ss_dssp             CEETTC--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTC
T ss_pred             ceeccc--ccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhh
Confidence            987643  3345789999999999977 589999999999999999999999999888777766654211110       


Q ss_pred             -----------CCccc-----------------C-------------------------CCHHHHHHHHHhchhhhcCCC
Q 012170          316 -----------SGVWE-----------------T-------------------------VSKPARDLMARMLTRDVSARI  342 (469)
Q Consensus       316 -----------~~~~~-----------------~-------------------------~s~~~~~lI~~~L~~dP~~Rp  342 (469)
                                 ...|.                 .                         .++++.+||.+||+.||.+||
T Consensus       286 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rp  365 (382)
T 2vx3_A          286 PKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRI  365 (382)
T ss_dssp             TTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSC
T ss_pred             HHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCC
Confidence                       00000                 0                         014789999999999999999


Q ss_pred             CHHHHHcCCCcccc
Q 012170          343 TADEVLRHPWILFY  356 (469)
Q Consensus       343 sa~elL~hp~~~~~  356 (469)
                      |+.|+|+||||...
T Consensus       366 ta~e~L~hp~f~~~  379 (382)
T 2vx3_A          366 QPYYALQHSFFKKT  379 (382)
T ss_dssp             CHHHHTTSGGGCC-
T ss_pred             CHHHHhcCcccccC
Confidence            99999999999654

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=2.9e-48  Score=380.94  Aligned_cols=253  Identities=28%  Similarity=0.443  Sum_probs=213.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .+.++|++++.||+|+||.||+|.+..++..||+|++...       ...+.+|+.+++.+. ||||+++++++.+.+.+
T Consensus         8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~   86 (294)
T 4eqm_A            8 IINERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLS-HQNIVSMIDVDEEDDCY   86 (294)
T ss_dssp             CEETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-BTTBCCEEEEEECSSEE
T ss_pred             HhhccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCC-CCCCceEEEeeeeCCeE
Confidence            4678999999999999999999999999999999998431       246788999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      |+||||++||+|.+++...+++++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus        87 ~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  166 (294)
T 4eqm_A           87 YLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL  166 (294)
T ss_dssp             EEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC-----
T ss_pred             EEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc
Confidence            9999999999999999998999999999999999999999999999999999999999999999999999997654332 


Q ss_pred             -cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-CCCCCCcccCCCHHHHH
Q 012170          252 -TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-LDFHSGVWETVSKPARD  328 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~  328 (469)
                       .....+||+.|+|||++.+. ++.++||||||+++|+|++|..||.+.+............ ..........+++.+.+
T Consensus       167 ~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  246 (294)
T 4eqm_A          167 TQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSN  246 (294)
T ss_dssp             --------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHH
T ss_pred             cccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHH
Confidence             23346799999999999774 8899999999999999999999999988766554444332 22222234578999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +|.+||..||.+||+..+.+.+.|.
T Consensus       247 li~~~l~~dp~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          247 VILRATEKDKANRYKTIQEMKDDLS  271 (294)
T ss_dssp             HHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHHhcCCHhHccccHHHHHHHHH
Confidence            9999999999999966566655553

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.9e-48  Score=378.47  Aligned_cols=252  Identities=23%  Similarity=0.353  Sum_probs=198.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HH-HHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ET-VHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~-~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||+|+++...     .. +..+...++.+ .||||+++++++.+.+..|+
T Consensus         5 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~-~h~~iv~~~~~~~~~~~~~l   83 (290)
T 3fme_A            5 KADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNSQEQKRLLMDLDISMRTV-DCPFTVTFYGALFREGDVWI   83 (290)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC---CHHHHHHHHHHHHHHHTTC-CCTTBCCEEEEEECSSSEEE
T ss_pred             cHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeecccCcHHHHHHHHHHHHHHHhC-CCCeEEEEeeeeeccCCEEE
Confidence            4578999999999999999999999999999999996531     12 23344445566 49999999999999999999


Q ss_pred             EEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          175 VMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ||||++| +|.+++..    .+.+++..+..++.||+.||.|||++ ||+||||||+|||++.++.+||+|||++.....
T Consensus        84 v~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~  162 (290)
T 3fme_A           84 CMELMDT-SLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD  162 (290)
T ss_dssp             EEECCSE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEECTTCCEEBCCC--------
T ss_pred             EEehhcc-chHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccc
Confidence            9999975 77776643    46799999999999999999999998 999999999999999999999999999987766


Q ss_pred             CCcccccCCCCcccCceecc----C-CCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHH-HHHcCcCCCCCCcccCC
Q 012170          250 GQTLSGLAGSPAYVAPEVLS----G-NYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFD-AIKNVKLDFHSGVWETV  322 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~----~-~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~-~i~~~~~~~~~~~~~~~  322 (469)
                      ........||+.|+|||++.    + .++.++||||||+++|+|++|..||.. ......+. .+.......+   ...+
T Consensus       163 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~  239 (290)
T 3fme_A          163 DVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQLP---ADKF  239 (290)
T ss_dssp             -------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCC---TTTS
T ss_pred             cccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHHHHHHhccCCCCcc---cccC
Confidence            55555568999999999963    2 488899999999999999999999985 33333333 3333333322   2467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~  274 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHE  274 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCc
Confidence            99999999999999999999999999999996543

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=1.8e-47  Score=377.66  Aligned_cols=256  Identities=28%  Similarity=0.409  Sum_probs=218.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ...++|++++.||+|+||.||+|.+..+|+.||||++...  ...+.+|+.+++.+. ||||+++++++...+.+|+|||
T Consensus        26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e  104 (314)
T 3com_A           26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVESDLQEIIKEISIMQQCD-SPHVVKYYGSYFKNTDLWIVME  104 (314)
T ss_dssp             ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTSCCHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchHHHHHHHHHHHHHHhCC-CCCCccEEEEEEeCCEEEEEee
Confidence            3567899999999999999999999999999999999653  467899999999996 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||+.|++|+||||+|||++.++.+||+|||++....... ....
T Consensus       105 ~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~  184 (314)
T 3com_A          105 YCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT  184 (314)
T ss_dssp             CCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBSCBCC
T ss_pred             cCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhccccCc
Confidence            9999999999863 5679999999999999999999999999999999999999999999999999998765432 2345


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      ..||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+....... ......++.++.+||.+||
T Consensus       185 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~l~~li~~~l  263 (314)
T 3com_A          185 VIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPT-FRKPELWSDNFTDFVKQCL  263 (314)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCC-CSSGGGSCHHHHHHHHHHT
T ss_pred             cCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhcCCCcc-cCCcccCCHHHHHHHHHHc
Confidence            679999999999976 48999999999999999999999999887766665554443221 1123467999999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccccc
Q 012170          335 TRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ..||.+|||+.++|+||||....
T Consensus       264 ~~dp~~Rpt~~~ll~~~~~~~~~  286 (314)
T 3com_A          264 VKSPEQRATATQLLQHPFVRSAK  286 (314)
T ss_dssp             CSCTTTSCCHHHHTTSHHHHTCC
T ss_pred             cCChhhCcCHHHHHhCHHHhcCC
Confidence            99999999999999999996543

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.9e-48  Score=386.96  Aligned_cols=251  Identities=23%  Similarity=0.362  Sum_probs=207.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCC-CCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGH-TGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~h-pnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++++.||+|+||.||+|.+. +++.||||++...      ...+.+|+.+|+.+..| |||+++++++.+.+.+|
T Consensus         7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~   85 (343)
T 3dbq_A            7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY   85 (343)
T ss_dssp             SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTTCCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred             ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccccchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEE
Confidence            3467999999999999999999885 6899999998643      14678899999999732 99999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      +|||+ .+|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ 
T Consensus        86 lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~  163 (343)
T 3dbq_A           86 MVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  163 (343)
T ss_dssp             EEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------
T ss_pred             EEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCccccc
Confidence            99995 5889999999989999999999999999999999999999999999999996 68899999999976543322 


Q ss_pred             --ccccCCCCcccCceecc------------CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCC
Q 012170          253 --LSGLAGSPAYVAPEVLS------------GNYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       253 --~~~~~gt~~y~aPE~l~------------~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~  317 (469)
                        ....+||+.|+|||++.            +.++.++|||||||++|+|++|..||.+.. ....+..+.......  .
T Consensus       164 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~--~  241 (343)
T 3dbq_A          164 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEI--E  241 (343)
T ss_dssp             ------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCC--C
T ss_pred             ccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCccc--C
Confidence              34568999999999985            358889999999999999999999998643 333444444332222  1


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .....+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       242 ~~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~  280 (343)
T 3dbq_A          242 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  280 (343)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSC
T ss_pred             CcccCCHHHHHHHHHHcCCChhHCCCHHHHHhCcccccc
Confidence            224567899999999999999999999999999999644

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=2.6e-48  Score=389.19  Aligned_cols=260  Identities=25%  Similarity=0.468  Sum_probs=226.8

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---------------------HHHHHHHHHHHHhhCC
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---------------------ETVHREVEIMQHLSGH  156 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---------------------~~~~~E~~il~~l~~h  156 (469)
                      .....++|.+++.||+|+||.||+|.+  +|+.||||++....                     ..+.+|+.+++.+. |
T Consensus        26 ~~~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h  102 (348)
T 2pml_X           26 KDKYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK-N  102 (348)
T ss_dssp             SCEEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCC-C
T ss_pred             cccccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCC-C
Confidence            345668999999999999999999998  79999999985321                     77899999999997 9


Q ss_pred             CCeeEEEEEEEeCCeEEEEEeccCCCchHHH------HHH--hCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCc
Q 012170          157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQ------MVE--VGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPEN  227 (469)
Q Consensus       157 pnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~------l~~--~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~N  227 (469)
                      |||+++++++.+.+.+|+||||+++|+|.++      +..  ...+++..+..++.||+.||.|||+ .||+||||||+|
T Consensus       103 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dl~p~N  182 (348)
T 2pml_X          103 EYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSN  182 (348)
T ss_dssp             TTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTSCEECCCCCGGG
T ss_pred             CCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhccCCEeecCCChHh
Confidence            9999999999999999999999999999988      655  5679999999999999999999999 999999999999


Q ss_pred             EEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccCC--CCC-ccchHHHHHHHHHHHhCCCCCCCCCH-HHH
Q 012170          228 ILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN--YSE-KVDIWSAGVLLHALLVAALPFKGDSL-EAV  303 (469)
Q Consensus       228 ILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~-~~DiwSlG~il~elltG~~Pf~~~~~-~~~  303 (469)
                      ||++.++.+||+|||++...... ......||+.|+|||++.+.  ++. ++||||||+++|+|++|..||.+... .+.
T Consensus       183 il~~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~  261 (348)
T 2pml_X          183 ILMDKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVEL  261 (348)
T ss_dssp             EEECTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSCSHHH
T ss_pred             EEEcCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCcHHHH
Confidence            99999999999999999876544 44557899999999999764  555 89999999999999999999988766 777


Q ss_pred             HHHHHcCcCCCCCCc---------------ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccc
Q 012170          304 FDAIKNVKLDFHSGV---------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTL  361 (469)
Q Consensus       304 ~~~i~~~~~~~~~~~---------------~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~  361 (469)
                      ...+......++...               ...++.++.+||.+||..||.+|||+.|+|+||||.......+
T Consensus       262 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~~~~~  334 (348)
T 2pml_X          262 FNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLADTNIEDL  334 (348)
T ss_dssp             HHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCCHHHH
T ss_pred             HHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhcCccccCCCHHHH
Confidence            778877665554211               1468999999999999999999999999999999977654443

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=2e-48  Score=391.73  Aligned_cols=254  Identities=27%  Similarity=0.371  Sum_probs=203.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe------
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADC------  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~------  171 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...   .....+|++.+..+. ||||++++++|...+.      
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~l~~l~-h~niv~~~~~~~~~~~~~~~~~   99 (360)
T 3e3p_A           21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRNRELQIMQDLAVLH-HPNIVQLQSYFYTLGERDRRDI   99 (360)
T ss_dssp             HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCCHHHHHHHHHHHHC-CTTBCCEEEEEEEECSSCTTCE
T ss_pred             hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccHHHHHHHHHHHhcC-CCCcccHHHhhhccccccccce
Confidence            457899999999999999999999999999999998654   245667888888886 9999999999965433      


Q ss_pred             -EEEEEeccCCCchHHHH----HHhCCCCHHHHHHHHHHHHHHHHHHH--hcCeEeccCCCCcEEEcc-CCcEEEEeccc
Q 012170          172 -FHLVMELCSGGRLIDQM----VEVGQYSEQRAANIFKDVMWVIKYCH--DMGVVHRDIKPENILLTT-SGKIKLADFGL  243 (469)
Q Consensus       172 -~~lV~E~~~gg~L~~~l----~~~~~l~~~~~~~i~~qil~aL~yLH--~~givHrDlkp~NILl~~-~~~vkL~DFgl  243 (469)
                       +++||||+.++ |.+.+    .....+++..+..++.||+.||.|||  ++||+||||||+|||++. ++.+||+|||+
T Consensus       100 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~  178 (360)
T 3e3p_A          100 YLNVVMEYVPDT-LHRCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGS  178 (360)
T ss_dssp             EEEEEEECCSCB-HHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTT
T ss_pred             eEEEEeeccccc-HHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCC
Confidence             88999999875 44333    24567899999999999999999999  999999999999999997 89999999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC------
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH------  315 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------  315 (469)
                      +.............||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+....+..+.......+      
T Consensus       179 a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (360)
T 3e3p_A          179 AKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRK  258 (360)
T ss_dssp             CBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHH
T ss_pred             ceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHh
Confidence            988776666667789999999999865  389999999999999999999999999888777766643211100      


Q ss_pred             ----------------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          316 ----------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       316 ----------------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                            .......+.++.+||.+||+.||.+|||+.|+|+||||...
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  321 (360)
T 3e3p_A          259 LNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERMKPYEALCHPYFDEL  321 (360)
T ss_dssp             HCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGG
T ss_pred             cccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccCCHHHHhcCcccccc
Confidence                                  00111257899999999999999999999999999999654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=5.5e-48  Score=379.50  Aligned_cols=250  Identities=30%  Similarity=0.511  Sum_probs=217.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEE--EeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVY--EEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~--~~~~  170 (469)
                      +.++|.+++.||+|+||.||+|.+..++..||+|++...        ...+.+|+.+++.+. ||||+++++++  .+.+
T Consensus         3 l~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   81 (305)
T 2wtk_C            3 LIGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLR-HKNVIQLVDVLYNEEKQ   81 (305)
T ss_dssp             --CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECC---
T ss_pred             cccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcC-CCCeeEEEEEEEcCCCC
Confidence            567899999999999999999999999999999998642        356889999999996 99999999998  4456


Q ss_pred             eEEEEEeccCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          171 CFHLVMELCSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      .+|+||||+.++ |.+++..  .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....
T Consensus        82 ~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~  160 (305)
T 2wtk_C           82 KMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALH  160 (305)
T ss_dssp             CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECC
T ss_pred             eEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEcCCCcEEeeccccccccC
Confidence            899999999876 7676655  3569999999999999999999999999999999999999999999999999998764


Q ss_pred             CC---CcccccCCCCcccCceeccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          249 NG---QTLSGLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       249 ~~---~~~~~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      ..   .......||+.|+|||++.+.   ++.++||||||+++|+|++|..||.+.+.......+......++    ..+
T Consensus       161 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----~~~  236 (305)
T 2wtk_C          161 PFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP----GDC  236 (305)
T ss_dssp             TTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCC----SSS
T ss_pred             ccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHHHHHHHhcCCCCCC----Ccc
Confidence            32   223456799999999999763   47799999999999999999999999998888888887765554    467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++++.+||.+||..||.+|||+.|+++||||...
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~  270 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKK  270 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccC
Confidence            9999999999999999999999999999999543

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=1.5e-47  Score=379.95  Aligned_cols=256  Identities=30%  Similarity=0.445  Sum_probs=218.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-CCCcEEEEEEcccC------hHHHHHHHHHHHHhh--CCCCeeEEEEEEE----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-ASGAEFACKTLRKG------EETVHREVEIMQHLS--GHTGVVTLHSVYE----  167 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-~~~~~vAvK~~~~~------~~~~~~E~~il~~l~--~hpnIv~l~~~~~----  167 (469)
                      ..++|++++.||+|+||.||+|.+. .+|+.||+|++...      ...+.+|+.+++.+.  .||||+++++++.    
T Consensus         9 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~   88 (326)
T 1blx_A            9 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   88 (326)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             chhceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc
Confidence            4578999999999999999999995 67899999998531      236778999988884  5999999999987    


Q ss_pred             -eCCeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          168 -EADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       168 -~~~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                       ....+++||||+. |+|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++
T Consensus        89 ~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~  167 (326)
T 1blx_A           89 DRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA  167 (326)
T ss_dssp             SSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSC
T ss_pred             CCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCccc
Confidence             5567999999997 59999987754  4999999999999999999999999999999999999999999999999999


Q ss_pred             eeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-----C----
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-----F----  314 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-----~----  314 (469)
                      .............||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+.+....+..+......     +    
T Consensus       168 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~  247 (326)
T 1blx_A          168 RIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV  247 (326)
T ss_dssp             CCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTC
T ss_pred             ccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCcccc
Confidence            87655555566789999999999976 5899999999999999999999999998877776666431100     0    


Q ss_pred             --------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          315 --------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       315 --------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                    ....+..++..+.+||.+||..||.+|||+.|+|+||||....
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          248 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             SSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             ccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCCHHHHhcCccccccc
Confidence                          0112346899999999999999999999999999999996543

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=5.4e-48  Score=391.62  Aligned_cols=251  Identities=31%  Similarity=0.505  Sum_probs=212.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE-
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~-  172 (469)
                      .+.++|.+++.||+|+||.||+|.+..+|+.||||++...      ...+.+|+.+++.+. ||||+++++++...+.. 
T Consensus        39 ~l~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  117 (371)
T 4exu_A           39 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR  117 (371)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSST
T ss_pred             cccccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccccchhHHHHHHHHHHHHHhcC-CCCchhhhhheeccCCcc
Confidence            4678999999999999999999999999999999999653      256779999999997 99999999999877654 


Q ss_pred             -----EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          173 -----HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       173 -----~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                           |+||||+. ++|.+.+  ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       118 ~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~  194 (371)
T 4exu_A          118 NFYDFYLVMPFMQ-TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  194 (371)
T ss_dssp             TCCCCEEEEECCC-EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSTTCC---
T ss_pred             cceeEEEEEcccc-ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHeEECCCCCEEEEecCccccc
Confidence                 99999997 5787766  346999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-----------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-----------  314 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  314 (469)
                      ..  .....+||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.......           
T Consensus       195 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  272 (371)
T 4exu_A          195 DA--EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  272 (371)
T ss_dssp             -------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCH
T ss_pred             cc--CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhh
Confidence            43  3445689999999999976  58999999999999999999999999988777666654311110           


Q ss_pred             ------------CC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 ------------HS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 ------------~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                  +.    ..+..+++++.+||.+||+.||.+|||+.|+|+||||..+
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  330 (371)
T 4exu_A          273 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  330 (371)
T ss_dssp             HHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcCCHHHHhcCcccccC
Confidence                        00    1124579999999999999999999999999999999654

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=3.9e-48  Score=394.02  Aligned_cols=252  Identities=26%  Similarity=0.403  Sum_probs=207.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhh-------CCCCeeEEEEEEE--
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-------GHTGVVTLHSVYE--  167 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~-------~hpnIv~l~~~~~--  167 (469)
                      .+.++|++++.||+|+||.||+|++..+++.||||++....   +.+.+|+.+|+.+.       +||||+++++++.  
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~  113 (397)
T 1wak_A           34 LFNGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKIS  113 (397)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEE
T ss_pred             hcCCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecCCcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeec
Confidence            46689999999999999999999999999999999997653   56788999999996       2788999999997  


Q ss_pred             --eCCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCC--------
Q 012170          168 --EADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSG--------  234 (469)
Q Consensus       168 --~~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~--------  234 (469)
                        ....+|+||||+ +++|.+.+...  +.+++..+..++.||+.||.|||++ ||+||||||+||||+.++        
T Consensus       114 ~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~  192 (397)
T 1wak_A          114 GVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAA  192 (397)
T ss_dssp             ETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHH
T ss_pred             CCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhh
Confidence              556899999999 56777766554  4699999999999999999999998 999999999999999775        


Q ss_pred             -----------------------------------------cEEEEeccceeeecCCCcccccCCCCcccCceeccC-CC
Q 012170          235 -----------------------------------------KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NY  272 (469)
Q Consensus       235 -----------------------------------------~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~  272 (469)
                                                               .+||+|||++......  ....+||+.|+|||++.+ .|
T Consensus       193 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~  270 (397)
T 1wak_A          193 EATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGY  270 (397)
T ss_dssp             HHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCC
T ss_pred             hhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEecccccccccccc--CccCCCCCcccCChhhcCCCC
Confidence                                                     7999999999875432  445689999999999976 48


Q ss_pred             CCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHHHcCcCCCCC------------------------------
Q 012170          273 SEKVDIWSAGVLLHALLVAALPFKGDS------LEAVFDAIKNVKLDFHS------------------------------  316 (469)
Q Consensus       273 ~~~~DiwSlG~il~elltG~~Pf~~~~------~~~~~~~i~~~~~~~~~------------------------------  316 (469)
                      +.++|||||||++|+|++|..||.+.+      ....+..+.......+.                              
T Consensus       271 ~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  350 (397)
T 1wak_A          271 NTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGL  350 (397)
T ss_dssp             CTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCH
T ss_pred             CcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcch
Confidence            999999999999999999999997654      22222222211100000                              


Q ss_pred             --------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          317 --------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       317 --------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                              ......+..+.+||.+||+.||.+|||+.|+|+||||.
T Consensus       351 ~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~  396 (397)
T 1wak_A          351 FEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAAECLRHPWLN  396 (397)
T ss_dssp             HHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGG
T ss_pred             hHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHHHHhhCcccc
Confidence                    00122356788999999999999999999999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=1.3e-47  Score=384.82  Aligned_cols=255  Identities=27%  Similarity=0.470  Sum_probs=214.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA-----  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----  169 (469)
                      .+.++|.+++.||+|+||.||+|.+..+|+.||||++...     ...+.+|+.+|+.+. ||||+++++++...     
T Consensus         8 ~i~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   86 (353)
T 2b9h_A            8 NISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPFDKPLFALRTLREIKILKHFK-HENIITIFNIQRPDSFENF   86 (353)
T ss_dssp             CSCTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCSSHHHHHHHHHHHHHHHHCC-CTTBCCEEEECCCSCSTTC
T ss_pred             ccccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeecccccchHHHHHHHHHHHHHhCc-CCCcCCeeeeecccccCcc
Confidence            4678999999999999999999999999999999999643     245678999999996 99999999988654     


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ...|+||||+. |+|.+++.. +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~  164 (353)
T 2b9h_A           87 NEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDE  164 (353)
T ss_dssp             CCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC-
T ss_pred             ceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEEcCCCcEEEEeccccccccc
Confidence            67899999997 588888754 6899999999999999999999999999999999999999999999999999986543


Q ss_pred             CCc-----------ccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC---
Q 012170          250 GQT-----------LSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD---  313 (469)
Q Consensus       250 ~~~-----------~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~---  313 (469)
                      ...           ....+||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+....+..+......   
T Consensus       165 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~  244 (353)
T 2b9h_A          165 SAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHS  244 (353)
T ss_dssp             ---------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCS
T ss_pred             ccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCch
Confidence            211           233578999999998753  5899999999999999999999999998876655544321100   


Q ss_pred             ---------------------CCC----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          314 ---------------------FHS----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       314 ---------------------~~~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                                           ++.    ..+..+++++.+||.+||..||.+|||+.|+|+||||....
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          245 DNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             TTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCCCHHHHhcCccccccC
Confidence                                 000    11246899999999999999999999999999999996543

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=6.8e-48  Score=377.25  Aligned_cols=253  Identities=28%  Similarity=0.547  Sum_probs=212.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEe---------
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEE---------  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~---------  168 (469)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++....   ..+.+|+.+++.+. ||||+++++++.+         
T Consensus         4 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~   82 (303)
T 1zy4_A            4 YASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEKLSTILSEVMLLASLN-HQYVVRYYAAWLERRNFVKPMT   82 (303)
T ss_dssp             HHHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEEHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEECCCCCC---
T ss_pred             ccccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEeccHHHHHHHHHHHHHHHhcC-chHHHHHHHHHHhhcchhhhhc
Confidence            4578999999999999999999999999999999996543   45778999999996 9999999998865         


Q ss_pred             ----CCeEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          169 ----ADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       169 ----~~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                          .+.+|+||||++||+|.+++...+ .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+
T Consensus        83 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~  162 (303)
T 1zy4_A           83 AVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGL  162 (303)
T ss_dssp             ---CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCC
T ss_pred             ccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcc
Confidence                457899999999999999997654 578899999999999999999999999999999999999999999999999


Q ss_pred             eeeecCC---------------CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHH
Q 012170          244 AMRISNG---------------QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFD  305 (469)
Q Consensus       244 a~~~~~~---------------~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~  305 (469)
                      +......               .......||+.|+|||++.+  .++.++|||||||++|+|++   ||. +........
T Consensus       163 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~  239 (303)
T 1zy4_A          163 AKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILK  239 (303)
T ss_dssp             CSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHH
T ss_pred             hhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHH
Confidence            9754321               12344679999999999975  48999999999999999998   554 334456667


Q ss_pred             HHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          306 AIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       306 ~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+......++.......+..+.+||.+||..||.+|||+.++|+||||....
T Consensus       240 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          240 KLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             HHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             hccccccccCccccccchHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            7777666666666667889999999999999999999999999999996543

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=1.3e-47  Score=372.05  Aligned_cols=251  Identities=29%  Similarity=0.489  Sum_probs=218.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEE--eCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYE--EADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~--~~~~~~  173 (469)
                      .++|++++.||+|+||.||+|.++.+|+.||+|++...      .+.+.+|+.+++.+. ||||+++++++.  ..+.+|
T Consensus         5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~   83 (279)
T 2w5a_A            5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLY   83 (279)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEEGGGTEEE
T ss_pred             hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccCCHHHHHHHHHHHHHHHhcC-CCCCCeEEEEEecCCCceEE
Confidence            47899999999999999999999999999999999642      245789999999996 999999999874  467899


Q ss_pred             EEEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhcC-----eEeccCCCCcEEEccCCcEEEEeccce
Q 012170          174 LVMELCSGGRLIDQMVEVG----QYSEQRAANIFKDVMWVIKYCHDMG-----VVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~g-----ivHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      +||||++||+|.+++....    .+++..++.++.||+.||.|||+.|     |+||||||+|||++.++.+||+|||++
T Consensus        84 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~  163 (279)
T 2w5a_A           84 IVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLA  163 (279)
T ss_dssp             EEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHH
T ss_pred             EEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchh
Confidence            9999999999999987643    4999999999999999999999999     999999999999999999999999999


Q ss_pred             eeecCCCc-ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          245 MRISNGQT-LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       245 ~~~~~~~~-~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      ........ .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+...+...+.......   ....+
T Consensus       164 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~  240 (279)
T 2w5a_A          164 RILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRY  240 (279)
T ss_dssp             HHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC---CCTTS
T ss_pred             eeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc---CCccc
Confidence            76543322 234579999999999976 58999999999999999999999999998888888887765432   22467


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +.++.+||.+||..||.+|||+.|+|+|+|+...
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            9999999999999999999999999999999543

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2.4e-47  Score=386.95  Aligned_cols=247  Identities=23%  Similarity=0.338  Sum_probs=215.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-------CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-------ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..++|++++.||+|+||.||+|.+.       .++..||||+++..     ...+.+|+.+|+.+..||||+++++++.+
T Consensus        79 ~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  158 (370)
T 2psq_A           79 PRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  158 (370)
T ss_dssp             CGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTTCBHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECS
T ss_pred             cHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCCcCHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEcc
Confidence            4578999999999999999999874       34567999999753     24678999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+.+|+||||++||+|.+++...+                .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       159 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~  238 (370)
T 2psq_A          159 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  238 (370)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred             CCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECC
Confidence            999999999999999999997754                4789999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      +|.+||+|||++........   .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+....+++..+
T Consensus       239 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~  318 (370)
T 2psq_A          239 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  318 (370)
T ss_dssp             TCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHH
T ss_pred             CCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence            99999999999986654322   234567889999999976 58999999999999999999 99999998888888777


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ......   .....++.++.+||.+||..||.+|||+.|++++
T Consensus       319 ~~~~~~---~~~~~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          319 KEGHRM---DKPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             HTTCCC---CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            765432   1234689999999999999999999999999875

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=3.6e-49  Score=401.01  Aligned_cols=243  Identities=16%  Similarity=0.204  Sum_probs=201.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhh--CCCCeeEEE-------E
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLS--GHTGVVTLH-------S  164 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~--~hpnIv~l~-------~  164 (469)
                      ..++|.+.+.||+|+||.||+|.+..+|+.||||++...       .+.+.+|+.+|+.+.  .||||++++       +
T Consensus        71 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~  150 (377)
T 3byv_A           71 RPRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFD  150 (377)
T ss_dssp             CCEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSE
T ss_pred             CCceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhh
Confidence            457899999999999999999999999999999998632       256889995555443  499999998       7


Q ss_pred             EEEeCCe-----------------EEEEEeccCCCchHHHHHHhCCCCH-------HHHHHHHHHHHHHHHHHHhcCeEe
Q 012170          165 VYEEADC-----------------FHLVMELCSGGRLIDQMVEVGQYSE-------QRAANIFKDVMWVIKYCHDMGVVH  220 (469)
Q Consensus       165 ~~~~~~~-----------------~~lV~E~~~gg~L~~~l~~~~~l~~-------~~~~~i~~qil~aL~yLH~~givH  220 (469)
                      ++++.+.                 .|+||||+ +|+|.+++...+.+++       ..+..++.||+.||.|||++||+|
T Consensus       151 ~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH  229 (377)
T 3byv_A          151 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  229 (377)
T ss_dssp             EEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHhCCeec
Confidence            7766542                 88999999 6899999987766665       788889999999999999999999


Q ss_pred             ccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC------------CCCCccchHHHHHHHHHH
Q 012170          221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG------------NYSEKVDIWSAGVLLHAL  288 (469)
Q Consensus       221 rDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~el  288 (469)
                      |||||+||||+.+|.+||+|||++....  ......+| +.|+|||++.+            .|+.++|||||||++|+|
T Consensus       230 rDikp~NIll~~~~~~kL~DFG~a~~~~--~~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~el  306 (377)
T 3byv_A          230 TYLRPVDIVLDQRGGVFLTGFEHLVRDG--ARVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWI  306 (377)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETT--CEEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHH
T ss_pred             CCCCHHHEEEcCCCCEEEEechhheecC--CcccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHH
Confidence            9999999999999999999999997633  34456678 99999999865            489999999999999999


Q ss_pred             HhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          289 LVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       289 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ++|..||.+.+.......+..        .+..+++++.+||.+||..||.+|||+.|+|+||||..
T Consensus       307 ltg~~Pf~~~~~~~~~~~~~~--------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          307 WCADLPITKDAALGGSEWIFR--------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             HHSSCCC------CCSGGGGS--------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             HHCCCCCcccccccchhhhhh--------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            999999987654333222221        23578999999999999999999999999999999954

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=4.4e-48  Score=379.22  Aligned_cols=256  Identities=29%  Similarity=0.450  Sum_probs=199.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..++|.+++.||+|+||.||+|.+..+++.||||++...     ...+.+|+.+++.+. ||||+++++++...+..|+|
T Consensus        13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv   91 (303)
T 2vwi_A           13 NRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH-HPNIVSYYTSFVVKDELWLV   91 (303)
T ss_dssp             CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC----------------CCCCCC-CTTBCCEEEEEESSSCEEEE
T ss_pred             chhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhcchhHHHHHHHHHHHhhcC-CCCEeeEEEEEeecCCcEEE
Confidence            457899999999999999999999999999999998642     346778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH--------hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          176 MELCSGGRLIDQMVE--------VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~--------~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      |||++|++|.+++..        .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus        92 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~  171 (303)
T 2vwi_A           92 MKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFL  171 (303)
T ss_dssp             EECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHC
T ss_pred             ehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchhee
Confidence            999999999999864        356899999999999999999999999999999999999999999999999998654


Q ss_pred             cCCC------cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC-CC---
Q 012170          248 SNGQ------TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD-FH---  315 (469)
Q Consensus       248 ~~~~------~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~-~~---  315 (469)
                      ....      ......||+.|+|||++.+  .++.++||||||+++|+|++|..||.+................ ..   
T Consensus       172 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~  251 (303)
T 2vwi_A          172 ATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGV  251 (303)
T ss_dssp             C---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC--
T ss_pred             ccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCcccccc
Confidence            3221      1234679999999999864  5899999999999999999999999887665554444332221 11   


Q ss_pred             --CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          316 --SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       316 --~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                        ...+..++.++.+||.+||..||.+|||+.++++||||....
T Consensus       252 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          252 QDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             ---CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             ccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence              122356889999999999999999999999999999996544

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=8.3e-48  Score=388.02  Aligned_cols=255  Identities=26%  Similarity=0.416  Sum_probs=206.3

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------------hHHHHHHHHHHHHhhCCCCeeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------------EETVHREVEIMQHLSGHTGVVTLH  163 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------------~~~~~~E~~il~~l~~hpnIv~l~  163 (469)
                      ..+.++|.+++.||+|+||.||+|.+.. |..||||++...               ...+.+|+.+|+.+. ||||++++
T Consensus        18 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~   95 (362)
T 3pg1_A           18 HAMQSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFH-HPNILGLR   95 (362)
T ss_dssp             HHTTCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCC-CTTBCCCS
T ss_pred             HHhccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCC-CcCcccee
Confidence            4567899999999999999999999865 999999998531               156889999999997 99999999


Q ss_pred             EEEEe-----CCeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEE
Q 012170          164 SVYEE-----ADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       164 ~~~~~-----~~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vk  237 (469)
                      +++..     ...+|+||||+. |+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        96 ~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~k  174 (362)
T 3pg1_A           96 DIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDIT  174 (362)
T ss_dssp             EEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEE
T ss_pred             eeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCEecCCChHHEEEcCCCCEE
Confidence            99854     347899999997 5787777654 4799999999999999999999999999999999999999999999


Q ss_pred             EEeccceeeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC---
Q 012170          238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL---  312 (469)
Q Consensus       238 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~---  312 (469)
                      |+|||++.............||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.....   
T Consensus       175 l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~  254 (362)
T 3pg1_A          175 ICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTPK  254 (362)
T ss_dssp             ECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCC
T ss_pred             EEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCC
Confidence            999999986665555566789999999999865  489999999999999999999999999887776666543111   


Q ss_pred             ---------------------CCCCC----cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 ---------------------DFHSG----VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 ---------------------~~~~~----~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                           ..+..    ....+++.+.+||.+||..||.+|||+.|+|+||||...
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  323 (362)
T 3pg1_A          255 IEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRISTEQALRHPYFESL  323 (362)
T ss_dssp             HHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhc
Confidence                                 11111    123568899999999999999999999999999999654

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=3.1e-47  Score=381.30  Aligned_cols=254  Identities=25%  Similarity=0.412  Sum_probs=213.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCC-cEEEEEEcccC---hHHHHHHHHHHHHhhCCCC------eeEEEEEEEeC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASG-AEFACKTLRKG---EETVHREVEIMQHLSGHTG------VVTLHSVYEEA  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-~~vAvK~~~~~---~~~~~~E~~il~~l~~hpn------Iv~l~~~~~~~  169 (469)
                      .+.++|++++.||+|+||.||+|.+..++ ..||+|+++..   .+.+.+|+.+++.+. |++      ++.+++++...
T Consensus        16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-~~~~~~~~~~~~~~~~~~~~   94 (355)
T 2eu9_A           16 WLQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNVGKYREAARLEINVLKKIK-EKDKENKFLCVLMSDWFNFH   94 (355)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHH-HHCTTSCSCBCCEEEEEEET
T ss_pred             eecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEcccccchhHHHHHHHHHHHHh-hcCCCCceeEEEeeeeeeeC
Confidence            46789999999999999999999998777 68999999754   356778999999997 655      99999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE-----------------
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL-----------------  230 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl-----------------  230 (469)
                      +.+|+||||+ +++|.+.+....  .+++..+..++.||+.||.|||++||+||||||+|||+                 
T Consensus        95 ~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~  173 (355)
T 2eu9_A           95 GHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEE  173 (355)
T ss_dssp             TEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCE
T ss_pred             CeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccc
Confidence            9999999999 667777776654  69999999999999999999999999999999999999                 


Q ss_pred             --ccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 012170          231 --TTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI  307 (469)
Q Consensus       231 --~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  307 (469)
                        +.++.+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+..+.+..+
T Consensus       174 ~~~~~~~~kl~Dfg~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~  251 (355)
T 2eu9_A          174 KSVKNTSIRVADFGSATFDHE--HHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMM  251 (355)
T ss_dssp             EEESCCCEEECCCTTCEETTS--CCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHH
T ss_pred             cccCCCcEEEeecCccccccc--cccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence              6678999999999976433  3345689999999999976 5899999999999999999999999988877665555


Q ss_pred             HcCcCCCCCC----------------cc------------------------cCCCHHHHHHHHHhchhhhcCCCCHHHH
Q 012170          308 KNVKLDFHSG----------------VW------------------------ETVSKPARDLMARMLTRDVSARITADEV  347 (469)
Q Consensus       308 ~~~~~~~~~~----------------~~------------------------~~~s~~~~~lI~~~L~~dP~~Rpsa~el  347 (469)
                      ......++..                .|                        ...+.++.+||.+||..||.+|||+.|+
T Consensus       252 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~  331 (355)
T 2eu9_A          252 EKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEA  331 (355)
T ss_dssp             HHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred             HHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHH
Confidence            4322221110                00                        1124578899999999999999999999


Q ss_pred             HcCCCccccc
Q 012170          348 LRHPWILFYT  357 (469)
Q Consensus       348 L~hp~~~~~~  357 (469)
                      |+||||....
T Consensus       332 l~hp~f~~~~  341 (355)
T 2eu9_A          332 LLHPFFAGLT  341 (355)
T ss_dssp             TTSGGGGGCC
T ss_pred             hcChhhcCCC
Confidence            9999996543

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=9.5e-48  Score=379.50  Aligned_cols=256  Identities=25%  Similarity=0.428  Sum_probs=210.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEE--------
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYE--------  167 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~--------  167 (469)
                      .+.++|.+++.||+|+||.||+|.+..+|+.||||++....    ..+.+|+.+++.+. ||||+++++++.        
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~~~   86 (320)
T 2i6l_A            8 DLGSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLTDPQSVKHALREIKIIRRLD-HDNIVKVFEILGPSGSQLTD   86 (320)
T ss_dssp             EETTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECCSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECTTSCBCCC
T ss_pred             ccCCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecCChHHHHHHHHHHHHHHhcC-CCCeeEEEEecccccccccc
Confidence            46789999999999999999999999999999999986432    45788999999996 999999999873        


Q ss_pred             ------eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-cCCcEEEEe
Q 012170          168 ------EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLAD  240 (469)
Q Consensus       168 ------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-~~~~vkL~D  240 (469)
                            +.+.+|+||||+. |+|.+++ ..+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|
T Consensus        87 ~~~~~~~~~~~~lv~e~~~-~~L~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~D  164 (320)
T 2i6l_A           87 DVGSLTELNSVYIVQEYME-TDLANVL-EQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGD  164 (320)
T ss_dssp             ----CCSCSEEEEEEECCS-EEHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECC
T ss_pred             ccccccccCceeEEeeccC-CCHHHHh-hcCCccHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEcc
Confidence                  4468999999997 5998887 457899999999999999999999999999999999999997 567999999


Q ss_pred             ccceeeecCC----CcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC
Q 012170          241 FGLAMRISNG----QTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF  314 (469)
Q Consensus       241 Fgla~~~~~~----~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~  314 (469)
                      ||++......    .......||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.......
T Consensus       165 fg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~  244 (320)
T 2i6l_A          165 FGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVV  244 (320)
T ss_dssp             CTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCC
T ss_pred             CccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCC
Confidence            9999765432    22334568999999998854  58999999999999999999999999988777666554322111


Q ss_pred             C----------------------C----CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          315 H----------------------S----GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       315 ~----------------------~----~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      .                      .    ..+..++.++.+||.+||..||.+|||+.|+|+||||..+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~  314 (320)
T 2i6l_A          245 HEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSF  314 (320)
T ss_dssp             CHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC
T ss_pred             chhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccCCHHHHhCCcccccccC
Confidence            0                      0    112458999999999999999999999999999999965543

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=5.4e-47  Score=374.87  Aligned_cols=244  Identities=26%  Similarity=0.380  Sum_probs=205.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ...+|++++.||+|+||.||+|.+  +|..||||++....      ..+.+|+.+|++++ ||||+++++++.+.+.+|+
T Consensus        35 ~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~l  111 (309)
T 3p86_A           35 PWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDFHAERVNEFLREVAIMKRLR-HPNIVLFMGAVTQPPNLSI  111 (309)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCCSHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSTTCCEE
T ss_pred             ChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEECCceEE
Confidence            457899999999999999999987  48899999986432      45788999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          175 VMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ||||+++|+|.+++...+.   +++..+..++.||+.||.|||++|  |+||||||+|||++.++.+||+|||++.....
T Consensus       112 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~  191 (309)
T 3p86_A          112 VTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKAS  191 (309)
T ss_dssp             EEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC-------
T ss_pred             EEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccc
Confidence            9999999999999976553   999999999999999999999999  99999999999999999999999999975443


Q ss_pred             CC-cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          250 GQ-TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       250 ~~-~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .. ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+........  ....+++++.
T Consensus       192 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~  269 (309)
T 3p86_A          192 TFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE--IPRNLNPQVA  269 (309)
T ss_dssp             ----------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC--CCTTSCHHHH
T ss_pred             cccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC--CCccCCHHHH
Confidence            32 23456899999999999774 89999999999999999999999999988888777754332222  2256899999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHc
Q 012170          328 DLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +||.+||..||.+|||+.++++
T Consensus       270 ~li~~~l~~dP~~Rps~~~ll~  291 (309)
T 3p86_A          270 AIIEGCWTNEPWKRPSFATIMD  291 (309)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHH
Confidence            9999999999999999999987

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=1.2e-46  Score=363.29  Aligned_cols=245  Identities=23%  Similarity=0.344  Sum_probs=217.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++...   ...+.+|+.+++++. ||||+++++++.+.+.+|+|||
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   83 (268)
T 3sxs_A            6 KREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSMSEDEFFQEAQTMMKLS-HPKLVKFYGVCSKEYPIYIVTE   83 (268)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTBCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEEE
T ss_pred             chhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCCcHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCceEEEEE
Confidence            4578999999999999999999887 4778999999753   467899999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          178 LCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      |+++++|.+++...+ .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........  ..
T Consensus        84 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~  163 (268)
T 3sxs_A           84 YISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV  163 (268)
T ss_dssp             CCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEEECC
T ss_pred             ccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhhhccc
Confidence            999999999997764 599999999999999999999999999999999999999999999999999987654432  23


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+.........   ..+++++.+||.+
T Consensus       164 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~  240 (268)
T 3sxs_A          164 GTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYRP---HLASDTIYQIMYS  240 (268)
T ss_dssp             SCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC---TTSCHHHHHHHHH
T ss_pred             CCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHHHHHcCCCCCCC---CcChHHHHHHHHH
Confidence            3456778999999976 58999999999999999999 99999998888888877766543332   4579999999999


Q ss_pred             hchhhhcCCCCHHHHHcC
Q 012170          333 MLTRDVSARITADEVLRH  350 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~h  350 (469)
                      ||..||.+|||+.++++|
T Consensus       241 ~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          241 CWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HcCCChhhCcCHHHHHHH
Confidence            999999999999999986

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=4.4e-48  Score=392.02  Aligned_cols=252  Identities=17%  Similarity=0.236  Sum_probs=193.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhh-CCCCeeEEE-------EEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLS-GHTGVVTLH-------SVY  166 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~-~hpnIv~l~-------~~~  166 (469)
                      ...|.+++.||+|+||.||+|.+..+|+.||||++....       ..+.+|+.+++.|. .||||++++       +++
T Consensus        61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~  140 (371)
T 3q60_A           61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAV  140 (371)
T ss_dssp             EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC----------CBCCCCEEE
T ss_pred             ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehhe
Confidence            346999999999999999999999999999999997632       35677876666665 499988865       455


Q ss_pred             EeC-----------------CeEEEEEeccCCCchHHHHHHhC-CCCHHHH------HHHHHHHHHHHHHHHhcCeEecc
Q 012170          167 EEA-----------------DCFHLVMELCSGGRLIDQMVEVG-QYSEQRA------ANIFKDVMWVIKYCHDMGVVHRD  222 (469)
Q Consensus       167 ~~~-----------------~~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~------~~i~~qil~aL~yLH~~givHrD  222 (469)
                      ...                 ..+|+|||||+ |+|.+++...+ .+.+...      ..++.||+.||.|||++||+|||
T Consensus       141 ~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrD  219 (371)
T 3q60_A          141 AVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGH  219 (371)
T ss_dssp             EETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred             ecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCc
Confidence            433                 34899999998 89999997643 4444444      57779999999999999999999


Q ss_pred             CCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCC
Q 012170          223 IKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDS  299 (469)
Q Consensus       223 lkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~  299 (469)
                      |||+||||+.+|.+||+|||++.....  ......||+.|+|||++.+   .|+.++|||||||++|+|++|..||.+..
T Consensus       220 ikp~NIll~~~~~~kL~DFG~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~  297 (371)
T 3q60_A          220 FTPDNLFIMPDGRLMLGDVSALWKVGT--RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT  297 (371)
T ss_dssp             CSGGGEEECTTSCEEECCGGGEEETTC--EEEGGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCC
T ss_pred             CCHHHEEECCCCCEEEEecceeeecCC--CccCccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcC
Confidence            999999999999999999999986542  2224567799999999975   48999999999999999999999998764


Q ss_pred             HHHH--HHH---HHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          300 LEAV--FDA---IKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       300 ~~~~--~~~---i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ....  +..   .......+....+..+++.+.+||.+||..||.+|||+.++|+||||...
T Consensus       298 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  359 (371)
T 3q60_A          298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQL  359 (371)
T ss_dssp             TTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHHH
T ss_pred             cccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHHH
Confidence            2210  000   11111122233345789999999999999999999999999999999544

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=3.5e-47  Score=378.97  Aligned_cols=248  Identities=22%  Similarity=0.292  Sum_probs=212.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +.++|++++.||+|+||.||+|.+..+|+.||||++..  ....+.+|+.+++.|..||||+++++++.+.+..|+||||
T Consensus         7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~   86 (330)
T 2izr_A            7 VGPNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLEL   86 (330)
T ss_dssp             ETTTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEEC
T ss_pred             EcCCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEe
Confidence            45789999999999999999999999999999999864  3456899999999995599999999999999999999999


Q ss_pred             cCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc-----EEEEeccceeeecCCCc
Q 012170          179 CSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK-----IKLADFGLAMRISNGQT  252 (469)
Q Consensus       179 ~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~-----vkL~DFgla~~~~~~~~  252 (469)
                      + +++|.+++.. .+.+++..+..++.||+.||.|||+.||+||||||+|||++.++.     +||+|||++........
T Consensus        87 ~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~  165 (330)
T 2izr_A           87 L-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPET  165 (330)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTT
T ss_pred             C-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCC
Confidence            9 9999999976 468999999999999999999999999999999999999999887     99999999987654322


Q ss_pred             --------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCC---CCHHHHHHHHHcCcCCCCCCccc
Q 012170          253 --------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKG---DSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       253 --------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~---~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                              ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+   ....+.+..+.......+.....
T Consensus       166 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~  245 (330)
T 2izr_A          166 KKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLC  245 (330)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHT
T ss_pred             CccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHh
Confidence                    2457899999999999774 89999999999999999999999987   34455555554443333322222


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ...+++.+||..||..||.+||++.+|++
T Consensus       246 ~~~p~~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          246 ENFPEMATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             TTCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             ccChHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence            22339999999999999999999999876

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=2.9e-47  Score=378.24  Aligned_cols=248  Identities=30%  Similarity=0.512  Sum_probs=215.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhh-CCCCeeEEEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLS-GHTGVVTLHSVYE  167 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~-~hpnIv~l~~~~~  167 (469)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++...          ...+.+|+.+++.+. .||||+++++++.
T Consensus        39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~  118 (320)
T 3a99_A           39 EPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFE  118 (320)
T ss_dssp             -CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEE
T ss_pred             CCccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEe
Confidence            45778999999999999999999999999999999998643          145678999999997 3799999999999


Q ss_pred             eCCeEEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-cCCcEEEEecccee
Q 012170          168 EADCFHLVMELCSG-GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGLAM  245 (469)
Q Consensus       168 ~~~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-~~~~vkL~DFgla~  245 (469)
                      ..+.+++||||+.+ ++|.+++...+.+++..+..++.||+.||.|||+.||+||||||+|||++ .++.+||+|||++.
T Consensus       119 ~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~  198 (320)
T 3a99_A          119 RPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGA  198 (320)
T ss_dssp             CSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCE
T ss_pred             cCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCcccc
Confidence            99999999999986 89999999889999999999999999999999999999999999999999 78999999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ..... ......||+.|+|||++.+ . ++.++||||||+++|+|++|..||....      .+......++    ..++
T Consensus       199 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~------~~~~~~~~~~----~~~~  267 (320)
T 3a99_A          199 LLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVS  267 (320)
T ss_dssp             ECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCC
T ss_pred             ccccc-cccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh------hhhccccccc----ccCC
Confidence            76543 3345679999999999865 3 4678999999999999999999997532      1222222222    4689


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +++.+||.+||..||.+|||+.|+++||||....
T Consensus       268 ~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~  301 (320)
T 3a99_A          268 SECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL  301 (320)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCC
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHhcCHhhcCcc
Confidence            9999999999999999999999999999996543

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=8.9e-47  Score=375.83  Aligned_cols=246  Identities=22%  Similarity=0.345  Sum_probs=213.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|.+.+.||+|+||.||+|.+..+|.   .||||+++..     ...+.+|+.+|+.+. ||||+++++++.+.+.+
T Consensus        47 ~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  125 (325)
T 3kul_A           47 EASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQRRDFLSEASIMGQFD-HPNIIRLEGVVTRGRLA  125 (325)
T ss_dssp             CGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECGGGCC
T ss_pred             ChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEeCCcc
Confidence            45789999999999999999999986665   4999999753     246889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||++||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       126 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  205 (325)
T 3kul_A          126 MIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDP  205 (325)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC---
T ss_pred             EEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCc
Confidence            9999999999999999654 579999999999999999999999999999999999999999999999999998765432


Q ss_pred             c----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          252 T----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .    .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+.......   ....++++
T Consensus       206 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  282 (325)
T 3kul_A          206 DAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP---APMGCPHA  282 (325)
T ss_dssp             -CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHH
T ss_pred             cceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCCCC---CCCCcCHH
Confidence            1    233456888999999975 58999999999999999999 999999999888888887653221   23568999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.++++.
T Consensus       283 l~~li~~~l~~dp~~Rps~~eil~~  307 (325)
T 3kul_A          283 LHQLMLDCWHKDRAQRPRFSQIVSV  307 (325)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHccCChhhCcCHHHHHHH
Confidence            9999999999999999999999863

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=5.9e-47  Score=380.85  Aligned_cols=251  Identities=31%  Similarity=0.516  Sum_probs=211.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe--
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC--  171 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~--  171 (469)
                      .+.++|.+.+.||+|+||.||+|.++.+|+.||||++...      ...+.+|+.+|+.+. ||||+++++++...+.  
T Consensus        21 ~l~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~   99 (353)
T 3coi_A           21 ELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPFQSEIFAKRAYRELLLLKHMQ-HENVIGLLDVFTPASSLR   99 (353)
T ss_dssp             EEETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSGG
T ss_pred             ccCceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCCcccHhheEecccccc
Confidence            3568999999999999999999999999999999998642      245778999999997 9999999999987654  


Q ss_pred             ----EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          172 ----FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       172 ----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                          +|+||||+. |+|.+++.  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...
T Consensus       100 ~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~  176 (353)
T 3coi_A          100 NFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHA  176 (353)
T ss_dssp             GCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC-
T ss_pred             cceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEeECCCCcEEEeecccccCC
Confidence                499999997 58887763  46999999999999999999999999999999999999999999999999999764


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC-------------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL-------------  312 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~-------------  312 (469)
                      ...  .....||+.|+|||++.+  .++.++|||||||++|+|++|..||.+.+..+.+..+.....             
T Consensus       177 ~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~  254 (353)
T 3coi_A          177 DAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDK  254 (353)
T ss_dssp             ---------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCH
T ss_pred             CCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhH
Confidence            432  345689999999999875  589999999999999999999999999887766655533110             


Q ss_pred             --------------CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 --------------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 --------------~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                    ......+..+++++.+||.+||..||.+|||+.|+|+||||..+
T Consensus       255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~  312 (353)
T 3coi_A          255 AAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRLTAAQALTHPFFEPF  312 (353)
T ss_dssp             HHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTT
T ss_pred             HHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhc
Confidence                          00111234679999999999999999999999999999999644

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=4.3e-47  Score=376.65  Aligned_cols=257  Identities=21%  Similarity=0.306  Sum_probs=198.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ....++|++++.||+|+||.||+|.+..++.   .||||+++..      .+.+.+|+.+++.+. ||||+++++++...
T Consensus        19 ~i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   97 (323)
T 3qup_A           19 LIPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFD-HPHVAKLVGVSLRS   97 (323)
T ss_dssp             BCC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC------CHHHHHHHHHHHHHTTCC-CTTBCCCCEEEECC
T ss_pred             ccChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEecccccCHHHHHHHHHHHHHHHHCC-CCceehhhceeecc
Confidence            3456789999999999999999999887765   8999999643      256889999999996 99999999999877


Q ss_pred             CeE------EEEEeccCCCchHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEE
Q 012170          170 DCF------HLVMELCSGGRLIDQMVEVG------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIK  237 (469)
Q Consensus       170 ~~~------~lV~E~~~gg~L~~~l~~~~------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vk  237 (469)
                      +..      ++||||+.+|+|.+++....      .+++..+..++.||+.||.|||++||+||||||+|||++.++.+|
T Consensus        98 ~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ivH~Dikp~NIli~~~~~~k  177 (323)
T 3qup_A           98 RAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVC  177 (323)
T ss_dssp             -------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEE
T ss_pred             ccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcCCcccCCCCcceEEEcCCCCEE
Confidence            665      99999999999999986543      589999999999999999999999999999999999999999999


Q ss_pred             EEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcC
Q 012170          238 LADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKL  312 (469)
Q Consensus       238 L~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~  312 (469)
                      |+|||++........   .....+++.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+....+.....
T Consensus       178 l~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~  257 (323)
T 3qup_A          178 VADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNR  257 (323)
T ss_dssp             ECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCC
T ss_pred             EeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCC
Confidence            999999976544332   223457889999999866 48999999999999999999 9999999888888777766543


Q ss_pred             CCCCCcccCCCHHHHHHHHHhchhhhcCCCC-------HHHHHcCCCccccccc
Q 012170          313 DFHSGVWETVSKPARDLMARMLTRDVSARIT-------ADEVLRHPWILFYTER  359 (469)
Q Consensus       313 ~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rps-------a~elL~hp~~~~~~~~  359 (469)
                      ..   ....+++++.+||.+||..||.+|||       +++++.|||+......
T Consensus       258 ~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~  308 (323)
T 3qup_A          258 LK---QPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQD  308 (323)
T ss_dssp             CC---CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC---------
T ss_pred             CC---CCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCC
Confidence            22   22468999999999999999999999       7889999999655443

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=1.6e-46  Score=367.64  Aligned_cols=251  Identities=22%  Similarity=0.269  Sum_probs=215.1

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++...  ...+.+|+.+++.+..|+||+++++++.+....|+||
T Consensus         6 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~   85 (298)
T 1csn_A            6 NVVGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVI   85 (298)
T ss_dssp             CEETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEE
T ss_pred             cccccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEE
Confidence            34668899999999999999999999999999999998643  3568999999999977999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc-----EEEEeccceeeecCC
Q 012170          177 ELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK-----IKLADFGLAMRISNG  250 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~-----vkL~DFgla~~~~~~  250 (469)
                      ||+ +++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.     +||+|||++......
T Consensus        86 e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~  164 (298)
T 1csn_A           86 DLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP  164 (298)
T ss_dssp             ECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCT
T ss_pred             Eec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccc
Confidence            999 999999997754 5999999999999999999999999999999999999988776     999999999876543


Q ss_pred             Cc--------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHcCcCCCC-CC
Q 012170          251 QT--------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---SLEAVFDAIKNVKLDFH-SG  317 (469)
Q Consensus       251 ~~--------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---~~~~~~~~i~~~~~~~~-~~  317 (469)
                      ..        .....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.   .....+..+.......+ ..
T Consensus       165 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (298)
T 1csn_A          165 VTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRE  244 (298)
T ss_dssp             TTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHH
T ss_pred             cccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHH
Confidence            22        345679999999999976 4899999999999999999999999873   34444444433322221 11


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....+++++.+||.+||..||.+|||+.+|++.
T Consensus       245 ~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~  277 (298)
T 1csn_A          245 LCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL  277 (298)
T ss_dssp             HTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred             HHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            224689999999999999999999999999764

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=8.3e-47  Score=369.04  Aligned_cols=250  Identities=26%  Similarity=0.458  Sum_probs=208.1

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .|.....||+|+||.||+|.+..++..||||++...    .+.+.+|+.+++.+. ||||+++++++.+.+.+++||||+
T Consensus        23 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~lv~e~~  101 (295)
T 2clq_A           23 ENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYSQPLHEEIALHKHLK-HKNIVQYLGSFSENGFIKIFMEQV  101 (295)
T ss_dssp             TTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCCC---HHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEEEECC
T ss_pred             CCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCchHHHHHHHHHHHHHHhCC-CCCEeeEeeEEEeCCcEEEEEEeC
Confidence            344456899999999999999999999999998643    356889999999996 999999999999999999999999


Q ss_pred             CCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-CCcEEEEeccceeeecCCC-ccc
Q 012170          180 SGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-SGKIKLADFGLAMRISNGQ-TLS  254 (469)
Q Consensus       180 ~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-~~~vkL~DFgla~~~~~~~-~~~  254 (469)
                      ++++|.+++....   .+++..+..++.||+.||.|||++||+||||||+|||++. ++.+||+|||++....... ...
T Consensus       102 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~  181 (295)
T 2clq_A          102 PGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTE  181 (295)
T ss_dssp             SEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-----C
T ss_pred             CCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCCCccc
Confidence            9999999997652   4678999999999999999999999999999999999988 8999999999998764322 234


Q ss_pred             ccCCCCcccCceeccCC---CCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~---~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...||+.|+|||++.+.   ++.++||||||+++|+|++|..||.+... ..........  .........++.++.+||
T Consensus       182 ~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~li  259 (295)
T 2clq_A          182 TFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMF--KVHPEIPESMSAEAKAFI  259 (295)
T ss_dssp             CCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHHHHHHHHHH--CCCCCCCTTSCHHHHHHH
T ss_pred             ccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhHHHHhhccc--cccccccccCCHHHHHHH
Confidence            56799999999999652   78999999999999999999999975432 2222211111  111222356899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          331 ARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+||..||.+|||+.++|+||||...
T Consensus       260 ~~~l~~dp~~Rps~~~ll~~~~~~~~  285 (295)
T 2clq_A          260 LKCFEPDPDKRACANDLLVDEFLKVS  285 (295)
T ss_dssp             HHTTCSSTTTSCCHHHHHTSGGGCC-
T ss_pred             HHHccCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999644

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=4.1e-47  Score=384.69  Aligned_cols=250  Identities=23%  Similarity=0.316  Sum_probs=216.3

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEE-----ECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCR-----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ...++|++++.||+|+||.||+|.     +..++..||||+++..     ...+.+|+.+|+.+. ||||+++++++.+.
T Consensus        68 ~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~  146 (367)
T 3l9p_A           68 VPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQS  146 (367)
T ss_dssp             CCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSS
T ss_pred             cCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccccChhhHHHHHHHHHHHHhCC-CCCCCeEEEEEecC
Confidence            345789999999999999999999     4457789999998642     245788999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---cEEEE
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVG-------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---KIKLA  239 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---~vkL~  239 (469)
                      +..|+|||||+||+|.+++...+       .+++..+..++.||+.||.|||++||+||||||+|||++.+|   .+||+
T Consensus       147 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~  226 (367)
T 3l9p_A          147 LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIG  226 (367)
T ss_dssp             SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEEC
T ss_pred             CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEEC
Confidence            99999999999999999997764       489999999999999999999999999999999999999655   49999


Q ss_pred             eccceeeecCC---CcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCC
Q 012170          240 DFGLAMRISNG---QTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDF  314 (469)
Q Consensus       240 DFgla~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  314 (469)
                      |||++......   .......||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+.+..++...+.......
T Consensus       227 DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~  306 (367)
T 3l9p_A          227 DFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMD  306 (367)
T ss_dssp             CCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCC
T ss_pred             CCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC
Confidence            99999754321   22334578999999999855 59999999999999999998 999999999999888887765332


Q ss_pred             CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          315 HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       315 ~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .   ...++..+.+||.+||+.||.+|||+.+|++|.|+
T Consensus       307 ~---~~~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~  342 (367)
T 3l9p_A          307 P---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  342 (367)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             C---CccCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHH
Confidence            2   24679999999999999999999999999999775

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=1.4e-46  Score=371.45  Aligned_cols=256  Identities=25%  Similarity=0.411  Sum_probs=197.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HH-HHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ET-VHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~-~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      -.++|++++.||+|+||.||+|.+..+|+.||||++....     .. +..+..+++.+. ||||+++++++.+.+.+|+
T Consensus        23 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~-h~~i~~~~~~~~~~~~~~l  101 (318)
T 2dyl_A           23 EINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSGNKEENKRILMDLDVVLKSHD-CPYIVQCFGTFITNTDVFI  101 (318)
T ss_dssp             CGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTSCHHHHHHHHHHHHHHHHTTT-CTTBCCEEEEEECSSEEEE
T ss_pred             hhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccccchHHHHHHHHHHHHHHhcC-CCceeeEEEEEecCCcEEE
Confidence            3478999999999999999999999999999999996532     12 333444566664 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          175 VMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      ||||+ ++.+..+... .+.+++..+..++.||+.||.|||+. ||+||||||+|||++.++.+||+|||++........
T Consensus       102 v~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~  180 (318)
T 2dyl_A          102 AMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA  180 (318)
T ss_dssp             EECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGEEECTTSCEEECCCTTC--------
T ss_pred             EEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc
Confidence            99999 5555555443 46899999999999999999999995 999999999999999999999999999987665555


Q ss_pred             ccccCCCCcccCceecc------CCCCCccchHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          253 LSGLAGSPAYVAPEVLS------GNYSEKVDIWSAGVLLHALLVAALPFKG-DSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~------~~~~~~~DiwSlG~il~elltG~~Pf~~-~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .....||+.|+|||++.      ..++.++||||||+++|+|++|..||.+ ......+..+......... .+..++.+
T Consensus       181 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~  259 (318)
T 2dyl_A          181 KDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTDFEVLTKVLQEEPPLLP-GHMGFSGD  259 (318)
T ss_dssp             ------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHHSCCCCCC-SSSCCCHH
T ss_pred             ccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCccHHHHHHHhccCCCCCC-ccCCCCHH
Confidence            55668999999999984      2488999999999999999999999986 4455566666554433221 23468999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCccccccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFYTER  359 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~  359 (469)
                      +.+||.+||..||.+|||+.++|+||||..+...
T Consensus       260 l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~~  293 (318)
T 2dyl_A          260 FQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYETL  293 (318)
T ss_dssp             HHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHHHS
T ss_pred             HHHHHHHHccCChhHCcCHHHHhhCHHHHhcccc
Confidence            9999999999999999999999999999765443

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-46  Score=363.16  Aligned_cols=244  Identities=29%  Similarity=0.408  Sum_probs=215.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|.+. ++..||+|++...   .+.+.+|+.+++++. ||||+++++++.+.+.+|+||||
T Consensus         9 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   86 (269)
T 4hcu_A            9 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEF   86 (269)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEEC
T ss_pred             hhhceeeheecCCCccEEEEEEec-CCCeEEEEEecccccCHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCceEEEEEe
Confidence            468999999999999999999987 4778999999753   467899999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--cccc
Q 012170          179 CSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSG  255 (469)
Q Consensus       179 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~~  255 (469)
                      +++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  ....
T Consensus        87 ~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~  166 (269)
T 4hcu_A           87 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  166 (269)
T ss_dssp             CTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEEEcCCCCEEeccccccccccccccccccC
Confidence            9999999999654 468999999999999999999999999999999999999999999999999997554322  2234


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+........   ...+++++.+||.+|
T Consensus       167 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~  243 (269)
T 4hcu_A          167 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHC  243 (269)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHH
T ss_pred             cccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHhcCccCCC---CCcCCHHHHHHHHHH
Confidence            567889999999964 68999999999999999999 9999999999888888877643322   245799999999999


Q ss_pred             chhhhcCCCCHHHHHcC
Q 012170          334 LTRDVSARITADEVLRH  350 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~h  350 (469)
                      |..||.+|||+.++++|
T Consensus       244 l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          244 WRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCCcccCcCHHHHHHH
Confidence            99999999999999986

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=3.8e-47  Score=377.83  Aligned_cols=261  Identities=26%  Similarity=0.380  Sum_probs=194.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHH-HHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVE-IMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~-il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++|.+++.||+|+||.||+|.++.+|+.||||++....     ..+..|+. +++.+ .||||+++++++.+.+..|+
T Consensus        20 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~-~h~niv~~~~~~~~~~~~~l   98 (327)
T 3aln_A           20 TAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVDEKEQKQLLMDLDVVMRSS-DCPYIVQFYGALFREGDCWI   98 (327)
T ss_dssp             CSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCCCHHHHHHHHHHHHHHHSSC-CCTTBCCEEEEEECSSEEEE
T ss_pred             CHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeecccCchHHHHHHHHHHHHHHcC-CCCcEeeeeeEEEeCCceEE
Confidence            3478999999999999999999999999999999996532     34555666 45555 59999999999999999999


Q ss_pred             EEeccCCCchHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          175 VMELCSGGRLIDQMVE-----VGQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ||||+.+ +|.+++..     ...+++..+..++.|++.||.|||+. ||+||||||+|||++.++.+||+|||++....
T Consensus        99 v~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~  177 (327)
T 3aln_A           99 CMELMST-SFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV  177 (327)
T ss_dssp             EECCCSE-EHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC--
T ss_pred             EEeecCC-ChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceecc
Confidence            9999985 77777653     46799999999999999999999999 99999999999999999999999999998765


Q ss_pred             CCCcccccCCCCcccCceecc----C-CCCCccchHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHcC-cCCCCCCcccC
Q 012170          249 NGQTLSGLAGSPAYVAPEVLS----G-NYSEKVDIWSAGVLLHALLVAALPFKGDSL-EAVFDAIKNV-KLDFHSGVWET  321 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~----~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~-~~~~~~i~~~-~~~~~~~~~~~  321 (469)
                      .........||+.|+|||++.    + .++.++||||||+++|+|++|..||.+... .+.+..+... ...+....+..
T Consensus       178 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~  257 (327)
T 3aln_A          178 DSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEERE  257 (327)
T ss_dssp             ----------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCC
T ss_pred             cccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCccccc
Confidence            554445568999999999983    2 489999999999999999999999986432 1222222111 12223333456


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccccccchh
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRT  363 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~~~~~~  363 (469)
                      +++++.+||.+||..||.+|||+.++++||||....++....
T Consensus       258 ~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~~~~  299 (327)
T 3aln_A          258 FSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEV  299 (327)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHHSCCCH
T ss_pred             CCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHhhHHHH
Confidence            899999999999999999999999999999997766554443

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.3e-47  Score=374.13  Aligned_cols=248  Identities=31%  Similarity=0.531  Sum_probs=205.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----------HHHHHHHHHHHHhh---CCCCeeEEEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------ETVHREVEIMQHLS---GHTGVVTLHSV  165 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------~~~~~E~~il~~l~---~hpnIv~l~~~  165 (469)
                      ..+.++|++++.||+|+||.||+|.+..+|+.||||++....          ..+.+|+.+++++.   .||||++++++
T Consensus        27 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~  106 (312)
T 2iwi_A           27 EAFEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDW  106 (312)
T ss_dssp             ------CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEE
T ss_pred             hhhhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEE
Confidence            457789999999999999999999999999999999996432          23557999999994   49999999999


Q ss_pred             EEeCCeEEEEEec-cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc-cCCcEEEEeccc
Q 012170          166 YEEADCFHLVMEL-CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT-TSGKIKLADFGL  243 (469)
Q Consensus       166 ~~~~~~~~lV~E~-~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~-~~~~vkL~DFgl  243 (469)
                      +...+..++|||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ .++.+||+|||+
T Consensus       107 ~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~  186 (312)
T 2iwi_A          107 FETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGS  186 (312)
T ss_dssp             C-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSS
T ss_pred             EecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcch
Confidence            9999999999999 78999999999888999999999999999999999999999999999999999 789999999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC-CC-CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG-NY-SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~-~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      +...... ......||+.|+|||++.+ .+ +.++||||||+++|+|++|..||.+..      .+......++    ..
T Consensus       187 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~------~~~~~~~~~~----~~  255 (312)
T 2iwi_A          187 GALLHDE-PYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ------EILEAELHFP----AH  255 (312)
T ss_dssp             CEECCSS-CBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHTCCCCC----TT
T ss_pred             hhhcccC-cccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH------HHhhhccCCc----cc
Confidence            9876543 3455679999999999865 34 458999999999999999999997532      2222333333    46


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      ++.++.+||.+||..||.+|||+.|+|+||||....
T Consensus       256 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          256 VSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             SCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCch
Confidence            899999999999999999999999999999996543

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=3.4e-47  Score=382.66  Aligned_cols=248  Identities=23%  Similarity=0.340  Sum_probs=209.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEE-----ECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCR-----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ...++|.+++.||+|+||.||+|.     +..+++.||||+++..     ...+.+|+++|.++..||||+++++++.+.
T Consensus        19 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~   98 (359)
T 3vhe_A           19 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKP   98 (359)
T ss_dssp             CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECST
T ss_pred             ccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCcCCHHHHHHHHHHHHHHHhhcCCcceeeeeeeeecC
Confidence            346899999999999999999998     5567789999999753     245889999999996699999999999875


Q ss_pred             C-eEEEEEeccCCCchHHHHHHhCC-------------------------------------------------------
Q 012170          170 D-CFHLVMELCSGGRLIDQMVEVGQ-------------------------------------------------------  193 (469)
Q Consensus       170 ~-~~~lV~E~~~gg~L~~~l~~~~~-------------------------------------------------------  193 (469)
                      + .+++|||||+||+|.+++.....                                                       
T Consensus        99 ~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  178 (359)
T 3vhe_A           99 GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEE  178 (359)
T ss_dssp             TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------------------------------------------
T ss_pred             CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhh
Confidence            5 48999999999999999976543                                                       


Q ss_pred             -----------CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---cccccCCC
Q 012170          194 -----------YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGS  259 (469)
Q Consensus       194 -----------l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~~~~~~gt  259 (469)
                                 +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......   ......||
T Consensus       179 ~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t  258 (359)
T 3vhe_A          179 EEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP  258 (359)
T ss_dssp             -----CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEEC
T ss_pred             cccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCC
Confidence                       8999999999999999999999999999999999999999999999999997654332   23345789


Q ss_pred             CcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          260 PAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       260 ~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      +.|+|||++.+ .++.++|||||||++|+|++ |..||.+.... .....+......   .....+++++.+||.+||..
T Consensus       259 ~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li~~~l~~  335 (359)
T 3vhe_A          259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRM---RAPDYTTPEMYQTMLDCWHG  335 (359)
T ss_dssp             GGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCC---CCCTTCCHHHHHHHHHHTCS
T ss_pred             ceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCC---CCCCCCCHHHHHHHHHHccC
Confidence            99999999865 58999999999999999998 99999876543 333444433221   12246899999999999999


Q ss_pred             hhcCCCCHHHHHcC
Q 012170          337 DVSARITADEVLRH  350 (469)
Q Consensus       337 dP~~Rpsa~elL~h  350 (469)
                      ||.+|||+.|+++|
T Consensus       336 dP~~Rps~~ell~~  349 (359)
T 3vhe_A          336 EPSQRPTFSELVEH  349 (359)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCCCHHHHHHH
Confidence            99999999999987

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=5.8e-46  Score=366.59  Aligned_cols=240  Identities=25%  Similarity=0.373  Sum_probs=205.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++|.+.+.||+|+||.||+|.+..++..||+|++...    ...+.+|+++|+.+. ||||+++++++.+++.+|+|||
T Consensus         9 ~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~~~lv~e   87 (310)
T 3s95_A            9 PSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFLKEVKVMRCLE-HPNVLKFIGVLYKDKRLNFITE   87 (310)
T ss_dssp             GGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEEE
T ss_pred             hhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CcCcccEEEEEecCCeeEEEEE
Confidence            47899999999999999999999999999999988543    356789999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc---
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~---  253 (469)
                      |++||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.........   
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~  167 (310)
T 3s95_A           88 YIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEG  167 (310)
T ss_dssp             CCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------
T ss_pred             ecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccc
Confidence            9999999999977 467999999999999999999999999999999999999999999999999999865433221   


Q ss_pred             ------------cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH------HHHHHHcCcCCC
Q 012170          254 ------------SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA------VFDAIKNVKLDF  314 (469)
Q Consensus       254 ------------~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~------~~~~i~~~~~~~  314 (469)
                                  ...+||+.|+|||++.+ .++.++||||||+++|+|++|..||.......      ........    
T Consensus       168 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~----  243 (310)
T 3s95_A          168 LRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFLDRY----  243 (310)
T ss_dssp             ------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHHHHT----
T ss_pred             cccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhcccccc----
Confidence                        15679999999999977 48999999999999999999999986532110      00111110    


Q ss_pred             CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          315 HSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       315 ~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                         ....+++.+.+||.+||..||.+|||+.++++
T Consensus       244 ---~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          244 ---CPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             ---CCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             ---CCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence               12467889999999999999999999999986

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=1.3e-46  Score=365.45  Aligned_cols=245  Identities=24%  Similarity=0.515  Sum_probs=216.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe-----------
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE-----------  168 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~-----------  168 (469)
                      .+..+|++++.||+|+||.||+|.+..+|+.||+|++......+.+|+++++.+. ||||+++++++..           
T Consensus         8 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~~~~~~~   86 (284)
T 2a19_B            8 RFGMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNNEKAEREVKALAKLD-HVNIVHYNGCWDGFDYDPETSSKN   86 (284)
T ss_dssp             HHHHHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCSGGGHHHHHHHHHCC-CTTBCCEEEEEEEEEEC-------
T ss_pred             hhccccceeeeeccCCceEEEEEEEcCCCeEEEEEEeccccHHHHHHHHHHHhCC-CCCEEEEeeeEeccccCccccccc
Confidence            4567899999999999999999999999999999999887788999999999996 9999999999864           


Q ss_pred             -----CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEec
Q 012170          169 -----ADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF  241 (469)
Q Consensus       169 -----~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DF  241 (469)
                           ...+|+||||+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+||
T Consensus        87 ~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Df  166 (284)
T 2a19_B           87 SSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF  166 (284)
T ss_dssp             --CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCC
T ss_pred             ccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcc
Confidence                 45689999999999999999765  57999999999999999999999999999999999999999999999999


Q ss_pred             cceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          242 GLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       242 gla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      |++.............||+.|+|||++.+ .++.++||||||+++|+|++|..||..  .......+.....      ..
T Consensus       167 g~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~--~~~~~~~~~~~~~------~~  238 (284)
T 2a19_B          167 GLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFE--TSKFFTDLRDGII------SD  238 (284)
T ss_dssp             TTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHH--HHHHHHHHHTTCC------CT
T ss_pred             hhheeccccccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchh--HHHHHHHhhcccc------cc
Confidence            99988766555566789999999999976 489999999999999999999998853  2333444443321      24


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .++.++.+||.+||..||.+|||+.|+++|.|.
T Consensus       239 ~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~  271 (284)
T 2a19_B          239 IFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTV  271 (284)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHHHHH
Confidence            578999999999999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=2.5e-46  Score=363.93  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=214.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++..   ..+.+.+|+++++.+. ||||+++++++.+.+.+|+|||
T Consensus        22 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e   99 (283)
T 3gen_A           22 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITE   99 (283)
T ss_dssp             CGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEEEEEC
T ss_pred             CHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCCCHHHHHHHHHHHhcCC-CCCEeeEEEEEecCCCeEEEEe
Confidence            4578999999999999999999887 577899999975   3567899999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      |+++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  ..
T Consensus       100 ~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~  179 (283)
T 3gen_A          100 YMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSV  179 (283)
T ss_dssp             CCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHHHSTT
T ss_pred             ccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEEEcCCCCEEEcccccccccccccccccc
Confidence            9999999999976 56799999999999999999999999999999999999999999999999999976543221  23


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.......+........   ...+++.+.+||.+
T Consensus       180 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~  256 (283)
T 3gen_A          180 GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR---PHLASEKVYTIMYS  256 (283)
T ss_dssp             STTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC---CTTCCHHHHHHHHH
T ss_pred             CCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHHHHhcccCCCC---CCcCCHHHHHHHHH
Confidence            3457888999999964 58999999999999999998 9999999998888888877643332   24579999999999


Q ss_pred             hchhhhcCCCCHHHHHcC
Q 012170          333 MLTRDVSARITADEVLRH  350 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~h  350 (469)
                      ||..||.+|||+.++++|
T Consensus       257 ~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          257 CWHEKADERPTFKILLSN  274 (283)
T ss_dssp             TTCSSGGGSCCHHHHHHH
T ss_pred             HccCChhHCcCHHHHHHH
Confidence            999999999999999986

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=5.1e-46  Score=367.37  Aligned_cols=249  Identities=24%  Similarity=0.353  Sum_probs=206.4

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ....++|.+++.||+|+||.||+|.+..+++.||||++...       ...+.+|+.+++.+. ||||+++++++...+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~  108 (309)
T 2h34_A           30 GTQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQ-EPHVVPIHDFGEIDGQ  108 (309)
T ss_dssp             ----CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTE
T ss_pred             CcEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcC-CCCeeEEEEEEeeCCe
Confidence            34568999999999999999999999999999999998643       256788999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+||||++|++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       109 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~  188 (309)
T 2h34_A          109 LYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEK  188 (309)
T ss_dssp             EEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSCCC--------
T ss_pred             EEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEcCCCCEEEecCccCccccccc
Confidence            99999999999999999988899999999999999999999999999999999999999999999999999997654432


Q ss_pred             --cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          252 --TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       252 --~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                        ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+...+...+... ...+...+..++.++.+
T Consensus       189 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~l~~  267 (309)
T 2h34_A          189 LTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHINQA-IPRPSTVRPGIPVAFDA  267 (309)
T ss_dssp             --------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHHSC-CCCGGGTSTTCCTHHHH
T ss_pred             cccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhccC-CCCccccCCCCCHHHHH
Confidence              2335679999999999976 4889999999999999999999999987766554444433 22233344678999999


Q ss_pred             HHHHhchhhhcCCC-CHHHHHc
Q 012170          329 LMARMLTRDVSARI-TADEVLR  349 (469)
Q Consensus       329 lI~~~L~~dP~~Rp-sa~elL~  349 (469)
                      ||.+||..||.+|| +++++++
T Consensus       268 li~~~l~~dP~~Rp~s~~~l~~  289 (309)
T 2h34_A          268 VIARGMAKNPEDRYVTCGDLSA  289 (309)
T ss_dssp             HHHHHTCSSGGGSCSSHHHHHH
T ss_pred             HHHHhccCCHHHHHHhHHHHHH
Confidence            99999999999999 8888875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=2e-46  Score=369.61  Aligned_cols=246  Identities=22%  Similarity=0.338  Sum_probs=215.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+.+.||+|+||.||+|.+     +.++..||+|++....     ..+.+|+.+|+.+. ||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~   99 (314)
T 2ivs_A           21 PRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQVN-HPHVIKLYGACSQDG   99 (314)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSS
T ss_pred             chhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCC-CCceeeEEEEEecCC
Confidence            457899999999999999999988     3456899999997532     46788999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhCC------------------------CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQ------------------------YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE  226 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~------------------------l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~  226 (469)
                      .+|+||||++||+|.+++.....                        +++..+..++.||+.||.|||++||+||||||+
T Consensus       100 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~  179 (314)
T 2ivs_A          100 PLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAAR  179 (314)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred             ceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchh
Confidence            99999999999999999987543                        889999999999999999999999999999999


Q ss_pred             cEEEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHH
Q 012170          227 NILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLE  301 (469)
Q Consensus       227 NILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~  301 (469)
                      |||++.++.+||+|||++........   .....+|+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....
T Consensus       180 NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~  259 (314)
T 2ivs_A          180 NILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE  259 (314)
T ss_dssp             GEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred             eEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence            99999999999999999987654332   233467889999999866 48999999999999999999 99999998888


Q ss_pred             HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       302 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+...+......   .....+++++.+||.+||..||.+|||+.+++++
T Consensus       260 ~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          260 RLFNLLKTGHRM---ERPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             GHHHHHHTTCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhhcCCcC---CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            877777665422   2235689999999999999999999999999875

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-46  Score=375.60  Aligned_cols=247  Identities=23%  Similarity=0.306  Sum_probs=216.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ...++|++++.||+|+||.||+|.+.     .+++.||||+++..     ...+.+|+.+|+.+. ||||+++++++.+.
T Consensus        44 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~  122 (343)
T 1luf_A           44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVG  122 (343)
T ss_dssp             CCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSS
T ss_pred             ecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEccC
Confidence            35678999999999999999999987     45589999999753     246789999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh------------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV------------------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP  225 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~------------------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp  225 (469)
                      +.+|+||||+++|+|.+++...                        ..+++..+..++.||+.||.|||++||+||||||
T Consensus       123 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp  202 (343)
T 1luf_A          123 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT  202 (343)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred             CceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCc
Confidence            9999999999999999999764                        5789999999999999999999999999999999


Q ss_pred             CcEEEccCCcEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCH
Q 012170          226 ENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSL  300 (469)
Q Consensus       226 ~NILl~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~  300 (469)
                      +|||++.++.+||+|||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.
T Consensus       203 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~  282 (343)
T 1luf_A          203 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH  282 (343)
T ss_dssp             GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred             ceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence            99999999999999999997653322   2234578999999999865 58999999999999999999 9999999998


Q ss_pred             HHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          301 EAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       301 ~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++...+........   ...++.++.+||.+||..||.+|||+.+++++
T Consensus       283 ~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          283 EEVIYYVRDGNILAC---PENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             HHHHHHHHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhCCCcCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence            888888877654322   24689999999999999999999999999864

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=5.5e-46  Score=378.28  Aligned_cols=247  Identities=23%  Similarity=0.340  Sum_probs=216.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-------CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..++|.+++.||+|+||.||+|.+..       ++..||||+++..     ...+.+|+++++.+..||||+++++++.+
T Consensus        67 ~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~  146 (382)
T 3tt0_A           67 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ  146 (382)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             chhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccccCHHHHHHHHHHHHHHHHhcCCchhhhheeeecc
Confidence            45799999999999999999999753       3357999999653     24578999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+.+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus       147 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  226 (382)
T 3tt0_A          147 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  226 (382)
T ss_dssp             SSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred             CCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcC
Confidence            999999999999999999998754                4899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.+||+|||++.......   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+
T Consensus       227 ~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~  306 (382)
T 3tt0_A          227 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  306 (382)
T ss_dssp             TCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence            9999999999998654332   2334567889999999976 48999999999999999999 99999999998888888


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ........   ...+++++.+||.+||..||.+|||+.|++++
T Consensus       307 ~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          307 KEGHRMDK---PSNCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             HTTCCCCC---CSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HcCCCCCC---CccCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            76643222   25689999999999999999999999999986

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=2.2e-46  Score=380.72  Aligned_cols=245  Identities=24%  Similarity=0.347  Sum_probs=214.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      -.++|.+.+.||+|+||.||+|.++.+++.||||+++...     ..+.+|+++|+.+. ||||+++++++...+.+|+|
T Consensus       112 ~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~lv  190 (377)
T 3cbl_A          112 NHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLPPDLKAKFLQEARILKQYS-HPNIVRLIGVCTQKQPIYIV  190 (377)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTTSCHHHHTTTTHHHHHHTTCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             chHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEccccCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEecCCCcEEE
Confidence            3478999999999999999999999999999999987532     35778999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      |||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++..........
T Consensus       191 ~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~  270 (377)
T 3cbl_A          191 MELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAA  270 (377)
T ss_dssp             EECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEEC
T ss_pred             EEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceee
Confidence            99999999999997764 69999999999999999999999999999999999999999999999999997654332211


Q ss_pred             ---ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          255 ---GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       255 ---~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                         ...+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+.......   ....+++++.+|
T Consensus       271 ~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~l  347 (377)
T 3cbl_A          271 SGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLP---CPELCPDAVFRL  347 (377)
T ss_dssp             CSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHH
T ss_pred             cCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHH
Confidence               1235678999999964 58999999999999999998 999999998888877776653221   224679999999


Q ss_pred             HHHhchhhhcCCCCHHHHHc
Q 012170          330 MARMLTRDVSARITADEVLR  349 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~  349 (469)
                      |.+||..||.+|||+.++++
T Consensus       348 i~~cl~~dP~~Rps~~~i~~  367 (377)
T 3cbl_A          348 MEQCWAYEPGQRPSFSTIYQ  367 (377)
T ss_dssp             HHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHcCCCchhCcCHHHHHH
Confidence            99999999999999999985

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=2.4e-46  Score=372.25  Aligned_cols=246  Identities=24%  Similarity=0.330  Sum_probs=213.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEE--EEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEF--ACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v--AvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++.+.||+|+||.||+|++..+|..+  |+|.+...     ...+.+|+.+|+++..||||+++++++.+.+.+|+
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~l  103 (327)
T 1fvr_A           24 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYL  103 (327)
T ss_dssp             GGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEE
T ss_pred             HHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEE
Confidence            368999999999999999999999888865  99988642     35688999999999559999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          175 VMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      ||||+++|+|.+++...+                .+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       104 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL  183 (327)
T 1fvr_A          104 AIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI  183 (327)
T ss_dssp             EECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEE
T ss_pred             EEecCCCCCHHHHHHhcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEE
Confidence            999999999999997654                6999999999999999999999999999999999999999999999


Q ss_pred             EeccceeeecCCCcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCC
Q 012170          239 ADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHS  316 (469)
Q Consensus       239 ~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~  316 (469)
                      +|||++.............+++.|+|||++.+. ++.++|||||||++|+|++ |..||.+.+..+....+......   
T Consensus       184 ~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---  260 (327)
T 1fvr_A          184 ADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL---  260 (327)
T ss_dssp             CCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC---
T ss_pred             cccCcCccccccccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC---
Confidence            999999754333333445678999999999764 8999999999999999998 99999999988888777654221   


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .....+++++.+||.+||..||.+|||+.++++|
T Consensus       261 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          261 EKPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            1234679999999999999999999999999986

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2e-46  Score=378.82  Aligned_cols=253  Identities=25%  Similarity=0.438  Sum_probs=205.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhh----------CCCCeeEEEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS----------GHTGVVTLHSVYE  167 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~----------~hpnIv~l~~~~~  167 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++....   ..+.+|+.+++++.          .||||+++++++.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~   96 (373)
T 1q8y_A           17 KDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFN   96 (373)
T ss_dssp             TTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEE
T ss_pred             cCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCccchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhh
Confidence            3468999999999999999999999999999999997643   56788999999886          2789999999998


Q ss_pred             eCC----eEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhc-CeEeccCCCCcEEEcc------CC
Q 012170          168 EAD----CFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDM-GVVHRDIKPENILLTT------SG  234 (469)
Q Consensus       168 ~~~----~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~-givHrDlkp~NILl~~------~~  234 (469)
                      ..+    .+++||||+ +++|.+++...  +.+++..+..++.||+.||.|||++ ||+||||||+|||++.      .+
T Consensus        97 ~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~  175 (373)
T 1q8y_A           97 HKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI  175 (373)
T ss_dssp             EEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEE
T ss_pred             ccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcc
Confidence            654    789999999 89999999764  4599999999999999999999998 9999999999999954      34


Q ss_pred             cEEEEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC------HHHHHHHH
Q 012170          235 KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS------LEAVFDAI  307 (469)
Q Consensus       235 ~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~------~~~~~~~i  307 (469)
                      .+||+|||++.....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+      ....+..+
T Consensus       176 ~~kl~Dfg~a~~~~~--~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~  253 (373)
T 1q8y_A          176 QIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQI  253 (373)
T ss_dssp             EEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHH
T ss_pred             eEEEcccccccccCC--CCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHH
Confidence            799999999976543  2344689999999999976 48999999999999999999999998654      22222222


Q ss_pred             HcCcCCCCC--------------------------------------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          308 KNVKLDFHS--------------------------------------GVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       308 ~~~~~~~~~--------------------------------------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .......+.                                      .....++.++.+||.+||+.||.+|||+.|+|+
T Consensus       254 ~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~  333 (373)
T 1q8y_A          254 IELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVN  333 (373)
T ss_dssp             HHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHT
T ss_pred             HHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhh
Confidence            211000000                                      011234678899999999999999999999999


Q ss_pred             CCCcccc
Q 012170          350 HPWILFY  356 (469)
Q Consensus       350 hp~~~~~  356 (469)
                      ||||...
T Consensus       334 hp~f~~~  340 (373)
T 1q8y_A          334 HPWLKDT  340 (373)
T ss_dssp             CGGGTTC
T ss_pred             Chhhhcc
Confidence            9999643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=1e-45  Score=365.39  Aligned_cols=251  Identities=23%  Similarity=0.372  Sum_probs=207.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhC-CCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSG-HTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~-hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|.+++.||+|+||.||+|.+. +++.||||++...      ...+.+|+.+++++.. ||||+++++++...+.+|
T Consensus        26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~  104 (313)
T 3cek_A           26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY  104 (313)
T ss_dssp             TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSCCHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEE
T ss_pred             ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccccccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEE
Confidence            3467999999999999999999986 4899999998542      2567899999999974 699999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      +||| +.+++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++ ++.+||+|||++........ 
T Consensus       105 lv~e-~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~~  182 (313)
T 3cek_A          105 MVME-CGNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTS  182 (313)
T ss_dssp             EEEC-CCSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC-------
T ss_pred             EEEe-cCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCcccc
Confidence            9999 55889999999888999999999999999999999999999999999999996 48999999999976543322 


Q ss_pred             --ccccCCCCcccCceeccC------------CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCCCC
Q 012170          253 --LSGLAGSPAYVAPEVLSG------------NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       253 --~~~~~gt~~y~aPE~l~~------------~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~~~  317 (469)
                        .....||+.|+|||++.+            .++.++||||||+++|+|++|..||.... ....+..+........  
T Consensus       183 ~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~--  260 (313)
T 3cek_A          183 VVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIE--  260 (313)
T ss_dssp             -------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCC--
T ss_pred             ccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccC--
Confidence              234579999999999864            57889999999999999999999998653 3334444443332221  


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .....+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       261 ~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~  299 (313)
T 3cek_A          261 FPDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQ  299 (313)
T ss_dssp             CCCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC
T ss_pred             CcccchHHHHHHHHHHccCCcccCcCHHHHhcCccccCC
Confidence            224568899999999999999999999999999999543

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=5.6e-46  Score=365.17  Aligned_cols=237  Identities=32%  Similarity=0.573  Sum_probs=198.5

Q ss_pred             ccccCCeeee-eeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEE
Q 012170           99 NKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~-~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~  173 (469)
                      ..+.++|.++ +.||+|+||.||+|.+..+|+.||||++.. ...+.+|+.++.++..||||+++++++..    ...+|
T Consensus        13 ~~~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~-~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~   91 (299)
T 3m2w_A           13 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   91 (299)
T ss_dssp             SCGGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             cccccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEecc-cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEE
Confidence            3466788887 789999999999999999999999999975 46788999999666679999999999987    67899


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEeccceeeec
Q 012170          174 LVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRIS  248 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~~~~  248 (469)
                      +||||++||+|.+++...+  .+++..+..++.||+.||.|||++||+||||||+|||++.   ++.+||+|||++....
T Consensus        92 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~  171 (299)
T 3m2w_A           92 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  171 (299)
T ss_dssp             EEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT
T ss_pred             EEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc
Confidence            9999999999999998764  6999999999999999999999999999999999999998   7889999999986543


Q ss_pred             CCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH----HcCcCCCCCCcccCCCH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI----KNVKLDFHSGVWETVSK  324 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i----~~~~~~~~~~~~~~~s~  324 (469)
                      .                    ..|+.++|||||||++|+|++|..||.+.........+    ......++...+..+++
T Consensus       172 ~--------------------~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (299)
T 3m2w_A          172 G--------------------EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSE  231 (299)
T ss_dssp             T--------------------CGGGGHHHHHHHHHHHHHHHHSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCH
T ss_pred             c--------------------ccCCchhhHHHHHHHHHHHHHCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCH
Confidence            1                    24678999999999999999999999876544332211    12222333333467899


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          325 PARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ++.+||.+||..||.+|||+.|+|+||||...
T Consensus       232 ~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          232 EVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            99999999999999999999999999999644

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=4.1e-46  Score=372.81  Aligned_cols=249  Identities=22%  Similarity=0.319  Sum_probs=210.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+++.||+|+||.||+|.+     ..++..||||++...     .+.+.+|+.+|+++..||||+++++++...+
T Consensus        43 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  122 (344)
T 1rjb_A           43 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSG  122 (344)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEecccccCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCC
Confidence            457899999999999999999997     346678999998642     3568899999999955999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-----------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCc
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG-----------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPEN  227 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~-----------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~N  227 (469)
                      .+|+||||+++|+|.+++....                       .+++..+..++.||+.||.|||++||+||||||+|
T Consensus       123 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N  202 (344)
T 1rjb_A          123 PIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN  202 (344)
T ss_dssp             SCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGG
T ss_pred             ccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhh
Confidence            9999999999999999997653                       37899999999999999999999999999999999


Q ss_pred             EEEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHH
Q 012170          228 ILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEA  302 (469)
Q Consensus       228 ILl~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~  302 (469)
                      ||++.++.+||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.....
T Consensus       203 Ill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~  282 (344)
T 1rjb_A          203 VLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDA  282 (344)
T ss_dssp             EEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSH
T ss_pred             EEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHH
Confidence            9999999999999999976543322   234567889999999855 58999999999999999998 999998866444


Q ss_pred             HHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          303 VFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       303 ~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      .+..+........  ....+++++.+||.+||..||.+|||+.++++|-
T Consensus       283 ~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          283 NFYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             HHHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHhcCCCCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            4433333222222  2246799999999999999999999999999874

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=9.9e-46  Score=357.22  Aligned_cols=242  Identities=31%  Similarity=0.454  Sum_probs=202.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|++.+.||+|+||.||+|.+.  |..||||+++..        .+.+.+|+++++.++ ||||+++++++.+.+.+|
T Consensus         6 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~   82 (271)
T 3dtc_A            6 FAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLK-HPNIIALRGVCLKEPNLC   82 (271)
T ss_dssp             TTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCC-CTTBCCEEEEECCC--CE
T ss_pred             hhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcC-CCCEeeEEEEEecCCceE
Confidence            468999999999999999999975  889999998642        256789999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC---eEeccCCCCcEEEcc--------CCcEEEEecc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG---VVHRDIKPENILLTT--------SGKIKLADFG  242 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g---ivHrDlkp~NILl~~--------~~~vkL~DFg  242 (469)
                      +||||++|++|.+++ ..+.+++..+..++.||+.||.|||++|   |+||||||+|||++.        ++.+||+|||
T Consensus        83 lv~e~~~~~~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg  161 (271)
T 3dtc_A           83 LVMEFARGGPLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFG  161 (271)
T ss_dssp             EEEECCTTEEHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCC
T ss_pred             EEEEcCCCCCHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchHHEEEecccccccccCcceEEccCC
Confidence            999999999998887 4568999999999999999999999999   999999999999986        6789999999


Q ss_pred             ceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccC
Q 012170          243 LAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET  321 (469)
Q Consensus       243 la~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~  321 (469)
                      ++........ ....||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+.......+.......+  ....
T Consensus       162 ~~~~~~~~~~-~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~  238 (271)
T 3dtc_A          162 LAREWHRTTK-MSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP--IPST  238 (271)
T ss_dssp             C--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC--CCTT
T ss_pred             cccccccccc-cCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC--CCcc
Confidence            9976544332 34579999999999866 489999999999999999999999999888777777766554433  2356


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          322 VSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +++.+.+||.+||..||.+|||+.|+++|
T Consensus       239 ~~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          239 CPEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            89999999999999999999999999975

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=1.9e-46  Score=378.95  Aligned_cols=248  Identities=18%  Similarity=0.235  Sum_probs=200.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC-----CcEEEEEEcccChHHHHHHHHHHHHhhC--------------CCCeeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS-----GAEFACKTLRKGEETVHREVEIMQHLSG--------------HTGVVT  161 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-----~~~vAvK~~~~~~~~~~~E~~il~~l~~--------------hpnIv~  161 (469)
                      ..++|.+++.||+|+||.||+|.+..+     ++.||||++......+.+|+++++.+..              ||||++
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~  112 (364)
T 3op5_A           33 AAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPK  112 (364)
T ss_dssp             TCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCC
T ss_pred             CCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCe
Confidence            456899999999999999999998765     5789999998776666677766665543              999999


Q ss_pred             EEEEEEeC----CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc--cCC
Q 012170          162 LHSVYEEA----DCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT--TSG  234 (469)
Q Consensus       162 l~~~~~~~----~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~--~~~  234 (469)
                      +++++...    ...||||||+ |++|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++  .++
T Consensus       113 ~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~iiHrDlkp~Nill~~~~~~  191 (364)
T 3op5_A          113 YWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPD  191 (364)
T ss_dssp             EEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEESSCTT
T ss_pred             EEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeEEecCCHHHEEEecCCCC
Confidence            99998764    5689999999 99999999776 6799999999999999999999999999999999999999  889


Q ss_pred             cEEEEeccceeeecCCCc--------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHH
Q 012170          235 KIKLADFGLAMRISNGQT--------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVF  304 (469)
Q Consensus       235 ~vkL~DFgla~~~~~~~~--------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~  304 (469)
                      .+||+|||++..+.....        ....+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.... ...
T Consensus       192 ~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~~~~~~~  271 (364)
T 3op5_A          192 QVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNLKDPKYV  271 (364)
T ss_dssp             CEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHH
T ss_pred             eEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccccCHHHH
Confidence            999999999977543321        1345699999999999774 899999999999999999999999853221 111


Q ss_pred             HHHHcC-cCC---CCCC--cccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          305 DAIKNV-KLD---FHSG--VWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       305 ~~i~~~-~~~---~~~~--~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ...... ...   +...  ....++.++.+||..||..||.+||++.+|++
T Consensus       272 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          272 RDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD  322 (364)
T ss_dssp             HHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence            111100 000   0000  01467999999999999999999999999976

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=6e-46  Score=361.33  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=201.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|++++.||+|+||.||+|.+..+   +..||+|++...     .+.+.+|+.+++.+. ||||+++++++. ++..
T Consensus        13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~~   90 (281)
T 1mp8_A           13 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPV   90 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSC
T ss_pred             ehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCccceEEEEEc-cCcc
Confidence            457899999999999999999998654   457999998653     246788999999996 999999999985 4567


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        91 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  170 (281)
T 1mp8_A           91 WIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  170 (281)
T ss_dssp             EEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-----------
T ss_pred             EEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHEEECCCCCEEECccccccccCccc
Confidence            89999999999999997654 69999999999999999999999999999999999999999999999999998765433


Q ss_pred             c--ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 T--LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+....+....+.......   ....+++++.
T Consensus       171 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~  247 (281)
T 1mp8_A          171 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLY  247 (281)
T ss_dssp             --------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             ccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHHHHHHHcCCCCC---CCCCCCHHHH
Confidence            2  233457889999999965 58999999999999999996 999999888878777777654321   2357899999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcC
Q 012170          328 DLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +||.+||..||.+|||+.+++++
T Consensus       248 ~li~~~l~~~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          248 SLMTKCWAYDPSRRPRFTELKAQ  270 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCChhhCcCHHHHHHH
Confidence            99999999999999999999875

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=2e-46  Score=383.45  Aligned_cols=251  Identities=25%  Similarity=0.412  Sum_probs=210.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--e
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEAD--C  171 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--~  171 (469)
                      ....++|.+.+.||+|+||.||+|.+..+|+.||||++..     ..+.+.+|+++|+++. ||||+++++++.+.+  .
T Consensus         5 ~~~~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~   83 (396)
T 4eut_A            5 STSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN-HKNIVKLFAIEEETTTRH   83 (396)
T ss_dssp             ECSSEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGGGSCHHHHHHHHHHHHHCC-CTTBCCEEEEEECTTTCC
T ss_pred             CCCCCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccccchHHHHHHHHHHHHhcC-CCCCCeEEEeeccCCCCe
Confidence            4467899999999999999999999999999999999864     2356789999999997 999999999998765  7


Q ss_pred             EEEEEeccCCCchHHHHHHhCC---CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE----ccCCcEEEEeccce
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQ---YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL----TTSGKIKLADFGLA  244 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~---l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl----~~~~~vkL~DFgla  244 (469)
                      +|+|||||+||+|.+++.....   +++..+..++.||+.||.|||++||+||||||+|||+    +.++.+||+|||++
T Consensus        84 ~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a  163 (396)
T 4eut_A           84 KVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA  163 (396)
T ss_dssp             EEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGC
T ss_pred             eEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCc
Confidence            8999999999999999865433   9999999999999999999999999999999999999    77788999999999


Q ss_pred             eeecCCCcccccCCCCcccCceeccC---------CCCCccchHHHHHHHHHHHhCCCCCCC----CCHHHHHHHHHcCc
Q 012170          245 MRISNGQTLSGLAGSPAYVAPEVLSG---------NYSEKVDIWSAGVLLHALLVAALPFKG----DSLEAVFDAIKNVK  311 (469)
Q Consensus       245 ~~~~~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~DiwSlG~il~elltG~~Pf~~----~~~~~~~~~i~~~~  311 (469)
                      .............||+.|+|||++.+         .++.++|||||||++|+|++|..||.+    ....+++..+....
T Consensus       164 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~  243 (396)
T 4eut_A          164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK  243 (396)
T ss_dssp             EECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSC
T ss_pred             eEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCC
Confidence            88766666667789999999999853         478899999999999999999999964    22334444454433


Q ss_pred             CCC---------------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDF---------------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~---------------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +..                     .......++..+.+||.+||..||++|||+.|++++
T Consensus       244 p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~s~~e~l~~  303 (396)
T 4eut_A          244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWGFDQFFAE  303 (396)
T ss_dssp             CTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSCCHHHHHHH
T ss_pred             CcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhccHHHHHHH
Confidence            211                     011113356688999999999999999999998543

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.7e-45  Score=367.45  Aligned_cols=247  Identities=23%  Similarity=0.335  Sum_probs=214.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-------CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-------ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-------~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      ..++|++++.||+|+||.||+|.+.       .++..||||+++..     ...+.+|+.+++.+..||||+++++++.+
T Consensus        33 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~  112 (334)
T 2pvf_A           33 PRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ  112 (334)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             CHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccCCcHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEcc
Confidence            3478999999999999999999976       46778999999753     24578999999999559999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      .+.+|+||||+++|+|.+++....                .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       113 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~  192 (334)
T 2pvf_A          113 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTE  192 (334)
T ss_dssp             SSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred             CCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcC
Confidence            999999999999999999997654                3899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.+||+|||++........   .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++...+
T Consensus       193 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  272 (334)
T 2pvf_A          193 NNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLL  272 (334)
T ss_dssp             TCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHH
Confidence            99999999999987654332   233467889999999865 48999999999999999999 99999999988888877


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .......   ....++.++.+||.+||..||.+|||+.|++++
T Consensus       273 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          273 KEGHRMD---KPANCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             HHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hcCCCCC---CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7654222   225689999999999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.1e-45  Score=360.23  Aligned_cols=242  Identities=26%  Similarity=0.431  Sum_probs=206.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----------HHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----------ETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----------~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ..++|++.+.||+|+||.||+|.+..+++.||+|++....           ..+.+|+.+++.+. ||||+++++++.+.
T Consensus        17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~   95 (287)
T 4f0f_A           17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLN-HPNIVKLYGLMHNP   95 (287)
T ss_dssp             CSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCC-CTTBCCEEEEETTT
T ss_pred             hhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCC-CCCchhhheeecCC
Confidence            4578999999999999999999999999999999985321           56889999999996 99999999999776


Q ss_pred             CeEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCc-----EEEEec
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGK-----IKLADF  241 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~-----vkL~DF  241 (469)
                      .  ++||||+++|+|.+.+... ..+++..+..++.||+.||.|||++|  |+||||||+|||++.++.     +||+||
T Consensus        96 ~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Df  173 (287)
T 4f0f_A           96 P--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADF  173 (287)
T ss_dssp             T--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCC
T ss_pred             C--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCC
Confidence            5  5899999999999888655 47999999999999999999999999  999999999999988876     999999


Q ss_pred             cceeeecCCCcccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHcCcCCCCC
Q 012170          242 GLAMRISNGQTLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA--VFDAIKNVKLDFHS  316 (469)
Q Consensus       242 gla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~--~~~~i~~~~~~~~~  316 (469)
                      |++.....  ......||+.|+|||++.+   .++.++|||||||++|+|++|..||.+.+...  ....+......  .
T Consensus       174 g~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~--~  249 (287)
T 4f0f_A          174 GLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLR--P  249 (287)
T ss_dssp             TTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHHSCCC--C
T ss_pred             Cccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCccccccHHHHHHHHhccCCC--C
Confidence            99975433  3455789999999999843   37889999999999999999999998654333  23444333222  2


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .....+++++.+||.+||..||.+|||+.++++
T Consensus       250 ~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          250 TIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            233578999999999999999999999999986

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=5.2e-46  Score=366.45  Aligned_cols=247  Identities=23%  Similarity=0.331  Sum_probs=210.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+.+.||+|+||.||+|.+     ..+++.||||++...     .+.+.+|+.+|+++.+||||+++++++.+.+
T Consensus        21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~  100 (313)
T 1t46_A           21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGG  100 (313)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             ChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcchhHHHHHHHHHHHHHHhhcccCCCeeeEEEEEecCC
Confidence            347899999999999999999985     457889999999753     2568899999999955999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      ..++||||+++|+|.+++....                  .+++..+..++.||+.||.|||++||+||||||+|||++.
T Consensus       101 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~  180 (313)
T 1t46_A          101 PTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTH  180 (313)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEET
T ss_pred             CcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcC
Confidence            9999999999999999997654                  4899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHH-H
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFD-A  306 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~-~  306 (469)
                      ++.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+......+. .
T Consensus       181 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~  260 (313)
T 1t46_A          181 GRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM  260 (313)
T ss_dssp             TTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHH
T ss_pred             CCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHH
Confidence            99999999999976654332   233457889999999855 58999999999999999998 999998766443333 3


Q ss_pred             HHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          307 IKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       307 i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.... ..  .....++.++.+||.+||..||.+|||+.|++++
T Consensus       261 ~~~~~-~~--~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          261 IKEGF-RM--LSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             HHHTC-CC--CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hccCC-CC--CCcccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            33322 11  1224689999999999999999999999999975

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.6e-46  Score=361.63  Aligned_cols=247  Identities=24%  Similarity=0.354  Sum_probs=217.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ...++|++.+.||+|+||.||+|.+..++..||+|++....   +.+.+|+.+++.++ ||||+++++++.+.+.+|+||
T Consensus        10 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~~v~   88 (288)
T 3kfa_A           10 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIIT   88 (288)
T ss_dssp             CCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSCSTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSEEEEE
T ss_pred             ccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCEEEEE
Confidence            35678999999999999999999999999999999997543   56889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      ||++|++|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++........  
T Consensus        89 e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~~  168 (288)
T 3kfa_A           89 EFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA  168 (288)
T ss_dssp             ECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSSEE
T ss_pred             EcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcccc
Confidence            999999999999764  4599999999999999999999999999999999999999999999999999976543322  


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+|+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+.......+......   .....+++.+.+||
T Consensus       169 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~~li  245 (288)
T 3kfa_A          169 HAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRM---ERPEGCPEKVYELM  245 (288)
T ss_dssp             ETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHHHH
T ss_pred             ccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhccCCC---CCCCCCCHHHHHHH
Confidence            233567889999999965 58999999999999999999 99999988877777777654322   22357899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcC
Q 012170          331 ARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+||..||.+|||+.++++.
T Consensus       246 ~~~l~~dp~~Rps~~~~~~~  265 (288)
T 3kfa_A          246 RACWQWNPSDRPSFAEIHQA  265 (288)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhCCChhhCcCHHHHHHH
Confidence            99999999999999999863

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=1e-45  Score=362.07  Aligned_cols=245  Identities=24%  Similarity=0.364  Sum_probs=201.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEE----ECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEe--CC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEE--AD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~  170 (469)
                      ..++|++++.||+|+||.||+|+    +..+++.||||++....    ..+.+|+.+|+.+. ||||+++++++..  ..
T Consensus         8 ~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~   86 (295)
T 3ugc_A            8 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR   86 (295)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECHHHHT
T ss_pred             CHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecCCCC
Confidence            45789999999999999999998    56789999999997543    46789999999997 9999999999854  35


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      .+|+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        87 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~  166 (295)
T 3ugc_A           87 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  166 (295)
T ss_dssp             SCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC----
T ss_pred             ceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccC
Confidence            6899999999999999997754 599999999999999999999999999999999999999999999999999986644


Q ss_pred             CCc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Q 012170          250 GQT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE----------------AVFDAIK  308 (469)
Q Consensus       250 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----------------~~~~~i~  308 (469)
                      ...    .....|++.|+|||++.+ .++.++||||||+++|+|++|..||......                .....+.
T Consensus       167 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  246 (295)
T 3ugc_A          167 DKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  246 (295)
T ss_dssp             ---------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             CcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHh
Confidence            321    233457788999999965 5899999999999999999999998653211                1222222


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ...   .......+++++.+||.+||..||.+|||+.|+++
T Consensus       247 ~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          247 NNG---RLPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             TTC---CCCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             ccC---cCCCCcCcCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            221   11223578999999999999999999999999986

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2e-45  Score=354.03  Aligned_cols=244  Identities=29%  Similarity=0.405  Sum_probs=215.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|.+. ++..||+|++...   .+.+.+|+++++.+. ||||+++++++.+.+.+|+||||
T Consensus         7 ~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~~~~lv~e~   84 (267)
T 3t9t_A            7 PSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVTEF   84 (267)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTBCHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSCEEEECC
T ss_pred             hhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEccCCCeEEEEeC
Confidence            468999999999999999999987 5788999999753   467899999999996 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--cccc
Q 012170          179 CSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSG  255 (469)
Q Consensus       179 ~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~~  255 (469)
                      +++++|.+++... +.+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+|||++.......  ....
T Consensus        85 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~  164 (267)
T 3t9t_A           85 MEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG  164 (267)
T ss_dssp             CTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHHHSTTS
T ss_pred             CCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEECCCCCEEEccccccccccccccccccc
Confidence            9999999999765 568999999999999999999999999999999999999999999999999997653321  1234


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+..+....+........   ...++.++.+||.+|
T Consensus       165 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~~---~~~~~~~l~~li~~~  241 (267)
T 3t9t_A          165 TKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHC  241 (267)
T ss_dssp             TTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC---CTTSCHHHHHHHHHH
T ss_pred             ccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHHHhcCCcCCC---CccCcHHHHHHHHHH
Confidence            567889999999964 58999999999999999999 9999999988888888876543222   245799999999999


Q ss_pred             chhhhcCCCCHHHHHcC
Q 012170          334 LTRDVSARITADEVLRH  350 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~h  350 (469)
                      |..||.+|||+.+++++
T Consensus       242 l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          242 WRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             TCSSGGGSCCHHHHHHH
T ss_pred             ccCChhhCcCHHHHHHH
Confidence            99999999999999875

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.1e-45  Score=368.08  Aligned_cols=245  Identities=23%  Similarity=0.339  Sum_probs=206.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEE----EEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----AvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.+    |+|.+..     ....+.+|+.+++++. ||||+++++++.+.+ 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~-   90 (327)
T 3poz_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-   90 (327)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC-------CHHHHHHHHHHHHHCC-BTTBCCEEEEEESSS-
T ss_pred             CHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEecCC-
Confidence            3578999999999999999999998887754    7787743     2357889999999997 999999999998765 


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~  170 (327)
T 3poz_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTT
T ss_pred             eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCC
Confidence            67999999999999999774 57999999999999999999999999999999999999999999999999999765433


Q ss_pred             Cc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          251 QT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ..   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+...+...+.......   ....++.+
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~  247 (327)
T 3poz_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTID  247 (327)
T ss_dssp             CC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCC---CCTTBCHH
T ss_pred             cccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCHHHHHHHHHcCCCCC---CCccCCHH
Confidence            22   233457889999999865 58999999999999999999 999999988777777776554222   22457999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.+++++
T Consensus       248 ~~~li~~~l~~~p~~Rps~~ell~~  272 (327)
T 3poz_A          248 VYMIMVKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=3.2e-46  Score=371.45  Aligned_cols=245  Identities=23%  Similarity=0.340  Sum_probs=209.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcE----EEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~----vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..++|++++.||+|+||.||+|.+..+++.    ||+|++...     ...+.+|+.+++.+. ||||+++++++. ++.
T Consensus        11 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~-~~~   88 (325)
T 3kex_A           11 KETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLD-HAHIVRLLGLCP-GSS   88 (325)
T ss_dssp             CTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTTSCSCBCSCCHHHHHHHTCC-CTTBCCEEEEEC-BSS
T ss_pred             CHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccccHHHHHHHHHHHHHHhcCC-CCCcCeEEEEEc-CCc
Confidence            357899999999999999999999988876    777776432     245778999999996 999999999986 456


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        89 ~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~  168 (325)
T 3kex_A           89 LQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD  168 (325)
T ss_dssp             EEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCC
T ss_pred             cEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccchheEEECCCCeEEECCCCcccccCcc
Confidence            88999999999999999764 57999999999999999999999999999999999999999999999999999865433


Q ss_pred             C---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          251 Q---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .   ......||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+.........   ..++.+
T Consensus       169 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~  245 (325)
T 3kex_A          169 DKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLAQP---QICTID  245 (325)
T ss_dssp             TTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCTTHHHHHHHTTCBCCCC---TTBCTT
T ss_pred             cccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCCCC---CcCcHH
Confidence            2   2344678889999999964 69999999999999999999 99999998877887777765433222   356889


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.++++|
T Consensus       246 ~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          246 VYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             TTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999987

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=3.7e-45  Score=360.59  Aligned_cols=247  Identities=26%  Similarity=0.419  Sum_probs=200.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ..++|++.+.||+|+||.||+|.+..+|+.||||++...       ...+.+|+.+++.+. ||||+++++++...+.++
T Consensus        30 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  108 (310)
T 2wqm_A           30 TLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLN-HPNVIKYYASFIEDNELN  108 (310)
T ss_dssp             SGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCcEE
Confidence            456899999999999999999999999999999998642       246788999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          174 LVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +||||+.+|+|.+++..    ...+++..+..++.||+.||.|||+.|++||||||+|||++.+|.+||+|||++.....
T Consensus       109 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~  188 (310)
T 2wqm_A          109 IVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS  188 (310)
T ss_dssp             EEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCC--------
T ss_pred             EEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecC
Confidence            99999999999998865    35689999999999999999999999999999999999999999999999999976543


Q ss_pred             CC-cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          250 GQ-TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD--SLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       250 ~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .. ......||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.  ........+......  ......++.+
T Consensus       189 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~  266 (310)
T 2wqm_A          189 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYP--PLPSDHYSEE  266 (310)
T ss_dssp             ----------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHHHHHHHTTCSC--CCCTTTSCHH
T ss_pred             CCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHHHHHhhcccCC--CCcccccCHH
Confidence            32 2344679999999999976 4899999999999999999999999764  344555555554332  2223568999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.+++++
T Consensus       267 l~~li~~~l~~dp~~Rps~~~il~~  291 (310)
T 2wqm_A          267 LRQLVNMCINPDPEKRPDVTYVYDV  291 (310)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCCCHHHHHHH
Confidence            9999999999999999999999874

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.6e-45  Score=357.68  Aligned_cols=243  Identities=25%  Similarity=0.338  Sum_probs=211.0

Q ss_pred             cCCeeeee-eeeccCCeEEEEEE--ECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          102 EDDHTKVE-VIGHGKFGSVWLCR--SKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       102 ~~~y~~~~-~lG~G~~g~Vy~~~--~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .++|.+.+ .||+|+||.||+|.  ...++..||||+++..      .+.+.+|+.+++.+. ||||+++++++ ..+.+
T Consensus        15 ~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~-~~~~~   92 (291)
T 1xbb_A           15 RKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGIC-EAESW   92 (291)
T ss_dssp             GGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEE-ESSSE
T ss_pred             chhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccccCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEE-CCCCc
Confidence            46799988 99999999999995  4667889999999653      356889999999996 99999999999 56778


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||+++++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus        93 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  172 (291)
T 1xbb_A           93 MLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN  172 (291)
T ss_dssp             EEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCS
T ss_pred             EEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCC
Confidence            89999999999999998888899999999999999999999999999999999999999999999999999987654332


Q ss_pred             ----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          253 ----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       253 ----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                          .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++...+.......   ....+++++
T Consensus       173 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l  249 (291)
T 1xbb_A          173 YYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREM  249 (291)
T ss_dssp             EEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             cccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHH
Confidence                122456789999999965 48899999999999999999 999999998888888877654321   235689999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+||.+||..||.+|||+.++++
T Consensus       250 ~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          250 YDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHH
Confidence            99999999999999999999986

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=1.7e-45  Score=364.67  Aligned_cols=247  Identities=21%  Similarity=0.281  Sum_probs=215.5

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ...++|++.+.||+|+||.||+|.+.     .++..||||++...     ...+.+|+.+|+.+. ||||+++++++.+.
T Consensus        22 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~  100 (322)
T 1p4o_A           22 VAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQG  100 (322)
T ss_dssp             CCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSS
T ss_pred             chhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCCEeeeEEEEccC
Confidence            35678999999999999999999876     46788999999653     235788999999996 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEE
Q 012170          170 DCFHLVMELCSGGRLIDQMVEV----------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA  239 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~  239 (469)
                      +..|+||||+++|+|.+++...          ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus       101 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~  180 (322)
T 1p4o_A          101 QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG  180 (322)
T ss_dssp             SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEEC
T ss_pred             CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHHCCCccCCCccceEEEcCCCeEEEC
Confidence            9999999999999999998653          356899999999999999999999999999999999999999999999


Q ss_pred             eccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCC
Q 012170          240 DFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDF  314 (469)
Q Consensus       240 DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~  314 (469)
                      |||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+.......+.......
T Consensus       181 Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~  260 (322)
T 1p4o_A          181 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD  260 (322)
T ss_dssp             CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC
T ss_pred             cCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCC
Confidence            9999976543321   223457899999999865 58999999999999999999 899999999888888877654322


Q ss_pred             CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          315 HSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       315 ~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .   ...++..+.+||.+||..||.+|||+.|+++|
T Consensus       261 ~---~~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          261 K---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             C---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             C---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            2   24689999999999999999999999999987

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=4.1e-45  Score=358.51  Aligned_cols=244  Identities=23%  Similarity=0.390  Sum_probs=204.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEE----ECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--C
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEA--D  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~  170 (469)
                      ...|++++.||+|+||.||+|+    +..+++.||+|++...     ...+.+|+.+|+.+. ||||+++++++.+.  +
T Consensus        20 ~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~   98 (302)
T 4e5w_A           20 KRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLY-HENIVKYKGICTEDGGN   98 (302)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-----CCHHHHHHHHHHHHTCC-CTTBCCEEEEEEC---C
T ss_pred             hhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccccchhHHHHHHHHHHHHhCC-CCCeeeeeeEEecCCCc
Confidence            4579999999999999999999    5678999999998643     367889999999997 99999999999876  6


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      .+|+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.++|+|||++.....
T Consensus        99 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~  178 (302)
T 4e5w_A           99 GIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIET  178 (302)
T ss_dssp             CEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCT
T ss_pred             eEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCCchheEEEcCCCCEEECcccccccccC
Confidence            789999999999999999554 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC---------------CHHHHHHHHHc
Q 012170          250 GQT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD---------------SLEAVFDAIKN  309 (469)
Q Consensus       250 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~---------------~~~~~~~~i~~  309 (469)
                      ...    .....||+.|+|||++.+ .++.++||||||+++|+|++|..|+...               ........+..
T Consensus       179 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  258 (302)
T 4e5w_A          179 DKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKE  258 (302)
T ss_dssp             TCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHT
T ss_pred             CCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcchhhHHhhccCCcccccCHHHHHHHHhc
Confidence            432    334568889999999865 4889999999999999999999886322               11222333333


Q ss_pred             CcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       310 ~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..   .......+++++.+||.+||..||.+|||+.++++
T Consensus       259 ~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          259 GK---RLPCPPNCPDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             TC---CCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             cC---CCCCCCCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            22   12223578999999999999999999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=9.9e-46  Score=360.59  Aligned_cols=241  Identities=20%  Similarity=0.281  Sum_probs=207.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCC-------cEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASG-------AEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ..++|.+.+.||+|+||.||+|.+..++       ..||+|++...    .+.+.+|+.+|+.+. ||||+++++++.+.
T Consensus         6 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~   84 (289)
T 4fvq_A            6 RNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLS-HKHLVLNYGVCVCG   84 (289)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGGGGGGHHHHHHHHHHHHTSC-CTTBCCEEEEECCT
T ss_pred             chhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccccHHHHHHHHHHHHHHHhCC-CCCEeEEEEEEEeC
Confidence            4578999999999999999999998877       46999998643    356889999999997 99999999999999


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCC-CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc--------EEEEe
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK--------IKLAD  240 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~-l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~--------vkL~D  240 (469)
                      +..|+||||++||+|.+++...+. +++..+..++.||+.||.|||++||+||||||+|||++.++.        +||+|
T Consensus        85 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~D  164 (289)
T 4fvq_A           85 DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSD  164 (289)
T ss_dssp             TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECC
T ss_pred             CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECCCcCcceEEEecCCcccccccceeeecc
Confidence            999999999999999999977654 999999999999999999999999999999999999999887        99999


Q ss_pred             ccceeeecCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          241 FGLAMRISNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       241 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      ||++.....   .....||+.|+|||++.+  .++.++|||||||++|+|++ |.+||.............. ...++  
T Consensus       165 fg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~~~~~--  238 (289)
T 4fvq_A          165 PGISITVLP---KDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-RHQLP--  238 (289)
T ss_dssp             CCSCTTTSC---HHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCCC--
T ss_pred             CcccccccC---ccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-cCCCC--
Confidence            999864322   233468999999999975  48999999999999999999 5566666666555544433 22222  


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                        ...+.++.+||.+||..||.+|||+.++++|
T Consensus       239 --~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          239 --APKAAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             --CCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             --CCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence              3458889999999999999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=2.5e-45  Score=364.68  Aligned_cols=245  Identities=24%  Similarity=0.363  Sum_probs=200.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC----eEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEAD----CFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~----~~~l  174 (469)
                      .++|++++.||+|+||.||+|++.  ++.||||++....   ....+|+.+|++++ ||||+++++++....    .+|+
T Consensus        23 ~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~~~~~~~~~~l   99 (322)
T 3soc_A           23 SMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQDKQSWQNEYEVYSLPGMK-HENILQFIGAEKRGTSVDVDLWL   99 (322)
T ss_dssp             TEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEE
T ss_pred             hhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCchHHHHHHHHHHHHhcCC-CCCchhhcceeccCCCCCceEEE
Confidence            368999999999999999999876  7899999996543   34566888899996 999999999998744    4799


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc----------CeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM----------GVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~----------givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      |||||++|+|.+++.. ..+++..+..++.||+.||.|||+.          ||+||||||+|||++.++.+||+|||++
T Consensus       100 v~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a  178 (322)
T 3soc_A          100 ITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLA  178 (322)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred             EEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcc
Confidence            9999999999999855 5699999999999999999999999          9999999999999999999999999999


Q ss_pred             eeecCCCc---ccccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCC----------------C
Q 012170          245 MRISNGQT---LSGLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGD----------------S  299 (469)
Q Consensus       245 ~~~~~~~~---~~~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~----------------~  299 (469)
                      ........   .....||+.|+|||++.+      .++.++|||||||++|+|++|..||.+.                .
T Consensus       179 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~  258 (322)
T 3soc_A          179 LKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPS  258 (322)
T ss_dssp             EEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCC
T ss_pred             cccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCc
Confidence            87654332   334679999999999976      3566889999999999999999999753                2


Q ss_pred             HHHHHHHHHcCcCCCC-CCccc--CCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          300 LEAVFDAIKNVKLDFH-SGVWE--TVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       300 ~~~~~~~i~~~~~~~~-~~~~~--~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .......+........ ...|.  ..+.++.+||.+||+.||.+|||+.|+++.
T Consensus       259 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~  312 (322)
T 3soc_A          259 LEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARLSAGCVGER  312 (322)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2333333332222111 11111  224569999999999999999999999863

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=4.4e-45  Score=356.99  Aligned_cols=249  Identities=23%  Similarity=0.335  Sum_probs=206.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++..  ....+.+|+.+++.+..|+++..+..++...+..++|||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 3uzp_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             EETTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             eeccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcchhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEE
Confidence            356899999999999999999999999999999999854  345789999999999844445566666678889999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeecCCCc-
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      |+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~  164 (296)
T 3uzp_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             ec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccc
Confidence            99 8999999974 4579999999999999999999999999999999999999   4888999999999987654432 


Q ss_pred             -------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCC-CCccc
Q 012170          253 -------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFH-SGVWE  320 (469)
Q Consensus       253 -------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~~  320 (469)
                             .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ....+..+.......+ .....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T 3uzp_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  244 (296)
T ss_dssp             CBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred             cccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHh
Confidence                   245689999999999977 58999999999999999999999998632   2223333322222222 11224


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+++++.+||.+||+.||.+|||+.++++
T Consensus       245 ~~~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             hCCHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            67999999999999999999999999986

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=1e-45  Score=370.96  Aligned_cols=248  Identities=19%  Similarity=0.223  Sum_probs=198.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC---CCcEEEEEEcccChH---------------HHHHHHHHHHHhhCCCCeeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKGEE---------------TVHREVEIMQHLSGHTGVVTL  162 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~~~---------------~~~~E~~il~~l~~hpnIv~l  162 (469)
                      ..++|.+++.||+|+||.||+|.+..   ++..||||++.....               .+.+|+.+++.+. ||||+++
T Consensus        35 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~-h~ni~~~  113 (345)
T 2v62_A           35 EGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLD-YLGIPLF  113 (345)
T ss_dssp             TSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCS-CCCCCCE
T ss_pred             cCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhcccc-ccCccee
Confidence            34789999999999999999999987   788999999876432               2445666677775 9999999


Q ss_pred             EEEEEe----CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC--cE
Q 012170          163 HSVYEE----ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG--KI  236 (469)
Q Consensus       163 ~~~~~~----~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~--~v  236 (469)
                      ++++..    ...+|+||||+ |++|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++  .+
T Consensus       114 ~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~~~  192 (345)
T 2v62_A          114 YGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQV  192 (345)
T ss_dssp             EEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEESSSTTSE
T ss_pred             ecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCcCHHHEEEccCCCCcE
Confidence            999988    78899999999 999999998888999999999999999999999999999999999999999887  99


Q ss_pred             EEEeccceeeecCCC--------cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCC--CCHHHHHH
Q 012170          237 KLADFGLAMRISNGQ--------TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKG--DSLEAVFD  305 (469)
Q Consensus       237 kL~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~--~~~~~~~~  305 (469)
                      ||+|||++..+....        ......||+.|+|||++.+. ++.++|||||||++|+|++|..||.+  ........
T Consensus       193 kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~~~~~~~  272 (345)
T 2v62_A          193 YLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQNLKDPVAVQT  272 (345)
T ss_dssp             EECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGGTTCHHHHHH
T ss_pred             EEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCccccccccHHHHH
Confidence            999999998654321        12456899999999999775 89999999999999999999999965  33333322


Q ss_pred             HHHcCcCCCCCCc-----ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          306 AIKNVKLDFHSGV-----WETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       306 ~i~~~~~~~~~~~-----~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ........++...     ...++.++.+||.+||..||.+|||+.+|++.
T Consensus       273 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  322 (345)
T 2v62_A          273 AKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKKI  322 (345)
T ss_dssp             HHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHHH
Confidence            2222211222110     12689999999999999999999999999863

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=1.8e-45  Score=366.05  Aligned_cols=249  Identities=23%  Similarity=0.310  Sum_probs=211.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEE-----ECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCR-----SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~-----~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++++.||+|+||.||+|.     +..++..||||++...     ...+.+|+.+++.+. ||||+++++++.+.+
T Consensus        28 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~  106 (327)
T 2yfx_A           28 PRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFN-HQNIVRCIGVSLQSL  106 (327)
T ss_dssp             CGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             ChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccccchhhHHHHHHHHHHHhhCC-CCCCCeEEEEEcCCC
Confidence            45789999999999999999998     5567889999999642     246788999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC-------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC---CcEEEEe
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG-------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS---GKIKLAD  240 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~-------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~---~~vkL~D  240 (469)
                      ..|+||||++||+|.+++....       .+++..+..++.||+.||.|||++||+||||||+|||++.+   +.+||+|
T Consensus       107 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~D  186 (327)
T 2yfx_A          107 PRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGD  186 (327)
T ss_dssp             SCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECC
T ss_pred             CcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECc
Confidence            9999999999999999998763       48999999999999999999999999999999999999954   4699999


Q ss_pred             ccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCC
Q 012170          241 FGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFH  315 (469)
Q Consensus       241 Fgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~  315 (469)
                      ||++.......   ......||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.........+........
T Consensus       187 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~  266 (327)
T 2yfx_A          187 FGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP  266 (327)
T ss_dssp             CHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC
T ss_pred             cccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC
Confidence            99997543322   2234568999999999854 58999999999999999998 9999999988888888776543222


Q ss_pred             CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          316 SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       316 ~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                         ...++..+.+||.+||..||.+|||+.++++|.|+
T Consensus       267 ---~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~  301 (327)
T 2yfx_A          267 ---PKNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEY  301 (327)
T ss_dssp             ---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred             ---CCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHH
Confidence               24689999999999999999999999999999876

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=9.2e-45  Score=377.33  Aligned_cols=241  Identities=24%  Similarity=0.374  Sum_probs=209.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC-eEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEAD-CFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~-~~~lV~E  177 (469)
                      -.++|++++.||+|+||.||+|.+.  |+.||||+++..  .+.+.+|+.+|++++ ||||+++++++...+ .+|+|||
T Consensus       191 ~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~~iv~e  267 (450)
T 1k9a_A          191 NMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTE  267 (450)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCTTSHHHHHHHHHHHTCC-CTTBCCEEEEEECTTSCEEEEEE
T ss_pred             ChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCchHHHHHHHHHHHHHhcc-CCCEEEEEEEEEcCCCceEEEEE
Confidence            4578999999999999999999886  789999999754  467899999999996 999999999987655 7999999


Q ss_pred             ccCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          178 LCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      ||++|+|.+++...+.  +++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......  ...
T Consensus       268 ~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~--~~~  345 (450)
T 1k9a_A          268 YMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDT  345 (450)
T ss_dssp             CCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------
T ss_pred             ecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc--ccC
Confidence            9999999999987654  799999999999999999999999999999999999999999999999999864332  223


Q ss_pred             cCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          256 LAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+..+..   ......+++++.+||.+|
T Consensus       346 ~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~---~~~p~~~~~~l~~li~~c  422 (450)
T 1k9a_A          346 GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYDVMKNC  422 (450)
T ss_dssp             -CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHHHHHHTTCC---CCCCTTCCHHHHHHHHHH
T ss_pred             CCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCcCCHHHHHHHHHH
Confidence            467899999999965 59999999999999999998 9999998877777777766532   122357899999999999


Q ss_pred             chhhhcCCCCHHHHHc
Q 012170          334 LTRDVSARITADEVLR  349 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~  349 (469)
                      |..||.+|||+.++++
T Consensus       423 l~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          423 WHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             cCCChhHCcCHHHHHH
Confidence            9999999999999975

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=1.3e-45  Score=364.10  Aligned_cols=247  Identities=24%  Similarity=0.346  Sum_probs=209.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEE-----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~-----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+++.||+|+||.||+|.+     ..+++.||||++...     ...+.+|+.+++.+..||||+++++++...+
T Consensus        25 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~  104 (316)
T 2xir_A           25 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPG  104 (316)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTT
T ss_pred             chhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCCCcHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCC
Confidence            457899999999999999999985     457789999999753     2457899999999966999999999987654


Q ss_pred             -eEEEEEeccCCCchHHHHHHhCC----------------CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC
Q 012170          171 -CFHLVMELCSGGRLIDQMVEVGQ----------------YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       171 -~~~lV~E~~~gg~L~~~l~~~~~----------------l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~  233 (469)
                       .+|+||||++||+|.+++.....                +++..+..++.||+.||.|||++||+||||||+|||++.+
T Consensus       105 ~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~  184 (316)
T 2xir_A          105 GPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEK  184 (316)
T ss_dssp             SCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGG
T ss_pred             CceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCC
Confidence             58999999999999999977554                8999999999999999999999999999999999999999


Q ss_pred             CcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCH-HHHHHHH
Q 012170          234 GKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSL-EAVFDAI  307 (469)
Q Consensus       234 ~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~-~~~~~~i  307 (469)
                      +.+||+|||++........   .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+... ......+
T Consensus       185 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~  264 (316)
T 2xir_A          185 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRL  264 (316)
T ss_dssp             GCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHH
T ss_pred             CCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHh
Confidence            9999999999976543322   234568899999999865 58999999999999999998 9999987653 3344444


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .......   ....+++++.++|.+||..||.+|||+.++++|
T Consensus       265 ~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          265 KEGTRMR---APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             HHTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCccCC---CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            4432211   124579999999999999999999999999987

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=2.6e-45  Score=379.78  Aligned_cols=253  Identities=24%  Similarity=0.388  Sum_probs=198.6

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .+.+.|.+.+.||+|+||+||.+. ..+|+.||||++... .+.+.+|+.+|+.+..||||+++++++.+.+.+|+||||
T Consensus        12 ~l~~~~~~~~~LG~G~~g~V~~~~-~~~g~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~   90 (434)
T 2rio_A           12 SLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALEL   90 (434)
T ss_dssp             SCSSCEEEEEEEEECSTTCEEEEE-ESSSSEEEEEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECC
T ss_pred             hhhheeeccCeEeeCCCeEEEEEE-EECCeEEEEEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEec
Confidence            356677778999999999998754 457999999998654 356789999999885699999999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCC-------HHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-------------CcEEE
Q 012170          179 CSGGRLIDQMVEVGQYS-------EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-------------GKIKL  238 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~-------~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-------------~~vkL  238 (469)
                      |. |+|.+++...+...       +..+..++.||+.||.|||++||+||||||+|||++.+             +.+||
T Consensus        91 ~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL  169 (434)
T 2rio_A           91 CN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILI  169 (434)
T ss_dssp             CS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEE
T ss_pred             CC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEE
Confidence            95 69999997654332       33457899999999999999999999999999999764             48999


Q ss_pred             EeccceeeecCCCc-----ccccCCCCcccCceeccC--------CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q 012170          239 ADFGLAMRISNGQT-----LSGLAGSPAYVAPEVLSG--------NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVF  304 (469)
Q Consensus       239 ~DFgla~~~~~~~~-----~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~  304 (469)
                      +|||++........     ....+||+.|+|||++.+        .++.++|||||||++|+|++ |..||.+.....  
T Consensus       170 ~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--  247 (434)
T 2rio_A          170 SDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--  247 (434)
T ss_dssp             CCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--
T ss_pred             cccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--
Confidence            99999987654322     234689999999999854        48899999999999999999 999997654433  


Q ss_pred             HHHHcCcCCCCCC---cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          305 DAIKNVKLDFHSG---VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       305 ~~i~~~~~~~~~~---~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ..+......++..   ....++.++.+||.+||..||.+|||+.++|+||||...
T Consensus       248 ~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~~  302 (434)
T 2rio_A          248 SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWPK  302 (434)
T ss_dssp             HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSCH
T ss_pred             HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCCc
Confidence            2333333222211   122456889999999999999999999999999999543

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=2.5e-45  Score=365.44  Aligned_cols=248  Identities=23%  Similarity=0.342  Sum_probs=210.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCc-----EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGA-----EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|.+.+.||+|+||.||+|.+..++.     .||+|++...     .+.+.+|+.+|+.+..||||+++++++.+.+
T Consensus        44 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~  123 (333)
T 2i1m_A           44 PRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSHLGQHENIVNLLGACTHGG  123 (333)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS
T ss_pred             CHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhcccccChHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCC
Confidence            35789999999999999999999987665     7999999653     2568899999999955999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHh--------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcE
Q 012170          171 CFHLVMELCSGGRLIDQMVEV--------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKI  236 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~--------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~v  236 (469)
                      .+|+||||+++|+|.+++...              ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+
T Consensus       124 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~  203 (333)
T 2i1m_A          124 PVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA  203 (333)
T ss_dssp             SCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEE
T ss_pred             ceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeE
Confidence            999999999999999998653              357999999999999999999999999999999999999999999


Q ss_pred             EEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCc
Q 012170          237 KLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVK  311 (469)
Q Consensus       237 kL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~  311 (469)
                      ||+|||++........   .....||+.|+|||++.+ .++.++|||||||++|+|++ |..||.+......+..+....
T Consensus       204 kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~  283 (333)
T 2i1m_A          204 KIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDG  283 (333)
T ss_dssp             EBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHT
T ss_pred             EECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcC
Confidence            9999999976543322   233457889999999865 58999999999999999998 999998766544443333322


Q ss_pred             CCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          312 LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       312 ~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....  ....++..+.+||.+||..||.+|||+.|++++
T Consensus       284 ~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~  320 (333)
T 2i1m_A          284 YQMA--QPAFAPKNIYSIMQACWALEPTHRPTFQQICSF  320 (333)
T ss_dssp             CCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCC--CCCCCCHHHHHHHHHHhccChhhCcCHHHHHHH
Confidence            2221  224578999999999999999999999999874

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=2.2e-45  Score=372.88  Aligned_cols=245  Identities=23%  Similarity=0.352  Sum_probs=202.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC---CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK---ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~---~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ...+|.+.+.||+|+||.||+|+++   .++..||||+++..     ...+.+|+.+|+++. ||||+++++++.+.+.+
T Consensus        43 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~  121 (373)
T 2qol_A           43 DATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQRRDFLGEASIMGQFD-HPNIIRLEGVVTKSKPV  121 (373)
T ss_dssp             CGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTTCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSC
T ss_pred             CHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCccCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCce
Confidence            3468999999999999999999887   46778999999753     246889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||++||+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       122 ~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~  201 (373)
T 2qol_A          122 MIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDP  201 (373)
T ss_dssp             EEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC----------
T ss_pred             EEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCC
Confidence            99999999999999997654 69999999999999999999999999999999999999999999999999998664432


Q ss_pred             c----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          252 T----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .    .....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+.......   ....++.+
T Consensus       202 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~~~~~~~i~~~~~~~---~~~~~~~~  278 (373)
T 2qol_A          202 EAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP---PPMDCPAA  278 (373)
T ss_dssp             ------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCHHHHHHHHHTTEECC---CCTTCBHH
T ss_pred             ccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCccccHH
Confidence            1    122346788999999965 58999999999999999998 999999998888888876653221   12467899


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHc
Q 012170          326 ARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+||.+||..||.+||++.++++
T Consensus       279 l~~li~~cl~~dp~~RPs~~~i~~  302 (373)
T 2qol_A          279 LYQLMLDCWQKDRNNRPKFEQIVS  302 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHhCcChhhCcCHHHHHH
Confidence            999999999999999999999986

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=2.7e-45  Score=365.43  Aligned_cols=245  Identities=23%  Similarity=0.342  Sum_probs=205.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEE----EEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEF----ACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~v----AvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ..++|++++.||+|+||.||+|.+..+++.|    |+|.+..     ....+.+|+.+|+.+. ||||+++++++...+ 
T Consensus        13 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~-   90 (327)
T 3lzb_A           13 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTST-   90 (327)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCC-BTTBCCCCEEEESSS-
T ss_pred             CHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCC-CCCeeEEEEEEecCC-
Confidence            3578999999999999999999999888765    6666532     3467889999999997 999999999998765 


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      .++|+||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus        91 ~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~  170 (327)
T 3lzb_A           91 VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAE  170 (327)
T ss_dssp             EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCTTC-------
T ss_pred             ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCc
Confidence            77999999999999999774 57999999999999999999999999999999999999999999999999999865433


Q ss_pred             Cc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          251 QT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       251 ~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      ..   .....||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+.....+...+........   ...++.+
T Consensus       171 ~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~  247 (327)
T 3lzb_A          171 EKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQ---PPICTID  247 (327)
T ss_dssp             ---------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC---CTTBCHH
T ss_pred             cccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---CccCCHH
Confidence            22   233457889999999966 58999999999999999999 9999999888777777766543222   2467999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.|+++.
T Consensus       248 l~~li~~~l~~dp~~Rps~~ell~~  272 (327)
T 3lzb_A          248 VYMIMRKCWMIDADSRPKFRELIIE  272 (327)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhHCcCHHHHHHH
Confidence            9999999999999999999999974

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.5e-45  Score=381.32  Aligned_cols=252  Identities=25%  Similarity=0.402  Sum_probs=200.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCC
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSG  181 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~g  181 (469)
                      .+|.+.+.||+|+||+||. ....+|+.||||++... ...+.+|+.+|+.+..||||+++++++.+.+.+|+|||||. 
T Consensus        24 ~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-  101 (432)
T 3p23_A           24 ISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-  101 (432)
T ss_dssp             EEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-
T ss_pred             EEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-
Confidence            4699999999999999764 34457899999998653 35578999999999669999999999999999999999996 


Q ss_pred             CchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---C--CcEEEEeccceeeecCCC----
Q 012170          182 GRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---S--GKIKLADFGLAMRISNGQ----  251 (469)
Q Consensus       182 g~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~--~~vkL~DFgla~~~~~~~----  251 (469)
                      |+|.+++.... .+.+..+..++.||+.||.|||++||+||||||+|||++.   +  ..+||+|||++.......    
T Consensus       102 g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~  181 (432)
T 3p23_A          102 ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFS  181 (432)
T ss_dssp             EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC--------
T ss_pred             CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCccee
Confidence            59999887654 4566677899999999999999999999999999999953   2  358899999998765332    


Q ss_pred             cccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      .....+||+.|+|||++.+    .++.++|||||||++|+|++ |..||...........+........ ......+..+
T Consensus       182 ~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~  260 (432)
T 3p23_A          182 RRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCL-HPEKHEDVIA  260 (432)
T ss_dssp             ----CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTS-CTTCHHHHHH
T ss_pred             eccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCcccc-CccccccHHH
Confidence            2345789999999999963    46789999999999999999 9999976654444333322222211 1112346678


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      .+||.+||+.||.+|||+.++|+||||....
T Consensus       261 ~~li~~~L~~dP~~Rps~~evl~hp~f~~~~  291 (432)
T 3p23_A          261 RELIEKMIAMDPQKRPSAKHVLKHPFFWSLE  291 (432)
T ss_dssp             HHHHHHHSCSSGGGSCCHHHHHTSTTTCCHH
T ss_pred             HHHHHHHHhCCHhhCCCHHHHHhCccccChH
Confidence            9999999999999999999999999996543

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=4.7e-45  Score=356.49  Aligned_cols=249  Identities=23%  Similarity=0.333  Sum_probs=202.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .+.++|++++.||+|+||.||+|.+..+++.||||++..  ....+.+|+.+++.+..|++|..+..++...+..++|||
T Consensus         6 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e   85 (296)
T 4hgt_A            6 RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME   85 (296)
T ss_dssp             -----CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             ccCCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEE
Confidence            356899999999999999999999999999999998753  335688999999999844555566666688899999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeecCCCc-
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      |+ +++|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||+   +.++.+||+|||++........ 
T Consensus        86 ~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~  164 (296)
T 4hgt_A           86 LL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH  164 (296)
T ss_dssp             CC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             cc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccC
Confidence            99 9999999875 4679999999999999999999999999999999999999   7889999999999987654322 


Q ss_pred             -------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCH---HHHHHHHHcCcCCCCC-Cccc
Q 012170          253 -------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSL---EAVFDAIKNVKLDFHS-GVWE  320 (469)
Q Consensus       253 -------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~---~~~~~~i~~~~~~~~~-~~~~  320 (469)
                             .....||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.+.   ...+..+.......+. ....
T Consensus       165 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  244 (296)
T 4hgt_A          165 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCK  244 (296)
T ss_dssp             CBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTT
T ss_pred             ccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhc
Confidence                   235689999999999977 589999999999999999999999976432   1222222222222211 1124


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+++++.+||.+||..||.+|||+.++++
T Consensus       245 ~~~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          245 GYPSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             TSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             cCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            67999999999999999999999999986

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=3.7e-45  Score=384.78  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=216.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      -..+|++.+.||+|+||.||+|.++.++..||||+++..   .+.+.+|+.+|+++. ||||+++++++.+.+.+|||||
T Consensus       218 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~l~~~~~~~~~~~lv~E  296 (495)
T 1opk_A          218 ERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITE  296 (495)
T ss_dssp             CGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEE
T ss_pred             CHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcccchHHHHHHHHHHHhcC-CCCEeeEEEEEecCCcEEEEEE
Confidence            457899999999999999999999999999999999753   467889999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      ||++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus       297 ~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  376 (495)
T 1opk_A          297 FMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH  376 (495)
T ss_dssp             CCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCEECC
T ss_pred             ccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCceeec
Confidence            99999999999764  4589999999999999999999999999999999999999999999999999987654322  2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+.+..++...+.....   ...+..+++++.+||.
T Consensus       377 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~  453 (495)
T 1opk_A          377 AGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYR---MERPEGCPEKVYELMR  453 (495)
T ss_dssp             TTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCC---CCCCTTCCHHHHHHHH
T ss_pred             CCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCCCCCCCHHHHHHHH
Confidence            33456789999999965 58999999999999999999 9999999887777777765422   2223578999999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..||.+|||+.+|++
T Consensus       454 ~cl~~dP~~RPs~~el~~  471 (495)
T 1opk_A          454 ACWQWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCcChhHCcCHHHHHH
Confidence            999999999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=8.6e-45  Score=354.26  Aligned_cols=246  Identities=26%  Similarity=0.354  Sum_probs=211.6

Q ss_pred             cCCeeeee-eeeccCCeEEEEEEEC--CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVE-VIGHGKFGSVWLCRSK--ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|.+++ .||+|+||.||+|.+.  .++..||||+++..     .+.+.+|+++++.+. ||||+++++++ ..+.+|
T Consensus         8 ~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~-~~~~~~   85 (287)
T 1u59_A            8 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVC-QAEALM   85 (287)
T ss_dssp             GGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEE-ESSSEE
T ss_pred             HHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCccchhHHHHHHHHHHHHHhCC-CCCEeEEEEEe-cCCCcE
Confidence            45677777 9999999999999864  46788999999753     246789999999996 99999999999 456689


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+.+++|.+++... ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.++|+|||++........
T Consensus        86 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  165 (287)
T 1u59_A           86 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS  165 (287)
T ss_dssp             EEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC
T ss_pred             EEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc
Confidence            999999999999998644 5699999999999999999999999999999999999999999999999999987654322


Q ss_pred             ----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          253 ----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       253 ----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                          .....||+.|+|||++.+ .++.++||||||+++|+|++ |..||.+....++...+.......   ....+++++
T Consensus       166 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~i~~~~~~~---~~~~~~~~l  242 (287)
T 1u59_A          166 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPEL  242 (287)
T ss_dssp             EECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             eeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHhcCCcCC---CCCCcCHHH
Confidence                223457899999999965 58999999999999999998 999999888888888777654221   225789999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCC
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~  352 (469)
                      .+||.+||..||.+||++.++++|.+
T Consensus       243 ~~li~~~l~~~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          243 YALMSDCWIYKWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             HHHHHHTTCSSGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHcCCChhhCcCHHHHHHHHH
Confidence            99999999999999999999998853

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=6e-45  Score=354.07  Aligned_cols=245  Identities=24%  Similarity=0.284  Sum_probs=207.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC---CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|.+.+.||+|+||.||+|.+..   ++..||+|++...     .+.+.+|+.+++.+. ||||+++++++.++ ..
T Consensus        10 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~-~~   87 (281)
T 3cc6_A           10 AREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLD-HPHIVKLIGIIEEE-PT   87 (281)
T ss_dssp             CGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTSCHHHHHHHHHHHHHHHHHC-CTTBCCEEEEECSS-SC
T ss_pred             cccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEecccccCchHHHHHHHHHHHHHhCC-CCCcceEEEEEcCC-CC
Confidence            45789999999999999999998653   3456999999753     356888999999996 99999999998754 46


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+++++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus        88 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~  167 (281)
T 3cc6_A           88 WIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED  167 (281)
T ss_dssp             EEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----
T ss_pred             EEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEECCCCcEEeCccCCCccccccc
Confidence            89999999999999997754 59999999999999999999999999999999999999999999999999997654432


Q ss_pred             c--ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 T--LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .  .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||...........+.......   ....+++.+.
T Consensus       168 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~  244 (281)
T 3cc6_A          168 YYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP---KPDLCPPVLY  244 (281)
T ss_dssp             -----CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGGHHHHHHHTCCCC---CCTTCCHHHH
T ss_pred             ccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHHHHHHHhcCCCCC---CCCCCCHHHH
Confidence            2  234567889999999965 58999999999999999998 999998877766666665543221   2246799999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcC
Q 012170          328 DLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +||.+||..||.+|||+.|++++
T Consensus       245 ~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          245 TLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHccCCchhCcCHHHHHHH
Confidence            99999999999999999999976

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=1.7e-44  Score=350.34  Aligned_cols=243  Identities=23%  Similarity=0.392  Sum_probs=211.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++++.||+|+||.||+|.+. ++..||+|++...   .+.+.+|+++|+.+. ||||+++++++.. +..|+|||
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~-~~~~~v~e   87 (279)
T 1qpc_A           11 PRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITE   87 (279)
T ss_dssp             CGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEE
T ss_pred             CHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcccHHHHHHHHHHHHhCC-CcCcceEEEEEcC-CCcEEEEe
Confidence            4578999999999999999999976 5678999999653   467889999999996 9999999999864 45789999


Q ss_pred             ccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+++++|.+++....  .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus        88 ~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~  167 (279)
T 1qpc_A           88 YMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAR  167 (279)
T ss_dssp             CCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECC
T ss_pred             cCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccccc
Confidence            999999999986543  799999999999999999999999999999999999999999999999999987654332  2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+++.|+|||++.+ .++.++||||||+++|+|++ |..||.+....+....+.......   ....++.++.+||.
T Consensus       168 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~  244 (279)
T 1qpc_A          168 EGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMR  244 (279)
T ss_dssp             TTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHH
T ss_pred             cCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHHHHhcccCCC---CcccccHHHHHHHH
Confidence            33467889999999965 58999999999999999999 999999988888888776653222   23568999999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..||.+|||+.++++
T Consensus       245 ~~l~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          245 LCWKERPEDRPTFDYLRS  262 (279)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHhccChhhCCCHHHHHH
Confidence            999999999999999986

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=8.3e-45  Score=349.92  Aligned_cols=240  Identities=18%  Similarity=0.252  Sum_probs=208.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC--CeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA--DCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~--~~~  172 (469)
                      ..++|.+++.||+|+||.||+|.+.  |..||||++...      .+.+.+|+.++++++ ||||+++++++.+.  +.+
T Consensus         8 ~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~   84 (271)
T 3kmu_A            8 DFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFS-HPNVLPVLGACQSPPAPHP   84 (271)
T ss_dssp             CGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTCCHHHHHHHHHHGGGGCCCS-CTTEECEEEEECTTTSSSC
T ss_pred             CHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEecccccCHHHHHHHHHHHHHHHhcC-CCchhheEEEEccCCCCCe
Confidence            4578999999999999999999985  889999999643      246889999999996 99999999999877  788


Q ss_pred             EEEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          173 HLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ++||||++||+|.+++...+  .+++..+..++.||+.||.|||++|  ++||||||+|||++.++.++|+|||++... 
T Consensus        85 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~-  163 (271)
T 3kmu_A           85 TLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSF-  163 (271)
T ss_dssp             EEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTT-
T ss_pred             EeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCccceEEEcCCcceeEEeccceeee-
Confidence            99999999999999997765  4899999999999999999999999  999999999999999999999999987542 


Q ss_pred             CCCcccccCCCCcccCceeccCC-C---CCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSGN-Y---SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~~-~---~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                         ......||+.|+|||++.+. +   +.++||||||+++|+|++|..||.+.+.......+.......  ..+..+++
T Consensus       164 ---~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~  238 (271)
T 3kmu_A          164 ---QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--TIPPGISP  238 (271)
T ss_dssp             ---SCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--CCCTTCCH
T ss_pred             ---cccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--CCCCCCCH
Confidence               22345789999999999764 3   347999999999999999999999988877766665443322  22357899


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          325 PARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++.+||.+||..||.+|||+.++++
T Consensus       239 ~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          239 HVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=5.9e-45  Score=356.94  Aligned_cols=246  Identities=25%  Similarity=0.383  Sum_probs=199.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHH--hhCCCCeeEEEEEEEe----CCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQH--LSGHTGVVTLHSVYEE----ADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~--l~~hpnIv~l~~~~~~----~~~~  172 (469)
                      .+.++|++++.||+|+||.||+|.+  +|+.||||++... ...+.+|.+++..  +. ||||+++++++..    ...+
T Consensus         5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~-h~niv~~~~~~~~~~~~~~~~   81 (301)
T 3q4u_A            5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSRDEKSWFRETELYNTVMLR-HENILGFIASDMTSRHSSTQL   81 (301)
T ss_dssp             CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHTCCC-CTTBCCEEEEEEEEETTEEEE
T ss_pred             cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccccchhhHHHHHHHHHhhcc-CcCeeeEEEeeccccCCCcee
Confidence            4678999999999999999999987  5899999999754 3556778888887  54 9999999998654    3568


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hcCeEeccCCCCcEEEccCCcEEEEeccce
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH--------DMGVVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~givHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      |+||||+++|+|.+++ +...+++..+..++.||+.||.|||        +.||+||||||+|||++.++.+||+|||++
T Consensus        82 ~lv~e~~~~g~L~~~l-~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a  160 (301)
T 3q4u_A           82 WLITHYHEMGSLYDYL-QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLA  160 (301)
T ss_dssp             EEEECCCTTCBHHHHH-TTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTC
T ss_pred             EEehhhccCCCHHHHH-hhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCe
Confidence            9999999999999998 4568999999999999999999999        999999999999999999999999999999


Q ss_pred             eeecCCCc-----ccccCCCCcccCceeccCC-------CCCccchHHHHHHHHHHHhC----------CCCCCCC----
Q 012170          245 MRISNGQT-----LSGLAGSPAYVAPEVLSGN-------YSEKVDIWSAGVLLHALLVA----------ALPFKGD----  298 (469)
Q Consensus       245 ~~~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~elltG----------~~Pf~~~----  298 (469)
                      ........     .....||+.|+|||++.+.       ++.++|||||||++|+|++|          ..||.+.    
T Consensus       161 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~  240 (301)
T 3q4u_A          161 VMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPND  240 (301)
T ss_dssp             EEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSS
T ss_pred             eecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCC
Confidence            87654432     2335799999999999764       34689999999999999999          8888642    


Q ss_pred             -CHHHHHHHHHcCcCC--CCCC-cccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          299 -SLEAVFDAIKNVKLD--FHSG-VWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       299 -~~~~~~~~i~~~~~~--~~~~-~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                       ........+......  .+.. ....++.++.+||.+||..||.+|||+.++++
T Consensus       241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          241 PSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             CCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             cchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence             223333222222111  1110 01235678999999999999999999999986

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=5.8e-46  Score=368.60  Aligned_cols=251  Identities=23%  Similarity=0.332  Sum_probs=206.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ....++|++.+.||+|+||.||+|.+. +|+.||||++...    .+.+.+|+.+|+.+. ||||+++++++.+.+.+|+
T Consensus        35 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~l  112 (321)
T 2qkw_B           35 EEATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPESSQGIEEFETEIETLSFCR-HPHLVSLIGFCDERNEMIL  112 (321)
T ss_dssp             CCCCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSCCSSHHHHHHHHHHGGGSCC-CTTBCCEEEECCCTTCCEE
T ss_pred             HHHHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEecccChHHHHHHHHHHHHHHhCC-CCCEeeEEEEEcCCCeEEE
Confidence            446789999999999999999999965 6899999998643    356889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          175 VMELCSGGRLIDQMVEVG----QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ||||+++|+|.+++....    .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       113 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~  192 (321)
T 2qkw_B          113 IYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTEL  192 (321)
T ss_dssp             EEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSS
T ss_pred             EEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence            999999999999886543    5899999999999999999999999999999999999999999999999999765432


Q ss_pred             C---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-------HHHHcCcC------C
Q 012170          251 Q---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF-------DAIKNVKL------D  313 (469)
Q Consensus       251 ~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-------~~i~~~~~------~  313 (469)
                      .   ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+....+..       ........      .
T Consensus       193 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (321)
T 2qkw_B          193 DQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPN  272 (321)
T ss_dssp             SCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSS
T ss_pred             cccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChh
Confidence            2   2334568999999999854 6899999999999999999999999764322111       11111111      1


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      ........++..+.++|.+||..||.+|||+.|+++|-
T Consensus       273 ~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          273 LADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             CTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             hccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence            11111234567889999999999999999999999873

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=9.8e-45  Score=360.68  Aligned_cols=245  Identities=25%  Similarity=0.350  Sum_probs=207.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEE----ECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEE--eCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYE--EADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~--~~~~  171 (469)
                      .++|++++.||+|+||.||+|+    +..+++.||||++....    +.+.+|+++|+.+. ||||+++++++.  +.+.
T Consensus        22 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~  100 (327)
T 3lxl_A           22 ERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHSGPDQQRDFQREIQILKALH-SDFIVKYRGVSYGPGRQS  100 (327)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSSCE
T ss_pred             hhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccCCHHHHHHHHHHHHHHHhcC-CCceeEEEEEEecCCCce
Confidence            4689999999999999999999    56789999999997543    45789999999996 999999999886  5567


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +|+||||++|++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       101 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  180 (327)
T 3lxl_A          101 LRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLD  180 (327)
T ss_dssp             EEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTT
T ss_pred             EEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChhhEEECCCCCEEEcccccceecccC
Confidence            99999999999999999774 56999999999999999999999999999999999999999999999999999876543


Q ss_pred             Cc----ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCH---------------HHHHHHHHcC
Q 012170          251 QT----LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSL---------------EAVFDAIKNV  310 (469)
Q Consensus       251 ~~----~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~---------------~~~~~~i~~~  310 (469)
                      ..    .....||+.|+|||++.+. ++.++||||||+++|+|++|..||.....               ..+...+...
T Consensus       181 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  260 (327)
T 3lxl_A          181 KDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEG  260 (327)
T ss_dssp             CSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTT
T ss_pred             CccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcc
Confidence            32    2335688899999999664 88999999999999999999999865432               1222333332


Q ss_pred             cCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       311 ~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .   .......+++++.+||.+||..||.+|||+.|+++|
T Consensus       261 ~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          261 Q---RLPAPPACPAEVHELMKLCWAPSPQDRPSFSALGPQ  297 (327)
T ss_dssp             C---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             c---CCCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            2   112235789999999999999999999999999765

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=4.7e-45  Score=367.01  Aligned_cols=246  Identities=16%  Similarity=0.220  Sum_probs=206.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCC--------CcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeE------------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKAS--------GAEFACKTLRKGEETVHREVEIMQHLSGHTGVVT------------  161 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~--------~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~------------  161 (469)
                      .++|++.+.||+|+||.||+|.+..+        ++.||||++... ..+.+|+++++++. ||||++            
T Consensus        41 ~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~-~~~~~E~~~l~~l~-h~niv~~~~~~~~~~~~~  118 (352)
T 2jii_A           41 GRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD-GRLFNEQNFFQRAA-KPLQVNKWKKLYSTPLLA  118 (352)
T ss_dssp             SCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT-STHHHHHHHHHHHC-CHHHHHHHHHHTTCTTCS
T ss_pred             CCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc-chHHHHHHHHHHhc-ccchhhhhhhhccCCccC
Confidence            47899999999999999999999874        889999999764 57889999999997 999887            


Q ss_pred             ---EEEEEEe-CCeEEEEEeccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-
Q 012170          162 ---LHSVYEE-ADCFHLVMELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-  234 (469)
Q Consensus       162 ---l~~~~~~-~~~~~lV~E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-  234 (469)
                         +++++.. ++.+|+||||+ +++|.+++...  +.+++..+..++.||+.||.|||++||+||||||+|||++.++ 
T Consensus       119 i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~  197 (352)
T 2jii_A          119 IPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQ  197 (352)
T ss_dssp             CCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEE
T ss_pred             ccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCC
Confidence               6777766 78899999999 99999999876  7899999999999999999999999999999999999999998 


Q ss_pred             -cEEEEeccceeeecCCC--------cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC--CHHH
Q 012170          235 -KIKLADFGLAMRISNGQ--------TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD--SLEA  302 (469)
Q Consensus       235 -~vkL~DFgla~~~~~~~--------~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~  302 (469)
                       .+||+|||++.......        ......||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.  ....
T Consensus       198 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~  277 (352)
T 2jii_A          198 SQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTED  277 (352)
T ss_dssp             EEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHH
T ss_pred             ceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHH
Confidence             89999999997654322        1234589999999999977 5899999999999999999999999875  3333


Q ss_pred             HHHHHH---cCcCCC--CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          303 VFDAIK---NVKLDF--HSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       303 ~~~~i~---~~~~~~--~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +...+.   .....+  ....|..++.++.+||.+||..||.+|||+.++++.
T Consensus       278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  330 (352)
T 2jii_A          278 IMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRNN  330 (352)
T ss_dssp             HHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHHH
T ss_pred             HHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHHH
Confidence            333332   111111  122345689999999999999999999999999863

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.6e-44  Score=360.61  Aligned_cols=246  Identities=25%  Similarity=0.362  Sum_probs=207.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCC----cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASG----AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ...+|.+.+.||+|+||.||+|.+..++    ..||||+++..     ...+.+|+.+++.+. ||||+++++++.+.+.
T Consensus        42 ~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~  120 (333)
T 1mqb_A           42 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKP  120 (333)
T ss_dssp             CTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSS
T ss_pred             ChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEecCCC
Confidence            4578999999999999999999987553    45999999753     245788999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +|+||||+++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++......
T Consensus       121 ~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~  200 (333)
T 1mqb_A          121 MMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDD  200 (333)
T ss_dssp             EEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-------
T ss_pred             cEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChheEEECCCCcEEECCCCcchhhccc
Confidence            99999999999999999765 57999999999999999999999999999999999999999999999999999866433


Q ss_pred             Cc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          251 QT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       251 ~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ..    .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..++...+......   .....++.
T Consensus       201 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~  277 (333)
T 1mqb_A          201 PEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMDCPS  277 (333)
T ss_dssp             ----------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCBH
T ss_pred             cccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHCCCcC---CCcccCCH
Confidence            21    223456889999999975 58999999999999999999 99999998888888887765321   12246899


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          325 PARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+.+||.+||..||.+||++.+++++
T Consensus       278 ~l~~li~~~l~~~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          278 AIYQLMMQCWQQERARRPKFADIVSI  303 (333)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            99999999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=7.4e-45  Score=361.40  Aligned_cols=243  Identities=29%  Similarity=0.455  Sum_probs=186.3

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEE--------eC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYE--------EA  169 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~--------~~  169 (469)
                      ..+|++.+.||+|+||.||+|.+..+|+.||||++...    ...+.+|+.+++++.+||||+++++++.        ..
T Consensus        27 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~  106 (337)
T 3ll6_A           27 ELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQ  106 (337)
T ss_dssp             TEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSS
T ss_pred             CceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCCchHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCC
Confidence            45899999999999999999999999999999998543    2457889999999977999999999994        34


Q ss_pred             CeEEEEEeccCCCchHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEccCCcEEEEeccce
Q 012170          170 DCFHLVMELCSGGRLIDQMVE---VGQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLTTSGKIKLADFGLA  244 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~---~~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~~~~~vkL~DFgla  244 (469)
                      ..+++||||+. |+|.+++..   .+.+++..+..++.||+.||.|||+.|  |+||||||+|||++.++.+||+|||++
T Consensus       107 ~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~  185 (337)
T 3ll6_A          107 AEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSA  185 (337)
T ss_dssp             EEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTC
T ss_pred             ceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccc
Confidence            46899999996 688888765   467999999999999999999999999  999999999999999999999999999


Q ss_pred             eeecCCCcc-------------cccCCCCcccCceecc---C-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q 012170          245 MRISNGQTL-------------SGLAGSPAYVAPEVLS---G-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI  307 (469)
Q Consensus       245 ~~~~~~~~~-------------~~~~gt~~y~aPE~l~---~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i  307 (469)
                      .........             ....||+.|+|||++.   + .++.++|||||||++|+|++|..||.+.....+....
T Consensus       186 ~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~  265 (337)
T 3ll6_A          186 TTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK  265 (337)
T ss_dssp             BCCSSCC-------------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC------------
T ss_pred             eeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc
Confidence            765543221             1456999999999983   3 4788999999999999999999999875544333221


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                          ...+  .....+..+.+||.+||+.||.+|||+.|+++|-
T Consensus       266 ----~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          266 ----YSIP--PHDTQYTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             ----CCCC--TTCCSSGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             ----ccCC--cccccchHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence                1111  2245678899999999999999999999999874

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=8.7e-45  Score=377.93  Aligned_cols=244  Identities=25%  Similarity=0.401  Sum_probs=212.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ...++|.+.+.||+|+||.||+|.+.. +..||||+++..   .+.+.+|+.+|+.+. ||||+++++++. .+.+|+||
T Consensus       185 i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~l~~~~~-~~~~~lv~  261 (454)
T 1qcf_A          185 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGSMSVEAFLAEANVMKTLQ-HDKLVKLHAVVT-KEPIYIIT  261 (454)
T ss_dssp             CCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTSBCHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEEE
T ss_pred             echHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCCccHHHHHHHHHHHhhCC-CCCEeeEEEEEe-CCccEEEE
Confidence            345789999999999999999999864 778999999753   467899999999996 999999999986 56789999


Q ss_pred             eccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--
Q 012170          177 ELCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       177 E~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--  252 (469)
                      |||.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  
T Consensus       262 e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~~~  341 (454)
T 1qcf_A          262 EFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTA  341 (454)
T ss_dssp             CCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHHHT
T ss_pred             eecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCceec
Confidence            999999999999754  3789999999999999999999999999999999999999999999999999976543221  


Q ss_pred             ccccCCCCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+|+.|+|||++. +.++.++|||||||++|+|++ |..||.+.+..++...+......   .....+++++.+||
T Consensus       342 ~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li  418 (454)
T 1qcf_A          342 REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRM---PRPENCPEELYNIM  418 (454)
T ss_dssp             TCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCC---CCCTTSCHHHHHHH
T ss_pred             cCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHH
Confidence            23345778999999996 469999999999999999999 99999999988888887765321   12356899999999


Q ss_pred             HHhchhhhcCCCCHHHHHc
Q 012170          331 ARMLTRDVSARITADEVLR  349 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+||..||.+|||+.+|++
T Consensus       419 ~~cl~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          419 MRCWKNRPEERPTFEYIQS  437 (454)
T ss_dssp             HHHTCSSGGGSCCHHHHHH
T ss_pred             HHHccCChhHCcCHHHHHH
Confidence            9999999999999999975

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=9.2e-45  Score=358.25  Aligned_cols=248  Identities=21%  Similarity=0.264  Sum_probs=202.9

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECC---CCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEA  169 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~---~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~  169 (469)
                      ....++|.+.+.||+|+||.||+|.+..   ++..||+|+++..      .+.+.+|+.+++.+. ||||+++++++.+.
T Consensus        30 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~  108 (313)
T 3brb_A           30 VIDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFS-HPNVIRLLGVCIEM  108 (313)
T ss_dssp             BCCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---CCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEC-
T ss_pred             ccCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccccchhHHHHHHHHHHHHhcCC-CCCeeeeeEEEeec
Confidence            3445789999999999999999998765   5568999998643      245788999999997 99999999999865


Q ss_pred             C-----eEEEEEeccCCCchHHHHHH------hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEE
Q 012170          170 D-----CFHLVMELCSGGRLIDQMVE------VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKL  238 (469)
Q Consensus       170 ~-----~~~lV~E~~~gg~L~~~l~~------~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL  238 (469)
                      +     ..|+||||+++|+|.+++..      ...+++..++.++.||+.||.|||++||+||||||+|||++.++.+||
T Consensus       109 ~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kl  188 (313)
T 3brb_A          109 SSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCV  188 (313)
T ss_dssp             ------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCSGGGEEECTTSCEEE
T ss_pred             cccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEE
Confidence            5     35999999999999999853      356999999999999999999999999999999999999999999999


Q ss_pred             EeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCC
Q 012170          239 ADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLD  313 (469)
Q Consensus       239 ~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~  313 (469)
                      +|||++........   .....+++.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.........+......
T Consensus       189 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~  268 (313)
T 3brb_A          189 ADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRL  268 (313)
T ss_dssp             CSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCC
T ss_pred             eecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCC
Confidence            99999976543321   233467889999999976 48999999999999999999 99999988877777777665322


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                         .....+++++.+||.+||..||.+|||+.+++++
T Consensus       269 ---~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          269 ---KQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             ---CCBTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             ---CCCccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence               2235789999999999999999999999999875

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=1.7e-44  Score=352.76  Aligned_cols=245  Identities=24%  Similarity=0.433  Sum_probs=196.0

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ...++|++.+.||+|+||.||+|.+..   .||+|+++..      .+.+.+|+.+|+.+. ||||++++++. ..+.++
T Consensus        21 i~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~-~~~~~~   95 (289)
T 3og7_A           21 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYS-TAPQLA   95 (289)
T ss_dssp             CCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEE-CSSSCE
T ss_pred             cCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccCCCHHHHHHHHHHHHHHHhCC-CCcEEEEEeec-cCCccE
Confidence            355789999999999999999998653   5999998642      246789999999997 99999999965 556688


Q ss_pred             EEEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC---
Q 012170          174 LVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN---  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~---  249 (469)
                      +||||+.|++|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....   
T Consensus        96 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~  175 (289)
T 3og7_A           96 IVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG  175 (289)
T ss_dssp             EEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC----------
T ss_pred             EEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEEccceeccccccccc
Confidence            99999999999998854 35699999999999999999999999999999999999999999999999999975542   


Q ss_pred             CCcccccCCCCcccCceecc----CCCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHcCcCCCC-CCcccCCC
Q 012170          250 GQTLSGLAGSPAYVAPEVLS----GNYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFH-SGVWETVS  323 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~----~~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~~~~~~~-~~~~~~~s  323 (469)
                      ........||+.|+|||++.    ..++.++||||||+++|+|++|..||.+.. ...+...+........ ......++
T Consensus       176 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  255 (289)
T 3og7_A          176 SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCP  255 (289)
T ss_dssp             --------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSC
T ss_pred             cccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCC
Confidence            22234567999999999985    247889999999999999999999998744 4455555555443322 22335789


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      +.+.+||.+||..||.+|||+.++++
T Consensus       256 ~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          256 KRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCCCHHHHHH
Confidence            99999999999999999999999986

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=7.6e-45  Score=359.29  Aligned_cols=245  Identities=23%  Similarity=0.316  Sum_probs=201.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEE----eCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYE----EADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~----~~~~~~  173 (469)
                      .++|++++.||+|+||.||+|.+..+|+.||||++...    .+.+.+|+.+++.+. ||||+++++++.    .....|
T Consensus        28 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~~~  106 (317)
T 2buj_A           28 NKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFN-HPNILRLVAYCLRERGAKHEAW  106 (317)
T ss_dssp             TEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEESSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEEEETTEEEEE
T ss_pred             CeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecCCHHHHHHHHHHHHHHhhcC-CCCeeeEEEEEEeccCCCceeE
Confidence            46899999999999999999999999999999998542    356789999999996 999999999986    234789


Q ss_pred             EEEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          174 LVMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      +||||+.+|+|.+++..    ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       107 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~  186 (317)
T 2buj_A          107 LLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACI  186 (317)
T ss_dssp             EEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCE
T ss_pred             EEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhccc
Confidence            99999999999999876    36799999999999999999999999999999999999999999999999999875432


Q ss_pred             CC----------cccccCCCCcccCceeccCC----CCCccchHHHHHHHHHHHhCCCCCCCCCH--HHHHHHHHcCcCC
Q 012170          250 GQ----------TLSGLAGSPAYVAPEVLSGN----YSEKVDIWSAGVLLHALLVAALPFKGDSL--EAVFDAIKNVKLD  313 (469)
Q Consensus       250 ~~----------~~~~~~gt~~y~aPE~l~~~----~~~~~DiwSlG~il~elltG~~Pf~~~~~--~~~~~~i~~~~~~  313 (469)
                      ..          ......||+.|+|||++.+.    ++.++||||||+++|+|++|..||.....  ......+.. ...
T Consensus       187 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~-~~~  265 (317)
T 2buj_A          187 HVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQN-QLS  265 (317)
T ss_dssp             EEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHC-C--
T ss_pred             ccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhc-cCC
Confidence            11          11234689999999998653    68999999999999999999999953110  111222222 222


Q ss_pred             CCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          314 FHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       314 ~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ++  ....++.++.+||.+||..||.+|||+.++++|
T Consensus       266 ~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          266 IP--QSPRHSSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CC--ccccCCHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            22  235689999999999999999999999999986

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-44  Score=351.84  Aligned_cols=246  Identities=25%  Similarity=0.341  Sum_probs=204.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECC-CCc--EEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKA-SGA--EFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~--~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++++.||+|+||.||+|.+.. ++.  .||||+++..       .+.+.+|+.+++.+. ||||+++++++...+
T Consensus        16 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~i~~~~~~~~~~~   94 (291)
T 1u46_A           16 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLTPP   94 (291)
T ss_dssp             CGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSS
T ss_pred             chhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCC-CCCcccEEEEEccCC
Confidence            34689999999999999999998643 333  6899998642       246789999999996 999999999998765


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                       .++||||+.+|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus        95 -~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~  173 (291)
T 1u46_A           95 -MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ  173 (291)
T ss_dssp             -CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC
T ss_pred             -ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEEcCCCCEEEccccccccccc
Confidence             78999999999999999765 5799999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          250 GQT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       250 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ...    .....+|+.|+|||++.+ .++.++||||||+++|+|++ |..||.+.+..+....+......++  ....++
T Consensus       174 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~  251 (291)
T 1u46_A          174 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCP  251 (291)
T ss_dssp             -CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTCC
T ss_pred             cccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHHHHHHHHHccCCCCC--CCcCcC
Confidence            322    233567889999999966 48899999999999999999 9999999998888888876554433  235689


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .++.++|.+||..||.+|||+.+++++
T Consensus       252 ~~l~~li~~~l~~~p~~Rps~~~l~~~  278 (291)
T 1u46_A          252 QDIYNVMVQCWAHKPEDRPTFVALRDF  278 (291)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            999999999999999999999999874

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.5e-44  Score=350.71  Aligned_cols=240  Identities=24%  Similarity=0.378  Sum_probs=202.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeC-CeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEA-DCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~-~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|.+.  |+.||||+++..  .+.+.+|+.+++.+. ||||+++++++.+. +.+|+||||
T Consensus        20 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~lv~e~   96 (278)
T 1byg_A           20 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEY   96 (278)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECC
T ss_pred             hhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchhHHHHHHHHHHHHHhCC-CCCEeeEEEEEEcCCCceEEEEec
Confidence            478999999999999999999875  889999999754  367889999999996 99999999997544 578999999


Q ss_pred             cCCCchHHHHHHhCC--CCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          179 CSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~--l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      +++|+|.+++...+.  +++..+..++.||+.||.|||++|++||||||+|||++.++.++|+|||++.......  ...
T Consensus        97 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~--~~~  174 (278)
T 1byg_A           97 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--DTG  174 (278)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             CCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcceEEEeCCCcEEEeeccccccccccc--cCC
Confidence            999999999976643  8999999999999999999999999999999999999999999999999997654332  234


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+++.|+|||++.+ .++.++||||||+++|+|++ |..||......+....+.....   ......+++++.++|.+||
T Consensus       175 ~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l  251 (278)
T 1byg_A          175 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MDAPDGCPPAVYEVMKNCW  251 (278)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCC---CCCCTTCCHHHHHHHHHHT
T ss_pred             CccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CCCcccCCHHHHHHHHHHh
Confidence            68899999999965 58999999999999999998 9999998887777777655422   2223578999999999999


Q ss_pred             hhhhcCCCCHHHHHc
Q 012170          335 TRDVSARITADEVLR  349 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~  349 (469)
                      ..||.+|||+.++++
T Consensus       252 ~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          252 HLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhhCCCHHHHHH
Confidence            999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=2e-44  Score=357.38  Aligned_cols=245  Identities=23%  Similarity=0.343  Sum_probs=203.0

Q ss_pred             cccCCe-eeeeeeeccCCeEEEEEEE----CCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-
Q 012170          100 KIEDDH-TKVEVIGHGKFGSVWLCRS----KASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-  168 (469)
Q Consensus       100 ~~~~~y-~~~~~lG~G~~g~Vy~~~~----~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-  168 (469)
                      .+.++| ++++.||+|+||.||+|..    ..+|+.||||++...     ...+.+|+++|+.+. ||||+++++++.+ 
T Consensus        27 ~~~~r~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~  105 (318)
T 3lxp_A           27 VFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLY-HEHIIKYKGCCEDA  105 (318)
T ss_dssp             BCCGGGEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTTCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEEET
T ss_pred             eecHHHHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccccChHHHHHHHHHHHHHHhCC-CcchhhEEEEEecC
Confidence            355566 9999999999999988754    457899999999754     245789999999997 9999999999987 


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          169 -ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                       ...+|+||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++...
T Consensus       106 ~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~  184 (318)
T 3lxp_A          106 GAASLQLVMEYVPLGSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV  184 (318)
T ss_dssp             TTTEEEEEECCCTTCBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCGGGCEEC
T ss_pred             CCceEEEEEecccCCcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEEcCCCCEEECCccccccc
Confidence             4689999999999999998854 46999999999999999999999999999999999999999999999999999876


Q ss_pred             cCCCc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH---------------HHHHHH
Q 012170          248 SNGQT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE---------------AVFDAI  307 (469)
Q Consensus       248 ~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~---------------~~~~~i  307 (469)
                      .....    .....||+.|+|||++.+ .++.++||||||+++|+|++|..||......               .....+
T Consensus       185 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (318)
T 3lxp_A          185 PEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELL  264 (318)
T ss_dssp             CTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHH
T ss_pred             cccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhhhhcccccchhHHHHHHHH
Confidence            54432    234568889999999976 5889999999999999999999999753211               122222


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ....   .......++.++.+||.+||..||.+|||+.|+++
T Consensus       265 ~~~~---~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          265 ERGE---RLPRPDKCPAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             HTTC---CCCCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hccc---CCCCCccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            2222   12223578999999999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=8.9e-45  Score=360.40  Aligned_cols=250  Identities=24%  Similarity=0.318  Sum_probs=204.8

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ...++|.+.+.||+|+||.||+|.+. +|+.||||++....     ..+.+|+.+++.+. ||||+++++++.+.+..++
T Consensus        27 ~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~l  104 (326)
T 3uim_A           27 VASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQGGELQFQTEVEMISMAV-HRNLLRLRGFCMTPTERLL  104 (326)
T ss_dssp             TTTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-----CCCHHHHHHHGGGTCC-CTTBCCCCEEECCSSCCEE
T ss_pred             HHhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCchHHHHHHHHHHHHHhcc-CCCccceEEEEecCCceEE
Confidence            45689999999999999999999854 68999999996532     36889999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC----CCCHHHHHHHHHHHHHHHHHHHhc---CeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          175 VMELCSGGRLIDQMVEVG----QYSEQRAANIFKDVMWVIKYCHDM---GVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~----~l~~~~~~~i~~qil~aL~yLH~~---givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      ||||+.+|+|.+++....    .+++..+..++.||+.||.|||+.   ||+||||||+|||++.++.+||+|||++...
T Consensus       105 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~  184 (326)
T 3uim_A          105 VYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM  184 (326)
T ss_dssp             EEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEEC
T ss_pred             EEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCcccccc
Confidence            999999999999997653    389999999999999999999999   9999999999999999999999999999876


Q ss_pred             cCCC--cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC-----CHHHHHHHHHcCcC-------
Q 012170          248 SNGQ--TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD-----SLEAVFDAIKNVKL-------  312 (469)
Q Consensus       248 ~~~~--~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~-----~~~~~~~~i~~~~~-------  312 (469)
                      ....  ......||+.|+|||++.+ .++.++|||||||++|+|++|..||...     ........+.....       
T Consensus       185 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  264 (326)
T 3uim_A          185 DYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEAL  264 (326)
T ss_dssp             CSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTS
T ss_pred             CcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccccccccchhHHHHHHHHhhchhhhhh
Confidence            4332  2344569999999999955 5899999999999999999999999521     10111111111100       


Q ss_pred             ---CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          313 ---DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       313 ---~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                         ..........+..+.+||.+||..||.+|||+.|+++|-
T Consensus       265 ~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L  306 (326)
T 3uim_A          265 VDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML  306 (326)
T ss_dssp             SCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred             cChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence               001111123347899999999999999999999999874

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=2.6e-44  Score=352.39  Aligned_cols=244  Identities=23%  Similarity=0.292  Sum_probs=205.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCC---cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEE-EeCCeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVY-EEADCF  172 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~-~~~~~~  172 (469)
                      ..+|++.+.||+|+||.||+|.+..++   ..||+|.+...     .+.+.+|+.+++++. ||||+++++++ ..++..
T Consensus        24 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~  102 (298)
T 3f66_A           24 SLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSP  102 (298)
T ss_dssp             GEEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCC
T ss_pred             ceehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccCCCHHHHHHHHHHHHHHHhCC-CCCEeeeeeEEEcCCCce
Confidence            457999999999999999999976433   45899998642     246789999999997 99999999985 556688


Q ss_pred             EEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       103 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~  182 (298)
T 3f66_A          103 LVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKE  182 (298)
T ss_dssp             EEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGG
T ss_pred             EEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEEECCCCCEEECcccccccccccc
Confidence            9999999999999999753 468999999999999999999999999999999999999999999999999997654322


Q ss_pred             -----cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          252 -----TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       252 -----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                           ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+..+....+.........   ..++.
T Consensus       183 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~  259 (298)
T 3f66_A          183 YYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPD  259 (298)
T ss_dssp             GCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTTHHHHHHTTCCCCCC---TTCCH
T ss_pred             hhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHHHHHHHhcCCCCCCC---ccCCH
Confidence                 2234567889999999965 58999999999999999999 77888887776666666665543332   45799


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          325 PARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++.++|.+||..||.+|||+.++++
T Consensus       260 ~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          260 PLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhhCcCHHHHHH
Confidence            9999999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=5.8e-44  Score=349.37  Aligned_cols=243  Identities=24%  Similarity=0.295  Sum_probs=206.4

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE-EE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCF-HL  174 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~-~l  174 (469)
                      .|.+.+.||+|+||.||+|.+..++.   .||+|++...     .+.+.+|+.+++.+. ||||+++++++.+.+.. ++
T Consensus        22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~~~~  100 (298)
T 3pls_A           22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRITEMQQVEAFLREGLLMRGLN-HPNVLALIGIMLPPEGLPHV  100 (298)
T ss_dssp             EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTCCSHHHHHHHHHHHHHHHTCC-CTTBCCCCEEECCSSSCCEE
T ss_pred             EEccCceeccCCCceEEEEEEecCCCceeeeeeeeccccccHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEecCCCCcEE
Confidence            56777999999999999999765554   7999998643     246779999999996 99999999999876655 89


Q ss_pred             EEeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--
Q 012170          175 VMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--  251 (469)
                      ||||+.+|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......  
T Consensus       101 v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~  180 (298)
T 3pls_A          101 LLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYY  180 (298)
T ss_dssp             EECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGG
T ss_pred             EEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCccc
Confidence            9999999999999976 4568999999999999999999999999999999999999999999999999997543321  


Q ss_pred             ---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                         ......||+.|+|||++.+ .++.++||||||+++|+|++ |.+||.+.+.......+........   ...+++.+
T Consensus       181 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l  257 (298)
T 3pls_A          181 SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ---PEYCPDSL  257 (298)
T ss_dssp             CSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC---CTTCCHHH
T ss_pred             ccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHHHHHhhcCCCCCC---CccchHHH
Confidence               2234568899999999977 58999999999999999999 6667777777777777766543222   24679999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcC
Q 012170          327 RDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+||.+||..||.+|||+.++++.
T Consensus       258 ~~li~~~l~~~p~~Rps~~~ll~~  281 (298)
T 3pls_A          258 YQVMQQCWEADPAVRPTFRVLVGE  281 (298)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHHH
Confidence            999999999999999999999863

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=2.1e-45  Score=367.01  Aligned_cols=241  Identities=20%  Similarity=0.280  Sum_probs=199.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------HHHHHHHHHHHHhh--------CCCCeeE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------ETVHREVEIMQHLS--------GHTGVVT  161 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------~~~~~E~~il~~l~--------~hpnIv~  161 (469)
                      .++|++++.||+|+||.||+|++  +|+.||||++....            +.+.+|+.+|+.+.        .||||++
T Consensus        19 ~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~niv~   96 (336)
T 2vuw_A           19 TEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGFIG   96 (336)
T ss_dssp             HHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCBCC
T ss_pred             cccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCchhh
Confidence            46899999999999999999998  68999999996532            67899999999997        5888888


Q ss_pred             EEEEEE------------------------------eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHH
Q 012170          162 LHSVYE------------------------------EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK  211 (469)
Q Consensus       162 l~~~~~------------------------------~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~  211 (469)
                      +.+++.                              ..+.+|||||||++|++.+.+.+ +.+++..++.++.||+.||.
T Consensus        97 l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~  175 (336)
T 2vuw_A           97 LNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGIDLEQMRT-KLSSLATAKSILHQLTASLA  175 (336)
T ss_dssp             EEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEETGGGTT-TCCCHHHHHHHHHHHHHHHH
T ss_pred             hcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCccHHHHHh-cCCCHHHHHHHHHHHHHHHH
Confidence            887653                              26789999999999988777744 67899999999999999999


Q ss_pred             HHH-hcCeEeccCCCCcEEEccCC--------------------cEEEEeccceeeecCCCcccccCCCCcccCceeccC
Q 012170          212 YCH-DMGVVHRDIKPENILLTTSG--------------------KIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG  270 (469)
Q Consensus       212 yLH-~~givHrDlkp~NILl~~~~--------------------~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~  270 (469)
                      ||| ++||+||||||+||||+.+|                    .+||+|||+|+.....    ..+||+.|+|||++.+
T Consensus       176 ~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~~~~----~~~gt~~y~aPE~~~g  251 (336)
T 2vuw_A          176 VAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDG----IVVFCDVSMDEDLFTG  251 (336)
T ss_dssp             HHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEEETT----EEECCCCTTCSGGGCC
T ss_pred             HHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEecCCC----cEEEeecccChhhhcC
Confidence            999 99999999999999999987                    8999999999876543    3479999999999998


Q ss_pred             CCCCccchHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHH-c--CcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHH
Q 012170          271 NYSEKVDIWSAGVL-LHALLVAALPFKGDSL-EAVFDAIK-N--VKLDFHSGVWETVSKPARDLMARMLTRDVSARITAD  345 (469)
Q Consensus       271 ~~~~~~DiwSlG~i-l~elltG~~Pf~~~~~-~~~~~~i~-~--~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~  345 (469)
                      ..+.++||||||++ .++++.|..||.+... ......+. .  .........+..+++++++||.+||++|     ||.
T Consensus       252 ~~~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~d-----sa~  326 (336)
T 2vuw_A          252 DGDYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKIQEFHRTMLNFS-----SAT  326 (336)
T ss_dssp             CSSHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHHHHHHHHHHHHHHGGGSS-----SHH
T ss_pred             CCccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhhhcCHHHHHHHHHHhccC-----CHH
Confidence            77899999998777 7888899999954221 12223332 1  1122223335568999999999999977     999


Q ss_pred             HHH-cCCCcc
Q 012170          346 EVL-RHPWIL  354 (469)
Q Consensus       346 elL-~hp~~~  354 (469)
                      |+| +||||+
T Consensus       327 e~l~~Hp~f~  336 (336)
T 2vuw_A          327 DLLCQHSLFK  336 (336)
T ss_dssp             HHHHHCGGGC
T ss_pred             HHHhcCCCcC
Confidence            999 999983

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=3.7e-44  Score=373.00  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=207.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++..   .+.+.+|+.+|++++ ||||+++++++.+ +.+|+|||
T Consensus       182 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~-~~~~iv~e  258 (452)
T 1fmk_A          182 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTE  258 (452)
T ss_dssp             CGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEC
T ss_pred             ChhHceeeeeecCCCCeEEEEEEECC-CceEEEEEeccCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEcC-CceEEEeh
Confidence            45789999999999999999999875 467999999753   467899999999997 9999999999876 67889999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      |+++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........  .
T Consensus       259 ~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~  338 (452)
T 1fmk_A          259 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  338 (452)
T ss_dssp             CCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC----------
T ss_pred             hhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCceecc
Confidence            99999999999643  5699999999999999999999999999999999999999999999999999986643322  2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+++.|+|||++.+ .++.++|||||||++|+|++ |..||.+....++...+......   .....+++.+.+||.
T Consensus       339 ~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~  415 (452)
T 1fmk_A          339 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLHDLMC  415 (452)
T ss_dssp             ----CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHHHHHHH
T ss_pred             cCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHH
Confidence            33457889999999864 69999999999999999999 99999999988888887765321   122568999999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..||.+|||+.++++
T Consensus       416 ~cl~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          416 QCWRKEPEERPTFEYLQA  433 (452)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHccCChhhCcCHHHHHH
Confidence            999999999999999986

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=6.3e-44  Score=373.55  Aligned_cols=259  Identities=22%  Similarity=0.312  Sum_probs=216.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .+.++|.+++.||+|+||.||+|.+..+++.||||++..  ....+.+|+++++.|..|++|+.+..++...+..|||||
T Consensus         4 ~i~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme   83 (483)
T 3sv0_A            4 RVGNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMD   83 (483)
T ss_dssp             EETTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred             CcCCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEE
Confidence            466899999999999999999999999999999998753  345689999999999866888888888889999999999


Q ss_pred             ccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEE---ccCCcEEEEeccceeeecCCCc-
Q 012170          178 LCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILL---TTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       178 ~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl---~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      |+ +++|.+++.. .+.+++..+..|+.||+.||.|||++||+||||||+||||   +.++.+||+|||++........ 
T Consensus        84 ~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~  162 (483)
T 3sv0_A           84 LL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTH  162 (483)
T ss_dssp             CC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTC
T ss_pred             CC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccc
Confidence            99 9999999975 5679999999999999999999999999999999999999   6889999999999987654432 


Q ss_pred             -------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCC-CCccc
Q 012170          253 -------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFH-SGVWE  320 (469)
Q Consensus       253 -------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~~  320 (469)
                             ....+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+..   ....+..+........ .....
T Consensus       163 ~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~  242 (483)
T 3sv0_A          163 QHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCR  242 (483)
T ss_dssp             CBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHT
T ss_pred             cccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhc
Confidence                   225689999999999977 58999999999999999999999998743   3444444433222111 11224


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHc----------CCCccccccc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLR----------HPWILFYTER  359 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~----------hp~~~~~~~~  359 (469)
                      .++.++.+||.+||..||.+||++.+|++          ++|+..+.+.
T Consensus       243 ~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~  291 (483)
T 3sv0_A          243 GYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWT  291 (483)
T ss_dssp             TSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHH
T ss_pred             CCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCch
Confidence            67999999999999999999999987754          5666555443

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=8.5e-44  Score=351.26  Aligned_cols=239  Identities=29%  Similarity=0.480  Sum_probs=197.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      .++|++.+.||+|+||.||+|.+.  ++.||||++...  ...+.+|+.+|+++. ||||+++++++.+  ..|+||||+
T Consensus         7 ~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~--~~~lv~e~~   81 (307)
T 2eva_A            7 YKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESESERKAFIVELRQLSRVN-HPNIVKLYGACLN--PVCLVMEYA   81 (307)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSSTTHHHHHHHHHHHHHHCC-CTTBCCEEEBCTT--TTEEEEECC
T ss_pred             HhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecChhHHHHHHHHHHHHhcCC-CCCcCeEEEEEcC--CcEEEEEcC
Confidence            368999999999999999999885  788999999754  356889999999996 9999999998874  478999999


Q ss_pred             CCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHh---cCeEeccCCCCcEEEccCCc-EEEEeccceeeecCCCc
Q 012170          180 SGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHD---MGVVHRDIKPENILLTTSGK-IKLADFGLAMRISNGQT  252 (469)
Q Consensus       180 ~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~---~givHrDlkp~NILl~~~~~-vkL~DFgla~~~~~~~~  252 (469)
                      +||+|.+++....   .+++..+..++.||+.||.|||+   +||+||||||+|||++.++. +||+|||++......  
T Consensus        82 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~--  159 (307)
T 2eva_A           82 EGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH--  159 (307)
T ss_dssp             TTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC---------
T ss_pred             CCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc--
Confidence            9999999997654   37899999999999999999999   89999999999999999887 799999999765432  


Q ss_pred             ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCC--CHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGD--SLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~--~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .....||+.|+|||++.+ .++.++||||||+++|+|++|..||...  ........+.....   ......++..+.+|
T Consensus       160 ~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~l  236 (307)
T 2eva_A          160 MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTR---PPLIKNLPKPIESL  236 (307)
T ss_dssp             -----CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCC---CCCBTTCCHHHHHH
T ss_pred             cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCC---CCcccccCHHHHHH
Confidence            234579999999999977 5899999999999999999999999753  33334444443322   22335789999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcC
Q 012170          330 MARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~h  350 (469)
                      |.+||..||.+|||+.+++++
T Consensus       237 i~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          237 MTRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHhcCChhhCcCHHHHHHH
Confidence            999999999999999999874

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.2e-43  Score=353.31  Aligned_cols=248  Identities=24%  Similarity=0.386  Sum_probs=199.1

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhh-CCCCeeEEEEEEEeC----CeEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLS-GHTGVVTLHSVYEEA----DCFH  173 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~-~hpnIv~l~~~~~~~----~~~~  173 (469)
                      .+.++|++++.||+|+||.||+|.+.  |+.||||++... .....+|.+++..+. .||||+++++++...    ..+|
T Consensus        34 ~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~  111 (337)
T 3mdy_A           34 TIAKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLY  111 (337)
T ss_dssp             THHHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEE
T ss_pred             ccccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceE
Confidence            46689999999999999999999886  899999998653 345566777776552 499999999999887    7899


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc--------CeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM--------GVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      +||||+++|+|.+++.. ..+++..+..++.||+.||.|||+.        ||+||||||+|||++.++.+||+|||++.
T Consensus       112 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~  190 (337)
T 3mdy_A          112 LITDYHENGSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  190 (337)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCce
Confidence            99999999999999854 5799999999999999999999999        99999999999999999999999999997


Q ss_pred             eecCCCc-----ccccCCCCcccCceeccCC-CCCc------cchHHHHHHHHHHHhC----------CCCCCCC-----
Q 012170          246 RISNGQT-----LSGLAGSPAYVAPEVLSGN-YSEK------VDIWSAGVLLHALLVA----------ALPFKGD-----  298 (469)
Q Consensus       246 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~-~~~~------~DiwSlG~il~elltG----------~~Pf~~~-----  298 (469)
                      .......     ....+||+.|+|||++.+. +...      +|||||||++|+|++|          ..||...     
T Consensus       191 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  270 (337)
T 3mdy_A          191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP  270 (337)
T ss_dssp             ECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCC
Confidence            6543322     2346899999999999764 3443      8999999999999999          7777542     


Q ss_pred             CHHHHHHHHHcCcCC--CCCC-cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          299 SLEAVFDAIKNVKLD--FHSG-VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       299 ~~~~~~~~i~~~~~~--~~~~-~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ........+......  ++.. ....+++++.+||.+||..||.+|||+.++++|
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          271 SYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             chhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            223333333222211  1110 012456789999999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=2.5e-44  Score=353.98  Aligned_cols=244  Identities=24%  Similarity=0.332  Sum_probs=202.3

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .|...+.||+|+||.||+|.+  ++..||||++...        .+.+.+|+.+++.+. ||||+++++++.+.+..|+|
T Consensus        32 ~~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~-h~~i~~~~~~~~~~~~~~lv  108 (307)
T 2nru_A           32 ISVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ-HENLVELLGFSSDGDDLCLV  108 (307)
T ss_dssp             TTTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEE
T ss_pred             ccccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHHhcC-CCCeEEEEEEEecCCceEEE
Confidence            355568999999999999986  5889999998542        256889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHh---CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          176 MELCSGGRLIDQMVEV---GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~---~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |||+++|+|.+++...   ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++........
T Consensus       109 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~  188 (307)
T 2nru_A          109 YVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ  188 (307)
T ss_dssp             EECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS
T ss_pred             EEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc
Confidence            9999999999998643   4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ---ccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH----HHHHHHHcCcCCC-------CCCc
Q 012170          253 ---LSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLE----AVFDAIKNVKLDF-------HSGV  318 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----~~~~~i~~~~~~~-------~~~~  318 (469)
                         .....||+.|+|||++.+.++.++||||||+++|+|++|.+||.+....    .+...+......+       ....
T Consensus       189 ~~~~~~~~g~~~y~aPE~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  268 (307)
T 2nru_A          189 TVMTSRIVGTTAYMAPEALRGEITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDA  268 (307)
T ss_dssp             CEECSSCCSCGGGCCHHHHTTEECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCC
T ss_pred             cccccccCCCcCcCChHHhcCCCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhcccccccc
Confidence               3346799999999999988999999999999999999999999865422    2222222211110       0111


Q ss_pred             ccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          319 WETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       319 ~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....+..+.++|.+||..||.+|||+.+++++
T Consensus       269 ~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          269 DSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             chHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            22346788999999999999999999999875

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=2.5e-44  Score=363.46  Aligned_cols=243  Identities=17%  Similarity=0.226  Sum_probs=199.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEE-----EECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhC--CCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLC-----RSKASGAEFACKTLRKG-EETVHREVEIMQHLSG--HTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~-----~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~--hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|.+.+.||+|+||.||+|     .+..+++.||||+++.. ...+.+|+++++.+..  |+||+.+++++...+..
T Consensus        63 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~  142 (365)
T 3e7e_A           63 GSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGS  142 (365)
T ss_dssp             SSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCE
T ss_pred             CCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCc
Confidence            3578999999999999999999     46778999999999764 4678889999988853  89999999999999999


Q ss_pred             EEEEeccCCCchHHHHHH-----hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-----------CCcE
Q 012170          173 HLVMELCSGGRLIDQMVE-----VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-----------SGKI  236 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~-----~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-----------~~~v  236 (469)
                      |+|||||+||+|.+++..     .+.+++..+..++.||+.||.|||++||+||||||+||||+.           ++.+
T Consensus       143 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~  222 (365)
T 3e7e_A          143 VLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGL  222 (365)
T ss_dssp             EEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTE
T ss_pred             EEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCE
Confidence            999999999999999974     456999999999999999999999999999999999999998           8999


Q ss_pred             EEEeccceeeec---CCCcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcC
Q 012170          237 KLADFGLAMRIS---NGQTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKL  312 (469)
Q Consensus       237 kL~DFgla~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~  312 (469)
                      ||+|||++..+.   ........+||+.|+|||++.+. |+.++|||||||++|+|++|..||.......     .....
T Consensus       223 kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~-----~~~~~  297 (365)
T 3e7e_A          223 ALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE-----CKPEG  297 (365)
T ss_dssp             EECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE-----EEECS
T ss_pred             EEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCCCc-----eeech
Confidence            999999997653   23345567899999999999774 8999999999999999999999996432110     00001


Q ss_pred             CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCC
Q 012170          313 DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHP  351 (469)
Q Consensus       313 ~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp  351 (469)
                      .+..   ...++.+.+++..||+.+|.+|++..+.|.+.
T Consensus       298 ~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~~  333 (365)
T 3e7e_A          298 LFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQK  333 (365)
T ss_dssp             CCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHHHHH
T ss_pred             hccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHHHHH
Confidence            1111   12467889999999999999997655555443

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=2e-43  Score=381.79  Aligned_cols=236  Identities=25%  Similarity=0.351  Sum_probs=203.9

Q ss_pred             eeeeccCCeEEEEEEE--CCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRS--KASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~--~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.+  +.+++.||||+++..      .+.+.+|+++|++++ ||||+++++++.. +.+++|||||+
T Consensus       375 ~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~l~~~~~~-~~~~lv~E~~~  452 (635)
T 4fl3_A          375 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAE  452 (635)
T ss_dssp             EEEEECSSEEEEEEEEECSSCEEEEEEEEECGGGGCGGGHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CEeccCCCEEEEEEEEcCCCcceEEEEEEeccccCCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEec-CCEEEEEEccC
Confidence            4799999999999954  566789999999642      257889999999997 9999999999965 55789999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc----cccc
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGL  256 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~----~~~~  256 (469)
                      +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++..+.....    ....
T Consensus       453 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~  532 (635)
T 4fl3_A          453 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  532 (635)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-----------
T ss_pred             CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCC
Confidence            999999998888999999999999999999999999999999999999999999999999999976543321    2334


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .||+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+.+..++...+.......   ....++.++.+||.+||
T Consensus       533 ~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl  609 (635)
T 4fl3_A          533 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG---CPAGCPREMYDLMNLCW  609 (635)
T ss_dssp             --CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHHT
T ss_pred             CCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCCCCHHHHHHHHHHc
Confidence            57889999999966 69999999999999999998 999999999988888887764322   22468999999999999


Q ss_pred             hhhhcCCCCHHHHHc
Q 012170          335 TRDVSARITADEVLR  349 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~  349 (469)
                      ..||.+|||+.+|++
T Consensus       610 ~~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          610 TYDVENRPGFAAVEL  624 (635)
T ss_dssp             CSSTTTSCCHHHHHH
T ss_pred             CCCHhHCcCHHHHHH
Confidence            999999999999975

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.4e-44  Score=365.31  Aligned_cols=244  Identities=23%  Similarity=0.277  Sum_probs=197.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCC---cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEE-eCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYE-EADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~-~~~~~~  173 (469)
                      ..|.+.+.||+|+||.||+|.+..++   ..||+|.++..     ...+.+|+.+|+++. ||||+++++++. .++..|
T Consensus        89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~  167 (373)
T 3c1x_A           89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPL  167 (373)
T ss_dssp             EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSCSCSHHHHHHHHHHTTSTTCC-CTTBCCCCEEECCCSSCCE
T ss_pred             ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCCCCHHHHHHHHHHHHHHHhCC-CCCcceEEEEEEcCCCCeE
Confidence            45888999999999999999875432   46899998642     256889999999996 999999999864 456789


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      +||||+++|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++....... 
T Consensus       168 lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~  247 (373)
T 3c1x_A          168 VVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEF  247 (373)
T ss_dssp             EEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEEECCCCCEEEeecccccccccccc
Confidence            999999999999999765 458999999999999999999999999999999999999999999999999997654322 


Q ss_pred             ----cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          252 ----TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       252 ----~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                          ......+|+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+.+..+....+........   ...++.+
T Consensus       248 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~---p~~~~~~  324 (373)
T 3c1x_A          248 DSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDP  324 (373)
T ss_dssp             ----------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSCHHHHHHTTCCCCC---CTTCCHH
T ss_pred             ccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHHHHHHHHcCCCCCC---CCCCCHH
Confidence                1234567889999999965 58999999999999999999 7889987776666666665543322   2467999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.++|.+||..||.+|||+.+++++
T Consensus       325 l~~li~~cl~~dp~~RPs~~ell~~  349 (373)
T 3c1x_A          325 LYEVMLKCWHPKAEMRPSFSELVSR  349 (373)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999999875

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=3.1e-43  Score=351.18  Aligned_cols=246  Identities=26%  Similarity=0.386  Sum_probs=205.2

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHH--hhCCCCeeEEEEEEEeCC----eEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQH--LSGHTGVVTLHSVYEEAD----CFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~--l~~hpnIv~l~~~~~~~~----~~~  173 (469)
                      +.++|.+.+.||+|+||.||+|.+  +|+.||||++... ...+.+|++++..  +. ||||+++++++...+    .+|
T Consensus        40 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~l~-h~ni~~~~~~~~~~~~~~~~~~  116 (342)
T 1b6c_B           40 IARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLW  116 (342)
T ss_dssp             HHHHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHHHSCCC-CTTBCCEEEEEECCCSSCCCEE
T ss_pred             ccccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCchhHHHHHHHHHHHHHhhcC-CCcEEEEEeeecccCCccceeE
Confidence            567899999999999999999998  4899999999753 4567889999988  54 999999999998876    899


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------hcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH--------DMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      +||||+++|+|.+++.. ..+++..+..++.||+.||.|||        +.||+||||||+|||++.++.+||+|||++.
T Consensus       117 lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~  195 (342)
T 1b6c_B          117 LVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV  195 (342)
T ss_dssp             EEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCE
T ss_pred             EEEeecCCCcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCce
Confidence            99999999999999954 57999999999999999999999        8999999999999999999999999999998


Q ss_pred             eecCCCc-----ccccCCCCcccCceeccCC-------CCCccchHHHHHHHHHHHhC----------CCCCCCC-----
Q 012170          246 RISNGQT-----LSGLAGSPAYVAPEVLSGN-------YSEKVDIWSAGVLLHALLVA----------ALPFKGD-----  298 (469)
Q Consensus       246 ~~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~elltG----------~~Pf~~~-----  298 (469)
                      .......     .....||+.|+|||++.+.       ++.++|||||||++|+|++|          ..||.+.     
T Consensus       196 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~  275 (342)
T 1b6c_B          196 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP  275 (342)
T ss_dssp             EEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSC
T ss_pred             eccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcc
Confidence            7665432     3456799999999999764       23689999999999999999          7898754     


Q ss_pred             CHHHHHHHHHcCcCCCCCC-cc--cCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          299 SLEAVFDAIKNVKLDFHSG-VW--ETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       299 ~~~~~~~~i~~~~~~~~~~-~~--~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....+...+.......... .+  ..++..+.+||.+||..||.+|||+.++++|
T Consensus       276 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          276 SVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             CHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            3344444443332221111 11  1344688999999999999999999999986

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=6.8e-45  Score=390.71  Aligned_cols=254  Identities=26%  Similarity=0.391  Sum_probs=208.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe------C
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE------A  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~------~  169 (469)
                      ..++|++++.||+|+||.||+|.+..+|+.||||++...     .+.+.+|+.+|+.+. ||||+++++++..      .
T Consensus        12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~~~~~~~~~~~~Ei~iL~~L~-HpnIV~l~~v~~~~~~~~~~   90 (676)
T 3qa8_A           12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLN-HPNVVSAREVPDGLQKLAPN   90 (676)
T ss_dssp             -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSCCCHHHHHHHHHHHHHHHHCC-BTTBCCEEECCTTTCCCCTT
T ss_pred             CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCceeeeecccccccCC
Confidence            347899999999999999999999999999999998653     356788999999996 9999999999765      6


Q ss_pred             CeEEEEEeccCCCchHHHHHHhC---CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCc---EEEEeccc
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVG---QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGK---IKLADFGL  243 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~---~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~---vkL~DFgl  243 (469)
                      +..|+|||||+||+|.+++....   .+++..++.++.||+.||.|||+.||+||||||+|||++.++.   +||+|||+
T Consensus        91 ~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~  170 (676)
T 3qa8_A           91 DLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGY  170 (676)
T ss_dssp             SSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCC
T ss_pred             CeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEccccc
Confidence            77899999999999999997654   5899999999999999999999999999999999999998775   99999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---------HH-----H
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFD---------AI-----K  308 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---------~i-----~  308 (469)
                      +.............||+.|+|||++.+ .++.++|||||||++|+|++|..||.+........         .+     .
T Consensus       171 a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l  250 (676)
T 3qa8_A          171 AKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDL  250 (676)
T ss_dssp             CCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCC
T ss_pred             ccccccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhh
Confidence            988766666667789999999999976 58999999999999999999999997653322110         00     0


Q ss_pred             cCcCCC------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          309 NVKLDF------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       309 ~~~~~~------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .....+      +......+++.+.+||.+||..||.+|||+.|+|+||||..
T Consensus       251 ~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          251 TGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             SSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             ccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            011111      11223346789999999999999999999999999999954

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.9e-43  Score=379.31  Aligned_cols=243  Identities=26%  Similarity=0.356  Sum_probs=204.7

Q ss_pred             cCCeeeee-eeeccCCeEEEEEEEC--CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVE-VIGHGKFGSVWLCRSK--ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~-~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .+.+.+.+ .||+|+||.||+|.++  .++..||||+++..     .+.+.+|+++|+.+. ||||+++++++.. +.+|
T Consensus       334 ~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-hpniv~l~~~~~~-~~~~  411 (613)
T 2ozo_A          334 RDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALM  411 (613)
T ss_dssp             TTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCCCSSTTHHHHHHHHHHHTTCC-CTTBCCEEEEEES-SSEE
T ss_pred             ccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCCCChHHHHHHHHHHHHHHhCC-CCCEeeEEEEecc-CCeE
Confidence            34555655 8999999999999875  35667999999752     467899999999996 9999999999976 5689


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +|||||.+|+|.+++... ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........
T Consensus       412 lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~  491 (613)
T 2ozo_A          412 LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS  491 (613)
T ss_dssp             EEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC----
T ss_pred             EEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc
Confidence            999999999999998654 4699999999999999999999999999999999999999999999999999976543221


Q ss_pred             ----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          253 ----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       253 ----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                          .....+|+.|+|||++.+ .|+.++|||||||++|+|++ |..||.+.+..++...+..+....   ....+++++
T Consensus       492 ~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l  568 (613)
T 2ozo_A          492 YYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPEL  568 (613)
T ss_dssp             ----------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHHHHHHHHTTCCCC---CCTTCCHHH
T ss_pred             eeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHH
Confidence                122346789999999964 69999999999999999998 999999988888888887764321   224689999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+||.+||..||.+||++.+|++
T Consensus       569 ~~li~~cl~~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          569 YALMSDCWIYKWEDRPDFLTVEQ  591 (613)
T ss_dssp             HHHHHHTTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHcCCChhHCcCHHHHHH
Confidence            99999999999999999999864

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=1.6e-43  Score=375.77  Aligned_cols=243  Identities=26%  Similarity=0.379  Sum_probs=211.6

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ..++|++.+.||+|+||.||+|.+.. +..||||+++..   .+.+.+|+++|++|. ||||+++++++.+ +.+|||||
T Consensus       265 ~~~~~~~~~~lG~G~fg~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~E~~~l~~l~-hpniv~~~~~~~~-~~~~lv~e  341 (535)
T 2h8h_A          265 PRESLRLEVKLGQGCFGEVWMGTWNG-TTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTE  341 (535)
T ss_dssp             CGGGEEEEEEEEECSSEEEEEEEETT-TEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEC
T ss_pred             chhhhhhheecccCCCeEEEEEEECC-CceEEEEEeCCCCCCHHHHHHHHHHHHhCC-CCCEeeEEEEEee-ccceEeee
Confidence            45789999999999999999999875 467999999753   467899999999997 9999999999876 67889999


Q ss_pred             ccCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--c
Q 012170          178 LCSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--L  253 (469)
Q Consensus       178 ~~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~  253 (469)
                      ||.+|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||++........  .
T Consensus       342 ~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~  421 (535)
T 2h8h_A          342 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTAR  421 (535)
T ss_dssp             CCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHHHTT
T ss_pred             hhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCceecc
Confidence            99999999999643  5699999999999999999999999999999999999999999999999999976543221  2


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....++..|+|||++.+ .++.++|||||||++|+|++ |..||.+....+++..+......   .....++.++.+||.
T Consensus       422 ~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~  498 (535)
T 2h8h_A          422 QGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLHDLMC  498 (535)
T ss_dssp             CSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHH
T ss_pred             cCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHHHHH
Confidence            33457889999999864 69999999999999999999 99999999988888888765321   122568999999999


Q ss_pred             HhchhhhcCCCCHHHHHc
Q 012170          332 RMLTRDVSARITADEVLR  349 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~  349 (469)
                      +||..||.+|||+.+|++
T Consensus       499 ~cl~~dP~~RPt~~~l~~  516 (535)
T 2h8h_A          499 QCWRKEPEERPTFEYLQA  516 (535)
T ss_dssp             HHTCSSGGGSCCHHHHHH
T ss_pred             HHcCCChhHCcCHHHHHH
Confidence            999999999999999986

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.4e-43  Score=349.55  Aligned_cols=245  Identities=24%  Similarity=0.368  Sum_probs=203.5

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEE----ECCCCcEEEEEEcccCh----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCR----SKASGAEFACKTLRKGE----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD--  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~----~~~~~~~vAvK~~~~~~----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--  170 (469)
                      ...+|++++.||+|+||.||+|.    +..+|+.||||++....    ..+.+|+.+|+.+. ||||+++++++...+  
T Consensus        39 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~E~~~l~~l~-h~~iv~~~~~~~~~~~~  117 (326)
T 2w1i_A           39 EERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQ-HDNIVKYKGVCYSAGRR  117 (326)
T ss_dssp             CGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSCCSHHHHHHHHHHHHHHTCC-CTTBCCEEEEECC----
T ss_pred             CHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEEecCCC
Confidence            45689999999999999999998    46689999999996532    46889999999996 999999999987644  


Q ss_pred             eEEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          171 CFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      .+++||||+++++|.+++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.....
T Consensus       118 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~  197 (326)
T 2w1i_A          118 NLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQ  197 (326)
T ss_dssp             CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCS
T ss_pred             ceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccc
Confidence            789999999999999999776 4599999999999999999999999999999999999999999999999999987654


Q ss_pred             CCc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH----------------HHHHHHH
Q 012170          250 GQT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE----------------AVFDAIK  308 (469)
Q Consensus       250 ~~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~----------------~~~~~i~  308 (469)
                      ...    .....+++.|+|||++.+ .++.++||||||+++|+|++|..||......                .+...+.
T Consensus       198 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  277 (326)
T 2w1i_A          198 DKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLK  277 (326)
T ss_dssp             SCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHH
T ss_pred             cccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhh
Confidence            432    223457888999999966 4889999999999999999999998642110                1122222


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ... .  ......++.++.+||.+||..||.+|||+.++++
T Consensus       278 ~~~-~--~~~~~~~~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          278 NNG-R--LPRPDGCPDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             TTC-C--CCCCTTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cCC-C--CCCCCcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            221 1  1123568999999999999999999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=350.93  Aligned_cols=243  Identities=21%  Similarity=0.327  Sum_probs=206.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++|++.+.||+|+||.||+|.+..   .||+|++...      .+.+.+|+.+++.+. ||||+++++++.+.+.+++
T Consensus        31 ~~~~~~~~~~lg~G~~g~V~~~~~~~---~~avk~~~~~~~~~~~~~~~~~e~~~l~~l~-h~~iv~~~~~~~~~~~~~i  106 (319)
T 2y4i_B           31 PFEQLEIGELIGKGRFGQVYHGRWHG---EVAIRLIDIERDNEDQLKAFKREVMAYRQTR-HENVVLFMGACMSPPHLAI  106 (319)
T ss_dssp             CCSCEECCCBCCCSSSSEEEEEEESS---SEEEEECCCCSCCCCCCCCCCTTGGGGTTCC-CTTBCCCCEEEECSSCEEE
T ss_pred             CHHHeEEeeEeccCCceEEEEEEEcC---eEEEEEeecCCCCHHHHHHHHHHHHHHhcCC-CCCEeEEEEEEecCCceEE
Confidence            45789999999999999999999864   4999998642      245778999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC----
Q 012170          175 VMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN----  249 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~----  249 (469)
                      ||||++|++|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++ ++.++|+|||++.....    
T Consensus       107 v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~  185 (319)
T 2y4i_B          107 ITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAG  185 (319)
T ss_dssp             ECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC--------
T ss_pred             EeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEEEe-CCCEEEeecCCcccccccccc
Confidence            999999999999987654 699999999999999999999999999999999999998 68999999999865421    


Q ss_pred             --CCcccccCCCCcccCceeccC----------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          250 --GQTLSGLAGSPAYVAPEVLSG----------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       250 --~~~~~~~~gt~~y~aPE~l~~----------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                        ........||+.|+|||++.+          .++.++||||||+++|+|++|..||.+.........+........  
T Consensus       186 ~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--  263 (319)
T 2y4i_B          186 RREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNL--  263 (319)
T ss_dssp             --CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCC--
T ss_pred             ccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCC--
Confidence              122334569999999999864          378899999999999999999999999988888877776543322  


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ....++.++.+||.+||..||.+|||+.++++.
T Consensus       264 ~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~~  296 (319)
T 2y4i_B          264 SQIGMGKEISDILLFCWAFEQEERPTFTKLMDM  296 (319)
T ss_dssp             CCSSCCTTHHHHHHHHHCSSTTTSCCHHHHHHH
T ss_pred             CcCCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence            123578999999999999999999999999873

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=1.1e-43  Score=353.88  Aligned_cols=245  Identities=22%  Similarity=0.369  Sum_probs=189.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHH--HhhCCCCeeEEEEEEEe-----CCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQ--HLSGHTGVVTLHSVYEE-----ADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~--~l~~hpnIv~l~~~~~~-----~~~~  172 (469)
                      -.++|++++.||+|+||.||+|++  +++.||||++... ...+..|.+++.  .+. ||||+++++.+..     ...+
T Consensus        11 ~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~e~~~~~~~~~~-h~~i~~~~~~~~~~~~~~~~~~   87 (336)
T 3g2f_A           11 DLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFANRQNFINEKNIYRVPLME-HDNIARFIVGDERVTADGRMEY   87 (336)
T ss_dssp             CTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECTTSCEEE
T ss_pred             ChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccchhhHHHHHHHHHHHhcc-CcchhhheecccccccCCCceE
Confidence            347899999999999999999977  5899999999653 344555555543  465 9999999986542     3367


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc---------CeEeccCCCCcEEEccCCcEEEEeccc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM---------GVVHRDIKPENILLTTSGKIKLADFGL  243 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~---------givHrDlkp~NILl~~~~~vkL~DFgl  243 (469)
                      |+|||||++|+|.+++.. ..+++..+..++.||+.||.|||+.         ||+||||||+|||++.++.+||+|||+
T Consensus        88 ~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~  166 (336)
T 3g2f_A           88 LLVMEYYPNGSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGL  166 (336)
T ss_dssp             EEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTT
T ss_pred             EEEEecCCCCcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccc
Confidence            899999999999999855 4568999999999999999999999         999999999999999999999999999


Q ss_pred             eeeecCCC---------cccccCCCCcccCceeccC--------CCCCccchHHHHHHHHHHHhCCCCCC-CCC------
Q 012170          244 AMRISNGQ---------TLSGLAGSPAYVAPEVLSG--------NYSEKVDIWSAGVLLHALLVAALPFK-GDS------  299 (469)
Q Consensus       244 a~~~~~~~---------~~~~~~gt~~y~aPE~l~~--------~~~~~~DiwSlG~il~elltG~~Pf~-~~~------  299 (469)
                      +..+....         .....+||+.|+|||++.+        .++.++|||||||++|+|++|..||. +..      
T Consensus       167 a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~  246 (336)
T 3g2f_A          167 SMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQM  246 (336)
T ss_dssp             CEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCC
T ss_pred             eeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHH
Confidence            98764322         1234579999999999976        25678999999999999999976653 221      


Q ss_pred             -----------HHHHHHHHHcCc--CCCCCC--cccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          300 -----------LEAVFDAIKNVK--LDFHSG--VWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       300 -----------~~~~~~~i~~~~--~~~~~~--~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                                 .......+....  ..++..  ....+++++.+||.+||..||.+|||+.|+++
T Consensus       247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~  311 (336)
T 3g2f_A          247 AFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEE  311 (336)
T ss_dssp             TTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             hhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcCChhhCcchHHHHH
Confidence                       111111121111  111111  11224568999999999999999999999954

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=1.7e-42  Score=375.84  Aligned_cols=245  Identities=23%  Similarity=0.307  Sum_probs=209.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC---CcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~---~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      ..++|++.+.||+|+||.||+|.+..+   +..||+|.++...     +.+.+|+.+|+.+. ||||+++++++. ++.+
T Consensus       388 ~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~  465 (656)
T 2j0j_A          388 QRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPV  465 (656)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSSTTCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEC-SSSC
T ss_pred             ccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEecccCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEe-cCce
Confidence            457899999999999999999998654   4579999986532     56789999999996 999999999985 4568


Q ss_pred             EEEEeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          173 HLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      |+||||+++|+|.+++...+ .+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++.......
T Consensus       466 ~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~  545 (656)
T 2j0j_A          466 WIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST  545 (656)
T ss_dssp             EEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC--
T ss_pred             EEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCc
Confidence            89999999999999997654 68999999999999999999999999999999999999999999999999998664432


Q ss_pred             c--ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          252 T--LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       252 ~--~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                      .  .....||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+++..+.......   ....+++.+.
T Consensus       546 ~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~l~  622 (656)
T 2j0j_A          546 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP---MPPNCPPTLY  622 (656)
T ss_dssp             --------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHHTCCCC---CCTTCCHHHH
T ss_pred             ceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHcCCCCC---CCccccHHHH
Confidence            2  223457889999999965 58999999999999999997 999999999888888887654321   2256899999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcC
Q 012170          328 DLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +||.+||..||.+|||+.+++++
T Consensus       623 ~li~~~l~~dP~~RPs~~el~~~  645 (656)
T 2j0j_A          623 SLMTKCWAYDPSRRPRFTELKAQ  645 (656)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999864

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=3.2e-43  Score=361.83  Aligned_cols=242  Identities=16%  Similarity=0.179  Sum_probs=191.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCC-CCe--------------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGH-TGV--------------  159 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~h-pnI--------------  159 (469)
                      ...|...+.||+|+||.||+|.+..+|+.||||++...       .+.+.+|+.+++.+. | +|.              
T Consensus        77 ~~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~~~~~~~~~~~~~~~~~~~  155 (413)
T 3dzo_A           77 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLR-GIKNQKQAKVHLRFIFPFD  155 (413)
T ss_dssp             CEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGST-TCCSHHHHHHHTCBCCCCE
T ss_pred             ceeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhc-cCCCHHHHHHhcccccchh
Confidence            34688899999999999999999999999999998621       356889999999886 5 221              


Q ss_pred             -------eEEEEEEEe-----CCeEEEEEeccCCCchHHHHHH-------hCCCCHHHHHHHHHHHHHHHHHHHhcCeEe
Q 012170          160 -------VTLHSVYEE-----ADCFHLVMELCSGGRLIDQMVE-------VGQYSEQRAANIFKDVMWVIKYCHDMGVVH  220 (469)
Q Consensus       160 -------v~l~~~~~~-----~~~~~lV~E~~~gg~L~~~l~~-------~~~l~~~~~~~i~~qil~aL~yLH~~givH  220 (469)
                             ..+..++..     ...++++|+++ +++|.+++..       .+.+++..+..++.||+.||.|||++||+|
T Consensus       156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiH  234 (413)
T 3dzo_A          156 LVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVH  234 (413)
T ss_dssp             EEECCC---------------CCSEEEEEECC-SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred             hcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence                   111122222     22467888877 6799888742       234778889999999999999999999999


Q ss_pred             ccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceec----------cC-CCCCccchHHHHHHHHHHH
Q 012170          221 RDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL----------SG-NYSEKVDIWSAGVLLHALL  289 (469)
Q Consensus       221 rDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l----------~~-~~~~~~DiwSlG~il~ell  289 (469)
                      |||||+||||+.++.+||+|||++......  ....+| +.|+|||++          .+ .|+.++|||||||++|+|+
T Consensus       235 rDiKp~NILl~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~ell  311 (413)
T 3dzo_A          235 TYLRPVDIVLDQRGGVFLTGFEHLVRDGAS--AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIW  311 (413)
T ss_dssp             SCCCGGGEEECTTCCEEECCGGGCEETTEE--ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHH
T ss_pred             CCcccceEEEecCCeEEEEeccceeecCCc--cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHH
Confidence            999999999999999999999998764332  455678 999999998          33 3788999999999999999


Q ss_pred             hCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          290 VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       290 tG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +|..||.+.+.......+.        ..+..+++++.+||.+||..||.+|||+.++|+||||...
T Consensus       312 tg~~Pf~~~~~~~~~~~~~--------~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~~  370 (413)
T 3dzo_A          312 CADLPNTDDAALGGSEWIF--------RSCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQL  370 (413)
T ss_dssp             HSSCCCCTTGGGSCSGGGG--------SSCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred             HCCCCCCCcchhhhHHHHH--------hhcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHHH
Confidence            9999998765433222221        1234689999999999999999999999999999999543

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=100.00  E-value=1.1e-42  Score=340.23  Aligned_cols=222  Identities=16%  Similarity=0.117  Sum_probs=185.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCF  172 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~  172 (469)
                      .+.++|++++.||+|+||.||+|.+..+|+.||||++....       ..+.+|+.++..+. ||||+++++++.+.+.+
T Consensus        28 ~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-hp~iv~~~~~~~~~~~~  106 (286)
T 3uqc_A           28 IANGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRID-KPGVARVLDVVHTRAGG  106 (286)
T ss_dssp             ETTTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEETTEE
T ss_pred             EecCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCC-CCCcceeeEEEEECCcE
Confidence            35678999999999999999999999999999999996531       56889999999996 99999999999999999


Q ss_pred             EEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          173 HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       173 ~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      |+||||++|++|.+++. .+ ....++..++.||+.||.|||++||+||||||+|||++.+|.+||+++|          
T Consensus       107 ~lv~e~~~g~~L~~~l~-~~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~g~~kl~~~~----------  174 (286)
T 3uqc_A          107 LVVAEWIRGGSLQEVAD-TS-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA----------  174 (286)
T ss_dssp             EEEEECCCEEEHHHHHT-TC-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETTSCEEECSCC----------
T ss_pred             EEEEEecCCCCHHHHHh-cC-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCCCCEEEEecc----------
Confidence            99999999999999984 33 4666789999999999999999999999999999999999999998443          


Q ss_pred             ccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHHcCcCCCCCCcccCCCHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFD---AIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~---~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                               |++|      ++.++|||||||++|+|++|..||.+.+....+.   .........+......+++++.+|
T Consensus       175 ---------~~~~------~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  239 (286)
T 3uqc_A          175 ---------TMPD------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAV  239 (286)
T ss_dssp             ---------CCTT------CCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHH
T ss_pred             ---------ccCC------CCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHH
Confidence                     3443      6889999999999999999999998765322110   000111111112235689999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcC
Q 012170          330 MARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~h  350 (469)
                      |.+||..||.+| |+.|+++.
T Consensus       240 i~~~l~~dP~~R-s~~el~~~  259 (286)
T 3uqc_A          240 AARSVQGDGGIR-SASTLLNL  259 (286)
T ss_dssp             HHHHHCTTSSCC-CHHHHHHH
T ss_pred             HHHHcccCCccC-CHHHHHHH
Confidence            999999999999 99999873

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=100.00  E-value=2.3e-42  Score=377.01  Aligned_cols=239  Identities=24%  Similarity=0.363  Sum_probs=202.2

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECC-CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKA-SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~-~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ...+.++|++++.||+|+||.||+|.+.. +|+.||||++...     ...+.+|+.+|+++. ||||+++++++...+.
T Consensus        75 g~~~~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~-hp~iv~~~~~~~~~~~  153 (681)
T 2pzi_A           75 GDIVAGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVV-HPSIVQIFNFVEHTDR  153 (681)
T ss_dssp             TCEETTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSSCCHHHHHHHHHHHGGGGGCC-CTTBCCEEEEEEEECT
T ss_pred             CCEeCCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCccCCHHHHHHHHHHHHHHHhcC-CCCcCeEeeeEeecCC
Confidence            34567899999999999999999999976 7899999998643     245778999999997 9999999999987665


Q ss_pred             -----EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          172 -----FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       172 -----~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                           .||||||++|++|.+++..  .+++..+..++.||+.||.|||++||+||||||+|||++.+ .+||+|||++..
T Consensus       154 ~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~  230 (681)
T 2pzi_A          154 HGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR  230 (681)
T ss_dssp             TSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHHeEEeCC-cEEEEecccchh
Confidence                 7999999999999987744  79999999999999999999999999999999999999875 999999999987


Q ss_pred             ecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          247 ISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       247 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                      ....   ....||+.|+|||++.+.++.++|||||||++|+|++|.+||.+....         ... .......+++.+
T Consensus       231 ~~~~---~~~~gt~~y~aPE~~~~~~~~~sDi~slG~~l~~l~~g~~~~~~~~~~---------~~~-~~~~~~~~~~~l  297 (681)
T 2pzi_A          231 INSF---GYLYGTPGFQAPEIVRTGPTVATDIYTVGRTLAALTLDLPTRNGRYVD---------GLP-EDDPVLKTYDSY  297 (681)
T ss_dssp             TTCC---SCCCCCTTTSCTTHHHHCSCHHHHHHHHHHHHHHHHSCCCEETTEECS---------SCC-TTCHHHHHCHHH
T ss_pred             cccC---CccCCCccccCHHHHcCCCCCceehhhhHHHHHHHHhCCCCCcccccc---------ccc-ccccccccCHHH
Confidence            6543   456799999999999888899999999999999999999998753210         000 111122357889


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          327 RDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      .+||.+||..||.+||+..+++.|+|+
T Consensus       298 ~~li~~~l~~dP~~R~~~~~~l~~~l~  324 (681)
T 2pzi_A          298 GRLLRRAIDPDPRQRFTTAEEMSAQLT  324 (681)
T ss_dssp             HHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             HHHHhhhccCChhhCCCHHHHHHHHHH
Confidence            999999999999999999999999987

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=100.00  E-value=1.9e-37  Score=330.80  Aligned_cols=225  Identities=18%  Similarity=0.144  Sum_probs=159.5

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEcccC--------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG--------------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ..++.|++|.+..++...+|+.||||++.+.              .+.+.+|+++|+++..|+||+++++++++++.+||
T Consensus       240 ~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yL  319 (569)
T 4azs_A          240 NQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWL  319 (569)
T ss_dssp             CC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEE
T ss_pred             hccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEE
Confidence            3467888888888888888999999999643              14588999999999879999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~  253 (469)
                      |||||+|++|.++|.+.+++++.   .|+.||+.||.|||++|||||||||+||||+.+|.+||+|||+|+..... ...
T Consensus       320 VMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~~~  396 (569)
T 4azs_A          320 VMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCSWP  396 (569)
T ss_dssp             EEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC---CCS
T ss_pred             EEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCCccc
Confidence            99999999999999998889875   47899999999999999999999999999999999999999999866543 335


Q ss_pred             cccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          254 SGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      .+.+||+.|||||++.+.+..++|+||+|++++.|.++..|+        ...+...    +..     ...+.+++..+
T Consensus       397 ~t~vGTp~YmAPE~l~g~~~~~~d~~s~g~~~~~l~~~~~~~--------~~~l~~~----~~~-----~~~~~~l~~~l  459 (569)
T 4azs_A          397 TNLVQSFFVFVNELFAENKSWNGFWRSAPVHPFNLPQPWSNW--------LYAVWQE----PVE-----RWNFVLLLALF  459 (569)
T ss_dssp             HHHHHHHHHHHHHHC-----------------CCCCTTHHHH--------HHHHHTS----CGG-----GCSHHHHHHHH
T ss_pred             cCceechhhccHHHhCCCCCCcccccccccchhhhccccchh--------HHHhhcC----CCC-----CCcHHHHHHHH
Confidence            567899999999999999999999999999998887665443        1111111    111     11245667777


Q ss_pred             chhhhcCCCCHHHHHcCCCc
Q 012170          334 LTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       334 L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +..+|..|+.......|+|.
T Consensus       460 ~~~~~~~~~~~~~~~~~~~~  479 (569)
T 4azs_A          460 EKKAKLPSAEQQRGATEQWI  479 (569)
T ss_dssp             HTGGGSCCGGGSSCCHHHHH
T ss_pred             hCCCCCCCCChhhhccchhH
Confidence            77888888776666666664

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.95  E-value=2.5e-29  Score=266.54  Aligned_cols=178  Identities=15%  Similarity=0.172  Sum_probs=142.0

Q ss_pred             eeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       106 ~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ...+.||+|+||.||+|..  .+..+|+|.....            .+.+.+|+++|++++ ||||+++..++...+..|
T Consensus       339 ~~~~~LG~G~fg~Vy~~~~--~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~~~  415 (540)
T 3en9_A          339 IPEHLIGKGAEADIKRDSY--LDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLALVK-DFGIPAPYIFDVDLDNKR  415 (540)
T ss_dssp             ---------CCEEEEEEEC--SSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHHHGG-GGTCCCCCEEEEETTTTE
T ss_pred             CCCCEEeeCCCEEEEEEEE--CCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHHhcC-CCCcCceEEEEEeCCccE
Confidence            3356899999999999943  4788999986321            134789999999997 999996555555677779


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      ||||||+|++|.+++..        +..++.||+.||.|||++||+||||||+|||++.  .+||+|||+++....... 
T Consensus       416 lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~  485 (540)
T 3en9_A          416 IMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDK  485 (540)
T ss_dssp             EEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHH
T ss_pred             EEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCcccc
Confidence            99999999999998854        6689999999999999999999999999999998  999999999987754322 


Q ss_pred             -------ccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCC
Q 012170          253 -------LSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFK  296 (469)
Q Consensus       253 -------~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~  296 (469)
                             ....+||+.|||||++.+   .|+..+|+|+..+-..+.+.++.+|.
T Consensus       486 ~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~  539 (540)
T 3en9_A          486 AVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV  539 (540)
T ss_dssp             HHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred             ccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence                   235789999999999975   48888999999988888887776663

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.93  E-value=2.4e-26  Score=224.00  Aligned_cols=141  Identities=21%  Similarity=0.278  Sum_probs=116.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------------------hHHHHHHHHHHHHhhCCCCee
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------------------EETVHREVEIMQHLSGHTGVV  160 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------------------~~~~~~E~~il~~l~~hpnIv  160 (469)
                      ..|.+++.||+|+||.||+|.+ .+|+.||||+++.+                      ...+.+|+.+|+.+. |++++
T Consensus        90 ~~~~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~-~~~v~  167 (282)
T 1zar_A           90 KVDAIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVP  167 (282)
T ss_dssp             SCSEEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSC
T ss_pred             eEEEecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhcc-CCCcC
Confidence            3566779999999999999999 78999999999642                      234789999999997 55554


Q ss_pred             EEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEe
Q 012170          161 TLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLAD  240 (469)
Q Consensus       161 ~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~D  240 (469)
                      .   ++.. +..|+||||++||+|.+ +      .......++.||+.||.|||++||+||||||+|||++ +|.+||+|
T Consensus       168 ~---~~~~-~~~~lvmE~~~g~~L~~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrDlkp~NILl~-~~~vkl~D  235 (282)
T 1zar_A          168 K---VYAW-EGNAVLMELIDAKELYR-V------RVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIID  235 (282)
T ss_dssp             C---EEEE-ETTEEEEECCCCEEGGG-C------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEE-TTEEEECC
T ss_pred             e---EEec-cceEEEEEecCCCcHHH-c------chhhHHHHHHHHHHHHHHHHHCCCEeCCCCHHHEEEE-CCcEEEEE
Confidence            4   4433 45689999999999987 4      1234557999999999999999999999999999999 99999999


Q ss_pred             ccceeeecCCCcccccCCCCcccCceecc
Q 012170          241 FGLAMRISNGQTLSGLAGSPAYVAPEVLS  269 (469)
Q Consensus       241 Fgla~~~~~~~~~~~~~gt~~y~aPE~l~  269 (469)
                      ||++..            +..|+|||++.
T Consensus       236 FG~a~~------------~~~~~a~e~l~  252 (282)
T 1zar_A          236 FPQSVE------------VGEEGWREILE  252 (282)
T ss_dssp             CTTCEE------------TTSTTHHHHHH
T ss_pred             CCCCeE------------CCCCCHHHHHH
Confidence            999953            44578899874

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.87  E-value=2.2e-22  Score=193.26  Aligned_cols=134  Identities=24%  Similarity=0.269  Sum_probs=107.5

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcE--EEEEEcccCh----------------------------HHHHHHHHHHHHh
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAE--FACKTLRKGE----------------------------ETVHREVEIMQHL  153 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vAvK~~~~~~----------------------------~~~~~E~~il~~l  153 (469)
                      .|.+.+.||+|+||.||+|.+..+|+.  ||||+++...                            ..+.+|+.+|..|
T Consensus        48 ~~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l  127 (258)
T 1zth_A           48 ITAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLERA  127 (258)
T ss_dssp             EEEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHHH
T ss_pred             chhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHHH
Confidence            377889999999999999999778999  9999875321                            2577899999999


Q ss_pred             hCCCCe--eEEEEEEEeCCeEEEEEeccCC-C----chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH-hcCeEeccCCC
Q 012170          154 SGHTGV--VTLHSVYEEADCFHLVMELCSG-G----RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH-DMGVVHRDIKP  225 (469)
Q Consensus       154 ~~hpnI--v~l~~~~~~~~~~~lV~E~~~g-g----~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH-~~givHrDlkp  225 (469)
                      . |++|  +.++.+    +..+|||||+.+ |    .|.+....   .++..+..++.||+.||.||| +.||+||||||
T Consensus       128 ~-~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~lH~~~givHrDlkp  199 (258)
T 1zth_A          128 K-EAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRLYQEAELVHADLSE  199 (258)
T ss_dssp             H-HTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHHHHTSCEECSSCST
T ss_pred             H-hCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHHHHHCCEEeCCCCH
Confidence            7 7754  444443    245799999942 4    55554321   345678899999999999999 99999999999


Q ss_pred             CcEEEccCCcEEEEeccceeee
Q 012170          226 ENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       226 ~NILl~~~~~vkL~DFgla~~~  247 (469)
                      +|||++.  .++|+|||+|...
T Consensus       200 ~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          200 YNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             TSEEESS--SEEECCCTTCEET
T ss_pred             HHEEEcC--cEEEEECcccccC
Confidence            9999988  9999999999754

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.78  E-value=2.2e-19  Score=180.64  Aligned_cols=134  Identities=19%  Similarity=0.258  Sum_probs=102.2

Q ss_pred             CeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------------------H--------HHHHHHHHHHHhhCCC
Q 012170          104 DHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------------------E--------TVHREVEIMQHLSGHT  157 (469)
Q Consensus       104 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------------------~--------~~~~E~~il~~l~~hp  157 (469)
                      -|.+++.||.|+||.||+|.+. +|+.||||+++...                  .        ...+|...|.+|. +.
T Consensus        96 iY~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~rL~-~~  173 (397)
T 4gyi_A           96 VYSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKALY-EE  173 (397)
T ss_dssp             CSEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHHHH-HT
T ss_pred             EEEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHH-hc
Confidence            3899999999999999999985 69999999975320                  0        1235778888885 55


Q ss_pred             CeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC---
Q 012170          158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG---  234 (469)
Q Consensus       158 nIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~---  234 (469)
                      ++....-+....  .+|||||++|++|..+.      ....+..++.||+.+|.|||+.|||||||||.|||++++|   
T Consensus       174 gv~vp~p~~~~~--~~LVME~i~G~~L~~l~------~~~~~~~l~~qll~~l~~lH~~gIVHrDLKp~NILl~~dgd~~  245 (397)
T 4gyi_A          174 GFPVPEPIAQSR--HTIVMSLVDALPMRQVS------SVPDPASLYADLIALILRLAKHGLIHGDFNEFNILIREEKDAE  245 (397)
T ss_dssp             TCSCCCEEEEET--TEEEEECCSCEEGGGCC------CCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEEEEECSS
T ss_pred             CCCCCeeeeccC--ceEEEEecCCccHhhhc------ccHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHHEEEeCCCCcc
Confidence            443222222222  26999999998886532      2234567899999999999999999999999999999877   


Q ss_pred             -------cEEEEeccceeee
Q 012170          235 -------KIKLADFGLAMRI  247 (469)
Q Consensus       235 -------~vkL~DFgla~~~  247 (469)
                             .+.|+||+.+...
T Consensus       246 d~~~~~~~~~iID~~Q~V~~  265 (397)
T 4gyi_A          246 DPSSITLTPIIIXFPQMVSM  265 (397)
T ss_dssp             CTTSEEEEEEECCCTTCEET
T ss_pred             cccccccceEEEEeCCcccC
Confidence                   3899999988653

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=99.54  E-value=5.1e-14  Score=134.59  Aligned_cols=137  Identities=18%  Similarity=0.167  Sum_probs=114.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +.|.+...+|.|+.+.||++...  +..+++|+...    ....+.+|+.+|+.|..+..++++++++.+.+..|+||||
T Consensus        14 ~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~   91 (263)
T 3tm0_A           14 EKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             ccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEe
Confidence            56888889999999999999754  68999999863    3456999999999997677899999999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-------------------------------------------
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-------------------------------------------  215 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-------------------------------------------  215 (469)
                      ++|.+|.+.+     .+......++.++..+|..||+                                           
T Consensus        92 i~G~~l~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T 3tm0_A           92 ADGVLCSEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSS
T ss_pred             cCCeehhhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCC
Confidence            9999887642     1223345788899999999998                                           


Q ss_pred             ----------------cCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          216 ----------------MGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       216 ----------------~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                                      ..++|+|++|.|||+++++.+.|+||+.+..
T Consensus       167 ~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T 3tm0_A          167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence                            4599999999999998765567999998854

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=99.40  E-value=1.5e-12  Score=123.53  Aligned_cols=135  Identities=16%  Similarity=0.078  Sum_probs=101.4

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCC-eeEEEEEEEeCCeEEEEEeccC
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTG-VVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpn-Iv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      ..|.+..+.+.|..+.||++.. .+|..+++|+.... ...+.+|+.+|+.+..+.- +++++.+...++..|+||||++
T Consensus        20 ~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~   98 (264)
T 1nd4_A           20 FGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP   98 (264)
T ss_dssp             TTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred             CCCceEecccCCCCceEEEEec-CCCCeEEEEeCCcccchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecC
Confidence            3455544445667799999964 46788999998653 2568899999999985522 6678998888888999999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC-------------------------------------------
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG-------------------------------------------  217 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g-------------------------------------------  217 (469)
                      |.+|.  .   ....   ...++.+++..|..||+..                                           
T Consensus        99 G~~l~--~---~~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  170 (264)
T 1nd4_A           99 GQDLL--S---SHLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAEL  170 (264)
T ss_dssp             SEETT--T---SCCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHH
T ss_pred             CcccC--c---CcCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHH
Confidence            98883  1   1122   2356677777777777643                                           


Q ss_pred             ---------------eEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          218 ---------------VVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       218 ---------------ivHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                                     ++|+|++|.|||++.++.+.|+|||.+..
T Consensus       171 ~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~  214 (264)
T 1nd4_A          171 FARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV  214 (264)
T ss_dssp             HHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence                           99999999999998776677999999854

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=99.29  E-value=1.1e-11  Score=124.07  Aligned_cols=137  Identities=22%  Similarity=0.361  Sum_probs=108.2

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcc--cC-----hHHHHHHHHHHHHhhC-CCCeeEEEEEEEeC---CeEEEE
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLR--KG-----EETVHREVEIMQHLSG-HTGVVTLHSVYEEA---DCFHLV  175 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~--~~-----~~~~~~E~~il~~l~~-hpnIv~l~~~~~~~---~~~~lV  175 (469)
                      .++.|+.|.++.||++...  +..+++|+..  .+     ...+.+|+.+|+.|.. +..+++++.++.+.   +..|+|
T Consensus        42 ~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~v  119 (359)
T 3dxp_A           42 SVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLLPSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYI  119 (359)
T ss_dssp             EEEECCC-CCSCEEEEECS--SCEEEEECCCC----------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEE
T ss_pred             eEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCCCcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEE
Confidence            4678999999999998764  4689999886  32     3578899999999974 34588899988776   457899


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh----------------------------------------
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD----------------------------------------  215 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~----------------------------------------  215 (469)
                      |||++|..+.+..  ...+++.....++.+++..|..||+                                        
T Consensus       120 me~v~G~~l~~~~--~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  197 (359)
T 3dxp_A          120 MEFVSGRVLWDQS--LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAM  197 (359)
T ss_dssp             EECCCCBCCCCTT--CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHH
T ss_pred             EEecCCeecCCCc--cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHH
Confidence            9999998775421  2346788888999999999999997                                        


Q ss_pred             ------------------cCeEeccCCCCcEEEccCCc--EEEEeccceeee
Q 012170          216 ------------------MGVVHRDIKPENILLTTSGK--IKLADFGLAMRI  247 (469)
Q Consensus       216 ------------------~givHrDlkp~NILl~~~~~--vkL~DFgla~~~  247 (469)
                                        .+++|+|++|.|||++.++.  +.|+||+.+...
T Consensus       198 ~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~g  249 (359)
T 3dxp_A          198 DSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTLG  249 (359)
T ss_dssp             HHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEEE
T ss_pred             HHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECccccccC
Confidence                              36999999999999998753  689999998653

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=99.25  E-value=9.7e-12  Score=121.56  Aligned_cols=181  Identities=17%  Similarity=0.224  Sum_probs=125.4

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCC--eeEEEEEEEeCC---eEEEEEeccC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTG--VVTLHSVYEEAD---CFHLVMELCS  180 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpn--Iv~l~~~~~~~~---~~~lV~E~~~  180 (469)
                      ++.++.|....||++.     ..+++|+....  ...+.+|+.+|+.+..+..  +++++......+   ..|+||++++
T Consensus        25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~   99 (304)
T 3sg8_A           25 IEISGEGNDCIAYEIN-----RDFIFKFPKHSRGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIK   99 (304)
T ss_dssp             CCEEEECSSEEEEEST-----TSEEEEEESSHHHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCC
T ss_pred             eEecCCCCcceEEEEC-----CEEEEEecCCcchHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccC
Confidence            3568999999999873     56999987643  3578899999999854433  445555544333   3479999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh---------------------------------------------
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD---------------------------------------------  215 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~---------------------------------------------  215 (469)
                      |.+|.+...  ..++..+...++.+++..|..||+                                             
T Consensus       100 G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  177 (304)
T 3sg8_A          100 GVPLTPLLL--NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFY  177 (304)
T ss_dssp             CEECCHHHH--HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHH
T ss_pred             CeECCcccc--ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHH
Confidence            988875433  356777788888888888888885                                             


Q ss_pred             -------------cCeEeccCCCCcEEEcc--CCcEEEEeccceeeecCCCcccccCCCCcccCceeccC---CCCC---
Q 012170          216 -------------MGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG---NYSE---  274 (469)
Q Consensus       216 -------------~givHrDlkp~NILl~~--~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~---  274 (469)
                                   ..++|+|++|.||+++.  .+.+.|+||+.+.................-..|+....   .|..   
T Consensus       178 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~  257 (304)
T 3sg8_A          178 RDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDI  257 (304)
T ss_dssp             HHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCH
T ss_pred             HHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCc
Confidence                         13799999999999998  45688999999876432221111111100023332211   1211   


Q ss_pred             ---------ccchHHHHHHHHHHHhCCCCC
Q 012170          275 ---------KVDIWSAGVLLHALLVAALPF  295 (469)
Q Consensus       275 ---------~~DiwSlG~il~elltG~~Pf  295 (469)
                               ..+.|++|.++|.+.+|.++|
T Consensus       258 ~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~  287 (304)
T 3sg8_A          258 PTVLEKYRMKEKYWSFEKIIYGKEYGYMDW  287 (304)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHHHHHTTCHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHHHHcCCHHH
Confidence                     258899999999999998877

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=98.88  E-value=3e-08  Score=94.58  Aligned_cols=134  Identities=17%  Similarity=0.211  Sum_probs=98.9

Q ss_pred             eeeeccCCe-EEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHH
Q 012170          109 EVIGHGKFG-SVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLID  186 (469)
Q Consensus       109 ~~lG~G~~g-~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~  186 (469)
                      +.+..|..| .||+......+..+++|+-... ...+.+|..+|+.|..+--+++++.++.+.+..|+|||+++|.++.+
T Consensus        30 ~~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~  109 (272)
T 4gkh_A           30 ARDNVGQSGATIYRLYGKPNAPELFLKHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQ  109 (272)
T ss_dssp             EEEECSSSSCEEEEEECCTTCCCEEEEEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHH
T ss_pred             EEccCCCcCCeEEEEEecCCCeEEEEEECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccc
Confidence            344556555 6999887777888999987653 35688999999999766558899999999999999999999988766


Q ss_pred             HHHHhCCCCHHHHHHHHHHHHHHHHHHHhc--------------------------------------------------
Q 012170          187 QMVEVGQYSEQRAANIFKDVMWVIKYCHDM--------------------------------------------------  216 (469)
Q Consensus       187 ~l~~~~~l~~~~~~~i~~qil~aL~yLH~~--------------------------------------------------  216 (469)
                      .....    ......+..++...|.-||..                                                  
T Consensus       110 ~~~~~----~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~  185 (272)
T 4gkh_A          110 VLEEY----PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHK  185 (272)
T ss_dssp             HHHHC----GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHT
T ss_pred             cccCC----HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHh
Confidence            54321    112233444454555544421                                                  


Q ss_pred             --------CeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          217 --------GVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       217 --------givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                              .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       186 ~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~  223 (272)
T 4gkh_A          186 LLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI  223 (272)
T ss_dssp             TCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             cccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence                    279999999999999877777999999854

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=98.79  E-value=8.3e-08  Score=93.75  Aligned_cols=133  Identities=14%  Similarity=0.224  Sum_probs=94.2

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCC--CeeEEEEEEE-eCCeEEEEEeccCCC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHT--GVVTLHSVYE-EADCFHLVMELCSGG  182 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hp--nIv~l~~~~~-~~~~~~lV~E~~~gg  182 (469)
                      ++.++.|....||+.     |..+++|+....  ...+.+|+.+|+.|..+-  .+++++.+.. ..+..|+||||++|.
T Consensus        24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~   98 (306)
T 3tdw_A           24 VESLGEGFRNYAILV-----NGDWVFRFPKSQQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQ   98 (306)
T ss_dssp             EEEEEECSSEEEEEE-----TTTEEEEEESSHHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSE
T ss_pred             eeecCCCcceeEEEE-----CCEEEEEecCCchHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCe
Confidence            466889999999988     567999986532  356889999999997442  2567777764 455678999999998


Q ss_pred             chHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhc----------------------------------------------
Q 012170          183 RLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM----------------------------------------------  216 (469)
Q Consensus       183 ~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~----------------------------------------------  216 (469)
                      .+.+..  -..++......++.++...|..||+.                                              
T Consensus        99 ~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~  176 (306)
T 3tdw_A           99 ILGEDG--MAVLPDDAKDRLALQLAEFMNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRF  176 (306)
T ss_dssp             ECHHHH--HTTSCHHHHHHHHHHHHHHHHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHH
T ss_pred             ECchhh--hhhCCHHHHHHHHHHHHHHHHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHH
Confidence            886532  12334444444455555544444431                                              


Q ss_pred             --------------CeEeccCCCCcEEEcc---CCcE-EEEeccceeee
Q 012170          217 --------------GVVHRDIKPENILLTT---SGKI-KLADFGLAMRI  247 (469)
Q Consensus       217 --------------givHrDlkp~NILl~~---~~~v-kL~DFgla~~~  247 (469)
                                    .++|+|++|.|||++.   ++.+ .|+||+.+...
T Consensus       177 ~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g  225 (306)
T 3tdw_A          177 QSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS  225 (306)
T ss_dssp             HHHHHCHHHHCCCCEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred             HHHHhCcccccCCCeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence                          4699999999999987   4554 89999988653

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=98.59  E-value=2.4e-07  Score=93.64  Aligned_cols=74  Identities=16%  Similarity=0.121  Sum_probs=51.5

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEccc-----------ChHHHHHHHHHHHHhhCC-C-CeeEEEEEEEeCCeEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----------GEETVHREVEIMQHLSGH-T-GVVTLHSVYEEADCFHL  174 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----------~~~~~~~E~~il~~l~~h-p-nIv~l~~~~~~~~~~~l  174 (469)
                      ++.||.|..+.||++....++..|+||....           ....+..|.++|+.+..+ | .+++++.+  +.+..++
T Consensus        35 ~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~l  112 (397)
T 2olc_A           35 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  112 (397)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccEE
Confidence            5789999999999997766678999997532           124567899999988643 3 34566644  3445579


Q ss_pred             EEeccCCCc
Q 012170          175 VMELCSGGR  183 (469)
Q Consensus       175 V~E~~~gg~  183 (469)
                      ||||++|..
T Consensus       113 vmE~l~g~~  121 (397)
T 2olc_A          113 VMEDLSHLK  121 (397)
T ss_dssp             EECCCTTSE
T ss_pred             EEEeCCCcc
Confidence            999998743

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=98.56  E-value=1.1e-07  Score=94.73  Aligned_cols=79  Identities=8%  Similarity=0.088  Sum_probs=58.7

Q ss_pred             eeeee-eccCCeEEEEEEEC--C----CCcEEEEEEcccCh-------HHHHHHHHHHHHhhCC--CCeeEEEEEEEeC-
Q 012170          107 KVEVI-GHGKFGSVWLCRSK--A----SGAEFACKTLRKGE-------ETVHREVEIMQHLSGH--TGVVTLHSVYEEA-  169 (469)
Q Consensus       107 ~~~~l-G~G~~g~Vy~~~~~--~----~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~h--pnIv~l~~~~~~~-  169 (469)
                      .++.| +.|....+|++...  .    ++..+++|+.....       ..+.+|+.+|+.|..+  -.+++++.+..+. 
T Consensus        24 ~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~  103 (357)
T 3ats_A           24 VESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTYRLDHQFEVIRLVGELTDVPVPRVRWIETTGD  103 (357)
T ss_dssp             EEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCCCHHHHHHHHHHHHHHCCSCCCCEEEEECSST
T ss_pred             EEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchhHHHHHHHHHHHHhhcCCCCCCcEEEEccCCC
Confidence            35678 88999999988653  1    25689999876432       4688999999999755  3477888887665 


Q ss_pred             --CeEEEEEeccCCCchH
Q 012170          170 --DCFHLVMELCSGGRLI  185 (469)
Q Consensus       170 --~~~~lV~E~~~gg~L~  185 (469)
                        +..|+||||++|..+.
T Consensus       104 ~~g~~~~v~e~l~G~~l~  121 (357)
T 3ats_A          104 VLGTPFFLMDYVEGVVPP  121 (357)
T ss_dssp             TTSSCEEEEECCCCBCCC
T ss_pred             ccCCceEEEEecCCCChh
Confidence              3567999999986543

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=98.54  E-value=5.7e-07  Score=88.37  Aligned_cols=137  Identities=14%  Similarity=0.192  Sum_probs=86.3

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCC-CCeeEEEE------EEEeCCeEEEEEeccC
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGH-TGVVTLHS------VYEEADCFHLVMELCS  180 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~h-pnIv~l~~------~~~~~~~~~lV~E~~~  180 (469)
                      ++.|+.|..+.||++...  +..+++|+.......+..|+.+++.|..+ -.+++++.      +....+..|+||+|++
T Consensus        37 ~~~l~gG~~n~~~~v~~~--~~~~vlk~~~~~~~~~~~e~~~l~~L~~~g~~vp~~~~~~~g~~~~~~~~~~~~l~~~i~  114 (346)
T 2q83_A           37 IDVIQGNQMALVWKVHTD--SGAVCLKRIHRPEKKALFSIFAQDYLAKKGMNVPGILPNKKGSLYSKHGSFLFVVYDWIE  114 (346)
T ss_dssp             EEECC----CEEEEEEET--TEEEEEEEECSCHHHHHHHHHHHHHHHHHTCSSCCBCCCTTSCSCEEETTEEEEEEECCC
T ss_pred             eeeccccccCcEEEEEeC--CCCEEEEecCCCHHHHHHHHHHHHHHHHcCCCCCceeecCCCCEEEEECCEEEEEEEeec
Confidence            456777789999999764  34599999987666677788888877632 12444443      2245678899999999


Q ss_pred             CCchH--------------HHHHHh-CCC--C-----------HH--------H-----------------------HHH
Q 012170          181 GGRLI--------------DQMVEV-GQY--S-----------EQ--------R-----------------------AAN  201 (469)
Q Consensus       181 gg~L~--------------~~l~~~-~~l--~-----------~~--------~-----------------------~~~  201 (469)
                      |..+.              ..+... ..+  +           ..        .                       +..
T Consensus       115 G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  194 (346)
T 2q83_A          115 GRPFELTVKQDLEFIMKGLADFHTASVGYQPPNGVPIFTKLGRWPNHYTKRCKQMETWKLMAEAEKEDPFSQLYLQEIDG  194 (346)
T ss_dssp             CBCCCTTSHHHHHHHHHHHHHHHHHHTTCCCCTTCCCCBCTTCHHHHHHHHHHHHHHHHHHHHHCSSCHHHHHHHHHHHH
T ss_pred             CccCCCCCHHHHHHHHHHHHHHHHhCCCCCCCccchhcccccchHHHHHHHHHHHHHHHHHHHhccCCcHHHHHHHHHHH
Confidence            86542              111111 111  0           00        0                       111


Q ss_pred             HHHHHHHHHHHHH-------------hcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          202 IFKDVMWVIKYCH-------------DMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       202 i~~qil~aL~yLH-------------~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      +..++..++.+|+             ..+++|+|+++.|||++.++.+.|+||+.+..
T Consensus       195 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~  252 (346)
T 2q83_A          195 FIEDGLRIKDRLLQSTYVPWTEQLKKSPNLCHQDYGTGNTLLGENEQIWVIDLDTVSF  252 (346)
T ss_dssp             HHHHHHHHHHHHHHTTHHHHHHHHHHSCCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred             HHHHHHHHHHHHHhchHHHHHHhccccCceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence            2223344566665             25799999999999998888999999998743

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=98.17  E-value=8.2e-06  Score=83.09  Aligned_cols=70  Identities=13%  Similarity=0.147  Sum_probs=45.5

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEc-------ccC-h---HHHHHHHHHHHHhh--CCCCeeEEEEEEEeCCeEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTL-------RKG-E---ETVHREVEIMQHLS--GHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~-------~~~-~---~~~~~E~~il~~l~--~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ++.||.|..+.||++..  ++..++||..       ... .   .....|.+++..+.  ....+++++.+.  .+..++
T Consensus        39 i~~l~~G~~n~vyrv~~--~~~~~vvK~~~p~~~~~~~~~~~~~~~~~~E~e~l~~~~~~~~~~vP~v~~~~--~~~~~l  114 (420)
T 2pyw_A           39 IKEVGDGNLNFVFIVVG--SSGSLVIKQALPYIRCIGESWPMTKERAYFEATTLRKHGNLSPDHVPEVYHFD--RTMALI  114 (420)
T ss_dssp             EEECCCSSSCEEEEEEC--SSCEEEEEECCSBCTTTCTTSBCCTTHHHHHHHHHHHHHHHSGGGSCCEEEEE--TTTTEE
T ss_pred             EEEccCCCcEEEEEEEc--CCceEEEEECchhhcccCcccccchhHHHHHHHHHHHHHhhCCCCCCeEEEEC--CCccEE
Confidence            57789999999999954  4678999932       111 1   23333444444332  234577777765  456689


Q ss_pred             EEecc-CC
Q 012170          175 VMELC-SG  181 (469)
Q Consensus       175 V~E~~-~g  181 (469)
                      ||||+ +|
T Consensus       115 v~e~l~~g  122 (420)
T 2pyw_A          115 GMRYLEPP  122 (420)
T ss_dssp             EECCCCTT
T ss_pred             EEeecCCc
Confidence            99999 77

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=98.16  E-value=1.2e-05  Score=78.73  Aligned_cols=75  Identities=13%  Similarity=0.187  Sum_probs=61.7

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCC--CCeeEEEEEEEeCCeEEEEEeccCCCch
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGH--TGVVTLHSVYEEADCFHLVMELCSGGRL  184 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~h--pnIv~l~~~~~~~~~~~lV~E~~~gg~L  184 (469)
                      ++.|+.|....||+...  ++..+++|+.... ...+..|+..|+.|..+  ..+++++.+....+..|+||||++|..+
T Consensus        41 ~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~  118 (312)
T 3jr1_A           41 KEKLYSGEMNEIWLIND--EVQTVFVKINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN  118 (312)
T ss_dssp             EEEECCSSSSEEEEEES--SSCEEEEEEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred             eEEeCCccceeeeEEEE--CCCeEEEEeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence            57789999999999875  4678999988643 35688999999999743  5688899988888899999999998754

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=98.06  E-value=1.1e-05  Score=78.29  Aligned_cols=130  Identities=14%  Similarity=0.051  Sum_probs=78.9

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc-CCCc
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC-SGGR  183 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~-~gg~  183 (469)
                      ++.|+.|....+|++      ..+++|+...+..   ...+|+.+++.+..+.-.++++.+.  .+.-++|+||+ +|.+
T Consensus        23 i~~l~gG~tN~~~~~------~~~vlR~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~~~~~--~~~~~~v~e~i~~g~~   94 (301)
T 3dxq_A           23 PLERLGGLTNLVFRA------GDLCLRIPGKGTEEYINRANEAVAAREAAKAGVSPEVLHVD--PATGVMVTRYIAGAQT   94 (301)
T ss_dssp             CEEEESCSSEEEEEE------TTEEEEEECC----CCCHHHHHHHHHHHHHTTSSCCEEEEC--TTTCCEEEECCTTCEE
T ss_pred             eeEcCCcccccccee------eeEEEECCCCCccceeCHHHHHHHHHHHHHcCCCCceEEEE--CCCCEEEEeecCCCcc
Confidence            688999999999999      4689998865422   3467999999887554345666553  33346899999 6655


Q ss_pred             hHHHH------------------HHhC-CC----C-HHHHHHHHHH--------------HHHHHHH----HH----hcC
Q 012170          184 LIDQM------------------VEVG-QY----S-EQRAANIFKD--------------VMWVIKY----CH----DMG  217 (469)
Q Consensus       184 L~~~l------------------~~~~-~l----~-~~~~~~i~~q--------------il~aL~y----LH----~~g  217 (469)
                      +....                  ...+ .+    . ...+..+...              +...+..    |.    ...
T Consensus        95 l~~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~l~~~~~~~~  174 (301)
T 3dxq_A           95 MSPEKFKTRPGSPARAGEAFRKLHGSGAVFPFRFELFAMIDDYLKVLSTKNVTLPAGYHDVVREAGGVRSALAAHPLPLA  174 (301)
T ss_dssp             CCHHHHHHSTTHHHHHHHHHHHHHTSCCCCSSBCCHHHHHHHHHHHHC--CCCCCTTHHHHHHHHHHHHHHHHSSCCCCE
T ss_pred             CCHhhHhhhHHHHHHHHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHhhcCCCchhhHHHHHHHHHHHHHHHHhcCCCce
Confidence            43210                  0001 01    1 1111111111              1111111    11    123


Q ss_pred             eEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          218 VVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       218 ivHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      ++|+|+.|.||+ ..++.+.|+||..+..
T Consensus       175 l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          175 ACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            899999999999 5677899999998864

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=98.03  E-value=1.3e-05  Score=78.16  Aligned_cols=138  Identities=18%  Similarity=0.149  Sum_probs=84.1

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCC-eeEEEEE------EEeCCeEEEEEe
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTG-VVTLHSV------YEEADCFHLVME  177 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpn-Iv~l~~~------~~~~~~~~lV~E  177 (469)
                      -++.|+.|....||++...  +..+++|+...  ....+..|+.+++.|..+.- +++++..      ....+..++||+
T Consensus        26 ~~~~i~~G~~n~~~~v~~~--~g~~vlk~~~~~~~~~~l~~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~g~~~~l~~  103 (322)
T 2ppq_A           26 SYKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS  103 (322)
T ss_dssp             EEEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             EeeccCCCcccceEEEEeC--CccEEEEEeCCCCCHHHHHHHHHHHHHHHHCCCCCCcccCCCCCCEEEEECCEEEEEEE
Confidence            3567888999999998764  23689999876  34678889999999874421 3444421      234567889999


Q ss_pred             ccCCCchHH--------------HHHHh-CCC--------CHHHHHH---------------HHHHHHHHHHHHHh----
Q 012170          178 LCSGGRLID--------------QMVEV-GQY--------SEQRAAN---------------IFKDVMWVIKYCHD----  215 (469)
Q Consensus       178 ~~~gg~L~~--------------~l~~~-~~l--------~~~~~~~---------------i~~qil~aL~yLH~----  215 (469)
                      |++|..+..              .+... ..+        ....-..               +...+...+.+++.    
T Consensus       104 ~l~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~l~~~l~~~~~~l~~~~~~  183 (322)
T 2ppq_A          104 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  183 (322)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             eCCCcCCCCCCHHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhCcc
Confidence            999864310              11111 011        1000000               00113344555552    


Q ss_pred             ---cCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          216 ---MGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       216 ---~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                         .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus       184 ~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~  217 (322)
T 2ppq_A          184 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  217 (322)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             cCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence               4699999999999998876568999998854

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=97.99  E-value=2e-05  Score=77.35  Aligned_cols=136  Identities=16%  Similarity=0.141  Sum_probs=77.8

Q ss_pred             eeeeccCCeE-EEEEEECCCCcEEEEEEcccCh-HHHHHHHHHHHHhhCCC-CeeEEEEEEEeCCeEEEEEeccCCCchH
Q 012170          109 EVIGHGKFGS-VWLCRSKASGAEFACKTLRKGE-ETVHREVEIMQHLSGHT-GVVTLHSVYEEADCFHLVMELCSGGRLI  185 (469)
Q Consensus       109 ~~lG~G~~g~-Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il~~l~~hp-nIv~l~~~~~~~~~~~lV~E~~~gg~L~  185 (469)
                      +.|+.|+... +|+... .+|..+++|...... ..+..|+.+++.|..+. .+++++.+....+  ++|||++.+..+.
T Consensus        24 ~~l~gg~s~~~~~r~~~-~~~~~~vlk~~~~~~~~~~~~e~~~l~~L~~~g~~vP~v~~~d~~~g--~ll~e~l~~~~l~  100 (333)
T 3csv_A           24 TPLAGDASSRRYQRLRS-PTGAKAVLMDWSPEEGGDTQPFVDLAQYLRNLDISAPEIYAEEHARG--LLLIEDLGDALFT  100 (333)
T ss_dssp             CC--------CCEEEEC-TTCCEEEEEECCTTTTCCSHHHHHHHHHHHHTTCBCCCEEEEETTTT--EEEECCCCSCBHH
T ss_pred             eECCCCCCCceEEEEEc-CCCCeEEEEECCCCCCccccHHHHHHHHHHhCCCCCCceeeecCCCC--EEEEeeCCCcchH
Confidence            4565555544 666643 236678888765544 56788999999887543 2566776643333  6899999776654


Q ss_pred             HHHHHh--------------------------CCCCHHHHH-------HHH-------------HHHHHHHHHH------
Q 012170          186 DQMVEV--------------------------GQYSEQRAA-------NIF-------------KDVMWVIKYC------  213 (469)
Q Consensus       186 ~~l~~~--------------------------~~l~~~~~~-------~i~-------------~qil~aL~yL------  213 (469)
                      +.+...                          ..+......       .+.             ..+...+..+      
T Consensus       101 ~~l~~~~~~~~~~~~~~~~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~l~~~~~~  180 (333)
T 3csv_A          101 EVINNDPAQEMPLYRAAVDLLIHLHDAQTPELARLDPETLSEMTRLAFSEYRYAILGDAAEDNRKRFEHRFAQILSAQLE  180 (333)
T ss_dssp             HHHHHCGGGHHHHHHHHHHHHHHHHTSCCCCCCBCCHHHHHHTTTHHHHTHHHHHHSSCCHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHhcCCCccHHHHHHHHHHHHHHHhcCCCccCCccCHHHHHHHHHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHHhccc
Confidence            433210                          012221110       000             0111122223      


Q ss_pred             HhcCeEeccCCCCcEEEccC----CcEEEEeccceeee
Q 012170          214 HDMGVVHRDIKPENILLTTS----GKIKLADFGLAMRI  247 (469)
Q Consensus       214 H~~givHrDlkp~NILl~~~----~~vkL~DFgla~~~  247 (469)
                      +...++|+|+.+.|||++.+    +.+.|+||+.+...
T Consensus       181 ~~~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G  218 (333)
T 3csv_A          181 GDMVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG  218 (333)
T ss_dssp             SCCEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred             CCCeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence            23469999999999999875    67999999998654

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=97.93  E-value=2.5e-05  Score=78.36  Aligned_cols=135  Identities=16%  Similarity=0.171  Sum_probs=87.8

Q ss_pred             eeeeeccCCeEEEEEEECC-------CCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          108 VEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      ++.|..|-...+|++....       ++..|++|+...   ....+.+|..+++.|..+.-.+++++++.+    .+|||
T Consensus        55 v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~~~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e  130 (379)
T 3feg_A           55 VYPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAILQGVDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQ  130 (379)
T ss_dssp             CEEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC---CCHHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEE
T ss_pred             EEEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCccchHHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEE
Confidence            4677788889999998642       357899999743   345677999999999866556778777654    28999


Q ss_pred             ccCCCchHH----------HH----HH---h-----CCC--CHHHHHHHHHHHHH-------------------HHHHHH
Q 012170          178 LCSGGRLID----------QM----VE---V-----GQY--SEQRAANIFKDVMW-------------------VIKYCH  214 (469)
Q Consensus       178 ~~~gg~L~~----------~l----~~---~-----~~l--~~~~~~~i~~qil~-------------------aL~yLH  214 (469)
                      |++|..|..          .+    .+   .     +..  -...+..++.++-.                   .+..|.
T Consensus       131 ~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~  210 (379)
T 3feg_A          131 YIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLR  210 (379)
T ss_dssp             CCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHH
T ss_pred             EecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHH
Confidence            999865421          11    11   0     011  23556666554422                   233332


Q ss_pred             ----h----cCeEeccCCCCcEEEccC----CcEEEEeccceee
Q 012170          215 ----D----MGVVHRDIKPENILLTTS----GKIKLADFGLAMR  246 (469)
Q Consensus       215 ----~----~givHrDlkp~NILl~~~----~~vkL~DFgla~~  246 (469)
                          .    ..++|+|+.+.|||++.+    +.+.|+||..+..
T Consensus       211 ~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          211 KLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             HHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             HHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence                2    259999999999999886    7899999999854

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=97.92  E-value=3.5e-05  Score=78.73  Aligned_cols=74  Identities=16%  Similarity=0.173  Sum_probs=55.5

Q ss_pred             eeeeeeccCCeEEEEEEECC-------CCcEEEEEEccc-Ch-HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          107 KVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRK-GE-ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~-~~-~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++.|+.|....||++....       ++..|++|+... .. ..+.+|..+++.|..+.-.+++++.+.+    .+|+|
T Consensus        77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~~~~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e  152 (429)
T 1nw1_A           77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  152 (429)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCCcHHHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEE
Confidence            35778899999999998653       357899999854 33 6677899999999855545777776643    28999


Q ss_pred             ccCCCch
Q 012170          178 LCSGGRL  184 (469)
Q Consensus       178 ~~~gg~L  184 (469)
                      |++|..|
T Consensus       153 ~l~G~~l  159 (429)
T 1nw1_A          153 YIPSRPL  159 (429)
T ss_dssp             CCCEEEC
T ss_pred             EeCCccc
Confidence            9987443

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.84  E-value=0.00015  Score=66.27  Aligned_cols=122  Identities=20%  Similarity=0.144  Sum_probs=82.0

Q ss_pred             CchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHH-hcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccccCCC
Q 012170          182 GRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCH-DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS  259 (469)
Q Consensus       182 g~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH-~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt  259 (469)
                      .+|.++|... .+++|+++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|-+.+ +.+.           ...
T Consensus        33 vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~-----------~~~  100 (229)
T 2yle_A           33 LSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD-----------AGE  100 (229)
T ss_dssp             EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C-----------------
T ss_pred             ccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc-----------ccc
Confidence            3788888654 58999999999999999987662 11212334557899999999988774 2110           122


Q ss_pred             CcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchh
Q 012170          260 PAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTR  336 (469)
Q Consensus       260 ~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~  336 (469)
                      ..+.|||......+.+.=|||||+++|.-+--..|                     ...-..+|+++..||..|..-
T Consensus       101 ~~~~~pe~~~~~~te~~~IysLG~tLY~ALDygL~---------------------e~eE~eLS~~LE~LL~~Mt~~  156 (229)
T 2yle_A          101 PPPVAGKLGYSQCMETEVIESLGIIIYKALDYGLK---------------------ENEERELSPPLEQLIDHMANT  156 (229)
T ss_dssp             ------CCSSSSSCHHHHHHHHHHHHHHHHTTTCC---------------------TTEEECCCHHHHHHHHHHTTC
T ss_pred             cCCCChhhccccchHHHHHHHHHHHHHHHhhcCCC---------------------cccchhhCHHHHHHHHHHHhc
Confidence            34668887754556778899999999998853322                     223357899999999999755

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=97.79  E-value=7e-05  Score=74.66  Aligned_cols=73  Identities=16%  Similarity=0.130  Sum_probs=48.9

Q ss_pred             eeeeeccCCeEEEEEEECC--------CCcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKA--------SGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~--------~~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++.|+.|....||++....        .+..+++|+......   ....|..+++.|..+.-+++++..+  .+  ++||
T Consensus        38 ~~~l~~G~~N~~y~v~~~~~~~~~~~~~~~~~vlRi~~~~~~~~~~~~~E~~~l~~L~~~g~~P~~~~~~--~~--~~v~  113 (369)
T 3c5i_A           38 VKQILSGLTNQLFEVGLKEETANNYNSIRTRVLFRIYGKHVDELYNTISEFEVYKTMSKYKIAPQLLNTF--NG--GRIE  113 (369)
T ss_dssp             EEEC----CCEEEEEEECHHHHTTCTTSCCEEEEEECCTTGGGTSCHHHHHHHHHHHHHTTSSCCEEEEE--TT--EEEE
T ss_pred             EEEeCCcccceEEEEEeCCCCcccccCCCceEEEEecCCCccceecHHHHHHHHHHHHhcCCCCceEEec--CC--cEEE
Confidence            4678888889999997653        136899999865433   2468999999997554355777654  22  5899


Q ss_pred             eccCCCch
Q 012170          177 ELCSGGRL  184 (469)
Q Consensus       177 E~~~gg~L  184 (469)
                      ||++|..+
T Consensus       114 e~i~G~~l  121 (369)
T 3c5i_A          114 EWLYGDPL  121 (369)
T ss_dssp             ECCCSEEC
T ss_pred             EEecCCcC
Confidence            99988543

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=97.78  E-value=8.9e-05  Score=72.36  Aligned_cols=134  Identities=14%  Similarity=0.158  Sum_probs=82.4

Q ss_pred             eeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCC-CeeEEEEE-----EEeCCeEEEEEecc
Q 012170          109 EVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHT-GVVTLHSV-----YEEADCFHLVMELC  179 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hp-nIv~l~~~-----~~~~~~~~lV~E~~  179 (469)
                      ..|+ |....||++... +|..+++|+...   ....+..|..+++.|..+. .+++++..     ....+..++||+++
T Consensus        32 ~~l~-g~~n~~y~v~~~-~g~~~vlK~~~~~~~~~~~~~~E~~~~~~L~~~g~~vp~~~~~~g~~~~~~~g~~~~l~~~i  109 (328)
T 1zyl_A           32 TPLN-SYENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSV  109 (328)
T ss_dssp             EEEC-CSSSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECC
T ss_pred             Eeec-CcccceEEEEcC-CCCEEEEEEcCCCCCCHHHHHHHHHHHHHHHHcCCeecceeecCCcEEEEECCEEEEEEEec
Confidence            4566 888899987543 466899999863   3567888999999987432 14444443     23456778999999


Q ss_pred             CCCchH----HH----------HHHh---C------CCCHHHH----------------------HHHHHHHHHHHHHH-
Q 012170          180 SGGRLI----DQ----------MVEV---G------QYSEQRA----------------------ANIFKDVMWVIKYC-  213 (469)
Q Consensus       180 ~gg~L~----~~----------l~~~---~------~l~~~~~----------------------~~i~~qil~aL~yL-  213 (469)
                      +|..+.    +.          +...   .      .++....                      ...+.+++..+.-+ 
T Consensus       110 ~G~~~~~~~~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~~  189 (328)
T 1zyl_A          110 GGRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHW  189 (328)
T ss_dssp             CCEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHC
T ss_pred             CCCCCCCCCHHHHHHHHHHHHHHHHhhccCCCccCCCCCHHHHHhhHHHHHhhcCcCCHHHHHHHHHHHHHHHHHHHHHh
Confidence            885431    11          1110   0      1111110                      11111222222211 


Q ss_pred             ---HhcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          214 ---HDMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       214 ---H~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                         ....++|+|+++.|||++ + .+.|+||+.+..
T Consensus       190 ~~~~~~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          190 REDFTVLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CSCSCCEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             hhcCCeeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence               234589999999999998 4 899999998854

>3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX}

Probab=97.76  E-value=0.00035  Score=66.98  Aligned_cols=75  Identities=16%  Similarity=0.113  Sum_probs=55.0

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCC--CeeEEEEEEEeCCeEEEEEec
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHT--GVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hp--nIv~l~~~~~~~~~~~lV~E~  178 (469)
                      ..-++.+|.|..+.||++... +|+.|.+|+....    ...+..|+..|+.|....  -+++++.+  +.  -++||||
T Consensus        17 v~~v~~~g~G~~~~vyrv~l~-DG~~~~vK~~~~~~~~~~~~~~~Ea~~L~~L~~~~~vpvP~v~~~--~~--~~lv~e~   91 (288)
T 3f7w_A           17 VAAVAERGHSHRWHLYRVELA-DGTPLFVKALPDDAPALDGLFRAEALGLDWLGRSFGSPVPQVAGW--DD--RTLAMEW   91 (288)
T ss_dssp             EEEEEEEEEETTEEEEEEEET-TSCEEEEEECCTTCCCCTTHHHHHHHHHHHHTCSTTCCSCCEEEE--ET--TEEEEEC
T ss_pred             eEEEEecCCCCCeEEEEEEEC-CCCEEEEEEeCCCCcchhhHHHHHHHHHHHHHhhCCCCcceEEec--cC--ceEEEEe
Confidence            345688999999999999865 6899999987532    246789999999996432  24555554  22  2589999


Q ss_pred             cCCCch
Q 012170          179 CSGGRL  184 (469)
Q Consensus       179 ~~gg~L  184 (469)
                      +.++..
T Consensus        92 l~~~~~   97 (288)
T 3f7w_A           92 VDERPP   97 (288)
T ss_dssp             CCCCCC
T ss_pred             ecccCC
Confidence            987654

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=97.56  E-value=0.00019  Score=73.81  Aligned_cols=74  Identities=14%  Similarity=0.159  Sum_probs=52.6

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCc
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~  183 (469)
                      .++.|+.|-...+|++.....+..|++|+......   +..+|..+|+.|..+.-.+++++++.  +.  +||||++|..
T Consensus       112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~~~~idR~~E~~vl~~L~~~gl~P~ll~~~~--~G--~v~e~I~G~~  187 (458)
T 2qg7_A          112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKTDEIINREREKKISCILYNKNIAKKIYVFFT--NG--RIEEFMDGYA  187 (458)
T ss_dssp             EEEEECC--CEEEEEEEETTTTEEEEEEEECC-CCSCSCHHHHHHHHHHHTTSSSBCCEEEEET--TE--EEEECCCSEE
T ss_pred             EEEEcCCCeEeEEEEEEECCCCceEEEEECCCChhhhcCHHHHHHHHHHHHhcCCCCCEEEEeC--Ce--EEEEeeCCcc
Confidence            45788999999999998765457899998854322   23689999999985544567887773  22  5999998854


Q ss_pred             h
Q 012170          184 L  184 (469)
Q Consensus       184 L  184 (469)
                      |
T Consensus       188 l  188 (458)
T 2qg7_A          188 L  188 (458)
T ss_dssp             C
T ss_pred             C
Confidence            4

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=97.53  E-value=0.00031  Score=69.25  Aligned_cols=69  Identities=9%  Similarity=-0.007  Sum_probs=47.4

Q ss_pred             eccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCC--CCeeEEEEE------EEeCCeEEEEEeccCCCc
Q 012170          112 GHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGH--TGVVTLHSV------YEEADCFHLVMELCSGGR  183 (469)
Q Consensus       112 G~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~h--pnIv~l~~~------~~~~~~~~lV~E~~~gg~  183 (469)
                      |.|....||++... +| .+++|+.....  ...|+.+++.|..+  |++++++..      ....+..++||+|++|..
T Consensus        32 G~g~~N~vy~v~~~-~g-~~vLK~~~~~~--~~~E~~~l~~L~~~g~~~vp~pi~~~~G~~~~~~~g~~~~l~~~i~G~~  107 (339)
T 3i1a_A           32 GADTNAFAYQADSE-SK-SYFIKLKYGYH--DEINLSIIRLLHDSGIKEIIFPIHTLEAKLFQQLKHFKIIAYPFIHAPN  107 (339)
T ss_dssp             TSCSSCEEEEEECS-SC-EEEEEEEECSS--CCHHHHHHHHHHHTTCCSSCCCCCCTTSCSSEECSSEEEEEEECCCCCB
T ss_pred             cCccccceEEEEeC-CC-CEEEEEecCcc--chHHHHHHHHHHhcCCcccccceecCCCCEEEEECCEEEEEEeccCCCc
Confidence            34446899999754 35 89999886543  35788888888633  324555432      344678899999999876


Q ss_pred             h
Q 012170          184 L  184 (469)
Q Consensus       184 L  184 (469)
                      +
T Consensus       108 ~  108 (339)
T 3i1a_A          108 G  108 (339)
T ss_dssp             T
T ss_pred             C
Confidence            5

>3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum}

Probab=96.99  E-value=0.0044  Score=62.94  Aligned_cols=74  Identities=14%  Similarity=0.156  Sum_probs=53.8

Q ss_pred             eeeeeeccCCeEEEEEEECCC-------CcEEEEEEcccChH---HHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          107 KVEVIGHGKFGSVWLCRSKAS-------GAEFACKTLRKGEE---TVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~-------~~~vAvK~~~~~~~---~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++.|..|-...+|++.....       +..|++++.....+   +..+|..+++.|..+.-.+++++.+.  +  ++||
T Consensus        74 ~v~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlRi~g~~t~~~idR~~E~~~l~~L~~~gi~P~l~~~~~--~--~~I~  149 (424)
T 3mes_A           74 EVKQIFSGLTNQLFVVSIVNESMSLSLKHPRILFRIYGKHVGKFYDSKVELDVFRYLSNINIAPNIIADFP--E--GRIE  149 (424)
T ss_dssp             EEEEECCCSSSEEEEEEECCC-----CCCSEEEEEECCCCC-CCCCHHHHHHHHHHHHHTTSSCCEEEEET--T--EEEE
T ss_pred             EEEEcCCCcccceEEEEeCCCcccccCCCCeEEEEECCCCcchhcCHHHHHHHHHHHHhcCCCCCEEEEcC--C--CEEE
Confidence            356788888999999987521       57899999755332   35689999999986655667776442  2  6899


Q ss_pred             eccCCCch
Q 012170          177 ELCSGGRL  184 (469)
Q Consensus       177 E~~~gg~L  184 (469)
                      ||++|..|
T Consensus       150 efI~G~~l  157 (424)
T 3mes_A          150 EFIDGEPL  157 (424)
T ss_dssp             ECCCSEEC
T ss_pred             EEeCCccC
Confidence            99998653

>3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A*

Probab=95.91  E-value=0.033  Score=55.93  Aligned_cols=29  Identities=34%  Similarity=0.496  Sum_probs=25.0

Q ss_pred             eEeccCCCCcEEE------ccCCcEEEEeccceee
Q 012170          218 VVHRDIKPENILL------TTSGKIKLADFGLAMR  246 (469)
Q Consensus       218 ivHrDlkp~NILl------~~~~~vkL~DFgla~~  246 (469)
                      ++|+|+.+.|||+      ++++.+.++||..|..
T Consensus       246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~  280 (401)
T 3g15_A          246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY  280 (401)
T ss_dssp             EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred             eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence            7899999999999      3456799999999854

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=90.74  E-value=0.025  Score=45.00  Aligned_cols=24  Identities=4%  Similarity=-0.033  Sum_probs=12.5

Q ss_pred             cCCCCcccccccccccCHHHHhhh
Q 012170          445 LCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       445 l~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +..-+..+|.|++|.|+.+|++++
T Consensus        74 i~~l~~~~D~d~dG~I~~~EF~~~   97 (100)
T 2lv7_A           74 LEVIIQRLDMDGDGQVDFEEFVTL   97 (100)
T ss_dssp             HHHHHHHHCSSCSSSBCHHHHHHH
T ss_pred             HHHHHHHHCCCCCCeEeHHHHHHH
Confidence            333445555555555555555544

>2lhi_A Calmodulin, serine/threonine-protein phosphatase catalytic subunit A1; yeast calmodulin, CNA1, metal binding protein; NMR {Saccharomyces cerevisiae}

Probab=89.49  E-value=0.042  Score=48.25  Aligned_cols=29  Identities=10%  Similarity=0.111  Sum_probs=24.5

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ....|..+|+.||.|++|+|+++||.++|
T Consensus        82 ~~~~l~~aF~~fD~d~~G~I~~~el~~~l  110 (176)
T 2lhi_A           82 SEQELLEAFKVFDKNGDGLISAAELKHVL  110 (176)
T ss_dssp             HHHHHHHHHHHHCSSCSSSBCHHHHHHHH
T ss_pred             cHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            34568889999999999999999998764

>1s6j_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=88.49  E-value=0.074  Score=40.18  Aligned_cols=24  Identities=8%  Similarity=0.026  Sum_probs=11.9

Q ss_pred             cCCCCcccccccccccCHHHHhhh
Q 012170          445 LCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       445 l~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +...+..+|.+++|.|+.+|++.+
T Consensus        61 ~~~l~~~~d~~~~g~i~~~eF~~~   84 (87)
T 1s6j_A           61 IKDLMDAADIDKSGTIDYGEFIAA   84 (87)
T ss_dssp             HHHHHHHHCTTCSSEECHHHHTTC
T ss_pred             HHHHHHHhCCCCCCcCcHHHHHHH
Confidence            333444555555555555555443

>3h4s_E KCBP interacting Ca2+-binding protein; kinesin, motor protein, regulation, complex, calcium, EF- hand, calmodulin, ATP-binding, microtubule; HET: ADP; 2.40A {Arabidopsis thaliana}

Probab=88.40  E-value=0.023  Score=47.55  Aligned_cols=25  Identities=24%  Similarity=0.288  Sum_probs=15.1

Q ss_pred             ccCCCCcccccccccccCHHHHhhh
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      .+..+|..||.|++|+|+.+||.++
T Consensus        41 ~l~~~F~~~D~d~~G~I~~~el~~~   65 (135)
T 3h4s_E           41 ELCKGFSLLADPERHLITAESLRRN   65 (135)
T ss_dssp             HHHHHHHHHSBTTTTBBCHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCcCCHHHHHHH
Confidence            3455666666666666666666554

>2lmt_A Calmodulin-related protein 97A; spermatogenesis, metal binding protein; NMR {Drosophila melanogaster} PDB: 2lmu_A 2lmv_A

Probab=88.13  E-value=0.042  Score=46.47  Aligned_cols=29  Identities=3%  Similarity=0.016  Sum_probs=23.6

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ....|..+|..||.|++|+|+++||.++|
T Consensus        81 ~~~~l~~aF~~~D~d~~G~I~~~El~~~l  109 (148)
T 2lmt_A           81 TEEEMREAFKIFDRDGDGFISPAELRFVM  109 (148)
T ss_dssp             THHHHHHHHHHHHSSCSSEECHHHHHHHH
T ss_pred             cHHHHHHHHHHHCCCCcCcCcHHHHHHHH
Confidence            34567788999999999999999988763

>1yx7_A Calsensin, LAN3-6 antigen; calcium-binding protein EF-hand, helix-loop- helix, nervous system, metal binding protein; NMR {Haemopis marmorata} PDB: 1yx8_A

Probab=87.78  E-value=0.06  Score=40.30  Aligned_cols=30  Identities=13%  Similarity=0.081  Sum_probs=25.9

Q ss_pred             ccccccCCCCcccccccccccCHHHHhhhC
Q 012170          440 PKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       440 ~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ....++...|..+|.|++|.|+.+||..++
T Consensus         4 ~~~~~l~~~F~~~D~d~~G~i~~~el~~~l   33 (83)
T 1yx7_A            4 KVKAELEAAFKKLDANGDGYVTALELQTFM   33 (83)
T ss_dssp             CSCTHHHHHHHHHSSSCSSSCSHHHHHHHH
T ss_pred             cHHHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence            356678889999999999999999998763

>4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid}

Probab=87.66  E-value=1.2  Score=40.49  Aligned_cols=83  Identities=10%  Similarity=0.035  Sum_probs=63.1

Q ss_pred             CCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHH-HHHhcCeEeccCCCCcEEEccC
Q 012170          155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK-YCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       155 ~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~-yLH~~givHrDlkp~NILl~~~  233 (469)
                      .||++  -..+-.+++.+.+.++.-+++.-+..+   ..++....++++.+|+.... ++  ..-+|--|+|+||+++.+
T Consensus        48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f~~~  120 (219)
T 4ano_A           48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMFNRA  120 (219)
T ss_dssp             SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEECTT
T ss_pred             cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEEeCC
Confidence            48888  555557888888888776555444444   46788889999999888766 44  345777899999999999


Q ss_pred             CcEEEEeccce
Q 012170          234 GKIKLADFGLA  244 (469)
Q Consensus       234 ~~vkL~DFgla  244 (469)
                      +.++|.-.|+-
T Consensus       121 ~~p~i~hRGi~  131 (219)
T 4ano_A          121 LEPFFLHVGVK  131 (219)
T ss_dssp             CCEEESCCEET
T ss_pred             CcEEEEEcCCc
Confidence            99999977764

>3pm8_A PFCDPK2, calcium-dependent protein kinase 2; malaria, structural genomics, structural genomics CONS SGC; 2.00A {Plasmodium falciparum K1}

Probab=87.43  E-value=0.03  Score=50.09  Aligned_cols=42  Identities=21%  Similarity=0.216  Sum_probs=31.1

Q ss_pred             HHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          426 DALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       426 ~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +|+++........  .++++..+|..+|.|++|+|+.+||.++|
T Consensus       114 EF~~~~~~~~~~~--~~~~l~~~F~~~D~d~~G~Is~~El~~~l  155 (197)
T 3pm8_A          114 DFLAATIDKQTYL--KKEVCLIPFKFFDIDGNGKISVEELKRIF  155 (197)
T ss_dssp             HHHHTTCCHHHHC--SHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred             HHHHHHHHHHhhh--hHHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            3655554443333  55678889999999999999999998764

>3i5g_B Myosin regulatory light chain LC-2, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_B 3i5h_B 3i5i_B

Probab=87.18  E-value=0.089  Score=45.00  Aligned_cols=45  Identities=11%  Similarity=0.064  Sum_probs=31.1

Q ss_pred             hHHHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          424 FVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       424 ~~~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.+|+.......... .....|..+|+.||.|++|+|+++||.++|
T Consensus        67 f~ef~~~~~~~~~~~-~~~~~l~~aF~~fD~d~~G~I~~~el~~~l  111 (153)
T 3i5g_B           67 FTAFLTLFGEKVSGT-DPEDALRNAFSMFDEDGQGFIPEDYLKDLL  111 (153)
T ss_dssp             SHHHHHTTTTTTTTC-CCHHHHHHHHHTTCSSCSSCCCHHHHHHHH
T ss_pred             HHHHHHHHHhhhccc-ccHHHHHHHHhccccCCCCeEeHHHHHHHH
Confidence            334554443333222 234568889999999999999999998864

>3i5g_C Myosin catalytic light chain LC-1, mantle muscle; rigor-like, squid, muscle myosin, contractIle protein; 2.60A {Todarodes pacificus} PDB: 3i5f_C 3i5h_C 3i5i_C

Probab=86.73  E-value=0.086  Score=45.41  Aligned_cols=28  Identities=0%  Similarity=0.094  Sum_probs=24.3

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...|..+|+.||.|++|+|+++||.++|
T Consensus        84 ~~~l~~aF~~fD~d~~G~I~~~el~~~l  111 (159)
T 3i5g_C           84 ADEFMEAFKTFDREGQGLISSAEIRNVL  111 (159)
T ss_dssp             HHHHHHHHHHHCTTSSSEECHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCcHHHHHHHH
Confidence            4457889999999999999999998874

>3a4u_B Multiple coagulation factor deficiency protein 2; lectin, ergic, ER, golgi, transport, disulfide bond, endopla reticulum, ER-golgi transport; 1.84A {Homo sapiens} PDB: 2vrg_A 3lcp_C

Probab=85.80  E-value=0.077  Score=44.86  Aligned_cols=27  Identities=11%  Similarity=-0.128  Sum_probs=23.4

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..+...|..+|.|++|+|+.+||.+++
T Consensus        68 ~~l~~~F~~~D~d~dG~I~~~El~~~l   94 (143)
T 3a4u_B           68 ELQLHYFKMHDYDGNNLLDGLELSTAI   94 (143)
T ss_dssp             HHHHHHHHHTCTTCSSCEEHHHHHHTC
T ss_pred             HHHHHHHHHhCCCCCCccCHHHHHHHH
Confidence            446667999999999999999998875

>2lv7_A Calcium-binding protein 7; metal binding protein; NMR {Homo sapiens}

Probab=84.89  E-value=0.17  Score=40.00  Aligned_cols=29  Identities=7%  Similarity=0.079  Sum_probs=24.7

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +...|..+|..||.|++|+|+.+||+++|
T Consensus        34 ~~~el~~~F~~~D~d~~G~I~~~El~~~l   62 (100)
T 2lv7_A           34 ELEEIREAFKVFDRDGNGFISKQELGTAM   62 (100)
T ss_dssp             GHHHHHHHHHHTCSSCSSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCcCCHHHHHHHH
Confidence            34457779999999999999999999874

>1iq3_A Ralbp1-interacting protein (partner of ralbp1); EF-hand domain, POB1 EH domain, riken structural genomics/proteomics initiative, RSGI; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=84.88  E-value=0.092  Score=42.41  Aligned_cols=21  Identities=24%  Similarity=0.388  Sum_probs=11.9

Q ss_pred             CCcccccccccccCHHHHhhh
Q 012170          448 PSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       448 ~~~~~d~~~~~~~~~~el~~~  468 (469)
                      -+..+|.|++|.|+.+|++.+
T Consensus        61 i~~~~D~d~dG~I~~~EF~~~   81 (110)
T 1iq3_A           61 IWELSDADCDGALTLPEFCAA   81 (110)
T ss_dssp             HHHHHCSSSCSEEEHHHHHHH
T ss_pred             HHHHHcCCCCCcCcHHHHHHH
Confidence            344455566666666666554

>2b1u_A Calmodulin-like protein 5; CLSP, calmodulin-like SKIN protein, solution structure, backbone dynamic, structural genomics; NMR {Homo sapiens}

Probab=84.39  E-value=0.09  Score=37.84  Aligned_cols=28  Identities=21%  Similarity=0.220  Sum_probs=20.5

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..++...|..+|.+++|.|+.+||..++
T Consensus         5 ~~~l~~~F~~~D~d~~G~i~~~el~~~l   32 (71)
T 2b1u_A            5 LEDLQVAFRAFDQDGDGHITVDELRRAM   32 (71)
T ss_dssp             HHHHHHHHTTSCCSSSSEEEHHHHHHHG
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence            3456667778888888888888887653

>1fi6_A EH domain protein REPS1; EPS15 homology domain, EF hand, calcium, RAS signal transduction, endocytosis/exocytosis complex; NMR {Mus musculus} SCOP: a.39.1.6

Probab=84.30  E-value=0.066  Score=41.54  Aligned_cols=27  Identities=11%  Similarity=0.044  Sum_probs=17.7

Q ss_pred             ccccCCCCcccccccccccCHHHHhhh
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +.++..+|..||.|++|+|+.+||..+
T Consensus         8 ~~~~~~~F~~~D~d~dG~I~~~el~~~   34 (92)
T 1fi6_A            8 RQYYVNQFKTIQPDLNGFIPGSAAKEF   34 (92)
T ss_dssp             HHHHHHHHTTTCCSTTCEEEHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHH
Confidence            334555677777777777777777655

>2l4h_A Calcium and integrin-binding protein 1; metal binding protei; NMR {Homo sapiens} PDB: 2l4i_A 2lm5_A

Probab=84.25  E-value=0.11  Score=46.95  Aligned_cols=29  Identities=10%  Similarity=-0.010  Sum_probs=25.5

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...++..+|..+|.|++|+|+.+||.+++
T Consensus       127 ~~~~l~~~F~~~D~d~dG~Is~~El~~~l  155 (214)
T 2l4h_A          127 PDIKSHYAFRIFDFDDDGTLNREDLSRLV  155 (214)
T ss_dssp             HHHHHHHHHHHHCTTCSSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence            45678889999999999999999998763

>3k21_A PFCDPK3, calcium-dependent protein kinase 3; calcium kinase structural genomics malaria, structural genom consortium, SGC, ATP-binding; 1.15A {Plasmodium falciparum} PDB: 3o4y_A

Probab=83.53  E-value=0.13  Score=45.51  Aligned_cols=49  Identities=14%  Similarity=0.205  Sum_probs=34.0

Q ss_pred             cccccchHH---HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          418 VQDEGGFVD---ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       418 ~~~~~g~~~---~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.+..|.|+   |+...+....   .....+..+|..+|.|++|.|+.+||.+++
T Consensus        97 D~d~~g~i~~~EF~~~~~~~~~---~~~~~l~~~F~~~D~d~~G~Is~~El~~~l  148 (191)
T 3k21_A           97 DSDGSGKIDYTEFIAAALDRKQ---LSKKLIYCAFRVFDVDNDGEITTAELAHIL  148 (191)
T ss_dssp             CTTCSSSEEHHHHHHHHSCGGG---CCHHHHHHHHHHHSTTCSSCBCHHHHHHHH
T ss_pred             CCCCCCeEeHHHHHHHHHhhhh---ccHHHHHHHHHHhCCCCCCcCCHHHHHHHH
Confidence            334444443   5555444332   245678889999999999999999998864

>1c07_A Protein (epidermal growth factor receptor pathway substrate 15); calcium binding, signaling domain, NPF binding, FW binding, EF-hand, EH domain; NMR {Homo sapiens} SCOP: a.39.1.6

Probab=83.49  E-value=0.078  Score=41.42  Aligned_cols=29  Identities=3%  Similarity=0.022  Sum_probs=21.1

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ++.++..+|..||.|++|+|+.+||..+|
T Consensus         8 ~~~~~~~~F~~~D~d~dG~I~~~el~~~l   36 (95)
T 1c07_A            8 EKAKYDEIFLKTDKDMDGFVSGLEVREIF   36 (95)
T ss_dssp             HHHHHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence            34456667888888888888888887653

>1ij5_A Plasmodial specific LAV1-2 protein; fourty kDa calcium binding protein, CBP40, metal binding protein; 3.00A {Physarum polycephalum} SCOP: a.39.1.9 PDB: 1ij6_A

Probab=83.46  E-value=0.048  Score=53.09  Aligned_cols=42  Identities=10%  Similarity=0.102  Sum_probs=29.4

Q ss_pred             cccCCCHHHHHHHHHhc---hhhhcCCCCHHHHHcC------CCccccccc
Q 012170          318 VWETVSKPARDLMARML---TRDVSARITADEVLRH------PWILFYTER  359 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L---~~dP~~Rpsa~elL~h------p~~~~~~~~  359 (469)
                      .|..++.++.+|.++++   ..+|..|...++.+.|      +|+..+..+
T Consensus        13 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~   63 (323)
T 1ij5_A           13 NVKKVHENLEELQKKLDHTSFAHKEDRDRLEAQIAQKEQEQKAKLAEYDQK   63 (323)
T ss_dssp             HHHHHHHHHHHHHHHHTTCCCC-----CCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            34567889999999998   8999999999999998      887555433

>2kyc_A Parvalbumin-3, parvalbumin, thymic CPV3; EF-hand protein, calcium binding protein; NMR {Gallus gallus} PDB: 2kyf_A

Probab=82.74  E-value=0.36  Score=37.90  Aligned_cols=29  Identities=14%  Similarity=0.039  Sum_probs=23.5

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...++..+|..+|.|++|+|+.+||.+++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l   67 (108)
T 2kyc_A           39 SSSQLKEIFRILDNDQSGFIEEDELKYFL   67 (108)
T ss_dssp             CSSSHHHHCSSSCSCCSSCCCGGGTTTSH
T ss_pred             cHHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence            45677778999999999999999887653

>2obh_A Centrin-2; DNA repair complex EF hand superfamily protein-peptide compl cycle; 1.80A {Homo sapiens} SCOP: a.39.1.5 PDB: 3kf9_A 1m39_A 2a4j_A 2k2i_A 1oqp_A

Probab=82.45  E-value=0.067  Score=44.75  Aligned_cols=28  Identities=7%  Similarity=0.109  Sum_probs=22.8

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...+..+|+.+|.|++|+|+.+||.+++
T Consensus        78 ~~~l~~~F~~~D~d~~G~I~~~el~~~l  105 (143)
T 2obh_A           78 KEEILKAFKLFDDDETGKISFKNLKRVA  105 (143)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            3457778999999999999999998763

>1c7v_A CAVP, calcium vector protein; EF-hand family, calcium binding protein, metal binding protein; NMR {Branchiostoma lanceolatum} SCOP: a.39.1.5 PDB: 1c7w_A

Probab=82.27  E-value=0.14  Score=38.10  Aligned_cols=27  Identities=4%  Similarity=-0.059  Sum_probs=21.0

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..++. +|..+|.|++|.|+.+||+.++
T Consensus         8 ~~~l~-~F~~~D~d~~G~i~~~el~~~l   34 (81)
T 1c7v_A            8 EEILR-AFKVFDANGDGVIDFDEFKFIM   34 (81)
T ss_dssp             HHHHH-HHHHHSCSGGGEECHHHHHHHS
T ss_pred             HHHHH-HHHHHCCCCCCcCCHHHHHHHH
Confidence            44577 7888888888888888887764

>1qjt_A EH1, epidermal growth factor receptor substrate substrate 15, EPS15; EH domain, EF-hand, solution structure, S100 protein; NMR {Mus musculus} SCOP: a.39.1.6

Probab=82.23  E-value=0.12  Score=40.88  Aligned_cols=29  Identities=7%  Similarity=-0.098  Sum_probs=21.8

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +..++..+|..||.|++|+|+.+|+.++|
T Consensus         9 ~~~~~~~~F~~~D~d~dG~Is~~el~~~l   37 (99)
T 1qjt_A            9 GNPVYEKYYRQVEAGNTGRVLALDAAAFL   37 (99)
T ss_dssp             TCTHHHHHHHHHCCTTSSCCCSHHHHHHH
T ss_pred             hHHHHHHHHHHHCCCCCCcCCHHHHHHHH
Confidence            34556677888888888888888887653

>1tiz_A Calmodulin-related protein, putative; helix-turn-helix, structural genomics, protein structure initiative; NMR {Arabidopsis thaliana} SCOP: a.39.1.5

Probab=82.00  E-value=0.11  Score=36.76  Aligned_cols=24  Identities=4%  Similarity=0.011  Sum_probs=15.3

Q ss_pred             cCCCCcccccccccccCHHHHhhh
Q 012170          445 LCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       445 l~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +...|..+|.+++|.|+.+|+..+
T Consensus         3 l~~~F~~~D~d~~G~i~~~el~~~   26 (67)
T 1tiz_A            3 AKRVFEKFDKNKDGKLSLDEFREV   26 (67)
T ss_dssp             HHHHHHHHCTTSSSCEEHHHHHHH
T ss_pred             HHHHHHHHCCCCCCcCcHHHHHHH
Confidence            334566667777777777776654

>3mse_B Calcium-dependent protein kinase, putative; CDPKS, malaria, structural genomics consortium, SGC, transfe; 2.10A {Plasmodium falciparum}

Probab=81.82  E-value=0.24  Score=43.08  Aligned_cols=28  Identities=7%  Similarity=0.106  Sum_probs=24.6

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...+..+|..+|.|++|.|+.+||.+++
T Consensus       107 ~~~~~~~F~~~D~d~~G~I~~~El~~~l  134 (180)
T 3mse_B          107 STFLKAAFNKIDKDEDGYISKSDIVSLV  134 (180)
T ss_dssp             -CHHHHHHHHHCTTCSSCBCHHHHHHHT
T ss_pred             HHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence            4678889999999999999999999875

>1s6i_A CDPK, calcium-dependent protein kinase SK5; EF-hand, helix-loop-helix, calcium-binding, calmodulin superfamily, transferase, plant protein; NMR {Glycine max} SCOP: a.39.1.5

Probab=81.73  E-value=0.27  Score=43.30  Aligned_cols=28  Identities=14%  Similarity=0.183  Sum_probs=21.0

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...+..+|..+|.|++|.|+.+||.++|
T Consensus        81 ~~~l~~~F~~~D~d~dG~Is~~El~~~l  108 (188)
T 1s6i_A           81 EENLVSAFSYFDKDGSGYITLDEIQQAC  108 (188)
T ss_dssp             CCSTHHHHHHTTTTCSSEEEHHHHHHTT
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHHH
Confidence            4456667888888888888888887664

>3ll8_B Calcineurin subunit B type 1; protein-peptide docking, protein targeting, AKA beta-augmentation, calmodulin-binding, membrane, hydrolase; 2.00A {Homo sapiens} PDB: 1mf8_B* 2p6b_B 1aui_B 1m63_B* 1tco_B*

Probab=81.70  E-value=0.19  Score=42.01  Aligned_cols=30  Identities=10%  Similarity=0.070  Sum_probs=25.5

Q ss_pred             ccccccCCCCcccccccccccCHHHHhhhC
Q 012170          440 PKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       440 ~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .....+..+|..+|.|++|.|+.+|+.+++
T Consensus        72 ~~~~~~~~~F~~~D~d~~G~i~~~e~~~~l  101 (155)
T 3ll8_B           72 DKEQKLRFAFRIYDMDKDGYISNGELFQVL  101 (155)
T ss_dssp             CHHHHHHHHHHHHCTTCSSCBCHHHHHHHH
T ss_pred             CHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            355678889999999999999999998763

>3li6_A Calcium-binding protein; calcium signaling protein, assemble free energy, dynamic behaviour, cytoskeleton, metal binding; 2.50A {Entamoeba histolytica}

Probab=81.36  E-value=0.2  Score=35.32  Aligned_cols=22  Identities=5%  Similarity=-0.052  Sum_probs=15.7

Q ss_pred             CCCcccccccccccCHHHHhhh
Q 012170          447 GPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       447 ~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      ..|..+|.|++|.|+.+|+..+
T Consensus         4 ~~F~~~D~d~~G~i~~~e~~~~   25 (66)
T 3li6_A            4 ALFKEIDVNGDGAVSYEEVKAF   25 (66)
T ss_dssp             HHHHHHCTTCSSSCCHHHHHHH
T ss_pred             HHHHHHCCCCCCcccHHHHHHH
Confidence            3566777777777777777664

>4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp}

Probab=81.33  E-value=2  Score=38.87  Aligned_cols=122  Identities=11%  Similarity=0.139  Sum_probs=81.3

Q ss_pred             HHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCC
Q 012170          146 EVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP  225 (469)
Q Consensus       146 E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp  225 (469)
                      |+.+|..  .||+++.. .+-++++.+.+.++.-+.+.=+..+   ..++....++++.+|+....+++  .-+|--|+|
T Consensus        36 el~LL~~--~~~~Fl~~-~I~e~eD~v~~~y~~~~~~~~f~~i---k~~~~~eKlr~l~ni~~l~~~~~--~r~tf~L~P  107 (215)
T 4ann_A           36 LMYLLEQ--HSPYFIDA-ELTELRDSFQIHYDINDNHTPFDNI---KSFTKNEKLRYLLNIKNLEEVNR--TRYTFVLAP  107 (215)
T ss_dssp             GGGGGGS--CCTTBCCE-EEEECSSEEEEEECCCTTSEEGGGG---GGSCHHHHHHHHHHGGGGGGGGG--SSEECCCSG
T ss_pred             HHHHHhc--cCCcccce-EEEEcccEEEEEEEcCcccCCHHHH---HhcCHHHHHHHHHHHHHHHHHhc--CceEEEEec
Confidence            4555543  48888866 5667778877777765533333323   45688889999999998875543  347778999


Q ss_pred             CcEEEccCCcEEEEeccceeeecCCCcccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCC
Q 012170          226 ENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPF  295 (469)
Q Consensus       226 ~NILl~~~~~vkL~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf  295 (469)
                      +||+++.++.+++.-.|+-..+                +|.-    ++...=+-.+=|++..++.++..|
T Consensus       108 ~NL~f~~~~~p~i~~RGik~~l----------------~P~~----~~ee~fL~qyKAliiall~~K~~F  157 (215)
T 4ann_A          108 DELFFTRDGLPIAKTRGLQNVV----------------DPLP----VSEAEFLTRYKALVICAFNEKQSF  157 (215)
T ss_dssp             GGEEECTTSCEEESCCEETTTB----------------SCCC----CCHHHHHHHHHHHHHHHHCTTCCH
T ss_pred             ceEEEcCCCCEEEEEccCccCC----------------CCCC----CCHHHHHHHHHHHHHHHHcCCCCH
Confidence            9999999999999977764221                1210    111112335677888888888776

>2kgr_A Intersectin-1; structure, alternative splicing, calcium, cell junction, cell projection, coiled coil, endocytosis, membrane, phosphoprotein; NMR {Homo sapiens}

Probab=81.13  E-value=0.094  Score=42.37  Aligned_cols=27  Identities=15%  Similarity=0.054  Sum_probs=17.3

Q ss_pred             ccccCCCCcccccccccccCHHHHhhh
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +.++..+|..||.|++|+|+.+||.++
T Consensus        13 ~~~l~~~F~~~D~d~dG~I~~~El~~~   39 (111)
T 2kgr_A           13 RLKYRQLFNSHDKTMSGHLTGPQARTI   39 (111)
T ss_dssp             HHHHHHHHHTTSCSSCCEEEHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCcCcHHHHHHH
Confidence            334555666677777777777776654

>3khe_A Calmodulin-like domain protein kinase isoform 3; calcium dependent kinase, structural genomics, structural GE consortium, SGC, ATP-binding; 1.95A {Toxoplasma gondii}

Probab=80.14  E-value=0.16  Score=44.27  Aligned_cols=29  Identities=28%  Similarity=0.388  Sum_probs=23.4

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .+..+..+|..+|.|++|.|+.+|+.++|
T Consensus       121 ~~~~~~~~F~~~D~d~~G~I~~~E~~~~l  149 (191)
T 3khe_A          121 SRERLLAAFQQFDSDGSGKITNEELGRLF  149 (191)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHHHT
T ss_pred             hHHHHHHHHHHHCCCCcCcCCHHHHHHHH
Confidence            44567778888999999999999988764

>2ehb_A Calcineurin B-like protein 4; protein complex, Ca(II) IONS bound to SOS3 (EF-hands 1 and 4 FISL motif; 2.10A {Arabidopsis thaliana} PDB: 1v1g_A 1v1f_A

Probab=80.10  E-value=0.18  Score=44.79  Aligned_cols=51  Identities=8%  Similarity=0.096  Sum_probs=33.8

Q ss_pred             ccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          419 QDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       419 ~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .+..|.++  -+..++.......+...++..+|..+|.|++|.|+.+|+.+++
T Consensus        85 ~d~~g~i~~~Ef~~~~~~~~~~~~~~~~l~~~F~~~D~d~~G~I~~~E~~~~l  137 (207)
T 2ehb_A           85 VKRNGVIEFGEFVRSLGVFHPSAPVHEKVKFAFKLYDLRQTGFIEREELKEMV  137 (207)
T ss_dssp             TTCSSEECHHHHHHHHGGGSTTSCHHHHHHHHHHHHCTTCCSSEEHHHHHHHH
T ss_pred             CCCCCeEeHHHHHHHHHHHccCCCHHHHHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            34445444  1223333333333456678889999999999999999998763

>2joj_A Centrin protein; N-terminal domain, centrin solution structure, EF-hand calcium binding protein, cell cycle; NMR {Euplotes octocarinatus}

Probab=80.01  E-value=0.084  Score=38.77  Aligned_cols=26  Identities=8%  Similarity=0.040  Sum_probs=17.6

Q ss_pred             cccCCCCcccccccccccCHHHHhhh
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      .++...|..+|.+++|.|+.+|++.+
T Consensus         7 ~~l~~~F~~~D~d~~G~i~~~el~~~   32 (77)
T 2joj_A            7 QEIKEAFDLFDTNKTGSIDYHELKVA   32 (77)
T ss_dssp             HHHHHHHHHHCCSSSSEEEHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCcHHHHHHH
Confidence            34555677777777777777777665

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	469
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	7e-81
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-80
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	3e-80
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	6e-79
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	4e-78
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	2e-77
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	2e-75
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	4e-75
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-74
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	2e-73
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	4e-73
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	3e-72
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	7e-72
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	8e-72
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	2e-70
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-70
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	1e-69
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	2e-68
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	7e-66
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	1e-65
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-64
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-63
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	1e-62
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	5e-62
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	2e-60
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	4e-60
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-59
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-59
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	1e-58
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	2e-58
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-57
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	1e-56
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	1e-56
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	2e-56
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	6e-56
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	6e-56
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	7e-56
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	1e-55
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	1e-55
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	2e-55
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	2e-55
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	1e-54
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	2e-54
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-54
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	8e-54
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	2e-53
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	2e-53
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	3e-53
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	3e-52
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	3e-51
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-50
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	2e-50
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-49
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	6e-49
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-48
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	9e-48
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	5e-47
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	3e-45
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	5e-44
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	9e-43
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	2e-42
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	9e-40
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	4e-21
d2pula1	392	d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {	0.003

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  249 bits (637), Expect = 7e-81
 Identities = 91/259 (35%), Positives = 146/259 (56%), Gaps = 14/259 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSG 155
           +D      +G GKFG+V+L R K S    A K L K        E  + REVEI  HL  
Sbjct: 6   EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR- 64

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ L+  + +A   +L++E    G +  ++ ++ ++ EQR A    ++   + YCH 
Sbjct: 65  HPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHS 124

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
             V+HRDIKPEN+LL ++G++K+ADFG ++   + +  + L G+  Y+ PE++ G  + E
Sbjct: 125 KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSRRTT-LCGTLDYLPPEMIEGRMHDE 183

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
           KVD+WS GVL +  LV   PF+ ++ +  +  I  V+  F     + V++ ARDL++R+L
Sbjct: 184 KVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTF----PDFVTEGARDLISRLL 239

Query: 335 TRDVSARITADEVLRHPWI 353
             + S R    EVL HPWI
Sbjct: 240 KHNPSQRPMLREVLEHPWI 258

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  249 bits (637), Expect = 1e-80
 Identities = 85/271 (31%), Positives = 135/271 (49%), Gaps = 20/271 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------------EETVHREVEI 149
           +++   E++G G    V  C  K +  E+A K +                 E   +EV+I
Sbjct: 3   ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
           ++ +SGH  ++ L   YE    F LV +L   G L D + E    SE+    I + ++ V
Sbjct: 63  LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEV 122

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           I   H + +VHRD+KPENILL     IKL DFG + ++  G+ L  + G+P+Y+APE++ 
Sbjct: 123 ICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIE 182

Query: 270 GN-------YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
            +       Y ++VD+WS GV+++ LL  + PF       +   I +    F S  W+  
Sbjct: 183 CSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWDDY 242

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S   +DL++R L      R TA+E L HP+ 
Sbjct: 243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFF 273

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  251 bits (641), Expect = 3e-80
 Identities = 80/265 (30%), Positives = 134/265 (50%), Gaps = 9/265 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
           + + + D +   E +G G FG V     +A+G  FA K +       +ETV +E++ M  
Sbjct: 20  KHDHVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSV 79

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIK 211
           L  H  +V LH  +E+ +   ++ E  SGG L +++  E  + SE  A    + V   + 
Sbjct: 80  LR-HPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC 138

Query: 212 YCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           + H+   VH D+KPENI+ TT  S ++KL DFGL   +   Q++    G+  + APEV  
Sbjct: 139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAE 198

Query: 270 GN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
           G       D+WS GVL + LL    PF G++ +     +K+   +     +  +S+  +D
Sbjct: 199 GKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKD 258

Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
            + ++L  D + R+T  + L HPW+
Sbjct: 259 FIRKLLLADPNTRMTIHQALEHPWL 283

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  247 bits (632), Expect = 6e-79
 Identities = 78/265 (29%), Positives = 131/265 (49%), Gaps = 9/265 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQH 152
           ++  + D +  +E +G G FG V  C  KA+G  F  K +       + TV  E+ IM  
Sbjct: 23  KQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQ 82

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIK 211
           L  H  ++ LH  +E+     L++E  SGG L D++  E  + SE    N  +     +K
Sbjct: 83  LH-HPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK 141

Query: 212 YCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           + H+  +VH DIKPENI+  T  +  +K+ DFGLA +++  + +     +  + APE++ 
Sbjct: 142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVD 201

Query: 270 GN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD 328
                   D+W+ GVL + LL    PF G+        +K    +F    + +VS  A+D
Sbjct: 202 REPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKD 261

Query: 329 LMARMLTRDVSARITADEVLRHPWI 353
            +  +L ++   R+T  + L HPW+
Sbjct: 262 FIKNLLQKEPRKRLTVHDALEHPWL 286

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  242 bits (620), Expect = 4e-78
 Identities = 74/288 (25%), Positives = 133/288 (46%), Gaps = 14/288 (4%)

Query: 94  QMGRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEI 149
            + R    ED    +  +G G FG V+  ++K +    A K +        E    E++I
Sbjct: 3   HVTRDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDI 62

Query: 150 MQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQ-YSEQRAANIFKDVMW 208
           +     H  +V L   +   +   +++E C+GG +   M+E+ +  +E +   + K  + 
Sbjct: 63  LASCD-HPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLD 121

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGLAGSPAYVAPEV 267
            + Y HD  ++HRD+K  NIL T  G IKLADFG++ + +   Q      G+P ++APEV
Sbjct: 122 ALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEV 181

Query: 268 LSGN------YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           +         Y  K D+WS G+ L  +     P    +   V   I   +    +     
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTLA-QPSR 240

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWILFYTERTLRTLTIKSK 369
            S   +D + + L ++V AR T  ++L+HP++   + + +R L  ++K
Sbjct: 241 WSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDSNKPIRELIAEAK 288

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  241 bits (617), Expect = 2e-77
 Identities = 94/266 (35%), Positives = 148/266 (55%), Gaps = 10/266 (3%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQ 151
           +   I D +   +V+G G F  V L   K +    A K + K      E ++  E+ ++ 
Sbjct: 3   QAEDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLH 62

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
            +  H  +V L  +YE     +L+M+L SGG L D++VE G Y+E+ A+ +   V+  +K
Sbjct: 63  KIK-HPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVK 121

Query: 212 YCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
           Y HD+G+VHRD+KPEN+L  +     KI ++DFGL+     G  LS   G+P YVAPEVL
Sbjct: 122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVL 181

Query: 269 SGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
           +   YS+ VD WS GV+ + LL    PF  ++   +F+ I   + +F S  W+ +S  A+
Sbjct: 182 AQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAK 241

Query: 328 DLMARMLTRDVSARITADEVLRHPWI 353
           D +  ++ +D   R T ++ L+HPWI
Sbjct: 242 DFIRHLMEKDPEKRFTCEQALQHPWI 267

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  236 bits (602), Expect = 2e-75
 Identities = 70/268 (26%), Positives = 129/268 (48%), Gaps = 16/268 (5%)

Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIM 150
           + K  +D    +++G G F +V L R  A+  E+A K L K           V RE ++M
Sbjct: 3   RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
             L  H   V L+  +++ +  +  +     G L+  + ++G + E        +++  +
Sbjct: 63  SRLD-HPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSAL 121

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEV 267
           +Y H  G++HRD+KPENILL     I++ DFG A  +S        +   G+  YV+PE+
Sbjct: 122 EYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181

Query: 268 LSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
           L+     +  D+W+ G +++ L+    PF+  +   +F  I  ++ DF     E     A
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDF----PEKFFPKA 237

Query: 327 RDLMARMLTRDVSARITADEVLRHPWIL 354
           RDL+ ++L  D + R+  +E+  +  + 
Sbjct: 238 RDLVEKLLVLDATKRLGCEEMEGYGPLK 265

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  235 bits (601), Expect = 4e-75
 Identities = 90/272 (33%), Positives = 145/272 (53%), Gaps = 16/272 (5%)

Query: 97  RKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHRE 146
           R+  ++D +   E +G G+F  V  CR K++G ++A K ++K            E + RE
Sbjct: 4   RQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIERE 63

Query: 147 VEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDV 206
           V I++ +  H  V+TLH VYE      L++EL +GG L D + E    +E+ A    K +
Sbjct: 64  VSILKEIQ-HPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGLAMRISNGQTLSGLAGSPAY 262
           +  + Y H + + H D+KPENI+L        +IK+ DFGLA +I  G     + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182

Query: 263 VAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
           VAPE+++      + D+WS GV+ + LL  A PF GD+ +     +  V  +F    +  
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSN 242

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
            S  A+D + R+L +D   R+T  + L+HPWI
Sbjct: 243 TSALAKDFIRRLLVKDPKKRMTIQDSLQHPWI 274

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  234 bits (599), Expect = 2e-74
 Identities = 80/321 (24%), Positives = 151/321 (47%), Gaps = 19/321 (5%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGH 156
           ++ + +   E +G G+FG V  C   +S   +  K ++     +  V +E+ I+     H
Sbjct: 2   ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHD 215
             ++ LH  +E  +   ++ E  SG  + +++     + +E+   +    V   +++ H 
Sbjct: 61  RNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHS 120

Query: 216 MGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-Y 272
             + H DI+PENI+  T  S  IK+ +FG A ++  G     L  +P Y APEV   +  
Sbjct: 121 HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVV 180

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
           S   D+WS G L++ LL    PF  ++ + + + I N +  F    ++ +S  A D + R
Sbjct: 181 STATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR 240

Query: 333 MLTRDVSARITADEVLRHPWILFYTERTLRTLT-IKSKLKNQVGASHHHPAILSGVESDE 391
           +L ++  +R+TA E L+HPW+    ++  R  T +   LK       H     + ++ D 
Sbjct: 241 LLVKERKSRMTASEALQHPWL---KQKIERVSTKVIRTLK-------HRRYYHTLIKKDL 290

Query: 392 NKIDRGSRNDESHALSSSESL 412
           N +   +R     A+ S + +
Sbjct: 291 NMVVSAARISCGGAIRSQKGV 311

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  230 bits (588), Expect = 2e-73
 Identities = 78/261 (29%), Positives = 129/261 (49%), Gaps = 12/261 (4%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----GEETVHREVEIMQHLSGHT 157
           +D   V+ +G G +G V L  ++ +    A K +         E + +E+ I + L+ H 
Sbjct: 5   EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HE 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            VV  +    E +  +L +E CSGG L D++       E  A   F  +M  + Y H +G
Sbjct: 64  NVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIG 123

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNG---QTLSGLAGSPAYVAPEVLSGN--Y 272
           + HRDIKPEN+LL     +K++DFGLA         + L+ + G+  YVAPE+L     +
Sbjct: 124 ITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFH 183

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR 332
           +E VD+WS G++L A+L   LP+   S      +    K  + +  W+ +      L+ +
Sbjct: 184 AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN-PWKKIDSAPLALLHK 242

Query: 333 MLTRDVSARITADEVLRHPWI 353
           +L  + SARIT  ++ +  W 
Sbjct: 243 ILVENPSARITIPDIKKDRWY 263

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  231 bits (589), Expect = 4e-73
 Identities = 69/268 (25%), Positives = 113/268 (42%), Gaps = 17/268 (6%)

Query: 98  KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIM 150
           K+  E   + +  IGHG FG+V+  R   +    A K +           + + +EV  +
Sbjct: 10  KDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFL 69

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           Q L  H   +     Y       LVME C G       V      E   A +    +  +
Sbjct: 70  QKLR-HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGL 128

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS- 269
            Y H   ++HRD+K  NILL+  G +KL DFG A  ++   +     G+P ++APEV+  
Sbjct: 129 AYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPANS---FVGTPYWMAPEVILA 185

Query: 270 ---GNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA 326
              G Y  KVD+WS G+    L     P    +  +    I   + +  +      S+  
Sbjct: 186 MDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--AQNESPALQSGHWSEYF 243

Query: 327 RDLMARMLTRDVSARITADEVLRHPWIL 354
           R+ +   L +    R T++ +L+H ++L
Sbjct: 244 RNFVDSCLQKIPQDRPTSEVLLKHRFVL 271

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  227 bits (581), Expect = 3e-72
 Identities = 81/272 (29%), Positives = 138/272 (50%), Gaps = 13/272 (4%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGH 156
            +  +T+ E IG G  G+V+     A+G E A + +       +E +  E+ +M+    +
Sbjct: 18  PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-N 76

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V     Y   D   +VME  +GG L D + E     E + A + ++ +  +++ H  
Sbjct: 77  PNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSN 135

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-LSGLAGSPAYVAPEVLSGN-YSE 274
            V+HRDIK +NILL   G +KL DFG   +I+  Q+  S + G+P ++APEV++   Y  
Sbjct: 136 QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGP 195

Query: 275 KVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           KVDIWS G++   ++    P+  ++ L A++    N   +  +   E +S   RD + R 
Sbjct: 196 KVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQN--PEKLSAIFRDFLNRC 253

Query: 334 LTRDVSARITADEVLRHPWILFYTERTLRTLT 365
           L  DV  R +A E+L+H +      + L +LT
Sbjct: 254 LDMDVEKRGSAKELLQHQF--LKIAKPLSSLT 283

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  228 bits (583), Expect = 7e-72
 Identities = 87/272 (31%), Positives = 140/272 (51%), Gaps = 16/272 (5%)

Query: 97  RKNKIEDDHTKV-EVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           +KN I DD+    +V+G G  G V    +K +  +FA K L+   +   REVE+    S 
Sbjct: 5   KKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDCPK-ARREVELHWRASQ 63

Query: 156 HTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWV 209
              +V +  VYE       C  +VME   GG L  ++ + G   ++E+ A+ I K +   
Sbjct: 64  CPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA 123

Query: 210 IKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPE 266
           I+Y H + + HRD+KPEN+L T+   +  +KL DFG A   ++  +L+    +P YVAPE
Sbjct: 124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPE 183

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS----LEAVFDAIKNVKLDFHSGVWET 321
           VL    Y +  D+WS GV+++ LL    PF  +        +   I+  + +F +  W  
Sbjct: 184 VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSE 243

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
           VS+  + L+  +L  + + R+T  E + HPWI
Sbjct: 244 VSEEVKMLIRNLLKTEPTQRMTITEFMNHPWI 275

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  226 bits (577), Expect = 8e-72
 Identities = 73/270 (27%), Positives = 120/270 (44%), Gaps = 23/270 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGH 156
           +D+  +  IG G +G     R K+ G     K L  G      ++ +  EV +++ L  H
Sbjct: 4   EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-H 62

Query: 157 TGVVTLHSVY--EEADCFHLVMELCSGGRLIDQMV----EVGQYSEQRAANIFKDVMWVI 210
             +V  +           ++VME C GG L   +     E     E+    +   +   +
Sbjct: 63  PNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122

Query: 211 KYCHDMG-----VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-GLAGSPAYVA 264
           K CH        V+HRD+KP N+ L     +KL DFGLA  +++  + +    G+P Y++
Sbjct: 123 KECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMS 182

Query: 265 PEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS 323
           PE ++   Y+EK DIWS G LL+ L     PF   S + +   I+  K      +    S
Sbjct: 183 PEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYS 239

Query: 324 KPARDLMARMLTRDVSARITADEVLRHPWI 353
               +++ RML      R + +E+L +P I
Sbjct: 240 DELNEIITRMLNLKDYHRPSVEEILENPLI 269

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  222 bits (567), Expect = 2e-70
 Identities = 52/272 (19%), Positives = 113/272 (41%), Gaps = 24/272 (8%)

Query: 96  GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEI 149
           GR  K +        IG G F +V+      +  E A   L+         +    E E+
Sbjct: 8   GRFLKFD------IEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEM 61

Query: 150 MQHLSGHTGVVTLHSVYEEA----DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKD 205
           ++ L  H  +V  +  +E       C  LV EL + G L   +        +   +  + 
Sbjct: 62  LKGLQ-HPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQ 120

Query: 206 VMWVIKYCHDMG--VVHRDIKPENILLT-TSGKIKLADFGLAMRISNGQTLSGLAGSPAY 262
           ++  +++ H     ++HRD+K +NI +T  +G +K+ D GLA  +        + G+P +
Sbjct: 121 ILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLA-TLKRASFAKAVIGTPEF 179

Query: 263 VAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVWET 321
           +APE+    Y E VD+++ G+ +  +  +  P+    +   ++  + +          + 
Sbjct: 180 MAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPAS--FDKV 237

Query: 322 VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                ++++   + ++   R +  ++L H + 
Sbjct: 238 AIPEVKEIIEGCIRQNKDERYSIKDLLNHAFF 269

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  224 bits (571), Expect = 3e-70
 Identities = 62/299 (20%), Positives = 116/299 (38%), Gaps = 49/299 (16%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGH 156
           +DD  K+  +G G  G V+    K SG   A K +           + RE++++   +  
Sbjct: 5   DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-S 63

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V  +  +       + ME   GG L   + + G+  EQ    +   V+  + Y  + 
Sbjct: 64  PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123

Query: 217 -GVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
             ++HRD+KP NIL+ + G+IKL DFG++ ++ +    +   G+ +Y++PE L G  YS 
Sbjct: 124 HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMA-NSFVGTRSYMSPERLQGTHYSV 182

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV---------------- 318
           + DIWS G+ L  + V   P      + +            +                  
Sbjct: 183 QSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGM 242

Query: 319 ------------------------WETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                                       S   +D + + L ++ + R    +++ H +I
Sbjct: 243 DSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 301

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  222 bits (566), Expect = 1e-69
 Identities = 84/322 (26%), Positives = 156/322 (48%), Gaps = 30/322 (9%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSG 155
            D   +  +G G FG V L RS+ +G  +A K L+K         E  + E  ++  ++ 
Sbjct: 4   QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT- 62

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  ++ +   +++A    ++M+   GG L   + +  ++    A     +V   ++Y H 
Sbjct: 63  HPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHS 122

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
             +++RD+KPENILL  +G IK+ DFG A  + +      L G+P Y+APEV+S   Y++
Sbjct: 123 KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTY--TLCGTPDYIAPEVVSTKPYNK 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            +D WS G+L++ +L    PF   +    ++ I N +L F        ++  +DL++R++
Sbjct: 181 SIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRF----PPFFNEDVKDLLSRLI 236

Query: 335 TRDVSARI-----TADEVLRHPWILFYTERTLRTLTIKSKLKNQVGASHHHPAILSGVES 389
           TRD+S R+       ++V  HPW        L +  I++  +         P I  G + 
Sbjct: 237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVWEKLLSRNIETPYE---------PPIQQG-QG 286

Query: 390 DENKIDRGSRNDESHALSSSES 411
           D ++ D+    D ++ +   + 
Sbjct: 287 DTSQFDKYPEEDINYGVQGEDP 308

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  219 bits (559), Expect = 2e-68
 Identities = 74/261 (28%), Positives = 127/261 (48%), Gaps = 14/261 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           +D    +++G G FG V+L   K +   FA K L+K         E    E  ++     
Sbjct: 2   EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  +   ++  +    VME  +GG L+  +    ++   RA     +++  +++ H 
Sbjct: 62  HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHS 121

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-SGLAGSPAYVAPEVLSGN-YS 273
            G+V+RD+K +NILL   G IK+ADFG+      G    +   G+P Y+APE+L G  Y+
Sbjct: 122 KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYN 181

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD WS GVLL+ +L+   PF G   E +F +I+     +       + K A+DL+ ++
Sbjct: 182 HSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFY----PRWLEKEAKDLLVKL 237

Query: 334 LTRDVSARITA-DEVLRHPWI 353
             R+   R+    ++ +HP  
Sbjct: 238 FVREPEKRLGVRGDIRQHPLF 258

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  214 bits (545), Expect = 7e-66
 Identities = 74/267 (27%), Positives = 122/267 (45%), Gaps = 18/267 (6%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLS- 154
           +D +   +IG G FG V+ CR   +G  +A K L K       GE     E  ++  +S 
Sbjct: 4   NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63

Query: 155 -GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYC 213
                +V +   +   D    +++L +GG L   + + G +SE        +++  +++ 
Sbjct: 64  GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHM 123

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-- 271
           H+  VV+RD+KP NILL   G ++++D GLA   S  +      G+  Y+APEVL     
Sbjct: 124 HNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKP-HASVGTHGYMAPEVLQKGVA 182

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           Y    D +S G +L  LL    PF+    +     I  + L     + ++ S   R L+ 
Sbjct: 183 YDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH-EIDRMTLTMAVELPDSFSPELRSLLE 241

Query: 332 RMLTRDVSARIT-----ADEVLRHPWI 353
            +L RDV+ R+      A EV   P+ 
Sbjct: 242 GLLQRDVNRRLGCLGRGAQEVKESPFF 268

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  212 bits (541), Expect = 1e-65
 Identities = 85/265 (32%), Positives = 133/265 (50%), Gaps = 19/265 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSG 155
           +D   ++++G G FG V L R KA+G  +A K LRK              E  ++Q+   
Sbjct: 5   NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR- 63

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
           H  +  L   ++  D    VME  +GG L   +     ++E+RA     +++  ++Y H 
Sbjct: 64  HPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHS 123

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSGN-YS 273
             VV+RDIK EN++L   G IK+ DFGL     S+G T+    G+P Y+APEVL  N Y 
Sbjct: 124 RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYG 183

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
             VD W  GV+++ ++   LPF     E +F+ I   ++ F      T+S  A+ L+A +
Sbjct: 184 RAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRF----PRTLSPEAKSLLAGL 239

Query: 334 LTRDVSARI-----TADEVLRHPWI 353
           L +D   R+      A EV+ H + 
Sbjct: 240 LKKDPKQRLGGGPSDAKEVMEHRFF 264

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  208 bits (530), Expect = 1e-64
 Identities = 67/283 (23%), Positives = 109/283 (38%), Gaps = 37/283 (13%)

Query: 107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHT 157
           K++ +G G+F +V+  R K +    A K ++ G           T  RE++++Q LS H 
Sbjct: 2   KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HP 60

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
            ++ L   +       LV +       +         +           +  ++Y H   
Sbjct: 61  NIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHW 120

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRI-SNGQTLSGLAGSPAYVAPEVLSG--NYSE 274
           ++HRD+KP N+LL  +G +KLADFGLA    S  +  +    +  Y APE+L G   Y  
Sbjct: 121 ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGV 180

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE-------------- 320
            VD+W+ G +L  LL+      GDS       I           W               
Sbjct: 181 GVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF 240

Query: 321 ----------TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                            DL+  +   +  ARITA + L+  + 
Sbjct: 241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYF 283

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  204 bits (519), Expect = 4e-63
 Identities = 73/268 (27%), Positives = 126/268 (47%), Gaps = 26/268 (9%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIM 150
           +E  +    ++G G FGSV+     +     A K + K              V  EV ++
Sbjct: 2   LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLL 61

Query: 151 QHLS-GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMW 208
           + +S G +GV+ L   +E  D F L++E     + +   + E G   E+ A + F  V+ 
Sbjct: 62  KKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLE 121

Query: 209 VIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
            +++CH+ GV+HRDIK ENIL+  + G++KL DFG    +      +   G+  Y  PE 
Sbjct: 122 AVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG-ALLKDTVYTDFDGTRVYSPPEW 180

Query: 268 LSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +  +  +     +WS G+LL+ ++   +PF+ D      + I   ++ F     + VS  
Sbjct: 181 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EEIIRGQVFF----RQRVSSE 230

Query: 326 ARDLMARMLTRDVSARITADEVLRHPWI 353
            + L+   L    S R T +E+  HPW+
Sbjct: 231 CQHLIRWCLALRPSDRPTFEEIQNHPWM 258

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  202 bits (515), Expect = 1e-62
 Identities = 62/268 (23%), Positives = 109/268 (40%), Gaps = 21/268 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGH 156
              T  + IG G FG+V+  +      + A K L          +    EV +++    H
Sbjct: 8   GQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-H 63

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHD 215
             ++     Y  A    +V + C G  L   +  +  ++   +  +I +     + Y H 
Sbjct: 64  VNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAM---RISNGQTLSGLAGSPAYVAPEVL---- 268
             ++HRD+K  NI L     +K+ DFGLA    R S       L+GS  ++APEV+    
Sbjct: 123 KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQD 182

Query: 269 SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAI--KNVKLDFHSGVWETVSKPA 326
              YS + D+++ G++L+ L+   LP+   +       +  +       S V     K  
Sbjct: 183 KNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAM 242

Query: 327 RDLMARMLTRDVSARITADEVLRHPWIL 354
           + LMA  L +    R    ++L    +L
Sbjct: 243 KRLMAECLKKKRDERPLFPQILASIELL 270

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  201 bits (511), Expect = 5e-62
 Identities = 64/271 (23%), Positives = 116/271 (42%), Gaps = 17/271 (6%)

Query: 99  NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQ 151
           + + D +   E++G G    V L R      + A K LR              RE +   
Sbjct: 3   SHLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA 62

Query: 152 HLSGHTGVVTLHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
            L+ H  +V ++   E         ++VME   G  L D +   G  + +RA  +  D  
Sbjct: 63  ALN-HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 121

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGLAGSPAYV 263
             + + H  G++HRD+KP NI+++ +  +K+ DFG+A  I++        + + G+  Y+
Sbjct: 122 QALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYL 181

Query: 264 APEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV 322
           +PE   G+    + D++S G +L+ +L    PF GDS  +V            S   E +
Sbjct: 182 SPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGL 241

Query: 323 SKPARDLMARMLTRDVSARITADEVLRHPWI 353
           S     ++ + L ++   R      +R   +
Sbjct: 242 SADLDAVVLKALAKNPENRYQTAAEMRADLV 272

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  199 bits (507), Expect = 2e-60
 Identities = 73/295 (24%), Positives = 113/295 (38%), Gaps = 38/295 (12%)

Query: 96  GRKNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSG 155
           G     E  +T  +VIG+G FG V+  +   SG   A K + + +   +RE++IM+ L  
Sbjct: 13  GPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD- 71

Query: 156 HTGVVTLHSVYEEAD------CFHLVMELCSGGR---LIDQMVEVGQYSEQRAANIFKDV 206
           H  +V L   +  +         +LV++                               +
Sbjct: 72  HCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQL 131

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGK-IKLADFGLAMRISNGQTLSGLAGSPAYVAP 265
              + Y H  G+ HRDIKP+N+LL      +KL DFG A ++  G+       S  Y AP
Sbjct: 132 FRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAP 191

Query: 266 EVLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNV------------- 310
           E++ G   Y+  +D+WSAG +L  LL+    F GDS       I  V             
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251

Query: 311 ------------KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                          +           A  L +R+L    +AR+T  E   H + 
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  197 bits (502), Expect = 4e-60
 Identities = 77/280 (27%), Positives = 139/280 (49%), Gaps = 22/280 (7%)

Query: 96  GRKNKIE-DDHTKVEVIGHGKFGSVWLCR---SKASGAEFACKTLRKGE--------ETV 143
           G   K+  ++   ++V+G G +G V+L R      +G  +A K L+K          E  
Sbjct: 16  GHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHT 75

Query: 144 HREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF 203
             E ++++H+     +VTLH  ++     HL+++  +GG L   + +  +++E       
Sbjct: 76  RTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYV 135

Query: 204 KDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGLAGSPA 261
            +++  +++ H +G+++RDIK ENILL ++G + L DFGL+      +T       G+  
Sbjct: 136 GEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIE 195

Query: 262 YVAPEVLSGN---YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGV 318
           Y+AP+++ G    + + VD WS GVL++ LL  A PF  D  +     I    L      
Sbjct: 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPY 255

Query: 319 WETVSKPARDLMARMLTRDVSARI-----TADEVLRHPWI 353
            + +S  A+DL+ R+L +D   R+      ADE+  H + 
Sbjct: 256 PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFF 295

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  197 bits (502), Expect = 1e-59
 Identities = 72/264 (27%), Positives = 130/264 (49%), Gaps = 20/264 (7%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSG 155
           D   +++ +G G FG V L + K SG  +A K L K +       E    E  I+Q ++ 
Sbjct: 41  DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN- 99

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
              +V L   +++    ++VME  +GG +   +  +G++SE  A      ++   +Y H 
Sbjct: 100 FPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN-YSE 274
           + +++RD+KPEN+L+   G I++ DFG A R+        L G+P  +APE++    Y++
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGRTW--TLCGTPEALAPEIILSKGYNK 217

Query: 275 KVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            VD W+ GVL++ +     PF  D    +++ I + K+ F        S   +DL+  +L
Sbjct: 218 AVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRF----PSHFSSDLKDLLRNLL 273

Query: 335 TRDVSARI-----TADEVLRHPWI 353
             D++ R        +++  H W 
Sbjct: 274 QVDLTKRFGNLKNGVNDIKNHKWF 297

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  195 bits (495), Expect = 4e-59
 Identities = 71/313 (22%), Positives = 132/313 (42%), Gaps = 53/313 (16%)

Query: 90  DVHTQMGRK------NKIE----DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG 139
           DV+T   R+      + +E    DD+  V  +G GK+  V+   +  +  +   K L+  
Sbjct: 12  DVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV 71

Query: 140 -EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--CFHLVMELCSGGRLIDQMVEVGQYSE 196
            ++ + RE++I+++L G   ++TL  + ++       LV E  +              ++
Sbjct: 72  KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTD 128

Query: 197 QRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSG 255
                   +++  + YCH MG++HRD+KP N+++     K++L D+GLA     GQ  + 
Sbjct: 129 YDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNV 188

Query: 256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEA----------- 302
              S  +  PE+L     Y   +D+WS G +L +++    PF                  
Sbjct: 189 RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLG 248

Query: 303 ---VFDAIKNVKLD--------------------FHSGVWETVSKPARDLMARMLTRDVS 339
              ++D I    ++                     HS     VS  A D + ++L  D  
Sbjct: 249 TEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQ 308

Query: 340 ARITADEVLRHPW 352
           +R+TA E + HP+
Sbjct: 309 SRLTAREAMEHPY 321

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  193 bits (491), Expect = 1e-58
 Identities = 68/300 (22%), Positives = 119/300 (39%), Gaps = 50/300 (16%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGH 156
             + K+  IG G FG V+  R + +G + A K +           T  RE++I+Q L  H
Sbjct: 10  SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-H 68

Query: 157 TGVVTLHSVYEEAD--------CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
             VV L  +               +LV + C           + +++      + + ++ 
Sbjct: 69  ENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLN 128

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-----LSGLAGSPAYV 263
            + Y H   ++HRD+K  N+L+T  G +KLADFGLA   S  +       +    +  Y 
Sbjct: 129 GLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYR 188

Query: 264 APEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWET 321
            PE+L G  +Y   +D+W AG ++  +   +   +G++ +     I  +       VW  
Sbjct: 189 PPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPN 248

Query: 322 VSKP----------------------------ARDLMARMLTRDVSARITADEVLRHPWI 353
           V                               A DL+ ++L  D + RI +D+ L H + 
Sbjct: 249 VDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFF 308

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  192 bits (487), Expect = 2e-58
 Identities = 72/286 (25%), Positives = 123/286 (43%), Gaps = 36/286 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGH 156
             + K+E IG G +G+V+  +++ +    A K +R          +  RE+ +++ L  H
Sbjct: 2   QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
             +V LH V        LV E C            G    +   +    ++  + +CH  
Sbjct: 61  KNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSR 120

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--YS 273
            V+HRD+KP+N+L+  +G++KLA+FGLA       +  S    +  Y  P+VL G   YS
Sbjct: 121 NVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYS 180

Query: 274 EKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKNVKLDFHSGVWET----------- 321
             +D+WSAG +   L  A  P F G+ ++     I  +        W +           
Sbjct: 181 TSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP 240

Query: 322 --------------VSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                         ++   RDL+  +L  +   RI+A+E L+HP+ 
Sbjct: 241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYF 286

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  189 bits (480), Expect = 2e-57
 Identities = 77/285 (27%), Positives = 122/285 (42%), Gaps = 36/285 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGH 156
           + +  +E IG G +G V+  ++   G  FA K +R          T  RE+ I++ L  H
Sbjct: 2   EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-H 59

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDM 216
           + +V L+ V        LV E           V  G      A +    ++  I YCHD 
Sbjct: 60  SNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119

Query: 217 GVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTLSGLAGSPAYVAPEVLSGN--YS 273
            V+HRD+KP+N+L+   G++K+ADFGLA       +  +    +  Y AP+VL G+  YS
Sbjct: 120 RVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYS 179

Query: 274 EKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW-------------- 319
             +DIWS G +   ++     F G S       I  +    +S  W              
Sbjct: 180 TTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT 239

Query: 320 -----------ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                      + + +   DL+++ML  D + RITA + L H + 
Sbjct: 240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  187 bits (476), Expect = 1e-56
 Identities = 65/262 (24%), Positives = 110/262 (41%), Gaps = 17/262 (6%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV 159
           +       +G G FG VW+          A KTL+ G    E   +E ++M+ L  H  +
Sbjct: 17  ESLRLEVKLGQGCFGEVWMGTWN-GTTRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKL 74

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMV--EVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           V L++V  E +  ++V E  S G L+D +           +  ++   +   + Y   M 
Sbjct: 75  VQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLS-GNYSE 274
            VHRD++  NIL+  +   K+ADFGLA  I + +     G      + APE    G ++ 
Sbjct: 134 YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTI 193

Query: 275 KVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K D+WS G+LL  L     +P+ G     V D ++     +         +   DLM + 
Sbjct: 194 KSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVER---GYRMPCPPECPESLHDLMCQC 250

Query: 334 LTRDVSARITADEVLR--HPWI 353
             ++   R T + +      + 
Sbjct: 251 WRKEPEERPTFEYLQAFLEDYF 272

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  189 bits (480), Expect = 1e-56
 Identities = 63/296 (21%), Positives = 114/296 (38%), Gaps = 46/296 (15%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSG 155
           +   +T +  IG G +G V       +    A K +   E     +   RE++I+     
Sbjct: 6   VGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR- 64

Query: 156 HTGVVTLHSVYEEADC-----FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVI 210
           H  ++ ++ +            +LV  L        ++++    S          ++  +
Sbjct: 65  HENIIGINDIIRAPTIEQMKDVYLVTHLMGADL--YKLLKTQHLSNDHICYFLYQILRGL 122

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----TLSGLAGSPAYVAPE 266
           KY H   V+HRD+KP N+LL T+  +K+ DFGLA            L+    +  Y APE
Sbjct: 123 KYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPE 182

Query: 267 VLSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH--------- 315
           ++  +  Y++ +DIWS G +L  +L     F G       + I  +              
Sbjct: 183 IMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN 242

Query: 316 ------------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                             + ++      A DL+ +MLT +   RI  ++ L HP++
Sbjct: 243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYL 298

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 2e-56
 Identities = 58/256 (22%), Positives = 113/256 (44%), Gaps = 13/256 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV 159
            D T ++ +G G+FG V   + +    + A K +++G   E+    E ++M +LS H  +
Sbjct: 4   KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKL 61

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLID-QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V L+ V  +     ++ E  + G L++       ++  Q+   + KDV   ++Y      
Sbjct: 62  VQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 121

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLSGN-YSEK 275
           +HRD+   N L+   G +K++DFGL+  + + +  +  G      +  PEVL  + +S K
Sbjct: 122 LHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSK 181

Query: 276 VDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML 334
            DIW+ GVL+  +     +P++  +     + I      +        S+    +M    
Sbjct: 182 SDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYTIMYSCW 238

Query: 335 TRDVSARITADEVLRH 350
                 R T   +L +
Sbjct: 239 HEKADERPTFKILLSN 254

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (469), Expect = 6e-56
 Identities = 59/255 (23%), Positives = 104/255 (40%), Gaps = 15/255 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE--ETVHREVEIMQHLSGHTGVV 160
            +   ++ IG G+FG V L   +  G + A K ++     +    E  +M  L  H+ +V
Sbjct: 7   KELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLV 63

Query: 161 TLHSV-YEEADCFHLVMELCSGGRLIDQMVEVGQ--YSEQRAANIFKDVMWVIKYCHDMG 217
            L  V  EE    ++V E  + G L+D +   G+             DV   ++Y     
Sbjct: 64  QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNN 123

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS-GNYSEKV 276
            VHRD+   N+L++     K++DFGL    S+ Q          + APE L    +S K 
Sbjct: 124 FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD--TGKLPVKWTAPEALREKKFSTKS 181

Query: 277 DIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           D+WS G+LL  +     +P+    L+ V   ++     +     +       ++M     
Sbjct: 182 DVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEK---GYKMDAPDGCPPAVYEVMKNCWH 238

Query: 336 RDVSARITADEVLRH 350
            D + R +  ++   
Sbjct: 239 LDAAMRPSFLQLREQ 253

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  185 bits (471), Expect = 6e-56
 Identities = 79/286 (27%), Positives = 121/286 (42%), Gaps = 36/286 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLSGH 156
           ++  KVE IG G +G V+  R+K +G   A K +R          T  RE+ +++ L+ H
Sbjct: 2   ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-H 60

Query: 157 TGVVTLHSVYEEADCFHLVMELCS-GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD 215
             +V L  V    +  +LV E      +       +         +    ++  + +CH 
Sbjct: 61  PNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRIS-NGQTLSGLAGSPAYVAPEVLSGN--Y 272
             V+HRD+KP+N+L+ T G IKLADFGLA       +T +    +  Y APE+L G   Y
Sbjct: 121 HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYY 180

Query: 273 SEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE------------ 320
           S  VDIWS G +   ++     F GDS       I          VW             
Sbjct: 181 STAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF 240

Query: 321 -------------TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                         + +  R L+++ML  D + RI+A   L HP+ 
Sbjct: 241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFF 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 7e-56
 Identities = 79/293 (26%), Positives = 122/293 (41%), Gaps = 39/293 (13%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEF-ACKTLRKG------EETVHREVEIMQH 152
           + +  +  V  IG G +G V+  R   +G  F A K +R          +  REV +++H
Sbjct: 4   RADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRH 63

Query: 153 LSG--HTGVVTLHSVY-----EEADCFHLVMELCSGGRL-IDQMVEVGQYSEQRAANIFK 204
           L    H  VV L  V      +      LV E            V       +   ++  
Sbjct: 64  LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMF 123

Query: 205 DVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVA 264
            ++  + + H   VVHRD+KP+NIL+T+SG+IKLADFGLA   S    L+ +  +  Y A
Sbjct: 124 QLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMALTSVVVTLWYRA 183

Query: 265 PEVL-SGNYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVW---- 319
           PEVL   +Y+  VD+WS G +   +      F+G S       I +V        W    
Sbjct: 184 PEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDV 243

Query: 320 -------------------ETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                                + +  +DL+ + LT + + RI+A   L HP+ 
Sbjct: 244 ALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 69/255 (27%), Positives = 111/255 (43%), Gaps = 11/255 (4%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV 159
            + T V+ IG G+FG V L     +  + A KT+R+G   EE    E E+M  LS H  +
Sbjct: 5   SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKL 62

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           V L+ V  E     LV E    G L D +  + G ++ +    +  DV   + Y  +  V
Sbjct: 63  VQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS--GLAGSPAYVAPEVLSGN-YSEK 275
           +HRD+   N L+  +  IK++DFG+   + + Q  S  G      + +PEV S + YS K
Sbjct: 123 IHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSK 182

Query: 276 VDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
            D+WS GVL+  +         +   +  + ++++   F        S     +M     
Sbjct: 183 SDVWSFGVLMWEVFSEGKIPYEN--RSNSEVVEDISTGFRLYKPRLASTHVYQIMNHCWK 240

Query: 336 RDVSARITADEVLRH 350
                R     +LR 
Sbjct: 241 ERPEDRPAFSRLLRQ 255

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  184 bits (467), Expect = 1e-55
 Identities = 57/256 (22%), Positives = 114/256 (44%), Gaps = 15/256 (5%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV 159
           +    VE +G G+FG VW+        + A K+L++G    +    E  +M+ L  H  +
Sbjct: 13  ETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRL 70

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMG 217
           V L++V  + +  +++ E    G L+D +      + +  +  ++   +   + +  +  
Sbjct: 71  VRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLS-GNYSE 274
            +HRD++  NIL++ +   K+ADFGLA  I + +     G      + APE ++ G ++ 
Sbjct: 130 YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTI 189

Query: 275 KVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K D+WS G+LL  ++    +P+ G +   V   ++     +     +   +    LM   
Sbjct: 190 KSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLER---GYRMVRPDNCPEELYQLMRLC 246

Query: 334 LTRDVSARITADEVLR 349
                  R T D +  
Sbjct: 247 WKERPEDRPTFDYLRS 262

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  184 bits (469), Expect = 2e-55
 Identities = 62/276 (22%), Positives = 110/276 (39%), Gaps = 28/276 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLS 154
                 +VIG G+FG V     K  G      A KTL+ G           E  IM    
Sbjct: 26  SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD 85

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYC 213
            H  V+ L  V  ++    ++ E    G L   +    GQ++  +   + + +   +KY 
Sbjct: 86  -HPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYL 144

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS------GLAGSPAYVAPEV 267
            DM  VHRD+   NIL+ ++   K++DFGL+  + +  +        G      + APE 
Sbjct: 145 ADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEA 204

Query: 268 L-SGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP 325
           +    ++   D+WS G+++  ++     P+   + + V +AI+    D+           
Sbjct: 205 IQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQ---DYRLPPPMDCPSA 261

Query: 326 ARDLMARMLTRDVSARITADEV-------LRHPWIL 354
              LM     +D + R    ++       +R+P  L
Sbjct: 262 LHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRNPNSL 297

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  186 bits (472), Expect = 2e-55
 Identities = 69/295 (23%), Positives = 128/295 (43%), Gaps = 46/295 (15%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHL 153
           ++   +  ++ +G G +G+V       +GA+ A K L +        +  +RE+ +++H+
Sbjct: 15  EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHM 74

Query: 154 SGHTGVVTLHSVYEEADC------FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVM 207
             H  V+ L  V+   +       F+LVM     G  + ++++  +  E R   +   ++
Sbjct: 75  R-HENVIGLLDVFTPDETLDDFTDFYLVMPFM--GTDLGKLMKHEKLGEDRIQFLVYQML 131

Query: 208 WVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEV 267
             ++Y H  G++HRD+KP N+ +    ++K+ DFGLA +      ++G   +  Y APEV
Sbjct: 132 KGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA--DSEMTGYVVTRWYRAPEV 189

Query: 268 LSGN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE----- 320
           +     Y++ VDIWS G ++  ++     FKG         I  V     +   +     
Sbjct: 190 ILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD 249

Query: 321 ----------------------TVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                                   S  A +L+ +ML  D   R+TA E L HP+ 
Sbjct: 250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF 304

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 1e-54
 Identities = 62/260 (23%), Positives = 104/260 (40%), Gaps = 22/260 (8%)

Query: 110 VIGHGKFGSVWLC--RSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVT 161
            +G G FG+V     + K      A K L+        ++ +  E  +MQ L  +  +V 
Sbjct: 14  ELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVR 72

Query: 162 LHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHR 221
           +  + E  + + LVME+   G L   + +     ++    +   V   +KY  +   VHR
Sbjct: 73  MIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHR 131

Query: 222 DIKPENILLTTSGKIKLADFGLAMRISNGQ----TLSGLAGSPAYVAPEVL-SGNYSEKV 276
           D+   N+LL T    K++DFGL+  +   +      +       + APE +    +S K 
Sbjct: 132 DLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKS 191

Query: 277 DIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARMLT 335
           D+WS GVL+         P++G     V   ++        G      +   DLM    T
Sbjct: 192 DVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEK---GERMGCPAGCPREMYDLMNLCWT 248

Query: 336 RDVSARITADEV---LRHPW 352
            DV  R     V   LR+ +
Sbjct: 249 YDVENRPGFAAVELRLRNYY 268

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  181 bits (460), Expect = 2e-54
 Identities = 65/281 (23%), Positives = 120/281 (42%), Gaps = 23/281 (8%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGV 159
            D T    +G G++G V+    K      A KTL++     E   +E  +M+ +  H  +
Sbjct: 17  TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNL 75

Query: 160 VTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY--SEQRAANIFKDVMWVIKYCHDMG 217
           V L  V      F+++ E  + G L+D + E  +   S      +   +   ++Y     
Sbjct: 76  VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 135

Query: 218 VVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLSGLAGSPAYVAPEVLSGN-YSE 274
            +HRD+   N L+  +  +K+ADFGL+  ++       +G      + APE L+ N +S 
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSI 195

Query: 275 KVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM 333
           K D+W+ GVLL  +      P+ G  L  V++ ++    D+     E   +   +LM   
Sbjct: 196 KSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEK---DYRMERPEGCPEKVYELMRAC 252

Query: 334 LTRDVSARITADEVLRHPWILFYTERTLRTLTIKSKLKNQV 374
              + S R +  E+           +   T+  +S + ++V
Sbjct: 253 WQWNPSDRPSFAEIH----------QAFETMFQESSISDEV 283

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  182 bits (462), Expect = 2e-54
 Identities = 49/263 (18%), Positives = 94/263 (35%), Gaps = 18/263 (6%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---------GEETVHREVEIMQH 152
           E +  K++V+G G FG+V+       G +       K           + +  E  +M  
Sbjct: 8   ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMAS 67

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKY 212
           +  +  V  L  +   +    +   +  G  L            Q   N    +   + Y
Sbjct: 68  VD-NPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNY 126

Query: 213 CHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVL- 268
             D  +VHRD+   N+L+ T   +K+ DFGLA  +   +      G      ++A E + 
Sbjct: 127 LEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESIL 186

Query: 269 SGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR 327
              Y+ + D+WS GV +  L+   + P+ G     +   ++              +    
Sbjct: 187 HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEK---GERLPQPPICTIDVY 243

Query: 328 DLMARMLTRDVSARITADEVLRH 350
            +M +    D  +R    E++  
Sbjct: 244 MIMVKCWMIDADSRPKFRELIIE 266

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (459), Expect = 8e-54
 Identities = 56/286 (19%), Positives = 106/286 (37%), Gaps = 40/286 (13%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQH 152
           ++    +V+G G FG V    +          + A K L++       E +  E+++M  
Sbjct: 37  ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM-----------------------V 189
           L  H  +V L      +   +L+ E C  G L++ +                        
Sbjct: 97  LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156

Query: 190 EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN 249
           ++   + +        V   +++      VHRD+   N+L+T    +K+ DFGLA  I +
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMS 216

Query: 250 GQTLS---GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVF 304
                          ++APE L    Y+ K D+WS G+LL  +  +   P+ G  ++A F
Sbjct: 217 DSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANF 276

Query: 305 DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
             +  ++  F        ++    +M      D   R +   +   
Sbjct: 277 YKL--IQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF 320

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  179 bits (454), Expect = 2e-53
 Identities = 54/275 (19%), Positives = 103/275 (37%), Gaps = 21/275 (7%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHT 157
           ++ + +     IG G FG ++L    A+G E A K          +H E +I + + G  
Sbjct: 4   RVGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGV 63

Query: 158 GVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG 217
           G+ T+     E D   +VMEL              ++S +    +   ++  I+Y H   
Sbjct: 64  GIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123

Query: 218 VVHRDIKPENILLTTSG---KIKLADFGLAMRISNGQT--------LSGLAGSPAYVAPE 266
            +HRD+KP+N L+        + + DFGLA +  + +T           L G+  Y +  
Sbjct: 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASIN 183

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG----VWET 321
              G   S + D+ S G +L    + +LP++G          + +     S     + + 
Sbjct: 184 THLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG 243

Query: 322 VSKPARDLMARMLTRDVSARITADEV---LRHPWI 353
                   +    +     +     +    R+ + 
Sbjct: 244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH 278

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 59/273 (21%), Positives = 101/273 (36%), Gaps = 28/273 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKASGAEF--ACKTLRK-----GEETVHREVEIMQHLSG 155
           +D    +VIG G FG V   R K  G     A K +++            E+E++  L  
Sbjct: 10  NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69

Query: 156 HTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE----------------VGQYSEQRA 199
           H  ++ L    E     +L +E    G L+D + +                    S Q+ 
Sbjct: 70  HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129

Query: 200 ANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGS 259
            +   DV   + Y      +HRD+   NIL+  +   K+ADFGL+         +     
Sbjct: 130 LHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGRLP 189

Query: 260 PAYVAPEVL-SGNYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSG 317
             ++A E L    Y+   D+WS GVLL  ++     P+ G +   +++ +      +   
Sbjct: 190 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLE 246

Query: 318 VWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                     DLM +        R +  ++L  
Sbjct: 247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS 279

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  180 bits (457), Expect = 3e-53
 Identities = 65/293 (22%), Positives = 120/293 (40%), Gaps = 42/293 (14%)

Query: 100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHL 153
           ++ + +  +  +G G +GSV       +G   A K L +        +  +RE+ +++H+
Sbjct: 15  EVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHM 74

Query: 154 SGHTGVVTLHSVYEEADCF----HLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWV 209
             H  V+ L  V+  A        + +     G  ++ +V+  + ++     +   ++  
Sbjct: 75  K-HENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRG 133

Query: 210 IKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLS 269
           +KY H   ++HRD+KP N+ +    ++K+ DFGLA    +  T  G   +  Y APE++ 
Sbjct: 134 LKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT--GYVATRWYRAPEIML 191

Query: 270 GN--YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF------------- 314
               Y++ VDIWS G ++  LL     F G         I  +                 
Sbjct: 192 NWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA 251

Query: 315 --------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWI 353
                          + V+   +  A DL+ +ML  D   RITA + L H + 
Sbjct: 252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYF 304

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  175 bits (445), Expect = 3e-52
 Identities = 72/303 (23%), Positives = 116/303 (38%), Gaps = 38/303 (12%)

Query: 97  RKNKIEDDHTKVE--VIGHGKFGSVWLC--RSKASGAEFACKTLRKG-----EETVHREV 147
           +K  ++ D+  +    +G G FGSV     R +    + A K L++G      E + RE 
Sbjct: 1   KKLFLKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREA 60

Query: 148 EIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDV 206
           +IM  L  +  +V L  V +      LVME+  GG L   +V    +      A +   V
Sbjct: 61  QIMHQLD-NPYIVRLIGVCQAEALM-LVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQV 118

Query: 207 MWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL----SGLAGSPAY 262
              +KY  +   VHRD+   N+LL      K++DFGL+  +    +     S       +
Sbjct: 119 SMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKW 178

Query: 263 VAPEVLS-GNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSGVWE 320
            APE ++   +S + D+WS GV +   L     P+K      V   I+  K         
Sbjct: 179 YAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGK---RMECPP 235

Query: 321 TVSKPARDLMARMLTRDVSARITADEV---LRHPWILFYTERTLRTLTIKSKLKNQVGAS 377
                   LM+         R     V   +R  +            ++ SK++      
Sbjct: 236 ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY-----------SLASKVEGH---H 281

Query: 378 HHH 380
           HHH
Sbjct: 282 HHH 284

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  172 bits (437), Expect = 3e-51
 Identities = 59/264 (22%), Positives = 90/264 (34%), Gaps = 21/264 (7%)

Query: 102 EDDHTKVEVIGHGKFGSVWLCRSKAS---GAEFACKTLRK-------GEETVHREVEIMQ 151
           E D   +E +G G FG V      A        A K L+          +   REV  M 
Sbjct: 7   EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH 66

Query: 152 HLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVI 210
            L  H  ++ L+ V        +V EL   G L+D++    G +     +     V   +
Sbjct: 67  SLD-HRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGM 124

Query: 211 KYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGLAGSPAYVAPE 266
            Y      +HRD+   N+LL T   +K+ DFGL   +                 A+ APE
Sbjct: 125 GYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPE 184

Query: 267 VLSGN-YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK 324
            L    +S   D W  GV L  +      P+ G +   +   I            E   +
Sbjct: 185 SLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLPR--PEDCPQ 242

Query: 325 PARDLMARMLTRDVSARITADEVL 348
              ++M +        R T   + 
Sbjct: 243 DIYNVMVQCWAHKPEDRPTFVALR 266

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  173 bits (440), Expect = 1e-50
 Identities = 70/304 (23%), Positives = 125/304 (41%), Gaps = 55/304 (18%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK------GEETVHREVEIMQHLS 154
           +   +  ++ IG G  G V            A K L +        +  +RE+ +M+ ++
Sbjct: 15  VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN 74

Query: 155 GHTGVVTLHSVY------EEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMW 208
            H  +++L +V+      EE    +LVMEL              +   +R + +   ++ 
Sbjct: 75  -HKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLC 130

Query: 209 VIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVL 268
            IK+ H  G++HRD+KP NI++ +   +K+ DFGLA        ++    +  Y APEV+
Sbjct: 131 GIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVI 190

Query: 269 SG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK---------------- 311
            G  Y E VDIWS G ++  ++   + F G      ++ +                    
Sbjct: 191 LGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR 250

Query: 312 ----------------------LDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
                                     S   +  +  ARDL+++ML  D + RI+ D+ L+
Sbjct: 251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQ 310

Query: 350 HPWI 353
           HP+I
Sbjct: 311 HPYI 314

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  171 bits (434), Expect = 2e-50
 Identities = 58/286 (20%), Positives = 105/286 (36%), Gaps = 43/286 (15%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRK-----GEETVHREVEIMQH 152
           ++   V  IG G FG V+  R+            A K L++      +    RE  +M  
Sbjct: 13  NNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAE 72

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQY------------------ 194
              +  +V L  V        L+ E  + G L + +  +  +                  
Sbjct: 73  FD-NPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSS 131

Query: 195 ------SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS 248
                 S      I + V   + Y  +   VHRD+   N L+  +  +K+ADFGL+  I 
Sbjct: 132 PGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIY 191

Query: 249 NGQTL---SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAAL-PFKGDSLEAV 303
           +          A    ++ PE +  N Y+ + D+W+ GV+L  +    L P+ G + E V
Sbjct: 192 SADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEV 251

Query: 304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
              +++  +       E       +LM    ++  + R +   + R
Sbjct: 252 IYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR 294

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  167 bits (424), Expect = 5e-49
 Identities = 48/262 (18%), Positives = 96/262 (36%), Gaps = 20/262 (7%)

Query: 108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSV 165
              IG G FG ++   +  +  + A K   +      +  E    + L+G TG+  ++  
Sbjct: 10  GRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYF 69

Query: 166 YEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKP 225
            +E     LV++L          +   ++S +  A   K ++  ++  H+  +V+RDIKP
Sbjct: 70  GQEGLHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKP 129

Query: 226 ENILLT-----TSGKIKLADFGLAMRISNGQT--------LSGLAGSPAYVAPEVLSGN- 271
           +N L+       +  I + DFG+     +  T           L+G+  Y++     G  
Sbjct: 130 DNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE 189

Query: 272 YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG----VWETVSKPAR 327
            S + D+ + G +    L  +LP++G          + +     S     +     +   
Sbjct: 190 QSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFY 249

Query: 328 DLMARMLTRDVSARITADEVLR 349
             M         A    D +  
Sbjct: 250 KYMHYARNLAFDATPDYDYLQG 271

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (422), Expect = 6e-49
 Identities = 59/261 (22%), Positives = 97/261 (37%), Gaps = 18/261 (6%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKA---SGAEFACKTLRKG-----EETVHREVEIMQHLS 154
           +       IG G+FG V      +        A KT +        E   +E   M+   
Sbjct: 7   ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66

Query: 155 GHTGVVTLHSVYEEADCFHLVMELCSGGRLID-QMVEVGQYSEQRAANIFKDVMWVIKYC 213
            H  +V L  V  E +   ++MELC+ G L     V                +   + Y 
Sbjct: 67  -HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYL 124

Query: 214 HDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL--SGLAGSPAYVAPEVLSGN 271
                VHRDI   N+L++++  +KL DFGL+  + +      S       ++APE ++  
Sbjct: 125 ESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFR 184

Query: 272 -YSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL 329
            ++   D+W  GV +  +L+    PF+G     V   I+N +      +          L
Sbjct: 185 RFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGE---RLPMPPNCPPTLYSL 241

Query: 330 MARMLTRDVSARITADEVLRH 350
           M +    D S R    E+   
Sbjct: 242 MTKCWAYDPSRRPRFTELKAQ 262

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  165 bits (419), Expect = 2e-48
 Identities = 63/274 (22%), Positives = 116/274 (42%), Gaps = 18/274 (6%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAE----FACKTLRKG-----EETVHREVEIMQHLSGH 156
           T+ +VIG G+FG V+    K S  +     A KTL+ G           E  IM   S H
Sbjct: 10  TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-H 68

Query: 157 TGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHD 215
             ++ L  V  +     ++ E    G L   + E  G++S  +   + + +   +KY  +
Sbjct: 69  HNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128

Query: 216 MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ----TLSGLAGSPAYVAPEVLS-G 270
           M  VHRD+   NIL+ ++   K++DFGL+  + +      T SG      + APE +S  
Sbjct: 129 MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYR 188

Query: 271 NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM 330
            ++   D+WS G+++  ++        +   +  + +K +   F              LM
Sbjct: 189 KFTSASDVWSFGIVMWEVMTYGERPYWE--LSNHEVMKAINDGFRLPTPMDCPSAIYQLM 246

Query: 331 ARMLTRDVSARITADEVLRHPWILFYTERTLRTL 364
            +   ++ + R    +++     L     +L+TL
Sbjct: 247 MQCWQQERARRPKFADIVSILDKLIRAPDSLKTL 280

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  164 bits (416), Expect = 9e-48
 Identities = 58/281 (20%), Positives = 104/281 (37%), Gaps = 36/281 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRK-----GEETVHREVEIM 150
           D     + +G G FG V L  +            + A K L+          +  E+E+M
Sbjct: 13  DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72

Query: 151 QHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM----------------VEVGQY 194
           + +  H  ++ L     +    ++++E  S G L + +                    Q 
Sbjct: 73  KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--- 251
           S +   +    V   ++Y      +HRD+   N+L+T    +K+ADFGLA  I +     
Sbjct: 133 SSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYK 192

Query: 252 TLSGLAGSPAYVAPEVL-SGNYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKN 309
             +       ++APE L    Y+ + D+WS GVLL  +      P+ G  +E +F  +K 
Sbjct: 193 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKE 252

Query: 310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
                        +     +M        S R T  +++  
Sbjct: 253 ---GHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVED 290

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  162 bits (411), Expect = 5e-47
 Identities = 54/280 (19%), Positives = 99/280 (35%), Gaps = 35/280 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQH 152
           +  +  + +G G FG V    +       +    A K L+        E +  E++++ +
Sbjct: 23  NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM------------------VEVGQY 194
           L  H  +V L           ++ E C  G L++ +                   +    
Sbjct: 83  LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142

Query: 195 SEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL- 253
             +   +    V   + +      +HRD+   NILLT     K+ DFGLA  I N     
Sbjct: 143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYV 202

Query: 254 --SGLAGSPAYVAPEVLSGNY-SEKVDIWSAGVLLHALLVAALP-FKGDSLEAVFDAIKN 309
                     ++APE +     + + D+WS G+ L  L       + G  +++ F  +  
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKM-- 260

Query: 310 VKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
           +K  F     E       D+M      D   R T  ++++
Sbjct: 261 IKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 3e-45
 Identities = 58/259 (22%), Positives = 100/259 (38%), Gaps = 21/259 (8%)

Query: 109 EVIGHGKFGSVWLCR---SKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVV 160
           EVIG G FG V+      +       A K+L +            E  IM+  S H  V+
Sbjct: 33  EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVL 91

Query: 161 TLHSVYEEAD-CFHLVMELCSGGRLID-QMVEVGQYSEQRAANIFKDVMWVIKYCHDMGV 218
           +L  +   ++    +V+     G L +    E    + +        V   +K+      
Sbjct: 92  SLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKF 151

Query: 219 VHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS-----GLAGSPAYVAPEVL-SGNY 272
           VHRD+   N +L     +K+ADFGLA  + + +  S     G      ++A E L +  +
Sbjct: 152 VHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKF 211

Query: 273 SEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA 331
           + K D+WS GVLL  L+   A P+   +   +   +   +        E    P  ++M 
Sbjct: 212 TTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQP---EYCPDPLYEVML 268

Query: 332 RMLTRDVSARITADEVLRH 350
           +        R +  E++  
Sbjct: 269 KCWHPKAEMRPSFSELVSR 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (390), Expect = 5e-44
 Identities = 54/273 (19%), Positives = 99/273 (36%), Gaps = 29/273 (10%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRK-----GEETVHREVEIMQH 152
           +  T    +G G FG V+   +K           A KT+ +            E  +M+ 
Sbjct: 20  EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79

Query: 153 LSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQM----------VEVGQYSEQRAANI 202
            +    VV L  V  +     ++MEL + G L   +            +   S  +   +
Sbjct: 80  FN-CHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQM 138

Query: 203 FKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL---SGLAGS 259
             ++   + Y +    VHRD+   N ++     +K+ DFG+   I               
Sbjct: 139 AGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLP 198

Query: 260 PAYVAPEVL-SGNYSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNVKLDFHSG 317
             +++PE L  G ++   D+WS GV+L  +  +A  P++G S E V   +    L     
Sbjct: 199 VRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--- 255

Query: 318 VWETVSKPARDLMARMLTRDVSARITADEVLRH 350
             +       +LM      +   R +  E++  
Sbjct: 256 KPDNCPDMLFELMRMCWQYNPKMRPSFLEIISS 288

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  151 bits (381), Expect = 9e-43
 Identities = 60/293 (20%), Positives = 107/293 (36%), Gaps = 47/293 (16%)

Query: 101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEE-TVHREVEIMQHLS-GHTG 158
           I       E IG G+FG VW  + +  G E A K     EE +  RE EI Q +   H  
Sbjct: 1   IARTIVLQESIGKGRFGEVWRGKWR--GEEVAVKIFSSREERSWFREAEIYQTVMLRHEN 58

Query: 159 VVTLHSVYEEAD----CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH 214
           ++   +   + +       LV +    G L D +      + +    +       + + H
Sbjct: 59  ILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLH 117

Query: 215 --------DMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-----TLSGLAGSPA 261
                      + HRD+K +NIL+  +G   +AD GLA+R  +         +   G+  
Sbjct: 118 MEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKR 177

Query: 262 YVAPEVLSGN-------YSEKVDIWSAGVLLHALLVAALPFKGD---------------S 299
           Y+APEVL  +         ++ DI++ G++   +                         S
Sbjct: 178 YMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS 237

Query: 300 LEAVFDAIKNVKLDFH---SGVWETVSKPARDLMARMLTRDVSARITADEVLR 349
           +E +   +   KL  +           +    +M      + +AR+TA  + +
Sbjct: 238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKK 290

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  150 bits (379), Expect = 2e-42
 Identities = 59/280 (21%), Positives = 104/280 (37%), Gaps = 34/280 (12%)

Query: 103 DDHTKVEVIGHGKFGSVWLCRS-----KASGAEFACKTLRKG-----EETVHREVEIMQH 152
           D     + +G G FG V    +      A+    A K L++G        +  E++I+ H
Sbjct: 13  DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72

Query: 153 LSGHTGVVTLH-SVYEEADCFHLVMELCSGGRLIDQMVEVGQY----------------S 195
           +  H  VV L  +  +      +++E C  G L   +                      +
Sbjct: 73  IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132

Query: 196 EQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL-- 253
            +        V   +++      +HRD+   NILL+    +K+ DFGLA  I        
Sbjct: 133 LEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVR 192

Query: 254 -SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALL-VAALPFKGDSLEAVFDAIKNV 310
                    ++APE +    Y+ + D+WS GVLL  +  + A P+ G  ++  F   + +
Sbjct: 193 KGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF--CRRL 250

Query: 311 KLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH 350
           K        +  +      M      + S R T  E++ H
Sbjct: 251 KEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH 290

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  144 bits (364), Expect = 9e-40
 Identities = 64/318 (20%), Positives = 108/318 (33%), Gaps = 72/318 (22%)

Query: 106 TKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS-------- 154
             V  +G G F +VWL +   +    A K +R  +   E    E++++Q ++        
Sbjct: 16  ILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKED 75

Query: 155 --GHTGVVTLHSVYEE--ADCFHLVMELCSGGR---LIDQMVEVGQYSEQRAANIFKDVM 207
             G   ++ L   +     +  H+VM     G     + +  E           I K ++
Sbjct: 76  SMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLL 135

Query: 208 WVIKYC-HDMGVVHRDIKPENILLTTSG------KIKLADFGLAMRISNGQTLSGLAGSP 260
             + Y     G++H DIKPEN+L+          +IK+AD G A       T S    + 
Sbjct: 136 LGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSI--QTR 193

Query: 261 AYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH---- 315
            Y +PEVL G  +    DIWS   L+  L+     F+ D   +      ++         
Sbjct: 194 EYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGE 253

Query: 316 ----------------------------------------SGVWETVSKPARDLMARMLT 335
                                                       +  +K   D ++ ML 
Sbjct: 254 LPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQ 313

Query: 336 RDVSARITADEVLRHPWI 353
            D   R  A  ++ HPW+
Sbjct: 314 LDPRKRADAGGLVNHPWL 331

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 88.7 bits (219), Expect = 4e-21
 Identities = 32/191 (16%), Positives = 65/191 (34%), Gaps = 27/191 (14%)

Query: 109 EVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------------EETVHREVEIMQHLSG 155
           +++G GK  +V+ C S+    E   K  + G              +     + I    + 
Sbjct: 6   KLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNE 64

Query: 156 HTGVVTLHSVYE----EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIK 211
              +  L  +        +   ++MEL           E+ +   +    +   ++  + 
Sbjct: 65  FRALQKLQGLAVPKVYAWEGNAVLMELI-------DAKELYRVRVENPDEVLDMILEEVA 117

Query: 212 YCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGLAGSPAYVAPEVLSGN 271
             +  G+VH D+   N+L++  G I + DF  ++ +        L            S  
Sbjct: 118 KFYHRGIVHGDLSQYNVLVSEEG-IWIIDFPQSVEVGEEGWREILERDV-RNIITYFSRT 175

Query: 272 YSEKVDIWSAG 282
           Y  + DI SA 
Sbjct: 176 YRTEKDINSAI 186

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} Length = 392

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

 Score = 37.5 bits (86), Expect = 0.003
 Identities = 19/141 (13%), Positives = 42/141 (29%), Gaps = 13/141 (9%)

Query: 97  RKNKIEDDHTKVEV--IGHGKFGSVWLCRSKASGAEFACK----TLRKGEETVH------ 144
            K  +    + +    IG G    V+    +        K      +   E+        
Sbjct: 18  VKLGLFPSKSTLTCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRA 77

Query: 145 -REVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIF 203
             E   +     H   +     Y + +    VME  S  ++  + +  G+     + +I 
Sbjct: 78  RIESSALIRQGEHVPHLVPRVFYSDTEMAVTVMEDLSHLKIARKGLIEGENYPHLSQHIG 137

Query: 204 KDVMWVIKYCHDMGVVHRDIK 224
           + +   + Y  D  +  +  K
Sbjct: 138 EFLGKTLFYSSDYALEPKVKK 158

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	469
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.93
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	98.7
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	98.44
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	98.25
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	97.59
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	97.42
d2hf5a1	33	Troponin C {Human (Homo sapiens), cardiac isoform	97.24
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	96.88
d1ctda_	34	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	94.46
d5pala_	109	Parvalbumin {Leopard shark (Triakis semifasciata)	90.62
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	89.55
d1pvaa_	109	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	89.08
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	87.51
d1jc2a_	75	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	86.84
d1fi5a_	81	Troponin C {Chicken (Gallus gallus), cardiac isofo	86.84
d1c7va_	68	Calcium vector protein {Amphioxus (Branchiostoma l	86.55
d1avsa_	81	Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}	86.33
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	85.24
d1wdcc_	152	Myosin Regulatory Chain {Bay scallop (Aequipecten	85.19
d2fcea1	61	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	84.99
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	84.78
d1f54a_	77	Calmodulin {Baker's yeast (Saccharomyces cerevisia	84.46
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	84.21
d1s6ja_	87	Calcium-dependent protein kinase sk5 CLD {Soybean	84.17
d1xo5a_	180	Calcium- and integrin-binding protein, CIB {Human	83.97
d2pvba_	107	Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}	83.79
d1c07a_	95	Eps15 {Human (Homo sapiens) [TaxId: 9606]}	83.17
d2mysc_	145	Myosin Regulatory Chain {Chicken (Gallus gallus) [	82.84
d1oqpa_	77	Caltractin (centrin 2) {Green algae (Chlamydomonas	82.8
d1wdcb_	142	Myosin Essential Chain {Bay scallop (Aequipecten i	82.31
d2pq3a1	73	Calmodulin {Rattus norvegicus [TaxId: 10116]}	82.26
d1fw4a_	65	Calmodulin {Cow (Bos taurus) [TaxId: 9913]}	82.15
d1g8ia_	187	Frequenin (neuronal calcium sensor 1) {Human (Homo	81.31
d2opoa1	81	Polcalcin Che a 3 {Pigweed (Chenopodium album) [Ta	80.65
d1wlza1	83	DJ-1-binding protein, DJBP {Human (Homo sapiens) [	80.33
d1tiza_	67	Calmodulin-related protein T21P5.17 {Thale cress (	80.27

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.5e-63  Score=474.84  Aligned_cols=247  Identities=37%  Similarity=0.664  Sum_probs=229.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc-------ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK-------GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-------~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||+|++.+       ....+.+|+++|+.++ |||||++++++.+++.+|+|
T Consensus         6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~iv   84 (263)
T d2j4za1           6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLR-HPNILRLYGYFHDATRVYLI   84 (263)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcC-CCCCCeEEEEEEECCEEEEE
Confidence            689999999999999999999999999999999853       2356889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      ||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ....
T Consensus        85 mEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~-~~~~  163 (263)
T d2j4za1          85 LEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS-RRTT  163 (263)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC-CCEE
T ss_pred             EeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC-cccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999765543 3455


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..+.+..+.++    ..+|+++++||.+||
T Consensus       164 ~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L  239 (263)
T d2j4za1         164 LCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFP----DFVTEGARDLISRLL  239 (263)
T ss_dssp             TTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC----TTSCHHHHHHHHHHT
T ss_pred             cCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHHc
Confidence            7899999999999875 89999999999999999999999999999999999988877665    468999999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccc
Q 012170          335 TRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      ++||.+|||++|+|+||||..
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999953

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=1.2e-62  Score=484.28  Aligned_cols=256  Identities=37%  Similarity=0.677  Sum_probs=221.7

Q ss_pred             ccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170           99 NKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +.+.+.|++++.||+|+||+||+|+++.+|+.||||++.+.     ...+.+|+.+|+.++ |||||+++++|++++.+|
T Consensus         5 edi~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~   83 (307)
T d1a06a_           5 EDIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK-HPNIVALDDIYESGGHLY   83 (307)
T ss_dssp             SCGGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCC-CTTBCCEEEEEECSSEEE
T ss_pred             CCCccceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhhhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEE
Confidence            45788899999999999999999999999999999998643     245778999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc---cCCcEEEEeccceeeecCC
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT---TSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~---~~~~vkL~DFgla~~~~~~  250 (469)
                      ||||||+||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||+.   .+|.+||+|||++......
T Consensus        84 lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~  163 (307)
T d1a06a_          84 LIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG  163 (307)
T ss_dssp             EEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC---------
T ss_pred             EEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCC
Confidence            9999999999999999889999999999999999999999999999999999999995   4789999999999877766


Q ss_pred             CcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          251 QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       251 ~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ....+.+||+.|||||++.+. |+.++|||||||++|+|++|.+||.+.+..++...+......++...+..+|+++++|
T Consensus       164 ~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  243 (307)
T d1a06a_         164 SVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYWDDISDSAKDF  243 (307)
T ss_dssp             ---------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTTTTSCHHHHHH
T ss_pred             CeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccccCCCHHHHHH
Confidence            666778999999999999774 9999999999999999999999999999999999999988888877888999999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      |.+||.+||.+|||+.|+|+||||..
T Consensus       244 i~~~L~~dP~~R~s~~eil~hp~~~~  269 (307)
T d1a06a_         244 IRHLMEKDPEKRFTCEQALQHPWIAG  269 (307)
T ss_dssp             HHHHSCSSGGGSCCHHHHHHSTTTTS
T ss_pred             HHHHccCCHhHCcCHHHHhcCHhhCC
Confidence            99999999999999999999999964

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-62  Score=475.72  Aligned_cols=253  Identities=31%  Similarity=0.549  Sum_probs=220.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++...     .+.+.+|+++|++++ |||||++++++.+++.+|||
T Consensus         3 f~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~-HpnIv~~~~~~~~~~~~~iv   81 (271)
T d1nvra_           3 FVEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLN-HENVVKFYGHRREGNIQYLF   81 (271)
T ss_dssp             TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHhCC-CCCEeeEeeeeccCceeEEE
Confidence            467899999999999999999999999999999998643     246889999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC---c
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ---T  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~---~  252 (469)
                      ||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|.......   .
T Consensus        82 mEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~  161 (271)
T d1nvra_          82 LEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERL  161 (271)
T ss_dssp             EECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECC
T ss_pred             EeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCcccc
Confidence            9999999999999888899999999999999999999999999999999999999999999999999998764332   2


Q ss_pred             ccccCCCCcccCceeccCC-C-CCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-Y-SEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~-~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ....+||+.|||||++.+. | +.++|||||||++|+|++|.+||.+.+.. ..+..+.....  ....+..+|+++++|
T Consensus       162 ~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~l  239 (271)
T d1nvra_         162 LNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKT--YLNPWKKIDSAPLAL  239 (271)
T ss_dssp             BCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCT--TSTTGGGSCHHHHHH
T ss_pred             ccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHHhcCCC--CCCccccCCHHHHHH
Confidence            4567899999999999764 4 67899999999999999999999765433 23333333222  223467899999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      |.+||+.||.+|||++|+|+||||+..
T Consensus       240 i~~~L~~dP~~R~t~~eil~hpwf~~~  266 (271)
T d1nvra_         240 LHKILVENPSARITIPDIKKDRWYNKP  266 (271)
T ss_dssp             HHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             HHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence            999999999999999999999999643

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-61  Score=474.27  Aligned_cols=257  Identities=35%  Similarity=0.655  Sum_probs=239.7

Q ss_pred             cccccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhhCCCCeeEEEEEEE
Q 012170           98 KNKIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLSGHTGVVTLHSVYE  167 (469)
Q Consensus        98 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~~hpnIv~l~~~~~  167 (469)
                      +..+.++|++++.||+|+||+||+|+++.+|+.||||++++.          .+.+.+|+.+|++|+ |||||+++++|+
T Consensus         5 ~~~i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~   83 (293)
T d1jksa_           5 QENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQ-HPNVITLHEVYE   83 (293)
T ss_dssp             CSCGGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCC-CTTBCCEEEEEE
T ss_pred             CCCcccCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCC-CCCCCcEEEEEE
Confidence            445778999999999999999999999999999999998532          356889999999996 999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC----cEEEEeccc
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG----KIKLADFGL  243 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~----~vkL~DFgl  243 (469)
                      +.+.+|||||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|    .+||+|||+
T Consensus        84 ~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~  163 (293)
T d1jksa_          84 NKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL  163 (293)
T ss_dssp             CSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred             ECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEecCCCcccceEecchhh
Confidence            9999999999999999999999999999999999999999999999999999999999999998877    499999999


Q ss_pred             eeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCC
Q 012170          244 AMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETV  322 (469)
Q Consensus       244 a~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  322 (469)
                      +..........+..||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+.+..|......++...+..+
T Consensus       164 a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~  243 (293)
T d1jksa_         164 AHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNYEFEDEYFSNT  243 (293)
T ss_dssp             CEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCCHHHHTTS
T ss_pred             hhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCCchhcCCC
Confidence            998877766777899999999999987 4999999999999999999999999999999999999998888877777889


Q ss_pred             CHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          323 SKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       323 s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      |+++++||.+||+.||.+|||++|+|+||||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            999999999999999999999999999999964

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-62  Score=473.90  Aligned_cols=253  Identities=28%  Similarity=0.519  Sum_probs=228.4

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||+||+|+++.+|+.||||++.+.       .+.+.+|+++|++++ ||||++++++|++++.+|+
T Consensus         7 p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~i   85 (288)
T d1uu3a_           7 PEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLD-HPFFVKLYFTFQDDEKLYF   85 (288)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCC-STTBCCEEEEEECSSEEEE
T ss_pred             CCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcC-CCCeeEEEEEEEECCEEEE
Confidence            46899999999999999999999999999999998532       256889999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC---C
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---Q  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~---~  251 (469)
                      |||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.+...   .
T Consensus        86 vmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~  165 (288)
T d1uu3a_          86 GLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQA  165 (288)
T ss_dssp             EECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------
T ss_pred             EEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCCCceEEecccccceecccCCccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876533   2


Q ss_pred             cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..|.+..+.++    ..+++++++||
T Consensus       166 ~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li  241 (288)
T d1uu3a_         166 RANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP----EKFFPKARDLV  241 (288)
T ss_dssp             ----CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC----TTCCHHHHHHH
T ss_pred             ccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHHcCCCCCC----ccCCHHHHHHH
Confidence            3445789999999999977 599999999999999999999999999999999999998877765    46899999999


Q ss_pred             HHhchhhhcCCCCHHH------HHcCCCccccccc
Q 012170          331 ARMLTRDVSARITADE------VLRHPWILFYTER  359 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~e------lL~hp~~~~~~~~  359 (469)
                      .+||++||.+|||++|      +++||||....+.
T Consensus       242 ~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~  276 (288)
T d1uu3a_         242 EKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWE  276 (288)
T ss_dssp             HTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCT
T ss_pred             HHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHH
Confidence            9999999999999988      5889999665443

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=3e-61  Score=482.44  Aligned_cols=257  Identities=31%  Similarity=0.552  Sum_probs=237.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+.++|++++.||+|+||.||+|+++.+|+.||||++...    .+.+.+|+.+|++|+ |||||+++++|++++.+|||
T Consensus        23 ~il~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv  101 (350)
T d1koaa2          23 HVLDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLR-HPTLVNLHDAFEDDNEMVMI  101 (350)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTC-CTTBCCEEEEEEETTEEEEE
T ss_pred             CCccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccchhhHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            3567999999999999999999999999999999999654    245789999999997 99999999999999999999


Q ss_pred             EeccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc--CCcEEEEeccceeeecCCCc
Q 012170          176 MELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT--SGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~--~~~vkL~DFgla~~~~~~~~  252 (469)
                      ||||+||+|.+++.. .+.+++..+..++.||+.||.|||++||+||||||+|||++.  +|.+||+|||++..+.....
T Consensus       102 mE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~  181 (350)
T d1koaa2         102 YEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQS  181 (350)
T ss_dssp             ECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeeccCCCCeEEEeecchheecccccc
Confidence            999999999999854 467999999999999999999999999999999999999964  57899999999998877777


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|||||++.+. |+.++|||||||++|+|++|..||.+.+..+++..|......++...+..+|+++++||.
T Consensus       182 ~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  261 (350)
T d1koaa2         182 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAFSGISEDGKDFIR  261 (350)
T ss_dssp             EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGGGGCCHHHHHHHH
T ss_pred             cceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7778999999999999774 899999999999999999999999999999999999998888888788889999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCccccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      +||..||.+|||+.|+|+||||....
T Consensus       262 ~~L~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         262 KLLLADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             HHCCSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             HHccCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999997553

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3e-61  Score=470.89  Aligned_cols=252  Identities=29%  Similarity=0.482  Sum_probs=224.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ..++|++++.||+|+||+||+|+++.+|+.||||+++.    ..+.+.+|+.+|+.++ |||||+++++|.+++.+||||
T Consensus        18 p~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~ivm   96 (293)
T d1yhwa1          18 PKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENK-NPNIVNYLDSYLVGDELWVVM   96 (293)
T ss_dssp             TTTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             cccccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccChHHHHHHHHHHHHHhCC-CCCEeeEeEEEEECCEEEEEE
Confidence            45689999999999999999999999999999999853    3456899999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Ccccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~  255 (469)
                      |||+||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|++||+|||+|..+... .....
T Consensus        97 Ey~~gg~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~~~~~  175 (293)
T d1yhwa1          97 EYLAGGSLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST  175 (293)
T ss_dssp             ECCTTCBHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTCCBCC
T ss_pred             EecCCCcHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCCcEeeccchhheeeccccccccc
Confidence            9999999998774 468999999999999999999999999999999999999999999999999999876543 34556


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+....+..+...... ....+..+|+++++||.+||
T Consensus       176 ~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~s~~~~~li~~~L  254 (293)
T d1yhwa1         176 MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTP-ELQNPEKLSAIFRDFLNRCL  254 (293)
T ss_dssp             CCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCSC-CCSSGGGSCHHHHHHHHHHT
T ss_pred             cccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCCC-CCCCcccCCHHHHHHHHHHc
Confidence            7899999999999774 899999999999999999999999998877776665543221 12334678999999999999


Q ss_pred             hhhhcCCCCHHHHHcCCCccc
Q 012170          335 TRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~hp~~~~  355 (469)
                      .+||.+|||+.|+|+||||+.
T Consensus       255 ~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         255 DMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CSSTTTSCCHHHHTTCGGGGG
T ss_pred             cCChhHCcCHHHHhcCHhhCC
Confidence            999999999999999999953

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=8.9e-61  Score=464.15  Aligned_cols=256  Identities=34%  Similarity=0.610  Sum_probs=238.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------------HHHHHHHHHHHHhhCCCCeeEEEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------------ETVHREVEIMQHLSGHTGVVTLHSVYE  167 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------------~~~~~E~~il~~l~~hpnIv~l~~~~~  167 (469)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++++..             +.+.+|+.+|++|..||||+++++++.
T Consensus         1 f~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~   80 (277)
T d1phka_           1 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE   80 (277)
T ss_dssp             CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred             CcccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecc
Confidence            4589999999999999999999999999999999986421             357789999999977999999999999


Q ss_pred             eCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          168 EADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       168 ~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                      +++.+|||||||+||+|.+++..++++++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        81 ~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~  160 (277)
T d1phka_          81 TNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQL  160 (277)
T ss_dssp             CSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEEC
T ss_pred             cCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccceEEEcCCCCeEEccchheeEc
Confidence            99999999999999999999999999999999999999999999999999999999999999999999999999999988


Q ss_pred             cCCCcccccCCCCcccCceeccC-------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      .........+||+.|+|||++.+       .|+.++||||+||++|+|++|..||.+.+.......+......++...+.
T Consensus       161 ~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  240 (277)
T d1phka_         161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEWD  240 (277)
T ss_dssp             CTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTGG
T ss_pred             cCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcccc
Confidence            77666677899999999999853       37889999999999999999999999999999999999888877777778


Q ss_pred             CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          321 TVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       321 ~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .+|+++++||.+||++||.+|||++|||+||||..+
T Consensus       241 ~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~  276 (277)
T d1phka_         241 DYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  276 (277)
T ss_dssp             GSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             cCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence            999999999999999999999999999999999754

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.9e-61  Score=476.42  Aligned_cols=250  Identities=34%  Similarity=0.580  Sum_probs=231.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++++.       ...+.+|+.+|+.+. ||||++++++|++.+.+|+
T Consensus         4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~-hp~Iv~l~~~~~~~~~~~i   82 (337)
T d1o6la_           4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTR-HPFLTALKYAFQTHDRLCF   82 (337)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-CTTBCCEEEEEECSSEEEE
T ss_pred             hHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCC-CCCEEEEEeeecccccccc
Confidence            36899999999999999999999999999999998642       356789999999997 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC-CCcc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN-GQTL  253 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~-~~~~  253 (469)
                      |||||+||+|.+++.+.+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|+.... ....
T Consensus        83 v~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~~~  162 (337)
T d1o6la_          83 VMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATM  162 (337)
T ss_dssp             EEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTCCB
T ss_pred             ceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEecCCCCEEEeecccccccccCCccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999986543 4455


Q ss_pred             cccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+....+.++    ..+|+++++||.+
T Consensus       163 ~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~  238 (337)
T d1o6la_         163 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFP----RTLSPEAKSLLAG  238 (337)
T ss_dssp             CCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHH
T ss_pred             ccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHh
Confidence            67899999999999977 499999999999999999999999999999999999998887765    5689999999999


Q ss_pred             hchhhhcCCCC-----HHHHHcCCCcccc
Q 012170          333 MLTRDVSARIT-----ADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rps-----a~elL~hp~~~~~  356 (469)
                      ||++||.+|++     ++|+++||||...
T Consensus       239 ~L~~dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         239 LLKKDPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             HTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             hccCCchhhcccccccHHHHHcCcccccC
Confidence            99999999994     9999999999654

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=4.8e-61  Score=481.30  Aligned_cols=256  Identities=30%  Similarity=0.541  Sum_probs=237.4

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .+.++|++++.||+|+||.||+|+++.+|+.||||+++..    ...+.+|+.+|++|. |||||+++++|.+++.+|||
T Consensus        26 ~~~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~iv  104 (352)
T d1koba_          26 SVYDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLH-HPKLINLHDAFEDKYEMVLI  104 (352)
T ss_dssp             CGGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCC-STTBCCEEEEEECSSEEEEE
T ss_pred             CcccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcchhHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            3567899999999999999999999999999999999653    246788999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEc--cCCcEEEEeccceeeecCCCc
Q 012170          176 MELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLT--TSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~--~~~~vkL~DFgla~~~~~~~~  252 (469)
                      ||||+||+|.+.+...+ ++++.+++.|+.||+.||.|||++||+||||||+||||+  .+|.+||+|||+|........
T Consensus       105 mE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~  184 (352)
T d1koba_         105 LEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI  184 (352)
T ss_dssp             EECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSC
T ss_pred             EEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccccCCCeEEEeecccceecCCCCc
Confidence            99999999998876554 699999999999999999999999999999999999998  578999999999998877777


Q ss_pred             ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMA  331 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~  331 (469)
                      ....+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..|......++...+..+|+++++||.
T Consensus       185 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~  264 (352)
T d1koba_         185 VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFSSVSPEAKDFIK  264 (352)
T ss_dssp             EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTTTSCHHHHHHHH
T ss_pred             eeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccccCCCHHHHHHHH
Confidence            7778999999999999774 999999999999999999999999999999999999999888888888899999999999


Q ss_pred             HhchhhhcCCCCHHHHHcCCCcccc
Q 012170          332 RMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       332 ~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +||++||.+|||+.|+|+||||+..
T Consensus       265 ~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         265 NLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             TTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             HHccCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999653

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.9e-61  Score=469.27  Aligned_cols=256  Identities=27%  Similarity=0.460  Sum_probs=227.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      .++.|++++.||+|+||.||+|+++.+|+.||||+++..    .+.+.+|+++|++|+ |||||++++++.+++.+||||
T Consensus        10 p~d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~~~~~~~~~~~lvm   88 (288)
T d2jfla1          10 PEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCD-HPNIVKLLDAFYYENNLWILI   88 (288)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             cccCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcCCHHHHHHHHHHHHHHHhCC-CCCCCeEEEEEeeCCeEEEEE
Confidence            457899999999999999999999999999999998642    256889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      |||+||+|.+++.+. +.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|...... ....
T Consensus        89 Ey~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~~~~  168 (288)
T d2jfla1          89 EFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRD  168 (288)
T ss_dssp             ECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHHHHT
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCccccc
Confidence            999999999987664 57999999999999999999999999999999999999999999999999999765433 2345


Q ss_pred             ccCCCCcccCceeccC------CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG------NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~------~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                      +.+||+.|+|||++.+      .|+.++|||||||++|+|++|.+||.+.+..+++..+........ ..+..+|+++++
T Consensus       169 ~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~i~~~~~~~~-~~~~~~s~~~~~  247 (288)
T d2jfla1         169 SFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLKIAKSEPPTL-AQPSRWSSNFKD  247 (288)
T ss_dssp             CCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHHSCCCCC-SSGGGSCHHHHH
T ss_pred             ccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-CccccCCHHHHH
Confidence            6789999999999842      388999999999999999999999999888888888877654332 234678999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          329 LMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                      ||.+||++||.+|||+.|+|+||||.....
T Consensus       248 li~~~L~~dp~~R~t~~ell~hp~~~~~~~  277 (288)
T d2jfla1         248 FLKKCLEKNVDARWTTSQLLQHPFVTVDSN  277 (288)
T ss_dssp             HHHHHSCSSTTTSCCHHHHTTSGGGCCCCC
T ss_pred             HHHHHccCChhHCcCHHHHhcCcccCCCCC
Confidence            999999999999999999999999965443

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=459.62  Aligned_cols=247  Identities=29%  Similarity=0.501  Sum_probs=210.5

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~l  174 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||++....      +.+.+|+++|++++ |||||++++++.+  ++.+|+
T Consensus         4 edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~i   82 (269)
T d2java1           4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELK-HPNIVRYYDRIIDRTNTTLYI   82 (269)
T ss_dssp             GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCC-CTTBCCEEEEEEC----CEEE
T ss_pred             hhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhCCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEeCCCCEEEE
Confidence            68999999999999999999999999999999986432      45788999999996 9999999999864  567899


Q ss_pred             EEeccCCCchHHHHHH----hCCCCHHHHHHHHHHHHHHHHHHHhcC-----eEeccCCCCcEEEccCCcEEEEecccee
Q 012170          175 VMELCSGGRLIDQMVE----VGQYSEQRAANIFKDVMWVIKYCHDMG-----VVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~----~~~l~~~~~~~i~~qil~aL~yLH~~g-----ivHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                      |||||+||+|.+++.+    .+.+++..++.++.||+.||.|||+.|     |+||||||+||||+.+|.+||+|||+|.
T Consensus        83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~  162 (269)
T d2java1          83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR  162 (269)
T ss_dssp             EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred             EEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeecccee
Confidence            9999999999998864    357999999999999999999999976     9999999999999999999999999998


Q ss_pred             eecCCC-cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          246 RISNGQ-TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       246 ~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ...... .....+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..++...|.......   .+..+|
T Consensus       163 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~s  239 (269)
T d2java1         163 ILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR---IPYRYS  239 (269)
T ss_dssp             HC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCC---CCTTSC
T ss_pred             ecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCC---CCcccC
Confidence            765433 3456789999999999976 59999999999999999999999999999999999888776542   235689


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWI  353 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~  353 (469)
                      +++++||.+||+.||.+|||+.|+|+|||+
T Consensus       240 ~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         240 DELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999999999996

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-60  Score=470.48  Aligned_cols=256  Identities=27%  Similarity=0.511  Sum_probs=237.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++.++|++++.||+|+||+||+|.++.+|+.||||+++...   ..+.+|+++|+.++ |||||+++++|++++.+||||
T Consensus         2 ~~~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~lvm   80 (321)
T d1tkia_           2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVLVKKEISILNIAR-HRNILHLHESFESMEELVMIF   80 (321)
T ss_dssp             CCTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTHHHHHHHHHHHHHHHSC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             CCccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCcccHHHHHHHHHHHHhCC-CCCCCeEEEEEEECCEEEEEE
Confidence            46789999999999999999999999999999999997643   35779999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC--CcEEEEeccceeeecCCCcc
Q 012170          177 ELCSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS--GKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~--~~vkL~DFgla~~~~~~~~~  253 (469)
                      |||+||+|.+++...+ .+++.+++.++.||+.||.|||++||+||||||+|||++.+  +.+||+|||++.........
T Consensus        81 E~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~  160 (321)
T d1tkia_          81 EFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF  160 (321)
T ss_dssp             CCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE
T ss_pred             ecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCCcc
Confidence            9999999999997665 79999999999999999999999999999999999999854  47999999999887766666


Q ss_pred             cccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...+||+.|+|||++.+. |+.++|||||||++|+|++|.+||.+.+..+++..|.+..+.++...|..+|+++++||.+
T Consensus       161 ~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~  240 (321)
T d1tkia_         161 RLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDR  240 (321)
T ss_dssp             EEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHHTTSCHHHHHHHHT
T ss_pred             cccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhccCCCHHHHHHHHH
Confidence            677899999999999764 8999999999999999999999999999999999999998888877788899999999999


Q ss_pred             hchhhhcCCCCHHHHHcCCCcccc
Q 012170          333 MLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      ||.+||.+|||++|+|+||||...
T Consensus       241 ~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         241 LLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             TSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             HccCChhHCcCHHHHhcCHhhccC
Confidence            999999999999999999999654

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=1.3e-59  Score=464.30  Aligned_cols=249  Identities=31%  Similarity=0.589  Sum_probs=230.0

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++.       .+.+.+|+.+|+.++ |||||++++++.+.+.+|+|
T Consensus         4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv   82 (316)
T d1fota_           4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVT-HPFIIRMWGTFQDAQQIFMI   82 (316)
T ss_dssp             GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCC-BTTBCCEEEEEECSSEEEEE
T ss_pred             hHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhcc-CcChhheeeeEeeCCeeeeE
Confidence            6799999999999999999999999999999998642       356889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSG  255 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~  255 (469)
                      ||||.||+|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|......  ..+
T Consensus        83 mE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~--~~~  160 (316)
T d1fota_          83 MDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV--TYT  160 (316)
T ss_dssp             ECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC--BCC
T ss_pred             eeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEcCCCCEEEecCccceEeccc--ccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999876533  345


Q ss_pred             cCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          256 LAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.+..+++..|.+....++    ..+|++++++|.+||
T Consensus       161 ~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~L  236 (316)
T d1fota_         161 LCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP----PFFNEDVKDLLSRLI  236 (316)
T ss_dssp             CCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHT
T ss_pred             ccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHcCCCCCC----CCCCHHHHHHHHHHh
Confidence            7899999999999875 99999999999999999999999999999999999988876665    468999999999999


Q ss_pred             hhhhcCCC-----CHHHHHcCCCcccccc
Q 012170          335 TRDVSARI-----TADEVLRHPWILFYTE  358 (469)
Q Consensus       335 ~~dP~~Rp-----sa~elL~hp~~~~~~~  358 (469)
                      .+||.+|+     |++++|+||||....+
T Consensus       237 ~~dp~~R~~~~r~t~~~il~Hp~f~~i~~  265 (316)
T d1fota_         237 TRDLSQRLGNLQNGTEDVKNHPWFKEVVW  265 (316)
T ss_dssp             CSCTTTCTTSSTTTTHHHHTSGGGSSCCH
T ss_pred             hhCHHhccccchhhHHHHHcCcccccCCH
Confidence            99999996     9999999999966543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=3.8e-60  Score=466.66  Aligned_cols=251  Identities=27%  Similarity=0.405  Sum_probs=224.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-------HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-------ETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-------~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++.|++++.||+|+||+||+|+++.+|+.||||++....       +.+.+|+++|++|+ |||||++++++.+++.+|
T Consensus        13 p~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~~~~~~~~~~~~~   91 (309)
T d1u5ra_          13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR-HPNTIQYRGCYLREHTAW   91 (309)
T ss_dssp             HHHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEE
T ss_pred             cHHhcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCC-CCCEeeEEEEEEECCEEE
Confidence            4567999999999999999999999999999999986431       35788999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCcc
Q 012170          174 LVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTL  253 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~  253 (469)
                      +|||||.||+|..++...+++++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|.....   .
T Consensus        92 iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~---~  168 (309)
T d1u5ra_          92 LVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP---A  168 (309)
T ss_dssp             EEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS---B
T ss_pred             EEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCCEEEeecccccccCC---C
Confidence            9999999999988888888999999999999999999999999999999999999999999999999999976543   3


Q ss_pred             cccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          254 SGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       254 ~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      ...+||+.|||||++.+    .|+.++|||||||++|+|++|..||.+.+..+.+..+........  ....+|+++++|
T Consensus       169 ~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~s~~~~~l  246 (309)
T d1u5ra_         169 NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPAL--QSGHWSEYFRNF  246 (309)
T ss_dssp             CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC--SCTTSCHHHHHH
T ss_pred             CccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC--CCCCCCHHHHHH
Confidence            45689999999999853    489999999999999999999999999888887777766544332  234679999999


Q ss_pred             HHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          330 MARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       330 I~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                      |.+||++||.+|||+.|+|+||||....
T Consensus       247 i~~~L~~dP~~Rpt~~ell~Hp~~~~~~  274 (309)
T d1u5ra_         247 VDSCLQKIPQDRPTSEVLLKHRFVLRER  274 (309)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred             HHHHCcCChhHCcCHHHHHhCHHhcCCC
Confidence            9999999999999999999999996543

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-60  Score=471.56  Aligned_cols=254  Identities=26%  Similarity=0.420  Sum_probs=216.8

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ..++|++++.||+|+||+||+|+++.+|+.||+|+++..     ...+.+|+.+|++++ |||||+++++|.+.+.+|||
T Consensus         4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~-HpnIv~l~~~~~~~~~~~iV   82 (322)
T d1s9ja_           4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECN-SPYIVGFYGAFYSDGEISIC   82 (322)
T ss_dssp             CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCC-CTTBCCEEEEEECSSEEEEE
T ss_pred             CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhhCHHHHHHHHHHHHHHHhCC-CCCCCcEEEEEEECCEEEEE
Confidence            468999999999999999999999999999999998643     256889999999996 99999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||||+||+|.+++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+.+|.+||+|||+|....+. ...
T Consensus        83 mEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-~~~  161 (322)
T d1s9ja_          83 MEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-MAN  161 (322)
T ss_dssp             EECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH-TC-
T ss_pred             EEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC-ccc
Confidence            9999999999999999999999999999999999999997 59999999999999999999999999999865432 234


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHH-----------------------------
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVF-----------------------------  304 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~-----------------------------  304 (469)
                      +.+||+.|+|||++.+ .|+.++||||+||++|+|++|..||.+.+.....                             
T Consensus       162 ~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  241 (322)
T d1s9ja_         162 SFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYG  241 (322)
T ss_dssp             --CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--------------------------
T ss_pred             cccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccc
Confidence            5799999999999987 5999999999999999999999999765432211                             


Q ss_pred             -------------HHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          305 -------------DAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       305 -------------~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                                   ..+....  .+......+|.++++||.+||+.||.+||||+|+|+||||+....
T Consensus       242 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~~~~  306 (322)
T d1s9ja_         242 MDSRPPMAIFELLDYIVNEP--PPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDA  306 (322)
T ss_dssp             ----CCCCHHHHHHHHHTSC--CCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHHHH
T ss_pred             cccccchhHHHHHhhhhccC--CccCccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCcCCc
Confidence                         1111100  011111346899999999999999999999999999999965443

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-59  Score=453.66  Aligned_cols=246  Identities=20%  Similarity=0.397  Sum_probs=216.0

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFHL  174 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~l  174 (469)
                      |++.+.||+|+||+||+|.++.+++.||+|++...      .+.+.+|+++|++++ |||||+++++|++    ...+|+
T Consensus        11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~~~~~i   89 (270)
T d1t4ha_          11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQ-HPNIVRFYDSWESTVKGKKCIVL   89 (270)
T ss_dssp             EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEEEEESSSCEEEEE
T ss_pred             EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhCCHHHHHHHHHHHHHHHhCC-CCCeeeEEEEEeeccccCCEEEE
Confidence            36677899999999999999999999999998542      246789999999997 9999999999875    456899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcC--eEeccCCCCcEEEc-cCCcEEEEeccceeeecCCC
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMG--VVHRDIKPENILLT-TSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~g--ivHrDlkp~NILl~-~~~~vkL~DFgla~~~~~~~  251 (469)
                      |||||+||+|.+++.+.+.+++..+..++.||+.||.|||++|  |+||||||+|||++ +++.+||+|||+|+... ..
T Consensus        90 vmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~-~~  168 (270)
T d1t4ha_          90 VTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKR-AS  168 (270)
T ss_dssp             EEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCC-TT
T ss_pred             EEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceecc-CC
Confidence            9999999999999999999999999999999999999999999  99999999999997 47899999999997543 33


Q ss_pred             cccccCCCCcccCceeccCCCCCccchHHHHHHHHHHHhCCCCCCCC-CHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSGNYSEKVDIWSAGVLLHALLVAALPFKGD-SLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~~~~~~~DiwSlG~il~elltG~~Pf~~~-~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      ...+.+||+.|||||++.+.|+.++|||||||++|+|++|..||.+. +...+...+.....  +...+..+++++++||
T Consensus       169 ~~~~~~GT~~Y~aPE~~~~~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~i~~~~~--~~~~~~~~~~~~~~li  246 (270)
T d1t4ha_         169 FAKAVIGTPEFMAPEMYEEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVK--PASFDKVAIPEVKEII  246 (270)
T ss_dssp             SBEESCSSCCCCCGGGGGTCCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHHHTTTCC--CGGGGGCCCHHHHHHH
T ss_pred             ccCCcccCccccCHHHhCCCCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHHHHcCCC--CcccCccCCHHHHHHH
Confidence            34567899999999999999999999999999999999999999764 45566666655432  2223456899999999


Q ss_pred             HHhchhhhcCCCCHHHHHcCCCcc
Q 012170          331 ARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                      .+||++||++|||++|+|+||||+
T Consensus       247 ~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         247 EGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             HHHccCCHhHCcCHHHHhCCcccC
Confidence            999999999999999999999984

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.8e-59  Score=467.32  Aligned_cols=249  Identities=29%  Similarity=0.557  Sum_probs=229.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.       .+.+.+|+.+|+.+. |||||++++++.+.+.+|+
T Consensus        40 ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~~  118 (350)
T d1rdqe_          40 LDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVN-FPFLVKLEFSFKDNSNLYM  118 (350)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEE
T ss_pred             ccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcC-CCcEeeccccccccccccc
Confidence            37899999999999999999999999999999998532       356789999999996 9999999999999999999


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccc
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLS  254 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~  254 (469)
                      ||||+.||+|..++.+.+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||+|+.+...  ..
T Consensus       119 v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~--~~  196 (350)
T d1rdqe_         119 VMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR--TW  196 (350)
T ss_dssp             EEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC--BC
T ss_pred             ccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc--cc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999876533  34


Q ss_pred             ccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+||+.|||||++.+. |+.++|||||||++|+|++|.+||.+.+...++..|....+.++    ..+++++.+||.+|
T Consensus       197 ~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~~  272 (350)
T d1rdqe_         197 TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFP----SHFSSDLKDLLRNL  272 (350)
T ss_dssp             CCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTCCHHHHHHHHHH
T ss_pred             cccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHhcCCCCCC----ccCCHHHHHHHHHH
Confidence            57899999999999875 89999999999999999999999999999999999988876655    46899999999999


Q ss_pred             chhhhcCCC-----CHHHHHcCCCccccc
Q 012170          334 LTRDVSARI-----TADEVLRHPWILFYT  357 (469)
Q Consensus       334 L~~dP~~Rp-----sa~elL~hp~~~~~~  357 (469)
                      |.+||.+|+     |+++||+||||....
T Consensus       273 L~~dP~kR~~~~r~t~~ell~Hp~f~~~~  301 (350)
T d1rdqe_         273 LQVDLTKRFGNLKNGVNDIKNHKWFATTD  301 (350)
T ss_dssp             SCSCTTTCTTSSTTTTHHHHTSGGGTTCC
T ss_pred             hhhCHHhccccccccHHHHHcCccccCCC
Confidence            999999995     999999999996554

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-59  Score=459.23  Aligned_cols=251  Identities=29%  Similarity=0.542  Sum_probs=227.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||++++.       .+.+..|..++.+..+|||||++++++.+++.+|||
T Consensus         2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv   81 (320)
T d1xjda_           2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV   81 (320)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred             CCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEE
Confidence            6899999999999999999999999999999999642       245677887776433599999999999999999999


Q ss_pred             EeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          176 MELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      ||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.+|++||+|||++...... ....
T Consensus        82 mEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~~~~  161 (320)
T d1xjda_          82 MEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTN  161 (320)
T ss_dssp             EECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTCCBC
T ss_pred             EeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCCCceeccccchhhhccccccccc
Confidence            999999999999999999999999999999999999999999999999999999999999999999999865543 3345


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHh
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARM  333 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~  333 (469)
                      ..+||+.|+|||++.+ .|+.++|||||||++|+|++|..||.+.+..+++..|....+.++    ..+|+++++||.+|
T Consensus       162 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~~~~p----~~~s~~~~dli~~~  237 (320)
T d1xjda_         162 TFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYP----RWLEKEAKDLLVKL  237 (320)
T ss_dssp             CCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHH
T ss_pred             ccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC----ccCCHHHHHHHHHh
Confidence            5789999999999977 599999999999999999999999999999999999988877665    46899999999999


Q ss_pred             chhhhcCCCCHH-HHHcCCCccccc
Q 012170          334 LTRDVSARITAD-EVLRHPWILFYT  357 (469)
Q Consensus       334 L~~dP~~Rpsa~-elL~hp~~~~~~  357 (469)
                      |++||.+|||+. |+++||||....
T Consensus       238 L~~dP~~R~s~~~~l~~hpff~~~~  262 (320)
T d1xjda_         238 FVREPEKRLGVRGDIRQHPLFREIN  262 (320)
T ss_dssp             SCSSGGGSBTTBSCGGGSGGGTTCC
T ss_pred             cccCCCCCcCHHHHHHhCchhccCC
Confidence            999999999995 899999996543

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-59  Score=468.24  Aligned_cols=257  Identities=34%  Similarity=0.578  Sum_probs=224.8

Q ss_pred             ccccCCeeeee-eeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe----CCeEE
Q 012170           99 NKIEDDHTKVE-VIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE----ADCFH  173 (469)
Q Consensus        99 ~~~~~~y~~~~-~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~----~~~~~  173 (469)
                      ..+.++|.++. .||+|+||.||+|+++.+|+.||||++++ ...+.+|+.++.++.+|||||+++++|++    ...+|
T Consensus         7 ~~i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~   85 (335)
T d2ozaa1           7 NAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLL   85 (335)
T ss_dssp             SCGGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEE
T ss_pred             CCcccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECC-cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEE
Confidence            34667899875 69999999999999999999999999975 46788999998777669999999999976    46799


Q ss_pred             EEEeccCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEeccceeeec
Q 012170          174 LVMELCSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRIS  248 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~~~~  248 (469)
                      ||||||+||+|.+++...+  .+++.+++.|+.||+.||.|||++||+||||||+|||++.   ++.+||+|||+|+...
T Consensus        86 ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~  165 (335)
T d2ozaa1          86 IVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT  165 (335)
T ss_dssp             EEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECC
T ss_pred             EEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccccccccccccccccccccccceeeecc
Confidence            9999999999999997753  6999999999999999999999999999999999999986   4679999999999877


Q ss_pred             CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHH----HHHHHcCcCCCCCCcccCCC
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAV----FDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~----~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+....    ...+......++...+..+|
T Consensus       166 ~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s  245 (335)
T d2ozaa1         166 SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVS  245 (335)
T ss_dssp             CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC--------CCCSCSSSCCTTHHHHSC
T ss_pred             CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCC
Confidence            7777777899999999999977 499999999999999999999999987654333    33444555667766777899


Q ss_pred             HHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          324 KPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +++++||.+||+.||.+|||+.|+|+||||...
T Consensus       246 ~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         246 EEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHHHHHccCChhHCcCHHHHHcCHHhhCC
Confidence            999999999999999999999999999999543

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=4.2e-58  Score=462.05  Aligned_cols=253  Identities=28%  Similarity=0.466  Sum_probs=215.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHH---HHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHRE---VEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E---~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||.||+|+++.+|+.||||++.+.       ...+.+|   +.+++.+. |||||+++++|.+.+.
T Consensus         3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~-hpnIv~l~~~~~~~~~   81 (364)
T d1omwa3           3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGD-CPFIVCMSYAFHTPDK   81 (364)
T ss_dssp             STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSC-CTTBCCEEEEEECSSE
T ss_pred             HHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCC-CCcEEEEEEEEEECCE
Confidence            36899999999999999999999999999999998532       2334455   45555554 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ  251 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~  251 (469)
                      +|+|||||+||+|.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||+|..+... 
T Consensus        82 ~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~-  160 (364)
T d1omwa3          82 LSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK-  160 (364)
T ss_dssp             EEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS-
T ss_pred             EEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC-
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876544 


Q ss_pred             cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDL  329 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~l  329 (469)
                      .....+||+.|+|||++.+  .|+.++|||||||++|+|++|..||.+.+.......+.. ....+...+..+|+++++|
T Consensus       161 ~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~l  239 (364)
T d1omwa3         161 KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRM-TLTMAVELPDSFSPELRSL  239 (364)
T ss_dssp             CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHHHH-SSSCCCCCCSSSCHHHHHH
T ss_pred             cccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-cccCCCCCCCCCCHHHHHH
Confidence            3455689999999999964  489999999999999999999999987553333222221 1222233346789999999


Q ss_pred             HHHhchhhhcCCCC-----HHHHHcCCCccccc
Q 012170          330 MARMLTRDVSARIT-----ADEVLRHPWILFYT  357 (469)
Q Consensus       330 I~~~L~~dP~~Rps-----a~elL~hp~~~~~~  357 (469)
                      |.+||.+||.+|||     |+|+|+||||....
T Consensus       240 i~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i~  272 (364)
T d1omwa3         240 LEGLLQRDVNRRLGCLGRGAQEVKESPFFRSLD  272 (364)
T ss_dssp             HHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTCC
T ss_pred             HHHHcccCHHHhCCCcccCHHHHHcCccccCCC
Confidence            99999999999999     89999999996544

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-58  Score=450.31  Aligned_cols=248  Identities=26%  Similarity=0.409  Sum_probs=215.0

Q ss_pred             eeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          107 KVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .+++||+|+||+||+|+++.+|+.||||+++..         ...+.+|+.+|++++ |||||++++++.+++.+|||||
T Consensus         2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~~~~~~~~~ivmE   80 (299)
T d1ua2a_           2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELS-HPNIIGLLDAFGHKSNISLVFD   80 (299)
T ss_dssp             EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCC-CTTBCCEEEEECCTTCCEEEEE
T ss_pred             cceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCC-CCCEeEEEeeeccCCceeehhh
Confidence            568999999999999999999999999998642         135789999999997 9999999999999999999999


Q ss_pred             ccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccccc
Q 012170          178 LCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLSGL  256 (469)
Q Consensus       178 ~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~~~  256 (469)
                      ||.|+++..++...+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||++...... ......
T Consensus        81 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~~~~~  160 (299)
T d1ua2a_          81 FMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ  160 (299)
T ss_dssp             CCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCCCCCS
T ss_pred             hhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCccccccCccccccCCCcccccce
Confidence            9999888777766778999999999999999999999999999999999999999999999999999765443 334557


Q ss_pred             CCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC------------------
Q 012170          257 AGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS------------------  316 (469)
Q Consensus       257 ~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~------------------  316 (469)
                      +||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+..+.+..|.........                  
T Consensus       161 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (299)
T d1ua2a_         161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSF  240 (299)
T ss_dssp             CCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCC
T ss_pred             ecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccC
Confidence            89999999999864  4899999999999999999999999999988887777542111100                  


Q ss_pred             ------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          317 ------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       317 ------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                            ..+..+++++.+||.+||+.||++||||.|+|+||||..
T Consensus       241 ~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~  285 (299)
T d1ua2a_         241 PGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKMKYFSN  285 (299)
T ss_dssp             CCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTS
T ss_pred             CCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCCHhhCC
Confidence                  012357899999999999999999999999999999954

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-57  Score=437.35  Aligned_cols=245  Identities=31%  Similarity=0.520  Sum_probs=214.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----------hHHHHHHHHHHHHhh-CCCCeeEEEEEEEeC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----------EETVHREVEIMQHLS-GHTGVVTLHSVYEEA  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----------~~~~~~E~~il~~l~-~hpnIv~l~~~~~~~  169 (469)
                      +.++|++.+.||+|+||+||+|+++.+|+.||||++++.          ...+.+|+.+|+++. .|||||+++++|.+.
T Consensus         2 l~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~   81 (273)
T d1xwsa_           2 LESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERP   81 (273)
T ss_dssp             CTTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECS
T ss_pred             CCCeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeC
Confidence            568999999999999999999999999999999998642          133678999999996 489999999999999


Q ss_pred             CeEEEEEeccCC-CchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC-CcEEEEeccceeee
Q 012170          170 DCFHLVMELCSG-GRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS-GKIKLADFGLAMRI  247 (469)
Q Consensus       170 ~~~~lV~E~~~g-g~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~-~~vkL~DFgla~~~  247 (469)
                      +.+|+||||+.+ +++.+++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+ +.+||+|||+|...
T Consensus        82 ~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~  161 (273)
T d1xwsa_          82 DSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALL  161 (273)
T ss_dssp             SEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEEC
T ss_pred             CeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEEecCCCeEEECccccceec
Confidence            999999999986 6788888888999999999999999999999999999999999999999854 79999999999765


Q ss_pred             cCCCcccccCCCCcccCceeccC-C-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHH
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG-N-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKP  325 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~-~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~  325 (469)
                      .. ....+.+||+.|+|||++.+ . ++.++|||||||++|+|++|..||.+.+      .+......++    ..+|++
T Consensus       162 ~~-~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~------~i~~~~~~~~----~~~s~~  230 (273)
T d1xwsa_         162 KD-TVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE------EIIRGQVFFR----QRVSSE  230 (273)
T ss_dssp             CS-SCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH------HHHHCCCCCS----SCCCHH
T ss_pred             cc-ccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch------HHhhcccCCC----CCCCHH
Confidence            43 34456789999999999965 3 4677999999999999999999997632      3444444444    468999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          326 ARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      +++||.+||.+||.+|||++|+|+||||+..
T Consensus       231 ~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  261 (273)
T d1xwsa_         231 CQHLIRWCLALRPSDRPTFEEIQNHPWMQDV  261 (273)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred             HHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999999999999653

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.1e-56  Score=437.98  Aligned_cols=255  Identities=31%  Similarity=0.452  Sum_probs=216.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..      .+.+.+|+++|+++. |||||+++++|.+++.+|+||
T Consensus         2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-Hp~Iv~~~~~~~~~~~~~iv~   80 (298)
T d1gz8a_           2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELN-HPNIVKLLDVIHTENKLYLVF   80 (298)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCC-CTTBCCEEEEEEETTEEEEEE
T ss_pred             CCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEEeccccccccceeEEE
Confidence            6899999999999999999999999999999998542      356889999999996 999999999999999999999


Q ss_pred             eccCCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-Cccc
Q 012170          177 ELCSGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-QTLS  254 (469)
Q Consensus       177 E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-~~~~  254 (469)
                      |||.++.+...... .+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...... ....
T Consensus        81 e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~~~~  160 (298)
T d1gz8a_          81 EFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYT  160 (298)
T ss_dssp             ECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSBCTT
T ss_pred             eecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecccCcceeccCCcceeccCCcccce
Confidence            99976544433333 356999999999999999999999999999999999999999999999999999766443 3445


Q ss_pred             ccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCC---------------
Q 012170          255 GLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSG---------------  317 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~---------------  317 (469)
                      ...||+.|+|||++..  .++.++|||||||++|+|++|..||.+.+..+.+..+..........               
T Consensus       161 ~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  240 (298)
T d1gz8a_         161 HEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSF  240 (298)
T ss_dssp             CCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTS
T ss_pred             eecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhcccccccccccccc
Confidence            5689999999999865  36889999999999999999999999988877776654321111100               


Q ss_pred             ----------cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccccc
Q 012170          318 ----------VWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYTE  358 (469)
Q Consensus       318 ----------~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~~  358 (469)
                                ....+|+++++||.+||.+||.+|||+.|||+||||.....
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~  291 (298)
T d1gz8a_         241 PKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTK  291 (298)
T ss_dssp             CCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             ccccccchhhhccCCCHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCC
Confidence                      12356899999999999999999999999999999965543

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-56  Score=446.14  Aligned_cols=254  Identities=29%  Similarity=0.420  Sum_probs=217.1

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccChHHHHHHHHHHHHhhCCCCeeEEEEEEEe------CCeEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGEETVHREVEIMQHLSGHTGVVTLHSVYEE------ADCFHLV  175 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~~~~~~E~~il~~l~~hpnIv~l~~~~~~------~~~~~lV  175 (469)
                      .-+|+.+++||+|+||+||+|+++.+|+.||||++.++.....+|+++|++|+ ||||++++++|..      ..++|||
T Consensus        19 ~~~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~Ei~il~~l~-h~niv~~~~~~~~~~~~~~~~~~~lv   97 (350)
T d1q5ka_          19 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFKNRELQIMRKLD-HCNIVRLRYFFYSSGEKKDEVYLNLV   97 (350)
T ss_dssp             EEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSCCHHHHHHHHCC-CTTBCCEEEEEEEC--CCSCCEEEEE
T ss_pred             cCCcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHHHHHHHHHHhcC-CCCCCcEEEEEEecCccCCceEEEEE
Confidence            34799999999999999999999999999999999887777789999999996 9999999999854      3358999


Q ss_pred             EeccCCCchHHHH---HHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCC
Q 012170          176 MELCSGGRLIDQM---VEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQ  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l---~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~  251 (469)
                      ||||++|.+....   .....+++..++.++.||+.||.|||++||+||||||+|||++.++ .+||+|||++.......
T Consensus        98 ~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~  177 (350)
T d1q5ka_          98 LDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE  177 (350)
T ss_dssp             EECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS
T ss_pred             EeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc
Confidence            9999876443332   3345799999999999999999999999999999999999999876 89999999999887777


Q ss_pred             cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCc-----------------C
Q 012170          252 TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVK-----------------L  312 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~-----------------~  312 (469)
                      ...+.+||+.|+|||++.+  .|+.++||||+||++|+|++|.+||.+.+..+.+..|.+..                 .
T Consensus       178 ~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~  257 (350)
T d1q5ka_         178 PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEF  257 (350)
T ss_dssp             CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CC
T ss_pred             ccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhc
Confidence            7777899999999999865  48999999999999999999999999988777766654210                 0


Q ss_pred             CCC--------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 DFH--------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 ~~~--------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                      .++        ......+++++.+||.+||.+||.+||||.|+|+||||...
T Consensus       258 ~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         258 KFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             CCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             cccccccCchhhhcccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccc
Confidence            011        01123579999999999999999999999999999999644

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.9e-56  Score=434.27  Aligned_cols=256  Identities=30%  Similarity=0.405  Sum_probs=217.1

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCC-CcEEEEEEcccC------hHHHHHHHHHHHHhh--CCCCeeEEEEEEEe---
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKAS-GAEFACKTLRKG------EETVHREVEIMQHLS--GHTGVVTLHSVYEE---  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~-~~~vAvK~~~~~------~~~~~~E~~il~~l~--~hpnIv~l~~~~~~---  168 (469)
                      ..++|++++.||+|+||+||+|++..+ ++.||||+++..      ...+.+|+.+|+.|.  .||||++++++|..   
T Consensus         5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~   84 (305)
T d1blxa_           5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT   84 (305)
T ss_dssp             GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred             CcCCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhccchHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc
Confidence            458999999999999999999999765 667999998531      245778999988874  49999999999853   


Q ss_pred             --CCeEEEEEeccCCCchHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecccee
Q 012170          169 --ADCFHLVMELCSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAM  245 (469)
Q Consensus       169 --~~~~~lV~E~~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~  245 (469)
                        ...+|+|||||.+|.+..... ....+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||++.
T Consensus        85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~  164 (305)
T d1blxa_          85 DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR  164 (305)
T ss_dssp             SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCC
T ss_pred             ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhh
Confidence              347899999999887754443 34569999999999999999999999999999999999999999999999999998


Q ss_pred             eecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC----------
Q 012170          246 RISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF----------  314 (469)
Q Consensus       246 ~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------  314 (469)
                      ...........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+.+..|.......          
T Consensus       165 ~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~  244 (305)
T d1blxa_         165 IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVA  244 (305)
T ss_dssp             CCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCS
T ss_pred             hhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhccccccc
Confidence            7666666677899999999999966 59999999999999999999999999998888777764321100          


Q ss_pred             -------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 -------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 -------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                   ....+..+++++++||.+||++||.+||||.|+|+||||+..
T Consensus       245 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         245 LPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             SCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             chhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence                         011234679999999999999999999999999999999654

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=6.9e-56  Score=429.80  Aligned_cols=252  Identities=27%  Similarity=0.417  Sum_probs=216.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC--
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD--  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~--  170 (469)
                      .+.++|++++.||+|+||.||+|++..+|+.||||++++.       ...+.+|+++|+.++ ||||+++++++...+  
T Consensus         4 ~l~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~-hpniv~~~~~~~~~~~~   82 (277)
T d1o6ya_           4 HLSDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN-HPAIVAVYDTGEAETPA   82 (277)
T ss_dssp             EETTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEEEECSS
T ss_pred             CccceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcC-CCCCCcccceeeeccCC
Confidence            4678899999999999999999999999999999999643       135789999999996 999999999997654  


Q ss_pred             --eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          171 --CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       171 --~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                        .+|||||||+||+|.+++...+.+++.++..++.||+.||.|||++||+||||||+|||++.++.++|+|||.+....
T Consensus        83 ~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~  162 (277)
T d1o6ya_          83 GPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIA  162 (277)
T ss_dssp             SEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC
T ss_pred             CceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCcccccCccccceeehhhhhhhhc
Confidence              489999999999999999999999999999999999999999999999999999999999999999999999987553


Q ss_pred             CC----CcccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCC
Q 012170          249 NG----QTLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVS  323 (469)
Q Consensus       249 ~~----~~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s  323 (469)
                      ..    ......+||+.|+|||++.+. |+.++|||||||++|+|+||.+||.+.+..+.+..+......++...+..+|
T Consensus       163 ~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~s  242 (277)
T d1o6ya_         163 DSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVREDPIPPSARHEGLS  242 (277)
T ss_dssp             ----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGGTSSSCC
T ss_pred             cccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHHHHHhcCCCCCchhccCCC
Confidence            32    234456899999999999774 8999999999999999999999999999888888877776666656667899


Q ss_pred             HHHHHHHHHhchhhhcCCC-CHHHHHcCCCc
Q 012170          324 KPARDLMARMLTRDVSARI-TADEVLRHPWI  353 (469)
Q Consensus       324 ~~~~~lI~~~L~~dP~~Rp-sa~elL~hp~~  353 (469)
                      +++.+||.+||.+||.+|| |++++ .|+|+
T Consensus       243 ~~l~~li~~~L~~dp~~R~~sa~~l-~~~l~  272 (277)
T d1o6ya_         243 ADLDAVVLKALAKNPENRYQTAAEM-RADLV  272 (277)
T ss_dssp             HHHHHHHHHHTCSSGGGSCSSHHHH-HHHHH
T ss_pred             HHHHHHHHHHccCCHhHCHhHHHHH-HHHHH
Confidence            9999999999999999999 55554 46654

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=1.2e-55  Score=430.01  Aligned_cols=250  Identities=30%  Similarity=0.463  Sum_probs=214.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||+||+|+++ +|+.||||+++..      ...+.+|+.+|++++ ||||++++++|.+.+..|+||
T Consensus         2 ~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-hpnIv~~~~~~~~~~~~~i~~   79 (286)
T d1ob3a_           2 EKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKEDEGIPSTTIREISILKELK-HSNIVKLYDVIHTKKRLVLVF   79 (286)
T ss_dssp             CSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCC-CTTBCCEEEEEECSSCEEEEE
T ss_pred             CCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhcChHHHHHHHHHHHHHHhCC-CCcEEeeeeecccCCceeEEE
Confidence            68999999999999999999986 7899999998543      357889999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      ||+.++.+..+....+.+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++....... ....
T Consensus        80 e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~  159 (286)
T d1ob3a_          80 EHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH  159 (286)
T ss_dssp             ECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------
T ss_pred             EeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCccccce
Confidence            999988877777778889999999999999999999999999999999999999999999999999997654332 2345


Q ss_pred             cCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCC------------------
Q 012170          256 LAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFH------------------  315 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~------------------  315 (469)
                      ..|++.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+..+.+..+........                  
T Consensus       160 ~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~  239 (286)
T d1ob3a_         160 EIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFT  239 (286)
T ss_dssp             --CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCC
T ss_pred             ecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccc
Confidence            679999999999965  379999999999999999999999999888777766543211110                  


Q ss_pred             -------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          316 -------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       316 -------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                             ......+++++.|||++||++||++|||+.|+|+||||+
T Consensus       240 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~  285 (286)
T d1ob3a_         240 VYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALEHAYFK  285 (286)
T ss_dssp             CCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGG
T ss_pred             cccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccC
Confidence                   011245789999999999999999999999999999995

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.3e-54  Score=427.84  Aligned_cols=252  Identities=26%  Similarity=0.464  Sum_probs=214.7

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC-hHHHHHHHHHHHHhhCCCCeeEEEEEEEe--CCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG-EETVHREVEIMQHLSGHTGVVTLHSVYEE--ADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~-~~~~~~E~~il~~l~~hpnIv~l~~~~~~--~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||+||+|+++.+|+.||||+++.. ...+.+|+.+|+.+.+||||++++++|..  ...+|+||||
T Consensus        34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~  113 (328)
T d3bqca1          34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEH  113 (328)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEEC
T ss_pred             CcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEee
Confidence            47899999999999999999999999999999999764 46788999999999779999999999974  4569999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC-cEEEEeccceeeecCCCcccccC
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG-KIKLADFGLAMRISNGQTLSGLA  257 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~-~vkL~DFgla~~~~~~~~~~~~~  257 (469)
                      |.+|+|....   +.+++..++.++.||+.||.|||++||+||||||+||||+.++ .+||+|||+|............+
T Consensus       114 ~~~~~L~~~~---~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~~~~~~  190 (328)
T d3bqca1         114 VNNTDFKQLY---QTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRV  190 (328)
T ss_dssp             CCSCBGGGTT---TSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCCCCSCC
T ss_pred             cCCCcHHHHh---cCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCCcccccc
Confidence            9999997653   5799999999999999999999999999999999999998765 69999999998877777777789


Q ss_pred             CCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHHc-------------CcC---------
Q 012170          258 GSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDS-LEAVFDAIKN-------------VKL---------  312 (469)
Q Consensus       258 gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~-~~~~~~~i~~-------------~~~---------  312 (469)
                      ||+.|+|||++.+  .|+.++||||+||++|+|++|..||.... .......+..             ...         
T Consensus       191 ~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  270 (328)
T d3bqca1         191 ASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDI  270 (328)
T ss_dssp             SCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGT
T ss_pred             cCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchh
Confidence            9999999999866  38999999999999999999999997543 2222222211             000         


Q ss_pred             -----------CCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          313 -----------DFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       313 -----------~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                 .+....+..++++++|||++||++||.+|||++|||+||||+..
T Consensus       271 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         271 LGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             CCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             cccccccchhhcccccccccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence                       01122334589999999999999999999999999999999643

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-54  Score=428.35  Aligned_cols=252  Identities=27%  Similarity=0.450  Sum_probs=213.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-------
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE-------  168 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~-------  168 (469)
                      .++|++++.||+|+||+||+|+++.+|+.||||++...      ...+.+|+++|++++ ||||+++++++..       
T Consensus         9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~nii~~~~~~~~~~~~~~~   87 (318)
T d3blha1           9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLK-HENVVNLIEICRTKASPYNR   87 (318)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCC-CTTBCCEEEEEEC-------
T ss_pred             cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhcchHHHHHHHHHHHHHHHhc-CCCccceEeeeecccccccc
Confidence            47899999999999999999999999999999998532      256889999999997 9999999999855       


Q ss_pred             -CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          169 -ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                       .+.+|+|||||.++.+.........+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||++..+
T Consensus        88 ~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~  167 (318)
T d3blha1          88 CKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF  167 (318)
T ss_dssp             ---CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred             cCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCchheeecCCCcEEeeecceeeec
Confidence             3468999999988877666666678999999999999999999999999999999999999999999999999999765


Q ss_pred             cCCC-----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCccc
Q 012170          248 SNGQ-----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWE  320 (469)
Q Consensus       248 ~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~  320 (469)
                      ....     ...+.+||+.|+|||++.+  .|+.++|||||||++|+|++|.+||.+.+.......+......+....+.
T Consensus       168 ~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~  247 (318)
T d3blha1         168 SLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWP  247 (318)
T ss_dssp             CC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTST
T ss_pred             ccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhcc
Confidence            4322     2344689999999999865  48999999999999999999999999988887777765543332222111


Q ss_pred             ----------------------------CCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcc
Q 012170          321 ----------------------------TVSKPARDLMARMLTRDVSARITADEVLRHPWIL  354 (469)
Q Consensus       321 ----------------------------~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~  354 (469)
                                                  ..++++.|||.+||++||++||||+|+|+||||+
T Consensus       248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~  309 (318)
T d3blha1         248 NVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFW  309 (318)
T ss_dssp             TCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGS
T ss_pred             ccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhc
Confidence                                        1377889999999999999999999999999995

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.2e-55  Score=431.50  Aligned_cols=254  Identities=29%  Similarity=0.538  Sum_probs=218.6

Q ss_pred             CCeeeeeeeeccCCeEEEEEEE---CCCCcEEEEEEcccC--------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRS---KASGAEFACKTLRKG--------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~---~~~~~~vAvK~~~~~--------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      ++|++++.||+|+||+||+|.+   +.+|+.||||++++.        .+.+.+|+++|++++.||||+++++++.+...
T Consensus        24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~  103 (322)
T d1vzoa_          24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK  103 (322)
T ss_dssp             GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred             hceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCc
Confidence            7899999999999999999987   457999999998532        35678999999999845899999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC-
Q 012170          172 FHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG-  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~-  250 (469)
                      +|+||||+.||+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||++..+... 
T Consensus       104 ~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~  183 (322)
T d1vzoa_         104 LHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADE  183 (322)
T ss_dssp             EEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGG
T ss_pred             eeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhcccc
Confidence            9999999999999999999999999999999999999999999999999999999999999999999999999876433 


Q ss_pred             -CcccccCCCCcccCceeccC---CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          251 -QTLSGLAGSPAYVAPEVLSG---NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       251 -~~~~~~~gt~~y~aPE~l~~---~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                       .......|++.|+|||++.+   .++.++|||||||+||+|++|..||.+.+.......+...........+..+|+++
T Consensus       184 ~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  263 (322)
T d1vzoa_         184 TERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALA  263 (322)
T ss_dssp             GGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCCCCTTSCHHH
T ss_pred             cccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCCCcccCCHHH
Confidence             23445789999999999965   37889999999999999999999998765444444443333222333345789999


Q ss_pred             HHHHHHhchhhhcCCC-----CHHHHHcCCCcccc
Q 012170          327 RDLMARMLTRDVSARI-----TADEVLRHPWILFY  356 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rp-----sa~elL~hp~~~~~  356 (469)
                      .+||.+||.+||.+||     |++|+|+||||...
T Consensus       264 ~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~i  298 (322)
T d1vzoa_         264 KDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI  298 (322)
T ss_dssp             HHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred             HHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcCC
Confidence            9999999999999999     58999999999654

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=7.8e-55  Score=424.49  Aligned_cols=244  Identities=25%  Similarity=0.366  Sum_probs=214.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++.+.||+|+||+||+|.++.+|+.||||+++.+   .+.+.+|+++|++++ |||||++++++.+++.+|+||||
T Consensus        16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~E~~il~~l~-HpnIv~~~~~~~~~~~~~iv~E~   94 (287)
T d1opja_          16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEIK-HPNLVQLLGVCTREPPFYIITEF   94 (287)
T ss_dssp             GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEEC
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCccchHHHHHHHHHHHHhCC-CCCEecCCccEeeCCeeEEEeec
Confidence            46899999999999999999999999999999999653   467899999999997 99999999999999999999999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      |++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......  ..
T Consensus        95 ~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~~~~  174 (287)
T d1opja_          95 MTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA  174 (287)
T ss_dssp             CTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSEEET
T ss_pred             ccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCceeec
Confidence            9999999998764  5689999999999999999999999999999999999999999999999999986544332  33


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAA-LPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      +..||+.|+|||++.+ .|+.++|||||||++|+|++|. +||.+.+...+...+....   ....+..+++++.+||.+
T Consensus       175 ~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~~~i~~~~---~~~~~~~~~~~l~~li~~  251 (287)
T d1opja_         175 GAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDY---RMERPEGCPEKVYELMRA  251 (287)
T ss_dssp             TEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTC---CCCCCTTCCHHHHHHHHH
T ss_pred             cccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHHHHHhcCC---CCCCCccchHHHHHHHHH
Confidence            4568999999999864 6999999999999999999955 5566777777777776543   222335789999999999


Q ss_pred             hchhhhcCCCCHHHHHc
Q 012170          333 MLTRDVSARITADEVLR  349 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~  349 (469)
                      ||+.||.+|||+.||++
T Consensus       252 cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         252 CWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHH
Confidence            99999999999999976

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=416.79  Aligned_cols=243  Identities=29%  Similarity=0.397  Sum_probs=206.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ++|++++.||+|+||.||+|+++ +++.||||+++.   ..+.+.+|+++|++++ ||||+++++++.+++.+|+|||||
T Consensus         5 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~lv~E~~   82 (263)
T d1sm2a_           5 SELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAMSEEDFIEEAEVMMKLS-HPKLVQLYGVCLEQAPICLVFEFM   82 (263)
T ss_dssp             SCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECSSSSCEEEEECC
T ss_pred             HHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcCcHHHHHHHHHHHHhcC-CCCcccccceeccCCceEEEEEec
Confidence            57999999999999999999987 477899999975   3477899999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cccc
Q 012170          180 SGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~~~  256 (469)
                      ++|+|.+++... ..+++..+..++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        83 ~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~  162 (263)
T d1sm2a_          83 EHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTGT  162 (263)
T ss_dssp             TTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------------
T ss_pred             CCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeecCCCCeEecccchheeccCCCceeecce
Confidence            999999988655 5689999999999999999999999999999999999999999999999999987654332  2346


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..+++..+........   +..+++++.+||.+||
T Consensus       163 ~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~---p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         163 KFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK---PRLASTHVYQIMNHCW  239 (263)
T ss_dssp             --CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC---CTTSCHHHHHHHHHHT
T ss_pred             ecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC---ccccCHHHHHHHHHHc
Confidence            79999999999976 59999999999999999999 6788888888888888877643322   2467999999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      +.||.+|||++||++|
T Consensus       240 ~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         240 KERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHH
Confidence            9999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-54  Score=430.99  Aligned_cols=247  Identities=22%  Similarity=0.327  Sum_probs=211.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc-----EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA-----EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~-----~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||+||+|++..+++     .||+|.+...     ...+.+|+.+|.++.+|||||++++++.+.+.
T Consensus        36 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~  115 (325)
T d1rjba_          36 RENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGP  115 (325)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEeccccCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCe
Confidence            3789999999999999999999876554     6999998542     35688999999999669999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh-----------------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcE
Q 012170          172 FHLVMELCSGGRLIDQMVEV-----------------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENI  228 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-----------------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NI  228 (469)
                      +|+|||||+||+|.++|...                       +.+++..+..++.||+.||.|||++||+||||||+||
T Consensus       116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Ni  195 (325)
T d1rjba_         116 IYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNV  195 (325)
T ss_dssp             CEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGE
T ss_pred             EEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcc
Confidence            99999999999999999654                       2488999999999999999999999999999999999


Q ss_pred             EEccCCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHH
Q 012170          229 LLTTSGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAV  303 (469)
Q Consensus       229 Ll~~~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~  303 (469)
                      |++.++.+||+|||+|+.......   ..+..||+.|||||++.+ .|+.++|||||||++|||++ |.+||.+.+....
T Consensus       196 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~  275 (325)
T d1rjba_         196 LVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN  275 (325)
T ss_dssp             EEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHH
T ss_pred             ccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHH
Confidence            999999999999999986554332   235678999999999864 69999999999999999997 8999998766555


Q ss_pred             HHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          304 FDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       304 ~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +..+......++  .+..+|+++++||.+||+.||++|||++||++|
T Consensus       276 ~~~~~~~~~~~~--~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         276 FYKLIQNGFKMD--QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             HHHHHHTTCCCC--CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhcCCCCC--CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            555544433322  235789999999999999999999999999986

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-54  Score=431.84  Aligned_cols=251  Identities=28%  Similarity=0.497  Sum_probs=209.7

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC---
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEAD---  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~---  170 (469)
                      ++.++|++++.||+|+||+||+|.++.+|+.||||++++.      .+.+.+|+++|+.+. |||||+++++|...+   
T Consensus        15 ~~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpniv~l~~~~~~~~~~~   93 (346)
T d1cm8a_          15 EVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMR-HENVIGLLDVFTPDETLD   93 (346)
T ss_dssp             CCBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCC-BTTBCCCSEEECSCSSTT
T ss_pred             ecCCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhhcChHHHHHHHHHHHHHHhcC-CCCeeEEEEEeccCcccc
Confidence            4788999999999999999999999999999999999753      245778999999996 999999999998655   


Q ss_pred             ---eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeee
Q 012170          171 ---CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRI  247 (469)
Q Consensus       171 ---~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~  247 (469)
                         .+|+||||| |++|... .+.+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+|...
T Consensus        94 ~~~~~~lv~e~~-~~~l~~~-~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~  171 (346)
T d1cm8a_          94 DFTDFYLVMPFM-GTDLGKL-MKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQA  171 (346)
T ss_dssp             TCCCCEEEEECC-SEEHHHH-HHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred             ccceEEEEEecc-cccHHHH-HHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcchhhcccccccccccccceecc
Confidence               579999999 5566554 46778999999999999999999999999999999999999999999999999999875


Q ss_pred             cCCCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC-----------
Q 012170          248 SNGQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF-----------  314 (469)
Q Consensus       248 ~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~-----------  314 (469)
                      ..  ..+...||+.|+|||++.+  .++.++||||+||++|+|++|.+||.+.+....+..+.......           
T Consensus       172 ~~--~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  249 (346)
T d1cm8a_         172 DS--EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSD  249 (346)
T ss_dssp             CS--SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCH
T ss_pred             CC--ccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcch
Confidence            43  3456789999999999865  37899999999999999999999999988776655543321111           


Q ss_pred             ------------C----CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccc
Q 012170          315 ------------H----SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILF  355 (469)
Q Consensus       315 ------------~----~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~  355 (469)
                                  .    ......+++++.+||.+||..||.+|||+.|||+||||..
T Consensus       250 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~  306 (346)
T d1cm8a_         250 EAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRVTAGEALAHPYFES  306 (346)
T ss_dssp             HHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTT
T ss_pred             hhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCcCHHHHhcChhhCc
Confidence                        1    1122457899999999999999999999999999999954

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.8e-54  Score=418.72  Aligned_cols=247  Identities=23%  Similarity=0.387  Sum_probs=215.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|.++ ++..||||+++..   .+.+.+|+++|++++ |||||++++++.+ +.+|+||||
T Consensus        12 ~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~-~~~~iv~Ey   88 (272)
T d1qpca_          12 RETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSMSPDAFLAEANLMKQLQ-HQRLVRLYAVVTQ-EPIYIITEY   88 (272)
T ss_dssp             GGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEEEC
T ss_pred             HHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcCCHHHHHHHHHHHHhCC-CCCEeEEEeeecc-CCeEEEEEe
Confidence            468999999999999999999986 5788999999653   467899999999996 9999999998865 567899999


Q ss_pred             cCCCchHHHHHHh--CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cc
Q 012170          179 CSGGRLIDQMVEV--GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~~--~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~  254 (469)
                      |++|+|.+++...  ..+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|+.......  ..
T Consensus        89 ~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~~~~  168 (272)
T d1qpca_          89 MENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE  168 (272)
T ss_dssp             CTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEECCT
T ss_pred             CCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhheeeecccceeeccccceEEccCCcccccc
Confidence            9999999876433  3699999999999999999999999999999999999999999999999999987754432  34


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...||+.|+|||++.+ .|+.++|||||||++|||+| |.+||...+..+++..+.......   .+..+++++.+||.+
T Consensus       169 ~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~  245 (272)
T d1qpca_         169 GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV---RPDNCPEELYQLMRL  245 (272)
T ss_dssp             TCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHH
T ss_pred             ccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCC---CcccChHHHHHHHHH
Confidence            5679999999999965 59999999999999999999 567778888888888887754322   235789999999999


Q ss_pred             hchhhhcCCCCHHHHHc--CCCcc
Q 012170          333 MLTRDVSARITADEVLR--HPWIL  354 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~--hp~~~  354 (469)
                      ||+.||++|||+.||++  |+||.
T Consensus       246 cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         246 CWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HcCCCHhHCcCHHHHHHHhhhhhh
Confidence            99999999999999998  77773

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-54  Score=419.22  Aligned_cols=240  Identities=25%  Similarity=0.380  Sum_probs=207.1

Q ss_pred             eeeeccCCeEEEEEEEC--CCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEeccC
Q 012170          109 EVIGHGKFGSVWLCRSK--ASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELCS  180 (469)
Q Consensus       109 ~~lG~G~~g~Vy~~~~~--~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~~  180 (469)
                      +.||+|+||.||+|.++  .+++.||||+++..      .+.+.+|+++|++++ |||||++++++++ +.+|||||||+
T Consensus        13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~-HpnIv~~~g~~~~-~~~~lvmE~~~   90 (277)
T d1xbba_          13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLD-NPYIVRMIGICEA-ESWMLVMEMAE   90 (277)
T ss_dssp             EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCC-CTTBCCEEEEEES-SSEEEEEECCT
T ss_pred             CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhhCCHHHHHHHHHHHHHHHhCC-CCCCceEEEEecc-CCEEEEEEcCC
Confidence            47999999999999864  45678999998642      246889999999996 9999999999965 45789999999


Q ss_pred             CCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc----cccc
Q 012170          181 GGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT----LSGL  256 (469)
Q Consensus       181 gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~----~~~~  256 (469)
                      +|+|.+++...+.+++..+..++.||+.||.|||++||+||||||+|||++.+|.+||+|||+++.......    ....
T Consensus        91 ~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~  170 (277)
T d1xbba_          91 LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHG  170 (277)
T ss_dssp             TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----
T ss_pred             CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccccchhhhhhcccccccccccccc
Confidence            999999999889999999999999999999999999999999999999999999999999999987654322    2335


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .||+.|+|||++.+ .|+.++|||||||++|||++ |.+||.+.+..++...+..+...   ..+..+|+++.+||.+||
T Consensus       171 ~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~~---~~p~~~~~~~~~li~~cl  247 (277)
T d1xbba_         171 KWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERM---GCPAGCPREMYDLMNLCW  247 (277)
T ss_dssp             CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTCCHHHHHHHHHHT
T ss_pred             CCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCCC---CCCcccCHHHHHHHHHHc
Confidence            79999999999965 58999999999999999998 89999999998888888775422   123568999999999999


Q ss_pred             hhhhcCCCCHHHH---HcCCCc
Q 012170          335 TRDVSARITADEV---LRHPWI  353 (469)
Q Consensus       335 ~~dP~~Rpsa~el---L~hp~~  353 (469)
                      +.||.+|||+.+|   |+|+|+
T Consensus       248 ~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         248 TYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhCHHh
Confidence            9999999999998   466654

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=3.4e-54  Score=422.40  Aligned_cols=245  Identities=24%  Similarity=0.357  Sum_probs=203.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCc---EEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGA---EFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~---~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|++.+.||+|+||+||+|.++.+|+   .||||.+...     .+.+.+|+++|++|+ |||||++++++.+++.+|
T Consensus        25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~~~~~  103 (299)
T d1jpaa_          25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFD-HPNVIHLEGVVTKSTPVM  103 (299)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCC-CTTBCCEEEEECSSSSCE
T ss_pred             hhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCCccEEEEEeeCCEEE
Confidence            4689999999999999999999987765   5899988643     246889999999996 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +|||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++.......
T Consensus       104 iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  183 (299)
T d1jpaa_         104 IITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS  183 (299)
T ss_dssp             EEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC-----------
T ss_pred             EEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccceEEECCCCcEEECCcccceEccCCCC
Confidence            999999999999988764 5699999999999999999999999999999999999999999999999999987654322


Q ss_pred             ------ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          253 ------LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       253 ------~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                            .....||+.|||||++.+ .|+.++|||||||++|||+| |.+||.+.+..+++..+......   ..+..+++
T Consensus       184 ~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~~~~~~i~~~~~~---~~~~~~~~  260 (299)
T d1jpaa_         184 DPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINAIEQDYRL---PPPMDCPS  260 (299)
T ss_dssp             ------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCCH
T ss_pred             cceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCC---CCCccchH
Confidence                  123468999999999965 59999999999999999998 89999999999988888765322   22357899


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          325 PARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ++.+||.+||+.||.+|||+.||+++
T Consensus       261 ~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         261 ALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             HHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999999998864

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.3e-54  Score=420.49  Aligned_cols=244  Identities=25%  Similarity=0.396  Sum_probs=203.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      .++|++++.||+|+||+||+|+++   ..||||+++..      .+.+.+|+.+|++++ |||||++++++. ++.+|+|
T Consensus         7 ~~~~~~~~~lG~G~fg~Vy~~~~~---~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~~~~~-~~~~~lv   81 (276)
T d1uwha_           7 DGQITVGQRIGSGSFGTVYKGKWH---GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTR-HVNILLFMGYST-APQLAIV   81 (276)
T ss_dssp             TTCCCCCSEEEECSSCEEEEEESS---SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEC-SSSCEEE
T ss_pred             cccEEEEEEEeeCCCcEEEEEEEC---CEEEEEEEEcccCCHHHHHHHHHHHHHHHhCC-CCCEeeeeEEEe-ccEEEEE
Confidence            468999999999999999999864   35999998632      256889999999996 999999999875 4568899


Q ss_pred             EeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC---C
Q 012170          176 MELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG---Q  251 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~---~  251 (469)
                      ||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+|......   .
T Consensus        82 ~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~  161 (276)
T d1uwha_          82 TQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH  161 (276)
T ss_dssp             EECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------
T ss_pred             EecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcc
Confidence            9999999999999765 56999999999999999999999999999999999999999999999999999765432   2


Q ss_pred             cccccCCCCcccCceeccC----CCCCccchHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHHcCcCCC-CCCcccCCCHH
Q 012170          252 TLSGLAGSPAYVAPEVLSG----NYSEKVDIWSAGVLLHALLVAALPFKGDSLE-AVFDAIKNVKLDF-HSGVWETVSKP  325 (469)
Q Consensus       252 ~~~~~~gt~~y~aPE~l~~----~~~~~~DiwSlG~il~elltG~~Pf~~~~~~-~~~~~i~~~~~~~-~~~~~~~~s~~  325 (469)
                      ......||+.|||||++.+    .|+.++|||||||++|||+||..||.+.+.. .+...+....... ....+..++++
T Consensus       162 ~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~  241 (276)
T d1uwha_         162 QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKA  241 (276)
T ss_dssp             ----CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHH
T ss_pred             cccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHH
Confidence            3455789999999999853    3889999999999999999999999886544 4444444433221 12334578999


Q ss_pred             HHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          326 ARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       326 ~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +.+||.+||..||.+|||+.||++|
T Consensus       242 l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         242 MKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999999986

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-54  Score=418.57  Aligned_cols=246  Identities=26%  Similarity=0.372  Sum_probs=211.8

Q ss_pred             CCeeeeee-eeccCCeEEEEEEECC--CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEE
Q 012170          103 DDHTKVEV-IGHGKFGSVWLCRSKA--SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       103 ~~y~~~~~-lG~G~~g~Vy~~~~~~--~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~l  174 (469)
                      ++|.+.+. ||+|+||.||+|.++.  ++..||||+++..     .+.+.+|+++|++++ |||||++++++.+ +.+||
T Consensus         8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~-HpnIv~l~g~~~~-~~~~l   85 (285)
T d1u59a_           8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLD-NPYIVRLIGVCQA-EALML   85 (285)
T ss_dssp             GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCC-CTTBCCEEEEEES-SSEEE
T ss_pred             cCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChhcCHHHHHHHHHHHHHHHhCC-CCCEeeEeeeecc-CeEEE
Confidence            56778885 9999999999998764  4557999999643     246889999999996 9999999999975 46789


Q ss_pred             EEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-
Q 012170          175 VMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-  252 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-  252 (469)
                      |||||+||+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... 
T Consensus        86 vmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~  165 (285)
T d1u59a_          86 VMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY  165 (285)
T ss_dssp             EEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCE
T ss_pred             EEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhheeeccCCceeeccchhhhcccccccc
Confidence            99999999999987554 5799999999999999999999999999999999999999999999999999987654332 


Q ss_pred             ---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 ---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                         .....||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+.+..++...|..+....   .+..+|+++.
T Consensus       166 ~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~  242 (285)
T d1u59a_         166 YTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME---CPPECPPELY  242 (285)
T ss_dssp             ECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHHHHHHHHTTCCCC---CCTTCCHHHH
T ss_pred             cccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC---CCCcCCHHHH
Confidence               234578999999999964 59999999999999999998 999999988888888887765322   2357899999


Q ss_pred             HHHHHhchhhhcCCCCHHHH---HcCCCc
Q 012170          328 DLMARMLTRDVSARITADEV---LRHPWI  353 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~el---L~hp~~  353 (469)
                      +||.+||..||++|||+.+|   |+|+|+
T Consensus       243 ~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         243 ALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             HHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            99999999999999999888   566665

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.4e-54  Score=412.07  Aligned_cols=243  Identities=24%  Similarity=0.369  Sum_probs=217.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc---ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEecc
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK---GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMELC  179 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~---~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~~  179 (469)
                      ++|++++.||+|+||+||+|+++ ++..||||++++   ..+.+.+|+.++++++ ||||+++++++.+++.+|+||||+
T Consensus         4 ~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~~~~~~~~Ev~~~~~l~-HpnIv~~~g~~~~~~~~~iv~Ey~   81 (258)
T d1k2pa_           4 KDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSMSEDEFIEEAKVMMNLS-HEKLVQLYGVCTKQRPIFIITEYM   81 (258)
T ss_dssp             CCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSSCHHHHHHHHHHHHTCC-CTTBCCEEEEECCSSSEEEEEECC
T ss_pred             HHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcCCHHHHHHHHHHHHhcC-CCceeeEEEEEeeCCceEEEEEcc
Confidence            68899999999999999999986 688999999975   4578999999999997 999999999999999999999999


Q ss_pred             CCCchHHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc--cccc
Q 012170          180 SGGRLIDQMVE-VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT--LSGL  256 (469)
Q Consensus       180 ~gg~L~~~l~~-~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~--~~~~  256 (469)
                      ++|+|.+++.. ...+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......  ....
T Consensus        82 ~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~  161 (258)
T d1k2pa_          82 ANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGS  161 (258)
T ss_dssp             TTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCCCCCCS
T ss_pred             CCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCceeeccc
Confidence            99999988655 46799999999999999999999999999999999999999999999999999976554332  3346


Q ss_pred             CCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .||+.|+|||++.+ .|+.++|||||||++|||+| |..||.+.+..++...+..+....   .+..+++++.+||.+||
T Consensus       162 ~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~---~p~~~~~~l~~li~~cl  238 (258)
T d1k2pa_         162 KFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIAQGLRLY---RPHLASEKVYTIMYSCW  238 (258)
T ss_dssp             CCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCC---CCTTCCHHHHHHHHHTT
T ss_pred             CCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCC---CcccccHHHHHHHHHHc
Confidence            79999999999965 69999999999999999998 899999999999999888764332   23578999999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      +.||++|||+++||+|
T Consensus       239 ~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         239 HEKADERPTFKILLSN  254 (258)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHH
Confidence            9999999999999987

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-53  Score=415.54  Aligned_cols=254  Identities=28%  Similarity=0.484  Sum_probs=219.8

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVM  176 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~  176 (469)
                      ++|++++.||+|+||+||+|+++.+|+.||||+++..      ...+.+|+.+|+.++ ||||+++++++.+.+.+++||
T Consensus         2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~~~~iv~   80 (292)
T d1unla_           2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELK-HKNIVRLHDVLHSDKKLTLVF   80 (292)
T ss_dssp             CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCC-CTTBCCEEEEEECSSEEEEEE
T ss_pred             CCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhhCChHHHHHHHHHHHHHHhcC-cCCEEeeccccccccceeEEe
Confidence            6899999999999999999999999999999998542      256789999999997 999999999999999999999


Q ss_pred             eccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-cccc
Q 012170          177 ELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-TLSG  255 (469)
Q Consensus       177 E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-~~~~  255 (469)
                      |++.|++|..++...+.+++..+..++.|++.||+|||++||+||||||+|||++.++.+||+|||.+....... ....
T Consensus        81 ~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~~~~  160 (292)
T d1unla_          81 EFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA  160 (292)
T ss_dssp             ECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSCCCS
T ss_pred             eeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccCCceeeeecchhhcccCCCcccee
Confidence            999999999988888899999999999999999999999999999999999999999999999999998766443 3344


Q ss_pred             cCCCCcccCceeccCC--CCCccchHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHcCcCCC------------------
Q 012170          256 LAGSPAYVAPEVLSGN--YSEKVDIWSAGVLLHALLVAALPF-KGDSLEAVFDAIKNVKLDF------------------  314 (469)
Q Consensus       256 ~~gt~~y~aPE~l~~~--~~~~~DiwSlG~il~elltG~~Pf-~~~~~~~~~~~i~~~~~~~------------------  314 (469)
                      ..+++.|+|||++.+.  ++.++|||||||++|+|++|..|| .+.+..+.+..+.......                  
T Consensus       161 ~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  240 (292)
T d1unla_         161 EVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYP  240 (292)
T ss_dssp             CCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCC
T ss_pred             eccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccc
Confidence            5688999999998653  789999999999999999999874 5666666666553321111                  


Q ss_pred             -------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCccccc
Q 012170          315 -------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFYT  357 (469)
Q Consensus       315 -------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~~  357 (469)
                             .......+++++.+||.+||++||.+||||+|+|+||||..+.
T Consensus       241 ~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         241 MYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             CCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCS
T ss_pred             cccccchhhhccccCCHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCC
Confidence                   1112245789999999999999999999999999999997653

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.5e-54  Score=427.63  Aligned_cols=255  Identities=25%  Similarity=0.434  Sum_probs=210.2

Q ss_pred             cccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCC----
Q 012170          100 KIEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEAD----  170 (469)
Q Consensus       100 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~----  170 (469)
                      ++.++|++++.||+|+||+||+|.++.+|+.||||++++..     +.+.+|+.+|+.|+ ||||+++++++....    
T Consensus         5 ~i~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~-hp~iv~~~~~~~~~~~~~~   83 (345)
T d1pmea_           5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR-HENIIGINDIIRAPTIEQM   83 (345)
T ss_dssp             CCCTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCC-CTTBCCCCEEECCSSTTTC
T ss_pred             CcCCCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhcChHHHHHHHHHHHHHHHcC-CCCCCcEEEEEeecccccc
Confidence            46678999999999999999999999999999999996532     35778999999996 999999999997643    


Q ss_pred             eEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      ..+++++|+.||+|.+++. .+.+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|||++......
T Consensus        84 ~~~~l~~~~~~g~L~~~l~-~~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~  162 (345)
T d1pmea_          84 KDVYLVTHLMGADLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPD  162 (345)
T ss_dssp             CCEEEEEECCCEEHHHHHH-HCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGG
T ss_pred             ceEEEEEeecCCchhhhhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCC
Confidence            2344455666999999885 458999999999999999999999999999999999999999999999999999865433


Q ss_pred             C----cccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCC----------
Q 012170          251 Q----TLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDF----------  314 (469)
Q Consensus       251 ~----~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~----------  314 (469)
                      .    .....+||+.|+|||++..  .|+.++||||+||++|+|++|.+||.+.+.......+......+          
T Consensus       163 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  242 (345)
T d1pmea_         163 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIIN  242 (345)
T ss_dssp             GCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCC
T ss_pred             CccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhh
Confidence            2    2345679999999999854  47899999999999999999999999887665554442211100          


Q ss_pred             ----------C-------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          315 ----------H-------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       315 ----------~-------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                +       ...+..+++++++||.+||++||.+||||.|+|+||||...
T Consensus       243 ~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~  301 (345)
T d1pmea_         243 LKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQY  301 (345)
T ss_dssp             HHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTT
T ss_pred             hhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence                      0       01234678999999999999999999999999999999644

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.7e-53  Score=425.92  Aligned_cols=252  Identities=26%  Similarity=0.455  Sum_probs=212.4

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh------HHHHHHHHHHHHhhCCCCeeEEEEEEEeC-----
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE------ETVHREVEIMQHLSGHTGVVTLHSVYEEA-----  169 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~------~~~~~E~~il~~l~~hpnIv~l~~~~~~~-----  169 (469)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++++..      ..+.+|+++|++|. |||||++++++...     
T Consensus        16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~-h~~iv~~~~~~~~~~~~~~   94 (348)
T d2gfsa1          16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMK-HENVIGLLDVFTPARSLEE   94 (348)
T ss_dssp             EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCSSTTT
T ss_pred             CCCCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchhcChHHHHHHHHHHHHHHhcC-CCCeeeEEEEEeecccccc
Confidence            5688999999999999999999999999999999996532      45779999999996 99999999999643     


Q ss_pred             CeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecC
Q 012170          170 DCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISN  249 (469)
Q Consensus       170 ~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~  249 (469)
                      ...++||+|+.||+|.+++ ..+++++..++.++.||+.||.|||++||+||||||+|||++.+|.+|++|||++.... 
T Consensus        95 ~~~~~i~~~~~gg~L~~~~-~~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~-  172 (348)
T d2gfsa1          95 FNDVYLVTHLMGADLNNIV-KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD-  172 (348)
T ss_dssp             CCCCEEEEECCSEEHHHHH-TTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----CCT-
T ss_pred             CceEEEEEeecCCchhhhc-ccccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCccccccccccccccccchhcccC-
Confidence            3446677788899999987 45689999999999999999999999999999999999999999999999999996543 


Q ss_pred             CCcccccCCCCcccCceeccC--CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCCCCC-----------
Q 012170          250 GQTLSGLAGSPAYVAPEVLSG--NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLDFHS-----------  316 (469)
Q Consensus       250 ~~~~~~~~gt~~y~aPE~l~~--~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~-----------  316 (469)
                       ....+..||+.|+|||++.+  .++.++|||||||++|+|++|.+||.+.+.......|.........           
T Consensus       173 -~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  251 (348)
T d2gfsa1         173 -DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESA  251 (348)
T ss_dssp             -GGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHH
T ss_pred             -cccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhh
Confidence             33455789999999999765  3689999999999999999999999998887777666443221110           


Q ss_pred             ----------------CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          317 ----------------GVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       317 ----------------~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                                      ..+..+++++++||.+||..||.+||||.|+|+||||+.+
T Consensus       252 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~  307 (348)
T d2gfsa1         252 RNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQY  307 (348)
T ss_dssp             HHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTT
T ss_pred             hhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCC
Confidence                            1124679999999999999999999999999999999654

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-53  Score=423.11  Aligned_cols=252  Identities=27%  Similarity=0.458  Sum_probs=201.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC------hHHHHHHHHHHHHhhCCCCeeEEEEEEEe------
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG------EETVHREVEIMQHLSGHTGVVTLHSVYEE------  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~------~~~~~~E~~il~~l~~hpnIv~l~~~~~~------  168 (469)
                      +.++|++++.||+|+||+||+|+++.+|+.||||++.+.      ...+.+|+.+|++++ ||||++++++|..      
T Consensus        15 i~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~-hpnIv~~~~~f~~~~~~~~   93 (355)
T d2b1pa1          15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVN-HKNIISLLNVFTPQKTLEE   93 (355)
T ss_dssp             EETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCC-CTTBCCCSEEECSCCSTTT
T ss_pred             ecCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhhcCHHHHHHHHHHHHHHHhcC-CCCeeEEEEEEeccccccc
Confidence            457899999999999999999999999999999999643      235789999999996 9999999999963      


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeec
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRIS  248 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~  248 (469)
                      ...+|+|||||.++.+ +.+  ...+++..++.++.||+.||.|||++||+||||||+|||++.++.++++|||++....
T Consensus        94 ~~~~~iv~Ey~~~~l~-~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~  170 (355)
T d2b1pa1          94 FQDVYLVMELMDANLC-QVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG  170 (355)
T ss_dssp             CCEEEEEEECCSEEHH-HHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred             CceeEEEEeccchHHH-Hhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccccccccccceeeechhhhhccc
Confidence            4689999999976544 433  4679999999999999999999999999999999999999999999999999998777


Q ss_pred             CCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCC--------------
Q 012170          249 NGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIKNVKLD--------------  313 (469)
Q Consensus       249 ~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~--------------  313 (469)
                      ........+||+.|+|||++.+ .++.++||||+||++|+|++|.+||.+.+.......+......              
T Consensus       171 ~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~  250 (355)
T d2b1pa1         171 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVR  250 (355)
T ss_dssp             ----------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHH
T ss_pred             cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHH
Confidence            6666677889999999999977 4899999999999999999999999988876665554321110              


Q ss_pred             --------CC----------------CCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCCcccc
Q 012170          314 --------FH----------------SGVWETVSKPARDLMARMLTRDVSARITADEVLRHPWILFY  356 (469)
Q Consensus       314 --------~~----------------~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~~~~~  356 (469)
                              ..                ...+..+++++.+||++||..||++||||+|||+||||+..
T Consensus       251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~  317 (355)
T d2b1pa1         251 NYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVW  317 (355)
T ss_dssp             HHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence                    00                00112346789999999999999999999999999999643

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1e-52  Score=406.51  Aligned_cols=244  Identities=23%  Similarity=0.311  Sum_probs=202.8

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCC---cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      .++|++++.||+|+||.||+|++..++   ..||||.++..     .+.+.+|+.+|++++ ||||+++++++. ++.+|
T Consensus         6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~~~~~-~~~~~   83 (273)
T d1mp8a_           6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD-HPHIVKLIGVIT-ENPVW   83 (273)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCC-CTTBCCEEEEEC-SSSCE
T ss_pred             HHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEe-cCeEE
Confidence            478999999999999999999987543   56899998642     245889999999996 999999999996 46789


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      +|||||++|+|.+++... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++...... 
T Consensus        84 iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~  163 (273)
T d1mp8a_          84 IIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY  163 (273)
T ss_dssp             EEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC------------
T ss_pred             EEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhheeecCCCcEEEccchhheeccCCcc
Confidence            999999999999987654 579999999999999999999999999999999999999999999999999998765432 


Q ss_pred             -cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHH
Q 012170          252 -TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARD  328 (469)
Q Consensus       252 -~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~  328 (469)
                       ......||+.|+|||++.+ .|+.++|||||||++|||++ |.+||.+.+..+++..+.+....   ..+..+|+++.+
T Consensus       164 ~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~  240 (273)
T d1mp8a_         164 YKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERL---PMPPNCPPTLYS  240 (273)
T ss_dssp             -------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCC---CCCTTCCHHHHH
T ss_pred             eeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC---CCCCCCCHHHHH
Confidence             2344678999999999965 69999999999999999998 89999999988888888776532   234678999999


Q ss_pred             HHHHhchhhhcCCCCHHHHHcC
Q 012170          329 LMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       329 lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      ||.+||..||.+|||+.||++|
T Consensus       241 li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         241 LMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCHhHCcCHHHHHHH
Confidence            9999999999999999999976

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-52  Score=404.39  Aligned_cols=247  Identities=26%  Similarity=0.386  Sum_probs=209.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      .++|++.+.||+|+||.||+|+++.+ ..||||+++..   .+.+.+|+.+|++++ |||||++++++.+ +.+|+||||
T Consensus        16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~-~~vAiK~l~~~~~~~~~~~~E~~~l~~l~-h~nIv~~~g~~~~-~~~~lv~Ey   92 (285)
T d1fmka3          16 RESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEAFLQEAQVMKKLR-HEKLVQLYAVVSE-EPIYIVTEY   92 (285)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSSCHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SSCEEEECC
T ss_pred             HHHEEEeeEEeeCCCeEEEEEEECCC-CEEEEEEECcccCCHHHHHHHHHHHHhcc-cCCEeEEEEEEec-CCeEEEEEe
Confidence            36899999999999999999999765 57999999653   467999999999997 9999999999965 557899999


Q ss_pred             cCCCchHHHHHH--hCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC--ccc
Q 012170          179 CSGGRLIDQMVE--VGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ--TLS  254 (469)
Q Consensus       179 ~~gg~L~~~l~~--~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~--~~~  254 (469)
                      |++|+|..++..  .+.+++.++..++.||+.||.|||++||+||||||+||||+.++++||+|||+++......  ...
T Consensus        93 ~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~  172 (285)
T d1fmka3          93 MSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTARQ  172 (285)
T ss_dssp             CTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------
T ss_pred             cCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCceeec
Confidence            999999988754  3579999999999999999999999999999999999999999999999999998664333  234


Q ss_pred             ccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHH
Q 012170          255 GLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMAR  332 (469)
Q Consensus       255 ~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~  332 (469)
                      ...||+.|+|||++.+ .++.++|||||||++|+|++ |.+||.+....+++..+......   ..+..+++++++||.+
T Consensus       173 ~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l~~li~~  249 (285)
T d1fmka3         173 GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRM---PCPPECPESLHDLMCQ  249 (285)
T ss_dssp             ---CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCCC---CCCTTSCHHHHHHHHH
T ss_pred             cccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCC---CCCcccCHHHHHHHHH
Confidence            4679999999999954 69999999999999999999 56677788888888888765321   2345789999999999


Q ss_pred             hchhhhcCCCCHHHHHc--CCCcc
Q 012170          333 MLTRDVSARITADEVLR--HPWIL  354 (469)
Q Consensus       333 ~L~~dP~~Rpsa~elL~--hp~~~  354 (469)
                      ||+.||++|||+++|++  |+||.
T Consensus       250 cl~~dP~~Rps~~~i~~~L~~~~~  273 (285)
T d1fmka3         250 CWRKEPEERPTFEYLQAFLEDYFT  273 (285)
T ss_dssp             HTCSSGGGSCCHHHHHHHHHTTTS
T ss_pred             HcccCHhHCcCHHHHHHHHhhhhc
Confidence            99999999999999988  88884

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.2e-52  Score=402.33  Aligned_cols=243  Identities=26%  Similarity=0.373  Sum_probs=203.7

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCC----cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASG----AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~----~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      +.|++.++||+|+||.||+|.++.++    ..||||++...     ...+.+|+++|++++ |||||++++++.+.+.++
T Consensus         7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~-H~nIv~~~g~~~~~~~~~   85 (283)
T d1mqba_           7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFS-HHNIIRLEGVISKYKPMM   85 (283)
T ss_dssp             TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSSSEE
T ss_pred             HHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcccChHHHHHHHHHHHHHHhcC-CCCEeeeeEEEecCCceE
Confidence            56999999999999999999987655    46999998643     245789999999997 999999999999999999


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCC-
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~-  251 (469)
                      +|||||.+|++.+.+... +.+++..+..++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... 
T Consensus        86 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~  165 (283)
T d1mqba_          86 IITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE  165 (283)
T ss_dssp             EEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC---------
T ss_pred             EEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCccccceEEECCCCeEEEcccchhhcccCCCc
Confidence            999999999999887655 579999999999999999999999999999999999999999999999999998754432 


Q ss_pred             ---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHH
Q 012170          252 ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPA  326 (469)
Q Consensus       252 ---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~  326 (469)
                         ......||+.|+|||++.+ .|+.++|||||||++|||++| .+||.+.+..+++..+......   ..+..++.++
T Consensus       166 ~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~~~~~~~i~~~~~~---~~~~~~~~~l  242 (283)
T d1mqba_         166 ATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRL---PTPMDCPSAI  242 (283)
T ss_dssp             --------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTTCCC---CCCTTCBHHH
T ss_pred             cceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCCHHHHHHHHhccCCC---CCchhhHHHH
Confidence               2234578999999999866 599999999999999999994 6667777888888888765322   2235689999


Q ss_pred             HHHHHHhchhhhcCCCCHHHHHc
Q 012170          327 RDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       327 ~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .+||.+||..||++|||+.||++
T Consensus       243 ~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         243 YQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHCcCCHhHCcCHHHHHH
Confidence            99999999999999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-52  Score=409.77  Aligned_cols=243  Identities=23%  Similarity=0.337  Sum_probs=207.2

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCc----EEEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGA----EFACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFH  173 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~----~vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~  173 (469)
                      ++|++++.||+|+||+||+|.+..+|+    .||+|.++.     ..+.+.+|+.+|++++ |||||++++++.++ ..+
T Consensus         9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~l~g~~~~~-~~~   86 (317)
T d1xkka_           9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVD-NPHVCRLLGICLTS-TVQ   86 (317)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCC-CTTBCCEEEEEESS-SEE
T ss_pred             HHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccccCHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEecC-Cee
Confidence            579999999999999999999988876    578888753     2357899999999997 99999999999865 567


Q ss_pred             EEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc
Q 012170          174 LVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT  252 (469)
Q Consensus       174 lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~  252 (469)
                      +||||+.+|+|.+.+... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.......
T Consensus        87 ~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~  166 (317)
T d1xkka_          87 LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK  166 (317)
T ss_dssp             EEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC
T ss_pred             EEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc
Confidence            889999999999888665 5799999999999999999999999999999999999999999999999999986543322


Q ss_pred             ---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHH
Q 012170          253 ---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPAR  327 (469)
Q Consensus       253 ---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~  327 (469)
                         .....||+.|+|||++.+ .|+.++|||||||++|||+| |.+||.+.+..++...+..+....   .+..+++++.
T Consensus       167 ~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~~~~~i~~~~~~~---~p~~~~~~~~  243 (317)
T d1xkka_         167 EYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP---QPPICTIDVY  243 (317)
T ss_dssp             --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGGHHHHHHHTCCCC---CCTTBCHHHH
T ss_pred             cccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC---CCcccCHHHH
Confidence               234568999999999865 59999999999999999998 899999988888888877654321   2256899999


Q ss_pred             HHHHHhchhhhcCCCCHHHHHcC
Q 012170          328 DLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       328 ~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      +||.+||..||.+|||+.||++|
T Consensus       244 ~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         244 MIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHhCCCChhhCcCHHHHHHH
Confidence            99999999999999999999998

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.1e-52  Score=409.52  Aligned_cols=245  Identities=24%  Similarity=0.335  Sum_probs=213.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcE--EEEEEccc-----ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEE
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAE--FACKTLRK-----GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLV  175 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~--vAvK~~~~-----~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV  175 (469)
                      ++|++.+.||+|+||.||+|.++.+|..  ||||.++.     ..+.+.+|+++|+++.+|||||++++++.+.+.+|+|
T Consensus        10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV   89 (309)
T d1fvra_          10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA   89 (309)
T ss_dssp             GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred             HHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEE
Confidence            6899999999999999999999988875  67787743     2346889999999995599999999999999999999


Q ss_pred             EeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEE
Q 012170          176 MELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLA  239 (469)
Q Consensus       176 ~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~  239 (469)
                      ||||+||+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus        90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~  169 (309)
T d1fvra_          90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA  169 (309)
T ss_dssp             ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEEC
T ss_pred             EEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEc
Confidence            9999999999998654                568999999999999999999999999999999999999999999999


Q ss_pred             eccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCCCCCC
Q 012170          240 DFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHSG  317 (469)
Q Consensus       240 DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~~  317 (469)
                      |||+++............||+.|+|||.+.+ .|+.++|||||||++|+|++| .+||.+.+..+++..+.....   ..
T Consensus       170 DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---~~  246 (309)
T d1fvra_         170 DFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LE  246 (309)
T ss_dssp             CTTCEESSCEECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---CC
T ss_pred             cccccccccccccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CC
Confidence            9999976554444456679999999999965 599999999999999999996 478999999998888876532   22


Q ss_pred             cccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          318 VWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       318 ~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+..+++++++||.+||+.||++|||+.||++|
T Consensus       247 ~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         247 KPLNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            345789999999999999999999999999986

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.5e-52  Score=406.58  Aligned_cols=246  Identities=23%  Similarity=0.347  Sum_probs=199.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CC
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-AD  170 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~  170 (469)
                      .++|++++.||+|+||.||+|.+..     +++.||||+++..     ...+.+|..++.++..|+||+.+++++.. ++
T Consensus        12 ~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~   91 (299)
T d1ywna1          12 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGG   91 (299)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTS
T ss_pred             HHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEccccCcHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCC
Confidence            4789999999999999999999754     4568999999643     24577888999998779999999998765 45


Q ss_pred             eEEEEEeccCCCchHHHHHHh----------------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEV----------------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSG  234 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~----------------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~  234 (469)
                      .+++|||||++|+|.+++...                ..+++..+..++.||+.||.|||++||+||||||+||||+.++
T Consensus        92 ~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~  171 (299)
T d1ywna1          92 PLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKN  171 (299)
T ss_dssp             CCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGG
T ss_pred             eEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCC
Confidence            689999999999999999654                2488999999999999999999999999999999999999999


Q ss_pred             cEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCHH-HHHHHHH
Q 012170          235 KIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLE-AVFDAIK  308 (469)
Q Consensus       235 ~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~-~~~~~i~  308 (469)
                      .+||+|||+|+......   ......||+.|+|||++.+ .|+.++|||||||++|+|++| .+||.+.... .+...+.
T Consensus       172 ~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~  251 (299)
T d1ywna1         172 VVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLK  251 (299)
T ss_dssp             CEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHH
T ss_pred             cEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence            99999999998654332   2345689999999999965 589999999999999999986 5788776543 3444444


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .... +  ..+..+++++.+||.+||+.||.+|||+.||++|
T Consensus       252 ~~~~-~--~~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         252 EGTR-M--RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             HTCC-C--CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCC-C--CCCccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4322 1  2235689999999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-51  Score=397.55  Aligned_cols=244  Identities=25%  Similarity=0.346  Sum_probs=202.9

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-CC--cEEEEEEcccC-------hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-SG--AEFACKTLRKG-------EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-~~--~~vAvK~~~~~-------~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||.||+|++.. ++  ..||||++++.       .+.+.+|+.+|++++ ||||+++++++.+ +.
T Consensus         7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~~~g~~~~-~~   84 (273)
T d1u46a_           7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLD-HRNLIRLYGVVLT-PP   84 (273)
T ss_dssp             GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCC-CTTBCCEEEEECS-SS
T ss_pred             hHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCC-CCCEEEEEEEEee-cc
Confidence            3679999999999999999998653 33  36899998642       246889999999996 9999999999975 46


Q ss_pred             EEEEEeccCCCchHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCC
Q 012170          172 FHLVMELCSGGRLIDQMVEV-GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNG  250 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~  250 (469)
                      +++|||||++|++.+.+... +.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++.....
T Consensus        85 ~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~  164 (273)
T d1u46a_          85 MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQN  164 (273)
T ss_dssp             CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-
T ss_pred             hheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHHhccccccceeeccchhhhhcccC
Confidence            78999999999999877554 57999999999999999999999999999999999999999999999999999876544


Q ss_pred             Cc----ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCH
Q 012170          251 QT----LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSK  324 (469)
Q Consensus       251 ~~----~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~  324 (469)
                      ..    .....|++.|+|||++.+ .++.++|||||||++|||++ |.+||.+.+..+++..+......++  .+..+|+
T Consensus       165 ~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~~--~~~~~~~  242 (273)
T d1u46a_         165 DDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKIDKEGERLP--RPEDCPQ  242 (273)
T ss_dssp             CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC--CCTTCCH
T ss_pred             CCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHHHHHHHHHhCCCCCC--CcccccH
Confidence            32    233568889999999976 48999999999999999998 8999999999999988877654433  3467899


Q ss_pred             HHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          325 PARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       325 ~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++.+||.+||..||++|||+.||++
T Consensus       243 ~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         243 DIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999999999999999999999864

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.2e-52  Score=397.29  Aligned_cols=241  Identities=24%  Similarity=0.365  Sum_probs=204.2

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CCeEEEEEec
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGVVTLHSVYEE-ADCFHLVMEL  178 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~~~~lV~E~  178 (469)
                      .++|++++.||+|+||.||+|+++  |..||||+++++  .+.+.+|+++|++++ ||||+++++++.+ .+.+|+||||
T Consensus         6 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~ey   82 (262)
T d1byga_           6 MKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDATAQAFLAEASVMTQLR-HSNLVQLLGVIVEEKGGLYIVTEY   82 (262)
T ss_dssp             GGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC--HHHHHTHHHHTTCC-CTTBCCEEEEECCC--CCEEEECC
T ss_pred             HHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHHHHHHHHHHHHHHHhCC-CCCEeeEEEEEEecCCcEEEEEec
Confidence            467999999999999999999985  789999999764  467899999999996 9999999998854 5668999999


Q ss_pred             cCCCchHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCccccc
Q 012170          179 CSGGRLIDQMVEVG--QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQTLSGL  256 (469)
Q Consensus       179 ~~gg~L~~~l~~~~--~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~~~~~  256 (469)
                      +++|+|.+++...+  .+++..+..++.||+.||.|||+.+|+||||||+|||++.+|.+||+|||+++.....  ....
T Consensus        83 ~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~--~~~~  160 (262)
T d1byga_          83 MAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST--QDTG  160 (262)
T ss_dssp             CTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------
T ss_pred             cCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHhheecCCCCEeecccccceecCCC--Cccc
Confidence            99999999996643  5899999999999999999999999999999999999999999999999999865433  3345


Q ss_pred             CCCCcccCceecc-CCCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhc
Q 012170          257 AGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLMARML  334 (469)
Q Consensus       257 ~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L  334 (469)
                      .+|+.|+|||++. +.++.++|||||||++|||+| |.+||.+.+..++...+.+....   .....+++++.+||.+||
T Consensus       161 ~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~---~~~~~~~~~~~~li~~cl  237 (262)
T d1byga_         161 KLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---DAPDGCPPAVYEVMKNCW  237 (262)
T ss_dssp             -CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---CCCTTCCHHHHHHHHHHT
T ss_pred             cccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCC---CCCccCCHHHHHHHHHHc
Confidence            7899999999985 469999999999999999998 79999998888888888764322   123568999999999999


Q ss_pred             hhhhcCCCCHHHHHcC
Q 012170          335 TRDVSARITADEVLRH  350 (469)
Q Consensus       335 ~~dP~~Rpsa~elL~h  350 (469)
                      ..||.+|||+.+++++
T Consensus       238 ~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         238 HLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             ccCHhHCcCHHHHHHH
Confidence            9999999999999874

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.6e-51  Score=402.26  Aligned_cols=245  Identities=23%  Similarity=0.317  Sum_probs=214.0

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCC
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEAD  170 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~  170 (469)
                      ..++|++++.||+|+||+||+|+++     .+++.||||+++..     ...+.+|+++|++++ ||||+++++++.+.+
T Consensus        11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~-h~niv~~~~~~~~~~   89 (301)
T d1lufa_          11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFD-NPNIVKLLGVCAVGK   89 (301)
T ss_dssp             CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCC-CTTBCCEEEEECSSS
T ss_pred             CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChhcChHHHHHHHHHHHHHHhcC-CCCcccceeeeccCC
Confidence            3578999999999999999999975     35678999999653     256889999999996 999999999999999


Q ss_pred             eEEEEEeccCCCchHHHHHHhC------------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCC
Q 012170          171 CFHLVMELCSGGRLIDQMVEVG------------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPE  226 (469)
Q Consensus       171 ~~~lV~E~~~gg~L~~~l~~~~------------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~  226 (469)
                      .+++||||+++|+|.+++....                        .+++..+..++.||+.||.|||++||+||||||+
T Consensus        90 ~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~  169 (301)
T d1lufa_          90 PMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR  169 (301)
T ss_dssp             SCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             ceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEccc
Confidence            9999999999999999986532                        3788999999999999999999999999999999


Q ss_pred             cEEEccCCcEEEEeccceeeecCCC---cccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCC-CCCCCCCHH
Q 012170          227 NILLTTSGKIKLADFGLAMRISNGQ---TLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAA-LPFKGDSLE  301 (469)
Q Consensus       227 NILl~~~~~vkL~DFgla~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~-~Pf~~~~~~  301 (469)
                      ||||+.++.+||+|||+++......   ...+.+||+.|+|||++.+ .|+.++|||||||++|||++|. +||.+.+..
T Consensus       170 NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~  249 (301)
T d1lufa_         170 NCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE  249 (301)
T ss_dssp             GEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred             ceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence            9999999999999999997653322   2345679999999999976 5999999999999999999985 789999999


Q ss_pred             HHHHHHHcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          302 AVFDAIKNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       302 ~~~~~i~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ++...+.......   .+..+++++.+||.+||+.||++|||+.||++
T Consensus       250 e~~~~v~~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         250 EVIYYVRDGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             HHHHHHHTTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHcCCCCC---CCccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            9999988776432   23578999999999999999999999999965

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-51  Score=399.69  Aligned_cols=246  Identities=24%  Similarity=0.347  Sum_probs=210.7

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCC-------cEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEe
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASG-------AEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEE  168 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~-------~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~  168 (469)
                      -.++|++++.||+|+||.||+|++..++       ..||||+++++.     ..+.+|+..+.++..|||||++++++.+
T Consensus        11 ~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~   90 (299)
T d1fgka_          11 PRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQ   90 (299)
T ss_dssp             CGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred             cHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcccChHHHHHHHHHHHHHHHhcCCCeEEeccccccc
Confidence            3579999999999999999999876554       479999996532     4577899999999669999999999999


Q ss_pred             CCeEEEEEeccCCCchHHHHHHhC----------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc
Q 012170          169 ADCFHLVMELCSGGRLIDQMVEVG----------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT  232 (469)
Q Consensus       169 ~~~~~lV~E~~~gg~L~~~l~~~~----------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~  232 (469)
                      ++.+|+|||||++|+|.+++....                .+++..+..++.||+.||.|||+.||+||||||+|||++.
T Consensus        91 ~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~  170 (299)
T d1fgka_          91 DGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE  170 (299)
T ss_dssp             SSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred             CCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecC
Confidence            999999999999999999996553                4899999999999999999999999999999999999999


Q ss_pred             CCcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q 012170          233 SGKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAI  307 (469)
Q Consensus       233 ~~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i  307 (469)
                      ++.+||+|||++........   .....||+.|+|||++.+ .|+.++|||||||++|+|++ |.+||.+.+...++..+
T Consensus       171 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i  250 (299)
T d1fgka_         171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLL  250 (299)
T ss_dssp             TCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHH
T ss_pred             CCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHH
Confidence            99999999999987654432   334679999999999854 69999999999999999998 79999999999988888


Q ss_pred             HcCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          308 KNVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       308 ~~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+...   ..+..+++++.+||.+||+.||.+|||+.||++
T Consensus       251 ~~~~~~---~~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         251 KEGHRM---DKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             HTTCCC---CCCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HcCCCC---CCCccchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            765322   223568999999999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.3e-50  Score=397.25  Aligned_cols=246  Identities=22%  Similarity=0.337  Sum_probs=210.0

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEEC-----CCCcEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSK-----ASGAEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~-----~~~~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||.||+|++.     .+++.||||+++..     ...+.+|+.+++++.+|||||++++++.+.+.
T Consensus        22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~  101 (311)
T d1t46a_          22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP  101 (311)
T ss_dssp             GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECcccCHHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCE
Confidence            479999999999999999999863     46778999999753     24578899999999669999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHhC------------------CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccC
Q 012170          172 FHLVMELCSGGRLIDQMVEVG------------------QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTS  233 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~~------------------~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~  233 (469)
                      +|+|||||++|+|.+++....                  .+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus       102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~  181 (311)
T d1t46a_         102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHG  181 (311)
T ss_dssp             CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETT
T ss_pred             EEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccccccccccc
Confidence            999999999999999987643                  58999999999999999999999999999999999999999


Q ss_pred             CcEEEEeccceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q 012170          234 GKIKLADFGLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLV-AALPFKGDSLEAVFDAIK  308 (469)
Q Consensus       234 ~~vkL~DFgla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~ellt-G~~Pf~~~~~~~~~~~i~  308 (469)
                      +.+||+|||+++.......   ....+||+.|+|||++.+ .++.++|||||||++|+|+| |.+||.+.+..+.+..+.
T Consensus       182 ~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i  261 (311)
T d1t46a_         182 RITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMI  261 (311)
T ss_dssp             TEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHH
T ss_pred             CcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHH
Confidence            9999999999987654322   234678999999999964 68999999999999999998 777787766655544443


Q ss_pred             cCcCCCCCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          309 NVKLDFHSGVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       309 ~~~~~~~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      .......  ....+++++.+||.+||+.||.+|||+.||++
T Consensus       262 ~~~~~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         262 KEGFRML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             HHTCCCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hcCCCCC--CcccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            3222222  22467999999999999999999999999986

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.8e-50  Score=392.92  Aligned_cols=244  Identities=21%  Similarity=0.280  Sum_probs=213.5

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECC-----CCcEEEEEEcccCh-----HHHHHHHHHHHHhhCCCCeeEEEEEEEeCCe
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKA-----SGAEFACKTLRKGE-----ETVHREVEIMQHLSGHTGVVTLHSVYEEADC  171 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~-----~~~~vAvK~~~~~~-----~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~  171 (469)
                      .++|++++.||+|+||.||+|.++.     +++.||||++++..     ..+.+|+++++++. ||||+++++++...+.
T Consensus        19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~-h~nIv~~~~~~~~~~~   97 (308)
T d1p4oa_          19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFN-CHHVVRLLGVVSQGQP   97 (308)
T ss_dssp             GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCC-CTTBCCEEEEECSSSS
T ss_pred             HHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcccChHHHHHHHHHHHHHHHcC-CCCEeeeeeEEecCCc
Confidence            4789999999999999999998753     45789999997532     35789999999996 9999999999999999


Q ss_pred             EEEEEeccCCCchHHHHHHh----------CCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEec
Q 012170          172 FHLVMELCSGGRLIDQMVEV----------GQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADF  241 (469)
Q Consensus       172 ~~lV~E~~~gg~L~~~l~~~----------~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DF  241 (469)
                      .++|||||++|+|.+++...          ..+++..+..++.||+.||.|||+++|+||||||+||||+.++++||+||
T Consensus        98 ~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DF  177 (308)
T d1p4oa_          98 TLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDF  177 (308)
T ss_dssp             CEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCT
T ss_pred             eeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeec
Confidence            99999999999999988643          24688999999999999999999999999999999999999999999999


Q ss_pred             cceeeecCCCc---ccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhC-CCCCCCCCHHHHHHHHHcCcCCCCC
Q 012170          242 GLAMRISNGQT---LSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVA-ALPFKGDSLEAVFDAIKNVKLDFHS  316 (469)
Q Consensus       242 gla~~~~~~~~---~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG-~~Pf~~~~~~~~~~~i~~~~~~~~~  316 (469)
                      |+++.......   .....||+.|+|||.+.+ .++.++|||||||++|||+|| .+||.+.+..+++..+.+.....  
T Consensus       178 Gla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~--  255 (308)
T d1p4oa_         178 GMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLD--  255 (308)
T ss_dssp             TCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCC--
T ss_pred             ccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCC--
Confidence            99976543322   334578999999999865 589999999999999999998 58999999999999887765322  


Q ss_pred             CcccCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          317 GVWETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       317 ~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                       ....+++.+.+||.+||+.||.+|||+.+|++
T Consensus       256 -~p~~~~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         256 -KPDNCPDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             -CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -CcccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence             23568999999999999999999999999998

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=2.3e-49  Score=387.74  Aligned_cols=252  Identities=22%  Similarity=0.306  Sum_probs=203.3

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +-++|++++.||+|+||.||+|++..+|+.||||++..  ....+.+|+++++.+..|++|+.+..++.+.+..++||||
T Consensus         5 vg~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~   84 (299)
T d1ckia_           5 VGNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMEL   84 (299)
T ss_dssp             ETTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEEC
T ss_pred             ECCEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEE
Confidence            34689999999999999999999999999999999864  3457889999999998566677788888999999999999


Q ss_pred             cCCCchHHHHH-HhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc---CCcEEEEeccceeeecCCCc--
Q 012170          179 CSGGRLIDQMV-EVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT---SGKIKLADFGLAMRISNGQT--  252 (469)
Q Consensus       179 ~~gg~L~~~l~-~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~---~~~vkL~DFgla~~~~~~~~--  252 (469)
                      +.+ +|.+.+. ..+.+++..+..++.|++.||+|||++||+||||||+|||++.   +..++|+|||+|+.+.....  
T Consensus        85 ~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~  163 (299)
T d1ckia_          85 LGP-SLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQ  163 (299)
T ss_dssp             CCC-BHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCC
T ss_pred             cCC-chhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhccccccCCCceeeeeccCcceecccccccc
Confidence            955 5555554 4568999999999999999999999999999999999999864   45799999999987754322  


Q ss_pred             ------ccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH---cCcCCCC-CCcccC
Q 012170          253 ------LSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDSLEAVFDAIK---NVKLDFH-SGVWET  321 (469)
Q Consensus       253 ------~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~---~~~~~~~-~~~~~~  321 (469)
                            ....+||+.|+|||++.+. |+.++|||||||++|+|++|..||.+.........+.   ......+ ...+..
T Consensus       164 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  243 (299)
T d1ckia_         164 HIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKG  243 (299)
T ss_dssp             BCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTT
T ss_pred             ceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccC
Confidence                  2456899999999999874 9999999999999999999999998765544333221   1111111 112356


Q ss_pred             CCHHHHHHHHHhchhhhcCCCCHHH---HHcCCCc
Q 012170          322 VSKPARDLMARMLTRDVSARITADE---VLRHPWI  353 (469)
Q Consensus       322 ~s~~~~~lI~~~L~~dP~~Rpsa~e---lL~hp~~  353 (469)
                      +|+++.+||.+||..||.+||++.+   +|+|+|.
T Consensus       244 ~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~  278 (299)
T d1ckia_         244 YPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFH  278 (299)
T ss_dssp             SCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHH
T ss_pred             CCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHH
Confidence            8999999999999999999999875   4667654

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-48  Score=383.35  Aligned_cols=239  Identities=23%  Similarity=0.281  Sum_probs=197.4

Q ss_pred             eeeeeccCCeEEEEEEECCCC---cEEEEEEcccC-----hHHHHHHHHHHHHhhCCCCeeEEEEEEEe-CCeEEEEEec
Q 012170          108 VEVIGHGKFGSVWLCRSKASG---AEFACKTLRKG-----EETVHREVEIMQHLSGHTGVVTLHSVYEE-ADCFHLVMEL  178 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~---~~vAvK~~~~~-----~~~~~~E~~il~~l~~hpnIv~l~~~~~~-~~~~~lV~E~  178 (469)
                      .++||+|+||+||+|++..++   ..||||.+++.     .+.+.+|+++|++|+ ||||+++++++.. ++.+++||||
T Consensus        32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~-HpnIv~~~g~~~~~~~~~~lv~E~  110 (311)
T d1r0pa_          32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFS-HPNVLSLLGICLRSEGSPLVVLPY  110 (311)
T ss_dssp             EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCC-CTTBCCCCEEEEETTTEEEEEEEC
T ss_pred             ceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcccCHHHHHHHHHHHHHHHhCC-CCCEeEEeEEEEecCCceEEEEEE
Confidence            578999999999999987643   36899998642     256889999999997 9999999999765 5689999999


Q ss_pred             cCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEeccceeeecCCCc-----
Q 012170          179 CSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFGLAMRISNGQT-----  252 (469)
Q Consensus       179 ~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFgla~~~~~~~~-----  252 (469)
                      |++|+|.+++.... .+++..+..++.|++.||.|||+.||+||||||+||||++++.+||+|||+++.......     
T Consensus       111 ~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~  190 (311)
T d1r0pa_         111 MKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHN  190 (311)
T ss_dssp             CTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTC
T ss_pred             eecCchhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECCCCCEEEecccchhhcccccccccee
Confidence            99999999886543 577889999999999999999999999999999999999999999999999986544322     


Q ss_pred             ccccCCCCcccCceecc-CCCCCccchHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHcCcCCCCCCcccCCCHHHHHHH
Q 012170          253 LSGLAGSPAYVAPEVLS-GNYSEKVDIWSAGVLLHALLVAALPFK-GDSLEAVFDAIKNVKLDFHSGVWETVSKPARDLM  330 (469)
Q Consensus       253 ~~~~~gt~~y~aPE~l~-~~~~~~~DiwSlG~il~elltG~~Pf~-~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~lI  330 (469)
                      .....||+.|+|||++. +.++.++||||||+++|||++|..||. ..+..++...+..+.....   ...+++++.+||
T Consensus       191 ~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~---p~~~~~~l~~li  267 (311)
T d1r0pa_         191 KTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLLQ---PEYCPDPLYEVM  267 (311)
T ss_dssp             TTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHHHHHTTCCCCC---CTTCCHHHHHHH
T ss_pred             cccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC---cccCcHHHHHHH
Confidence            23357899999999985 469999999999999999999766665 4445556666666543322   246799999999


Q ss_pred             HHhchhhhcCCCCHHHHHcC
Q 012170          331 ARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       331 ~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .+||..||++|||+.||++|
T Consensus       268 ~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         268 LKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHcCCCHhHCcCHHHHHHH
Confidence            99999999999999999986

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=5.2e-48  Score=377.23  Aligned_cols=248  Identities=21%  Similarity=0.266  Sum_probs=208.9

Q ss_pred             ccCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          101 IEDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       101 ~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +-++|++++.||+|+||+||+|++..+|+.||||++..  ....+.+|+++++.|..|+||+.+++++..+...|+||||
T Consensus         3 ig~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~   82 (293)
T d1csna_           3 VGVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDL   82 (293)
T ss_dssp             ETTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEEC
T ss_pred             CCCceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEe
Confidence            44689999999999999999999999999999999854  3456889999999998679999999999999999999999


Q ss_pred             cCCCchHHHHHHhC-CCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEcc-----CCcEEEEeccceeeecCCC-
Q 012170          179 CSGGRLIDQMVEVG-QYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTT-----SGKIKLADFGLAMRISNGQ-  251 (469)
Q Consensus       179 ~~gg~L~~~l~~~~-~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~-----~~~vkL~DFgla~~~~~~~-  251 (469)
                      + |++|.+++...+ .+++..+..++.|++.||.|||++||+||||||+|||++.     ++.+||+|||+|+...... 
T Consensus        83 ~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~  161 (293)
T d1csna_          83 L-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVT  161 (293)
T ss_dssp             C-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTT
T ss_pred             c-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCcc
Confidence            9 789998887654 6999999999999999999999999999999999999974     5789999999998764321 


Q ss_pred             -------cccccCCCCcccCceeccCC-CCCccchHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHcCcCCCC-CCcc
Q 012170          252 -------TLSGLAGSPAYVAPEVLSGN-YSEKVDIWSAGVLLHALLVAALPFKGDS---LEAVFDAIKNVKLDFH-SGVW  319 (469)
Q Consensus       252 -------~~~~~~gt~~y~aPE~l~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~---~~~~~~~i~~~~~~~~-~~~~  319 (469)
                             .....+||+.|||||++.+. ++.++|||||||++|+|++|..||.+..   .......+.......+ ....
T Consensus       162 ~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~  241 (293)
T d1csna_         162 KQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELC  241 (293)
T ss_dssp             CCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHT
T ss_pred             ccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhc
Confidence                   23456899999999999875 9999999999999999999999997543   3333333433222111 1123


Q ss_pred             cCCCHHHHHHHHHhchhhhcCCCCHHHHHc
Q 012170          320 ETVSKPARDLMARMLTRDVSARITADEVLR  349 (469)
Q Consensus       320 ~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~  349 (469)
                      ..+|+++.+++..|+..+|.+||+++.+.+
T Consensus       242 ~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~  271 (293)
T d1csna_         242 AGFPEEFYKYMHYARNLAFDATPDYDYLQG  271 (293)
T ss_dssp             TTSCHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             CCCCHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence            468999999999999999999999877653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.3e-48  Score=378.91  Aligned_cols=245  Identities=24%  Similarity=0.339  Sum_probs=193.6

Q ss_pred             cCCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh-HHHHHHHHHH--HHhhCCCCeeEEEEEEEeCC----eEEE
Q 012170          102 EDDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE-ETVHREVEIM--QHLSGHTGVVTLHSVYEEAD----CFHL  174 (469)
Q Consensus       102 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il--~~l~~hpnIv~l~~~~~~~~----~~~l  174 (469)
                      ..+|.+.+.||+|+||.||+|++  +|+.||||+++... ....+|.+++  ..++ ||||+++++++.+.+    .+|+
T Consensus         2 ~~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~~~~~~~~e~ei~~~~~~~-HpnIv~~~~~~~~~~~~~~~~~l   78 (303)
T d1vjya_           2 ARTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSREERSWFREAEIYQTVMLR-HENILGFIAADNKDNGTWTQLWL   78 (303)
T ss_dssp             GGGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGGGHHHHHHHHHHHTSTTCC-CTTBCCEEEEEEEECSSSEEEEE
T ss_pred             CcEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccchhHHHHHHHHHHHhhCC-CCcCcceEEEEEeCCCcceEEEE
Confidence            46789999999999999999987  48999999996543 3344555544  5665 999999999997654    6899


Q ss_pred             EEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHh--------cCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          175 VMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHD--------MGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       175 V~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~--------~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      |||||++|+|.+++.+ ..+++.....++.|++.||.|||+        +||+||||||+||||+.+|.+||+|||++..
T Consensus        79 v~Ey~~~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~  157 (303)
T d1vjya_          79 VSDYHEHGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR  157 (303)
T ss_dssp             EEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEE
T ss_pred             EEecccCCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCcccc
Confidence            9999999999999965 578999999999999999999996        5999999999999999999999999999987


Q ss_pred             ecCCCc-----ccccCCCCcccCceeccCC-------CCCccchHHHHHHHHHHHhCCCCCCCC---------------C
Q 012170          247 ISNGQT-----LSGLAGSPAYVAPEVLSGN-------YSEKVDIWSAGVLLHALLVAALPFKGD---------------S  299 (469)
Q Consensus       247 ~~~~~~-----~~~~~gt~~y~aPE~l~~~-------~~~~~DiwSlG~il~elltG~~Pf~~~---------------~  299 (469)
                      ......     ....+||+.|+|||++.+.       ++.++|||||||++|||+||.+||...               .
T Consensus       158 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~  237 (303)
T d1vjya_         158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPS  237 (303)
T ss_dssp             EETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCC
T ss_pred             ccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccch
Confidence            755432     3356899999999998753       567899999999999999998877321               2


Q ss_pred             HHHHHHHHHcCcCCCCC-Ccc--cCCCHHHHHHHHHhchhhhcCCCCHHHHHcC
Q 012170          300 LEAVFDAIKNVKLDFHS-GVW--ETVSKPARDLMARMLTRDVSARITADEVLRH  350 (469)
Q Consensus       300 ~~~~~~~i~~~~~~~~~-~~~--~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~h  350 (469)
                      .......+......... ..+  ......+.+|+.+||+.||++|||+.||+++
T Consensus       238 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~  291 (303)
T d1vjya_         238 VEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  291 (303)
T ss_dssp             HHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            33333333332221111 111  1123468899999999999999999999874

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.6e-46  Score=372.73  Aligned_cols=250  Identities=26%  Similarity=0.458  Sum_probs=195.9

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh---HHHHHHHHHHHHhh----------CCCCeeEEEEEEEe-
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE---ETVHREVEIMQHLS----------GHTGVVTLHSVYEE-  168 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~---~~~~~E~~il~~l~----------~hpnIv~l~~~~~~-  168 (469)
                      .+|++++.||+|+||+||+|+++.+|+.||||++++..   +.+.+|+++|+.+.          +|+||+++++++.. 
T Consensus        13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~   92 (362)
T d1q8ya_          13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHK   92 (362)
T ss_dssp             TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHHHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEE
T ss_pred             CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeccccchHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeec
Confidence            46999999999999999999999999999999998753   56788999998885          26889999988754 


Q ss_pred             -CCeEEEEEeccCCCchHHHHH---HhCCCCHHHHHHHHHHHHHHHHHHHh-cCeEeccCCCCcEEEccCC------cEE
Q 012170          169 -ADCFHLVMELCSGGRLIDQMV---EVGQYSEQRAANIFKDVMWVIKYCHD-MGVVHRDIKPENILLTTSG------KIK  237 (469)
Q Consensus       169 -~~~~~lV~E~~~gg~L~~~l~---~~~~l~~~~~~~i~~qil~aL~yLH~-~givHrDlkp~NILl~~~~------~vk  237 (469)
                       ....++||+++..+.......   ....+++..+..++.||+.||.|||+ .||+||||||+||||+.++      .++
T Consensus        93 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~k  172 (362)
T d1q8ya_          93 GPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIK  172 (362)
T ss_dssp             ETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEE
T ss_pred             cccceeeeeeecccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceee
Confidence             456777887776655433332   23578999999999999999999998 8999999999999998765      399


Q ss_pred             EEeccceeeecCCCcccccCCCCcccCceeccC-CCCCccchHHHHHHHHHHHhCCCCCCCCCHH------HHHHHHHcC
Q 012170          238 LADFGLAMRISNGQTLSGLAGSPAYVAPEVLSG-NYSEKVDIWSAGVLLHALLVAALPFKGDSLE------AVFDAIKNV  310 (469)
Q Consensus       238 L~DFgla~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwSlG~il~elltG~~Pf~~~~~~------~~~~~i~~~  310 (469)
                      |+|||.+.....  .....+||+.|+|||++.+ .|+.++||||+||++++|++|..||......      ..+..+...
T Consensus       173 l~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~  250 (362)
T d1q8ya_         173 IADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIEL  250 (362)
T ss_dssp             ECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHH
T ss_pred             Eeeccccccccc--ccccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHH
Confidence            999999976443  3355689999999999865 5999999999999999999999999754321      111111000


Q ss_pred             ------------c------------CCC--------------CCCcccCCCHHHHHHHHHhchhhhcCCCCHHHHHcCCC
Q 012170          311 ------------K------------LDF--------------HSGVWETVSKPARDLMARMLTRDVSARITADEVLRHPW  352 (469)
Q Consensus       311 ------------~------------~~~--------------~~~~~~~~s~~~~~lI~~~L~~dP~~Rpsa~elL~hp~  352 (469)
                                  .            ...              ....+...+++++|||.+||.+||.+||||+|||+|||
T Consensus       251 lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~  330 (362)
T d1q8ya_         251 LGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPW  330 (362)
T ss_dssp             HCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGG
T ss_pred             hCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcc
Confidence                        0            000              00112235678999999999999999999999999999


Q ss_pred             cc
Q 012170          353 IL  354 (469)
Q Consensus       353 ~~  354 (469)
                      |.
T Consensus       331 f~  332 (362)
T d1q8ya_         331 LK  332 (362)
T ss_dssp             GT
T ss_pred             cC
Confidence            96

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.93  E-value=7.9e-27  Score=211.98  Aligned_cols=160  Identities=20%  Similarity=0.249  Sum_probs=121.9

Q ss_pred             eeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccCh----------------------HHHHHHHHHHHHhhCCCCeeEE
Q 012170          105 HTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKGE----------------------ETVHREVEIMQHLSGHTGVVTL  162 (469)
Q Consensus       105 y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~~----------------------~~~~~E~~il~~l~~hpnIv~l  162 (469)
                      +.+.+.||+|+||.||+|.+. +|+.||||+++.+.                      ....+|...|.++. |++++..
T Consensus         2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~-~~~v~~~   79 (191)
T d1zara2           2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQ-GLAVPKV   79 (191)
T ss_dssp             SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTT-TSSSCCE
T ss_pred             chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHHHcc-CCCcceE
Confidence            457899999999999999986 68999999875311                      22456888999996 9999988


Q ss_pred             EEEEEeCCeEEEEEeccCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhcCeEeccCCCCcEEEccCCcEEEEecc
Q 012170          163 HSVYEEADCFHLVMELCSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCHDMGVVHRDIKPENILLTTSGKIKLADFG  242 (469)
Q Consensus       163 ~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH~~givHrDlkp~NILl~~~~~vkL~DFg  242 (469)
                      +++..    .++||||++++.+..       ++...+..++.|++.+|.|||++||+||||||+|||++++ .++|+|||
T Consensus        80 ~~~~~----~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liDFG  147 (191)
T d1zara2          80 YAWEG----NAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIIDFP  147 (191)
T ss_dssp             EEEET----TEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECCCT
T ss_pred             EEecC----CEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEEEccCChhheeeeCC-CEEEEECC
Confidence            76632    269999998876532       4556677899999999999999999999999999999865 59999999


Q ss_pred             ceeeecCCCcccccCCCCcccC------ceeccCCCCCccchHHHHHHH
Q 012170          243 LAMRISNGQTLSGLAGSPAYVA------PEVLSGNYSEKVDIWSAGVLL  285 (469)
Q Consensus       243 la~~~~~~~~~~~~~gt~~y~a------PE~l~~~~~~~~DiwSlG~il  285 (469)
                      +|.....+...       .|..      .+.+...|+.++|+||+.--+
T Consensus       148 ~a~~~~~~~~~-------~~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~  189 (191)
T d1zara2         148 QSVEVGEEGWR-------EILERDVRNIITYFSRTYRTEKDINSAIDRI  189 (191)
T ss_dssp             TCEETTSTTHH-------HHHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred             CcccCCCCCcH-------HHHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            99765433221       1111      122334688999999986443

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=98.70  E-value=6.5e-08  Score=89.45  Aligned_cols=137  Identities=18%  Similarity=0.158  Sum_probs=94.3

Q ss_pred             CCeeeeeeeeccCCeEEEEEEECCCCcEEEEEEcccC----hHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEec
Q 012170          103 DDHTKVEVIGHGKFGSVWLCRSKASGAEFACKTLRKG----EETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVMEL  178 (469)
Q Consensus       103 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~----~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E~  178 (469)
                      +.|+.++..+-++.+.||+..  .++..+.+|.....    ...+.+|+.+|..|.++--+++++.+..+++..|+||++
T Consensus        14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~   91 (263)
T d1j7la_          14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSE   91 (263)
T ss_dssp             TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEEC
T ss_pred             hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEe
Confidence            456666665556667999885  34677889987532    346889999999997665578899999999999999999


Q ss_pred             cCCCchHHHHHHhCCCCHHHHHHHHHHHHHHHHHHH--------------------------------------------
Q 012170          179 CSGGRLIDQMVEVGQYSEQRAANIFKDVMWVIKYCH--------------------------------------------  214 (469)
Q Consensus       179 ~~gg~L~~~l~~~~~l~~~~~~~i~~qil~aL~yLH--------------------------------------------  214 (469)
                      ++|..+.+.....     .....++.++...+..||                                            
T Consensus        92 l~G~~~~~~~~~~-----~~~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  166 (263)
T d1j7la_          92 ADGVLCSEEYEDE-----QSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKD  166 (263)
T ss_dssp             CSSEEHHHHTTTC-----SCHHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSS
T ss_pred             ccccccccccccc-----ccHHHHHHHHHHHHHHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchH
Confidence            9997764432110     011112222222222222                                            


Q ss_pred             ---------h------cCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          215 ---------D------MGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       215 ---------~------~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                               .      ..++|+|+.|.|||+++++.+-|+||+.+..
T Consensus       167 ~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         167 PRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR  213 (263)
T ss_dssp             HHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred             HHHHHHHHHhcCCcCCcEEEEeeccCcceeecCCceEEEeechhccc
Confidence                     1      1389999999999998776667999999854

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=98.44  E-value=5.9e-07  Score=88.48  Aligned_cols=75  Identities=16%  Similarity=0.131  Sum_probs=51.9

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEccc-----------ChHHHHHHHHHHHHhhCC--CCeeEEEEEEEeCCeEEE
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRK-----------GEETVHREVEIMQHLSGH--TGVVTLHSVYEEADCFHL  174 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~-----------~~~~~~~E~~il~~l~~h--pnIv~l~~~~~~~~~~~l  174 (469)
                      .+.||.|....||++.+..+++.|+||.-..           ...+...|.++|+.+..+  ..+++++.+  +.+..++
T Consensus        31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l  108 (392)
T d2pula1          31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT  108 (392)
T ss_dssp             EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred             EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence            4678999999999999887788999996421           124567799999888654  335666654  4445569


Q ss_pred             EEeccCCCch
Q 012170          175 VMELCSGGRL  184 (469)
Q Consensus       175 V~E~~~gg~L  184 (469)
                      |||++.+..+
T Consensus       109 vmE~L~~~~~  118 (392)
T d2pula1         109 VMEDLSHLKI  118 (392)
T ss_dssp             EECCCTTSEE
T ss_pred             EEeccCCccc
Confidence            9999987654

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=98.25  E-value=2.2e-06  Score=78.43  Aligned_cols=136  Identities=15%  Similarity=0.108  Sum_probs=86.5

Q ss_pred             eeeccC-CeEEEEEEECCCCcEEEEEEcccCh-HHHHHHHHHHHHhhCCC-CeeEEEEEEEeCCeEEEEEeccCCCchHH
Q 012170          110 VIGHGK-FGSVWLCRSKASGAEFACKTLRKGE-ETVHREVEIMQHLSGHT-GVVTLHSVYEEADCFHLVMELCSGGRLID  186 (469)
Q Consensus       110 ~lG~G~-~g~Vy~~~~~~~~~~vAvK~~~~~~-~~~~~E~~il~~l~~hp-nIv~l~~~~~~~~~~~lV~E~~~gg~L~~  186 (469)
                      .+..|. -+.||+.... ++..+++|...... ..+..|+..|+.|..+. .+++++.+..+++..|+||++++|.++.+
T Consensus        17 ~~~~G~s~~~v~r~~~~-~~~~~vlK~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~~~   95 (255)
T d1nd4a_          17 QQTIGCSDAAVFRLSAQ-GRPVLFVKTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLLS   95 (255)
T ss_dssp             ECSCTTSSCEEEEEECT-TSCCEEEEEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETTT
T ss_pred             EcCCcccCCeEEEEEeC-CCCEEEEEeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccccc
Confidence            344454 3678988754 57778999886543 45888999999887542 26778888888889999999998866522


Q ss_pred             --------------HHHHhC-------CCC--HHHH-HHH---H----------------HHHHHHHHHHHhc-------
Q 012170          187 --------------QMVEVG-------QYS--EQRA-ANI---F----------------KDVMWVIKYCHDM-------  216 (469)
Q Consensus       187 --------------~l~~~~-------~l~--~~~~-~~i---~----------------~qil~aL~yLH~~-------  216 (469)
                                    .+.+-.       ++.  .... ...   .                ......+..+...       
T Consensus        96 ~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~  175 (255)
T d1nd4a_          96 SHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDL  175 (255)
T ss_dssp             SCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCE
T ss_pred             ccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhhhHHHHHHHHHHHhCCccCCc
Confidence                          111100       010  0000 000   0                0011223333322       


Q ss_pred             CeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          217 GVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       217 givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                      .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus       176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~  205 (255)
T d1nd4a_         176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV  205 (255)
T ss_dssp             EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence            389999999999999876678999999854

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=97.59  E-value=0.00014  Score=70.89  Aligned_cols=74  Identities=18%  Similarity=0.188  Sum_probs=55.4

Q ss_pred             eeeeeeccCCeEEEEEEECC-------CCcEEEEEEccc--ChHHHHHHHHHHHHhhCCCCeeEEEEEEEeCCeEEEEEe
Q 012170          107 KVEVIGHGKFGSVWLCRSKA-------SGAEFACKTLRK--GEETVHREVEIMQHLSGHTGVVTLHSVYEEADCFHLVME  177 (469)
Q Consensus       107 ~~~~lG~G~~g~Vy~~~~~~-------~~~~vAvK~~~~--~~~~~~~E~~il~~l~~hpnIv~l~~~~~~~~~~~lV~E  177 (469)
                      .++.|+.|-.-.+|++....       .+..|.+++.-.  ......+|..+++.+..+.-.+++++++.+    ++|||
T Consensus        46 ~v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~e  121 (395)
T d1nw1a_          46 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEE  121 (395)
T ss_dssp             EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEEC
T ss_pred             EEEEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCcchhhHHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEE
Confidence            35788899999999998653       345688888743  234567899999999877666788888753    48999


Q ss_pred             ccCCCch
Q 012170          178 LCSGGRL  184 (469)
Q Consensus       178 ~~~gg~L  184 (469)
                      |++|..+
T Consensus       122 fi~g~~l  128 (395)
T d1nw1a_         122 YIPSRPL  128 (395)
T ss_dssp             CCCEEEC
T ss_pred             EeccccC
Confidence            9987544

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=97.42  E-value=0.00022  Score=67.47  Aligned_cols=66  Identities=14%  Similarity=0.219  Sum_probs=47.1

Q ss_pred             CeEEEEEEECCCCcEEEEEEcccC---hHHHHHHHHHHHHhhCCCCe--eEEE-----EEEEeCCeEEEEEeccCCCc
Q 012170          116 FGSVWLCRSKASGAEFACKTLRKG---EETVHREVEIMQHLSGHTGV--VTLH-----SVYEEADCFHLVMELCSGGR  183 (469)
Q Consensus       116 ~g~Vy~~~~~~~~~~vAvK~~~~~---~~~~~~E~~il~~l~~hpnI--v~l~-----~~~~~~~~~~lV~E~~~gg~  183 (469)
                      --.||++... +|..|++|+.+.+   .+.+..|...|..|..+ +|  +...     ..+...+..+.|++++.|..
T Consensus        35 EN~vy~v~~~-dg~~~VlK~~rp~~~s~~~i~~E~~~l~~L~~~-gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~  110 (325)
T d1zyla1          35 ENRVYQFQDE-DRRRFVVKFYRPERWTADQILEEHQFALQLVND-EVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ  110 (325)
T ss_dssp             SSEEEEECCT-TCCCEEEEEECTTTSCHHHHHHHHHHHHHHHHT-TCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred             cceeEEEEcC-CCCEEEEEEeCCCCCCHHHHHHHHHHHHHHHhc-CCCCCCceecCCCeeeeeeeEEEEEEeecCCcC
Confidence            3589999764 6889999998764   46788999999998732 22  2111     12455778899999998743

>d2hf5a1 a.39.1.5 (A:81-113) Troponin C {Human (Homo sapiens), cardiac isoform [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Human (Homo sapiens), cardiac isoform [TaxId: 9606]

Probab=97.24  E-value=9.3e-06  Score=49.20  Aligned_cols=26  Identities=8%  Similarity=0.123  Sum_probs=23.4

Q ss_pred             ccCCCCcccccccccccCHHHHhhhC
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      -|..||+.||.||+|+|+++||..+|
T Consensus         4 el~eAF~~FDkDg~G~Is~~EL~~vm   29 (33)
T d2hf5a1           4 EIREAFRVFDKDGNGYISAAELRHVM   29 (33)
T ss_dssp             HHHHHHHHHSSSCCSCBCHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCcCcHHHHHHHH
Confidence            45669999999999999999999886

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=96.88  E-value=0.0015  Score=60.98  Aligned_cols=136  Identities=18%  Similarity=0.162  Sum_probs=77.3

Q ss_pred             eeeeeccCCeEEEEEEECCCCcEEEEEEcccC--hHHHHHHHHHHHHhhCCCCe--eEEEE------EEEeCCeEEEEEe
Q 012170          108 VEVIGHGKFGSVWLCRSKASGAEFACKTLRKG--EETVHREVEIMQHLSGHTGV--VTLHS------VYEEADCFHLVME  177 (469)
Q Consensus       108 ~~~lG~G~~g~Vy~~~~~~~~~~vAvK~~~~~--~~~~~~E~~il~~l~~hpnI--v~l~~------~~~~~~~~~lV~E  177 (469)
                      ++.|..|---+.|++...  +..|++|++...  ...+..|+++|..|..+ ++  +....      +.......+.++.
T Consensus        23 ~~~i~~G~~N~ny~v~t~--~g~yVLri~~~~~~~~~l~~~~~~l~~L~~~-g~pvp~pi~~~~g~~~~~~~~~~~~~~~   99 (316)
T d2ppqa1          23 YKGIAEGVENSNFLLHTT--KDPLILTLYEKRVEKNDLPFFLGLMQHLAAK-GLSCPLPLPRKDGELLGELSGRPAALIS   99 (316)
T ss_dssp             EEEECC---EEEEEEEES--SCCEEEEEECC---CCHHHHHHHHHHHHHHT-TCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred             eecCCCCcccCeEEEEEC--CCcEEEEEcCCCCCHHHHHHHHHHHHhhhhc-cccccccceecCCCcceeeecccceeee
Confidence            345667777889998765  345999998653  45678899999998732 22  11111      1233456667777


Q ss_pred             ccCCCchHH--------------HHHHhC---------CCCH------------------HHHHHHHHHHHHHHHHHH--
Q 012170          178 LCSGGRLID--------------QMVEVG---------QYSE------------------QRAANIFKDVMWVIKYCH--  214 (469)
Q Consensus       178 ~~~gg~L~~--------------~l~~~~---------~l~~------------------~~~~~i~~qil~aL~yLH--  214 (469)
                      ++.|.....              .+....         ....                  ......+..+...+.-.+  
T Consensus       100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~  179 (316)
T d2ppqa1         100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK  179 (316)
T ss_dssp             CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred             ecccccccccchhHHHHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHHHHhhhccCcc
Confidence            776643210              010000         0000                  011122222222233222  


Q ss_pred             --hcCeEeccCCCCcEEEccCCcEEEEeccceee
Q 012170          215 --DMGVVHRDIKPENILLTTSGKIKLADFGLAMR  246 (469)
Q Consensus       215 --~~givHrDlkp~NILl~~~~~vkL~DFgla~~  246 (469)
                        ..|+||+|+.++||+++.+...-|+||+.+..
T Consensus       180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~  213 (316)
T d2ppqa1         180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN  213 (316)
T ss_dssp             SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred             ccccccccCCcchhhhhcccccceeEeccccccc
Confidence              24799999999999999887778999999854

>d1ctda_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=94.46  E-value=0.0011  Score=38.39  Aligned_cols=27  Identities=7%  Similarity=0.148  Sum_probs=22.6

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.|..-|.+||.+++|+|+.+||.++|
T Consensus         4 eELae~FRifDkNaDGyiD~eEl~~il   30 (34)
T d1ctda_           4 EELANAFRIFDKNADGYIDIEELGEIL   30 (34)
T ss_dssp             HHHHHHHHTTCCSSSSCBCHHHHHHHH
T ss_pred             HHHHHHHHHHccCCcccccHHHHHHHH
Confidence            345557899999999999999998764

>d5pala_ a.39.1.4 (A:) Parvalbumin {Leopard shark (Triakis semifasciata) [TaxId: 30493]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Leopard shark (Triakis semifasciata) [TaxId: 30493]

Probab=90.62  E-value=0.0096  Score=46.34  Aligned_cols=28  Identities=7%  Similarity=0.021  Sum_probs=24.1

Q ss_pred             cccccCCCCcccccccccccCHHHHhhh
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      ....|..+|..||.|++|+|+++||.++
T Consensus        39 ~~~~l~~~F~~~D~d~~G~I~~~El~~~   66 (109)
T d5pala_          39 TDAQVKEVFEILDKDQSGFIEEEELKGV   66 (109)
T ss_dssp             CHHHHHHHHHHHCTTCSSEECHHHHHTH
T ss_pred             CHHHHHHHHhhhcCCCCCeEcHHHHHHH
Confidence            3456888999999999999999999875

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=89.55  E-value=0.011  Score=41.20  Aligned_cols=26  Identities=8%  Similarity=0.123  Sum_probs=20.7

Q ss_pred             ccCCCCcccccccccccCHHHHhhhC
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .|..+|+.||.+++|+|+.+||+.++
T Consensus         4 el~~aF~~fD~d~~G~I~~~el~~~l   29 (65)
T d1fw4a_           4 EIREAFRVFDKDGNGYISAAELRHVM   29 (65)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCCHHHHHHHH
Confidence            45667888888888888888888763

>d1pvaa_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=89.08  E-value=0.021  Score=44.28  Aligned_cols=28  Identities=11%  Similarity=0.045  Sum_probs=21.2

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...+..+|..+|.|++|+|+++||+.++
T Consensus        40 ~~~~~~~F~~~D~d~~G~I~~~El~~~l   67 (109)
T d1pvaa_          40 ANDVKKVFKAIDADASGFIEEEELKFVL   67 (109)
T ss_dssp             HHHHHHHHHHHCTTCSSSBCHHHHHTGG
T ss_pred             HHHHHHHhhCccCCCcCeEcHHHHHHHH
Confidence            3446668888888888888888887653

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=87.51  E-value=0.023  Score=39.94  Aligned_cols=25  Identities=0%  Similarity=-0.060  Sum_probs=19.8

Q ss_pred             cCCCCcccccccccccCHHHHhhhC
Q 012170          445 LCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       445 l~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      |..+|..||.+++|+|+.+||+++|
T Consensus         4 l~~~F~~~D~d~~G~I~~~el~~~l   28 (68)
T d1c7va_           4 ILRAFKVFDANGDGVIDFDEFKFIM   28 (68)
T ss_dssp             HHHHHHHHSCSGGGEECHHHHHHHS
T ss_pred             HHHHHHHHcCCCcCeEcHHHHHHHH
Confidence            4557888888888888888888765

>d1jc2a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=86.84  E-value=0.019  Score=41.17  Aligned_cols=28  Identities=7%  Similarity=0.087  Sum_probs=23.7

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +..|..+|..||.+++|+|+.+||.++|
T Consensus         8 eeel~~~F~~fD~~~~G~I~~~el~~~l   35 (75)
T d1jc2a_           8 EEELANCFRIFDKNADGFIDIEELGEIL   35 (75)
T ss_dssp             HHHHHHHHHHHCCSTTSSEEHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCcCeEcHHHHHHHH
Confidence            4457778999999999999999998874

>d1fi5a_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus), cardiac isoform [TaxId: 9031]

Probab=86.84  E-value=0.02  Score=41.75  Aligned_cols=27  Identities=7%  Similarity=0.062  Sum_probs=23.3

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.|..+|..||.+++|+|+++||..+|
T Consensus        15 e~l~~~F~~~D~d~~G~I~~~el~~~l   41 (81)
T d1fi5a_          15 EELSDLFRMFDKNADGYIDLEELKIML   41 (81)
T ss_dssp             HHHHHHHHHHCSSCSSEECHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence            457778999999999999999998764

>d1c7va_ a.39.1.5 (A:) Calcium vector protein {Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium vector protein
species: Amphioxus (Branchiostoma lanceolatum) [TaxId: 7740]

Probab=86.55  E-value=0.023  Score=39.90  Aligned_cols=52  Identities=6%  Similarity=0.094  Sum_probs=37.9

Q ss_pred             cccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          418 VQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       418 ~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.+..|.|+  -|..++..+-.......-+..-+..+|.|++|.|+.+|++++|
T Consensus        12 D~d~~G~I~~~el~~~l~~~g~~~~s~~e~~~~~~~~D~d~dG~i~~~EF~~~m   65 (68)
T d1c7va_          12 DANGDGVIDFDEFKFIMQKVGEEPLTDAEVEEAMKEADEDGNGVIDIPEFMDLI   65 (68)
T ss_dssp             SCSGGGEECHHHHHHHSSTTTTCCCCHHHHHHHHHHHCSSGGGSEEHHHHHHHH
T ss_pred             cCCCcCeEcHHHHHHHHHHhCCCCCCHHHHHHHHHHhCCCCCCcEeHHHHHHHH
Confidence            456666666  5566666664433355567777889999999999999999864

>d1avsa_ a.39.1.5 (A:) Troponin C {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Troponin C
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=86.33  E-value=0.027  Score=40.97  Aligned_cols=26  Identities=4%  Similarity=0.129  Sum_probs=23.2

Q ss_pred             ccCCCCcccccccccccCHHHHhhhC
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .+..+|..||.+++|+|+.+||+.+|
T Consensus        15 el~~~F~~~D~d~~G~I~~~el~~~l   40 (81)
T d1avsa_          15 EFKAAFDMFDADGGGDISTKELGTVM   40 (81)
T ss_dssp             HHHHHHHHHCTTCSSEECHHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCeEchhHHHHHH
Confidence            46678999999999999999999874

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=85.24  E-value=0.072  Score=39.21  Aligned_cols=25  Identities=20%  Similarity=0.086  Sum_probs=16.1

Q ss_pred             ccCCCCcccccccccccCHHHHhhh
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      .|..+|..||.+++|.|+.+||+++
T Consensus        24 ~l~~~F~~~D~d~~G~I~~~el~~~   48 (87)
T d1s6ja_          24 GLKELFKMIDTDNSGTITFDELKDG   48 (87)
T ss_dssp             TTTTHHHHHCTTCSSCEEHHHHHHH
T ss_pred             HHHHHHHHHcCCCCCcCcHHHHHHH
Confidence            4555666666666666666666655

>d1wdcc_ a.39.1.5 (C:) Myosin Regulatory Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=85.19  E-value=0.042  Score=44.81  Aligned_cols=29  Identities=3%  Similarity=0.047  Sum_probs=25.0

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ....|..+|+.||.+++|+|+++||.++|
T Consensus        80 ~~~~l~~aF~~~D~~~~G~I~~~el~~~l  108 (152)
T d1wdcc_          80 TFADYMEAFKTFDREGQGFISGAELRHVL  108 (152)
T ss_dssp             CHHHHHHHHHTTCSSSSSEEEHHHHHHHH
T ss_pred             HHHhhhhhhhccccccCccchHHHHHHHH
Confidence            44567789999999999999999998774

>d2fcea1 a.39.1.5 (A:84-144) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=84.99  E-value=0.03  Score=38.25  Aligned_cols=25  Identities=4%  Similarity=0.137  Sum_probs=21.3

Q ss_pred             cCCCCcccccccccccCHHHHhhhC
Q 012170          445 LCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       445 l~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +..+|..||.+++|+|+.+||..++
T Consensus         3 l~~aF~~fD~~~~G~I~~~el~~~l   27 (61)
T d2fcea1           3 FVKAFQVFDKESTGKVSVGDLRYML   27 (61)
T ss_dssp             HHHHHHHHCTTCCSCEEHHHHHHHH
T ss_pred             HHHHHHHHCCCCCCeEeHHHHHHHH
Confidence            3457899999999999999998764

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=84.78  E-value=0.038  Score=40.16  Aligned_cols=50  Identities=8%  Similarity=0.066  Sum_probs=37.8

Q ss_pred             ccccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhh
Q 012170          417 EVQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       417 ~~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      .|.|..|.|+  -|..++..+.  .|...-+...+..+|.|++|.|+.+|++.+
T Consensus        15 ~D~d~~G~I~~~El~~~l~~lg--~~~~~ei~~~~~~~D~d~~G~I~~~EF~~~   66 (81)
T d2opoa1          15 FDTNGDGKISSSELGDALKTLG--SVTPDEVRRMMAEIDTDGDGFISFDEFTDF   66 (81)
T ss_dssp             HCTTCSSEEEHHHHHHHHHTTT--TCCHHHHHHHHHHHCTTCSSEECHHHHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHHhh--cCCHHHHHHHHHHhCCCCCCeEeHHHHHHH
Confidence            4667777777  5556666554  345666777899999999999999999875

>d1f54a_ a.39.1.5 (A:) Calmodulin {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=84.46  E-value=0.035  Score=39.83  Aligned_cols=27  Identities=4%  Similarity=0.180  Sum_probs=23.5

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..+..+|..||.|++|+|+.+||+++|
T Consensus        10 ~el~~~F~~~D~d~~G~I~~~el~~~l   36 (77)
T d1f54a_          10 AEFKEAFALFDKDNNGSISSSELATVM   36 (77)
T ss_dssp             HHHHHHHHHTCTTCSSEEEHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCeEChHHHHHHH
Confidence            346678999999999999999999874

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=84.21  E-value=0.038  Score=38.50  Aligned_cols=24  Identities=4%  Similarity=-0.004  Sum_probs=18.5

Q ss_pred             CCCCcccccccccccCHHHHhhhC
Q 012170          446 CGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       446 ~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..+|..+|.+++|+|+.+||..+|
T Consensus         4 r~~F~~~D~d~~G~I~~~El~~~l   27 (67)
T d1tiza_           4 KRVFEKFDKNKDGKLSLDEFREVA   27 (67)
T ss_dssp             HHHHHHHCTTSSSCEEHHHHHHHH
T ss_pred             HHHHHHHCCCCcCcCcHHHHHHHH
Confidence            346778888888888888887763

>d1s6ja_ a.39.1.5 (A:) Calcium-dependent protein kinase sk5 CLD {Soybean (Glycine max) [TaxId: 3847]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium-dependent protein kinase sk5 CLD
species: Soybean (Glycine max) [TaxId: 3847]

Probab=84.17  E-value=0.056  Score=39.81  Aligned_cols=54  Identities=15%  Similarity=0.096  Sum_probs=42.5

Q ss_pred             CcccccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          415 ESEVQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       415 ~~~~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...|.+..|.++  -|..++..+-. .|....+..-+.-+|.|++|.|+.+|++.|+
T Consensus        30 ~~~D~d~~G~I~~~el~~~l~~lg~-~~s~~e~~~l~~~~D~d~~g~I~~~EFl~am   85 (87)
T d1s6ja_          30 KMIDTDNSGTITFDELKDGLKRVGS-ELMESEIKDLMDAADIDKSGTIDYGEFIAAT   85 (87)
T ss_dssp             HHHCTTCSSCEEHHHHHHHHHTTTS-SCCHHHHHHHHHHHCTTCSSEECHHHHTTCC
T ss_pred             HHHcCCCCCcCcHHHHHHHHHHcCC-CCCHHHHHHHHHHcCCCCCCeEeHHHHHHHH
Confidence            345677888877  66777777654 3566678888999999999999999999885

>d1xo5a_ a.39.1.5 (A:) Calcium- and integrin-binding protein, CIB {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calcium- and integrin-binding protein, CIB
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.97  E-value=0.051  Score=45.90  Aligned_cols=28  Identities=11%  Similarity=-0.012  Sum_probs=25.6

Q ss_pred             cccccCCCCcccccccccccCHHHHhhh
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      .++++..+|+.+|.|++|+|+.+|+.++
T Consensus        93 ~~~kl~~~F~~~D~d~~G~I~~~el~~~  120 (180)
T d1xo5a_          93 PDIKSHYAFRIFDFDDDGTLNREDLSRL  120 (180)
T ss_dssp             HHHHHHHHHHHHCTTCSSSBCHHHHHHH
T ss_pred             HHHHHHHhhccccCCCCCeeeHHHHHHH
Confidence            5678888999999999999999999875

>d2pvba_ a.39.1.4 (A:) Parvalbumin {Pike (Esox lucius) [TaxId: 8010]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Parvalbumin
domain: Parvalbumin
species: Pike (Esox lucius) [TaxId: 8010]

Probab=83.79  E-value=0.053  Score=41.70  Aligned_cols=29  Identities=14%  Similarity=-0.017  Sum_probs=22.6

Q ss_pred             cccccCCCCcccccccccccCHHHHhhhC
Q 012170          441 KRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       441 ~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ....|..+|..+|.+++|+|+.+||+.++
T Consensus        38 ~~~~l~~~F~~~D~d~~G~I~~~el~~~l   66 (107)
T d2pvba_          38 SLDDVKKAFYVIDQDKSGFIEEDELKLFL   66 (107)
T ss_dssp             CHHHHHHHHHHHCTTCSSSBCHHHHHTGG
T ss_pred             CHHHHHHHHHhhccCCCCcCcHHHHHHHH
Confidence            34457778888888888888888887763

>d1c07a_ a.39.1.6 (A:) Eps15 {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Eps15 homology domain (EH domain)
domain: Eps15
species: Human (Homo sapiens) [TaxId: 9606]

Probab=83.17  E-value=0.037  Score=41.62  Aligned_cols=50  Identities=16%  Similarity=0.212  Sum_probs=35.4

Q ss_pred             ccccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          417 EVQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       417 ~~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .|.+..|.|+  -+...+....+.   ++.|...+..+|.|++|.|+.+|+|.||
T Consensus        19 ~D~d~~G~is~~e~~~~l~~~~l~---~~~l~~i~~~~D~d~dG~l~~~EF~~am   70 (95)
T d1c07a_          19 TDKDMDGFVSGLEVREIFLKTGLP---STLLAHIWSLCDTKDCGKLSKDQFALAF   70 (95)
T ss_dssp             HCTTCSSEECHHHHHHHHHTTTCC---HHHHHHHHHHHCTTCSSSEETTTHHHHH
T ss_pred             HCCCCCCCCcHHHHHHHHHhcCCC---HHHHHHHHHHhCCCCCCeEcHHHHHHHH
Confidence            3556666665  344455544432   4567778889999999999999999874

>d2mysc_ a.39.1.5 (C:) Myosin Regulatory Chain {Chicken (Gallus gallus) [TaxId: 9031]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Regulatory Chain
species: Chicken (Gallus gallus) [TaxId: 9031]

Probab=82.84  E-value=0.12  Score=41.36  Aligned_cols=28  Identities=4%  Similarity=0.050  Sum_probs=22.5

Q ss_pred             ccccCCCCcccccccccccCHHHHhhhC
Q 012170          442 RSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       442 ~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ...|..+|+.+|.+++|+|+.+||.++|
T Consensus        80 ~~~l~~aF~~~D~d~~G~I~~~el~~~l  107 (145)
T d2mysc_          80 FEDFVEGLRVFDKEGNGTVMGAELRHVL  107 (145)
T ss_pred             HHHHHHHHHHhhcCCCCEEcHHHHHHHH
Confidence            3447778999999999999999988764

>d1oqpa_ a.39.1.5 (A:) Caltractin (centrin 2) {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Caltractin (centrin 2)
species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]

Probab=82.80  E-value=0.035  Score=39.81  Aligned_cols=27  Identities=15%  Similarity=0.139  Sum_probs=22.3

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.|..+|..+|.+++|+|+.+||..+|
T Consensus         9 e~l~~~F~~~D~d~~G~I~~~el~~~l   35 (77)
T d1oqpa_           9 EEILKAFRLFDDDNSGTITIKDLRRVA   35 (77)
T ss_dssp             HHHHHHHHHHCTTCSSSEEHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCEechHHHHHHH
Confidence            356678999999999999999988764

>d1wdcb_ a.39.1.5 (B:) Myosin Essential Chain {Bay scallop (Aequipecten irradians) [TaxId: 31199]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Myosin Essential Chain
species: Bay scallop (Aequipecten irradians) [TaxId: 31199]

Probab=82.31  E-value=0.067  Score=43.02  Aligned_cols=45  Identities=9%  Similarity=0.095  Sum_probs=31.2

Q ss_pred             hHHHHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          424 FVDALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       424 ~~~~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      +.+|+........-. ..+..|..+|+.||.+++|+|+.+||.++|
T Consensus        58 ~~eF~~~~~~~~~~~-~~~~~l~~aF~~~D~d~~G~I~~~el~~~l  102 (142)
T d1wdcb_          58 FTMFLSIFSDKLSGT-DSEETIRNAFAMFDEQETKKLNIEYIKDLL  102 (142)
T ss_dssp             HHHHHHHHHHHTCSC-CCHHHHHHHHHTTCTTCCSCEEHHHHHHHH
T ss_pred             ccccccccccccccc-chhhhHHHhhhhhcccCCCcccHHHHHHHH
Confidence            344554443333222 235568889999999999999999998874

>d2pq3a1 a.39.1.5 (A:3-75) Calmodulin {Rattus norvegicus [TaxId: 10116]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Rattus norvegicus [TaxId: 10116]

Probab=82.26  E-value=0.045  Score=38.84  Aligned_cols=27  Identities=7%  Similarity=0.140  Sum_probs=23.1

Q ss_pred             cccCCCCcccccccccccCHHHHhhhC
Q 012170          443 SRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       443 ~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      ..+..+|..||.+++|+|+.+||+.+|
T Consensus         8 ~el~~~F~~~D~d~~G~I~~~el~~~l   34 (73)
T d2pq3a1           8 AEFKEAFSLFDKDGDGTITTKELGTVM   34 (73)
T ss_dssp             HHHHHHHHHTCTTSSSEEEGGGHHHHH
T ss_pred             HHHHHHHHHHcCCCCceEeHHHHHHHH
Confidence            346678999999999999999998874

>d1fw4a_ a.39.1.5 (A:) Calmodulin {Cow (Bos taurus) [TaxId: 9913]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin
species: Cow (Bos taurus) [TaxId: 9913]

Probab=82.15  E-value=0.082  Score=36.42  Aligned_cols=52  Identities=8%  Similarity=0.117  Sum_probs=38.9

Q ss_pred             ccccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          417 EVQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       417 ~~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      -|.+..|+|+  -+..++..+-.. +....+...+..+|.+++|.|+.+|+++++
T Consensus        12 fD~d~~G~I~~~el~~~l~~lg~~-~~~~e~~~l~~~~D~d~~g~I~~~eF~~~m   65 (65)
T d1fw4a_          12 FDKDGNGYISAAELRHVMTNLGEK-LTDEEVDEMIREADIDGDGQVNYEEFVQMM   65 (65)
T ss_dssp             HCTTCSSEECHHHHHHHHHHTTCC-CCHHHHHHHHHTTCTTCSSSEEHHHHHHHC
T ss_pred             HcCCCCCcCCHHHHHHHHHHhCCC-CCHHHHHHHHHHcCCCCCCcEeHHHHHHHC
Confidence            3567778877  555666665443 345567777889999999999999999875

>d1g8ia_ a.39.1.5 (A:) Frequenin (neuronal calcium sensor 1) {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Frequenin (neuronal calcium sensor 1)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=81.31  E-value=0.049  Score=46.08  Aligned_cols=29  Identities=10%  Similarity=0.005  Sum_probs=25.9

Q ss_pred             ccccccCCCCcccccccccccCHHHHhhh
Q 012170          440 PKRSRLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       440 ~~~~rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +.++++..+|+.+|.|++|+|+.+|++.+
T Consensus        93 ~~~e~l~~~F~~~D~d~dG~i~~~El~~~  121 (187)
T d1g8ia_          93 TLDEKLRWAFKLYDLDNDGYITRNEMLDI  121 (187)
T ss_dssp             CHHHHHHHHHHHHCTTCSSEEEHHHHHHH
T ss_pred             chhhhHHHHHHHHhcCCCCeEcHHHHHHH
Confidence            35678988999999999999999999875

>d2opoa1 a.39.1.10 (A:6-86) Polcalcin Che a 3 {Pigweed (Chenopodium album) [TaxId: 3559]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Polcalcin
domain: Polcalcin Che a 3
species: Pigweed (Chenopodium album) [TaxId: 3559]

Probab=80.65  E-value=0.056  Score=39.19  Aligned_cols=26  Identities=8%  Similarity=0.036  Sum_probs=22.7

Q ss_pred             ccCCCCcccccccccccCHHHHhhhC
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .+...|..+|.|++|.|+.+||.++|
T Consensus         7 e~~~~F~~~D~d~~G~I~~~El~~~l   32 (81)
T d2opoa1           7 DRERIFKRFDTNGDGKISSSELGDAL   32 (81)
T ss_dssp             HHHHHHHHHCTTCSSEEEHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCcHHHHHHHH
Confidence            45668999999999999999998864

>d1wlza1 a.39.1.7 (A:229-311) DJ-1-binding protein, DJBP {Human (Homo sapiens) [TaxId: 9606]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: EF-hand modules in multidomain proteins
domain: DJ-1-binding protein, DJBP
species: Human (Homo sapiens) [TaxId: 9606]

Probab=80.33  E-value=0.054  Score=39.34  Aligned_cols=25  Identities=0%  Similarity=0.022  Sum_probs=13.8

Q ss_pred             ccCCCCcccccccccccCHHHHhhh
Q 012170          444 RLCGPSGPIEQQCSSNLTANALCRA  468 (469)
Q Consensus       444 rl~~~~~~~d~~~~~~~~~~el~~~  468 (469)
                      +|..+|..+|.+++|+|+.+||.++
T Consensus        21 ~l~~~F~~~D~~~~G~i~~~ef~~~   45 (83)
T d1wlza1          21 AITQEFENFDTMKTNTISREEFRAI   45 (83)
T ss_dssp             HHHHHHHHHCTTCSSCBCHHHHHHH
T ss_pred             HHHHHHHHHCCCCCceEChhHHHHH
Confidence            4445555555555555555555544

>d1tiza_ a.39.1.5 (A:) Calmodulin-related protein T21P5.17 {Thale cress (Arabidopsis thaliana) [TaxId: 3702]}

class: All alpha proteins
fold: EF Hand-like
superfamily: EF-hand
family: Calmodulin-like
domain: Calmodulin-related protein T21P5.17
species: Thale cress (Arabidopsis thaliana) [TaxId: 3702]

Probab=80.27  E-value=0.071  Score=36.99  Aligned_cols=52  Identities=8%  Similarity=0.031  Sum_probs=37.4

Q ss_pred             ccccccchHH--HHHHhhhccccCCccccccCCCCcccccccccccCHHHHhhhC
Q 012170          417 EVQDEGGFVD--ALAVAISNVRISEPKRSRLCGPSGPIEQQCSSNLTANALCRAF  469 (469)
Q Consensus       417 ~~~~~~g~~~--~l~~~i~~~~~~~~~~~rl~~~~~~~d~~~~~~~~~~el~~~~  469 (469)
                      .|.+..|.|+  -+..++..+-. .+....+..-+..+|.|++|.|+.+|+.+++
T Consensus        10 ~D~d~~G~I~~~El~~~l~~lg~-~~~~~~i~~~~~~~D~d~dg~I~~~EF~~~m   63 (67)
T d1tiza_          10 FDKNKDGKLSLDEFREVALAFSP-YFTQEDIVKFFEEIDVDGNGELNADEFTSCI   63 (67)
T ss_dssp             HCTTSSSCEEHHHHHHHHHHTCT-TSCHHHHHHHHHHHCCSSSSEECHHHHHHHH
T ss_pred             HCCCCcCcCcHHHHHHHHHHhcc-ccchHHHHHHHHHhCCCCCCeEeHHHHHHHH
Confidence            3556677776  44455554443 3456667778999999999999999998764